data_1ezc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ezc _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.2 mt . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 106.468 -1.679 . . . . 1.5700000000000001 106.468 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.0 m -105.98 119.99 40.62 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.652 -1.24 . . . . 1.4399999999999999 107.652 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.17 -160.96 23.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.531 -1.827 . . . . 1.01 108.531 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.453 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 95.6 mt -95.98 1.29 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.447 -1.031 . . . . 1.6299999999999999 113.076 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 tp 51.8 93.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.536 -1.353 . . . . 1.5800000000000001 112.297 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.75 -34.11 17.25 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.052 -1.03 . . . . 1.3400000000000001 111.001 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 201' ' ' ALA . 1.9 p -149.8 140.89 14.46 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 107.682 -1.229 . . . . 1.8600000000000001 107.682 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.28 146.99 22.76 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.518 2.145 . . . . 1.01 112.173 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 153.15 173.69 22.71 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 108.722 -1.751 . . . . 0.81000000000000005 108.722 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 11' ' ' ILE . 88.0 mt -132.12 136.42 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.073 -1.251 . . . . 1.3700000000000001 107.683 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.34 155.92 45.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.004 -1.06 . . . . 1.1399999999999999 109.429 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 4.6 m-85 -128.38 140.19 51.98 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.391 -0.966 . . . . 0.87 108.391 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.36 172.01 39.86 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 118.546 -1.788 . . . . 0.56999999999999995 110.061 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -76.02 156.07 34.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.86 -0.788 . . . . 2.3500000000000001 109.144 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.52 122.87 29.61 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.454 -1.313 . . . . 1.21 107.454 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.4 tp -100.2 106.97 18.7 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 105.558 -2.016 . . . . 1.3999999999999999 105.558 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.4 tp -91.04 131.36 36.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.917 -1.142 . . . . 1.4399999999999999 107.917 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.4 mt -99.52 118.04 35.23 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.878 -1.527 . . . . 1.45 106.878 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -110.15 136.09 49.92 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.79 -1.189 . . . . 2.5 107.79 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -128.56 151.21 49.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.08 -1.013 . . . . 2.6600000000000001 109.748 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -81.52 135.61 35.6 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.816 -1.179 . . . . 2.3199999999999998 107.816 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -63.67 147.89 50.43 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.743 -0.836 . . . . 2.1099999999999999 108.743 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.2 mt -93.23 125.48 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.728 -1.212 . . . . 1.29 107.728 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.2 t -109.96 129.95 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.43 -0.952 . . . . 1.4099999999999999 108.43 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.9 mt -95.02 141.44 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.152 -0.968 . . . . 1.3100000000000001 108.612 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -90.53 122.68 33.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.033 . . . . 1.3400000000000001 108.414 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.493 ' HG2' HH11 ' A' ' 28' ' ' ARG . 4.6 mmt-85 -94.46 17.02 13.82 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.37 -0.831 . . . . 3.48 111.983 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -74.85 140.42 43.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.259 -0.901 . . . . 2.52 109.006 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -90.97 129.55 36.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.958 -1.089 . . . . 2.6299999999999999 108.074 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 pt -89.31 166.19 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 1.3100000000000001 110.835 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.8 p -96.81 167.19 11.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.405 -0.81 . . . . 1.24 109.653 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -15.16 2.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.922 -1.111 . . . . 1.49 112.39 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -70.33 -39.61 74.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 2.2799999999999998 110.824 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -94.61 -4.73 47.23 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.635 -1.291 . . . . 2.0499999999999998 113.029 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.71 -41.38 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.272 -0.893 . . . . 1.3400000000000001 110.358 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -56.09 -40.1 73.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 1.54 110.189 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -63.16 -36.12 82.58 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.335 -0.853 . . . . 2.8500000000000001 110.688 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 42' ' ' ARG . 78.6 mm-40 -60.23 -42.06 94.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 1.3100000000000001 110.398 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.98 -46.0 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.387 -0.821 . . . . 1.3799999999999999 110.731 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.24 -50.01 74.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.058 -1.026 . . . . 1.5 110.392 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 76.6 mtm180 -62.41 -41.0 98.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -0.897 . . . . 2.7799999999999998 110.231 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -70.26 -55.33 9.51 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.383 -0.823 . . . . 1.0600000000000001 109.566 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.25 -47.67 85.0 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.797 0.808 . . . . 1.3999999999999999 110.361 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.2 t -68.67 -38.19 80.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.303 -0.873 . . . . 1.3200000000000001 110.208 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.61 -46.57 88.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.775 -1.33 . . . . 0.69999999999999996 109.775 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -59.91 -29.31 68.28 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.405 -1.056 . . . . 3.4399999999999999 110.311 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.86 80.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.808 -0.557 . . . . 1.3600000000000001 110.97 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -82.55 -35.93 26.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.833 -1.167 . . . . 2.8300000000000001 110.084 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -45.33 89.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.369 -0.832 . . . . 1.23 109.95 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 t -61.73 -39.8 92.84 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.917 0.865 . . . . 1.9199999999999999 109.558 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.03 -49.86 63.87 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.287 -0.565 . . . . 1.25 110.873 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -61.7 -51.0 70.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.97 -1.081 . . . . 1.97 110.955 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.72 -38.94 89.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.241 -0.912 . . . . 2.1800000000000002 110.483 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -58.68 -40.09 82.57 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.059 -0.656 . . . . 1.1899999999999999 110.654 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 m -63.08 -41.75 99.49 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.839 -1.163 . . . . 1.3400000000000001 110.247 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.11 -36.32 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.571 -0.706 . . . . 1.23 110.778 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -52.97 -42.56 65.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 1.5600000000000001 110.76 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.31 -36.12 76.67 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.139 -0.975 . . . . 1.3 110.21 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -62.14 -39.34 92.24 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.246 -0.981 . . . . 2.3199999999999998 109.454 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.02 -34.74 78.78 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.342 0.591 . . . . 1.1399999999999999 110.113 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.43 19.02 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.749 -1.215 . . . . 0.68999999999999995 111.355 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.26 -23.32 35.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -1.183 . . . . 1.48 111.406 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.5 m -86.6 -49.71 7.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.793 -0.567 . . . . 1.52 110.649 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.527 ' CZ ' ' SD ' ' A' ' 193' ' ' MET . 72.2 m-85 -108.43 -6.65 16.08 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 113.954 1.094 . . . . 1.3100000000000001 113.954 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.0 168.03 29.4 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.115 -1.04 . . . . 0.84999999999999998 111.745 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.94 -20.49 38.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.273 -1.134 . . . . 3.8599999999999999 112.603 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.47 -42.03 73.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.618 -1.301 . . . . 2.3500000000000001 110.945 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -88.43 -25.18 22.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.017 -1.052 . . . . 2.2599999999999998 111.998 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -59.99 -37.28 79.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 1.45 111.356 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.36 84.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 1.25 111.299 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.8 mt -65.2 -43.98 95.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.494 -1.379 . . . . 1.26 110.303 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -70.63 -34.53 72.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.938 -1.102 . . . . 0.82999999999999996 110.423 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.49 -38.55 84.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.3 -0.875 . . . . 1.1899999999999999 110.491 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.94 -41.15 88.53 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.972 -1.108 . . . . 0.57999999999999996 110.938 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -59.36 -43.21 92.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.417 -1.049 . . . . 2.0499999999999998 110.56 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.48 -37.17 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.161 -0.962 . . . . 1.21 110.564 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.2 ttt -59.26 -39.75 83.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.531 -0.731 . . . . 2.29 110.558 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.8 tp -59.6 -48.21 82.54 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.454 -0.898 . . . . 1.21 109.612 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.44 -39.72 88.53 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.541 0.686 . . . . 1.1399999999999999 110.049 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.62 -1.52 54.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.451 -0.781 . . . . 1.4199999999999999 112.902 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -58.68 123.88 17.85 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.14 -1.424 . . . . 1.27 110.584 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.36 -16.57 62.51 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.751 -1.218 . . . . 1.3500000000000001 111.355 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -77.46 -50.08 13.43 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.407 -0.917 . . . . 2.2200000000000002 111.148 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.09 -39.46 92.55 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.28 -0.888 . . . . 1.22 110.577 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -59.84 -45.71 91.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 1.29 110.348 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -62.72 -39.98 95.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 2.1699999999999999 110.837 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -64.84 -48.31 74.8 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.798 -1.189 . . . . 1.3 110.273 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.2 mt -55.84 -44.19 76.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.169 -0.957 . . . . 1.1699999999999999 110.048 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 90' ' ' ILE . 82.9 mt -60.36 -41.58 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.443 0.64 . . . . 1.3999999999999999 110.453 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.51 95.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.682 -0.636 . . . . 1.3300000000000001 110.977 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.86 -42.26 97.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.866 -1.146 . . . . 1.48 110.783 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.21 -49.72 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.857 -1.152 . . . . 1.28 109.931 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -78.0 -35.42 50.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.399 -0.813 . . . . 2.6000000000000001 111.645 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.12 -42.09 27.07 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.499 -1.375 . . . . 1.51 111.767 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -105.8 7.92 32.6 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.92 -1.112 . . . . 2.48 112.422 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.8 m80 50.77 47.85 23.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.858 -1.151 . . . . 1.6100000000000001 111.285 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.6 mtt -105.28 154.02 20.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.598 -0.689 . . . . 1.8999999999999999 109.567 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.441 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 27.9 p -71.32 162.98 28.55 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.79 -0.569 . . . . 1.3200000000000001 110.034 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.51 -39.84 94.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.964 -1.085 . . . . 1.1499999999999999 110.856 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.441 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 25.4 p-10 -68.5 -42.76 78.14 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 120.807 -1.183 . . . . 2.25 109.971 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.35 -48.06 62.45 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.508 0.671 . . . . 1.22 110.606 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.28 94.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 1.1899999999999999 110.494 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.34 86.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.651 -0.656 . . . . 1.2 110.552 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -60.08 -38.57 83.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.17 -0.956 . . . . 2.1000000000000001 110.937 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.14 -49.46 76.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.9 -1.125 . . . . 1.3 111.174 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.68 -49.5 84.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.402 -1.319 . . . . 1.27 109.714 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.0 mm -60.09 -32.73 51.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.605 0.717 . . . . 1.1899999999999999 110.149 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -54.84 -40.78 69.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.266 -0.896 . . . . 2.1099999999999999 110.627 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.49 -34.65 10.15 Favored Glycine 0 N--CA 1.5 2.919 0 C-N-CA 119.618 -1.277 . . . . 0.88 112.236 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -61.86 -42.77 99.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.499 -1.589 . . . . 1.99 109.914 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.11 -49.84 32.95 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.948 -0.701 . . . . 1.28 110.107 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.0 p -61.79 -36.94 82.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.173 -0.954 . . . . 2.2200000000000002 110.411 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.91 98.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 1.45 110.633 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.37 -29.39 69.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.083 -1.011 . . . . 1.47 110.715 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -67.04 -23.73 65.92 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.383 -0.823 . . . . 2.04 110.961 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -71.56 -15.39 62.28 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.06 -1.025 . . . . 1.73 111.227 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.6 mt -88.45 141.07 28.83 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.829 -0.804 . . . . 1.79 108.829 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -98.1 40.78 1.16 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.146 -0.971 . . . . 2.8799999999999999 112.048 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -112.39 138.57 48.94 Favored 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 108.174 -1.047 . . . . 1.5800000000000001 108.174 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 47.7 mp0 -58.58 -36.6 74.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 3.04 111.016 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -73.59 -51.15 17.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.677 -1.264 . . . . 1.29 109.99 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.96 -43.08 96.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.96 -1.087 . . . . 1.6000000000000001 110.215 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -63.05 -50.22 71.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.913 . . . . 2.7599999999999998 110.198 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -61.55 -30.5 70.69 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.076 0.941 . . . . 2.1499999999999999 109.589 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -64.7 -29.55 70.54 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.082 0.944 . . . . 2.8100000000000001 109.274 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.22 82.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.708 0.766 . . . . 1.3899999999999999 109.484 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.06 84.58 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.527 -0.869 . . . . 1.4099999999999999 109.986 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -64.45 -35.49 81.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.516 -0.74 . . . . 1.3899999999999999 110.348 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.2 t -67.59 -39.51 82.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.106 -0.996 . . . . 1.1899999999999999 109.58 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -58.91 -37.1 75.86 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.895 -1.122 . . . . 3.6299999999999999 109.214 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -60.25 -37.68 81.12 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.899 -0.591 . . . . 1.28 110.418 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.6 mt -60.48 -40.04 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.318 -0.864 . . . . 1.1799999999999999 109.71 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.82 -39.97 32.34 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.098 -1.201 . . . . 0.51000000000000001 110.098 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.72 -46.29 84.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -1.129 . . . . 3.1699999999999999 109.996 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -63.63 -40.1 96.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.788 -1.195 . . . . 2.8500000000000001 109.8 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.29 -41.94 90.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.49 -0.756 . . . . 1.6499999999999999 109.7 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 54.7 mt -59.94 -44.83 94.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.599 -0.84 . . . . 1.2 110.014 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -60.6 -33.84 73.34 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.488 -0.758 . . . . 2.7999999999999998 110.17 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -74.01 -43.11 59.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.662 -0.649 . . . . 2.1499999999999999 110.167 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.92 -37.32 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 1.21 110.741 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 56.4 mt -86.23 -4.8 59.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.156 -0.965 . . . . 1.3400000000000001 112.148 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.06 23.36 69.08 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 120.175 -1.012 . . . . 0.91000000000000003 113.22 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.5 tp -73.52 137.51 44.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.531 -0.982 . . . . 1.51 108.932 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -68.41 149.79 48.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.17 -0.956 . . . . 2.8799999999999999 109.757 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.4 mt -104.07 140.35 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.504 -0.924 . . . . 1.6200000000000001 108.504 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.5 mp -77.34 128.23 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.86 -1.163 . . . . 2.1099999999999999 107.86 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -96.8 100.08 11.63 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 105.861 -1.903 . . . . 1.6200000000000001 105.861 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.0 mt -75.56 -15.52 60.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.508 -0.745 . . . . 1.3999999999999999 111.437 -177.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.5 t -78.19 -1.45 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 2.0499999999999998 112.088 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.35 22.4 10.68 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.735 0.778 . . . . 1.3500000000000001 111.744 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.461 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 18.0 mt -72.0 135.76 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.742 . . . . 1.4199999999999999 109.1 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -121.67 -6.82 9.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.571 -0.706 . . . . 2.9900000000000002 112.343 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -112.71 135.45 53.43 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.957 -1.127 . . . . 1.54 107.957 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.85 113.98 17.4 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.695 -0.854 . . . . 1.3799999999999999 108.695 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.9 m -148.29 178.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.303 -0.873 . . . . 1.28 109.224 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.0 mt -87.31 144.45 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.046 -0.724 . . . . 1.1599999999999999 109.046 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.4 tp -94.76 125.81 39.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.981 -1.118 . . . . 1.3100000000000001 107.981 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.19 129.9 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.981 -1.118 . . . . 1.25 107.981 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.78 153.44 22.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.156 -0.965 . . . . 1.26 109.667 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.3 73.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.663 -1.273 . . . . 1.6000000000000001 109.413 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -173.22 151.2 2.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.882 -0.785 . . . . 2.4199999999999999 108.882 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.0 mt -119.85 140.79 50.27 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.049 -0.722 . . . . 1.3500000000000001 109.049 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 56.5 p -90.8 148.1 37.56 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.048 -1.033 . . . . 1.3200000000000001 108.79 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.9 -40.59 6.03 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.919 1.746 . . . . 0.69999999999999996 113.342 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.0 m -63.53 -46.22 87.03 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.052 -1.03 . . . . 1.1200000000000001 110.134 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -65.26 -38.33 90.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 1.21 110.332 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.686 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 69.2 p -68.7 -41.43 79.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.492 -0.755 . . . . 1.1899999999999999 110.585 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.11 83.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.685 -0.635 . . . . 1.24 110.768 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -93.63 2.46 56.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.001 -1.062 . . . . 1.6899999999999999 112.543 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.82 150.39 37.31 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.341 -0.849 . . . . 1.3400000000000001 109.857 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -95.89 116.19 28.55 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.52 -1.289 . . . . 2.77 107.52 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 75.1 mt -80.04 -11.25 59.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.607 -0.683 . . . . 2.0899999999999999 112.368 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -83.86 -26.83 29.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 2.6699999999999999 112.218 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -102.76 -3.88 25.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.305 -0.872 . . . . 2.5800000000000001 113.245 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.39 126.93 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.462 -1.31 . . . . 1.1799999999999999 107.462 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 28.8 tp -90.4 -7.17 53.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.788 -1.195 . . . . 2.1800000000000002 112.349 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.54 173.95 41.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.367 -1.493 . . . . 0.48999999999999999 109.367 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -128.88 130.65 47.13 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.138 -1.06 . . . . 0.64000000000000001 108.138 179.233 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 94.8 mt -134.12 105.54 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 105.83 -1.915 . . . . 1.21 105.83 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 39.1 p -126.99 176.11 7.58 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.954 -1.091 . . . . 1.3799999999999999 110.991 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.581 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -104.02 56.33 0.73 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 115.931 -0.577 . . . . 2.3700000000000001 109.841 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -100.59 144.37 29.65 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.15 -0.969 . . . . 1.52 109.31 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.6 -32.91 25.09 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.098 -1.049 . . . . 1.8 110.907 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 98.15 0.11 58.61 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.302 -1.117 . . . . 2.04 113.692 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.461 ' O ' ' OG1' ' A' ' 187' ' ' THR . 35.6 ttm180 -87.75 112.6 22.58 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.892 -1.521 . . . . 5.0 106.892 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 20.9 p 49.52 44.74 24.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 3.02 112.291 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.3 m -78.35 126.81 31.3 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.679 -1.23 . . . . 2.1099999999999999 107.679 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.686 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 40.4 t60 -58.94 -40.8 85.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.227 -0.92 . . . . 1.24 110.292 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -48.44 81.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.113 -0.992 . . . . 2.1499999999999999 110.284 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.501 ' HG ' ' N ' ' A' ' 192' ' ' ILE . 53.7 p -61.39 -38.74 88.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.473 -0.767 . . . . 2.02 110.576 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.501 ' N ' ' HG ' ' A' ' 191' ' ' SER . 85.5 mt -60.71 -42.42 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.095 -1.003 . . . . 2.1200000000000001 110.903 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.527 ' SD ' ' CZ ' ' A' ' 65' ' ' PHE . 9.5 mtm -66.74 -36.92 83.6 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.502 -1.374 . . . . 1.3600000000000001 109.461 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.76 -48.66 80.78 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.843 -0.617 . . . . 1.29 111.006 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.435 HH21 HG12 ' A' ' 192' ' ' ILE . 85.3 mtm180 -60.0 -40.45 89.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 3.5600000000000001 110.409 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.3 m -64.46 -37.84 88.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 1.1799999999999999 109.902 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.5 mt -89.21 -1.1 57.94 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.459 0.647 . . . . 1.3400000000000001 112.045 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 54.82 8.31 0.22 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.059 1.133 . . . . 1.45 114.059 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.476 ' O ' ' OG ' ' A' ' 8' ' ' SER . 45.3 mt -71.5 149.25 93.52 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.073 -1.084 . . . . 1.25 108.073 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -59.1 144.95 99.17 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.653 1.569 . . . . 0.78000000000000003 109.948 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.499 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -160.89 159.58 29.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.442 -1.411 . . . . 1.2 109.852 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 73.0 mt -148.1 155.65 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.059 -1.089 . . . . 1.25 108.059 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.75 -28.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.145 -0.972 . . . . 1.3899999999999999 111.758 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.87 41.32 1.71 Allowed Glycine 0 N--CA 1.487 2.034 0 C-N-CA 120.332 -0.937 . . . . 0.96999999999999997 111.846 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.449 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 75.7 p -63.45 -20.92 65.98 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.341 -1.094 . . . . 1.3500000000000001 110.938 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.25 -95.88 1.33 Allowed Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.669 -1.253 . . . . 1.0700000000000001 109.978 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.0 t -129.03 30.65 5.02 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.444 -1.033 . . . . 1.9199999999999999 111.868 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.03 -38.34 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.701 -1.249 . . . . 1.3300000000000001 110.829 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 67.6 p -57.49 -24.84 58.17 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.442 -0.903 . . . . 1.4199999999999999 112.02 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.2 m -93.31 0.72 57.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.017 -1.052 . . . . 2.1200000000000001 111.974 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -122.96 -4.8 8.53 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 113.082 0.771 . . . . 2.6899999999999999 113.082 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 52.0 t -119.38 149.11 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 121.568 0.699 . . . . 1.29 109.723 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -116.81 158.56 23.73 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.809 -1.182 . . . . 2.6899999999999999 107.809 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 45.3 p-10 -55.01 145.17 21.11 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.986 -1.071 . . . . 2.79 110.572 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t70 80.61 2.52 1.81 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 114.803 1.409 . . . . 2.3500000000000001 114.803 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 62.8 t0 -65.85 146.62 54.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.941 -1.1 . . . . 1.97 108.37 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.499 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 43.3 t80 -88.18 120.64 29.73 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.993 -1.484 . . . . 2.9700000000000002 106.993 178.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 79.0 mt -127.75 150.01 49.99 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.527 -0.733 . . . . 1.25 109.92 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.5 mt -118.41 123.59 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 106.691 -1.596 . . . . 1.22 106.691 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.5 tp -99.32 114.87 27.97 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.639 -1.615 . . . . 1.24 106.639 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 223' ' ' VAL . 37.2 t0 -91.36 -25.06 19.57 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.849 -1.157 . . . . 2.0499999999999998 112.325 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.433 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 38.65 19.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.667 0.617 . . . . 1.25 112.667 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.0 t -110.94 -61.22 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.097 0.951 . . . . 1.4299999999999999 108.924 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -93.19 8.72 39.03 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.7 0.762 . . . . 3.0299999999999998 110.489 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 60.1 t30 62.98 52.35 2.62 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.483 0.658 . . . . 2.25 111.704 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -147.49 147.81 30.57 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.272 1.034 . . . . 2.52 109.453 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 52.0 t -117.45 139.74 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.293 -1.002 . . . . 1.29 108.293 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -103.84 132.59 49.95 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.983 -1.073 . . . . 1.3400000000000001 109.01 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.9 130.04 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.953 -1.129 . . . . 1.3400000000000001 107.953 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.473 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 17.9 t-20 54.05 48.09 4.4 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.241 -0.912 . . . . 2.1800000000000002 113.015 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 56.1 Cg_endo -69.6 150.75 69.58 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.845 2.363 . . . . 0.93999999999999995 110.921 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 68.2 p -77.75 163.03 26.49 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.314 -0.866 . . . . 2.3999999999999999 110.562 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -60.47 -35.21 75.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.945 . . . . 3.3300000000000001 110.56 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -59.14 -39.34 82.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.166 -0.959 . . . . 3.1699999999999999 110.385 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.8 t -70.88 -42.06 77.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.175 -1.01 . . . . 1.6899999999999999 110.219 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 67.0 mt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.769 0.795 . . . . 1.6000000000000001 109.822 -178.605 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.9 mt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 107.497 -1.297 . . . . 1.5700000000000001 107.497 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -102.56 128.43 49.22 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.209 -1.034 . . . . 1.4399999999999999 108.209 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.53 -152.39 11.51 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 108.536 -1.826 . . . . 1.01 108.536 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 81.5 mt -97.23 -3.22 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.293 -1.122 . . . . 1.6299999999999999 113.027 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.8 tp 49.49 95.62 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.07 -1.019 . . . . 1.5800000000000001 112.126 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.26 -40.16 16.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.11 -0.994 . . . . 1.3400000000000001 110.587 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -147.12 141.8 16.29 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.706 -1.22 . . . . 1.8600000000000001 107.706 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.33 149.69 40.51 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.575 2.183 . . . . 1.01 112.144 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 151.13 166.16 13.51 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.885 -1.686 . . . . 0.81000000000000005 108.885 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.406 HG22 HD11 ' A' ' 11' ' ' ILE . 87.8 mt -123.76 135.18 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.232 -1.158 . . . . 1.3700000000000001 108.424 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.48 44.6 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.963 -1.086 . . . . 1.1399999999999999 109.293 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -121.86 139.66 53.35 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.841 -1.17 . . . . 0.87 107.841 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.72 165.47 31.75 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 118.356 -1.878 . . . . 0.56999999999999995 110.254 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -76.03 158.66 31.63 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.938 -0.742 . . . . 2.3500000000000001 109.262 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.08 123.25 31.95 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.526 -1.287 . . . . 1.21 107.526 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.4 tp -100.85 108.73 20.59 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 105.28 -2.118 . . . . 1.3999999999999999 105.28 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.5 tp -90.41 137.42 32.36 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.847 -1.168 . . . . 1.4399999999999999 107.847 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.9 mt -101.87 120.01 39.7 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 107.714 -1.217 . . . . 1.45 107.714 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -110.97 140.15 45.72 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.056 -1.09 . . . . 2.5 108.056 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.58 139.43 53.6 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.071 -1.018 . . . . 2.6600000000000001 108.758 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -84.87 133.36 34.31 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.682 -1.229 . . . . 2.3199999999999998 107.682 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -64.38 146.38 54.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.074 -1.016 . . . . 2.1099999999999999 109.264 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.5 mt -95.53 132.81 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.278 -0.889 . . . . 1.29 108.691 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -106.42 128.98 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.84 -1.17 . . . . 1.4099999999999999 107.84 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 mt -98.17 140.17 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.714 -0.847 . . . . 1.3100000000000001 108.714 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -89.35 119.95 30.26 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.626 -1.25 . . . . 1.3400000000000001 107.626 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -96.73 15.68 21.22 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.187 -0.946 . . . . 3.48 112.227 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -69.22 151.09 46.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.971 -1.081 . . . . 2.52 110.35 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -90.12 131.87 35.74 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.176 -1.046 . . . . 2.6299999999999999 108.176 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.2 pt -96.1 168.5 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.577 0.703 . . . . 1.3100000000000001 110.499 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.9 p -92.48 166.19 12.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.474 -0.766 . . . . 1.24 110.252 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.6 -22.78 47.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.335 -0.853 . . . . 1.49 112.142 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.02 -36.65 80.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.919 -1.113 . . . . 2.2799999999999998 111.026 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -85.85 -5.5 59.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.574 -1.329 . . . . 2.0499999999999998 112.501 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.93 -44.55 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.218 -0.926 . . . . 1.3400000000000001 110.478 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -58.73 -40.35 83.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.082 -1.011 . . . . 1.54 110.247 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -64.64 -40.78 96.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.484 -0.76 . . . . 2.8500000000000001 110.965 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -60.72 -39.99 90.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.102 -0.999 . . . . 1.3100000000000001 110.613 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.36 -40.83 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.956 -1.09 . . . . 1.3799999999999999 110.242 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -62.23 -40.82 97.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.941 -1.099 . . . . 1.5 110.365 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -62.01 -41.75 98.42 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.194 -0.941 . . . . 2.7799999999999998 110.131 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -76.12 -51.4 12.27 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.319 -0.863 . . . . 1.0600000000000001 109.973 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.03 -49.03 79.44 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.741 -0.784 . . . . 1.3999999999999999 109.606 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 t -70.55 -40.84 73.16 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.59 -0.694 . . . . 1.3200000000000001 109.962 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.67 -44.51 96.83 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.118 -1.593 . . . . 0.69999999999999996 109.118 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -57.75 -31.46 66.5 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.498 -1.001 . . . . 3.4399999999999999 109.548 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.63 92.63 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.589 0.709 . . . . 1.3600000000000001 110.194 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -80.23 -40.82 26.3 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.474 -0.767 . . . . 2.8300000000000001 111.035 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.64 90.03 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.56 0.695 . . . . 1.23 109.928 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.9 t -60.71 -40.01 90.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.244 1.021 . . . . 1.9199999999999999 109.238 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.5 78.51 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.824 -0.626 . . . . 1.25 109.804 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -61.27 -50.32 73.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.056 -1.028 . . . . 1.97 110.193 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.86 -39.36 91.63 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.309 -0.869 . . . . 2.1800000000000002 109.897 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -60.21 -41.33 92.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.802 -0.562 . . . . 1.1899999999999999 110.915 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.3 m -67.13 -43.0 83.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.94 -1.1 . . . . 1.3400000000000001 110.244 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.401 HD11 HG22 ' A' ' 57' ' ' ILE . 88.0 mt -59.87 -38.44 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.467 -0.771 . . . . 1.23 110.59 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -53.04 -42.5 65.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 1.5600000000000001 110.865 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -69.87 -33.05 71.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.982 -1.074 . . . . 1.3 110.383 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -63.22 -39.95 96.08 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.175 -1.01 . . . . 2.3199999999999998 109.818 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.78 78.31 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.366 -0.834 . . . . 1.1399999999999999 110.021 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.52 -35.32 29.46 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 119.55 -1.31 . . . . 0.68999999999999995 110.613 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.45 -19.79 38.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.121 -1.223 . . . . 1.48 111.016 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.9 m -89.59 -55.3 3.7 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.852 -0.53 . . . . 1.52 110.274 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.51 -2.74 20.1 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 113.807 1.04 . . . . 1.3100000000000001 113.807 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.05 160.95 26.49 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.746 -0.74 . . . . 0.84999999999999998 112.559 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -52.93 -18.95 2.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.458 -1.025 . . . . 3.8599999999999999 112.697 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -56.99 -44.18 82.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.049 -1.032 . . . . 2.3500000000000001 110.842 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -84.57 -21.01 30.57 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.606 -1.309 . . . . 2.2599999999999998 111.534 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -59.83 -38.61 82.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.567 -0.708 . . . . 1.45 110.956 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.98 82.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.457 -0.777 . . . . 1.25 111.693 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.9 mt -63.72 -45.01 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.586 -1.321 . . . . 1.26 110.518 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -69.23 -32.37 71.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.82999999999999996 110.508 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -62.36 -40.11 95.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.532 -0.867 . . . . 1.1899999999999999 110.597 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.55 -39.88 98.42 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 120.133 -1.032 . . . . 0.57999999999999996 110.713 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -58.68 -41.69 86.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.295 -1.12 . . . . 2.0499999999999998 110.44 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.3 mt -60.04 -36.46 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.932 -1.105 . . . . 1.21 110.448 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.3 ttm -59.8 -39.43 84.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.852 . . . . 2.29 110.61 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 tp -60.82 -48.79 80.2 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.591 -0.844 . . . . 1.21 110.007 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.46 -42.59 96.48 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.458 0.647 . . . . 1.1399999999999999 110.949 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -87.56 5.65 38.28 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.271 -0.893 . . . . 1.4199999999999999 113.05 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -60.59 121.19 11.57 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.689 -1.257 . . . . 1.27 108.585 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.15 -18.55 65.4 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.875 0.845 . . . . 1.3500000000000001 110.631 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -75.16 -52.63 10.49 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.675 -0.81 . . . . 2.2200000000000002 110.079 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.32 -37.0 79.22 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.688 -0.805 . . . . 1.22 110.525 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -57.59 -47.86 80.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.199 -0.938 . . . . 1.29 110.992 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.7 -37.27 81.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.436 -0.79 . . . . 2.1699999999999999 110.635 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.58 -48.8 68.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.71 -1.244 . . . . 1.3 110.26 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.2 mt -56.57 -45.96 82.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.923 -1.11 . . . . 1.1699999999999999 109.947 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.0 mt -60.77 -41.9 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.541 0.686 . . . . 1.3999999999999999 110.36 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.7 98.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.905 . . . . 1.3300000000000001 110.711 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.67 -42.49 97.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.048 -1.032 . . . . 1.48 110.679 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.41 -45.59 98.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.204 -0.935 . . . . 1.28 110.323 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.45 ' HZ1' ' CB ' ' A' ' 94' ' ' LYS . 6.8 mtmp? -83.67 -34.5 24.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 2.6000000000000001 112.132 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -80.86 -44.86 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.693 -1.254 . . . . 1.51 111.856 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -102.53 8.36 39.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.593 -0.692 . . . . 2.48 112.318 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.0 m170 49.66 49.02 20.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 1.6100000000000001 111.641 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.4 mtp -101.68 156.58 17.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.583 -0.698 . . . . 1.8999999999999999 109.397 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.3 p -74.14 160.16 31.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.573 -0.529 . . . . 1.3200000000000001 109.573 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.14 -40.52 81.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.155 -0.966 . . . . 1.1499999999999999 110.301 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.406 ' OD1' ' CG2' ' A' ' 141' ' ' ILE . 73.6 m-20 -68.08 -44.09 77.05 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.905 0.86 . . . . 2.25 110.241 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.06 -49.09 63.5 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.625 -0.83 . . . . 1.22 110.955 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.13 87.91 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.267 -0.896 . . . . 1.1899999999999999 110.181 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.54 95.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 1.2 110.539 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -60.29 -36.18 77.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 2.1000000000000001 111.423 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.05 -50.21 74.63 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.039 -1.038 . . . . 1.3 110.954 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -60.24 -48.01 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.552 -1.343 . . . . 1.27 109.947 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -60.92 -31.86 50.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 121.599 -0.688 . . . . 1.1899999999999999 110.331 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -57.08 -41.04 78.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.123 -0.986 . . . . 2.1099999999999999 111.175 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.73 -35.36 11.67 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.231 -1.462 . . . . 0.88 112.191 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -59.99 -40.9 90.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.504 -1.586 . . . . 1.99 110.241 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.48 -51.49 14.65 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.892 0.853 . . . . 1.28 110.224 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.2 m -59.31 -39.85 84.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.307 -0.871 . . . . 2.2200000000000002 110.619 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.79 98.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -0.784 . . . . 1.45 111.064 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.93 -31.11 72.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.725 -1.234 . . . . 1.47 110.961 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -66.43 -22.65 66.22 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.923 -1.111 . . . . 2.04 110.915 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -72.5 -12.41 61.07 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.676 0.751 . . . . 1.73 111.059 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 82.9 mt -86.53 149.54 24.88 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.363 0.602 . . . . 1.79 109.426 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -103.02 39.11 1.61 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.127 -0.983 . . . . 2.8799999999999999 111.769 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -115.78 139.07 50.53 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 121.141 -0.975 . . . . 1.5800000000000001 108.77 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.06 -40.16 84.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 3.04 110.97 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -72.46 -48.82 37.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.846 -1.159 . . . . 1.29 111.068 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 19.3 mt -61.5 -43.43 98.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.878 -1.138 . . . . 1.6000000000000001 110.116 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -63.79 -50.09 70.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.954 . . . . 2.7599999999999998 110.06 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -59.9 -32.89 71.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.415 -0.803 . . . . 2.1499999999999999 110.122 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -63.79 -28.17 69.68 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.716 -1.194 . . . . 2.8100000000000001 109.343 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.82 83.86 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.684 0.754 . . . . 1.3899999999999999 109.685 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.95 -42.35 97.33 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.222 -0.991 . . . . 1.4099999999999999 109.509 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.48 -31.31 71.96 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.313 0.577 . . . . 1.3899999999999999 110.26 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.3 t -68.1 -44.97 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 1.1899999999999999 109.942 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -59.36 -36.15 75.2 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.071 -1.018 . . . . 3.6299999999999999 110.099 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -60.0 -39.69 86.65 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.067 -0.515 . . . . 1.28 110.579 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.48 -40.02 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.206 -0.934 . . . . 1.1799999999999999 109.936 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.02 -41.75 31.53 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 119.838 -1.172 . . . . 0.51000000000000001 110.691 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.617 ' HZ2' ' CZ ' ' A' ' 139' ' ' ARG . 16.6 ttpp -58.29 -41.94 85.49 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.305 -1.115 . . . . 3.1699999999999999 110.355 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.408 ' NH1' ' HG2' ' A' ' 136' ' ' ARG . 63.7 mtt-85 -63.31 -44.58 94.58 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.478 -0.889 . . . . 2.8500000000000001 110.019 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 32.2 tp -60.84 -42.06 97.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.625 -0.672 . . . . 1.6499999999999999 110.084 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.1 mt -59.76 -40.83 89.46 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.377 -0.827 . . . . 1.2 110.367 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.617 ' CZ ' ' HZ2' ' A' ' 135' ' ' LYS . 99.2 mtt180 -61.33 -36.16 79.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.188 -0.945 . . . . 2.7999999999999998 110.806 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -74.31 -41.36 61.28 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.218 -0.993 . . . . 2.1499999999999999 110.698 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.406 ' CG2' ' OD1' ' A' ' 101' ' ' ASP . 88.5 mt -60.48 -39.02 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.335 -0.853 . . . . 1.21 110.454 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 70.0 mt -85.09 -8.01 58.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.968 -1.082 . . . . 1.3400000000000001 112.263 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.12 15.6 80.14 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 120.334 -0.936 . . . . 0.91000000000000003 112.314 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 27.7 tp -70.0 142.37 52.8 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.715 0.769 . . . . 1.51 109.474 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -68.35 151.27 47.11 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.313 -0.867 . . . . 2.8799999999999999 110.205 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.1 mt -104.61 135.17 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.261 -1.014 . . . . 1.6200000000000001 108.261 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.494 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.1 mp -78.49 117.91 24.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.696 -0.853 . . . . 2.1099999999999999 108.696 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -99.35 103.32 15.13 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.263 -1.755 . . . . 1.6200000000000001 106.263 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -74.12 -15.21 61.05 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.604 -0.685 . . . . 1.3999999999999999 111.573 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -81.59 1.8 32.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.224 -0.922 . . . . 2.0499999999999998 112.279 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.44 23.85 8.02 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.317 -0.864 . . . . 1.3500000000000001 112.546 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.5 mt -72.41 139.92 18.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.102 -0.999 . . . . 1.4199999999999999 108.923 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -110.52 -18.88 13.1 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.865 0.841 . . . . 2.9900000000000002 112.611 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -114.33 134.17 55.15 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.802 -1.185 . . . . 1.54 107.802 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.54 127.57 33.2 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.039 -1.038 . . . . 1.3799999999999999 108.402 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.84 173.49 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.014 -0.736 . . . . 1.28 109.014 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 29.6 mt -86.75 139.58 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.396 -0.965 . . . . 1.1599999999999999 108.396 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.5 tp -94.7 122.94 37.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.119 -0.988 . . . . 1.3100000000000001 108.681 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.48 131.17 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.091 -1.077 . . . . 1.25 108.091 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.7 153.7 21.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 1.26 108.73 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.471 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -62.5 -36.29 82.09 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.502 -1.374 . . . . 1.6000000000000001 109.411 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 57.7 t0 -170.86 150.54 3.21 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.651 -0.87 . . . . 2.4199999999999999 108.651 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.468 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 79.8 mt -119.19 143.21 47.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.27 -0.894 . . . . 1.3500000000000001 109.261 177.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.4 p -91.83 146.49 33.09 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 120.988 -1.07 . . . . 1.3200000000000001 108.625 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -39.31 -42.62 2.48 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.216 1.944 . . . . 0.69999999999999996 114.045 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.3 m -59.81 -48.33 82.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 1.1200000000000001 110.154 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -64.5 -39.95 94.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.002 -1.061 . . . . 1.21 110.284 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.581 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 35.0 p -68.47 -35.0 76.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.608 -0.683 . . . . 1.1899999999999999 110.659 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.68 88.36 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.424 -0.798 . . . . 1.24 110.364 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -93.21 -1.21 56.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.318 -0.864 . . . . 1.6899999999999999 112.597 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.71 150.87 35.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.342 -0.849 . . . . 1.3400000000000001 109.361 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -94.76 115.03 27.01 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 107.331 -1.359 . . . . 2.77 107.331 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 23.1 mt -73.83 -20.39 60.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.864 -0.523 . . . . 2.0899999999999999 111.459 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -83.03 -23.04 33.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 2.6699999999999999 112.252 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -100.88 -1.88 33.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.263 0.838 . . . . 2.5800000000000001 113.263 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.38 125.52 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.648 -1.241 . . . . 1.1799999999999999 107.648 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 13.0 tp -84.25 -4.1 58.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 2.1800000000000002 111.796 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 165.83 170.31 30.59 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.858 -1.697 . . . . 0.48999999999999999 108.858 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.09 129.33 47.76 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 107.785 -1.191 . . . . 0.64000000000000001 107.785 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 87.2 mt -130.99 109.85 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 106.409 -1.7 . . . . 1.21 106.409 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.437 ' O ' ' O ' ' A' ' 203' ' ' VAL . 66.9 p -127.39 169.86 13.15 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.974 -1.079 . . . . 1.3799999999999999 109.586 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 21.4 p-10 -101.67 53.43 0.82 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.719 -0.613 . . . . 2.3700000000000001 110.643 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -99.53 133.37 43.95 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.371 -0.974 . . . . 1.52 108.371 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.4 3.17 4.82 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.733 -1.222 . . . . 1.8 112.638 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 92.92 -4.68 75.43 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.247 -1.149 . . . . 2.04 113.198 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.448 ' O ' ' CG ' ' A' ' 186' ' ' ARG . 26.2 ptt180 -81.63 118.36 22.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.813 -1.551 . . . . 5.0 106.813 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 73.5 p 46.95 40.28 9.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.763 -1.211 . . . . 3.02 111.881 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 82.0 p -84.34 109.44 17.83 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.029 -1.471 . . . . 2.1099999999999999 107.029 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.581 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 17.3 t60 -61.54 -32.97 73.06 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.509 -0.744 . . . . 1.24 110.811 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.3 p -57.13 -40.3 76.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.748 -1.22 . . . . 2.1499999999999999 110.218 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.0 t -60.17 -39.62 87.11 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.018 -1.051 . . . . 2.02 109.892 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.1 mm -59.88 -40.13 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 2.1200000000000001 110.351 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.4 mtp -65.06 -42.74 93.92 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.339 1.066 . . . . 1.3600000000000001 109.605 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.28 -47.42 86.06 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.797 -0.638 . . . . 1.29 110.979 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -61.38 -42.79 99.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.977 -1.077 . . . . 3.5600000000000001 110.436 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 72.4 m -70.59 -42.73 70.63 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.956 0.884 . . . . 1.1799999999999999 110.127 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.2 mt -91.84 -8.14 47.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.46 -0.775 . . . . 1.3400000000000001 112.182 -177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 54.43 9.78 0.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.912 1.078 . . . . 1.45 113.912 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 37.7 mt -70.14 164.97 48.0 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.079 -1.013 . . . . 1.25 109.283 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -70.68 144.28 48.69 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.7 1.6 . . . . 0.78000000000000003 110.444 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.91 166.11 28.95 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.701 -1.6 . . . . 1.2 109.611 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 65.0 mt -146.9 156.48 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.447 -1.316 . . . . 1.25 107.447 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.5 m -140.94 -31.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 O-C-N 120.687 -1.258 . . . . 1.3899999999999999 112.366 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.05 43.29 2.44 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.007 -1.058 . . . . 0.96999999999999997 111.997 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 30.6 p -63.03 -16.73 60.85 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.134 -1.216 . . . . 1.3500000000000001 111.202 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.96 -94.71 1.0 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 110.14 -1.184 . . . . 1.0700000000000001 110.14 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 86.8 p -129.07 30.92 4.97 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.607 -0.937 . . . . 1.9199999999999999 111.716 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.13 -38.18 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.506 -1.371 . . . . 1.3300000000000001 110.165 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 76.2 p -52.86 -25.81 12.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 1.4199999999999999 111.379 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.9 p -96.27 6.2 49.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 2.1200000000000001 111.814 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -128.82 -4.17 5.19 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 113.136 0.791 . . . . 2.6899999999999999 113.136 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 13.4 t -117.96 149.51 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.675 0.75 . . . . 1.29 109.784 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -118.46 152.53 35.73 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.079 -1.082 . . . . 2.6899999999999999 108.079 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 40.4 p-10 -54.31 146.3 15.85 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.932 -1.107 . . . . 2.79 110.113 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 t70 81.07 -3.42 1.74 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 114.304 1.224 . . . . 2.3500000000000001 114.304 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.76 146.16 53.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.948 -1.095 . . . . 1.97 108.74 177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -88.78 120.22 29.99 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.003 -1.48 . . . . 2.9700000000000002 107.003 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 84.1 mt -126.67 143.39 51.25 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.274 -0.891 . . . . 1.25 109.846 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.7 mt -109.53 121.37 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.859 -1.534 . . . . 1.22 106.859 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 32.8 tp -98.91 109.79 22.49 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.12 -1.807 . . . . 1.24 106.12 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.9 p30 -93.76 -22.52 18.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.907 -1.121 . . . . 2.0499999999999998 112.958 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.566 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 37.64 19.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.58 0.705 . . . . 1.25 112.804 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.7 t -108.42 -60.14 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.015 -1.053 . . . . 1.4299999999999999 108.837 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -88.7 8.25 29.62 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.159 0.98 . . . . 3.0299999999999998 110.028 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 65.86 49.55 1.65 Allowed 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.9 -1.045 . . . . 2.25 111.944 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.51 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 16.8 pt20 -154.65 156.34 36.3 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.642 1.21 . . . . 2.52 110.873 178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 54.8 t -118.14 141.58 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 115.176 -0.92 . . . . 1.29 108.626 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.51 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 94.8 m-85 -100.98 139.09 37.16 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.961 -1.087 . . . . 1.3400000000000001 108.431 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.1 t -111.11 129.71 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 107.945 -1.132 . . . . 1.3400000000000001 107.945 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.429 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 4.1 t30 49.57 50.17 8.66 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 113.4 0.889 . . . . 2.1800000000000002 113.4 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 29.8 Cg_endo -65.14 151.71 84.68 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.42 2.08 . . . . 0.93999999999999995 110.41 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 35.9 p -73.4 159.63 33.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.053 -1.029 . . . . 2.3999999999999999 108.84 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -63.26 -33.81 76.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.365 -0.834 . . . . 3.3300000000000001 111.143 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.22 -39.25 82.11 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.081 -1.012 . . . . 3.1699999999999999 110.699 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 98.2 t -71.94 -39.34 66.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.264 -0.897 . . . . 1.6899999999999999 110.77 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.0 mt . . . . . 0 C--N 1.302 -1.471 0 O-C-N 121.178 -0.951 . . . . 1.6000000000000001 110.154 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 106.564 -1.643 . . . . 1.5700000000000001 106.564 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.1 m -104.9 120.57 41.75 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.004 -1.11 . . . . 1.4399999999999999 108.004 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.08 -158.5 22.21 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.74 -1.744 . . . . 1.01 108.74 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 84.4 mt -96.26 -0.59 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.303 -1.116 . . . . 1.6299999999999999 113.002 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tp 50.06 98.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.925 -1.109 . . . . 1.5800000000000001 112.583 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.13 -45.12 12.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.106 -0.996 . . . . 1.3400000000000001 110.849 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -146.58 140.87 15.62 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 107.639 -1.245 . . . . 1.8600000000000001 107.639 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.38 150.75 41.86 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.506 2.138 . . . . 1.01 112.345 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 152.41 170.34 18.8 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 108.992 -1.643 . . . . 0.81000000000000005 108.992 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 11' ' ' ILE . 98.5 mt -129.86 138.8 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.026 -1.279 . . . . 1.3700000000000001 108.288 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.35 149.88 38.36 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.054 -1.029 . . . . 1.1399999999999999 109.417 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.3 m-85 -122.04 139.83 53.23 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.969 -1.123 . . . . 0.87 107.969 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.24 171.21 41.34 Favored Glycine 0 N--CA 1.499 2.848 0 C-N-CA 118.746 -1.692 . . . . 0.56999999999999995 110.213 178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -76.4 158.77 31.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.604 -0.939 . . . . 2.3500000000000001 108.742 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.59 132.83 33.8 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.225 -0.922 . . . . 1.21 108.827 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.6 tp -110.63 102.69 11.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.78 -1.933 . . . . 1.3999999999999999 105.78 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.8 tp -91.51 136.84 32.83 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.078 -1.082 . . . . 1.4399999999999999 108.078 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.5 mt -102.34 116.23 32.2 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.947 -1.501 . . . . 1.45 106.947 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -111.18 137.88 48.32 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.656 -1.238 . . . . 2.5 107.656 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -125.65 149.66 48.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.089 -1.007 . . . . 2.6600000000000001 108.864 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -85.21 137.56 32.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.736 -1.209 . . . . 2.3199999999999998 107.736 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -63.3 148.29 48.7 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.599 -0.84 . . . . 2.1099999999999999 108.818 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -92.55 135.38 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.403 -0.962 . . . . 1.29 108.403 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.7 t -104.4 130.16 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.061 -1.089 . . . . 1.4099999999999999 108.061 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.1 mt -98.32 135.22 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.278 -1.008 . . . . 1.3100000000000001 108.278 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -90.64 119.23 30.71 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 106.948 -1.501 . . . . 1.3400000000000001 106.948 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.432 HH11 ' HG3' ' A' ' 28' ' ' ARG . 19.1 mmm-85 -96.81 11.74 34.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 3.48 112.111 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -72.01 152.26 42.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.176 -0.952 . . . . 2.52 109.619 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -91.71 135.14 34.12 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.54 -0.911 . . . . 2.6299999999999999 108.54 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -94.64 167.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.886 -1.133 . . . . 1.3100000000000001 109.957 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.5 p -93.8 166.06 12.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.112 -0.993 . . . . 1.24 109.332 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.06 -19.81 34.57 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.876 -1.14 . . . . 1.49 112.814 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 60.1 t0 -70.01 -38.06 75.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.784 -1.197 . . . . 2.2799999999999998 110.749 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -86.38 -11.0 53.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.809 -1.182 . . . . 2.0499999999999998 112.202 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.34 -43.94 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.003 -1.061 . . . . 1.3400000000000001 110.362 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.1 -39.81 83.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.357 -0.839 . . . . 1.54 110.621 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -63.68 -42.66 98.0 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.25 -0.907 . . . . 2.8500000000000001 111.019 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -61.53 -38.78 88.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.986 -1.071 . . . . 1.3100000000000001 110.901 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.4 t -60.0 -45.4 95.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.155 -0.965 . . . . 1.3799999999999999 110.329 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -61.55 -45.49 93.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.975 . . . . 1.5 110.081 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.65 -43.31 97.77 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.387 -0.821 . . . . 2.7799999999999998 110.286 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -71.41 -56.94 4.97 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.185 -0.947 . . . . 1.0600000000000001 109.987 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.6 tp -58.18 -47.46 83.34 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.203 -0.999 . . . . 1.3999999999999999 109.786 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 t -69.95 -37.47 75.86 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.141 -0.975 . . . . 1.3200000000000001 109.997 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.45 -46.89 91.43 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.912 -1.137 . . . . 0.69999999999999996 110.366 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -59.83 -30.6 69.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.406 -1.056 . . . . 3.4399999999999999 109.437 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.16 -45.2 87.87 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.163 -0.615 . . . . 1.3600000000000001 109.868 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -80.8 -42.26 22.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 2.8300000000000001 110.885 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.43 85.5 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.599 -0.841 . . . . 1.23 109.42 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 t -60.68 -41.13 94.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.217 1.008 . . . . 1.9199999999999999 109.077 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.47 -46.07 77.59 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.62 -0.718 . . . . 1.25 110.144 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -62.92 -49.98 72.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.092 -1.005 . . . . 1.97 109.997 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.1 mt -61.69 -40.01 93.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.163 -0.96 . . . . 2.1800000000000002 109.978 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -60.15 -40.02 88.41 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.93 -0.481 . . . . 1.1899999999999999 110.497 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.2 m -65.59 -45.01 84.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.924 -1.11 . . . . 1.3400000000000001 110.043 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.57 -37.84 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 1.23 110.3 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.432 ' NZ ' ' OE2' ' A' ' 70' ' ' GLU . 9.0 ttpp -49.25 -43.4 42.83 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.968 -0.693 . . . . 1.5600000000000001 110.915 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -69.54 -38.99 77.72 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.581 -0.699 . . . . 1.3 109.659 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.01 -40.32 93.09 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.46 -1.296 . . . . 2.3199999999999998 108.996 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.24 77.73 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.922 -0.711 . . . . 1.1399999999999999 109.835 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.47 -36.74 19.42 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.704 -1.236 . . . . 0.68999999999999995 110.939 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -80.79 -27.28 36.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.041 -1.27 . . . . 1.48 111.125 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -83.9 -49.87 8.6 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.565 -0.709 . . . . 1.52 111.021 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.87 -5.08 18.55 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.031 1.123 . . . . 1.3100000000000001 114.031 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.88 163.84 28.97 Favored Glycine 0 N--CA 1.502 3.096 0 O-C-N 121.291 -0.881 . . . . 0.84999999999999998 111.82 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -56.49 -24.34 45.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.685 -0.891 . . . . 3.8599999999999999 112.218 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.6 -39.93 68.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 2.3500000000000001 110.715 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -87.72 -25.03 23.66 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.931 -1.106 . . . . 2.2599999999999998 111.386 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.432 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 71.1 tt0 -59.72 -37.31 78.54 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.489 0.661 . . . . 1.45 110.647 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.96 74.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 1.25 111.341 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.55 -42.37 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.634 -1.291 . . . . 1.26 110.517 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -70.13 -31.66 69.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.392 -0.817 . . . . 0.82999999999999996 110.252 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -59.99 -38.44 82.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.042 -1.036 . . . . 1.1899999999999999 110.278 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.48 -39.87 86.85 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.004 -1.238 . . . . 0.57999999999999996 110.004 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -60.21 -45.72 92.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.273 -1.133 . . . . 2.0499999999999998 110.312 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.5 mt -60.92 -39.34 81.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.193 -0.942 . . . . 1.21 110.318 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.7 ttm -56.9 -40.55 76.47 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.594 -0.842 . . . . 2.29 110.101 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -59.52 -50.05 75.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 1.21 109.992 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.4 tp -61.88 -41.04 97.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.502 -0.748 . . . . 1.1399999999999999 110.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -86.38 8.05 23.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.506 -0.746 . . . . 1.4199999999999999 112.518 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -65.5 125.69 25.98 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.448 -1.407 . . . . 1.27 108.346 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.0 -18.73 65.52 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.107 0.956 . . . . 1.3500000000000001 110.711 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -76.46 -54.65 6.42 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.752 -0.779 . . . . 2.2200000000000002 110.428 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.68 -35.15 75.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.408 -0.807 . . . . 1.22 110.962 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -59.93 -49.19 78.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.416 -0.802 . . . . 1.29 110.522 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -61.6 -35.72 78.65 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.61 -0.681 . . . . 2.1699999999999999 110.625 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.82 -46.87 73.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.02 . . . . 1.3 110.619 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.8 mt -59.51 -46.52 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.146 -0.971 . . . . 1.1699999999999999 109.718 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.7 mt -62.18 -41.25 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.446 0.641 . . . . 1.3999999999999999 110.529 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.5 -44.24 97.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.103 -0.998 . . . . 1.3300000000000001 110.741 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.58 -42.31 96.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.045 -1.034 . . . . 1.48 110.434 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.58 -49.43 83.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.034 -1.041 . . . . 1.28 110.386 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -82.8 -31.48 28.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.157 -0.965 . . . . 2.6000000000000001 111.644 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 91' ' ' ALA . 35.8 t0 -83.03 -45.83 13.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.735 -1.228 . . . . 1.51 111.886 -178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -103.26 11.24 37.06 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.307 -0.87 . . . . 2.48 111.998 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.2 m80 51.3 51.95 15.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.441 -0.787 . . . . 1.6100000000000001 111.999 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -105.89 151.93 23.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.456 -0.777 . . . . 1.8999999999999999 109.178 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 68.7 p -71.61 161.92 30.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.43 -0.794 . . . . 1.3200000000000001 109.583 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.95 -44.4 91.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.261 -0.899 . . . . 1.1499999999999999 110.875 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 21.0 p-10 -68.71 -39.25 80.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.996 -1.065 . . . . 2.25 110.133 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -48.21 63.78 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.727 -0.789 . . . . 1.22 111.176 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.35 77.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.242 -0.911 . . . . 1.1899999999999999 110.577 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.7 89.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.448 -0.783 . . . . 1.2 110.656 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.9 -39.48 89.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.852 -1.155 . . . . 2.1000000000000001 110.937 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.53 -48.74 79.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.857 -1.152 . . . . 1.3 110.742 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.9 t -59.74 -47.91 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.707 -1.246 . . . . 1.27 109.877 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.0 mm -61.71 -35.64 68.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.934 -0.479 . . . . 1.1899999999999999 110.617 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -56.58 -40.2 74.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.893 -1.129 . . . . 2.1099999999999999 111.073 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.36 -28.89 23.67 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.346 -1.407 . . . . 0.88 113.185 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -62.35 -39.94 94.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.466 -1.608 . . . . 1.99 109.973 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.03 -48.49 35.72 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.787 0.803 . . . . 1.28 110.517 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.4 m -61.45 -40.62 95.14 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.208 -0.597 . . . . 2.2200000000000002 110.239 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.55 95.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.503 -0.748 . . . . 1.45 110.63 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.46 -28.28 69.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.903 -1.123 . . . . 1.47 110.826 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -66.34 -23.24 66.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.561 0.696 . . . . 2.04 110.917 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -76.33 -11.0 59.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.728 -0.608 . . . . 1.73 111.438 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.0 mt -87.27 138.78 31.19 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.038 -1.097 . . . . 1.79 108.038 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 14.2 t70 -96.24 62.52 2.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.308 -0.87 . . . . 2.8799999999999999 110.48 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -138.36 135.96 35.87 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 107.574 -1.269 . . . . 1.5800000000000001 107.574 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -59.18 -37.26 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 3.04 110.837 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -71.21 -55.68 7.62 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.809 -1.182 . . . . 1.29 110.402 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.9 mt -60.83 -38.41 85.4 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.109 -0.994 . . . . 1.6000000000000001 110.704 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -60.7 -49.53 77.12 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.952 -1.099 . . . . 2.7599999999999998 109.507 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -60.21 -30.41 69.36 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.49 -0.884 . . . . 2.1499999999999999 109.431 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -62.26 -29.86 70.71 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.06 -1.056 . . . . 2.8100000000000001 109.03 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.98 75.47 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.939 0.876 . . . . 1.3899999999999999 109.32 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -42.55 77.26 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.881 -0.6 . . . . 1.4099999999999999 110.513 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -62.78 -36.52 83.38 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.626 0.727 . . . . 1.3899999999999999 110.25 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.21 -39.41 79.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.406 -0.809 . . . . 1.1899999999999999 110.14 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.9 ttm-85 -56.4 -38.96 72.22 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 118.912 -1.115 . . . . 3.6299999999999999 109.489 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -60.02 -38.6 83.18 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.391 0.615 . . . . 1.28 110.121 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.3 mt -60.33 -39.93 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.703 -0.623 . . . . 1.1799999999999999 110.027 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.85 -43.79 40.45 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.925 -1.131 . . . . 0.51000000000000001 110.734 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -57.19 -42.5 81.33 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.145 -1.209 . . . . 3.1699999999999999 110.099 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 -62.95 -40.69 98.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.13 -0.981 . . . . 2.8500000000000001 109.815 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.84 -45.95 92.45 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.534 -0.729 . . . . 1.6499999999999999 110.122 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.69 -42.17 92.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.585 -0.697 . . . . 1.2 110.62 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -60.27 -37.59 80.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.518 -0.739 . . . . 2.7999999999999998 110.831 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -75.28 -41.38 57.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 2.1499999999999999 111.191 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.02 -42.17 88.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.991 -1.068 . . . . 1.21 110.292 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.2 -11.0 36.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.926 -1.109 . . . . 1.3400000000000001 112.276 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.07 26.82 61.29 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 119.611 -1.281 . . . . 0.91000000000000003 113.11 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 22.3 tp -62.57 149.83 42.1 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.713 -0.875 . . . . 1.51 108.96 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -64.55 149.02 49.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 2.8799999999999999 109.603 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 70.4 mt -106.7 142.73 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.547 -0.908 . . . . 1.6200000000000001 108.547 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.507 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.9 mp -78.75 129.82 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.001 -1.062 . . . . 2.1099999999999999 108.253 178.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -97.8 87.17 3.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.221 -1.029 . . . . 1.6200000000000001 108.221 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.97 -24.92 60.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.369 -0.832 . . . . 1.3999999999999999 111.302 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' A' ' 172' ' ' ASN . 34.5 t -82.01 -0.54 44.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 2.0499999999999998 112.1 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.49 25.74 7.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.546 -0.721 . . . . 1.3500000000000001 111.6 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 mt -70.96 139.98 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.138 -0.976 . . . . 1.4199999999999999 109.439 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -112.02 -20.18 12.06 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.645 0.735 . . . . 2.9900000000000002 112.073 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -117.63 137.75 52.42 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.704 -1.221 . . . . 1.54 107.704 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.25 128.34 35.37 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.977 -1.119 . . . . 1.3799999999999999 107.977 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.0 m -148.33 176.76 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.064 -0.717 . . . . 1.28 109.064 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 44.4 mt -88.17 143.72 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.138 -0.976 . . . . 1.1599999999999999 109.007 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.5 tp -95.93 120.21 35.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.014 -1.054 . . . . 1.3100000000000001 108.61 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.0 t -120.15 129.58 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 107.506 -1.294 . . . . 1.25 107.506 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.69 151.65 16.9 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.174 -0.954 . . . . 1.26 109.084 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.74 -32.46 72.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.358 -1.464 . . . . 1.6000000000000001 109.616 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -173.42 152.01 2.09 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.655 -0.868 . . . . 2.4199999999999999 108.655 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 41.7 mt -112.73 140.27 47.64 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.382 -0.824 . . . . 1.3500000000000001 108.965 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.9 p -91.11 146.87 34.44 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.072 -1.018 . . . . 1.3200000000000001 108.852 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -39.19 -43.02 2.43 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 122.173 1.915 . . . . 0.69999999999999996 113.405 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.6 m -60.16 -48.5 81.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.066 . . . . 1.1200000000000001 110.234 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -64.68 -39.91 94.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.019 -1.051 . . . . 1.21 109.9 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 43.2 p -65.47 -43.32 90.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.602 -0.686 . . . . 1.1899999999999999 110.978 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.75 82.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 1.24 110.617 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -95.87 -1.14 50.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.171 -0.955 . . . . 1.6899999999999999 112.79 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.74 145.85 51.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.973 -1.079 . . . . 1.3400000000000001 108.181 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' A' ' 150' ' ' SER . 97.6 m-20 -94.99 117.49 30.22 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 106.979 -1.489 . . . . 2.77 106.979 177.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -72.93 -18.59 61.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.781 -0.574 . . . . 2.0899999999999999 111.151 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -84.06 -16.17 44.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 2.6699999999999999 112.222 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -103.38 -11.97 17.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.538 -0.726 . . . . 2.5800000000000001 112.812 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.9 t -106.15 128.49 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 107.888 -1.153 . . . . 1.1799999999999999 107.888 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.62 -8.41 58.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.031 -1.043 . . . . 2.1800000000000002 112.326 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 177.22 173.94 43.19 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.437 -1.465 . . . . 0.48999999999999999 109.437 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -127.48 131.62 50.12 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 107.79 -1.189 . . . . 0.64000000000000001 107.79 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 62.5 mt -137.18 118.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 105.932 -1.877 . . . . 1.21 105.932 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 203' ' ' VAL . 62.9 p -140.46 170.81 15.11 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.693 -1.254 . . . . 1.3799999999999999 110.08 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -104.09 65.36 0.8 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.791 -0.568 . . . . 2.3700000000000001 109.627 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -104.33 152.22 22.51 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.494 -0.754 . . . . 1.52 109.484 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.45 -38.47 70.04 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 120.222 -0.99 . . . . 1.8 110.864 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.63 -2.37 64.67 Favored Glycine 0 N--CA 1.494 2.561 0 O-C-N 121.094 -1.239 . . . . 2.04 113.292 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 186' ' ' ARG . 3.5 ptt-85 -88.83 101.45 14.05 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.624 -1.991 . . . . 5.0 105.624 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 p 53.4 47.64 23.7 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.993 -1.067 . . . . 3.02 112.001 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 59.1 m -83.63 135.86 34.44 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.697 -1.223 . . . . 2.1099999999999999 107.697 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -59.36 -39.92 84.81 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.286 -0.884 . . . . 1.24 111.026 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.0 m -59.62 -40.33 87.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.898 -1.126 . . . . 2.1499999999999999 110.089 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.2 p -61.88 -35.04 77.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 2.02 110.652 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 32.0 mm -59.99 -39.29 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.519 -0.738 . . . . 2.1200000000000001 110.656 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.4 mtp -62.23 -43.16 99.46 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 122.319 1.057 . . . . 1.3600000000000001 109.595 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.89 -47.76 83.82 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.717 -0.614 . . . . 1.29 110.504 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.481 ' HG2' HH11 ' A' ' 195' ' ' ARG . 33.8 mtt-85 -60.12 -41.34 92.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 3.5600000000000001 110.586 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.7 m -70.13 -41.53 73.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.182 -0.949 . . . . 1.1799999999999999 110.079 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.83 -8.18 50.28 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.577 0.703 . . . . 1.3400000000000001 112.49 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 194' ' ' ALA . 94.5 mt-10 49.6 12.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.82 1.045 . . . . 1.45 113.82 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.57 149.06 93.31 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 107.872 -1.159 . . . . 1.25 107.872 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.34 135.86 71.0 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 120.948 1.099 . . . . 0.78000000000000003 110.017 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.75 163.11 34.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.31 -1.494 . . . . 1.2 109.397 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 32.2 mt -146.79 147.51 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.639 -1.245 . . . . 1.25 107.639 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.5 m -125.24 -31.55 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.146 -0.971 . . . . 1.3899999999999999 113.052 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.1 45.01 2.46 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 119.542 -1.313 . . . . 0.96999999999999997 111.016 -178.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 58.6 p -61.86 -19.54 62.73 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.537 -0.978 . . . . 1.3500000000000001 111.372 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.65 -90.7 0.86 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.48 -1.048 . . . . 1.0700000000000001 110.48 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.3 p -130.62 28.69 4.87 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.503 -0.998 . . . . 1.9199999999999999 113.288 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.31 -40.02 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.44 -1.412 . . . . 1.3300000000000001 110.603 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.2 p -58.28 -22.72 53.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.968 -1.082 . . . . 1.4199999999999999 111.707 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.5 p -94.15 -1.88 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.424 -0.797 . . . . 2.1200000000000001 112.183 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -125.88 3.07 7.37 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.645 0.736 . . . . 2.6899999999999999 112.436 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 22.4 t -116.13 146.54 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.528 -0.733 . . . . 1.29 109.263 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -119.81 160.45 22.61 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.998 -1.112 . . . . 2.6899999999999999 107.998 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 3.7 m120 -57.36 139.81 51.96 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.85 -1.156 . . . . 2.79 110.812 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 79.11 5.55 2.23 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.193 1.182 . . . . 2.3500000000000001 114.193 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 61.0 t0 -66.08 149.08 50.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.911 -1.118 . . . . 1.97 108.437 177.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.496 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 36.3 t80 -89.82 122.18 32.65 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.916 -1.513 . . . . 2.9700000000000002 106.916 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.4 mt -129.52 147.53 51.34 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.035 0.922 . . . . 1.25 110.105 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 21.0 mt -119.92 130.75 73.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.408 -1.33 . . . . 1.22 107.408 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 60.8 tp -99.65 120.2 39.31 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.407 -1.331 . . . . 1.24 107.407 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 223' ' ' VAL . 33.5 t0 -89.77 -35.78 15.52 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.976 -1.077 . . . . 2.0499999999999998 111.431 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.405 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 39.78 17.75 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.566 0.698 . . . . 1.25 112.459 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.1 t -109.15 -58.25 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.168 -0.957 . . . . 1.4299999999999999 109.33 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.448 HD21 ' NE2' ' A' ' 226' ' ' GLN . 56.6 t30 -95.69 14.72 22.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.961 0.886 . . . . 3.0299999999999998 110.598 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.93 52.27 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.608 -0.724 . . . . 2.25 112.834 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.52 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 28.8 pt20 -151.93 157.13 41.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.031 -1.043 . . . . 2.52 110.168 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.35 135.19 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.071 -1.085 . . . . 1.29 108.071 177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.52 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 83.4 m-85 -103.24 130.01 50.36 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.065 -1.022 . . . . 1.3400000000000001 108.588 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.9 t -110.53 129.85 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.991 -1.114 . . . . 1.3400000000000001 107.991 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.443 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 61.8 t30 53.59 48.75 5.26 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 113.434 0.902 . . . . 2.1800000000000002 113.434 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 37.0 Cg_endo -65.73 153.5 77.88 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.656 2.237 . . . . 0.93999999999999995 110.911 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.0 p -72.17 160.21 32.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.997 -1.065 . . . . 2.3999999999999999 110.134 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -60.19 -37.96 81.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.216 -0.928 . . . . 3.3300000000000001 110.642 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.98 -39.16 84.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 3.1699999999999999 110.558 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.7 -35.71 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.207 -0.933 . . . . 1.6899999999999999 110.176 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.488 1.459 0 O-C-N 121.351 -0.843 . . . . 1.6000000000000001 110.598 179.175 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 106.544 -1.65 . . . . 1.5700000000000001 106.544 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.8 m -102.09 124.51 47.82 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.634 -1.247 . . . . 1.4399999999999999 107.634 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' A' ' 225' ' ' ASN . . . -118.42 -160.72 11.6 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.77 -1.732 . . . . 1.01 108.77 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 90.2 mt -95.8 1.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.372 -1.075 . . . . 1.6299999999999999 112.711 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.91 97.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 1.5800000000000001 112.195 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.41 -37.4 18.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.36 -0.837 . . . . 1.3400000000000001 111.477 179.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -150.6 145.71 18.75 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 120.682 -1.261 . . . . 1.8600000000000001 107.738 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.45 144.77 23.08 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 122.647 2.231 . . . . 1.01 112.121 178.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 222' ' ' ALA . . . 154.65 170.69 20.7 Favored Glycine 0 N--CA 1.504 3.197 0 N-CA-C 109.556 -1.417 . . . . 0.81000000000000005 109.556 178.032 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.5 mt -133.24 133.68 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 107.71 -1.219 . . . . 1.3700000000000001 107.71 179.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.0 151.94 41.4 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.19 -0.944 . . . . 1.1399999999999999 109.305 179.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.48 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 11.2 m-85 -119.25 140.82 49.62 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.668 -0.864 . . . . 0.87 108.668 177.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.19 169.22 41.4 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 118.586 -1.769 . . . . 0.56999999999999995 110.472 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -77.76 158.18 29.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.688 -0.889 . . . . 2.3500000000000001 109.076 177.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.42 126.74 33.53 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.957 -1.089 . . . . 1.21 108.291 178.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.0 tp -110.11 102.27 10.99 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.621 -1.992 . . . . 1.3999999999999999 105.621 178.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 tp -88.42 140.33 29.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.937 -1.102 . . . . 1.4399999999999999 108.922 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.8 mt -99.86 119.72 38.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.923 -1.111 . . . . 1.45 108.061 178.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -110.31 141.01 43.91 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.22 -1.029 . . . . 2.5 108.22 179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -118.67 141.32 48.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.103 -0.998 . . . . 2.6600000000000001 109.281 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -82.91 133.68 35.11 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.746 -1.205 . . . . 2.3199999999999998 107.746 177.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -62.95 149.13 45.52 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.759 -0.83 . . . . 2.1099999999999999 108.759 178.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.6 mt -95.15 133.79 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.584 -0.895 . . . . 1.29 108.584 178.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 t -103.6 130.14 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.936 -1.135 . . . . 1.4099999999999999 107.936 178.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.0 mt -98.31 133.12 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.287 -1.005 . . . . 1.3100000000000001 108.287 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -87.28 119.51 27.61 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.249 -1.389 . . . . 1.3400000000000001 107.249 178.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -101.37 20.02 16.68 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.86 -0.525 . . . . 3.48 111.619 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -63.27 149.89 44.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.254 -0.904 . . . . 2.52 110.154 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -91.33 125.38 36.08 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.47 -1.307 . . . . 2.6299999999999999 107.47 177.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 pt -97.07 166.5 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.338 -0.852 . . . . 1.3100000000000001 110.15 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.8 p -99.3 164.3 12.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.595 -0.69 . . . . 1.24 109.697 178.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.89 -28.38 36.05 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.052 -1.03 . . . . 1.49 111.18 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -69.23 -34.11 74.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.009 . . . . 2.2799999999999998 110.393 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -87.61 -15.32 37.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.136 -0.978 . . . . 2.0499999999999998 112.193 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.76 -41.34 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.977 -1.077 . . . . 1.3400000000000001 110.367 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.32 -40.07 81.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.828 -1.17 . . . . 1.54 110.841 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -61.24 -42.27 98.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.569 -0.707 . . . . 2.8500000000000001 111.245 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.08 -38.02 81.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.827 -1.17 . . . . 1.3100000000000001 111.154 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.54 -44.78 93.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.976 -1.077 . . . . 1.3799999999999999 110.26 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -62.36 -44.64 96.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.201 -0.937 . . . . 1.5 110.266 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -62.15 -41.51 98.35 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.154 -0.966 . . . . 2.7799999999999998 109.638 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 32.1 t80 -74.06 -51.99 14.07 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.262 -0.899 . . . . 1.0600000000000001 109.249 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.01 -47.72 85.11 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 117.924 -1.511 . . . . 1.3999999999999999 110.367 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.4 t -69.57 -40.63 76.63 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.362 0.601 . . . . 1.3200000000000001 110.172 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.56 -44.67 90.71 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.292 -1.432 . . . . 0.69999999999999996 110.079 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -59.37 -30.86 68.72 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.573 -0.957 . . . . 3.4399999999999999 109.36 178.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.72 -45.64 85.51 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.745 -0.661 . . . . 1.3600000000000001 109.773 178.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -80.11 -45.03 18.92 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.452 0.644 . . . . 2.8300000000000001 110.427 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.66 -41.98 91.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.317 -0.864 . . . . 1.23 110.156 -178.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.6 t -60.02 -41.54 92.41 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 122.45 1.119 . . . . 1.9199999999999999 109.098 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.47 -46.57 79.29 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.265 -0.88 . . . . 1.25 110.209 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -62.55 -50.38 71.58 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.117 -0.989 . . . . 1.97 110.063 179.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 66.4 mt -61.23 -36.78 80.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.214 -0.929 . . . . 2.1800000000000002 110.192 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.81 -41.12 95.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.791 -0.568 . . . . 1.1899999999999999 110.819 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.6 m -64.74 -42.67 95.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.813 -1.179 . . . . 1.3400000000000001 110.009 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.51 -38.29 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.818 -0.551 . . . . 1.23 110.672 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -50.32 -45.75 55.01 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 120.122 -0.631 . . . . 1.5600000000000001 111.182 179.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -68.32 -32.56 72.78 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.937 -1.102 . . . . 1.3 109.91 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -61.64 -39.88 92.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.617 -1.233 . . . . 2.3199999999999998 109.295 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.9 -34.9 78.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.516 -0.74 . . . . 1.1399999999999999 110.097 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.61 -35.09 23.53 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.856 -1.164 . . . . 0.68999999999999995 111.364 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -83.33 -18.47 38.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.017 -1.284 . . . . 1.48 111.679 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -87.83 -53.17 4.89 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.747 -0.66 . . . . 1.52 110.3 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -106.95 -17.21 14.25 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 113.275 0.843 . . . . 1.3100000000000001 113.275 -176.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.59 158.98 10.53 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 120.893 -0.67 . . . . 0.84999999999999998 111.83 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -55.24 -25.8 35.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.721 -0.87 . . . . 3.8599999999999999 112.763 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.4 -35.25 71.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.781 -1.199 . . . . 2.3500000000000001 111.226 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -82.16 -26.38 33.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.055 -1.028 . . . . 2.2599999999999998 111.702 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -59.82 -33.8 72.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.758 -0.589 . . . . 1.45 111.401 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.07 83.7 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.432 -0.793 . . . . 1.25 111.563 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -65.62 -42.78 93.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.365 -1.459 . . . . 1.26 110.156 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -70.93 -30.86 67.3 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.828 -1.17 . . . . 0.82999999999999996 110.895 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -61.36 -39.14 89.54 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.61 -0.836 . . . . 1.1899999999999999 109.955 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.67 -39.53 90.42 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 120.225 -0.988 . . . . 0.57999999999999996 110.793 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -57.39 -46.86 82.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.623 -1.516 . . . . 2.0499999999999998 110.804 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 77' ' ' ILE . 88.6 mt -59.9 -38.11 74.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.011 -1.056 . . . . 1.21 110.703 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.2 ttp -58.95 -39.4 81.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.915 -1.116 . . . . 2.29 110.308 179.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 tp -59.92 -49.62 76.99 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.994 -1.066 . . . . 1.21 109.783 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.9 tp -60.46 -43.72 96.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.066 0.936 . . . . 1.1399999999999999 110.341 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -87.67 9.65 20.73 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 112.783 0.66 . . . . 1.4199999999999999 112.783 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -65.27 123.82 20.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.737 -1.227 . . . . 1.27 108.428 178.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.78 -18.44 65.33 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.842 0.829 . . . . 1.3500000000000001 110.854 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -74.11 -52.37 12.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.564 -0.854 . . . . 2.2200000000000002 110.167 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.0 -37.85 86.42 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.443 -0.903 . . . . 1.22 110.897 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.78 -45.97 81.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.743 -1.223 . . . . 1.29 110.545 179.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -60.73 -36.86 79.93 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.486 -0.759 . . . . 2.1699999999999999 110.665 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -67.01 -46.86 73.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.183 -1.007 . . . . 1.3 110.574 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.06 -43.77 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.428 -0.795 . . . . 1.1699999999999999 110.024 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 90' ' ' ILE . 81.6 mt -59.78 -42.26 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.531 -0.73 . . . . 1.3999999999999999 110.589 179.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.52 -43.86 98.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.638 -0.663 . . . . 1.3300000000000001 111.007 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.18 -44.47 97.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.741 -1.224 . . . . 1.48 110.474 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.99 -47.5 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.954 -1.091 . . . . 1.28 110.466 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -83.63 -31.3 26.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.195 -0.94 . . . . 2.6000000000000001 111.655 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 91' ' ' ALA . 51.0 t0 -80.79 -45.84 16.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.81 -1.181 . . . . 1.51 111.399 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -100.78 7.04 44.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.626 -0.671 . . . . 2.48 112.328 -178.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.3 m80 51.96 49.72 20.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.181 -0.95 . . . . 1.6100000000000001 112.153 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 91.1 mtp -109.64 160.74 16.03 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.223 -0.923 . . . . 1.8999999999999999 109.341 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.5 p -71.21 159.34 34.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.619 -0.676 . . . . 1.3200000000000001 109.852 178.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.59 93.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 1.1499999999999999 110.415 178.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -66.85 -39.72 87.7 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.282 -0.967 . . . . 2.25 109.727 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.83 -50.9 46.18 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.118 -1.033 . . . . 1.22 110.851 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.42 -41.03 96.52 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.061 -1.056 . . . . 1.1899999999999999 110.569 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.48 87.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.689 -0.632 . . . . 1.2 110.703 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -60.56 -39.63 88.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 2.1000000000000001 110.965 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -59.7 -48.87 79.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.011 -1.056 . . . . 1.3 111.055 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.29 -44.34 98.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.149 -0.969 . . . . 1.27 110.229 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.17 -32.97 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.803 -0.56 . . . . 1.1899999999999999 110.475 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -59.83 -39.81 86.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.593 -0.692 . . . . 2.1099999999999999 110.688 179.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.38 -29.73 26.71 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.331 -1.414 . . . . 0.88 113.097 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -61.03 -40.51 93.86 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.186 -1.773 . . . . 1.99 109.309 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.49 -50.02 42.3 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.82 0.819 . . . . 1.28 109.905 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.7 p -60.14 -39.72 87.28 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.725 . . . . 2.2200000000000002 110.357 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.31 -43.75 96.06 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.231 -0.918 . . . . 1.45 110.194 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.78 -28.48 69.05 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.03 -1.044 . . . . 1.47 111.295 -179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -67.15 -23.0 65.74 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.754 -0.591 . . . . 2.04 110.833 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -74.17 -11.83 60.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.696 0.76 . . . . 1.73 111.232 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 15.5 mt -86.37 141.91 28.84 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.157 -0.682 . . . . 1.79 109.157 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -99.41 55.26 0.97 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.029 -1.045 . . . . 2.8799999999999999 111.058 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -130.77 142.15 50.39 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.293 -0.88 . . . . 1.5800000000000001 109.202 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.33 -40.28 81.72 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.739 -0.601 . . . . 3.04 110.938 178.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -72.8 -54.99 7.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.942 -1.099 . . . . 1.29 111.034 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.5 mt -59.83 -40.33 88.1 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.069 -1.019 . . . . 1.6000000000000001 110.616 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -62.53 -49.42 75.41 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.67 -1.269 . . . . 2.7599999999999998 110.084 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.6 -31.03 70.2 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.04 0.924 . . . . 2.1499999999999999 109.717 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -61.99 -30.97 71.3 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.159 -1.016 . . . . 2.8100000000000001 109.558 179.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.84 -48.9 79.81 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.588 -0.845 . . . . 1.3899999999999999 109.434 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.58 -44.11 75.09 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.647 -0.821 . . . . 1.4099999999999999 110.251 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.37 -31.78 73.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.106 -0.997 . . . . 1.3899999999999999 110.272 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.0 t -67.98 -39.35 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.76 -0.776 . . . . 1.1899999999999999 109.922 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 131' ' ' ARG . 28.4 ttm-85 -56.97 -39.51 74.75 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.022 -1.071 . . . . 3.6299999999999999 109.311 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -59.8 -39.23 84.28 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.499 -0.75 . . . . 1.28 110.379 179.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.5 mt -61.54 -39.15 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.542 -0.724 . . . . 1.1799999999999999 109.968 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.45 -47.04 53.28 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 120.011 -1.09 . . . . 0.51000000000000001 110.6 179.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -57.46 -39.79 77.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.156 -1.203 . . . . 3.1699999999999999 110.496 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.43 ' HG2' HH11 ' A' ' 136' ' ' ARG . 45.5 mtt-85 -61.52 -44.31 97.29 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.247 -0.981 . . . . 2.8500000000000001 109.944 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.85 -44.73 96.6 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.327 -0.858 . . . . 1.6499999999999999 109.972 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.6 mt -59.47 -46.25 89.32 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.468 -0.77 . . . . 1.2 110.389 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -59.94 -33.73 72.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.427 -0.795 . . . . 2.7999999999999998 110.669 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.43 -41.91 45.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.606 -0.684 . . . . 2.1499999999999999 111.004 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.68 -38.31 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 1.21 110.78 -178.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.2 mt -83.97 -4.39 58.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 1.3400000000000001 112.294 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.25 20.31 79.12 Favored Glycine 0 N--CA 1.484 1.871 0 C-N-CA 119.265 -1.445 . . . . 0.91000000000000003 113.112 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.7 tp -66.97 148.43 51.97 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.665 0.745 . . . . 1.51 109.312 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -67.21 149.64 50.17 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.14 -0.975 . . . . 2.8799999999999999 109.374 178.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 65.5 mt -105.23 139.94 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.12 -1.066 . . . . 1.6200000000000001 108.12 178.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.438 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.6 mp -75.66 126.05 35.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.313 -0.995 . . . . 2.1099999999999999 108.313 178.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -96.22 98.03 9.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.877 -1.527 . . . . 1.6200000000000001 106.877 179.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 64.5 mt -74.83 -11.51 60.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.272 -0.893 . . . . 1.3999999999999999 111.582 -177.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.6 t -91.41 11.24 24.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.776 -0.577 . . . . 2.0499999999999998 112.3 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.74 17.54 14.86 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 113.658 0.985 . . . . 1.3500000000000001 113.658 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.478 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 2.4 mp -72.77 140.84 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.299 -1.5 . . . . 1.4199999999999999 109.599 178.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -119.24 -11.99 9.5 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.065 0.936 . . . . 2.9900000000000002 111.998 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -112.89 149.18 33.51 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.616 -0.883 . . . . 1.54 108.616 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -76.32 123.23 25.61 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.527 -0.916 . . . . 1.3799999999999999 108.527 178.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.0 m -148.51 174.46 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.469 -0.769 . . . . 1.28 109.308 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.9 mt -93.08 142.52 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.804 -0.813 . . . . 1.1599999999999999 108.804 178.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 23.8 tp -95.07 125.81 39.98 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.753 -1.217 . . . . 1.3100000000000001 108.022 178.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.91 129.96 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 107.68 -1.229 . . . . 1.25 107.68 179.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.44 151.52 17.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.511 -1.368 . . . . 1.26 108.838 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.49 -35.94 79.09 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.01 -1.056 . . . . 1.6000000000000001 109.475 178.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -173.09 151.84 2.2 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.734 -0.839 . . . . 2.4199999999999999 108.734 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.5 mt -115.86 139.59 50.06 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.774 -0.825 . . . . 1.3500000000000001 108.774 177.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.3 p -89.39 149.26 42.32 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.965 -1.084 . . . . 1.3200000000000001 108.762 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -41.3 -42.1 5.14 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.563 2.175 . . . . 0.69999999999999996 113.627 179.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.7 m -62.87 -51.41 67.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 1.1200000000000001 110.121 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -60.94 -39.39 89.28 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.32 -0.862 . . . . 1.21 110.115 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.4 p -67.92 -41.01 83.26 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.372 -0.83 . . . . 1.1899999999999999 110.464 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.03 -37.03 81.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.304 -0.873 . . . . 1.24 110.819 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -97.22 3.18 51.54 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.027 -1.046 . . . . 1.6899999999999999 112.685 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 46.2 tp -59.65 149.62 29.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.076 -1.015 . . . . 1.3400000000000001 109.217 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -95.42 111.17 23.1 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.763 -1.569 . . . . 2.77 106.763 177.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 73.9 mt -80.74 -10.07 59.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.643 -0.66 . . . . 2.0899999999999999 112.615 -177.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -80.29 -29.63 38.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.15 -0.969 . . . . 2.6699999999999999 111.935 -178.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -100.5 -0.92 36.96 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.126 -0.984 . . . . 2.5800000000000001 113.417 -178.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 40.0 t -108.45 129.02 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 107.749 -1.204 . . . . 1.1799999999999999 107.749 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.21 -16.09 30.12 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.366 1.079 . . . . 2.1800000000000002 111.446 -179.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.86 173.33 45.94 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.852 -1.699 . . . . 0.48999999999999999 108.852 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -130.16 131.32 45.59 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 107.784 -1.191 . . . . 0.64000000000000001 107.784 179.392 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 94.8 mt -126.77 115.3 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 106.388 -1.708 . . . . 1.21 106.388 178.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 203' ' ' VAL . 70.6 p -132.92 169.61 16.54 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.104 -0.997 . . . . 1.3799999999999999 109.599 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.455 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 2.8 m-20 -101.86 36.01 2.19 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.563 -0.711 . . . . 2.3700000000000001 110.711 179.074 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -97.88 175.64 6.07 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.766 -1.209 . . . . 1.52 109.983 177.428 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 183' ' ' ALA . . . -61.13 -132.41 0.01 OUTLIER Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.577 -1.409 . . . . 1.8 109.577 179.145 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.44 -32.89 0.1 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.63 -1.271 . . . . 2.04 113.73 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' ' 186' ' ' ARG . 36.6 mtm-85 -56.24 -39.2 72.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.678 -1.483 . . . . 5.0 110.318 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.7 p -137.72 29.27 2.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.691 -0.63 . . . . 3.02 111.686 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.1 p -82.04 139.24 34.6 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.878 0.847 . . . . 2.1099999999999999 109.204 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -59.08 -38.83 80.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 1.24 110.777 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 33.8 p -59.76 -39.78 85.94 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.268 -0.973 . . . . 2.1499999999999999 110.37 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.8 m -60.16 -37.63 80.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.382 -0.824 . . . . 2.02 110.42 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 37.3 mm -60.1 -37.25 72.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.576 -0.702 . . . . 2.1200000000000001 110.603 179.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.8 mtp -62.21 -44.22 97.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.567 1.175 . . . . 1.3600000000000001 109.418 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.48 -47.34 85.87 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.473 -0.785 . . . . 1.29 110.802 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -61.64 -42.58 99.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.214 -0.929 . . . . 3.5600000000000001 110.804 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 20.4 m -69.46 -39.82 77.5 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.38 -0.928 . . . . 1.1799999999999999 110.204 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.7 mt -90.37 -7.56 52.91 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.512 0.672 . . . . 1.3400000000000001 112.451 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 194' ' ' ALA . 99.0 mt-10 53.72 8.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 113.853 1.057 . . . . 1.45 113.853 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 66.1 mt -71.5 149.99 93.69 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 1.25 108.419 178.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.92 143.03 99.75 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.459 1.439 . . . . 0.78000000000000003 109.602 178.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.73 167.44 28.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.361 -1.462 . . . . 1.2 110.194 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.6 mt -150.58 150.53 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.626 -1.25 . . . . 1.25 107.626 178.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.2 m -141.54 -28.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.7 0 O-C-N 120.383 -1.448 . . . . 1.3899999999999999 113.156 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.34 35.12 3.64 Favored Glycine 0 N--CA 1.488 2.107 0 O-C-N 120.961 -1.087 . . . . 0.96999999999999997 112.627 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.455 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 20.1 p -59.7 -34.4 72.84 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.462 -1.611 . . . . 1.3500000000000001 110.23 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 94.26 -78.55 0.97 Allowed Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.196 -1.002 . . . . 1.0700000000000001 112.445 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.1 p -117.51 23.25 11.89 Favored 'General case' 0 N--CA 1.517 2.919 0 CA-C-N 119.262 1.531 . . . . 1.9199999999999999 114.061 -178.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.419 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 4.8 t -55.08 -30.97 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 119.479 -2.013 . . . . 1.3300000000000001 110.572 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.9 p -58.83 -28.66 66.26 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.929 -1.108 . . . . 1.4199999999999999 111.421 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 13.8 m -94.26 5.28 52.26 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.885 -1.134 . . . . 2.1200000000000001 112.32 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -129.5 -7.12 4.68 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 113.404 0.89 . . . . 2.6899999999999999 113.404 -178.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 17.2 t -118.96 139.56 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.564 -0.902 . . . . 1.29 108.564 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.448 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 31.1 mmtp -120.16 157.46 28.99 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.087 -1.079 . . . . 2.6899999999999999 108.087 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 2.7 t-20 -57.74 140.83 50.56 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.964 -1.094 . . . . 2.79 110.538 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.7 t0 80.1 0.54 2.04 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.451 1.278 . . . . 2.3500000000000001 114.451 179.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.448 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 94.5 m-20 -66.21 147.35 53.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.552 -1.342 . . . . 1.97 108.374 177.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -90.18 118.5 29.75 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.054 -1.832 . . . . 2.9700000000000002 106.054 177.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.3 mt -127.05 143.8 51.19 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.459 0.647 . . . . 1.25 109.48 -178.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 61.2 mt -111.36 127.59 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 106.399 -1.704 . . . . 1.22 106.399 177.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.9 tp -100.86 120.12 39.67 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.428 -1.323 . . . . 1.24 107.428 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.587 ' O ' ' N ' ' A' ' 223' ' ' VAL . 52.3 t0 -93.94 -23.68 17.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.872 -1.143 . . . . 2.0499999999999998 112.777 -178.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 10' ' ' GLY . . . 37.94 18.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.098 0.777 . . . . 1.25 113.098 -178.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.9 t -108.14 -60.3 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.924 -1.11 . . . . 1.4299999999999999 109.037 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -100.15 16.3 24.6 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.53 0.681 . . . . 3.0299999999999998 110.345 -179.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 4' ' ' GLY . 4.1 t-20 61.2 51.61 4.27 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.362 0.601 . . . . 2.25 111.771 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -145.83 144.87 30.52 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.277 1.036 . . . . 2.52 110.193 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.61 145.16 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.948 -0.76 . . . . 1.29 108.948 178.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -101.95 136.58 41.54 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.208 -1.034 . . . . 1.3400000000000001 108.208 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.62 129.93 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.004 -0.739 . . . . 1.3400000000000001 109.004 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 42.6 t30 49.63 58.63 17.52 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 113.79 1.033 . . . . 2.1800000000000002 113.79 178.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.66 141.51 38.0 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 121.96 1.773 . . . . 0.93999999999999995 110.791 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.4 p -74.08 156.72 37.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.942 -1.099 . . . . 2.3999999999999999 109.277 177.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -58.49 -37.73 76.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.333 -0.854 . . . . 3.3300000000000001 110.472 178.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.16 -40.98 82.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.452 -0.78 . . . . 3.1699999999999999 110.223 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 96.6 t -71.06 -42.99 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.386 -0.821 . . . . 1.6899999999999999 109.979 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.3 mt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.556 -0.715 . . . . 1.6000000000000001 110.084 -179.043 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 107.654 -1.239 . . . . 1.5700000000000001 107.654 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.2 m -105.73 123.3 47.72 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.784 -1.191 . . . . 1.4399999999999999 107.784 178.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.22 -162.94 11.64 Favored Glycine 0 N--CA 1.499 2.884 0 N-CA-C 108.274 -1.93 . . . . 1.01 108.274 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 90.9 mt -100.59 2.28 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.174 -1.191 . . . . 1.6299999999999999 112.671 -179.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 5' ' ' ILE . 12.3 tp 50.71 101.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.078 -1.014 . . . . 1.5800000000000001 112.134 179.166 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.87 -41.55 13.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.939 -1.1 . . . . 1.3400000000000001 111.549 179.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 t -145.19 146.17 29.52 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.045 -1.095 . . . . 1.8600000000000001 108.045 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.59 143.85 21.89 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.815 2.343 . . . . 1.01 112.377 178.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 151.19 -177.47 29.16 Favored Glycine 0 N--CA 1.503 3.129 0 N-CA-C 109.658 -1.377 . . . . 0.81000000000000005 109.658 177.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.9 mt -137.81 140.75 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.25 -1.147 . . . . 1.3700000000000001 108.578 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.48 149.99 43.22 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.317 -0.865 . . . . 1.1399999999999999 109.005 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -119.56 139.8 51.56 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.713 -1.217 . . . . 0.87 107.713 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.49 163.95 27.92 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 118.125 -1.988 . . . . 0.56999999999999995 110.485 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -76.48 160.68 29.29 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.506 -0.997 . . . . 2.3500000000000001 109.837 179.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.15 122.29 28.64 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.965 -1.124 . . . . 1.21 107.965 178.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.7 tp -101.71 101.97 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.089 -2.189 . . . . 1.3999999999999999 105.089 177.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.6 tp -88.25 140.37 29.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.176 -0.952 . . . . 1.4399999999999999 108.632 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.9 mt -98.28 118.5 35.06 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 106.271 -1.752 . . . . 1.45 106.271 177.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.428 ' CB ' ' HZ1' ' A' ' 20' ' ' LYS . 8.3 mtpm? -111.01 134.07 52.91 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.201 -1.037 . . . . 2.5 108.201 -179.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -125.95 140.8 52.33 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.584 -0.895 . . . . 2.6600000000000001 108.584 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -81.81 138.01 35.2 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.371 -0.974 . . . . 2.3199999999999998 108.371 177.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -63.29 143.63 57.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -0.773 . . . . 2.1099999999999999 108.991 178.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 87.9 mt -94.53 132.13 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.174 -1.047 . . . . 1.29 108.174 178.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.16 130.19 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.233 -1.025 . . . . 1.4099999999999999 108.233 179.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.8 mt -94.07 138.13 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.374 -0.973 . . . . 1.3100000000000001 108.374 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -92.19 122.23 34.48 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.572 -1.27 . . . . 1.3400000000000001 107.572 178.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -93.54 10.93 30.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.289 -0.882 . . . . 3.48 112.651 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -71.57 153.01 42.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.706 -1.246 . . . . 2.52 109.349 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -92.18 140.04 30.02 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 109.102 -0.703 . . . . 2.6299999999999999 109.102 178.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -92.39 175.29 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.229 -0.919 . . . . 1.3100000000000001 109.915 177.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 p -103.5 166.62 10.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.522 -0.736 . . . . 1.24 109.549 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.56 -35.26 67.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.488 -0.758 . . . . 1.49 111.519 178.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -69.86 -22.23 63.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.846 -1.159 . . . . 2.2799999999999998 110.626 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -94.02 -20.44 19.96 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.492 0.663 . . . . 2.0499999999999998 112.213 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.84 -46.4 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.626 -0.671 . . . . 1.3400000000000001 110.236 -178.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -58.86 -40.36 84.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.323 -0.861 . . . . 1.54 110.658 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -64.0 -45.32 89.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 2.8500000000000001 110.808 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -60.82 -37.74 83.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.256 -0.903 . . . . 1.3100000000000001 110.945 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -59.13 -40.07 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.176 -0.953 . . . . 1.3799999999999999 110.082 179.274 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.72 -41.74 95.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.072 -1.018 . . . . 1.5 109.645 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -63.1 -39.16 93.88 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.343 -0.848 . . . . 2.7799999999999998 110.094 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -72.11 -54.52 9.52 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.411 -0.806 . . . . 1.0600000000000001 110.06 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.7 tp -60.78 -50.14 74.65 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.969 0.89 . . . . 1.3999999999999999 109.74 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.0 t -67.41 -38.91 85.35 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.422 -0.799 . . . . 1.3200000000000001 110.247 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.58 90.85 Favored Glycine 0 N--CA 1.485 1.934 0 C-N-CA 119.648 -1.263 . . . . 0.69999999999999996 110.056 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -59.94 -31.65 70.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.24 -1.153 . . . . 3.4399999999999999 109.63 178.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.63 90.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.619 0.723 . . . . 1.3600000000000001 109.764 179.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -80.52 -48.65 12.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 2.8300000000000001 110.85 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.99 79.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.515 -0.741 . . . . 1.23 110.102 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.6 ' HG ' ' N ' ' A' ' 52' ' ' ALA . 89.4 p -61.68 -38.56 88.28 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.867 0.842 . . . . 1.9199999999999999 109.343 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.6 ' N ' ' HG ' ' A' ' 51' ' ' SER . . . -68.82 -46.19 69.25 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.948 -0.569 . . . . 1.25 110.313 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.74 -49.35 75.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.633 -1.292 . . . . 1.97 110.122 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.9 mt -61.34 -40.0 92.62 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.034 0.921 . . . . 2.1800000000000002 109.513 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -60.64 -39.73 89.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.577 -0.702 . . . . 1.1899999999999999 110.105 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.0 m -62.06 -42.89 99.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.866 . . . . 1.3400000000000001 110.366 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.0 -36.94 70.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.609 -0.682 . . . . 1.23 110.645 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -51.1 -43.5 61.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.938 . . . . 1.5600000000000001 110.443 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -70.27 -36.42 74.41 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.926 -1.109 . . . . 1.3 110.009 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -62.69 -39.34 93.68 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.819 -1.153 . . . . 2.3199999999999998 109.316 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.74 81.74 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.852 -0.613 . . . . 1.1399999999999999 110.091 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.78 -35.86 23.97 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.467 -1.349 . . . . 0.68999999999999995 110.964 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.03 -17.59 46.22 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.17 -1.194 . . . . 1.48 111.575 -179.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.7 m -93.46 -52.73 4.37 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.716 -0.615 . . . . 1.52 110.672 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -107.65 -6.23 17.0 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 114.004 1.112 . . . . 1.3100000000000001 114.004 -178.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.96 149.88 11.85 Favored Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.375 -0.828 . . . . 0.84999999999999998 112.432 178.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.47 -15.35 0.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.386 -1.067 . . . . 3.8599999999999999 112.464 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.46 -31.32 69.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.395 -0.816 . . . . 2.3500000000000001 111.291 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -83.35 -16.93 44.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.807 -1.183 . . . . 2.2599999999999998 112.109 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.16 -30.76 69.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.888 -1.133 . . . . 1.45 111.228 -179.094 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.32 90.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 1.25 110.767 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.6 mt -67.5 -41.48 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.842 -1.161 . . . . 1.26 109.337 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -71.39 -29.88 65.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.82999999999999996 110.734 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.25 -39.88 88.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.869 . . . . 1.1899999999999999 110.046 179.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.44 -44.31 74.02 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.745 -0.942 . . . . 0.57999999999999996 110.745 179.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -60.0 -48.06 83.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.934 -1.333 . . . . 2.0499999999999998 110.726 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.5 mt -62.41 -39.49 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 120.9 -1.125 . . . . 1.21 110.016 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.8 ttp -60.28 -39.98 88.79 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.806 -0.758 . . . . 2.29 110.506 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.1 tp -59.37 -48.52 81.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 1.21 110.355 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.05 -41.24 91.9 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.861 0.838 . . . . 1.1399999999999999 110.144 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -85.93 4.17 38.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.607 -0.683 . . . . 1.4199999999999999 112.496 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -59.7 124.54 20.46 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.182 -0.949 . . . . 1.27 110.894 -178.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.02 -16.42 63.42 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.418 -0.801 . . . . 1.3500000000000001 111.226 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -76.94 -54.31 6.73 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.769 0.795 . . . . 2.2200000000000002 110.568 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.84 -38.24 87.49 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.386 -0.821 . . . . 1.22 110.923 -179.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.0 -49.58 77.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.073 -1.017 . . . . 1.29 110.786 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.67 -39.48 94.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.027 -1.046 . . . . 2.1699999999999999 110.708 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.95 -49.42 61.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 1.3 110.87 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.11 -45.64 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.836 -1.165 . . . . 1.1699999999999999 110.097 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.45 -41.92 91.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.515 0.674 . . . . 1.3999999999999999 110.43 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -60.07 -42.95 95.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.258 -0.901 . . . . 1.3300000000000001 111.036 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.29 -39.56 87.32 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.254 -0.904 . . . . 1.48 110.332 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.0 -51.18 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 1.28 110.365 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.86 -33.99 62.19 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.382 -0.824 . . . . 2.6000000000000001 111.493 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 91' ' ' ALA . 54.5 t0 -80.42 -45.92 16.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.139 -0.976 . . . . 1.51 111.842 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -103.07 8.64 38.76 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.058 -1.026 . . . . 2.48 112.581 -178.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 56.0 m80 53.17 49.9 18.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 1.6100000000000001 111.752 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.1 mtt -102.02 152.97 20.33 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.211 -0.931 . . . . 1.8999999999999999 109.668 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.511 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 68.1 p -71.34 156.52 39.41 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.321 -0.862 . . . . 1.3200000000000001 109.304 177.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.02 -45.75 79.04 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.276 -0.89 . . . . 1.1499999999999999 110.366 178.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -68.35 -39.3 81.92 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.063 -1.023 . . . . 2.25 110.267 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.511 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -70.87 -47.78 57.39 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.516 -1.274 . . . . 1.22 110.856 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.25 90.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 1.1899999999999999 110.178 -178.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.12 91.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.252 -0.905 . . . . 1.2 110.621 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -60.31 -38.39 83.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 2.1000000000000001 111.249 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -58.49 -49.2 78.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.998 -1.064 . . . . 1.3 111.267 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.3 t -61.5 -44.86 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.834 -1.166 . . . . 1.27 110.321 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.66 -33.24 56.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.556 -0.715 . . . . 1.1899999999999999 110.403 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -58.5 -41.91 86.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.377 -0.827 . . . . 2.1099999999999999 110.802 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.36 -30.39 22.26 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.142 -1.504 . . . . 0.88 112.121 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -62.21 -40.6 96.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.523 -1.575 . . . . 1.99 110.252 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.35 -50.59 30.69 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.539 -0.726 . . . . 1.28 111.092 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.1 m -59.63 -39.81 85.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -0.902 . . . . 2.2200000000000002 110.926 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.19 -42.18 98.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 1.45 111.323 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.27 -29.86 70.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.575 -1.328 . . . . 1.47 111.023 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.91 -21.95 65.97 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.17 -0.956 . . . . 2.04 110.958 179.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -74.96 -12.04 60.25 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.019 -0.672 . . . . 1.73 111.412 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.8 mt -87.08 149.22 24.86 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.146 -0.687 . . . . 1.79 109.146 179.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -102.61 47.49 0.89 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.456 -0.778 . . . . 2.8799999999999999 111.197 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -124.58 134.5 52.94 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 108.502 -0.925 . . . . 1.5800000000000001 108.502 179.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -57.34 -38.5 74.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.373 -0.829 . . . . 3.04 110.979 178.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -70.88 -49.1 49.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.666 -1.271 . . . . 1.29 110.055 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.8 mt -62.89 -39.14 93.57 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.848 -1.158 . . . . 1.6000000000000001 109.994 -178.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -64.09 -50.18 69.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.627 -1.296 . . . . 2.7599999999999998 110.149 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.54 -30.14 69.58 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.925 -1.109 . . . . 2.1499999999999999 109.535 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -64.79 -29.5 70.47 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.959 0.885 . . . . 2.8100000000000001 109.551 179.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.55 -49.31 78.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.465 -0.894 . . . . 1.3899999999999999 109.71 178.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.27 83.22 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.477 -0.889 . . . . 1.4099999999999999 110.022 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.55 -35.0 78.07 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.186 0.517 . . . . 1.3899999999999999 110.839 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 t -69.01 -40.98 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.146 -0.971 . . . . 1.1899999999999999 110.568 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.456 ' HG2' HH11 ' A' ' 131' ' ' ARG . 24.2 ttt-85 -57.74 -38.57 75.56 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.397 -1.321 . . . . 3.6299999999999999 109.52 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -60.79 -38.39 85.14 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.421 0.629 . . . . 1.28 110.397 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.25 -39.91 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.252 -0.905 . . . . 1.1799999999999999 109.821 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.52 -43.76 60.21 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.634 -1.27 . . . . 0.51000000000000001 110.202 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -57.92 -41.26 82.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.458 -1.025 . . . . 3.1699999999999999 110.364 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.435 ' HG2' HH11 ' A' ' 136' ' ' ARG . 62.4 mtt-85 -61.7 -43.18 99.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.88 -1.137 . . . . 2.8500000000000001 110.093 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.7 tp -60.56 -44.9 95.65 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.957 0.884 . . . . 1.6499999999999999 109.452 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.76 -38.0 83.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.314 -0.866 . . . . 1.2 110.16 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -39.32 85.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 2.7999999999999998 111.171 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -75.17 -40.86 59.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.872 -1.143 . . . . 2.1499999999999999 111.008 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.94 -39.77 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 1.21 110.618 -178.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -86.51 -10.07 54.86 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.962 -1.086 . . . . 1.3400000000000001 111.927 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.39 19.52 71.43 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.992 -1.099 . . . . 0.91000000000000003 112.634 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 46.2 tp -71.07 140.23 50.64 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.673 -0.898 . . . . 1.51 109.317 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -67.55 150.73 48.44 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.226 -0.921 . . . . 2.8799999999999999 110.65 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 81.0 mt -106.18 142.11 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.453 -0.944 . . . . 1.6200000000000001 108.453 178.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 23.3 mm -74.56 122.59 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.326 -0.991 . . . . 2.1099999999999999 108.326 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -95.85 100.65 12.32 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.891 -1.892 . . . . 1.6200000000000001 105.891 178.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 53.8 mt -73.56 -21.46 60.35 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.295 -0.878 . . . . 1.3999999999999999 111.396 -177.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 82.5 p -83.97 7.05 19.62 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.443 -0.786 . . . . 2.0499999999999998 112.169 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.16 17.7 19.26 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.531 0.681 . . . . 1.3500000000000001 112.212 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.4 mt -74.98 144.49 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.636 -0.665 . . . . 1.4199999999999999 109.785 179.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -120.85 -9.76 9.23 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.359 -0.838 . . . . 2.9900000000000002 112.522 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -118.77 141.92 48.18 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.963 -0.755 . . . . 1.54 108.963 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.86 124.19 26.42 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.159 0.981 . . . . 1.3799999999999999 108.791 178.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.68 176.84 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.038 -0.727 . . . . 1.28 109.038 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 67.8 mt -91.98 141.59 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.225 -1.028 . . . . 1.1599999999999999 108.225 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.7 tp -93.95 126.53 39.21 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.851 -1.155 . . . . 1.3100000000000001 108.447 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 32.3 t -123.42 129.99 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.059 -1.089 . . . . 1.25 108.059 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.83 158.18 27.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.226 -0.921 . . . . 1.26 108.783 179.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 162' ' ' ASP . . . -62.05 -39.43 92.34 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.573 -1.33 . . . . 1.6000000000000001 109.772 178.224 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 55.8 m-20 -168.93 156.63 7.53 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.192 -1.04 . . . . 2.4199999999999999 108.192 179.187 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 38.4 mt -117.25 139.62 50.57 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.231 -0.918 . . . . 1.3500000000000001 108.612 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.0 p -95.96 151.02 38.05 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.141 -1.059 . . . . 1.3200000000000001 108.141 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -39.87 -43.72 3.44 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.779 1.652 . . . . 0.69999999999999996 113.351 179.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 74.8 m -61.28 -50.38 73.23 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.288 -0.882 . . . . 1.1200000000000001 109.953 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.68 -39.4 88.29 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.409 -0.807 . . . . 1.21 110.153 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.8 p -68.77 -41.08 79.33 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.852 -0.739 . . . . 1.1899999999999999 110.575 179.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.21 -34.86 74.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.07 -1.019 . . . . 1.24 110.531 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -96.97 -1.37 45.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.125 -0.984 . . . . 1.6899999999999999 112.879 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.46 151.71 31.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.98 -1.075 . . . . 1.3400000000000001 109.695 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 172' ' ' ASN . 25.0 p-10 -92.91 108.13 19.76 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 106.439 -1.689 . . . . 2.77 106.439 178.007 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 3.1 mm? -76.96 -18.71 58.07 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.488 -0.757 . . . . 2.0899999999999999 111.63 -177.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -81.1 -25.66 36.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.064 -1.023 . . . . 2.6699999999999999 112.255 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -102.75 -4.43 25.01 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 113.829 1.048 . . . . 2.5800000000000001 113.829 -178.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 63.0 t -101.68 120.1 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.302 -1.74 . . . . 1.1799999999999999 106.302 178.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 22.0 tp -84.89 -0.73 55.11 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.657 0.742 . . . . 2.1800000000000002 111.873 -178.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.34 169.95 34.09 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.035 -1.626 . . . . 0.48999999999999999 109.035 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -129.31 137.74 51.18 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.193 -1.18 . . . . 0.64000000000000001 108.31 179.107 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.2 mt -135.67 110.87 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 105.798 -1.927 . . . . 1.21 105.798 178.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 203' ' ' VAL . 41.7 p -135.8 179.31 6.42 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.667 -1.27 . . . . 1.3799999999999999 110.089 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -102.43 55.52 0.78 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 115.91 -0.586 . . . . 2.3700000000000001 109.735 179.555 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.01 166.55 10.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.663 -0.648 . . . . 1.52 109.448 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.23 -81.93 0.1 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.797 -1.192 . . . . 1.8 111.244 178.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.82 -67.53 0.28 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.31 -1.112 . . . . 2.04 111.954 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -61.36 -39.47 90.74 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.378 -1.072 . . . . 5.0 110.143 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.2 p -105.76 13.79 29.17 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.614 -0.679 . . . . 3.02 111.831 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.5 t -86.91 120.46 28.2 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.413 -1.329 . . . . 2.1099999999999999 107.413 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -60.7 -40.54 92.59 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.696 -0.628 . . . . 1.24 110.767 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 11.9 t -59.68 -40.03 86.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.916 -1.115 . . . . 2.1499999999999999 110.29 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.5 t -58.57 -37.56 76.03 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.325 -0.86 . . . . 2.02 110.48 179.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.81 -38.66 77.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.123 -0.986 . . . . 2.1200000000000001 110.415 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 74.4 mtp -62.3 -43.63 98.38 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.395 1.093 . . . . 1.3600000000000001 109.128 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.31 -41.15 83.86 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.223 -0.899 . . . . 1.29 110.464 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.41 ' HG2' HH11 ' A' ' 195' ' ' ARG . 47.0 mtt-85 -60.47 -42.07 95.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.915 -1.115 . . . . 3.5600000000000001 110.095 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 64.4 m -71.06 -39.31 72.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 1.1799999999999999 110.305 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.3 mt -91.24 -9.3 45.72 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.841 0.829 . . . . 1.3400000000000001 112.392 -178.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.4 mt-10 52.29 12.5 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.846 1.054 . . . . 1.45 113.846 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.66 147.81 96.58 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 1.25 108.238 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -56.73 139.68 89.11 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.379 1.386 . . . . 0.78000000000000003 110.134 178.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.77 165.85 31.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.518 -1.364 . . . . 1.2 109.798 179.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 59.6 mt -145.39 156.84 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.656 -1.238 . . . . 1.25 107.656 178.199 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 181' ' ' THR . 8.0 m -137.9 -32.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.162 -0.961 . . . . 1.3899999999999999 112.942 -179.374 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -72.27 34.03 0.66 Allowed Glycine 0 N--CA 1.486 1.983 0 C-N-CA 120.25 -0.976 . . . . 0.96999999999999997 113.052 -178.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.414 ' H ' ' C ' ' A' ' 203' ' ' VAL . 54.8 p -58.65 -26.81 64.16 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.198 -1.178 . . . . 1.3500000000000001 111.074 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.31 -93.54 0.89 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 110.525 -1.03 . . . . 1.0700000000000001 110.525 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.4 t -126.19 30.56 5.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.848 -0.795 . . . . 1.9199999999999999 112.269 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 94.7 t -59.62 -34.96 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.525 -1.359 . . . . 1.3300000000000001 110.23 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 29.4 p -56.13 -24.5 41.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 1.4199999999999999 111.344 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.6 m -91.97 1.67 57.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.139 -0.975 . . . . 2.1200000000000001 111.919 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -125.23 -7.25 7.07 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.038 0.755 . . . . 2.6899999999999999 113.038 -178.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 48.8 t -114.97 150.76 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.789 -0.819 . . . . 1.29 108.789 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -120.57 154.1 35.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.354 -0.98 . . . . 2.6899999999999999 108.354 177.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.435 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 51.4 p-10 -53.56 144.67 16.76 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.988 -1.07 . . . . 2.79 110.797 178.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.9 OUTLIER 81.18 0.11 1.7 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.808 1.41 . . . . 2.3500000000000001 114.808 179.415 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.0 146.13 55.06 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.382 -1.449 . . . . 1.97 108.473 177.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -87.83 120.26 28.99 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.353 -1.351 . . . . 2.9700000000000002 107.353 178.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.62 145.76 50.01 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.704 0.764 . . . . 1.25 110.055 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.91 126.05 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 106.276 -1.75 . . . . 1.22 106.276 177.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.3 tp -102.13 119.59 39.05 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.797 -1.557 . . . . 1.24 106.797 179.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.62 ' O ' ' N ' ' A' ' 223' ' ' VAL . 78.8 m-20 -94.22 -22.85 18.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 2.0499999999999998 112.238 -178.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 39.11 14.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 112.508 0.558 . . . . 1.25 112.508 -178.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.3 t -112.31 -59.91 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.279 -0.888 . . . . 1.4299999999999999 109.857 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -92.21 12.12 23.36 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.52 0.676 . . . . 3.0299999999999998 110.963 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 60.22 48.9 7.72 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.262 0.553 . . . . 2.25 111.127 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -147.92 145.38 28.59 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.181 0.991 . . . . 2.52 109.836 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.5 t -117.16 138.82 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.822 -1.177 . . . . 1.29 107.822 177.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -100.13 130.08 46.23 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.913 -1.117 . . . . 1.3400000000000001 108.235 178.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.8 t -109.67 130.03 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.382 -0.969 . . . . 1.3400000000000001 108.382 179.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 25.0 t30 56.62 49.9 4.46 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 114.225 1.194 . . . . 2.1800000000000002 114.225 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 44.2 Cg_endo -67.88 149.94 78.19 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.41 2.073 . . . . 0.93999999999999995 110.263 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 45.8 p -72.81 152.71 41.42 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.574 -1.329 . . . . 2.3999999999999999 109.272 177.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -59.93 -34.51 73.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 3.3300000000000001 110.308 178.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.77 -40.6 88.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 3.1699999999999999 110.497 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 67.9 t -70.51 -40.87 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.154 -0.966 . . . . 1.6899999999999999 109.974 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.2 mt . . . . . 0 C--N 1.303 -1.418 0 O-C-N 121.379 -0.826 . . . . 1.6000000000000001 110.606 -178.591 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.3 mt . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 106.761 -1.57 . . . . 1.5700000000000001 106.761 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.4 m -104.35 124.76 49.77 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.53 -1.285 . . . . 1.4399999999999999 107.53 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.22 -159.24 17.2 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 108.46 -1.856 . . . . 1.01 108.46 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 97.0 mt -94.44 0.52 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.186 -1.185 . . . . 1.6299999999999999 112.677 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 51.8 93.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.854 -1.153 . . . . 1.5800000000000001 112.043 178.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.61 -34.41 18.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.832 -1.167 . . . . 1.3400000000000001 111.12 179.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.559 ' HG ' ' N ' ' A' ' 201' ' ' ALA . 1.2 p -149.55 143.98 17.37 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.59 -1.319 . . . . 1.8600000000000001 107.96 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.37 145.67 21.42 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.464 2.11 . . . . 1.01 112.758 178.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.42 162.08 9.98 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 109.835 -1.306 . . . . 0.81000000000000005 109.835 178.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.3 132.55 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 O-C-N 120.861 -1.376 . . . . 1.3700000000000001 107.966 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.85 150.12 45.65 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.231 -0.918 . . . . 1.1399999999999999 109.307 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.0 m-85 -123.26 144.03 49.67 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.911 -0.774 . . . . 0.87 108.911 178.278 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.12 169.67 36.55 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.03 -1.557 . . . . 0.56999999999999995 109.897 177.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -76.95 154.79 33.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.542 -0.975 . . . . 2.3500000000000001 108.786 178.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.76 125.65 33.4 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.453 -1.314 . . . . 1.21 107.453 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.3 tp -101.95 107.46 18.61 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.262 -2.125 . . . . 1.3999999999999999 105.262 177.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -90.28 135.66 33.54 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.839 -1.171 . . . . 1.4399999999999999 107.839 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.5 mt -100.29 114.34 27.73 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.78 -1.563 . . . . 1.45 106.78 178.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -109.77 137.34 47.71 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.389 -1.337 . . . . 2.5 107.389 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -129.55 144.92 51.48 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.918 -1.114 . . . . 2.6600000000000001 109.041 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -83.58 136.19 34.34 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.154 -1.054 . . . . 2.3199999999999998 108.154 177.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.99 149.41 44.94 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.278 -0.889 . . . . 2.1099999999999999 108.627 178.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.8 mt -94.68 134.74 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.68 -0.859 . . . . 1.29 108.68 178.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.99 131.46 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.757 -1.201 . . . . 1.4099999999999999 107.757 179.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -91.03 144.94 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.08 -0.711 . . . . 1.3100000000000001 109.08 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -88.97 122.44 32.33 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.633 -1.247 . . . . 1.3400000000000001 107.633 178.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -97.9 16.93 19.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.612 -0.68 . . . . 3.48 112.314 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.51 143.02 56.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.283 -0.885 . . . . 2.52 109.383 179.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -90.93 135.73 33.54 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.929 -1.138 . . . . 2.6299999999999999 107.929 178.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.6 pt -97.68 172.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 122.101 0.953 . . . . 1.3100000000000001 109.889 177.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.44 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 38.2 p -102.85 161.31 13.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.873 -0.788 . . . . 1.24 108.873 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.03 -31.88 19.77 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.996 -1.065 . . . . 1.49 111.947 178.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.44 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 3.5 p-10 -69.99 -40.15 75.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 2.2799999999999998 110.037 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -77.47 -19.03 56.57 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.363 -0.836 . . . . 2.0499999999999998 111.413 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.5 t -59.76 -42.56 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.069 -1.019 . . . . 1.3400000000000001 110.568 179.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -57.1 -39.96 76.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.808 -1.183 . . . . 1.54 110.841 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.275 -0.891 . . . . 2.8500000000000001 110.402 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -62.76 -35.34 79.51 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.752 -1.217 . . . . 1.3100000000000001 110.87 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.69 -40.36 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.61 -1.306 . . . . 1.3799999999999999 110.21 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -61.4 -39.67 91.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 1.5 109.654 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.473 ' HG2' HH11 ' A' ' 42' ' ' ARG . 21.6 mtt-85 -63.07 -42.96 99.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 2.7799999999999998 110.06 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -72.12 -54.17 10.55 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 119.838 -0.745 . . . . 1.0600000000000001 110.138 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.96 -48.05 82.93 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.236 -0.985 . . . . 1.3999999999999999 110.013 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 t -70.06 -38.68 75.84 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.321 -0.862 . . . . 1.3200000000000001 110.061 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.78 -43.11 96.68 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.674 -1.37 . . . . 0.69999999999999996 109.674 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -58.21 -33.34 69.2 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.217 1.008 . . . . 3.4399999999999999 108.742 179.125 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.06 -46.05 79.06 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.015 0.912 . . . . 1.3600000000000001 109.274 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.616 ' HZ1' ' NE2' ' A' ' 53' ' ' GLN . 25.8 ttpp -76.81 -43.54 36.16 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.355 -0.841 . . . . 2.8300000000000001 110.658 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.96 82.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.089 -1.007 . . . . 1.23 109.91 -178.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -59.52 -40.0 85.72 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.342 -0.943 . . . . 1.9199999999999999 109.346 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.81 -48.84 65.1 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.736 -0.602 . . . . 1.25 110.327 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.616 ' NE2' ' HZ1' ' A' ' 49' ' ' LYS . 93.4 mt-30 -60.83 -49.94 75.46 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.356 -1.465 . . . . 1.97 110.566 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.31 -39.31 92.6 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.237 -0.914 . . . . 2.1800000000000002 109.923 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -59.89 -41.2 91.08 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.017 -0.673 . . . . 1.1899999999999999 110.543 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.403 HG21 ' HZ1' ' A' ' 60' ' ' LYS . 23.6 m -64.62 -42.57 95.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.405 -0.809 . . . . 1.3400000000000001 110.273 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.444 HD11 HG22 ' A' ' 57' ' ' ILE . 98.1 mt -59.57 -39.32 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.459 -0.776 . . . . 1.23 110.617 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -51.66 -40.25 59.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.86 -1.15 . . . . 1.5600000000000001 110.523 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.56 -40.0 73.61 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.328 -0.858 . . . . 1.3 109.974 -179.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.403 ' HZ1' HG21 ' A' ' 56' ' ' THR . 61.7 mttp -63.42 -39.01 93.33 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.53 -1.268 . . . . 2.3199999999999998 108.583 -178.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.37 75.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.568 -0.707 . . . . 1.1399999999999999 110.112 179.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.85 -38.16 10.77 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 119.697 -1.24 . . . . 0.68999999999999995 111.322 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.46 -23.48 43.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.793 -1.416 . . . . 1.48 110.688 -179.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -88.72 -50.42 6.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.088 -1.008 . . . . 1.52 111.067 179.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -106.79 -9.5 16.38 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 114.378 1.251 . . . . 1.3100000000000001 114.378 -177.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.36 154.13 12.11 Favored Glycine 0 N--CA 1.502 3.091 0 O-C-N 121.128 -0.982 . . . . 0.84999999999999998 111.736 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -54.31 -17.15 2.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -1.033 . . . . 3.8599999999999999 112.544 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -58.38 -35.3 71.79 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.39 -0.819 . . . . 2.3500000000000001 110.903 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -82.46 -21.99 35.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.741 -1.224 . . . . 2.2599999999999998 111.708 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.05 -32.91 71.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.9 . . . . 1.45 111.279 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.53 93.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.948 -1.095 . . . . 1.25 110.534 179.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.1 mt -68.17 -45.29 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.487 -1.383 . . . . 1.26 110.547 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -69.65 -31.32 69.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.912 -1.117 . . . . 0.82999999999999996 110.934 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.02 -39.64 86.55 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.295 -0.878 . . . . 1.1899999999999999 109.974 178.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.96 -38.09 95.06 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.866 -1.294 . . . . 0.57999999999999996 109.866 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -58.0 -44.03 86.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.414 -1.05 . . . . 2.0499999999999998 110.001 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.48 -40.59 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.942 -1.099 . . . . 1.21 110.432 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.4 ttt -60.01 -38.95 84.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.271 -0.893 . . . . 2.29 110.108 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -60.96 -50.62 72.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.807 . . . . 1.21 110.201 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.57 -40.44 87.36 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.445 -0.902 . . . . 1.1399999999999999 110.493 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -88.64 10.54 20.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.645 -0.66 . . . . 1.4199999999999999 112.68 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -62.93 123.27 18.09 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.035 -1.041 . . . . 1.27 109.151 178.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -67.39 -19.13 65.36 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.951 0.882 . . . . 1.3500000000000001 110.708 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -77.7 -49.65 14.04 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.658 0.742 . . . . 2.2200000000000002 110.748 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.79 -38.97 90.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.318 -0.864 . . . . 1.22 110.346 -179.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -57.83 -46.95 83.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.84 -0.537 . . . . 1.29 110.91 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -61.04 -39.92 91.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.136 -0.977 . . . . 2.1699999999999999 110.381 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -65.75 -47.2 76.07 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 118.827 -1.149 . . . . 1.3 111.145 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.3 mt -57.56 -44.27 84.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.861 -1.149 . . . . 1.1699999999999999 110.4 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.406 HG22 HD11 ' A' ' 90' ' ' ILE . 91.7 mt -63.42 -41.54 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.665 0.745 . . . . 1.3999999999999999 110.967 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.54 -42.08 98.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 1.3300000000000001 111.17 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.5 mt -60.43 -45.09 94.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.087 . . . . 1.48 110.536 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.4 mt -60.79 -49.88 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.495 -0.753 . . . . 1.28 110.205 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -77.3 -37.17 53.31 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.59 -0.694 . . . . 2.6000000000000001 111.776 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -80.71 -46.95 14.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.874 -1.141 . . . . 1.51 112.455 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -100.59 8.33 43.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.964 -1.085 . . . . 2.48 112.677 -178.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 37.3 m80 51.94 50.5 18.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.902 -1.124 . . . . 1.6100000000000001 111.998 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.4 mtt -107.17 155.54 19.79 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.197 -0.939 . . . . 1.8999999999999999 109.456 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.2 p -72.23 166.4 22.5 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.609 -0.682 . . . . 1.3200000000000001 110.51 178.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.7 -43.79 97.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.429 -0.794 . . . . 1.1499999999999999 110.413 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 6.2 p-10 -69.59 -43.41 72.86 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.437 -0.79 . . . . 2.25 109.934 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.08 -47.69 70.51 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.945 -1.102 . . . . 1.22 110.463 -179.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.33 98.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.977 -1.077 . . . . 1.1899999999999999 110.571 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.38 -43.2 92.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.147 -0.971 . . . . 1.2 110.526 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -61.41 -40.21 93.59 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.144 -0.972 . . . . 2.1000000000000001 111.403 -179.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -58.54 -48.43 80.89 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.996 -1.065 . . . . 1.3 111.101 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.3 t -61.04 -46.89 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.205 -0.935 . . . . 1.27 109.816 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -62.24 -32.38 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.271 0.557 . . . . 1.1899999999999999 110.443 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -55.41 -40.8 71.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 2.1099999999999999 110.18 179.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.12 -27.69 30.29 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.636 -1.268 . . . . 0.88 113.269 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -62.18 -40.35 95.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.404 -1.645 . . . . 1.99 109.67 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.21 -52.15 10.64 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.919 -0.488 . . . . 1.28 111.025 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.2 m -59.51 -39.03 82.49 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.628 -0.829 . . . . 2.2200000000000002 110.634 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.43 98.18 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.452 -0.78 . . . . 1.45 111.288 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.2 -30.11 71.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.1 -1.0 . . . . 1.47 111.347 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -68.53 -20.21 64.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.956 -1.09 . . . . 2.04 111.006 179.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -75.49 -14.24 60.41 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.519 -0.738 . . . . 1.73 111.158 -179.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.8 mt -84.35 150.98 25.01 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.439 -0.788 . . . . 1.79 109.015 179.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -98.21 35.77 1.7 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.954 -1.091 . . . . 2.8799999999999999 112.468 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -116.0 130.99 57.06 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.667 -0.864 . . . . 1.5800000000000001 108.667 179.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.28 -35.89 74.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 3.04 111.107 178.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -69.18 -48.9 60.95 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.499 -1.376 . . . . 1.29 110.289 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.9 mt -62.57 -39.94 95.26 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.011 -1.055 . . . . 1.6000000000000001 110.854 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -62.82 -49.75 73.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.872 -1.143 . . . . 2.7599999999999998 109.98 178.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.77 -32.44 71.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 2.1499999999999999 109.637 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -61.31 -29.59 69.97 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.022 -1.071 . . . . 2.8100000000000001 108.958 179.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.63 -47.9 83.78 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.838 0.828 . . . . 1.3899999999999999 109.032 178.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.87 -47.02 86.9 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.499 -0.88 . . . . 1.4099999999999999 109.444 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.33 -31.96 72.66 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.469 0.652 . . . . 1.3899999999999999 109.963 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.66 -41.73 80.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.652 -0.655 . . . . 1.1899999999999999 110.003 179.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -57.51 -40.69 79.27 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.829 -1.169 . . . . 3.6299999999999999 109.549 179.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -60.3 -43.16 96.56 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.621 -0.674 . . . . 1.28 110.535 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.08 -38.28 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.102 -0.999 . . . . 1.1799999999999999 109.947 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.05 -49.96 37.43 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.846 -1.169 . . . . 0.51000000000000001 110.406 179.074 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -58.4 -43.36 88.53 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.963 -1.316 . . . . 3.1699999999999999 110.209 179.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.436 ' NH2' ' CB ' ' A' ' 166' ' ' SER . 88.5 mtt180 -62.29 -41.43 98.49 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.705 -1.198 . . . . 2.8500000000000001 109.22 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.68 -40.72 88.77 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.543 0.687 . . . . 1.6499999999999999 109.95 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.2 -42.56 95.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.029 . . . . 1.2 110.668 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -59.82 -34.07 72.59 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.428 -0.795 . . . . 2.7999999999999998 110.614 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -75.03 -42.55 56.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.179 -0.951 . . . . 2.1499999999999999 110.821 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.9 -39.98 83.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.148 -0.97 . . . . 1.21 110.281 -178.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.1 mt -89.94 -12.01 40.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -0.932 . . . . 1.3400000000000001 112.701 -179.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.3 19.72 76.27 Favored Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.569 -1.3 . . . . 0.91000000000000003 113.066 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.5 150.44 48.95 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.525 -0.985 . . . . 1.51 109.952 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -65.26 148.56 51.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 2.8799999999999999 109.751 178.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.4 mt -106.88 144.13 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.56 -0.904 . . . . 1.6200000000000001 108.56 178.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.1 mm -79.11 120.78 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.885 -1.135 . . . . 2.1099999999999999 108.388 178.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -98.09 96.72 8.32 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.369 -1.715 . . . . 1.6200000000000001 106.369 179.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.6 mt -75.92 -17.51 59.73 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.612 -0.68 . . . . 1.3999999999999999 111.512 -177.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.6 m -81.19 4.81 18.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.928 -1.108 . . . . 2.0499999999999998 112.383 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.72 20.83 11.32 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.791 0.805 . . . . 1.3500000000000001 112.33 -179.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 18.0 mt -72.65 139.23 19.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.264 -0.897 . . . . 1.4199999999999999 108.752 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -116.77 -11.54 10.92 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.491 -0.756 . . . . 2.9900000000000002 112.885 -178.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -115.86 134.09 55.35 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.736 -1.209 . . . . 1.54 107.736 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -72.98 119.28 17.01 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.44 -0.788 . . . . 1.3799999999999999 108.879 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.0 177.01 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.373 -0.829 . . . . 1.28 109.343 -179.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.0 mt -85.87 142.15 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.008 -1.058 . . . . 1.1599999999999999 109.117 178.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.0 tp -95.28 125.17 39.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.155 -0.966 . . . . 1.3100000000000001 108.613 178.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.7 t -124.54 129.69 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.536 -1.283 . . . . 1.25 107.536 179.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.33 160.12 29.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 1.26 108.548 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.72 -40.85 89.36 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.275 -1.516 . . . . 1.6000000000000001 109.521 177.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 9.2 t70 -174.17 158.57 3.04 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.236 -1.024 . . . . 2.4199999999999999 108.236 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.451 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 35.5 mt -118.3 139.16 51.75 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.149 -1.056 . . . . 1.3500000000000001 108.149 177.184 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.9 p -90.24 149.36 41.14 Favored Pre-proline 0 N--CA 1.485 1.312 0 N-CA-C 108.293 -1.003 . . . . 1.3200000000000001 108.293 179.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -40.18 -45.23 4.08 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.035 1.824 . . . . 0.69999999999999996 113.393 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.436 ' CB ' ' NH2' ' A' ' 136' ' ' ARG . 15.3 m -59.94 -50.31 74.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.677 -1.264 . . . . 1.1200000000000001 110.96 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.94 -40.32 92.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.447 -0.783 . . . . 1.21 109.934 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.5 p -66.41 -39.0 88.72 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.689 0.757 . . . . 1.1899999999999999 110.141 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.23 85.31 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.358 -0.937 . . . . 1.24 111.11 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -94.8 1.56 55.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.994 -1.066 . . . . 1.6899999999999999 113.569 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.8 148.74 46.04 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.483 -0.932 . . . . 1.3400000000000001 108.483 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -95.27 115.01 26.86 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 106.537 -1.653 . . . . 2.77 106.537 177.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 26.1 mt -75.46 -14.93 60.46 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.484 -0.76 . . . . 2.0899999999999999 111.71 -177.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -84.03 -19.67 34.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.081 -1.012 . . . . 2.6699999999999999 112.276 -178.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -102.14 -6.16 23.6 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.327 -0.858 . . . . 2.5800000000000001 113.033 -177.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.5 t -110.69 129.57 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.106 -1.442 . . . . 1.1799999999999999 107.106 179.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 tp -90.94 -4.93 56.11 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.985 0.897 . . . . 2.1800000000000002 112.595 -179.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.86 170.46 41.7 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.691 -1.764 . . . . 0.48999999999999999 108.691 179.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -125.83 126.18 44.08 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.786 -1.42 . . . . 0.64000000000000001 107.42 178.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.5 mt -125.65 128.61 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 106.913 -1.514 . . . . 1.21 106.913 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 203' ' ' VAL . 74.6 p -139.58 166.78 23.69 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.894 -1.129 . . . . 1.3799999999999999 109.247 179.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 29.0 p-10 -103.16 32.19 3.88 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.397 -0.814 . . . . 2.3700000000000001 111.504 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -97.02 120.64 37.75 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.091 -1.077 . . . . 1.52 108.091 178.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -88.44 27.19 7.19 Favored Glycine 0 N--CA 1.484 1.875 0 C-N-CA 120.15 -1.024 . . . . 1.8 113.515 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -88.1 115.76 4.44 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 107.882 -2.087 . . . . 2.04 107.882 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -58.03 -31.37 66.93 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.525 -0.985 . . . . 5.0 109.287 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.8 p -105.06 37.32 2.2 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.684 0.754 . . . . 3.02 110.265 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.5 t -72.07 146.71 47.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.365 -0.835 . . . . 2.1099999999999999 109.569 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -58.16 -39.74 79.63 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.245 -0.909 . . . . 1.24 110.999 178.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 56.8 p -57.84 -41.39 82.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.837 -1.164 . . . . 2.1499999999999999 110.221 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.3 t -61.45 -34.2 75.02 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.333 -0.854 . . . . 2.02 110.163 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.6 mm -60.26 -41.03 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.06 -1.025 . . . . 2.1200000000000001 110.914 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 60.9 mtp -61.66 -40.46 95.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.565 -1.334 . . . . 1.3600000000000001 110.103 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.96 -45.74 89.77 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.41 -0.814 . . . . 1.29 111.127 179.372 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -60.7 -42.2 96.74 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.656 -0.817 . . . . 3.5600000000000001 110.479 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.4 m -69.49 -39.01 77.89 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.328 -0.857 . . . . 1.1799999999999999 109.942 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.26 -7.29 51.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.234 -0.916 . . . . 1.3400000000000001 112.753 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 194' ' ' ALA . 89.7 mt-10 53.36 8.53 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.364 1.246 . . . . 1.45 114.364 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.502 ' O ' ' OG ' ' A' ' 8' ' ' SER . 57.2 mt -73.89 147.6 86.44 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.646 -1.284 . . . . 1.25 108.162 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.78 143.43 58.91 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.353 1.369 . . . . 0.78000000000000003 109.503 178.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.559 ' N ' ' HG ' ' A' ' 8' ' ' SER . . . -158.82 163.02 37.06 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 117.767 -1.573 . . . . 1.2 109.679 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.2 mt -149.45 151.31 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.654 -1.239 . . . . 1.25 107.654 178.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 183' ' ' ALA . 15.1 m -136.05 -28.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 120.79 -1.194 . . . . 1.3899999999999999 112.235 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.39 41.42 3.06 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 120.845 -1.159 . . . . 0.96999999999999997 112.166 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.6 p -61.58 -17.65 55.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.873 -1.369 . . . . 1.3500000000000001 111.535 -178.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.12 -93.04 1.8 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.401 -1.08 . . . . 1.0700000000000001 110.401 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.1 m -133.58 32.84 3.56 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 122.214 -0.58 . . . . 1.9199999999999999 112.26 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.5 t -59.43 -37.69 71.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.324 -1.485 . . . . 1.3300000000000001 110.527 179.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 67.5 p -55.34 -28.52 54.3 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.422 -0.911 . . . . 1.4199999999999999 111.203 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 19.6 m -92.1 0.86 57.47 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.106 -0.996 . . . . 2.1200000000000001 112.143 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -122.86 -7.19 8.45 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 113.395 0.887 . . . . 2.6899999999999999 113.395 -177.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.5 t -118.92 151.62 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.59 0.709 . . . . 1.29 109.296 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -117.7 157.12 27.05 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.118 -1.068 . . . . 2.6899999999999999 108.118 177.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.595 HD21 ' H ' ' A' ' 215' ' ' ASP . 1.6 t-20 -52.48 141.49 19.92 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.871 -1.143 . . . . 2.79 110.805 178.572 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.595 ' H ' HD21 ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.72 2.75 1.43 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 115.185 1.55 . . . . 2.3500000000000001 115.185 179.397 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.2 t0 -64.72 148.08 51.81 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.862 -1.148 . . . . 1.97 108.797 177.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.522 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 44.3 t80 -88.6 119.38 29.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.544 -1.347 . . . . 2.9700000000000002 107.664 177.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 84.7 mt -127.22 148.89 50.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.426 -0.797 . . . . 1.25 110.292 -178.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.4 mt -116.81 123.97 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 106.158 -1.793 . . . . 1.22 106.158 177.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.2 tp -99.16 120.12 38.98 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.692 -1.595 . . . . 1.24 106.692 178.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.623 ' O ' ' N ' ' A' ' 223' ' ' VAL . 77.8 m-20 -93.84 -29.15 15.47 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.781 -1.168 . . . . 2.0499999999999998 113.129 -177.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 40.06 12.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.432 -0.793 . . . . 1.25 112.654 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.623 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.4 t -108.53 -61.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.746 -1.222 . . . . 1.4299999999999999 109.525 179.092 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -94.19 11.59 29.6 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.389 0.614 . . . . 3.0299999999999998 110.675 179.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 61.48 54.53 3.07 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.148 0.499 . . . . 2.25 111.951 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -148.97 143.52 26.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.173 -0.954 . . . . 2.52 109.831 178.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.1 t -115.9 136.91 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.077 -1.083 . . . . 1.29 108.077 178.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -102.68 131.74 49.28 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.606 -0.887 . . . . 1.3400000000000001 108.606 178.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.41 130.96 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 108.653 -0.869 . . . . 1.3400000000000001 108.653 178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 52.11 53.69 13.07 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.188 -0.945 . . . . 2.1800000000000002 113.549 178.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.65 151.07 63.73 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 C-N-CA 122.513 2.142 . . . . 0.93999999999999995 111.069 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.0 m -71.33 157.77 37.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.072 -1.017 . . . . 2.3999999999999999 108.995 177.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -57.31 -40.89 78.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 3.3300000000000001 109.898 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.85 -39.82 86.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.815 . . . . 3.1699999999999999 110.692 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.2 t -69.2 -38.05 77.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.23 -0.919 . . . . 1.6899999999999999 110.818 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 84.4 mt . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 1.6000000000000001 110.261 179.239 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.4 mt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 112.431 0.53 . . . . 1.5700000000000001 112.431 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -90.73 115.4 27.79 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.61 -1.626 . . . . 1.4399999999999999 106.61 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.35 -154.85 22.12 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.081 -2.007 . . . . 1.01 108.081 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 72.6 mt -93.92 -4.33 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -1.141 . . . . 1.6299999999999999 112.64 -178.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 5' ' ' ILE . 38.4 tp 50.61 100.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.831 -1.168 . . . . 1.5800000000000001 112.235 178.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.63 -37.24 14.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 1.3400000000000001 111.498 179.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -145.77 138.75 14.11 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 108.027 -1.101 . . . . 1.8600000000000001 108.027 -178.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.88 148.92 28.73 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.725 2.283 . . . . 1.01 112.505 179.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 152.85 166.05 13.98 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.891 -1.684 . . . . 0.81000000000000005 108.891 178.357 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.52 136.11 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.046 -1.267 . . . . 1.3700000000000001 108.704 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.06 156.67 44.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.303 -0.873 . . . . 1.1399999999999999 109.495 179.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 23.8 m-85 -124.48 140.74 52.67 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.206 -1.035 . . . . 0.87 108.206 178.247 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.72 168.48 37.39 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 118.551 -1.785 . . . . 0.56999999999999995 109.906 177.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -78.64 160.22 27.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.427 -1.043 . . . . 2.3500000000000001 109.547 179.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.57 129.71 34.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.791 -1.193 . . . . 1.21 108.195 178.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.7 tp -107.53 101.94 11.24 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 105.029 -2.212 . . . . 1.3999999999999999 105.029 177.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.5 tp -89.88 137.32 32.43 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.173 -1.047 . . . . 1.4399999999999999 108.173 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.6 mt -100.49 114.79 28.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.592 -1.633 . . . . 1.45 106.592 178.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -108.97 131.49 55.0 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.617 -1.253 . . . . 2.5 107.617 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -127.13 149.98 49.7 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.254 -0.904 . . . . 2.6600000000000001 109.228 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -83.04 135.0 35.01 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.778 -1.193 . . . . 2.3199999999999998 107.778 177.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.39 147.32 48.85 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.592 -0.693 . . . . 2.1099999999999999 109.315 178.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 24' ' ' ILE . 61.9 mt -97.7 135.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.166 -0.959 . . . . 1.29 108.72 178.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.8 t -107.69 130.88 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.489 -0.93 . . . . 1.4099999999999999 108.489 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.5 mt -97.56 131.44 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.335 -0.987 . . . . 1.3100000000000001 108.335 178.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -93.51 123.26 36.7 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.814 -1.179 . . . . 1.3400000000000001 108.371 178.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -95.81 10.25 37.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.299 -0.876 . . . . 3.48 112.333 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.63 149.22 46.97 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.118 -0.988 . . . . 2.52 109.332 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -89.93 131.02 36.06 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.74 -1.207 . . . . 2.6299999999999999 107.74 177.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 pt -92.53 165.47 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.007 -1.058 . . . . 1.3100000000000001 110.345 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.3 p -92.51 163.43 13.83 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.446 -0.575 . . . . 1.24 109.446 178.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.39 -17.49 1.94 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.214 -0.929 . . . . 1.49 112.482 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -69.45 -41.78 75.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.355 -0.841 . . . . 2.2799999999999998 110.685 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -90.75 -5.76 55.28 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.62 -1.3 . . . . 2.0499999999999998 112.697 -178.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.91 -42.29 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.803 -1.186 . . . . 1.3400000000000001 110.477 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.14 -39.97 88.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.034 -1.041 . . . . 1.54 110.767 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -62.67 -38.13 89.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.509 -0.745 . . . . 2.8500000000000001 110.845 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -60.19 -40.73 91.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.907 -1.121 . . . . 1.3100000000000001 110.656 179.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -62.43 -41.16 90.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.187 -0.945 . . . . 1.3799999999999999 110.551 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -60.8 -49.52 77.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.109 -0.995 . . . . 1.5 110.369 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 46' ' ' GLY . 65.1 mtm180 -62.86 -40.35 97.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.231 -0.918 . . . . 2.7799999999999998 110.09 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -70.04 -54.6 12.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.434 -0.791 . . . . 1.0600000000000001 110.184 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.49 -49.88 73.63 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.937 -1.105 . . . . 1.3999999999999999 109.834 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 t -67.81 -39.75 83.95 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.783 0.802 . . . . 1.3200000000000001 109.91 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 42' ' ' ARG . . . -56.43 -43.25 90.25 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.808 -1.317 . . . . 0.69999999999999996 109.808 178.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -59.54 -31.26 69.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.891 0.853 . . . . 3.4399999999999999 109.394 178.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.08 -43.2 77.78 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.492 0.663 . . . . 1.3600000000000001 109.762 178.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -79.07 -42.94 25.21 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.325 -0.95 . . . . 2.8300000000000001 110.009 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.87 86.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.099 -1.001 . . . . 1.23 110.225 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.0 p -59.98 -41.76 92.71 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.268 1.032 . . . . 1.9199999999999999 109.241 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.74 90.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.728 -0.669 . . . . 1.25 110.133 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -60.09 -49.8 76.21 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.39 -0.924 . . . . 1.97 110.264 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.59 -42.74 91.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 2.1800000000000002 110.059 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -59.86 -40.3 88.15 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.736 -0.602 . . . . 1.1899999999999999 110.47 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.6 m -67.43 -47.69 69.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.06 -1.025 . . . . 1.3400000000000001 110.18 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.5 mt -61.36 -34.36 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 1.23 110.849 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -51.62 -43.94 62.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.114 -0.991 . . . . 1.5600000000000001 111.013 179.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.9 m -68.97 -39.62 79.35 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.985 -1.072 . . . . 1.3 110.197 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -60.11 -40.0 88.17 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.807 -1.157 . . . . 2.3199999999999998 109.529 179.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.41 73.83 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.326 -0.858 . . . . 1.1399999999999999 109.934 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.59 -37.03 9.87 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.978 -1.106 . . . . 0.68999999999999995 111.112 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -81.59 -23.94 36.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.092 -1.24 . . . . 1.48 111.001 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.4 m -88.82 -50.37 6.26 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.461 -0.774 . . . . 1.52 110.57 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.591 ' CZ ' ' SD ' ' A' ' 193' ' ' MET . 75.4 m-85 -107.23 -3.67 19.55 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 113.805 1.039 . . . . 1.3100000000000001 113.805 -177.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.1 166.49 34.21 Favored Glycine 0 N--CA 1.495 2.617 0 O-C-N 121.088 -1.007 . . . . 0.84999999999999998 111.699 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -56.31 -19.54 14.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.558 -0.966 . . . . 3.8599999999999999 112.787 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -56.74 -41.5 77.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.684 -1.26 . . . . 2.3500000000000001 110.561 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -89.27 -23.12 22.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.97 -1.081 . . . . 2.2599999999999998 111.563 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -60.78 -38.93 86.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.502 -0.749 . . . . 1.45 110.745 -179.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.1 -39.37 89.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.36 -0.837 . . . . 1.25 110.816 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.6 mt -62.12 -44.24 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.865 -1.147 . . . . 1.26 110.513 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -71.7 -31.65 66.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.856 -1.152 . . . . 0.82999999999999996 110.701 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.24 -41.17 92.57 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.115 -0.99 . . . . 1.1899999999999999 109.903 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.88 -36.74 91.53 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.656 -1.259 . . . . 0.57999999999999996 110.143 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -59.31 -40.83 87.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -1.155 . . . . 2.0499999999999998 110.492 179.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 77' ' ' ILE . 87.8 mt -60.3 -39.66 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.982 -1.074 . . . . 1.21 110.276 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.8 ttp -59.58 -39.36 83.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.335 -0.853 . . . . 2.29 110.396 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.43 -49.93 73.13 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.466 -0.894 . . . . 1.21 110.105 179.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.5 tp -60.45 -46.92 88.3 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.763 0.792 . . . . 1.1399999999999999 110.272 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -85.74 8.43 19.87 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.034 0.753 . . . . 1.4199999999999999 113.034 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -62.31 122.06 14.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.878 -1.139 . . . . 1.27 108.581 179.091 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -64.07 -18.67 64.6 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.733 0.777 . . . . 1.3500000000000001 111.099 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.14 -53.74 7.84 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.74 -0.784 . . . . 2.2200000000000002 110.253 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.52 -35.12 78.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.551 -0.718 . . . . 1.22 110.495 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -60.01 -48.92 79.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.306 -0.871 . . . . 1.29 110.739 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -62.68 -39.97 95.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 2.1699999999999999 110.513 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.97 -48.41 76.59 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.292 -0.88 . . . . 1.3 110.152 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -57.89 -43.48 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.291 -0.881 . . . . 1.1699999999999999 109.879 179.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.43 -40.81 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.718 -0.614 . . . . 1.3999999999999999 110.479 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.19 -45.04 95.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -0.894 . . . . 1.3300000000000001 110.873 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.91 -39.05 84.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 1.48 110.521 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.8 mt -70.18 -49.73 52.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 1.28 111.066 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -81.78 -36.37 28.54 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.833 -1.167 . . . . 2.6000000000000001 111.795 -179.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 91' ' ' ALA . 24.1 t0 -81.8 -42.43 19.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.83 -1.169 . . . . 1.51 112.132 -178.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -103.38 8.25 38.09 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.212 -0.93 . . . . 2.48 112.452 -178.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.3 m80 51.08 51.17 17.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.14 -0.975 . . . . 1.6100000000000001 111.804 -179.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.6 mtt -104.91 152.07 23.1 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.353 -0.842 . . . . 1.8999999999999999 108.899 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.658 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 80.1 p -71.92 160.03 33.25 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.577 -0.702 . . . . 1.3200000000000001 109.292 177.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.7 92.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.149 -0.969 . . . . 1.1499999999999999 110.571 178.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -67.24 -42.1 84.54 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.044 -1.035 . . . . 2.25 109.925 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.658 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -68.49 -51.0 48.15 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.635 -0.665 . . . . 1.22 111.224 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.31 -45.74 92.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.037 -1.04 . . . . 1.1899999999999999 110.65 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.7 97.12 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.494 -0.883 . . . . 1.2 110.408 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -60.28 -39.22 86.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 2.1000000000000001 110.972 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -57.9 -48.72 79.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.949 -1.094 . . . . 1.3 110.567 179.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.99 -47.44 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.943 -1.098 . . . . 1.27 110.031 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.0 mm -62.64 -30.95 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.779 -0.576 . . . . 1.1899999999999999 110.56 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.59 -41.61 86.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.44 -0.788 . . . . 2.1099999999999999 110.85 179.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.75 -34.52 10.05 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.231 -1.462 . . . . 0.88 112.678 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -61.13 -41.68 97.16 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.788 -1.419 . . . . 1.99 110.259 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.39 -54.93 7.99 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.741 0.781 . . . . 1.28 110.29 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 65.3 m -59.97 -38.49 82.67 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.686 -0.634 . . . . 2.2200000000000002 110.477 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.61 96.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.991 -1.068 . . . . 1.45 110.575 179.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.17 -30.14 71.03 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.217 -0.993 . . . . 1.47 110.35 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -66.6 -20.07 65.92 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.164 -0.96 . . . . 2.04 110.986 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -72.63 -10.51 59.87 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.99 0.9 . . . . 1.73 111.02 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 23.2 mt -87.84 144.84 26.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.936 -0.765 . . . . 1.79 108.936 179.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -100.19 37.13 1.71 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.132 -0.98 . . . . 2.8799999999999999 111.787 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -115.22 137.71 51.72 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.179 -0.951 . . . . 1.5800000000000001 108.81 178.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -59.86 -35.24 74.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.67 -0.644 . . . . 3.04 111.089 179.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -73.53 -49.74 24.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.926 -1.109 . . . . 1.29 109.848 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.1 mt -63.73 -39.73 95.0 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.281 -0.887 . . . . 1.6000000000000001 109.604 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -60.96 -45.07 96.21 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.864 0.84 . . . . 2.7599999999999998 109.67 179.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -61.29 -32.78 72.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.812 0.815 . . . . 2.1499999999999999 109.535 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -62.04 -29.57 70.38 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.996 0.903 . . . . 2.8100000000000001 109.463 179.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.93 74.6 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.926 0.87 . . . . 1.3899999999999999 109.501 178.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.56 -41.59 79.53 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.703 0.763 . . . . 1.4099999999999999 110.08 179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -62.55 -40.47 96.92 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.413 0.625 . . . . 1.3899999999999999 110.243 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 52.1 t -68.96 -38.33 78.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.504 -0.748 . . . . 1.1899999999999999 109.755 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -58.92 -38.89 79.98 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.057 -1.027 . . . . 3.6299999999999999 109.715 178.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.498 ' OD2' ' NE ' ' A' ' 136' ' ' ARG . 32.2 t70 -60.12 -39.79 87.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.61 -0.682 . . . . 1.28 110.352 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 57.7 mt -60.05 -39.83 81.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.363 -0.836 . . . . 1.1799999999999999 109.983 179.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.13 -48.3 26.5 Favored Glycine 0 N--CA 1.485 1.943 0 C-N-CA 120.209 -0.995 . . . . 0.51000000000000001 110.799 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -58.89 -44.16 91.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.039 -1.271 . . . . 3.1699999999999999 110.202 179.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.498 ' NE ' ' OD2' ' A' ' 132' ' ' ASP . 54.3 mtm180 -61.62 -41.48 97.54 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.707 -1.197 . . . . 2.8500000000000001 109.774 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.45 -41.71 94.65 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.865 -0.734 . . . . 1.6499999999999999 110.079 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.6 mt -60.57 -43.35 97.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.437 -0.789 . . . . 1.2 110.765 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 48.7 mtt-85 -59.84 -32.81 71.02 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.363 -0.836 . . . . 2.7999999999999998 111.318 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -75.39 -40.17 58.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.011 -1.056 . . . . 2.1499999999999999 110.708 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.4 mt -59.58 -40.13 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.227 -0.921 . . . . 1.21 110.972 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.2 mt -90.47 -9.2 48.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.916 -1.115 . . . . 1.3400000000000001 112.926 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.09 23.16 66.8 Favored Glycine 0 N--CA 1.483 1.78 0 C-N-CA 119.91 -1.138 . . . . 0.91000000000000003 113.112 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 29.0 tp -63.08 142.21 58.47 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.757 -0.849 . . . . 1.51 109.012 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -66.53 141.35 57.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.239 -0.913 . . . . 2.8799999999999999 109.378 178.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.4 mt -112.18 136.52 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 108.32 -0.993 . . . . 1.6200000000000001 108.32 178.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.2 mp -76.2 131.07 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 2.1099999999999999 108.792 178.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.09 97.63 11.04 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.721 -1.585 . . . . 1.6200000000000001 106.721 178.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.455 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 50.4 mt -71.51 -29.45 64.8 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.378 0.609 . . . . 1.3999999999999999 110.942 -178.146 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.0 t -79.47 -3.29 45.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.35 -0.844 . . . . 2.0499999999999998 112.297 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -101.27 23.1 11.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.677 -0.64 . . . . 1.3500000000000001 111.919 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.455 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 16.4 mt -72.1 144.87 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 1.4199999999999999 109.861 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -118.64 -10.85 9.96 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.979 0.895 . . . . 2.9900000000000002 112.372 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -118.22 140.36 49.92 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.72 0.772 . . . . 1.54 109.152 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.04 119.8 22.69 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.285 -0.885 . . . . 1.3799999999999999 108.741 178.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.71 175.79 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.578 0.704 . . . . 1.28 109.328 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.5 mt -86.98 140.9 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.805 . . . . 1.1599999999999999 109.01 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 24.6 tp -98.32 122.3 41.31 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.044 -1.035 . . . . 1.3100000000000001 108.777 178.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.8 t -123.93 133.96 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.337 -0.986 . . . . 1.25 108.337 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.86 157.81 29.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.477 -0.764 . . . . 1.26 109.113 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.449 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.4 -38.7 88.03 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.672 -1.268 . . . . 1.6000000000000001 109.196 178.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.2 t0 -172.45 148.0 1.97 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.524 -0.735 . . . . 2.4199999999999999 109.02 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.521 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 66.1 mt -119.15 138.98 52.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.243 -0.911 . . . . 1.3500000000000001 108.555 177.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.2 p -93.6 151.6 40.2 Favored Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 108.327 -0.99 . . . . 1.3200000000000001 108.327 178.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -39.93 -38.72 2.04 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.767 1.645 . . . . 0.69999999999999996 113.433 179.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.5 m -58.92 -42.87 90.7 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.036 -1.065 . . . . 1.1200000000000001 109.699 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -72.64 -45.1 60.64 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.693 -0.803 . . . . 1.21 110.164 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.504 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 20.4 p -66.19 -38.95 89.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.372 -0.83 . . . . 1.1899999999999999 109.812 -178.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.72 87.34 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.677 -0.64 . . . . 1.24 110.844 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -92.96 0.49 57.41 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.126 -0.984 . . . . 1.6899999999999999 112.738 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.7 tp -65.99 150.26 48.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.729 . . . . 1.3400000000000001 109.756 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -96.94 117.82 32.0 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.035 -1.469 . . . . 2.77 107.035 177.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 39.1 mt -76.32 -18.07 59.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 2.0899999999999999 111.404 -178.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -82.97 -20.58 34.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.205 -0.935 . . . . 2.6699999999999999 112.282 -179.208 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -102.69 -6.28 22.86 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.261 -0.899 . . . . 2.5800000000000001 113.383 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 45.5 t -111.7 131.8 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.063 -1.088 . . . . 1.1799999999999999 108.063 179.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.412 ' CD2' ' O ' ' A' ' 177' ' ' LEU . 2.0 tt -86.04 -11.52 52.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.004 -1.06 . . . . 2.1800000000000002 111.684 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.31 177.39 43.43 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.013 -1.565 . . . . 0.48999999999999999 109.748 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.64 132.48 46.73 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.405 -1.056 . . . . 0.64000000000000001 108.199 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 72.6 mt -134.14 109.39 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 106.423 -1.695 . . . . 1.21 106.423 178.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 203' ' ' VAL . 65.6 p -129.63 170.47 13.75 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.9 -1.125 . . . . 1.3799999999999999 110.568 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 15.4 p-10 -103.03 49.56 0.83 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.277 0.561 . . . . 2.3700000000000001 110.423 179.435 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.0 154.46 18.95 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.338 -0.851 . . . . 1.52 109.356 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.91 -80.92 0.06 OUTLIER Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.598 -1.286 . . . . 1.8 111.302 178.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.38 -40.74 0.82 Allowed Glycine 0 N--CA 1.492 2.392 0 O-C-N 120.941 -1.329 . . . . 2.04 112.354 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -60.22 -36.25 77.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.947 . . . . 5.0 110.518 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 12.6 p -121.25 26.85 8.69 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.517 -0.74 . . . . 3.02 111.399 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -86.52 109.84 19.37 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.351 -1.351 . . . . 2.1099999999999999 107.351 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.504 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 72.9 t60 -61.69 -37.83 85.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.588 -0.695 . . . . 1.24 110.727 -178.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 25.8 m -57.24 -40.49 77.7 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.136 -0.977 . . . . 2.1499999999999999 110.304 179.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 50.4 m -60.01 -38.45 82.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 2.02 110.6 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.9 mt -59.36 -41.04 83.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.148 -0.97 . . . . 2.1200000000000001 110.522 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.591 ' SD ' ' CZ ' ' A' ' 65' ' ' PHE . 7.7 mtm -68.96 -35.07 76.33 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.707 -1.197 . . . . 1.3600000000000001 109.325 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.26 -44.62 88.44 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.174 -0.61 . . . . 1.29 110.56 179.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.45 ' HG2' HH11 ' A' ' 195' ' ' ARG . 32.8 mtt-85 -60.2 -41.27 92.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 3.5600000000000001 110.448 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.0 m -68.91 -37.46 78.96 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.749 0.785 . . . . 1.1799999999999999 110.028 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.1 mt -90.4 -5.91 55.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.413 -0.804 . . . . 1.3400000000000001 112.472 -179.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 54.11 8.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.67 0.989 . . . . 1.45 113.67 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 30.8 mt -71.58 150.03 93.5 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.971 -1.081 . . . . 1.25 108.773 178.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -55.89 145.79 71.33 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.745 1.63 . . . . 0.78000000000000003 109.68 178.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.9 158.9 31.69 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.715 -1.241 . . . . 1.2 109.989 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.0 mt -149.77 148.03 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.878 -1.156 . . . . 1.25 107.878 178.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.2 m -134.11 -32.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.995 -1.066 . . . . 1.3899999999999999 113.557 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.11 45.32 2.51 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.102 -0.999 . . . . 0.96999999999999997 112.227 -178.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 32.5 p -67.19 -11.1 56.46 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.189 -1.183 . . . . 1.3500000000000001 111.328 -179.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.0 -97.08 0.81 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.802 -1.189 . . . . 1.0700000000000001 110.182 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.6 m -127.18 29.07 5.64 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.457 -1.025 . . . . 1.9199999999999999 112.473 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.53 -37.85 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.595 -1.316 . . . . 1.3300000000000001 110.7 179.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 60.4 p -54.35 -25.1 22.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.001 -1.062 . . . . 1.4199999999999999 111.36 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.2 t -93.63 -0.2 56.24 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.705 0.764 . . . . 2.1200000000000001 111.742 -179.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -124.37 -2.05 8.06 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 113.291 0.849 . . . . 2.6899999999999999 113.291 -177.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.4 t -117.12 150.04 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.443 -0.786 . . . . 1.29 109.156 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -122.2 153.07 39.3 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.638 -0.875 . . . . 2.6899999999999999 108.638 178.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 52.3 t30 -52.2 141.53 18.67 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.235 -0.915 . . . . 2.79 110.093 178.518 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 10.0 t0 81.07 -1.76 1.76 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.111 1.152 . . . . 2.3500000000000001 114.111 179.521 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -61.71 148.56 42.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.796 -1.19 . . . . 1.97 108.578 177.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -90.47 118.97 30.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.116 -1.439 . . . . 2.9700000000000002 107.116 177.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 82.9 mt -129.33 148.41 51.25 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.55 -0.719 . . . . 1.25 109.511 -178.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.6 mt -117.54 129.66 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 106.602 -1.629 . . . . 1.22 106.602 177.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.6 tp -99.75 118.84 37.09 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 106.713 -1.588 . . . . 1.24 106.713 178.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 223' ' ' VAL . 50.4 t0 -93.71 -30.94 14.64 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.119 -0.988 . . . . 2.0499999999999998 112.654 -177.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.438 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 37.87 20.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.42 0.896 . . . . 1.25 113.42 -178.079 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.7 t -109.62 -62.03 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.839 -1.163 . . . . 1.4299999999999999 108.788 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -91.83 15.22 13.42 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.024 0.916 . . . . 3.0299999999999998 110.247 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.3 t30 60.75 51.54 4.8 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.355 -0.839 . . . . 2.25 112.409 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.475 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 15.4 pt20 -152.73 156.19 38.66 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.776 -1.202 . . . . 2.52 110.451 178.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 69.9 t -117.97 144.96 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.702 -0.624 . . . . 1.29 109.462 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.475 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 93.8 m-85 -101.92 130.34 48.39 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 107.973 -1.121 . . . . 1.3400000000000001 107.973 177.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.07 129.86 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.22 -0.925 . . . . 1.3400000000000001 108.815 179.181 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.436 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 0.4 OUTLIER 52.51 49.85 7.2 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.115 -0.991 . . . . 2.1800000000000002 113.557 178.184 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 40.9 Cg_endo -66.51 149.71 84.3 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.623 2.216 . . . . 0.93999999999999995 111.432 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.9 m -75.57 154.08 36.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 2.3999999999999999 109.031 177.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 34.0 p-10 -60.74 -35.44 76.38 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.569 -0.707 . . . . 3.3300000000000001 110.487 179.06 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.497 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 81.0 tt0 -59.47 -43.44 93.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 3.1699999999999999 110.453 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 99.0 t -71.34 -39.79 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.241 -0.912 . . . . 1.6899999999999999 110.165 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 1.6000000000000001 110.512 179.806 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 106.497 -1.668 . . . . 1.5700000000000001 106.497 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 m -105.94 128.13 53.59 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.762 -1.199 . . . . 1.4399999999999999 107.762 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.28 -156.98 22.76 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 108.968 -1.653 . . . . 1.01 108.968 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.445 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 86.6 mt -95.82 -1.81 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.554 -0.968 . . . . 1.6299999999999999 112.581 -178.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 49.38 99.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.468 0.544 . . . . 1.5800000000000001 112.468 178.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.89 -52.69 6.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.066 -1.021 . . . . 1.3400000000000001 110.775 179.383 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.43 146.34 41.76 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 107.449 -1.315 . . . . 1.8600000000000001 107.449 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -74.07 144.38 33.83 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.866 2.377 . . . . 1.01 112.993 178.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.46 166.81 17.55 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 109.539 -1.425 . . . . 0.81000000000000005 109.539 178.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.7 mt -127.22 134.56 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.302 -1.116 . . . . 1.3700000000000001 108.225 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.12 155.94 46.77 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.318 -0.864 . . . . 1.1399999999999999 109.498 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.2 m-85 -125.09 143.22 51.03 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.482 -0.761 . . . . 0.87 108.995 178.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.32 167.39 34.39 Favored Glycine 0 N--CA 1.499 2.897 0 C-N-CA 118.98 -1.581 . . . . 0.56999999999999995 110.002 177.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -78.82 157.65 28.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.753 -0.851 . . . . 2.3500000000000001 109.198 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.31 134.84 35.65 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.842 -1.161 . . . . 1.21 108.636 178.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.2 tp -116.18 101.19 8.49 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 105.801 -1.925 . . . . 1.3999999999999999 105.801 178.199 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -93.72 132.97 37.57 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.01 -1.107 . . . . 1.4399999999999999 108.01 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.6 mt -103.31 118.09 35.99 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 106.802 -1.555 . . . . 1.45 106.802 178.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -110.63 137.72 47.95 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.749 -1.204 . . . . 2.5 107.749 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -121.02 151.33 39.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 2.6600000000000001 109.703 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -81.92 132.98 35.28 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.941 -1.133 . . . . 2.3199999999999998 107.941 177.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -60.87 148.84 38.09 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.876 -1.14 . . . . 2.1099999999999999 108.941 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.0 mt -96.9 129.83 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.175 -0.953 . . . . 1.29 108.517 178.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.5 129.6 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.005 -1.109 . . . . 1.4099999999999999 108.005 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.6 mt -91.64 130.91 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.24 -1.022 . . . . 1.3100000000000001 108.24 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -90.62 116.54 28.59 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.061 -1.459 . . . . 1.3400000000000001 107.061 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -97.92 17.07 19.06 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.424 -0.797 . . . . 3.48 112.673 -179.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -68.42 147.28 52.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 2.52 109.326 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -87.23 128.35 35.15 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.576 -1.268 . . . . 2.6299999999999999 107.576 178.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 pt -93.84 163.97 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.026 -1.046 . . . . 1.3100000000000001 110.132 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.8 p -92.57 162.03 14.35 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.206 0.527 . . . . 1.24 109.712 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.3 -15.98 1.91 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.046 -1.034 . . . . 1.49 112.011 179.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -71.27 -38.95 71.82 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.409 -0.807 . . . . 2.2799999999999998 110.895 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -92.68 -6.06 50.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.744 -1.222 . . . . 2.0499999999999998 112.934 -178.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -59.67 -40.58 82.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 120.154 -0.618 . . . . 1.3400000000000001 110.48 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -59.24 -40.19 85.15 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.017 -1.052 . . . . 1.54 110.528 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -62.14 -41.47 98.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.326 -0.859 . . . . 2.8500000000000001 111.213 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -59.71 -40.27 87.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.316 -0.865 . . . . 1.3100000000000001 111.047 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.31 -40.63 84.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.169 -0.957 . . . . 1.3799999999999999 110.982 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -60.37 -48.82 80.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.587 -1.321 . . . . 1.5 110.449 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -62.45 -40.97 98.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.472 -0.767 . . . . 2.7799999999999998 110.649 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -70.39 -57.6 4.64 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.177 -0.952 . . . . 1.0600000000000001 109.374 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.39 -48.73 80.53 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.55 -0.86 . . . . 1.3999999999999999 110.121 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t -68.03 -39.67 83.04 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.106 -0.996 . . . . 1.3200000000000001 110.074 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.16 -46.67 70.07 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.74 -1.219 . . . . 0.69999999999999996 110.056 178.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -59.96 -29.92 68.75 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.44 -1.035 . . . . 3.4399999999999999 110.311 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.67 -49.48 77.58 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.671 0.748 . . . . 1.3600000000000001 109.923 179.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -79.27 -41.56 27.85 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.599 -0.688 . . . . 2.8300000000000001 110.657 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.58 -41.37 90.1 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.05 -1.06 . . . . 1.23 110.206 -178.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.491 ' HG ' ' N ' ' A' ' 52' ' ' ALA . 67.2 p -60.78 -40.34 92.23 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.319 1.056 . . . . 1.9199999999999999 109.246 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.491 ' N ' ' HG ' ' A' ' 51' ' ' SER . . . -65.71 -49.63 67.79 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.65 -0.705 . . . . 1.25 110.435 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.67 -49.78 76.41 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 118.85 -1.14 . . . . 1.97 110.392 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.94 -40.6 98.15 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.877 0.846 . . . . 2.1800000000000002 110.164 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -59.93 -41.4 91.7 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.195 -0.94 . . . . 1.1899999999999999 110.471 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 m -63.89 -43.7 95.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.851 -1.156 . . . . 1.3400000000000001 110.067 179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.9 mt -60.43 -36.66 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.561 0.696 . . . . 1.23 110.943 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -51.01 -44.09 60.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.401 -0.812 . . . . 1.5600000000000001 110.81 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -68.98 -38.91 79.61 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.031 -1.043 . . . . 1.3 110.029 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.71 -37.71 87.56 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.887 -1.125 . . . . 2.3199999999999998 108.873 179.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.8 -33.17 75.35 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.887 -0.725 . . . . 1.1399999999999999 109.818 179.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.83 -37.1 12.08 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 120.139 -1.029 . . . . 0.68999999999999995 111.135 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -81.63 -28.45 33.66 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.787 -1.42 . . . . 1.48 110.723 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.3 m -88.19 -45.45 10.08 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.49 -0.757 . . . . 1.52 111.383 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.89 -7.54 17.04 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 114.102 1.149 . . . . 1.3100000000000001 114.102 -177.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.46 161.27 30.2 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.498 -0.751 . . . . 0.84999999999999998 111.633 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.87 -25.39 63.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.73 -0.865 . . . . 3.8599999999999999 112.341 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -57.27 -44.18 83.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.763 -1.211 . . . . 2.3500000000000001 110.669 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -82.64 -24.29 33.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.554 -1.341 . . . . 2.2599999999999998 111.405 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.72 -36.84 77.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.531 -0.731 . . . . 1.45 110.981 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.05 83.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.163 -0.961 . . . . 1.25 110.628 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.7 mt -64.74 -41.86 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.913 -1.117 . . . . 1.26 110.178 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -71.42 -32.41 68.36 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.971 -1.081 . . . . 0.82999999999999996 109.776 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -61.74 -39.19 90.69 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 1.1899999999999999 109.953 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.71 -40.93 99.04 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.265 -0.969 . . . . 0.57999999999999996 110.986 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -58.93 -43.07 91.1 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.913 -1.345 . . . . 2.0499999999999998 110.475 179.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 77' ' ' ILE . 98.5 mt -60.88 -37.51 76.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.038 -1.039 . . . . 1.21 110.333 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -57.7 -40.27 79.1 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.602 -0.687 . . . . 2.29 110.045 179.12 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 tp -60.31 -50.35 73.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.368 -0.832 . . . . 1.21 110.232 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.01 -41.26 91.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.896 0.855 . . . . 1.1399999999999999 110.183 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -85.91 5.69 31.83 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.446 -0.784 . . . . 1.4199999999999999 112.937 -179.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -61.59 121.79 13.64 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.204 -0.935 . . . . 1.27 108.491 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.95 -17.26 64.55 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.752 -0.779 . . . . 1.3500000000000001 110.822 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.77 -51.8 10.73 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.768 -0.773 . . . . 2.2200000000000002 110.495 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.95 -40.61 93.94 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.48 -0.888 . . . . 1.22 111.204 -179.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -57.48 -49.85 74.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.932 . . . . 1.29 110.236 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -61.86 -40.34 95.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 2.1699999999999999 110.469 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.02 -46.66 77.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.936 -1.102 . . . . 1.3 110.521 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -57.11 -42.87 80.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.049 -1.032 . . . . 1.1699999999999999 110.065 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.8 -44.51 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.39 -0.819 . . . . 1.3999999999999999 110.245 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.6 97.33 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.493 -0.754 . . . . 1.3300000000000001 111.016 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.03 -43.29 99.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.872 -1.142 . . . . 1.48 110.198 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.62 -47.94 89.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.38 -0.825 . . . . 1.28 110.247 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -78.09 -38.76 43.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.125 -0.984 . . . . 2.6000000000000001 112.059 -179.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -82.35 -42.25 18.96 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.964 -1.085 . . . . 1.51 112.359 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -99.04 5.04 47.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.173 -0.955 . . . . 2.48 112.374 -178.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 40.7 m80 51.37 49.11 21.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.0 . . . . 1.6100000000000001 111.338 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 64.5 mtt -105.82 154.68 20.19 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.14 -0.975 . . . . 1.8999999999999999 109.711 178.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 82.5 p -70.82 160.37 32.87 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.701 -0.624 . . . . 1.3200000000000001 109.6 177.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.01 86.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.043 -1.035 . . . . 1.1499999999999999 110.539 179.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -67.68 -39.36 84.46 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.318 -0.863 . . . . 2.25 110.568 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.06 67.96 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 120.928 -1.108 . . . . 1.22 111.439 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.76 88.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 1.1899999999999999 110.626 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.74 -41.33 86.25 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.234 -0.916 . . . . 1.2 111.148 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -61.13 -40.25 93.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.631 -1.293 . . . . 2.1000000000000001 110.285 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -59.9 -49.86 76.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.856 -1.152 . . . . 1.3 110.243 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.21 -47.27 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.982 -1.074 . . . . 1.27 110.182 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.3 mm -61.33 -33.26 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 1.1899999999999999 110.521 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -57.26 -39.93 76.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.592 -0.693 . . . . 2.1099999999999999 110.979 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.67 -24.91 44.18 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 118.948 -1.596 . . . . 0.88 113.304 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -63.36 -41.06 98.8 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.527 -1.572 . . . . 1.99 109.702 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.81 63.33 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.018 -0.537 . . . . 1.28 110.759 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.624 ' HG ' ' N ' ' A' ' 114' ' ' ALA . 44.7 p -62.43 -41.14 98.49 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.077 -1.049 . . . . 2.2200000000000002 109.918 -178.141 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.624 ' N ' ' HG ' ' A' ' 113' ' ' SER . . . -62.34 -43.47 98.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.099 -1.0 . . . . 1.45 110.893 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 87.9 mt -64.92 -29.66 70.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.106 -0.996 . . . . 1.47 110.722 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -66.38 -21.59 66.23 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.34 -0.85 . . . . 2.04 110.967 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -71.72 -13.38 61.71 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.222 1.01 . . . . 1.73 110.814 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.8 mt -87.62 136.35 32.98 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.429 -1.323 . . . . 1.79 107.429 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 7.3 t0 -97.01 37.42 1.31 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.556 -0.715 . . . . 2.8799999999999999 112.266 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -111.96 138.77 48.13 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 107.984 -1.117 . . . . 1.5800000000000001 107.984 178.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.92 -38.84 76.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.476 -0.765 . . . . 3.04 111.454 179.114 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -73.37 -50.12 23.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.65 -1.281 . . . . 1.29 110.594 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.59 -43.3 97.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.022 -1.049 . . . . 1.6000000000000001 110.367 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -62.55 -45.11 94.44 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.345 -0.942 . . . . 2.7599999999999998 109.416 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.84 -31.22 69.54 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.489 -0.885 . . . . 2.1499999999999999 109.27 179.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -61.67 -30.17 70.56 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.308 -0.957 . . . . 2.8100000000000001 108.832 179.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.8 -50.51 72.04 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.157 -0.617 . . . . 1.3899999999999999 110.273 178.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.37 -42.74 78.74 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.843 -0.743 . . . . 1.4099999999999999 110.38 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.69 -36.84 84.22 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.733 -0.605 . . . . 1.3899999999999999 110.567 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.5 t -68.54 -40.94 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.235 -0.986 . . . . 1.1899999999999999 110.732 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.595 ' HE ' ' HZ3' ' A' ' 135' ' ' LYS . 62.4 ttt180 -59.53 -37.6 78.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.031 -1.043 . . . . 3.6299999999999999 109.704 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.407 ' CG ' ' NH1' ' A' ' 136' ' ' ARG . 49.2 t0 -60.37 -36.63 78.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.692 -0.63 . . . . 1.28 109.907 179.469 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.99 -39.76 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.729 0.776 . . . . 1.1799999999999999 109.842 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.16 -42.64 94.25 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 119.567 -1.301 . . . . 0.51000000000000001 109.973 178.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.595 ' HZ3' ' HE ' ' A' ' 131' ' ' ARG . 40.4 mmtm -59.05 -49.33 78.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.477 -1.014 . . . . 3.1699999999999999 110.421 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.407 ' NH1' ' CG ' ' A' ' 132' ' ' ASP . 51.5 mtm-85 -64.96 -40.93 95.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.848 -1.158 . . . . 2.8500000000000001 109.844 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 35.6 tp -61.09 -39.44 89.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.263 -0.898 . . . . 1.6499999999999999 110.217 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.7 mt -60.24 -38.6 83.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.56 -0.712 . . . . 1.2 111.074 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -60.13 -37.83 81.23 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.288 -0.883 . . . . 2.7999999999999998 110.734 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -75.47 -40.79 56.95 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.62 -0.832 . . . . 2.1499999999999999 110.581 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -60.37 -39.62 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 1.21 110.17 -178.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.2 mt -87.28 -4.33 59.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.955 -1.091 . . . . 1.3400000000000001 111.522 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.47 29.5 65.85 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 119.62 -1.276 . . . . 0.91000000000000003 112.819 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 33.2 tp -75.03 151.09 38.76 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.632 0.729 . . . . 1.51 109.136 179.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -64.1 146.65 53.83 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.695 -1.253 . . . . 2.8799999999999999 109.231 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.8 mt -105.27 138.79 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.574 -0.899 . . . . 1.6200000000000001 108.574 178.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.9 mp -81.0 127.32 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.671 -1.233 . . . . 2.1099999999999999 107.671 178.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -94.7 96.16 9.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.484 -1.672 . . . . 1.6200000000000001 106.484 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.494 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.9 mt -75.76 -15.77 60.22 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.699 0.762 . . . . 1.3999999999999999 111.683 -177.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.411 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 94.7 p -89.92 8.35 32.68 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.613 -1.305 . . . . 2.0499999999999998 112.147 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.29 21.21 12.3 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.672 0.99 . . . . 1.3500000000000001 113.672 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.494 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 3.2 mp -70.51 139.94 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.343 -1.473 . . . . 1.4199999999999999 108.437 179.302 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -114.65 -20.41 10.69 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.471 -0.768 . . . . 2.9900000000000002 112.278 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -114.2 139.19 49.57 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.535 -1.284 . . . . 1.54 107.535 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.81 122.97 20.87 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.426 -0.954 . . . . 1.3799999999999999 108.426 178.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.6 m -144.84 173.87 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 109.071 -0.714 . . . . 1.28 109.071 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.9 mt -85.78 142.87 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.065 -1.022 . . . . 1.1599999999999999 109.583 178.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.2 tp -97.19 124.0 41.13 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.124 -0.985 . . . . 1.3100000000000001 108.554 178.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.6 129.51 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.623 -1.251 . . . . 1.25 107.623 179.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.21 152.34 18.66 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.94 -1.1 . . . . 1.26 109.051 179.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.83 78.22 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.435 -1.416 . . . . 1.6000000000000001 109.673 178.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 56.1 t0 -171.96 149.79 2.47 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.001 -0.74 . . . . 2.4199999999999999 109.001 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.464 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 36.1 mt -114.39 140.85 48.33 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.537 -0.727 . . . . 1.3500000000000001 109.397 177.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 81.2 p -90.0 149.02 40.89 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.954 -1.091 . . . . 1.3200000000000001 109.096 178.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.97 -44.53 12.06 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 C-N-CA 122.159 1.906 . . . . 0.69999999999999996 113.51 179.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.8 m -60.85 -46.54 90.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.834 -1.166 . . . . 1.1200000000000001 109.742 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -63.81 -39.76 95.0 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.697 -0.801 . . . . 1.21 110.399 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.435 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 64.9 p -69.43 -39.4 77.88 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.63 -0.668 . . . . 1.1899999999999999 110.587 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.79 78.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.618 -0.676 . . . . 1.24 110.662 179.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -95.58 1.3 53.68 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.202 -0.936 . . . . 1.6899999999999999 112.931 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.4 tp -61.57 151.94 31.82 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.718 -1.238 . . . . 1.3400000000000001 109.548 179.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 150' ' ' SER . 94.3 m-20 -94.65 107.54 19.53 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 106.269 -1.752 . . . . 2.77 106.269 178.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 8.9 mp -69.36 -25.04 63.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.858 -0.526 . . . . 2.0899999999999999 111.548 -178.074 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -83.37 -14.25 53.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.251 -0.906 . . . . 2.6699999999999999 112.925 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -102.98 -1.91 28.52 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.274 0.842 . . . . 2.5800000000000001 113.274 -177.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.6 t -111.41 130.26 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.249 -1.019 . . . . 1.1799999999999999 108.249 179.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 27.8 tp -84.54 -10.47 57.39 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.124 -0.985 . . . . 2.1800000000000002 111.992 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.45 167.21 35.92 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 108.995 -1.642 . . . . 0.48999999999999999 108.995 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -121.75 130.15 53.21 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.869 -1.16 . . . . 0.64000000000000001 107.869 178.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 18.8 mt -130.07 130.45 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 107.444 -1.317 . . . . 1.21 107.444 178.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.2 p -140.29 172.33 12.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.936 -1.103 . . . . 1.3799999999999999 109.818 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 2.8 m-20 -111.95 42.51 1.74 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.338 0.59 . . . . 2.3700000000000001 110.369 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.55 168.73 9.04 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.783 0.801 . . . . 1.52 110.074 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.17 -6.8 48.55 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 120.107 -1.044 . . . . 1.8 113.086 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 77.6 -52.43 3.5 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.17 -1.194 . . . . 2.04 113.539 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -58.8 -42.37 88.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.817 -1.402 . . . . 5.0 110.986 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 81.8 p -105.38 11.3 32.88 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 120.79 -1.193 . . . . 3.02 112.074 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.5 t -92.18 125.53 36.89 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.839 -0.8 . . . . 2.1099999999999999 108.839 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.435 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 85.3 t60 -62.08 -32.47 73.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 1.24 110.357 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.6 m -58.66 -38.9 79.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.406 -0.809 . . . . 2.1499999999999999 110.39 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 93.6 p -59.03 -37.76 77.71 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.38 -0.825 . . . . 2.02 110.085 179.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.447 ' CD1' ' NH2' ' A' ' 195' ' ' ARG . 5.3 mm -58.75 -39.71 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.652 -0.819 . . . . 2.1200000000000001 110.151 179.375 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 51.1 mtp -62.97 -44.52 95.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.088 -1.008 . . . . 1.3600000000000001 110.146 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.26 -49.82 76.36 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.08 -0.648 . . . . 1.29 111.484 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.447 ' NH2' ' CD1' ' A' ' 192' ' ' ILE . 65.0 mtm-85 -62.96 -42.14 99.73 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.188 -0.945 . . . . 3.5600000000000001 111.199 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.0 m -68.31 -38.75 81.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.173 -0.954 . . . . 1.1799999999999999 109.855 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.62 -6.95 51.4 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.82 0.674 . . . . 1.3400000000000001 112.82 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.6 mt-10 53.52 11.26 0.27 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 113.804 1.039 . . . . 1.45 113.804 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.11 144.71 87.73 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.856 -1.153 . . . . 1.25 108.239 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.28 131.2 43.47 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.785 1.657 . . . . 0.78000000000000003 110.636 178.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.6 171.84 16.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.272 -1.371 . . . . 1.2 110.118 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 10.1 mt -147.03 157.04 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.045 -1.094 . . . . 1.25 108.045 178.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 181' ' ' THR . 23.8 m -141.59 -29.05 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.644 -1.285 . . . . 1.3899999999999999 112.791 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.72 33.18 1.89 Allowed Glycine 0 C--N 1.289 -2.04 0 O-C-N 120.927 -1.108 . . . . 0.96999999999999997 113.685 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 27.6 p -55.47 -24.79 33.05 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.249 -1.148 . . . . 1.3500000000000001 111.194 -179.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.34 -87.86 1.56 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.825 -0.91 . . . . 1.0700000000000001 110.825 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 45.2 p -129.02 26.83 5.46 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 121.167 -1.196 . . . . 1.9199999999999999 113.069 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 30.4 t -57.0 -39.7 67.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.317 -1.489 . . . . 1.3300000000000001 110.807 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 64.4 p -61.27 -18.95 60.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 1.4199999999999999 111.93 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 67.4 m -98.83 5.44 47.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 2.1200000000000001 112.002 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -133.62 -4.19 2.93 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.916 -0.49 . . . . 2.6899999999999999 112.146 -178.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.0 t -121.3 152.95 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 121.504 0.668 . . . . 1.29 109.41 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -117.81 161.21 20.1 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.751 -0.833 . . . . 2.6899999999999999 108.751 178.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.0 p-10 -61.78 149.87 38.68 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.906 -1.117 . . . . 2.79 109.88 177.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.5 t70 82.88 -10.27 1.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.233 1.197 . . . . 2.3500000000000001 114.233 178.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.23 149.44 37.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.534 -1.354 . . . . 1.97 109.276 177.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -87.18 123.88 32.68 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.282 -1.377 . . . . 2.9700000000000002 107.282 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 74.8 mt -127.51 150.23 49.77 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.017 0.913 . . . . 1.25 110.093 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 88.0 mt -119.05 122.29 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.237 -1.764 . . . . 1.22 106.237 177.114 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 37.1 tp -98.65 118.01 34.4 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.441 -1.688 . . . . 1.24 106.441 178.434 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 223' ' ' VAL . 87.7 m-20 -94.22 -27.84 15.95 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.502 -1.374 . . . . 2.0499999999999998 112.917 -177.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 39.63 15.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.914 0.709 . . . . 1.25 112.914 -179.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.8 t -108.66 -62.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.196 -0.94 . . . . 1.4299999999999999 109.217 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -94.34 11.31 30.92 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.009 0.909 . . . . 3.0299999999999998 110.514 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 60.9 54.99 3.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.618 -0.719 . . . . 2.25 112.03 178.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -144.72 146.53 32.24 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.234 1.016 . . . . 2.52 109.586 178.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.84 131.32 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.658 -1.238 . . . . 1.29 107.658 177.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -102.05 132.02 48.16 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.846 -1.159 . . . . 1.3400000000000001 108.483 178.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.28 129.94 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 107.998 -1.112 . . . . 1.3400000000000001 107.998 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.5 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 48.3 t30 59.05 44.01 0.96 Allowed Pre-proline 0 N--CA 1.485 1.309 0 N-CA-C 113.631 0.974 . . . . 2.1800000000000002 113.631 178.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.1 Cg_endo -64.7 149.35 89.88 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.349 2.033 . . . . 0.93999999999999995 111.56 -179.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 36.9 p -77.03 160.18 29.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.475 -0.766 . . . . 2.3999999999999999 110.255 178.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -60.28 -36.73 78.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.753 -0.592 . . . . 3.3300000000000001 110.385 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.12 -40.34 85.1 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.447 -0.783 . . . . 3.1699999999999999 110.15 179.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 79.4 t -70.15 -39.87 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.824 0.821 . . . . 1.6899999999999999 110.571 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.3 mt . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.499 -0.751 . . . . 1.6000000000000001 110.799 -179.894 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.6 mt . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 107.433 -1.321 . . . . 1.5700000000000001 107.433 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.0 m -100.47 127.48 46.8 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.505 -1.294 . . . . 1.4399999999999999 107.505 178.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -124.5 -163.29 11.64 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.451 -1.86 . . . . 1.01 108.451 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.465 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 96.7 mt -97.91 2.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.984 -1.303 . . . . 1.6299999999999999 112.593 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tp 51.56 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.762 -1.211 . . . . 1.5800000000000001 111.825 178.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.07 -38.83 17.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.914 -1.116 . . . . 1.3400000000000001 110.939 179.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 m -148.1 144.36 18.78 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.619 -1.301 . . . . 1.8600000000000001 108.173 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.08 145.99 22.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.356 2.037 . . . . 1.01 111.904 178.263 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.421 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 151.93 171.02 19.27 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.23 -1.548 . . . . 0.81000000000000005 109.23 178.047 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.1 mt -128.79 135.56 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.208 -1.172 . . . . 1.3700000000000001 107.919 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.39 152.69 44.55 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.027 -1.046 . . . . 1.1399999999999999 109.996 179.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -125.08 140.28 53.03 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.33 -0.989 . . . . 0.87 108.33 178.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.54 170.14 37.38 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 118.216 -1.945 . . . . 0.56999999999999995 110.473 178.155 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -78.74 157.14 28.57 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.803 -0.822 . . . . 2.3500000000000001 109.003 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.89 127.45 35.05 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.257 -1.016 . . . . 1.21 108.257 178.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.3 tp -105.07 102.99 12.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.497 -2.038 . . . . 1.3999999999999999 105.497 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.7 tp -90.62 140.82 29.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.936 -1.102 . . . . 1.4399999999999999 108.672 -179.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.5 mt -97.0 114.22 25.82 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.697 -1.594 . . . . 1.45 106.697 177.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -106.23 130.11 54.16 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.317 -1.364 . . . . 2.5 107.317 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -125.31 149.61 47.91 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.476 -0.765 . . . . 2.6600000000000001 109.527 -179.473 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -82.4 133.28 35.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.079 -1.082 . . . . 2.3199999999999998 108.079 177.258 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -65.34 146.67 54.62 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.168 -0.957 . . . . 2.1099999999999999 108.758 178.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.1 mt -93.45 136.18 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.694 -0.854 . . . . 1.29 108.694 178.431 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.09 130.27 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.821 -1.177 . . . . 1.4099999999999999 107.821 179.064 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.7 mt -97.94 135.34 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.181 -1.044 . . . . 1.3100000000000001 108.181 178.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -91.22 122.45 33.87 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.747 -1.205 . . . . 1.3400000000000001 107.747 178.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -95.4 16.96 15.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.201 -0.937 . . . . 3.48 112.216 -179.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -73.82 148.57 42.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 2.52 109.728 178.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -90.6 135.59 33.61 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.333 -0.988 . . . . 2.6299999999999999 108.333 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 pt -100.48 166.36 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.131 -0.98 . . . . 1.3100000000000001 109.976 179.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.2 p -95.43 168.68 10.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.501 -0.749 . . . . 1.24 109.583 178.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.66 -18.61 21.47 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.078 -1.014 . . . . 1.49 112.476 179.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -68.06 -37.54 81.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.881 -1.137 . . . . 2.2799999999999998 110.711 -179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -92.26 -5.35 52.54 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.634 -1.292 . . . . 2.0499999999999998 113.132 -179.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.28 -43.8 94.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.063 -1.023 . . . . 1.3400000000000001 110.134 -179.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -57.93 -40.76 81.22 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.567 -0.853 . . . . 1.54 110.241 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -63.89 -39.76 94.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.704 -0.623 . . . . 2.8500000000000001 110.714 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.23 -42.58 95.54 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.157 -0.964 . . . . 1.3100000000000001 110.913 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.34 -42.22 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.09 -1.006 . . . . 1.3799999999999999 110.727 -179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -60.96 -42.27 97.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 1.5 109.919 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -60.75 -42.67 97.88 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.466 -0.894 . . . . 2.7799999999999998 109.803 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -72.84 -56.7 4.84 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.815 0.817 . . . . 1.0600000000000001 110.231 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 tp -58.47 -47.44 84.03 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.42 -0.912 . . . . 1.3999999999999999 110.252 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.8 t -68.73 -39.82 80.18 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.121 -0.987 . . . . 1.3200000000000001 110.035 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.44 -45.55 94.26 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.434 -1.365 . . . . 0.69999999999999996 109.783 178.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -58.76 -30.19 67.33 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.516 -0.991 . . . . 3.4399999999999999 110.28 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.67 -42.14 87.78 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.972 0.891 . . . . 1.3600000000000001 109.779 179.024 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -81.19 -40.71 23.48 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.412 -0.805 . . . . 2.8300000000000001 110.73 179.445 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.86 -43.68 90.89 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.747 -0.781 . . . . 1.23 109.938 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.8 m -59.32 -39.93 84.67 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.863 0.84 . . . . 1.9199999999999999 109.381 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.31 -44.36 71.9 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.629 -0.714 . . . . 1.25 110.587 179.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.5 -51.57 59.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.004 . . . . 1.97 110.472 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.58 -38.99 86.44 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.371 -0.931 . . . . 2.1800000000000002 109.874 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -59.99 -40.99 91.06 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.456 -0.777 . . . . 1.1899999999999999 110.487 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -65.63 -42.33 91.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 1.3400000000000001 110.175 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.81 -35.17 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.495 -0.753 . . . . 1.23 110.703 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -52.44 -43.01 64.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.659 -1.275 . . . . 1.5600000000000001 110.771 179.237 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.13 -37.17 78.18 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.389 -0.819 . . . . 1.3 110.151 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -62.05 -39.54 92.7 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.853 -1.139 . . . . 2.3199999999999998 109.531 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.83 -32.08 72.37 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.598 -0.689 . . . . 1.1399999999999999 110.322 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.41 -36.67 16.44 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.242 -1.456 . . . . 0.68999999999999995 110.478 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.02 -16.43 50.27 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.637 -1.508 . . . . 1.48 111.306 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.2 m -92.94 -51.12 5.22 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.785 -0.572 . . . . 1.52 110.768 -179.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -107.82 -19.86 13.39 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.303 -0.873 . . . . 1.3100000000000001 112.799 -177.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.06 160.55 11.1 Favored Glycine 0 N--CA 1.504 3.219 0 O-C-N 120.96 -1.087 . . . . 0.84999999999999998 112.028 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -56.06 -22.77 29.48 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.983 -0.716 . . . . 3.8599999999999999 112.727 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -58.14 -35.47 71.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 2.3500000000000001 111.3 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -81.02 -25.78 36.92 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.721 -1.237 . . . . 2.2599999999999998 112.315 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.09 -32.41 69.79 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.377 -0.827 . . . . 1.45 110.803 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.43 85.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.019 . . . . 1.25 111.17 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.58 -42.92 87.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.394 -1.441 . . . . 1.26 110.114 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -70.48 -30.69 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.82999999999999996 110.729 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -59.91 -40.26 88.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.128 -0.982 . . . . 1.1899999999999999 110.142 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.33 -39.46 97.01 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.537 -1.316 . . . . 0.57999999999999996 110.47 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -59.1 -41.84 89.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.655 -0.909 . . . . 2.0499999999999998 111.113 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.3 mt -60.67 -42.09 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.92 -1.112 . . . . 1.21 110.028 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.5 ttm -60.42 -40.25 90.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.511 -0.743 . . . . 2.29 110.067 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 tp -59.77 -49.82 76.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.422 -0.799 . . . . 1.21 109.872 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.54 -41.85 95.33 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.055 -0.658 . . . . 1.1399999999999999 110.299 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -85.29 4.96 32.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.5 -0.75 . . . . 1.4199999999999999 112.972 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -61.54 118.17 6.69 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.627 -1.296 . . . . 1.27 109.191 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -63.69 -16.69 61.7 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.03 0.919 . . . . 1.3500000000000001 110.904 -179.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -77.49 -52.24 9.42 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.95 0.881 . . . . 2.2200000000000002 110.248 179.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.71 -37.79 85.47 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.668 -0.813 . . . . 1.22 110.588 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -59.05 -47.99 83.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 1.29 110.781 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -61.61 -38.0 86.02 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.314 -0.866 . . . . 2.1699999999999999 111.142 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -64.6 -47.7 77.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.236 -0.915 . . . . 1.3 110.324 179.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 89' ' ' ILE . 96.1 mt -58.3 -45.05 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.444 -0.785 . . . . 1.1699999999999999 109.665 179.181 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.1 mt -60.79 -40.59 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.994 0.902 . . . . 1.3999999999999999 109.862 179.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.67 97.32 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.995 -1.065 . . . . 1.3300000000000001 110.601 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.45 -41.37 97.1 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.426 -0.91 . . . . 1.48 110.245 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.26 -47.99 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.054 -1.029 . . . . 1.28 110.387 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -77.09 -35.77 56.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.508 -0.745 . . . . 2.6000000000000001 112.121 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -80.7 -44.99 17.85 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.407 -1.433 . . . . 1.51 112.184 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -102.82 12.08 36.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.292 -0.88 . . . . 2.48 112.559 -178.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.9 m80 49.23 49.07 20.25 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.026 -1.07 . . . . 1.6100000000000001 111.56 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.6 mtt -102.57 154.58 18.98 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.146 -0.971 . . . . 1.8999999999999999 109.715 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.8 p -70.63 159.8 33.73 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.377 0.608 . . . . 1.3200000000000001 109.412 177.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.99 83.39 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.383 -0.823 . . . . 1.1499999999999999 111.284 178.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -72.07 -44.44 63.29 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.212 -0.93 . . . . 2.25 110.44 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.11 74.39 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.35 -0.94 . . . . 1.22 111.165 -178.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.89 93.17 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.182 -0.948 . . . . 1.1899999999999999 110.945 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.67 86.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 1.2 110.683 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -60.63 -37.94 83.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.925 . . . . 2.1000000000000001 110.65 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -57.57 -50.01 74.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.821 -1.175 . . . . 1.3 111.078 179.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.9 -46.88 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.882 -1.136 . . . . 1.27 109.97 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.02 -33.4 55.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.66 -0.65 . . . . 1.1899999999999999 110.233 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -58.62 -40.19 82.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.17 -0.956 . . . . 2.1099999999999999 110.922 179.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.41 -35.7 10.4 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.046 -1.55 . . . . 0.88 112.3 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -60.49 -41.16 93.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.394 -1.651 . . . . 1.99 109.889 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.37 -49.82 38.37 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.684 0.754 . . . . 1.28 110.59 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.9 m -60.64 -39.13 87.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 2.2200000000000002 110.772 -179.432 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.51 -41.9 95.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.423 -0.798 . . . . 1.45 110.847 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.68 -30.35 71.37 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.15 -1.02 . . . . 1.47 110.994 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.0 -20.56 64.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.071 -1.018 . . . . 2.04 111.067 179.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.53 -17.84 61.7 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.784 0.802 . . . . 1.73 111.19 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 29.7 mt -86.34 148.76 25.45 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.396 -0.815 . . . . 1.79 109.285 179.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -101.7 41.66 1.19 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.48 -0.763 . . . . 2.8799999999999999 111.007 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -114.06 130.86 56.54 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.273 -1.01 . . . . 1.5800000000000001 108.273 178.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.468 ' OE2' ' N ' ' A' ' 121' ' ' GLU . 1.6 mp0 -58.71 -33.08 69.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.278 -0.889 . . . . 3.04 110.77 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -71.1 -51.43 25.13 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.689 -1.257 . . . . 1.29 110.318 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.2 mt -67.11 -39.25 86.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.426 -0.796 . . . . 1.6000000000000001 110.331 -179.312 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -61.99 -49.61 75.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.971 -1.08 . . . . 2.7599999999999998 109.796 179.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 187' ' ' THR . 50.5 mt-10 -61.49 -31.66 71.65 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.529 -0.868 . . . . 2.1499999999999999 109.203 179.699 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -64.75 -28.94 69.93 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.251 1.024 . . . . 2.8100000000000001 109.091 179.187 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.11 -47.16 86.27 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.575 -0.85 . . . . 1.3899999999999999 109.54 178.375 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.7 87.59 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.57 -0.852 . . . . 1.4099999999999999 109.612 179.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -63.29 -36.32 83.29 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.189 0.519 . . . . 1.3899999999999999 110.546 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.6 t -67.85 -36.59 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.966 -1.084 . . . . 1.1899999999999999 110.237 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -59.45 -38.8 81.66 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.869 -1.132 . . . . 3.6299999999999999 109.109 178.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.558 ' CG ' HH21 ' A' ' 136' ' ' ARG . 58.2 t0 -59.61 -40.34 87.2 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.676 -0.693 . . . . 1.28 109.9 179.114 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -60.83 -33.86 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 1.1799999999999999 109.7 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.41 -49.74 14.24 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.098 -1.049 . . . . 0.51000000000000001 111.186 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.475 ' NZ ' ' OD1' ' A' ' 132' ' ' ASP . 5.3 pttm -58.86 -39.46 81.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.998 -1.295 . . . . 3.1699999999999999 110.649 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.558 HH21 ' CG ' ' A' ' 132' ' ' ASP . 37.0 mtt180 -59.4 -45.22 92.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.947 -1.095 . . . . 2.8500000000000001 109.936 179.03 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.96 -42.57 98.54 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.66 -0.65 . . . . 1.6499999999999999 110.427 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 23.8 mt -59.9 -43.48 94.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.577 -0.702 . . . . 1.2 110.566 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -60.47 -34.55 74.19 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.433 -0.792 . . . . 2.7999999999999998 111.298 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -76.13 -41.13 51.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.92 -1.112 . . . . 2.1499999999999999 110.43 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.26 -39.84 83.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 120.83 -1.169 . . . . 1.21 110.887 -178.368 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 76.1 mt -88.53 -10.02 50.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 1.3400000000000001 112.246 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.0 19.96 71.41 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.887 -1.149 . . . . 0.91000000000000003 113.261 -179.298 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.9 tp -64.99 143.82 57.7 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.503 -0.998 . . . . 1.51 109.248 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -70.02 151.7 45.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.366 -0.834 . . . . 2.8799999999999999 109.626 178.113 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.3 mt -105.44 140.19 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.218 -1.03 . . . . 1.6200000000000001 108.218 178.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.427 HD11 HG22 ' A' ' 147' ' ' ILE . 12.3 mm -75.74 136.2 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 2.1099999999999999 108.973 178.398 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.38 92.55 7.22 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.495 -1.669 . . . . 1.6200000000000001 106.495 178.526 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 81.3 mt -78.36 -20.86 50.42 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.357 -0.839 . . . . 1.3999999999999999 111.061 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.6 t -78.86 -6.9 57.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 2.0499999999999998 112.458 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.39 35.94 1.55 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.597 -0.689 . . . . 1.3500000000000001 112.489 -178.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.1 mm -68.9 149.13 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.865 -1.147 . . . . 1.4199999999999999 108.986 178.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -129.37 -9.12 4.68 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.531 -0.73 . . . . 2.9900000000000002 112.613 -179.296 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -120.01 145.75 46.52 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.851 -0.796 . . . . 1.54 108.851 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -80.37 114.73 19.48 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.655 -1.239 . . . . 1.3799999999999999 107.655 177.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -148.2 175.45 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 1.28 109.305 -178.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.3 mt -93.83 143.33 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.389 -0.967 . . . . 1.1599999999999999 108.389 178.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.8 tp -96.49 129.81 43.78 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.772 -1.205 . . . . 1.3100000000000001 108.828 178.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.84 130.47 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.813 -1.18 . . . . 1.25 107.813 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.06 155.55 23.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.861 -1.149 . . . . 1.26 108.868 179.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.01 79.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.492 -1.38 . . . . 1.6000000000000001 109.712 178.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -174.3 148.46 1.28 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.908 -0.775 . . . . 2.4199999999999999 108.908 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.2 mt -118.15 141.69 48.23 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.585 -0.895 . . . . 1.3500000000000001 108.585 177.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.2 p -90.93 148.9 39.17 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.992 . . . . 1.3200000000000001 108.671 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -38.81 -41.2 1.64 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.73 1.62 . . . . 0.69999999999999996 113.542 178.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.538 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 25.4 m -62.66 -51.48 67.07 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.878 -1.139 . . . . 1.1200000000000001 110.508 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.2 -39.09 88.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 1.21 109.855 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.683 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 61.7 p -68.48 -39.18 81.46 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.615 -0.678 . . . . 1.1899999999999999 110.419 179.332 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.8 -35.73 80.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.051 -1.03 . . . . 1.24 110.761 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -96.21 -1.0 49.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.02 -1.05 . . . . 1.6899999999999999 112.827 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -60.61 156.41 16.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.929 . . . . 1.3400000000000001 109.863 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -88.97 106.28 18.32 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.788 -1.56 . . . . 2.77 106.788 178.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 50.9 mt -80.49 -17.47 51.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.623 -0.673 . . . . 2.0899999999999999 112.133 -177.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -81.13 -23.05 38.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.381 -0.824 . . . . 2.6699999999999999 111.769 -178.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -105.95 -2.87 22.39 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.614 0.968 . . . . 2.5800000000000001 113.614 -178.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.94 128.4 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 107.74 -1.207 . . . . 1.1799999999999999 107.74 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.4 tp -90.44 -10.4 43.92 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.246 -0.909 . . . . 2.1800000000000002 112.251 -178.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.22 171.02 41.13 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.116 -1.593 . . . . 0.48999999999999999 109.116 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.585 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -130.77 135.75 48.06 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.563 -1.273 . . . . 0.64000000000000001 107.563 179.334 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 97.0 mt -133.11 107.94 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 105.938 -1.875 . . . . 1.21 105.938 178.156 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 203' ' ' VAL . 72.2 p -128.82 175.37 8.68 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.676 -1.265 . . . . 1.3799999999999999 110.746 -178.696 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.7 OUTLIER -100.51 53.92 0.88 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.578 -0.737 . . . . 2.3700000000000001 110.071 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.93 156.37 16.65 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.091 -1.006 . . . . 1.52 109.773 179.149 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.14 -5.03 57.93 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.769 -1.205 . . . . 1.8 112.397 178.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 73.66 -12.37 4.84 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.488 -1.339 . . . . 2.04 115.213 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.456 ' O ' ' OG1' ' A' ' 187' ' ' THR . 79.0 mtm180 -81.8 113.41 19.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.001 -1.481 . . . . 5.0 107.001 178.42 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 22.2 p 48.54 39.96 14.25 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.893 -1.129 . . . . 3.02 111.931 -178.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.45 ' HG ' ' CB ' ' A' ' 191' ' ' SER . 7.3 p -82.14 133.67 35.28 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.309 -0.997 . . . . 2.1099999999999999 108.309 177.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.683 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 18.0 t60 -60.15 -40.41 89.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.442 -0.786 . . . . 1.24 110.681 179.645 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 87.4 m -60.83 -42.04 96.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 2.1499999999999999 110.256 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.505 ' HG ' ' N ' ' A' ' 192' ' ' ILE . 98.1 p -61.61 -38.58 88.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.945 -1.097 . . . . 2.02 110.411 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.505 ' N ' ' HG ' ' A' ' 191' ' ' SER . 96.1 mt -60.11 -35.32 60.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.431 -0.793 . . . . 2.1200000000000001 110.833 179.576 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.6 mtp -62.64 -42.65 99.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 122.395 1.093 . . . . 1.3600000000000001 109.202 179.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.89 -49.54 77.07 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.552 -0.749 . . . . 1.29 110.789 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -60.38 -44.34 95.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 3.5600000000000001 110.697 -179.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.4 m -69.88 -40.08 75.89 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.295 -0.878 . . . . 1.1799999999999999 110.315 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.4 mt -90.83 -4.43 56.61 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.1 0.952 . . . . 1.3400000000000001 112.42 -178.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 194' ' ' ALA . 94.1 mt-10 54.56 7.32 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.4 1.259 . . . . 1.45 114.4 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.9 mt -71.46 147.39 92.58 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.948 -1.095 . . . . 1.25 108.092 179.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -58.49 141.66 97.42 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.765 1.643 . . . . 0.78000000000000003 109.714 178.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -158.74 168.39 26.96 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 117.831 -1.548 . . . . 1.2 109.776 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 54.8 mt -149.01 159.02 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.519 -1.289 . . . . 1.25 107.519 178.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.3 m -140.48 -32.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.702 0 O-C-N 120.647 -1.283 . . . . 1.3899999999999999 111.951 -179.756 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.3 37.4 0.81 Allowed Glycine 0 N--CA 1.485 1.934 0 C-N-CA 120.497 -0.859 . . . . 0.96999999999999997 112.865 -178.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.488 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 45.6 p -63.94 -20.55 65.94 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.673 -0.898 . . . . 1.3500000000000001 111.499 -179.098 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.68 -92.43 0.61 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 110.045 -1.222 . . . . 1.0700000000000001 110.045 179.471 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.481 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 70.4 m -128.16 23.93 6.0 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.275 -1.132 . . . . 1.9199999999999999 112.696 -178.825 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 79.5 t -51.52 -34.48 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.541 -1.349 . . . . 1.3300000000000001 110.609 179.085 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.0 p -58.62 -20.91 51.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.58 -0.7 . . . . 1.4199999999999999 111.58 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.618 ' HG ' ' NE2' ' A' ' 211' ' ' GLN . 15.9 t -90.59 -3.16 57.76 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.013 -1.054 . . . . 2.1200000000000001 111.698 -179.037 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.618 ' NE2' ' HG ' ' A' ' 210' ' ' SER . 24.6 mp0 -122.83 -4.42 8.62 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.502 0.668 . . . . 2.6899999999999999 112.522 -177.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 44.6 t -112.85 148.0 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.533 -0.729 . . . . 1.29 109.415 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -121.3 157.08 31.14 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.071 -1.085 . . . . 2.6899999999999999 108.071 178.055 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 19.1 p30 -56.76 140.92 46.06 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.671 -1.268 . . . . 2.79 110.43 178.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 m-20 81.57 7.02 1.13 Allowed 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 114.465 1.283 . . . . 2.3500000000000001 114.465 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -67.48 151.75 46.84 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.424 -1.423 . . . . 1.97 109.945 177.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -90.51 115.11 27.4 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.691 -1.596 . . . . 2.9700000000000002 106.691 177.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.8 mt -127.71 141.94 51.46 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.236 -0.915 . . . . 1.25 109.56 -178.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 50.8 mt -113.54 127.72 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 106.607 -1.627 . . . . 1.22 106.607 177.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.6 tp -102.17 118.47 36.97 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.193 -1.78 . . . . 1.24 106.193 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 223' ' ' VAL . 44.8 p-10 -93.14 -21.04 19.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.042 -1.036 . . . . 2.0499999999999998 112.297 -178.184 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.496 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 38.47 17.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.031 0.752 . . . . 1.25 113.031 -179.177 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.5 t -112.77 -62.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 121.807 0.813 . . . . 1.4299999999999999 109.135 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -90.3 9.62 28.07 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.294 1.045 . . . . 3.0299999999999998 110.303 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 41.9 t30 60.82 52.37 4.31 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.91 -0.586 . . . . 2.25 111.462 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -150.87 147.89 27.79 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.222 1.011 . . . . 2.52 110.055 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 50.3 t -115.02 138.78 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 107.494 -1.299 . . . . 1.29 107.494 176.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -104.53 137.73 41.94 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.096 -1.002 . . . . 1.3400000000000001 108.602 178.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.3 t -109.3 129.4 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 107.638 -1.245 . . . . 1.3400000000000001 107.638 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.432 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 48.5 t-20 48.15 49.87 8.05 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 113.507 0.929 . . . . 2.1800000000000002 113.507 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 22.3 Cg_endo -62.53 154.21 66.18 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.141 1.894 . . . . 0.93999999999999995 110.394 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.6 m -72.77 158.72 35.04 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.987 -1.07 . . . . 2.3999999999999999 109.272 177.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 22.0 p30 -58.59 -38.0 77.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.849 -1.157 . . . . 3.3300000000000001 110.483 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.51 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 82.1 tt0 -60.93 -39.45 89.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.005 -1.059 . . . . 3.1699999999999999 110.013 179.355 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.08 -36.84 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 1.6899999999999999 110.319 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 80.8 mt . . . . . 0 C--N 1.302 -1.475 0 O-C-N 121.397 -0.814 . . . . 1.6000000000000001 110.252 178.962 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.0 mt . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 107.41 -1.33 . . . . 1.5700000000000001 107.41 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.4 m -104.8 127.45 52.6 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.791 -1.189 . . . . 1.4399999999999999 107.791 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.88 -147.79 22.86 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.246 -1.142 . . . . 1.01 110.246 179.42 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.474 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 80.5 mt -97.6 1.31 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.546 -0.973 . . . . 1.6299999999999999 112.571 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' ILE . 8.6 tp 50.42 100.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.737 -1.227 . . . . 1.5800000000000001 112.063 178.458 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.7 -41.4 11.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.924 -1.11 . . . . 1.3400000000000001 111.791 179.211 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t -146.19 140.98 15.97 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 107.78 -1.193 . . . . 1.8600000000000001 107.78 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.77 149.73 38.27 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.585 2.19 . . . . 1.01 112.555 178.607 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.443 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 149.66 161.65 9.94 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.367 -1.493 . . . . 0.81000000000000005 109.367 178.306 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.3 mt -119.95 132.82 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.132 -1.217 . . . . 1.3700000000000001 107.893 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.16 151.07 47.38 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.216 -0.928 . . . . 1.1399999999999999 109.03 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -123.16 141.54 51.86 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.577 -0.898 . . . . 0.87 108.577 178.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.94 166.2 32.98 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.046 -1.55 . . . . 0.56999999999999995 109.798 177.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -76.3 158.2 31.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.816 -0.814 . . . . 2.3500000000000001 109.133 178.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.3 123.49 29.11 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.607 -1.257 . . . . 1.21 107.607 178.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.2 tp -102.9 99.64 9.57 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.228 -1.768 . . . . 1.3999999999999999 106.228 178.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 tp -87.52 140.92 29.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 1.4399999999999999 108.962 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.7 mt -96.51 115.66 27.8 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.653 -1.61 . . . . 1.45 106.653 177.497 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -108.84 130.62 55.41 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.816 -1.179 . . . . 2.5 107.816 -179.46 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -128.4 146.83 50.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 2.6600000000000001 109.054 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -80.41 138.89 36.69 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.933 -1.105 . . . . 2.3199999999999998 108.041 177.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -63.48 140.33 58.86 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.612 -0.884 . . . . 2.1099999999999999 108.612 178.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -89.7 130.16 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.086 -1.079 . . . . 1.29 108.086 178.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.6 129.95 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.752 -1.203 . . . . 1.4099999999999999 107.752 178.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.2 mt -91.25 138.99 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.387 -0.968 . . . . 1.3100000000000001 108.387 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -88.23 120.73 29.86 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.91 -1.515 . . . . 1.3400000000000001 106.91 178.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -93.57 10.27 33.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.522 -0.736 . . . . 3.48 112.868 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -73.12 143.96 47.14 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.881 -1.137 . . . . 2.52 110.039 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -89.77 132.16 35.36 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.185 -1.043 . . . . 2.6299999999999999 108.185 177.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -93.27 165.01 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.333 -0.854 . . . . 1.3100000000000001 110.477 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.9 p -93.21 165.12 12.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.772 -0.58 . . . . 1.24 109.713 178.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.95 -22.45 15.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.302 -0.874 . . . . 1.49 112.18 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.95 -37.73 81.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.867 -1.146 . . . . 2.2799999999999998 110.914 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -91.54 -7.26 50.81 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.44 -1.412 . . . . 2.0499999999999998 112.782 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.3 -41.21 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.218 -0.926 . . . . 1.3400000000000001 110.56 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -56.42 -39.99 73.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.027 . . . . 1.54 110.602 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -63.47 -41.95 98.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 2.8500000000000001 111.079 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.96 -41.58 98.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.081 -1.012 . . . . 1.3100000000000001 110.843 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.6 t -60.66 -40.06 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.611 -0.836 . . . . 1.3799999999999999 110.217 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -60.85 -43.62 98.08 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.736 -0.786 . . . . 1.5 109.677 179.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -62.1 -40.05 94.55 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.909 -0.716 . . . . 2.7799999999999998 110.325 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -73.16 -54.22 9.02 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.149 -0.969 . . . . 1.0600000000000001 110.017 179.116 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -60.52 -49.06 79.04 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.002 -1.062 . . . . 1.3999999999999999 110.306 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.6 t -68.85 -36.92 78.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.361 -0.837 . . . . 1.3200000000000001 110.02 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.01 -46.3 84.87 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.499 -1.334 . . . . 0.69999999999999996 109.862 178.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -57.92 -31.72 67.07 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.246 -1.149 . . . . 3.4399999999999999 109.655 178.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.31 -51.1 71.2 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.204 -0.998 . . . . 1.3600000000000001 110.965 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 42.7 pttt -81.9 -42.1 19.99 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.175 -0.953 . . . . 2.8300000000000001 110.966 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.409 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -60.22 -41.82 93.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.8 . . . . 1.23 110.383 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.1 p -59.46 -41.15 89.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.218 -1.03 . . . . 1.9199999999999999 108.218 179.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.51 -48.65 59.85 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.559 -0.746 . . . . 1.25 109.782 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -62.13 -48.72 78.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.442 -1.411 . . . . 1.97 110.077 -178.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.71 -38.9 89.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 2.1800000000000002 109.81 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -59.62 -40.17 86.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.724 -0.61 . . . . 1.1899999999999999 110.471 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.51 ' CG2' ' HZ3' ' A' ' 60' ' ' LYS . 11.2 m -63.65 -39.81 95.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.926 -1.109 . . . . 1.3400000000000001 110.148 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.71 -40.17 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.468 -0.77 . . . . 1.23 110.573 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -51.75 -40.65 60.64 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.424 -0.798 . . . . 1.5600000000000001 110.482 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.8 -37.08 73.26 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.11 -0.994 . . . . 1.3 110.348 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.51 ' HZ3' ' CG2' ' A' ' 56' ' ' THR . 52.4 mttp -63.34 -38.82 92.65 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.669 -1.212 . . . . 2.3199999999999998 109.025 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.8 -30.14 68.65 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.907 -0.588 . . . . 1.1399999999999999 110.337 179.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.11 -38.88 8.84 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 119.893 -1.146 . . . . 0.68999999999999995 111.214 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -81.03 -22.69 39.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.856 -1.379 . . . . 1.48 111.282 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 28.7 m -87.31 -51.56 5.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.656 -0.652 . . . . 1.52 110.687 -179.704 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -107.21 -7.28 16.84 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.07 1.137 . . . . 1.3100000000000001 114.07 -177.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.45 157.95 17.73 Favored Glycine 0 N--CA 1.5 2.909 0 O-C-N 121.599 -0.688 . . . . 0.84999999999999998 113.22 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -53.32 -19.06 2.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.592 -0.946 . . . . 3.8599999999999999 113.341 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -57.41 -33.92 68.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.714 -1.241 . . . . 2.3500000000000001 110.996 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -80.13 -23.53 41.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.959 -1.088 . . . . 2.2599999999999998 111.468 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.87 -38.32 81.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.093 -1.004 . . . . 1.45 111.007 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.22 -40.09 84.76 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.954 -1.091 . . . . 1.25 110.999 179.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.7 mt -69.3 -47.99 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.665 -1.272 . . . . 1.26 110.13 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -70.52 -29.94 66.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.864 . . . . 0.82999999999999996 110.62 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.79 -38.63 85.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.275 -0.891 . . . . 1.1899999999999999 110.403 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.3 -37.25 59.27 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 110.074 -1.211 . . . . 0.57999999999999996 110.074 179.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -59.81 -44.21 94.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.279 -1.13 . . . . 2.0499999999999998 110.087 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.12 -39.37 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 1.21 110.045 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.5 ttm -59.88 -39.5 85.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.5 -0.75 . . . . 2.29 110.552 179.46 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.6 tp -58.36 -48.15 81.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.853 . . . . 1.21 110.204 179.028 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.01 -40.29 88.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.602 0.715 . . . . 1.1399999999999999 110.262 -179.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -86.04 5.14 34.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.791 . . . . 1.4199999999999999 112.75 -179.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -61.79 119.18 8.26 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.846 -1.159 . . . . 1.27 108.928 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.85 -17.49 64.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.462 -0.774 . . . . 1.3500000000000001 110.84 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.83 -47.8 28.54 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.023 -1.071 . . . . 2.2200000000000002 109.889 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.66 -36.44 82.86 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.301 -0.96 . . . . 1.22 110.011 -178.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.77 -48.36 79.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.404 -0.81 . . . . 1.29 110.495 179.05 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.52 -39.49 87.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 2.1699999999999999 110.492 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.25 -49.88 62.69 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.091 -1.005 . . . . 1.3 110.488 179.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.5 mt -56.83 -43.58 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.935 -1.103 . . . . 1.1699999999999999 110.234 179.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.9 -43.2 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.567 -0.708 . . . . 1.3999999999999999 110.116 179.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.65 -41.81 91.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.409 -0.807 . . . . 1.3300000000000001 110.574 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.08 -43.6 95.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.113 -0.992 . . . . 1.48 110.254 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.1 mt -65.61 -48.45 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.094 -1.004 . . . . 1.28 110.179 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -78.72 -36.2 43.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.266 -0.896 . . . . 2.6000000000000001 112.197 -179.414 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 91' ' ' ALA . 58.2 t0 -81.74 -40.02 23.33 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.438 -1.414 . . . . 1.51 111.76 -179.405 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -108.59 10.61 27.05 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.211 -0.931 . . . . 2.48 111.965 -178.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.0 m80 49.46 50.52 18.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.982 -1.074 . . . . 1.6100000000000001 111.612 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -104.23 152.89 21.64 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.14 0.971 . . . . 1.8999999999999999 109.791 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.439 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 23.2 p -72.8 160.8 31.59 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.57 -0.706 . . . . 1.3200000000000001 109.535 178.009 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.45 -40.09 81.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -0.926 . . . . 1.1499999999999999 110.914 178.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 26.2 p-10 -69.86 -42.1 73.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.051 -1.031 . . . . 2.25 110.519 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.35 61.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.348 -0.845 . . . . 1.22 110.882 -179.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.84 93.64 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.265 -0.897 . . . . 1.1899999999999999 110.696 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.66 -43.75 93.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 1.2 110.943 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -60.19 -40.01 88.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.865 -1.147 . . . . 2.1000000000000001 111.036 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.73 -48.86 76.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.671 -1.268 . . . . 1.3 110.617 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 83.4 t -62.86 -49.22 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.71 -1.243 . . . . 1.27 110.29 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 mm -61.54 -30.23 47.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.193 0.521 . . . . 1.1899999999999999 110.538 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -59.87 -40.12 87.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 2.1099999999999999 110.922 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.95 -31.45 17.6 Favored Glycine 0 N--CA 1.502 3.066 0 C-N-CA 118.668 -1.729 . . . . 0.88 112.925 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -61.49 -40.99 96.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.521 -1.576 . . . . 1.99 110.063 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.22 -48.78 40.3 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.62 -0.675 . . . . 1.28 110.4 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.0 m -61.4 -40.79 95.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 2.2200000000000002 110.477 -178.185 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.75 97.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.422 -0.799 . . . . 1.45 110.679 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.2 mt -64.57 -30.86 71.89 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.054 -1.029 . . . . 1.47 110.817 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -66.86 -21.11 66.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.945 -1.097 . . . . 2.04 111.158 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -75.0 -12.81 60.42 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.313 -0.867 . . . . 1.73 111.532 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 mt -85.55 144.67 27.77 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.484 -0.76 . . . . 1.79 109.292 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -100.45 53.03 0.88 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.185 -0.947 . . . . 2.8799999999999999 110.581 -179.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -129.46 138.28 51.33 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.211 -1.033 . . . . 1.5800000000000001 108.211 179.171 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -58.39 -39.8 80.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.544 -0.722 . . . . 3.04 110.999 179.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -71.43 -53.61 13.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.002 -1.061 . . . . 1.29 110.332 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.5 mt -61.4 -41.09 96.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.339 -0.851 . . . . 1.6000000000000001 110.506 -179.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -62.22 -50.16 72.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.954 -1.091 . . . . 2.7599999999999998 109.983 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.02 -31.68 70.18 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.309 -0.869 . . . . 2.1499999999999999 109.644 179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -61.26 -30.43 70.46 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.086 -1.045 . . . . 2.8100000000000001 108.782 179.241 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.46 -49.58 77.01 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.921 0.867 . . . . 1.3899999999999999 109.398 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.86 81.7 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.895 -0.722 . . . . 1.4099999999999999 110.104 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -64.18 -36.69 84.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.347 -0.846 . . . . 1.3899999999999999 110.52 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.9 t -67.12 -39.16 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.439 -0.788 . . . . 1.1899999999999999 109.983 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -60.4 -38.06 82.78 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.879 0.847 . . . . 3.6299999999999999 110.009 179.066 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.12 -38.33 82.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.766 -0.584 . . . . 1.28 110.481 179.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.7 mt -61.54 -40.17 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.472 -0.767 . . . . 1.1799999999999999 110.24 179.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.27 -42.44 35.15 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 120.078 -1.058 . . . . 0.51000000000000001 110.993 -179.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -58.77 -48.12 82.34 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.072 -1.251 . . . . 3.1699999999999999 110.484 179.346 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -64.89 -41.25 95.78 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.511 -0.876 . . . . 2.8500000000000001 109.972 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.05 -39.58 86.45 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.314 -0.866 . . . . 1.6499999999999999 110.033 179.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.14 -41.93 93.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.882 . . . . 1.2 110.902 179.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -60.44 -33.08 72.02 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.121 -0.987 . . . . 2.7999999999999998 110.678 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -77.64 -42.5 34.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 2.1499999999999999 110.846 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 141' ' ' ILE . 97.4 mt -60.99 -38.33 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.231 -0.918 . . . . 1.21 110.344 -178.294 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.7 mt -86.27 -7.43 58.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.31 -0.869 . . . . 1.3400000000000001 112.276 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.71 19.91 69.69 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.645 -1.264 . . . . 0.91000000000000003 112.844 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.5 tp -67.22 145.19 55.46 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.815 -0.815 . . . . 1.51 109.163 179.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -67.79 149.74 49.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 2.8799999999999999 108.845 178.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.0 mt -109.49 137.38 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.369 -0.974 . . . . 1.6200000000000001 108.369 178.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.443 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.8 mp -80.11 128.59 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.654 -1.239 . . . . 2.1099999999999999 107.654 178.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -94.78 96.08 9.13 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.85 -1.537 . . . . 1.6200000000000001 106.85 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.41 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 53.1 mt -70.72 -25.23 62.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.337 -0.852 . . . . 1.3999999999999999 111.12 -178.33 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 p -80.57 0.25 34.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 2.0499999999999998 111.861 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.14 23.87 9.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.455 -0.778 . . . . 1.3500000000000001 111.852 -179.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.41 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 14.2 mt -72.04 146.33 11.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.234 -0.916 . . . . 1.4199999999999999 109.457 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -119.41 -14.77 9.15 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.757 0.789 . . . . 2.9900000000000002 112.756 -178.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -115.06 140.51 49.0 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.682 -0.858 . . . . 1.54 108.682 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -77.41 123.52 26.64 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.384 -0.969 . . . . 1.3799999999999999 108.384 178.005 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.3 m -148.56 175.28 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.608 -0.682 . . . . 1.28 109.266 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 157' ' ' ILE . 45.8 mt -88.23 145.05 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.641 -0.874 . . . . 1.1599999999999999 108.641 178.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.1 tp -97.08 126.49 42.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.12 -0.987 . . . . 1.3100000000000001 108.507 178.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.0 t -122.58 128.98 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.573 -1.269 . . . . 1.25 107.573 178.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.39 153.18 21.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.932 . . . . 1.26 108.847 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.66 84.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.701 -1.249 . . . . 1.6000000000000001 109.65 178.131 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 10.4 t0 -172.37 154.66 3.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.481 -0.933 . . . . 2.4199999999999999 108.481 179.638 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.501 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 61.6 mt -117.75 139.32 51.21 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.222 -0.924 . . . . 1.3500000000000001 108.759 177.629 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.2 p -91.2 153.03 44.56 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 107.879 -1.156 . . . . 1.3200000000000001 107.879 178.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -41.81 -44.82 6.82 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.559 1.506 . . . . 0.69999999999999996 113.375 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 23.9 m -60.26 -48.79 80.23 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.044 -1.035 . . . . 1.1200000000000001 110.252 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.22 -40.83 98.57 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.204 -0.935 . . . . 1.21 110.177 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.434 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 79.5 p -68.33 -38.45 81.53 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.416 -0.802 . . . . 1.1899999999999999 110.254 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.58 74.52 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.578 -0.701 . . . . 1.24 110.609 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -93.86 -5.87 47.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.166 -0.959 . . . . 1.6899999999999999 112.734 -179.316 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.73 146.89 51.28 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.959 -1.126 . . . . 1.3400000000000001 107.959 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -97.34 119.73 36.39 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.31 -1.367 . . . . 2.77 107.31 178.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.2 mm? -76.25 -18.24 59.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.77 -0.581 . . . . 2.0899999999999999 111.526 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -80.99 -25.77 37.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.276 -0.89 . . . . 2.6699999999999999 111.863 -178.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -101.05 -1.69 33.53 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.112 0.782 . . . . 2.5800000000000001 113.112 -178.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.01 126.44 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 107.556 -1.276 . . . . 1.1799999999999999 107.556 178.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.8 tp -91.27 -2.01 57.53 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.052 -1.03 . . . . 2.1800000000000002 112.862 -178.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.94 169.83 34.42 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.797 -1.721 . . . . 0.48999999999999999 108.797 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -127.2 135.43 50.63 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.812 -1.181 . . . . 0.64000000000000001 107.812 179.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 76.1 mt -137.67 106.04 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 105.965 -1.865 . . . . 1.21 105.965 178.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 203' ' ' VAL . 68.0 p -131.2 176.98 7.82 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.785 -1.197 . . . . 1.3799999999999999 110.204 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.552 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.3 OUTLIER -99.29 51.71 0.95 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.736 -0.603 . . . . 2.3700000000000001 110.843 179.28 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -100.66 145.32 28.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.303 -0.873 . . . . 1.52 108.829 179.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -60.05 -32.55 76.06 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 120.15 -1.024 . . . . 1.8 110.897 179.186 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 91.69 -4.37 79.12 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 120.898 -1.354 . . . . 2.04 113.328 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.436 ' O ' ' OG1' ' A' ' 187' ' ' THR . 80.1 mtm180 -90.36 115.65 27.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.243 -1.762 . . . . 5.0 106.243 177.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 13.6 p 48.98 31.93 3.57 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.36 -0.837 . . . . 3.02 112.226 -178.667 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.4 t -85.47 142.03 29.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.97 -1.081 . . . . 2.1099999999999999 109.837 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.434 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 15.8 t60 -58.74 -38.93 79.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 1.24 111.135 178.481 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.3 m -60.38 -39.61 87.9 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.215 -0.928 . . . . 2.1499999999999999 110.085 179.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 70.8 m -60.34 -39.36 86.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 2.02 110.554 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.8 -39.99 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 2.1200000000000001 110.959 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.9 mtp -63.76 -44.31 93.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.895 -1.128 . . . . 1.3600000000000001 109.671 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.12 -49.57 77.11 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.77 -0.65 . . . . 1.29 111.004 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -61.73 -41.1 97.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.985 . . . . 3.5600000000000001 110.946 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 56.0 m -69.36 -39.94 77.79 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.923 -1.111 . . . . 1.1799999999999999 110.561 -179.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.3 mt -89.28 -7.83 54.63 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.819 0.818 . . . . 1.3400000000000001 112.101 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 194' ' ' ALA . 45.2 mt-10 49.03 15.5 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.876 1.065 . . . . 1.45 113.876 -179.8 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.8 mt -74.75 150.58 86.46 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.022 -1.048 . . . . 1.25 108.607 178.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.36 139.05 88.94 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.309 1.339 . . . . 0.78000000000000003 109.833 178.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.92 166.65 25.88 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 117.737 -1.585 . . . . 1.2 109.431 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.5 mt -145.68 147.06 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.681 -1.229 . . . . 1.25 107.681 177.216 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.435 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.8 m -126.99 -34.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 113.302 0.853 . . . . 1.3899999999999999 113.302 -179.009 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.17 40.83 1.73 Allowed Glycine 0 N--CA 1.489 2.18 0 C-N-CA 120.196 -1.002 . . . . 0.96999999999999997 111.913 -177.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.447 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 58.6 p -60.82 -18.75 57.45 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.273 -1.134 . . . . 1.3500000000000001 111.371 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.43 -95.82 0.99 Allowed Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.83 -1.176 . . . . 1.0700000000000001 110.503 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 60.7 m -127.72 31.51 5.13 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.634 -0.921 . . . . 1.9199999999999999 112.215 -179.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.87 -35.33 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.393 -1.442 . . . . 1.3300000000000001 110.532 179.096 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 46.4 p -61.46 -20.06 62.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.195 -0.94 . . . . 1.4199999999999999 111.452 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.9 t -93.93 -1.03 55.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -0.951 . . . . 2.1200000000000001 112.099 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -128.22 -1.66 5.72 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 112.797 0.665 . . . . 2.6899999999999999 112.797 -177.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.04 148.39 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.226 -0.657 . . . . 1.29 109.226 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -119.85 157.18 29.22 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.851 -1.166 . . . . 2.6899999999999999 107.851 178.062 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.42 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 38.6 p30 -54.12 142.82 24.27 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.049 -1.032 . . . . 2.79 110.813 178.491 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.7 OUTLIER 80.18 1.3 2.01 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 114.905 1.446 . . . . 2.3500000000000001 114.905 179.183 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -63.46 146.41 53.66 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.765 -1.209 . . . . 1.97 108.371 177.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -88.29 118.69 28.07 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.835 -1.542 . . . . 2.9700000000000002 106.835 177.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 87.3 mt -127.93 142.02 51.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.585 -0.697 . . . . 1.25 109.57 -178.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.6 mt -111.16 129.32 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.528 -1.656 . . . . 1.22 106.528 177.529 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 20.4 tp -99.1 119.05 37.19 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.384 -1.71 . . . . 1.24 106.384 178.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.0 t0 -94.93 -29.28 14.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.818 -1.176 . . . . 2.0499999999999998 112.506 -177.631 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.443 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 36.79 20.79 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.773 0.657 . . . . 1.25 112.773 -178.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.7 t -109.25 -55.95 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.125 -0.985 . . . . 1.4299999999999999 109.075 178.335 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.46 14.8 30.02 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.625 -0.716 . . . . 3.0299999999999998 110.293 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.51 55.38 4.14 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.397 0.617 . . . . 2.25 111.21 179.67 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -151.49 148.48 28.11 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.254 1.026 . . . . 2.52 109.91 179.596 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 20.0 t -116.09 139.61 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.235 -1.024 . . . . 1.29 108.235 177.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -102.01 135.6 43.29 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.057 -1.027 . . . . 1.3400000000000001 108.739 178.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.0 t -112.83 130.24 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-O 121.779 0.8 . . . . 1.3400000000000001 109.127 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.439 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 13.6 t-20 52.06 48.95 6.14 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 113.577 0.955 . . . . 2.1800000000000002 113.577 178.092 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.3 Cg_endo -64.5 150.05 88.9 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.585 2.19 . . . . 0.93999999999999995 110.724 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.1 m -74.77 154.16 38.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.265 -0.897 . . . . 2.3999999999999999 108.947 177.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -52.99 -41.11 64.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 3.3300000000000001 110.708 178.716 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -59.2 -40.29 85.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 3.1699999999999999 109.812 179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.04 -38.91 76.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.647 -0.658 . . . . 1.6899999999999999 110.166 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.448 -0.782 . . . . 1.6000000000000001 110.785 179.198 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 106.856 -1.535 . . . . 1.5700000000000001 106.856 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -105.31 122.56 46.21 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.391 -1.336 . . . . 1.4399999999999999 107.391 -179.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.95 -150.65 27.15 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.784 -1.326 . . . . 1.01 109.784 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.453 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 95.4 mt -95.22 1.05 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.408 -1.054 . . . . 1.6299999999999999 112.942 -179.635 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 tp 49.64 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.801 -1.187 . . . . 1.5800000000000001 112.867 178.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.83 -37.23 14.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.956 -1.09 . . . . 1.3400000000000001 111.431 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 t -146.34 137.02 12.4 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 107.965 -1.124 . . . . 1.8600000000000001 107.965 -178.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.27 152.56 35.14 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.934 1.756 . . . . 1.01 112.122 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 147.13 135.41 2.68 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.768 -0.933 . . . . 0.81000000000000005 110.768 177.683 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -96.15 132.48 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.549 -1.559 . . . . 1.3700000000000001 108.941 178.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.3 148.95 45.2 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.895 -0.78 . . . . 1.1399999999999999 108.895 179.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 3.2 m-85 -121.22 142.75 49.62 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.301 -0.875 . . . . 0.87 109.018 178.474 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.84 168.38 37.32 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.575 -1.774 . . . . 0.56999999999999995 109.721 177.797 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -78.08 158.68 29.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.763 -0.845 . . . . 2.3500000000000001 108.799 178.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.59 123.78 29.54 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.898 -1.149 . . . . 1.21 107.898 178.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 tp -102.47 98.86 8.88 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.22 -1.77 . . . . 1.3999999999999999 106.22 178.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.1 tp -86.99 141.1 28.92 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.681 -0.859 . . . . 1.4399999999999999 108.681 -179.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 mt -99.72 107.11 19.11 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.27 -1.381 . . . . 1.45 107.27 178.158 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -110.81 134.23 52.68 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.673 -1.232 . . . . 2.5 107.673 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -131.11 155.12 47.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.211 -0.931 . . . . 2.6600000000000001 109.163 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -82.11 137.16 35.07 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.907 -1.146 . . . . 2.3199999999999998 107.907 177.338 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -65.7 148.36 51.89 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.346 -0.847 . . . . 2.1099999999999999 108.881 178.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.6 mt -99.85 134.61 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.359 -0.838 . . . . 1.29 108.799 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.89 130.01 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.571 -1.27 . . . . 1.4099999999999999 107.571 178.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.6 mt -95.83 135.8 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.297 -0.877 . . . . 1.3100000000000001 108.976 179.257 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -94.45 126.65 39.86 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.265 -1.013 . . . . 1.3400000000000001 108.265 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.479 ' HG2' HH11 ' A' ' 28' ' ' ARG . 4.4 mmt-85 -97.7 15.08 24.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.343 -0.848 . . . . 3.48 112.481 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -63.34 142.32 58.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.004 -1.06 . . . . 2.52 109.117 178.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -88.02 130.82 34.86 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.136 -1.061 . . . . 2.6299999999999999 108.136 177.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -89.37 170.19 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.178 -0.951 . . . . 1.3100000000000001 110.09 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.3 p -94.64 163.44 13.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.577 -0.702 . . . . 1.24 109.645 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.75 -19.94 4.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 1.49 112.67 179.249 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -68.71 -43.16 76.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.832 -1.167 . . . . 2.2799999999999998 111.229 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -87.42 -5.79 58.7 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.711 -1.243 . . . . 2.0499999999999998 112.674 -179.098 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.05 -46.52 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 1.3400000000000001 110.891 -178.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -56.49 -40.02 74.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.954 . . . . 1.54 110.316 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.61 -39.6 91.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.535 -0.728 . . . . 2.8500000000000001 110.824 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -60.0 -40.63 89.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.026 -1.046 . . . . 1.3100000000000001 110.747 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.83 -39.69 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 1.3799999999999999 110.38 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -62.87 -48.12 80.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.364 -0.835 . . . . 1.5 110.794 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -62.87 -40.93 99.01 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.917 -1.113 . . . . 2.7799999999999998 110.256 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -71.13 -52.86 16.85 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.204 -0.935 . . . . 1.0600000000000001 110.191 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.2 tp -62.3 -47.47 84.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.037 -1.04 . . . . 1.3999999999999999 109.816 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 t -70.23 -42.46 72.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.472 -0.768 . . . . 1.3200000000000001 109.697 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.58 -38.08 85.86 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.148 -1.501 . . . . 0.69999999999999996 109.414 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 20.5 ttm180 -59.32 -32.02 69.69 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.958 0.885 . . . . 3.4399999999999999 109.095 178.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.04 -44.19 91.74 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.787 0.803 . . . . 1.3600000000000001 109.636 178.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -79.63 -40.17 29.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.115 -0.991 . . . . 2.8300000000000001 110.332 179.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.28 -44.9 92.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.468 -0.77 . . . . 1.23 110.132 -178.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.645 ' HG ' ' N ' ' A' ' 52' ' ' ALA . 53.5 p -60.45 -38.63 84.76 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.124 0.964 . . . . 1.9199999999999999 109.313 179.685 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.645 ' N ' ' HG ' ' A' ' 51' ' ' SER . . . -63.11 -41.57 99.38 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.126 -0.63 . . . . 1.25 110.661 179.481 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -62.0 -50.14 73.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.569 -1.332 . . . . 1.97 110.479 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 54' ' ' LEU . 3.2 mm? -67.63 -40.64 84.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.329 -0.857 . . . . 2.1800000000000002 110.399 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -59.21 -40.78 86.86 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.389 -0.819 . . . . 1.1899999999999999 110.467 179.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -67.21 -46.93 72.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.084 -1.01 . . . . 1.3400000000000001 110.671 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.11 -38.16 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.417 -0.802 . . . . 1.23 110.524 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -49.93 -44.72 50.55 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.367 -0.833 . . . . 1.5600000000000001 111.322 179.183 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -68.16 -40.48 82.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.195 -0.941 . . . . 1.3 109.946 -179.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -61.87 -37.98 86.6 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.883 -1.127 . . . . 2.3199999999999998 109.334 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -33.77 76.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.448 0.642 . . . . 1.1399999999999999 110.2 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.61 -37.13 12.35 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.771 -1.204 . . . . 0.68999999999999995 111.255 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.67 -24.41 38.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.07 -1.253 . . . . 1.48 110.755 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.4 m -88.0 -50.77 6.2 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.537 -0.865 . . . . 1.52 110.271 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -107.06 -2.96 20.51 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 113.965 1.098 . . . . 1.3100000000000001 113.965 -177.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.24 155.87 26.88 Favored Glycine 0 N--CA 1.504 3.201 0 O-C-N 120.82 -1.175 . . . . 0.84999999999999998 113.858 178.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.58 -15.55 1.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -1.018 . . . . 3.8599999999999999 112.979 179.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.66 -35.8 71.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 2.3500000000000001 110.917 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -82.91 -19.03 38.11 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.143 -0.973 . . . . 2.2599999999999998 111.996 -179.382 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.23 -35.19 74.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.074 -1.016 . . . . 1.45 111.038 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.36 89.18 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.079 -1.013 . . . . 1.25 110.847 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.6 mt -68.64 -42.38 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.943 -1.098 . . . . 1.26 110.098 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -72.05 -31.15 65.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.139 -0.976 . . . . 0.82999999999999996 110.253 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -59.79 -37.65 79.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.826 . . . . 1.1899999999999999 110.004 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.92 -40.54 84.42 Favored Glycine 0 N--CA 1.48 1.622 0 C-N-CA 119.733 -1.222 . . . . 0.57999999999999996 110.277 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -59.93 -47.28 86.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.184 -1.186 . . . . 2.0499999999999998 110.593 179.506 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.7 mt -60.3 -38.64 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.951 -1.093 . . . . 1.21 110.231 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.9 ttt -59.9 -39.39 85.21 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.365 -0.834 . . . . 2.29 110.904 179.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 tp -60.31 -50.04 75.2 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.106 -0.996 . . . . 1.21 110.46 179.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.31 -39.28 92.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.033 -1.042 . . . . 1.1399999999999999 110.303 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -87.22 1.5 52.95 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.445 0.906 . . . . 1.4199999999999999 113.445 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.41 121.45 12.11 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.357 -1.465 . . . . 1.27 108.244 178.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -66.36 -16.88 64.41 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.88 0.847 . . . . 1.3500000000000001 110.964 -178.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.97 -53.35 9.12 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.507 0.67 . . . . 2.2200000000000002 110.087 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.31 -36.78 81.04 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.568 -0.853 . . . . 1.22 110.485 -179.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 47' ' ' ARG . 87.0 tt0 -59.43 -46.84 87.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.203 -0.936 . . . . 1.29 110.918 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.73 -38.56 85.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.393 -0.817 . . . . 2.1699999999999999 110.701 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.02 -48.7 70.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.831 -1.168 . . . . 1.3 110.872 179.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.31 -43.95 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.173 -0.954 . . . . 1.1699999999999999 110.138 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.5 mt -60.41 -43.96 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.658 -0.651 . . . . 1.3999999999999999 110.486 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.21 -42.34 98.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.425 -0.797 . . . . 1.3300000000000001 110.991 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.66 -47.79 83.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.162 -0.961 . . . . 1.48 110.296 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.4 mt -60.89 -44.88 98.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.304 -0.872 . . . . 1.28 110.683 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -84.07 -34.45 24.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.007 -1.058 . . . . 2.6000000000000001 111.954 -179.71 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 91' ' ' ALA . 44.9 t0 -82.94 -43.62 16.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.809 -1.182 . . . . 1.51 111.445 -178.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -101.9 5.79 41.09 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.642 -0.661 . . . . 2.48 112.302 -178.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.7 m80 52.09 47.92 23.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 1.6100000000000001 111.795 -179.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.4 mtt -100.34 153.76 19.05 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.146 -0.971 . . . . 1.8999999999999999 110.018 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.653 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 72.5 p -71.57 161.21 31.38 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.507 -0.746 . . . . 1.3200000000000001 109.746 178.149 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.22 90.61 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.85 -0.74 . . . . 1.1499999999999999 110.748 178.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -68.49 -40.21 81.0 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.959 -1.088 . . . . 2.25 110.248 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.653 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -67.91 -50.68 54.72 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.855 -0.738 . . . . 1.22 111.064 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.58 -44.23 96.84 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 1.1899999999999999 110.195 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.97 -44.17 94.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.603 -0.686 . . . . 1.2 110.665 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -61.71 -38.65 88.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 2.1000000000000001 111.321 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -57.44 -49.77 75.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.675 -1.266 . . . . 1.3 110.888 179.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.04 -47.42 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.635 -1.291 . . . . 1.27 110.424 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -61.02 -30.35 47.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.563 -0.711 . . . . 1.1899999999999999 110.438 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -58.65 -41.27 85.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.358 -0.839 . . . . 2.1099999999999999 110.776 179.218 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.82 -30.61 23.15 Favored Glycine 0 N--CA 1.498 2.808 0 C-N-CA 119.071 -1.538 . . . . 0.88 112.991 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -62.09 -42.84 99.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.188 -1.772 . . . . 1.99 110.055 -179.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.41 -52.03 25.26 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.379 -0.825 . . . . 1.28 110.312 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.597 ' HG ' ' N ' ' A' ' 114' ' ' ALA . 25.0 p -60.33 -34.81 74.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.186 -0.946 . . . . 2.2200000000000002 110.421 -179.365 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.597 ' N ' ' HG ' ' A' ' 113' ' ' SER . . . -62.04 -47.02 86.59 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.766 -0.584 . . . . 1.45 110.934 179.576 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.48 -29.94 70.9 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.127 -1.029 . . . . 1.47 111.148 -179.506 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -67.43 -22.29 65.52 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.929 -1.107 . . . . 2.04 111.511 179.455 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -70.59 -18.32 62.89 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.94 -1.104 . . . . 1.73 110.932 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.7 mt -83.79 145.34 28.74 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.359 -0.838 . . . . 1.79 109.623 179.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -101.08 41.93 1.15 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.359 -0.838 . . . . 2.8799999999999999 110.996 179.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -113.13 135.76 53.46 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.961 -1.125 . . . . 1.5800000000000001 107.961 178.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.423 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 25.1 mp0 -59.13 -34.24 71.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.45 -0.781 . . . . 3.04 111.151 179.111 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -74.22 -50.51 18.83 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.108 -0.995 . . . . 1.29 110.51 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.6 mt -63.4 -36.65 84.44 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.199 -0.938 . . . . 1.6000000000000001 110.207 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -62.56 -49.24 76.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.166 -1.014 . . . . 2.7599999999999998 109.758 179.209 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -63.04 -28.98 70.46 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.448 -0.901 . . . . 2.1499999999999999 110.27 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -63.55 -30.38 71.5 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.069 0.937 . . . . 2.8100000000000001 108.879 178.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.1 -48.72 80.56 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.645 0.736 . . . . 1.3899999999999999 109.665 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.87 91.63 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.847 0.832 . . . . 1.4099999999999999 109.449 179.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.76 -37.61 88.0 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.574 -0.704 . . . . 1.3899999999999999 110.476 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.75 -39.83 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.407 -0.808 . . . . 1.1899999999999999 110.202 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -59.1 -38.86 80.54 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.265 -0.974 . . . . 3.6299999999999999 110.134 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -59.68 -39.74 85.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.557 -0.715 . . . . 1.28 110.469 179.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 66.2 mt -60.5 -39.97 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.01 . . . . 1.1799999999999999 110.1 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.01 -44.96 87.24 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.844 -1.169 . . . . 0.51000000000000001 110.279 179.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -59.54 -40.6 87.75 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.311 -1.111 . . . . 3.1699999999999999 110.383 179.248 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -61.74 -45.08 95.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.994 -1.066 . . . . 2.8500000000000001 110.161 179.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 50.5 tp -59.92 -43.19 95.06 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.123 -0.986 . . . . 1.6499999999999999 110.016 179.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.89 -44.16 94.4 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.234 -0.916 . . . . 1.2 110.189 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.87 -34.32 74.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.246 -0.909 . . . . 2.7999999999999998 110.585 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -77.44 -40.5 43.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 2.1499999999999999 111.058 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.3 -40.05 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.236 -0.915 . . . . 1.21 110.196 -178.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 68.7 mt -90.2 -9.42 48.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.91 -1.119 . . . . 1.3400000000000001 112.041 -179.236 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.37 20.27 77.24 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 120.375 -0.917 . . . . 0.91000000000000003 112.961 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.2 tp -63.78 149.91 45.78 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.686 0.755 . . . . 1.51 109.408 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.73 146.29 54.99 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.245 -0.909 . . . . 2.8799999999999999 109.009 178.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.82 143.5 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.391 -0.966 . . . . 1.6200000000000001 108.391 178.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 mp -76.23 114.12 16.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.925 -1.11 . . . . 2.1099999999999999 108.501 178.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -98.18 102.13 13.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.441 -1.689 . . . . 1.6200000000000001 106.441 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.406 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.0 mt -77.37 -18.03 57.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 1.3999999999999999 111.17 -177.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.3 m -80.11 -1.53 40.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -0.823 . . . . 2.0499999999999998 112.325 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.61 27.11 5.04 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.807 0.813 . . . . 1.3500000000000001 111.897 -178.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.406 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 17.5 mt -75.19 139.55 18.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.522 -0.736 . . . . 1.4199999999999999 109.392 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -111.63 -19.95 12.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.029 0.919 . . . . 2.9900000000000002 112.535 -178.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -119.12 142.88 47.53 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.723 -0.843 . . . . 1.54 108.723 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -73.14 122.42 21.83 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.052 -1.092 . . . . 1.3799999999999999 108.052 178.042 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.1 m -144.75 175.56 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.594 -0.691 . . . . 1.28 109.253 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 44.9 mt -88.3 143.91 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.282 -0.886 . . . . 1.1599999999999999 108.802 178.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.3 tp -96.8 125.35 41.19 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.06 -1.089 . . . . 1.3100000000000001 108.06 178.209 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.4 t -123.22 129.93 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.552 -1.277 . . . . 1.25 107.552 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.79 154.21 21.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.159 -0.963 . . . . 1.26 108.678 179.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.83 80.6 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.583 -1.323 . . . . 1.6000000000000001 109.365 178.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -171.58 153.9 3.59 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.862 -0.792 . . . . 2.4199999999999999 108.862 179.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.3 mt -118.73 142.26 47.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.932 -0.766 . . . . 1.3500000000000001 108.932 177.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.2 p -92.48 150.56 40.15 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.13 -0.981 . . . . 1.3200000000000001 108.52 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -42.72 -38.63 6.66 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.857 1.705 . . . . 0.69999999999999996 113.206 179.329 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 62.1 m -63.52 -50.12 70.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.005 -1.059 . . . . 1.1200000000000001 109.884 -179.692 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.92 -39.03 90.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.913 . . . . 1.21 110.127 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.419 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 70.2 p -68.7 -40.81 79.84 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.827 -0.749 . . . . 1.1899999999999999 110.328 179.421 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.57 77.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 1.24 110.585 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -95.91 -0.98 50.2 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.949 -1.094 . . . . 1.6899999999999999 112.921 -179.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.95 148.62 46.95 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.72 -1.238 . . . . 1.3400000000000001 108.49 179.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -97.01 115.3 27.2 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.096 -1.446 . . . . 2.77 107.096 177.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.0 mt -73.67 -14.12 61.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.59 -0.694 . . . . 2.0899999999999999 111.778 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.72 -21.94 32.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.347 -0.845 . . . . 2.6699999999999999 112.491 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -99.43 -7.06 26.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.129 -0.982 . . . . 2.5800000000000001 112.549 -178.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.99 131.0 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.198 -1.038 . . . . 1.1799999999999999 108.198 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.32 -13.87 36.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 2.1800000000000002 111.275 -179.744 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.14 172.92 45.83 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.889 -1.684 . . . . 0.48999999999999999 108.889 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -126.56 132.79 51.25 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.947 -1.131 . . . . 0.64000000000000001 107.947 179.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 67.4 mt -132.66 112.17 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.323 -1.732 . . . . 1.21 106.323 179.052 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 203' ' ' VAL . 73.3 p -135.86 173.3 11.86 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.608 -1.308 . . . . 1.3799999999999999 110.173 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -98.59 54.66 1.05 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.353 0.597 . . . . 2.3700000000000001 110.546 179.049 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.47 160.62 14.4 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 1.52 109.921 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.93 -82.7 0.07 OUTLIER Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.84 -1.171 . . . . 1.8 111.141 178.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 148.47 -38.48 1.01 Allowed Glycine 0 N--CA 1.5 2.942 0 O-C-N 120.582 -1.54 . . . . 2.04 113.223 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -60.05 -39.52 86.22 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.844 -1.386 . . . . 5.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 23.0 p -136.83 38.02 2.6 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.295 -0.878 . . . . 3.02 111.623 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 59.0 m -85.68 124.07 31.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.404 -1.332 . . . . 2.1099999999999999 107.404 178.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.419 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 76.2 t60 -56.69 -37.52 70.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.264 -0.897 . . . . 1.24 110.824 179.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.545 ' HG1' ' N ' ' A' ' 191' ' ' SER . 30.3 p -60.88 -38.93 87.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 2.1499999999999999 110.351 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.545 ' N ' ' HG1' ' A' ' 190' ' ' THR . 39.0 t -60.21 -40.54 90.47 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.224 -0.923 . . . . 2.02 110.12 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.55 -35.92 61.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.333 -0.854 . . . . 2.1200000000000001 110.457 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 59.1 mtp -63.23 -41.44 99.11 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.995 -1.066 . . . . 1.3600000000000001 109.566 179.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.75 -47.09 87.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.701 -0.681 . . . . 1.29 111.021 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -62.17 -43.46 98.77 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.061 -1.024 . . . . 3.5600000000000001 110.748 -179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.4 m -70.5 -39.78 73.95 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.308 -0.87 . . . . 1.1799999999999999 110.492 -179.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.0 mt -93.3 -4.47 51.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 1.3400000000000001 112.817 -178.295 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 53.87 10.84 0.28 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.862 1.06 . . . . 1.45 113.862 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.6 mt -72.36 150.22 91.68 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.871 -1.143 . . . . 1.25 108.904 179.4 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.63 140.81 88.59 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.038 1.159 . . . . 0.78000000000000003 110.239 178.391 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.94 162.04 31.85 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.049 -1.657 . . . . 1.2 109.479 178.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.2 mt -147.02 146.6 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.063 -1.088 . . . . 1.25 108.063 177.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.2 m -125.93 -28.28 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 O-C-N 121.041 -1.037 . . . . 1.3899999999999999 113.266 -179.182 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.21 42.2 1.63 Allowed Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.634 -1.27 . . . . 0.96999999999999997 111.759 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 45.0 p -65.34 -18.04 65.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.964 -1.315 . . . . 1.3500000000000001 111.116 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.07 -95.9 0.86 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.833 -1.307 . . . . 1.0700000000000001 109.833 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 60.8 m -127.46 31.09 5.25 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.709 -0.877 . . . . 1.9199999999999999 111.866 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 78.2 t -57.06 -35.89 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.32 -1.488 . . . . 1.3300000000000001 110.593 179.233 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.4 p -59.99 -19.89 54.81 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.939 -1.101 . . . . 1.4199999999999999 111.974 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 48.9 m -94.56 1.87 55.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.945 . . . . 2.1200000000000001 112.089 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -128.77 1.67 5.43 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 113.086 0.773 . . . . 2.6899999999999999 113.086 -178.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.53 152.87 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.739 0.781 . . . . 1.29 109.773 -179.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -118.82 152.69 35.77 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.044 -1.095 . . . . 2.6899999999999999 108.044 177.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 43.7 p-10 -55.11 143.2 27.88 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.983 -1.073 . . . . 2.79 110.17 178.285 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 80.97 -0.72 1.78 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 114.117 1.155 . . . . 2.3500000000000001 114.117 179.431 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.14 150.07 43.73 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.646 -1.284 . . . . 1.97 109.338 177.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -89.72 120.86 31.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.507 -1.371 . . . . 2.9700000000000002 107.521 178.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.8 mt -128.33 146.8 50.66 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.44 -0.788 . . . . 1.25 109.729 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.47 127.88 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.15 -1.426 . . . . 1.22 107.15 177.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.8 tp -101.52 118.3 36.67 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 105.883 -1.895 . . . . 1.24 105.883 178.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 223' ' ' VAL . 39.4 t0 -91.7 -26.81 18.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.753 -1.217 . . . . 2.0499999999999998 112.361 -177.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.417 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 37.82 19.74 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 113.264 0.839 . . . . 1.25 113.264 -179.25 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.1 t -112.14 -55.74 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.147 0.975 . . . . 1.4299999999999999 108.981 -179.426 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -100.73 10.89 40.58 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.252 1.025 . . . . 3.0299999999999998 109.65 -179.169 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 62.03 53.31 3.04 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.317 -0.856 . . . . 2.25 112.05 179.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -149.58 146.64 27.44 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.213 1.006 . . . . 2.52 109.792 178.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.9 t -116.79 135.37 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.509 -1.293 . . . . 1.29 107.509 178.056 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -102.42 134.77 45.19 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.831 -1.168 . . . . 1.3400000000000001 108.442 178.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.26 129.25 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 107.795 -1.187 . . . . 1.3400000000000001 107.795 178.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.488 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 18.4 t30 56.66 44.88 1.53 Allowed Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 113.467 0.914 . . . . 2.1800000000000002 113.467 179.092 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 52.2 Cg_endo -68.9 155.47 68.46 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.383 2.055 . . . . 0.93999999999999995 110.681 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 29.8 p -73.72 162.56 29.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.962 -1.086 . . . . 2.3999999999999999 110.723 178.544 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.12 -34.04 74.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.507 -0.746 . . . . 3.3300000000000001 110.337 178.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -59.85 -39.53 85.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 3.1699999999999999 110.747 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.04 -39.07 79.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.217 -0.927 . . . . 1.6899999999999999 110.405 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 80.5 mt . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.525 -0.734 . . . . 1.6000000000000001 111.304 179.28 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.6 mt . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 106.318 -1.734 . . . . 1.5700000000000001 106.318 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 m -105.76 121.02 43.18 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.504 -1.295 . . . . 1.4399999999999999 107.504 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.01 -149.82 26.15 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.512 -1.035 . . . . 1.01 110.512 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 81.3 mt -94.34 0.77 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.783 -0.833 . . . . 1.6299999999999999 112.086 -179.67 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 50.26 99.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.355 -0.841 . . . . 1.5800000000000001 112.335 178.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.8 -52.97 6.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.108 . . . . 1.3400000000000001 110.628 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.33 149.41 44.53 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 107.719 -1.215 . . . . 1.8600000000000001 107.719 -179.541 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.26 144.5 29.48 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 123.029 2.486 . . . . 1.01 112.937 178.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.35 168.67 18.15 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 109.206 -1.558 . . . . 0.81000000000000005 109.206 178.119 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.87 133.46 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.108 -1.23 . . . . 1.3700000000000001 108.803 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.33 150.86 43.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.366 -0.834 . . . . 1.1399999999999999 109.132 179.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.418 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 22.0 m-85 -117.87 139.78 50.63 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.047 -1.094 . . . . 0.87 108.047 177.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.82 167.25 38.52 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.34 -1.886 . . . . 0.56999999999999995 110.442 178.182 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -78.38 156.62 29.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.768 -0.842 . . . . 2.3500000000000001 108.774 177.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.67 124.96 32.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.042 -1.095 . . . . 1.21 108.042 178.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.2 tp -100.24 101.9 13.03 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 104.721 -2.326 . . . . 1.3999999999999999 104.721 177.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.25 138.48 31.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.21 -1.034 . . . . 1.4399999999999999 108.21 179.673 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.3 mt -98.98 114.83 27.67 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 106.119 -1.808 . . . . 1.45 106.119 177.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -102.29 129.84 48.83 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.799 -1.186 . . . . 2.5 107.799 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -123.27 144.07 49.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.99 -0.744 . . . . 2.6600000000000001 108.99 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -81.15 134.34 35.62 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.758 -1.201 . . . . 2.3199999999999998 107.758 177.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.68 145.61 55.39 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.406 -0.809 . . . . 2.1099999999999999 108.981 178.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.9 mt -93.03 132.11 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.263 -1.014 . . . . 1.29 108.263 178.324 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -106.33 129.85 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.169 -1.048 . . . . 1.4099999999999999 108.169 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.2 mt -97.06 130.34 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.031 -1.1 . . . . 1.3100000000000001 108.031 178.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -89.91 122.51 33.01 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.741 -1.207 . . . . 1.3400000000000001 107.741 178.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mmm-85 -93.58 11.68 27.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.47 -0.768 . . . . 3.48 112.286 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -65.05 150.51 47.98 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.348 -0.845 . . . . 2.52 110.268 178.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -90.08 129.85 36.32 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.148 -1.056 . . . . 2.6299999999999999 108.148 177.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 pt -90.86 164.69 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.962 . . . . 1.3100000000000001 110.009 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.0 p -94.13 167.25 11.69 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.55 -0.719 . . . . 1.24 110.452 178.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.51 -26.89 55.91 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.91 . . . . 1.49 111.929 179.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -70.61 -27.98 64.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 2.2799999999999998 111.012 -179.786 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -93.52 -12.82 28.76 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.416 -0.802 . . . . 2.0499999999999998 112.151 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.3 t -59.54 -47.79 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.487 0.66 . . . . 1.3400000000000001 110.205 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.33 -38.27 76.81 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.444 -0.785 . . . . 1.54 110.63 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.28 -38.66 90.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.605 -0.685 . . . . 2.8500000000000001 110.88 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.45 ' CD ' HH21 ' A' ' 42' ' ' ARG . 79.3 mm-40 -60.35 -41.33 93.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.85 -1.156 . . . . 1.3100000000000001 110.503 179.573 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.27 -40.41 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.374 -0.828 . . . . 1.3799999999999999 110.547 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -60.29 -44.91 94.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.128 -0.983 . . . . 1.5 109.882 179.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.45 HH21 ' CD ' ' A' ' 39' ' ' GLU . 67.5 mtm180 -63.42 -41.96 98.71 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.929 -1.109 . . . . 2.7799999999999998 109.74 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -72.25 -54.5 9.41 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.309 -0.869 . . . . 1.0600000000000001 109.974 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.4 tp -57.79 -48.51 79.48 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.33 -0.948 . . . . 1.3999999999999999 110.051 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 t -68.78 -43.92 74.69 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.121 -0.987 . . . . 1.3200000000000001 109.489 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.45 -35.71 73.59 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.348 -1.501 . . . . 0.69999999999999996 109.348 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 47' ' ' ARG . 0.3 OUTLIER -58.62 -33.66 70.28 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.434 1.111 . . . . 3.4399999999999999 108.819 178.71 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.87 -48.21 82.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.035 -0.984 . . . . 1.3600000000000001 110.212 179.439 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -79.0 -38.6 36.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 2.8300000000000001 111.261 -179.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.76 86.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 1.23 110.513 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.5 m -61.43 -39.54 91.18 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.042 -1.036 . . . . 1.9199999999999999 109.893 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.31 92.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.866 -0.521 . . . . 1.25 111.373 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -63.01 -52.16 64.02 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.716 -1.24 . . . . 1.97 111.199 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.75 -38.22 90.26 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.804 -1.185 . . . . 2.1800000000000002 110.401 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.1 -43.33 87.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.737 -0.602 . . . . 1.1899999999999999 110.781 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.5 m -67.74 -44.65 77.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.784 -1.197 . . . . 1.3400000000000001 110.311 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.92 -34.92 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.641 -0.662 . . . . 1.23 110.869 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -50.74 -45.55 58.83 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.297 -0.877 . . . . 1.5600000000000001 110.743 179.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -69.58 -34.57 74.33 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.129 -0.982 . . . . 1.3 110.305 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -62.75 -39.62 94.69 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.834 -1.147 . . . . 2.3199999999999998 109.686 179.455 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.36 73.93 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.683 -0.635 . . . . 1.1399999999999999 110.427 179.205 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.41 -33.7 21.94 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.8 -1.19 . . . . 0.68999999999999995 111.042 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.44 -24.58 39.5 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.117 -1.225 . . . . 1.48 111.296 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -86.38 -48.84 8.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.374 -0.828 . . . . 1.52 111.221 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -107.36 -15.36 14.65 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 113.484 0.92 . . . . 1.3100000000000001 113.484 -177.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.85 151.98 8.92 Favored Glycine 0 N--CA 1.501 3.026 0 O-C-N 121.406 -0.809 . . . . 0.84999999999999998 112.043 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -52.73 -21.22 3.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.53 -0.982 . . . . 3.8599999999999999 112.417 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.27 -29.89 67.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.974 -1.079 . . . . 2.3500000000000001 111.689 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -82.82 -17.42 44.07 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.823 -1.173 . . . . 2.2599999999999998 111.948 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.34 -33.81 72.94 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.419 -0.8 . . . . 1.45 111.109 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.69 -39.97 86.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.086 -1.009 . . . . 1.25 110.701 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.2 mt -66.12 -47.54 84.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.401 -0.92 . . . . 1.26 109.734 179.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -71.19 -33.41 69.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.339 -0.851 . . . . 0.82999999999999996 110.547 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.88 -38.58 86.14 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.139 -0.976 . . . . 1.1899999999999999 109.854 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.84 95.1 Favored Glycine 0 N--CA 1.483 1.833 0 C-N-CA 120.026 -1.083 . . . . 0.57999999999999996 110.479 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -58.73 -43.0 90.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.026 -1.279 . . . . 2.0499999999999998 110.362 179.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.33 -40.85 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.083 -1.011 . . . . 1.21 110.081 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.9 ttm -60.57 -41.99 95.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.438 -0.789 . . . . 2.29 110.081 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.1 tp -60.55 -48.09 83.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.417 -0.802 . . . . 1.21 109.995 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.466 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.1 tp -59.83 -39.66 85.87 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.72 0.771 . . . . 1.1399999999999999 110.248 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -87.06 7.6 27.15 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.725 0.639 . . . . 1.4199999999999999 112.725 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -63.49 125.2 23.43 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.833 -1.167 . . . . 1.27 108.762 178.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.49 -16.72 63.94 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.265 -0.897 . . . . 1.3500000000000001 111.096 -179.051 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.37 -50.29 19.22 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.274 -0.97 . . . . 2.2200000000000002 110.623 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.97 -39.72 90.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.379 -0.826 . . . . 1.22 110.631 -179.489 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.84 -48.65 80.84 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.07 -1.019 . . . . 1.29 110.986 179.367 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -62.01 -38.64 89.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 2.1699999999999999 110.949 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -66.36 -47.98 71.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.899 -1.126 . . . . 1.3 110.319 179.486 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.7 mt -58.33 -46.48 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.968 -1.082 . . . . 1.1699999999999999 109.991 179.381 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.99 -40.94 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.45 -0.781 . . . . 1.3999999999999999 110.354 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.43 -46.93 88.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 1.3300000000000001 111.033 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.8 -42.98 94.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.087 -1.008 . . . . 1.48 110.511 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.8 mt -61.84 -46.77 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.982 . . . . 1.28 110.029 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -82.14 -37.87 25.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 2.6000000000000001 111.82 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 91' ' ' ALA . 56.3 t0 -81.58 -45.74 15.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.696 -1.253 . . . . 1.51 111.994 -178.681 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -100.01 8.81 43.74 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.991 -1.068 . . . . 2.48 112.61 -178.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.0 m170 50.88 50.21 19.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.959 -1.088 . . . . 1.6100000000000001 111.816 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.9 mtt -107.72 151.45 25.67 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.442 -0.786 . . . . 1.8999999999999999 109.734 179.486 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.5 p -70.43 163.34 26.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.729 -0.607 . . . . 1.3200000000000001 109.97 178.351 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.79 -42.29 88.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.933 . . . . 1.1499999999999999 110.698 178.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.93 -41.43 82.6 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.042 -1.036 . . . . 2.25 110.205 -179.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.22 -50.87 51.21 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.634 -0.666 . . . . 1.22 111.344 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.71 94.89 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.033 -1.042 . . . . 1.1899999999999999 110.314 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -43.74 95.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 1.2 110.669 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -61.28 -39.75 91.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 2.1000000000000001 111.309 -179.481 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -57.63 -49.84 75.12 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.852 -1.155 . . . . 1.3 110.795 179.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.14 -46.06 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.047 -1.033 . . . . 1.27 109.974 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -64.93 -31.96 56.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.871 -0.518 . . . . 1.1899999999999999 110.418 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.21 -41.0 71.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.181 -0.949 . . . . 2.1099999999999999 110.7 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.01 -30.93 18.97 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 119.142 -1.504 . . . . 0.88 112.452 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -61.21 -39.69 91.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.516 -1.579 . . . . 1.99 109.903 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.14 -48.91 40.07 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.323 0.582 . . . . 1.28 110.755 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.8 t -60.05 -40.34 89.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.319 -0.863 . . . . 2.2200000000000002 110.433 -178.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.07 99.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.382 -0.824 . . . . 1.45 110.745 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.55 -30.11 70.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.814 -1.179 . . . . 1.47 110.733 -179.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -66.24 -20.14 66.03 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.78 -1.2 . . . . 2.04 111.039 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.37 -18.77 63.06 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.351 -0.94 . . . . 1.73 110.827 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 15.0 mt -88.88 136.49 32.98 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.843 -1.169 . . . . 1.79 107.843 178.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -100.59 42.92 1.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.272 -0.893 . . . . 2.8799999999999999 111.272 -179.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -111.85 142.31 44.39 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.164 -0.96 . . . . 1.5800000000000001 109.456 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -58.8 -39.27 80.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.228 -0.92 . . . . 3.04 110.797 178.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -71.87 -50.58 28.19 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.851 -1.156 . . . . 1.29 109.875 179.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt -67.5 -43.28 81.28 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.386 -0.821 . . . . 1.6000000000000001 110.118 -178.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -61.25 -47.87 84.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.16 -0.962 . . . . 2.7599999999999998 109.787 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.91 -30.92 69.36 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.505 -0.878 . . . . 2.1499999999999999 109.635 179.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -61.68 -30.43 70.73 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.092 0.949 . . . . 2.8100000000000001 108.696 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -49.86 74.56 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.071 0.939 . . . . 1.3899999999999999 109.537 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.65 -43.34 80.52 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.598 0.713 . . . . 1.4099999999999999 110.078 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -63.21 -33.51 75.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.623 -0.673 . . . . 1.3899999999999999 110.573 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.0 -39.28 77.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.472 -0.767 . . . . 1.1899999999999999 110.105 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -59.26 -39.92 84.39 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.822 -1.151 . . . . 3.6299999999999999 109.752 178.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.441 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 51.3 t0 -60.12 -40.8 90.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.588 -0.695 . . . . 1.28 110.059 179.437 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.7 mt -61.77 -39.07 82.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.062 -1.023 . . . . 1.1799999999999999 110.116 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.35 -46.51 20.18 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.655 -1.259 . . . . 0.51000000000000001 110.486 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -56.62 -41.63 77.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.559 -0.965 . . . . 3.1699999999999999 110.079 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.441 ' NH2' ' OD2' ' A' ' 132' ' ' ASP . 40.7 mtt-85 -60.19 -41.52 93.11 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.003 -1.061 . . . . 2.8500000000000001 109.832 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.9 tp -60.22 -42.78 95.9 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.318 -0.953 . . . . 1.6499999999999999 109.358 179.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.4 mt -59.84 -47.31 86.24 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.828 -0.545 . . . . 1.2 109.949 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -59.88 -35.4 74.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 2.7999999999999998 111.017 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -73.99 -41.5 61.81 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.026 -1.046 . . . . 2.1499999999999999 110.684 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.57 -38.89 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -0.925 . . . . 1.21 110.462 -178.388 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.7 mt -89.07 -6.96 56.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.093 -1.004 . . . . 1.3400000000000001 112.099 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.47 30.0 67.31 Favored Glycine 0 N--CA 1.482 1.746 0 C-N-CA 120.065 -1.064 . . . . 0.91000000000000003 112.075 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.94 148.23 44.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.686 -0.891 . . . . 1.51 109.844 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -68.01 141.29 56.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 2.8799999999999999 109.27 178.095 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.91 131.5 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.202 -1.036 . . . . 1.6200000000000001 108.202 178.463 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.41 ' CD1' ' H ' ' A' ' 147' ' ' ILE . 4.1 mp -77.02 131.02 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.408 -0.808 . . . . 2.1099999999999999 108.928 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.9 97.93 11.27 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.466 -1.679 . . . . 1.6200000000000001 106.466 178.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 77.2 mt -78.84 -6.0 54.91 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 112.72 0.637 . . . . 1.3999999999999999 112.72 -177.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.8 p -88.85 -2.59 58.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.903 -1.123 . . . . 2.0499999999999998 112.745 -179.123 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -106.17 36.68 2.5 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.147 -0.97 . . . . 1.3500000000000001 112.414 -177.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.521 ' CD1' ' N ' ' A' ' 152' ' ' ILE . 1.5 mp -72.72 139.89 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.575 -1.328 . . . . 1.4199999999999999 109.406 178.493 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -118.86 -16.73 9.25 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.706 0.765 . . . . 2.9900000000000002 112.408 -179.097 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -116.03 138.47 51.19 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.771 -1.196 . . . . 1.54 107.771 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -76.12 121.39 22.75 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.284 -1.006 . . . . 1.3799999999999999 108.284 178.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 m -146.28 174.03 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.493 -0.755 . . . . 1.28 109.144 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.7 mt -87.89 140.76 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 1.1599999999999999 109.143 178.02 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 42.5 tp -94.8 124.15 38.67 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.98 -1.075 . . . . 1.3100000000000001 108.183 178.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.97 129.18 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 107.604 -1.258 . . . . 1.25 107.604 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.36 153.98 22.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 1.26 108.943 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.65 -34.38 76.96 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.607 -1.308 . . . . 1.6000000000000001 109.213 178.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -173.8 149.77 1.6 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.236 -0.653 . . . . 2.4199999999999999 109.236 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 58.9 mt -116.03 136.32 53.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.601 -1.259 . . . . 1.3500000000000001 107.601 177.337 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.9 p -92.2 150.15 39.8 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.164 -0.96 . . . . 1.3200000000000001 108.786 179.069 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -39.49 -44.38 3.09 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.886 1.724 . . . . 0.69999999999999996 113.441 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.8 m -58.92 -50.06 75.47 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.835 -1.166 . . . . 1.1200000000000001 111.014 -179.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -62.99 -40.07 96.66 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.253 -0.904 . . . . 1.21 110.212 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.491 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 73.0 p -68.58 -39.2 81.07 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.334 -0.854 . . . . 1.1899999999999999 110.327 179.585 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.5 78.17 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.595 -0.842 . . . . 1.24 110.638 179.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -94.88 -2.37 50.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.111 -0.993 . . . . 1.6899999999999999 113.226 -179.014 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.94 149.94 46.14 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.904 -1.123 . . . . 1.3400000000000001 109.14 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -95.63 104.63 16.55 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.056 -1.831 . . . . 2.77 106.056 177.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 8.6 mp -72.2 -18.3 61.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 2.0899999999999999 112.054 -177.57 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -77.97 -27.45 49.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.203 -0.936 . . . . 2.6699999999999999 111.45 -178.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -100.11 6.07 44.91 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.284 -0.885 . . . . 2.5800000000000001 112.362 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.5 t -109.75 129.84 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.962 -1.125 . . . . 1.1799999999999999 107.962 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 48.9 tp -81.85 -15.47 53.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.815 . . . . 2.1800000000000002 112.288 -179.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.29 179.91 44.27 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.472 -1.451 . . . . 0.48999999999999999 109.472 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -131.68 138.24 48.63 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.533 -1.284 . . . . 0.64000000000000001 107.533 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.9 mt -138.21 119.03 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.424 -1.695 . . . . 1.21 106.424 178.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 203' ' ' VAL . 60.0 p -132.1 164.53 26.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.087 -1.008 . . . . 1.3799999999999999 108.952 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 208' ' ' VAL . 1.9 m-20 -104.82 15.98 26.83 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.577 -0.702 . . . . 2.3700000000000001 112.329 179.047 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -134.12 -51.17 0.82 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 120.808 -1.182 . . . . 1.52 114.0 -177.712 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.54 153.74 0.29 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.199 -1.0 . . . . 1.8 110.84 -176.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 152.65 -61.31 0.39 Allowed Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.156 -1.021 . . . . 2.04 112.295 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.83 77.37 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.061 -1.258 . . . . 5.0 109.023 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.6 p 53.67 40.75 31.86 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.672 -0.811 . . . . 3.02 111.596 -178.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 38.5 t -79.74 153.99 28.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.816 . . . . 2.1099999999999999 109.559 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.491 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 82.8 t60 -59.0 -39.91 83.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.859 . . . . 1.24 110.893 178.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 33.6 p -56.42 -40.89 75.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 2.1499999999999999 110.732 179.417 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 82.2 p -62.3 -37.95 87.49 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.066 -1.021 . . . . 2.02 110.485 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.83 -38.7 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.383 -0.823 . . . . 2.1200000000000001 110.73 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.7 mtp -61.75 -44.86 96.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.84 -1.162 . . . . 1.3600000000000001 108.905 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.95 -48.6 81.05 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.116 -0.947 . . . . 1.29 111.029 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.442 ' HG2' HH11 ' A' ' 195' ' ' ARG . 23.7 mtt-85 -60.81 -43.48 98.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.099 -1.001 . . . . 3.5600000000000001 110.751 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 41.5 m -69.88 -41.04 75.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.443 -0.786 . . . . 1.1799999999999999 110.306 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 13.3 mt -91.75 -6.84 51.19 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.623 0.725 . . . . 1.3400000000000001 112.284 -178.221 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.5 mt-10 45.52 18.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.529 0.937 . . . . 1.45 113.529 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 18.6 mt -71.84 142.25 85.45 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.953 -1.092 . . . . 1.25 108.372 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -56.24 130.36 39.75 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.678 1.585 . . . . 0.78000000000000003 110.357 178.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.05 175.88 9.05 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 117.911 -1.516 . . . . 1.2 111.517 179.555 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.2 mt -146.63 157.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.632 -1.247 . . . . 1.25 107.632 178.467 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 183' ' ' ALA . 4.6 m -141.8 -23.62 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 120.818 -1.176 . . . . 1.3899999999999999 113.286 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -104.25 42.3 1.93 Allowed Glycine 0 N--CA 1.503 3.136 0 N-CA-C 110.637 -0.985 . . . . 0.96999999999999997 110.637 -178.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 36.3 p -59.86 -20.76 58.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.056 -1.261 . . . . 1.3500000000000001 111.841 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.22 -85.37 0.61 Allowed Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.18 -1.01 . . . . 1.0700000000000001 111.437 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 58.8 p -134.66 32.11 3.32 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 121.008 -1.29 . . . . 1.9199999999999999 113.331 -178.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.527 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 60.2 t -58.84 -34.15 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.223 -1.548 . . . . 1.3300000000000001 111.076 179.451 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 43.8 p -64.12 -21.73 66.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.835 -1.165 . . . . 1.4199999999999999 112.199 -179.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 53.8 p -96.32 3.16 53.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.943 -1.098 . . . . 2.1200000000000001 112.339 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -129.76 4.12 4.98 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.684 -0.635 . . . . 2.6899999999999999 112.691 -178.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.1 t -123.04 152.92 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.404 -0.81 . . . . 1.29 109.768 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -118.48 156.76 28.51 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.096 -1.076 . . . . 2.6899999999999999 108.096 178.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.513 ' ND2' ' OD1' ' A' ' 215' ' ' ASP . 46.7 t30 -54.8 139.97 37.89 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.052 -1.03 . . . . 2.79 110.119 178.257 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.513 ' OD1' ' ND2' ' A' ' 214' ' ' ASN . 1.2 m-20 79.56 5.36 2.06 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.281 1.215 . . . . 2.3500000000000001 114.281 179.58 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -63.39 148.63 47.93 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.385 -0.969 . . . . 1.97 108.385 177.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -89.64 119.96 30.51 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.583 -1.636 . . . . 2.9700000000000002 106.583 178.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.7 mt -128.26 146.36 50.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.585 -0.697 . . . . 1.25 109.86 -179.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 47.0 mt -112.13 124.19 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.691 -1.596 . . . . 1.22 106.691 177.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.0 tp -97.21 111.58 23.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.981 -1.859 . . . . 1.24 105.981 178.117 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.6 t0 -89.72 -28.95 19.07 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.718 -1.239 . . . . 2.0499999999999998 111.549 -178.423 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 40.81 10.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 113.285 0.846 . . . . 1.25 113.285 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.625 ' N ' ' O ' ' A' ' 221' ' ' ASP . 39.3 t -110.57 -56.44 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.987 -1.071 . . . . 1.4299999999999999 109.173 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -92.57 8.87 37.04 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.297 1.046 . . . . 3.0299999999999998 110.271 -179.097 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 60.51 49.97 6.25 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.026 -0.988 . . . . 2.25 111.632 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -148.47 149.55 31.86 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.608 1.194 . . . . 2.52 109.93 178.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.66 135.03 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.653 -1.239 . . . . 1.29 107.653 177.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -100.5 130.26 46.55 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.968 -1.123 . . . . 1.3400000000000001 107.968 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.31 130.01 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.784 -0.821 . . . . 1.3400000000000001 108.784 179.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.412 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 0.7 OUTLIER 49.93 50.59 9.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 113.426 0.898 . . . . 2.1800000000000002 113.426 178.763 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.7 Cg_endo -69.02 150.29 72.56 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.366 2.044 . . . . 0.93999999999999995 110.701 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.1 p -73.83 160.29 31.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 2.3999999999999999 109.821 178.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.72 -36.61 72.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.486 -0.759 . . . . 3.3300000000000001 111.105 179.021 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -59.59 -41.22 89.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 3.1699999999999999 110.122 179.321 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -71.39 -40.24 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.47 -0.769 . . . . 1.6899999999999999 110.115 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.487 1.391 0 O-C-N 121.391 -0.818 . . . . 1.6000000000000001 110.322 -178.549 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.1 mt . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 106.41 -1.7 . . . . 1.5700000000000001 106.41 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -105.02 120.52 41.68 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.744 -1.206 . . . . 1.4399999999999999 107.744 -179.418 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.6 -160.37 26.9 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.179 -1.568 . . . . 1.01 109.179 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.472 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 74.9 mt -96.05 -0.18 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.419 -1.047 . . . . 1.6299999999999999 112.343 -179.295 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.7 tp 49.24 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 1.5800000000000001 112.656 178.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.76 -43.55 11.8 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.933 -1.105 . . . . 1.3400000000000001 111.562 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -141.33 143.51 30.62 Favored Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 107.72 -1.215 . . . . 1.8600000000000001 107.72 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.32 146.55 22.28 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.616 2.211 . . . . 1.01 112.634 178.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 153.39 177.98 27.46 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 108.866 -1.694 . . . . 0.81000000000000005 108.866 177.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.9 mt -134.67 140.04 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.041 -1.27 . . . . 1.3700000000000001 108.345 179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.94 158.03 43.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -0.984 . . . . 1.1399999999999999 109.451 178.177 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 11.5 m-85 -127.75 140.54 52.0 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.769 -1.197 . . . . 0.87 107.769 178.223 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.23 166.02 34.41 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 118.38 -1.867 . . . . 0.56999999999999995 110.411 178.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -78.11 158.08 29.25 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.402 -0.962 . . . . 2.3500000000000001 108.402 178.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.16 130.96 35.15 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.743 -0.836 . . . . 1.21 108.743 178.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.2 tp -113.35 103.78 11.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 105.604 -1.998 . . . . 1.3999999999999999 105.604 178.113 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.482 ' O ' ' ND2' ' A' ' 214' ' ' ASN . 13.8 tp -91.84 139.05 31.04 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.66 -0.867 . . . . 1.4399999999999999 108.66 -179.575 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.2 mt -99.39 120.9 40.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.293 -1.373 . . . . 1.45 107.293 178.318 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -111.12 138.96 46.9 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.995 -1.113 . . . . 2.5 107.995 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -119.78 140.29 50.98 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.172 -0.955 . . . . 2.6600000000000001 109.245 178.446 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -85.02 133.36 34.25 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.727 -1.212 . . . . 2.3199999999999998 107.727 177.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -60.74 149.1 36.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.07 -1.019 . . . . 2.1099999999999999 108.732 178.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.8 mt -96.99 134.17 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.027 -1.046 . . . . 1.29 108.263 178.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.74 129.67 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.586 -1.264 . . . . 1.4099999999999999 107.586 178.531 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.0 mt -100.62 137.74 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.145 -1.058 . . . . 1.3100000000000001 108.145 179.546 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -94.33 120.74 35.01 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.324 -0.991 . . . . 1.3400000000000001 108.324 178.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -94.55 15.13 18.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.393 -0.817 . . . . 3.48 112.805 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.98 147.31 53.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.382 -0.824 . . . . 2.52 109.264 178.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -88.1 139.42 30.52 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.618 -0.882 . . . . 2.6299999999999999 108.618 177.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 pt -99.77 164.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.857 -1.152 . . . . 1.3100000000000001 109.912 179.088 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.0 p -93.87 165.95 12.42 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.386 -0.821 . . . . 1.24 109.698 178.472 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -21.24 14.4 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.4 -0.812 . . . . 1.49 112.154 179.242 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -68.15 -39.1 82.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.063 -1.023 . . . . 2.2799999999999998 110.873 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -91.02 -7.4 52.01 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.814 -1.179 . . . . 2.0499999999999998 112.744 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.22 -47.44 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.526 -1.358 . . . . 1.3400000000000001 110.788 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -59.24 -39.15 81.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.124 -0.985 . . . . 1.54 109.972 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -61.36 -37.92 85.1 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.705 -0.798 . . . . 2.8500000000000001 110.825 179.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -59.91 -40.86 90.25 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.17 -1.012 . . . . 1.3100000000000001 110.639 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.24 -41.77 88.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.165 -0.959 . . . . 1.3799999999999999 110.504 179.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -62.73 -41.39 99.15 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.78 -1.2 . . . . 1.5 110.358 179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -61.05 -41.08 95.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 2.7799999999999998 110.616 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -75.37 -54.11 7.6 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.844 -1.16 . . . . 1.0600000000000001 110.463 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.2 tp -57.55 -47.8 81.07 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.721 0.772 . . . . 1.3999999999999999 110.674 -179.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.0 t -69.06 -40.05 78.75 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.833 0.825 . . . . 1.3200000000000001 110.346 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.91 -44.6 92.44 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 109.811 -1.316 . . . . 0.69999999999999996 109.811 179.298 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -60.67 -28.91 68.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.779 -0.836 . . . . 3.4399999999999999 110.251 179.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.5 -49.34 77.7 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.834 0.826 . . . . 1.3600000000000001 110.604 179.072 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -81.77 -38.62 25.37 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.337 -0.852 . . . . 2.8300000000000001 110.668 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.6 -42.36 92.42 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.614 -0.834 . . . . 1.23 109.925 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 m -62.08 -39.92 94.06 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.985 0.898 . . . . 1.9199999999999999 109.582 179.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.45 88.83 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.723 -0.791 . . . . 1.25 109.879 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.52 -50.44 69.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.99 -1.069 . . . . 1.97 109.998 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.45 -40.33 94.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.941 -1.1 . . . . 2.1800000000000002 109.832 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -59.33 -39.89 84.55 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.393 -0.817 . . . . 1.1899999999999999 110.226 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -62.91 -43.41 98.87 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.388 -0.82 . . . . 1.3400000000000001 110.277 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 57' ' ' ILE . 95.4 mt -60.23 -34.43 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.078 -1.014 . . . . 1.23 110.279 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -53.3 -45.55 69.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.45 -0.781 . . . . 1.5600000000000001 110.877 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -68.87 -39.93 79.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.206 -0.934 . . . . 1.3 109.778 -179.708 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -61.78 -37.58 84.87 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.128 -1.029 . . . . 2.3199999999999998 109.139 179.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.95 79.44 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.308 -0.557 . . . . 1.1399999999999999 110.193 179.197 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.82 -35.21 16.65 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.8 -1.191 . . . . 0.68999999999999995 111.267 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -79.9 -25.7 40.48 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.956 -1.32 . . . . 1.48 110.709 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.2 m -86.93 -50.97 6.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.729 -0.607 . . . . 1.52 110.287 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -105.92 -6.14 19.1 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 114.079 1.14 . . . . 1.3100000000000001 114.079 -177.412 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.57 164.3 27.22 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 120.228 -0.986 . . . . 0.84999999999999998 112.447 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -56.38 -23.24 36.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.852 -0.793 . . . . 3.8599999999999999 112.645 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -57.9 -39.0 76.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.356 -1.465 . . . . 2.3500000000000001 110.515 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -86.99 -25.27 24.36 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.216 -0.928 . . . . 2.2599999999999998 111.746 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.42 -39.97 85.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.219 -0.925 . . . . 1.45 110.776 -179.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.21 84.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.496 -0.752 . . . . 1.25 111.286 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.2 mt -65.41 -44.75 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.622 -1.299 . . . . 1.26 110.649 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -69.87 -31.55 69.44 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.841 -1.162 . . . . 0.82999999999999996 110.698 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -59.98 -39.33 85.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.064 -1.023 . . . . 1.1899999999999999 110.94 179.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.93 -40.36 93.48 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.535 -1.317 . . . . 0.57999999999999996 110.863 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -59.35 -40.78 87.5 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.084 -1.245 . . . . 2.0499999999999998 110.616 179.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.7 mt -60.82 -37.55 76.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.202 -0.936 . . . . 1.21 110.497 179.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 26.3 ttt -58.64 -38.89 79.07 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.703 -0.799 . . . . 2.29 110.449 179.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.05 -49.43 77.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.949 -1.094 . . . . 1.21 110.879 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.6 tp -61.35 -38.81 88.3 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.21 -0.931 . . . . 1.1399999999999999 110.252 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -86.34 7.65 24.68 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.175 0.806 . . . . 1.4199999999999999 113.175 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -67.43 116.16 7.87 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 120.793 -1.192 . . . . 1.27 108.655 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -64.37 -20.23 65.99 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.626 0.727 . . . . 1.3500000000000001 110.946 -179.226 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -71.64 -47.98 50.85 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.991 -1.083 . . . . 2.2200000000000002 110.364 179.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.32 -38.4 89.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.395 -0.816 . . . . 1.22 110.521 -178.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -59.54 -41.76 90.81 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.008 -1.058 . . . . 1.29 110.515 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.17 -39.23 85.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.941 -1.099 . . . . 2.1699999999999999 110.582 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -66.62 -48.06 70.65 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.106 -1.037 . . . . 1.3 110.448 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.59 -43.48 83.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.936 -1.102 . . . . 1.1699999999999999 110.01 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.73 -44.04 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 1.3999999999999999 110.685 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.74 -40.89 96.69 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.247 -0.908 . . . . 1.3300000000000001 110.856 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.0 mt -60.39 -44.77 95.34 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.496 -1.377 . . . . 1.48 110.418 -179.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.64 -47.64 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.907 -1.121 . . . . 1.28 110.812 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -79.75 -35.48 38.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.004 -1.06 . . . . 2.6000000000000001 111.665 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.78 -43.34 22.67 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.02 -1.05 . . . . 1.51 111.312 -179.001 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -101.13 4.55 42.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.047 -1.033 . . . . 2.48 112.251 -177.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.1 m80 51.48 49.35 21.13 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.238 -0.914 . . . . 1.6100000000000001 111.646 -179.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 70.3 mtm -110.04 157.89 18.85 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.494 -0.754 . . . . 1.8999999999999999 109.558 178.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.431 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 29.8 p -71.51 162.46 29.41 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.296 0.569 . . . . 1.3200000000000001 110.403 178.247 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.67 -41.11 97.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.53 -0.731 . . . . 1.1499999999999999 110.827 179.149 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 31.8 p-10 -69.59 -38.59 77.39 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.196 -0.94 . . . . 2.25 109.978 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.527 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -71.27 -52.89 16.43 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.831 -1.148 . . . . 1.22 110.872 179.363 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.25 88.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 1.1899999999999999 110.604 -179.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.25 93.46 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.026 -0.67 . . . . 1.2 110.878 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -59.76 -41.31 90.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.843 -1.16 . . . . 2.1000000000000001 111.039 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -56.14 -47.57 77.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.235 -1.54 . . . . 1.3 110.73 179.658 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.53 -44.18 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.548 -1.345 . . . . 1.27 110.22 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.79 -32.31 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.282 -0.886 . . . . 1.1899999999999999 110.071 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.22 -39.93 92.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.12 -0.987 . . . . 2.1099999999999999 111.022 179.308 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.9 -30.4 29.11 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.079 -1.534 . . . . 0.88 112.795 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -60.57 -39.68 88.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 119.675 -2.073 . . . . 1.99 109.858 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.53 -48.04 43.45 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.638 0.733 . . . . 1.28 109.696 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.532 ' HG ' ' N ' ' A' ' 114' ' ' ALA . 12.3 p -60.81 -39.73 90.04 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.704 -0.798 . . . . 2.2200000000000002 110.063 -178.649 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.532 ' N ' ' HG ' ' A' ' 113' ' ' SER . . . -60.24 -46.45 89.74 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.954 -1.091 . . . . 1.45 110.821 179.535 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.3 mt -65.44 -29.54 70.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.699 -1.25 . . . . 1.47 111.09 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -64.31 -21.39 66.59 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.975 -1.078 . . . . 2.04 111.426 179.549 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -71.83 -15.51 62.14 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.763 0.792 . . . . 1.73 110.923 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 36.8 mt -86.9 141.55 28.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.953 -0.758 . . . . 1.79 108.953 179.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -97.56 41.58 1.12 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.987 -1.071 . . . . 2.8799999999999999 111.853 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -114.48 140.88 48.37 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.305 -0.872 . . . . 1.5800000000000001 109.391 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -59.05 -39.39 81.89 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.338 -0.851 . . . . 3.04 111.515 178.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -72.68 -53.01 12.91 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 1.29 110.313 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.4 mt -61.42 -41.32 96.97 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.107 -0.995 . . . . 1.6000000000000001 110.394 -179.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -63.16 -49.05 75.85 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.276 1.036 . . . . 2.7599999999999998 109.563 179.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -63.2 -29.93 71.18 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.092 -1.043 . . . . 2.1499999999999999 109.968 179.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.443 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 15.2 ttt-85 -60.82 -30.47 70.1 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.741 0.782 . . . . 2.8100000000000001 108.951 178.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.25 87.28 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.155 0.979 . . . . 1.3899999999999999 109.001 178.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -43.65 80.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.739 -0.784 . . . . 1.4099999999999999 109.981 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -64.57 -33.17 75.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.492 -0.755 . . . . 1.3899999999999999 110.616 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.443 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 24.5 t -68.19 -39.63 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 1.1899999999999999 109.834 179.377 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -58.91 -39.67 82.22 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.087 -1.045 . . . . 3.6299999999999999 109.896 178.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -59.35 -38.86 81.48 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.21 -0.45 . . . . 1.28 110.544 179.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 54.1 mt -60.72 -40.29 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.673 -1.267 . . . . 1.1799999999999999 110.116 179.496 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.19 -36.65 60.01 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.395 -1.082 . . . . 0.51000000000000001 110.395 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -56.63 -48.65 77.05 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.547 -0.972 . . . . 3.1699999999999999 110.66 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -63.38 -41.03 98.77 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.013 -1.075 . . . . 2.8500000000000001 110.169 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.9 tp -59.76 -40.37 87.94 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.69 -0.631 . . . . 1.6499999999999999 110.301 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.2 mt -59.24 -44.3 92.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.094 -1.004 . . . . 1.2 110.463 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -60.62 -33.24 72.48 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.146 -0.971 . . . . 2.7999999999999998 111.181 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -75.74 -41.4 53.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.909 -1.119 . . . . 2.1499999999999999 110.867 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.406 HG22 HD11 ' A' ' 141' ' ' ILE . 90.1 mt -60.14 -38.6 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.969 -1.082 . . . . 1.21 110.571 -178.45 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.0 mt -85.35 -7.11 59.14 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.457 -0.777 . . . . 1.3400000000000001 111.764 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.81 16.42 80.78 Favored Glycine 0 N--CA 1.483 1.82 0 C-N-CA 120.319 -0.943 . . . . 0.91000000000000003 112.454 -179.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.27 149.28 48.37 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.769 -0.842 . . . . 1.51 109.688 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -65.66 150.83 47.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.528 -0.732 . . . . 2.8799999999999999 109.695 178.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.2 mt -104.02 138.43 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.177 -0.952 . . . . 1.6200000000000001 108.711 178.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 mp -82.72 118.84 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.439 -1.319 . . . . 2.1099999999999999 107.439 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -100.81 102.62 13.74 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.965 -1.865 . . . . 1.6200000000000001 105.965 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 70.1 mt -74.86 -14.79 60.71 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.563 -0.855 . . . . 1.3999999999999999 111.505 -178.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.2 m -80.09 2.41 24.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.414 -0.804 . . . . 2.0499999999999998 112.852 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -93.94 21.17 6.92 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.67 0.747 . . . . 1.3500000000000001 112.325 -179.226 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.2 mt -73.15 140.22 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.811 -0.556 . . . . 1.4199999999999999 109.672 179.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -117.46 -16.37 10.21 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.224 1.011 . . . . 2.9900000000000002 112.468 -178.715 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -118.03 139.39 51.27 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.288 -1.004 . . . . 1.54 108.288 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -70.87 128.7 36.89 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.826 -1.171 . . . . 1.3799999999999999 108.294 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.1 m -146.57 175.42 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.92 -0.77 . . . . 1.28 108.92 -179.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.28 140.65 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.884 -1.135 . . . . 1.1599999999999999 108.757 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.6 tp -96.66 123.36 40.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.807 -1.183 . . . . 1.3100000000000001 108.626 178.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.23 130.7 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.431 -0.951 . . . . 1.25 108.431 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 152.01 16.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -0.86 . . . . 1.26 109.157 178.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.42 -34.19 74.97 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.897 -1.127 . . . . 1.6000000000000001 109.344 178.055 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -171.53 153.06 3.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.77 -0.826 . . . . 2.4199999999999999 108.77 179.455 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 68.9 mt -118.95 142.86 47.4 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.437 -0.79 . . . . 1.3500000000000001 109.214 177.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.4 p -91.81 146.91 33.91 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.275 -0.89 . . . . 1.3200000000000001 109.071 179.185 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -41.15 -39.23 3.6 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.464 1.443 . . . . 0.69999999999999996 113.537 178.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.1 m -61.37 -50.17 73.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.764 -1.21 . . . . 1.1200000000000001 110.208 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.22 -39.13 93.76 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.41 0.624 . . . . 1.21 110.327 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 56.5 p -68.44 -40.03 81.31 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.285 -0.884 . . . . 1.1899999999999999 110.678 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.78 84.05 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.123 -0.985 . . . . 1.24 110.338 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -94.32 1.85 55.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.791 -1.193 . . . . 1.6899999999999999 112.991 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.7 149.6 34.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.0 -1.063 . . . . 1.3400000000000001 109.037 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.02 116.62 29.23 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.621 -1.622 . . . . 2.77 106.621 177.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.3 mt -75.66 -13.67 60.33 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.353 0.597 . . . . 2.0899999999999999 111.717 -177.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -85.76 -22.16 27.86 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.319 0.581 . . . . 2.6699999999999999 112.072 -179.118 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -102.73 -2.41 28.2 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.884 0.698 . . . . 2.5800000000000001 112.884 -178.165 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.7 t -112.15 130.04 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 107.65 -1.241 . . . . 1.1799999999999999 107.65 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.401 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 1.7 tt -92.96 -11.11 34.09 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.239 1.019 . . . . 2.1800000000000002 111.735 -179.208 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.89 173.67 42.66 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 109.537 -1.425 . . . . 0.48999999999999999 109.537 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -126.2 132.49 51.75 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.992 -1.299 . . . . 0.64000000000000001 107.61 179.17 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 75.0 mt -132.48 106.86 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 106.133 -1.803 . . . . 1.21 106.133 178.366 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 203' ' ' VAL . 71.7 p -129.31 170.21 13.9 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 120.497 -1.377 . . . . 1.3799999999999999 110.018 -178.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 20.9 p-10 -99.01 53.23 0.97 Allowed 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 120.118 -0.633 . . . . 2.3700000000000001 110.881 179.433 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.33 156.14 17.78 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 108.887 -0.783 . . . . 1.52 108.887 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.59 -3.39 58.45 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.431 -1.366 . . . . 1.8 112.821 179.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 77.2 -40.22 1.7 Allowed Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.444 -1.36 . . . . 2.04 113.967 179.624 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.456 HH11 ' HG2' ' A' ' 186' ' ' ARG . 14.5 ttt-85 -61.31 127.06 29.69 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.996 -1.297 . . . . 5.0 109.019 179.037 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 10.5 p 46.38 28.94 0.78 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -0.859 . . . . 3.02 112.245 -179.541 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 42.4 t -83.07 130.04 35.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.922 -1.111 . . . . 2.1099999999999999 108.089 178.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -59.37 -40.74 87.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -0.925 . . . . 1.24 110.625 179.295 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -61.28 -40.72 95.2 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.631 -1.293 . . . . 2.1499999999999999 110.258 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 91.6 p -60.81 -36.16 78.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.231 -0.918 . . . . 2.02 110.455 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.84 -38.29 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.191 -0.943 . . . . 2.1200000000000001 110.186 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 67.1 mtp -63.18 -41.85 99.28 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.09 -1.006 . . . . 1.3600000000000001 109.639 179.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.06 -47.13 86.35 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.491 0.662 . . . . 1.29 111.14 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -59.99 -42.6 94.58 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.065 -1.022 . . . . 3.5600000000000001 110.623 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 31.5 m -70.18 -41.0 74.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 1.1799999999999999 110.007 179.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -90.44 -9.3 47.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.522 -0.736 . . . . 1.3400000000000001 111.841 -178.085 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 194' ' ' ALA . 54.3 mt-10 51.38 12.71 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 114.013 1.116 . . . . 1.45 114.013 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 42.9 mt -70.5 162.03 73.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.902 -1.124 . . . . 1.25 108.64 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -68.88 140.67 46.7 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.345 1.363 . . . . 0.78000000000000003 110.59 178.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.82 167.88 27.14 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 117.338 -1.745 . . . . 1.2 110.268 178.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 75.6 mt -143.48 157.57 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.257 -1.386 . . . . 1.25 107.257 178.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.0 m -138.59 -29.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.868 -1.145 . . . . 1.3899999999999999 112.736 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.25 44.69 2.69 Favored Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.273 -0.892 . . . . 0.96999999999999997 111.555 -178.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 33.5 p -66.31 -18.61 65.46 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.961 -1.317 . . . . 1.3500000000000001 110.841 -179.167 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.35 -94.91 0.74 Allowed Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.51 -1.328 . . . . 1.0700000000000001 110.123 179.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 207' ' ' SER . 22.5 t -126.43 28.19 6.02 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.304 -1.115 . . . . 1.9199999999999999 112.623 -178.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 84.6 t -59.05 -35.23 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.33 -1.482 . . . . 1.3300000000000001 110.592 179.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.4 p -55.31 -25.24 33.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.058 -1.026 . . . . 1.4199999999999999 111.378 -179.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t -93.89 1.05 56.45 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.141 -0.974 . . . . 2.1200000000000001 111.992 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -121.03 -6.1 9.51 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.18 0.808 . . . . 2.6899999999999999 113.18 -178.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 29.8 t -114.94 150.15 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.705 -0.622 . . . . 1.29 109.509 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -124.32 160.61 27.66 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.741 -1.207 . . . . 2.6899999999999999 107.741 177.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 10.2 m120 -54.79 140.88 34.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.581 -1.324 . . . . 2.79 110.981 178.541 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.5 m-20 79.03 4.9 2.33 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 114.73 1.381 . . . . 2.3500000000000001 114.73 179.173 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -65.26 142.55 58.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.702 -1.248 . . . . 1.97 108.479 177.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -85.94 115.68 23.71 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.584 -1.265 . . . . 2.9700000000000002 107.584 177.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 75.9 mt -125.19 143.61 50.85 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.767 0.794 . . . . 1.25 109.849 -178.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.2 mt -112.64 128.86 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 106.545 -1.65 . . . . 1.22 106.545 177.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.6 tp -103.55 114.48 28.79 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 105.954 -1.869 . . . . 1.24 105.954 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 223' ' ' VAL . 40.8 t0 -90.5 -25.06 20.47 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.945 -1.097 . . . . 2.0499999999999998 112.704 -177.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 38.56 14.12 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 113.128 0.788 . . . . 1.25 113.128 -179.051 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 221' ' ' ASP . 34.3 t -110.95 -61.24 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.054 -1.028 . . . . 1.4299999999999999 109.332 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -89.91 9.28 28.28 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.238 1.018 . . . . 3.0299999999999998 110.446 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.64 51.64 3.91 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.389 -0.823 . . . . 2.25 112.171 179.293 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -146.79 151.61 37.41 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.254 1.026 . . . . 2.52 109.789 179.025 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.56 139.09 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.54 -1.282 . . . . 1.29 107.54 177.412 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.76 130.48 49.73 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.06 -1.025 . . . . 1.3400000000000001 108.292 178.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.05 129.57 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.205 -1.035 . . . . 1.3400000000000001 108.205 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.434 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 10.9 t-20 52.24 51.29 9.42 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 113.365 0.876 . . . . 2.1800000000000002 113.365 179.128 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.2 Cg_endo -63.48 149.42 91.11 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.367 2.044 . . . . 0.93999999999999995 111.2 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.7 m -74.41 152.29 39.52 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.055 -1.028 . . . . 2.3999999999999999 109.098 177.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.82 -36.51 76.93 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.162 -0.961 . . . . 3.3300000000000001 110.302 178.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -59.45 -39.83 84.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.674 -0.641 . . . . 3.1699999999999999 110.293 179.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 98.5 t -71.69 -42.93 70.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.887 -1.133 . . . . 1.6899999999999999 109.867 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.5 mt . . . . . 0 C--N 1.302 -1.46 0 C-N-CA 119.419 -0.912 . . . . 1.6000000000000001 110.356 -179.033 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.8 mt . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 107.568 -1.271 . . . . 1.5700000000000001 107.568 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 m -106.59 115.22 29.82 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.346 -1.724 . . . . 1.4399999999999999 106.346 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.8 -161.06 28.76 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.658 -1.377 . . . . 1.01 109.658 -179.496 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.457 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 92.7 mt -95.75 1.0 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.415 -1.05 . . . . 1.6299999999999999 112.69 -179.836 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tp 50.15 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.028 -1.045 . . . . 1.5800000000000001 112.27 178.596 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.43 -47.97 10.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.071 -1.018 . . . . 1.3400000000000001 111.274 179.15 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -143.53 146.14 34.36 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 107.83 -1.174 . . . . 1.8600000000000001 107.83 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.13 147.24 29.64 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.099 1.866 . . . . 1.01 112.14 178.549 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.42 147.31 4.64 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 119.732 -1.223 . . . . 0.81000000000000005 110.051 178.417 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 11' ' ' ILE . 84.9 mt -112.2 130.94 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.797 -1.413 . . . . 1.3700000000000001 108.352 179.261 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.18 149.65 46.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.88 -0.785 . . . . 1.1399999999999999 108.88 178.837 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.5 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.5 m-85 -118.58 139.45 51.46 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 107.652 -1.24 . . . . 0.87 107.652 177.352 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.8 169.53 42.49 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 118.585 -1.769 . . . . 0.56999999999999995 110.195 178.452 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HB3' ' HZ2' ' A' ' 15' ' ' LYS . 7.9 mtpm? -78.72 154.84 29.74 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.732 -0.864 . . . . 2.3500000000000001 109.281 178.042 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.88 133.35 35.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.12 -0.988 . . . . 1.21 109.007 178.071 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.5 tp -116.33 99.73 7.4 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.009 -1.848 . . . . 1.3999999999999999 106.009 178.123 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.523 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 11.7 tp -85.5 137.61 32.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.667 -1.234 . . . . 1.4399999999999999 107.667 179.659 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.4 mt -102.74 118.31 36.56 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 106.784 -1.561 . . . . 1.45 106.784 178.863 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -111.75 136.74 50.61 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.966 -1.124 . . . . 2.5 107.966 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -126.36 151.28 47.82 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.179 -0.95 . . . . 2.6600000000000001 109.706 179.009 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -82.44 135.99 35.03 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.622 -1.251 . . . . 2.3199999999999998 107.622 177.329 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -64.21 149.72 47.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 2.1099999999999999 109.159 178.792 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mt -88.19 130.1 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.914 -1.143 . . . . 1.29 107.914 177.826 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.2 t -108.57 129.13 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.794 -1.188 . . . . 1.4099999999999999 107.794 178.711 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.41 136.58 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.157 -1.053 . . . . 1.3100000000000001 108.157 179.233 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -90.54 120.68 31.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.734 -1.21 . . . . 1.3400000000000001 107.734 178.8 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.425 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.3 mmm-85 -96.17 11.19 35.24 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.198 -0.939 . . . . 3.48 112.667 -179.695 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -64.02 146.07 54.78 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.789 -1.194 . . . . 2.52 109.258 178.683 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.37 139.43 30.5 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.889 -1.152 . . . . 2.6299999999999999 107.889 177.708 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -100.75 164.39 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 122.014 0.911 . . . . 1.3100000000000001 109.904 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.6 p -96.64 165.26 12.23 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.3 0.571 . . . . 1.24 109.668 178.369 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.07 -22.13 15.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 1.49 112.045 179.176 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -68.64 -37.08 79.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.97 -1.081 . . . . 2.2799999999999998 110.8 -179.881 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -92.68 -5.79 50.62 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.052 -1.03 . . . . 2.0499999999999998 112.907 -179.315 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.3 t -59.88 -41.45 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.128 -0.982 . . . . 1.3400000000000001 110.615 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.4 -39.89 84.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.911 -1.118 . . . . 1.54 110.128 179.657 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -60.47 -38.25 83.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.612 -0.68 . . . . 2.8500000000000001 110.744 179.903 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.62 -40.96 89.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.003 -1.061 . . . . 1.3100000000000001 110.37 179.319 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.9 t -60.13 -43.6 93.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.158 -0.964 . . . . 1.3799999999999999 110.322 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -60.55 -43.62 97.02 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.238 -0.914 . . . . 1.5 109.974 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -60.62 -42.92 97.84 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.224 -0.99 . . . . 2.7799999999999998 109.914 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -73.22 -54.85 7.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.457 -0.777 . . . . 1.0600000000000001 110.016 179.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.6 tp -57.74 -47.76 81.53 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.761 -0.776 . . . . 1.3999999999999999 109.971 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.6 t -69.9 -41.17 75.07 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.447 -0.783 . . . . 1.3200000000000001 109.905 179.764 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.66 -43.11 94.5 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.284 -1.526 . . . . 0.69999999999999996 109.284 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -59.97 -29.93 68.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.359 -1.083 . . . . 3.4399999999999999 109.615 179.002 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.23 -49.93 75.97 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.723 -0.791 . . . . 1.3600000000000001 111.078 179.309 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -82.62 -38.53 23.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.239 -0.913 . . . . 2.8300000000000001 110.873 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.11 -44.54 91.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.905 -1.122 . . . . 1.23 109.766 -179.381 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.7 t -60.28 -38.18 82.79 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.212 1.006 . . . . 1.9199999999999999 109.348 179.603 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.89 78.5 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.845 -0.616 . . . . 1.25 110.326 179.47 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -61.68 -49.76 75.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 1.97 110.365 179.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.97 -40.37 93.12 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.985 0.898 . . . . 2.1800000000000002 109.656 179.777 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.11 -40.82 90.99 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.298 0.57 . . . . 1.1899999999999999 110.183 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.4 m -67.55 -41.42 84.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 1.3400000000000001 110.471 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 57' ' ' ILE . 97.4 mt -60.12 -38.35 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.481 -0.762 . . . . 1.23 110.712 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -50.92 -41.6 58.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.853 . . . . 1.5600000000000001 110.475 179.362 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.71 -37.23 76.49 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.908 -1.12 . . . . 1.3 109.988 -179.672 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -62.28 -38.93 91.22 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.343 -0.943 . . . . 2.3199999999999998 109.505 179.201 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.25 -30.08 68.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.68 -0.638 . . . . 1.1399999999999999 110.344 179.207 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.95 -37.12 11.86 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.024 -1.084 . . . . 0.68999999999999995 111.511 179.9 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -80.01 -28.18 39.44 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.071 -1.252 . . . . 1.48 110.895 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.4 m -84.57 -47.57 10.43 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.285 -0.884 . . . . 1.52 111.086 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -107.22 -10.84 15.73 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.547 0.943 . . . . 1.3100000000000001 113.547 -177.285 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.17 157.99 16.55 Favored Glycine 0 N--CA 1.501 2.968 0 O-C-N 121.269 -0.894 . . . . 0.84999999999999998 113.051 179.02 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -54.45 -21.66 10.49 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.736 -0.861 . . . . 3.8599999999999999 112.58 179.491 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -55.93 -36.87 68.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.019 -1.051 . . . . 2.3500000000000001 111.347 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -80.08 -22.26 42.43 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.1 -1.0 . . . . 2.2599999999999998 112.446 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.1 -35.66 75.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.806 -1.184 . . . . 1.45 111.39 -179.744 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.26 93.6 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.946 -1.096 . . . . 1.25 111.724 179.767 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.4 mt -66.83 -44.56 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.59 -1.319 . . . . 1.26 110.245 -179.786 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -70.15 -32.87 71.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.074 -1.016 . . . . 0.82999999999999996 110.207 -179.901 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.72 -36.61 79.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 1.1899999999999999 110.11 -179.781 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.93 -41.05 83.79 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 120.396 -0.907 . . . . 0.57999999999999996 110.964 179.401 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -58.68 -44.21 90.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.102 -1.234 . . . . 2.0499999999999998 110.81 179.562 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 77' ' ' ILE . 81.6 mt -60.61 -40.09 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.052 -1.03 . . . . 1.21 110.329 -179.999 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 34.2 ttp -60.21 -38.86 84.64 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.35 -0.844 . . . . 2.29 110.428 179.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -58.63 -48.81 79.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.19 -0.944 . . . . 1.21 109.919 179.111 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.01 -40.4 89.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.576 -0.702 . . . . 1.1399999999999999 110.376 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -86.16 10.85 13.3 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.386 -0.821 . . . . 1.4199999999999999 112.411 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.14 124.45 21.69 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.038 -1.039 . . . . 1.27 108.659 178.594 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.32 -19.64 65.57 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.746 0.784 . . . . 1.3500000000000001 110.819 -179.162 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -76.39 -52.96 8.85 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.762 -0.775 . . . . 2.2200000000000002 110.406 179.919 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -60.62 -41.26 94.46 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.256 -0.977 . . . . 1.22 110.495 -179.455 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -58.18 -48.62 79.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.939 -1.1 . . . . 1.29 110.58 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -62.28 -38.63 90.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.863 -1.148 . . . . 2.1699999999999999 110.873 -179.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.38 -48.37 67.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.989 -1.07 . . . . 1.3 110.999 179.694 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.8 mt -56.21 -43.47 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.066 -1.021 . . . . 1.1699999999999999 109.735 179.527 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.12 -44.03 99.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.317 0.579 . . . . 1.3999999999999999 110.515 179.874 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.37 -43.71 98.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 1.3300000000000001 110.772 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.32 -46.51 90.0 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.083 -1.011 . . . . 1.48 110.483 -179.787 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.65 -43.41 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 1.28 110.617 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -84.41 -33.68 23.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.729 -0.607 . . . . 2.6000000000000001 111.549 -179.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 91' ' ' ALA . 55.7 t0 -79.76 -42.34 24.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.914 -1.116 . . . . 1.51 111.209 -178.4 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -102.65 5.73 39.24 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 2.48 112.921 -177.946 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.9 m170 52.86 48.99 21.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.987 . . . . 1.6100000000000001 111.85 -179.495 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.27 158.27 17.62 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.418 -0.801 . . . . 1.8999999999999999 109.451 178.459 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.4 p -70.96 159.07 35.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.679 -0.638 . . . . 1.3200000000000001 109.414 177.808 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.2 -41.4 88.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 1.1499999999999999 110.8 178.743 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -68.27 -38.74 82.03 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.931 -1.106 . . . . 2.25 110.502 -179.82 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.91 -54.53 15.0 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.754 -0.778 . . . . 1.22 111.186 179.691 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.58 94.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.263 -0.898 . . . . 1.1899999999999999 110.408 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.34 88.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.445 -0.785 . . . . 1.2 110.442 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -60.14 -39.8 87.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 2.1000000000000001 111.081 -179.936 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.76 -48.0 82.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 1.3 110.69 179.628 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.32 -43.61 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.895 -1.128 . . . . 1.27 110.61 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mm -61.52 -32.38 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.649 -0.657 . . . . 1.1899999999999999 110.102 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -58.77 -40.66 84.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.51 -0.744 . . . . 2.1099999999999999 110.469 179.274 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.67 -28.3 27.07 Favored Glycine 0 N--CA 1.499 2.848 0 C-N-CA 119.495 -1.336 . . . . 0.88 113.482 179.724 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -63.68 -42.48 98.01 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.31 -1.7 . . . . 1.99 110.061 -179.841 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.24 -50.61 21.42 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.616 0.722 . . . . 1.28 110.468 -179.961 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.9 t -60.74 -37.53 82.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.314 -0.866 . . . . 2.2200000000000002 110.627 -179.66 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.24 97.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 1.45 110.901 179.769 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.12 -30.05 70.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.915 -1.116 . . . . 1.47 110.678 -179.748 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -65.71 -22.28 66.6 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.568 -0.707 . . . . 2.04 110.979 179.409 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -70.03 -21.49 63.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.518 -0.739 . . . . 1.73 110.963 179.563 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.2 mt -82.48 145.66 29.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.786 . . . . 1.79 109.544 178.391 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -100.09 39.9 1.3 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.402 -0.811 . . . . 2.8799999999999999 111.787 179.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -112.72 139.76 48.07 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.102 -0.999 . . . . 1.5800000000000001 108.923 178.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 42.1 mp0 -59.57 -38.9 82.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.558 -0.714 . . . . 3.04 111.064 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.494 ' HH ' ' NH1' ' A' ' 126' ' ' ARG . 7.6 t80 -70.96 -55.58 8.05 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.671 -1.268 . . . . 1.29 110.592 179.723 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.7 mt -59.8 -40.77 89.44 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.034 -1.041 . . . . 1.6000000000000001 110.371 -179.685 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -64.24 -49.81 70.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.066 . . . . 2.7599999999999998 109.511 179.599 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -60.37 -32.73 71.57 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.399 -0.921 . . . . 2.1499999999999999 109.468 179.76 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.494 ' NH1' ' HH ' ' A' ' 122' ' ' TYR . 56.5 ttt180 -63.83 -28.79 70.09 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.385 -0.926 . . . . 2.8100000000000001 109.529 179.165 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.27 -47.31 85.84 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 119.784 -0.766 . . . . 1.3899999999999999 109.335 178.453 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.55 88.57 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.486 -0.886 . . . . 1.4099999999999999 110.143 179.718 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.04 -32.39 73.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.821 . . . . 1.3899999999999999 110.694 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.24 -39.53 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 1.1899999999999999 110.161 179.684 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -55.33 -39.94 70.59 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.514 -1.275 . . . . 3.6299999999999999 109.17 178.609 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -60.59 -36.1 77.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.746 -0.596 . . . . 1.28 110.433 179.604 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.3 mt -60.33 -39.62 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.328 -0.858 . . . . 1.1799999999999999 110.389 179.856 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.01 72.31 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.426 -1.369 . . . . 0.51000000000000001 110.675 178.828 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -59.03 -40.79 86.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.429 -1.042 . . . . 3.1699999999999999 110.336 179.26 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.528 ' NH1' ' OG ' ' A' ' 166' ' ' SER . 24.7 mtp180 -60.99 -40.53 93.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 2.8500000000000001 109.693 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.59 -45.52 78.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.714 -0.616 . . . . 1.6499999999999999 110.279 179.953 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.3 mt -58.43 -41.99 86.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.227 -0.92 . . . . 1.2 110.637 179.671 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -61.03 -32.52 72.12 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.143 -0.973 . . . . 2.7999999999999998 111.022 -179.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -75.37 -43.82 48.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.906 -1.121 . . . . 2.1499999999999999 111.412 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 141' ' ' ILE . 95.7 mt -61.21 -35.8 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 1.21 110.905 -178.071 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.9 mt -85.47 -7.86 58.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.074 -1.016 . . . . 1.3400000000000001 112.119 -179.829 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.27 22.07 78.53 Favored Glycine 0 N--CA 1.479 1.521 0 C-N-CA 119.095 -1.526 . . . . 0.91000000000000003 113.053 -179.18 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.36 146.41 39.92 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.83 -0.806 . . . . 1.51 110.229 -179.621 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -67.74 148.26 51.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 2.8799999999999999 108.955 178.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 63.2 mt -102.32 139.23 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.785 -1.191 . . . . 1.6200000000000001 107.785 178.464 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.8 mp -77.52 132.72 32.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.386 -0.821 . . . . 2.1099999999999999 108.807 179.169 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -95.17 86.81 4.68 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.242 -1.392 . . . . 1.6200000000000001 107.242 179.349 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -75.76 -21.73 57.16 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.87 -0.732 . . . . 1.3999999999999999 111.33 -177.82 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.424 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 32.4 t -80.27 1.08 30.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.369 -0.832 . . . . 2.0499999999999998 112.445 179.598 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.54 24.72 7.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.561 -0.712 . . . . 1.3500000000000001 112.372 -179.08 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 15.1 mt -71.42 140.77 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.372 -0.83 . . . . 1.4199999999999999 109.646 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -114.9 -18.95 11.16 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.582 0.706 . . . . 2.9900000000000002 112.883 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -115.07 134.28 55.31 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.939 -1.134 . . . . 1.54 107.939 -179.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -73.36 126.22 29.65 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.271 -1.011 . . . . 1.3799999999999999 108.271 178.503 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -148.12 177.08 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 1.28 109.284 -179.615 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.7 mt -85.74 141.91 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 1.1599999999999999 108.651 178.111 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 24.2 tp -96.19 122.84 39.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.23 -0.919 . . . . 1.3100000000000001 108.886 178.446 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.88 129.96 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.917 -1.142 . . . . 1.25 107.917 179.754 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.16 155.27 22.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 1.26 109.048 179.152 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -60.72 -40.59 92.9 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.42 -1.425 . . . . 1.6000000000000001 109.358 177.992 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -171.04 151.13 3.19 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.739 -0.838 . . . . 2.4199999999999999 108.739 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 85.2 mt -118.7 139.31 51.74 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.001 -1.111 . . . . 1.3500000000000001 108.001 177.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.9 p -92.8 150.37 39.4 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.238 -0.914 . . . . 1.3200000000000001 108.77 178.844 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -39.8 -41.65 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.34 2.027 . . . . 0.69999999999999996 113.686 179.26 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.528 ' OG ' ' NH1' ' A' ' 136' ' ' ARG . 44.1 m -59.97 -48.26 82.43 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.062 -1.024 . . . . 1.1200000000000001 110.119 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -65.23 -40.06 93.55 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.409 -0.807 . . . . 1.21 110.245 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.468 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 43.4 p -67.84 -38.53 83.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.435 -0.791 . . . . 1.1899999999999999 110.3 179.97 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.61 80.59 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.182 -0.949 . . . . 1.24 110.529 179.624 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -95.05 -0.88 53.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.055 -1.028 . . . . 1.6899999999999999 113.133 -179.326 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.1 tp -62.98 150.42 42.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 1.3400000000000001 109.17 179.801 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 150' ' ' SER . 71.4 m-20 -95.31 112.92 24.56 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.146 -1.428 . . . . 2.77 107.146 177.686 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.93 -15.54 61.12 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.139 0.495 . . . . 2.0899999999999999 112.118 -178.106 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -83.72 -23.03 31.81 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.126 -0.984 . . . . 2.6699999999999999 112.612 -178.834 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -104.08 3.02 32.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.138 -0.976 . . . . 2.5800000000000001 112.877 -178.803 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.78 127.9 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.711 -1.218 . . . . 1.1799999999999999 107.711 179.556 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 16.1 tp -87.73 -5.47 58.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.504 -0.748 . . . . 2.1800000000000002 111.895 -179.427 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 165.7 175.01 35.82 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.797 -1.721 . . . . 0.48999999999999999 108.797 -179.367 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -130.58 137.39 49.64 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.814 -1.18 . . . . 0.64000000000000001 107.814 179.823 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 83.5 mt -137.48 110.86 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 106.688 -1.597 . . . . 1.21 106.688 178.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 203' ' ' VAL . 70.7 p -130.59 168.49 17.02 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.831 -1.168 . . . . 1.3799999999999999 109.829 -179.668 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 25.8 p-10 -101.7 50.42 0.85 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.626 -0.671 . . . . 2.3700000000000001 110.529 179.841 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.35 147.51 24.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.243 -0.911 . . . . 1.52 109.323 179.333 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.43 -16.03 19.46 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.804 -1.189 . . . . 1.8 112.36 179.204 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 80.7 -19.47 7.32 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 121.402 -1.058 . . . . 2.04 114.474 179.341 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -60.13 -39.88 87.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.161 -1.199 . . . . 5.0 110.569 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 31.1 p -139.84 34.87 1.97 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.587 -0.696 . . . . 3.02 111.195 -179.691 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.466 ' HG ' ' H ' ' A' ' 191' ' ' SER . 19.0 p -84.02 118.87 24.33 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.974 -1.121 . . . . 2.1099999999999999 107.974 178.877 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.468 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 76.3 t60 -60.11 -30.6 69.37 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.584 -0.697 . . . . 1.24 110.274 -179.549 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 40.0 m -59.41 -40.9 88.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.497 -0.752 . . . . 2.1499999999999999 110.392 179.225 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.466 ' H ' ' HG ' ' A' ' 188' ' ' SER . 83.3 p -59.97 -39.05 84.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.995 -1.066 . . . . 2.02 110.074 179.53 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 75.7 mt -59.94 -39.62 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.41 -0.916 . . . . 2.1200000000000001 110.516 179.41 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 56.5 mtp -62.43 -42.25 99.32 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.293 1.044 . . . . 1.3600000000000001 109.423 179.473 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.4 -46.28 86.72 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.646 -0.707 . . . . 1.29 110.776 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.406 ' HG2' HH11 ' A' ' 195' ' ' ARG . 46.8 mtt-85 -60.07 -43.78 95.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 3.5600000000000001 110.518 -179.945 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 51.2 m -68.92 -39.14 79.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.492 -0.755 . . . . 1.1799999999999999 110.316 -179.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.2 mt -90.86 -6.86 53.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.569 -0.707 . . . . 1.3400000000000001 112.729 -179.148 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 194' ' ' ALA . 43.6 mt-10 53.2 9.8 0.16 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.918 1.081 . . . . 1.45 113.918 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 34.8 mt -71.27 150.79 94.39 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.043 -1.036 . . . . 1.25 108.462 178.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.7 141.32 95.5 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.269 1.313 . . . . 0.78000000000000003 109.465 178.532 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.96 163.79 33.88 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.574 -1.651 . . . . 1.2 110.065 179.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.6 mt -148.69 152.36 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.919 -1.141 . . . . 1.25 107.919 178.321 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.3 m -135.1 -28.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 O-C-N 120.758 -1.214 . . . . 1.3899999999999999 111.657 179.568 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.46 40.12 2.56 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.161 -0.962 . . . . 0.96999999999999997 112.219 -178.993 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 51.5 p -60.96 -18.73 58.82 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.988 -1.301 . . . . 1.3500000000000001 111.42 -179.261 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 77.15 -93.41 1.08 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.971 -1.109 . . . . 1.0700000000000001 110.501 179.539 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 47.8 p -128.8 27.3 5.48 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.472 -1.017 . . . . 1.9199999999999999 112.597 -178.767 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 83.8 t -59.23 -33.99 52.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.686 -1.259 . . . . 1.3300000000000001 110.872 179.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 44.2 p -59.71 -23.08 62.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.095 -1.003 . . . . 1.4199999999999999 111.729 -179.813 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 37.6 t -93.27 1.01 57.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 2.1200000000000001 112.113 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -126.29 0.46 7.05 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.847 0.684 . . . . 2.6899999999999999 112.847 -178.281 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 32.0 t -116.11 145.55 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.587 -0.696 . . . . 1.29 109.34 179.772 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -119.92 161.33 21.05 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.486 -0.931 . . . . 2.6899999999999999 108.486 177.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 18' ' ' LEU . 73.6 m-80 -59.57 142.27 53.1 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 120.749 -1.219 . . . . 2.79 110.639 179.159 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.6 t70 80.61 1.04 1.87 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.496 1.295 . . . . 2.3500000000000001 114.496 179.438 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -63.66 148.57 48.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.622 -1.298 . . . . 1.97 108.549 177.706 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -91.69 118.11 30.35 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 106.477 -1.675 . . . . 2.9700000000000002 106.477 177.698 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 82.3 mt -126.84 144.64 50.91 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.663 0.744 . . . . 1.25 109.867 -178.536 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.3 mt -114.15 127.37 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.711 -1.588 . . . . 1.22 106.711 177.567 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.9 tp -99.58 115.31 29.09 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 105.82 -1.918 . . . . 1.24 105.82 178.272 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 223' ' ' VAL . 28.7 t0 -89.13 -26.95 21.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.024 -1.047 . . . . 2.0499999999999998 111.701 -178.197 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 38.28 20.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.598 -0.689 . . . . 1.25 112.666 -179.28 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 221' ' ' ASP . 17.3 t -112.33 -59.77 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 122.065 0.936 . . . . 1.4299999999999999 109.522 179.573 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -99.58 14.39 30.16 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.933 0.873 . . . . 3.0299999999999998 110.87 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 45.6 t30 61.22 50.99 4.52 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 116.031 -0.531 . . . . 2.25 112.195 179.163 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -147.06 147.91 31.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.049 -1.032 . . . . 2.52 109.605 178.431 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.05 139.12 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 107.821 -1.177 . . . . 1.29 107.821 178.114 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -99.74 133.29 44.31 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.966 -1.084 . . . . 1.3400000000000001 108.419 178.394 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.0 t -110.57 130.87 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.589 -0.694 . . . . 1.3400000000000001 109.381 179.23 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.426 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 58.7 t30 52.23 51.52 9.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 113.596 0.962 . . . . 2.1800000000000002 113.596 178.117 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 55.9 Cg_endo -69.88 152.51 68.73 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.729 2.286 . . . . 0.93999999999999995 110.59 179.879 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.402 ' HG1' ' H ' ' A' ' 235' ' ' VAL . 1.3 p -73.64 161.76 29.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.669 -1.269 . . . . 2.3999999999999999 109.914 178.216 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -59.87 -38.39 82.06 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.192 -0.942 . . . . 3.3300000000000001 110.216 178.737 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.83 -41.37 91.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.59 -0.694 . . . . 3.1699999999999999 109.913 179.179 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.402 ' H ' ' HG1' ' A' ' 232' ' ' THR . 86.1 t -70.55 -43.11 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.448 -0.783 . . . . 1.6899999999999999 110.492 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.6 mt . . . . . 0 N--CA 1.488 1.438 0 C-N-CA 118.803 -1.159 . . . . 1.6000000000000001 109.829 -178.709 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 106.36 -1.718 . . . . 1.5700000000000001 106.36 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.7 m -102.5 120.57 40.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.364 -0.976 . . . . 1.4399999999999999 108.364 -179.717 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.31 -142.82 11.45 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.791 -1.724 . . . . 1.01 108.791 179.498 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 81.5 mt -100.53 -1.0 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.984 -1.304 . . . . 1.6299999999999999 113.399 -178.893 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 tp 49.35 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.659 -1.276 . . . . 1.5800000000000001 112.312 178.556 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.54 -39.87 16.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.259 -0.9 . . . . 1.3400000000000001 111.029 179.307 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -149.06 145.68 19.96 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.105 -1.072 . . . . 1.8600000000000001 108.105 -179.126 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.95 148.14 31.35 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.849 2.366 . . . . 1.01 112.436 178.585 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.422 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 153.73 152.13 5.96 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 109.817 -1.313 . . . . 0.81000000000000005 109.817 178.088 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 11' ' ' ILE . 82.4 mt -118.04 130.17 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.199 -1.177 . . . . 1.3700000000000001 108.072 179.183 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.53 143.89 43.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.315 -0.865 . . . . 1.1399999999999999 109.024 179.006 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.07 138.27 46.68 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.596 -1.261 . . . . 0.87 107.596 177.346 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.0 169.73 42.45 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 117.708 -2.187 . . . . 0.56999999999999995 110.4 178.154 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -79.56 159.68 26.76 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.776 -0.824 . . . . 2.3500000000000001 108.776 177.922 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.6 130.31 34.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.094 -1.004 . . . . 1.21 109.11 178.152 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.8 tp -109.46 107.51 17.68 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 104.917 -2.253 . . . . 1.3999999999999999 104.917 176.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 tp -94.2 132.79 38.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.105 -0.997 . . . . 1.4399999999999999 108.977 -179.833 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.3 mt -100.93 122.22 43.1 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.417 -1.327 . . . . 1.45 107.417 178.437 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.408 ' CB ' ' HZ1' ' A' ' 20' ' ' LYS . 8.9 mtpm? -108.81 131.31 55.1 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.25 -1.018 . . . . 2.5 108.25 179.521 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.485 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 83.5 tt0 -111.34 140.38 45.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.554 -0.716 . . . . 2.6600000000000001 109.471 179.073 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -83.87 129.32 34.93 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.412 -1.329 . . . . 2.3199999999999998 107.412 177.893 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -65.9 143.62 57.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.85 . . . . 2.1099999999999999 109.153 179.342 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.0 mt -96.55 135.47 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.506 -0.924 . . . . 1.29 108.506 178.587 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.49 130.19 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.376 -0.972 . . . . 1.4099999999999999 108.376 178.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.2 mt -97.57 141.24 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.644 -0.873 . . . . 1.3100000000000001 108.644 179.325 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -89.77 120.67 31.23 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.755 -1.202 . . . . 1.3400000000000001 107.755 178.083 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.482 ' HG2' HH11 ' A' ' 28' ' ' ARG . 2.1 mmt-85 -95.19 12.49 28.65 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.256 -0.902 . . . . 3.48 112.605 179.635 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -66.98 146.64 54.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.878 -1.139 . . . . 2.52 109.533 178.879 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -90.18 135.37 33.71 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.964 -1.125 . . . . 2.6299999999999999 107.964 178.032 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.0 pt -100.43 164.76 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.285 -0.884 . . . . 1.3100000000000001 110.321 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.5 p -94.86 164.89 12.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.475 -0.565 . . . . 1.24 109.475 178.4 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.85 -20.23 14.7 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.116 -0.99 . . . . 1.49 112.088 179.35 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -68.9 -39.14 79.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.038 -1.039 . . . . 2.2799999999999998 110.986 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -87.22 -9.24 55.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.62 -1.3 . . . . 2.0499999999999998 112.423 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.23 -43.2 89.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.186 -0.947 . . . . 1.3400000000000001 110.557 -179.394 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -56.65 -40.66 75.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.853 -1.154 . . . . 1.54 110.607 179.548 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -65.04 -46.76 79.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.195 -0.94 . . . . 2.8500000000000001 110.957 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.29 -36.19 79.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.954 -1.092 . . . . 1.3100000000000001 111.17 -179.772 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.84 -40.81 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.933 -1.104 . . . . 1.3799999999999999 110.541 179.287 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -61.12 -41.06 96.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.006 -1.059 . . . . 1.5 109.981 179.673 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.8 mtt-85 -61.15 -39.32 89.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.844 . . . . 2.7799999999999998 110.695 -179.933 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -72.82 -57.04 4.37 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.38 -0.825 . . . . 1.0600000000000001 110.76 179.517 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.8 tp -59.89 -47.53 85.38 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.314 -0.954 . . . . 1.3999999999999999 110.088 -179.724 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.3 t -67.88 -36.17 79.78 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.75 0.786 . . . . 1.3200000000000001 109.88 179.855 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.19 -43.15 99.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.864 -1.294 . . . . 0.69999999999999996 109.864 178.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -59.54 -30.55 68.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.02 0.915 . . . . 3.4399999999999999 109.344 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.72 -43.11 90.06 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.814 0.816 . . . . 1.3600000000000001 109.511 179.056 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HZ1' ' NE2' ' A' ' 53' ' ' GLN . 24.1 ttpp -80.34 -45.88 17.05 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.434 -0.791 . . . . 2.8300000000000001 110.837 179.374 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.64 -41.57 81.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.585 -0.697 . . . . 1.23 110.022 179.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.3 p -61.88 -37.16 83.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.119 0.961 . . . . 1.9199999999999999 109.17 179.765 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.4 -50.2 48.16 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.753 -0.658 . . . . 1.25 110.531 179.454 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.401 ' NE2' ' HZ1' ' A' ' 49' ' ' LYS . 96.0 mt-30 -63.53 -48.43 77.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.447 -0.783 . . . . 1.97 110.578 -179.865 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.7 mt -61.2 -38.21 85.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 2.1800000000000002 110.01 179.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -59.78 -39.98 86.72 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.666 -0.646 . . . . 1.1899999999999999 110.713 179.113 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -65.1 -44.16 89.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.781 -1.2 . . . . 1.3400000000000001 110.243 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.1 -31.97 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.754 . . . . 1.23 110.186 179.791 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -52.07 -47.08 65.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.604 -0.685 . . . . 1.5600000000000001 110.61 179.075 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -68.77 -33.78 74.46 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.744 -1.222 . . . . 1.3 109.843 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -62.15 -39.45 92.67 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.531 -1.267 . . . . 2.3199999999999998 109.363 179.173 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.84 88.9 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.348 -0.845 . . . . 1.1399999999999999 109.988 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.93 -37.95 42.59 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.573 -1.298 . . . . 0.68999999999999995 110.476 179.474 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -81.57 -22.46 37.78 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.087 -1.243 . . . . 1.48 111.131 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.8 m -84.74 -46.05 11.8 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.548 -0.72 . . . . 1.52 110.907 179.941 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -106.5 -23.68 12.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.441 -0.787 . . . . 1.3100000000000001 112.229 -178.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.21 168.97 15.28 Favored Glycine 0 N--CA 1.499 2.889 0 CA-C-O 121.785 0.659 . . . . 0.84999999999999998 111.665 -179.534 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -55.68 -28.2 54.26 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.415 -1.05 . . . . 3.8599999999999999 112.717 -179.652 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -57.65 -39.91 78.09 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.911 -1.118 . . . . 2.3500000000000001 111.356 -179.718 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -88.59 -14.53 37.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.618 -1.301 . . . . 2.2599999999999998 112.385 -178.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -60.07 -38.72 83.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.872 . . . . 1.45 110.948 -179.25 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.38 82.97 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.167 -0.958 . . . . 1.25 111.245 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.3 mt -63.14 -43.5 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.572 -1.33 . . . . 1.26 110.475 179.696 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -68.97 -33.28 73.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.968 -1.083 . . . . 0.82999999999999996 110.001 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.02 -38.84 83.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 1.1899999999999999 110.114 179.365 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.82 -38.14 94.06 Favored Glycine 0 N--CA 1.486 1.985 0 C-N-CA 120.137 -1.03 . . . . 0.57999999999999996 110.585 179.552 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -57.16 -42.33 80.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.841 -1.388 . . . . 2.0499999999999998 110.284 179.368 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.2 mt -60.34 -41.59 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.08 -1.012 . . . . 1.21 109.556 179.641 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.1 ttm -60.19 -39.82 87.88 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 2.29 109.803 179.562 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -58.28 -50.0 75.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.413 -0.804 . . . . 1.21 110.45 178.996 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.67 -40.34 91.75 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.331 -0.856 . . . . 1.1399999999999999 110.402 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -87.72 5.62 38.97 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.87 0.693 . . . . 1.4199999999999999 112.87 -179.62 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.31 122.82 15.47 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.911 -1.118 . . . . 1.27 109.581 179.3 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -66.16 -16.29 63.85 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.686 0.755 . . . . 1.3500000000000001 110.749 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -77.06 -49.17 15.92 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.496 -0.882 . . . . 2.2200000000000002 110.523 179.94 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.21 -38.29 90.58 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.386 -0.925 . . . . 1.22 110.24 -178.305 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.88 -47.88 83.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.023 -1.048 . . . . 1.29 111.282 179.314 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -60.7 -39.26 87.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.883 -1.136 . . . . 2.1699999999999999 110.663 -179.721 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.7 -48.48 71.85 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.575 -0.85 . . . . 1.3 110.638 179.692 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.96 -41.6 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.222 -0.991 . . . . 1.1699999999999999 109.914 179.494 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.81 -42.81 95.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.352 -0.842 . . . . 1.3999999999999999 110.297 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.88 98.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 1.3300000000000001 110.67 -179.965 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.02 -43.06 95.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 1.48 110.442 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.51 -49.08 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.988 -1.07 . . . . 1.28 110.159 179.817 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -76.66 -35.47 57.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 2.6000000000000001 111.824 -179.524 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -80.77 -48.25 12.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.887 -1.133 . . . . 1.51 111.98 -179.643 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -101.41 8.69 42.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.227 -0.921 . . . . 2.48 112.994 -178.658 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.5 m80 51.56 49.36 21.06 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.024 -1.071 . . . . 1.6100000000000001 111.426 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.9 mtt -104.86 149.43 25.69 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.435 1.112 . . . . 1.8999999999999999 109.052 179.834 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.5 p -72.62 159.63 33.56 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.59 0.709 . . . . 1.3200000000000001 109.433 177.81 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.33 81.79 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.51 -0.744 . . . . 1.1499999999999999 110.646 178.627 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.4 p-10 -68.54 -42.31 78.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.977 -1.077 . . . . 2.25 110.268 -179.792 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -70.74 -51.46 27.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.332 -0.855 . . . . 1.22 111.386 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.99 84.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.499 -0.751 . . . . 1.1899999999999999 110.528 -179.616 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.6 96.53 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.82 -0.752 . . . . 1.2 111.127 179.658 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -60.42 -39.37 87.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.829 -1.169 . . . . 2.1000000000000001 110.782 179.942 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -54.83 -49.75 70.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.129 -0.982 . . . . 1.3 110.761 179.701 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.1 -42.28 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.718 -1.239 . . . . 1.27 109.853 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.5 mm -61.76 -32.02 52.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.541 -0.724 . . . . 1.1899999999999999 110.356 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.14 -41.75 89.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 2.1099999999999999 110.388 179.083 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.09 -31.68 19.47 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.063 -1.542 . . . . 0.88 112.279 -179.896 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -62.16 -41.88 98.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.414 -1.639 . . . . 1.99 109.635 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.59 -51.26 20.48 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.982 0.896 . . . . 1.28 109.713 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.6 t -60.19 -39.93 88.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.358 -0.839 . . . . 2.2200000000000002 110.176 -179.802 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.32 98.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.176 -0.952 . . . . 1.45 110.454 -179.808 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.84 -30.61 71.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.966 -1.084 . . . . 1.47 110.224 179.988 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -66.53 -22.2 66.16 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.342 -0.849 . . . . 2.04 110.877 179.712 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.39 -20.45 64.68 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.415 -0.914 . . . . 1.73 110.625 179.511 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 38.8 mt -83.15 142.41 31.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.441 -0.787 . . . . 1.79 109.321 178.362 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -101.4 40.01 1.35 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.398 -0.814 . . . . 2.8799999999999999 111.078 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -112.75 133.48 54.74 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.609 -0.886 . . . . 1.5800000000000001 108.609 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.557 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 5.7 pm0 -60.5 -28.09 68.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.095 -1.003 . . . . 3.04 111.553 179.552 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -74.25 -59.54 2.68 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.072 -1.017 . . . . 1.29 110.027 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.0 mt -66.26 -35.73 81.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 1.6000000000000001 110.642 -179.554 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -61.81 -48.51 80.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.803 -1.185 . . . . 2.7599999999999998 110.396 179.466 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -59.74 -30.24 68.71 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.589 -1.244 . . . . 2.1499999999999999 109.649 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -62.27 -29.19 70.24 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.22 -0.992 . . . . 2.8100000000000001 109.17 179.306 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.17 -49.75 76.39 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.868 0.842 . . . . 1.3899999999999999 109.805 178.361 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.23 75.92 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.676 -0.809 . . . . 1.4099999999999999 110.234 179.854 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -61.22 -34.08 74.53 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.635 0.731 . . . . 1.3899999999999999 110.648 -179.884 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.6 t -68.95 -37.28 77.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.324 -0.86 . . . . 1.1899999999999999 110.033 179.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.406 ' HG2' HH11 ' A' ' 131' ' ' ARG . 22.9 ttt-85 -57.93 -38.31 75.69 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.471 -1.292 . . . . 3.6299999999999999 109.429 178.656 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.498 ' OD1' ' NE ' ' A' ' 136' ' ' ARG . 8.3 t70 -60.11 -40.06 88.35 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.396 0.617 . . . . 1.28 110.568 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 73.1 mt -61.41 -34.68 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.378 -0.826 . . . . 1.1799999999999999 110.18 -179.611 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -64.91 -51.4 51.66 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.131 -1.033 . . . . 0.51000000000000001 110.657 178.783 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -57.9 -40.37 80.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.87 -1.371 . . . . 3.1699999999999999 110.467 179.547 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.498 ' NE ' ' OD1' ' A' ' 132' ' ' ASP . 58.5 mtt-85 -60.5 -43.24 97.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.998 -1.064 . . . . 2.8500000000000001 110.131 -179.979 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.5 tp -61.26 -44.57 97.03 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.087 -1.008 . . . . 1.6499999999999999 110.224 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.09 -42.4 90.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.553 -0.717 . . . . 1.2 110.547 179.666 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.485 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 98.1 mtt180 -61.38 -34.42 75.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.159 -0.963 . . . . 2.7999999999999998 111.206 -179.851 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -74.06 -43.4 57.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.557 -1.339 . . . . 2.1499999999999999 110.618 179.827 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 141' ' ' ILE . 90.4 mt -60.9 -39.38 81.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.52 -0.737 . . . . 1.21 110.455 -178.521 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.4 mt -88.84 -11.65 44.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.532 -0.73 . . . . 1.3400000000000001 111.996 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.4 22.83 69.44 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 120.323 -0.941 . . . . 0.91000000000000003 113.581 -179.542 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.39 142.9 58.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.58 -0.953 . . . . 1.51 109.534 179.647 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -68.05 151.94 46.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.894 . . . . 2.8799999999999999 110.307 178.377 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.7 mt -104.58 136.89 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.033 -1.099 . . . . 1.6200000000000001 108.033 178.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.502 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.9 mp -81.86 129.62 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.979 -1.119 . . . . 2.1099999999999999 107.979 179.125 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -95.85 98.68 10.61 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.067 -1.827 . . . . 1.6200000000000001 106.067 178.873 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.7 mt -77.37 -14.28 59.75 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.529 -0.732 . . . . 1.3999999999999999 111.775 -177.745 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.6 t -80.1 8.32 7.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.379 -0.826 . . . . 2.0499999999999998 112.323 -179.574 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.34 17.22 17.91 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.647 0.737 . . . . 1.3500000000000001 112.315 179.565 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.4 mt -73.22 136.2 25.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.942 -0.762 . . . . 1.4199999999999999 108.942 179.0 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -124.29 -7.25 7.62 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.547 -0.721 . . . . 2.9900000000000002 112.651 -178.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -110.63 137.5 48.23 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.06 -1.089 . . . . 1.54 108.06 179.794 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -77.25 119.82 21.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.247 -0.908 . . . . 1.3799999999999999 108.695 178.851 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.2 m -148.12 179.49 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.835 -0.802 . . . . 1.28 108.835 -178.965 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 30.6 mt -88.33 142.86 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.991 -1.068 . . . . 1.1599999999999999 108.943 178.212 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.0 tp -98.02 120.5 38.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.816 -1.178 . . . . 1.3100000000000001 108.141 178.251 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.24 130.15 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.418 -0.956 . . . . 1.25 108.418 179.397 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.36 159.14 27.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.243 -0.911 . . . . 1.26 108.752 179.534 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.03 95.6 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.494 -1.378 . . . . 1.6000000000000001 109.778 177.855 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -172.67 152.65 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.906 -0.775 . . . . 2.4199999999999999 108.906 -179.744 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 64.9 mt -118.99 141.33 48.77 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.315 -0.866 . . . . 1.3500000000000001 109.09 177.383 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.9 p -90.55 148.82 39.59 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.182 -0.949 . . . . 1.3200000000000001 108.919 179.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -40.15 -45.52 4.06 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.645 2.23 . . . . 0.69999999999999996 113.891 179.142 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.0 m -60.09 -46.3 90.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.918 -1.114 . . . . 1.1200000000000001 110.063 -179.607 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.41 -38.49 91.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.27 -0.894 . . . . 1.21 110.331 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.438 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 23.8 p -67.61 -40.75 84.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 1.1899999999999999 110.83 179.662 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.3 74.41 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.791 -0.764 . . . . 1.24 110.339 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -93.38 -4.85 50.72 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.007 -1.058 . . . . 1.6899999999999999 112.862 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.23 153.45 34.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 1.3400000000000001 109.631 179.878 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -94.13 117.33 29.96 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.292 -1.744 . . . . 2.77 106.292 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.438 ' H ' ' CD2' ' A' ' 173' ' ' LEU . 0.7 OUTLIER -82.46 -19.47 38.81 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.472 -0.767 . . . . 2.0899999999999999 112.396 -177.701 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -84.23 -20.87 31.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.238 -0.913 . . . . 2.6699999999999999 111.912 -178.569 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -99.96 2.32 43.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.187 -0.946 . . . . 2.5800000000000001 112.528 -179.254 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.4 t -112.99 129.95 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 107.873 -1.158 . . . . 1.1799999999999999 107.873 179.352 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.413 ' CD1' ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -82.81 -16.35 48.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.007 -1.058 . . . . 2.1800000000000002 111.705 -179.541 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -176.69 171.33 44.27 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.073 -1.611 . . . . 0.48999999999999999 109.073 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -125.79 124.56 41.26 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 107.344 -1.354 . . . . 0.64000000000000001 107.344 178.196 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 46.6 mt -123.27 129.75 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 106.952 -1.499 . . . . 1.21 106.952 178.215 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 203' ' ' VAL . 34.2 p -140.61 170.0 16.6 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.907 -1.12 . . . . 1.3799999999999999 109.802 179.772 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.94 36.08 3.0 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.871 -0.518 . . . . 2.3700000000000001 111.007 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -96.87 151.53 19.58 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.191 -0.943 . . . . 1.52 110.352 178.75 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -46.33 -28.36 3.23 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 120.162 -1.018 . . . . 1.8 112.609 177.696 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 87.69 -33.12 4.03 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 121.037 -1.272 . . . . 2.04 113.625 179.406 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -60.44 -40.65 91.86 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.007 -1.29 . . . . 5.0 110.346 179.709 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.4 p -118.38 20.18 13.16 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.52 -0.737 . . . . 3.02 111.208 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.3 p -89.11 120.46 30.53 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.772 -1.196 . . . . 2.1099999999999999 107.772 178.771 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.438 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 77.4 t60 -60.46 -32.27 71.23 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.388 -0.82 . . . . 1.24 110.407 179.827 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 63.0 p -54.68 -41.11 69.82 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.037 -1.039 . . . . 2.1499999999999999 110.68 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.3 t -60.02 -39.83 87.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.298 -0.876 . . . . 2.02 109.918 179.818 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.1 mm -59.72 -36.36 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.74 . . . . 2.1200000000000001 110.392 179.119 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 82.5 mtp -63.0 -43.53 98.54 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.225 1.012 . . . . 1.3600000000000001 109.209 179.509 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -57.38 -45.09 84.83 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.691 -0.631 . . . . 1.29 110.656 179.538 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -63.23 -44.95 93.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.95 -1.093 . . . . 3.5600000000000001 110.435 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.2 m -70.3 -40.88 74.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.913 . . . . 1.1799999999999999 110.257 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.8 mt -91.21 -6.36 53.5 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.494 0.664 . . . . 1.3400000000000001 112.242 -177.145 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 194' ' ' ALA . 98.0 mt-10 50.54 9.42 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.991 1.108 . . . . 1.45 113.991 179.899 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.455 ' O ' ' OG ' ' A' ' 8' ' ' SER . 80.9 mt -71.63 147.67 92.31 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.675 -1.266 . . . . 1.25 108.212 179.113 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.52 138.76 81.37 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.454 1.436 . . . . 0.78000000000000003 110.227 178.66 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.54 166.67 20.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.312 -1.755 . . . . 1.2 109.865 179.694 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.4 mt -146.25 156.03 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.188 -1.412 . . . . 1.25 107.188 177.541 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.0 m -140.38 -32.37 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 120.742 -1.224 . . . . 1.3899999999999999 113.035 -179.166 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -95.28 39.87 2.78 Favored Glycine 0 N--CA 1.497 2.744 0 O-C-N 120.942 -1.099 . . . . 0.96999999999999997 112.076 -177.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 23.1 p -59.21 -23.75 62.55 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.089 -1.242 . . . . 1.3500000000000001 111.799 -179.482 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 101.78 -86.16 0.58 Allowed Glycine 0 N--CA 1.496 2.654 0 C-N-CA 120.396 -0.907 . . . . 1.0700000000000001 111.345 179.807 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.7 m -132.58 36.56 3.55 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 121.124 -1.221 . . . . 1.9199999999999999 113.16 -178.529 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 93.1 t -53.06 -33.83 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.336 -1.477 . . . . 1.3300000000000001 110.396 179.252 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.2 p -61.31 -20.62 63.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 1.4199999999999999 112.018 -179.675 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.2 m -96.08 2.72 53.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.057 -1.027 . . . . 2.1200000000000001 112.289 179.63 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -132.05 2.97 4.01 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 112.907 0.706 . . . . 2.6899999999999999 112.907 -178.281 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 36.0 t -122.54 142.43 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.439 -0.788 . . . . 1.29 109.658 -178.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -119.27 149.15 42.25 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.261 -1.014 . . . . 2.6899999999999999 108.261 177.596 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.464 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 40.3 p-10 -50.73 140.16 15.21 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.876 -1.14 . . . . 2.79 110.023 178.688 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t0 79.62 -2.07 2.13 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.482 1.29 . . . . 2.3500000000000001 114.482 179.639 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.09 147.0 53.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.532 -1.355 . . . . 1.97 108.233 177.632 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -88.67 120.84 30.43 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.184 -1.413 . . . . 2.9700000000000002 107.184 178.274 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 56.6 mt -128.14 146.41 50.72 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.55 -0.719 . . . . 1.25 109.854 -179.56 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.5 mt -114.07 125.02 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 106.788 -1.56 . . . . 1.22 106.788 177.522 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.0 tp -99.86 115.26 29.2 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.315 -1.735 . . . . 1.24 106.315 178.528 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 223' ' ' VAL . 30.0 p-10 -92.72 -25.53 18.17 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.663 -1.215 . . . . 2.0499999999999998 112.664 -177.848 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.531 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 38.47 21.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 112.903 0.705 . . . . 1.25 112.903 -178.659 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.3 t -112.79 -59.67 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 121.116 -0.99 . . . . 1.4299999999999999 109.451 -179.876 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 36.7 m120 -95.79 13.5 26.39 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.148 0.975 . . . . 3.0299999999999998 110.096 -179.701 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 60.76 51.82 4.66 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.23 -0.895 . . . . 2.25 111.85 179.326 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.451 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 81.2 mt-30 -149.54 148.17 29.05 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.246 1.022 . . . . 2.52 110.079 178.454 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.54 138.07 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.312 -1.366 . . . . 1.29 107.312 177.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -99.58 136.92 38.79 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.933 -1.104 . . . . 1.3400000000000001 108.516 178.694 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.7 t -109.82 130.18 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 109.001 -0.741 . . . . 1.3400000000000001 109.001 179.135 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 49.42 55.6 17.31 Favored Pre-proline 0 N--CA 1.498 1.973 0 N-CA-C 113.566 0.95 . . . . 2.1800000000000002 113.566 178.792 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.08 150.66 82.39 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.474 2.116 . . . . 0.93999999999999995 110.412 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 31.1 p -72.08 154.55 41.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 2.3999999999999999 108.915 177.647 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -57.39 -40.14 77.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.058 -1.026 . . . . 3.3300000000000001 110.8 178.952 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -60.96 -39.04 88.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -0.984 . . . . 3.1699999999999999 110.332 -179.852 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.6 t -69.38 -36.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.331 -0.856 . . . . 1.6899999999999999 110.038 179.413 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 1.6000000000000001 110.462 178.977 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 106.018 -1.845 . . . . 1.5700000000000001 106.018 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.3 m -105.85 124.06 48.96 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.661 -1.236 . . . . 1.4399999999999999 107.661 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.506 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -104.51 -144.44 13.14 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 108.88 -1.688 . . . . 1.01 108.88 179.527 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.441 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 73.1 mt -97.28 -3.77 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.146 -1.208 . . . . 1.6299999999999999 112.635 -179.085 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tp 49.77 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.226 -0.921 . . . . 1.5800000000000001 112.437 178.947 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.58 -40.07 16.67 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.0 . . . . 1.3400000000000001 112.152 178.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 m -147.02 144.9 20.55 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 120.982 -1.074 . . . . 1.8600000000000001 108.379 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.53 143.95 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.724 2.283 . . . . 1.01 112.127 178.246 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.08 171.41 21.73 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.319 -1.512 . . . . 0.81000000000000005 109.319 178.189 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.8 mt -129.92 133.8 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 N-CA-C 107.702 -1.222 . . . . 1.3700000000000001 107.702 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.38 155.52 47.6 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.564 -0.71 . . . . 1.1399999999999999 109.119 178.742 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.571 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.9 m-85 -126.46 140.18 52.67 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.681 -1.229 . . . . 0.87 107.681 177.97 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.83 170.5 41.78 Favored Glycine 0 N--CA 1.499 2.882 0 C-N-CA 118.382 -1.866 . . . . 0.56999999999999995 110.297 178.175 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -77.12 154.26 33.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.965 . . . . 2.3500000000000001 108.938 178.502 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -85.03 125.79 33.02 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.233 -1.025 . . . . 1.21 108.233 178.373 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.3 tp -105.49 105.92 16.19 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.458 -2.053 . . . . 1.3999999999999999 105.458 177.659 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.6 tp -94.18 135.39 35.61 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.957 -1.127 . . . . 1.4399999999999999 107.957 179.96 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.4 mt -99.36 114.94 28.11 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.832 -1.544 . . . . 1.45 106.832 178.353 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -110.38 124.41 51.65 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.626 -1.62 . . . . 2.5 106.626 -179.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -129.77 147.52 51.55 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.418 -0.801 . . . . 2.6600000000000001 109.39 -179.493 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 27.6 p-10 -81.55 140.9 34.24 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.912 -1.118 . . . . 2.3199999999999998 109.088 177.807 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -64.69 149.94 48.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.04 -1.038 . . . . 2.1099999999999999 110.976 178.283 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.9 mt -90.8 133.8 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.15 -0.969 . . . . 1.29 108.811 178.15 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.3 t -109.29 129.79 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.225 -1.028 . . . . 1.4099999999999999 108.225 179.119 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.0 mt -94.66 137.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.127 -1.064 . . . . 1.3100000000000001 108.127 178.778 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.95 122.44 35.32 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.977 -1.12 . . . . 1.3400000000000001 107.977 178.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -99.56 18.12 18.72 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.342 -0.849 . . . . 3.48 112.631 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -69.18 146.79 52.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 2.52 109.428 178.738 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -88.98 130.88 35.38 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.329 -0.989 . . . . 2.6299999999999999 108.329 177.669 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.7 pt -93.33 164.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.751 0.786 . . . . 1.3100000000000001 110.066 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.2 p -95.41 163.85 13.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.587 -0.695 . . . . 1.24 109.659 178.525 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.8 -22.3 13.9 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.113 -0.992 . . . . 1.49 111.91 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -68.69 -37.06 79.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.932 . . . . 2.2799999999999998 110.54 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -92.29 -6.31 50.6 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.791 -1.193 . . . . 2.0499999999999998 113.174 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.31 -42.98 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.055 -1.028 . . . . 1.3400000000000001 110.576 -179.433 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.36 -37.55 75.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.137 -0.977 . . . . 1.54 110.263 179.726 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -61.93 -43.92 97.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.646 -0.659 . . . . 2.8500000000000001 110.847 179.906 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.47 -39.12 86.49 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.045 -1.035 . . . . 1.3100000000000001 111.367 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.26 -40.19 83.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.045 -1.035 . . . . 1.3799999999999999 110.757 179.429 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -60.95 -48.32 82.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.155 -0.965 . . . . 1.5 110.064 179.663 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -62.17 -38.31 88.55 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.167 -0.958 . . . . 2.7799999999999998 110.278 179.842 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -74.16 -51.03 16.81 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.858 -1.151 . . . . 1.0600000000000001 110.285 179.437 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.4 tp -62.81 -49.67 74.0 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.29 -0.964 . . . . 1.3999999999999999 109.448 -179.622 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.7 t -69.3 -38.77 78.46 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.505 0.669 . . . . 1.3200000000000001 109.653 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.09 -43.54 93.29 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.601 -1.4 . . . . 0.69999999999999996 109.601 179.629 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -59.31 -31.74 69.43 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.07 -1.052 . . . . 3.4399999999999999 109.644 178.871 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.78 -47.67 70.53 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.835 -0.746 . . . . 1.3600000000000001 109.919 179.089 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -77.78 -39.77 42.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 2.8300000000000001 110.344 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.76 91.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 1.23 110.049 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.555 ' HG ' ' N ' ' A' ' 52' ' ' ALA . 59.5 p -60.47 -39.6 88.18 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.223 1.011 . . . . 1.9199999999999999 109.357 179.942 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.555 ' N ' ' HG ' ' A' ' 51' ' ' SER . . . -68.12 -46.02 72.06 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.602 -0.727 . . . . 1.25 110.942 179.494 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.5 -50.09 72.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.222 -0.924 . . . . 1.97 110.753 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.21 -36.83 84.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 2.1800000000000002 109.844 -179.889 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -59.39 -40.24 85.95 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.639 -0.663 . . . . 1.1899999999999999 110.53 179.155 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.9 m -66.89 -41.69 86.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.047 -1.033 . . . . 1.3400000000000001 110.324 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.3 -34.03 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.439 -0.788 . . . . 1.23 110.834 -179.703 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -55.93 -45.02 78.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.412 -0.805 . . . . 1.5600000000000001 111.018 179.301 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.49 -33.44 71.23 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.003 -1.061 . . . . 1.3 110.545 -179.626 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.401 ' O ' ' OG1' ' A' ' 64' ' ' THR . 44.4 mtpt -62.75 -40.27 96.7 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.653 -1.219 . . . . 2.3199999999999998 109.443 -179.844 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.72 -34.52 78.03 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.776 -0.577 . . . . 1.1399999999999999 110.363 179.679 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.88 -37.52 25.7 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.536 -1.316 . . . . 0.68999999999999995 111.41 179.701 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -79.88 -22.31 43.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.036 -1.273 . . . . 1.48 110.815 -179.676 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 27.1 m -89.43 -50.96 5.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.363 -0.836 . . . . 1.52 110.597 179.853 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -108.34 -6.99 16.0 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.143 1.164 . . . . 1.3100000000000001 114.143 -177.543 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.6 157.48 23.58 Favored Glycine 0 N--CA 1.502 3.072 0 O-C-N 121.056 -1.028 . . . . 0.84999999999999998 113.473 178.519 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -51.03 -20.69 1.48 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.498 -1.001 . . . . 3.8599999999999999 112.791 179.197 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.49 -35.31 72.03 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.822 -1.174 . . . . 2.3500000000000001 111.489 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -84.16 -18.85 35.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.021 -1.049 . . . . 2.2599999999999998 112.494 -179.555 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.96 -32.71 71.07 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.975 -1.078 . . . . 1.45 110.636 -179.372 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.51 86.88 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.038 -1.039 . . . . 1.25 110.598 179.329 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.0 mt -66.33 -47.66 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.118 -0.989 . . . . 1.26 109.828 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -72.04 -36.54 69.65 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.219 -0.925 . . . . 0.82999999999999996 110.018 179.822 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.92 -39.11 84.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.493 -0.754 . . . . 1.1899999999999999 110.074 -179.966 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.01 -35.37 83.92 Favored Glycine 0 N--CA 1.484 1.867 0 C-N-CA 119.795 -1.193 . . . . 0.57999999999999996 110.491 179.579 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -60.22 -41.27 92.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -1.135 . . . . 2.0499999999999998 110.542 179.117 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.4 mt -60.96 -41.94 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.025 -1.047 . . . . 1.21 110.423 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.0 ttm -59.77 -40.57 88.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -0.866 . . . . 2.29 110.576 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -60.39 -46.32 90.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.914 -1.116 . . . . 1.21 110.032 179.799 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.0 tp -59.0 -40.36 84.65 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.402 -0.811 . . . . 1.1399999999999999 110.487 179.81 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -87.08 8.01 25.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.506 -0.746 . . . . 1.4199999999999999 112.685 -179.887 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -60.26 118.94 7.01 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.185 -0.947 . . . . 1.27 109.61 179.609 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.57 -18.36 63.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.772 0.796 . . . . 1.3500000000000001 110.954 -179.532 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.82 -52.79 8.33 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.747 -0.781 . . . . 2.2200000000000002 110.401 -179.918 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.4 mt -61.24 -37.87 84.62 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.18 -1.008 . . . . 1.22 110.441 -179.529 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -58.88 -48.6 80.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 1.29 110.497 179.216 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.4 -38.81 91.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.285 -0.884 . . . . 2.1699999999999999 110.476 179.814 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.78 -48.17 72.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.991 -1.068 . . . . 1.3 110.503 179.713 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 93.1 mt -58.29 -42.09 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.252 -0.905 . . . . 1.1699999999999999 109.973 179.419 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.2 mt -63.43 -41.39 92.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.466 -0.772 . . . . 1.3999999999999999 110.167 179.797 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -63.26 -42.93 99.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.426 -0.796 . . . . 1.3300000000000001 110.664 -179.778 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.0 mt -59.66 -43.72 93.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 1.48 110.492 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.56 -48.2 89.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.051 -1.031 . . . . 1.28 109.911 179.72 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.94 -36.23 41.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.783 . . . . 2.6000000000000001 111.709 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 91' ' ' ALA . 53.1 t0 -78.94 -48.29 14.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.709 -1.244 . . . . 1.51 111.315 -178.985 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -101.32 8.65 42.27 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.311 -0.868 . . . . 2.48 112.358 -177.685 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m80 50.67 51.31 17.18 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.972 -1.091 . . . . 1.6100000000000001 111.568 179.892 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.9 mtp -107.79 157.0 18.51 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.55 -0.719 . . . . 1.8999999999999999 109.239 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 27.2 p -73.95 158.76 33.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.606 -0.684 . . . . 1.3200000000000001 109.407 177.784 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.75 91.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.485 -0.76 . . . . 1.1499999999999999 110.613 179.347 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 28.8 p-10 -68.05 -42.84 79.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.953 -1.092 . . . . 2.25 110.014 179.314 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -68.28 -50.64 52.34 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.461 -0.896 . . . . 1.22 110.734 -179.885 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.24 88.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 1.1899999999999999 110.592 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.69 -45.65 91.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 1.2 111.39 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -60.45 -39.24 86.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.792 -1.192 . . . . 2.1000000000000001 111.539 -179.686 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.49 -47.89 78.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.693 -1.255 . . . . 1.3 111.031 179.597 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.18 -44.25 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.723 -1.235 . . . . 1.27 109.742 179.854 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -62.74 -34.7 67.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.631 -0.668 . . . . 1.1899999999999999 110.755 179.998 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -56.6 -40.55 75.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.845 . . . . 2.1099999999999999 111.214 179.469 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.21 -34.07 13.26 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.201 -1.476 . . . . 0.88 112.91 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -59.97 -38.26 82.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.398 -1.648 . . . . 1.99 110.04 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.04 -47.23 38.2 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.722 0.773 . . . . 1.28 110.704 179.599 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.7 m -60.37 -40.17 89.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.092 -1.005 . . . . 2.2200000000000002 110.599 -178.585 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.6 -47.16 86.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.377 -0.827 . . . . 1.45 110.929 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.12 -29.76 69.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.881 -1.137 . . . . 1.47 110.837 -179.829 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -65.06 -22.35 66.96 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.342 -0.849 . . . . 2.04 110.571 179.437 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -71.1 -12.94 61.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.909 0.862 . . . . 1.73 110.815 179.87 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.5 mt -88.49 135.86 33.27 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.806 -1.183 . . . . 1.79 107.806 178.712 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 45.6 t0 -97.99 40.99 1.14 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.388 -0.82 . . . . 2.8799999999999999 111.98 -179.381 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -114.53 140.38 48.81 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 121.007 -1.058 . . . . 1.5800000000000001 108.966 178.987 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.07 -40.35 73.46 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.871 -0.732 . . . . 3.04 110.816 178.557 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -71.23 -56.88 5.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.102 -0.999 . . . . 1.29 110.59 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.62 -40.5 83.51 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.19 -0.944 . . . . 1.6000000000000001 110.41 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -63.31 -47.77 80.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.02 -1.05 . . . . 2.7599999999999998 109.794 179.866 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -60.17 -31.15 69.85 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.213 -0.929 . . . . 2.1499999999999999 110.092 179.715 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -61.66 -30.07 70.48 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.552 -1.259 . . . . 2.8100000000000001 109.262 179.269 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.78 -50.38 73.69 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.74 -0.784 . . . . 1.3899999999999999 109.423 178.682 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.55 -43.42 80.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.679 0.752 . . . . 1.4099999999999999 110.315 179.769 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -62.8 -32.7 73.94 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.671 0.748 . . . . 1.3899999999999999 110.283 -179.691 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 t -68.69 -39.63 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.419 -0.801 . . . . 1.1899999999999999 110.097 179.589 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -59.48 -37.45 78.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.057 -1.027 . . . . 3.6299999999999999 109.764 178.852 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -59.92 -40.16 87.93 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.484 0.659 . . . . 1.28 110.259 179.436 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.6 mt -59.57 -39.8 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 1.1799999999999999 110.456 179.598 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.33 -45.51 69.09 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 110.54 -1.024 . . . . 0.51000000000000001 110.54 179.388 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -59.15 -46.77 87.5 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.059 -1.259 . . . . 3.1699999999999999 110.208 179.41 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 64.4 mtt-85 -62.22 -38.89 90.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.888 -1.132 . . . . 2.8500000000000001 110.273 179.751 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.0 tp -60.15 -41.02 91.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.682 -0.637 . . . . 1.6499999999999999 109.852 178.911 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.3 mt -59.66 -40.05 86.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.606 -0.684 . . . . 1.2 110.58 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -60.28 -39.21 86.08 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.206 -0.934 . . . . 2.7999999999999998 111.256 179.942 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -73.56 -41.62 62.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.108 . . . . 2.1499999999999999 110.985 -179.866 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.33 -40.08 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.849 . . . . 1.21 110.548 -178.436 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.3 mt -89.32 -8.0 54.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.031 -1.043 . . . . 1.3400000000000001 111.891 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.57 23.22 70.79 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.761 -1.209 . . . . 0.91000000000000003 113.518 -179.511 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 18.6 tp -67.23 139.91 57.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.934 -0.745 . . . . 1.51 109.115 179.578 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -70.03 146.97 50.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.421 -0.799 . . . . 2.8799999999999999 109.357 177.892 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 79.7 mt -108.68 138.67 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 121.128 -0.982 . . . . 1.6200000000000001 108.619 178.746 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.467 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.1 mp -78.66 131.65 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.702 -1.249 . . . . 2.1099999999999999 108.808 178.888 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -94.51 97.37 10.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.396 -1.705 . . . . 1.6200000000000001 106.396 178.686 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 mt -77.58 -13.37 59.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.473 -0.767 . . . . 1.3999999999999999 111.916 -177.861 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.8 t -82.9 3.33 30.27 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.906 -1.121 . . . . 2.0499999999999998 112.584 -179.734 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.5 15.26 22.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.316 -0.865 . . . . 1.3500000000000001 112.31 179.451 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 24.6 mt -71.93 140.05 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.565 -0.71 . . . . 1.4199999999999999 109.591 178.801 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -127.91 -6.71 5.56 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.717 0.77 . . . . 2.9900000000000002 112.323 -179.436 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -110.2 140.21 44.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.571 -0.9 . . . . 1.54 108.571 179.459 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -71.61 120.84 17.77 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.589 -0.893 . . . . 1.3799999999999999 108.589 178.403 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.51 171.74 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.985 -0.746 . . . . 1.28 108.985 -179.864 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.3 mt -93.18 141.12 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.295 -1.002 . . . . 1.1599999999999999 108.295 178.275 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 26.8 tp -96.79 120.98 38.13 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.0 -1.063 . . . . 1.3100000000000001 108.627 178.46 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.21 131.15 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 107.816 -1.179 . . . . 1.25 107.816 179.781 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.94 157.98 21.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.018 . . . . 1.26 108.785 179.084 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.35 -34.45 75.31 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.303 -1.498 . . . . 1.6000000000000001 109.474 178.079 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -173.04 154.91 2.91 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.827 -0.805 . . . . 2.4199999999999999 108.827 179.574 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 69.0 mt -121.64 137.81 54.59 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.375 -1.343 . . . . 1.3500000000000001 107.375 177.519 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.8 p -93.45 148.24 35.17 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.843 -1.161 . . . . 1.3200000000000001 108.676 179.529 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -39.72 -40.99 2.52 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 122.066 1.844 . . . . 0.69999999999999996 113.485 178.811 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.4 m -60.98 -50.23 74.22 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.254 -0.903 . . . . 1.1200000000000001 110.238 -179.727 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -61.61 -38.55 88.0 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.952 -1.093 . . . . 1.21 109.704 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.61 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 38.4 p -68.61 -36.93 79.32 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.335 0.588 . . . . 1.1899999999999999 110.639 179.524 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.36 -35.02 79.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.402 -0.811 . . . . 1.24 110.64 179.869 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -97.26 -0.6 46.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.477 -0.764 . . . . 1.6899999999999999 112.503 -179.08 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.6 tp -64.21 153.72 37.12 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.735 -0.603 . . . . 1.3400000000000001 109.646 179.749 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.13 113.15 24.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 106.848 -1.538 . . . . 2.77 106.848 177.615 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.36 -17.0 60.88 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.873 -0.517 . . . . 2.0899999999999999 112.356 -178.018 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -84.63 -15.43 45.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.105 -0.997 . . . . 2.6699999999999999 112.421 -178.574 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -103.69 -9.7 18.93 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.685 0.994 . . . . 2.5800000000000001 113.685 -178.032 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.3 t -109.51 129.98 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.768 -0.827 . . . . 1.1799999999999999 108.768 179.666 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.421 ' CD1' ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -88.07 -11.56 46.78 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.075 -1.016 . . . . 2.1800000000000002 111.827 -179.428 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -173.8 167.78 40.43 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.292 -1.523 . . . . 0.48999999999999999 109.292 179.807 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -124.15 131.99 53.59 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.218 -1.166 . . . . 0.64000000000000001 107.995 178.586 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.5 mt -131.49 132.14 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.019 -1.104 . . . . 1.21 108.019 178.795 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 203' ' ' VAL . 55.5 p -135.5 163.37 30.23 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.192 -1.04 . . . . 1.3799999999999999 108.192 178.08 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.452 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 17.6 m-20 -106.51 12.35 29.65 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.248 -0.908 . . . . 2.3700000000000001 112.133 179.065 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 184' ' ' GLY . . . -134.66 -62.5 0.73 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.154 -0.966 . . . . 1.52 113.184 -177.068 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 183' ' ' ALA . . . -38.27 151.22 0.04 OUTLIER Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.453 -0.659 . . . . 1.8 111.453 -176.443 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 172.2 -70.3 0.11 Allowed Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.194 -1.479 . . . . 2.04 112.516 179.343 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.415 ' O ' ' CG2' ' A' ' 187' ' ' THR . 57.7 mtp180 -54.61 -42.2 70.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -1.223 . . . . 5.0 110.755 -178.915 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 186' ' ' ARG . 31.2 p -159.08 45.73 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.825 . . . . 3.02 111.114 -179.498 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.0 p -78.85 136.94 37.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.908 -1.12 . . . . 2.1099999999999999 109.355 -179.476 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.61 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 75.6 t60 -60.14 -30.86 69.57 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.627 -0.671 . . . . 1.24 110.492 178.863 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.4 m -59.43 -39.6 84.05 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.152 -0.968 . . . . 2.1499999999999999 110.028 179.424 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 87.0 p -59.52 -37.56 78.68 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.271 -0.893 . . . . 2.02 110.281 179.366 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.09 -39.75 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 2.1200000000000001 110.493 179.48 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 45.0 mtp -61.74 -44.31 97.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.994 -1.067 . . . . 1.3600000000000001 109.524 179.484 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.72 -50.58 72.91 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.373 -0.83 . . . . 1.29 111.187 179.992 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -60.57 -42.75 97.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.025 -1.047 . . . . 3.5600000000000001 110.886 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.7 m -69.98 -38.44 76.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.932 -1.105 . . . . 1.1799999999999999 110.521 179.968 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.9 mt -91.66 -8.48 47.0 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.686 0.755 . . . . 1.3400000000000001 112.918 -179.222 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 194' ' ' ALA . 93.8 mt-10 56.75 9.88 0.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.244 1.201 . . . . 1.45 114.244 179.725 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.7 mt -71.41 149.49 93.8 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.945 -1.097 . . . . 1.25 108.086 179.167 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.76 140.22 94.09 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.376 1.384 . . . . 0.78000000000000003 109.86 178.741 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.26 163.66 35.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.206 -1.559 . . . . 1.2 110.132 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 11.8 mt -150.25 158.15 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.343 -1.354 . . . . 1.25 107.343 178.17 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 181' ' ' THR . 7.0 m -146.78 -25.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 O-C-N 119.958 -1.714 . . . . 1.3899999999999999 113.672 -179.578 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -100.93 43.64 1.7 Allowed Glycine 0 N--CA 1.5 2.948 0 O-C-N 120.886 -1.134 . . . . 0.96999999999999997 110.564 -178.679 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.452 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 33.5 p -63.05 -21.02 65.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.08 -1.247 . . . . 1.3500000000000001 111.658 -179.651 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.84 -83.01 0.51 Allowed Glycine 0 N--CA 1.499 2.88 0 O-C-N 121.518 -0.739 . . . . 1.0700000000000001 111.32 179.148 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 77.7 p -134.82 31.67 3.31 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.843 -1.386 . . . . 1.9199999999999999 113.256 -178.58 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.447 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 78.8 t -60.05 -37.92 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.173 -1.58 . . . . 1.3300000000000001 110.645 179.576 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 51.9 p -60.12 -18.97 51.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.174 -0.954 . . . . 1.4199999999999999 112.474 -179.623 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.7 m -94.31 -0.27 55.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 2.1200000000000001 112.213 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -131.53 8.35 4.58 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.627 -0.671 . . . . 2.6899999999999999 112.545 -178.161 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.85 148.63 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.601 -0.687 . . . . 1.29 109.625 -179.146 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.445 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 13.7 mptt -119.01 150.25 40.26 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.939 -1.134 . . . . 2.6899999999999999 107.939 177.857 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 49.6 p-10 -55.68 142.69 33.17 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.899 -1.125 . . . . 2.79 110.374 178.414 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 m-20 80.34 -1.8 1.95 Allowed 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 114.276 1.213 . . . . 2.3500000000000001 114.276 179.289 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 98.8 m-20 -63.14 147.63 50.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.921 -1.112 . . . . 1.97 108.816 177.718 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -88.64 118.35 28.25 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.362 -1.461 . . . . 2.9700000000000002 107.274 177.782 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 84.2 mt -128.22 150.34 50.07 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.837 -0.539 . . . . 1.25 109.788 -179.26 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.37 127.92 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 106.964 -1.495 . . . . 1.22 106.964 177.79 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.7 tp -100.35 119.92 39.16 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.005 -1.48 . . . . 1.24 107.005 178.478 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.638 ' O ' ' N ' ' A' ' 223' ' ' VAL . 34.4 t0 -92.35 -25.37 18.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.771 -1.206 . . . . 2.0499999999999998 112.258 -177.873 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 39.34 11.11 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.025 0.75 . . . . 1.25 113.025 -179.077 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.6 t -110.45 -62.27 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 120.836 -1.165 . . . . 1.4299999999999999 109.108 179.776 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -88.52 5.9 40.44 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.213 1.006 . . . . 3.0299999999999998 110.23 -179.804 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.506 HD22 ' H ' ' A' ' 4' ' ' GLY . 1.0 OUTLIER 62.73 52.39 2.8 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.208 -0.905 . . . . 2.25 112.184 179.355 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -145.54 150.51 36.55 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.279 1.038 . . . . 2.52 109.973 178.111 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.11 138.23 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.29 -1.374 . . . . 1.29 107.29 178.261 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -103.51 130.92 50.99 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.174 -1.047 . . . . 1.3400000000000001 108.174 178.463 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 30.2 t -109.2 129.8 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 107.789 -1.189 . . . . 1.3400000000000001 107.789 178.815 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.442 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 19.4 t-20 54.26 49.98 6.27 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 2.1800000000000002 113.47 178.764 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.4 Cg_endo -68.4 150.27 75.68 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.847 2.365 . . . . 0.93999999999999995 110.608 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.8 p -73.74 160.59 31.3 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.805 -1.184 . . . . 2.3999999999999999 110.137 178.238 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.37 -41.62 89.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.537 -0.727 . . . . 3.3300000000000001 110.702 179.046 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -61.94 -34.93 77.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.257 -0.902 . . . . 3.1699999999999999 110.586 -179.804 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.21 -37.4 76.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.965 -1.084 . . . . 1.6899999999999999 109.865 179.386 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--N 1.3 -1.57 0 O-C-N 121.127 -0.983 . . . . 1.6000000000000001 110.386 179.066 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 105.869 -1.9 . . . . 1.5700000000000001 105.869 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.8 m -106.93 120.28 41.62 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.929 -1.137 . . . . 1.4399999999999999 107.929 -179.358 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.62 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -100.94 -156.21 27.25 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.602 -1.799 . . . . 1.01 108.602 179.496 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.497 ' CD1' ' O ' ' A' ' 184' ' ' GLY . 67.4 mt -96.88 1.41 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -1.209 . . . . 1.6299999999999999 112.713 -179.507 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 tp 48.82 98.11 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.044 -1.035 . . . . 1.5800000000000001 112.674 178.565 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.28 -39.16 15.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 1.3400000000000001 110.842 179.364 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -146.55 144.66 21.19 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.049 -1.093 . . . . 1.8600000000000001 108.049 -179.454 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.87 145.32 25.17 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.396 2.064 . . . . 1.01 111.917 178.307 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 152.96 174.36 23.28 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.803 -1.719 . . . . 0.81000000000000005 108.803 178.116 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 11' ' ' ILE . 93.9 mt -131.28 139.59 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.846 -1.168 . . . . 1.3700000000000001 107.846 179.759 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.52 148.54 42.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.662 -1.274 . . . . 1.1399999999999999 108.963 178.402 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -119.23 135.7 54.57 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 107.575 -1.269 . . . . 0.87 107.575 177.348 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.1 168.41 40.23 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 118.304 -1.903 . . . . 0.56999999999999995 110.112 178.239 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -77.39 159.32 29.55 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.836 -0.802 . . . . 2.3500000000000001 108.836 178.12 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -83.85 120.26 25.85 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.766 -1.209 . . . . 1.21 108.011 178.557 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.0 tp -102.46 102.66 12.98 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 105.266 -2.124 . . . . 1.3999999999999999 105.266 178.138 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.8 tp -88.96 130.03 35.52 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.735 -1.209 . . . . 1.4399999999999999 107.735 179.427 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.43 119.54 35.1 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.994 -1.484 . . . . 1.45 106.994 178.389 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.606 ' CB ' ' HZ1' ' A' ' 20' ' ' LYS . 7.9 mtmp? -110.19 137.57 47.75 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.465 -1.309 . . . . 2.5 107.465 -179.787 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -116.22 139.31 50.48 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.111 -0.993 . . . . 2.6600000000000001 108.843 179.004 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -81.66 130.2 34.97 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.599 -1.26 . . . . 2.3199999999999998 107.599 177.758 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.35 141.17 58.87 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.575 -0.898 . . . . 2.1099999999999999 108.575 178.847 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.4 mt -95.73 132.55 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.275 -1.009 . . . . 1.29 108.275 178.289 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.95 129.56 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.686 -1.227 . . . . 1.4099999999999999 107.686 178.87 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.99 137.55 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.541 -0.911 . . . . 1.3100000000000001 108.541 179.302 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -92.34 125.18 36.89 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.944 -1.097 . . . . 1.3400000000000001 108.25 178.751 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -96.98 18.09 15.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -0.853 . . . . 3.48 112.1 -179.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -66.9 152.63 45.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.17 -0.956 . . . . 2.52 110.377 179.307 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -93.71 134.6 35.86 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.87 -0.789 . . . . 2.6299999999999999 108.87 177.975 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -95.92 169.26 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.526 -0.733 . . . . 1.3100000000000001 109.784 179.336 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.0 p -94.25 161.93 14.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 1.24 109.932 178.494 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.65 -23.08 15.69 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.799 -1.188 . . . . 1.49 111.891 179.137 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -69.29 -37.41 77.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.424 -0.798 . . . . 2.2799999999999998 111.016 -179.47 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -88.47 -7.92 55.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.898 -1.126 . . . . 2.0499999999999998 112.854 -179.852 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.75 -41.18 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.329 -0.857 . . . . 1.3400000000000001 110.219 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.4 -39.3 82.94 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.104 -0.998 . . . . 1.54 110.157 179.243 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -62.29 -40.28 95.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.622 -0.674 . . . . 2.8500000000000001 110.922 -179.993 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.63 -39.58 88.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 1.3100000000000001 110.771 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.12 -41.53 86.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.246 -0.982 . . . . 1.3799999999999999 110.111 179.275 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -61.54 -48.36 81.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.847 -1.158 . . . . 1.5 109.938 179.594 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.484 ' HG2' HH11 ' A' ' 42' ' ' ARG . 14.9 mtt-85 -60.52 -39.5 88.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.123 -0.986 . . . . 2.7799999999999998 109.628 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -73.39 -52.85 12.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.979 -1.076 . . . . 1.0600000000000001 110.029 179.23 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.97 -45.12 95.06 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.121 -1.032 . . . . 1.3999999999999999 109.643 -179.868 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.3 t -67.99 -35.23 77.98 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.957 0.884 . . . . 1.3200000000000001 109.812 -179.761 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.84 -44.49 94.28 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.758 -1.337 . . . . 0.69999999999999996 109.758 178.733 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.416 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 38.1 ttm-85 -57.25 -32.29 66.41 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.065 0.936 . . . . 3.4399999999999999 109.495 178.869 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.76 -44.39 86.12 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.884 0.849 . . . . 1.3600000000000001 109.947 179.251 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -83.47 -43.92 15.29 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.59 -0.694 . . . . 2.8300000000000001 110.964 179.347 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -42.96 89.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 1.23 110.244 -179.898 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.415 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 22.9 t -62.89 -40.72 98.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.331 -0.856 . . . . 1.9199999999999999 109.362 179.772 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.46 -48.79 54.18 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.411 0.624 . . . . 1.25 110.915 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -61.82 -47.75 83.67 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.581 -1.324 . . . . 1.97 110.727 -178.592 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.69 -39.2 91.02 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.202 -0.936 . . . . 2.1800000000000002 110.34 -179.611 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 51' ' ' SER . 32.8 mm-40 -60.01 -40.55 89.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.807 -0.558 . . . . 1.1899999999999999 110.724 179.3 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.8 m -64.49 -41.56 96.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 1.3400000000000001 110.964 -179.887 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.78 -38.83 77.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.379 -0.826 . . . . 1.23 110.97 -179.873 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -52.92 -43.53 66.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 1.5600000000000001 110.945 179.305 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -70.2 -38.32 75.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.912 -1.117 . . . . 1.3 110.279 -179.638 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -62.26 -39.13 91.87 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 118.637 -1.225 . . . . 2.3199999999999998 109.427 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.24 -28.88 65.6 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.438 -0.789 . . . . 1.1399999999999999 110.768 179.52 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.4 -35.69 13.87 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.423 -1.37 . . . . 0.68999999999999995 110.815 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -81.34 -23.62 37.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.127 -1.219 . . . . 1.48 111.261 -179.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -88.66 -48.87 7.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.902 -0.499 . . . . 1.52 111.182 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -108.34 -8.05 15.75 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.996 1.11 . . . . 1.3100000000000001 113.996 -177.759 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.06 156.89 19.27 Favored Glycine 0 N--CA 1.501 2.987 0 O-C-N 121.369 -0.832 . . . . 0.84999999999999998 113.577 178.452 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -50.7 -21.73 1.75 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.573 -0.957 . . . . 3.8599999999999999 112.536 179.072 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -54.3 -38.15 65.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.785 -1.197 . . . . 2.3500000000000001 111.814 -179.972 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -80.18 -19.24 47.55 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.747 -1.221 . . . . 2.2599999999999998 112.443 -178.989 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -61.08 -35.5 77.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.984 -1.072 . . . . 1.45 110.811 -179.47 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.79 88.01 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.107 -0.996 . . . . 1.25 111.364 179.773 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt -67.91 -46.86 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.465 -1.397 . . . . 1.26 110.178 179.771 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -72.25 -28.57 63.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.87 . . . . 0.82999999999999996 111.129 -179.885 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -60.92 -40.56 93.64 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.679 -0.808 . . . . 1.1899999999999999 109.888 179.565 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.22 -42.17 91.25 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.192 -1.163 . . . . 0.57999999999999996 110.192 179.857 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -59.58 -45.99 90.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.472 -1.017 . . . . 2.0499999999999998 110.79 179.39 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.6 mt -61.21 -40.48 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.663 -1.273 . . . . 1.21 110.504 -179.945 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.4 ttm -60.29 -38.35 83.31 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.295 -0.878 . . . . 2.29 110.214 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.5 tp -59.3 -45.77 90.37 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.055 -1.028 . . . . 1.21 110.358 179.208 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.416 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 60.0 tp -60.56 -42.38 96.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.526 -0.734 . . . . 1.1399999999999999 110.225 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -84.81 4.87 31.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.304 -0.872 . . . . 1.4199999999999999 112.849 -179.55 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -59.84 125.96 25.71 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.829 -1.169 . . . . 1.27 110.087 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.2 -19.14 65.13 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.542 -0.724 . . . . 1.3500000000000001 111.351 -179.332 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.61 -53.36 9.52 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.144 -1.023 . . . . 2.2200000000000002 110.687 179.946 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.3 mt -62.48 -39.28 92.93 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.32 -0.862 . . . . 1.22 110.753 -179.524 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -58.56 -47.0 85.69 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.152 -0.967 . . . . 1.29 110.822 179.338 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -63.12 -40.48 97.73 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.282 -0.886 . . . . 2.1699999999999999 110.683 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -66.3 -48.3 70.8 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.939 -1.105 . . . . 1.3 110.646 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.38 -44.79 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.636 -1.29 . . . . 1.1699999999999999 110.028 179.632 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.1 -43.85 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.457 -0.777 . . . . 1.3999999999999999 110.486 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.4 -44.52 94.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 1.3300000000000001 111.027 -179.673 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -60.04 -40.25 88.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.075 -1.016 . . . . 1.48 110.735 -179.716 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.55 -47.31 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.056 -1.027 . . . . 1.28 110.57 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -83.31 -31.73 26.69 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.327 -0.858 . . . . 2.6000000000000001 112.035 -179.786 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -78.05 -47.85 17.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.511 -1.368 . . . . 1.51 110.9 -178.365 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -104.55 11.45 34.28 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 119.672 -0.811 . . . . 2.48 111.796 -178.05 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.3 m80 52.0 47.56 24.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.043 -1.036 . . . . 1.6100000000000001 111.913 179.809 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 64.5 mtt -98.39 159.85 14.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.141 -0.975 . . . . 1.8999999999999999 109.796 178.656 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.5 p -76.24 160.81 29.32 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.591 -0.693 . . . . 1.3200000000000001 109.894 178.173 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.23 -42.75 86.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.368 -0.832 . . . . 1.1499999999999999 110.989 178.786 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -70.04 -38.97 75.99 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.658 -1.276 . . . . 2.25 110.19 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.85 -51.56 39.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.859 -1.151 . . . . 1.22 111.589 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.96 92.26 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.792 -1.163 . . . . 1.1899999999999999 110.811 -179.813 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.35 95.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.798 -0.564 . . . . 1.2 110.988 179.832 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -60.78 -40.25 91.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.629 -1.294 . . . . 2.1000000000000001 111.236 -179.514 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.27 -49.87 76.19 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.843 -1.16 . . . . 1.3 111.4 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -59.43 -45.75 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.924 -1.11 . . . . 1.27 109.99 179.929 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.6 mm -62.72 -30.45 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-O 121.388 0.613 . . . . 1.1899999999999999 110.329 179.768 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -57.36 -40.22 77.64 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.793 -0.763 . . . . 2.1099999999999999 110.509 179.16 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.16 -30.67 22.05 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 119.249 -1.453 . . . . 0.88 112.877 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -61.34 -41.54 97.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.383 -1.657 . . . . 1.99 110.293 -179.914 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.7 -46.91 51.32 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 119.805 -0.758 . . . . 1.28 110.524 -179.975 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 50.4 p -62.99 -35.67 80.98 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.33 -0.856 . . . . 2.2200000000000002 110.782 -178.447 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.97 87.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.604 -0.685 . . . . 1.45 110.898 179.951 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 mt -65.33 -28.74 69.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.868 -1.145 . . . . 1.47 111.271 -179.509 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -66.43 -19.69 65.86 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.355 -0.938 . . . . 2.04 110.671 179.179 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -72.42 -11.22 60.59 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.471 -0.891 . . . . 1.73 110.654 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 69.4 mt -86.44 141.61 29.0 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.522 0.677 . . . . 1.79 109.213 179.535 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -98.13 38.14 1.35 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.193 -0.942 . . . . 2.8799999999999999 112.206 179.48 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -113.79 137.7 51.28 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.26 -1.015 . . . . 1.5800000000000001 108.26 178.873 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.547 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 28.2 mp0 -59.12 -39.86 83.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.972 -1.08 . . . . 3.04 111.076 179.182 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -71.24 -52.92 16.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.743 -1.223 . . . . 1.29 110.531 179.774 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.2 mt -59.98 -40.39 88.97 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.865 -1.147 . . . . 1.6000000000000001 110.384 -179.595 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -59.1 -45.72 90.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.893 -1.129 . . . . 2.7599999999999998 110.2 179.483 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.48 -31.98 70.98 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.369 -0.933 . . . . 2.1499999999999999 109.906 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -60.6 -31.2 70.37 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.829 -1.148 . . . . 2.8100000000000001 109.106 178.896 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.61 76.44 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.556 0.693 . . . . 1.3899999999999999 110.249 179.026 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.98 78.03 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.126 -0.63 . . . . 1.4099999999999999 110.138 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.34 -34.84 78.58 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.629 0.728 . . . . 1.3899999999999999 110.673 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.6 t -68.23 -41.02 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.128 -0.982 . . . . 1.1899999999999999 110.3 179.723 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -57.9 -38.73 76.34 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.445 -1.302 . . . . 3.6299999999999999 109.429 179.121 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -59.79 -37.58 79.51 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 120.124 -0.631 . . . . 1.28 110.181 179.199 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.99 -39.81 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 1.1799999999999999 109.591 179.355 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.93 -46.03 77.56 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.885 -1.15 . . . . 0.51000000000000001 110.408 179.082 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -57.38 -41.85 81.01 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.356 -1.085 . . . . 3.1699999999999999 110.163 179.299 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 136' ' ' ARG . 50.7 mtt-85 -61.52 -42.98 99.62 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.251 -0.979 . . . . 2.8500000000000001 110.006 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.77 -42.33 97.25 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.782 -0.767 . . . . 1.6499999999999999 109.536 179.78 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.5 mt -60.05 -43.78 95.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.526 -0.734 . . . . 1.2 110.404 179.698 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -60.54 -36.41 78.36 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.622 -0.674 . . . . 2.7999999999999998 110.703 -179.974 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -73.94 -40.36 63.12 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.32 -0.863 . . . . 2.1499999999999999 111.011 179.719 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.55 -40.38 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.889 -1.132 . . . . 1.21 110.614 -178.815 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.51 -11.17 49.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.669 -1.27 . . . . 1.3400000000000001 111.855 -178.951 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.79 18.61 74.9 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.763 -1.208 . . . . 0.91000000000000003 112.402 -179.71 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.74 145.32 55.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.921 -0.752 . . . . 1.51 109.194 179.218 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -69.02 147.27 51.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.51 -0.744 . . . . 2.8799999999999999 109.534 178.508 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.0 mt -106.84 141.21 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.383 -0.969 . . . . 1.6200000000000001 108.383 178.143 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.3 mp -76.01 123.72 32.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.357 -0.979 . . . . 2.1099999999999999 108.357 178.238 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -99.62 100.52 11.53 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 106.064 -1.828 . . . . 1.6200000000000001 106.064 178.98 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.4 mt -75.2 -14.26 60.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.313 -0.867 . . . . 1.3999999999999999 111.759 -177.885 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.6 p -78.42 3.07 16.78 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.317 1.055 . . . . 2.0499999999999998 112.153 -179.331 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.28 19.83 14.7 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.125 -0.984 . . . . 1.3500000000000001 112.744 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 22.6 mt -74.1 137.42 23.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.907 -1.121 . . . . 1.4199999999999999 109.241 179.172 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -115.52 -14.27 11.53 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.856 0.836 . . . . 2.9900000000000002 112.558 -178.717 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -113.47 136.35 52.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.502 -1.295 . . . . 1.54 107.502 179.932 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -73.67 124.55 26.19 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.588 -0.893 . . . . 1.3799999999999999 108.588 178.689 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -146.45 175.58 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.46 -0.775 . . . . 1.28 109.404 -179.69 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.1 mt -87.53 148.49 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 1.1599999999999999 108.975 178.135 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -99.75 120.54 39.89 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.055 -1.091 . . . . 1.3100000000000001 108.055 178.114 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -121.58 129.59 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 N-CA-C 107.718 -1.215 . . . . 1.25 107.718 179.391 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.1 155.97 21.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.968 -1.083 . . . . 1.26 108.863 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.454 ' O ' ' CG ' ' A' ' 162' ' ' ASP . . . -60.59 -37.58 81.81 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.395 -1.441 . . . . 1.6000000000000001 109.674 178.131 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 161' ' ' ALA . 58.0 m-20 -167.81 153.86 7.51 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.733 -0.839 . . . . 2.4199999999999999 108.733 179.179 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.8 mt -116.46 139.91 49.94 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 108.374 -0.972 . . . . 1.3500000000000001 108.374 177.76 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.5 p -96.85 148.97 35.2 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.22 -0.925 . . . . 1.3200000000000001 108.892 179.402 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.68 -40.01 7.53 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.747 1.632 . . . . 0.69999999999999996 113.599 179.092 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.6 m -61.75 -49.69 75.39 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.024 -1.047 . . . . 1.1200000000000001 109.922 -179.336 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -61.87 -39.96 93.71 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.085 -1.01 . . . . 1.21 110.077 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.51 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 42.8 p -67.67 -37.62 82.63 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.417 -0.802 . . . . 1.1899999999999999 110.267 179.506 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.22 -36.05 82.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.402 -0.811 . . . . 1.24 111.322 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -98.44 -0.47 43.47 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.351 -0.843 . . . . 1.6899999999999999 112.795 -179.276 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.7 tp -64.14 154.88 33.31 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.951 -0.7 . . . . 1.3400000000000001 109.906 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.588 HD21 ' N ' ' A' ' 173' ' ' LEU . 0.3 OUTLIER -97.41 118.76 34.62 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.984 -1.487 . . . . 2.77 106.984 177.427 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.588 ' N ' HD21 ' A' ' 172' ' ' ASN . 44.9 mt -76.52 -19.6 57.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.512 -0.742 . . . . 2.0899999999999999 111.953 -178.126 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.557 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 66.3 mttm -82.39 -19.86 38.27 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.06 -1.025 . . . . 2.6699999999999999 112.455 -178.904 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -102.44 -0.76 31.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.46 -0.775 . . . . 2.5800000000000001 113.065 -178.012 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 46.9 t -109.23 121.22 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.591 -1.262 . . . . 1.1799999999999999 107.591 179.049 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.1 tp -84.74 -4.04 58.86 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.144 -0.972 . . . . 2.1800000000000002 111.821 -179.434 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.96 171.29 36.82 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.872 -1.691 . . . . 0.48999999999999999 108.872 -179.901 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 3.6 m-85 -125.0 129.69 50.82 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.941 -1.133 . . . . 0.64000000000000001 107.941 178.463 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 30.1 mt -129.92 121.43 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 106.173 -1.788 . . . . 1.21 106.173 177.908 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 203' ' ' VAL . 39.4 p -139.88 172.31 12.96 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.631 -1.293 . . . . 1.3799999999999999 110.355 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.497 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 4.8 m-20 -105.29 51.96 0.75 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.529 -0.732 . . . . 2.3700000000000001 109.676 179.382 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -103.93 153.94 20.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.366 -0.834 . . . . 1.52 109.709 179.617 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -58.88 -36.2 86.38 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 120.212 -0.994 . . . . 1.8 110.712 178.517 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 96.52 -17.86 58.52 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 121.164 -1.198 . . . . 2.04 114.157 179.458 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 59.4 mtt-85 -58.67 -41.13 85.45 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.835 -1.391 . . . . 5.0 110.212 179.289 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 75.5 p -140.83 36.29 1.78 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.539 -0.726 . . . . 3.02 111.212 -179.391 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 69.9 m -81.9 123.06 28.51 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.553 -1.277 . . . . 2.1099999999999999 107.553 179.489 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.51 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 32.1 t60 -60.5 -37.58 81.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.669 -0.645 . . . . 1.24 110.741 -179.828 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 23.0 m -52.96 -42.51 65.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 2.1499999999999999 110.439 179.253 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.8 m -59.65 -40.43 87.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.03 -1.044 . . . . 2.02 110.107 179.463 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.34 -35.69 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.593 -0.692 . . . . 2.1200000000000001 110.848 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 57.1 mtp -62.6 -40.81 98.1 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.093 0.949 . . . . 1.3600000000000001 109.453 179.481 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.0 -41.73 92.71 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.589 -0.732 . . . . 1.29 110.515 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -59.8 -44.93 93.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 3.5600000000000001 110.712 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.1 m -71.19 -39.35 71.88 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.002 -1.061 . . . . 1.1799999999999999 110.164 -179.843 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.1 mt -90.98 -7.94 50.6 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 112.712 0.634 . . . . 1.3400000000000001 112.712 -178.124 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 54.29 9.03 0.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.207 1.188 . . . . 1.45 114.207 179.836 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 39.5 mt -71.37 148.92 93.77 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 108.326 -0.99 . . . . 1.25 108.326 179.133 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.45 144.25 92.29 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.456 1.438 . . . . 0.78000000000000003 109.368 178.608 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -157.9 160.67 37.88 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.086 -1.446 . . . . 1.2 109.65 179.647 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.8 mt -150.78 149.07 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.862 -1.162 . . . . 1.25 107.862 178.386 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.5 m -134.21 -32.18 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.245 -0.909 . . . . 1.3899999999999999 112.811 -179.755 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.51 33.56 0.83 Allowed Glycine 0 N--CA 1.483 1.792 0 O-C-N 121.183 -0.948 . . . . 0.96999999999999997 113.037 -178.135 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.497 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 35.0 p -59.67 -26.95 65.97 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 121.465 -1.021 . . . . 1.3500000000000001 111.085 -179.199 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 79.53 -93.38 1.35 Allowed Glycine 0 N--CA 1.488 2.102 0 C-N-CA 120.181 -1.009 . . . . 1.0700000000000001 110.952 179.386 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.5 m -123.54 29.74 6.49 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.246 0.832 . . . . 1.9199999999999999 113.246 -178.798 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 70.3 t -59.84 -33.59 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.824 -1.172 . . . . 1.3300000000000001 110.237 179.027 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 58.8 p -59.33 -23.23 62.32 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.087 -1.008 . . . . 1.4199999999999999 111.459 179.947 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.1 t -92.27 -0.38 57.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.914 -1.116 . . . . 2.1200000000000001 111.428 -179.288 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -124.47 -7.22 7.51 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.617 -0.72 . . . . 2.6899999999999999 112.681 -177.938 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.43 141.82 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.164 -0.68 . . . . 1.29 109.164 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.4 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 12.0 mptt -116.72 151.44 36.38 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.1 -1.074 . . . . 2.6899999999999999 108.1 178.296 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 48.2 t30 -53.25 143.29 18.79 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.279 -0.968 . . . . 2.79 110.44 178.318 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.1 t0 82.2 -6.99 1.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.099 1.148 . . . . 2.3500000000000001 114.099 179.524 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 16' ' ' ALA . 87.6 m-20 -63.18 143.23 57.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.636 -1.29 . . . . 1.97 108.288 177.466 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -88.23 119.1 28.31 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.388 -1.338 . . . . 2.9700000000000002 107.388 178.124 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 42.4 mt -127.83 144.51 51.09 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.137 -0.69 . . . . 1.25 109.137 -179.04 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.9 mt -111.94 128.61 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 106.918 -1.512 . . . . 1.22 106.918 177.72 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.1 tp -99.97 118.67 36.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.975 -1.861 . . . . 1.24 105.975 178.35 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 223' ' ' VAL . 35.0 p-10 -92.65 -22.19 19.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 2.0499999999999998 112.736 -177.558 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.474 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 37.75 16.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 112.756 0.65 . . . . 1.25 112.756 -179.206 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.632 ' N ' ' O ' ' A' ' 221' ' ' ASP . 15.7 t -111.21 -63.81 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.056 -1.027 . . . . 1.4299999999999999 108.78 179.694 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -90.22 9.15 29.65 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.245 1.021 . . . . 3.0299999999999998 110.463 -179.779 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.62 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.8 OUTLIER 61.62 52.8 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.067 -0.97 . . . . 2.25 112.157 179.61 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -148.29 153.46 38.7 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.409 1.1 . . . . 2.52 110.25 179.131 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.4 135.48 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.542 -1.281 . . . . 1.29 107.542 177.465 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -101.15 136.93 40.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.987 -1.071 . . . . 1.3400000000000001 108.719 178.744 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.7 t -109.84 130.04 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.171 -1.048 . . . . 1.3400000000000001 108.171 179.104 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.451 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 60.7 t30 48.44 50.32 8.86 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.914 . . . . 2.1800000000000002 113.292 178.913 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.7 Cg_endo -63.41 151.66 83.82 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.32 2.013 . . . . 0.93999999999999995 110.712 -179.904 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.9 m -73.97 156.79 37.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.795 -1.191 . . . . 2.3999999999999999 109.226 177.65 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -56.79 -40.05 75.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.033 -1.042 . . . . 3.3300000000000001 111.133 179.054 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 234' ' ' GLU . 45.2 mp0 -59.12 -39.52 82.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.044 -1.035 . . . . 3.1699999999999999 110.288 179.687 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.8 -37.94 78.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.759 0.79 . . . . 1.6899999999999999 110.097 179.732 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.488 1.46 0 O-C-N 121.133 -0.979 . . . . 1.6000000000000001 110.398 179.292 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.246 -0.65 . . . . 3.5299999999999998 109.246 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.2 mt -91.92 112.36 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.468 -1.679 . . . . 1.5700000000000001 106.468 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.0 m -105.98 119.99 40.62 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.652 -1.24 . . . . 1.4399999999999999 107.652 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.17 -160.96 23.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.531 -1.827 . . . . 1.01 108.531 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.453 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 95.6 mt -95.98 1.29 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.447 -1.031 . . . . 1.6299999999999999 113.076 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 tp 51.8 93.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.536 -1.353 . . . . 1.5800000000000001 112.297 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.75 -34.11 17.25 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.052 -1.03 . . . . 1.3400000000000001 111.001 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 201' ' ' ALA . 1.9 p -149.8 140.89 14.46 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 107.682 -1.229 . . . . 1.8600000000000001 107.682 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.28 146.99 22.76 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.518 2.145 . . . . 1.01 112.173 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 153.15 173.69 22.71 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 108.722 -1.751 . . . . 0.81000000000000005 108.722 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 11' ' ' ILE . 88.0 mt -132.12 136.42 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.073 -1.251 . . . . 1.3700000000000001 107.683 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.34 155.92 45.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.004 -1.06 . . . . 1.1399999999999999 109.429 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.606 ' CE1' ' NH2' ' A' ' 240' ' ' ARG . 4.6 m-85 -128.38 140.19 51.98 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.391 -0.966 . . . . 0.87 108.391 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.36 172.01 39.86 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 118.546 -1.788 . . . . 0.56999999999999995 110.061 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -76.02 156.07 34.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.86 -0.788 . . . . 2.3500000000000001 109.144 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.52 122.87 29.61 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.454 -1.313 . . . . 1.21 107.454 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.4 tp -100.2 106.97 18.7 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 105.558 -2.016 . . . . 1.3999999999999999 105.558 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.4 tp -91.04 131.36 36.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.917 -1.142 . . . . 1.4399999999999999 107.917 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.4 mt -99.52 118.04 35.23 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.878 -1.527 . . . . 1.45 106.878 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -110.15 136.09 49.92 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.79 -1.189 . . . . 2.5 107.79 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -128.56 151.21 49.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.08 -1.013 . . . . 2.6600000000000001 109.748 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -81.52 135.61 35.6 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.816 -1.179 . . . . 2.3199999999999998 107.816 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -63.67 147.89 50.43 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.743 -0.836 . . . . 2.1099999999999999 108.743 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.2 mt -93.23 125.48 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.728 -1.212 . . . . 1.29 107.728 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.2 t -109.96 129.95 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.43 -0.952 . . . . 1.4099999999999999 108.43 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.9 mt -95.02 141.44 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.152 -0.968 . . . . 1.3100000000000001 108.612 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -90.53 122.68 33.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.033 . . . . 1.3400000000000001 108.414 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.493 ' HG2' HH11 ' A' ' 28' ' ' ARG . 4.6 mmt-85 -94.46 17.02 13.82 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.37 -0.831 . . . . 3.48 111.983 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -74.85 140.42 43.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.259 -0.901 . . . . 2.52 109.006 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -90.97 129.55 36.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.958 -1.089 . . . . 2.6299999999999999 108.074 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 pt -89.31 166.19 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 1.3100000000000001 110.835 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.8 p -96.81 167.19 11.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.405 -0.81 . . . . 1.24 109.653 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -15.16 2.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.922 -1.111 . . . . 1.49 112.39 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -70.33 -39.61 74.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 2.2799999999999998 110.824 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -94.61 -4.73 47.23 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.635 -1.291 . . . . 2.0499999999999998 113.029 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.71 -41.38 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.272 -0.893 . . . . 1.3400000000000001 110.358 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -56.09 -40.1 73.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 1.54 110.189 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -63.16 -36.12 82.58 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.335 -0.853 . . . . 2.8500000000000001 110.688 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 42' ' ' ARG . 78.6 mm-40 -60.23 -42.06 94.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 1.3100000000000001 110.398 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.98 -46.0 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.387 -0.821 . . . . 1.3799999999999999 110.731 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.24 -50.01 74.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.058 -1.026 . . . . 1.5 110.392 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 76.6 mtm180 -62.41 -41.0 98.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -0.897 . . . . 2.7799999999999998 110.231 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -70.26 -55.33 9.51 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.383 -0.823 . . . . 1.0600000000000001 109.566 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.25 -47.67 85.0 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.797 0.808 . . . . 1.3999999999999999 110.361 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.2 t -68.67 -38.19 80.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.303 -0.873 . . . . 1.3200000000000001 110.208 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.61 -46.57 88.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.775 -1.33 . . . . 0.69999999999999996 109.775 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -59.91 -29.31 68.28 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.405 -1.056 . . . . 3.4399999999999999 110.311 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.86 80.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.808 -0.557 . . . . 1.3600000000000001 110.97 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -82.55 -35.93 26.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.833 -1.167 . . . . 2.8300000000000001 110.084 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -45.33 89.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.369 -0.832 . . . . 1.23 109.95 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 t -61.73 -39.8 92.84 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.917 0.865 . . . . 1.9199999999999999 109.558 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.03 -49.86 63.87 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.287 -0.565 . . . . 1.25 110.873 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -61.7 -51.0 70.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.97 -1.081 . . . . 1.97 110.955 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.72 -38.94 89.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.241 -0.912 . . . . 2.1800000000000002 110.483 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -58.68 -40.09 82.57 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.059 -0.656 . . . . 1.1899999999999999 110.654 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 m -63.08 -41.75 99.49 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.839 -1.163 . . . . 1.3400000000000001 110.247 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.11 -36.32 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.571 -0.706 . . . . 1.23 110.778 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -52.97 -42.56 65.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 1.5600000000000001 110.76 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.31 -36.12 76.67 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.139 -0.975 . . . . 1.3 110.21 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -62.14 -39.34 92.24 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.246 -0.981 . . . . 2.3199999999999998 109.454 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.02 -34.74 78.78 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.342 0.591 . . . . 1.1399999999999999 110.113 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.43 19.02 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.749 -1.215 . . . . 0.68999999999999995 111.355 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.26 -23.32 35.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -1.183 . . . . 1.48 111.406 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.5 m -86.6 -49.71 7.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.793 -0.567 . . . . 1.52 110.649 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.527 ' CZ ' ' SD ' ' A' ' 193' ' ' MET . 72.2 m-85 -108.43 -6.65 16.08 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 113.954 1.094 . . . . 1.3100000000000001 113.954 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.0 168.03 29.4 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.115 -1.04 . . . . 0.84999999999999998 111.745 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.94 -20.49 38.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.273 -1.134 . . . . 3.8599999999999999 112.603 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.47 -42.03 73.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.618 -1.301 . . . . 2.3500000000000001 110.945 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -88.43 -25.18 22.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.017 -1.052 . . . . 2.2599999999999998 111.998 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -59.99 -37.28 79.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 1.45 111.356 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.36 84.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 1.25 111.299 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.8 mt -65.2 -43.98 95.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.494 -1.379 . . . . 1.26 110.303 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -70.63 -34.53 72.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.938 -1.102 . . . . 0.82999999999999996 110.423 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.49 -38.55 84.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.3 -0.875 . . . . 1.1899999999999999 110.491 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.94 -41.15 88.53 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.972 -1.108 . . . . 0.57999999999999996 110.938 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -59.36 -43.21 92.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.417 -1.049 . . . . 2.0499999999999998 110.56 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.48 -37.17 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.161 -0.962 . . . . 1.21 110.564 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.2 ttt -59.26 -39.75 83.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.531 -0.731 . . . . 2.29 110.558 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.8 tp -59.6 -48.21 82.54 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.454 -0.898 . . . . 1.21 109.612 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.44 -39.72 88.53 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.541 0.686 . . . . 1.1399999999999999 110.049 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.62 -1.52 54.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.451 -0.781 . . . . 1.4199999999999999 112.902 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -58.68 123.88 17.85 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.14 -1.424 . . . . 1.27 110.584 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.36 -16.57 62.51 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.751 -1.218 . . . . 1.3500000000000001 111.355 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -77.46 -50.08 13.43 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.407 -0.917 . . . . 2.2200000000000002 111.148 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.09 -39.46 92.55 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.28 -0.888 . . . . 1.22 110.577 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -59.84 -45.71 91.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 1.29 110.348 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -62.72 -39.98 95.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 2.1699999999999999 110.837 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -64.84 -48.31 74.8 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.798 -1.189 . . . . 1.3 110.273 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.2 mt -55.84 -44.19 76.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.169 -0.957 . . . . 1.1699999999999999 110.048 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 90' ' ' ILE . 82.9 mt -60.36 -41.58 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.443 0.64 . . . . 1.3999999999999999 110.453 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.51 95.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.682 -0.636 . . . . 1.3300000000000001 110.977 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.86 -42.26 97.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.866 -1.146 . . . . 1.48 110.783 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.21 -49.72 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.857 -1.152 . . . . 1.28 109.931 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -78.0 -35.42 50.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.399 -0.813 . . . . 2.6000000000000001 111.645 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.12 -42.09 27.07 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.499 -1.375 . . . . 1.51 111.767 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -105.8 7.92 32.6 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.92 -1.112 . . . . 2.48 112.422 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.8 m80 50.77 47.85 23.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.858 -1.151 . . . . 1.6100000000000001 111.285 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.6 mtt -105.28 154.02 20.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.598 -0.689 . . . . 1.8999999999999999 109.567 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.441 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 27.9 p -71.32 162.98 28.55 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.79 -0.569 . . . . 1.3200000000000001 110.034 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.51 -39.84 94.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.964 -1.085 . . . . 1.1499999999999999 110.856 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.441 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 25.4 p-10 -68.5 -42.76 78.14 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 120.807 -1.183 . . . . 2.25 109.971 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.35 -48.06 62.45 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.508 0.671 . . . . 1.22 110.606 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.28 94.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 1.1899999999999999 110.494 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.34 86.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.651 -0.656 . . . . 1.2 110.552 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -60.08 -38.57 83.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.17 -0.956 . . . . 2.1000000000000001 110.937 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.14 -49.46 76.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.9 -1.125 . . . . 1.3 111.174 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.68 -49.5 84.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.402 -1.319 . . . . 1.27 109.714 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.0 mm -60.09 -32.73 51.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.605 0.717 . . . . 1.1899999999999999 110.149 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -54.84 -40.78 69.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.266 -0.896 . . . . 2.1099999999999999 110.627 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.49 -34.65 10.15 Favored Glycine 0 N--CA 1.5 2.919 0 C-N-CA 119.618 -1.277 . . . . 0.88 112.236 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -61.86 -42.77 99.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.499 -1.589 . . . . 1.99 109.914 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.11 -49.84 32.95 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.948 -0.701 . . . . 1.28 110.107 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.0 p -61.79 -36.94 82.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.173 -0.954 . . . . 2.2200000000000002 110.411 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.91 98.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 1.45 110.633 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.37 -29.39 69.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.083 -1.011 . . . . 1.47 110.715 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -67.04 -23.73 65.92 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.383 -0.823 . . . . 2.04 110.961 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -71.56 -15.39 62.28 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.06 -1.025 . . . . 1.73 111.227 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.6 mt -88.45 141.07 28.83 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.829 -0.804 . . . . 1.79 108.829 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -98.1 40.78 1.16 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.146 -0.971 . . . . 2.8799999999999999 112.048 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -112.39 138.57 48.94 Favored 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 108.174 -1.047 . . . . 1.5800000000000001 108.174 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 47.7 mp0 -58.58 -36.6 74.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 3.04 111.016 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -73.59 -51.15 17.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.677 -1.264 . . . . 1.29 109.99 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.96 -43.08 96.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.96 -1.087 . . . . 1.6000000000000001 110.215 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -63.05 -50.22 71.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.913 . . . . 2.7599999999999998 110.198 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -61.55 -30.5 70.69 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.076 0.941 . . . . 2.1499999999999999 109.589 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -64.7 -29.55 70.54 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.082 0.944 . . . . 2.8100000000000001 109.274 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.22 82.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.708 0.766 . . . . 1.3899999999999999 109.484 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.06 84.58 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.527 -0.869 . . . . 1.4099999999999999 109.986 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -64.45 -35.49 81.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.516 -0.74 . . . . 1.3899999999999999 110.348 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.2 t -67.59 -39.51 82.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.106 -0.996 . . . . 1.1899999999999999 109.58 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -58.91 -37.1 75.86 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.895 -1.122 . . . . 3.6299999999999999 109.214 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -60.25 -37.68 81.12 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.899 -0.591 . . . . 1.28 110.418 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.6 mt -60.48 -40.04 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.318 -0.864 . . . . 1.1799999999999999 109.71 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.82 -39.97 32.34 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.098 -1.201 . . . . 0.51000000000000001 110.098 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.72 -46.29 84.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -1.129 . . . . 3.1699999999999999 109.996 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -63.63 -40.1 96.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.788 -1.195 . . . . 2.8500000000000001 109.8 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.29 -41.94 90.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.49 -0.756 . . . . 1.6499999999999999 109.7 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 54.7 mt -59.94 -44.83 94.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.599 -0.84 . . . . 1.2 110.014 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -60.6 -33.84 73.34 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.488 -0.758 . . . . 2.7999999999999998 110.17 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -74.01 -43.11 59.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.662 -0.649 . . . . 2.1499999999999999 110.167 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.92 -37.32 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 1.21 110.741 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 56.4 mt -86.23 -4.8 59.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.156 -0.965 . . . . 1.3400000000000001 112.148 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.06 23.36 69.08 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 120.175 -1.012 . . . . 0.91000000000000003 113.22 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.5 tp -73.52 137.51 44.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.531 -0.982 . . . . 1.51 108.932 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -68.41 149.79 48.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.17 -0.956 . . . . 2.8799999999999999 109.757 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.4 mt -104.07 140.35 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.504 -0.924 . . . . 1.6200000000000001 108.504 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.5 mp -77.34 128.23 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.86 -1.163 . . . . 2.1099999999999999 107.86 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -96.8 100.08 11.63 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 105.861 -1.903 . . . . 1.6200000000000001 105.861 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.0 mt -75.56 -15.52 60.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.508 -0.745 . . . . 1.3999999999999999 111.437 -177.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.5 t -78.19 -1.45 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 2.0499999999999998 112.088 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.35 22.4 10.68 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.735 0.778 . . . . 1.3500000000000001 111.744 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.461 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 18.0 mt -72.0 135.76 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.742 . . . . 1.4199999999999999 109.1 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -121.67 -6.82 9.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.571 -0.706 . . . . 2.9900000000000002 112.343 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -112.71 135.45 53.43 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.957 -1.127 . . . . 1.54 107.957 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.85 113.98 17.4 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.695 -0.854 . . . . 1.3799999999999999 108.695 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.9 m -148.29 178.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.303 -0.873 . . . . 1.28 109.224 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.0 mt -87.31 144.45 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.046 -0.724 . . . . 1.1599999999999999 109.046 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.4 tp -94.76 125.81 39.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.981 -1.118 . . . . 1.3100000000000001 107.981 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.19 129.9 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.981 -1.118 . . . . 1.25 107.981 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.78 153.44 22.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.156 -0.965 . . . . 1.26 109.667 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.3 73.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.663 -1.273 . . . . 1.6000000000000001 109.413 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -173.22 151.2 2.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.882 -0.785 . . . . 2.4199999999999999 108.882 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.0 mt -119.85 140.79 50.27 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.049 -0.722 . . . . 1.3500000000000001 109.049 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 56.5 p -90.8 148.1 37.56 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.048 -1.033 . . . . 1.3200000000000001 108.79 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.9 -40.59 6.03 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.919 1.746 . . . . 0.69999999999999996 113.342 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.0 m -63.53 -46.22 87.03 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.052 -1.03 . . . . 1.1200000000000001 110.134 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -65.26 -38.33 90.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 1.21 110.332 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.686 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 69.2 p -68.7 -41.43 79.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.492 -0.755 . . . . 1.1899999999999999 110.585 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.11 83.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.685 -0.635 . . . . 1.24 110.768 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -93.63 2.46 56.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.001 -1.062 . . . . 1.6899999999999999 112.543 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.82 150.39 37.31 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.341 -0.849 . . . . 1.3400000000000001 109.857 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -95.89 116.19 28.55 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.52 -1.289 . . . . 2.77 107.52 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 75.1 mt -80.04 -11.25 59.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.607 -0.683 . . . . 2.0899999999999999 112.368 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -83.86 -26.83 29.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 2.6699999999999999 112.218 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -102.76 -3.88 25.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.305 -0.872 . . . . 2.5800000000000001 113.245 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.39 126.93 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.462 -1.31 . . . . 1.1799999999999999 107.462 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 28.8 tp -90.4 -7.17 53.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.788 -1.195 . . . . 2.1800000000000002 112.349 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.54 173.95 41.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.367 -1.493 . . . . 0.48999999999999999 109.367 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -128.88 130.65 47.13 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.138 -1.06 . . . . 0.64000000000000001 108.138 179.233 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 94.8 mt -134.12 105.54 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 105.83 -1.915 . . . . 1.21 105.83 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 39.1 p -126.99 176.11 7.58 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.954 -1.091 . . . . 1.3799999999999999 110.991 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.581 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -104.02 56.33 0.73 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 115.931 -0.577 . . . . 2.3700000000000001 109.841 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -100.59 144.37 29.65 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.15 -0.969 . . . . 1.52 109.31 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.6 -32.91 25.09 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.098 -1.049 . . . . 1.8 110.907 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 98.15 0.11 58.61 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.302 -1.117 . . . . 2.04 113.692 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.461 ' O ' ' OG1' ' A' ' 187' ' ' THR . 35.6 ttm180 -87.75 112.6 22.58 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.892 -1.521 . . . . 5.0 106.892 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 20.9 p 49.52 44.74 24.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 3.02 112.291 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.3 m -78.35 126.81 31.3 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.679 -1.23 . . . . 2.1099999999999999 107.679 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.686 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 40.4 t60 -58.94 -40.8 85.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.227 -0.92 . . . . 1.24 110.292 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -48.44 81.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.113 -0.992 . . . . 2.1499999999999999 110.284 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.501 ' HG ' ' N ' ' A' ' 192' ' ' ILE . 53.7 p -61.39 -38.74 88.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.473 -0.767 . . . . 2.02 110.576 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.501 ' N ' ' HG ' ' A' ' 191' ' ' SER . 85.5 mt -60.71 -42.42 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.095 -1.003 . . . . 2.1200000000000001 110.903 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.527 ' SD ' ' CZ ' ' A' ' 65' ' ' PHE . 9.5 mtm -66.74 -36.92 83.6 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.502 -1.374 . . . . 1.3600000000000001 109.461 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.76 -48.66 80.78 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.843 -0.617 . . . . 1.29 111.006 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.435 HH21 HG12 ' A' ' 192' ' ' ILE . 85.3 mtm180 -60.0 -40.45 89.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 3.5600000000000001 110.409 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.3 m -64.46 -37.84 88.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 1.1799999999999999 109.902 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.5 mt -89.21 -1.1 57.94 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.459 0.647 . . . . 1.3400000000000001 112.045 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 54.82 8.31 0.22 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.059 1.133 . . . . 1.45 114.059 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.476 ' O ' ' OG ' ' A' ' 8' ' ' SER . 45.3 mt -71.5 149.25 93.52 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.073 -1.084 . . . . 1.25 108.073 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -59.1 144.95 99.17 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.653 1.569 . . . . 0.78000000000000003 109.948 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.499 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -160.89 159.58 29.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.442 -1.411 . . . . 1.2 109.852 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 73.0 mt -148.1 155.65 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.059 -1.089 . . . . 1.25 108.059 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.75 -28.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.145 -0.972 . . . . 1.3899999999999999 111.758 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.87 41.32 1.71 Allowed Glycine 0 N--CA 1.487 2.034 0 C-N-CA 120.332 -0.937 . . . . 0.96999999999999997 111.846 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.449 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 75.7 p -63.45 -20.92 65.98 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.341 -1.094 . . . . 1.3500000000000001 110.938 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.25 -95.88 1.33 Allowed Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.669 -1.253 . . . . 1.0700000000000001 109.978 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.0 t -129.03 30.65 5.02 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.444 -1.033 . . . . 1.9199999999999999 111.868 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.03 -38.34 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.701 -1.249 . . . . 1.3300000000000001 110.829 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 67.6 p -57.49 -24.84 58.17 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.442 -0.903 . . . . 1.4199999999999999 112.02 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.2 m -93.31 0.72 57.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.017 -1.052 . . . . 2.1200000000000001 111.974 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -122.96 -4.8 8.53 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 113.082 0.771 . . . . 2.6899999999999999 113.082 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 52.0 t -119.38 149.11 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 121.568 0.699 . . . . 1.29 109.723 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -116.81 158.56 23.73 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.809 -1.182 . . . . 2.6899999999999999 107.809 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 45.3 p-10 -55.01 145.17 21.11 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.986 -1.071 . . . . 2.79 110.572 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t70 80.61 2.52 1.81 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 114.803 1.409 . . . . 2.3500000000000001 114.803 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 62.8 t0 -65.85 146.62 54.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.941 -1.1 . . . . 1.97 108.37 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.499 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 43.3 t80 -88.18 120.64 29.73 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.993 -1.484 . . . . 2.9700000000000002 106.993 178.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 79.0 mt -127.75 150.01 49.99 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.527 -0.733 . . . . 1.25 109.92 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.5 mt -118.41 123.59 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 106.691 -1.596 . . . . 1.22 106.691 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.5 tp -99.32 114.87 27.97 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.639 -1.615 . . . . 1.24 106.639 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 223' ' ' VAL . 37.2 t0 -91.36 -25.06 19.57 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.849 -1.157 . . . . 2.0499999999999998 112.325 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.433 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 38.65 19.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.667 0.617 . . . . 1.25 112.667 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.0 t -110.94 -61.22 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.097 0.951 . . . . 1.4299999999999999 108.924 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -93.19 8.72 39.03 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.7 0.762 . . . . 3.0299999999999998 110.489 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 60.1 t30 62.98 52.35 2.62 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.483 0.658 . . . . 2.25 111.704 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -147.49 147.81 30.57 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.272 1.034 . . . . 2.52 109.453 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 52.0 t -117.45 139.74 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.293 -1.002 . . . . 1.29 108.293 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -103.84 132.59 49.95 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.983 -1.073 . . . . 1.3400000000000001 109.01 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.9 130.04 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.953 -1.129 . . . . 1.3400000000000001 107.953 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.473 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 17.9 t-20 54.05 48.09 4.4 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.241 -0.912 . . . . 2.1800000000000002 113.015 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 56.1 Cg_endo -69.6 150.75 69.58 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.845 2.363 . . . . 0.93999999999999995 110.921 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 68.2 p -77.75 163.03 26.49 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.314 -0.866 . . . . 2.3999999999999999 110.562 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -60.47 -35.21 75.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.945 . . . . 3.3300000000000001 110.56 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -59.14 -39.34 82.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.166 -0.959 . . . . 3.1699999999999999 110.385 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.8 t -70.88 -42.06 77.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.175 -1.01 . . . . 1.6899999999999999 110.219 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 67.0 mt -60.31 -44.61 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.769 0.795 . . . . 1.6000000000000001 109.822 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.98 -40.76 90.22 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.499 -0.751 . . . . 2.7000000000000002 110.81 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -62.57 -47.41 83.95 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.993 -1.067 . . . . 2.96 110.885 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.6 mtp -69.45 -36.52 76.68 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.316 -0.865 . . . . 1.6299999999999999 110.677 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.606 ' NH2' ' CE1' ' A' ' 13' ' ' PHE . 1.7 mmp_? -58.01 -39.5 78.48 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.943 -1.098 . . . . 3.27 111.156 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.17 -59.4 2.76 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.131 -0.98 . . . . 2.23 111.259 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 61.4 t -60.74 -46.5 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 2.79 110.993 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.435 HE21 HH21 ' A' ' 240' ' ' ARG . 1.0 OUTLIER -59.8 -52.19 66.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.938 . . . . 4.2599999999999998 111.08 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.14 -29.57 68.5 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.231 -0.988 . . . . 1.8799999999999999 111.095 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -60.1 -32.48 71.03 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.495 -0.882 . . . . 3.3799999999999999 109.845 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.32 -46.72 83.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.636 -0.826 . . . . 2.8799999999999999 110.012 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.83 92.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.586 -0.696 . . . . 2.75 110.427 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.424 ' HG ' ' N ' ' A' ' 249' ' ' GLU . 35.7 p -68.58 -31.57 70.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.369 -0.832 . . . . 3.4199999999999999 110.827 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.424 ' N ' ' HG ' ' A' ' 248' ' ' SER . 86.8 tt0 -63.4 -40.75 98.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.431 -0.793 . . . . 3.5699999999999998 110.339 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -68.46 -29.74 68.44 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.395 -0.815 . . . . 4.6100000000000003 111.057 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -68.76 -23.69 64.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.941 . . . . 4.4500000000000002 111.725 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -67.13 -31.6 72.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.914 -1.116 . . . . 5.9699999999999998 110.948 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.33 -48.8 76.49 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.693 -1.255 . . . . 6.4500000000000002 110.48 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -81.09 0.68 34.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.415 -0.803 . . . . 6.6600000000000001 112.965 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -81.96 -44.13 17.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.941 -1.099 . . . . 8.5399999999999991 111.073 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 95.1 mt -88.42 -98.82 0.09 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.044 -1.095 . . . . 8.0700000000000003 108.044 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -127.03 -94.0 0.46 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.224 -1.028 . . . . 9.7200000000000006 108.224 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -118.63 12.7 13.19 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 116.075 -0.512 . . . . 10.119999999999999 110.667 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 . . . . . 0 N--CA 1.5 2.032 0 CA-C-O 117.937 -1.03 . . . . 11.9 109.223 -179.254 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 108.97 -0.752 . . . . 3.5299999999999998 108.97 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.9 mt -87.61 117.25 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.497 -1.297 . . . . 1.5700000000000001 107.497 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -102.56 128.43 49.22 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.209 -1.034 . . . . 1.4399999999999999 108.209 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.53 -152.39 11.51 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 108.536 -1.826 . . . . 1.01 108.536 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 81.5 mt -97.23 -3.22 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.293 -1.122 . . . . 1.6299999999999999 113.027 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.8 tp 49.49 95.62 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.07 -1.019 . . . . 1.5800000000000001 112.126 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.26 -40.16 16.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.11 -0.994 . . . . 1.3400000000000001 110.587 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -147.12 141.8 16.29 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.706 -1.22 . . . . 1.8600000000000001 107.706 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.33 149.69 40.51 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.575 2.183 . . . . 1.01 112.144 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 151.13 166.16 13.51 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.885 -1.686 . . . . 0.81000000000000005 108.885 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.406 HG22 HD11 ' A' ' 11' ' ' ILE . 87.8 mt -123.76 135.18 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.232 -1.158 . . . . 1.3700000000000001 108.424 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.48 44.6 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.963 -1.086 . . . . 1.1399999999999999 109.293 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -121.86 139.66 53.35 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.841 -1.17 . . . . 0.87 107.841 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.72 165.47 31.75 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 118.356 -1.878 . . . . 0.56999999999999995 110.254 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -76.03 158.66 31.63 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.938 -0.742 . . . . 2.3500000000000001 109.262 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.08 123.25 31.95 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.526 -1.287 . . . . 1.21 107.526 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.4 tp -100.85 108.73 20.59 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 105.28 -2.118 . . . . 1.3999999999999999 105.28 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.5 tp -90.41 137.42 32.36 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.847 -1.168 . . . . 1.4399999999999999 107.847 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.9 mt -101.87 120.01 39.7 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 107.714 -1.217 . . . . 1.45 107.714 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -110.97 140.15 45.72 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.056 -1.09 . . . . 2.5 108.056 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.58 139.43 53.6 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.071 -1.018 . . . . 2.6600000000000001 108.758 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -84.87 133.36 34.31 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.682 -1.229 . . . . 2.3199999999999998 107.682 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -64.38 146.38 54.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.074 -1.016 . . . . 2.1099999999999999 109.264 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.5 mt -95.53 132.81 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.278 -0.889 . . . . 1.29 108.691 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -106.42 128.98 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.84 -1.17 . . . . 1.4099999999999999 107.84 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 mt -98.17 140.17 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.714 -0.847 . . . . 1.3100000000000001 108.714 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -89.35 119.95 30.26 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.626 -1.25 . . . . 1.3400000000000001 107.626 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -96.73 15.68 21.22 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.187 -0.946 . . . . 3.48 112.227 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -69.22 151.09 46.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.971 -1.081 . . . . 2.52 110.35 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -90.12 131.87 35.74 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.176 -1.046 . . . . 2.6299999999999999 108.176 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.2 pt -96.1 168.5 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.577 0.703 . . . . 1.3100000000000001 110.499 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.9 p -92.48 166.19 12.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.474 -0.766 . . . . 1.24 110.252 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.6 -22.78 47.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.335 -0.853 . . . . 1.49 112.142 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.02 -36.65 80.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.919 -1.113 . . . . 2.2799999999999998 111.026 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -85.85 -5.5 59.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.574 -1.329 . . . . 2.0499999999999998 112.501 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.93 -44.55 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.218 -0.926 . . . . 1.3400000000000001 110.478 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -58.73 -40.35 83.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.082 -1.011 . . . . 1.54 110.247 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -64.64 -40.78 96.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.484 -0.76 . . . . 2.8500000000000001 110.965 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -60.72 -39.99 90.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.102 -0.999 . . . . 1.3100000000000001 110.613 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.36 -40.83 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.956 -1.09 . . . . 1.3799999999999999 110.242 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -62.23 -40.82 97.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.941 -1.099 . . . . 1.5 110.365 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -62.01 -41.75 98.42 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.194 -0.941 . . . . 2.7799999999999998 110.131 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -76.12 -51.4 12.27 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.319 -0.863 . . . . 1.0600000000000001 109.973 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.03 -49.03 79.44 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.741 -0.784 . . . . 1.3999999999999999 109.606 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 t -70.55 -40.84 73.16 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.59 -0.694 . . . . 1.3200000000000001 109.962 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.67 -44.51 96.83 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.118 -1.593 . . . . 0.69999999999999996 109.118 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -57.75 -31.46 66.5 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.498 -1.001 . . . . 3.4399999999999999 109.548 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.63 92.63 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.589 0.709 . . . . 1.3600000000000001 110.194 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -80.23 -40.82 26.3 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.474 -0.767 . . . . 2.8300000000000001 111.035 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.64 90.03 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.56 0.695 . . . . 1.23 109.928 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.9 t -60.71 -40.01 90.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.244 1.021 . . . . 1.9199999999999999 109.238 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.5 78.51 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.824 -0.626 . . . . 1.25 109.804 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -61.27 -50.32 73.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.056 -1.028 . . . . 1.97 110.193 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.86 -39.36 91.63 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.309 -0.869 . . . . 2.1800000000000002 109.897 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -60.21 -41.33 92.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.802 -0.562 . . . . 1.1899999999999999 110.915 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.3 m -67.13 -43.0 83.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.94 -1.1 . . . . 1.3400000000000001 110.244 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.401 HD11 HG22 ' A' ' 57' ' ' ILE . 88.0 mt -59.87 -38.44 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.467 -0.771 . . . . 1.23 110.59 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -53.04 -42.5 65.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 1.5600000000000001 110.865 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -69.87 -33.05 71.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.982 -1.074 . . . . 1.3 110.383 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -63.22 -39.95 96.08 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.175 -1.01 . . . . 2.3199999999999998 109.818 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.78 78.31 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.366 -0.834 . . . . 1.1399999999999999 110.021 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.52 -35.32 29.46 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 119.55 -1.31 . . . . 0.68999999999999995 110.613 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.45 -19.79 38.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.121 -1.223 . . . . 1.48 111.016 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.9 m -89.59 -55.3 3.7 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.852 -0.53 . . . . 1.52 110.274 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.51 -2.74 20.1 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 113.807 1.04 . . . . 1.3100000000000001 113.807 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.05 160.95 26.49 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.746 -0.74 . . . . 0.84999999999999998 112.559 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -52.93 -18.95 2.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.458 -1.025 . . . . 3.8599999999999999 112.697 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -56.99 -44.18 82.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.049 -1.032 . . . . 2.3500000000000001 110.842 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -84.57 -21.01 30.57 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.606 -1.309 . . . . 2.2599999999999998 111.534 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -59.83 -38.61 82.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.567 -0.708 . . . . 1.45 110.956 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.98 82.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.457 -0.777 . . . . 1.25 111.693 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.9 mt -63.72 -45.01 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.586 -1.321 . . . . 1.26 110.518 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -69.23 -32.37 71.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.82999999999999996 110.508 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -62.36 -40.11 95.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.532 -0.867 . . . . 1.1899999999999999 110.597 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.55 -39.88 98.42 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 120.133 -1.032 . . . . 0.57999999999999996 110.713 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -58.68 -41.69 86.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.295 -1.12 . . . . 2.0499999999999998 110.44 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.3 mt -60.04 -36.46 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.932 -1.105 . . . . 1.21 110.448 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.3 ttm -59.8 -39.43 84.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.852 . . . . 2.29 110.61 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 tp -60.82 -48.79 80.2 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.591 -0.844 . . . . 1.21 110.007 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.46 -42.59 96.48 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.458 0.647 . . . . 1.1399999999999999 110.949 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -87.56 5.65 38.28 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.271 -0.893 . . . . 1.4199999999999999 113.05 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -60.59 121.19 11.57 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.689 -1.257 . . . . 1.27 108.585 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.15 -18.55 65.4 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.875 0.845 . . . . 1.3500000000000001 110.631 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -75.16 -52.63 10.49 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.675 -0.81 . . . . 2.2200000000000002 110.079 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.32 -37.0 79.22 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.688 -0.805 . . . . 1.22 110.525 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -57.59 -47.86 80.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.199 -0.938 . . . . 1.29 110.992 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.7 -37.27 81.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.436 -0.79 . . . . 2.1699999999999999 110.635 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.58 -48.8 68.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.71 -1.244 . . . . 1.3 110.26 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.2 mt -56.57 -45.96 82.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.923 -1.11 . . . . 1.1699999999999999 109.947 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.0 mt -60.77 -41.9 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.541 0.686 . . . . 1.3999999999999999 110.36 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.7 98.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.905 . . . . 1.3300000000000001 110.711 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.67 -42.49 97.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.048 -1.032 . . . . 1.48 110.679 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.41 -45.59 98.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.204 -0.935 . . . . 1.28 110.323 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.45 ' HZ1' ' CB ' ' A' ' 94' ' ' LYS . 6.8 mtmp? -83.67 -34.5 24.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 2.6000000000000001 112.132 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -80.86 -44.86 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.693 -1.254 . . . . 1.51 111.856 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -102.53 8.36 39.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.593 -0.692 . . . . 2.48 112.318 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.0 m170 49.66 49.02 20.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 1.6100000000000001 111.641 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.4 mtp -101.68 156.58 17.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.583 -0.698 . . . . 1.8999999999999999 109.397 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.3 p -74.14 160.16 31.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.573 -0.529 . . . . 1.3200000000000001 109.573 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.14 -40.52 81.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.155 -0.966 . . . . 1.1499999999999999 110.301 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.406 ' OD1' ' CG2' ' A' ' 141' ' ' ILE . 73.6 m-20 -68.08 -44.09 77.05 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.905 0.86 . . . . 2.25 110.241 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.06 -49.09 63.5 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.625 -0.83 . . . . 1.22 110.955 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.13 87.91 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.267 -0.896 . . . . 1.1899999999999999 110.181 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.54 95.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 1.2 110.539 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -60.29 -36.18 77.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 2.1000000000000001 111.423 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.05 -50.21 74.63 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.039 -1.038 . . . . 1.3 110.954 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -60.24 -48.01 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.552 -1.343 . . . . 1.27 109.947 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -60.92 -31.86 50.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 121.599 -0.688 . . . . 1.1899999999999999 110.331 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -57.08 -41.04 78.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.123 -0.986 . . . . 2.1099999999999999 111.175 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.73 -35.36 11.67 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.231 -1.462 . . . . 0.88 112.191 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -59.99 -40.9 90.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.504 -1.586 . . . . 1.99 110.241 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.48 -51.49 14.65 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.892 0.853 . . . . 1.28 110.224 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.2 m -59.31 -39.85 84.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.307 -0.871 . . . . 2.2200000000000002 110.619 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.79 98.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -0.784 . . . . 1.45 111.064 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.93 -31.11 72.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.725 -1.234 . . . . 1.47 110.961 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -66.43 -22.65 66.22 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.923 -1.111 . . . . 2.04 110.915 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -72.5 -12.41 61.07 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.676 0.751 . . . . 1.73 111.059 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 82.9 mt -86.53 149.54 24.88 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.363 0.602 . . . . 1.79 109.426 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -103.02 39.11 1.61 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.127 -0.983 . . . . 2.8799999999999999 111.769 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -115.78 139.07 50.53 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 121.141 -0.975 . . . . 1.5800000000000001 108.77 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.06 -40.16 84.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 3.04 110.97 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -72.46 -48.82 37.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.846 -1.159 . . . . 1.29 111.068 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 19.3 mt -61.5 -43.43 98.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.878 -1.138 . . . . 1.6000000000000001 110.116 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -63.79 -50.09 70.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.954 . . . . 2.7599999999999998 110.06 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -59.9 -32.89 71.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.415 -0.803 . . . . 2.1499999999999999 110.122 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -63.79 -28.17 69.68 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.716 -1.194 . . . . 2.8100000000000001 109.343 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.82 83.86 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.684 0.754 . . . . 1.3899999999999999 109.685 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.95 -42.35 97.33 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.222 -0.991 . . . . 1.4099999999999999 109.509 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.48 -31.31 71.96 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.313 0.577 . . . . 1.3899999999999999 110.26 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.3 t -68.1 -44.97 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 1.1899999999999999 109.942 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -59.36 -36.15 75.2 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.071 -1.018 . . . . 3.6299999999999999 110.099 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -60.0 -39.69 86.65 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.067 -0.515 . . . . 1.28 110.579 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.48 -40.02 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.206 -0.934 . . . . 1.1799999999999999 109.936 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.02 -41.75 31.53 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 119.838 -1.172 . . . . 0.51000000000000001 110.691 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.617 ' HZ2' ' CZ ' ' A' ' 139' ' ' ARG . 16.6 ttpp -58.29 -41.94 85.49 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.305 -1.115 . . . . 3.1699999999999999 110.355 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.408 ' NH1' ' HG2' ' A' ' 136' ' ' ARG . 63.7 mtt-85 -63.31 -44.58 94.58 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.478 -0.889 . . . . 2.8500000000000001 110.019 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 32.2 tp -60.84 -42.06 97.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.625 -0.672 . . . . 1.6499999999999999 110.084 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.1 mt -59.76 -40.83 89.46 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.377 -0.827 . . . . 1.2 110.367 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.617 ' CZ ' ' HZ2' ' A' ' 135' ' ' LYS . 99.2 mtt180 -61.33 -36.16 79.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.188 -0.945 . . . . 2.7999999999999998 110.806 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -74.31 -41.36 61.28 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.218 -0.993 . . . . 2.1499999999999999 110.698 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.406 ' CG2' ' OD1' ' A' ' 101' ' ' ASP . 88.5 mt -60.48 -39.02 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.335 -0.853 . . . . 1.21 110.454 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 70.0 mt -85.09 -8.01 58.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.968 -1.082 . . . . 1.3400000000000001 112.263 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.12 15.6 80.14 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 120.334 -0.936 . . . . 0.91000000000000003 112.314 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 27.7 tp -70.0 142.37 52.8 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.715 0.769 . . . . 1.51 109.474 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -68.35 151.27 47.11 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.313 -0.867 . . . . 2.8799999999999999 110.205 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.1 mt -104.61 135.17 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.261 -1.014 . . . . 1.6200000000000001 108.261 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.494 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.1 mp -78.49 117.91 24.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.696 -0.853 . . . . 2.1099999999999999 108.696 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -99.35 103.32 15.13 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.263 -1.755 . . . . 1.6200000000000001 106.263 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -74.12 -15.21 61.05 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.604 -0.685 . . . . 1.3999999999999999 111.573 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -81.59 1.8 32.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.224 -0.922 . . . . 2.0499999999999998 112.279 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.44 23.85 8.02 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.317 -0.864 . . . . 1.3500000000000001 112.546 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.5 mt -72.41 139.92 18.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.102 -0.999 . . . . 1.4199999999999999 108.923 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -110.52 -18.88 13.1 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.865 0.841 . . . . 2.9900000000000002 112.611 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -114.33 134.17 55.15 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.802 -1.185 . . . . 1.54 107.802 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.54 127.57 33.2 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.039 -1.038 . . . . 1.3799999999999999 108.402 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.84 173.49 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.014 -0.736 . . . . 1.28 109.014 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 29.6 mt -86.75 139.58 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.396 -0.965 . . . . 1.1599999999999999 108.396 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.5 tp -94.7 122.94 37.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.119 -0.988 . . . . 1.3100000000000001 108.681 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.48 131.17 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.091 -1.077 . . . . 1.25 108.091 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.7 153.7 21.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 1.26 108.73 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.471 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -62.5 -36.29 82.09 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.502 -1.374 . . . . 1.6000000000000001 109.411 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 57.7 t0 -170.86 150.54 3.21 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.651 -0.87 . . . . 2.4199999999999999 108.651 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.468 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 79.8 mt -119.19 143.21 47.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.27 -0.894 . . . . 1.3500000000000001 109.261 177.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.4 p -91.83 146.49 33.09 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 120.988 -1.07 . . . . 1.3200000000000001 108.625 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -39.31 -42.62 2.48 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.216 1.944 . . . . 0.69999999999999996 114.045 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.3 m -59.81 -48.33 82.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 1.1200000000000001 110.154 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -64.5 -39.95 94.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.002 -1.061 . . . . 1.21 110.284 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.581 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 35.0 p -68.47 -35.0 76.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.608 -0.683 . . . . 1.1899999999999999 110.659 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.68 88.36 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.424 -0.798 . . . . 1.24 110.364 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -93.21 -1.21 56.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.318 -0.864 . . . . 1.6899999999999999 112.597 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.71 150.87 35.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.342 -0.849 . . . . 1.3400000000000001 109.361 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -94.76 115.03 27.01 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 107.331 -1.359 . . . . 2.77 107.331 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 23.1 mt -73.83 -20.39 60.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.864 -0.523 . . . . 2.0899999999999999 111.459 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -83.03 -23.04 33.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 2.6699999999999999 112.252 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -100.88 -1.88 33.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.263 0.838 . . . . 2.5800000000000001 113.263 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.38 125.52 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.648 -1.241 . . . . 1.1799999999999999 107.648 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 13.0 tp -84.25 -4.1 58.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 2.1800000000000002 111.796 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 165.83 170.31 30.59 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.858 -1.697 . . . . 0.48999999999999999 108.858 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.09 129.33 47.76 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 107.785 -1.191 . . . . 0.64000000000000001 107.785 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 87.2 mt -130.99 109.85 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 106.409 -1.7 . . . . 1.21 106.409 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.437 ' O ' ' O ' ' A' ' 203' ' ' VAL . 66.9 p -127.39 169.86 13.15 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.974 -1.079 . . . . 1.3799999999999999 109.586 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 21.4 p-10 -101.67 53.43 0.82 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.719 -0.613 . . . . 2.3700000000000001 110.643 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -99.53 133.37 43.95 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.371 -0.974 . . . . 1.52 108.371 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.4 3.17 4.82 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.733 -1.222 . . . . 1.8 112.638 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 92.92 -4.68 75.43 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.247 -1.149 . . . . 2.04 113.198 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.448 ' O ' ' CG ' ' A' ' 186' ' ' ARG . 26.2 ptt180 -81.63 118.36 22.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.813 -1.551 . . . . 5.0 106.813 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 73.5 p 46.95 40.28 9.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.763 -1.211 . . . . 3.02 111.881 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 82.0 p -84.34 109.44 17.83 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.029 -1.471 . . . . 2.1099999999999999 107.029 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.581 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 17.3 t60 -61.54 -32.97 73.06 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.509 -0.744 . . . . 1.24 110.811 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.3 p -57.13 -40.3 76.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.748 -1.22 . . . . 2.1499999999999999 110.218 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.0 t -60.17 -39.62 87.11 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.018 -1.051 . . . . 2.02 109.892 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.1 mm -59.88 -40.13 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 2.1200000000000001 110.351 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.4 mtp -65.06 -42.74 93.92 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.339 1.066 . . . . 1.3600000000000001 109.605 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.28 -47.42 86.06 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.797 -0.638 . . . . 1.29 110.979 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -61.38 -42.79 99.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.977 -1.077 . . . . 3.5600000000000001 110.436 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 72.4 m -70.59 -42.73 70.63 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.956 0.884 . . . . 1.1799999999999999 110.127 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.2 mt -91.84 -8.14 47.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.46 -0.775 . . . . 1.3400000000000001 112.182 -177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 54.43 9.78 0.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.912 1.078 . . . . 1.45 113.912 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 37.7 mt -70.14 164.97 48.0 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.079 -1.013 . . . . 1.25 109.283 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -70.68 144.28 48.69 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.7 1.6 . . . . 0.78000000000000003 110.444 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.91 166.11 28.95 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.701 -1.6 . . . . 1.2 109.611 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 65.0 mt -146.9 156.48 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.447 -1.316 . . . . 1.25 107.447 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.5 m -140.94 -31.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 O-C-N 120.687 -1.258 . . . . 1.3899999999999999 112.366 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.05 43.29 2.44 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.007 -1.058 . . . . 0.96999999999999997 111.997 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 30.6 p -63.03 -16.73 60.85 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.134 -1.216 . . . . 1.3500000000000001 111.202 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.96 -94.71 1.0 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 110.14 -1.184 . . . . 1.0700000000000001 110.14 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 86.8 p -129.07 30.92 4.97 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.607 -0.937 . . . . 1.9199999999999999 111.716 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.13 -38.18 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.506 -1.371 . . . . 1.3300000000000001 110.165 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 76.2 p -52.86 -25.81 12.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 1.4199999999999999 111.379 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.9 p -96.27 6.2 49.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 2.1200000000000001 111.814 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -128.82 -4.17 5.19 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 113.136 0.791 . . . . 2.6899999999999999 113.136 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 13.4 t -117.96 149.51 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.675 0.75 . . . . 1.29 109.784 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -118.46 152.53 35.73 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.079 -1.082 . . . . 2.6899999999999999 108.079 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 40.4 p-10 -54.31 146.3 15.85 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.932 -1.107 . . . . 2.79 110.113 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 t70 81.07 -3.42 1.74 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 114.304 1.224 . . . . 2.3500000000000001 114.304 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.76 146.16 53.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.948 -1.095 . . . . 1.97 108.74 177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -88.78 120.22 29.99 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.003 -1.48 . . . . 2.9700000000000002 107.003 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 84.1 mt -126.67 143.39 51.25 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.274 -0.891 . . . . 1.25 109.846 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.7 mt -109.53 121.37 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.859 -1.534 . . . . 1.22 106.859 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 32.8 tp -98.91 109.79 22.49 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.12 -1.807 . . . . 1.24 106.12 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.9 p30 -93.76 -22.52 18.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.907 -1.121 . . . . 2.0499999999999998 112.958 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.566 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 37.64 19.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.58 0.705 . . . . 1.25 112.804 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.7 t -108.42 -60.14 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.015 -1.053 . . . . 1.4299999999999999 108.837 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -88.7 8.25 29.62 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.159 0.98 . . . . 3.0299999999999998 110.028 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 65.86 49.55 1.65 Allowed 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.9 -1.045 . . . . 2.25 111.944 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.51 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 16.8 pt20 -154.65 156.34 36.3 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.642 1.21 . . . . 2.52 110.873 178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 54.8 t -118.14 141.58 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 115.176 -0.92 . . . . 1.29 108.626 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.51 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 94.8 m-85 -100.98 139.09 37.16 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.961 -1.087 . . . . 1.3400000000000001 108.431 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.1 t -111.11 129.71 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 107.945 -1.132 . . . . 1.3400000000000001 107.945 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.429 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 4.1 t30 49.57 50.17 8.66 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 113.4 0.889 . . . . 2.1800000000000002 113.4 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 29.8 Cg_endo -65.14 151.71 84.68 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.42 2.08 . . . . 0.93999999999999995 110.41 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 35.9 p -73.4 159.63 33.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.053 -1.029 . . . . 2.3999999999999999 108.84 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -63.26 -33.81 76.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.365 -0.834 . . . . 3.3300000000000001 111.143 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.22 -39.25 82.11 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.081 -1.012 . . . . 3.1699999999999999 110.699 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 98.2 t -71.94 -39.34 66.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.264 -0.897 . . . . 1.6899999999999999 110.77 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.0 mt -58.11 -46.79 88.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.178 -0.951 . . . . 1.6000000000000001 110.154 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.01 -42.62 94.7 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.58 -0.848 . . . . 2.7000000000000002 110.748 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -61.98 -42.66 99.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.006 -1.058 . . . . 2.96 110.892 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 86.6 mtp -70.42 -38.45 74.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 1.6299999999999999 110.87 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.433 ' HG3' ' NH1' ' A' ' 240' ' ' ARG . 22.5 mmm-85 -59.19 -39.75 83.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.849 -1.157 . . . . 3.27 110.963 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -71.29 -57.12 4.77 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.523 -0.736 . . . . 2.23 110.682 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.13 -42.29 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.076 -1.015 . . . . 2.79 111.101 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.74 -54.28 47.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.896 -1.128 . . . . 4.2599999999999998 110.621 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.19 -30.97 72.0 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.928 -1.107 . . . . 1.8799999999999999 110.244 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -60.81 -31.03 70.44 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.437 -0.905 . . . . 3.3799999999999999 109.459 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.79 -45.63 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.46 -0.896 . . . . 2.8799999999999999 109.717 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.35 98.88 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.47 0.652 . . . . 2.75 110.174 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.0 t -70.26 -32.42 70.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 3.4199999999999999 110.811 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.92 -39.91 93.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.16 -0.963 . . . . 3.5699999999999998 111.117 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -64.98 -37.89 89.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.954 -1.091 . . . . 4.6100000000000003 110.648 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -68.03 -34.26 76.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 4.4500000000000002 110.681 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -69.57 -30.84 68.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 5.9699999999999998 111.304 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.474 ' C ' ' CD1' ' A' ' 253' ' ' LEU . 2.7 tm? -60.71 -46.79 89.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.913 -1.117 . . . . 6.4500000000000002 110.627 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -69.26 -37.14 77.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.097 -1.002 . . . . 6.6600000000000001 110.399 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -89.48 25.09 2.06 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.166 0.802 . . . . 8.5399999999999991 113.166 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.47 -3.97 46.13 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.177 -0.952 . . . . 8.0700000000000003 112.2 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -84.41 -14.01 50.57 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.784 -1.197 . . . . 9.7200000000000006 112.545 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -101.79 -28.78 12.25 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.072 -1.018 . . . . 10.119999999999999 112.828 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.859 -1.067 . . . . 11.9 109.686 -177.929 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.2 mtm . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 109.387 -0.598 . . . . 3.5299999999999998 109.387 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.9 mt -93.88 111.41 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 106.564 -1.643 . . . . 1.5700000000000001 106.564 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.1 m -104.9 120.57 41.75 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.004 -1.11 . . . . 1.4399999999999999 108.004 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.08 -158.5 22.21 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.74 -1.744 . . . . 1.01 108.74 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 84.4 mt -96.26 -0.59 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.303 -1.116 . . . . 1.6299999999999999 113.002 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tp 50.06 98.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.925 -1.109 . . . . 1.5800000000000001 112.583 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.13 -45.12 12.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.106 -0.996 . . . . 1.3400000000000001 110.849 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -146.58 140.87 15.62 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 107.639 -1.245 . . . . 1.8600000000000001 107.639 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.38 150.75 41.86 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.506 2.138 . . . . 1.01 112.345 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 152.41 170.34 18.8 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 108.992 -1.643 . . . . 0.81000000000000005 108.992 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.575 ' O ' ' NE2' ' A' ' 243' ' ' GLN . 98.5 mt -129.86 138.8 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.026 -1.279 . . . . 1.3700000000000001 108.288 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.35 149.88 38.36 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.054 -1.029 . . . . 1.1399999999999999 109.417 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.3 m-85 -122.04 139.83 53.23 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.969 -1.123 . . . . 0.87 107.969 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.24 171.21 41.34 Favored Glycine 0 N--CA 1.499 2.848 0 C-N-CA 118.746 -1.692 . . . . 0.56999999999999995 110.213 178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -76.4 158.77 31.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.604 -0.939 . . . . 2.3500000000000001 108.742 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.59 132.83 33.8 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.225 -0.922 . . . . 1.21 108.827 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.6 tp -110.63 102.69 11.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.78 -1.933 . . . . 1.3999999999999999 105.78 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.8 tp -91.51 136.84 32.83 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.078 -1.082 . . . . 1.4399999999999999 108.078 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.5 mt -102.34 116.23 32.2 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.947 -1.501 . . . . 1.45 106.947 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -111.18 137.88 48.32 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.656 -1.238 . . . . 2.5 107.656 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -125.65 149.66 48.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.089 -1.007 . . . . 2.6600000000000001 108.864 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -85.21 137.56 32.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.736 -1.209 . . . . 2.3199999999999998 107.736 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -63.3 148.29 48.7 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.599 -0.84 . . . . 2.1099999999999999 108.818 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -92.55 135.38 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.403 -0.962 . . . . 1.29 108.403 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.7 t -104.4 130.16 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.061 -1.089 . . . . 1.4099999999999999 108.061 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.1 mt -98.32 135.22 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.278 -1.008 . . . . 1.3100000000000001 108.278 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -90.64 119.23 30.71 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 106.948 -1.501 . . . . 1.3400000000000001 106.948 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.432 HH11 ' HG3' ' A' ' 28' ' ' ARG . 19.1 mmm-85 -96.81 11.74 34.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 3.48 112.111 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -72.01 152.26 42.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.176 -0.952 . . . . 2.52 109.619 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -91.71 135.14 34.12 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.54 -0.911 . . . . 2.6299999999999999 108.54 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -94.64 167.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.886 -1.133 . . . . 1.3100000000000001 109.957 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.5 p -93.8 166.06 12.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.112 -0.993 . . . . 1.24 109.332 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.06 -19.81 34.57 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.876 -1.14 . . . . 1.49 112.814 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 60.1 t0 -70.01 -38.06 75.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.784 -1.197 . . . . 2.2799999999999998 110.749 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -86.38 -11.0 53.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.809 -1.182 . . . . 2.0499999999999998 112.202 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.34 -43.94 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.003 -1.061 . . . . 1.3400000000000001 110.362 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.1 -39.81 83.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.357 -0.839 . . . . 1.54 110.621 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -63.68 -42.66 98.0 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.25 -0.907 . . . . 2.8500000000000001 111.019 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -61.53 -38.78 88.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.986 -1.071 . . . . 1.3100000000000001 110.901 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.4 t -60.0 -45.4 95.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.155 -0.965 . . . . 1.3799999999999999 110.329 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -61.55 -45.49 93.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.975 . . . . 1.5 110.081 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.65 -43.31 97.77 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.387 -0.821 . . . . 2.7799999999999998 110.286 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -71.41 -56.94 4.97 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.185 -0.947 . . . . 1.0600000000000001 109.987 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.6 tp -58.18 -47.46 83.34 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.203 -0.999 . . . . 1.3999999999999999 109.786 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 t -69.95 -37.47 75.86 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.141 -0.975 . . . . 1.3200000000000001 109.997 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.45 -46.89 91.43 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.912 -1.137 . . . . 0.69999999999999996 110.366 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -59.83 -30.6 69.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.406 -1.056 . . . . 3.4399999999999999 109.437 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.16 -45.2 87.87 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.163 -0.615 . . . . 1.3600000000000001 109.868 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -80.8 -42.26 22.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 2.8300000000000001 110.885 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.43 85.5 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.599 -0.841 . . . . 1.23 109.42 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 t -60.68 -41.13 94.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.217 1.008 . . . . 1.9199999999999999 109.077 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.47 -46.07 77.59 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.62 -0.718 . . . . 1.25 110.144 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -62.92 -49.98 72.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.092 -1.005 . . . . 1.97 109.997 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.1 mt -61.69 -40.01 93.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.163 -0.96 . . . . 2.1800000000000002 109.978 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -60.15 -40.02 88.41 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.93 -0.481 . . . . 1.1899999999999999 110.497 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.2 m -65.59 -45.01 84.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.924 -1.11 . . . . 1.3400000000000001 110.043 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.57 -37.84 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 1.23 110.3 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.432 ' NZ ' ' OE2' ' A' ' 70' ' ' GLU . 9.0 ttpp -49.25 -43.4 42.83 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.968 -0.693 . . . . 1.5600000000000001 110.915 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -69.54 -38.99 77.72 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.581 -0.699 . . . . 1.3 109.659 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.01 -40.32 93.09 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.46 -1.296 . . . . 2.3199999999999998 108.996 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.24 77.73 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.922 -0.711 . . . . 1.1399999999999999 109.835 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.47 -36.74 19.42 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.704 -1.236 . . . . 0.68999999999999995 110.939 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -80.79 -27.28 36.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.041 -1.27 . . . . 1.48 111.125 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -83.9 -49.87 8.6 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.565 -0.709 . . . . 1.52 111.021 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.87 -5.08 18.55 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.031 1.123 . . . . 1.3100000000000001 114.031 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.88 163.84 28.97 Favored Glycine 0 N--CA 1.502 3.096 0 O-C-N 121.291 -0.881 . . . . 0.84999999999999998 111.82 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -56.49 -24.34 45.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.685 -0.891 . . . . 3.8599999999999999 112.218 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.6 -39.93 68.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 2.3500000000000001 110.715 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -87.72 -25.03 23.66 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.931 -1.106 . . . . 2.2599999999999998 111.386 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.432 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 71.1 tt0 -59.72 -37.31 78.54 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.489 0.661 . . . . 1.45 110.647 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.96 74.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 1.25 111.341 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.55 -42.37 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.634 -1.291 . . . . 1.26 110.517 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -70.13 -31.66 69.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.392 -0.817 . . . . 0.82999999999999996 110.252 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -59.99 -38.44 82.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.042 -1.036 . . . . 1.1899999999999999 110.278 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.48 -39.87 86.85 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.004 -1.238 . . . . 0.57999999999999996 110.004 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -60.21 -45.72 92.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.273 -1.133 . . . . 2.0499999999999998 110.312 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.5 mt -60.92 -39.34 81.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.193 -0.942 . . . . 1.21 110.318 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.7 ttm -56.9 -40.55 76.47 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.594 -0.842 . . . . 2.29 110.101 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -59.52 -50.05 75.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 1.21 109.992 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.4 tp -61.88 -41.04 97.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.502 -0.748 . . . . 1.1399999999999999 110.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -86.38 8.05 23.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.506 -0.746 . . . . 1.4199999999999999 112.518 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -65.5 125.69 25.98 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.448 -1.407 . . . . 1.27 108.346 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.0 -18.73 65.52 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.107 0.956 . . . . 1.3500000000000001 110.711 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -76.46 -54.65 6.42 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.752 -0.779 . . . . 2.2200000000000002 110.428 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.68 -35.15 75.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.408 -0.807 . . . . 1.22 110.962 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -59.93 -49.19 78.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.416 -0.802 . . . . 1.29 110.522 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -61.6 -35.72 78.65 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.61 -0.681 . . . . 2.1699999999999999 110.625 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.82 -46.87 73.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.02 . . . . 1.3 110.619 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.8 mt -59.51 -46.52 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.146 -0.971 . . . . 1.1699999999999999 109.718 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.7 mt -62.18 -41.25 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.446 0.641 . . . . 1.3999999999999999 110.529 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.5 -44.24 97.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.103 -0.998 . . . . 1.3300000000000001 110.741 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.58 -42.31 96.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.045 -1.034 . . . . 1.48 110.434 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.58 -49.43 83.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.034 -1.041 . . . . 1.28 110.386 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -82.8 -31.48 28.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.157 -0.965 . . . . 2.6000000000000001 111.644 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 91' ' ' ALA . 35.8 t0 -83.03 -45.83 13.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.735 -1.228 . . . . 1.51 111.886 -178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -103.26 11.24 37.06 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.307 -0.87 . . . . 2.48 111.998 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.2 m80 51.3 51.95 15.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.441 -0.787 . . . . 1.6100000000000001 111.999 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -105.89 151.93 23.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.456 -0.777 . . . . 1.8999999999999999 109.178 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 68.7 p -71.61 161.92 30.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.43 -0.794 . . . . 1.3200000000000001 109.583 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.95 -44.4 91.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.261 -0.899 . . . . 1.1499999999999999 110.875 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 21.0 p-10 -68.71 -39.25 80.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.996 -1.065 . . . . 2.25 110.133 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -48.21 63.78 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.727 -0.789 . . . . 1.22 111.176 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.35 77.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.242 -0.911 . . . . 1.1899999999999999 110.577 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.7 89.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.448 -0.783 . . . . 1.2 110.656 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.9 -39.48 89.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.852 -1.155 . . . . 2.1000000000000001 110.937 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.53 -48.74 79.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.857 -1.152 . . . . 1.3 110.742 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.9 t -59.74 -47.91 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.707 -1.246 . . . . 1.27 109.877 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.0 mm -61.71 -35.64 68.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.934 -0.479 . . . . 1.1899999999999999 110.617 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -56.58 -40.2 74.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.893 -1.129 . . . . 2.1099999999999999 111.073 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.36 -28.89 23.67 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.346 -1.407 . . . . 0.88 113.185 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -62.35 -39.94 94.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.466 -1.608 . . . . 1.99 109.973 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.03 -48.49 35.72 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.787 0.803 . . . . 1.28 110.517 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.4 m -61.45 -40.62 95.14 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.208 -0.597 . . . . 2.2200000000000002 110.239 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.55 95.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.503 -0.748 . . . . 1.45 110.63 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.46 -28.28 69.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.903 -1.123 . . . . 1.47 110.826 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -66.34 -23.24 66.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.561 0.696 . . . . 2.04 110.917 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -76.33 -11.0 59.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.728 -0.608 . . . . 1.73 111.438 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.0 mt -87.27 138.78 31.19 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.038 -1.097 . . . . 1.79 108.038 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 14.2 t70 -96.24 62.52 2.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.308 -0.87 . . . . 2.8799999999999999 110.48 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -138.36 135.96 35.87 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 107.574 -1.269 . . . . 1.5800000000000001 107.574 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -59.18 -37.26 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 3.04 110.837 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -71.21 -55.68 7.62 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.809 -1.182 . . . . 1.29 110.402 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.9 mt -60.83 -38.41 85.4 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.109 -0.994 . . . . 1.6000000000000001 110.704 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -60.7 -49.53 77.12 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.952 -1.099 . . . . 2.7599999999999998 109.507 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -60.21 -30.41 69.36 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.49 -0.884 . . . . 2.1499999999999999 109.431 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -62.26 -29.86 70.71 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.06 -1.056 . . . . 2.8100000000000001 109.03 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.98 75.47 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.939 0.876 . . . . 1.3899999999999999 109.32 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -42.55 77.26 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.881 -0.6 . . . . 1.4099999999999999 110.513 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -62.78 -36.52 83.38 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.626 0.727 . . . . 1.3899999999999999 110.25 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.21 -39.41 79.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.406 -0.809 . . . . 1.1899999999999999 110.14 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.9 ttm-85 -56.4 -38.96 72.22 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 118.912 -1.115 . . . . 3.6299999999999999 109.489 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -60.02 -38.6 83.18 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.391 0.615 . . . . 1.28 110.121 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.3 mt -60.33 -39.93 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.703 -0.623 . . . . 1.1799999999999999 110.027 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.85 -43.79 40.45 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.925 -1.131 . . . . 0.51000000000000001 110.734 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -57.19 -42.5 81.33 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.145 -1.209 . . . . 3.1699999999999999 110.099 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 -62.95 -40.69 98.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.13 -0.981 . . . . 2.8500000000000001 109.815 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.84 -45.95 92.45 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.534 -0.729 . . . . 1.6499999999999999 110.122 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.69 -42.17 92.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.585 -0.697 . . . . 1.2 110.62 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -60.27 -37.59 80.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.518 -0.739 . . . . 2.7999999999999998 110.831 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -75.28 -41.38 57.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 2.1499999999999999 111.191 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.02 -42.17 88.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.991 -1.068 . . . . 1.21 110.292 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.2 -11.0 36.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.926 -1.109 . . . . 1.3400000000000001 112.276 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.07 26.82 61.29 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 119.611 -1.281 . . . . 0.91000000000000003 113.11 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 22.3 tp -62.57 149.83 42.1 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.713 -0.875 . . . . 1.51 108.96 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -64.55 149.02 49.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 2.8799999999999999 109.603 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 70.4 mt -106.7 142.73 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.547 -0.908 . . . . 1.6200000000000001 108.547 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.507 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.9 mp -78.75 129.82 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.001 -1.062 . . . . 2.1099999999999999 108.253 178.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -97.8 87.17 3.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.221 -1.029 . . . . 1.6200000000000001 108.221 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.97 -24.92 60.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.369 -0.832 . . . . 1.3999999999999999 111.302 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' A' ' 172' ' ' ASN . 34.5 t -82.01 -0.54 44.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 2.0499999999999998 112.1 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.49 25.74 7.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.546 -0.721 . . . . 1.3500000000000001 111.6 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 mt -70.96 139.98 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.138 -0.976 . . . . 1.4199999999999999 109.439 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -112.02 -20.18 12.06 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.645 0.735 . . . . 2.9900000000000002 112.073 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -117.63 137.75 52.42 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.704 -1.221 . . . . 1.54 107.704 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.25 128.34 35.37 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.977 -1.119 . . . . 1.3799999999999999 107.977 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.0 m -148.33 176.76 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.064 -0.717 . . . . 1.28 109.064 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 44.4 mt -88.17 143.72 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.138 -0.976 . . . . 1.1599999999999999 109.007 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.5 tp -95.93 120.21 35.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.014 -1.054 . . . . 1.3100000000000001 108.61 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.0 t -120.15 129.58 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 107.506 -1.294 . . . . 1.25 107.506 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.69 151.65 16.9 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.174 -0.954 . . . . 1.26 109.084 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.74 -32.46 72.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.358 -1.464 . . . . 1.6000000000000001 109.616 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -173.42 152.01 2.09 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.655 -0.868 . . . . 2.4199999999999999 108.655 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 41.7 mt -112.73 140.27 47.64 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.382 -0.824 . . . . 1.3500000000000001 108.965 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.9 p -91.11 146.87 34.44 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.072 -1.018 . . . . 1.3200000000000001 108.852 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -39.19 -43.02 2.43 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 122.173 1.915 . . . . 0.69999999999999996 113.405 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.6 m -60.16 -48.5 81.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.066 . . . . 1.1200000000000001 110.234 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -64.68 -39.91 94.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.019 -1.051 . . . . 1.21 109.9 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 43.2 p -65.47 -43.32 90.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.602 -0.686 . . . . 1.1899999999999999 110.978 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.75 82.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 1.24 110.617 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -95.87 -1.14 50.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.171 -0.955 . . . . 1.6899999999999999 112.79 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.74 145.85 51.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.973 -1.079 . . . . 1.3400000000000001 108.181 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' A' ' 150' ' ' SER . 97.6 m-20 -94.99 117.49 30.22 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 106.979 -1.489 . . . . 2.77 106.979 177.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -72.93 -18.59 61.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.781 -0.574 . . . . 2.0899999999999999 111.151 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -84.06 -16.17 44.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 2.6699999999999999 112.222 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -103.38 -11.97 17.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.538 -0.726 . . . . 2.5800000000000001 112.812 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.9 t -106.15 128.49 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 107.888 -1.153 . . . . 1.1799999999999999 107.888 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.62 -8.41 58.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.031 -1.043 . . . . 2.1800000000000002 112.326 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 177.22 173.94 43.19 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.437 -1.465 . . . . 0.48999999999999999 109.437 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -127.48 131.62 50.12 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 107.79 -1.189 . . . . 0.64000000000000001 107.79 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 62.5 mt -137.18 118.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 105.932 -1.877 . . . . 1.21 105.932 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 203' ' ' VAL . 62.9 p -140.46 170.81 15.11 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.693 -1.254 . . . . 1.3799999999999999 110.08 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -104.09 65.36 0.8 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.791 -0.568 . . . . 2.3700000000000001 109.627 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -104.33 152.22 22.51 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.494 -0.754 . . . . 1.52 109.484 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.45 -38.47 70.04 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 120.222 -0.99 . . . . 1.8 110.864 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.63 -2.37 64.67 Favored Glycine 0 N--CA 1.494 2.561 0 O-C-N 121.094 -1.239 . . . . 2.04 113.292 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 186' ' ' ARG . 3.5 ptt-85 -88.83 101.45 14.05 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.624 -1.991 . . . . 5.0 105.624 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 p 53.4 47.64 23.7 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.993 -1.067 . . . . 3.02 112.001 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 59.1 m -83.63 135.86 34.44 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.697 -1.223 . . . . 2.1099999999999999 107.697 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -59.36 -39.92 84.81 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.286 -0.884 . . . . 1.24 111.026 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.0 m -59.62 -40.33 87.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.898 -1.126 . . . . 2.1499999999999999 110.089 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.2 p -61.88 -35.04 77.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 2.02 110.652 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 32.0 mm -59.99 -39.29 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.519 -0.738 . . . . 2.1200000000000001 110.656 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.4 mtp -62.23 -43.16 99.46 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 122.319 1.057 . . . . 1.3600000000000001 109.595 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.89 -47.76 83.82 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.717 -0.614 . . . . 1.29 110.504 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.481 ' HG2' HH11 ' A' ' 195' ' ' ARG . 33.8 mtt-85 -60.12 -41.34 92.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 3.5600000000000001 110.586 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.7 m -70.13 -41.53 73.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.182 -0.949 . . . . 1.1799999999999999 110.079 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.83 -8.18 50.28 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.577 0.703 . . . . 1.3400000000000001 112.49 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 194' ' ' ALA . 94.5 mt-10 49.6 12.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.82 1.045 . . . . 1.45 113.82 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.57 149.06 93.31 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 107.872 -1.159 . . . . 1.25 107.872 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.34 135.86 71.0 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 120.948 1.099 . . . . 0.78000000000000003 110.017 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.75 163.11 34.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.31 -1.494 . . . . 1.2 109.397 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 32.2 mt -146.79 147.51 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.639 -1.245 . . . . 1.25 107.639 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.5 m -125.24 -31.55 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.146 -0.971 . . . . 1.3899999999999999 113.052 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.1 45.01 2.46 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 119.542 -1.313 . . . . 0.96999999999999997 111.016 -178.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 58.6 p -61.86 -19.54 62.73 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.537 -0.978 . . . . 1.3500000000000001 111.372 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.65 -90.7 0.86 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.48 -1.048 . . . . 1.0700000000000001 110.48 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.3 p -130.62 28.69 4.87 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.503 -0.998 . . . . 1.9199999999999999 113.288 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.31 -40.02 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.44 -1.412 . . . . 1.3300000000000001 110.603 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.2 p -58.28 -22.72 53.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.968 -1.082 . . . . 1.4199999999999999 111.707 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.5 p -94.15 -1.88 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.424 -0.797 . . . . 2.1200000000000001 112.183 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -125.88 3.07 7.37 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.645 0.736 . . . . 2.6899999999999999 112.436 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 22.4 t -116.13 146.54 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.528 -0.733 . . . . 1.29 109.263 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -119.81 160.45 22.61 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.998 -1.112 . . . . 2.6899999999999999 107.998 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 3.7 m120 -57.36 139.81 51.96 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.85 -1.156 . . . . 2.79 110.812 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 79.11 5.55 2.23 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.193 1.182 . . . . 2.3500000000000001 114.193 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 61.0 t0 -66.08 149.08 50.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.911 -1.118 . . . . 1.97 108.437 177.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.496 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 36.3 t80 -89.82 122.18 32.65 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.916 -1.513 . . . . 2.9700000000000002 106.916 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.4 mt -129.52 147.53 51.34 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.035 0.922 . . . . 1.25 110.105 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 21.0 mt -119.92 130.75 73.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.408 -1.33 . . . . 1.22 107.408 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 60.8 tp -99.65 120.2 39.31 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.407 -1.331 . . . . 1.24 107.407 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 223' ' ' VAL . 33.5 t0 -89.77 -35.78 15.52 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.976 -1.077 . . . . 2.0499999999999998 111.431 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.405 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 39.78 17.75 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.566 0.698 . . . . 1.25 112.459 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.1 t -109.15 -58.25 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.168 -0.957 . . . . 1.4299999999999999 109.33 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.448 HD21 ' NE2' ' A' ' 226' ' ' GLN . 56.6 t30 -95.69 14.72 22.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.961 0.886 . . . . 3.0299999999999998 110.598 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.93 52.27 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.608 -0.724 . . . . 2.25 112.834 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.52 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 28.8 pt20 -151.93 157.13 41.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.031 -1.043 . . . . 2.52 110.168 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.35 135.19 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.071 -1.085 . . . . 1.29 108.071 177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.52 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 83.4 m-85 -103.24 130.01 50.36 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.065 -1.022 . . . . 1.3400000000000001 108.588 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.9 t -110.53 129.85 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.991 -1.114 . . . . 1.3400000000000001 107.991 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.443 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 61.8 t30 53.59 48.75 5.26 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 113.434 0.902 . . . . 2.1800000000000002 113.434 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 37.0 Cg_endo -65.73 153.5 77.88 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.656 2.237 . . . . 0.93999999999999995 110.911 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.0 p -72.17 160.21 32.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.997 -1.065 . . . . 2.3999999999999999 110.134 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -60.19 -37.96 81.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.216 -0.928 . . . . 3.3300000000000001 110.642 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.98 -39.16 84.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 3.1699999999999999 110.558 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.7 -35.71 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.207 -0.933 . . . . 1.6899999999999999 110.176 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.71 -45.28 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.351 -0.843 . . . . 1.6000000000000001 110.598 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -59.24 -41.07 87.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.975 -1.078 . . . . 2.7000000000000002 110.585 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -65.87 -42.97 89.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.509 -0.745 . . . . 2.96 110.97 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.2 mtp -71.28 -39.39 71.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.955 . . . . 1.6299999999999999 111.01 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -57.0 -38.67 73.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.867 -1.145 . . . . 3.27 110.375 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 245' ' ' GLN . . . -70.33 -39.32 74.8 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.506 -0.746 . . . . 2.23 111.137 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 98.7 t -56.43 -49.57 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.915 -1.116 . . . . 2.79 111.17 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.575 ' NE2' ' O ' ' A' ' 11' ' ' ILE . 39.5 tt0 -64.14 -50.85 66.58 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.761 -1.212 . . . . 4.2599999999999998 109.954 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.47 -31.91 72.72 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.617 -0.719 . . . . 1.8799999999999999 110.414 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 241' ' ' ALA . 63.5 tt0 -60.67 -32.18 71.39 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.827 -1.149 . . . . 3.3799999999999999 109.19 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 88.0 t -62.46 -45.48 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 119.583 -0.847 . . . . 2.8799999999999999 109.787 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.02 81.36 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.666 0.746 . . . . 2.75 110.024 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.9 t -68.25 -32.18 72.18 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.767 -0.583 . . . . 3.4199999999999999 110.739 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -61.36 -49.75 75.68 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.295 -0.962 . . . . 3.5699999999999998 110.298 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -70.38 -34.15 72.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.373 -0.829 . . . . 4.6100000000000003 110.054 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.9 0.71 17.33 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 113.121 0.786 . . . . 4.4500000000000002 113.121 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -62.67 -23.9 67.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.175 -0.953 . . . . 5.9699999999999998 111.668 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.73 -21.56 63.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.28 -0.888 . . . . 6.4500000000000002 111.667 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.12 97.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 6.6600000000000001 111.36 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -82.25 -4.51 57.26 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.86 -1.15 . . . . 8.5399999999999991 112.779 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.24 44.15 1.16 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.937 -1.102 . . . . 8.0700000000000003 111.463 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -78.82 2.67 19.14 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.789 -0.765 . . . . 9.7200000000000006 112.164 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -91.85 14.23 16.12 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.525 0.679 . . . . 10.119999999999999 112.152 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.249 -0.881 . . . . 11.9 108.704 179.34 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.596 0.712 . . . . 3.5299999999999998 109.718 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.5 mt -95.68 112.43 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 106.544 -1.65 . . . . 1.5700000000000001 106.544 176.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.8 m -102.09 124.51 47.82 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.634 -1.247 . . . . 1.4399999999999999 107.634 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' A' ' 225' ' ' ASN . . . -118.42 -160.72 11.6 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.77 -1.732 . . . . 1.01 108.77 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 90.2 mt -95.8 1.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.372 -1.075 . . . . 1.6299999999999999 112.711 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.91 97.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 1.5800000000000001 112.195 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.41 -37.4 18.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.36 -0.837 . . . . 1.3400000000000001 111.477 179.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -150.6 145.71 18.75 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 120.682 -1.261 . . . . 1.8600000000000001 107.738 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.45 144.77 23.08 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 122.647 2.231 . . . . 1.01 112.121 178.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 222' ' ' ALA . . . 154.65 170.69 20.7 Favored Glycine 0 N--CA 1.504 3.197 0 N-CA-C 109.556 -1.417 . . . . 0.81000000000000005 109.556 178.032 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.5 mt -133.24 133.68 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 107.71 -1.219 . . . . 1.3700000000000001 107.71 179.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.0 151.94 41.4 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.19 -0.944 . . . . 1.1399999999999999 109.305 179.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.48 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 11.2 m-85 -119.25 140.82 49.62 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.668 -0.864 . . . . 0.87 108.668 177.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.19 169.22 41.4 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 118.586 -1.769 . . . . 0.56999999999999995 110.472 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -77.76 158.18 29.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.688 -0.889 . . . . 2.3500000000000001 109.076 177.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.42 126.74 33.53 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.957 -1.089 . . . . 1.21 108.291 178.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.0 tp -110.11 102.27 10.99 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.621 -1.992 . . . . 1.3999999999999999 105.621 178.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 tp -88.42 140.33 29.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.937 -1.102 . . . . 1.4399999999999999 108.922 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.8 mt -99.86 119.72 38.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.923 -1.111 . . . . 1.45 108.061 178.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -110.31 141.01 43.91 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.22 -1.029 . . . . 2.5 108.22 179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -118.67 141.32 48.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.103 -0.998 . . . . 2.6600000000000001 109.281 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -82.91 133.68 35.11 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.746 -1.205 . . . . 2.3199999999999998 107.746 177.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -62.95 149.13 45.52 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.759 -0.83 . . . . 2.1099999999999999 108.759 178.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.6 mt -95.15 133.79 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.584 -0.895 . . . . 1.29 108.584 178.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 t -103.6 130.14 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.936 -1.135 . . . . 1.4099999999999999 107.936 178.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.0 mt -98.31 133.12 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.287 -1.005 . . . . 1.3100000000000001 108.287 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -87.28 119.51 27.61 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.249 -1.389 . . . . 1.3400000000000001 107.249 178.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -101.37 20.02 16.68 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.86 -0.525 . . . . 3.48 111.619 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -63.27 149.89 44.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.254 -0.904 . . . . 2.52 110.154 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -91.33 125.38 36.08 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.47 -1.307 . . . . 2.6299999999999999 107.47 177.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 pt -97.07 166.5 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.338 -0.852 . . . . 1.3100000000000001 110.15 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.8 p -99.3 164.3 12.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.595 -0.69 . . . . 1.24 109.697 178.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.89 -28.38 36.05 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.052 -1.03 . . . . 1.49 111.18 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -69.23 -34.11 74.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.009 . . . . 2.2799999999999998 110.393 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -87.61 -15.32 37.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.136 -0.978 . . . . 2.0499999999999998 112.193 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.76 -41.34 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.977 -1.077 . . . . 1.3400000000000001 110.367 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.32 -40.07 81.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.828 -1.17 . . . . 1.54 110.841 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -61.24 -42.27 98.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.569 -0.707 . . . . 2.8500000000000001 111.245 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.08 -38.02 81.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.827 -1.17 . . . . 1.3100000000000001 111.154 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.54 -44.78 93.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.976 -1.077 . . . . 1.3799999999999999 110.26 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -62.36 -44.64 96.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.201 -0.937 . . . . 1.5 110.266 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -62.15 -41.51 98.35 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.154 -0.966 . . . . 2.7799999999999998 109.638 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 32.1 t80 -74.06 -51.99 14.07 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.262 -0.899 . . . . 1.0600000000000001 109.249 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.01 -47.72 85.11 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 117.924 -1.511 . . . . 1.3999999999999999 110.367 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.4 t -69.57 -40.63 76.63 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.362 0.601 . . . . 1.3200000000000001 110.172 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.56 -44.67 90.71 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.292 -1.432 . . . . 0.69999999999999996 110.079 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -59.37 -30.86 68.72 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.573 -0.957 . . . . 3.4399999999999999 109.36 178.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.72 -45.64 85.51 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.745 -0.661 . . . . 1.3600000000000001 109.773 178.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -80.11 -45.03 18.92 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.452 0.644 . . . . 2.8300000000000001 110.427 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.66 -41.98 91.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.317 -0.864 . . . . 1.23 110.156 -178.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.6 t -60.02 -41.54 92.41 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 122.45 1.119 . . . . 1.9199999999999999 109.098 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.47 -46.57 79.29 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.265 -0.88 . . . . 1.25 110.209 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -62.55 -50.38 71.58 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.117 -0.989 . . . . 1.97 110.063 179.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 66.4 mt -61.23 -36.78 80.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.214 -0.929 . . . . 2.1800000000000002 110.192 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.81 -41.12 95.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.791 -0.568 . . . . 1.1899999999999999 110.819 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.6 m -64.74 -42.67 95.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.813 -1.179 . . . . 1.3400000000000001 110.009 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.51 -38.29 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.818 -0.551 . . . . 1.23 110.672 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -50.32 -45.75 55.01 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 120.122 -0.631 . . . . 1.5600000000000001 111.182 179.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -68.32 -32.56 72.78 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.937 -1.102 . . . . 1.3 109.91 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -61.64 -39.88 92.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.617 -1.233 . . . . 2.3199999999999998 109.295 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.9 -34.9 78.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.516 -0.74 . . . . 1.1399999999999999 110.097 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.61 -35.09 23.53 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.856 -1.164 . . . . 0.68999999999999995 111.364 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -83.33 -18.47 38.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.017 -1.284 . . . . 1.48 111.679 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -87.83 -53.17 4.89 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.747 -0.66 . . . . 1.52 110.3 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -106.95 -17.21 14.25 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 113.275 0.843 . . . . 1.3100000000000001 113.275 -176.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.59 158.98 10.53 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 120.893 -0.67 . . . . 0.84999999999999998 111.83 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -55.24 -25.8 35.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.721 -0.87 . . . . 3.8599999999999999 112.763 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.4 -35.25 71.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.781 -1.199 . . . . 2.3500000000000001 111.226 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -82.16 -26.38 33.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.055 -1.028 . . . . 2.2599999999999998 111.702 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -59.82 -33.8 72.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.758 -0.589 . . . . 1.45 111.401 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.07 83.7 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.432 -0.793 . . . . 1.25 111.563 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -65.62 -42.78 93.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.365 -1.459 . . . . 1.26 110.156 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -70.93 -30.86 67.3 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.828 -1.17 . . . . 0.82999999999999996 110.895 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -61.36 -39.14 89.54 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.61 -0.836 . . . . 1.1899999999999999 109.955 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.67 -39.53 90.42 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 120.225 -0.988 . . . . 0.57999999999999996 110.793 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -57.39 -46.86 82.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.623 -1.516 . . . . 2.0499999999999998 110.804 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 77' ' ' ILE . 88.6 mt -59.9 -38.11 74.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.011 -1.056 . . . . 1.21 110.703 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.2 ttp -58.95 -39.4 81.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.915 -1.116 . . . . 2.29 110.308 179.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 tp -59.92 -49.62 76.99 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.994 -1.066 . . . . 1.21 109.783 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.9 tp -60.46 -43.72 96.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.066 0.936 . . . . 1.1399999999999999 110.341 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -87.67 9.65 20.73 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 112.783 0.66 . . . . 1.4199999999999999 112.783 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -65.27 123.82 20.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.737 -1.227 . . . . 1.27 108.428 178.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.78 -18.44 65.33 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.842 0.829 . . . . 1.3500000000000001 110.854 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -74.11 -52.37 12.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.564 -0.854 . . . . 2.2200000000000002 110.167 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.0 -37.85 86.42 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.443 -0.903 . . . . 1.22 110.897 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.78 -45.97 81.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.743 -1.223 . . . . 1.29 110.545 179.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -60.73 -36.86 79.93 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.486 -0.759 . . . . 2.1699999999999999 110.665 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -67.01 -46.86 73.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.183 -1.007 . . . . 1.3 110.574 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.06 -43.77 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.428 -0.795 . . . . 1.1699999999999999 110.024 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 90' ' ' ILE . 81.6 mt -59.78 -42.26 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.531 -0.73 . . . . 1.3999999999999999 110.589 179.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.52 -43.86 98.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.638 -0.663 . . . . 1.3300000000000001 111.007 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.18 -44.47 97.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.741 -1.224 . . . . 1.48 110.474 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.99 -47.5 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.954 -1.091 . . . . 1.28 110.466 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -83.63 -31.3 26.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.195 -0.94 . . . . 2.6000000000000001 111.655 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 91' ' ' ALA . 51.0 t0 -80.79 -45.84 16.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.81 -1.181 . . . . 1.51 111.399 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -100.78 7.04 44.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.626 -0.671 . . . . 2.48 112.328 -178.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.3 m80 51.96 49.72 20.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.181 -0.95 . . . . 1.6100000000000001 112.153 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 91.1 mtp -109.64 160.74 16.03 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.223 -0.923 . . . . 1.8999999999999999 109.341 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.5 p -71.21 159.34 34.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.619 -0.676 . . . . 1.3200000000000001 109.852 178.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.59 93.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 1.1499999999999999 110.415 178.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -66.85 -39.72 87.7 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.282 -0.967 . . . . 2.25 109.727 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.83 -50.9 46.18 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.118 -1.033 . . . . 1.22 110.851 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.42 -41.03 96.52 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.061 -1.056 . . . . 1.1899999999999999 110.569 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.48 87.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.689 -0.632 . . . . 1.2 110.703 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -60.56 -39.63 88.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 2.1000000000000001 110.965 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -59.7 -48.87 79.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.011 -1.056 . . . . 1.3 111.055 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.29 -44.34 98.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.149 -0.969 . . . . 1.27 110.229 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.17 -32.97 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.803 -0.56 . . . . 1.1899999999999999 110.475 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -59.83 -39.81 86.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.593 -0.692 . . . . 2.1099999999999999 110.688 179.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.38 -29.73 26.71 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.331 -1.414 . . . . 0.88 113.097 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -61.03 -40.51 93.86 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.186 -1.773 . . . . 1.99 109.309 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.49 -50.02 42.3 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.82 0.819 . . . . 1.28 109.905 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.7 p -60.14 -39.72 87.28 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.725 . . . . 2.2200000000000002 110.357 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.31 -43.75 96.06 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.231 -0.918 . . . . 1.45 110.194 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.78 -28.48 69.05 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.03 -1.044 . . . . 1.47 111.295 -179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -67.15 -23.0 65.74 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.754 -0.591 . . . . 2.04 110.833 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -74.17 -11.83 60.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.696 0.76 . . . . 1.73 111.232 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 15.5 mt -86.37 141.91 28.84 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.157 -0.682 . . . . 1.79 109.157 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -99.41 55.26 0.97 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.029 -1.045 . . . . 2.8799999999999999 111.058 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -130.77 142.15 50.39 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.293 -0.88 . . . . 1.5800000000000001 109.202 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.33 -40.28 81.72 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.739 -0.601 . . . . 3.04 110.938 178.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -72.8 -54.99 7.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.942 -1.099 . . . . 1.29 111.034 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.5 mt -59.83 -40.33 88.1 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.069 -1.019 . . . . 1.6000000000000001 110.616 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -62.53 -49.42 75.41 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.67 -1.269 . . . . 2.7599999999999998 110.084 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.6 -31.03 70.2 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.04 0.924 . . . . 2.1499999999999999 109.717 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -61.99 -30.97 71.3 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.159 -1.016 . . . . 2.8100000000000001 109.558 179.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.84 -48.9 79.81 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.588 -0.845 . . . . 1.3899999999999999 109.434 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.58 -44.11 75.09 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.647 -0.821 . . . . 1.4099999999999999 110.251 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.37 -31.78 73.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.106 -0.997 . . . . 1.3899999999999999 110.272 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.0 t -67.98 -39.35 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.76 -0.776 . . . . 1.1899999999999999 109.922 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 131' ' ' ARG . 28.4 ttm-85 -56.97 -39.51 74.75 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.022 -1.071 . . . . 3.6299999999999999 109.311 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -59.8 -39.23 84.28 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.499 -0.75 . . . . 1.28 110.379 179.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.5 mt -61.54 -39.15 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.542 -0.724 . . . . 1.1799999999999999 109.968 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.45 -47.04 53.28 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 120.011 -1.09 . . . . 0.51000000000000001 110.6 179.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -57.46 -39.79 77.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.156 -1.203 . . . . 3.1699999999999999 110.496 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.43 ' HG2' HH11 ' A' ' 136' ' ' ARG . 45.5 mtt-85 -61.52 -44.31 97.29 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.247 -0.981 . . . . 2.8500000000000001 109.944 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.85 -44.73 96.6 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.327 -0.858 . . . . 1.6499999999999999 109.972 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.6 mt -59.47 -46.25 89.32 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.468 -0.77 . . . . 1.2 110.389 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -59.94 -33.73 72.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.427 -0.795 . . . . 2.7999999999999998 110.669 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.43 -41.91 45.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.606 -0.684 . . . . 2.1499999999999999 111.004 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.68 -38.31 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 1.21 110.78 -178.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.2 mt -83.97 -4.39 58.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 1.3400000000000001 112.294 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.25 20.31 79.12 Favored Glycine 0 N--CA 1.484 1.871 0 C-N-CA 119.265 -1.445 . . . . 0.91000000000000003 113.112 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.7 tp -66.97 148.43 51.97 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.665 0.745 . . . . 1.51 109.312 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -67.21 149.64 50.17 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.14 -0.975 . . . . 2.8799999999999999 109.374 178.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 65.5 mt -105.23 139.94 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.12 -1.066 . . . . 1.6200000000000001 108.12 178.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.438 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.6 mp -75.66 126.05 35.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.313 -0.995 . . . . 2.1099999999999999 108.313 178.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -96.22 98.03 9.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.877 -1.527 . . . . 1.6200000000000001 106.877 179.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 64.5 mt -74.83 -11.51 60.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.272 -0.893 . . . . 1.3999999999999999 111.582 -177.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.6 t -91.41 11.24 24.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.776 -0.577 . . . . 2.0499999999999998 112.3 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.74 17.54 14.86 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 113.658 0.985 . . . . 1.3500000000000001 113.658 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.478 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 2.4 mp -72.77 140.84 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.299 -1.5 . . . . 1.4199999999999999 109.599 178.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -119.24 -11.99 9.5 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.065 0.936 . . . . 2.9900000000000002 111.998 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -112.89 149.18 33.51 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.616 -0.883 . . . . 1.54 108.616 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -76.32 123.23 25.61 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.527 -0.916 . . . . 1.3799999999999999 108.527 178.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.0 m -148.51 174.46 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.469 -0.769 . . . . 1.28 109.308 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.9 mt -93.08 142.52 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.804 -0.813 . . . . 1.1599999999999999 108.804 178.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 23.8 tp -95.07 125.81 39.98 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.753 -1.217 . . . . 1.3100000000000001 108.022 178.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.91 129.96 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 107.68 -1.229 . . . . 1.25 107.68 179.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.44 151.52 17.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.511 -1.368 . . . . 1.26 108.838 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.49 -35.94 79.09 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.01 -1.056 . . . . 1.6000000000000001 109.475 178.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -173.09 151.84 2.2 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.734 -0.839 . . . . 2.4199999999999999 108.734 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.5 mt -115.86 139.59 50.06 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.774 -0.825 . . . . 1.3500000000000001 108.774 177.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.3 p -89.39 149.26 42.32 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.965 -1.084 . . . . 1.3200000000000001 108.762 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -41.3 -42.1 5.14 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.563 2.175 . . . . 0.69999999999999996 113.627 179.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.7 m -62.87 -51.41 67.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 1.1200000000000001 110.121 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -60.94 -39.39 89.28 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.32 -0.862 . . . . 1.21 110.115 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.4 p -67.92 -41.01 83.26 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.372 -0.83 . . . . 1.1899999999999999 110.464 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.03 -37.03 81.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.304 -0.873 . . . . 1.24 110.819 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -97.22 3.18 51.54 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.027 -1.046 . . . . 1.6899999999999999 112.685 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 46.2 tp -59.65 149.62 29.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.076 -1.015 . . . . 1.3400000000000001 109.217 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -95.42 111.17 23.1 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.763 -1.569 . . . . 2.77 106.763 177.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 73.9 mt -80.74 -10.07 59.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.643 -0.66 . . . . 2.0899999999999999 112.615 -177.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -80.29 -29.63 38.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.15 -0.969 . . . . 2.6699999999999999 111.935 -178.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -100.5 -0.92 36.96 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.126 -0.984 . . . . 2.5800000000000001 113.417 -178.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 40.0 t -108.45 129.02 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 107.749 -1.204 . . . . 1.1799999999999999 107.749 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.21 -16.09 30.12 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.366 1.079 . . . . 2.1800000000000002 111.446 -179.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.86 173.33 45.94 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.852 -1.699 . . . . 0.48999999999999999 108.852 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -130.16 131.32 45.59 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 107.784 -1.191 . . . . 0.64000000000000001 107.784 179.392 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 94.8 mt -126.77 115.3 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 106.388 -1.708 . . . . 1.21 106.388 178.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 203' ' ' VAL . 70.6 p -132.92 169.61 16.54 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.104 -0.997 . . . . 1.3799999999999999 109.599 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.455 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 2.8 m-20 -101.86 36.01 2.19 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.563 -0.711 . . . . 2.3700000000000001 110.711 179.074 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -97.88 175.64 6.07 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.766 -1.209 . . . . 1.52 109.983 177.428 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 183' ' ' ALA . . . -61.13 -132.41 0.01 OUTLIER Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.577 -1.409 . . . . 1.8 109.577 179.145 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.44 -32.89 0.1 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.63 -1.271 . . . . 2.04 113.73 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' ' 186' ' ' ARG . 36.6 mtm-85 -56.24 -39.2 72.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.678 -1.483 . . . . 5.0 110.318 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.7 p -137.72 29.27 2.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.691 -0.63 . . . . 3.02 111.686 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.1 p -82.04 139.24 34.6 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.878 0.847 . . . . 2.1099999999999999 109.204 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -59.08 -38.83 80.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 1.24 110.777 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 33.8 p -59.76 -39.78 85.94 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.268 -0.973 . . . . 2.1499999999999999 110.37 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.8 m -60.16 -37.63 80.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.382 -0.824 . . . . 2.02 110.42 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 37.3 mm -60.1 -37.25 72.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.576 -0.702 . . . . 2.1200000000000001 110.603 179.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.8 mtp -62.21 -44.22 97.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.567 1.175 . . . . 1.3600000000000001 109.418 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.48 -47.34 85.87 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.473 -0.785 . . . . 1.29 110.802 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -61.64 -42.58 99.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.214 -0.929 . . . . 3.5600000000000001 110.804 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 20.4 m -69.46 -39.82 77.5 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.38 -0.928 . . . . 1.1799999999999999 110.204 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.7 mt -90.37 -7.56 52.91 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.512 0.672 . . . . 1.3400000000000001 112.451 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 194' ' ' ALA . 99.0 mt-10 53.72 8.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 113.853 1.057 . . . . 1.45 113.853 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 66.1 mt -71.5 149.99 93.69 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 1.25 108.419 178.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.92 143.03 99.75 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.459 1.439 . . . . 0.78000000000000003 109.602 178.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.73 167.44 28.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.361 -1.462 . . . . 1.2 110.194 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.6 mt -150.58 150.53 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.626 -1.25 . . . . 1.25 107.626 178.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.2 m -141.54 -28.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.7 0 O-C-N 120.383 -1.448 . . . . 1.3899999999999999 113.156 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.34 35.12 3.64 Favored Glycine 0 N--CA 1.488 2.107 0 O-C-N 120.961 -1.087 . . . . 0.96999999999999997 112.627 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.455 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 20.1 p -59.7 -34.4 72.84 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.462 -1.611 . . . . 1.3500000000000001 110.23 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 94.26 -78.55 0.97 Allowed Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.196 -1.002 . . . . 1.0700000000000001 112.445 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.1 p -117.51 23.25 11.89 Favored 'General case' 0 N--CA 1.517 2.919 0 CA-C-N 119.262 1.531 . . . . 1.9199999999999999 114.061 -178.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.419 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 4.8 t -55.08 -30.97 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 119.479 -2.013 . . . . 1.3300000000000001 110.572 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.9 p -58.83 -28.66 66.26 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.929 -1.108 . . . . 1.4199999999999999 111.421 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 13.8 m -94.26 5.28 52.26 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.885 -1.134 . . . . 2.1200000000000001 112.32 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -129.5 -7.12 4.68 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 113.404 0.89 . . . . 2.6899999999999999 113.404 -178.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 17.2 t -118.96 139.56 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.564 -0.902 . . . . 1.29 108.564 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.448 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 31.1 mmtp -120.16 157.46 28.99 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.087 -1.079 . . . . 2.6899999999999999 108.087 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 2.7 t-20 -57.74 140.83 50.56 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.964 -1.094 . . . . 2.79 110.538 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.7 t0 80.1 0.54 2.04 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.451 1.278 . . . . 2.3500000000000001 114.451 179.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.448 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 94.5 m-20 -66.21 147.35 53.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.552 -1.342 . . . . 1.97 108.374 177.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -90.18 118.5 29.75 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.054 -1.832 . . . . 2.9700000000000002 106.054 177.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.3 mt -127.05 143.8 51.19 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.459 0.647 . . . . 1.25 109.48 -178.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 61.2 mt -111.36 127.59 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 106.399 -1.704 . . . . 1.22 106.399 177.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.9 tp -100.86 120.12 39.67 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.428 -1.323 . . . . 1.24 107.428 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.587 ' O ' ' N ' ' A' ' 223' ' ' VAL . 52.3 t0 -93.94 -23.68 17.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.872 -1.143 . . . . 2.0499999999999998 112.777 -178.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 10' ' ' GLY . . . 37.94 18.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.098 0.777 . . . . 1.25 113.098 -178.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.9 t -108.14 -60.3 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.924 -1.11 . . . . 1.4299999999999999 109.037 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -100.15 16.3 24.6 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.53 0.681 . . . . 3.0299999999999998 110.345 -179.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 4' ' ' GLY . 4.1 t-20 61.2 51.61 4.27 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.362 0.601 . . . . 2.25 111.771 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -145.83 144.87 30.52 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.277 1.036 . . . . 2.52 110.193 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.61 145.16 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.948 -0.76 . . . . 1.29 108.948 178.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -101.95 136.58 41.54 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.208 -1.034 . . . . 1.3400000000000001 108.208 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.62 129.93 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.004 -0.739 . . . . 1.3400000000000001 109.004 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 42.6 t30 49.63 58.63 17.52 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 113.79 1.033 . . . . 2.1800000000000002 113.79 178.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.66 141.51 38.0 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 121.96 1.773 . . . . 0.93999999999999995 110.791 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.4 p -74.08 156.72 37.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.942 -1.099 . . . . 2.3999999999999999 109.277 177.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -58.49 -37.73 76.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.333 -0.854 . . . . 3.3300000000000001 110.472 178.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.16 -40.98 82.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.452 -0.78 . . . . 3.1699999999999999 110.223 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 96.6 t -71.06 -42.99 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.386 -0.821 . . . . 1.6899999999999999 109.979 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.48 -48.23 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.556 -0.715 . . . . 1.6000000000000001 110.084 -179.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -58.91 -41.37 87.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.991 -1.068 . . . . 2.7000000000000002 109.931 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -62.42 -42.15 99.23 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.597 0.713 . . . . 2.96 110.177 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 243' ' ' GLN . 81.5 mtp -72.3 -39.7 68.08 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.475 -0.766 . . . . 1.6299999999999999 110.923 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -52.91 -39.22 62.58 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.487 -1.383 . . . . 3.27 110.925 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.56 -56.76 4.47 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.045 -1.062 . . . . 2.23 110.567 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.12 -44.07 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.58 0.705 . . . . 2.79 111.268 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.493 ' N ' ' O ' ' A' ' 239' ' ' MET . 1.6 tm0? -60.63 -47.9 84.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.512 -1.368 . . . . 4.2599999999999998 111.002 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -61.55 -31.33 71.36 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.656 -1.278 . . . . 1.8799999999999999 109.945 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -59.93 -31.17 69.59 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.139 -1.024 . . . . 3.3799999999999999 109.317 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 82.4 t -62.01 -41.88 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.734 0.778 . . . . 2.8799999999999999 109.406 179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.95 89.0 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.157 -0.617 . . . . 2.75 110.115 179.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 25.8 p -70.55 -29.43 65.89 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.441 0.639 . . . . 3.4199999999999999 110.522 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.59 -32.54 74.04 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.192 -0.942 . . . . 3.5699999999999998 110.311 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -65.53 -30.27 71.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.403 -0.81 . . . . 4.6100000000000003 110.764 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.05 -19.2 65.64 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.377 -0.827 . . . . 4.4500000000000002 111.314 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -69.58 -18.91 63.67 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.313 -0.867 . . . . 5.9699999999999998 111.281 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.21 -30.65 71.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.484 -0.76 . . . . 6.4500000000000002 110.051 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -72.48 0.67 9.69 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.089 -1.007 . . . . 6.6600000000000001 112.36 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -80.9 32.17 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.087 0.946 . . . . 8.5399999999999991 112.411 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 90.5 mt -82.89 11.51 5.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.772 -1.205 . . . . 8.0700000000000003 111.783 179.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -84.28 5.73 25.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.255 -0.903 . . . . 9.7200000000000006 112.409 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -91.39 4.5 52.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.124 -0.985 . . . . 10.119999999999999 112.416 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 . . . . . 0 N--CA 1.498 1.954 0 O-C-N 121.051 -1.031 . . . . 11.9 109.106 179.947 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.3 mmm . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.518 -0.549 . . . . 3.5299999999999998 109.518 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt -103.34 122.65 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.654 -1.239 . . . . 1.5700000000000001 107.654 177.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.2 m -105.73 123.3 47.72 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.784 -1.191 . . . . 1.4399999999999999 107.784 178.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.22 -162.94 11.64 Favored Glycine 0 N--CA 1.499 2.884 0 N-CA-C 108.274 -1.93 . . . . 1.01 108.274 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 90.9 mt -100.59 2.28 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.174 -1.191 . . . . 1.6299999999999999 112.671 -179.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 5' ' ' ILE . 12.3 tp 50.71 101.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.078 -1.014 . . . . 1.5800000000000001 112.134 179.166 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.87 -41.55 13.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.939 -1.1 . . . . 1.3400000000000001 111.549 179.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 t -145.19 146.17 29.52 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.045 -1.095 . . . . 1.8600000000000001 108.045 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.59 143.85 21.89 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.815 2.343 . . . . 1.01 112.377 178.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 151.19 -177.47 29.16 Favored Glycine 0 N--CA 1.503 3.129 0 N-CA-C 109.658 -1.377 . . . . 0.81000000000000005 109.658 177.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.9 mt -137.81 140.75 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.25 -1.147 . . . . 1.3700000000000001 108.578 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.48 149.99 43.22 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.317 -0.865 . . . . 1.1399999999999999 109.005 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -119.56 139.8 51.56 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.713 -1.217 . . . . 0.87 107.713 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.49 163.95 27.92 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 118.125 -1.988 . . . . 0.56999999999999995 110.485 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -76.48 160.68 29.29 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.506 -0.997 . . . . 2.3500000000000001 109.837 179.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.15 122.29 28.64 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.965 -1.124 . . . . 1.21 107.965 178.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.7 tp -101.71 101.97 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.089 -2.189 . . . . 1.3999999999999999 105.089 177.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.6 tp -88.25 140.37 29.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.176 -0.952 . . . . 1.4399999999999999 108.632 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.9 mt -98.28 118.5 35.06 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 106.271 -1.752 . . . . 1.45 106.271 177.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.428 ' CB ' ' HZ1' ' A' ' 20' ' ' LYS . 8.3 mtpm? -111.01 134.07 52.91 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.201 -1.037 . . . . 2.5 108.201 -179.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -125.95 140.8 52.33 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.584 -0.895 . . . . 2.6600000000000001 108.584 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -81.81 138.01 35.2 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.371 -0.974 . . . . 2.3199999999999998 108.371 177.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -63.29 143.63 57.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -0.773 . . . . 2.1099999999999999 108.991 178.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 87.9 mt -94.53 132.13 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.174 -1.047 . . . . 1.29 108.174 178.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.16 130.19 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.233 -1.025 . . . . 1.4099999999999999 108.233 179.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.8 mt -94.07 138.13 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.374 -0.973 . . . . 1.3100000000000001 108.374 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -92.19 122.23 34.48 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.572 -1.27 . . . . 1.3400000000000001 107.572 178.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -93.54 10.93 30.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.289 -0.882 . . . . 3.48 112.651 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -71.57 153.01 42.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.706 -1.246 . . . . 2.52 109.349 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -92.18 140.04 30.02 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 109.102 -0.703 . . . . 2.6299999999999999 109.102 178.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -92.39 175.29 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.229 -0.919 . . . . 1.3100000000000001 109.915 177.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 p -103.5 166.62 10.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.522 -0.736 . . . . 1.24 109.549 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.56 -35.26 67.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.488 -0.758 . . . . 1.49 111.519 178.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -69.86 -22.23 63.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.846 -1.159 . . . . 2.2799999999999998 110.626 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -94.02 -20.44 19.96 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.492 0.663 . . . . 2.0499999999999998 112.213 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.84 -46.4 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.626 -0.671 . . . . 1.3400000000000001 110.236 -178.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -58.86 -40.36 84.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.323 -0.861 . . . . 1.54 110.658 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -64.0 -45.32 89.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 2.8500000000000001 110.808 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -60.82 -37.74 83.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.256 -0.903 . . . . 1.3100000000000001 110.945 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -59.13 -40.07 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.176 -0.953 . . . . 1.3799999999999999 110.082 179.274 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.72 -41.74 95.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.072 -1.018 . . . . 1.5 109.645 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -63.1 -39.16 93.88 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.343 -0.848 . . . . 2.7799999999999998 110.094 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -72.11 -54.52 9.52 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.411 -0.806 . . . . 1.0600000000000001 110.06 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.7 tp -60.78 -50.14 74.65 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.969 0.89 . . . . 1.3999999999999999 109.74 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.0 t -67.41 -38.91 85.35 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.422 -0.799 . . . . 1.3200000000000001 110.247 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.58 90.85 Favored Glycine 0 N--CA 1.485 1.934 0 C-N-CA 119.648 -1.263 . . . . 0.69999999999999996 110.056 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -59.94 -31.65 70.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.24 -1.153 . . . . 3.4399999999999999 109.63 178.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.63 90.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.619 0.723 . . . . 1.3600000000000001 109.764 179.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -80.52 -48.65 12.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 2.8300000000000001 110.85 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.99 79.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.515 -0.741 . . . . 1.23 110.102 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.6 ' HG ' ' N ' ' A' ' 52' ' ' ALA . 89.4 p -61.68 -38.56 88.28 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.867 0.842 . . . . 1.9199999999999999 109.343 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.6 ' N ' ' HG ' ' A' ' 51' ' ' SER . . . -68.82 -46.19 69.25 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.948 -0.569 . . . . 1.25 110.313 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.74 -49.35 75.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.633 -1.292 . . . . 1.97 110.122 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.9 mt -61.34 -40.0 92.62 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.034 0.921 . . . . 2.1800000000000002 109.513 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -60.64 -39.73 89.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.577 -0.702 . . . . 1.1899999999999999 110.105 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.0 m -62.06 -42.89 99.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.866 . . . . 1.3400000000000001 110.366 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.0 -36.94 70.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.609 -0.682 . . . . 1.23 110.645 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -51.1 -43.5 61.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.938 . . . . 1.5600000000000001 110.443 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -70.27 -36.42 74.41 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.926 -1.109 . . . . 1.3 110.009 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -62.69 -39.34 93.68 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.819 -1.153 . . . . 2.3199999999999998 109.316 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.74 81.74 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.852 -0.613 . . . . 1.1399999999999999 110.091 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.78 -35.86 23.97 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.467 -1.349 . . . . 0.68999999999999995 110.964 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.03 -17.59 46.22 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.17 -1.194 . . . . 1.48 111.575 -179.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.7 m -93.46 -52.73 4.37 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.716 -0.615 . . . . 1.52 110.672 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -107.65 -6.23 17.0 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 114.004 1.112 . . . . 1.3100000000000001 114.004 -178.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.96 149.88 11.85 Favored Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.375 -0.828 . . . . 0.84999999999999998 112.432 178.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.47 -15.35 0.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.386 -1.067 . . . . 3.8599999999999999 112.464 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.46 -31.32 69.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.395 -0.816 . . . . 2.3500000000000001 111.291 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -83.35 -16.93 44.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.807 -1.183 . . . . 2.2599999999999998 112.109 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.16 -30.76 69.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.888 -1.133 . . . . 1.45 111.228 -179.094 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.32 90.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 1.25 110.767 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.6 mt -67.5 -41.48 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.842 -1.161 . . . . 1.26 109.337 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -71.39 -29.88 65.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.82999999999999996 110.734 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.25 -39.88 88.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.869 . . . . 1.1899999999999999 110.046 179.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.44 -44.31 74.02 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.745 -0.942 . . . . 0.57999999999999996 110.745 179.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -60.0 -48.06 83.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.934 -1.333 . . . . 2.0499999999999998 110.726 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.5 mt -62.41 -39.49 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 120.9 -1.125 . . . . 1.21 110.016 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.8 ttp -60.28 -39.98 88.79 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.806 -0.758 . . . . 2.29 110.506 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.1 tp -59.37 -48.52 81.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 1.21 110.355 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.05 -41.24 91.9 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.861 0.838 . . . . 1.1399999999999999 110.144 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -85.93 4.17 38.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.607 -0.683 . . . . 1.4199999999999999 112.496 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -59.7 124.54 20.46 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.182 -0.949 . . . . 1.27 110.894 -178.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.02 -16.42 63.42 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.418 -0.801 . . . . 1.3500000000000001 111.226 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -76.94 -54.31 6.73 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.769 0.795 . . . . 2.2200000000000002 110.568 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.84 -38.24 87.49 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.386 -0.821 . . . . 1.22 110.923 -179.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.0 -49.58 77.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.073 -1.017 . . . . 1.29 110.786 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.67 -39.48 94.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.027 -1.046 . . . . 2.1699999999999999 110.708 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.95 -49.42 61.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 1.3 110.87 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.11 -45.64 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.836 -1.165 . . . . 1.1699999999999999 110.097 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.45 -41.92 91.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.515 0.674 . . . . 1.3999999999999999 110.43 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -60.07 -42.95 95.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.258 -0.901 . . . . 1.3300000000000001 111.036 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.29 -39.56 87.32 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.254 -0.904 . . . . 1.48 110.332 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.0 -51.18 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 1.28 110.365 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.86 -33.99 62.19 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.382 -0.824 . . . . 2.6000000000000001 111.493 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 91' ' ' ALA . 54.5 t0 -80.42 -45.92 16.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.139 -0.976 . . . . 1.51 111.842 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -103.07 8.64 38.76 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.058 -1.026 . . . . 2.48 112.581 -178.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 56.0 m80 53.17 49.9 18.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 1.6100000000000001 111.752 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.1 mtt -102.02 152.97 20.33 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.211 -0.931 . . . . 1.8999999999999999 109.668 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.511 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 68.1 p -71.34 156.52 39.41 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.321 -0.862 . . . . 1.3200000000000001 109.304 177.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.02 -45.75 79.04 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.276 -0.89 . . . . 1.1499999999999999 110.366 178.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -68.35 -39.3 81.92 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.063 -1.023 . . . . 2.25 110.267 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.511 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -70.87 -47.78 57.39 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.516 -1.274 . . . . 1.22 110.856 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.25 90.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 1.1899999999999999 110.178 -178.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.12 91.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.252 -0.905 . . . . 1.2 110.621 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -60.31 -38.39 83.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 2.1000000000000001 111.249 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -58.49 -49.2 78.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.998 -1.064 . . . . 1.3 111.267 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.3 t -61.5 -44.86 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.834 -1.166 . . . . 1.27 110.321 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.66 -33.24 56.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.556 -0.715 . . . . 1.1899999999999999 110.403 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -58.5 -41.91 86.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.377 -0.827 . . . . 2.1099999999999999 110.802 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.36 -30.39 22.26 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.142 -1.504 . . . . 0.88 112.121 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -62.21 -40.6 96.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.523 -1.575 . . . . 1.99 110.252 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.35 -50.59 30.69 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.539 -0.726 . . . . 1.28 111.092 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.1 m -59.63 -39.81 85.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -0.902 . . . . 2.2200000000000002 110.926 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.19 -42.18 98.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 1.45 111.323 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.27 -29.86 70.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.575 -1.328 . . . . 1.47 111.023 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.91 -21.95 65.97 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.17 -0.956 . . . . 2.04 110.958 179.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -74.96 -12.04 60.25 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.019 -0.672 . . . . 1.73 111.412 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.8 mt -87.08 149.22 24.86 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.146 -0.687 . . . . 1.79 109.146 179.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -102.61 47.49 0.89 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.456 -0.778 . . . . 2.8799999999999999 111.197 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -124.58 134.5 52.94 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 108.502 -0.925 . . . . 1.5800000000000001 108.502 179.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -57.34 -38.5 74.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.373 -0.829 . . . . 3.04 110.979 178.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -70.88 -49.1 49.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.666 -1.271 . . . . 1.29 110.055 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.8 mt -62.89 -39.14 93.57 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.848 -1.158 . . . . 1.6000000000000001 109.994 -178.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -64.09 -50.18 69.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.627 -1.296 . . . . 2.7599999999999998 110.149 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.54 -30.14 69.58 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.925 -1.109 . . . . 2.1499999999999999 109.535 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -64.79 -29.5 70.47 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.959 0.885 . . . . 2.8100000000000001 109.551 179.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.55 -49.31 78.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.465 -0.894 . . . . 1.3899999999999999 109.71 178.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.27 83.22 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.477 -0.889 . . . . 1.4099999999999999 110.022 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.55 -35.0 78.07 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.186 0.517 . . . . 1.3899999999999999 110.839 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 t -69.01 -40.98 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.146 -0.971 . . . . 1.1899999999999999 110.568 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.456 ' HG2' HH11 ' A' ' 131' ' ' ARG . 24.2 ttt-85 -57.74 -38.57 75.56 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.397 -1.321 . . . . 3.6299999999999999 109.52 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -60.79 -38.39 85.14 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.421 0.629 . . . . 1.28 110.397 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.25 -39.91 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.252 -0.905 . . . . 1.1799999999999999 109.821 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.52 -43.76 60.21 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.634 -1.27 . . . . 0.51000000000000001 110.202 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -57.92 -41.26 82.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.458 -1.025 . . . . 3.1699999999999999 110.364 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.435 ' HG2' HH11 ' A' ' 136' ' ' ARG . 62.4 mtt-85 -61.7 -43.18 99.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.88 -1.137 . . . . 2.8500000000000001 110.093 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.7 tp -60.56 -44.9 95.65 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.957 0.884 . . . . 1.6499999999999999 109.452 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.76 -38.0 83.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.314 -0.866 . . . . 1.2 110.16 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -39.32 85.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 2.7999999999999998 111.171 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -75.17 -40.86 59.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.872 -1.143 . . . . 2.1499999999999999 111.008 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.94 -39.77 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 1.21 110.618 -178.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -86.51 -10.07 54.86 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.962 -1.086 . . . . 1.3400000000000001 111.927 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.39 19.52 71.43 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.992 -1.099 . . . . 0.91000000000000003 112.634 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 46.2 tp -71.07 140.23 50.64 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.673 -0.898 . . . . 1.51 109.317 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -67.55 150.73 48.44 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.226 -0.921 . . . . 2.8799999999999999 110.65 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 81.0 mt -106.18 142.11 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.453 -0.944 . . . . 1.6200000000000001 108.453 178.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 23.3 mm -74.56 122.59 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.326 -0.991 . . . . 2.1099999999999999 108.326 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -95.85 100.65 12.32 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.891 -1.892 . . . . 1.6200000000000001 105.891 178.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 53.8 mt -73.56 -21.46 60.35 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.295 -0.878 . . . . 1.3999999999999999 111.396 -177.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 82.5 p -83.97 7.05 19.62 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.443 -0.786 . . . . 2.0499999999999998 112.169 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.16 17.7 19.26 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.531 0.681 . . . . 1.3500000000000001 112.212 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.4 mt -74.98 144.49 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.636 -0.665 . . . . 1.4199999999999999 109.785 179.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -120.85 -9.76 9.23 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.359 -0.838 . . . . 2.9900000000000002 112.522 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -118.77 141.92 48.18 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.963 -0.755 . . . . 1.54 108.963 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.86 124.19 26.42 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.159 0.981 . . . . 1.3799999999999999 108.791 178.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.68 176.84 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.038 -0.727 . . . . 1.28 109.038 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 67.8 mt -91.98 141.59 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.225 -1.028 . . . . 1.1599999999999999 108.225 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.7 tp -93.95 126.53 39.21 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.851 -1.155 . . . . 1.3100000000000001 108.447 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 32.3 t -123.42 129.99 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.059 -1.089 . . . . 1.25 108.059 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.83 158.18 27.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.226 -0.921 . . . . 1.26 108.783 179.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 162' ' ' ASP . . . -62.05 -39.43 92.34 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.573 -1.33 . . . . 1.6000000000000001 109.772 178.224 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 55.8 m-20 -168.93 156.63 7.53 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.192 -1.04 . . . . 2.4199999999999999 108.192 179.187 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 38.4 mt -117.25 139.62 50.57 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.231 -0.918 . . . . 1.3500000000000001 108.612 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.0 p -95.96 151.02 38.05 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.141 -1.059 . . . . 1.3200000000000001 108.141 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -39.87 -43.72 3.44 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.779 1.652 . . . . 0.69999999999999996 113.351 179.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 74.8 m -61.28 -50.38 73.23 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.288 -0.882 . . . . 1.1200000000000001 109.953 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.68 -39.4 88.29 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.409 -0.807 . . . . 1.21 110.153 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.8 p -68.77 -41.08 79.33 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.852 -0.739 . . . . 1.1899999999999999 110.575 179.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.21 -34.86 74.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.07 -1.019 . . . . 1.24 110.531 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -96.97 -1.37 45.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.125 -0.984 . . . . 1.6899999999999999 112.879 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.46 151.71 31.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.98 -1.075 . . . . 1.3400000000000001 109.695 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 172' ' ' ASN . 25.0 p-10 -92.91 108.13 19.76 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 106.439 -1.689 . . . . 2.77 106.439 178.007 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 3.1 mm? -76.96 -18.71 58.07 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.488 -0.757 . . . . 2.0899999999999999 111.63 -177.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -81.1 -25.66 36.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.064 -1.023 . . . . 2.6699999999999999 112.255 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -102.75 -4.43 25.01 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 113.829 1.048 . . . . 2.5800000000000001 113.829 -178.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 63.0 t -101.68 120.1 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.302 -1.74 . . . . 1.1799999999999999 106.302 178.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 22.0 tp -84.89 -0.73 55.11 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.657 0.742 . . . . 2.1800000000000002 111.873 -178.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.34 169.95 34.09 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.035 -1.626 . . . . 0.48999999999999999 109.035 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -129.31 137.74 51.18 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.193 -1.18 . . . . 0.64000000000000001 108.31 179.107 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.2 mt -135.67 110.87 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 105.798 -1.927 . . . . 1.21 105.798 178.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 203' ' ' VAL . 41.7 p -135.8 179.31 6.42 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.667 -1.27 . . . . 1.3799999999999999 110.089 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -102.43 55.52 0.78 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 115.91 -0.586 . . . . 2.3700000000000001 109.735 179.555 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.01 166.55 10.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.663 -0.648 . . . . 1.52 109.448 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.23 -81.93 0.1 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.797 -1.192 . . . . 1.8 111.244 178.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.82 -67.53 0.28 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.31 -1.112 . . . . 2.04 111.954 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -61.36 -39.47 90.74 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.378 -1.072 . . . . 5.0 110.143 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.2 p -105.76 13.79 29.17 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.614 -0.679 . . . . 3.02 111.831 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.5 t -86.91 120.46 28.2 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.413 -1.329 . . . . 2.1099999999999999 107.413 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -60.7 -40.54 92.59 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.696 -0.628 . . . . 1.24 110.767 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 11.9 t -59.68 -40.03 86.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.916 -1.115 . . . . 2.1499999999999999 110.29 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.5 t -58.57 -37.56 76.03 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.325 -0.86 . . . . 2.02 110.48 179.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.81 -38.66 77.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.123 -0.986 . . . . 2.1200000000000001 110.415 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 74.4 mtp -62.3 -43.63 98.38 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.395 1.093 . . . . 1.3600000000000001 109.128 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.31 -41.15 83.86 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.223 -0.899 . . . . 1.29 110.464 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.41 ' HG2' HH11 ' A' ' 195' ' ' ARG . 47.0 mtt-85 -60.47 -42.07 95.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.915 -1.115 . . . . 3.5600000000000001 110.095 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 64.4 m -71.06 -39.31 72.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 1.1799999999999999 110.305 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.3 mt -91.24 -9.3 45.72 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.841 0.829 . . . . 1.3400000000000001 112.392 -178.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.4 mt-10 52.29 12.5 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.846 1.054 . . . . 1.45 113.846 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.66 147.81 96.58 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 1.25 108.238 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -56.73 139.68 89.11 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.379 1.386 . . . . 0.78000000000000003 110.134 178.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.77 165.85 31.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.518 -1.364 . . . . 1.2 109.798 179.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 59.6 mt -145.39 156.84 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.656 -1.238 . . . . 1.25 107.656 178.199 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 181' ' ' THR . 8.0 m -137.9 -32.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.162 -0.961 . . . . 1.3899999999999999 112.942 -179.374 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -72.27 34.03 0.66 Allowed Glycine 0 N--CA 1.486 1.983 0 C-N-CA 120.25 -0.976 . . . . 0.96999999999999997 113.052 -178.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.414 ' H ' ' C ' ' A' ' 203' ' ' VAL . 54.8 p -58.65 -26.81 64.16 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.198 -1.178 . . . . 1.3500000000000001 111.074 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.31 -93.54 0.89 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 110.525 -1.03 . . . . 1.0700000000000001 110.525 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.4 t -126.19 30.56 5.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.848 -0.795 . . . . 1.9199999999999999 112.269 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 94.7 t -59.62 -34.96 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.525 -1.359 . . . . 1.3300000000000001 110.23 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 29.4 p -56.13 -24.5 41.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 1.4199999999999999 111.344 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.6 m -91.97 1.67 57.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.139 -0.975 . . . . 2.1200000000000001 111.919 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -125.23 -7.25 7.07 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.038 0.755 . . . . 2.6899999999999999 113.038 -178.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 48.8 t -114.97 150.76 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.789 -0.819 . . . . 1.29 108.789 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -120.57 154.1 35.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.354 -0.98 . . . . 2.6899999999999999 108.354 177.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.435 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 51.4 p-10 -53.56 144.67 16.76 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.988 -1.07 . . . . 2.79 110.797 178.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.9 OUTLIER 81.18 0.11 1.7 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.808 1.41 . . . . 2.3500000000000001 114.808 179.415 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.0 146.13 55.06 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.382 -1.449 . . . . 1.97 108.473 177.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -87.83 120.26 28.99 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.353 -1.351 . . . . 2.9700000000000002 107.353 178.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.62 145.76 50.01 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.704 0.764 . . . . 1.25 110.055 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.91 126.05 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 106.276 -1.75 . . . . 1.22 106.276 177.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.3 tp -102.13 119.59 39.05 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.797 -1.557 . . . . 1.24 106.797 179.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.62 ' O ' ' N ' ' A' ' 223' ' ' VAL . 78.8 m-20 -94.22 -22.85 18.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 2.0499999999999998 112.238 -178.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 39.11 14.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 112.508 0.558 . . . . 1.25 112.508 -178.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.3 t -112.31 -59.91 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.279 -0.888 . . . . 1.4299999999999999 109.857 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -92.21 12.12 23.36 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.52 0.676 . . . . 3.0299999999999998 110.963 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 60.22 48.9 7.72 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.262 0.553 . . . . 2.25 111.127 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -147.92 145.38 28.59 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.181 0.991 . . . . 2.52 109.836 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.5 t -117.16 138.82 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.822 -1.177 . . . . 1.29 107.822 177.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -100.13 130.08 46.23 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.913 -1.117 . . . . 1.3400000000000001 108.235 178.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.8 t -109.67 130.03 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.382 -0.969 . . . . 1.3400000000000001 108.382 179.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 25.0 t30 56.62 49.9 4.46 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 114.225 1.194 . . . . 2.1800000000000002 114.225 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 44.2 Cg_endo -67.88 149.94 78.19 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.41 2.073 . . . . 0.93999999999999995 110.263 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 45.8 p -72.81 152.71 41.42 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.574 -1.329 . . . . 2.3999999999999999 109.272 177.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -59.93 -34.51 73.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 3.3300000000000001 110.308 178.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.77 -40.6 88.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 3.1699999999999999 110.497 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 67.9 t -70.51 -40.87 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.154 -0.966 . . . . 1.6899999999999999 109.974 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.2 mt -59.06 -46.55 91.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.379 -0.826 . . . . 1.6000000000000001 110.606 -178.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -60.14 -44.25 95.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.283 -0.886 . . . . 2.7000000000000002 110.534 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -61.16 -40.19 92.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.647 -0.658 . . . . 2.96 110.288 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.443 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 90.2 mtp -71.47 -36.04 71.06 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.293 -0.879 . . . . 1.6299999999999999 110.739 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.401 ' NH1' ' HG3' ' A' ' 240' ' ' ARG . 20.8 mmm-85 -53.2 -45.22 68.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.545 -1.347 . . . . 3.27 110.31 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.61 -57.59 3.73 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.191 -0.943 . . . . 2.23 110.629 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.31 -46.84 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.302 -0.873 . . . . 2.79 111.339 -179.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.443 ' CB ' ' O ' ' A' ' 239' ' ' MET . 2.2 tp-100 -60.46 -48.98 79.38 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.628 -1.295 . . . . 4.2599999999999998 110.338 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -59.58 -32.83 70.73 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.507 -1.37 . . . . 1.8799999999999999 109.62 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -60.95 -28.33 68.89 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.33 -0.948 . . . . 3.3799999999999999 109.761 179.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 97.2 t -59.83 -40.61 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.131 -1.028 . . . . 2.8799999999999999 109.101 178.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.96 -48.65 80.85 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.348 -0.941 . . . . 2.75 109.578 179.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 11.2 t -74.01 -28.81 61.63 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.527 -0.733 . . . . 3.4199999999999999 111.162 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -60.76 -31.67 70.99 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.269 0.557 . . . . 3.5699999999999998 110.668 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -61.25 -38.99 88.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.254 -0.904 . . . . 4.6100000000000003 110.745 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -68.22 -38.6 82.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.955 . . . . 4.4500000000000002 110.31 179.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -71.85 -26.44 62.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.307 -0.871 . . . . 5.9699999999999998 111.571 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 1.9 tt -66.07 -19.85 65.98 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.291 -0.881 . . . . 6.4500000000000002 111.487 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -66.36 -26.75 67.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.72 -1.237 . . . . 6.6600000000000001 112.232 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -79.2 -9.53 59.59 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.801 -1.187 . . . . 8.5399999999999991 112.693 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 81.9 mt -83.23 -1.89 54.22 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.216 -0.927 . . . . 8.0700000000000003 112.359 -179.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -84.71 -10.13 57.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 9.7200000000000006 111.599 -178.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -99.48 -4.97 30.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.595 -0.691 . . . . 10.119999999999999 112.814 -178.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 117.859 -1.067 . . . . 11.9 109.042 -178.579 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 110.111 -0.329 . . . . 3.5299999999999998 110.111 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.3 mt -94.44 111.71 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.761 -1.57 . . . . 1.5700000000000001 106.761 176.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.4 m -104.35 124.76 49.77 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.53 -1.285 . . . . 1.4399999999999999 107.53 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.22 -159.24 17.2 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 108.46 -1.856 . . . . 1.01 108.46 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 97.0 mt -94.44 0.52 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.186 -1.185 . . . . 1.6299999999999999 112.677 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 51.8 93.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.854 -1.153 . . . . 1.5800000000000001 112.043 178.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.61 -34.41 18.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.832 -1.167 . . . . 1.3400000000000001 111.12 179.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.559 ' HG ' ' N ' ' A' ' 201' ' ' ALA . 1.2 p -149.55 143.98 17.37 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.59 -1.319 . . . . 1.8600000000000001 107.96 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.37 145.67 21.42 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.464 2.11 . . . . 1.01 112.758 178.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.42 162.08 9.98 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 109.835 -1.306 . . . . 0.81000000000000005 109.835 178.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.3 132.55 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 O-C-N 120.861 -1.376 . . . . 1.3700000000000001 107.966 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.85 150.12 45.65 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.231 -0.918 . . . . 1.1399999999999999 109.307 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.0 m-85 -123.26 144.03 49.67 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.911 -0.774 . . . . 0.87 108.911 178.278 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.12 169.67 36.55 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.03 -1.557 . . . . 0.56999999999999995 109.897 177.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -76.95 154.79 33.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.542 -0.975 . . . . 2.3500000000000001 108.786 178.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.76 125.65 33.4 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.453 -1.314 . . . . 1.21 107.453 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.3 tp -101.95 107.46 18.61 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.262 -2.125 . . . . 1.3999999999999999 105.262 177.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -90.28 135.66 33.54 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.839 -1.171 . . . . 1.4399999999999999 107.839 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.5 mt -100.29 114.34 27.73 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.78 -1.563 . . . . 1.45 106.78 178.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -109.77 137.34 47.71 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.389 -1.337 . . . . 2.5 107.389 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -129.55 144.92 51.48 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.918 -1.114 . . . . 2.6600000000000001 109.041 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -83.58 136.19 34.34 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.154 -1.054 . . . . 2.3199999999999998 108.154 177.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.99 149.41 44.94 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.278 -0.889 . . . . 2.1099999999999999 108.627 178.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.8 mt -94.68 134.74 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.68 -0.859 . . . . 1.29 108.68 178.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.99 131.46 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.757 -1.201 . . . . 1.4099999999999999 107.757 179.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -91.03 144.94 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.08 -0.711 . . . . 1.3100000000000001 109.08 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -88.97 122.44 32.33 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.633 -1.247 . . . . 1.3400000000000001 107.633 178.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -97.9 16.93 19.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.612 -0.68 . . . . 3.48 112.314 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.51 143.02 56.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.283 -0.885 . . . . 2.52 109.383 179.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -90.93 135.73 33.54 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.929 -1.138 . . . . 2.6299999999999999 107.929 178.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.6 pt -97.68 172.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 122.101 0.953 . . . . 1.3100000000000001 109.889 177.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.44 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 38.2 p -102.85 161.31 13.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.873 -0.788 . . . . 1.24 108.873 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.03 -31.88 19.77 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.996 -1.065 . . . . 1.49 111.947 178.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.44 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 3.5 p-10 -69.99 -40.15 75.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 2.2799999999999998 110.037 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -77.47 -19.03 56.57 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.363 -0.836 . . . . 2.0499999999999998 111.413 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.5 t -59.76 -42.56 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.069 -1.019 . . . . 1.3400000000000001 110.568 179.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -57.1 -39.96 76.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.808 -1.183 . . . . 1.54 110.841 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.275 -0.891 . . . . 2.8500000000000001 110.402 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -62.76 -35.34 79.51 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.752 -1.217 . . . . 1.3100000000000001 110.87 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.69 -40.36 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.61 -1.306 . . . . 1.3799999999999999 110.21 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -61.4 -39.67 91.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 1.5 109.654 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.473 ' HG2' HH11 ' A' ' 42' ' ' ARG . 21.6 mtt-85 -63.07 -42.96 99.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 2.7799999999999998 110.06 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -72.12 -54.17 10.55 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 119.838 -0.745 . . . . 1.0600000000000001 110.138 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.96 -48.05 82.93 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.236 -0.985 . . . . 1.3999999999999999 110.013 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 t -70.06 -38.68 75.84 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.321 -0.862 . . . . 1.3200000000000001 110.061 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.78 -43.11 96.68 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.674 -1.37 . . . . 0.69999999999999996 109.674 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -58.21 -33.34 69.2 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.217 1.008 . . . . 3.4399999999999999 108.742 179.125 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.06 -46.05 79.06 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.015 0.912 . . . . 1.3600000000000001 109.274 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.616 ' HZ1' ' NE2' ' A' ' 53' ' ' GLN . 25.8 ttpp -76.81 -43.54 36.16 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.355 -0.841 . . . . 2.8300000000000001 110.658 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.96 82.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.089 -1.007 . . . . 1.23 109.91 -178.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -59.52 -40.0 85.72 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.342 -0.943 . . . . 1.9199999999999999 109.346 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.81 -48.84 65.1 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.736 -0.602 . . . . 1.25 110.327 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.616 ' NE2' ' HZ1' ' A' ' 49' ' ' LYS . 93.4 mt-30 -60.83 -49.94 75.46 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.356 -1.465 . . . . 1.97 110.566 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.31 -39.31 92.6 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.237 -0.914 . . . . 2.1800000000000002 109.923 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -59.89 -41.2 91.08 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.017 -0.673 . . . . 1.1899999999999999 110.543 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.403 HG21 ' HZ1' ' A' ' 60' ' ' LYS . 23.6 m -64.62 -42.57 95.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.405 -0.809 . . . . 1.3400000000000001 110.273 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.444 HD11 HG22 ' A' ' 57' ' ' ILE . 98.1 mt -59.57 -39.32 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.459 -0.776 . . . . 1.23 110.617 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -51.66 -40.25 59.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.86 -1.15 . . . . 1.5600000000000001 110.523 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.56 -40.0 73.61 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.328 -0.858 . . . . 1.3 109.974 -179.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.403 ' HZ1' HG21 ' A' ' 56' ' ' THR . 61.7 mttp -63.42 -39.01 93.33 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.53 -1.268 . . . . 2.3199999999999998 108.583 -178.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.37 75.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.568 -0.707 . . . . 1.1399999999999999 110.112 179.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.85 -38.16 10.77 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 119.697 -1.24 . . . . 0.68999999999999995 111.322 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.46 -23.48 43.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.793 -1.416 . . . . 1.48 110.688 -179.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -88.72 -50.42 6.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.088 -1.008 . . . . 1.52 111.067 179.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -106.79 -9.5 16.38 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 114.378 1.251 . . . . 1.3100000000000001 114.378 -177.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.36 154.13 12.11 Favored Glycine 0 N--CA 1.502 3.091 0 O-C-N 121.128 -0.982 . . . . 0.84999999999999998 111.736 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -54.31 -17.15 2.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -1.033 . . . . 3.8599999999999999 112.544 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -58.38 -35.3 71.79 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.39 -0.819 . . . . 2.3500000000000001 110.903 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -82.46 -21.99 35.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.741 -1.224 . . . . 2.2599999999999998 111.708 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.05 -32.91 71.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.9 . . . . 1.45 111.279 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.53 93.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.948 -1.095 . . . . 1.25 110.534 179.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.1 mt -68.17 -45.29 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.487 -1.383 . . . . 1.26 110.547 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -69.65 -31.32 69.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.912 -1.117 . . . . 0.82999999999999996 110.934 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.02 -39.64 86.55 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.295 -0.878 . . . . 1.1899999999999999 109.974 178.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.96 -38.09 95.06 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.866 -1.294 . . . . 0.57999999999999996 109.866 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -58.0 -44.03 86.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.414 -1.05 . . . . 2.0499999999999998 110.001 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.48 -40.59 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.942 -1.099 . . . . 1.21 110.432 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.4 ttt -60.01 -38.95 84.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.271 -0.893 . . . . 2.29 110.108 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -60.96 -50.62 72.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.807 . . . . 1.21 110.201 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.57 -40.44 87.36 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.445 -0.902 . . . . 1.1399999999999999 110.493 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -88.64 10.54 20.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.645 -0.66 . . . . 1.4199999999999999 112.68 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -62.93 123.27 18.09 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.035 -1.041 . . . . 1.27 109.151 178.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -67.39 -19.13 65.36 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.951 0.882 . . . . 1.3500000000000001 110.708 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -77.7 -49.65 14.04 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.658 0.742 . . . . 2.2200000000000002 110.748 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.79 -38.97 90.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.318 -0.864 . . . . 1.22 110.346 -179.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -57.83 -46.95 83.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.84 -0.537 . . . . 1.29 110.91 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -61.04 -39.92 91.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.136 -0.977 . . . . 2.1699999999999999 110.381 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -65.75 -47.2 76.07 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 118.827 -1.149 . . . . 1.3 111.145 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.3 mt -57.56 -44.27 84.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.861 -1.149 . . . . 1.1699999999999999 110.4 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.406 HG22 HD11 ' A' ' 90' ' ' ILE . 91.7 mt -63.42 -41.54 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.665 0.745 . . . . 1.3999999999999999 110.967 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.54 -42.08 98.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 1.3300000000000001 111.17 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.5 mt -60.43 -45.09 94.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.087 . . . . 1.48 110.536 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.4 mt -60.79 -49.88 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.495 -0.753 . . . . 1.28 110.205 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -77.3 -37.17 53.31 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.59 -0.694 . . . . 2.6000000000000001 111.776 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -80.71 -46.95 14.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.874 -1.141 . . . . 1.51 112.455 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -100.59 8.33 43.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.964 -1.085 . . . . 2.48 112.677 -178.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 37.3 m80 51.94 50.5 18.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.902 -1.124 . . . . 1.6100000000000001 111.998 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.4 mtt -107.17 155.54 19.79 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.197 -0.939 . . . . 1.8999999999999999 109.456 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.2 p -72.23 166.4 22.5 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.609 -0.682 . . . . 1.3200000000000001 110.51 178.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.7 -43.79 97.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.429 -0.794 . . . . 1.1499999999999999 110.413 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 6.2 p-10 -69.59 -43.41 72.86 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.437 -0.79 . . . . 2.25 109.934 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.08 -47.69 70.51 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.945 -1.102 . . . . 1.22 110.463 -179.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.33 98.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.977 -1.077 . . . . 1.1899999999999999 110.571 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.38 -43.2 92.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.147 -0.971 . . . . 1.2 110.526 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -61.41 -40.21 93.59 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.144 -0.972 . . . . 2.1000000000000001 111.403 -179.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -58.54 -48.43 80.89 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.996 -1.065 . . . . 1.3 111.101 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.3 t -61.04 -46.89 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.205 -0.935 . . . . 1.27 109.816 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -62.24 -32.38 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.271 0.557 . . . . 1.1899999999999999 110.443 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -55.41 -40.8 71.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 2.1099999999999999 110.18 179.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.12 -27.69 30.29 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.636 -1.268 . . . . 0.88 113.269 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -62.18 -40.35 95.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.404 -1.645 . . . . 1.99 109.67 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.21 -52.15 10.64 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.919 -0.488 . . . . 1.28 111.025 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.2 m -59.51 -39.03 82.49 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.628 -0.829 . . . . 2.2200000000000002 110.634 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.43 98.18 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.452 -0.78 . . . . 1.45 111.288 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.2 -30.11 71.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.1 -1.0 . . . . 1.47 111.347 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -68.53 -20.21 64.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.956 -1.09 . . . . 2.04 111.006 179.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -75.49 -14.24 60.41 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.519 -0.738 . . . . 1.73 111.158 -179.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.8 mt -84.35 150.98 25.01 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.439 -0.788 . . . . 1.79 109.015 179.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -98.21 35.77 1.7 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.954 -1.091 . . . . 2.8799999999999999 112.468 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -116.0 130.99 57.06 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.667 -0.864 . . . . 1.5800000000000001 108.667 179.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.28 -35.89 74.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 3.04 111.107 178.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -69.18 -48.9 60.95 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.499 -1.376 . . . . 1.29 110.289 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.9 mt -62.57 -39.94 95.26 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.011 -1.055 . . . . 1.6000000000000001 110.854 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -62.82 -49.75 73.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.872 -1.143 . . . . 2.7599999999999998 109.98 178.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.77 -32.44 71.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 2.1499999999999999 109.637 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -61.31 -29.59 69.97 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.022 -1.071 . . . . 2.8100000000000001 108.958 179.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.63 -47.9 83.78 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.838 0.828 . . . . 1.3899999999999999 109.032 178.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.87 -47.02 86.9 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.499 -0.88 . . . . 1.4099999999999999 109.444 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.33 -31.96 72.66 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.469 0.652 . . . . 1.3899999999999999 109.963 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.66 -41.73 80.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.652 -0.655 . . . . 1.1899999999999999 110.003 179.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -57.51 -40.69 79.27 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.829 -1.169 . . . . 3.6299999999999999 109.549 179.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -60.3 -43.16 96.56 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.621 -0.674 . . . . 1.28 110.535 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.08 -38.28 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.102 -0.999 . . . . 1.1799999999999999 109.947 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.05 -49.96 37.43 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.846 -1.169 . . . . 0.51000000000000001 110.406 179.074 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -58.4 -43.36 88.53 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.963 -1.316 . . . . 3.1699999999999999 110.209 179.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.436 ' NH2' ' CB ' ' A' ' 166' ' ' SER . 88.5 mtt180 -62.29 -41.43 98.49 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.705 -1.198 . . . . 2.8500000000000001 109.22 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.68 -40.72 88.77 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.543 0.687 . . . . 1.6499999999999999 109.95 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.2 -42.56 95.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.029 . . . . 1.2 110.668 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -59.82 -34.07 72.59 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.428 -0.795 . . . . 2.7999999999999998 110.614 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -75.03 -42.55 56.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.179 -0.951 . . . . 2.1499999999999999 110.821 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.9 -39.98 83.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.148 -0.97 . . . . 1.21 110.281 -178.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.1 mt -89.94 -12.01 40.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -0.932 . . . . 1.3400000000000001 112.701 -179.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.3 19.72 76.27 Favored Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.569 -1.3 . . . . 0.91000000000000003 113.066 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.5 150.44 48.95 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.525 -0.985 . . . . 1.51 109.952 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -65.26 148.56 51.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 2.8799999999999999 109.751 178.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.4 mt -106.88 144.13 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.56 -0.904 . . . . 1.6200000000000001 108.56 178.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.1 mm -79.11 120.78 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.885 -1.135 . . . . 2.1099999999999999 108.388 178.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -98.09 96.72 8.32 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.369 -1.715 . . . . 1.6200000000000001 106.369 179.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.6 mt -75.92 -17.51 59.73 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.612 -0.68 . . . . 1.3999999999999999 111.512 -177.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.6 m -81.19 4.81 18.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.928 -1.108 . . . . 2.0499999999999998 112.383 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.72 20.83 11.32 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.791 0.805 . . . . 1.3500000000000001 112.33 -179.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 18.0 mt -72.65 139.23 19.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.264 -0.897 . . . . 1.4199999999999999 108.752 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -116.77 -11.54 10.92 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.491 -0.756 . . . . 2.9900000000000002 112.885 -178.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -115.86 134.09 55.35 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.736 -1.209 . . . . 1.54 107.736 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -72.98 119.28 17.01 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.44 -0.788 . . . . 1.3799999999999999 108.879 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.0 177.01 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.373 -0.829 . . . . 1.28 109.343 -179.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.0 mt -85.87 142.15 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.008 -1.058 . . . . 1.1599999999999999 109.117 178.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.0 tp -95.28 125.17 39.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.155 -0.966 . . . . 1.3100000000000001 108.613 178.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.7 t -124.54 129.69 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.536 -1.283 . . . . 1.25 107.536 179.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.33 160.12 29.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 1.26 108.548 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.72 -40.85 89.36 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.275 -1.516 . . . . 1.6000000000000001 109.521 177.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 9.2 t70 -174.17 158.57 3.04 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.236 -1.024 . . . . 2.4199999999999999 108.236 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.451 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 35.5 mt -118.3 139.16 51.75 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.149 -1.056 . . . . 1.3500000000000001 108.149 177.184 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.9 p -90.24 149.36 41.14 Favored Pre-proline 0 N--CA 1.485 1.312 0 N-CA-C 108.293 -1.003 . . . . 1.3200000000000001 108.293 179.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -40.18 -45.23 4.08 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.035 1.824 . . . . 0.69999999999999996 113.393 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.436 ' CB ' ' NH2' ' A' ' 136' ' ' ARG . 15.3 m -59.94 -50.31 74.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.677 -1.264 . . . . 1.1200000000000001 110.96 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.94 -40.32 92.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.447 -0.783 . . . . 1.21 109.934 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.5 p -66.41 -39.0 88.72 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.689 0.757 . . . . 1.1899999999999999 110.141 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.23 85.31 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.358 -0.937 . . . . 1.24 111.11 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -94.8 1.56 55.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.994 -1.066 . . . . 1.6899999999999999 113.569 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.8 148.74 46.04 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.483 -0.932 . . . . 1.3400000000000001 108.483 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -95.27 115.01 26.86 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 106.537 -1.653 . . . . 2.77 106.537 177.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 26.1 mt -75.46 -14.93 60.46 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.484 -0.76 . . . . 2.0899999999999999 111.71 -177.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -84.03 -19.67 34.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.081 -1.012 . . . . 2.6699999999999999 112.276 -178.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -102.14 -6.16 23.6 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.327 -0.858 . . . . 2.5800000000000001 113.033 -177.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.5 t -110.69 129.57 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.106 -1.442 . . . . 1.1799999999999999 107.106 179.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 tp -90.94 -4.93 56.11 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.985 0.897 . . . . 2.1800000000000002 112.595 -179.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.86 170.46 41.7 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.691 -1.764 . . . . 0.48999999999999999 108.691 179.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -125.83 126.18 44.08 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.786 -1.42 . . . . 0.64000000000000001 107.42 178.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.5 mt -125.65 128.61 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 106.913 -1.514 . . . . 1.21 106.913 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 203' ' ' VAL . 74.6 p -139.58 166.78 23.69 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.894 -1.129 . . . . 1.3799999999999999 109.247 179.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 29.0 p-10 -103.16 32.19 3.88 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.397 -0.814 . . . . 2.3700000000000001 111.504 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -97.02 120.64 37.75 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.091 -1.077 . . . . 1.52 108.091 178.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -88.44 27.19 7.19 Favored Glycine 0 N--CA 1.484 1.875 0 C-N-CA 120.15 -1.024 . . . . 1.8 113.515 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -88.1 115.76 4.44 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 107.882 -2.087 . . . . 2.04 107.882 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -58.03 -31.37 66.93 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.525 -0.985 . . . . 5.0 109.287 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.8 p -105.06 37.32 2.2 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.684 0.754 . . . . 3.02 110.265 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.5 t -72.07 146.71 47.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.365 -0.835 . . . . 2.1099999999999999 109.569 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -58.16 -39.74 79.63 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.245 -0.909 . . . . 1.24 110.999 178.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 56.8 p -57.84 -41.39 82.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.837 -1.164 . . . . 2.1499999999999999 110.221 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.3 t -61.45 -34.2 75.02 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.333 -0.854 . . . . 2.02 110.163 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.6 mm -60.26 -41.03 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.06 -1.025 . . . . 2.1200000000000001 110.914 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 60.9 mtp -61.66 -40.46 95.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.565 -1.334 . . . . 1.3600000000000001 110.103 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.96 -45.74 89.77 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.41 -0.814 . . . . 1.29 111.127 179.372 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -60.7 -42.2 96.74 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.656 -0.817 . . . . 3.5600000000000001 110.479 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.4 m -69.49 -39.01 77.89 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.328 -0.857 . . . . 1.1799999999999999 109.942 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.26 -7.29 51.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.234 -0.916 . . . . 1.3400000000000001 112.753 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 194' ' ' ALA . 89.7 mt-10 53.36 8.53 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.364 1.246 . . . . 1.45 114.364 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.502 ' O ' ' OG ' ' A' ' 8' ' ' SER . 57.2 mt -73.89 147.6 86.44 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.646 -1.284 . . . . 1.25 108.162 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.78 143.43 58.91 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.353 1.369 . . . . 0.78000000000000003 109.503 178.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.559 ' N ' ' HG ' ' A' ' 8' ' ' SER . . . -158.82 163.02 37.06 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 117.767 -1.573 . . . . 1.2 109.679 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.2 mt -149.45 151.31 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.654 -1.239 . . . . 1.25 107.654 178.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 183' ' ' ALA . 15.1 m -136.05 -28.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 120.79 -1.194 . . . . 1.3899999999999999 112.235 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.39 41.42 3.06 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 120.845 -1.159 . . . . 0.96999999999999997 112.166 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.6 p -61.58 -17.65 55.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.873 -1.369 . . . . 1.3500000000000001 111.535 -178.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.12 -93.04 1.8 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.401 -1.08 . . . . 1.0700000000000001 110.401 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.1 m -133.58 32.84 3.56 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 122.214 -0.58 . . . . 1.9199999999999999 112.26 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.5 t -59.43 -37.69 71.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.324 -1.485 . . . . 1.3300000000000001 110.527 179.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 67.5 p -55.34 -28.52 54.3 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.422 -0.911 . . . . 1.4199999999999999 111.203 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 19.6 m -92.1 0.86 57.47 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.106 -0.996 . . . . 2.1200000000000001 112.143 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -122.86 -7.19 8.45 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 113.395 0.887 . . . . 2.6899999999999999 113.395 -177.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.5 t -118.92 151.62 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.59 0.709 . . . . 1.29 109.296 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -117.7 157.12 27.05 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.118 -1.068 . . . . 2.6899999999999999 108.118 177.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.595 HD21 ' H ' ' A' ' 215' ' ' ASP . 1.6 t-20 -52.48 141.49 19.92 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.871 -1.143 . . . . 2.79 110.805 178.572 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.595 ' H ' HD21 ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.72 2.75 1.43 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 115.185 1.55 . . . . 2.3500000000000001 115.185 179.397 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.2 t0 -64.72 148.08 51.81 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.862 -1.148 . . . . 1.97 108.797 177.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.522 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 44.3 t80 -88.6 119.38 29.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.544 -1.347 . . . . 2.9700000000000002 107.664 177.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 84.7 mt -127.22 148.89 50.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.426 -0.797 . . . . 1.25 110.292 -178.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.4 mt -116.81 123.97 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 106.158 -1.793 . . . . 1.22 106.158 177.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.2 tp -99.16 120.12 38.98 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.692 -1.595 . . . . 1.24 106.692 178.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.623 ' O ' ' N ' ' A' ' 223' ' ' VAL . 77.8 m-20 -93.84 -29.15 15.47 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.781 -1.168 . . . . 2.0499999999999998 113.129 -177.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 40.06 12.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.432 -0.793 . . . . 1.25 112.654 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.623 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.4 t -108.53 -61.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.746 -1.222 . . . . 1.4299999999999999 109.525 179.092 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -94.19 11.59 29.6 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.389 0.614 . . . . 3.0299999999999998 110.675 179.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 61.48 54.53 3.07 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.148 0.499 . . . . 2.25 111.951 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -148.97 143.52 26.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.173 -0.954 . . . . 2.52 109.831 178.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.1 t -115.9 136.91 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.077 -1.083 . . . . 1.29 108.077 178.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -102.68 131.74 49.28 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.606 -0.887 . . . . 1.3400000000000001 108.606 178.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.41 130.96 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 108.653 -0.869 . . . . 1.3400000000000001 108.653 178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 52.11 53.69 13.07 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.188 -0.945 . . . . 2.1800000000000002 113.549 178.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.65 151.07 63.73 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 C-N-CA 122.513 2.142 . . . . 0.93999999999999995 111.069 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.0 m -71.33 157.77 37.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.072 -1.017 . . . . 2.3999999999999999 108.995 177.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -57.31 -40.89 78.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 3.3300000000000001 109.898 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.85 -39.82 86.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.815 . . . . 3.1699999999999999 110.692 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.2 t -69.2 -38.05 77.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.23 -0.919 . . . . 1.6899999999999999 110.818 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 84.4 mt -58.3 -49.13 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 1.6000000000000001 110.261 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -59.33 -39.32 82.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.322 -0.861 . . . . 2.7000000000000002 110.828 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -61.92 -47.41 85.03 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.366 -0.834 . . . . 2.96 110.901 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 66.8 mtp -71.1 -36.63 72.27 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.849 -1.157 . . . . 1.6299999999999999 111.005 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.1 mmm-85 -58.46 -39.63 80.42 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 120.091 -0.643 . . . . 3.27 110.975 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.68 -38.72 80.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 2.23 110.959 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 89.0 t -57.6 -50.09 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.444 -1.41 . . . . 2.79 112.128 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -66.12 -49.88 65.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.539 -1.351 . . . . 4.2599999999999998 109.709 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -61.24 -35.9 78.51 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.456 -0.777 . . . . 1.8799999999999999 110.119 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.86 -30.31 68.88 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.662 -1.274 . . . . 3.3799999999999999 109.958 179.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.56 -39.32 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.469 -0.892 . . . . 2.8799999999999999 110.042 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.29 -41.65 89.44 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.096 -1.042 . . . . 2.75 110.462 178.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 14.3 p -70.18 -28.67 65.5 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.153 -0.967 . . . . 3.4199999999999999 110.095 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -63.22 -33.55 75.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.587 -0.696 . . . . 3.5699999999999998 110.842 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -62.08 -30.42 70.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.18 -0.95 . . . . 4.6100000000000003 110.651 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -66.36 -14.42 62.06 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.362 -0.836 . . . . 4.4500000000000002 111.451 179.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -75.38 -3.87 36.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 5.9699999999999998 112.612 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 4.5 pp -64.05 -12.79 41.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.999 -1.063 . . . . 6.4500000000000002 111.803 -178.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.463 ' O ' ' NZ ' ' A' ' 257' ' ' LYS . . . -72.33 -11.8 60.86 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.158 -0.964 . . . . 6.6600000000000001 111.372 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -86.42 5.48 34.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.472 -0.767 . . . . 8.5399999999999991 111.982 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.496 ' N ' ' CD2' ' A' ' 256' ' ' LEU . 3.3 mm? -83.46 33.07 0.46 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 8.0700000000000003 112.869 -179.279 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' A' ' 254' ' ' ALA . 58.6 mttp -81.18 -2.99 50.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.158 -0.964 . . . . 9.7200000000000006 112.356 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -96.41 8.07 44.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.449 -0.782 . . . . 10.119999999999999 112.254 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 117.812 -1.089 . . . . 11.9 108.779 -179.634 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtt . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 109.341 -0.614 . . . . 3.5299999999999998 109.341 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.4 mt 51.01 73.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 1.5700000000000001 112.431 176.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -90.73 115.4 27.79 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.61 -1.626 . . . . 1.4399999999999999 106.61 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.35 -154.85 22.12 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.081 -2.007 . . . . 1.01 108.081 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 72.6 mt -93.92 -4.33 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -1.141 . . . . 1.6299999999999999 112.64 -178.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 5' ' ' ILE . 38.4 tp 50.61 100.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.831 -1.168 . . . . 1.5800000000000001 112.235 178.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.63 -37.24 14.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 1.3400000000000001 111.498 179.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -145.77 138.75 14.11 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 108.027 -1.101 . . . . 1.8600000000000001 108.027 -178.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.88 148.92 28.73 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.725 2.283 . . . . 1.01 112.505 179.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 152.85 166.05 13.98 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.891 -1.684 . . . . 0.81000000000000005 108.891 178.357 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.52 136.11 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.046 -1.267 . . . . 1.3700000000000001 108.704 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.06 156.67 44.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.303 -0.873 . . . . 1.1399999999999999 109.495 179.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 23.8 m-85 -124.48 140.74 52.67 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.206 -1.035 . . . . 0.87 108.206 178.247 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.72 168.48 37.39 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 118.551 -1.785 . . . . 0.56999999999999995 109.906 177.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -78.64 160.22 27.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.427 -1.043 . . . . 2.3500000000000001 109.547 179.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.57 129.71 34.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.791 -1.193 . . . . 1.21 108.195 178.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.7 tp -107.53 101.94 11.24 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 105.029 -2.212 . . . . 1.3999999999999999 105.029 177.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.5 tp -89.88 137.32 32.43 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.173 -1.047 . . . . 1.4399999999999999 108.173 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.6 mt -100.49 114.79 28.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.592 -1.633 . . . . 1.45 106.592 178.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -108.97 131.49 55.0 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.617 -1.253 . . . . 2.5 107.617 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -127.13 149.98 49.7 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.254 -0.904 . . . . 2.6600000000000001 109.228 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -83.04 135.0 35.01 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.778 -1.193 . . . . 2.3199999999999998 107.778 177.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.39 147.32 48.85 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.592 -0.693 . . . . 2.1099999999999999 109.315 178.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 24' ' ' ILE . 61.9 mt -97.7 135.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.166 -0.959 . . . . 1.29 108.72 178.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.8 t -107.69 130.88 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.489 -0.93 . . . . 1.4099999999999999 108.489 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.5 mt -97.56 131.44 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.335 -0.987 . . . . 1.3100000000000001 108.335 178.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -93.51 123.26 36.7 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.814 -1.179 . . . . 1.3400000000000001 108.371 178.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -95.81 10.25 37.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.299 -0.876 . . . . 3.48 112.333 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.63 149.22 46.97 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.118 -0.988 . . . . 2.52 109.332 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -89.93 131.02 36.06 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.74 -1.207 . . . . 2.6299999999999999 107.74 177.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 pt -92.53 165.47 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.007 -1.058 . . . . 1.3100000000000001 110.345 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.3 p -92.51 163.43 13.83 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.446 -0.575 . . . . 1.24 109.446 178.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.39 -17.49 1.94 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.214 -0.929 . . . . 1.49 112.482 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -69.45 -41.78 75.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.355 -0.841 . . . . 2.2799999999999998 110.685 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -90.75 -5.76 55.28 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.62 -1.3 . . . . 2.0499999999999998 112.697 -178.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.91 -42.29 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.803 -1.186 . . . . 1.3400000000000001 110.477 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.14 -39.97 88.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.034 -1.041 . . . . 1.54 110.767 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -62.67 -38.13 89.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.509 -0.745 . . . . 2.8500000000000001 110.845 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -60.19 -40.73 91.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.907 -1.121 . . . . 1.3100000000000001 110.656 179.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -62.43 -41.16 90.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.187 -0.945 . . . . 1.3799999999999999 110.551 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -60.8 -49.52 77.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.109 -0.995 . . . . 1.5 110.369 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 46' ' ' GLY . 65.1 mtm180 -62.86 -40.35 97.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.231 -0.918 . . . . 2.7799999999999998 110.09 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -70.04 -54.6 12.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.434 -0.791 . . . . 1.0600000000000001 110.184 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.49 -49.88 73.63 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.937 -1.105 . . . . 1.3999999999999999 109.834 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 t -67.81 -39.75 83.95 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.783 0.802 . . . . 1.3200000000000001 109.91 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 42' ' ' ARG . . . -56.43 -43.25 90.25 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.808 -1.317 . . . . 0.69999999999999996 109.808 178.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -59.54 -31.26 69.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.891 0.853 . . . . 3.4399999999999999 109.394 178.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.08 -43.2 77.78 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.492 0.663 . . . . 1.3600000000000001 109.762 178.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -79.07 -42.94 25.21 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.325 -0.95 . . . . 2.8300000000000001 110.009 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.87 86.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.099 -1.001 . . . . 1.23 110.225 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.0 p -59.98 -41.76 92.71 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.268 1.032 . . . . 1.9199999999999999 109.241 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.74 90.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.728 -0.669 . . . . 1.25 110.133 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -60.09 -49.8 76.21 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.39 -0.924 . . . . 1.97 110.264 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.59 -42.74 91.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 2.1800000000000002 110.059 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -59.86 -40.3 88.15 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.736 -0.602 . . . . 1.1899999999999999 110.47 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.6 m -67.43 -47.69 69.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.06 -1.025 . . . . 1.3400000000000001 110.18 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.5 mt -61.36 -34.36 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 1.23 110.849 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -51.62 -43.94 62.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.114 -0.991 . . . . 1.5600000000000001 111.013 179.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.9 m -68.97 -39.62 79.35 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.985 -1.072 . . . . 1.3 110.197 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -60.11 -40.0 88.17 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.807 -1.157 . . . . 2.3199999999999998 109.529 179.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.41 73.83 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.326 -0.858 . . . . 1.1399999999999999 109.934 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.59 -37.03 9.87 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.978 -1.106 . . . . 0.68999999999999995 111.112 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -81.59 -23.94 36.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.092 -1.24 . . . . 1.48 111.001 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.4 m -88.82 -50.37 6.26 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.461 -0.774 . . . . 1.52 110.57 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.591 ' CZ ' ' SD ' ' A' ' 193' ' ' MET . 75.4 m-85 -107.23 -3.67 19.55 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 113.805 1.039 . . . . 1.3100000000000001 113.805 -177.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.1 166.49 34.21 Favored Glycine 0 N--CA 1.495 2.617 0 O-C-N 121.088 -1.007 . . . . 0.84999999999999998 111.699 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -56.31 -19.54 14.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.558 -0.966 . . . . 3.8599999999999999 112.787 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -56.74 -41.5 77.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.684 -1.26 . . . . 2.3500000000000001 110.561 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -89.27 -23.12 22.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.97 -1.081 . . . . 2.2599999999999998 111.563 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -60.78 -38.93 86.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.502 -0.749 . . . . 1.45 110.745 -179.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.1 -39.37 89.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.36 -0.837 . . . . 1.25 110.816 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.6 mt -62.12 -44.24 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.865 -1.147 . . . . 1.26 110.513 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -71.7 -31.65 66.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.856 -1.152 . . . . 0.82999999999999996 110.701 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.24 -41.17 92.57 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.115 -0.99 . . . . 1.1899999999999999 109.903 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.88 -36.74 91.53 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.656 -1.259 . . . . 0.57999999999999996 110.143 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -59.31 -40.83 87.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -1.155 . . . . 2.0499999999999998 110.492 179.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 77' ' ' ILE . 87.8 mt -60.3 -39.66 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.982 -1.074 . . . . 1.21 110.276 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.8 ttp -59.58 -39.36 83.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.335 -0.853 . . . . 2.29 110.396 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.43 -49.93 73.13 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.466 -0.894 . . . . 1.21 110.105 179.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.5 tp -60.45 -46.92 88.3 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.763 0.792 . . . . 1.1399999999999999 110.272 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -85.74 8.43 19.87 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.034 0.753 . . . . 1.4199999999999999 113.034 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -62.31 122.06 14.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.878 -1.139 . . . . 1.27 108.581 179.091 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -64.07 -18.67 64.6 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.733 0.777 . . . . 1.3500000000000001 111.099 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.14 -53.74 7.84 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.74 -0.784 . . . . 2.2200000000000002 110.253 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.52 -35.12 78.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.551 -0.718 . . . . 1.22 110.495 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -60.01 -48.92 79.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.306 -0.871 . . . . 1.29 110.739 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -62.68 -39.97 95.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 2.1699999999999999 110.513 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.97 -48.41 76.59 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.292 -0.88 . . . . 1.3 110.152 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -57.89 -43.48 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.291 -0.881 . . . . 1.1699999999999999 109.879 179.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.43 -40.81 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.718 -0.614 . . . . 1.3999999999999999 110.479 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.19 -45.04 95.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -0.894 . . . . 1.3300000000000001 110.873 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.91 -39.05 84.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 1.48 110.521 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.8 mt -70.18 -49.73 52.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 1.28 111.066 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -81.78 -36.37 28.54 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.833 -1.167 . . . . 2.6000000000000001 111.795 -179.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 91' ' ' ALA . 24.1 t0 -81.8 -42.43 19.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.83 -1.169 . . . . 1.51 112.132 -178.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -103.38 8.25 38.09 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.212 -0.93 . . . . 2.48 112.452 -178.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.3 m80 51.08 51.17 17.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.14 -0.975 . . . . 1.6100000000000001 111.804 -179.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.6 mtt -104.91 152.07 23.1 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.353 -0.842 . . . . 1.8999999999999999 108.899 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.658 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 80.1 p -71.92 160.03 33.25 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.577 -0.702 . . . . 1.3200000000000001 109.292 177.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.7 92.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.149 -0.969 . . . . 1.1499999999999999 110.571 178.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -67.24 -42.1 84.54 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.044 -1.035 . . . . 2.25 109.925 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.658 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -68.49 -51.0 48.15 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.635 -0.665 . . . . 1.22 111.224 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.31 -45.74 92.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.037 -1.04 . . . . 1.1899999999999999 110.65 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.7 97.12 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.494 -0.883 . . . . 1.2 110.408 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -60.28 -39.22 86.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 2.1000000000000001 110.972 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -57.9 -48.72 79.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.949 -1.094 . . . . 1.3 110.567 179.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.99 -47.44 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.943 -1.098 . . . . 1.27 110.031 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.0 mm -62.64 -30.95 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.779 -0.576 . . . . 1.1899999999999999 110.56 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.59 -41.61 86.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.44 -0.788 . . . . 2.1099999999999999 110.85 179.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.75 -34.52 10.05 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.231 -1.462 . . . . 0.88 112.678 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -61.13 -41.68 97.16 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.788 -1.419 . . . . 1.99 110.259 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.39 -54.93 7.99 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.741 0.781 . . . . 1.28 110.29 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 65.3 m -59.97 -38.49 82.67 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.686 -0.634 . . . . 2.2200000000000002 110.477 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.61 96.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.991 -1.068 . . . . 1.45 110.575 179.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.17 -30.14 71.03 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.217 -0.993 . . . . 1.47 110.35 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -66.6 -20.07 65.92 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.164 -0.96 . . . . 2.04 110.986 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -72.63 -10.51 59.87 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.99 0.9 . . . . 1.73 111.02 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 23.2 mt -87.84 144.84 26.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.936 -0.765 . . . . 1.79 108.936 179.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -100.19 37.13 1.71 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.132 -0.98 . . . . 2.8799999999999999 111.787 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -115.22 137.71 51.72 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.179 -0.951 . . . . 1.5800000000000001 108.81 178.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -59.86 -35.24 74.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.67 -0.644 . . . . 3.04 111.089 179.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -73.53 -49.74 24.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.926 -1.109 . . . . 1.29 109.848 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.1 mt -63.73 -39.73 95.0 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.281 -0.887 . . . . 1.6000000000000001 109.604 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -60.96 -45.07 96.21 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.864 0.84 . . . . 2.7599999999999998 109.67 179.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -61.29 -32.78 72.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.812 0.815 . . . . 2.1499999999999999 109.535 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -62.04 -29.57 70.38 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.996 0.903 . . . . 2.8100000000000001 109.463 179.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.93 74.6 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.926 0.87 . . . . 1.3899999999999999 109.501 178.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.56 -41.59 79.53 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.703 0.763 . . . . 1.4099999999999999 110.08 179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -62.55 -40.47 96.92 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.413 0.625 . . . . 1.3899999999999999 110.243 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 52.1 t -68.96 -38.33 78.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.504 -0.748 . . . . 1.1899999999999999 109.755 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -58.92 -38.89 79.98 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.057 -1.027 . . . . 3.6299999999999999 109.715 178.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.498 ' OD2' ' NE ' ' A' ' 136' ' ' ARG . 32.2 t70 -60.12 -39.79 87.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.61 -0.682 . . . . 1.28 110.352 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 57.7 mt -60.05 -39.83 81.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.363 -0.836 . . . . 1.1799999999999999 109.983 179.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.13 -48.3 26.5 Favored Glycine 0 N--CA 1.485 1.943 0 C-N-CA 120.209 -0.995 . . . . 0.51000000000000001 110.799 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -58.89 -44.16 91.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.039 -1.271 . . . . 3.1699999999999999 110.202 179.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.498 ' NE ' ' OD2' ' A' ' 132' ' ' ASP . 54.3 mtm180 -61.62 -41.48 97.54 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.707 -1.197 . . . . 2.8500000000000001 109.774 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.45 -41.71 94.65 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.865 -0.734 . . . . 1.6499999999999999 110.079 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.6 mt -60.57 -43.35 97.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.437 -0.789 . . . . 1.2 110.765 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 48.7 mtt-85 -59.84 -32.81 71.02 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.363 -0.836 . . . . 2.7999999999999998 111.318 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -75.39 -40.17 58.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.011 -1.056 . . . . 2.1499999999999999 110.708 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.4 mt -59.58 -40.13 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.227 -0.921 . . . . 1.21 110.972 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.2 mt -90.47 -9.2 48.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.916 -1.115 . . . . 1.3400000000000001 112.926 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.09 23.16 66.8 Favored Glycine 0 N--CA 1.483 1.78 0 C-N-CA 119.91 -1.138 . . . . 0.91000000000000003 113.112 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 29.0 tp -63.08 142.21 58.47 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.757 -0.849 . . . . 1.51 109.012 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -66.53 141.35 57.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.239 -0.913 . . . . 2.8799999999999999 109.378 178.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.4 mt -112.18 136.52 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 108.32 -0.993 . . . . 1.6200000000000001 108.32 178.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.2 mp -76.2 131.07 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 2.1099999999999999 108.792 178.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.09 97.63 11.04 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.721 -1.585 . . . . 1.6200000000000001 106.721 178.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.455 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 50.4 mt -71.51 -29.45 64.8 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.378 0.609 . . . . 1.3999999999999999 110.942 -178.146 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.0 t -79.47 -3.29 45.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.35 -0.844 . . . . 2.0499999999999998 112.297 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -101.27 23.1 11.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.677 -0.64 . . . . 1.3500000000000001 111.919 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.455 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 16.4 mt -72.1 144.87 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 1.4199999999999999 109.861 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -118.64 -10.85 9.96 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.979 0.895 . . . . 2.9900000000000002 112.372 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -118.22 140.36 49.92 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.72 0.772 . . . . 1.54 109.152 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.04 119.8 22.69 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.285 -0.885 . . . . 1.3799999999999999 108.741 178.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.71 175.79 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.578 0.704 . . . . 1.28 109.328 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.5 mt -86.98 140.9 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.805 . . . . 1.1599999999999999 109.01 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 24.6 tp -98.32 122.3 41.31 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.044 -1.035 . . . . 1.3100000000000001 108.777 178.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.8 t -123.93 133.96 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.337 -0.986 . . . . 1.25 108.337 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.86 157.81 29.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.477 -0.764 . . . . 1.26 109.113 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.449 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.4 -38.7 88.03 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.672 -1.268 . . . . 1.6000000000000001 109.196 178.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.2 t0 -172.45 148.0 1.97 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.524 -0.735 . . . . 2.4199999999999999 109.02 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.521 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 66.1 mt -119.15 138.98 52.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.243 -0.911 . . . . 1.3500000000000001 108.555 177.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.2 p -93.6 151.6 40.2 Favored Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 108.327 -0.99 . . . . 1.3200000000000001 108.327 178.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -39.93 -38.72 2.04 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.767 1.645 . . . . 0.69999999999999996 113.433 179.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.5 m -58.92 -42.87 90.7 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.036 -1.065 . . . . 1.1200000000000001 109.699 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -72.64 -45.1 60.64 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.693 -0.803 . . . . 1.21 110.164 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.504 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 20.4 p -66.19 -38.95 89.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.372 -0.83 . . . . 1.1899999999999999 109.812 -178.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.72 87.34 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.677 -0.64 . . . . 1.24 110.844 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -92.96 0.49 57.41 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.126 -0.984 . . . . 1.6899999999999999 112.738 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.7 tp -65.99 150.26 48.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.729 . . . . 1.3400000000000001 109.756 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -96.94 117.82 32.0 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.035 -1.469 . . . . 2.77 107.035 177.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 39.1 mt -76.32 -18.07 59.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 2.0899999999999999 111.404 -178.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -82.97 -20.58 34.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.205 -0.935 . . . . 2.6699999999999999 112.282 -179.208 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -102.69 -6.28 22.86 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.261 -0.899 . . . . 2.5800000000000001 113.383 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 45.5 t -111.7 131.8 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.063 -1.088 . . . . 1.1799999999999999 108.063 179.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.412 ' CD2' ' O ' ' A' ' 177' ' ' LEU . 2.0 tt -86.04 -11.52 52.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.004 -1.06 . . . . 2.1800000000000002 111.684 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.31 177.39 43.43 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.013 -1.565 . . . . 0.48999999999999999 109.748 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.64 132.48 46.73 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.405 -1.056 . . . . 0.64000000000000001 108.199 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 72.6 mt -134.14 109.39 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 106.423 -1.695 . . . . 1.21 106.423 178.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 203' ' ' VAL . 65.6 p -129.63 170.47 13.75 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.9 -1.125 . . . . 1.3799999999999999 110.568 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 15.4 p-10 -103.03 49.56 0.83 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.277 0.561 . . . . 2.3700000000000001 110.423 179.435 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.0 154.46 18.95 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.338 -0.851 . . . . 1.52 109.356 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.91 -80.92 0.06 OUTLIER Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.598 -1.286 . . . . 1.8 111.302 178.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.38 -40.74 0.82 Allowed Glycine 0 N--CA 1.492 2.392 0 O-C-N 120.941 -1.329 . . . . 2.04 112.354 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -60.22 -36.25 77.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.947 . . . . 5.0 110.518 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 12.6 p -121.25 26.85 8.69 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.517 -0.74 . . . . 3.02 111.399 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -86.52 109.84 19.37 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.351 -1.351 . . . . 2.1099999999999999 107.351 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.504 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 72.9 t60 -61.69 -37.83 85.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.588 -0.695 . . . . 1.24 110.727 -178.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 25.8 m -57.24 -40.49 77.7 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.136 -0.977 . . . . 2.1499999999999999 110.304 179.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 50.4 m -60.01 -38.45 82.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 2.02 110.6 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.9 mt -59.36 -41.04 83.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.148 -0.97 . . . . 2.1200000000000001 110.522 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.591 ' SD ' ' CZ ' ' A' ' 65' ' ' PHE . 7.7 mtm -68.96 -35.07 76.33 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.707 -1.197 . . . . 1.3600000000000001 109.325 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.26 -44.62 88.44 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.174 -0.61 . . . . 1.29 110.56 179.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.45 ' HG2' HH11 ' A' ' 195' ' ' ARG . 32.8 mtt-85 -60.2 -41.27 92.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 3.5600000000000001 110.448 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.0 m -68.91 -37.46 78.96 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.749 0.785 . . . . 1.1799999999999999 110.028 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.1 mt -90.4 -5.91 55.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.413 -0.804 . . . . 1.3400000000000001 112.472 -179.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 54.11 8.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.67 0.989 . . . . 1.45 113.67 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 30.8 mt -71.58 150.03 93.5 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.971 -1.081 . . . . 1.25 108.773 178.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -55.89 145.79 71.33 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.745 1.63 . . . . 0.78000000000000003 109.68 178.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.9 158.9 31.69 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.715 -1.241 . . . . 1.2 109.989 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.0 mt -149.77 148.03 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.878 -1.156 . . . . 1.25 107.878 178.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.2 m -134.11 -32.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.995 -1.066 . . . . 1.3899999999999999 113.557 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.11 45.32 2.51 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.102 -0.999 . . . . 0.96999999999999997 112.227 -178.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 32.5 p -67.19 -11.1 56.46 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.189 -1.183 . . . . 1.3500000000000001 111.328 -179.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.0 -97.08 0.81 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.802 -1.189 . . . . 1.0700000000000001 110.182 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.6 m -127.18 29.07 5.64 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.457 -1.025 . . . . 1.9199999999999999 112.473 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.53 -37.85 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.595 -1.316 . . . . 1.3300000000000001 110.7 179.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 60.4 p -54.35 -25.1 22.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.001 -1.062 . . . . 1.4199999999999999 111.36 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.2 t -93.63 -0.2 56.24 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.705 0.764 . . . . 2.1200000000000001 111.742 -179.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -124.37 -2.05 8.06 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 113.291 0.849 . . . . 2.6899999999999999 113.291 -177.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.4 t -117.12 150.04 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.443 -0.786 . . . . 1.29 109.156 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -122.2 153.07 39.3 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.638 -0.875 . . . . 2.6899999999999999 108.638 178.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 52.3 t30 -52.2 141.53 18.67 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.235 -0.915 . . . . 2.79 110.093 178.518 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 10.0 t0 81.07 -1.76 1.76 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.111 1.152 . . . . 2.3500000000000001 114.111 179.521 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -61.71 148.56 42.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.796 -1.19 . . . . 1.97 108.578 177.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -90.47 118.97 30.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.116 -1.439 . . . . 2.9700000000000002 107.116 177.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 82.9 mt -129.33 148.41 51.25 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.55 -0.719 . . . . 1.25 109.511 -178.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.6 mt -117.54 129.66 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 106.602 -1.629 . . . . 1.22 106.602 177.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.6 tp -99.75 118.84 37.09 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 106.713 -1.588 . . . . 1.24 106.713 178.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 223' ' ' VAL . 50.4 t0 -93.71 -30.94 14.64 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.119 -0.988 . . . . 2.0499999999999998 112.654 -177.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.438 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 37.87 20.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.42 0.896 . . . . 1.25 113.42 -178.079 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.7 t -109.62 -62.03 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.839 -1.163 . . . . 1.4299999999999999 108.788 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -91.83 15.22 13.42 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.024 0.916 . . . . 3.0299999999999998 110.247 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.3 t30 60.75 51.54 4.8 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.355 -0.839 . . . . 2.25 112.409 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.475 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 15.4 pt20 -152.73 156.19 38.66 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.776 -1.202 . . . . 2.52 110.451 178.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 69.9 t -117.97 144.96 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.702 -0.624 . . . . 1.29 109.462 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.475 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 93.8 m-85 -101.92 130.34 48.39 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 107.973 -1.121 . . . . 1.3400000000000001 107.973 177.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.07 129.86 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.22 -0.925 . . . . 1.3400000000000001 108.815 179.181 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.436 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 0.4 OUTLIER 52.51 49.85 7.2 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.115 -0.991 . . . . 2.1800000000000002 113.557 178.184 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 40.9 Cg_endo -66.51 149.71 84.3 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.623 2.216 . . . . 0.93999999999999995 111.432 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.9 m -75.57 154.08 36.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 2.3999999999999999 109.031 177.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 34.0 p-10 -60.74 -35.44 76.38 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.569 -0.707 . . . . 3.3300000000000001 110.487 179.06 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.497 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 81.0 tt0 -59.47 -43.44 93.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 3.1699999999999999 110.453 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 99.0 t -71.34 -39.79 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.241 -0.912 . . . . 1.6899999999999999 110.165 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.494 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 96.3 mt -58.54 -46.73 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 1.6000000000000001 110.512 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -59.86 -41.14 90.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.501 -0.75 . . . . 2.7000000000000002 110.275 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -60.81 -41.88 96.55 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.513 -0.742 . . . . 2.96 110.455 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.463 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 87.1 mtp -73.09 -40.38 65.06 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.524 -0.735 . . . . 1.6299999999999999 110.674 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.515 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.1 OUTLIER -53.93 -41.8 68.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.031 -1.043 . . . . 3.27 110.516 -178.59 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.61 -59.21 2.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.635 -1.291 . . . . 2.23 110.471 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 63.1 t -64.52 -46.72 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.347 -0.845 . . . . 2.79 111.321 -179.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' A' ' 239' ' ' MET . 0.9 OUTLIER -59.16 -48.95 79.72 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.723 -1.236 . . . . 4.2599999999999998 110.92 179.959 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -60.78 -31.64 71.0 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.789 -1.194 . . . . 1.8799999999999999 110.365 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -60.23 -31.82 70.54 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.254 -0.904 . . . . 3.3799999999999999 109.209 178.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 90.6 t -62.56 -39.87 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 121.794 0.807 . . . . 2.8799999999999999 109.863 179.261 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.76 91.86 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.403 0.62 . . . . 2.75 110.538 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 11.7 m -69.52 -40.69 76.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.482 -0.762 . . . . 3.4199999999999999 110.326 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -61.39 -34.46 75.37 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.924 -0.71 . . . . 3.5699999999999998 110.216 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -63.34 -35.78 81.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.935 . . . . 4.6100000000000003 110.212 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -65.48 -30.32 71.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.606 -0.684 . . . . 4.4500000000000002 110.635 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -71.45 -11.12 60.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.214 -0.929 . . . . 5.9699999999999998 111.963 -179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 31.3 tp -64.37 -27.87 69.31 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.938 -1.101 . . . . 6.4500000000000002 111.17 -179.357 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -67.29 -4.98 12.18 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.554 -0.716 . . . . 6.6600000000000001 112.552 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -83.12 12.33 5.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.449 -0.782 . . . . 8.5399999999999991 112.436 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 3.7 pp -77.1 -4.52 44.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.788 -1.195 . . . . 8.0700000000000003 112.388 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -85.2 -5.03 59.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.193 -0.942 . . . . 9.7200000000000006 112.247 -179.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -94.17 4.86 53.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.496 -0.752 . . . . 10.119999999999999 112.559 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 117.991 -1.004 . . . . 11.9 110.108 -179.38 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mmt . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 108.591 -0.892 . . . . 3.5299999999999998 108.591 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.85 111.51 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.497 -1.668 . . . . 1.5700000000000001 106.497 176.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 m -105.94 128.13 53.59 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.762 -1.199 . . . . 1.4399999999999999 107.762 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.28 -156.98 22.76 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 108.968 -1.653 . . . . 1.01 108.968 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.445 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 86.6 mt -95.82 -1.81 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.554 -0.968 . . . . 1.6299999999999999 112.581 -178.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 49.38 99.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.468 0.544 . . . . 1.5800000000000001 112.468 178.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.89 -52.69 6.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.066 -1.021 . . . . 1.3400000000000001 110.775 179.383 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.43 146.34 41.76 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 107.449 -1.315 . . . . 1.8600000000000001 107.449 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -74.07 144.38 33.83 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.866 2.377 . . . . 1.01 112.993 178.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.46 166.81 17.55 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 109.539 -1.425 . . . . 0.81000000000000005 109.539 178.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.7 mt -127.22 134.56 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.302 -1.116 . . . . 1.3700000000000001 108.225 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.12 155.94 46.77 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.318 -0.864 . . . . 1.1399999999999999 109.498 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.2 m-85 -125.09 143.22 51.03 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.482 -0.761 . . . . 0.87 108.995 178.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.32 167.39 34.39 Favored Glycine 0 N--CA 1.499 2.897 0 C-N-CA 118.98 -1.581 . . . . 0.56999999999999995 110.002 177.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -78.82 157.65 28.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.753 -0.851 . . . . 2.3500000000000001 109.198 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.31 134.84 35.65 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.842 -1.161 . . . . 1.21 108.636 178.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.2 tp -116.18 101.19 8.49 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 105.801 -1.925 . . . . 1.3999999999999999 105.801 178.199 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -93.72 132.97 37.57 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.01 -1.107 . . . . 1.4399999999999999 108.01 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.6 mt -103.31 118.09 35.99 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 106.802 -1.555 . . . . 1.45 106.802 178.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -110.63 137.72 47.95 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.749 -1.204 . . . . 2.5 107.749 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -121.02 151.33 39.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 2.6600000000000001 109.703 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -81.92 132.98 35.28 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.941 -1.133 . . . . 2.3199999999999998 107.941 177.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -60.87 148.84 38.09 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.876 -1.14 . . . . 2.1099999999999999 108.941 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.0 mt -96.9 129.83 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.175 -0.953 . . . . 1.29 108.517 178.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.5 129.6 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.005 -1.109 . . . . 1.4099999999999999 108.005 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.6 mt -91.64 130.91 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.24 -1.022 . . . . 1.3100000000000001 108.24 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -90.62 116.54 28.59 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.061 -1.459 . . . . 1.3400000000000001 107.061 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -97.92 17.07 19.06 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.424 -0.797 . . . . 3.48 112.673 -179.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -68.42 147.28 52.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 2.52 109.326 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -87.23 128.35 35.15 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.576 -1.268 . . . . 2.6299999999999999 107.576 178.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 pt -93.84 163.97 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.026 -1.046 . . . . 1.3100000000000001 110.132 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.8 p -92.57 162.03 14.35 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.206 0.527 . . . . 1.24 109.712 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.3 -15.98 1.91 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.046 -1.034 . . . . 1.49 112.011 179.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -71.27 -38.95 71.82 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.409 -0.807 . . . . 2.2799999999999998 110.895 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -92.68 -6.06 50.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.744 -1.222 . . . . 2.0499999999999998 112.934 -178.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -59.67 -40.58 82.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 120.154 -0.618 . . . . 1.3400000000000001 110.48 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -59.24 -40.19 85.15 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.017 -1.052 . . . . 1.54 110.528 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -62.14 -41.47 98.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.326 -0.859 . . . . 2.8500000000000001 111.213 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -59.71 -40.27 87.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.316 -0.865 . . . . 1.3100000000000001 111.047 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.31 -40.63 84.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.169 -0.957 . . . . 1.3799999999999999 110.982 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -60.37 -48.82 80.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.587 -1.321 . . . . 1.5 110.449 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -62.45 -40.97 98.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.472 -0.767 . . . . 2.7799999999999998 110.649 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -70.39 -57.6 4.64 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.177 -0.952 . . . . 1.0600000000000001 109.374 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.39 -48.73 80.53 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.55 -0.86 . . . . 1.3999999999999999 110.121 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t -68.03 -39.67 83.04 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.106 -0.996 . . . . 1.3200000000000001 110.074 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.16 -46.67 70.07 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.74 -1.219 . . . . 0.69999999999999996 110.056 178.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -59.96 -29.92 68.75 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.44 -1.035 . . . . 3.4399999999999999 110.311 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.67 -49.48 77.58 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.671 0.748 . . . . 1.3600000000000001 109.923 179.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -79.27 -41.56 27.85 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.599 -0.688 . . . . 2.8300000000000001 110.657 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.58 -41.37 90.1 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.05 -1.06 . . . . 1.23 110.206 -178.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.491 ' HG ' ' N ' ' A' ' 52' ' ' ALA . 67.2 p -60.78 -40.34 92.23 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.319 1.056 . . . . 1.9199999999999999 109.246 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.491 ' N ' ' HG ' ' A' ' 51' ' ' SER . . . -65.71 -49.63 67.79 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.65 -0.705 . . . . 1.25 110.435 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.67 -49.78 76.41 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 118.85 -1.14 . . . . 1.97 110.392 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.94 -40.6 98.15 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.877 0.846 . . . . 2.1800000000000002 110.164 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -59.93 -41.4 91.7 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.195 -0.94 . . . . 1.1899999999999999 110.471 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 m -63.89 -43.7 95.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.851 -1.156 . . . . 1.3400000000000001 110.067 179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.9 mt -60.43 -36.66 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.561 0.696 . . . . 1.23 110.943 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -51.01 -44.09 60.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.401 -0.812 . . . . 1.5600000000000001 110.81 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -68.98 -38.91 79.61 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.031 -1.043 . . . . 1.3 110.029 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.71 -37.71 87.56 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.887 -1.125 . . . . 2.3199999999999998 108.873 179.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.8 -33.17 75.35 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.887 -0.725 . . . . 1.1399999999999999 109.818 179.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.83 -37.1 12.08 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 120.139 -1.029 . . . . 0.68999999999999995 111.135 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -81.63 -28.45 33.66 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.787 -1.42 . . . . 1.48 110.723 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.3 m -88.19 -45.45 10.08 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.49 -0.757 . . . . 1.52 111.383 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.89 -7.54 17.04 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 114.102 1.149 . . . . 1.3100000000000001 114.102 -177.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.46 161.27 30.2 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.498 -0.751 . . . . 0.84999999999999998 111.633 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.87 -25.39 63.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.73 -0.865 . . . . 3.8599999999999999 112.341 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -57.27 -44.18 83.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.763 -1.211 . . . . 2.3500000000000001 110.669 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -82.64 -24.29 33.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.554 -1.341 . . . . 2.2599999999999998 111.405 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.72 -36.84 77.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.531 -0.731 . . . . 1.45 110.981 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.05 83.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.163 -0.961 . . . . 1.25 110.628 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.7 mt -64.74 -41.86 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.913 -1.117 . . . . 1.26 110.178 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -71.42 -32.41 68.36 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.971 -1.081 . . . . 0.82999999999999996 109.776 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -61.74 -39.19 90.69 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 1.1899999999999999 109.953 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.71 -40.93 99.04 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.265 -0.969 . . . . 0.57999999999999996 110.986 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -58.93 -43.07 91.1 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.913 -1.345 . . . . 2.0499999999999998 110.475 179.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 77' ' ' ILE . 98.5 mt -60.88 -37.51 76.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.038 -1.039 . . . . 1.21 110.333 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -57.7 -40.27 79.1 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.602 -0.687 . . . . 2.29 110.045 179.12 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 tp -60.31 -50.35 73.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.368 -0.832 . . . . 1.21 110.232 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.01 -41.26 91.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.896 0.855 . . . . 1.1399999999999999 110.183 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -85.91 5.69 31.83 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.446 -0.784 . . . . 1.4199999999999999 112.937 -179.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -61.59 121.79 13.64 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.204 -0.935 . . . . 1.27 108.491 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.95 -17.26 64.55 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.752 -0.779 . . . . 1.3500000000000001 110.822 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.77 -51.8 10.73 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.768 -0.773 . . . . 2.2200000000000002 110.495 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.95 -40.61 93.94 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.48 -0.888 . . . . 1.22 111.204 -179.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -57.48 -49.85 74.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.932 . . . . 1.29 110.236 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -61.86 -40.34 95.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 2.1699999999999999 110.469 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.02 -46.66 77.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.936 -1.102 . . . . 1.3 110.521 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -57.11 -42.87 80.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.049 -1.032 . . . . 1.1699999999999999 110.065 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.8 -44.51 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.39 -0.819 . . . . 1.3999999999999999 110.245 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.6 97.33 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.493 -0.754 . . . . 1.3300000000000001 111.016 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.03 -43.29 99.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.872 -1.142 . . . . 1.48 110.198 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.62 -47.94 89.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.38 -0.825 . . . . 1.28 110.247 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -78.09 -38.76 43.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.125 -0.984 . . . . 2.6000000000000001 112.059 -179.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -82.35 -42.25 18.96 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.964 -1.085 . . . . 1.51 112.359 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -99.04 5.04 47.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.173 -0.955 . . . . 2.48 112.374 -178.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 40.7 m80 51.37 49.11 21.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.0 . . . . 1.6100000000000001 111.338 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 64.5 mtt -105.82 154.68 20.19 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.14 -0.975 . . . . 1.8999999999999999 109.711 178.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 82.5 p -70.82 160.37 32.87 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.701 -0.624 . . . . 1.3200000000000001 109.6 177.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.01 86.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.043 -1.035 . . . . 1.1499999999999999 110.539 179.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -67.68 -39.36 84.46 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.318 -0.863 . . . . 2.25 110.568 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.06 67.96 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 120.928 -1.108 . . . . 1.22 111.439 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.76 88.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 1.1899999999999999 110.626 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.74 -41.33 86.25 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.234 -0.916 . . . . 1.2 111.148 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -61.13 -40.25 93.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.631 -1.293 . . . . 2.1000000000000001 110.285 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -59.9 -49.86 76.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.856 -1.152 . . . . 1.3 110.243 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.21 -47.27 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.982 -1.074 . . . . 1.27 110.182 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.3 mm -61.33 -33.26 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 1.1899999999999999 110.521 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -57.26 -39.93 76.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.592 -0.693 . . . . 2.1099999999999999 110.979 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.67 -24.91 44.18 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 118.948 -1.596 . . . . 0.88 113.304 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -63.36 -41.06 98.8 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.527 -1.572 . . . . 1.99 109.702 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.81 63.33 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.018 -0.537 . . . . 1.28 110.759 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.624 ' HG ' ' N ' ' A' ' 114' ' ' ALA . 44.7 p -62.43 -41.14 98.49 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.077 -1.049 . . . . 2.2200000000000002 109.918 -178.141 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.624 ' N ' ' HG ' ' A' ' 113' ' ' SER . . . -62.34 -43.47 98.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.099 -1.0 . . . . 1.45 110.893 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 87.9 mt -64.92 -29.66 70.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.106 -0.996 . . . . 1.47 110.722 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -66.38 -21.59 66.23 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.34 -0.85 . . . . 2.04 110.967 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -71.72 -13.38 61.71 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.222 1.01 . . . . 1.73 110.814 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.8 mt -87.62 136.35 32.98 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.429 -1.323 . . . . 1.79 107.429 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 7.3 t0 -97.01 37.42 1.31 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.556 -0.715 . . . . 2.8799999999999999 112.266 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -111.96 138.77 48.13 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 107.984 -1.117 . . . . 1.5800000000000001 107.984 178.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.92 -38.84 76.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.476 -0.765 . . . . 3.04 111.454 179.114 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -73.37 -50.12 23.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.65 -1.281 . . . . 1.29 110.594 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.59 -43.3 97.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.022 -1.049 . . . . 1.6000000000000001 110.367 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -62.55 -45.11 94.44 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.345 -0.942 . . . . 2.7599999999999998 109.416 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.84 -31.22 69.54 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.489 -0.885 . . . . 2.1499999999999999 109.27 179.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -61.67 -30.17 70.56 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.308 -0.957 . . . . 2.8100000000000001 108.832 179.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.8 -50.51 72.04 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.157 -0.617 . . . . 1.3899999999999999 110.273 178.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.37 -42.74 78.74 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.843 -0.743 . . . . 1.4099999999999999 110.38 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.69 -36.84 84.22 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.733 -0.605 . . . . 1.3899999999999999 110.567 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.5 t -68.54 -40.94 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.235 -0.986 . . . . 1.1899999999999999 110.732 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.595 ' HE ' ' HZ3' ' A' ' 135' ' ' LYS . 62.4 ttt180 -59.53 -37.6 78.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.031 -1.043 . . . . 3.6299999999999999 109.704 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.407 ' CG ' ' NH1' ' A' ' 136' ' ' ARG . 49.2 t0 -60.37 -36.63 78.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.692 -0.63 . . . . 1.28 109.907 179.469 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.99 -39.76 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.729 0.776 . . . . 1.1799999999999999 109.842 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.16 -42.64 94.25 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 119.567 -1.301 . . . . 0.51000000000000001 109.973 178.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.595 ' HZ3' ' HE ' ' A' ' 131' ' ' ARG . 40.4 mmtm -59.05 -49.33 78.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.477 -1.014 . . . . 3.1699999999999999 110.421 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.407 ' NH1' ' CG ' ' A' ' 132' ' ' ASP . 51.5 mtm-85 -64.96 -40.93 95.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.848 -1.158 . . . . 2.8500000000000001 109.844 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 35.6 tp -61.09 -39.44 89.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.263 -0.898 . . . . 1.6499999999999999 110.217 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.7 mt -60.24 -38.6 83.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.56 -0.712 . . . . 1.2 111.074 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -60.13 -37.83 81.23 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.288 -0.883 . . . . 2.7999999999999998 110.734 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -75.47 -40.79 56.95 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.62 -0.832 . . . . 2.1499999999999999 110.581 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -60.37 -39.62 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 1.21 110.17 -178.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.2 mt -87.28 -4.33 59.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.955 -1.091 . . . . 1.3400000000000001 111.522 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.47 29.5 65.85 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 119.62 -1.276 . . . . 0.91000000000000003 112.819 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 33.2 tp -75.03 151.09 38.76 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.632 0.729 . . . . 1.51 109.136 179.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -64.1 146.65 53.83 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.695 -1.253 . . . . 2.8799999999999999 109.231 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.8 mt -105.27 138.79 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.574 -0.899 . . . . 1.6200000000000001 108.574 178.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.9 mp -81.0 127.32 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.671 -1.233 . . . . 2.1099999999999999 107.671 178.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -94.7 96.16 9.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.484 -1.672 . . . . 1.6200000000000001 106.484 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.494 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.9 mt -75.76 -15.77 60.22 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.699 0.762 . . . . 1.3999999999999999 111.683 -177.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.411 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 94.7 p -89.92 8.35 32.68 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.613 -1.305 . . . . 2.0499999999999998 112.147 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.29 21.21 12.3 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.672 0.99 . . . . 1.3500000000000001 113.672 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.494 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 3.2 mp -70.51 139.94 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.343 -1.473 . . . . 1.4199999999999999 108.437 179.302 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -114.65 -20.41 10.69 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.471 -0.768 . . . . 2.9900000000000002 112.278 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -114.2 139.19 49.57 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.535 -1.284 . . . . 1.54 107.535 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.81 122.97 20.87 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.426 -0.954 . . . . 1.3799999999999999 108.426 178.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.6 m -144.84 173.87 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 109.071 -0.714 . . . . 1.28 109.071 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.9 mt -85.78 142.87 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.065 -1.022 . . . . 1.1599999999999999 109.583 178.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.2 tp -97.19 124.0 41.13 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.124 -0.985 . . . . 1.3100000000000001 108.554 178.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.6 129.51 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.623 -1.251 . . . . 1.25 107.623 179.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.21 152.34 18.66 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.94 -1.1 . . . . 1.26 109.051 179.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.83 78.22 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.435 -1.416 . . . . 1.6000000000000001 109.673 178.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 56.1 t0 -171.96 149.79 2.47 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.001 -0.74 . . . . 2.4199999999999999 109.001 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.464 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 36.1 mt -114.39 140.85 48.33 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.537 -0.727 . . . . 1.3500000000000001 109.397 177.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 81.2 p -90.0 149.02 40.89 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.954 -1.091 . . . . 1.3200000000000001 109.096 178.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.97 -44.53 12.06 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 C-N-CA 122.159 1.906 . . . . 0.69999999999999996 113.51 179.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.8 m -60.85 -46.54 90.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.834 -1.166 . . . . 1.1200000000000001 109.742 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -63.81 -39.76 95.0 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.697 -0.801 . . . . 1.21 110.399 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.435 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 64.9 p -69.43 -39.4 77.88 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.63 -0.668 . . . . 1.1899999999999999 110.587 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.79 78.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.618 -0.676 . . . . 1.24 110.662 179.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -95.58 1.3 53.68 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.202 -0.936 . . . . 1.6899999999999999 112.931 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.4 tp -61.57 151.94 31.82 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.718 -1.238 . . . . 1.3400000000000001 109.548 179.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 150' ' ' SER . 94.3 m-20 -94.65 107.54 19.53 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 106.269 -1.752 . . . . 2.77 106.269 178.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 8.9 mp -69.36 -25.04 63.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.858 -0.526 . . . . 2.0899999999999999 111.548 -178.074 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -83.37 -14.25 53.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.251 -0.906 . . . . 2.6699999999999999 112.925 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -102.98 -1.91 28.52 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.274 0.842 . . . . 2.5800000000000001 113.274 -177.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.6 t -111.41 130.26 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.249 -1.019 . . . . 1.1799999999999999 108.249 179.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 27.8 tp -84.54 -10.47 57.39 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.124 -0.985 . . . . 2.1800000000000002 111.992 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.45 167.21 35.92 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 108.995 -1.642 . . . . 0.48999999999999999 108.995 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -121.75 130.15 53.21 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.869 -1.16 . . . . 0.64000000000000001 107.869 178.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 18.8 mt -130.07 130.45 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 107.444 -1.317 . . . . 1.21 107.444 178.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.2 p -140.29 172.33 12.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.936 -1.103 . . . . 1.3799999999999999 109.818 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 2.8 m-20 -111.95 42.51 1.74 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.338 0.59 . . . . 2.3700000000000001 110.369 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.55 168.73 9.04 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.783 0.801 . . . . 1.52 110.074 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.17 -6.8 48.55 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 120.107 -1.044 . . . . 1.8 113.086 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 77.6 -52.43 3.5 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.17 -1.194 . . . . 2.04 113.539 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -58.8 -42.37 88.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.817 -1.402 . . . . 5.0 110.986 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 81.8 p -105.38 11.3 32.88 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 120.79 -1.193 . . . . 3.02 112.074 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.5 t -92.18 125.53 36.89 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.839 -0.8 . . . . 2.1099999999999999 108.839 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.435 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 85.3 t60 -62.08 -32.47 73.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 1.24 110.357 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.6 m -58.66 -38.9 79.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.406 -0.809 . . . . 2.1499999999999999 110.39 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 93.6 p -59.03 -37.76 77.71 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.38 -0.825 . . . . 2.02 110.085 179.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.447 ' CD1' ' NH2' ' A' ' 195' ' ' ARG . 5.3 mm -58.75 -39.71 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.652 -0.819 . . . . 2.1200000000000001 110.151 179.375 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 51.1 mtp -62.97 -44.52 95.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.088 -1.008 . . . . 1.3600000000000001 110.146 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.26 -49.82 76.36 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.08 -0.648 . . . . 1.29 111.484 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.447 ' NH2' ' CD1' ' A' ' 192' ' ' ILE . 65.0 mtm-85 -62.96 -42.14 99.73 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.188 -0.945 . . . . 3.5600000000000001 111.199 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.0 m -68.31 -38.75 81.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.173 -0.954 . . . . 1.1799999999999999 109.855 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.62 -6.95 51.4 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.82 0.674 . . . . 1.3400000000000001 112.82 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.6 mt-10 53.52 11.26 0.27 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 113.804 1.039 . . . . 1.45 113.804 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.11 144.71 87.73 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.856 -1.153 . . . . 1.25 108.239 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.28 131.2 43.47 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.785 1.657 . . . . 0.78000000000000003 110.636 178.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.6 171.84 16.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.272 -1.371 . . . . 1.2 110.118 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 10.1 mt -147.03 157.04 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.045 -1.094 . . . . 1.25 108.045 178.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 181' ' ' THR . 23.8 m -141.59 -29.05 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.644 -1.285 . . . . 1.3899999999999999 112.791 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.72 33.18 1.89 Allowed Glycine 0 C--N 1.289 -2.04 0 O-C-N 120.927 -1.108 . . . . 0.96999999999999997 113.685 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 27.6 p -55.47 -24.79 33.05 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.249 -1.148 . . . . 1.3500000000000001 111.194 -179.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.34 -87.86 1.56 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.825 -0.91 . . . . 1.0700000000000001 110.825 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 45.2 p -129.02 26.83 5.46 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 121.167 -1.196 . . . . 1.9199999999999999 113.069 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 30.4 t -57.0 -39.7 67.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.317 -1.489 . . . . 1.3300000000000001 110.807 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 64.4 p -61.27 -18.95 60.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 1.4199999999999999 111.93 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 67.4 m -98.83 5.44 47.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 2.1200000000000001 112.002 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -133.62 -4.19 2.93 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.916 -0.49 . . . . 2.6899999999999999 112.146 -178.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.0 t -121.3 152.95 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 121.504 0.668 . . . . 1.29 109.41 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -117.81 161.21 20.1 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.751 -0.833 . . . . 2.6899999999999999 108.751 178.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.0 p-10 -61.78 149.87 38.68 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.906 -1.117 . . . . 2.79 109.88 177.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.5 t70 82.88 -10.27 1.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.233 1.197 . . . . 2.3500000000000001 114.233 178.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.23 149.44 37.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.534 -1.354 . . . . 1.97 109.276 177.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -87.18 123.88 32.68 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.282 -1.377 . . . . 2.9700000000000002 107.282 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 74.8 mt -127.51 150.23 49.77 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.017 0.913 . . . . 1.25 110.093 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 88.0 mt -119.05 122.29 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.237 -1.764 . . . . 1.22 106.237 177.114 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 37.1 tp -98.65 118.01 34.4 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.441 -1.688 . . . . 1.24 106.441 178.434 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 223' ' ' VAL . 87.7 m-20 -94.22 -27.84 15.95 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.502 -1.374 . . . . 2.0499999999999998 112.917 -177.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 39.63 15.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.914 0.709 . . . . 1.25 112.914 -179.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.8 t -108.66 -62.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.196 -0.94 . . . . 1.4299999999999999 109.217 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -94.34 11.31 30.92 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.009 0.909 . . . . 3.0299999999999998 110.514 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 60.9 54.99 3.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.618 -0.719 . . . . 2.25 112.03 178.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -144.72 146.53 32.24 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.234 1.016 . . . . 2.52 109.586 178.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.84 131.32 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.658 -1.238 . . . . 1.29 107.658 177.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -102.05 132.02 48.16 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.846 -1.159 . . . . 1.3400000000000001 108.483 178.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.28 129.94 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 107.998 -1.112 . . . . 1.3400000000000001 107.998 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.5 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 48.3 t30 59.05 44.01 0.96 Allowed Pre-proline 0 N--CA 1.485 1.309 0 N-CA-C 113.631 0.974 . . . . 2.1800000000000002 113.631 178.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.1 Cg_endo -64.7 149.35 89.88 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.349 2.033 . . . . 0.93999999999999995 111.56 -179.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 36.9 p -77.03 160.18 29.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.475 -0.766 . . . . 2.3999999999999999 110.255 178.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -60.28 -36.73 78.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.753 -0.592 . . . . 3.3300000000000001 110.385 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.12 -40.34 85.1 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.447 -0.783 . . . . 3.1699999999999999 110.15 179.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 79.4 t -70.15 -39.87 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.824 0.821 . . . . 1.6899999999999999 110.571 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.3 mt -60.4 -45.84 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.499 -0.751 . . . . 1.6000000000000001 110.799 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -59.86 -41.37 91.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.181 -0.949 . . . . 2.7000000000000002 110.441 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -63.0 -43.23 99.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 2.96 110.902 -179.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.6 mtp -70.92 -39.49 72.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 1.6299999999999999 110.936 -179.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -57.55 -41.28 80.69 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.053 -1.029 . . . . 3.27 110.025 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.79 -57.47 4.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.766 -0.584 . . . . 2.23 110.707 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.29 -44.2 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.943 -1.098 . . . . 2.79 110.737 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.3 -52.77 63.85 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.636 -1.29 . . . . 4.2599999999999998 111.119 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.0 -30.27 71.36 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.232 -0.918 . . . . 1.8799999999999999 110.64 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -59.37 -33.27 70.97 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.969 -1.092 . . . . 3.3799999999999999 109.058 178.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 95.3 t -64.17 -40.81 90.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 122.102 0.953 . . . . 2.8799999999999999 109.433 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.36 -40.11 85.41 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.402 0.62 . . . . 2.75 110.895 179.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.9 t -62.98 -33.81 76.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.544 -0.722 . . . . 3.4199999999999999 110.78 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -62.14 -39.09 91.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.12 -0.987 . . . . 3.5699999999999998 110.028 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -68.16 -29.95 68.96 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.359 -0.838 . . . . 4.6100000000000003 110.841 179.494 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -65.96 -15.76 63.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.481 -0.762 . . . . 4.4500000000000002 112.265 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -64.62 -30.78 71.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.927 -1.108 . . . . 5.9699999999999998 110.626 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 30.1 tp -61.93 -24.39 66.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.346 -0.846 . . . . 6.4500000000000002 111.077 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -68.19 -4.83 15.21 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.247 -0.908 . . . . 6.6600000000000001 112.692 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -78.18 1.36 21.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.978 -1.076 . . . . 8.5399999999999991 112.686 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.85 -9.73 59.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.448 -0.783 . . . . 8.0700000000000003 112.505 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -85.66 -1.89 57.62 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.232 -0.917 . . . . 9.7200000000000006 112.124 -178.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -92.94 8.38 40.01 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.239 -0.913 . . . . 10.119999999999999 112.583 -178.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 31.7 ttm-85 . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 117.934 -1.032 . . . . 11.9 110.614 -179.434 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.428 ' H1 ' ' H ' ' A' ' 2' ' ' ILE . 63.4 mtt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 121.126 0.489 . . . . 3.5299999999999998 109.783 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.428 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 60.6 mt -109.98 120.02 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 107.433 -1.321 . . . . 1.5700000000000001 107.433 178.155 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.0 m -100.47 127.48 46.8 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.505 -1.294 . . . . 1.4399999999999999 107.505 178.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -124.5 -163.29 11.64 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.451 -1.86 . . . . 1.01 108.451 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.465 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 96.7 mt -97.91 2.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.984 -1.303 . . . . 1.6299999999999999 112.593 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tp 51.56 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.762 -1.211 . . . . 1.5800000000000001 111.825 178.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.07 -38.83 17.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.914 -1.116 . . . . 1.3400000000000001 110.939 179.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 m -148.1 144.36 18.78 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.619 -1.301 . . . . 1.8600000000000001 108.173 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.08 145.99 22.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.356 2.037 . . . . 1.01 111.904 178.263 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.421 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 151.93 171.02 19.27 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.23 -1.548 . . . . 0.81000000000000005 109.23 178.047 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.1 mt -128.79 135.56 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.208 -1.172 . . . . 1.3700000000000001 107.919 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.39 152.69 44.55 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.027 -1.046 . . . . 1.1399999999999999 109.996 179.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -125.08 140.28 53.03 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.33 -0.989 . . . . 0.87 108.33 178.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.54 170.14 37.38 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 118.216 -1.945 . . . . 0.56999999999999995 110.473 178.155 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -78.74 157.14 28.57 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.803 -0.822 . . . . 2.3500000000000001 109.003 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.89 127.45 35.05 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.257 -1.016 . . . . 1.21 108.257 178.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.3 tp -105.07 102.99 12.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.497 -2.038 . . . . 1.3999999999999999 105.497 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.7 tp -90.62 140.82 29.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.936 -1.102 . . . . 1.4399999999999999 108.672 -179.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.5 mt -97.0 114.22 25.82 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.697 -1.594 . . . . 1.45 106.697 177.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -106.23 130.11 54.16 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.317 -1.364 . . . . 2.5 107.317 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -125.31 149.61 47.91 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.476 -0.765 . . . . 2.6600000000000001 109.527 -179.473 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -82.4 133.28 35.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.079 -1.082 . . . . 2.3199999999999998 108.079 177.258 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -65.34 146.67 54.62 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.168 -0.957 . . . . 2.1099999999999999 108.758 178.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.1 mt -93.45 136.18 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.694 -0.854 . . . . 1.29 108.694 178.431 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.09 130.27 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.821 -1.177 . . . . 1.4099999999999999 107.821 179.064 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.7 mt -97.94 135.34 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.181 -1.044 . . . . 1.3100000000000001 108.181 178.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -91.22 122.45 33.87 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.747 -1.205 . . . . 1.3400000000000001 107.747 178.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -95.4 16.96 15.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.201 -0.937 . . . . 3.48 112.216 -179.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -73.82 148.57 42.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 2.52 109.728 178.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -90.6 135.59 33.61 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.333 -0.988 . . . . 2.6299999999999999 108.333 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 pt -100.48 166.36 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.131 -0.98 . . . . 1.3100000000000001 109.976 179.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.2 p -95.43 168.68 10.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.501 -0.749 . . . . 1.24 109.583 178.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.66 -18.61 21.47 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.078 -1.014 . . . . 1.49 112.476 179.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -68.06 -37.54 81.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.881 -1.137 . . . . 2.2799999999999998 110.711 -179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -92.26 -5.35 52.54 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.634 -1.292 . . . . 2.0499999999999998 113.132 -179.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.28 -43.8 94.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.063 -1.023 . . . . 1.3400000000000001 110.134 -179.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -57.93 -40.76 81.22 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.567 -0.853 . . . . 1.54 110.241 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -63.89 -39.76 94.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.704 -0.623 . . . . 2.8500000000000001 110.714 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.23 -42.58 95.54 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.157 -0.964 . . . . 1.3100000000000001 110.913 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.34 -42.22 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.09 -1.006 . . . . 1.3799999999999999 110.727 -179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -60.96 -42.27 97.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 1.5 109.919 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -60.75 -42.67 97.88 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.466 -0.894 . . . . 2.7799999999999998 109.803 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -72.84 -56.7 4.84 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.815 0.817 . . . . 1.0600000000000001 110.231 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 tp -58.47 -47.44 84.03 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.42 -0.912 . . . . 1.3999999999999999 110.252 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.8 t -68.73 -39.82 80.18 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.121 -0.987 . . . . 1.3200000000000001 110.035 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.44 -45.55 94.26 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.434 -1.365 . . . . 0.69999999999999996 109.783 178.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -58.76 -30.19 67.33 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.516 -0.991 . . . . 3.4399999999999999 110.28 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.67 -42.14 87.78 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.972 0.891 . . . . 1.3600000000000001 109.779 179.024 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -81.19 -40.71 23.48 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.412 -0.805 . . . . 2.8300000000000001 110.73 179.445 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.86 -43.68 90.89 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.747 -0.781 . . . . 1.23 109.938 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.8 m -59.32 -39.93 84.67 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.863 0.84 . . . . 1.9199999999999999 109.381 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.31 -44.36 71.9 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.629 -0.714 . . . . 1.25 110.587 179.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.5 -51.57 59.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.004 . . . . 1.97 110.472 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.58 -38.99 86.44 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.371 -0.931 . . . . 2.1800000000000002 109.874 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -59.99 -40.99 91.06 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.456 -0.777 . . . . 1.1899999999999999 110.487 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -65.63 -42.33 91.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 1.3400000000000001 110.175 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.81 -35.17 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.495 -0.753 . . . . 1.23 110.703 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -52.44 -43.01 64.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.659 -1.275 . . . . 1.5600000000000001 110.771 179.237 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.13 -37.17 78.18 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.389 -0.819 . . . . 1.3 110.151 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -62.05 -39.54 92.7 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.853 -1.139 . . . . 2.3199999999999998 109.531 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.83 -32.08 72.37 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.598 -0.689 . . . . 1.1399999999999999 110.322 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.41 -36.67 16.44 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.242 -1.456 . . . . 0.68999999999999995 110.478 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.02 -16.43 50.27 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.637 -1.508 . . . . 1.48 111.306 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.2 m -92.94 -51.12 5.22 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.785 -0.572 . . . . 1.52 110.768 -179.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -107.82 -19.86 13.39 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.303 -0.873 . . . . 1.3100000000000001 112.799 -177.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.06 160.55 11.1 Favored Glycine 0 N--CA 1.504 3.219 0 O-C-N 120.96 -1.087 . . . . 0.84999999999999998 112.028 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -56.06 -22.77 29.48 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.983 -0.716 . . . . 3.8599999999999999 112.727 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -58.14 -35.47 71.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 2.3500000000000001 111.3 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -81.02 -25.78 36.92 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.721 -1.237 . . . . 2.2599999999999998 112.315 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.09 -32.41 69.79 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.377 -0.827 . . . . 1.45 110.803 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.43 85.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.019 . . . . 1.25 111.17 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.58 -42.92 87.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.394 -1.441 . . . . 1.26 110.114 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -70.48 -30.69 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.82999999999999996 110.729 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -59.91 -40.26 88.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.128 -0.982 . . . . 1.1899999999999999 110.142 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.33 -39.46 97.01 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.537 -1.316 . . . . 0.57999999999999996 110.47 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -59.1 -41.84 89.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.655 -0.909 . . . . 2.0499999999999998 111.113 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.3 mt -60.67 -42.09 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.92 -1.112 . . . . 1.21 110.028 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.5 ttm -60.42 -40.25 90.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.511 -0.743 . . . . 2.29 110.067 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 tp -59.77 -49.82 76.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.422 -0.799 . . . . 1.21 109.872 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.54 -41.85 95.33 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.055 -0.658 . . . . 1.1399999999999999 110.299 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -85.29 4.96 32.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.5 -0.75 . . . . 1.4199999999999999 112.972 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -61.54 118.17 6.69 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.627 -1.296 . . . . 1.27 109.191 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -63.69 -16.69 61.7 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.03 0.919 . . . . 1.3500000000000001 110.904 -179.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -77.49 -52.24 9.42 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.95 0.881 . . . . 2.2200000000000002 110.248 179.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.71 -37.79 85.47 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.668 -0.813 . . . . 1.22 110.588 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -59.05 -47.99 83.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 1.29 110.781 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -61.61 -38.0 86.02 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.314 -0.866 . . . . 2.1699999999999999 111.142 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -64.6 -47.7 77.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.236 -0.915 . . . . 1.3 110.324 179.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 89' ' ' ILE . 96.1 mt -58.3 -45.05 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.444 -0.785 . . . . 1.1699999999999999 109.665 179.181 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.1 mt -60.79 -40.59 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.994 0.902 . . . . 1.3999999999999999 109.862 179.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.67 97.32 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.995 -1.065 . . . . 1.3300000000000001 110.601 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.45 -41.37 97.1 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.426 -0.91 . . . . 1.48 110.245 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.26 -47.99 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.054 -1.029 . . . . 1.28 110.387 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -77.09 -35.77 56.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.508 -0.745 . . . . 2.6000000000000001 112.121 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -80.7 -44.99 17.85 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.407 -1.433 . . . . 1.51 112.184 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -102.82 12.08 36.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.292 -0.88 . . . . 2.48 112.559 -178.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.9 m80 49.23 49.07 20.25 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.026 -1.07 . . . . 1.6100000000000001 111.56 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.6 mtt -102.57 154.58 18.98 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.146 -0.971 . . . . 1.8999999999999999 109.715 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.8 p -70.63 159.8 33.73 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.377 0.608 . . . . 1.3200000000000001 109.412 177.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.99 83.39 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.383 -0.823 . . . . 1.1499999999999999 111.284 178.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -72.07 -44.44 63.29 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.212 -0.93 . . . . 2.25 110.44 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.11 74.39 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.35 -0.94 . . . . 1.22 111.165 -178.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.89 93.17 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.182 -0.948 . . . . 1.1899999999999999 110.945 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.67 86.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 1.2 110.683 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -60.63 -37.94 83.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.925 . . . . 2.1000000000000001 110.65 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -57.57 -50.01 74.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.821 -1.175 . . . . 1.3 111.078 179.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.9 -46.88 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.882 -1.136 . . . . 1.27 109.97 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.02 -33.4 55.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.66 -0.65 . . . . 1.1899999999999999 110.233 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -58.62 -40.19 82.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.17 -0.956 . . . . 2.1099999999999999 110.922 179.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.41 -35.7 10.4 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.046 -1.55 . . . . 0.88 112.3 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -60.49 -41.16 93.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.394 -1.651 . . . . 1.99 109.889 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.37 -49.82 38.37 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.684 0.754 . . . . 1.28 110.59 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.9 m -60.64 -39.13 87.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 2.2200000000000002 110.772 -179.432 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.51 -41.9 95.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.423 -0.798 . . . . 1.45 110.847 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.68 -30.35 71.37 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.15 -1.02 . . . . 1.47 110.994 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.0 -20.56 64.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.071 -1.018 . . . . 2.04 111.067 179.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.53 -17.84 61.7 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.784 0.802 . . . . 1.73 111.19 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 29.7 mt -86.34 148.76 25.45 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.396 -0.815 . . . . 1.79 109.285 179.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -101.7 41.66 1.19 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.48 -0.763 . . . . 2.8799999999999999 111.007 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -114.06 130.86 56.54 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.273 -1.01 . . . . 1.5800000000000001 108.273 178.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.468 ' OE2' ' N ' ' A' ' 121' ' ' GLU . 1.6 mp0 -58.71 -33.08 69.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.278 -0.889 . . . . 3.04 110.77 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -71.1 -51.43 25.13 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.689 -1.257 . . . . 1.29 110.318 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.2 mt -67.11 -39.25 86.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.426 -0.796 . . . . 1.6000000000000001 110.331 -179.312 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -61.99 -49.61 75.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.971 -1.08 . . . . 2.7599999999999998 109.796 179.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 187' ' ' THR . 50.5 mt-10 -61.49 -31.66 71.65 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.529 -0.868 . . . . 2.1499999999999999 109.203 179.699 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -64.75 -28.94 69.93 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.251 1.024 . . . . 2.8100000000000001 109.091 179.187 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.11 -47.16 86.27 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.575 -0.85 . . . . 1.3899999999999999 109.54 178.375 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.7 87.59 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.57 -0.852 . . . . 1.4099999999999999 109.612 179.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -63.29 -36.32 83.29 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.189 0.519 . . . . 1.3899999999999999 110.546 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.6 t -67.85 -36.59 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.966 -1.084 . . . . 1.1899999999999999 110.237 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -59.45 -38.8 81.66 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.869 -1.132 . . . . 3.6299999999999999 109.109 178.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.558 ' CG ' HH21 ' A' ' 136' ' ' ARG . 58.2 t0 -59.61 -40.34 87.2 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.676 -0.693 . . . . 1.28 109.9 179.114 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -60.83 -33.86 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 1.1799999999999999 109.7 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.41 -49.74 14.24 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.098 -1.049 . . . . 0.51000000000000001 111.186 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.475 ' NZ ' ' OD1' ' A' ' 132' ' ' ASP . 5.3 pttm -58.86 -39.46 81.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.998 -1.295 . . . . 3.1699999999999999 110.649 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.558 HH21 ' CG ' ' A' ' 132' ' ' ASP . 37.0 mtt180 -59.4 -45.22 92.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.947 -1.095 . . . . 2.8500000000000001 109.936 179.03 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.96 -42.57 98.54 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.66 -0.65 . . . . 1.6499999999999999 110.427 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 23.8 mt -59.9 -43.48 94.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.577 -0.702 . . . . 1.2 110.566 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -60.47 -34.55 74.19 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.433 -0.792 . . . . 2.7999999999999998 111.298 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -76.13 -41.13 51.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.92 -1.112 . . . . 2.1499999999999999 110.43 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.26 -39.84 83.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 120.83 -1.169 . . . . 1.21 110.887 -178.368 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 76.1 mt -88.53 -10.02 50.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 1.3400000000000001 112.246 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.0 19.96 71.41 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.887 -1.149 . . . . 0.91000000000000003 113.261 -179.298 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.9 tp -64.99 143.82 57.7 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.503 -0.998 . . . . 1.51 109.248 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -70.02 151.7 45.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.366 -0.834 . . . . 2.8799999999999999 109.626 178.113 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.3 mt -105.44 140.19 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.218 -1.03 . . . . 1.6200000000000001 108.218 178.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.427 HD11 HG22 ' A' ' 147' ' ' ILE . 12.3 mm -75.74 136.2 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 2.1099999999999999 108.973 178.398 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.38 92.55 7.22 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.495 -1.669 . . . . 1.6200000000000001 106.495 178.526 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 81.3 mt -78.36 -20.86 50.42 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.357 -0.839 . . . . 1.3999999999999999 111.061 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.6 t -78.86 -6.9 57.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 2.0499999999999998 112.458 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.39 35.94 1.55 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.597 -0.689 . . . . 1.3500000000000001 112.489 -178.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.1 mm -68.9 149.13 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.865 -1.147 . . . . 1.4199999999999999 108.986 178.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -129.37 -9.12 4.68 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.531 -0.73 . . . . 2.9900000000000002 112.613 -179.296 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -120.01 145.75 46.52 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.851 -0.796 . . . . 1.54 108.851 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -80.37 114.73 19.48 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.655 -1.239 . . . . 1.3799999999999999 107.655 177.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -148.2 175.45 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 1.28 109.305 -178.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.3 mt -93.83 143.33 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.389 -0.967 . . . . 1.1599999999999999 108.389 178.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.8 tp -96.49 129.81 43.78 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.772 -1.205 . . . . 1.3100000000000001 108.828 178.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.84 130.47 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.813 -1.18 . . . . 1.25 107.813 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.06 155.55 23.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.861 -1.149 . . . . 1.26 108.868 179.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.01 79.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.492 -1.38 . . . . 1.6000000000000001 109.712 178.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -174.3 148.46 1.28 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.908 -0.775 . . . . 2.4199999999999999 108.908 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.2 mt -118.15 141.69 48.23 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.585 -0.895 . . . . 1.3500000000000001 108.585 177.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.2 p -90.93 148.9 39.17 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.992 . . . . 1.3200000000000001 108.671 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -38.81 -41.2 1.64 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.73 1.62 . . . . 0.69999999999999996 113.542 178.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.538 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 25.4 m -62.66 -51.48 67.07 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.878 -1.139 . . . . 1.1200000000000001 110.508 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.2 -39.09 88.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 1.21 109.855 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.683 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 61.7 p -68.48 -39.18 81.46 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.615 -0.678 . . . . 1.1899999999999999 110.419 179.332 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.8 -35.73 80.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.051 -1.03 . . . . 1.24 110.761 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -96.21 -1.0 49.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.02 -1.05 . . . . 1.6899999999999999 112.827 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -60.61 156.41 16.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.929 . . . . 1.3400000000000001 109.863 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -88.97 106.28 18.32 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.788 -1.56 . . . . 2.77 106.788 178.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 50.9 mt -80.49 -17.47 51.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.623 -0.673 . . . . 2.0899999999999999 112.133 -177.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -81.13 -23.05 38.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.381 -0.824 . . . . 2.6699999999999999 111.769 -178.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -105.95 -2.87 22.39 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.614 0.968 . . . . 2.5800000000000001 113.614 -178.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.94 128.4 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 107.74 -1.207 . . . . 1.1799999999999999 107.74 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.4 tp -90.44 -10.4 43.92 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.246 -0.909 . . . . 2.1800000000000002 112.251 -178.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.22 171.02 41.13 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.116 -1.593 . . . . 0.48999999999999999 109.116 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.585 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -130.77 135.75 48.06 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.563 -1.273 . . . . 0.64000000000000001 107.563 179.334 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 97.0 mt -133.11 107.94 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 105.938 -1.875 . . . . 1.21 105.938 178.156 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 203' ' ' VAL . 72.2 p -128.82 175.37 8.68 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.676 -1.265 . . . . 1.3799999999999999 110.746 -178.696 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.7 OUTLIER -100.51 53.92 0.88 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.578 -0.737 . . . . 2.3700000000000001 110.071 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.93 156.37 16.65 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.091 -1.006 . . . . 1.52 109.773 179.149 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.14 -5.03 57.93 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.769 -1.205 . . . . 1.8 112.397 178.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 73.66 -12.37 4.84 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.488 -1.339 . . . . 2.04 115.213 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.456 ' O ' ' OG1' ' A' ' 187' ' ' THR . 79.0 mtm180 -81.8 113.41 19.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.001 -1.481 . . . . 5.0 107.001 178.42 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 22.2 p 48.54 39.96 14.25 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.893 -1.129 . . . . 3.02 111.931 -178.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.45 ' HG ' ' CB ' ' A' ' 191' ' ' SER . 7.3 p -82.14 133.67 35.28 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.309 -0.997 . . . . 2.1099999999999999 108.309 177.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.683 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 18.0 t60 -60.15 -40.41 89.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.442 -0.786 . . . . 1.24 110.681 179.645 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 87.4 m -60.83 -42.04 96.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 2.1499999999999999 110.256 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.505 ' HG ' ' N ' ' A' ' 192' ' ' ILE . 98.1 p -61.61 -38.58 88.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.945 -1.097 . . . . 2.02 110.411 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.505 ' N ' ' HG ' ' A' ' 191' ' ' SER . 96.1 mt -60.11 -35.32 60.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.431 -0.793 . . . . 2.1200000000000001 110.833 179.576 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.6 mtp -62.64 -42.65 99.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 122.395 1.093 . . . . 1.3600000000000001 109.202 179.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.89 -49.54 77.07 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.552 -0.749 . . . . 1.29 110.789 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -60.38 -44.34 95.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 3.5600000000000001 110.697 -179.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.4 m -69.88 -40.08 75.89 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.295 -0.878 . . . . 1.1799999999999999 110.315 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.4 mt -90.83 -4.43 56.61 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.1 0.952 . . . . 1.3400000000000001 112.42 -178.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 194' ' ' ALA . 94.1 mt-10 54.56 7.32 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.4 1.259 . . . . 1.45 114.4 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.9 mt -71.46 147.39 92.58 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.948 -1.095 . . . . 1.25 108.092 179.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -58.49 141.66 97.42 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.765 1.643 . . . . 0.78000000000000003 109.714 178.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -158.74 168.39 26.96 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 117.831 -1.548 . . . . 1.2 109.776 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 54.8 mt -149.01 159.02 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.519 -1.289 . . . . 1.25 107.519 178.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.3 m -140.48 -32.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.702 0 O-C-N 120.647 -1.283 . . . . 1.3899999999999999 111.951 -179.756 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.3 37.4 0.81 Allowed Glycine 0 N--CA 1.485 1.934 0 C-N-CA 120.497 -0.859 . . . . 0.96999999999999997 112.865 -178.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.488 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 45.6 p -63.94 -20.55 65.94 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.673 -0.898 . . . . 1.3500000000000001 111.499 -179.098 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.68 -92.43 0.61 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 110.045 -1.222 . . . . 1.0700000000000001 110.045 179.471 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.481 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 70.4 m -128.16 23.93 6.0 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.275 -1.132 . . . . 1.9199999999999999 112.696 -178.825 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 79.5 t -51.52 -34.48 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.541 -1.349 . . . . 1.3300000000000001 110.609 179.085 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.0 p -58.62 -20.91 51.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.58 -0.7 . . . . 1.4199999999999999 111.58 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.618 ' HG ' ' NE2' ' A' ' 211' ' ' GLN . 15.9 t -90.59 -3.16 57.76 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.013 -1.054 . . . . 2.1200000000000001 111.698 -179.037 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.618 ' NE2' ' HG ' ' A' ' 210' ' ' SER . 24.6 mp0 -122.83 -4.42 8.62 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.502 0.668 . . . . 2.6899999999999999 112.522 -177.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 44.6 t -112.85 148.0 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.533 -0.729 . . . . 1.29 109.415 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -121.3 157.08 31.14 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.071 -1.085 . . . . 2.6899999999999999 108.071 178.055 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 19.1 p30 -56.76 140.92 46.06 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.671 -1.268 . . . . 2.79 110.43 178.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 m-20 81.57 7.02 1.13 Allowed 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 114.465 1.283 . . . . 2.3500000000000001 114.465 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -67.48 151.75 46.84 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.424 -1.423 . . . . 1.97 109.945 177.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -90.51 115.11 27.4 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.691 -1.596 . . . . 2.9700000000000002 106.691 177.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.8 mt -127.71 141.94 51.46 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.236 -0.915 . . . . 1.25 109.56 -178.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 50.8 mt -113.54 127.72 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 106.607 -1.627 . . . . 1.22 106.607 177.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.6 tp -102.17 118.47 36.97 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.193 -1.78 . . . . 1.24 106.193 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 223' ' ' VAL . 44.8 p-10 -93.14 -21.04 19.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.042 -1.036 . . . . 2.0499999999999998 112.297 -178.184 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.496 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 38.47 17.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.031 0.752 . . . . 1.25 113.031 -179.177 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.5 t -112.77 -62.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 121.807 0.813 . . . . 1.4299999999999999 109.135 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -90.3 9.62 28.07 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.294 1.045 . . . . 3.0299999999999998 110.303 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 41.9 t30 60.82 52.37 4.31 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.91 -0.586 . . . . 2.25 111.462 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -150.87 147.89 27.79 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.222 1.011 . . . . 2.52 110.055 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 50.3 t -115.02 138.78 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 107.494 -1.299 . . . . 1.29 107.494 176.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -104.53 137.73 41.94 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.096 -1.002 . . . . 1.3400000000000001 108.602 178.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.3 t -109.3 129.4 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 107.638 -1.245 . . . . 1.3400000000000001 107.638 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.432 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 48.5 t-20 48.15 49.87 8.05 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 113.507 0.929 . . . . 2.1800000000000002 113.507 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 22.3 Cg_endo -62.53 154.21 66.18 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.141 1.894 . . . . 0.93999999999999995 110.394 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.6 m -72.77 158.72 35.04 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.987 -1.07 . . . . 2.3999999999999999 109.272 177.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 22.0 p30 -58.59 -38.0 77.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.849 -1.157 . . . . 3.3300000000000001 110.483 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.51 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 82.1 tt0 -60.93 -39.45 89.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.005 -1.059 . . . . 3.1699999999999999 110.013 179.355 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.08 -36.84 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 1.6899999999999999 110.319 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.462 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 80.8 mt -58.7 -43.61 88.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.397 -0.814 . . . . 1.6000000000000001 110.252 178.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -59.45 -38.74 81.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.001 -1.062 . . . . 2.7000000000000002 110.277 179.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -60.88 -49.26 78.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.507 -0.746 . . . . 2.96 110.591 179.546 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.5 mtp -70.56 -39.2 74.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.524 -0.735 . . . . 1.6299999999999999 110.601 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.487 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -57.85 -40.27 79.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 3.27 110.545 179.949 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 245' ' ' GLN . . . -71.45 -42.21 68.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 2.23 111.3 -179.598 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 76.8 t -54.48 -50.31 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.84 -1.163 . . . . 2.79 111.968 -178.314 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -66.97 -49.65 64.75 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.557 -1.339 . . . . 4.2599999999999998 110.039 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -64.73 -31.44 72.66 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.132 -0.627 . . . . 1.8799999999999999 110.618 -179.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 241' ' ' ALA . 31.6 tt0 -60.11 -31.25 69.88 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 118.7 -1.2 . . . . 3.3799999999999999 109.164 179.278 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 84.9 t -66.43 -42.01 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.4 -0.92 . . . . 2.8799999999999999 109.375 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.72 -40.32 91.89 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.664 0.745 . . . . 2.75 110.558 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.8 t -69.98 -39.14 76.13 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.106 -0.996 . . . . 3.4199999999999999 110.919 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -61.14 -31.49 71.21 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.67 0.748 . . . . 3.5699999999999998 111.044 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -68.77 -29.73 68.17 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.331 -0.855 . . . . 4.6100000000000003 111.592 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -61.89 -12.37 17.55 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.13 -0.981 . . . . 4.4500000000000002 112.629 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -75.22 6.15 4.69 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.319 -0.863 . . . . 5.9699999999999998 112.934 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 253' ' ' LEU . 0.0 OUTLIER -62.99 -12.03 22.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.388 -0.82 . . . . 6.4500000000000002 111.882 179.814 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -71.29 -4.41 25.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.692 -0.63 . . . . 6.6600000000000001 112.226 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.53 23.47 0.51 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.255 0.835 . . . . 8.5399999999999991 113.255 -179.201 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 7.0 tt -79.68 -7.1 58.37 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.044 -1.035 . . . . 8.0700000000000003 112.446 179.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -83.64 8.72 13.46 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.989 -1.069 . . . . 9.7200000000000006 112.626 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -89.83 4.03 51.08 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.202 -0.936 . . . . 10.119999999999999 112.597 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 107.472 -1.307 . . . . 11.9 107.472 179.738 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.567 ' H3 ' HE21 ' A' ' 226' ' ' GLN . 5.0 mpp? . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.484 -0.561 . . . . 3.5299999999999998 109.484 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.0 mt -88.21 111.22 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.41 -1.33 . . . . 1.5700000000000001 107.41 177.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.4 m -104.8 127.45 52.6 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.791 -1.189 . . . . 1.4399999999999999 107.791 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.88 -147.79 22.86 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.246 -1.142 . . . . 1.01 110.246 179.42 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.474 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 80.5 mt -97.6 1.31 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.546 -0.973 . . . . 1.6299999999999999 112.571 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' ILE . 8.6 tp 50.42 100.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.737 -1.227 . . . . 1.5800000000000001 112.063 178.458 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.7 -41.4 11.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.924 -1.11 . . . . 1.3400000000000001 111.791 179.211 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t -146.19 140.98 15.97 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 107.78 -1.193 . . . . 1.8600000000000001 107.78 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.77 149.73 38.27 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.585 2.19 . . . . 1.01 112.555 178.607 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.443 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 149.66 161.65 9.94 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.367 -1.493 . . . . 0.81000000000000005 109.367 178.306 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.521 ' O ' ' NE2' ' A' ' 243' ' ' GLN . 94.3 mt -119.95 132.82 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.132 -1.217 . . . . 1.3700000000000001 107.893 179.58 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.16 151.07 47.38 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.216 -0.928 . . . . 1.1399999999999999 109.03 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -123.16 141.54 51.86 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.577 -0.898 . . . . 0.87 108.577 178.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.94 166.2 32.98 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.046 -1.55 . . . . 0.56999999999999995 109.798 177.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -76.3 158.2 31.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.816 -0.814 . . . . 2.3500000000000001 109.133 178.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.3 123.49 29.11 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.607 -1.257 . . . . 1.21 107.607 178.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.2 tp -102.9 99.64 9.57 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.228 -1.768 . . . . 1.3999999999999999 106.228 178.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 tp -87.52 140.92 29.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 1.4399999999999999 108.962 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.7 mt -96.51 115.66 27.8 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.653 -1.61 . . . . 1.45 106.653 177.497 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -108.84 130.62 55.41 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.816 -1.179 . . . . 2.5 107.816 -179.46 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -128.4 146.83 50.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 2.6600000000000001 109.054 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -80.41 138.89 36.69 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.933 -1.105 . . . . 2.3199999999999998 108.041 177.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -63.48 140.33 58.86 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.612 -0.884 . . . . 2.1099999999999999 108.612 178.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -89.7 130.16 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.086 -1.079 . . . . 1.29 108.086 178.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.6 129.95 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.752 -1.203 . . . . 1.4099999999999999 107.752 178.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.2 mt -91.25 138.99 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.387 -0.968 . . . . 1.3100000000000001 108.387 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -88.23 120.73 29.86 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.91 -1.515 . . . . 1.3400000000000001 106.91 178.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -93.57 10.27 33.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.522 -0.736 . . . . 3.48 112.868 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -73.12 143.96 47.14 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.881 -1.137 . . . . 2.52 110.039 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -89.77 132.16 35.36 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.185 -1.043 . . . . 2.6299999999999999 108.185 177.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -93.27 165.01 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.333 -0.854 . . . . 1.3100000000000001 110.477 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.9 p -93.21 165.12 12.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.772 -0.58 . . . . 1.24 109.713 178.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.95 -22.45 15.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.302 -0.874 . . . . 1.49 112.18 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.95 -37.73 81.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.867 -1.146 . . . . 2.2799999999999998 110.914 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -91.54 -7.26 50.81 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.44 -1.412 . . . . 2.0499999999999998 112.782 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.3 -41.21 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.218 -0.926 . . . . 1.3400000000000001 110.56 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -56.42 -39.99 73.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.027 . . . . 1.54 110.602 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -63.47 -41.95 98.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 2.8500000000000001 111.079 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.96 -41.58 98.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.081 -1.012 . . . . 1.3100000000000001 110.843 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.6 t -60.66 -40.06 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.611 -0.836 . . . . 1.3799999999999999 110.217 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -60.85 -43.62 98.08 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.736 -0.786 . . . . 1.5 109.677 179.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -62.1 -40.05 94.55 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.909 -0.716 . . . . 2.7799999999999998 110.325 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -73.16 -54.22 9.02 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.149 -0.969 . . . . 1.0600000000000001 110.017 179.116 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -60.52 -49.06 79.04 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.002 -1.062 . . . . 1.3999999999999999 110.306 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.6 t -68.85 -36.92 78.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.361 -0.837 . . . . 1.3200000000000001 110.02 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.01 -46.3 84.87 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.499 -1.334 . . . . 0.69999999999999996 109.862 178.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -57.92 -31.72 67.07 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.246 -1.149 . . . . 3.4399999999999999 109.655 178.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.31 -51.1 71.2 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.204 -0.998 . . . . 1.3600000000000001 110.965 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 42.7 pttt -81.9 -42.1 19.99 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.175 -0.953 . . . . 2.8300000000000001 110.966 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.409 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -60.22 -41.82 93.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.8 . . . . 1.23 110.383 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.1 p -59.46 -41.15 89.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.218 -1.03 . . . . 1.9199999999999999 108.218 179.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.51 -48.65 59.85 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.559 -0.746 . . . . 1.25 109.782 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -62.13 -48.72 78.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.442 -1.411 . . . . 1.97 110.077 -178.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.71 -38.9 89.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 2.1800000000000002 109.81 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -59.62 -40.17 86.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.724 -0.61 . . . . 1.1899999999999999 110.471 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.51 ' CG2' ' HZ3' ' A' ' 60' ' ' LYS . 11.2 m -63.65 -39.81 95.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.926 -1.109 . . . . 1.3400000000000001 110.148 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.71 -40.17 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.468 -0.77 . . . . 1.23 110.573 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -51.75 -40.65 60.64 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.424 -0.798 . . . . 1.5600000000000001 110.482 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.8 -37.08 73.26 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.11 -0.994 . . . . 1.3 110.348 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.51 ' HZ3' ' CG2' ' A' ' 56' ' ' THR . 52.4 mttp -63.34 -38.82 92.65 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.669 -1.212 . . . . 2.3199999999999998 109.025 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.8 -30.14 68.65 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.907 -0.588 . . . . 1.1399999999999999 110.337 179.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.11 -38.88 8.84 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 119.893 -1.146 . . . . 0.68999999999999995 111.214 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -81.03 -22.69 39.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.856 -1.379 . . . . 1.48 111.282 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 28.7 m -87.31 -51.56 5.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.656 -0.652 . . . . 1.52 110.687 -179.704 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -107.21 -7.28 16.84 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.07 1.137 . . . . 1.3100000000000001 114.07 -177.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.45 157.95 17.73 Favored Glycine 0 N--CA 1.5 2.909 0 O-C-N 121.599 -0.688 . . . . 0.84999999999999998 113.22 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -53.32 -19.06 2.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.592 -0.946 . . . . 3.8599999999999999 113.341 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -57.41 -33.92 68.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.714 -1.241 . . . . 2.3500000000000001 110.996 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -80.13 -23.53 41.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.959 -1.088 . . . . 2.2599999999999998 111.468 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.87 -38.32 81.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.093 -1.004 . . . . 1.45 111.007 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.22 -40.09 84.76 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.954 -1.091 . . . . 1.25 110.999 179.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.7 mt -69.3 -47.99 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.665 -1.272 . . . . 1.26 110.13 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -70.52 -29.94 66.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.864 . . . . 0.82999999999999996 110.62 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.79 -38.63 85.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.275 -0.891 . . . . 1.1899999999999999 110.403 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.3 -37.25 59.27 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 110.074 -1.211 . . . . 0.57999999999999996 110.074 179.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -59.81 -44.21 94.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.279 -1.13 . . . . 2.0499999999999998 110.087 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.12 -39.37 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 1.21 110.045 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.5 ttm -59.88 -39.5 85.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.5 -0.75 . . . . 2.29 110.552 179.46 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.6 tp -58.36 -48.15 81.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.853 . . . . 1.21 110.204 179.028 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.01 -40.29 88.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.602 0.715 . . . . 1.1399999999999999 110.262 -179.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -86.04 5.14 34.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.791 . . . . 1.4199999999999999 112.75 -179.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -61.79 119.18 8.26 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.846 -1.159 . . . . 1.27 108.928 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.85 -17.49 64.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.462 -0.774 . . . . 1.3500000000000001 110.84 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.83 -47.8 28.54 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.023 -1.071 . . . . 2.2200000000000002 109.889 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.66 -36.44 82.86 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.301 -0.96 . . . . 1.22 110.011 -178.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.77 -48.36 79.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.404 -0.81 . . . . 1.29 110.495 179.05 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.52 -39.49 87.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 2.1699999999999999 110.492 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.25 -49.88 62.69 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.091 -1.005 . . . . 1.3 110.488 179.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.5 mt -56.83 -43.58 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.935 -1.103 . . . . 1.1699999999999999 110.234 179.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.9 -43.2 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.567 -0.708 . . . . 1.3999999999999999 110.116 179.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.65 -41.81 91.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.409 -0.807 . . . . 1.3300000000000001 110.574 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.08 -43.6 95.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.113 -0.992 . . . . 1.48 110.254 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.1 mt -65.61 -48.45 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.094 -1.004 . . . . 1.28 110.179 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -78.72 -36.2 43.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.266 -0.896 . . . . 2.6000000000000001 112.197 -179.414 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 91' ' ' ALA . 58.2 t0 -81.74 -40.02 23.33 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.438 -1.414 . . . . 1.51 111.76 -179.405 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -108.59 10.61 27.05 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.211 -0.931 . . . . 2.48 111.965 -178.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.0 m80 49.46 50.52 18.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.982 -1.074 . . . . 1.6100000000000001 111.612 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -104.23 152.89 21.64 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.14 0.971 . . . . 1.8999999999999999 109.791 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.439 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 23.2 p -72.8 160.8 31.59 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.57 -0.706 . . . . 1.3200000000000001 109.535 178.009 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.45 -40.09 81.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -0.926 . . . . 1.1499999999999999 110.914 178.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 26.2 p-10 -69.86 -42.1 73.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.051 -1.031 . . . . 2.25 110.519 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.35 61.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.348 -0.845 . . . . 1.22 110.882 -179.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.84 93.64 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.265 -0.897 . . . . 1.1899999999999999 110.696 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.66 -43.75 93.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 1.2 110.943 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -60.19 -40.01 88.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.865 -1.147 . . . . 2.1000000000000001 111.036 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.73 -48.86 76.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.671 -1.268 . . . . 1.3 110.617 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 83.4 t -62.86 -49.22 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.71 -1.243 . . . . 1.27 110.29 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 mm -61.54 -30.23 47.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.193 0.521 . . . . 1.1899999999999999 110.538 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -59.87 -40.12 87.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 2.1099999999999999 110.922 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.95 -31.45 17.6 Favored Glycine 0 N--CA 1.502 3.066 0 C-N-CA 118.668 -1.729 . . . . 0.88 112.925 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -61.49 -40.99 96.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.521 -1.576 . . . . 1.99 110.063 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.22 -48.78 40.3 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.62 -0.675 . . . . 1.28 110.4 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.0 m -61.4 -40.79 95.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 2.2200000000000002 110.477 -178.185 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.75 97.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.422 -0.799 . . . . 1.45 110.679 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.2 mt -64.57 -30.86 71.89 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.054 -1.029 . . . . 1.47 110.817 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -66.86 -21.11 66.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.945 -1.097 . . . . 2.04 111.158 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -75.0 -12.81 60.42 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.313 -0.867 . . . . 1.73 111.532 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 mt -85.55 144.67 27.77 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.484 -0.76 . . . . 1.79 109.292 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -100.45 53.03 0.88 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.185 -0.947 . . . . 2.8799999999999999 110.581 -179.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -129.46 138.28 51.33 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.211 -1.033 . . . . 1.5800000000000001 108.211 179.171 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -58.39 -39.8 80.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.544 -0.722 . . . . 3.04 110.999 179.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -71.43 -53.61 13.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.002 -1.061 . . . . 1.29 110.332 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.5 mt -61.4 -41.09 96.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.339 -0.851 . . . . 1.6000000000000001 110.506 -179.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -62.22 -50.16 72.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.954 -1.091 . . . . 2.7599999999999998 109.983 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.02 -31.68 70.18 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.309 -0.869 . . . . 2.1499999999999999 109.644 179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -61.26 -30.43 70.46 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.086 -1.045 . . . . 2.8100000000000001 108.782 179.241 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.46 -49.58 77.01 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.921 0.867 . . . . 1.3899999999999999 109.398 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.86 81.7 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.895 -0.722 . . . . 1.4099999999999999 110.104 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -64.18 -36.69 84.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.347 -0.846 . . . . 1.3899999999999999 110.52 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.9 t -67.12 -39.16 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.439 -0.788 . . . . 1.1899999999999999 109.983 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -60.4 -38.06 82.78 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.879 0.847 . . . . 3.6299999999999999 110.009 179.066 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.12 -38.33 82.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.766 -0.584 . . . . 1.28 110.481 179.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.7 mt -61.54 -40.17 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.472 -0.767 . . . . 1.1799999999999999 110.24 179.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.27 -42.44 35.15 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 120.078 -1.058 . . . . 0.51000000000000001 110.993 -179.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -58.77 -48.12 82.34 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.072 -1.251 . . . . 3.1699999999999999 110.484 179.346 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -64.89 -41.25 95.78 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.511 -0.876 . . . . 2.8500000000000001 109.972 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.05 -39.58 86.45 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.314 -0.866 . . . . 1.6499999999999999 110.033 179.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.14 -41.93 93.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.882 . . . . 1.2 110.902 179.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -60.44 -33.08 72.02 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.121 -0.987 . . . . 2.7999999999999998 110.678 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -77.64 -42.5 34.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 2.1499999999999999 110.846 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 141' ' ' ILE . 97.4 mt -60.99 -38.33 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.231 -0.918 . . . . 1.21 110.344 -178.294 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.7 mt -86.27 -7.43 58.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.31 -0.869 . . . . 1.3400000000000001 112.276 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.71 19.91 69.69 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.645 -1.264 . . . . 0.91000000000000003 112.844 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.5 tp -67.22 145.19 55.46 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.815 -0.815 . . . . 1.51 109.163 179.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -67.79 149.74 49.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 2.8799999999999999 108.845 178.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.0 mt -109.49 137.38 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.369 -0.974 . . . . 1.6200000000000001 108.369 178.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.443 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.8 mp -80.11 128.59 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.654 -1.239 . . . . 2.1099999999999999 107.654 178.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -94.78 96.08 9.13 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.85 -1.537 . . . . 1.6200000000000001 106.85 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.41 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 53.1 mt -70.72 -25.23 62.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.337 -0.852 . . . . 1.3999999999999999 111.12 -178.33 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 p -80.57 0.25 34.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 2.0499999999999998 111.861 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.14 23.87 9.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.455 -0.778 . . . . 1.3500000000000001 111.852 -179.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.41 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 14.2 mt -72.04 146.33 11.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.234 -0.916 . . . . 1.4199999999999999 109.457 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -119.41 -14.77 9.15 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.757 0.789 . . . . 2.9900000000000002 112.756 -178.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -115.06 140.51 49.0 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.682 -0.858 . . . . 1.54 108.682 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -77.41 123.52 26.64 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.384 -0.969 . . . . 1.3799999999999999 108.384 178.005 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.3 m -148.56 175.28 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.608 -0.682 . . . . 1.28 109.266 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 157' ' ' ILE . 45.8 mt -88.23 145.05 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.641 -0.874 . . . . 1.1599999999999999 108.641 178.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.1 tp -97.08 126.49 42.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.12 -0.987 . . . . 1.3100000000000001 108.507 178.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.0 t -122.58 128.98 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.573 -1.269 . . . . 1.25 107.573 178.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.39 153.18 21.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.932 . . . . 1.26 108.847 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.66 84.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.701 -1.249 . . . . 1.6000000000000001 109.65 178.131 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 10.4 t0 -172.37 154.66 3.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.481 -0.933 . . . . 2.4199999999999999 108.481 179.638 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.501 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 61.6 mt -117.75 139.32 51.21 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.222 -0.924 . . . . 1.3500000000000001 108.759 177.629 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.2 p -91.2 153.03 44.56 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 107.879 -1.156 . . . . 1.3200000000000001 107.879 178.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -41.81 -44.82 6.82 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.559 1.506 . . . . 0.69999999999999996 113.375 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 23.9 m -60.26 -48.79 80.23 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.044 -1.035 . . . . 1.1200000000000001 110.252 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.22 -40.83 98.57 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.204 -0.935 . . . . 1.21 110.177 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.434 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 79.5 p -68.33 -38.45 81.53 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.416 -0.802 . . . . 1.1899999999999999 110.254 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.58 74.52 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.578 -0.701 . . . . 1.24 110.609 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -93.86 -5.87 47.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.166 -0.959 . . . . 1.6899999999999999 112.734 -179.316 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.73 146.89 51.28 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.959 -1.126 . . . . 1.3400000000000001 107.959 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -97.34 119.73 36.39 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.31 -1.367 . . . . 2.77 107.31 178.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.2 mm? -76.25 -18.24 59.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.77 -0.581 . . . . 2.0899999999999999 111.526 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -80.99 -25.77 37.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.276 -0.89 . . . . 2.6699999999999999 111.863 -178.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -101.05 -1.69 33.53 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.112 0.782 . . . . 2.5800000000000001 113.112 -178.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.01 126.44 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 107.556 -1.276 . . . . 1.1799999999999999 107.556 178.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.8 tp -91.27 -2.01 57.53 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.052 -1.03 . . . . 2.1800000000000002 112.862 -178.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.94 169.83 34.42 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.797 -1.721 . . . . 0.48999999999999999 108.797 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -127.2 135.43 50.63 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.812 -1.181 . . . . 0.64000000000000001 107.812 179.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 76.1 mt -137.67 106.04 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 105.965 -1.865 . . . . 1.21 105.965 178.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 203' ' ' VAL . 68.0 p -131.2 176.98 7.82 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.785 -1.197 . . . . 1.3799999999999999 110.204 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.552 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.3 OUTLIER -99.29 51.71 0.95 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.736 -0.603 . . . . 2.3700000000000001 110.843 179.28 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -100.66 145.32 28.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.303 -0.873 . . . . 1.52 108.829 179.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -60.05 -32.55 76.06 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 120.15 -1.024 . . . . 1.8 110.897 179.186 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 91.69 -4.37 79.12 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 120.898 -1.354 . . . . 2.04 113.328 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.436 ' O ' ' OG1' ' A' ' 187' ' ' THR . 80.1 mtm180 -90.36 115.65 27.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.243 -1.762 . . . . 5.0 106.243 177.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 13.6 p 48.98 31.93 3.57 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.36 -0.837 . . . . 3.02 112.226 -178.667 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.4 t -85.47 142.03 29.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.97 -1.081 . . . . 2.1099999999999999 109.837 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.434 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 15.8 t60 -58.74 -38.93 79.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 1.24 111.135 178.481 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.3 m -60.38 -39.61 87.9 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.215 -0.928 . . . . 2.1499999999999999 110.085 179.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 70.8 m -60.34 -39.36 86.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 2.02 110.554 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.8 -39.99 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 2.1200000000000001 110.959 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.9 mtp -63.76 -44.31 93.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.895 -1.128 . . . . 1.3600000000000001 109.671 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.12 -49.57 77.11 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.77 -0.65 . . . . 1.29 111.004 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -61.73 -41.1 97.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.985 . . . . 3.5600000000000001 110.946 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 56.0 m -69.36 -39.94 77.79 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.923 -1.111 . . . . 1.1799999999999999 110.561 -179.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.3 mt -89.28 -7.83 54.63 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.819 0.818 . . . . 1.3400000000000001 112.101 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 194' ' ' ALA . 45.2 mt-10 49.03 15.5 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.876 1.065 . . . . 1.45 113.876 -179.8 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.8 mt -74.75 150.58 86.46 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.022 -1.048 . . . . 1.25 108.607 178.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.36 139.05 88.94 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.309 1.339 . . . . 0.78000000000000003 109.833 178.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.92 166.65 25.88 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 117.737 -1.585 . . . . 1.2 109.431 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.5 mt -145.68 147.06 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.681 -1.229 . . . . 1.25 107.681 177.216 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.435 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.8 m -126.99 -34.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 113.302 0.853 . . . . 1.3899999999999999 113.302 -179.009 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.17 40.83 1.73 Allowed Glycine 0 N--CA 1.489 2.18 0 C-N-CA 120.196 -1.002 . . . . 0.96999999999999997 111.913 -177.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.447 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 58.6 p -60.82 -18.75 57.45 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.273 -1.134 . . . . 1.3500000000000001 111.371 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.43 -95.82 0.99 Allowed Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.83 -1.176 . . . . 1.0700000000000001 110.503 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 60.7 m -127.72 31.51 5.13 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.634 -0.921 . . . . 1.9199999999999999 112.215 -179.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.87 -35.33 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.393 -1.442 . . . . 1.3300000000000001 110.532 179.096 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 46.4 p -61.46 -20.06 62.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.195 -0.94 . . . . 1.4199999999999999 111.452 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.9 t -93.93 -1.03 55.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -0.951 . . . . 2.1200000000000001 112.099 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -128.22 -1.66 5.72 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 112.797 0.665 . . . . 2.6899999999999999 112.797 -177.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.04 148.39 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.226 -0.657 . . . . 1.29 109.226 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -119.85 157.18 29.22 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.851 -1.166 . . . . 2.6899999999999999 107.851 178.062 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.42 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 38.6 p30 -54.12 142.82 24.27 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.049 -1.032 . . . . 2.79 110.813 178.491 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.7 OUTLIER 80.18 1.3 2.01 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 114.905 1.446 . . . . 2.3500000000000001 114.905 179.183 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -63.46 146.41 53.66 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.765 -1.209 . . . . 1.97 108.371 177.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -88.29 118.69 28.07 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.835 -1.542 . . . . 2.9700000000000002 106.835 177.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 87.3 mt -127.93 142.02 51.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.585 -0.697 . . . . 1.25 109.57 -178.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.6 mt -111.16 129.32 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.528 -1.656 . . . . 1.22 106.528 177.529 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 20.4 tp -99.1 119.05 37.19 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.384 -1.71 . . . . 1.24 106.384 178.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.0 t0 -94.93 -29.28 14.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.818 -1.176 . . . . 2.0499999999999998 112.506 -177.631 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.443 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 36.79 20.79 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.773 0.657 . . . . 1.25 112.773 -178.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.7 t -109.25 -55.95 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.125 -0.985 . . . . 1.4299999999999999 109.075 178.335 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.46 14.8 30.02 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.625 -0.716 . . . . 3.0299999999999998 110.293 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.51 55.38 4.14 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.397 0.617 . . . . 2.25 111.21 179.67 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.567 HE21 ' H3 ' ' A' ' 1' ' ' MET . 53.8 tt0 -151.49 148.48 28.11 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.254 1.026 . . . . 2.52 109.91 179.596 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 20.0 t -116.09 139.61 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.235 -1.024 . . . . 1.29 108.235 177.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -102.01 135.6 43.29 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.057 -1.027 . . . . 1.3400000000000001 108.739 178.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.0 t -112.83 130.24 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-O 121.779 0.8 . . . . 1.3400000000000001 109.127 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.439 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 13.6 t-20 52.06 48.95 6.14 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 113.577 0.955 . . . . 2.1800000000000002 113.577 178.092 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.3 Cg_endo -64.5 150.05 88.9 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.585 2.19 . . . . 0.93999999999999995 110.724 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.1 m -74.77 154.16 38.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.265 -0.897 . . . . 2.3999999999999999 108.947 177.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -52.99 -41.11 64.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 3.3300000000000001 110.708 178.716 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -59.2 -40.29 85.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 3.1699999999999999 109.812 179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.04 -38.91 76.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.647 -0.658 . . . . 1.6899999999999999 110.166 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.532 ' CG2' HH12 ' A' ' 240' ' ' ARG . 96.8 mt -58.31 -46.83 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.448 -0.782 . . . . 1.6000000000000001 110.785 179.198 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -59.14 -40.69 86.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.947 -1.096 . . . . 2.7000000000000002 110.406 179.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -60.76 -41.52 95.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.384 -0.822 . . . . 2.96 110.305 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 47.3 mtp -71.51 -36.75 71.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.354 -0.841 . . . . 1.6299999999999999 110.593 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.532 HH12 ' CG2' ' A' ' 236' ' ' ILE . 0.3 OUTLIER -57.88 -41.03 81.69 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.137 -0.977 . . . . 3.27 110.286 179.734 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.84 -37.58 73.16 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.375 -0.828 . . . . 2.23 111.047 -179.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.44 -56.35 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.708 -1.245 . . . . 2.79 111.919 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 11' ' ' ILE . 50.5 tt0 -62.89 -49.39 75.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.6 -1.313 . . . . 4.2599999999999998 109.751 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.37 -33.26 72.2 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.648 -0.658 . . . . 1.8799999999999999 110.523 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -60.63 -30.0 69.59 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.774 -1.17 . . . . 3.3799999999999999 109.358 179.058 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.55 -47.27 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 121.898 0.856 . . . . 2.8799999999999999 109.509 179.17 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.97 91.07 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.783 -0.767 . . . . 2.75 110.046 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 20.9 t -70.22 -40.23 74.65 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.523 -0.735 . . . . 3.4199999999999999 110.541 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -62.74 -40.79 98.34 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.427 -0.796 . . . . 3.5699999999999998 110.19 -178.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -67.98 -39.56 83.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 4.6100000000000003 110.614 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -66.57 -40.57 89.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 4.4500000000000002 110.636 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -70.04 -27.91 65.04 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.206 -0.934 . . . . 5.9699999999999998 111.44 -179.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.33 -40.38 94.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 6.4500000000000002 110.437 179.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -78.42 -7.92 57.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.019 -1.051 . . . . 6.6600000000000001 112.156 -179.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -77.25 -54.66 6.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.345 -0.847 . . . . 8.5399999999999991 111.386 -179.284 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.481 ' CD2' ' H ' ' A' ' 256' ' ' LEU . 1.3 pt? -82.9 -14.18 54.68 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.868 -1.145 . . . . 8.0700000000000003 112.95 -178.267 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -96.33 51.53 1.2 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.77 -1.206 . . . . 9.7200000000000006 110.924 -178.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -91.47 -7.92 49.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.309 -0.869 . . . . 10.119999999999999 112.663 -178.485 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.958 -1.02 . . . . 11.9 109.286 -178.788 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.199 -0.667 . . . . 3.5299999999999998 109.199 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt -99.14 98.14 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 106.856 -1.535 . . . . 1.5700000000000001 106.856 177.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -105.31 122.56 46.21 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.391 -1.336 . . . . 1.4399999999999999 107.391 -179.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.95 -150.65 27.15 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.784 -1.326 . . . . 1.01 109.784 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.453 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 95.4 mt -95.22 1.05 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.408 -1.054 . . . . 1.6299999999999999 112.942 -179.635 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 tp 49.64 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.801 -1.187 . . . . 1.5800000000000001 112.867 178.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.83 -37.23 14.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.956 -1.09 . . . . 1.3400000000000001 111.431 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 t -146.34 137.02 12.4 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 107.965 -1.124 . . . . 1.8600000000000001 107.965 -178.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.27 152.56 35.14 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.934 1.756 . . . . 1.01 112.122 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 147.13 135.41 2.68 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.768 -0.933 . . . . 0.81000000000000005 110.768 177.683 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -96.15 132.48 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.549 -1.559 . . . . 1.3700000000000001 108.941 178.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.3 148.95 45.2 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.895 -0.78 . . . . 1.1399999999999999 108.895 179.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 3.2 m-85 -121.22 142.75 49.62 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.301 -0.875 . . . . 0.87 109.018 178.474 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.84 168.38 37.32 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.575 -1.774 . . . . 0.56999999999999995 109.721 177.797 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -78.08 158.68 29.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.763 -0.845 . . . . 2.3500000000000001 108.799 178.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.59 123.78 29.54 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.898 -1.149 . . . . 1.21 107.898 178.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 tp -102.47 98.86 8.88 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.22 -1.77 . . . . 1.3999999999999999 106.22 178.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.1 tp -86.99 141.1 28.92 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.681 -0.859 . . . . 1.4399999999999999 108.681 -179.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 mt -99.72 107.11 19.11 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.27 -1.381 . . . . 1.45 107.27 178.158 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -110.81 134.23 52.68 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.673 -1.232 . . . . 2.5 107.673 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -131.11 155.12 47.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.211 -0.931 . . . . 2.6600000000000001 109.163 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -82.11 137.16 35.07 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.907 -1.146 . . . . 2.3199999999999998 107.907 177.338 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -65.7 148.36 51.89 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.346 -0.847 . . . . 2.1099999999999999 108.881 178.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.6 mt -99.85 134.61 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.359 -0.838 . . . . 1.29 108.799 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.89 130.01 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.571 -1.27 . . . . 1.4099999999999999 107.571 178.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.6 mt -95.83 135.8 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.297 -0.877 . . . . 1.3100000000000001 108.976 179.257 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -94.45 126.65 39.86 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.265 -1.013 . . . . 1.3400000000000001 108.265 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.479 ' HG2' HH11 ' A' ' 28' ' ' ARG . 4.4 mmt-85 -97.7 15.08 24.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.343 -0.848 . . . . 3.48 112.481 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -63.34 142.32 58.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.004 -1.06 . . . . 2.52 109.117 178.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -88.02 130.82 34.86 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.136 -1.061 . . . . 2.6299999999999999 108.136 177.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -89.37 170.19 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.178 -0.951 . . . . 1.3100000000000001 110.09 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.3 p -94.64 163.44 13.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.577 -0.702 . . . . 1.24 109.645 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.75 -19.94 4.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 1.49 112.67 179.249 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -68.71 -43.16 76.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.832 -1.167 . . . . 2.2799999999999998 111.229 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -87.42 -5.79 58.7 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.711 -1.243 . . . . 2.0499999999999998 112.674 -179.098 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.05 -46.52 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 1.3400000000000001 110.891 -178.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -56.49 -40.02 74.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.954 . . . . 1.54 110.316 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.61 -39.6 91.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.535 -0.728 . . . . 2.8500000000000001 110.824 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -60.0 -40.63 89.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.026 -1.046 . . . . 1.3100000000000001 110.747 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.83 -39.69 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 1.3799999999999999 110.38 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -62.87 -48.12 80.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.364 -0.835 . . . . 1.5 110.794 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -62.87 -40.93 99.01 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.917 -1.113 . . . . 2.7799999999999998 110.256 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -71.13 -52.86 16.85 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.204 -0.935 . . . . 1.0600000000000001 110.191 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.2 tp -62.3 -47.47 84.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.037 -1.04 . . . . 1.3999999999999999 109.816 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 t -70.23 -42.46 72.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.472 -0.768 . . . . 1.3200000000000001 109.697 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.58 -38.08 85.86 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.148 -1.501 . . . . 0.69999999999999996 109.414 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 20.5 ttm180 -59.32 -32.02 69.69 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.958 0.885 . . . . 3.4399999999999999 109.095 178.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.04 -44.19 91.74 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.787 0.803 . . . . 1.3600000000000001 109.636 178.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -79.63 -40.17 29.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.115 -0.991 . . . . 2.8300000000000001 110.332 179.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.28 -44.9 92.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.468 -0.77 . . . . 1.23 110.132 -178.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.645 ' HG ' ' N ' ' A' ' 52' ' ' ALA . 53.5 p -60.45 -38.63 84.76 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.124 0.964 . . . . 1.9199999999999999 109.313 179.685 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.645 ' N ' ' HG ' ' A' ' 51' ' ' SER . . . -63.11 -41.57 99.38 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.126 -0.63 . . . . 1.25 110.661 179.481 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -62.0 -50.14 73.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.569 -1.332 . . . . 1.97 110.479 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 54' ' ' LEU . 3.2 mm? -67.63 -40.64 84.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.329 -0.857 . . . . 2.1800000000000002 110.399 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -59.21 -40.78 86.86 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.389 -0.819 . . . . 1.1899999999999999 110.467 179.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -67.21 -46.93 72.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.084 -1.01 . . . . 1.3400000000000001 110.671 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.11 -38.16 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.417 -0.802 . . . . 1.23 110.524 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -49.93 -44.72 50.55 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.367 -0.833 . . . . 1.5600000000000001 111.322 179.183 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -68.16 -40.48 82.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.195 -0.941 . . . . 1.3 109.946 -179.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -61.87 -37.98 86.6 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.883 -1.127 . . . . 2.3199999999999998 109.334 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -33.77 76.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.448 0.642 . . . . 1.1399999999999999 110.2 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.61 -37.13 12.35 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.771 -1.204 . . . . 0.68999999999999995 111.255 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.67 -24.41 38.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.07 -1.253 . . . . 1.48 110.755 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.4 m -88.0 -50.77 6.2 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.537 -0.865 . . . . 1.52 110.271 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -107.06 -2.96 20.51 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 113.965 1.098 . . . . 1.3100000000000001 113.965 -177.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.24 155.87 26.88 Favored Glycine 0 N--CA 1.504 3.201 0 O-C-N 120.82 -1.175 . . . . 0.84999999999999998 113.858 178.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.58 -15.55 1.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -1.018 . . . . 3.8599999999999999 112.979 179.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.66 -35.8 71.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 2.3500000000000001 110.917 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -82.91 -19.03 38.11 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.143 -0.973 . . . . 2.2599999999999998 111.996 -179.382 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.23 -35.19 74.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.074 -1.016 . . . . 1.45 111.038 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.36 89.18 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.079 -1.013 . . . . 1.25 110.847 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.6 mt -68.64 -42.38 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.943 -1.098 . . . . 1.26 110.098 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -72.05 -31.15 65.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.139 -0.976 . . . . 0.82999999999999996 110.253 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -59.79 -37.65 79.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.826 . . . . 1.1899999999999999 110.004 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.92 -40.54 84.42 Favored Glycine 0 N--CA 1.48 1.622 0 C-N-CA 119.733 -1.222 . . . . 0.57999999999999996 110.277 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -59.93 -47.28 86.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.184 -1.186 . . . . 2.0499999999999998 110.593 179.506 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.7 mt -60.3 -38.64 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.951 -1.093 . . . . 1.21 110.231 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.9 ttt -59.9 -39.39 85.21 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.365 -0.834 . . . . 2.29 110.904 179.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 tp -60.31 -50.04 75.2 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.106 -0.996 . . . . 1.21 110.46 179.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.31 -39.28 92.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.033 -1.042 . . . . 1.1399999999999999 110.303 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -87.22 1.5 52.95 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.445 0.906 . . . . 1.4199999999999999 113.445 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.41 121.45 12.11 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.357 -1.465 . . . . 1.27 108.244 178.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -66.36 -16.88 64.41 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.88 0.847 . . . . 1.3500000000000001 110.964 -178.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.97 -53.35 9.12 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.507 0.67 . . . . 2.2200000000000002 110.087 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.31 -36.78 81.04 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.568 -0.853 . . . . 1.22 110.485 -179.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 47' ' ' ARG . 87.0 tt0 -59.43 -46.84 87.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.203 -0.936 . . . . 1.29 110.918 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.73 -38.56 85.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.393 -0.817 . . . . 2.1699999999999999 110.701 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.02 -48.7 70.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.831 -1.168 . . . . 1.3 110.872 179.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.31 -43.95 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.173 -0.954 . . . . 1.1699999999999999 110.138 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.5 mt -60.41 -43.96 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.658 -0.651 . . . . 1.3999999999999999 110.486 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.21 -42.34 98.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.425 -0.797 . . . . 1.3300000000000001 110.991 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.66 -47.79 83.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.162 -0.961 . . . . 1.48 110.296 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.4 mt -60.89 -44.88 98.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.304 -0.872 . . . . 1.28 110.683 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -84.07 -34.45 24.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.007 -1.058 . . . . 2.6000000000000001 111.954 -179.71 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 91' ' ' ALA . 44.9 t0 -82.94 -43.62 16.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.809 -1.182 . . . . 1.51 111.445 -178.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -101.9 5.79 41.09 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.642 -0.661 . . . . 2.48 112.302 -178.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.7 m80 52.09 47.92 23.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 1.6100000000000001 111.795 -179.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.4 mtt -100.34 153.76 19.05 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.146 -0.971 . . . . 1.8999999999999999 110.018 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.653 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 72.5 p -71.57 161.21 31.38 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.507 -0.746 . . . . 1.3200000000000001 109.746 178.149 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.22 90.61 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.85 -0.74 . . . . 1.1499999999999999 110.748 178.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -68.49 -40.21 81.0 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.959 -1.088 . . . . 2.25 110.248 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.653 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -67.91 -50.68 54.72 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.855 -0.738 . . . . 1.22 111.064 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.58 -44.23 96.84 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 1.1899999999999999 110.195 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.97 -44.17 94.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.603 -0.686 . . . . 1.2 110.665 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -61.71 -38.65 88.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 2.1000000000000001 111.321 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -57.44 -49.77 75.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.675 -1.266 . . . . 1.3 110.888 179.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.04 -47.42 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.635 -1.291 . . . . 1.27 110.424 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -61.02 -30.35 47.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.563 -0.711 . . . . 1.1899999999999999 110.438 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -58.65 -41.27 85.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.358 -0.839 . . . . 2.1099999999999999 110.776 179.218 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.82 -30.61 23.15 Favored Glycine 0 N--CA 1.498 2.808 0 C-N-CA 119.071 -1.538 . . . . 0.88 112.991 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -62.09 -42.84 99.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.188 -1.772 . . . . 1.99 110.055 -179.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.41 -52.03 25.26 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.379 -0.825 . . . . 1.28 110.312 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.597 ' HG ' ' N ' ' A' ' 114' ' ' ALA . 25.0 p -60.33 -34.81 74.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.186 -0.946 . . . . 2.2200000000000002 110.421 -179.365 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.597 ' N ' ' HG ' ' A' ' 113' ' ' SER . . . -62.04 -47.02 86.59 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.766 -0.584 . . . . 1.45 110.934 179.576 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.48 -29.94 70.9 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.127 -1.029 . . . . 1.47 111.148 -179.506 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -67.43 -22.29 65.52 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.929 -1.107 . . . . 2.04 111.511 179.455 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -70.59 -18.32 62.89 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.94 -1.104 . . . . 1.73 110.932 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.7 mt -83.79 145.34 28.74 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.359 -0.838 . . . . 1.79 109.623 179.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -101.08 41.93 1.15 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.359 -0.838 . . . . 2.8799999999999999 110.996 179.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -113.13 135.76 53.46 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.961 -1.125 . . . . 1.5800000000000001 107.961 178.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.423 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 25.1 mp0 -59.13 -34.24 71.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.45 -0.781 . . . . 3.04 111.151 179.111 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -74.22 -50.51 18.83 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.108 -0.995 . . . . 1.29 110.51 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.6 mt -63.4 -36.65 84.44 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.199 -0.938 . . . . 1.6000000000000001 110.207 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -62.56 -49.24 76.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.166 -1.014 . . . . 2.7599999999999998 109.758 179.209 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -63.04 -28.98 70.46 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.448 -0.901 . . . . 2.1499999999999999 110.27 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -63.55 -30.38 71.5 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.069 0.937 . . . . 2.8100000000000001 108.879 178.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.1 -48.72 80.56 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.645 0.736 . . . . 1.3899999999999999 109.665 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.87 91.63 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.847 0.832 . . . . 1.4099999999999999 109.449 179.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.76 -37.61 88.0 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.574 -0.704 . . . . 1.3899999999999999 110.476 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.75 -39.83 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.407 -0.808 . . . . 1.1899999999999999 110.202 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -59.1 -38.86 80.54 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.265 -0.974 . . . . 3.6299999999999999 110.134 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -59.68 -39.74 85.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.557 -0.715 . . . . 1.28 110.469 179.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 66.2 mt -60.5 -39.97 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.01 . . . . 1.1799999999999999 110.1 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.01 -44.96 87.24 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.844 -1.169 . . . . 0.51000000000000001 110.279 179.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -59.54 -40.6 87.75 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.311 -1.111 . . . . 3.1699999999999999 110.383 179.248 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -61.74 -45.08 95.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.994 -1.066 . . . . 2.8500000000000001 110.161 179.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 50.5 tp -59.92 -43.19 95.06 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.123 -0.986 . . . . 1.6499999999999999 110.016 179.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.89 -44.16 94.4 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.234 -0.916 . . . . 1.2 110.189 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.87 -34.32 74.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.246 -0.909 . . . . 2.7999999999999998 110.585 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -77.44 -40.5 43.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 2.1499999999999999 111.058 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.3 -40.05 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.236 -0.915 . . . . 1.21 110.196 -178.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 68.7 mt -90.2 -9.42 48.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.91 -1.119 . . . . 1.3400000000000001 112.041 -179.236 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.37 20.27 77.24 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 120.375 -0.917 . . . . 0.91000000000000003 112.961 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.2 tp -63.78 149.91 45.78 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.686 0.755 . . . . 1.51 109.408 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.73 146.29 54.99 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.245 -0.909 . . . . 2.8799999999999999 109.009 178.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.82 143.5 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.391 -0.966 . . . . 1.6200000000000001 108.391 178.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 mp -76.23 114.12 16.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.925 -1.11 . . . . 2.1099999999999999 108.501 178.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -98.18 102.13 13.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.441 -1.689 . . . . 1.6200000000000001 106.441 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.406 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.0 mt -77.37 -18.03 57.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 1.3999999999999999 111.17 -177.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.3 m -80.11 -1.53 40.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -0.823 . . . . 2.0499999999999998 112.325 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.61 27.11 5.04 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.807 0.813 . . . . 1.3500000000000001 111.897 -178.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.406 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 17.5 mt -75.19 139.55 18.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.522 -0.736 . . . . 1.4199999999999999 109.392 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -111.63 -19.95 12.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.029 0.919 . . . . 2.9900000000000002 112.535 -178.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -119.12 142.88 47.53 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.723 -0.843 . . . . 1.54 108.723 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -73.14 122.42 21.83 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.052 -1.092 . . . . 1.3799999999999999 108.052 178.042 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.1 m -144.75 175.56 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.594 -0.691 . . . . 1.28 109.253 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 44.9 mt -88.3 143.91 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.282 -0.886 . . . . 1.1599999999999999 108.802 178.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.3 tp -96.8 125.35 41.19 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.06 -1.089 . . . . 1.3100000000000001 108.06 178.209 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.4 t -123.22 129.93 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.552 -1.277 . . . . 1.25 107.552 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.79 154.21 21.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.159 -0.963 . . . . 1.26 108.678 179.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.83 80.6 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.583 -1.323 . . . . 1.6000000000000001 109.365 178.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -171.58 153.9 3.59 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.862 -0.792 . . . . 2.4199999999999999 108.862 179.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.3 mt -118.73 142.26 47.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.932 -0.766 . . . . 1.3500000000000001 108.932 177.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.2 p -92.48 150.56 40.15 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.13 -0.981 . . . . 1.3200000000000001 108.52 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -42.72 -38.63 6.66 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.857 1.705 . . . . 0.69999999999999996 113.206 179.329 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 62.1 m -63.52 -50.12 70.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.005 -1.059 . . . . 1.1200000000000001 109.884 -179.692 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.92 -39.03 90.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.913 . . . . 1.21 110.127 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.419 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 70.2 p -68.7 -40.81 79.84 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.827 -0.749 . . . . 1.1899999999999999 110.328 179.421 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.57 77.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 1.24 110.585 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -95.91 -0.98 50.2 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.949 -1.094 . . . . 1.6899999999999999 112.921 -179.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.95 148.62 46.95 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.72 -1.238 . . . . 1.3400000000000001 108.49 179.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -97.01 115.3 27.2 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.096 -1.446 . . . . 2.77 107.096 177.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.0 mt -73.67 -14.12 61.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.59 -0.694 . . . . 2.0899999999999999 111.778 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.72 -21.94 32.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.347 -0.845 . . . . 2.6699999999999999 112.491 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -99.43 -7.06 26.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.129 -0.982 . . . . 2.5800000000000001 112.549 -178.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.99 131.0 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.198 -1.038 . . . . 1.1799999999999999 108.198 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.32 -13.87 36.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 2.1800000000000002 111.275 -179.744 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.14 172.92 45.83 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.889 -1.684 . . . . 0.48999999999999999 108.889 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -126.56 132.79 51.25 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.947 -1.131 . . . . 0.64000000000000001 107.947 179.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 67.4 mt -132.66 112.17 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.323 -1.732 . . . . 1.21 106.323 179.052 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 203' ' ' VAL . 73.3 p -135.86 173.3 11.86 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.608 -1.308 . . . . 1.3799999999999999 110.173 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -98.59 54.66 1.05 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.353 0.597 . . . . 2.3700000000000001 110.546 179.049 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.47 160.62 14.4 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 1.52 109.921 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.93 -82.7 0.07 OUTLIER Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.84 -1.171 . . . . 1.8 111.141 178.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 148.47 -38.48 1.01 Allowed Glycine 0 N--CA 1.5 2.942 0 O-C-N 120.582 -1.54 . . . . 2.04 113.223 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -60.05 -39.52 86.22 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.844 -1.386 . . . . 5.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 23.0 p -136.83 38.02 2.6 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.295 -0.878 . . . . 3.02 111.623 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 59.0 m -85.68 124.07 31.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.404 -1.332 . . . . 2.1099999999999999 107.404 178.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.419 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 76.2 t60 -56.69 -37.52 70.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.264 -0.897 . . . . 1.24 110.824 179.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.545 ' HG1' ' N ' ' A' ' 191' ' ' SER . 30.3 p -60.88 -38.93 87.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 2.1499999999999999 110.351 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.545 ' N ' ' HG1' ' A' ' 190' ' ' THR . 39.0 t -60.21 -40.54 90.47 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.224 -0.923 . . . . 2.02 110.12 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.55 -35.92 61.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.333 -0.854 . . . . 2.1200000000000001 110.457 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 59.1 mtp -63.23 -41.44 99.11 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.995 -1.066 . . . . 1.3600000000000001 109.566 179.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.75 -47.09 87.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.701 -0.681 . . . . 1.29 111.021 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -62.17 -43.46 98.77 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.061 -1.024 . . . . 3.5600000000000001 110.748 -179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.4 m -70.5 -39.78 73.95 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.308 -0.87 . . . . 1.1799999999999999 110.492 -179.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.0 mt -93.3 -4.47 51.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 1.3400000000000001 112.817 -178.295 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 53.87 10.84 0.28 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.862 1.06 . . . . 1.45 113.862 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.6 mt -72.36 150.22 91.68 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.871 -1.143 . . . . 1.25 108.904 179.4 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.63 140.81 88.59 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.038 1.159 . . . . 0.78000000000000003 110.239 178.391 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.94 162.04 31.85 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.049 -1.657 . . . . 1.2 109.479 178.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.2 mt -147.02 146.6 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.063 -1.088 . . . . 1.25 108.063 177.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.2 m -125.93 -28.28 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 O-C-N 121.041 -1.037 . . . . 1.3899999999999999 113.266 -179.182 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.21 42.2 1.63 Allowed Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.634 -1.27 . . . . 0.96999999999999997 111.759 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 45.0 p -65.34 -18.04 65.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.964 -1.315 . . . . 1.3500000000000001 111.116 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.07 -95.9 0.86 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.833 -1.307 . . . . 1.0700000000000001 109.833 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 60.8 m -127.46 31.09 5.25 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.709 -0.877 . . . . 1.9199999999999999 111.866 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 78.2 t -57.06 -35.89 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.32 -1.488 . . . . 1.3300000000000001 110.593 179.233 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.4 p -59.99 -19.89 54.81 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.939 -1.101 . . . . 1.4199999999999999 111.974 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 48.9 m -94.56 1.87 55.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.945 . . . . 2.1200000000000001 112.089 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -128.77 1.67 5.43 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 113.086 0.773 . . . . 2.6899999999999999 113.086 -178.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.53 152.87 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.739 0.781 . . . . 1.29 109.773 -179.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -118.82 152.69 35.77 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.044 -1.095 . . . . 2.6899999999999999 108.044 177.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 43.7 p-10 -55.11 143.2 27.88 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.983 -1.073 . . . . 2.79 110.17 178.285 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 80.97 -0.72 1.78 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 114.117 1.155 . . . . 2.3500000000000001 114.117 179.431 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.14 150.07 43.73 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.646 -1.284 . . . . 1.97 109.338 177.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -89.72 120.86 31.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.507 -1.371 . . . . 2.9700000000000002 107.521 178.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.8 mt -128.33 146.8 50.66 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.44 -0.788 . . . . 1.25 109.729 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.47 127.88 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.15 -1.426 . . . . 1.22 107.15 177.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.8 tp -101.52 118.3 36.67 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 105.883 -1.895 . . . . 1.24 105.883 178.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 223' ' ' VAL . 39.4 t0 -91.7 -26.81 18.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.753 -1.217 . . . . 2.0499999999999998 112.361 -177.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.417 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 37.82 19.74 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 113.264 0.839 . . . . 1.25 113.264 -179.25 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.1 t -112.14 -55.74 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.147 0.975 . . . . 1.4299999999999999 108.981 -179.426 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -100.73 10.89 40.58 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.252 1.025 . . . . 3.0299999999999998 109.65 -179.169 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 62.03 53.31 3.04 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.317 -0.856 . . . . 2.25 112.05 179.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -149.58 146.64 27.44 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.213 1.006 . . . . 2.52 109.792 178.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.9 t -116.79 135.37 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.509 -1.293 . . . . 1.29 107.509 178.056 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -102.42 134.77 45.19 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.831 -1.168 . . . . 1.3400000000000001 108.442 178.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.26 129.25 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 107.795 -1.187 . . . . 1.3400000000000001 107.795 178.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.488 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 18.4 t30 56.66 44.88 1.53 Allowed Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 113.467 0.914 . . . . 2.1800000000000002 113.467 179.092 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 52.2 Cg_endo -68.9 155.47 68.46 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.383 2.055 . . . . 0.93999999999999995 110.681 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 29.8 p -73.72 162.56 29.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.962 -1.086 . . . . 2.3999999999999999 110.723 178.544 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.12 -34.04 74.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.507 -0.746 . . . . 3.3300000000000001 110.337 178.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -59.85 -39.53 85.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 3.1699999999999999 110.747 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.04 -39.07 79.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.217 -0.927 . . . . 1.6899999999999999 110.405 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 80.5 mt -59.74 -48.37 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.525 -0.734 . . . . 1.6000000000000001 111.304 179.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -59.06 -40.17 84.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.892 -1.13 . . . . 2.7000000000000002 110.824 -179.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -62.69 -47.49 83.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.256 -0.903 . . . . 2.96 110.76 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 87.6 mtp -71.29 -39.1 71.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.384 -0.823 . . . . 1.6299999999999999 110.89 -179.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -56.23 -39.93 73.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.866 -1.146 . . . . 3.27 110.751 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.91 -45.89 63.48 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.014 -1.054 . . . . 2.23 111.122 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.12 -48.59 84.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.648 -1.282 . . . . 2.79 110.895 -178.573 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -60.07 -50.73 72.57 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.647 -1.283 . . . . 4.2599999999999998 111.124 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.57 -36.78 85.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.761 -0.587 . . . . 1.8799999999999999 111.108 -179.4 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -61.98 -26.32 68.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.424 -1.31 . . . . 3.3799999999999999 110.428 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 77.5 t -69.49 -49.26 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 119.354 -0.939 . . . . 2.8799999999999999 110.308 179.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.13 97.02 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.17 -0.956 . . . . 2.75 110.023 -179.766 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.5 t -69.94 -39.81 75.86 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.701 -0.625 . . . . 3.4199999999999999 110.794 -179.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -62.54 -46.6 87.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.344 -0.847 . . . . 3.5699999999999998 110.833 -179.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -70.19 -29.19 65.99 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.426 -0.796 . . . . 4.6100000000000003 111.09 -179.576 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.24 -69.35 0.6 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.886 -1.134 . . . . 4.4500000000000002 111.636 179.378 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -78.45 -53.72 6.94 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.316 -0.865 . . . . 5.9699999999999998 113.03 -178.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 66.1 mt -68.4 -12.27 60.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.443 -1.411 . . . . 6.4500000000000002 112.887 -178.211 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -62.85 -28.29 69.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.371 -1.456 . . . . 6.6600000000000001 111.144 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -82.08 -11.37 58.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.917 -1.115 . . . . 8.5399999999999991 112.454 -179.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 256' ' ' LEU . 3.6 mm? -92.05 16.65 10.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.014 -1.054 . . . . 8.0700000000000003 112.28 -179.682 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.404 ' CB ' ' NZ ' ' A' ' 257' ' ' LYS . 9.3 mtmp? -85.75 11.27 11.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.059 -1.025 . . . . 9.7200000000000006 112.802 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -85.16 -8.14 58.74 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.856 -1.152 . . . . 10.119999999999999 112.422 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 51.2 mtt-85 . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.1 -1.0 . . . . 11.9 109.302 -178.111 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.293 0.568 . . . . 3.5299999999999998 109.519 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.6 mt -92.93 106.94 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.318 -1.734 . . . . 1.5700000000000001 106.318 177.666 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 m -105.76 121.02 43.18 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.504 -1.295 . . . . 1.4399999999999999 107.504 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.01 -149.82 26.15 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.512 -1.035 . . . . 1.01 110.512 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 81.3 mt -94.34 0.77 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.783 -0.833 . . . . 1.6299999999999999 112.086 -179.67 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 50.26 99.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.355 -0.841 . . . . 1.5800000000000001 112.335 178.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.8 -52.97 6.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.108 . . . . 1.3400000000000001 110.628 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.33 149.41 44.53 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 107.719 -1.215 . . . . 1.8600000000000001 107.719 -179.541 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.26 144.5 29.48 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 123.029 2.486 . . . . 1.01 112.937 178.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.35 168.67 18.15 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 109.206 -1.558 . . . . 0.81000000000000005 109.206 178.119 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.87 133.46 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.108 -1.23 . . . . 1.3700000000000001 108.803 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.33 150.86 43.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.366 -0.834 . . . . 1.1399999999999999 109.132 179.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.418 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 22.0 m-85 -117.87 139.78 50.63 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.047 -1.094 . . . . 0.87 108.047 177.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.82 167.25 38.52 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.34 -1.886 . . . . 0.56999999999999995 110.442 178.182 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -78.38 156.62 29.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.768 -0.842 . . . . 2.3500000000000001 108.774 177.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.67 124.96 32.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.042 -1.095 . . . . 1.21 108.042 178.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.2 tp -100.24 101.9 13.03 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 104.721 -2.326 . . . . 1.3999999999999999 104.721 177.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.25 138.48 31.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.21 -1.034 . . . . 1.4399999999999999 108.21 179.673 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.3 mt -98.98 114.83 27.67 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 106.119 -1.808 . . . . 1.45 106.119 177.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -102.29 129.84 48.83 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.799 -1.186 . . . . 2.5 107.799 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -123.27 144.07 49.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.99 -0.744 . . . . 2.6600000000000001 108.99 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -81.15 134.34 35.62 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.758 -1.201 . . . . 2.3199999999999998 107.758 177.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.68 145.61 55.39 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.406 -0.809 . . . . 2.1099999999999999 108.981 178.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.9 mt -93.03 132.11 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.263 -1.014 . . . . 1.29 108.263 178.324 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -106.33 129.85 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.169 -1.048 . . . . 1.4099999999999999 108.169 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.2 mt -97.06 130.34 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.031 -1.1 . . . . 1.3100000000000001 108.031 178.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -89.91 122.51 33.01 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.741 -1.207 . . . . 1.3400000000000001 107.741 178.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mmm-85 -93.58 11.68 27.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.47 -0.768 . . . . 3.48 112.286 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -65.05 150.51 47.98 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.348 -0.845 . . . . 2.52 110.268 178.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -90.08 129.85 36.32 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.148 -1.056 . . . . 2.6299999999999999 108.148 177.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 pt -90.86 164.69 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.962 . . . . 1.3100000000000001 110.009 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.0 p -94.13 167.25 11.69 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.55 -0.719 . . . . 1.24 110.452 178.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.51 -26.89 55.91 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.91 . . . . 1.49 111.929 179.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -70.61 -27.98 64.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 2.2799999999999998 111.012 -179.786 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -93.52 -12.82 28.76 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.416 -0.802 . . . . 2.0499999999999998 112.151 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.3 t -59.54 -47.79 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.487 0.66 . . . . 1.3400000000000001 110.205 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.33 -38.27 76.81 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.444 -0.785 . . . . 1.54 110.63 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.28 -38.66 90.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.605 -0.685 . . . . 2.8500000000000001 110.88 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.45 ' CD ' HH21 ' A' ' 42' ' ' ARG . 79.3 mm-40 -60.35 -41.33 93.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.85 -1.156 . . . . 1.3100000000000001 110.503 179.573 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.27 -40.41 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.374 -0.828 . . . . 1.3799999999999999 110.547 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -60.29 -44.91 94.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.128 -0.983 . . . . 1.5 109.882 179.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.45 HH21 ' CD ' ' A' ' 39' ' ' GLU . 67.5 mtm180 -63.42 -41.96 98.71 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.929 -1.109 . . . . 2.7799999999999998 109.74 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -72.25 -54.5 9.41 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.309 -0.869 . . . . 1.0600000000000001 109.974 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.4 tp -57.79 -48.51 79.48 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.33 -0.948 . . . . 1.3999999999999999 110.051 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 t -68.78 -43.92 74.69 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.121 -0.987 . . . . 1.3200000000000001 109.489 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.45 -35.71 73.59 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.348 -1.501 . . . . 0.69999999999999996 109.348 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 47' ' ' ARG . 0.3 OUTLIER -58.62 -33.66 70.28 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.434 1.111 . . . . 3.4399999999999999 108.819 178.71 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.87 -48.21 82.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.035 -0.984 . . . . 1.3600000000000001 110.212 179.439 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -79.0 -38.6 36.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 2.8300000000000001 111.261 -179.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.76 86.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 1.23 110.513 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.5 m -61.43 -39.54 91.18 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.042 -1.036 . . . . 1.9199999999999999 109.893 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.31 92.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.866 -0.521 . . . . 1.25 111.373 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -63.01 -52.16 64.02 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.716 -1.24 . . . . 1.97 111.199 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.75 -38.22 90.26 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.804 -1.185 . . . . 2.1800000000000002 110.401 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.1 -43.33 87.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.737 -0.602 . . . . 1.1899999999999999 110.781 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.5 m -67.74 -44.65 77.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.784 -1.197 . . . . 1.3400000000000001 110.311 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.92 -34.92 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.641 -0.662 . . . . 1.23 110.869 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -50.74 -45.55 58.83 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.297 -0.877 . . . . 1.5600000000000001 110.743 179.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -69.58 -34.57 74.33 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.129 -0.982 . . . . 1.3 110.305 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -62.75 -39.62 94.69 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.834 -1.147 . . . . 2.3199999999999998 109.686 179.455 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.36 73.93 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.683 -0.635 . . . . 1.1399999999999999 110.427 179.205 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.41 -33.7 21.94 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.8 -1.19 . . . . 0.68999999999999995 111.042 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.44 -24.58 39.5 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.117 -1.225 . . . . 1.48 111.296 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -86.38 -48.84 8.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.374 -0.828 . . . . 1.52 111.221 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -107.36 -15.36 14.65 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 113.484 0.92 . . . . 1.3100000000000001 113.484 -177.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.85 151.98 8.92 Favored Glycine 0 N--CA 1.501 3.026 0 O-C-N 121.406 -0.809 . . . . 0.84999999999999998 112.043 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -52.73 -21.22 3.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.53 -0.982 . . . . 3.8599999999999999 112.417 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.27 -29.89 67.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.974 -1.079 . . . . 2.3500000000000001 111.689 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -82.82 -17.42 44.07 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.823 -1.173 . . . . 2.2599999999999998 111.948 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.34 -33.81 72.94 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.419 -0.8 . . . . 1.45 111.109 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.69 -39.97 86.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.086 -1.009 . . . . 1.25 110.701 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.2 mt -66.12 -47.54 84.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.401 -0.92 . . . . 1.26 109.734 179.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -71.19 -33.41 69.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.339 -0.851 . . . . 0.82999999999999996 110.547 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.88 -38.58 86.14 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.139 -0.976 . . . . 1.1899999999999999 109.854 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.84 95.1 Favored Glycine 0 N--CA 1.483 1.833 0 C-N-CA 120.026 -1.083 . . . . 0.57999999999999996 110.479 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -58.73 -43.0 90.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.026 -1.279 . . . . 2.0499999999999998 110.362 179.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.33 -40.85 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.083 -1.011 . . . . 1.21 110.081 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.9 ttm -60.57 -41.99 95.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.438 -0.789 . . . . 2.29 110.081 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.1 tp -60.55 -48.09 83.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.417 -0.802 . . . . 1.21 109.995 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.466 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.1 tp -59.83 -39.66 85.87 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.72 0.771 . . . . 1.1399999999999999 110.248 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -87.06 7.6 27.15 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.725 0.639 . . . . 1.4199999999999999 112.725 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -63.49 125.2 23.43 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.833 -1.167 . . . . 1.27 108.762 178.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.49 -16.72 63.94 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.265 -0.897 . . . . 1.3500000000000001 111.096 -179.051 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.37 -50.29 19.22 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.274 -0.97 . . . . 2.2200000000000002 110.623 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.97 -39.72 90.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.379 -0.826 . . . . 1.22 110.631 -179.489 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.84 -48.65 80.84 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.07 -1.019 . . . . 1.29 110.986 179.367 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -62.01 -38.64 89.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 2.1699999999999999 110.949 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -66.36 -47.98 71.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.899 -1.126 . . . . 1.3 110.319 179.486 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.7 mt -58.33 -46.48 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.968 -1.082 . . . . 1.1699999999999999 109.991 179.381 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.99 -40.94 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.45 -0.781 . . . . 1.3999999999999999 110.354 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.43 -46.93 88.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 1.3300000000000001 111.033 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.8 -42.98 94.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.087 -1.008 . . . . 1.48 110.511 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.8 mt -61.84 -46.77 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.982 . . . . 1.28 110.029 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -82.14 -37.87 25.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 2.6000000000000001 111.82 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 91' ' ' ALA . 56.3 t0 -81.58 -45.74 15.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.696 -1.253 . . . . 1.51 111.994 -178.681 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -100.01 8.81 43.74 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.991 -1.068 . . . . 2.48 112.61 -178.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.0 m170 50.88 50.21 19.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.959 -1.088 . . . . 1.6100000000000001 111.816 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.9 mtt -107.72 151.45 25.67 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.442 -0.786 . . . . 1.8999999999999999 109.734 179.486 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.5 p -70.43 163.34 26.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.729 -0.607 . . . . 1.3200000000000001 109.97 178.351 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.79 -42.29 88.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.933 . . . . 1.1499999999999999 110.698 178.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.93 -41.43 82.6 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.042 -1.036 . . . . 2.25 110.205 -179.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.22 -50.87 51.21 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.634 -0.666 . . . . 1.22 111.344 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.71 94.89 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.033 -1.042 . . . . 1.1899999999999999 110.314 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -43.74 95.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 1.2 110.669 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -61.28 -39.75 91.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 2.1000000000000001 111.309 -179.481 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -57.63 -49.84 75.12 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.852 -1.155 . . . . 1.3 110.795 179.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.14 -46.06 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.047 -1.033 . . . . 1.27 109.974 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -64.93 -31.96 56.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.871 -0.518 . . . . 1.1899999999999999 110.418 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.21 -41.0 71.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.181 -0.949 . . . . 2.1099999999999999 110.7 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.01 -30.93 18.97 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 119.142 -1.504 . . . . 0.88 112.452 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -61.21 -39.69 91.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.516 -1.579 . . . . 1.99 109.903 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.14 -48.91 40.07 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.323 0.582 . . . . 1.28 110.755 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.8 t -60.05 -40.34 89.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.319 -0.863 . . . . 2.2200000000000002 110.433 -178.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.07 99.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.382 -0.824 . . . . 1.45 110.745 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.55 -30.11 70.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.814 -1.179 . . . . 1.47 110.733 -179.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -66.24 -20.14 66.03 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.78 -1.2 . . . . 2.04 111.039 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.37 -18.77 63.06 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.351 -0.94 . . . . 1.73 110.827 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 15.0 mt -88.88 136.49 32.98 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.843 -1.169 . . . . 1.79 107.843 178.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -100.59 42.92 1.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.272 -0.893 . . . . 2.8799999999999999 111.272 -179.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -111.85 142.31 44.39 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.164 -0.96 . . . . 1.5800000000000001 109.456 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -58.8 -39.27 80.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.228 -0.92 . . . . 3.04 110.797 178.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -71.87 -50.58 28.19 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.851 -1.156 . . . . 1.29 109.875 179.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt -67.5 -43.28 81.28 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.386 -0.821 . . . . 1.6000000000000001 110.118 -178.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -61.25 -47.87 84.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.16 -0.962 . . . . 2.7599999999999998 109.787 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.91 -30.92 69.36 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.505 -0.878 . . . . 2.1499999999999999 109.635 179.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -61.68 -30.43 70.73 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.092 0.949 . . . . 2.8100000000000001 108.696 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -49.86 74.56 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.071 0.939 . . . . 1.3899999999999999 109.537 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.65 -43.34 80.52 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.598 0.713 . . . . 1.4099999999999999 110.078 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -63.21 -33.51 75.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.623 -0.673 . . . . 1.3899999999999999 110.573 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.0 -39.28 77.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.472 -0.767 . . . . 1.1899999999999999 110.105 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -59.26 -39.92 84.39 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.822 -1.151 . . . . 3.6299999999999999 109.752 178.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.441 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 51.3 t0 -60.12 -40.8 90.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.588 -0.695 . . . . 1.28 110.059 179.437 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.7 mt -61.77 -39.07 82.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.062 -1.023 . . . . 1.1799999999999999 110.116 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.35 -46.51 20.18 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.655 -1.259 . . . . 0.51000000000000001 110.486 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -56.62 -41.63 77.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.559 -0.965 . . . . 3.1699999999999999 110.079 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.441 ' NH2' ' OD2' ' A' ' 132' ' ' ASP . 40.7 mtt-85 -60.19 -41.52 93.11 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.003 -1.061 . . . . 2.8500000000000001 109.832 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.9 tp -60.22 -42.78 95.9 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.318 -0.953 . . . . 1.6499999999999999 109.358 179.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.4 mt -59.84 -47.31 86.24 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.828 -0.545 . . . . 1.2 109.949 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -59.88 -35.4 74.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 2.7999999999999998 111.017 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -73.99 -41.5 61.81 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.026 -1.046 . . . . 2.1499999999999999 110.684 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.57 -38.89 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -0.925 . . . . 1.21 110.462 -178.388 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.7 mt -89.07 -6.96 56.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.093 -1.004 . . . . 1.3400000000000001 112.099 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.47 30.0 67.31 Favored Glycine 0 N--CA 1.482 1.746 0 C-N-CA 120.065 -1.064 . . . . 0.91000000000000003 112.075 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.94 148.23 44.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.686 -0.891 . . . . 1.51 109.844 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -68.01 141.29 56.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 2.8799999999999999 109.27 178.095 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.91 131.5 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.202 -1.036 . . . . 1.6200000000000001 108.202 178.463 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.41 ' CD1' ' H ' ' A' ' 147' ' ' ILE . 4.1 mp -77.02 131.02 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.408 -0.808 . . . . 2.1099999999999999 108.928 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.9 97.93 11.27 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.466 -1.679 . . . . 1.6200000000000001 106.466 178.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 77.2 mt -78.84 -6.0 54.91 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 112.72 0.637 . . . . 1.3999999999999999 112.72 -177.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.8 p -88.85 -2.59 58.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.903 -1.123 . . . . 2.0499999999999998 112.745 -179.123 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -106.17 36.68 2.5 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.147 -0.97 . . . . 1.3500000000000001 112.414 -177.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.521 ' CD1' ' N ' ' A' ' 152' ' ' ILE . 1.5 mp -72.72 139.89 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.575 -1.328 . . . . 1.4199999999999999 109.406 178.493 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -118.86 -16.73 9.25 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.706 0.765 . . . . 2.9900000000000002 112.408 -179.097 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -116.03 138.47 51.19 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.771 -1.196 . . . . 1.54 107.771 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -76.12 121.39 22.75 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.284 -1.006 . . . . 1.3799999999999999 108.284 178.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 m -146.28 174.03 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.493 -0.755 . . . . 1.28 109.144 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.7 mt -87.89 140.76 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 1.1599999999999999 109.143 178.02 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 42.5 tp -94.8 124.15 38.67 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.98 -1.075 . . . . 1.3100000000000001 108.183 178.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.97 129.18 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 107.604 -1.258 . . . . 1.25 107.604 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.36 153.98 22.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 1.26 108.943 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.65 -34.38 76.96 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.607 -1.308 . . . . 1.6000000000000001 109.213 178.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -173.8 149.77 1.6 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.236 -0.653 . . . . 2.4199999999999999 109.236 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 58.9 mt -116.03 136.32 53.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.601 -1.259 . . . . 1.3500000000000001 107.601 177.337 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.9 p -92.2 150.15 39.8 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.164 -0.96 . . . . 1.3200000000000001 108.786 179.069 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -39.49 -44.38 3.09 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.886 1.724 . . . . 0.69999999999999996 113.441 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.8 m -58.92 -50.06 75.47 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.835 -1.166 . . . . 1.1200000000000001 111.014 -179.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -62.99 -40.07 96.66 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.253 -0.904 . . . . 1.21 110.212 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.491 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 73.0 p -68.58 -39.2 81.07 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.334 -0.854 . . . . 1.1899999999999999 110.327 179.585 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.5 78.17 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.595 -0.842 . . . . 1.24 110.638 179.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -94.88 -2.37 50.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.111 -0.993 . . . . 1.6899999999999999 113.226 -179.014 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.94 149.94 46.14 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.904 -1.123 . . . . 1.3400000000000001 109.14 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -95.63 104.63 16.55 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.056 -1.831 . . . . 2.77 106.056 177.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 8.6 mp -72.2 -18.3 61.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 2.0899999999999999 112.054 -177.57 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -77.97 -27.45 49.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.203 -0.936 . . . . 2.6699999999999999 111.45 -178.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -100.11 6.07 44.91 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.284 -0.885 . . . . 2.5800000000000001 112.362 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.5 t -109.75 129.84 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.962 -1.125 . . . . 1.1799999999999999 107.962 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 48.9 tp -81.85 -15.47 53.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.815 . . . . 2.1800000000000002 112.288 -179.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.29 179.91 44.27 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.472 -1.451 . . . . 0.48999999999999999 109.472 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -131.68 138.24 48.63 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.533 -1.284 . . . . 0.64000000000000001 107.533 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.9 mt -138.21 119.03 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.424 -1.695 . . . . 1.21 106.424 178.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 203' ' ' VAL . 60.0 p -132.1 164.53 26.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.087 -1.008 . . . . 1.3799999999999999 108.952 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 208' ' ' VAL . 1.9 m-20 -104.82 15.98 26.83 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.577 -0.702 . . . . 2.3700000000000001 112.329 179.047 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -134.12 -51.17 0.82 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 120.808 -1.182 . . . . 1.52 114.0 -177.712 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.54 153.74 0.29 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.199 -1.0 . . . . 1.8 110.84 -176.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 152.65 -61.31 0.39 Allowed Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.156 -1.021 . . . . 2.04 112.295 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.83 77.37 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.061 -1.258 . . . . 5.0 109.023 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.6 p 53.67 40.75 31.86 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.672 -0.811 . . . . 3.02 111.596 -178.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 38.5 t -79.74 153.99 28.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.816 . . . . 2.1099999999999999 109.559 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.491 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 82.8 t60 -59.0 -39.91 83.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.859 . . . . 1.24 110.893 178.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 33.6 p -56.42 -40.89 75.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 2.1499999999999999 110.732 179.417 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 82.2 p -62.3 -37.95 87.49 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.066 -1.021 . . . . 2.02 110.485 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.83 -38.7 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.383 -0.823 . . . . 2.1200000000000001 110.73 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.7 mtp -61.75 -44.86 96.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.84 -1.162 . . . . 1.3600000000000001 108.905 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.95 -48.6 81.05 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.116 -0.947 . . . . 1.29 111.029 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.442 ' HG2' HH11 ' A' ' 195' ' ' ARG . 23.7 mtt-85 -60.81 -43.48 98.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.099 -1.001 . . . . 3.5600000000000001 110.751 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 41.5 m -69.88 -41.04 75.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.443 -0.786 . . . . 1.1799999999999999 110.306 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 13.3 mt -91.75 -6.84 51.19 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.623 0.725 . . . . 1.3400000000000001 112.284 -178.221 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.5 mt-10 45.52 18.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.529 0.937 . . . . 1.45 113.529 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 18.6 mt -71.84 142.25 85.45 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.953 -1.092 . . . . 1.25 108.372 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -56.24 130.36 39.75 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.678 1.585 . . . . 0.78000000000000003 110.357 178.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.05 175.88 9.05 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 117.911 -1.516 . . . . 1.2 111.517 179.555 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.2 mt -146.63 157.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.632 -1.247 . . . . 1.25 107.632 178.467 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 183' ' ' ALA . 4.6 m -141.8 -23.62 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 120.818 -1.176 . . . . 1.3899999999999999 113.286 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -104.25 42.3 1.93 Allowed Glycine 0 N--CA 1.503 3.136 0 N-CA-C 110.637 -0.985 . . . . 0.96999999999999997 110.637 -178.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 36.3 p -59.86 -20.76 58.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.056 -1.261 . . . . 1.3500000000000001 111.841 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.22 -85.37 0.61 Allowed Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.18 -1.01 . . . . 1.0700000000000001 111.437 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 58.8 p -134.66 32.11 3.32 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 121.008 -1.29 . . . . 1.9199999999999999 113.331 -178.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.527 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 60.2 t -58.84 -34.15 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.223 -1.548 . . . . 1.3300000000000001 111.076 179.451 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 43.8 p -64.12 -21.73 66.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.835 -1.165 . . . . 1.4199999999999999 112.199 -179.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 53.8 p -96.32 3.16 53.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.943 -1.098 . . . . 2.1200000000000001 112.339 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -129.76 4.12 4.98 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.684 -0.635 . . . . 2.6899999999999999 112.691 -178.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.1 t -123.04 152.92 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.404 -0.81 . . . . 1.29 109.768 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -118.48 156.76 28.51 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.096 -1.076 . . . . 2.6899999999999999 108.096 178.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.513 ' ND2' ' OD1' ' A' ' 215' ' ' ASP . 46.7 t30 -54.8 139.97 37.89 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.052 -1.03 . . . . 2.79 110.119 178.257 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.513 ' OD1' ' ND2' ' A' ' 214' ' ' ASN . 1.2 m-20 79.56 5.36 2.06 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.281 1.215 . . . . 2.3500000000000001 114.281 179.58 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -63.39 148.63 47.93 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.385 -0.969 . . . . 1.97 108.385 177.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -89.64 119.96 30.51 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.583 -1.636 . . . . 2.9700000000000002 106.583 178.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.7 mt -128.26 146.36 50.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.585 -0.697 . . . . 1.25 109.86 -179.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 47.0 mt -112.13 124.19 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.691 -1.596 . . . . 1.22 106.691 177.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.0 tp -97.21 111.58 23.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.981 -1.859 . . . . 1.24 105.981 178.117 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.6 t0 -89.72 -28.95 19.07 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.718 -1.239 . . . . 2.0499999999999998 111.549 -178.423 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 40.81 10.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 113.285 0.846 . . . . 1.25 113.285 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.625 ' N ' ' O ' ' A' ' 221' ' ' ASP . 39.3 t -110.57 -56.44 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.987 -1.071 . . . . 1.4299999999999999 109.173 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -92.57 8.87 37.04 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.297 1.046 . . . . 3.0299999999999998 110.271 -179.097 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 60.51 49.97 6.25 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.026 -0.988 . . . . 2.25 111.632 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -148.47 149.55 31.86 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.608 1.194 . . . . 2.52 109.93 178.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.66 135.03 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.653 -1.239 . . . . 1.29 107.653 177.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -100.5 130.26 46.55 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.968 -1.123 . . . . 1.3400000000000001 107.968 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.31 130.01 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.784 -0.821 . . . . 1.3400000000000001 108.784 179.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.412 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 0.7 OUTLIER 49.93 50.59 9.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 113.426 0.898 . . . . 2.1800000000000002 113.426 178.763 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.7 Cg_endo -69.02 150.29 72.56 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.366 2.044 . . . . 0.93999999999999995 110.701 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.1 p -73.83 160.29 31.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 2.3999999999999999 109.821 178.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.72 -36.61 72.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.486 -0.759 . . . . 3.3300000000000001 111.105 179.021 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -59.59 -41.22 89.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 3.1699999999999999 110.122 179.321 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -71.39 -40.24 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.47 -0.769 . . . . 1.6899999999999999 110.115 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.599 ' CG2' HH12 ' A' ' 240' ' ' ARG . 87.6 mt -60.53 -47.02 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.391 -0.818 . . . . 1.6000000000000001 110.322 -178.549 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.12 -39.86 87.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.047 -1.033 . . . . 2.7000000000000002 110.303 179.591 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -60.61 -40.96 93.78 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.558 -0.713 . . . . 2.96 110.063 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 72.8 mtp -72.15 -38.32 69.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.041 -1.037 . . . . 1.6299999999999999 110.94 -179.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.599 HH12 ' CG2' ' A' ' 236' ' ' ILE . 0.0 OUTLIER -57.45 -42.16 81.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.128 -0.982 . . . . 3.27 110.891 179.946 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.54 -50.41 21.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 2.23 110.585 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 90.1 t -63.89 -46.69 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.343 -0.848 . . . . 2.79 110.934 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.78 -51.48 69.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.075 -1.015 . . . . 4.2599999999999998 111.318 -179.716 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -62.58 -33.7 75.48 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.124 -0.985 . . . . 1.8799999999999999 110.363 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -61.12 -30.27 70.27 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.992 -1.083 . . . . 3.3799999999999999 109.641 179.129 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.46 -40.71 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.894 -0.723 . . . . 2.8799999999999999 109.949 179.342 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.79 87.78 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.583 -0.847 . . . . 2.75 110.181 179.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.2 p -71.77 -44.67 63.62 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.294 -0.879 . . . . 3.4199999999999999 110.91 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -63.48 -32.54 74.02 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.656 -0.652 . . . . 3.5699999999999998 110.661 -177.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -67.8 -28.76 67.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -0.952 . . . . 4.6100000000000003 111.007 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.81 98.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 4.4500000000000002 110.106 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -70.15 -37.7 75.31 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.322 -0.861 . . . . 5.9699999999999998 110.303 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 35.0 tp -69.3 -26.41 64.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.617 -0.677 . . . . 6.4500000000000002 111.302 -179.407 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -69.17 -6.76 30.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.377 -0.827 . . . . 6.6600000000000001 113.17 -179.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -69.67 -30.71 68.45 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.035 -1.041 . . . . 8.5399999999999991 110.917 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 86.2 mt -87.13 -10.89 51.65 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.942 -1.099 . . . . 8.0700000000000003 112.607 -179.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -93.52 33.8 1.23 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.984 -1.073 . . . . 9.7200000000000006 112.297 -178.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -88.88 2.92 52.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.938 -1.101 . . . . 10.119999999999999 112.353 179.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.977 -1.011 . . . . 11.9 108.936 179.998 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.218 -0.66 . . . . 3.5299999999999998 109.218 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.1 mt -99.24 109.7 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 106.41 -1.7 . . . . 1.5700000000000001 106.41 177.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -105.02 120.52 41.68 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.744 -1.206 . . . . 1.4399999999999999 107.744 -179.418 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.6 -160.37 26.9 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.179 -1.568 . . . . 1.01 109.179 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.472 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 74.9 mt -96.05 -0.18 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.419 -1.047 . . . . 1.6299999999999999 112.343 -179.295 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.7 tp 49.24 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 1.5800000000000001 112.656 178.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.76 -43.55 11.8 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.933 -1.105 . . . . 1.3400000000000001 111.562 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -141.33 143.51 30.62 Favored Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 107.72 -1.215 . . . . 1.8600000000000001 107.72 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.32 146.55 22.28 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.616 2.211 . . . . 1.01 112.634 178.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 153.39 177.98 27.46 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 108.866 -1.694 . . . . 0.81000000000000005 108.866 177.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.9 mt -134.67 140.04 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.041 -1.27 . . . . 1.3700000000000001 108.345 179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.94 158.03 43.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -0.984 . . . . 1.1399999999999999 109.451 178.177 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 11.5 m-85 -127.75 140.54 52.0 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.769 -1.197 . . . . 0.87 107.769 178.223 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.23 166.02 34.41 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 118.38 -1.867 . . . . 0.56999999999999995 110.411 178.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -78.11 158.08 29.25 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.402 -0.962 . . . . 2.3500000000000001 108.402 178.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.16 130.96 35.15 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.743 -0.836 . . . . 1.21 108.743 178.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.2 tp -113.35 103.78 11.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 105.604 -1.998 . . . . 1.3999999999999999 105.604 178.113 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.482 ' O ' ' ND2' ' A' ' 214' ' ' ASN . 13.8 tp -91.84 139.05 31.04 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.66 -0.867 . . . . 1.4399999999999999 108.66 -179.575 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.2 mt -99.39 120.9 40.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.293 -1.373 . . . . 1.45 107.293 178.318 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -111.12 138.96 46.9 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.995 -1.113 . . . . 2.5 107.995 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -119.78 140.29 50.98 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.172 -0.955 . . . . 2.6600000000000001 109.245 178.446 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -85.02 133.36 34.25 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.727 -1.212 . . . . 2.3199999999999998 107.727 177.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -60.74 149.1 36.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.07 -1.019 . . . . 2.1099999999999999 108.732 178.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.8 mt -96.99 134.17 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.027 -1.046 . . . . 1.29 108.263 178.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.74 129.67 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.586 -1.264 . . . . 1.4099999999999999 107.586 178.531 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.0 mt -100.62 137.74 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.145 -1.058 . . . . 1.3100000000000001 108.145 179.546 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -94.33 120.74 35.01 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.324 -0.991 . . . . 1.3400000000000001 108.324 178.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -94.55 15.13 18.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.393 -0.817 . . . . 3.48 112.805 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.98 147.31 53.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.382 -0.824 . . . . 2.52 109.264 178.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -88.1 139.42 30.52 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.618 -0.882 . . . . 2.6299999999999999 108.618 177.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 pt -99.77 164.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.857 -1.152 . . . . 1.3100000000000001 109.912 179.088 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.0 p -93.87 165.95 12.42 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.386 -0.821 . . . . 1.24 109.698 178.472 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -21.24 14.4 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.4 -0.812 . . . . 1.49 112.154 179.242 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -68.15 -39.1 82.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.063 -1.023 . . . . 2.2799999999999998 110.873 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -91.02 -7.4 52.01 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.814 -1.179 . . . . 2.0499999999999998 112.744 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.22 -47.44 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.526 -1.358 . . . . 1.3400000000000001 110.788 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -59.24 -39.15 81.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.124 -0.985 . . . . 1.54 109.972 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -61.36 -37.92 85.1 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.705 -0.798 . . . . 2.8500000000000001 110.825 179.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -59.91 -40.86 90.25 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.17 -1.012 . . . . 1.3100000000000001 110.639 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.24 -41.77 88.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.165 -0.959 . . . . 1.3799999999999999 110.504 179.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -62.73 -41.39 99.15 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.78 -1.2 . . . . 1.5 110.358 179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -61.05 -41.08 95.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 2.7799999999999998 110.616 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -75.37 -54.11 7.6 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.844 -1.16 . . . . 1.0600000000000001 110.463 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.2 tp -57.55 -47.8 81.07 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.721 0.772 . . . . 1.3999999999999999 110.674 -179.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.0 t -69.06 -40.05 78.75 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.833 0.825 . . . . 1.3200000000000001 110.346 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.91 -44.6 92.44 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 109.811 -1.316 . . . . 0.69999999999999996 109.811 179.298 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -60.67 -28.91 68.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.779 -0.836 . . . . 3.4399999999999999 110.251 179.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.5 -49.34 77.7 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.834 0.826 . . . . 1.3600000000000001 110.604 179.072 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -81.77 -38.62 25.37 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.337 -0.852 . . . . 2.8300000000000001 110.668 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.6 -42.36 92.42 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.614 -0.834 . . . . 1.23 109.925 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 m -62.08 -39.92 94.06 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.985 0.898 . . . . 1.9199999999999999 109.582 179.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.45 88.83 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.723 -0.791 . . . . 1.25 109.879 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.52 -50.44 69.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.99 -1.069 . . . . 1.97 109.998 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.45 -40.33 94.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.941 -1.1 . . . . 2.1800000000000002 109.832 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -59.33 -39.89 84.55 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.393 -0.817 . . . . 1.1899999999999999 110.226 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -62.91 -43.41 98.87 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.388 -0.82 . . . . 1.3400000000000001 110.277 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 57' ' ' ILE . 95.4 mt -60.23 -34.43 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.078 -1.014 . . . . 1.23 110.279 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -53.3 -45.55 69.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.45 -0.781 . . . . 1.5600000000000001 110.877 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -68.87 -39.93 79.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.206 -0.934 . . . . 1.3 109.778 -179.708 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -61.78 -37.58 84.87 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.128 -1.029 . . . . 2.3199999999999998 109.139 179.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.95 79.44 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.308 -0.557 . . . . 1.1399999999999999 110.193 179.197 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.82 -35.21 16.65 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.8 -1.191 . . . . 0.68999999999999995 111.267 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -79.9 -25.7 40.48 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.956 -1.32 . . . . 1.48 110.709 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.2 m -86.93 -50.97 6.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.729 -0.607 . . . . 1.52 110.287 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -105.92 -6.14 19.1 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 114.079 1.14 . . . . 1.3100000000000001 114.079 -177.412 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.57 164.3 27.22 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 120.228 -0.986 . . . . 0.84999999999999998 112.447 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -56.38 -23.24 36.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.852 -0.793 . . . . 3.8599999999999999 112.645 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -57.9 -39.0 76.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.356 -1.465 . . . . 2.3500000000000001 110.515 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -86.99 -25.27 24.36 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.216 -0.928 . . . . 2.2599999999999998 111.746 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.42 -39.97 85.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.219 -0.925 . . . . 1.45 110.776 -179.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.21 84.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.496 -0.752 . . . . 1.25 111.286 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.2 mt -65.41 -44.75 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.622 -1.299 . . . . 1.26 110.649 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -69.87 -31.55 69.44 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.841 -1.162 . . . . 0.82999999999999996 110.698 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -59.98 -39.33 85.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.064 -1.023 . . . . 1.1899999999999999 110.94 179.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.93 -40.36 93.48 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.535 -1.317 . . . . 0.57999999999999996 110.863 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -59.35 -40.78 87.5 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.084 -1.245 . . . . 2.0499999999999998 110.616 179.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.7 mt -60.82 -37.55 76.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.202 -0.936 . . . . 1.21 110.497 179.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 26.3 ttt -58.64 -38.89 79.07 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.703 -0.799 . . . . 2.29 110.449 179.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.05 -49.43 77.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.949 -1.094 . . . . 1.21 110.879 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.6 tp -61.35 -38.81 88.3 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.21 -0.931 . . . . 1.1399999999999999 110.252 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -86.34 7.65 24.68 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.175 0.806 . . . . 1.4199999999999999 113.175 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -67.43 116.16 7.87 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 120.793 -1.192 . . . . 1.27 108.655 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -64.37 -20.23 65.99 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.626 0.727 . . . . 1.3500000000000001 110.946 -179.226 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -71.64 -47.98 50.85 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.991 -1.083 . . . . 2.2200000000000002 110.364 179.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.32 -38.4 89.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.395 -0.816 . . . . 1.22 110.521 -178.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -59.54 -41.76 90.81 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.008 -1.058 . . . . 1.29 110.515 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.17 -39.23 85.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.941 -1.099 . . . . 2.1699999999999999 110.582 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -66.62 -48.06 70.65 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.106 -1.037 . . . . 1.3 110.448 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.59 -43.48 83.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.936 -1.102 . . . . 1.1699999999999999 110.01 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.73 -44.04 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 1.3999999999999999 110.685 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.74 -40.89 96.69 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.247 -0.908 . . . . 1.3300000000000001 110.856 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.0 mt -60.39 -44.77 95.34 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.496 -1.377 . . . . 1.48 110.418 -179.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.64 -47.64 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.907 -1.121 . . . . 1.28 110.812 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -79.75 -35.48 38.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.004 -1.06 . . . . 2.6000000000000001 111.665 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.78 -43.34 22.67 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.02 -1.05 . . . . 1.51 111.312 -179.001 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -101.13 4.55 42.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.047 -1.033 . . . . 2.48 112.251 -177.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.1 m80 51.48 49.35 21.13 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.238 -0.914 . . . . 1.6100000000000001 111.646 -179.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 70.3 mtm -110.04 157.89 18.85 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.494 -0.754 . . . . 1.8999999999999999 109.558 178.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.431 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 29.8 p -71.51 162.46 29.41 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.296 0.569 . . . . 1.3200000000000001 110.403 178.247 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.67 -41.11 97.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.53 -0.731 . . . . 1.1499999999999999 110.827 179.149 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 31.8 p-10 -69.59 -38.59 77.39 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.196 -0.94 . . . . 2.25 109.978 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.527 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -71.27 -52.89 16.43 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.831 -1.148 . . . . 1.22 110.872 179.363 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.25 88.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 1.1899999999999999 110.604 -179.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.25 93.46 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.026 -0.67 . . . . 1.2 110.878 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -59.76 -41.31 90.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.843 -1.16 . . . . 2.1000000000000001 111.039 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -56.14 -47.57 77.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.235 -1.54 . . . . 1.3 110.73 179.658 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.53 -44.18 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.548 -1.345 . . . . 1.27 110.22 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.79 -32.31 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.282 -0.886 . . . . 1.1899999999999999 110.071 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.22 -39.93 92.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.12 -0.987 . . . . 2.1099999999999999 111.022 179.308 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.9 -30.4 29.11 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.079 -1.534 . . . . 0.88 112.795 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -60.57 -39.68 88.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 119.675 -2.073 . . . . 1.99 109.858 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.53 -48.04 43.45 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.638 0.733 . . . . 1.28 109.696 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.532 ' HG ' ' N ' ' A' ' 114' ' ' ALA . 12.3 p -60.81 -39.73 90.04 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.704 -0.798 . . . . 2.2200000000000002 110.063 -178.649 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.532 ' N ' ' HG ' ' A' ' 113' ' ' SER . . . -60.24 -46.45 89.74 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.954 -1.091 . . . . 1.45 110.821 179.535 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.3 mt -65.44 -29.54 70.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.699 -1.25 . . . . 1.47 111.09 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -64.31 -21.39 66.59 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.975 -1.078 . . . . 2.04 111.426 179.549 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -71.83 -15.51 62.14 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.763 0.792 . . . . 1.73 110.923 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 36.8 mt -86.9 141.55 28.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.953 -0.758 . . . . 1.79 108.953 179.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -97.56 41.58 1.12 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.987 -1.071 . . . . 2.8799999999999999 111.853 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -114.48 140.88 48.37 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.305 -0.872 . . . . 1.5800000000000001 109.391 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -59.05 -39.39 81.89 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.338 -0.851 . . . . 3.04 111.515 178.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -72.68 -53.01 12.91 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 1.29 110.313 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.4 mt -61.42 -41.32 96.97 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.107 -0.995 . . . . 1.6000000000000001 110.394 -179.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -63.16 -49.05 75.85 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.276 1.036 . . . . 2.7599999999999998 109.563 179.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -63.2 -29.93 71.18 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.092 -1.043 . . . . 2.1499999999999999 109.968 179.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.443 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 15.2 ttt-85 -60.82 -30.47 70.1 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.741 0.782 . . . . 2.8100000000000001 108.951 178.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.25 87.28 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.155 0.979 . . . . 1.3899999999999999 109.001 178.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -43.65 80.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.739 -0.784 . . . . 1.4099999999999999 109.981 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -64.57 -33.17 75.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.492 -0.755 . . . . 1.3899999999999999 110.616 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.443 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 24.5 t -68.19 -39.63 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 1.1899999999999999 109.834 179.377 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -58.91 -39.67 82.22 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.087 -1.045 . . . . 3.6299999999999999 109.896 178.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -59.35 -38.86 81.48 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.21 -0.45 . . . . 1.28 110.544 179.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 54.1 mt -60.72 -40.29 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.673 -1.267 . . . . 1.1799999999999999 110.116 179.496 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.19 -36.65 60.01 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.395 -1.082 . . . . 0.51000000000000001 110.395 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -56.63 -48.65 77.05 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.547 -0.972 . . . . 3.1699999999999999 110.66 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -63.38 -41.03 98.77 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.013 -1.075 . . . . 2.8500000000000001 110.169 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.9 tp -59.76 -40.37 87.94 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.69 -0.631 . . . . 1.6499999999999999 110.301 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.2 mt -59.24 -44.3 92.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.094 -1.004 . . . . 1.2 110.463 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -60.62 -33.24 72.48 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.146 -0.971 . . . . 2.7999999999999998 111.181 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -75.74 -41.4 53.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.909 -1.119 . . . . 2.1499999999999999 110.867 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.406 HG22 HD11 ' A' ' 141' ' ' ILE . 90.1 mt -60.14 -38.6 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.969 -1.082 . . . . 1.21 110.571 -178.45 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.0 mt -85.35 -7.11 59.14 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.457 -0.777 . . . . 1.3400000000000001 111.764 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.81 16.42 80.78 Favored Glycine 0 N--CA 1.483 1.82 0 C-N-CA 120.319 -0.943 . . . . 0.91000000000000003 112.454 -179.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.27 149.28 48.37 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.769 -0.842 . . . . 1.51 109.688 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -65.66 150.83 47.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.528 -0.732 . . . . 2.8799999999999999 109.695 178.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.2 mt -104.02 138.43 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.177 -0.952 . . . . 1.6200000000000001 108.711 178.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 mp -82.72 118.84 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.439 -1.319 . . . . 2.1099999999999999 107.439 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -100.81 102.62 13.74 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.965 -1.865 . . . . 1.6200000000000001 105.965 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 70.1 mt -74.86 -14.79 60.71 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.563 -0.855 . . . . 1.3999999999999999 111.505 -178.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.2 m -80.09 2.41 24.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.414 -0.804 . . . . 2.0499999999999998 112.852 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -93.94 21.17 6.92 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.67 0.747 . . . . 1.3500000000000001 112.325 -179.226 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.2 mt -73.15 140.22 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.811 -0.556 . . . . 1.4199999999999999 109.672 179.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -117.46 -16.37 10.21 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.224 1.011 . . . . 2.9900000000000002 112.468 -178.715 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -118.03 139.39 51.27 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.288 -1.004 . . . . 1.54 108.288 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -70.87 128.7 36.89 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.826 -1.171 . . . . 1.3799999999999999 108.294 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.1 m -146.57 175.42 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.92 -0.77 . . . . 1.28 108.92 -179.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.28 140.65 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.884 -1.135 . . . . 1.1599999999999999 108.757 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.6 tp -96.66 123.36 40.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.807 -1.183 . . . . 1.3100000000000001 108.626 178.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.23 130.7 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.431 -0.951 . . . . 1.25 108.431 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 152.01 16.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -0.86 . . . . 1.26 109.157 178.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.42 -34.19 74.97 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.897 -1.127 . . . . 1.6000000000000001 109.344 178.055 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -171.53 153.06 3.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.77 -0.826 . . . . 2.4199999999999999 108.77 179.455 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 68.9 mt -118.95 142.86 47.4 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.437 -0.79 . . . . 1.3500000000000001 109.214 177.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.4 p -91.81 146.91 33.91 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.275 -0.89 . . . . 1.3200000000000001 109.071 179.185 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -41.15 -39.23 3.6 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.464 1.443 . . . . 0.69999999999999996 113.537 178.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.1 m -61.37 -50.17 73.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.764 -1.21 . . . . 1.1200000000000001 110.208 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.22 -39.13 93.76 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.41 0.624 . . . . 1.21 110.327 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 56.5 p -68.44 -40.03 81.31 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.285 -0.884 . . . . 1.1899999999999999 110.678 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.78 84.05 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.123 -0.985 . . . . 1.24 110.338 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -94.32 1.85 55.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.791 -1.193 . . . . 1.6899999999999999 112.991 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.7 149.6 34.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.0 -1.063 . . . . 1.3400000000000001 109.037 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.02 116.62 29.23 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.621 -1.622 . . . . 2.77 106.621 177.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.3 mt -75.66 -13.67 60.33 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.353 0.597 . . . . 2.0899999999999999 111.717 -177.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -85.76 -22.16 27.86 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.319 0.581 . . . . 2.6699999999999999 112.072 -179.118 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -102.73 -2.41 28.2 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.884 0.698 . . . . 2.5800000000000001 112.884 -178.165 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.7 t -112.15 130.04 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 107.65 -1.241 . . . . 1.1799999999999999 107.65 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.401 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 1.7 tt -92.96 -11.11 34.09 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.239 1.019 . . . . 2.1800000000000002 111.735 -179.208 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.89 173.67 42.66 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 109.537 -1.425 . . . . 0.48999999999999999 109.537 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -126.2 132.49 51.75 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.992 -1.299 . . . . 0.64000000000000001 107.61 179.17 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 75.0 mt -132.48 106.86 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 106.133 -1.803 . . . . 1.21 106.133 178.366 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 203' ' ' VAL . 71.7 p -129.31 170.21 13.9 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 120.497 -1.377 . . . . 1.3799999999999999 110.018 -178.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 20.9 p-10 -99.01 53.23 0.97 Allowed 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 120.118 -0.633 . . . . 2.3700000000000001 110.881 179.433 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.33 156.14 17.78 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 108.887 -0.783 . . . . 1.52 108.887 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.59 -3.39 58.45 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.431 -1.366 . . . . 1.8 112.821 179.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 77.2 -40.22 1.7 Allowed Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.444 -1.36 . . . . 2.04 113.967 179.624 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.456 HH11 ' HG2' ' A' ' 186' ' ' ARG . 14.5 ttt-85 -61.31 127.06 29.69 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.996 -1.297 . . . . 5.0 109.019 179.037 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 10.5 p 46.38 28.94 0.78 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -0.859 . . . . 3.02 112.245 -179.541 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 42.4 t -83.07 130.04 35.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.922 -1.111 . . . . 2.1099999999999999 108.089 178.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -59.37 -40.74 87.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -0.925 . . . . 1.24 110.625 179.295 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -61.28 -40.72 95.2 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.631 -1.293 . . . . 2.1499999999999999 110.258 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 91.6 p -60.81 -36.16 78.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.231 -0.918 . . . . 2.02 110.455 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.84 -38.29 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.191 -0.943 . . . . 2.1200000000000001 110.186 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 67.1 mtp -63.18 -41.85 99.28 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.09 -1.006 . . . . 1.3600000000000001 109.639 179.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.06 -47.13 86.35 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.491 0.662 . . . . 1.29 111.14 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -59.99 -42.6 94.58 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.065 -1.022 . . . . 3.5600000000000001 110.623 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 31.5 m -70.18 -41.0 74.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 1.1799999999999999 110.007 179.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -90.44 -9.3 47.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.522 -0.736 . . . . 1.3400000000000001 111.841 -178.085 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 194' ' ' ALA . 54.3 mt-10 51.38 12.71 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 114.013 1.116 . . . . 1.45 114.013 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 42.9 mt -70.5 162.03 73.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.902 -1.124 . . . . 1.25 108.64 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -68.88 140.67 46.7 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.345 1.363 . . . . 0.78000000000000003 110.59 178.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.82 167.88 27.14 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 117.338 -1.745 . . . . 1.2 110.268 178.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 75.6 mt -143.48 157.57 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.257 -1.386 . . . . 1.25 107.257 178.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.0 m -138.59 -29.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.868 -1.145 . . . . 1.3899999999999999 112.736 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.25 44.69 2.69 Favored Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.273 -0.892 . . . . 0.96999999999999997 111.555 -178.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 33.5 p -66.31 -18.61 65.46 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.961 -1.317 . . . . 1.3500000000000001 110.841 -179.167 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.35 -94.91 0.74 Allowed Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.51 -1.328 . . . . 1.0700000000000001 110.123 179.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 207' ' ' SER . 22.5 t -126.43 28.19 6.02 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.304 -1.115 . . . . 1.9199999999999999 112.623 -178.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 84.6 t -59.05 -35.23 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.33 -1.482 . . . . 1.3300000000000001 110.592 179.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.4 p -55.31 -25.24 33.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.058 -1.026 . . . . 1.4199999999999999 111.378 -179.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t -93.89 1.05 56.45 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.141 -0.974 . . . . 2.1200000000000001 111.992 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -121.03 -6.1 9.51 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.18 0.808 . . . . 2.6899999999999999 113.18 -178.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 29.8 t -114.94 150.15 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.705 -0.622 . . . . 1.29 109.509 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -124.32 160.61 27.66 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.741 -1.207 . . . . 2.6899999999999999 107.741 177.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 10.2 m120 -54.79 140.88 34.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.581 -1.324 . . . . 2.79 110.981 178.541 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.5 m-20 79.03 4.9 2.33 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 114.73 1.381 . . . . 2.3500000000000001 114.73 179.173 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -65.26 142.55 58.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.702 -1.248 . . . . 1.97 108.479 177.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -85.94 115.68 23.71 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.584 -1.265 . . . . 2.9700000000000002 107.584 177.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 75.9 mt -125.19 143.61 50.85 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.767 0.794 . . . . 1.25 109.849 -178.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.2 mt -112.64 128.86 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 106.545 -1.65 . . . . 1.22 106.545 177.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.6 tp -103.55 114.48 28.79 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 105.954 -1.869 . . . . 1.24 105.954 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 223' ' ' VAL . 40.8 t0 -90.5 -25.06 20.47 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.945 -1.097 . . . . 2.0499999999999998 112.704 -177.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 38.56 14.12 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 113.128 0.788 . . . . 1.25 113.128 -179.051 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 221' ' ' ASP . 34.3 t -110.95 -61.24 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.054 -1.028 . . . . 1.4299999999999999 109.332 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -89.91 9.28 28.28 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.238 1.018 . . . . 3.0299999999999998 110.446 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.64 51.64 3.91 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.389 -0.823 . . . . 2.25 112.171 179.293 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -146.79 151.61 37.41 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.254 1.026 . . . . 2.52 109.789 179.025 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.56 139.09 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.54 -1.282 . . . . 1.29 107.54 177.412 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.76 130.48 49.73 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.06 -1.025 . . . . 1.3400000000000001 108.292 178.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.05 129.57 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.205 -1.035 . . . . 1.3400000000000001 108.205 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.434 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 10.9 t-20 52.24 51.29 9.42 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 113.365 0.876 . . . . 2.1800000000000002 113.365 179.128 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.2 Cg_endo -63.48 149.42 91.11 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.367 2.044 . . . . 0.93999999999999995 111.2 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.7 m -74.41 152.29 39.52 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.055 -1.028 . . . . 2.3999999999999999 109.098 177.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.82 -36.51 76.93 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.162 -0.961 . . . . 3.3300000000000001 110.302 178.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -59.45 -39.83 84.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.674 -0.641 . . . . 3.1699999999999999 110.293 179.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 98.5 t -71.69 -42.93 70.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.887 -1.133 . . . . 1.6899999999999999 109.867 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.584 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 89.5 mt -58.54 -47.8 87.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.419 -0.912 . . . . 1.6000000000000001 110.356 -179.033 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.81 -42.15 92.82 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.184 -0.948 . . . . 2.7000000000000002 110.631 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -61.52 -45.05 95.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.29 -0.881 . . . . 2.96 110.079 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.464 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 90.6 mtp -70.26 -38.03 75.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.398 -0.814 . . . . 1.6299999999999999 111.046 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -53.36 -42.18 66.57 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.822 -1.174 . . . . 3.27 110.767 -179.897 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.22 -59.99 2.55 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.163 -0.961 . . . . 2.23 110.691 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.05 -46.46 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.178 -0.951 . . . . 2.79 111.747 -179.049 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.464 ' CB ' ' O ' ' A' ' 239' ' ' MET . 42.4 tp60 -60.46 -47.75 84.76 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.976 -1.09 . . . . 4.2599999999999998 110.393 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.32 -30.91 70.79 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.195 -1.402 . . . . 1.8799999999999999 109.853 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.72 -30.2 69.82 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.945 -1.102 . . . . 3.3799999999999999 109.498 178.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 95.9 t -61.75 -42.46 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.45 -0.9 . . . . 2.8799999999999999 109.36 178.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.91 91.37 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.784 -0.766 . . . . 2.75 110.057 179.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.1 t -69.86 -36.83 75.83 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.996 0.903 . . . . 3.4199999999999999 110.134 -179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -63.94 -28.22 69.68 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.44 -0.787 . . . . 3.5699999999999998 110.956 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -59.58 -40.6 87.94 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.848 -0.532 . . . . 4.6100000000000003 110.246 179.14 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.93 -33.27 74.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 4.4500000000000002 109.972 179.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -72.74 -11.2 60.52 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.763 -0.585 . . . . 5.9699999999999998 111.998 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 51.8 tp -60.36 -30.3 69.47 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.288 -0.882 . . . . 6.4500000000000002 110.421 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -69.52 7.1 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.015 0.746 . . . . 6.6600000000000001 113.015 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -81.72 11.31 4.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.421 -0.8 . . . . 8.5399999999999991 112.691 179.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 77.0 mt -78.8 -12.86 60.04 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.251 -0.906 . . . . 8.0700000000000003 111.627 -179.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -87.3 -29.3 21.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.578 -0.701 . . . . 9.7200000000000006 111.78 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -95.05 -6.65 41.66 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.303 0.853 . . . . 10.119999999999999 113.303 -178.122 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 117.758 -1.115 . . . . 11.9 109.09 -178.444 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.249 -0.649 . . . . 3.5299999999999998 109.249 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.8 mt -106.27 87.9 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 107.568 -1.271 . . . . 1.5700000000000001 107.568 179.394 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 m -106.59 115.22 29.82 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.346 -1.724 . . . . 1.4399999999999999 106.346 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.8 -161.06 28.76 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.658 -1.377 . . . . 1.01 109.658 -179.496 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.457 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 92.7 mt -95.75 1.0 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.415 -1.05 . . . . 1.6299999999999999 112.69 -179.836 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tp 50.15 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.028 -1.045 . . . . 1.5800000000000001 112.27 178.596 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.43 -47.97 10.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.071 -1.018 . . . . 1.3400000000000001 111.274 179.15 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -143.53 146.14 34.36 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 107.83 -1.174 . . . . 1.8600000000000001 107.83 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.13 147.24 29.64 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.099 1.866 . . . . 1.01 112.14 178.549 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.42 147.31 4.64 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 119.732 -1.223 . . . . 0.81000000000000005 110.051 178.417 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 11' ' ' ILE . 84.9 mt -112.2 130.94 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.797 -1.413 . . . . 1.3700000000000001 108.352 179.261 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.18 149.65 46.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.88 -0.785 . . . . 1.1399999999999999 108.88 178.837 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.5 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.5 m-85 -118.58 139.45 51.46 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 107.652 -1.24 . . . . 0.87 107.652 177.352 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.8 169.53 42.49 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 118.585 -1.769 . . . . 0.56999999999999995 110.195 178.452 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HB3' ' HZ2' ' A' ' 15' ' ' LYS . 7.9 mtpm? -78.72 154.84 29.74 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.732 -0.864 . . . . 2.3500000000000001 109.281 178.042 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.88 133.35 35.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.12 -0.988 . . . . 1.21 109.007 178.071 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.5 tp -116.33 99.73 7.4 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.009 -1.848 . . . . 1.3999999999999999 106.009 178.123 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.523 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 11.7 tp -85.5 137.61 32.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.667 -1.234 . . . . 1.4399999999999999 107.667 179.659 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.4 mt -102.74 118.31 36.56 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 106.784 -1.561 . . . . 1.45 106.784 178.863 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -111.75 136.74 50.61 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.966 -1.124 . . . . 2.5 107.966 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -126.36 151.28 47.82 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.179 -0.95 . . . . 2.6600000000000001 109.706 179.009 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -82.44 135.99 35.03 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.622 -1.251 . . . . 2.3199999999999998 107.622 177.329 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -64.21 149.72 47.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 2.1099999999999999 109.159 178.792 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mt -88.19 130.1 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.914 -1.143 . . . . 1.29 107.914 177.826 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.2 t -108.57 129.13 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.794 -1.188 . . . . 1.4099999999999999 107.794 178.711 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.41 136.58 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.157 -1.053 . . . . 1.3100000000000001 108.157 179.233 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -90.54 120.68 31.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.734 -1.21 . . . . 1.3400000000000001 107.734 178.8 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.425 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.3 mmm-85 -96.17 11.19 35.24 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.198 -0.939 . . . . 3.48 112.667 -179.695 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -64.02 146.07 54.78 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.789 -1.194 . . . . 2.52 109.258 178.683 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.37 139.43 30.5 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.889 -1.152 . . . . 2.6299999999999999 107.889 177.708 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -100.75 164.39 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 122.014 0.911 . . . . 1.3100000000000001 109.904 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.6 p -96.64 165.26 12.23 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.3 0.571 . . . . 1.24 109.668 178.369 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.07 -22.13 15.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 1.49 112.045 179.176 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -68.64 -37.08 79.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.97 -1.081 . . . . 2.2799999999999998 110.8 -179.881 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -92.68 -5.79 50.62 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.052 -1.03 . . . . 2.0499999999999998 112.907 -179.315 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.3 t -59.88 -41.45 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.128 -0.982 . . . . 1.3400000000000001 110.615 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.4 -39.89 84.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.911 -1.118 . . . . 1.54 110.128 179.657 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -60.47 -38.25 83.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.612 -0.68 . . . . 2.8500000000000001 110.744 179.903 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.62 -40.96 89.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.003 -1.061 . . . . 1.3100000000000001 110.37 179.319 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.9 t -60.13 -43.6 93.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.158 -0.964 . . . . 1.3799999999999999 110.322 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -60.55 -43.62 97.02 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.238 -0.914 . . . . 1.5 109.974 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -60.62 -42.92 97.84 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.224 -0.99 . . . . 2.7799999999999998 109.914 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -73.22 -54.85 7.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.457 -0.777 . . . . 1.0600000000000001 110.016 179.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.6 tp -57.74 -47.76 81.53 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.761 -0.776 . . . . 1.3999999999999999 109.971 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.6 t -69.9 -41.17 75.07 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.447 -0.783 . . . . 1.3200000000000001 109.905 179.764 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.66 -43.11 94.5 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.284 -1.526 . . . . 0.69999999999999996 109.284 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -59.97 -29.93 68.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.359 -1.083 . . . . 3.4399999999999999 109.615 179.002 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.23 -49.93 75.97 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.723 -0.791 . . . . 1.3600000000000001 111.078 179.309 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -82.62 -38.53 23.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.239 -0.913 . . . . 2.8300000000000001 110.873 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.11 -44.54 91.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.905 -1.122 . . . . 1.23 109.766 -179.381 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.7 t -60.28 -38.18 82.79 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.212 1.006 . . . . 1.9199999999999999 109.348 179.603 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.89 78.5 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.845 -0.616 . . . . 1.25 110.326 179.47 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -61.68 -49.76 75.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 1.97 110.365 179.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.97 -40.37 93.12 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.985 0.898 . . . . 2.1800000000000002 109.656 179.777 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.11 -40.82 90.99 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.298 0.57 . . . . 1.1899999999999999 110.183 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.4 m -67.55 -41.42 84.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 1.3400000000000001 110.471 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 57' ' ' ILE . 97.4 mt -60.12 -38.35 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.481 -0.762 . . . . 1.23 110.712 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -50.92 -41.6 58.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.853 . . . . 1.5600000000000001 110.475 179.362 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.71 -37.23 76.49 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.908 -1.12 . . . . 1.3 109.988 -179.672 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -62.28 -38.93 91.22 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.343 -0.943 . . . . 2.3199999999999998 109.505 179.201 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.25 -30.08 68.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.68 -0.638 . . . . 1.1399999999999999 110.344 179.207 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.95 -37.12 11.86 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.024 -1.084 . . . . 0.68999999999999995 111.511 179.9 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -80.01 -28.18 39.44 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.071 -1.252 . . . . 1.48 110.895 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.4 m -84.57 -47.57 10.43 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.285 -0.884 . . . . 1.52 111.086 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -107.22 -10.84 15.73 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.547 0.943 . . . . 1.3100000000000001 113.547 -177.285 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.17 157.99 16.55 Favored Glycine 0 N--CA 1.501 2.968 0 O-C-N 121.269 -0.894 . . . . 0.84999999999999998 113.051 179.02 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -54.45 -21.66 10.49 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.736 -0.861 . . . . 3.8599999999999999 112.58 179.491 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -55.93 -36.87 68.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.019 -1.051 . . . . 2.3500000000000001 111.347 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -80.08 -22.26 42.43 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.1 -1.0 . . . . 2.2599999999999998 112.446 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.1 -35.66 75.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.806 -1.184 . . . . 1.45 111.39 -179.744 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.26 93.6 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.946 -1.096 . . . . 1.25 111.724 179.767 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.4 mt -66.83 -44.56 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.59 -1.319 . . . . 1.26 110.245 -179.786 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -70.15 -32.87 71.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.074 -1.016 . . . . 0.82999999999999996 110.207 -179.901 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.72 -36.61 79.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 1.1899999999999999 110.11 -179.781 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.93 -41.05 83.79 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 120.396 -0.907 . . . . 0.57999999999999996 110.964 179.401 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -58.68 -44.21 90.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.102 -1.234 . . . . 2.0499999999999998 110.81 179.562 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 77' ' ' ILE . 81.6 mt -60.61 -40.09 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.052 -1.03 . . . . 1.21 110.329 -179.999 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 34.2 ttp -60.21 -38.86 84.64 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.35 -0.844 . . . . 2.29 110.428 179.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -58.63 -48.81 79.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.19 -0.944 . . . . 1.21 109.919 179.111 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.01 -40.4 89.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.576 -0.702 . . . . 1.1399999999999999 110.376 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -86.16 10.85 13.3 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.386 -0.821 . . . . 1.4199999999999999 112.411 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.14 124.45 21.69 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.038 -1.039 . . . . 1.27 108.659 178.594 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.32 -19.64 65.57 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.746 0.784 . . . . 1.3500000000000001 110.819 -179.162 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -76.39 -52.96 8.85 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.762 -0.775 . . . . 2.2200000000000002 110.406 179.919 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -60.62 -41.26 94.46 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.256 -0.977 . . . . 1.22 110.495 -179.455 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -58.18 -48.62 79.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.939 -1.1 . . . . 1.29 110.58 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -62.28 -38.63 90.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.863 -1.148 . . . . 2.1699999999999999 110.873 -179.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.38 -48.37 67.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.989 -1.07 . . . . 1.3 110.999 179.694 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.8 mt -56.21 -43.47 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.066 -1.021 . . . . 1.1699999999999999 109.735 179.527 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.12 -44.03 99.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.317 0.579 . . . . 1.3999999999999999 110.515 179.874 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.37 -43.71 98.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 1.3300000000000001 110.772 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.32 -46.51 90.0 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.083 -1.011 . . . . 1.48 110.483 -179.787 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.65 -43.41 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 1.28 110.617 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -84.41 -33.68 23.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.729 -0.607 . . . . 2.6000000000000001 111.549 -179.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 91' ' ' ALA . 55.7 t0 -79.76 -42.34 24.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.914 -1.116 . . . . 1.51 111.209 -178.4 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -102.65 5.73 39.24 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 2.48 112.921 -177.946 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.9 m170 52.86 48.99 21.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.987 . . . . 1.6100000000000001 111.85 -179.495 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.27 158.27 17.62 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.418 -0.801 . . . . 1.8999999999999999 109.451 178.459 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.4 p -70.96 159.07 35.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.679 -0.638 . . . . 1.3200000000000001 109.414 177.808 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.2 -41.4 88.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 1.1499999999999999 110.8 178.743 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -68.27 -38.74 82.03 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.931 -1.106 . . . . 2.25 110.502 -179.82 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.91 -54.53 15.0 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.754 -0.778 . . . . 1.22 111.186 179.691 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.58 94.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.263 -0.898 . . . . 1.1899999999999999 110.408 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.34 88.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.445 -0.785 . . . . 1.2 110.442 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -60.14 -39.8 87.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 2.1000000000000001 111.081 -179.936 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.76 -48.0 82.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 1.3 110.69 179.628 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.32 -43.61 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.895 -1.128 . . . . 1.27 110.61 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mm -61.52 -32.38 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.649 -0.657 . . . . 1.1899999999999999 110.102 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -58.77 -40.66 84.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.51 -0.744 . . . . 2.1099999999999999 110.469 179.274 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.67 -28.3 27.07 Favored Glycine 0 N--CA 1.499 2.848 0 C-N-CA 119.495 -1.336 . . . . 0.88 113.482 179.724 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -63.68 -42.48 98.01 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.31 -1.7 . . . . 1.99 110.061 -179.841 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.24 -50.61 21.42 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.616 0.722 . . . . 1.28 110.468 -179.961 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.9 t -60.74 -37.53 82.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.314 -0.866 . . . . 2.2200000000000002 110.627 -179.66 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.24 97.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 1.45 110.901 179.769 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.12 -30.05 70.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.915 -1.116 . . . . 1.47 110.678 -179.748 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -65.71 -22.28 66.6 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.568 -0.707 . . . . 2.04 110.979 179.409 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -70.03 -21.49 63.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.518 -0.739 . . . . 1.73 110.963 179.563 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.2 mt -82.48 145.66 29.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.786 . . . . 1.79 109.544 178.391 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -100.09 39.9 1.3 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.402 -0.811 . . . . 2.8799999999999999 111.787 179.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -112.72 139.76 48.07 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.102 -0.999 . . . . 1.5800000000000001 108.923 178.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 42.1 mp0 -59.57 -38.9 82.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.558 -0.714 . . . . 3.04 111.064 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.494 ' HH ' ' NH1' ' A' ' 126' ' ' ARG . 7.6 t80 -70.96 -55.58 8.05 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.671 -1.268 . . . . 1.29 110.592 179.723 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.7 mt -59.8 -40.77 89.44 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.034 -1.041 . . . . 1.6000000000000001 110.371 -179.685 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -64.24 -49.81 70.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.066 . . . . 2.7599999999999998 109.511 179.599 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -60.37 -32.73 71.57 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.399 -0.921 . . . . 2.1499999999999999 109.468 179.76 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.494 ' NH1' ' HH ' ' A' ' 122' ' ' TYR . 56.5 ttt180 -63.83 -28.79 70.09 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.385 -0.926 . . . . 2.8100000000000001 109.529 179.165 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.27 -47.31 85.84 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 119.784 -0.766 . . . . 1.3899999999999999 109.335 178.453 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.55 88.57 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.486 -0.886 . . . . 1.4099999999999999 110.143 179.718 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.04 -32.39 73.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.821 . . . . 1.3899999999999999 110.694 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.24 -39.53 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 1.1899999999999999 110.161 179.684 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -55.33 -39.94 70.59 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.514 -1.275 . . . . 3.6299999999999999 109.17 178.609 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -60.59 -36.1 77.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.746 -0.596 . . . . 1.28 110.433 179.604 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.3 mt -60.33 -39.62 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.328 -0.858 . . . . 1.1799999999999999 110.389 179.856 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.01 72.31 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.426 -1.369 . . . . 0.51000000000000001 110.675 178.828 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -59.03 -40.79 86.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.429 -1.042 . . . . 3.1699999999999999 110.336 179.26 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.528 ' NH1' ' OG ' ' A' ' 166' ' ' SER . 24.7 mtp180 -60.99 -40.53 93.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 2.8500000000000001 109.693 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.59 -45.52 78.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.714 -0.616 . . . . 1.6499999999999999 110.279 179.953 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.3 mt -58.43 -41.99 86.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.227 -0.92 . . . . 1.2 110.637 179.671 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -61.03 -32.52 72.12 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.143 -0.973 . . . . 2.7999999999999998 111.022 -179.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -75.37 -43.82 48.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.906 -1.121 . . . . 2.1499999999999999 111.412 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 141' ' ' ILE . 95.7 mt -61.21 -35.8 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 1.21 110.905 -178.071 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.9 mt -85.47 -7.86 58.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.074 -1.016 . . . . 1.3400000000000001 112.119 -179.829 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.27 22.07 78.53 Favored Glycine 0 N--CA 1.479 1.521 0 C-N-CA 119.095 -1.526 . . . . 0.91000000000000003 113.053 -179.18 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.36 146.41 39.92 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.83 -0.806 . . . . 1.51 110.229 -179.621 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -67.74 148.26 51.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 2.8799999999999999 108.955 178.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 63.2 mt -102.32 139.23 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.785 -1.191 . . . . 1.6200000000000001 107.785 178.464 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.8 mp -77.52 132.72 32.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.386 -0.821 . . . . 2.1099999999999999 108.807 179.169 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -95.17 86.81 4.68 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.242 -1.392 . . . . 1.6200000000000001 107.242 179.349 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -75.76 -21.73 57.16 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.87 -0.732 . . . . 1.3999999999999999 111.33 -177.82 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.424 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 32.4 t -80.27 1.08 30.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.369 -0.832 . . . . 2.0499999999999998 112.445 179.598 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.54 24.72 7.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.561 -0.712 . . . . 1.3500000000000001 112.372 -179.08 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 15.1 mt -71.42 140.77 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.372 -0.83 . . . . 1.4199999999999999 109.646 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -114.9 -18.95 11.16 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.582 0.706 . . . . 2.9900000000000002 112.883 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -115.07 134.28 55.31 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.939 -1.134 . . . . 1.54 107.939 -179.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -73.36 126.22 29.65 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.271 -1.011 . . . . 1.3799999999999999 108.271 178.503 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -148.12 177.08 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 1.28 109.284 -179.615 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.7 mt -85.74 141.91 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 1.1599999999999999 108.651 178.111 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 24.2 tp -96.19 122.84 39.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.23 -0.919 . . . . 1.3100000000000001 108.886 178.446 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.88 129.96 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.917 -1.142 . . . . 1.25 107.917 179.754 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.16 155.27 22.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 1.26 109.048 179.152 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -60.72 -40.59 92.9 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.42 -1.425 . . . . 1.6000000000000001 109.358 177.992 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -171.04 151.13 3.19 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.739 -0.838 . . . . 2.4199999999999999 108.739 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 85.2 mt -118.7 139.31 51.74 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.001 -1.111 . . . . 1.3500000000000001 108.001 177.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.9 p -92.8 150.37 39.4 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.238 -0.914 . . . . 1.3200000000000001 108.77 178.844 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -39.8 -41.65 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.34 2.027 . . . . 0.69999999999999996 113.686 179.26 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.528 ' OG ' ' NH1' ' A' ' 136' ' ' ARG . 44.1 m -59.97 -48.26 82.43 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.062 -1.024 . . . . 1.1200000000000001 110.119 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -65.23 -40.06 93.55 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.409 -0.807 . . . . 1.21 110.245 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.468 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 43.4 p -67.84 -38.53 83.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.435 -0.791 . . . . 1.1899999999999999 110.3 179.97 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.61 80.59 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.182 -0.949 . . . . 1.24 110.529 179.624 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -95.05 -0.88 53.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.055 -1.028 . . . . 1.6899999999999999 113.133 -179.326 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.1 tp -62.98 150.42 42.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 1.3400000000000001 109.17 179.801 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 150' ' ' SER . 71.4 m-20 -95.31 112.92 24.56 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.146 -1.428 . . . . 2.77 107.146 177.686 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.93 -15.54 61.12 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.139 0.495 . . . . 2.0899999999999999 112.118 -178.106 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -83.72 -23.03 31.81 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.126 -0.984 . . . . 2.6699999999999999 112.612 -178.834 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -104.08 3.02 32.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.138 -0.976 . . . . 2.5800000000000001 112.877 -178.803 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.78 127.9 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.711 -1.218 . . . . 1.1799999999999999 107.711 179.556 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 16.1 tp -87.73 -5.47 58.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.504 -0.748 . . . . 2.1800000000000002 111.895 -179.427 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 165.7 175.01 35.82 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.797 -1.721 . . . . 0.48999999999999999 108.797 -179.367 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -130.58 137.39 49.64 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.814 -1.18 . . . . 0.64000000000000001 107.814 179.823 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 83.5 mt -137.48 110.86 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 106.688 -1.597 . . . . 1.21 106.688 178.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 203' ' ' VAL . 70.7 p -130.59 168.49 17.02 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.831 -1.168 . . . . 1.3799999999999999 109.829 -179.668 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 25.8 p-10 -101.7 50.42 0.85 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.626 -0.671 . . . . 2.3700000000000001 110.529 179.841 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.35 147.51 24.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.243 -0.911 . . . . 1.52 109.323 179.333 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.43 -16.03 19.46 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.804 -1.189 . . . . 1.8 112.36 179.204 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 80.7 -19.47 7.32 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 121.402 -1.058 . . . . 2.04 114.474 179.341 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -60.13 -39.88 87.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.161 -1.199 . . . . 5.0 110.569 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 31.1 p -139.84 34.87 1.97 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.587 -0.696 . . . . 3.02 111.195 -179.691 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.466 ' HG ' ' H ' ' A' ' 191' ' ' SER . 19.0 p -84.02 118.87 24.33 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.974 -1.121 . . . . 2.1099999999999999 107.974 178.877 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.468 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 76.3 t60 -60.11 -30.6 69.37 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.584 -0.697 . . . . 1.24 110.274 -179.549 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 40.0 m -59.41 -40.9 88.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.497 -0.752 . . . . 2.1499999999999999 110.392 179.225 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.466 ' H ' ' HG ' ' A' ' 188' ' ' SER . 83.3 p -59.97 -39.05 84.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.995 -1.066 . . . . 2.02 110.074 179.53 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 75.7 mt -59.94 -39.62 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.41 -0.916 . . . . 2.1200000000000001 110.516 179.41 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 56.5 mtp -62.43 -42.25 99.32 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.293 1.044 . . . . 1.3600000000000001 109.423 179.473 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.4 -46.28 86.72 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.646 -0.707 . . . . 1.29 110.776 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.406 ' HG2' HH11 ' A' ' 195' ' ' ARG . 46.8 mtt-85 -60.07 -43.78 95.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 3.5600000000000001 110.518 -179.945 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 51.2 m -68.92 -39.14 79.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.492 -0.755 . . . . 1.1799999999999999 110.316 -179.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.2 mt -90.86 -6.86 53.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.569 -0.707 . . . . 1.3400000000000001 112.729 -179.148 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 194' ' ' ALA . 43.6 mt-10 53.2 9.8 0.16 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.918 1.081 . . . . 1.45 113.918 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 34.8 mt -71.27 150.79 94.39 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.043 -1.036 . . . . 1.25 108.462 178.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.7 141.32 95.5 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.269 1.313 . . . . 0.78000000000000003 109.465 178.532 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.96 163.79 33.88 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.574 -1.651 . . . . 1.2 110.065 179.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.6 mt -148.69 152.36 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.919 -1.141 . . . . 1.25 107.919 178.321 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.3 m -135.1 -28.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 O-C-N 120.758 -1.214 . . . . 1.3899999999999999 111.657 179.568 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.46 40.12 2.56 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.161 -0.962 . . . . 0.96999999999999997 112.219 -178.993 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 51.5 p -60.96 -18.73 58.82 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.988 -1.301 . . . . 1.3500000000000001 111.42 -179.261 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 77.15 -93.41 1.08 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.971 -1.109 . . . . 1.0700000000000001 110.501 179.539 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 47.8 p -128.8 27.3 5.48 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.472 -1.017 . . . . 1.9199999999999999 112.597 -178.767 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 83.8 t -59.23 -33.99 52.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.686 -1.259 . . . . 1.3300000000000001 110.872 179.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 44.2 p -59.71 -23.08 62.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.095 -1.003 . . . . 1.4199999999999999 111.729 -179.813 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 37.6 t -93.27 1.01 57.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 2.1200000000000001 112.113 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -126.29 0.46 7.05 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.847 0.684 . . . . 2.6899999999999999 112.847 -178.281 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 32.0 t -116.11 145.55 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.587 -0.696 . . . . 1.29 109.34 179.772 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -119.92 161.33 21.05 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.486 -0.931 . . . . 2.6899999999999999 108.486 177.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 18' ' ' LEU . 73.6 m-80 -59.57 142.27 53.1 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 120.749 -1.219 . . . . 2.79 110.639 179.159 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.6 t70 80.61 1.04 1.87 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.496 1.295 . . . . 2.3500000000000001 114.496 179.438 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -63.66 148.57 48.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.622 -1.298 . . . . 1.97 108.549 177.706 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -91.69 118.11 30.35 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 106.477 -1.675 . . . . 2.9700000000000002 106.477 177.698 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 82.3 mt -126.84 144.64 50.91 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.663 0.744 . . . . 1.25 109.867 -178.536 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.3 mt -114.15 127.37 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.711 -1.588 . . . . 1.22 106.711 177.567 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.9 tp -99.58 115.31 29.09 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 105.82 -1.918 . . . . 1.24 105.82 178.272 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 223' ' ' VAL . 28.7 t0 -89.13 -26.95 21.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.024 -1.047 . . . . 2.0499999999999998 111.701 -178.197 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 38.28 20.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.598 -0.689 . . . . 1.25 112.666 -179.28 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 221' ' ' ASP . 17.3 t -112.33 -59.77 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 122.065 0.936 . . . . 1.4299999999999999 109.522 179.573 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -99.58 14.39 30.16 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.933 0.873 . . . . 3.0299999999999998 110.87 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 45.6 t30 61.22 50.99 4.52 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 116.031 -0.531 . . . . 2.25 112.195 179.163 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -147.06 147.91 31.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.049 -1.032 . . . . 2.52 109.605 178.431 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.05 139.12 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 107.821 -1.177 . . . . 1.29 107.821 178.114 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -99.74 133.29 44.31 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.966 -1.084 . . . . 1.3400000000000001 108.419 178.394 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.0 t -110.57 130.87 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.589 -0.694 . . . . 1.3400000000000001 109.381 179.23 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.426 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 58.7 t30 52.23 51.52 9.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 113.596 0.962 . . . . 2.1800000000000002 113.596 178.117 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 55.9 Cg_endo -69.88 152.51 68.73 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.729 2.286 . . . . 0.93999999999999995 110.59 179.879 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.402 ' HG1' ' H ' ' A' ' 235' ' ' VAL . 1.3 p -73.64 161.76 29.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.669 -1.269 . . . . 2.3999999999999999 109.914 178.216 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -59.87 -38.39 82.06 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.192 -0.942 . . . . 3.3300000000000001 110.216 178.737 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.83 -41.37 91.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.59 -0.694 . . . . 3.1699999999999999 109.913 179.179 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.402 ' H ' ' HG1' ' A' ' 232' ' ' THR . 86.1 t -70.55 -43.11 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.448 -0.783 . . . . 1.6899999999999999 110.492 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.553 ' CG2' HH12 ' A' ' 240' ' ' ARG . 73.6 mt -58.33 -48.56 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 118.803 -1.159 . . . . 1.6000000000000001 109.829 -178.709 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -59.83 -40.9 90.04 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.726 -0.79 . . . . 2.7000000000000002 109.824 179.392 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -61.82 -41.56 97.94 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.415 -0.803 . . . . 2.96 110.18 179.827 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 72.5 mtp -71.55 -32.14 67.79 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.34 -0.85 . . . . 1.6299999999999999 110.548 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.58 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -55.81 -40.66 73.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 3.27 109.863 179.587 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 245' ' ' GLN . . . -72.59 -39.64 67.19 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.551 -0.718 . . . . 2.23 110.917 -179.884 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 79.5 t -51.0 -51.97 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.743 -1.223 . . . . 2.79 111.705 -179.34 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -63.47 -50.0 71.43 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.748 -1.22 . . . . 4.2599999999999998 109.566 179.916 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -61.65 -35.6 78.41 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.631 -0.827 . . . . 1.8799999999999999 110.252 -179.876 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 249' ' ' GLU . 80.2 mt-30 -65.45 -27.81 68.78 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.403 -0.919 . . . . 3.3799999999999999 110.291 179.18 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 52.6 t -60.41 -42.67 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 119.187 -1.005 . . . . 2.8799999999999999 109.554 178.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.3 -44.91 88.77 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.606 -1.238 . . . . 2.75 109.055 179.071 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.2 t -77.21 -25.08 51.33 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.453 0.644 . . . . 3.4199999999999999 111.058 -179.9 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 245' ' ' GLN . 29.3 tp10 -61.96 -30.05 70.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.659 -0.65 . . . . 3.5699999999999998 111.479 -179.791 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -61.41 -38.67 87.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.023 -1.048 . . . . 4.6100000000000003 110.244 179.565 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.67 -19.87 63.59 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.113 -0.992 . . . . 4.4500000000000002 111.341 179.605 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -71.66 -13.07 61.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.822 -0.549 . . . . 5.9699999999999998 111.979 -179.432 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.94 -30.67 70.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.993 -1.067 . . . . 6.4500000000000002 110.826 -179.434 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -69.9 -14.19 62.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.11 -0.994 . . . . 6.6600000000000001 112.08 179.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -89.11 26.02 1.7 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.437 -0.789 . . . . 8.5399999999999991 113.031 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 15.0 tp -74.34 -10.97 60.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 8.0700000000000003 112.414 179.211 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -87.92 1.92 52.89 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.571 -1.33 . . . . 9.7200000000000006 112.498 -179.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.5 -0.99 57.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.855 -1.153 . . . . 10.119999999999999 112.59 -179.467 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.939 -1.029 . . . . 11.9 108.78 -178.25 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.0 mtp . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 110.129 -0.323 . . . . 3.5299999999999998 110.129 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 93.0 mt -96.66 112.94 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.36 -1.718 . . . . 1.5700000000000001 106.36 176.66 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.7 m -102.5 120.57 40.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.364 -0.976 . . . . 1.4399999999999999 108.364 -179.717 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.31 -142.82 11.45 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.791 -1.724 . . . . 1.01 108.791 179.498 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 81.5 mt -100.53 -1.0 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.984 -1.304 . . . . 1.6299999999999999 113.399 -178.893 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 tp 49.35 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.659 -1.276 . . . . 1.5800000000000001 112.312 178.556 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.54 -39.87 16.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.259 -0.9 . . . . 1.3400000000000001 111.029 179.307 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -149.06 145.68 19.96 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.105 -1.072 . . . . 1.8600000000000001 108.105 -179.126 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.95 148.14 31.35 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.849 2.366 . . . . 1.01 112.436 178.585 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.422 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 153.73 152.13 5.96 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 109.817 -1.313 . . . . 0.81000000000000005 109.817 178.088 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 11' ' ' ILE . 82.4 mt -118.04 130.17 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.199 -1.177 . . . . 1.3700000000000001 108.072 179.183 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.53 143.89 43.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.315 -0.865 . . . . 1.1399999999999999 109.024 179.006 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.557 ' CE2' ' OE1' ' A' ' 243' ' ' GLN . 45.6 m-85 -110.07 138.27 46.68 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.596 -1.261 . . . . 0.87 107.596 177.346 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.0 169.73 42.45 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 117.708 -2.187 . . . . 0.56999999999999995 110.4 178.154 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -79.56 159.68 26.76 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.776 -0.824 . . . . 2.3500000000000001 108.776 177.922 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.6 130.31 34.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.094 -1.004 . . . . 1.21 109.11 178.152 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.8 tp -109.46 107.51 17.68 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 104.917 -2.253 . . . . 1.3999999999999999 104.917 176.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 tp -94.2 132.79 38.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.105 -0.997 . . . . 1.4399999999999999 108.977 -179.833 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.3 mt -100.93 122.22 43.1 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.417 -1.327 . . . . 1.45 107.417 178.437 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.408 ' CB ' ' HZ1' ' A' ' 20' ' ' LYS . 8.9 mtpm? -108.81 131.31 55.1 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.25 -1.018 . . . . 2.5 108.25 179.521 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.485 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 83.5 tt0 -111.34 140.38 45.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.554 -0.716 . . . . 2.6600000000000001 109.471 179.073 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -83.87 129.32 34.93 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.412 -1.329 . . . . 2.3199999999999998 107.412 177.893 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -65.9 143.62 57.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.85 . . . . 2.1099999999999999 109.153 179.342 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.0 mt -96.55 135.47 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.506 -0.924 . . . . 1.29 108.506 178.587 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.49 130.19 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.376 -0.972 . . . . 1.4099999999999999 108.376 178.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.2 mt -97.57 141.24 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.644 -0.873 . . . . 1.3100000000000001 108.644 179.325 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -89.77 120.67 31.23 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.755 -1.202 . . . . 1.3400000000000001 107.755 178.083 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.482 ' HG2' HH11 ' A' ' 28' ' ' ARG . 2.1 mmt-85 -95.19 12.49 28.65 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.256 -0.902 . . . . 3.48 112.605 179.635 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -66.98 146.64 54.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.878 -1.139 . . . . 2.52 109.533 178.879 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -90.18 135.37 33.71 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.964 -1.125 . . . . 2.6299999999999999 107.964 178.032 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.0 pt -100.43 164.76 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.285 -0.884 . . . . 1.3100000000000001 110.321 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.5 p -94.86 164.89 12.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.475 -0.565 . . . . 1.24 109.475 178.4 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.85 -20.23 14.7 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.116 -0.99 . . . . 1.49 112.088 179.35 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -68.9 -39.14 79.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.038 -1.039 . . . . 2.2799999999999998 110.986 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -87.22 -9.24 55.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.62 -1.3 . . . . 2.0499999999999998 112.423 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.23 -43.2 89.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.186 -0.947 . . . . 1.3400000000000001 110.557 -179.394 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -56.65 -40.66 75.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.853 -1.154 . . . . 1.54 110.607 179.548 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -65.04 -46.76 79.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.195 -0.94 . . . . 2.8500000000000001 110.957 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.29 -36.19 79.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.954 -1.092 . . . . 1.3100000000000001 111.17 -179.772 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.84 -40.81 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.933 -1.104 . . . . 1.3799999999999999 110.541 179.287 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -61.12 -41.06 96.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.006 -1.059 . . . . 1.5 109.981 179.673 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.8 mtt-85 -61.15 -39.32 89.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.844 . . . . 2.7799999999999998 110.695 -179.933 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -72.82 -57.04 4.37 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.38 -0.825 . . . . 1.0600000000000001 110.76 179.517 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.8 tp -59.89 -47.53 85.38 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.314 -0.954 . . . . 1.3999999999999999 110.088 -179.724 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.3 t -67.88 -36.17 79.78 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.75 0.786 . . . . 1.3200000000000001 109.88 179.855 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.19 -43.15 99.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.864 -1.294 . . . . 0.69999999999999996 109.864 178.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -59.54 -30.55 68.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.02 0.915 . . . . 3.4399999999999999 109.344 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.72 -43.11 90.06 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.814 0.816 . . . . 1.3600000000000001 109.511 179.056 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HZ1' ' NE2' ' A' ' 53' ' ' GLN . 24.1 ttpp -80.34 -45.88 17.05 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.434 -0.791 . . . . 2.8300000000000001 110.837 179.374 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.64 -41.57 81.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.585 -0.697 . . . . 1.23 110.022 179.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.3 p -61.88 -37.16 83.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.119 0.961 . . . . 1.9199999999999999 109.17 179.765 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.4 -50.2 48.16 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.753 -0.658 . . . . 1.25 110.531 179.454 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.401 ' NE2' ' HZ1' ' A' ' 49' ' ' LYS . 96.0 mt-30 -63.53 -48.43 77.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.447 -0.783 . . . . 1.97 110.578 -179.865 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.7 mt -61.2 -38.21 85.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 2.1800000000000002 110.01 179.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -59.78 -39.98 86.72 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.666 -0.646 . . . . 1.1899999999999999 110.713 179.113 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -65.1 -44.16 89.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.781 -1.2 . . . . 1.3400000000000001 110.243 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.1 -31.97 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.754 . . . . 1.23 110.186 179.791 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -52.07 -47.08 65.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.604 -0.685 . . . . 1.5600000000000001 110.61 179.075 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -68.77 -33.78 74.46 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.744 -1.222 . . . . 1.3 109.843 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -62.15 -39.45 92.67 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.531 -1.267 . . . . 2.3199999999999998 109.363 179.173 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.84 88.9 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.348 -0.845 . . . . 1.1399999999999999 109.988 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.93 -37.95 42.59 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.573 -1.298 . . . . 0.68999999999999995 110.476 179.474 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -81.57 -22.46 37.78 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.087 -1.243 . . . . 1.48 111.131 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.8 m -84.74 -46.05 11.8 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.548 -0.72 . . . . 1.52 110.907 179.941 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -106.5 -23.68 12.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.441 -0.787 . . . . 1.3100000000000001 112.229 -178.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.21 168.97 15.28 Favored Glycine 0 N--CA 1.499 2.889 0 CA-C-O 121.785 0.659 . . . . 0.84999999999999998 111.665 -179.534 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -55.68 -28.2 54.26 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.415 -1.05 . . . . 3.8599999999999999 112.717 -179.652 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -57.65 -39.91 78.09 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.911 -1.118 . . . . 2.3500000000000001 111.356 -179.718 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -88.59 -14.53 37.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.618 -1.301 . . . . 2.2599999999999998 112.385 -178.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -60.07 -38.72 83.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.872 . . . . 1.45 110.948 -179.25 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.38 82.97 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.167 -0.958 . . . . 1.25 111.245 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.3 mt -63.14 -43.5 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.572 -1.33 . . . . 1.26 110.475 179.696 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -68.97 -33.28 73.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.968 -1.083 . . . . 0.82999999999999996 110.001 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.02 -38.84 83.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 1.1899999999999999 110.114 179.365 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.82 -38.14 94.06 Favored Glycine 0 N--CA 1.486 1.985 0 C-N-CA 120.137 -1.03 . . . . 0.57999999999999996 110.585 179.552 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -57.16 -42.33 80.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.841 -1.388 . . . . 2.0499999999999998 110.284 179.368 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.2 mt -60.34 -41.59 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.08 -1.012 . . . . 1.21 109.556 179.641 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.1 ttm -60.19 -39.82 87.88 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 2.29 109.803 179.562 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -58.28 -50.0 75.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.413 -0.804 . . . . 1.21 110.45 178.996 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.67 -40.34 91.75 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.331 -0.856 . . . . 1.1399999999999999 110.402 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -87.72 5.62 38.97 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.87 0.693 . . . . 1.4199999999999999 112.87 -179.62 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.31 122.82 15.47 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.911 -1.118 . . . . 1.27 109.581 179.3 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -66.16 -16.29 63.85 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.686 0.755 . . . . 1.3500000000000001 110.749 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -77.06 -49.17 15.92 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.496 -0.882 . . . . 2.2200000000000002 110.523 179.94 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.21 -38.29 90.58 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.386 -0.925 . . . . 1.22 110.24 -178.305 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.88 -47.88 83.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.023 -1.048 . . . . 1.29 111.282 179.314 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -60.7 -39.26 87.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.883 -1.136 . . . . 2.1699999999999999 110.663 -179.721 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.7 -48.48 71.85 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.575 -0.85 . . . . 1.3 110.638 179.692 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.96 -41.6 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.222 -0.991 . . . . 1.1699999999999999 109.914 179.494 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.81 -42.81 95.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.352 -0.842 . . . . 1.3999999999999999 110.297 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.88 98.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 1.3300000000000001 110.67 -179.965 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.02 -43.06 95.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 1.48 110.442 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.51 -49.08 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.988 -1.07 . . . . 1.28 110.159 179.817 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -76.66 -35.47 57.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 2.6000000000000001 111.824 -179.524 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -80.77 -48.25 12.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.887 -1.133 . . . . 1.51 111.98 -179.643 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -101.41 8.69 42.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.227 -0.921 . . . . 2.48 112.994 -178.658 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.5 m80 51.56 49.36 21.06 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.024 -1.071 . . . . 1.6100000000000001 111.426 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.9 mtt -104.86 149.43 25.69 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.435 1.112 . . . . 1.8999999999999999 109.052 179.834 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.5 p -72.62 159.63 33.56 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.59 0.709 . . . . 1.3200000000000001 109.433 177.81 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.33 81.79 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.51 -0.744 . . . . 1.1499999999999999 110.646 178.627 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.4 p-10 -68.54 -42.31 78.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.977 -1.077 . . . . 2.25 110.268 -179.792 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -70.74 -51.46 27.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.332 -0.855 . . . . 1.22 111.386 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.99 84.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.499 -0.751 . . . . 1.1899999999999999 110.528 -179.616 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.6 96.53 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.82 -0.752 . . . . 1.2 111.127 179.658 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -60.42 -39.37 87.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.829 -1.169 . . . . 2.1000000000000001 110.782 179.942 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -54.83 -49.75 70.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.129 -0.982 . . . . 1.3 110.761 179.701 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.1 -42.28 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.718 -1.239 . . . . 1.27 109.853 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.5 mm -61.76 -32.02 52.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.541 -0.724 . . . . 1.1899999999999999 110.356 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.14 -41.75 89.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 2.1099999999999999 110.388 179.083 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.09 -31.68 19.47 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.063 -1.542 . . . . 0.88 112.279 -179.896 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -62.16 -41.88 98.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.414 -1.639 . . . . 1.99 109.635 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.59 -51.26 20.48 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.982 0.896 . . . . 1.28 109.713 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.6 t -60.19 -39.93 88.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.358 -0.839 . . . . 2.2200000000000002 110.176 -179.802 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.32 98.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.176 -0.952 . . . . 1.45 110.454 -179.808 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.84 -30.61 71.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.966 -1.084 . . . . 1.47 110.224 179.988 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -66.53 -22.2 66.16 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.342 -0.849 . . . . 2.04 110.877 179.712 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.39 -20.45 64.68 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.415 -0.914 . . . . 1.73 110.625 179.511 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 38.8 mt -83.15 142.41 31.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.441 -0.787 . . . . 1.79 109.321 178.362 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -101.4 40.01 1.35 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.398 -0.814 . . . . 2.8799999999999999 111.078 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -112.75 133.48 54.74 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.609 -0.886 . . . . 1.5800000000000001 108.609 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.557 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 5.7 pm0 -60.5 -28.09 68.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.095 -1.003 . . . . 3.04 111.553 179.552 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -74.25 -59.54 2.68 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.072 -1.017 . . . . 1.29 110.027 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.0 mt -66.26 -35.73 81.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 1.6000000000000001 110.642 -179.554 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -61.81 -48.51 80.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.803 -1.185 . . . . 2.7599999999999998 110.396 179.466 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -59.74 -30.24 68.71 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.589 -1.244 . . . . 2.1499999999999999 109.649 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -62.27 -29.19 70.24 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.22 -0.992 . . . . 2.8100000000000001 109.17 179.306 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.17 -49.75 76.39 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.868 0.842 . . . . 1.3899999999999999 109.805 178.361 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.23 75.92 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.676 -0.809 . . . . 1.4099999999999999 110.234 179.854 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -61.22 -34.08 74.53 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.635 0.731 . . . . 1.3899999999999999 110.648 -179.884 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.6 t -68.95 -37.28 77.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.324 -0.86 . . . . 1.1899999999999999 110.033 179.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.406 ' HG2' HH11 ' A' ' 131' ' ' ARG . 22.9 ttt-85 -57.93 -38.31 75.69 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.471 -1.292 . . . . 3.6299999999999999 109.429 178.656 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.498 ' OD1' ' NE ' ' A' ' 136' ' ' ARG . 8.3 t70 -60.11 -40.06 88.35 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.396 0.617 . . . . 1.28 110.568 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 73.1 mt -61.41 -34.68 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.378 -0.826 . . . . 1.1799999999999999 110.18 -179.611 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -64.91 -51.4 51.66 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.131 -1.033 . . . . 0.51000000000000001 110.657 178.783 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -57.9 -40.37 80.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.87 -1.371 . . . . 3.1699999999999999 110.467 179.547 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.498 ' NE ' ' OD1' ' A' ' 132' ' ' ASP . 58.5 mtt-85 -60.5 -43.24 97.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.998 -1.064 . . . . 2.8500000000000001 110.131 -179.979 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.5 tp -61.26 -44.57 97.03 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.087 -1.008 . . . . 1.6499999999999999 110.224 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.09 -42.4 90.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.553 -0.717 . . . . 1.2 110.547 179.666 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.485 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 98.1 mtt180 -61.38 -34.42 75.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.159 -0.963 . . . . 2.7999999999999998 111.206 -179.851 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -74.06 -43.4 57.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.557 -1.339 . . . . 2.1499999999999999 110.618 179.827 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 141' ' ' ILE . 90.4 mt -60.9 -39.38 81.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.52 -0.737 . . . . 1.21 110.455 -178.521 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.4 mt -88.84 -11.65 44.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.532 -0.73 . . . . 1.3400000000000001 111.996 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.4 22.83 69.44 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 120.323 -0.941 . . . . 0.91000000000000003 113.581 -179.542 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.39 142.9 58.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.58 -0.953 . . . . 1.51 109.534 179.647 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -68.05 151.94 46.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.894 . . . . 2.8799999999999999 110.307 178.377 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.7 mt -104.58 136.89 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.033 -1.099 . . . . 1.6200000000000001 108.033 178.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.502 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.9 mp -81.86 129.62 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.979 -1.119 . . . . 2.1099999999999999 107.979 179.125 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -95.85 98.68 10.61 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.067 -1.827 . . . . 1.6200000000000001 106.067 178.873 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.7 mt -77.37 -14.28 59.75 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.529 -0.732 . . . . 1.3999999999999999 111.775 -177.745 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.6 t -80.1 8.32 7.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.379 -0.826 . . . . 2.0499999999999998 112.323 -179.574 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.34 17.22 17.91 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.647 0.737 . . . . 1.3500000000000001 112.315 179.565 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.4 mt -73.22 136.2 25.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.942 -0.762 . . . . 1.4199999999999999 108.942 179.0 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -124.29 -7.25 7.62 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.547 -0.721 . . . . 2.9900000000000002 112.651 -178.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -110.63 137.5 48.23 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.06 -1.089 . . . . 1.54 108.06 179.794 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -77.25 119.82 21.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.247 -0.908 . . . . 1.3799999999999999 108.695 178.851 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.2 m -148.12 179.49 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.835 -0.802 . . . . 1.28 108.835 -178.965 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 30.6 mt -88.33 142.86 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.991 -1.068 . . . . 1.1599999999999999 108.943 178.212 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.0 tp -98.02 120.5 38.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.816 -1.178 . . . . 1.3100000000000001 108.141 178.251 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.24 130.15 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.418 -0.956 . . . . 1.25 108.418 179.397 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.36 159.14 27.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.243 -0.911 . . . . 1.26 108.752 179.534 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.03 95.6 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.494 -1.378 . . . . 1.6000000000000001 109.778 177.855 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -172.67 152.65 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.906 -0.775 . . . . 2.4199999999999999 108.906 -179.744 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 64.9 mt -118.99 141.33 48.77 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.315 -0.866 . . . . 1.3500000000000001 109.09 177.383 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.9 p -90.55 148.82 39.59 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.182 -0.949 . . . . 1.3200000000000001 108.919 179.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -40.15 -45.52 4.06 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.645 2.23 . . . . 0.69999999999999996 113.891 179.142 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.0 m -60.09 -46.3 90.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.918 -1.114 . . . . 1.1200000000000001 110.063 -179.607 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.41 -38.49 91.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.27 -0.894 . . . . 1.21 110.331 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.438 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 23.8 p -67.61 -40.75 84.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 1.1899999999999999 110.83 179.662 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.3 74.41 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.791 -0.764 . . . . 1.24 110.339 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -93.38 -4.85 50.72 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.007 -1.058 . . . . 1.6899999999999999 112.862 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.23 153.45 34.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 1.3400000000000001 109.631 179.878 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -94.13 117.33 29.96 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.292 -1.744 . . . . 2.77 106.292 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.438 ' H ' ' CD2' ' A' ' 173' ' ' LEU . 0.7 OUTLIER -82.46 -19.47 38.81 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.472 -0.767 . . . . 2.0899999999999999 112.396 -177.701 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -84.23 -20.87 31.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.238 -0.913 . . . . 2.6699999999999999 111.912 -178.569 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -99.96 2.32 43.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.187 -0.946 . . . . 2.5800000000000001 112.528 -179.254 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.4 t -112.99 129.95 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 107.873 -1.158 . . . . 1.1799999999999999 107.873 179.352 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.413 ' CD1' ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -82.81 -16.35 48.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.007 -1.058 . . . . 2.1800000000000002 111.705 -179.541 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -176.69 171.33 44.27 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.073 -1.611 . . . . 0.48999999999999999 109.073 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -125.79 124.56 41.26 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 107.344 -1.354 . . . . 0.64000000000000001 107.344 178.196 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 46.6 mt -123.27 129.75 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 106.952 -1.499 . . . . 1.21 106.952 178.215 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 203' ' ' VAL . 34.2 p -140.61 170.0 16.6 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.907 -1.12 . . . . 1.3799999999999999 109.802 179.772 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.94 36.08 3.0 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.871 -0.518 . . . . 2.3700000000000001 111.007 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -96.87 151.53 19.58 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.191 -0.943 . . . . 1.52 110.352 178.75 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -46.33 -28.36 3.23 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 120.162 -1.018 . . . . 1.8 112.609 177.696 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 87.69 -33.12 4.03 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 121.037 -1.272 . . . . 2.04 113.625 179.406 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -60.44 -40.65 91.86 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.007 -1.29 . . . . 5.0 110.346 179.709 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.4 p -118.38 20.18 13.16 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.52 -0.737 . . . . 3.02 111.208 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.3 p -89.11 120.46 30.53 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.772 -1.196 . . . . 2.1099999999999999 107.772 178.771 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.438 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 77.4 t60 -60.46 -32.27 71.23 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.388 -0.82 . . . . 1.24 110.407 179.827 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 63.0 p -54.68 -41.11 69.82 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.037 -1.039 . . . . 2.1499999999999999 110.68 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.3 t -60.02 -39.83 87.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.298 -0.876 . . . . 2.02 109.918 179.818 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.1 mm -59.72 -36.36 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.74 . . . . 2.1200000000000001 110.392 179.119 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 82.5 mtp -63.0 -43.53 98.54 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.225 1.012 . . . . 1.3600000000000001 109.209 179.509 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -57.38 -45.09 84.83 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.691 -0.631 . . . . 1.29 110.656 179.538 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -63.23 -44.95 93.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.95 -1.093 . . . . 3.5600000000000001 110.435 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.2 m -70.3 -40.88 74.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.913 . . . . 1.1799999999999999 110.257 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.8 mt -91.21 -6.36 53.5 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.494 0.664 . . . . 1.3400000000000001 112.242 -177.145 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 194' ' ' ALA . 98.0 mt-10 50.54 9.42 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.991 1.108 . . . . 1.45 113.991 179.899 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.455 ' O ' ' OG ' ' A' ' 8' ' ' SER . 80.9 mt -71.63 147.67 92.31 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.675 -1.266 . . . . 1.25 108.212 179.113 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.52 138.76 81.37 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.454 1.436 . . . . 0.78000000000000003 110.227 178.66 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.54 166.67 20.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.312 -1.755 . . . . 1.2 109.865 179.694 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.4 mt -146.25 156.03 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.188 -1.412 . . . . 1.25 107.188 177.541 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.0 m -140.38 -32.37 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 120.742 -1.224 . . . . 1.3899999999999999 113.035 -179.166 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -95.28 39.87 2.78 Favored Glycine 0 N--CA 1.497 2.744 0 O-C-N 120.942 -1.099 . . . . 0.96999999999999997 112.076 -177.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 23.1 p -59.21 -23.75 62.55 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.089 -1.242 . . . . 1.3500000000000001 111.799 -179.482 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 101.78 -86.16 0.58 Allowed Glycine 0 N--CA 1.496 2.654 0 C-N-CA 120.396 -0.907 . . . . 1.0700000000000001 111.345 179.807 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.7 m -132.58 36.56 3.55 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 121.124 -1.221 . . . . 1.9199999999999999 113.16 -178.529 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 93.1 t -53.06 -33.83 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.336 -1.477 . . . . 1.3300000000000001 110.396 179.252 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.2 p -61.31 -20.62 63.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 1.4199999999999999 112.018 -179.675 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.2 m -96.08 2.72 53.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.057 -1.027 . . . . 2.1200000000000001 112.289 179.63 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -132.05 2.97 4.01 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 112.907 0.706 . . . . 2.6899999999999999 112.907 -178.281 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 36.0 t -122.54 142.43 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.439 -0.788 . . . . 1.29 109.658 -178.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -119.27 149.15 42.25 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.261 -1.014 . . . . 2.6899999999999999 108.261 177.596 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.464 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 40.3 p-10 -50.73 140.16 15.21 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.876 -1.14 . . . . 2.79 110.023 178.688 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t0 79.62 -2.07 2.13 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.482 1.29 . . . . 2.3500000000000001 114.482 179.639 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.09 147.0 53.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.532 -1.355 . . . . 1.97 108.233 177.632 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -88.67 120.84 30.43 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.184 -1.413 . . . . 2.9700000000000002 107.184 178.274 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 56.6 mt -128.14 146.41 50.72 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.55 -0.719 . . . . 1.25 109.854 -179.56 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.5 mt -114.07 125.02 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 106.788 -1.56 . . . . 1.22 106.788 177.522 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.0 tp -99.86 115.26 29.2 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.315 -1.735 . . . . 1.24 106.315 178.528 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 223' ' ' VAL . 30.0 p-10 -92.72 -25.53 18.17 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.663 -1.215 . . . . 2.0499999999999998 112.664 -177.848 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.531 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 38.47 21.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 112.903 0.705 . . . . 1.25 112.903 -178.659 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.3 t -112.79 -59.67 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 121.116 -0.99 . . . . 1.4299999999999999 109.451 -179.876 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 36.7 m120 -95.79 13.5 26.39 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.148 0.975 . . . . 3.0299999999999998 110.096 -179.701 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 60.76 51.82 4.66 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.23 -0.895 . . . . 2.25 111.85 179.326 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.451 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 81.2 mt-30 -149.54 148.17 29.05 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.246 1.022 . . . . 2.52 110.079 178.454 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.54 138.07 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.312 -1.366 . . . . 1.29 107.312 177.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -99.58 136.92 38.79 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.933 -1.104 . . . . 1.3400000000000001 108.516 178.694 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.7 t -109.82 130.18 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 109.001 -0.741 . . . . 1.3400000000000001 109.001 179.135 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 49.42 55.6 17.31 Favored Pre-proline 0 N--CA 1.498 1.973 0 N-CA-C 113.566 0.95 . . . . 2.1800000000000002 113.566 178.792 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.08 150.66 82.39 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.474 2.116 . . . . 0.93999999999999995 110.412 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 31.1 p -72.08 154.55 41.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 2.3999999999999999 108.915 177.647 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -57.39 -40.14 77.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.058 -1.026 . . . . 3.3300000000000001 110.8 178.952 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -60.96 -39.04 88.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -0.984 . . . . 3.1699999999999999 110.332 -179.852 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.6 t -69.38 -36.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.331 -0.856 . . . . 1.6899999999999999 110.038 179.413 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.5 mt -59.16 -46.01 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 1.6000000000000001 110.462 178.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -59.66 -40.56 88.16 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.07 -1.052 . . . . 2.7000000000000002 109.969 179.491 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -61.17 -40.08 92.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.527 -0.733 . . . . 2.96 110.221 179.834 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 76.9 mtp -70.84 -33.78 71.01 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.36 -0.838 . . . . 1.6299999999999999 110.5 -179.807 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.539 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.1 OUTLIER -56.46 -41.14 76.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.942 -1.098 . . . . 3.27 109.364 179.619 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.05 -42.52 66.18 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.677 -0.639 . . . . 2.23 110.209 179.794 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 72.9 t -59.69 -48.76 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.388 -0.82 . . . . 2.79 110.452 -178.265 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 13' ' ' PHE . 51.5 tt0 -59.98 -50.59 73.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.622 -1.298 . . . . 4.2599999999999998 110.591 179.816 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.05 -31.08 72.13 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.188 -1.005 . . . . 1.8799999999999999 109.711 -179.747 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -62.81 -30.29 71.36 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.512 -0.875 . . . . 3.3799999999999999 109.138 178.755 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.24 -40.08 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.406 -0.917 . . . . 2.8799999999999999 109.192 178.792 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.6 -38.15 71.64 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.871 -1.132 . . . . 2.75 109.357 179.029 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.3 t -68.12 -30.45 69.61 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.42 0.629 . . . . 3.4199999999999999 109.645 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -63.48 -29.28 70.58 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.524 0.678 . . . . 3.5699999999999998 110.85 179.555 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -61.54 -28.38 69.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.425 -0.797 . . . . 4.6100000000000003 111.172 179.479 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -65.67 -10.76 39.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 4.4500000000000002 111.879 179.634 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.16 -7.97 52.11 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.277 -0.889 . . . . 5.9699999999999998 112.529 -179.396 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 34.4 tp -63.74 -24.64 67.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.125 -0.984 . . . . 6.4500000000000002 111.265 -179.258 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -70.12 -1.25 9.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.154 -0.966 . . . . 6.6600000000000001 112.657 179.844 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -82.04 11.85 4.76 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.181 -0.949 . . . . 8.5399999999999991 112.488 -179.346 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.449 ' CD2' ' H ' ' A' ' 256' ' ' LEU . 0.7 OUTLIER -82.09 9.4 8.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.117 -0.99 . . . . 8.0700000000000003 112.454 179.626 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -81.86 -2.3 50.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.989 . . . . 9.7200000000000006 111.919 -179.796 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -93.91 -1.6 54.5 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.301 -0.874 . . . . 10.119999999999999 112.628 -177.993 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 42.9 mtm-85 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.094 -0.955 . . . . 11.9 109.202 -178.839 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.087 -0.708 . . . . 3.5299999999999998 109.087 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.0 mt -102.24 109.53 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.018 -1.845 . . . . 1.5700000000000001 106.018 176.481 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.3 m -105.85 124.06 48.96 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.661 -1.236 . . . . 1.4399999999999999 107.661 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.506 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -104.51 -144.44 13.14 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 108.88 -1.688 . . . . 1.01 108.88 179.527 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.441 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 73.1 mt -97.28 -3.77 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.146 -1.208 . . . . 1.6299999999999999 112.635 -179.085 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tp 49.77 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.226 -0.921 . . . . 1.5800000000000001 112.437 178.947 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.58 -40.07 16.67 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.0 . . . . 1.3400000000000001 112.152 178.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 m -147.02 144.9 20.55 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 120.982 -1.074 . . . . 1.8600000000000001 108.379 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.53 143.95 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.724 2.283 . . . . 1.01 112.127 178.246 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.08 171.41 21.73 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.319 -1.512 . . . . 0.81000000000000005 109.319 178.189 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.8 mt -129.92 133.8 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 N-CA-C 107.702 -1.222 . . . . 1.3700000000000001 107.702 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.38 155.52 47.6 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.564 -0.71 . . . . 1.1399999999999999 109.119 178.742 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.571 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.9 m-85 -126.46 140.18 52.67 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.681 -1.229 . . . . 0.87 107.681 177.97 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.83 170.5 41.78 Favored Glycine 0 N--CA 1.499 2.882 0 C-N-CA 118.382 -1.866 . . . . 0.56999999999999995 110.297 178.175 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -77.12 154.26 33.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.965 . . . . 2.3500000000000001 108.938 178.502 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -85.03 125.79 33.02 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.233 -1.025 . . . . 1.21 108.233 178.373 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.3 tp -105.49 105.92 16.19 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.458 -2.053 . . . . 1.3999999999999999 105.458 177.659 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.6 tp -94.18 135.39 35.61 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.957 -1.127 . . . . 1.4399999999999999 107.957 179.96 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.4 mt -99.36 114.94 28.11 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.832 -1.544 . . . . 1.45 106.832 178.353 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -110.38 124.41 51.65 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.626 -1.62 . . . . 2.5 106.626 -179.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -129.77 147.52 51.55 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.418 -0.801 . . . . 2.6600000000000001 109.39 -179.493 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 27.6 p-10 -81.55 140.9 34.24 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.912 -1.118 . . . . 2.3199999999999998 109.088 177.807 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -64.69 149.94 48.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.04 -1.038 . . . . 2.1099999999999999 110.976 178.283 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.9 mt -90.8 133.8 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.15 -0.969 . . . . 1.29 108.811 178.15 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.3 t -109.29 129.79 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.225 -1.028 . . . . 1.4099999999999999 108.225 179.119 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.0 mt -94.66 137.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.127 -1.064 . . . . 1.3100000000000001 108.127 178.778 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.95 122.44 35.32 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.977 -1.12 . . . . 1.3400000000000001 107.977 178.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -99.56 18.12 18.72 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.342 -0.849 . . . . 3.48 112.631 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -69.18 146.79 52.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 2.52 109.428 178.738 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -88.98 130.88 35.38 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.329 -0.989 . . . . 2.6299999999999999 108.329 177.669 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.7 pt -93.33 164.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.751 0.786 . . . . 1.3100000000000001 110.066 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.2 p -95.41 163.85 13.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.587 -0.695 . . . . 1.24 109.659 178.525 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.8 -22.3 13.9 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.113 -0.992 . . . . 1.49 111.91 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -68.69 -37.06 79.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.932 . . . . 2.2799999999999998 110.54 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -92.29 -6.31 50.6 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.791 -1.193 . . . . 2.0499999999999998 113.174 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.31 -42.98 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.055 -1.028 . . . . 1.3400000000000001 110.576 -179.433 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.36 -37.55 75.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.137 -0.977 . . . . 1.54 110.263 179.726 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -61.93 -43.92 97.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.646 -0.659 . . . . 2.8500000000000001 110.847 179.906 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.47 -39.12 86.49 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.045 -1.035 . . . . 1.3100000000000001 111.367 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.26 -40.19 83.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.045 -1.035 . . . . 1.3799999999999999 110.757 179.429 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -60.95 -48.32 82.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.155 -0.965 . . . . 1.5 110.064 179.663 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -62.17 -38.31 88.55 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.167 -0.958 . . . . 2.7799999999999998 110.278 179.842 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -74.16 -51.03 16.81 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.858 -1.151 . . . . 1.0600000000000001 110.285 179.437 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.4 tp -62.81 -49.67 74.0 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.29 -0.964 . . . . 1.3999999999999999 109.448 -179.622 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.7 t -69.3 -38.77 78.46 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.505 0.669 . . . . 1.3200000000000001 109.653 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.09 -43.54 93.29 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.601 -1.4 . . . . 0.69999999999999996 109.601 179.629 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -59.31 -31.74 69.43 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.07 -1.052 . . . . 3.4399999999999999 109.644 178.871 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.78 -47.67 70.53 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.835 -0.746 . . . . 1.3600000000000001 109.919 179.089 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -77.78 -39.77 42.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 2.8300000000000001 110.344 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.76 91.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 1.23 110.049 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.555 ' HG ' ' N ' ' A' ' 52' ' ' ALA . 59.5 p -60.47 -39.6 88.18 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.223 1.011 . . . . 1.9199999999999999 109.357 179.942 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.555 ' N ' ' HG ' ' A' ' 51' ' ' SER . . . -68.12 -46.02 72.06 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.602 -0.727 . . . . 1.25 110.942 179.494 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.5 -50.09 72.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.222 -0.924 . . . . 1.97 110.753 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.21 -36.83 84.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 2.1800000000000002 109.844 -179.889 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -59.39 -40.24 85.95 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.639 -0.663 . . . . 1.1899999999999999 110.53 179.155 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.9 m -66.89 -41.69 86.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.047 -1.033 . . . . 1.3400000000000001 110.324 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.3 -34.03 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.439 -0.788 . . . . 1.23 110.834 -179.703 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -55.93 -45.02 78.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.412 -0.805 . . . . 1.5600000000000001 111.018 179.301 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.49 -33.44 71.23 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.003 -1.061 . . . . 1.3 110.545 -179.626 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.401 ' O ' ' OG1' ' A' ' 64' ' ' THR . 44.4 mtpt -62.75 -40.27 96.7 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.653 -1.219 . . . . 2.3199999999999998 109.443 -179.844 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.72 -34.52 78.03 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.776 -0.577 . . . . 1.1399999999999999 110.363 179.679 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.88 -37.52 25.7 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.536 -1.316 . . . . 0.68999999999999995 111.41 179.701 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -79.88 -22.31 43.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.036 -1.273 . . . . 1.48 110.815 -179.676 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 27.1 m -89.43 -50.96 5.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.363 -0.836 . . . . 1.52 110.597 179.853 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -108.34 -6.99 16.0 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.143 1.164 . . . . 1.3100000000000001 114.143 -177.543 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.6 157.48 23.58 Favored Glycine 0 N--CA 1.502 3.072 0 O-C-N 121.056 -1.028 . . . . 0.84999999999999998 113.473 178.519 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -51.03 -20.69 1.48 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.498 -1.001 . . . . 3.8599999999999999 112.791 179.197 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.49 -35.31 72.03 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.822 -1.174 . . . . 2.3500000000000001 111.489 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -84.16 -18.85 35.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.021 -1.049 . . . . 2.2599999999999998 112.494 -179.555 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.96 -32.71 71.07 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.975 -1.078 . . . . 1.45 110.636 -179.372 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.51 86.88 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.038 -1.039 . . . . 1.25 110.598 179.329 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.0 mt -66.33 -47.66 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.118 -0.989 . . . . 1.26 109.828 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -72.04 -36.54 69.65 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.219 -0.925 . . . . 0.82999999999999996 110.018 179.822 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.92 -39.11 84.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.493 -0.754 . . . . 1.1899999999999999 110.074 -179.966 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.01 -35.37 83.92 Favored Glycine 0 N--CA 1.484 1.867 0 C-N-CA 119.795 -1.193 . . . . 0.57999999999999996 110.491 179.579 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -60.22 -41.27 92.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -1.135 . . . . 2.0499999999999998 110.542 179.117 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.4 mt -60.96 -41.94 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.025 -1.047 . . . . 1.21 110.423 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.0 ttm -59.77 -40.57 88.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -0.866 . . . . 2.29 110.576 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -60.39 -46.32 90.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.914 -1.116 . . . . 1.21 110.032 179.799 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.0 tp -59.0 -40.36 84.65 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.402 -0.811 . . . . 1.1399999999999999 110.487 179.81 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -87.08 8.01 25.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.506 -0.746 . . . . 1.4199999999999999 112.685 -179.887 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -60.26 118.94 7.01 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.185 -0.947 . . . . 1.27 109.61 179.609 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.57 -18.36 63.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.772 0.796 . . . . 1.3500000000000001 110.954 -179.532 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.82 -52.79 8.33 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.747 -0.781 . . . . 2.2200000000000002 110.401 -179.918 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.4 mt -61.24 -37.87 84.62 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.18 -1.008 . . . . 1.22 110.441 -179.529 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -58.88 -48.6 80.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 1.29 110.497 179.216 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.4 -38.81 91.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.285 -0.884 . . . . 2.1699999999999999 110.476 179.814 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.78 -48.17 72.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.991 -1.068 . . . . 1.3 110.503 179.713 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 93.1 mt -58.29 -42.09 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.252 -0.905 . . . . 1.1699999999999999 109.973 179.419 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.2 mt -63.43 -41.39 92.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.466 -0.772 . . . . 1.3999999999999999 110.167 179.797 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -63.26 -42.93 99.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.426 -0.796 . . . . 1.3300000000000001 110.664 -179.778 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.0 mt -59.66 -43.72 93.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 1.48 110.492 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.56 -48.2 89.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.051 -1.031 . . . . 1.28 109.911 179.72 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.94 -36.23 41.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.783 . . . . 2.6000000000000001 111.709 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 91' ' ' ALA . 53.1 t0 -78.94 -48.29 14.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.709 -1.244 . . . . 1.51 111.315 -178.985 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -101.32 8.65 42.27 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.311 -0.868 . . . . 2.48 112.358 -177.685 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m80 50.67 51.31 17.18 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.972 -1.091 . . . . 1.6100000000000001 111.568 179.892 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.9 mtp -107.79 157.0 18.51 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.55 -0.719 . . . . 1.8999999999999999 109.239 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 27.2 p -73.95 158.76 33.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.606 -0.684 . . . . 1.3200000000000001 109.407 177.784 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.75 91.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.485 -0.76 . . . . 1.1499999999999999 110.613 179.347 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 28.8 p-10 -68.05 -42.84 79.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.953 -1.092 . . . . 2.25 110.014 179.314 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -68.28 -50.64 52.34 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.461 -0.896 . . . . 1.22 110.734 -179.885 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.24 88.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 1.1899999999999999 110.592 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.69 -45.65 91.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 1.2 111.39 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -60.45 -39.24 86.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.792 -1.192 . . . . 2.1000000000000001 111.539 -179.686 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.49 -47.89 78.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.693 -1.255 . . . . 1.3 111.031 179.597 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.18 -44.25 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.723 -1.235 . . . . 1.27 109.742 179.854 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -62.74 -34.7 67.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.631 -0.668 . . . . 1.1899999999999999 110.755 179.998 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -56.6 -40.55 75.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.845 . . . . 2.1099999999999999 111.214 179.469 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.21 -34.07 13.26 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.201 -1.476 . . . . 0.88 112.91 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -59.97 -38.26 82.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.398 -1.648 . . . . 1.99 110.04 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.04 -47.23 38.2 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.722 0.773 . . . . 1.28 110.704 179.599 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.7 m -60.37 -40.17 89.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.092 -1.005 . . . . 2.2200000000000002 110.599 -178.585 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.6 -47.16 86.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.377 -0.827 . . . . 1.45 110.929 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.12 -29.76 69.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.881 -1.137 . . . . 1.47 110.837 -179.829 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -65.06 -22.35 66.96 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.342 -0.849 . . . . 2.04 110.571 179.437 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -71.1 -12.94 61.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.909 0.862 . . . . 1.73 110.815 179.87 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.5 mt -88.49 135.86 33.27 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.806 -1.183 . . . . 1.79 107.806 178.712 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 45.6 t0 -97.99 40.99 1.14 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.388 -0.82 . . . . 2.8799999999999999 111.98 -179.381 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -114.53 140.38 48.81 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 121.007 -1.058 . . . . 1.5800000000000001 108.966 178.987 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.07 -40.35 73.46 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.871 -0.732 . . . . 3.04 110.816 178.557 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -71.23 -56.88 5.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.102 -0.999 . . . . 1.29 110.59 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.62 -40.5 83.51 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.19 -0.944 . . . . 1.6000000000000001 110.41 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -63.31 -47.77 80.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.02 -1.05 . . . . 2.7599999999999998 109.794 179.866 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -60.17 -31.15 69.85 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.213 -0.929 . . . . 2.1499999999999999 110.092 179.715 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -61.66 -30.07 70.48 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.552 -1.259 . . . . 2.8100000000000001 109.262 179.269 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.78 -50.38 73.69 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.74 -0.784 . . . . 1.3899999999999999 109.423 178.682 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.55 -43.42 80.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.679 0.752 . . . . 1.4099999999999999 110.315 179.769 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -62.8 -32.7 73.94 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.671 0.748 . . . . 1.3899999999999999 110.283 -179.691 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 t -68.69 -39.63 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.419 -0.801 . . . . 1.1899999999999999 110.097 179.589 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -59.48 -37.45 78.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.057 -1.027 . . . . 3.6299999999999999 109.764 178.852 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -59.92 -40.16 87.93 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.484 0.659 . . . . 1.28 110.259 179.436 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.6 mt -59.57 -39.8 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 1.1799999999999999 110.456 179.598 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.33 -45.51 69.09 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 110.54 -1.024 . . . . 0.51000000000000001 110.54 179.388 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -59.15 -46.77 87.5 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.059 -1.259 . . . . 3.1699999999999999 110.208 179.41 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 64.4 mtt-85 -62.22 -38.89 90.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.888 -1.132 . . . . 2.8500000000000001 110.273 179.751 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.0 tp -60.15 -41.02 91.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.682 -0.637 . . . . 1.6499999999999999 109.852 178.911 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.3 mt -59.66 -40.05 86.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.606 -0.684 . . . . 1.2 110.58 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -60.28 -39.21 86.08 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.206 -0.934 . . . . 2.7999999999999998 111.256 179.942 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -73.56 -41.62 62.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.108 . . . . 2.1499999999999999 110.985 -179.866 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.33 -40.08 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.849 . . . . 1.21 110.548 -178.436 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.3 mt -89.32 -8.0 54.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.031 -1.043 . . . . 1.3400000000000001 111.891 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.57 23.22 70.79 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.761 -1.209 . . . . 0.91000000000000003 113.518 -179.511 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 18.6 tp -67.23 139.91 57.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.934 -0.745 . . . . 1.51 109.115 179.578 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -70.03 146.97 50.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.421 -0.799 . . . . 2.8799999999999999 109.357 177.892 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 79.7 mt -108.68 138.67 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 121.128 -0.982 . . . . 1.6200000000000001 108.619 178.746 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.467 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.1 mp -78.66 131.65 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.702 -1.249 . . . . 2.1099999999999999 108.808 178.888 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -94.51 97.37 10.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.396 -1.705 . . . . 1.6200000000000001 106.396 178.686 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 mt -77.58 -13.37 59.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.473 -0.767 . . . . 1.3999999999999999 111.916 -177.861 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.8 t -82.9 3.33 30.27 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.906 -1.121 . . . . 2.0499999999999998 112.584 -179.734 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.5 15.26 22.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.316 -0.865 . . . . 1.3500000000000001 112.31 179.451 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 24.6 mt -71.93 140.05 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.565 -0.71 . . . . 1.4199999999999999 109.591 178.801 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -127.91 -6.71 5.56 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.717 0.77 . . . . 2.9900000000000002 112.323 -179.436 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -110.2 140.21 44.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.571 -0.9 . . . . 1.54 108.571 179.459 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -71.61 120.84 17.77 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.589 -0.893 . . . . 1.3799999999999999 108.589 178.403 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.51 171.74 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.985 -0.746 . . . . 1.28 108.985 -179.864 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.3 mt -93.18 141.12 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.295 -1.002 . . . . 1.1599999999999999 108.295 178.275 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 26.8 tp -96.79 120.98 38.13 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.0 -1.063 . . . . 1.3100000000000001 108.627 178.46 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.21 131.15 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 107.816 -1.179 . . . . 1.25 107.816 179.781 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.94 157.98 21.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.018 . . . . 1.26 108.785 179.084 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.35 -34.45 75.31 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.303 -1.498 . . . . 1.6000000000000001 109.474 178.079 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -173.04 154.91 2.91 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.827 -0.805 . . . . 2.4199999999999999 108.827 179.574 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 69.0 mt -121.64 137.81 54.59 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.375 -1.343 . . . . 1.3500000000000001 107.375 177.519 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.8 p -93.45 148.24 35.17 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.843 -1.161 . . . . 1.3200000000000001 108.676 179.529 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -39.72 -40.99 2.52 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 122.066 1.844 . . . . 0.69999999999999996 113.485 178.811 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.4 m -60.98 -50.23 74.22 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.254 -0.903 . . . . 1.1200000000000001 110.238 -179.727 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -61.61 -38.55 88.0 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.952 -1.093 . . . . 1.21 109.704 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.61 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 38.4 p -68.61 -36.93 79.32 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.335 0.588 . . . . 1.1899999999999999 110.639 179.524 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.36 -35.02 79.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.402 -0.811 . . . . 1.24 110.64 179.869 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -97.26 -0.6 46.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.477 -0.764 . . . . 1.6899999999999999 112.503 -179.08 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.6 tp -64.21 153.72 37.12 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.735 -0.603 . . . . 1.3400000000000001 109.646 179.749 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.13 113.15 24.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 106.848 -1.538 . . . . 2.77 106.848 177.615 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.36 -17.0 60.88 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.873 -0.517 . . . . 2.0899999999999999 112.356 -178.018 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -84.63 -15.43 45.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.105 -0.997 . . . . 2.6699999999999999 112.421 -178.574 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -103.69 -9.7 18.93 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.685 0.994 . . . . 2.5800000000000001 113.685 -178.032 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.3 t -109.51 129.98 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.768 -0.827 . . . . 1.1799999999999999 108.768 179.666 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.421 ' CD1' ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -88.07 -11.56 46.78 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.075 -1.016 . . . . 2.1800000000000002 111.827 -179.428 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -173.8 167.78 40.43 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.292 -1.523 . . . . 0.48999999999999999 109.292 179.807 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -124.15 131.99 53.59 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.218 -1.166 . . . . 0.64000000000000001 107.995 178.586 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.5 mt -131.49 132.14 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.019 -1.104 . . . . 1.21 108.019 178.795 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 203' ' ' VAL . 55.5 p -135.5 163.37 30.23 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.192 -1.04 . . . . 1.3799999999999999 108.192 178.08 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.452 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 17.6 m-20 -106.51 12.35 29.65 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.248 -0.908 . . . . 2.3700000000000001 112.133 179.065 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 184' ' ' GLY . . . -134.66 -62.5 0.73 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.154 -0.966 . . . . 1.52 113.184 -177.068 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 183' ' ' ALA . . . -38.27 151.22 0.04 OUTLIER Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.453 -0.659 . . . . 1.8 111.453 -176.443 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 172.2 -70.3 0.11 Allowed Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.194 -1.479 . . . . 2.04 112.516 179.343 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.415 ' O ' ' CG2' ' A' ' 187' ' ' THR . 57.7 mtp180 -54.61 -42.2 70.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -1.223 . . . . 5.0 110.755 -178.915 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 186' ' ' ARG . 31.2 p -159.08 45.73 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.825 . . . . 3.02 111.114 -179.498 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.0 p -78.85 136.94 37.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.908 -1.12 . . . . 2.1099999999999999 109.355 -179.476 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.61 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 75.6 t60 -60.14 -30.86 69.57 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.627 -0.671 . . . . 1.24 110.492 178.863 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.4 m -59.43 -39.6 84.05 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.152 -0.968 . . . . 2.1499999999999999 110.028 179.424 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 87.0 p -59.52 -37.56 78.68 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.271 -0.893 . . . . 2.02 110.281 179.366 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.09 -39.75 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 2.1200000000000001 110.493 179.48 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 45.0 mtp -61.74 -44.31 97.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.994 -1.067 . . . . 1.3600000000000001 109.524 179.484 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.72 -50.58 72.91 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.373 -0.83 . . . . 1.29 111.187 179.992 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -60.57 -42.75 97.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.025 -1.047 . . . . 3.5600000000000001 110.886 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.7 m -69.98 -38.44 76.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.932 -1.105 . . . . 1.1799999999999999 110.521 179.968 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.9 mt -91.66 -8.48 47.0 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.686 0.755 . . . . 1.3400000000000001 112.918 -179.222 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 194' ' ' ALA . 93.8 mt-10 56.75 9.88 0.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.244 1.201 . . . . 1.45 114.244 179.725 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.7 mt -71.41 149.49 93.8 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.945 -1.097 . . . . 1.25 108.086 179.167 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.76 140.22 94.09 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.376 1.384 . . . . 0.78000000000000003 109.86 178.741 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.26 163.66 35.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.206 -1.559 . . . . 1.2 110.132 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 11.8 mt -150.25 158.15 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.343 -1.354 . . . . 1.25 107.343 178.17 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 181' ' ' THR . 7.0 m -146.78 -25.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 O-C-N 119.958 -1.714 . . . . 1.3899999999999999 113.672 -179.578 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -100.93 43.64 1.7 Allowed Glycine 0 N--CA 1.5 2.948 0 O-C-N 120.886 -1.134 . . . . 0.96999999999999997 110.564 -178.679 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.452 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 33.5 p -63.05 -21.02 65.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.08 -1.247 . . . . 1.3500000000000001 111.658 -179.651 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.84 -83.01 0.51 Allowed Glycine 0 N--CA 1.499 2.88 0 O-C-N 121.518 -0.739 . . . . 1.0700000000000001 111.32 179.148 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 77.7 p -134.82 31.67 3.31 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.843 -1.386 . . . . 1.9199999999999999 113.256 -178.58 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.447 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 78.8 t -60.05 -37.92 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.173 -1.58 . . . . 1.3300000000000001 110.645 179.576 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 51.9 p -60.12 -18.97 51.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.174 -0.954 . . . . 1.4199999999999999 112.474 -179.623 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.7 m -94.31 -0.27 55.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 2.1200000000000001 112.213 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -131.53 8.35 4.58 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.627 -0.671 . . . . 2.6899999999999999 112.545 -178.161 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.85 148.63 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.601 -0.687 . . . . 1.29 109.625 -179.146 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.445 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 13.7 mptt -119.01 150.25 40.26 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.939 -1.134 . . . . 2.6899999999999999 107.939 177.857 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 49.6 p-10 -55.68 142.69 33.17 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.899 -1.125 . . . . 2.79 110.374 178.414 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 m-20 80.34 -1.8 1.95 Allowed 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 114.276 1.213 . . . . 2.3500000000000001 114.276 179.289 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 98.8 m-20 -63.14 147.63 50.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.921 -1.112 . . . . 1.97 108.816 177.718 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -88.64 118.35 28.25 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.362 -1.461 . . . . 2.9700000000000002 107.274 177.782 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 84.2 mt -128.22 150.34 50.07 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.837 -0.539 . . . . 1.25 109.788 -179.26 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.37 127.92 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 106.964 -1.495 . . . . 1.22 106.964 177.79 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.7 tp -100.35 119.92 39.16 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.005 -1.48 . . . . 1.24 107.005 178.478 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.638 ' O ' ' N ' ' A' ' 223' ' ' VAL . 34.4 t0 -92.35 -25.37 18.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.771 -1.206 . . . . 2.0499999999999998 112.258 -177.873 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 39.34 11.11 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.025 0.75 . . . . 1.25 113.025 -179.077 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.6 t -110.45 -62.27 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 120.836 -1.165 . . . . 1.4299999999999999 109.108 179.776 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -88.52 5.9 40.44 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.213 1.006 . . . . 3.0299999999999998 110.23 -179.804 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.506 HD22 ' H ' ' A' ' 4' ' ' GLY . 1.0 OUTLIER 62.73 52.39 2.8 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.208 -0.905 . . . . 2.25 112.184 179.355 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -145.54 150.51 36.55 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.279 1.038 . . . . 2.52 109.973 178.111 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.11 138.23 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.29 -1.374 . . . . 1.29 107.29 178.261 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -103.51 130.92 50.99 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.174 -1.047 . . . . 1.3400000000000001 108.174 178.463 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 30.2 t -109.2 129.8 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 107.789 -1.189 . . . . 1.3400000000000001 107.789 178.815 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.442 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 19.4 t-20 54.26 49.98 6.27 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 2.1800000000000002 113.47 178.764 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.4 Cg_endo -68.4 150.27 75.68 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.847 2.365 . . . . 0.93999999999999995 110.608 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.8 p -73.74 160.59 31.3 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.805 -1.184 . . . . 2.3999999999999999 110.137 178.238 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.37 -41.62 89.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.537 -0.727 . . . . 3.3300000000000001 110.702 179.046 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -61.94 -34.93 77.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.257 -0.902 . . . . 3.1699999999999999 110.586 -179.804 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.21 -37.4 76.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.965 -1.084 . . . . 1.6899999999999999 109.865 179.386 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.4 mt -58.29 -45.19 89.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.127 -0.983 . . . . 1.6000000000000001 110.386 179.066 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -58.48 -39.98 81.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 2.7000000000000002 110.489 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -61.63 -45.52 93.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.4 -0.813 . . . . 2.96 110.664 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 75.5 mtp -72.3 -35.52 68.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.036 -1.04 . . . . 1.6299999999999999 110.596 -179.697 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -57.46 -37.62 73.15 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.125 -0.985 . . . . 3.27 110.664 -179.904 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -69.27 -46.08 68.13 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.44 -0.904 . . . . 2.23 110.669 179.748 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 95.9 t -59.88 -47.72 90.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.111 -0.993 . . . . 2.79 111.817 -179.445 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.64 -49.32 78.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.765 -1.209 . . . . 4.2599999999999998 111.191 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.51 -36.63 84.39 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.21 -0.931 . . . . 1.8799999999999999 111.692 -179.455 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -61.22 -28.76 69.38 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.076 -1.449 . . . . 3.3799999999999999 110.041 179.426 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.04 -41.83 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.762 -0.775 . . . . 2.8799999999999999 110.368 178.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.09 -38.64 83.54 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.749 0.785 . . . . 2.75 110.233 179.566 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.8 t -68.69 -31.01 69.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.381 -0.824 . . . . 3.4199999999999999 110.863 179.761 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -62.24 -41.39 98.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.094 -1.004 . . . . 3.5699999999999998 110.507 179.631 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -68.52 -38.58 81.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 4.6100000000000003 110.491 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.49 -3.28 33.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.432 -0.793 . . . . 4.4500000000000002 112.368 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -70.85 -14.4 62.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.26 -0.9 . . . . 5.9699999999999998 112.034 -178.527 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.06 -39.62 86.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.673 -1.267 . . . . 6.4500000000000002 109.939 -179.9 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -71.5 -24.7 62.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 6.6600000000000001 110.832 179.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -88.45 32.95 0.76 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.135 0.969 . . . . 8.5399999999999991 112.153 -179.865 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.33 6.79 7.56 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.748 0.785 . . . . 8.0700000000000003 112.529 -179.675 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -81.24 -3.27 51.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 9.7200000000000006 112.399 179.809 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -96.83 -54.73 3.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.206 -0.934 . . . . 10.119999999999999 111.05 -179.438 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 117.928 -1.034 . . . . 11.9 108.806 -178.996 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.2 mtp . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.891 -0.411 . . . . 3.5299999999999998 109.891 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.8 mt -93.08 107.86 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 105.869 -1.9 . . . . 1.5700000000000001 105.869 177.315 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.8 m -106.93 120.28 41.62 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.929 -1.137 . . . . 1.4399999999999999 107.929 -179.358 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.62 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -100.94 -156.21 27.25 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.602 -1.799 . . . . 1.01 108.602 179.496 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.497 ' CD1' ' O ' ' A' ' 184' ' ' GLY . 67.4 mt -96.88 1.41 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -1.209 . . . . 1.6299999999999999 112.713 -179.507 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 tp 48.82 98.11 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.044 -1.035 . . . . 1.5800000000000001 112.674 178.565 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.28 -39.16 15.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 1.3400000000000001 110.842 179.364 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -146.55 144.66 21.19 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.049 -1.093 . . . . 1.8600000000000001 108.049 -179.454 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.87 145.32 25.17 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.396 2.064 . . . . 1.01 111.917 178.307 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 152.96 174.36 23.28 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.803 -1.719 . . . . 0.81000000000000005 108.803 178.116 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 11' ' ' ILE . 93.9 mt -131.28 139.59 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.846 -1.168 . . . . 1.3700000000000001 107.846 179.759 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.52 148.54 42.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.662 -1.274 . . . . 1.1399999999999999 108.963 178.402 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -119.23 135.7 54.57 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 107.575 -1.269 . . . . 0.87 107.575 177.348 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.1 168.41 40.23 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 118.304 -1.903 . . . . 0.56999999999999995 110.112 178.239 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -77.39 159.32 29.55 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.836 -0.802 . . . . 2.3500000000000001 108.836 178.12 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -83.85 120.26 25.85 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.766 -1.209 . . . . 1.21 108.011 178.557 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.0 tp -102.46 102.66 12.98 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 105.266 -2.124 . . . . 1.3999999999999999 105.266 178.138 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.8 tp -88.96 130.03 35.52 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.735 -1.209 . . . . 1.4399999999999999 107.735 179.427 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.43 119.54 35.1 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.994 -1.484 . . . . 1.45 106.994 178.389 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.606 ' CB ' ' HZ1' ' A' ' 20' ' ' LYS . 7.9 mtmp? -110.19 137.57 47.75 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.465 -1.309 . . . . 2.5 107.465 -179.787 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -116.22 139.31 50.48 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.111 -0.993 . . . . 2.6600000000000001 108.843 179.004 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -81.66 130.2 34.97 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.599 -1.26 . . . . 2.3199999999999998 107.599 177.758 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.35 141.17 58.87 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.575 -0.898 . . . . 2.1099999999999999 108.575 178.847 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.4 mt -95.73 132.55 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.275 -1.009 . . . . 1.29 108.275 178.289 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.95 129.56 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.686 -1.227 . . . . 1.4099999999999999 107.686 178.87 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.99 137.55 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.541 -0.911 . . . . 1.3100000000000001 108.541 179.302 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -92.34 125.18 36.89 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.944 -1.097 . . . . 1.3400000000000001 108.25 178.751 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -96.98 18.09 15.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -0.853 . . . . 3.48 112.1 -179.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -66.9 152.63 45.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.17 -0.956 . . . . 2.52 110.377 179.307 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -93.71 134.6 35.86 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.87 -0.789 . . . . 2.6299999999999999 108.87 177.975 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -95.92 169.26 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.526 -0.733 . . . . 1.3100000000000001 109.784 179.336 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.0 p -94.25 161.93 14.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 1.24 109.932 178.494 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.65 -23.08 15.69 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.799 -1.188 . . . . 1.49 111.891 179.137 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -69.29 -37.41 77.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.424 -0.798 . . . . 2.2799999999999998 111.016 -179.47 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -88.47 -7.92 55.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.898 -1.126 . . . . 2.0499999999999998 112.854 -179.852 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.75 -41.18 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.329 -0.857 . . . . 1.3400000000000001 110.219 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.4 -39.3 82.94 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.104 -0.998 . . . . 1.54 110.157 179.243 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -62.29 -40.28 95.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.622 -0.674 . . . . 2.8500000000000001 110.922 -179.993 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.63 -39.58 88.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 1.3100000000000001 110.771 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.12 -41.53 86.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.246 -0.982 . . . . 1.3799999999999999 110.111 179.275 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -61.54 -48.36 81.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.847 -1.158 . . . . 1.5 109.938 179.594 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.484 ' HG2' HH11 ' A' ' 42' ' ' ARG . 14.9 mtt-85 -60.52 -39.5 88.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.123 -0.986 . . . . 2.7799999999999998 109.628 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -73.39 -52.85 12.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.979 -1.076 . . . . 1.0600000000000001 110.029 179.23 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.97 -45.12 95.06 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.121 -1.032 . . . . 1.3999999999999999 109.643 -179.868 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.3 t -67.99 -35.23 77.98 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.957 0.884 . . . . 1.3200000000000001 109.812 -179.761 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.84 -44.49 94.28 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.758 -1.337 . . . . 0.69999999999999996 109.758 178.733 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.416 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 38.1 ttm-85 -57.25 -32.29 66.41 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.065 0.936 . . . . 3.4399999999999999 109.495 178.869 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.76 -44.39 86.12 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.884 0.849 . . . . 1.3600000000000001 109.947 179.251 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -83.47 -43.92 15.29 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.59 -0.694 . . . . 2.8300000000000001 110.964 179.347 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -42.96 89.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 1.23 110.244 -179.898 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.415 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 22.9 t -62.89 -40.72 98.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.331 -0.856 . . . . 1.9199999999999999 109.362 179.772 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.46 -48.79 54.18 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.411 0.624 . . . . 1.25 110.915 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -61.82 -47.75 83.67 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.581 -1.324 . . . . 1.97 110.727 -178.592 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.69 -39.2 91.02 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.202 -0.936 . . . . 2.1800000000000002 110.34 -179.611 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 51' ' ' SER . 32.8 mm-40 -60.01 -40.55 89.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.807 -0.558 . . . . 1.1899999999999999 110.724 179.3 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.8 m -64.49 -41.56 96.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 1.3400000000000001 110.964 -179.887 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.78 -38.83 77.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.379 -0.826 . . . . 1.23 110.97 -179.873 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -52.92 -43.53 66.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 1.5600000000000001 110.945 179.305 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -70.2 -38.32 75.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.912 -1.117 . . . . 1.3 110.279 -179.638 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -62.26 -39.13 91.87 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 118.637 -1.225 . . . . 2.3199999999999998 109.427 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.24 -28.88 65.6 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.438 -0.789 . . . . 1.1399999999999999 110.768 179.52 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.4 -35.69 13.87 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.423 -1.37 . . . . 0.68999999999999995 110.815 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -81.34 -23.62 37.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.127 -1.219 . . . . 1.48 111.261 -179.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -88.66 -48.87 7.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.902 -0.499 . . . . 1.52 111.182 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -108.34 -8.05 15.75 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.996 1.11 . . . . 1.3100000000000001 113.996 -177.759 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.06 156.89 19.27 Favored Glycine 0 N--CA 1.501 2.987 0 O-C-N 121.369 -0.832 . . . . 0.84999999999999998 113.577 178.452 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -50.7 -21.73 1.75 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.573 -0.957 . . . . 3.8599999999999999 112.536 179.072 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -54.3 -38.15 65.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.785 -1.197 . . . . 2.3500000000000001 111.814 -179.972 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -80.18 -19.24 47.55 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.747 -1.221 . . . . 2.2599999999999998 112.443 -178.989 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -61.08 -35.5 77.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.984 -1.072 . . . . 1.45 110.811 -179.47 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.79 88.01 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.107 -0.996 . . . . 1.25 111.364 179.773 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt -67.91 -46.86 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.465 -1.397 . . . . 1.26 110.178 179.771 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -72.25 -28.57 63.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.87 . . . . 0.82999999999999996 111.129 -179.885 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -60.92 -40.56 93.64 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.679 -0.808 . . . . 1.1899999999999999 109.888 179.565 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.22 -42.17 91.25 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.192 -1.163 . . . . 0.57999999999999996 110.192 179.857 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -59.58 -45.99 90.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.472 -1.017 . . . . 2.0499999999999998 110.79 179.39 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.6 mt -61.21 -40.48 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.663 -1.273 . . . . 1.21 110.504 -179.945 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.4 ttm -60.29 -38.35 83.31 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.295 -0.878 . . . . 2.29 110.214 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.5 tp -59.3 -45.77 90.37 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.055 -1.028 . . . . 1.21 110.358 179.208 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.416 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 60.0 tp -60.56 -42.38 96.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.526 -0.734 . . . . 1.1399999999999999 110.225 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -84.81 4.87 31.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.304 -0.872 . . . . 1.4199999999999999 112.849 -179.55 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -59.84 125.96 25.71 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.829 -1.169 . . . . 1.27 110.087 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.2 -19.14 65.13 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.542 -0.724 . . . . 1.3500000000000001 111.351 -179.332 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.61 -53.36 9.52 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.144 -1.023 . . . . 2.2200000000000002 110.687 179.946 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.3 mt -62.48 -39.28 92.93 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.32 -0.862 . . . . 1.22 110.753 -179.524 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -58.56 -47.0 85.69 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.152 -0.967 . . . . 1.29 110.822 179.338 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -63.12 -40.48 97.73 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.282 -0.886 . . . . 2.1699999999999999 110.683 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -66.3 -48.3 70.8 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.939 -1.105 . . . . 1.3 110.646 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.38 -44.79 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.636 -1.29 . . . . 1.1699999999999999 110.028 179.632 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.1 -43.85 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.457 -0.777 . . . . 1.3999999999999999 110.486 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.4 -44.52 94.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 1.3300000000000001 111.027 -179.673 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -60.04 -40.25 88.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.075 -1.016 . . . . 1.48 110.735 -179.716 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.55 -47.31 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.056 -1.027 . . . . 1.28 110.57 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -83.31 -31.73 26.69 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.327 -0.858 . . . . 2.6000000000000001 112.035 -179.786 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -78.05 -47.85 17.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.511 -1.368 . . . . 1.51 110.9 -178.365 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -104.55 11.45 34.28 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 119.672 -0.811 . . . . 2.48 111.796 -178.05 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.3 m80 52.0 47.56 24.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.043 -1.036 . . . . 1.6100000000000001 111.913 179.809 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 64.5 mtt -98.39 159.85 14.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.141 -0.975 . . . . 1.8999999999999999 109.796 178.656 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.5 p -76.24 160.81 29.32 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.591 -0.693 . . . . 1.3200000000000001 109.894 178.173 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.23 -42.75 86.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.368 -0.832 . . . . 1.1499999999999999 110.989 178.786 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -70.04 -38.97 75.99 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.658 -1.276 . . . . 2.25 110.19 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.85 -51.56 39.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.859 -1.151 . . . . 1.22 111.589 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.96 92.26 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.792 -1.163 . . . . 1.1899999999999999 110.811 -179.813 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.35 95.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.798 -0.564 . . . . 1.2 110.988 179.832 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -60.78 -40.25 91.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.629 -1.294 . . . . 2.1000000000000001 111.236 -179.514 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.27 -49.87 76.19 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.843 -1.16 . . . . 1.3 111.4 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -59.43 -45.75 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.924 -1.11 . . . . 1.27 109.99 179.929 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.6 mm -62.72 -30.45 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-O 121.388 0.613 . . . . 1.1899999999999999 110.329 179.768 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -57.36 -40.22 77.64 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.793 -0.763 . . . . 2.1099999999999999 110.509 179.16 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.16 -30.67 22.05 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 119.249 -1.453 . . . . 0.88 112.877 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -61.34 -41.54 97.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.383 -1.657 . . . . 1.99 110.293 -179.914 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.7 -46.91 51.32 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 119.805 -0.758 . . . . 1.28 110.524 -179.975 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 50.4 p -62.99 -35.67 80.98 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.33 -0.856 . . . . 2.2200000000000002 110.782 -178.447 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.97 87.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.604 -0.685 . . . . 1.45 110.898 179.951 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 mt -65.33 -28.74 69.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.868 -1.145 . . . . 1.47 111.271 -179.509 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -66.43 -19.69 65.86 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.355 -0.938 . . . . 2.04 110.671 179.179 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -72.42 -11.22 60.59 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.471 -0.891 . . . . 1.73 110.654 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 69.4 mt -86.44 141.61 29.0 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.522 0.677 . . . . 1.79 109.213 179.535 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -98.13 38.14 1.35 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.193 -0.942 . . . . 2.8799999999999999 112.206 179.48 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -113.79 137.7 51.28 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.26 -1.015 . . . . 1.5800000000000001 108.26 178.873 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.547 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 28.2 mp0 -59.12 -39.86 83.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.972 -1.08 . . . . 3.04 111.076 179.182 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -71.24 -52.92 16.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.743 -1.223 . . . . 1.29 110.531 179.774 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.2 mt -59.98 -40.39 88.97 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.865 -1.147 . . . . 1.6000000000000001 110.384 -179.595 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -59.1 -45.72 90.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.893 -1.129 . . . . 2.7599999999999998 110.2 179.483 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.48 -31.98 70.98 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.369 -0.933 . . . . 2.1499999999999999 109.906 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -60.6 -31.2 70.37 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.829 -1.148 . . . . 2.8100000000000001 109.106 178.896 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.61 76.44 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.556 0.693 . . . . 1.3899999999999999 110.249 179.026 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.98 78.03 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.126 -0.63 . . . . 1.4099999999999999 110.138 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.34 -34.84 78.58 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.629 0.728 . . . . 1.3899999999999999 110.673 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.6 t -68.23 -41.02 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.128 -0.982 . . . . 1.1899999999999999 110.3 179.723 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -57.9 -38.73 76.34 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.445 -1.302 . . . . 3.6299999999999999 109.429 179.121 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -59.79 -37.58 79.51 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 120.124 -0.631 . . . . 1.28 110.181 179.199 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.99 -39.81 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 1.1799999999999999 109.591 179.355 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.93 -46.03 77.56 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.885 -1.15 . . . . 0.51000000000000001 110.408 179.082 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -57.38 -41.85 81.01 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.356 -1.085 . . . . 3.1699999999999999 110.163 179.299 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 136' ' ' ARG . 50.7 mtt-85 -61.52 -42.98 99.62 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.251 -0.979 . . . . 2.8500000000000001 110.006 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.77 -42.33 97.25 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.782 -0.767 . . . . 1.6499999999999999 109.536 179.78 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.5 mt -60.05 -43.78 95.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.526 -0.734 . . . . 1.2 110.404 179.698 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -60.54 -36.41 78.36 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.622 -0.674 . . . . 2.7999999999999998 110.703 -179.974 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -73.94 -40.36 63.12 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.32 -0.863 . . . . 2.1499999999999999 111.011 179.719 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.55 -40.38 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.889 -1.132 . . . . 1.21 110.614 -178.815 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.51 -11.17 49.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.669 -1.27 . . . . 1.3400000000000001 111.855 -178.951 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.79 18.61 74.9 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.763 -1.208 . . . . 0.91000000000000003 112.402 -179.71 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.74 145.32 55.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.921 -0.752 . . . . 1.51 109.194 179.218 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -69.02 147.27 51.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.51 -0.744 . . . . 2.8799999999999999 109.534 178.508 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.0 mt -106.84 141.21 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.383 -0.969 . . . . 1.6200000000000001 108.383 178.143 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.3 mp -76.01 123.72 32.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.357 -0.979 . . . . 2.1099999999999999 108.357 178.238 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -99.62 100.52 11.53 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 106.064 -1.828 . . . . 1.6200000000000001 106.064 178.98 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.4 mt -75.2 -14.26 60.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.313 -0.867 . . . . 1.3999999999999999 111.759 -177.885 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.6 p -78.42 3.07 16.78 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.317 1.055 . . . . 2.0499999999999998 112.153 -179.331 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.28 19.83 14.7 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.125 -0.984 . . . . 1.3500000000000001 112.744 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 22.6 mt -74.1 137.42 23.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.907 -1.121 . . . . 1.4199999999999999 109.241 179.172 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -115.52 -14.27 11.53 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.856 0.836 . . . . 2.9900000000000002 112.558 -178.717 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -113.47 136.35 52.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.502 -1.295 . . . . 1.54 107.502 179.932 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -73.67 124.55 26.19 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.588 -0.893 . . . . 1.3799999999999999 108.588 178.689 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -146.45 175.58 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.46 -0.775 . . . . 1.28 109.404 -179.69 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.1 mt -87.53 148.49 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 1.1599999999999999 108.975 178.135 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -99.75 120.54 39.89 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.055 -1.091 . . . . 1.3100000000000001 108.055 178.114 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -121.58 129.59 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 N-CA-C 107.718 -1.215 . . . . 1.25 107.718 179.391 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.1 155.97 21.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.968 -1.083 . . . . 1.26 108.863 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.454 ' O ' ' CG ' ' A' ' 162' ' ' ASP . . . -60.59 -37.58 81.81 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.395 -1.441 . . . . 1.6000000000000001 109.674 178.131 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 161' ' ' ALA . 58.0 m-20 -167.81 153.86 7.51 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.733 -0.839 . . . . 2.4199999999999999 108.733 179.179 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.8 mt -116.46 139.91 49.94 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 108.374 -0.972 . . . . 1.3500000000000001 108.374 177.76 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.5 p -96.85 148.97 35.2 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.22 -0.925 . . . . 1.3200000000000001 108.892 179.402 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.68 -40.01 7.53 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.747 1.632 . . . . 0.69999999999999996 113.599 179.092 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.6 m -61.75 -49.69 75.39 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.024 -1.047 . . . . 1.1200000000000001 109.922 -179.336 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -61.87 -39.96 93.71 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.085 -1.01 . . . . 1.21 110.077 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.51 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 42.8 p -67.67 -37.62 82.63 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.417 -0.802 . . . . 1.1899999999999999 110.267 179.506 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.22 -36.05 82.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.402 -0.811 . . . . 1.24 111.322 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -98.44 -0.47 43.47 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.351 -0.843 . . . . 1.6899999999999999 112.795 -179.276 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.7 tp -64.14 154.88 33.31 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.951 -0.7 . . . . 1.3400000000000001 109.906 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.588 HD21 ' N ' ' A' ' 173' ' ' LEU . 0.3 OUTLIER -97.41 118.76 34.62 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.984 -1.487 . . . . 2.77 106.984 177.427 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.588 ' N ' HD21 ' A' ' 172' ' ' ASN . 44.9 mt -76.52 -19.6 57.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.512 -0.742 . . . . 2.0899999999999999 111.953 -178.126 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.557 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 66.3 mttm -82.39 -19.86 38.27 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.06 -1.025 . . . . 2.6699999999999999 112.455 -178.904 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -102.44 -0.76 31.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.46 -0.775 . . . . 2.5800000000000001 113.065 -178.012 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 46.9 t -109.23 121.22 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.591 -1.262 . . . . 1.1799999999999999 107.591 179.049 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.1 tp -84.74 -4.04 58.86 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.144 -0.972 . . . . 2.1800000000000002 111.821 -179.434 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.96 171.29 36.82 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.872 -1.691 . . . . 0.48999999999999999 108.872 -179.901 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 3.6 m-85 -125.0 129.69 50.82 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.941 -1.133 . . . . 0.64000000000000001 107.941 178.463 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 30.1 mt -129.92 121.43 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 106.173 -1.788 . . . . 1.21 106.173 177.908 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 203' ' ' VAL . 39.4 p -139.88 172.31 12.96 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.631 -1.293 . . . . 1.3799999999999999 110.355 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.497 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 4.8 m-20 -105.29 51.96 0.75 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.529 -0.732 . . . . 2.3700000000000001 109.676 179.382 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -103.93 153.94 20.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.366 -0.834 . . . . 1.52 109.709 179.617 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -58.88 -36.2 86.38 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 120.212 -0.994 . . . . 1.8 110.712 178.517 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 96.52 -17.86 58.52 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 121.164 -1.198 . . . . 2.04 114.157 179.458 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 59.4 mtt-85 -58.67 -41.13 85.45 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.835 -1.391 . . . . 5.0 110.212 179.289 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 75.5 p -140.83 36.29 1.78 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.539 -0.726 . . . . 3.02 111.212 -179.391 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 69.9 m -81.9 123.06 28.51 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.553 -1.277 . . . . 2.1099999999999999 107.553 179.489 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.51 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 32.1 t60 -60.5 -37.58 81.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.669 -0.645 . . . . 1.24 110.741 -179.828 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 23.0 m -52.96 -42.51 65.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 2.1499999999999999 110.439 179.253 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.8 m -59.65 -40.43 87.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.03 -1.044 . . . . 2.02 110.107 179.463 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.34 -35.69 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.593 -0.692 . . . . 2.1200000000000001 110.848 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 57.1 mtp -62.6 -40.81 98.1 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.093 0.949 . . . . 1.3600000000000001 109.453 179.481 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.0 -41.73 92.71 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.589 -0.732 . . . . 1.29 110.515 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -59.8 -44.93 93.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 3.5600000000000001 110.712 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.1 m -71.19 -39.35 71.88 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.002 -1.061 . . . . 1.1799999999999999 110.164 -179.843 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.1 mt -90.98 -7.94 50.6 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 112.712 0.634 . . . . 1.3400000000000001 112.712 -178.124 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 54.29 9.03 0.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.207 1.188 . . . . 1.45 114.207 179.836 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 39.5 mt -71.37 148.92 93.77 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 108.326 -0.99 . . . . 1.25 108.326 179.133 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.45 144.25 92.29 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.456 1.438 . . . . 0.78000000000000003 109.368 178.608 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -157.9 160.67 37.88 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.086 -1.446 . . . . 1.2 109.65 179.647 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.8 mt -150.78 149.07 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.862 -1.162 . . . . 1.25 107.862 178.386 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.5 m -134.21 -32.18 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.245 -0.909 . . . . 1.3899999999999999 112.811 -179.755 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.51 33.56 0.83 Allowed Glycine 0 N--CA 1.483 1.792 0 O-C-N 121.183 -0.948 . . . . 0.96999999999999997 113.037 -178.135 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.497 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 35.0 p -59.67 -26.95 65.97 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 121.465 -1.021 . . . . 1.3500000000000001 111.085 -179.199 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 79.53 -93.38 1.35 Allowed Glycine 0 N--CA 1.488 2.102 0 C-N-CA 120.181 -1.009 . . . . 1.0700000000000001 110.952 179.386 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.5 m -123.54 29.74 6.49 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.246 0.832 . . . . 1.9199999999999999 113.246 -178.798 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 70.3 t -59.84 -33.59 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.824 -1.172 . . . . 1.3300000000000001 110.237 179.027 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 58.8 p -59.33 -23.23 62.32 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.087 -1.008 . . . . 1.4199999999999999 111.459 179.947 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.1 t -92.27 -0.38 57.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.914 -1.116 . . . . 2.1200000000000001 111.428 -179.288 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -124.47 -7.22 7.51 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.617 -0.72 . . . . 2.6899999999999999 112.681 -177.938 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.43 141.82 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.164 -0.68 . . . . 1.29 109.164 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.4 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 12.0 mptt -116.72 151.44 36.38 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.1 -1.074 . . . . 2.6899999999999999 108.1 178.296 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 48.2 t30 -53.25 143.29 18.79 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.279 -0.968 . . . . 2.79 110.44 178.318 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.1 t0 82.2 -6.99 1.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.099 1.148 . . . . 2.3500000000000001 114.099 179.524 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 16' ' ' ALA . 87.6 m-20 -63.18 143.23 57.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.636 -1.29 . . . . 1.97 108.288 177.466 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -88.23 119.1 28.31 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.388 -1.338 . . . . 2.9700000000000002 107.388 178.124 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 42.4 mt -127.83 144.51 51.09 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.137 -0.69 . . . . 1.25 109.137 -179.04 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.9 mt -111.94 128.61 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 106.918 -1.512 . . . . 1.22 106.918 177.72 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.1 tp -99.97 118.67 36.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.975 -1.861 . . . . 1.24 105.975 178.35 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 223' ' ' VAL . 35.0 p-10 -92.65 -22.19 19.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 2.0499999999999998 112.736 -177.558 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.474 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 37.75 16.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 112.756 0.65 . . . . 1.25 112.756 -179.206 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.632 ' N ' ' O ' ' A' ' 221' ' ' ASP . 15.7 t -111.21 -63.81 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.056 -1.027 . . . . 1.4299999999999999 108.78 179.694 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -90.22 9.15 29.65 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.245 1.021 . . . . 3.0299999999999998 110.463 -179.779 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.62 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.8 OUTLIER 61.62 52.8 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.067 -0.97 . . . . 2.25 112.157 179.61 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -148.29 153.46 38.7 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.409 1.1 . . . . 2.52 110.25 179.131 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.4 135.48 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.542 -1.281 . . . . 1.29 107.542 177.465 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -101.15 136.93 40.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.987 -1.071 . . . . 1.3400000000000001 108.719 178.744 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.7 t -109.84 130.04 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.171 -1.048 . . . . 1.3400000000000001 108.171 179.104 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.451 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 60.7 t30 48.44 50.32 8.86 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.914 . . . . 2.1800000000000002 113.292 178.913 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.7 Cg_endo -63.41 151.66 83.82 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.32 2.013 . . . . 0.93999999999999995 110.712 -179.904 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.9 m -73.97 156.79 37.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.795 -1.191 . . . . 2.3999999999999999 109.226 177.65 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -56.79 -40.05 75.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.033 -1.042 . . . . 3.3300000000000001 111.133 179.054 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 234' ' ' GLU . 45.2 mp0 -59.12 -39.52 82.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.044 -1.035 . . . . 3.1699999999999999 110.288 179.687 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.8 -37.94 78.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.759 0.79 . . . . 1.6899999999999999 110.097 179.732 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 84.5 mt -58.09 -43.77 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.133 -0.979 . . . . 1.6000000000000001 110.398 179.292 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.73 -39.7 85.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 2.7000000000000002 110.768 179.822 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -61.72 -41.45 97.63 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.909 -1.119 . . . . 2.96 110.78 179.873 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.5 mtp -73.36 -36.5 66.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.325 -0.859 . . . . 1.6299999999999999 111.013 -179.419 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -59.73 -38.54 81.98 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.249 -0.907 . . . . 3.27 110.765 -179.729 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.52 -44.53 67.37 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.834 -1.166 . . . . 2.23 111.157 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 97.6 t -58.87 -51.02 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.551 -1.343 . . . . 2.79 111.557 -178.258 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -62.1 -49.88 74.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.054 -1.029 . . . . 4.2599999999999998 110.555 -179.921 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.43 -35.64 78.12 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.433 -0.792 . . . . 1.8799999999999999 110.87 -179.489 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.81 -29.32 69.39 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.569 -1.253 . . . . 3.3799999999999999 109.995 179.325 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.36 -47.63 88.76 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 C-N-CA 118.894 -1.122 . . . . 2.8799999999999999 109.529 178.81 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.03 -36.46 81.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 2.75 110.456 -179.943 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.7 t -66.94 -36.26 81.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.47 -0.769 . . . . 3.4199999999999999 110.582 179.657 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -62.18 -45.62 92.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 3.5699999999999998 110.244 179.65 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -68.8 -39.3 80.17 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.797 0.808 . . . . 4.6100000000000003 110.33 -179.868 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.16 23.98 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.389 -0.819 . . . . 4.4500000000000002 112.815 -179.808 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.68 -38.03 83.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.964 -1.085 . . . . 5.9699999999999998 111.113 -179.226 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.08 -32.84 74.55 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.837 -1.164 . . . . 6.4500000000000002 110.432 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -75.15 -8.88 57.82 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.474 -0.766 . . . . 6.6600000000000001 112.872 -179.765 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -80.14 0.59 31.54 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.058 -1.026 . . . . 8.5399999999999991 112.927 -178.969 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.53 ' N ' ' CD2' ' A' ' 256' ' ' LEU . 3.0 mm? -82.34 -5.47 58.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.778 -1.202 . . . . 8.0700000000000003 112.319 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -87.43 0.54 55.35 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.221 -0.924 . . . . 9.7200000000000006 112.925 -178.473 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -92.97 -40.91 10.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.355 -0.841 . . . . 10.119999999999999 112.046 -178.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 . . . . . 0 N--CA 1.498 1.929 0 O-C-N 120.966 -1.084 . . . . 11.9 110.15 -177.324 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.2 mt . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 106.468 -1.679 . . . . 1.07 106.468 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.0 m -105.98 119.99 40.62 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.652 -1.24 . . . . 1.24 107.652 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.17 -160.96 23.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.531 -1.827 . . . . 1.01 108.531 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 5' ' ' ILE . 95.6 mt -95.98 1.29 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.447 -1.031 . . . . 1.11 113.076 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 tp 51.8 93.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.536 -1.353 . . . . 0.99 112.297 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -88.75 -34.11 17.25 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.052 -1.03 . . . . 0.85 111.001 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 201' ' ' ALA . 1.9 p -149.8 140.89 14.46 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 107.682 -1.229 . . . . 1.38 107.682 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.28 146.99 22.76 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.518 2.145 . . . . 0.94 112.173 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.945 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.15 173.69 22.71 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 108.722 -1.751 . . . . 0.81 108.722 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.0 mt -132.12 136.42 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.073 -1.251 . . . . 0.83 107.683 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.34 155.92 45.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.004 -1.06 . . . . 0.53 109.429 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.6 m-85 -128.38 140.19 51.98 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.391 -0.966 . . . . 0.77 108.391 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.36 172.01 39.86 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 118.546 -1.788 . . . . 0.51 110.061 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -76.02 156.07 34.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.86 -0.788 . . . . 1.9 109.144 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -84.52 122.87 29.61 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.454 -1.313 . . . . 0.66 107.454 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.4 tp -100.2 106.97 18.7 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 105.558 -2.016 . . . . 0.83 105.558 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.4 tp -91.04 131.36 36.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.917 -1.142 . . . . 0.86 107.917 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 158' ' ' LEU . 44.4 mt -99.52 118.04 35.23 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.878 -1.527 . . . . 0.92 106.878 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -110.15 136.09 49.92 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.79 -1.189 . . . . 2.03 107.79 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -128.56 151.21 49.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.08 -1.013 . . . . 2.66 109.748 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -81.52 135.61 35.6 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.816 -1.179 . . . . 2.32 107.816 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -63.67 147.89 50.43 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.743 -0.836 . . . . 2.11 108.743 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.2 mt -93.23 125.48 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.728 -1.212 . . . . 0.73 107.728 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.2 t -109.96 129.95 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.43 -0.952 . . . . 0.87 108.43 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.9 mt -95.02 141.44 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.152 -0.968 . . . . 0.81 108.612 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -90.53 122.68 33.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.033 . . . . 1.34 108.414 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.531 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.6 mmt-85 -94.46 17.02 13.82 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.37 -0.831 . . . . 2.89 111.983 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -74.85 140.42 43.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.259 -0.901 . . . . 2.09 109.006 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -90.97 129.55 36.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.958 -1.089 . . . . 2.19 108.074 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 pt -89.31 166.19 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.75 110.835 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.8 p -96.81 167.19 11.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.405 -0.81 . . . . 0.91 109.653 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -15.16 2.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.922 -1.111 . . . . 0.93 112.39 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -70.33 -39.61 74.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 2.28 110.824 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -94.61 -4.73 47.23 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.635 -1.291 . . . . 1.45 113.029 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.71 -41.38 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.272 -0.893 . . . . 0.81 110.358 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -56.09 -40.1 73.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 1.54 110.189 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -63.16 -36.12 82.58 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.335 -0.853 . . . . 2.36 110.688 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 42' ' ' ARG . 78.6 mm-40 -60.23 -42.06 94.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 1.31 110.398 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.98 -46.0 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.387 -0.821 . . . . 0.82 110.731 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.24 -50.01 74.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.058 -1.026 . . . . 1.5 110.392 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 76.6 mtm180 -62.41 -41.0 98.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -0.897 . . . . 2.23 110.231 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -70.26 -55.33 9.51 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.383 -0.823 . . . . 0.85 109.566 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.25 -47.67 85.0 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.797 0.808 . . . . 0.91 110.361 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 12.2 t -68.67 -38.19 80.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.303 -0.873 . . . . 0.9 110.208 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.61 -46.57 88.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.775 -1.33 . . . . 0.69 109.775 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -59.91 -29.31 68.28 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.405 -1.056 . . . . 2.88 110.311 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.33 -48.86 80.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.808 -0.557 . . . . 0.85 110.97 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -82.55 -35.93 26.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.833 -1.167 . . . . 2.35 110.084 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -45.33 89.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.369 -0.832 . . . . 0.65 109.95 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 t -61.73 -39.8 92.84 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.917 0.865 . . . . 1.45 109.558 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.03 -49.86 63.87 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.287 -0.565 . . . . 0.63 110.873 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -61.7 -51.0 70.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.97 -1.081 . . . . 1.34 110.955 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.72 -38.94 89.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.241 -0.912 . . . . 1.56 110.483 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -58.68 -40.09 82.57 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.059 -0.656 . . . . 1.19 110.654 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 m -63.08 -41.75 99.49 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.839 -1.163 . . . . 0.72 110.247 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.11 -36.32 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.571 -0.706 . . . . 0.62 110.778 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -52.97 -42.56 65.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 1.05 110.76 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.31 -36.12 76.67 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.139 -0.975 . . . . 0.64 110.21 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -62.14 -39.34 92.24 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.246 -0.981 . . . . 1.73 109.454 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.02 -34.74 78.78 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.342 0.591 . . . . 0.56 110.113 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.43 19.02 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.749 -1.215 . . . . 0.69 111.355 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.26 -23.32 35.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -1.183 . . . . 1.48 111.406 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.5 m -86.6 -49.71 7.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.793 -0.567 . . . . 0.98 110.649 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.527 ' CZ ' ' SD ' ' A' ' 193' ' ' MET . 72.2 m-85 -108.43 -6.65 16.08 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 113.954 1.094 . . . . 1.16 113.954 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.0 168.03 29.4 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.115 -1.04 . . . . 0.85 111.745 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.94 -20.49 38.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.273 -1.134 . . . . 3.86 112.603 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.47 -42.03 73.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.618 -1.301 . . . . 2.35 110.945 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -88.43 -25.18 22.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.017 -1.052 . . . . 1.67 111.998 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -59.99 -37.28 79.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 1.45 111.356 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.36 84.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.61 111.299 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.8 mt -65.2 -43.98 95.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.494 -1.379 . . . . 0.65 110.303 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -70.63 -34.53 72.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.938 -1.102 . . . . 0.66 110.423 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.49 -38.55 84.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.3 -0.875 . . . . 1.19 110.491 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.94 -41.15 88.53 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.972 -1.108 . . . . 0.53 110.938 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -59.36 -43.21 92.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.417 -1.049 . . . . 1.27 110.56 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.48 -37.17 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.161 -0.962 . . . . 0.54 110.564 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.2 ttt -59.26 -39.75 83.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.531 -0.731 . . . . 1.74 110.558 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.8 tp -59.6 -48.21 82.54 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.454 -0.898 . . . . 0.55 109.612 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.44 -39.72 88.53 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.541 0.686 . . . . 0.47 110.049 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.62 -1.52 54.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.451 -0.781 . . . . 1.42 112.902 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -58.68 123.88 17.85 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.14 -1.424 . . . . 1.27 110.584 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.36 -16.57 62.51 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.751 -1.218 . . . . 1.35 111.355 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -77.46 -50.08 13.43 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.407 -0.917 . . . . 2.22 111.148 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.09 -39.46 92.55 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.28 -0.888 . . . . 0.62 110.577 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -59.84 -45.71 91.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 1.29 110.348 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -62.72 -39.98 95.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 1.52 110.837 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -64.84 -48.31 74.8 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.798 -1.189 . . . . 1.3 110.273 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.2 mt -55.84 -44.19 76.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.169 -0.957 . . . . 0.61 110.048 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.36 -41.58 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.443 0.64 . . . . 0.78 110.453 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.51 95.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.682 -0.636 . . . . 0.82 110.977 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.86 -42.26 97.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.866 -1.146 . . . . 0.8 110.783 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.21 -49.72 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.857 -1.152 . . . . 0.77 109.931 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -78.0 -35.42 50.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.399 -0.813 . . . . 2.12 111.645 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.12 -42.09 27.07 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.499 -1.375 . . . . 1.51 111.767 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -105.8 7.92 32.6 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.92 -1.112 . . . . 1.98 112.422 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.8 m80 50.77 47.85 23.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.858 -1.151 . . . . 1.32 111.285 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.6 mtt -105.28 154.02 20.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.598 -0.689 . . . . 1.38 109.567 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.9 p -71.32 162.98 28.55 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.79 -0.569 . . . . 0.67 110.034 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.51 -39.84 94.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.964 -1.085 . . . . 0.52 110.856 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -68.5 -42.76 78.14 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 120.807 -1.183 . . . . 2.25 109.971 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.35 -48.06 62.45 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.508 0.671 . . . . 0.64 110.606 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.28 94.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.56 110.494 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.34 86.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.651 -0.656 . . . . 0.46 110.552 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -60.08 -38.57 83.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.17 -0.956 . . . . 1.32 110.937 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.14 -49.46 76.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.9 -1.125 . . . . 1.3 111.174 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.68 -49.5 84.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.402 -1.319 . . . . 0.61 109.714 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.0 mm -60.09 -32.73 51.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.605 0.717 . . . . 0.65 110.149 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -54.84 -40.78 69.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.266 -0.896 . . . . 2.11 110.627 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.49 -34.65 10.15 Favored Glycine 0 N--CA 1.5 2.919 0 C-N-CA 119.618 -1.277 . . . . 0.83 112.236 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -61.86 -42.77 99.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.499 -1.589 . . . . 1.28 109.914 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.11 -49.84 32.95 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.948 -0.701 . . . . 0.89 110.107 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.0 p -61.79 -36.94 82.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.173 -0.954 . . . . 1.87 110.411 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.91 98.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 1.05 110.633 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 95.5 mt -66.37 -29.39 69.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.083 -1.011 . . . . 1.02 110.715 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -67.04 -23.73 65.92 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.383 -0.823 . . . . 2.04 110.961 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -71.56 -15.39 62.28 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.06 -1.025 . . . . 1.73 111.227 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.6 mt -88.45 141.07 28.83 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.829 -0.804 . . . . 1.37 108.829 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -98.1 40.78 1.16 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.146 -0.971 . . . . 2.88 112.048 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -112.39 138.57 48.94 Favored 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 108.174 -1.047 . . . . 1.58 108.174 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 47.7 mp0 -58.58 -36.6 74.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 3.04 111.016 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -73.59 -51.15 17.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.677 -1.264 . . . . 0.9 109.99 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.96 -43.08 96.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.96 -1.087 . . . . 1.06 110.215 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -63.05 -50.22 71.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.913 . . . . 2.18 110.198 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -61.55 -30.5 70.69 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.076 0.941 . . . . 2.15 109.589 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 130' ' ' VAL . 37.9 ttp180 -64.7 -29.55 70.54 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.082 0.944 . . . . 2.33 109.274 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -59.95 -48.22 82.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.708 0.766 . . . . 0.82 109.484 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.06 84.58 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.527 -0.869 . . . . 0.85 109.986 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -64.45 -35.49 81.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.516 -0.74 . . . . 1.39 110.348 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 126' ' ' ARG . 38.2 t -67.59 -39.51 82.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.106 -0.996 . . . . 0.56 109.58 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -58.91 -37.1 75.86 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.895 -1.122 . . . . 3.12 109.214 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -60.25 -37.68 81.12 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.899 -0.591 . . . . 1.28 110.418 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.6 mt -60.48 -40.04 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.318 -0.864 . . . . 0.49 109.71 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.82 -39.97 32.34 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.098 -1.201 . . . . 0.46 110.098 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.72 -46.29 84.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -1.129 . . . . 2.71 109.996 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -63.63 -40.1 96.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.788 -1.195 . . . . 2.14 109.8 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.29 -41.94 90.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.49 -0.756 . . . . 1.05 109.7 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 54.7 mt -59.94 -44.83 94.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.599 -0.84 . . . . 0.52 110.014 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -60.6 -33.84 73.34 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.488 -0.758 . . . . 2.35 110.17 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -74.01 -43.11 59.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.662 -0.649 . . . . 1.39 110.167 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.92 -37.32 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.68 110.741 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 56.4 mt -86.23 -4.8 59.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.156 -0.965 . . . . 0.83 112.148 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.06 23.36 69.08 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 120.175 -1.012 . . . . 0.91 113.22 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.5 tp -73.52 137.51 44.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.531 -0.982 . . . . 0.95 108.932 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -68.41 149.79 48.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.17 -0.956 . . . . 2.43 109.757 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.4 mt -104.07 140.35 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.504 -0.924 . . . . 1.1 108.504 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.751 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.5 mp -77.34 128.23 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.86 -1.163 . . . . 1.58 107.86 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -96.8 100.08 11.63 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 105.861 -1.903 . . . . 1.62 105.861 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.0 mt -75.56 -15.52 60.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.508 -0.745 . . . . 0.8 111.437 -177.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.5 t -78.19 -1.45 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 1.56 112.088 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.35 22.4 10.68 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.735 0.778 . . . . 0.84 111.744 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.461 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 18.0 mt -72.0 135.76 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.742 . . . . 0.82 109.1 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -121.67 -6.82 9.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.571 -0.706 . . . . 2.31 112.343 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -112.71 135.45 53.43 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.957 -1.127 . . . . 1.54 107.957 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.85 113.98 17.4 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.695 -0.854 . . . . 1.38 108.695 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.9 m -148.29 178.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.303 -0.873 . . . . 0.69 109.224 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.0 mt -87.31 144.45 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.046 -0.724 . . . . 0.53 109.046 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 19' ' ' LEU . 30.4 tp -94.76 125.81 39.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.981 -1.118 . . . . 0.64 107.981 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.19 129.9 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.981 -1.118 . . . . 0.67 107.981 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.409 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.78 153.44 22.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.156 -0.965 . . . . 0.78 109.667 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.3 73.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.663 -1.273 . . . . 1.0 109.413 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -173.22 151.2 2.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.882 -0.785 . . . . 2.42 108.882 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.0 mt -119.85 140.79 50.27 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.049 -0.722 . . . . 0.75 109.049 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 56.5 p -90.8 148.1 37.56 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.048 -1.033 . . . . 0.78 108.79 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.9 -40.59 6.03 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.919 1.746 . . . . 0.67 113.342 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.0 m -63.53 -46.22 87.03 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.052 -1.03 . . . . 0.7 110.134 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -65.26 -38.33 90.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 1.21 110.332 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 69.2 p -68.7 -41.43 79.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.492 -0.755 . . . . 0.6 110.585 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.11 83.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.685 -0.635 . . . . 0.62 110.768 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -93.63 2.46 56.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.001 -1.062 . . . . 1.16 112.543 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 171' ' ' LEU . 35.1 tp -61.82 150.39 37.31 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.341 -0.849 . . . . 0.73 109.857 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -95.89 116.19 28.55 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.52 -1.289 . . . . 2.24 107.52 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 75.1 mt -80.04 -11.25 59.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.607 -0.683 . . . . 1.43 112.368 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -83.86 -26.83 29.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 2.15 112.218 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -102.76 -3.88 25.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.305 -0.872 . . . . 2.04 113.245 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.39 126.93 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.462 -1.31 . . . . 0.55 107.462 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 28.8 tp -90.4 -7.17 53.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.788 -1.195 . . . . 1.63 112.349 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.54 173.95 41.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.367 -1.493 . . . . 0.47 109.367 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -128.88 130.65 47.13 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.138 -1.06 . . . . 0.54 108.138 179.233 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.547 HG22 HG21 ' A' ' 205' ' ' THR . 94.8 mt -134.12 105.54 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 105.83 -1.915 . . . . 0.69 105.83 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 39.1 p -126.99 176.11 7.58 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.954 -1.091 . . . . 0.82 110.991 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.581 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -104.02 56.33 0.73 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 115.931 -0.577 . . . . 2.37 109.841 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -100.59 144.37 29.65 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.15 -0.969 . . . . 1.11 109.31 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.6 -32.91 25.09 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.098 -1.049 . . . . 1.67 110.907 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 98.15 0.11 58.61 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.302 -1.117 . . . . 1.54 113.692 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.43 ' O ' ' OG1' ' A' ' 187' ' ' THR . 35.6 ttm180 -87.75 112.6 22.58 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.892 -1.521 . . . . 4.48 106.892 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 20.9 p 49.52 44.74 24.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 2.63 112.291 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.3 m -78.35 126.81 31.3 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.679 -1.23 . . . . 1.69 107.679 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -58.94 -40.8 85.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.227 -0.92 . . . . 1.07 110.292 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -59.94 -48.44 81.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.113 -0.992 . . . . 1.58 110.284 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.7 p -61.39 -38.74 88.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.473 -0.767 . . . . 1.6 110.576 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.475 HG12 HH21 ' A' ' 195' ' ' ARG . 85.5 mt -60.71 -42.42 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.095 -1.003 . . . . 1.45 110.903 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.527 ' SD ' ' CZ ' ' A' ' 65' ' ' PHE . 9.5 mtm -66.74 -36.92 83.6 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.502 -1.374 . . . . 1.05 109.461 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.76 -48.66 80.78 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.843 -0.617 . . . . 0.72 111.006 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.475 HH21 HG12 ' A' ' 192' ' ' ILE . 85.3 mtm180 -60.0 -40.45 89.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 3.05 110.409 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.3 m -64.46 -37.84 88.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 0.89 109.902 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.5 mt -89.21 -1.1 57.94 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.459 0.647 . . . . 0.78 112.045 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 54.82 8.31 0.22 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.059 1.133 . . . . 1.45 114.059 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.3 mt -71.5 149.25 93.52 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.073 -1.084 . . . . 0.67 108.073 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -59.1 144.95 99.17 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.653 1.569 . . . . 0.64 109.948 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -160.89 159.58 29.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.442 -1.411 . . . . 0.67 109.852 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 203' ' ' VAL . 73.0 mt -148.1 155.65 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.059 -1.089 . . . . 0.69 108.059 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.427 ' N ' HG22 ' A' ' 202' ' ' ILE . 2.9 m -137.75 -28.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.145 -0.972 . . . . 0.85 111.758 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.87 41.32 1.71 Allowed Glycine 0 N--CA 1.487 2.034 0 C-N-CA 120.332 -0.937 . . . . 0.92 111.846 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.547 HG21 HG22 ' A' ' 180' ' ' ILE . 75.7 p -63.45 -20.92 65.98 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.341 -1.094 . . . . 0.95 110.938 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.25 -95.88 1.33 Allowed Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.669 -1.253 . . . . 1.04 109.978 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.0 t -129.03 30.65 5.02 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.444 -1.033 . . . . 1.57 111.868 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.03 -38.34 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.701 -1.249 . . . . 0.84 110.829 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 67.6 p -57.49 -24.84 58.17 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.442 -0.903 . . . . 0.99 112.02 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.2 m -93.31 0.72 57.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.017 -1.052 . . . . 1.7 111.974 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -122.96 -4.8 8.53 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 113.082 0.771 . . . . 2.2 113.082 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 52.0 t -119.38 149.11 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 121.568 0.699 . . . . 0.84 109.723 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -116.81 158.56 23.73 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.809 -1.182 . . . . 2.2 107.809 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 45.3 p-10 -55.01 145.17 21.11 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.986 -1.071 . . . . 2.28 110.572 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t70 80.61 2.52 1.81 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 114.803 1.409 . . . . 2.35 114.803 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 62.8 t0 -65.85 146.62 54.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.941 -1.1 . . . . 1.97 108.37 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.499 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 43.3 t80 -88.18 120.64 29.73 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.993 -1.484 . . . . 2.65 106.993 178.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.591 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 79.0 mt -127.75 150.01 49.99 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.527 -0.733 . . . . 0.63 109.92 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.5 mt -118.41 123.59 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 106.691 -1.596 . . . . 0.62 106.691 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.5 tp -99.32 114.87 27.97 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.639 -1.615 . . . . 0.64 106.639 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 223' ' ' VAL . 37.2 t0 -91.36 -25.06 19.57 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.849 -1.157 . . . . 2.05 112.325 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.945 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.65 19.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.667 0.617 . . . . 0.84 112.667 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.0 t -110.94 -61.22 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.097 0.951 . . . . 1.02 108.924 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -93.19 8.72 39.03 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.7 0.762 . . . . 2.51 110.489 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 60.1 t30 62.98 52.35 2.62 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.483 0.658 . . . . 1.54 111.704 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -147.49 147.81 30.57 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.272 1.034 . . . . 1.95 109.453 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 52.0 t -117.45 139.74 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.293 -1.002 . . . . 0.71 108.293 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -103.84 132.59 49.95 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.983 -1.073 . . . . 1.01 109.01 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.9 130.04 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.953 -1.129 . . . . 0.82 107.953 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.473 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 17.9 t-20 54.05 48.09 4.4 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.241 -0.912 . . . . 1.54 113.015 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 56.1 Cg_endo -69.6 150.75 69.58 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.845 2.363 . . . . 0.94 110.921 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 68.2 p -77.75 163.03 26.49 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.314 -0.866 . . . . 1.8 110.562 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -60.47 -35.21 75.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.945 . . . . 2.73 110.56 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -59.14 -39.34 82.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.166 -0.959 . . . . 3.17 110.385 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.8 t -70.88 -42.06 77.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.175 -1.01 . . . . 1.34 110.219 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 67.0 mt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.769 0.795 . . . . 1.2 109.822 -178.605 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.9 mt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 107.497 -1.297 . . . . 1.07 107.497 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -102.56 128.43 49.22 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.209 -1.034 . . . . 1.24 108.209 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.53 -152.39 11.51 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 108.536 -1.826 . . . . 1.01 108.536 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 5' ' ' ILE . 81.5 mt -97.23 -3.22 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.293 -1.122 . . . . 1.11 113.027 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.8 tp 49.49 95.62 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.07 -1.019 . . . . 0.99 112.126 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -85.26 -40.16 16.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.11 -0.994 . . . . 0.85 110.587 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -147.12 141.8 16.29 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.706 -1.22 . . . . 1.38 107.706 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.33 149.69 40.51 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.575 2.183 . . . . 0.94 112.144 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.897 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.13 166.16 13.51 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.885 -1.686 . . . . 0.81 108.885 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.8 mt -123.76 135.18 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.232 -1.158 . . . . 0.83 108.424 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.48 44.6 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.963 -1.086 . . . . 0.53 109.293 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -121.86 139.66 53.35 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.841 -1.17 . . . . 0.77 107.841 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.72 165.47 31.75 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 118.356 -1.878 . . . . 0.51 110.254 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -76.03 158.66 31.63 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.938 -0.742 . . . . 1.9 109.262 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.46 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -87.08 123.25 31.95 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.526 -1.287 . . . . 0.66 107.526 178.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.4 tp -100.85 108.73 20.59 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 105.28 -2.118 . . . . 0.83 105.28 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.5 tp -90.41 137.42 32.36 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.847 -1.168 . . . . 0.86 107.847 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.492 HD12 ' HB2' ' A' ' 160' ' ' ALA . 39.9 mt -101.87 120.01 39.7 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 107.714 -1.217 . . . . 0.92 107.714 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -110.97 140.15 45.72 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.056 -1.09 . . . . 2.03 108.056 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.58 139.43 53.6 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.071 -1.018 . . . . 2.66 108.758 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -84.87 133.36 34.31 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.682 -1.229 . . . . 2.32 107.682 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -64.38 146.38 54.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.074 -1.016 . . . . 2.11 109.264 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.5 mt -95.53 132.81 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.278 -0.889 . . . . 0.73 108.691 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -106.42 128.98 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.84 -1.17 . . . . 0.87 107.84 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 mt -98.17 140.17 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.714 -0.847 . . . . 0.81 108.714 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -89.35 119.95 30.26 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.626 -1.25 . . . . 1.34 107.626 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -96.73 15.68 21.22 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.187 -0.946 . . . . 2.89 112.227 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -69.22 151.09 46.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.971 -1.081 . . . . 2.09 110.35 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -90.12 131.87 35.74 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.176 -1.046 . . . . 2.19 108.176 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.2 pt -96.1 168.5 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.577 0.703 . . . . 0.75 110.499 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.9 p -92.48 166.19 12.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.474 -0.766 . . . . 0.91 110.252 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.6 -22.78 47.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.335 -0.853 . . . . 0.93 112.142 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.02 -36.65 80.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.919 -1.113 . . . . 2.28 111.026 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -85.85 -5.5 59.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.574 -1.329 . . . . 1.45 112.501 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.93 -44.55 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.218 -0.926 . . . . 0.81 110.478 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -58.73 -40.35 83.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.082 -1.011 . . . . 1.54 110.247 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.64 -40.78 96.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.484 -0.76 . . . . 2.36 110.965 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -60.72 -39.99 90.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.102 -0.999 . . . . 1.31 110.613 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.36 -40.83 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.956 -1.09 . . . . 0.82 110.242 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -62.23 -40.82 97.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.941 -1.099 . . . . 1.5 110.365 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 42' ' ' ARG . 45.6 mtt-85 -62.01 -41.75 98.42 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.194 -0.941 . . . . 2.23 110.131 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -76.12 -51.4 12.27 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.319 -0.863 . . . . 0.85 109.973 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.03 -49.03 79.44 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.741 -0.784 . . . . 0.91 109.606 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.9 t -70.55 -40.84 73.16 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.59 -0.694 . . . . 0.9 109.962 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.67 -44.51 96.83 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.118 -1.593 . . . . 0.69 109.118 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -57.75 -31.46 66.5 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.498 -1.001 . . . . 2.88 109.548 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.27 -45.63 92.63 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.589 0.709 . . . . 0.85 110.194 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -80.23 -40.82 26.3 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.474 -0.767 . . . . 2.35 111.035 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.64 90.03 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.56 0.695 . . . . 0.65 109.928 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.9 t -60.71 -40.01 90.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.244 1.021 . . . . 1.45 109.238 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.5 78.51 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.824 -0.626 . . . . 0.63 109.804 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -61.27 -50.32 73.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.056 -1.028 . . . . 1.34 110.193 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.86 -39.36 91.63 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.309 -0.869 . . . . 1.56 109.897 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -60.21 -41.33 92.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.802 -0.562 . . . . 1.19 110.915 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.3 m -67.13 -43.0 83.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.94 -1.1 . . . . 0.72 110.244 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.0 mt -59.87 -38.44 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.467 -0.771 . . . . 0.62 110.59 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -53.04 -42.5 65.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 1.05 110.865 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -69.87 -33.05 71.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.982 -1.074 . . . . 0.64 110.383 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -63.22 -39.95 96.08 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.175 -1.01 . . . . 1.73 109.818 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.78 78.31 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.366 -0.834 . . . . 0.56 110.021 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.52 -35.32 29.46 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 119.55 -1.31 . . . . 0.69 110.613 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.45 -19.79 38.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.121 -1.223 . . . . 1.48 111.016 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.9 m -89.59 -55.3 3.7 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.852 -0.53 . . . . 0.98 110.274 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.51 -2.74 20.1 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 113.807 1.04 . . . . 1.16 113.807 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.05 160.95 26.49 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.746 -0.74 . . . . 0.85 112.559 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -52.93 -18.95 2.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.458 -1.025 . . . . 3.86 112.697 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 68' ' ' GLU . 4.9 pt-20 -56.99 -44.18 82.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.049 -1.032 . . . . 2.35 110.842 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -84.57 -21.01 30.57 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.606 -1.309 . . . . 1.67 111.534 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -59.83 -38.61 82.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.567 -0.708 . . . . 1.45 110.956 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.98 82.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.457 -0.777 . . . . 0.61 111.693 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 72' ' ' ILE . 22.9 mt -63.72 -45.01 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.586 -1.321 . . . . 0.65 110.518 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -69.23 -32.37 71.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.66 110.508 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -62.36 -40.11 95.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.532 -0.867 . . . . 1.19 110.597 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.55 -39.88 98.42 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 120.133 -1.032 . . . . 0.53 110.713 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -58.68 -41.69 86.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.295 -1.12 . . . . 1.27 110.44 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.3 mt -60.04 -36.46 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.932 -1.105 . . . . 0.54 110.448 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.3 ttm -59.8 -39.43 84.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.852 . . . . 1.74 110.61 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 tp -60.82 -48.79 80.2 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.591 -0.844 . . . . 0.55 110.007 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.46 -42.59 96.48 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.458 0.647 . . . . 0.47 110.949 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -87.56 5.65 38.28 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.271 -0.893 . . . . 1.42 113.05 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -60.59 121.19 11.57 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.689 -1.257 . . . . 1.27 108.585 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.15 -18.55 65.4 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.875 0.845 . . . . 1.35 110.631 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -75.16 -52.63 10.49 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.675 -0.81 . . . . 2.22 110.079 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.32 -37.0 79.22 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.688 -0.805 . . . . 0.62 110.525 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -57.59 -47.86 80.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.199 -0.938 . . . . 1.29 110.992 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.7 -37.27 81.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.436 -0.79 . . . . 1.52 110.635 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.58 -48.8 68.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.71 -1.244 . . . . 1.3 110.26 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.2 mt -56.57 -45.96 82.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.923 -1.11 . . . . 0.61 109.947 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.0 mt -60.77 -41.9 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.541 0.686 . . . . 0.78 110.36 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.7 98.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.905 . . . . 0.82 110.711 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.67 -42.49 97.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.048 -1.032 . . . . 0.8 110.679 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.41 -45.59 98.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.204 -0.935 . . . . 0.77 110.323 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -83.67 -34.5 24.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 2.12 112.132 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -80.86 -44.86 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.693 -1.254 . . . . 1.51 111.856 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -102.53 8.36 39.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.593 -0.692 . . . . 1.98 112.318 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.0 m170 49.66 49.02 20.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 1.32 111.641 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.4 mtp -101.68 156.58 17.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.583 -0.698 . . . . 1.38 109.397 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.3 p -74.14 160.16 31.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.573 -0.529 . . . . 0.67 109.573 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.14 -40.52 81.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.155 -0.966 . . . . 0.52 110.301 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.544 ' OD2' HD21 ' A' ' 142' ' ' LEU . 73.6 m-20 -68.08 -44.09 77.05 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.905 0.86 . . . . 2.25 110.241 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.06 -49.09 63.5 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.625 -0.83 . . . . 0.64 110.955 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.13 87.91 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.267 -0.896 . . . . 0.56 110.181 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.54 95.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.46 110.539 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -60.29 -36.18 77.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 1.32 111.423 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.05 -50.21 74.63 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.039 -1.038 . . . . 1.3 110.954 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -60.24 -48.01 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.552 -1.343 . . . . 0.61 109.947 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -60.92 -31.86 50.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 121.599 -0.688 . . . . 0.65 110.331 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -57.08 -41.04 78.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.123 -0.986 . . . . 2.11 111.175 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.73 -35.36 11.67 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.231 -1.462 . . . . 0.83 112.191 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -59.99 -40.9 90.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.504 -1.586 . . . . 1.28 110.241 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.48 -51.49 14.65 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.892 0.853 . . . . 0.89 110.224 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.2 m -59.31 -39.85 84.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.307 -0.871 . . . . 1.87 110.619 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.79 98.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -0.784 . . . . 1.05 111.064 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 80.9 mt -63.93 -31.11 72.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.725 -1.234 . . . . 1.02 110.961 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -66.43 -22.65 66.22 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.923 -1.111 . . . . 2.04 110.915 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -72.5 -12.41 61.07 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.676 0.751 . . . . 1.73 111.059 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.507 HD13 HD13 ' A' ' 123' ' ' LEU . 82.9 mt -86.53 149.54 24.88 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.363 0.602 . . . . 1.37 109.426 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -103.02 39.11 1.61 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.127 -0.983 . . . . 2.88 111.769 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.509 ' CB ' HD12 ' A' ' 123' ' ' LEU . 51.2 t0 -115.78 139.07 50.53 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 121.141 -0.975 . . . . 1.58 108.77 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.06 -40.16 84.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 3.04 110.97 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -72.46 -48.82 37.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.846 -1.159 . . . . 0.9 111.068 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.509 HD12 ' CB ' ' A' ' 120' ' ' ASP . 19.3 mt -61.5 -43.43 98.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.878 -1.138 . . . . 1.06 110.116 -178.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -63.79 -50.09 70.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.954 . . . . 2.18 110.06 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -59.9 -32.89 71.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.415 -0.803 . . . . 2.15 110.122 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -63.79 -28.17 69.68 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.716 -1.194 . . . . 2.33 109.343 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -59.06 -47.82 83.86 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.684 0.754 . . . . 0.82 109.685 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.95 -42.35 97.33 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.222 -0.991 . . . . 0.85 109.509 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.48 -31.31 71.96 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.313 0.577 . . . . 1.39 110.26 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.3 t -68.1 -44.97 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 0.56 109.942 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -59.36 -36.15 75.2 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.071 -1.018 . . . . 3.12 110.099 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -60.0 -39.69 86.65 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.067 -0.515 . . . . 1.28 110.579 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.48 -40.02 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.206 -0.934 . . . . 0.49 109.936 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.02 -41.75 31.53 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 119.838 -1.172 . . . . 0.46 110.691 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.457 ' HG2' ' HZ2' ' A' ' 135' ' ' LYS . 16.6 ttpp -58.29 -41.94 85.49 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.305 -1.115 . . . . 2.71 110.355 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HG2' ' NH1' ' A' ' 136' ' ' ARG . 63.7 mtt-85 -63.31 -44.58 94.58 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.478 -0.889 . . . . 2.14 110.019 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 32.2 tp -60.84 -42.06 97.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.625 -0.672 . . . . 1.05 110.084 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.1 mt -59.76 -40.83 89.46 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.377 -0.827 . . . . 0.52 110.367 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -61.33 -36.16 79.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.188 -0.945 . . . . 2.35 110.806 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -74.31 -41.36 61.28 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.218 -0.993 . . . . 1.39 110.698 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.484 HG21 ' OD1' ' A' ' 101' ' ' ASP . 88.5 mt -60.48 -39.02 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.335 -0.853 . . . . 0.68 110.454 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.544 HD21 ' OD2' ' A' ' 101' ' ' ASP . 70.0 mt -85.09 -8.01 58.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.968 -1.082 . . . . 0.83 112.263 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.12 15.6 80.14 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 120.334 -0.936 . . . . 0.91 112.314 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 27.7 tp -70.0 142.37 52.8 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.715 0.769 . . . . 0.95 109.474 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -68.35 151.27 47.11 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.313 -0.867 . . . . 2.43 110.205 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.1 mt -104.61 135.17 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.261 -1.014 . . . . 1.1 108.261 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.726 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -78.49 117.91 24.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.696 -0.853 . . . . 1.58 108.696 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -99.35 103.32 15.13 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.263 -1.755 . . . . 1.62 106.263 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -74.12 -15.21 61.05 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.604 -0.685 . . . . 0.8 111.573 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -81.59 1.8 32.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.224 -0.922 . . . . 1.56 112.279 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.44 23.85 8.02 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.317 -0.864 . . . . 0.84 112.546 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.5 mt -72.41 139.92 18.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.102 -0.999 . . . . 0.82 108.923 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -110.52 -18.88 13.1 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.865 0.841 . . . . 2.31 112.611 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -114.33 134.17 55.15 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.802 -1.185 . . . . 1.54 107.802 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.54 127.57 33.2 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.039 -1.038 . . . . 1.38 108.402 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.84 173.49 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.014 -0.736 . . . . 0.69 109.014 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 29.6 mt -86.75 139.58 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.396 -0.965 . . . . 0.53 108.396 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.5 tp -94.7 122.94 37.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.119 -0.988 . . . . 0.64 108.681 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.48 131.17 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.091 -1.077 . . . . 0.67 108.091 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.492 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -160.7 153.7 21.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 0.78 108.73 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.471 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -62.5 -36.29 82.09 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.502 -1.374 . . . . 1.0 109.411 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 57.7 t0 -170.86 150.54 3.21 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.651 -0.87 . . . . 2.42 108.651 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.468 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 79.8 mt -119.19 143.21 47.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.27 -0.894 . . . . 0.75 109.261 177.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.4 p -91.83 146.49 33.09 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 120.988 -1.07 . . . . 0.78 108.625 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -39.31 -42.62 2.48 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.216 1.944 . . . . 0.67 114.045 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.3 m -59.81 -48.33 82.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 0.7 110.154 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -64.5 -39.95 94.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.002 -1.061 . . . . 1.21 110.284 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 35.0 p -68.47 -35.0 76.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.608 -0.683 . . . . 0.6 110.659 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.68 88.36 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.424 -0.798 . . . . 0.62 110.364 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -93.21 -1.21 56.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.318 -0.864 . . . . 1.16 112.597 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 171' ' ' LEU . 39.0 tp -61.71 150.87 35.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.342 -0.849 . . . . 0.73 109.361 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -94.76 115.03 27.01 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 107.331 -1.359 . . . . 2.24 107.331 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 23.1 mt -73.83 -20.39 60.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.864 -0.523 . . . . 1.43 111.459 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -83.03 -23.04 33.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 2.15 112.252 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -100.88 -1.88 33.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.263 0.838 . . . . 2.04 113.263 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 178' ' ' GLY . 60.4 t -108.38 125.52 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.648 -1.241 . . . . 0.55 107.648 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 13.0 tp -84.25 -4.1 58.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 1.63 111.796 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.604 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.83 170.31 30.59 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.858 -1.697 . . . . 0.47 108.858 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.09 129.33 47.76 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 107.785 -1.191 . . . . 0.54 107.785 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.464 HG22 HG21 ' A' ' 205' ' ' THR . 87.2 mt -130.99 109.85 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 106.409 -1.7 . . . . 0.69 106.409 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 205' ' ' THR . 66.9 p -127.39 169.86 13.15 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.974 -1.079 . . . . 0.82 109.586 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 21.4 p-10 -101.67 53.43 0.82 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.719 -0.613 . . . . 2.37 110.643 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -99.53 133.37 43.95 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.371 -0.974 . . . . 1.11 108.371 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.4 3.17 4.82 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.733 -1.222 . . . . 1.67 112.638 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 92.92 -4.68 75.43 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.247 -1.149 . . . . 1.54 113.198 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.448 ' CG ' ' O ' ' A' ' 186' ' ' ARG . 26.2 ptt180 -81.63 118.36 22.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.813 -1.551 . . . . 4.48 106.813 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 73.5 p 46.95 40.28 9.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.763 -1.211 . . . . 2.63 111.881 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 82.0 p -84.34 109.44 17.83 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.029 -1.471 . . . . 1.69 107.029 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -61.54 -32.97 73.06 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.509 -0.744 . . . . 1.07 110.811 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.3 p -57.13 -40.3 76.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.748 -1.22 . . . . 1.58 110.218 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.0 t -60.17 -39.62 87.11 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.018 -1.051 . . . . 1.6 109.892 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.1 mm -59.88 -40.13 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 1.45 110.351 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.4 mtp -65.06 -42.74 93.92 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.339 1.066 . . . . 1.05 109.605 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.28 -47.42 86.06 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.797 -0.638 . . . . 0.72 110.979 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -61.38 -42.79 99.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.977 -1.077 . . . . 3.05 110.436 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 72.4 m -70.59 -42.73 70.63 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.956 0.884 . . . . 0.89 110.127 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.2 mt -91.84 -8.14 47.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.46 -0.775 . . . . 0.78 112.182 -177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 54.43 9.78 0.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.912 1.078 . . . . 1.45 113.912 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 37.7 mt -70.14 164.97 48.0 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.079 -1.013 . . . . 0.67 109.283 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -70.68 144.28 48.69 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.7 1.6 . . . . 0.64 110.444 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -160.91 166.11 28.95 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.701 -1.6 . . . . 0.67 109.611 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 65.0 mt -146.9 156.48 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.447 -1.316 . . . . 0.69 107.447 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.5 m -140.94 -31.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 O-C-N 120.687 -1.258 . . . . 0.85 112.366 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.05 43.29 2.44 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.007 -1.058 . . . . 0.92 111.997 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 181' ' ' THR . 30.6 p -63.03 -16.73 60.85 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.134 -1.216 . . . . 0.95 111.202 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.96 -94.71 1.0 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 110.14 -1.184 . . . . 1.04 110.14 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 86.8 p -129.07 30.92 4.97 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.607 -0.937 . . . . 1.57 111.716 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.13 -38.18 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.506 -1.371 . . . . 0.84 110.165 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 76.2 p -52.86 -25.81 12.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.99 111.379 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.9 p -96.27 6.2 49.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 1.7 111.814 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -128.82 -4.17 5.19 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 113.136 0.791 . . . . 2.2 113.136 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 13.4 t -117.96 149.51 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.675 0.75 . . . . 0.84 109.784 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -118.46 152.53 35.73 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.079 -1.082 . . . . 2.2 108.079 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 40.4 p-10 -54.31 146.3 15.85 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.932 -1.107 . . . . 2.28 110.113 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 t70 81.07 -3.42 1.74 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 114.304 1.224 . . . . 2.35 114.304 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.76 146.16 53.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.948 -1.095 . . . . 1.97 108.74 177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -88.78 120.22 29.99 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.003 -1.48 . . . . 2.65 107.003 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.46 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.1 mt -126.67 143.39 51.25 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.274 -0.891 . . . . 0.63 109.846 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.7 mt -109.53 121.37 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.859 -1.534 . . . . 0.62 106.859 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 32.8 tp -98.91 109.79 22.49 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.12 -1.807 . . . . 0.64 106.12 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.9 p30 -93.76 -22.52 18.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.907 -1.121 . . . . 2.05 112.958 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.897 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.64 19.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.58 0.705 . . . . 0.84 112.804 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.7 t -108.42 -60.14 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.015 -1.053 . . . . 1.02 108.837 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -88.7 8.25 29.62 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.159 0.98 . . . . 2.51 110.028 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 65.86 49.55 1.65 Allowed 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.9 -1.045 . . . . 1.54 111.944 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -154.65 156.34 36.3 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.642 1.21 . . . . 1.95 110.873 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 54.8 t -118.14 141.58 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 115.176 -0.92 . . . . 0.71 108.626 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -100.98 139.09 37.16 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.961 -1.087 . . . . 1.01 108.431 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.1 t -111.11 129.71 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 107.945 -1.132 . . . . 0.82 107.945 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.429 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 4.1 t30 49.57 50.17 8.66 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 113.4 0.889 . . . . 1.54 113.4 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 29.8 Cg_endo -65.14 151.71 84.68 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.42 2.08 . . . . 0.94 110.41 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 35.9 p -73.4 159.63 33.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.053 -1.029 . . . . 1.8 108.84 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -63.26 -33.81 76.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.365 -0.834 . . . . 2.73 111.143 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.22 -39.25 82.11 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.081 -1.012 . . . . 3.17 110.699 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 98.2 t -71.94 -39.34 66.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.264 -0.897 . . . . 1.34 110.77 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.0 mt . . . . . 0 C--N 1.302 -1.471 0 O-C-N 121.178 -0.951 . . . . 1.2 110.154 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 106.564 -1.643 . . . . 1.07 106.564 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.1 m -104.9 120.57 41.75 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.004 -1.11 . . . . 1.24 108.004 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.08 -158.5 22.21 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.74 -1.744 . . . . 1.01 108.74 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 5' ' ' ILE . 84.4 mt -96.26 -0.59 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.303 -1.116 . . . . 1.11 113.002 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tp 50.06 98.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.925 -1.109 . . . . 0.99 112.583 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.13 -45.12 12.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.106 -0.996 . . . . 0.85 110.849 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -146.58 140.87 15.62 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 107.639 -1.245 . . . . 1.38 107.639 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.38 150.75 41.86 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.506 2.138 . . . . 0.94 112.345 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.947 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.41 170.34 18.8 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 108.992 -1.643 . . . . 0.81 108.992 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.5 mt -129.86 138.8 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.026 -1.279 . . . . 0.83 108.288 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.35 149.88 38.36 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.054 -1.029 . . . . 0.53 109.417 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.3 m-85 -122.04 139.83 53.23 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.969 -1.123 . . . . 0.77 107.969 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.24 171.21 41.34 Favored Glycine 0 N--CA 1.499 2.848 0 C-N-CA 118.746 -1.692 . . . . 0.51 110.213 178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -76.4 158.77 31.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.604 -0.939 . . . . 1.9 108.742 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.59 132.83 33.8 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.225 -0.922 . . . . 0.66 108.827 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.6 tp -110.63 102.69 11.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.78 -1.933 . . . . 0.83 105.78 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.8 tp -91.51 136.84 32.83 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.078 -1.082 . . . . 0.86 108.078 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.5 mt -102.34 116.23 32.2 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.947 -1.501 . . . . 0.92 106.947 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -111.18 137.88 48.32 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.656 -1.238 . . . . 2.03 107.656 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -125.65 149.66 48.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.089 -1.007 . . . . 2.66 108.864 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -85.21 137.56 32.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.736 -1.209 . . . . 2.32 107.736 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -63.3 148.29 48.7 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.599 -0.84 . . . . 2.11 108.818 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -92.55 135.38 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.403 -0.962 . . . . 0.73 108.403 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.7 t -104.4 130.16 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.061 -1.089 . . . . 0.87 108.061 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.1 mt -98.32 135.22 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.278 -1.008 . . . . 0.81 108.278 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -90.64 119.23 30.71 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 106.948 -1.501 . . . . 1.34 106.948 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.451 HH11 ' HG3' ' A' ' 28' ' ' ARG . 19.1 mmm-85 -96.81 11.74 34.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 2.89 112.111 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -72.01 152.26 42.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.176 -0.952 . . . . 2.09 109.619 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -91.71 135.14 34.12 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.54 -0.911 . . . . 2.19 108.54 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -94.64 167.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.886 -1.133 . . . . 0.75 109.957 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.5 p -93.8 166.06 12.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.112 -0.993 . . . . 0.91 109.332 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.06 -19.81 34.57 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.876 -1.14 . . . . 0.93 112.814 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 60.1 t0 -70.01 -38.06 75.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.784 -1.197 . . . . 2.28 110.749 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -86.38 -11.0 53.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.809 -1.182 . . . . 1.45 112.202 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.34 -43.94 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.003 -1.061 . . . . 0.81 110.362 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.1 -39.81 83.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.357 -0.839 . . . . 1.54 110.621 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -63.68 -42.66 98.0 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.25 -0.907 . . . . 2.36 111.019 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -61.53 -38.78 88.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.986 -1.071 . . . . 1.31 110.901 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.4 t -60.0 -45.4 95.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.155 -0.965 . . . . 0.82 110.329 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -61.55 -45.49 93.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.975 . . . . 1.5 110.081 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.65 -43.31 97.77 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.387 -0.821 . . . . 2.23 110.286 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -71.41 -56.94 4.97 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.185 -0.947 . . . . 0.85 109.987 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.6 tp -58.18 -47.46 83.34 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.203 -0.999 . . . . 0.91 109.786 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.4 t -69.95 -37.47 75.86 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.141 -0.975 . . . . 0.9 109.997 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.45 -46.89 91.43 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.912 -1.137 . . . . 0.69 110.366 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -59.83 -30.6 69.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.406 -1.056 . . . . 2.88 109.437 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.16 -45.2 87.87 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.163 -0.615 . . . . 0.85 109.868 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -80.8 -42.26 22.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 2.35 110.885 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.43 85.5 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.599 -0.841 . . . . 0.65 109.42 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 t -60.68 -41.13 94.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.217 1.008 . . . . 1.45 109.077 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.47 -46.07 77.59 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.62 -0.718 . . . . 0.63 110.144 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -62.92 -49.98 72.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.092 -1.005 . . . . 1.34 109.997 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.1 mt -61.69 -40.01 93.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.163 -0.96 . . . . 1.56 109.978 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -60.15 -40.02 88.41 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.93 -0.481 . . . . 1.19 110.497 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.53 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 16.2 m -65.59 -45.01 84.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.924 -1.11 . . . . 0.72 110.043 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.57 -37.84 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 0.62 110.3 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.42 ' NZ ' ' OE2' ' A' ' 70' ' ' GLU . 9.0 ttpp -49.25 -43.4 42.83 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.968 -0.693 . . . . 1.05 110.915 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -69.54 -38.99 77.72 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.581 -0.699 . . . . 0.64 109.659 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.53 ' NZ ' HG22 ' A' ' 56' ' ' THR . 62.1 mttp -61.01 -40.32 93.09 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.46 -1.296 . . . . 1.73 108.996 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.24 77.73 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.922 -0.711 . . . . 0.56 109.835 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.47 -36.74 19.42 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.704 -1.236 . . . . 0.69 110.939 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -80.79 -27.28 36.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.041 -1.27 . . . . 1.48 111.125 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -83.9 -49.87 8.6 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.565 -0.709 . . . . 0.98 111.021 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.87 -5.08 18.55 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.031 1.123 . . . . 1.16 114.031 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.88 163.84 28.97 Favored Glycine 0 N--CA 1.502 3.096 0 O-C-N 121.291 -0.881 . . . . 0.85 111.82 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -56.49 -24.34 45.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.685 -0.891 . . . . 3.86 112.218 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.6 -39.93 68.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 2.35 110.715 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -87.72 -25.03 23.66 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.931 -1.106 . . . . 1.67 111.386 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.42 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 71.1 tt0 -59.72 -37.31 78.54 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.489 0.661 . . . . 1.45 110.647 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.96 74.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.61 111.341 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.55 -42.37 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.634 -1.291 . . . . 0.65 110.517 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -70.13 -31.66 69.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.392 -0.817 . . . . 0.66 110.252 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -59.99 -38.44 82.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.042 -1.036 . . . . 1.19 110.278 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.48 -39.87 86.85 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.004 -1.238 . . . . 0.53 110.004 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -60.21 -45.72 92.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.273 -1.133 . . . . 1.27 110.312 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.5 mt -60.92 -39.34 81.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.193 -0.942 . . . . 0.54 110.318 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.7 ttm -56.9 -40.55 76.47 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.594 -0.842 . . . . 1.74 110.101 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -59.52 -50.05 75.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 0.55 109.992 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.4 tp -61.88 -41.04 97.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.502 -0.748 . . . . 0.47 110.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -86.38 8.05 23.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.506 -0.746 . . . . 1.42 112.518 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -65.5 125.69 25.98 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.448 -1.407 . . . . 1.27 108.346 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.0 -18.73 65.52 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.107 0.956 . . . . 1.35 110.711 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -76.46 -54.65 6.42 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.752 -0.779 . . . . 2.22 110.428 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.68 -35.15 75.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.408 -0.807 . . . . 0.62 110.962 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -59.93 -49.19 78.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.416 -0.802 . . . . 1.29 110.522 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -61.6 -35.72 78.65 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.61 -0.681 . . . . 1.52 110.625 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.82 -46.87 73.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.02 . . . . 1.3 110.619 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.8 mt -59.51 -46.52 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.146 -0.971 . . . . 0.61 109.718 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.7 mt -62.18 -41.25 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.446 0.641 . . . . 0.78 110.529 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.5 -44.24 97.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.103 -0.998 . . . . 0.82 110.741 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.58 -42.31 96.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.045 -1.034 . . . . 0.8 110.434 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.58 -49.43 83.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.034 -1.041 . . . . 0.77 110.386 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -82.8 -31.48 28.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.157 -0.965 . . . . 2.12 111.644 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 91' ' ' ALA . 35.8 t0 -83.03 -45.83 13.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.735 -1.228 . . . . 1.51 111.886 -178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -103.26 11.24 37.06 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.307 -0.87 . . . . 1.98 111.998 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.2 m80 51.3 51.95 15.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.441 -0.787 . . . . 1.32 111.999 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -105.89 151.93 23.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.456 -0.777 . . . . 1.38 109.178 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.7 p -71.61 161.92 30.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.43 -0.794 . . . . 0.67 109.583 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.95 -44.4 91.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.261 -0.899 . . . . 0.52 110.875 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 21.0 p-10 -68.71 -39.25 80.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.996 -1.065 . . . . 2.25 110.133 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -48.21 63.78 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.727 -0.789 . . . . 0.64 111.176 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.35 77.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.242 -0.911 . . . . 0.56 110.577 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.7 89.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.448 -0.783 . . . . 0.46 110.656 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.9 -39.48 89.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.852 -1.155 . . . . 1.32 110.937 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.53 -48.74 79.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.857 -1.152 . . . . 1.3 110.742 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.9 t -59.74 -47.91 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.707 -1.246 . . . . 0.61 109.877 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.0 mm -61.71 -35.64 68.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.934 -0.479 . . . . 0.65 110.617 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -56.58 -40.2 74.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.893 -1.129 . . . . 2.11 111.073 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.36 -28.89 23.67 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.346 -1.407 . . . . 0.83 113.185 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -62.35 -39.94 94.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.466 -1.608 . . . . 1.28 109.973 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.03 -48.49 35.72 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.787 0.803 . . . . 0.89 110.517 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.4 m -61.45 -40.62 95.14 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.208 -0.597 . . . . 1.87 110.239 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.55 95.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.503 -0.748 . . . . 1.05 110.63 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.46 -28.28 69.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.903 -1.123 . . . . 1.02 110.826 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -66.34 -23.24 66.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.561 0.696 . . . . 2.04 110.917 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -76.33 -11.0 59.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.728 -0.608 . . . . 1.73 111.438 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.669 HD13 HD13 ' A' ' 123' ' ' LEU . 4.0 mt -87.27 138.78 31.19 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.038 -1.097 . . . . 1.37 108.038 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 14.2 t70 -96.24 62.52 2.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.308 -0.87 . . . . 2.88 110.48 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -138.36 135.96 35.87 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 107.574 -1.269 . . . . 1.58 107.574 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -59.18 -37.26 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 3.04 110.837 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -71.21 -55.68 7.62 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.809 -1.182 . . . . 0.9 110.402 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.669 HD13 HD13 ' A' ' 118' ' ' LEU . 29.9 mt -60.83 -38.41 85.4 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.109 -0.994 . . . . 1.06 110.704 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -60.7 -49.53 77.12 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.952 -1.099 . . . . 2.18 109.507 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -60.21 -30.41 69.36 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.49 -0.884 . . . . 2.15 109.431 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 130' ' ' VAL . 57.6 ttt180 -62.26 -29.86 70.71 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.06 -1.056 . . . . 2.33 109.03 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.98 75.47 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.939 0.876 . . . . 0.82 109.32 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -42.55 77.26 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.881 -0.6 . . . . 0.85 110.513 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -62.78 -36.52 83.38 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.626 0.727 . . . . 1.39 110.25 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 126' ' ' ARG . 41.7 t -69.21 -39.41 79.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.406 -0.809 . . . . 0.56 110.14 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.414 ' HG3' HH11 ' A' ' 131' ' ' ARG . 38.9 ttm-85 -56.4 -38.96 72.22 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 118.912 -1.115 . . . . 3.12 109.489 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -60.02 -38.6 83.18 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.391 0.615 . . . . 1.28 110.121 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.3 mt -60.33 -39.93 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.703 -0.623 . . . . 0.49 110.027 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.85 -43.79 40.45 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.925 -1.131 . . . . 0.46 110.734 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -57.19 -42.5 81.33 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.145 -1.209 . . . . 2.71 110.099 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 -62.95 -40.69 98.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.13 -0.981 . . . . 2.14 109.815 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.84 -45.95 92.45 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.534 -0.729 . . . . 1.05 110.122 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.69 -42.17 92.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.585 -0.697 . . . . 0.52 110.62 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -60.27 -37.59 80.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.518 -0.739 . . . . 2.35 110.831 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -75.28 -41.38 57.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 1.39 111.191 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.02 -42.17 88.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.991 -1.068 . . . . 0.68 110.292 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.2 -11.0 36.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.926 -1.109 . . . . 0.83 112.276 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.07 26.82 61.29 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 119.611 -1.281 . . . . 0.91 113.11 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 22.3 tp -62.57 149.83 42.1 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.713 -0.875 . . . . 0.95 108.96 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -64.55 149.02 49.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 2.43 109.603 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 70.4 mt -106.7 142.73 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.547 -0.908 . . . . 1.1 108.547 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.762 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -78.75 129.82 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.001 -1.062 . . . . 1.58 108.253 178.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -97.8 87.17 3.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.221 -1.029 . . . . 1.62 108.221 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.97 -24.92 60.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.369 -0.832 . . . . 0.8 111.302 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.5 t -82.01 -0.54 44.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 1.56 112.1 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.49 25.74 7.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.546 -0.721 . . . . 0.84 111.6 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 mt -70.96 139.98 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.138 -0.976 . . . . 0.82 109.439 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -112.02 -20.18 12.06 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.645 0.735 . . . . 2.31 112.073 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -117.63 137.75 52.42 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.704 -1.221 . . . . 1.54 107.704 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.25 128.34 35.37 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.977 -1.119 . . . . 1.38 107.977 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.0 m -148.33 176.76 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.064 -0.717 . . . . 0.69 109.064 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 44.4 mt -88.17 143.72 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.138 -0.976 . . . . 0.53 109.007 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.5 tp -95.93 120.21 35.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.014 -1.054 . . . . 0.64 108.61 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.0 t -120.15 129.58 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 107.506 -1.294 . . . . 0.67 107.506 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.69 151.65 16.9 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.174 -0.954 . . . . 0.78 109.084 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.74 -32.46 72.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.358 -1.464 . . . . 1.0 109.616 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -173.42 152.01 2.09 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.655 -0.868 . . . . 2.42 108.655 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 41.7 mt -112.73 140.27 47.64 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.382 -0.824 . . . . 0.75 108.965 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.9 p -91.11 146.87 34.44 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.072 -1.018 . . . . 0.78 108.852 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -39.19 -43.02 2.43 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 122.173 1.915 . . . . 0.67 113.405 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.6 m -60.16 -48.5 81.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.066 . . . . 0.7 110.234 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -64.68 -39.91 94.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.019 -1.051 . . . . 1.21 109.9 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 43.2 p -65.47 -43.32 90.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.602 -0.686 . . . . 0.6 110.978 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.75 82.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.62 110.617 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -95.87 -1.14 50.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.171 -0.955 . . . . 1.16 112.79 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.74 145.85 51.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.973 -1.079 . . . . 0.73 108.181 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -94.99 117.49 30.22 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 106.979 -1.489 . . . . 2.24 106.979 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.729 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -72.93 -18.59 61.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.781 -0.574 . . . . 1.43 111.151 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -84.06 -16.17 44.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 2.15 112.222 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -103.38 -11.97 17.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.538 -0.726 . . . . 2.04 112.812 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 178' ' ' GLY . 94.9 t -106.15 128.49 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 107.888 -1.153 . . . . 0.55 107.888 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.62 -8.41 58.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.031 -1.043 . . . . 1.63 112.326 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.552 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 177.22 173.94 43.19 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.437 -1.465 . . . . 0.47 109.437 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -127.48 131.62 50.12 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 107.79 -1.189 . . . . 0.54 107.79 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.533 HD11 HD13 ' A' ' 220' ' ' LEU . 62.5 mt -137.18 118.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 105.932 -1.877 . . . . 0.69 105.932 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 203' ' ' VAL . 62.9 p -140.46 170.81 15.11 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.693 -1.254 . . . . 0.82 110.08 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -104.09 65.36 0.8 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.791 -0.568 . . . . 2.37 109.627 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -104.33 152.22 22.51 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.494 -0.754 . . . . 1.11 109.484 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.45 -38.47 70.04 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 120.222 -0.99 . . . . 1.67 110.864 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.63 -2.37 64.67 Favored Glycine 0 N--CA 1.494 2.561 0 O-C-N 121.094 -1.239 . . . . 1.54 113.292 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.437 HH11 ' HG2' ' A' ' 186' ' ' ARG . 3.5 ptt-85 -88.83 101.45 14.05 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.624 -1.991 . . . . 4.48 105.624 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 p 53.4 47.64 23.7 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.993 -1.067 . . . . 2.63 112.001 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 59.1 m -83.63 135.86 34.44 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.697 -1.223 . . . . 1.69 107.697 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -59.36 -39.92 84.81 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.286 -0.884 . . . . 1.07 111.026 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.0 m -59.62 -40.33 87.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.898 -1.126 . . . . 1.58 110.089 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.2 p -61.88 -35.04 77.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 1.6 110.652 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 32.0 mm -59.99 -39.29 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.519 -0.738 . . . . 1.45 110.656 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.4 mtp -62.23 -43.16 99.46 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 122.319 1.057 . . . . 1.05 109.595 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.89 -47.76 83.82 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.717 -0.614 . . . . 0.72 110.504 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.516 HH11 ' HG2' ' A' ' 195' ' ' ARG . 33.8 mtt-85 -60.12 -41.34 92.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 3.05 110.586 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.7 m -70.13 -41.53 73.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.182 -0.949 . . . . 0.89 110.079 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.83 -8.18 50.28 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.577 0.703 . . . . 0.78 112.49 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 194' ' ' ALA . 94.5 mt-10 49.6 12.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.82 1.045 . . . . 1.45 113.82 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.57 149.06 93.31 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 107.872 -1.159 . . . . 0.67 107.872 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.34 135.86 71.0 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 120.948 1.099 . . . . 0.64 110.017 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.75 163.11 34.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.31 -1.494 . . . . 0.67 109.397 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.419 ' CD1' HD11 ' A' ' 220' ' ' LEU . 32.2 mt -146.79 147.51 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.639 -1.245 . . . . 0.69 107.639 177.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.5 m -125.24 -31.55 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.146 -0.971 . . . . 0.85 113.052 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.1 45.01 2.46 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 119.542 -1.313 . . . . 0.92 111.016 -178.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 181' ' ' THR . 58.6 p -61.86 -19.54 62.73 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.537 -0.978 . . . . 0.95 111.372 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.65 -90.7 0.86 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.48 -1.048 . . . . 1.04 110.48 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.3 p -130.62 28.69 4.87 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.503 -0.998 . . . . 1.57 113.288 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.31 -40.02 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.44 -1.412 . . . . 0.84 110.603 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.2 p -58.28 -22.72 53.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.968 -1.082 . . . . 0.99 111.707 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.5 p -94.15 -1.88 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.424 -0.797 . . . . 1.7 112.183 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -125.88 3.07 7.37 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.645 0.736 . . . . 2.2 112.436 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 22.4 t -116.13 146.54 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.528 -0.733 . . . . 0.84 109.263 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -119.81 160.45 22.61 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.998 -1.112 . . . . 2.2 107.998 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 3.7 m120 -57.36 139.81 51.96 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.85 -1.156 . . . . 2.28 110.812 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 79.11 5.55 2.23 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.193 1.182 . . . . 2.35 114.193 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 61.0 t0 -66.08 149.08 50.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.911 -1.118 . . . . 1.97 108.437 177.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.496 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 36.3 t80 -89.82 122.18 32.65 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.916 -1.513 . . . . 2.65 106.916 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.4 mt -129.52 147.53 51.34 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.035 0.922 . . . . 0.63 110.105 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 21.0 mt -119.92 130.75 73.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.408 -1.33 . . . . 0.62 107.408 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.533 HD13 HD11 ' A' ' 180' ' ' ILE . 60.8 tp -99.65 120.2 39.31 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.407 -1.331 . . . . 0.64 107.407 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 223' ' ' VAL . 33.5 t0 -89.77 -35.78 15.52 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.976 -1.077 . . . . 2.05 111.431 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.947 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.78 17.75 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.566 0.698 . . . . 0.84 112.459 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.1 t -109.15 -58.25 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.168 -0.957 . . . . 1.02 109.33 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -95.69 14.72 22.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.961 0.886 . . . . 2.51 110.598 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.0 t30 61.93 52.27 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.608 -0.724 . . . . 1.54 112.834 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -151.93 157.13 41.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.031 -1.043 . . . . 1.95 110.168 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.35 135.19 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.071 -1.085 . . . . 0.71 108.071 177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -103.24 130.01 50.36 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.065 -1.022 . . . . 1.01 108.588 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.9 t -110.53 129.85 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.991 -1.114 . . . . 0.82 107.991 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.443 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 61.8 t30 53.59 48.75 5.26 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 113.434 0.902 . . . . 1.54 113.434 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 37.0 Cg_endo -65.73 153.5 77.88 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.656 2.237 . . . . 0.94 110.911 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.0 p -72.17 160.21 32.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.997 -1.065 . . . . 1.8 110.134 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -60.19 -37.96 81.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.216 -0.928 . . . . 2.73 110.642 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.98 -39.16 84.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 3.17 110.558 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.7 -35.71 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.207 -0.933 . . . . 1.34 110.176 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.488 1.459 0 O-C-N 121.351 -0.843 . . . . 1.2 110.598 179.175 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 106.544 -1.65 . . . . 1.07 106.544 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.8 m -102.09 124.51 47.82 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.634 -1.247 . . . . 1.24 107.634 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' A' ' 225' ' ' ASN . . . -118.42 -160.72 11.6 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.77 -1.732 . . . . 1.01 108.77 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 5' ' ' ILE . 90.2 mt -95.8 1.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.372 -1.075 . . . . 1.11 112.711 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.91 97.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 0.99 112.195 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -86.41 -37.4 18.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.36 -0.837 . . . . 0.85 111.477 179.404 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -150.6 145.71 18.75 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 120.682 -1.261 . . . . 1.38 107.738 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.45 144.77 23.08 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 122.647 2.231 . . . . 0.94 112.121 178.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.924 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.65 170.69 20.7 Favored Glycine 0 N--CA 1.504 3.197 0 N-CA-C 109.556 -1.417 . . . . 0.81 109.556 178.032 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.5 mt -133.24 133.68 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 107.71 -1.219 . . . . 0.83 107.71 179.716 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.0 151.94 41.4 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.19 -0.944 . . . . 0.53 109.305 179.034 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 11.2 m-85 -119.25 140.82 49.62 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.668 -0.864 . . . . 0.77 108.668 177.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.19 169.22 41.4 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 118.586 -1.769 . . . . 0.51 110.472 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -77.76 158.18 29.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.688 -0.889 . . . . 1.9 109.076 177.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.42 126.74 33.53 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.957 -1.089 . . . . 0.66 108.291 178.479 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.0 tp -110.11 102.27 10.99 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.621 -1.992 . . . . 0.83 105.621 178.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 tp -88.42 140.33 29.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.937 -1.102 . . . . 0.86 108.922 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.46 HD11 HD11 ' A' ' 158' ' ' LEU . 44.8 mt -99.86 119.72 38.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.923 -1.111 . . . . 0.92 108.061 178.106 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -110.31 141.01 43.91 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.22 -1.029 . . . . 2.03 108.22 179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -118.67 141.32 48.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.103 -0.998 . . . . 2.66 109.281 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -82.91 133.68 35.11 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.746 -1.205 . . . . 2.32 107.746 177.307 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -62.95 149.13 45.52 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.759 -0.83 . . . . 2.11 108.759 178.69 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.6 mt -95.15 133.79 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.584 -0.895 . . . . 0.73 108.584 178.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 t -103.6 130.14 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.936 -1.135 . . . . 0.87 107.936 178.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.0 mt -98.31 133.12 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.287 -1.005 . . . . 0.81 108.287 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -87.28 119.51 27.61 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.249 -1.389 . . . . 1.34 107.249 178.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -101.37 20.02 16.68 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.86 -0.525 . . . . 2.89 111.619 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -63.27 149.89 44.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.254 -0.904 . . . . 2.09 110.154 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -91.33 125.38 36.08 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.47 -1.307 . . . . 2.19 107.47 177.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 pt -97.07 166.5 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.338 -0.852 . . . . 0.75 110.15 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.8 p -99.3 164.3 12.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.595 -0.69 . . . . 0.91 109.697 178.236 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.89 -28.38 36.05 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.052 -1.03 . . . . 0.93 111.18 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -69.23 -34.11 74.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.009 . . . . 2.28 110.393 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -87.61 -15.32 37.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.136 -0.978 . . . . 1.45 112.193 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.76 -41.34 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.977 -1.077 . . . . 0.81 110.367 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.32 -40.07 81.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.828 -1.17 . . . . 1.54 110.841 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -61.24 -42.27 98.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.569 -0.707 . . . . 2.36 111.245 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.08 -38.02 81.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.827 -1.17 . . . . 1.31 111.154 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.54 -44.78 93.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.976 -1.077 . . . . 0.82 110.26 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -62.36 -44.64 96.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.201 -0.937 . . . . 1.5 110.266 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -62.15 -41.51 98.35 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.154 -0.966 . . . . 2.23 109.638 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 32.1 t80 -74.06 -51.99 14.07 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.262 -0.899 . . . . 0.85 109.249 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.01 -47.72 85.11 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 117.924 -1.511 . . . . 0.91 110.367 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.605 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.4 t -69.57 -40.63 76.63 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.362 0.601 . . . . 0.9 110.172 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.56 -44.67 90.71 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.292 -1.432 . . . . 0.69 110.079 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.403 HH11 ' HB3' ' A' ' 47' ' ' ARG . 1.7 ttt-85 -59.37 -30.86 68.72 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.573 -0.957 . . . . 2.88 109.36 178.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.72 -45.64 85.51 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.745 -0.661 . . . . 0.85 109.773 178.76 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -80.11 -45.03 18.92 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.452 0.644 . . . . 2.35 110.427 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.66 -41.98 91.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.317 -0.864 . . . . 0.65 110.156 -178.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.6 t -60.02 -41.54 92.41 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 122.45 1.119 . . . . 1.45 109.098 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.47 -46.57 79.29 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.265 -0.88 . . . . 0.63 110.209 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -62.55 -50.38 71.58 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.117 -0.989 . . . . 1.34 110.063 179.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 66.4 mt -61.23 -36.78 80.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.214 -0.929 . . . . 1.56 110.192 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.81 -41.12 95.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.791 -0.568 . . . . 1.19 110.819 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.59 HG22 ' HZ2' ' A' ' 60' ' ' LYS . 18.6 m -64.74 -42.67 95.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.813 -1.179 . . . . 0.72 110.009 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.51 -38.29 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.818 -0.551 . . . . 0.62 110.672 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -50.32 -45.75 55.01 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 120.122 -0.631 . . . . 1.05 111.182 179.179 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -68.32 -32.56 72.78 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.937 -1.102 . . . . 0.64 109.91 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.59 ' HZ2' HG22 ' A' ' 56' ' ' THR . 54.0 mttp -61.64 -39.88 92.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.617 -1.233 . . . . 1.73 109.295 179.402 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.9 -34.9 78.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.516 -0.74 . . . . 0.56 110.097 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.61 -35.09 23.53 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.856 -1.164 . . . . 0.69 111.364 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -83.33 -18.47 38.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.017 -1.284 . . . . 1.48 111.679 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -87.83 -53.17 4.89 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.747 -0.66 . . . . 0.98 110.3 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -106.95 -17.21 14.25 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 113.275 0.843 . . . . 1.16 113.275 -176.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.59 158.98 10.53 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 120.893 -0.67 . . . . 0.85 111.83 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -55.24 -25.8 35.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.721 -0.87 . . . . 3.86 112.763 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.4 -35.25 71.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.781 -1.199 . . . . 2.35 111.226 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -82.16 -26.38 33.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.055 -1.028 . . . . 1.67 111.702 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -59.82 -33.8 72.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.758 -0.589 . . . . 1.45 111.401 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.07 83.7 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.432 -0.793 . . . . 0.61 111.563 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -65.62 -42.78 93.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.365 -1.459 . . . . 0.65 110.156 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -70.93 -30.86 67.3 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.828 -1.17 . . . . 0.66 110.895 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -61.36 -39.14 89.54 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.61 -0.836 . . . . 1.19 109.955 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.67 -39.53 90.42 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 120.225 -0.988 . . . . 0.53 110.793 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -57.39 -46.86 82.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.623 -1.516 . . . . 1.27 110.804 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.6 mt -59.9 -38.11 74.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.011 -1.056 . . . . 0.54 110.703 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.2 ttp -58.95 -39.4 81.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.915 -1.116 . . . . 1.74 110.308 179.202 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 tp -59.92 -49.62 76.99 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.994 -1.066 . . . . 0.55 109.783 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.9 tp -60.46 -43.72 96.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.066 0.936 . . . . 0.47 110.341 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -87.67 9.65 20.73 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 112.783 0.66 . . . . 1.42 112.783 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -65.27 123.82 20.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.737 -1.227 . . . . 1.27 108.428 178.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.78 -18.44 65.33 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.842 0.829 . . . . 1.35 110.854 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -74.11 -52.37 12.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.564 -0.854 . . . . 2.22 110.167 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.0 -37.85 86.42 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.443 -0.903 . . . . 0.62 110.897 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.78 -45.97 81.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.743 -1.223 . . . . 1.29 110.545 179.303 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -60.73 -36.86 79.93 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.486 -0.759 . . . . 1.52 110.665 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -67.01 -46.86 73.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.183 -1.007 . . . . 1.3 110.574 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.06 -43.77 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.428 -0.795 . . . . 0.61 110.024 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.6 mt -59.78 -42.26 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.531 -0.73 . . . . 0.78 110.589 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.52 -43.86 98.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.638 -0.663 . . . . 0.82 111.007 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.18 -44.47 97.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.741 -1.224 . . . . 0.8 110.474 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 93' ' ' ILE . 68.4 mt -62.99 -47.5 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.954 -1.091 . . . . 0.77 110.466 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -83.63 -31.3 26.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.195 -0.94 . . . . 2.12 111.655 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 91' ' ' ALA . 51.0 t0 -80.79 -45.84 16.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.81 -1.181 . . . . 1.51 111.399 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -100.78 7.04 44.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.626 -0.671 . . . . 1.98 112.328 -178.69 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.3 m80 51.96 49.72 20.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.181 -0.95 . . . . 1.32 112.153 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 91.1 mtp -109.64 160.74 16.03 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.223 -0.923 . . . . 1.38 109.341 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.5 p -71.21 159.34 34.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.619 -0.676 . . . . 0.67 109.852 178.001 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.59 93.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.52 110.415 178.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.481 ' OD2' HD21 ' A' ' 142' ' ' LEU . 91.9 m-20 -66.85 -39.72 87.7 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.282 -0.967 . . . . 2.25 109.727 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.83 -50.9 46.18 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.118 -1.033 . . . . 0.64 110.851 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.42 -41.03 96.52 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.061 -1.056 . . . . 0.56 110.569 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.48 87.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.689 -0.632 . . . . 0.46 110.703 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -60.56 -39.63 88.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 1.32 110.965 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -59.7 -48.87 79.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.011 -1.056 . . . . 1.3 111.055 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.29 -44.34 98.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.149 -0.969 . . . . 0.61 110.229 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.17 -32.97 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.803 -0.56 . . . . 0.65 110.475 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -59.83 -39.81 86.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.593 -0.692 . . . . 2.11 110.688 179.263 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.38 -29.73 26.71 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.331 -1.414 . . . . 0.83 113.097 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -61.03 -40.51 93.86 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.186 -1.773 . . . . 1.28 109.309 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.49 -50.02 42.3 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.82 0.819 . . . . 0.89 109.905 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.7 p -60.14 -39.72 87.28 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.725 . . . . 1.87 110.357 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.31 -43.75 96.06 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.231 -0.918 . . . . 1.05 110.194 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.78 -28.48 69.05 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.03 -1.044 . . . . 1.02 111.295 -179.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -67.15 -23.0 65.74 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.754 -0.591 . . . . 2.04 110.833 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -74.17 -11.83 60.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.696 0.76 . . . . 1.73 111.232 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.627 HD13 HD13 ' A' ' 123' ' ' LEU . 15.5 mt -86.37 141.91 28.84 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.157 -0.682 . . . . 1.37 109.157 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -99.41 55.26 0.97 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.029 -1.045 . . . . 2.88 111.058 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -130.77 142.15 50.39 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.293 -0.88 . . . . 1.58 109.202 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.33 -40.28 81.72 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.739 -0.601 . . . . 3.04 110.938 178.148 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -72.8 -54.99 7.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.942 -1.099 . . . . 0.9 111.034 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.627 HD13 HD13 ' A' ' 118' ' ' LEU . 45.5 mt -59.83 -40.33 88.1 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.069 -1.019 . . . . 1.06 110.616 -179.464 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -62.53 -49.42 75.41 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.67 -1.269 . . . . 2.18 110.084 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.6 -31.03 70.2 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.04 0.924 . . . . 2.15 109.717 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -61.99 -30.97 71.3 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.159 -1.016 . . . . 2.33 109.558 179.316 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.84 -48.9 79.81 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.588 -0.845 . . . . 0.82 109.434 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.58 -44.11 75.09 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.647 -0.821 . . . . 0.85 110.251 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.37 -31.78 73.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.106 -0.997 . . . . 1.39 110.272 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.0 t -67.98 -39.35 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.76 -0.776 . . . . 0.56 109.922 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.432 ' HG3' HH11 ' A' ' 131' ' ' ARG . 28.4 ttm-85 -56.97 -39.51 74.75 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.022 -1.071 . . . . 3.12 109.311 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -59.8 -39.23 84.28 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.499 -0.75 . . . . 1.28 110.379 179.106 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.5 mt -61.54 -39.15 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.542 -0.724 . . . . 0.49 109.968 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.45 -47.04 53.28 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 120.011 -1.09 . . . . 0.46 110.6 179.389 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -57.46 -39.79 77.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.156 -1.203 . . . . 2.71 110.496 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.446 HH11 ' HG2' ' A' ' 136' ' ' ARG . 45.5 mtt-85 -61.52 -44.31 97.29 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.247 -0.981 . . . . 2.14 109.944 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.85 -44.73 96.6 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.327 -0.858 . . . . 1.05 109.972 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.6 mt -59.47 -46.25 89.32 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.468 -0.77 . . . . 0.52 110.389 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -59.94 -33.73 72.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.427 -0.795 . . . . 2.35 110.669 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.43 -41.91 45.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.606 -0.684 . . . . 1.39 111.004 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.68 -38.31 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.68 110.78 -178.155 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.481 HD21 ' OD2' ' A' ' 101' ' ' ASP . 89.2 mt -83.97 -4.39 58.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.83 112.294 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.25 20.31 79.12 Favored Glycine 0 N--CA 1.484 1.871 0 C-N-CA 119.265 -1.445 . . . . 0.91 113.112 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.7 tp -66.97 148.43 51.97 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.665 0.745 . . . . 0.95 109.312 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -67.21 149.64 50.17 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.14 -0.975 . . . . 2.43 109.374 178.209 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 65.5 mt -105.23 139.94 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.12 -1.066 . . . . 1.1 108.12 178.074 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.682 ' H ' HD12 ' A' ' 147' ' ' ILE . 3.6 mp -75.66 126.05 35.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.313 -0.995 . . . . 1.58 108.313 178.327 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -96.22 98.03 9.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.877 -1.527 . . . . 1.62 106.877 179.289 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 64.5 mt -74.83 -11.51 60.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.272 -0.893 . . . . 0.8 111.582 -177.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.6 t -91.41 11.24 24.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.776 -0.577 . . . . 1.56 112.3 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.74 17.54 14.86 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 113.658 0.985 . . . . 0.84 113.658 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.706 HD12 ' N ' ' A' ' 152' ' ' ILE . 2.4 mp -72.77 140.84 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.299 -1.5 . . . . 0.82 109.599 178.613 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -119.24 -11.99 9.5 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.065 0.936 . . . . 2.31 111.998 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -112.89 149.18 33.51 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.616 -0.883 . . . . 1.54 108.616 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -76.32 123.23 25.61 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.527 -0.916 . . . . 1.38 108.527 178.244 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.0 m -148.51 174.46 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.469 -0.769 . . . . 0.69 109.308 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.9 mt -93.08 142.52 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.804 -0.813 . . . . 0.53 108.804 178.217 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.46 HD11 HD11 ' A' ' 19' ' ' LEU . 23.8 tp -95.07 125.81 39.98 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.753 -1.217 . . . . 0.64 108.022 178.282 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.91 129.96 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 107.68 -1.229 . . . . 0.67 107.68 179.04 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.44 151.52 17.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.511 -1.368 . . . . 0.78 108.838 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.49 -35.94 79.09 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.01 -1.056 . . . . 1.0 109.475 178.154 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -173.09 151.84 2.2 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.734 -0.839 . . . . 2.42 108.734 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.5 mt -115.86 139.59 50.06 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.774 -0.825 . . . . 0.75 108.774 177.669 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.3 p -89.39 149.26 42.32 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.965 -1.084 . . . . 0.78 108.762 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -41.3 -42.1 5.14 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.563 2.175 . . . . 0.67 113.627 179.162 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.7 m -62.87 -51.41 67.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 0.7 110.121 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -60.94 -39.39 89.28 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.32 -0.862 . . . . 1.21 110.115 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.4 p -67.92 -41.01 83.26 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.372 -0.83 . . . . 0.6 110.464 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.03 -37.03 81.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.304 -0.873 . . . . 0.62 110.819 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -97.22 3.18 51.54 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.027 -1.046 . . . . 1.16 112.685 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 46.2 tp -59.65 149.62 29.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.076 -1.015 . . . . 0.73 109.217 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -95.42 111.17 23.1 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.763 -1.569 . . . . 2.24 106.763 177.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 73.9 mt -80.74 -10.07 59.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.643 -0.66 . . . . 1.43 112.615 -177.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -80.29 -29.63 38.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.15 -0.969 . . . . 2.15 111.935 -178.422 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -100.5 -0.92 36.96 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.126 -0.984 . . . . 2.04 113.417 -178.283 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 40.0 t -108.45 129.02 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 107.749 -1.204 . . . . 0.55 107.749 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.55 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -90.21 -16.09 30.12 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.366 1.079 . . . . 1.63 111.446 -179.223 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.86 173.33 45.94 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.852 -1.699 . . . . 0.47 108.852 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -130.16 131.32 45.59 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 107.784 -1.191 . . . . 0.54 107.784 179.392 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.48 HD11 HD13 ' A' ' 220' ' ' LEU . 94.8 mt -126.77 115.3 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 106.388 -1.708 . . . . 0.69 106.388 178.169 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 203' ' ' VAL . 70.6 p -132.92 169.61 16.54 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.104 -0.997 . . . . 0.82 109.599 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.455 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 2.8 m-20 -101.86 36.01 2.19 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.563 -0.711 . . . . 2.37 110.711 179.074 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -97.88 175.64 6.07 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.766 -1.209 . . . . 1.11 109.983 177.428 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 183' ' ' ALA . . . -61.13 -132.41 0.01 OUTLIER Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.577 -1.409 . . . . 1.67 109.577 179.145 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.44 -32.89 0.1 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.63 -1.271 . . . . 1.54 113.73 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.46 ' HG3' HH11 ' A' ' 186' ' ' ARG . 36.6 mtm-85 -56.24 -39.2 72.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.678 -1.483 . . . . 4.48 110.318 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.7 p -137.72 29.27 2.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.691 -0.63 . . . . 2.63 111.686 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.1 p -82.04 139.24 34.6 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.878 0.847 . . . . 1.69 109.204 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -59.08 -38.83 80.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 1.07 110.777 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 33.8 p -59.76 -39.78 85.94 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.268 -0.973 . . . . 1.58 110.37 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.8 m -60.16 -37.63 80.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.382 -0.824 . . . . 1.6 110.42 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 37.3 mm -60.1 -37.25 72.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.576 -0.702 . . . . 1.45 110.603 179.462 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.8 mtp -62.21 -44.22 97.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.567 1.175 . . . . 1.05 109.418 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.48 -47.34 85.87 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.473 -0.785 . . . . 0.72 110.802 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -61.64 -42.58 99.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.214 -0.929 . . . . 3.05 110.804 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 20.4 m -69.46 -39.82 77.5 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.38 -0.928 . . . . 0.89 110.204 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.7 mt -90.37 -7.56 52.91 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.512 0.672 . . . . 0.78 112.451 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 194' ' ' ALA . 99.0 mt-10 53.72 8.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 113.853 1.057 . . . . 1.45 113.853 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 66.1 mt -71.5 149.99 93.69 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 0.67 108.419 178.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.92 143.03 99.75 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.459 1.439 . . . . 0.64 109.602 178.719 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.73 167.44 28.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.361 -1.462 . . . . 0.67 110.194 179.604 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.6 mt -150.58 150.53 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.626 -1.25 . . . . 0.69 107.626 178.101 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.2 m -141.54 -28.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.7 0 O-C-N 120.383 -1.448 . . . . 0.85 113.156 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.34 35.12 3.64 Favored Glycine 0 N--CA 1.488 2.107 0 O-C-N 120.961 -1.087 . . . . 0.92 112.627 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.455 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 20.1 p -59.7 -34.4 72.84 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.462 -1.611 . . . . 0.95 110.23 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 94.26 -78.55 0.97 Allowed Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.196 -1.002 . . . . 1.04 112.445 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.1 p -117.51 23.25 11.89 Favored 'General case' 0 N--CA 1.517 2.919 0 CA-C-N 119.262 1.531 . . . . 1.57 114.061 -178.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.419 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 4.8 t -55.08 -30.97 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 119.479 -2.013 . . . . 0.84 110.572 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.9 p -58.83 -28.66 66.26 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.929 -1.108 . . . . 0.99 111.421 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 13.8 m -94.26 5.28 52.26 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.885 -1.134 . . . . 1.7 112.32 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -129.5 -7.12 4.68 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 113.404 0.89 . . . . 2.2 113.404 -178.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 17.2 t -118.96 139.56 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.564 -0.902 . . . . 0.84 108.564 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -120.16 157.46 28.99 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.087 -1.079 . . . . 2.2 108.087 178.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 37.6 t30 -57.74 140.83 50.56 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.964 -1.094 . . . . 2.28 110.538 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.7 t0 80.1 0.54 2.04 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.451 1.278 . . . . 2.35 114.451 179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -66.21 147.35 53.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.552 -1.342 . . . . 1.97 108.374 177.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -90.18 118.5 29.75 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.054 -1.832 . . . . 2.65 106.054 177.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.3 mt -127.05 143.8 51.19 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.459 0.647 . . . . 0.63 109.48 -178.307 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 61.2 mt -111.36 127.59 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 106.399 -1.704 . . . . 0.62 106.399 177.551 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.48 HD13 HD11 ' A' ' 180' ' ' ILE . 62.9 tp -100.86 120.12 39.67 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.428 -1.323 . . . . 0.64 107.428 179.135 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.587 ' O ' ' N ' ' A' ' 223' ' ' VAL . 52.3 t0 -93.94 -23.68 17.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.872 -1.143 . . . . 2.05 112.777 -178.689 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.924 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.94 18.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.098 0.777 . . . . 0.84 113.098 -178.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.9 t -108.14 -60.3 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.924 -1.11 . . . . 1.02 109.037 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -100.15 16.3 24.6 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.53 0.681 . . . . 2.51 110.345 -179.436 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 4' ' ' GLY . 4.1 t-20 61.2 51.61 4.27 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.362 0.601 . . . . 1.54 111.771 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -145.83 144.87 30.52 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.277 1.036 . . . . 1.95 110.193 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.61 145.16 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.948 -0.76 . . . . 0.71 108.948 178.02 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -101.95 136.58 41.54 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.208 -1.034 . . . . 1.01 108.208 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.62 129.93 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.004 -0.739 . . . . 0.82 109.004 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 42.6 t30 49.63 58.63 17.52 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 113.79 1.033 . . . . 1.54 113.79 178.153 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.66 141.51 38.0 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 121.96 1.773 . . . . 0.94 110.791 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.4 p -74.08 156.72 37.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.942 -1.099 . . . . 1.8 109.277 177.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -58.49 -37.73 76.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.333 -0.854 . . . . 2.73 110.472 178.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.16 -40.98 82.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.452 -0.78 . . . . 3.17 110.223 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 96.6 t -71.06 -42.99 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.386 -0.821 . . . . 1.34 109.979 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.3 mt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.556 -0.715 . . . . 1.2 110.084 -179.043 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 107.654 -1.239 . . . . 1.07 107.654 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.2 m -105.73 123.3 47.72 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.784 -1.191 . . . . 1.24 107.784 178.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.22 -162.94 11.64 Favored Glycine 0 N--CA 1.499 2.884 0 N-CA-C 108.274 -1.93 . . . . 1.01 108.274 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 5' ' ' ILE . 90.9 mt -100.59 2.28 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.174 -1.191 . . . . 1.11 112.671 -179.542 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 5' ' ' ILE . 12.3 tp 50.71 101.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.078 -1.014 . . . . 0.99 112.134 179.166 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -87.87 -41.55 13.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.939 -1.1 . . . . 0.85 111.549 179.419 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 t -145.19 146.17 29.52 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.045 -1.095 . . . . 1.38 108.045 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.59 143.85 21.89 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.815 2.343 . . . . 0.94 112.377 178.389 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.922 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.19 -177.47 29.16 Favored Glycine 0 N--CA 1.503 3.129 0 N-CA-C 109.658 -1.377 . . . . 0.81 109.658 177.846 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.9 mt -137.81 140.75 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.25 -1.147 . . . . 0.83 108.578 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.48 149.99 43.22 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.317 -0.865 . . . . 0.53 109.005 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -119.56 139.8 51.56 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.713 -1.217 . . . . 0.77 107.713 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.49 163.95 27.92 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 118.125 -1.988 . . . . 0.51 110.485 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -76.48 160.68 29.29 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.506 -0.997 . . . . 1.9 109.837 179.146 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -84.15 122.29 28.64 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.965 -1.124 . . . . 0.66 107.965 178.616 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.7 tp -101.71 101.97 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.089 -2.189 . . . . 0.83 105.089 177.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.6 tp -88.25 140.37 29.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.176 -0.952 . . . . 0.86 108.632 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.9 mt -98.28 118.5 35.06 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 106.271 -1.752 . . . . 0.92 106.271 177.179 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -111.01 134.07 52.91 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.201 -1.037 . . . . 2.03 108.201 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -125.95 140.8 52.33 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.584 -0.895 . . . . 2.66 108.584 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -81.81 138.01 35.2 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.371 -0.974 . . . . 2.32 108.371 177.446 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -63.29 143.63 57.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -0.773 . . . . 2.11 108.991 178.74 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 87.9 mt -94.53 132.13 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.174 -1.047 . . . . 0.73 108.174 178.251 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.16 130.19 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.233 -1.025 . . . . 0.87 108.233 179.047 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.8 mt -94.07 138.13 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.374 -0.973 . . . . 0.81 108.374 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -92.19 122.23 34.48 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.572 -1.27 . . . . 1.34 107.572 178.557 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -93.54 10.93 30.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.289 -0.882 . . . . 2.89 112.651 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -71.57 153.01 42.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.706 -1.246 . . . . 2.09 109.349 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -92.18 140.04 30.02 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 109.102 -0.703 . . . . 2.19 109.102 178.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -92.39 175.29 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.229 -0.919 . . . . 0.75 109.915 177.369 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.473 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 6.3 p -103.5 166.62 10.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.522 -0.736 . . . . 0.91 109.549 179.459 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.56 -35.26 67.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.488 -0.758 . . . . 0.93 111.519 178.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.473 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 10.9 p-10 -69.86 -22.23 63.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.846 -1.159 . . . . 2.28 110.626 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -94.02 -20.44 19.96 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.492 0.663 . . . . 1.45 112.213 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.84 -46.4 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.626 -0.671 . . . . 0.81 110.236 -178.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -58.86 -40.36 84.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.323 -0.861 . . . . 1.54 110.658 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -64.0 -45.32 89.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 2.36 110.808 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -60.82 -37.74 83.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.256 -0.903 . . . . 1.31 110.945 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -59.13 -40.07 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.176 -0.953 . . . . 0.82 110.082 179.274 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.72 -41.74 95.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.072 -1.018 . . . . 1.5 109.645 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -63.1 -39.16 93.88 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.343 -0.848 . . . . 2.23 110.094 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -72.11 -54.52 9.52 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.411 -0.806 . . . . 0.85 110.06 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.7 tp -60.78 -50.14 74.65 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.969 0.89 . . . . 0.91 109.74 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.0 t -67.41 -38.91 85.35 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.422 -0.799 . . . . 0.9 110.247 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.58 90.85 Favored Glycine 0 N--CA 1.485 1.934 0 C-N-CA 119.648 -1.263 . . . . 0.69 110.056 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.4 HH12 ' CG ' ' A' ' 86' ' ' GLU . 39.3 ttm180 -59.94 -31.65 70.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.24 -1.153 . . . . 2.88 109.63 178.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.89 -42.63 90.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.619 0.723 . . . . 0.85 109.764 179.063 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -80.52 -48.65 12.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 2.35 110.85 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.99 79.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.515 -0.741 . . . . 0.65 110.102 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.4 p -61.68 -38.56 88.28 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.867 0.842 . . . . 1.45 109.343 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.82 -46.19 69.25 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.948 -0.569 . . . . 0.63 110.313 179.289 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.74 -49.35 75.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.633 -1.292 . . . . 1.34 110.122 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.9 mt -61.34 -40.0 92.62 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.034 0.921 . . . . 1.56 109.513 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -60.64 -39.73 89.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.577 -0.702 . . . . 1.19 110.105 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.0 m -62.06 -42.89 99.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.866 . . . . 0.72 110.366 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.0 -36.94 70.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.609 -0.682 . . . . 0.62 110.645 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -51.1 -43.5 61.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.938 . . . . 1.05 110.443 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -70.27 -36.42 74.41 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.926 -1.109 . . . . 0.64 110.009 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -62.69 -39.34 93.68 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.819 -1.153 . . . . 1.73 109.316 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.74 81.74 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.852 -0.613 . . . . 0.56 110.091 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.78 -35.86 23.97 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.467 -1.349 . . . . 0.69 110.964 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.03 -17.59 46.22 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.17 -1.194 . . . . 1.48 111.575 -179.271 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.7 m -93.46 -52.73 4.37 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.716 -0.615 . . . . 0.98 110.672 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -107.65 -6.23 17.0 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 114.004 1.112 . . . . 1.16 114.004 -178.076 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.96 149.88 11.85 Favored Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.375 -0.828 . . . . 0.85 112.432 178.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.47 -15.35 0.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.386 -1.067 . . . . 3.86 112.464 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.46 -31.32 69.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.395 -0.816 . . . . 2.35 111.291 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -83.35 -16.93 44.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.807 -1.183 . . . . 1.67 112.109 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.16 -30.76 69.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.888 -1.133 . . . . 1.45 111.228 -179.094 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.32 90.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.61 110.767 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.6 mt -67.5 -41.48 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.842 -1.161 . . . . 0.65 109.337 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -71.39 -29.88 65.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.66 110.734 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.25 -39.88 88.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.869 . . . . 1.19 110.046 179.584 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.44 -44.31 74.02 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.745 -0.942 . . . . 0.53 110.745 179.337 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -60.0 -48.06 83.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.934 -1.333 . . . . 1.27 110.726 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.5 mt -62.41 -39.49 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 120.9 -1.125 . . . . 0.54 110.016 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.8 ttp -60.28 -39.98 88.79 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.806 -0.758 . . . . 1.74 110.506 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.1 tp -59.37 -48.52 81.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.55 110.355 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.05 -41.24 91.9 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.861 0.838 . . . . 0.47 110.144 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -85.93 4.17 38.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.607 -0.683 . . . . 1.42 112.496 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -59.7 124.54 20.46 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.182 -0.949 . . . . 1.27 110.894 -178.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.02 -16.42 63.42 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.418 -0.801 . . . . 1.35 111.226 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -76.94 -54.31 6.73 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.769 0.795 . . . . 2.22 110.568 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.84 -38.24 87.49 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.386 -0.821 . . . . 0.62 110.923 -179.325 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.4 ' CG ' HH12 ' A' ' 47' ' ' ARG . 88.3 tt0 -59.0 -49.58 77.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.073 -1.017 . . . . 1.29 110.786 179.147 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.67 -39.48 94.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.027 -1.046 . . . . 1.52 110.708 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.95 -49.42 61.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 1.3 110.87 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.11 -45.64 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.836 -1.165 . . . . 0.61 110.097 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.45 -41.92 91.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.515 0.674 . . . . 0.78 110.43 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.95 95.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.258 -0.901 . . . . 0.82 111.036 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.29 -39.56 87.32 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.254 -0.904 . . . . 0.8 110.332 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.0 -51.18 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.77 110.365 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.86 -33.99 62.19 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.382 -0.824 . . . . 2.12 111.493 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -80.42 -45.92 16.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.139 -0.976 . . . . 1.51 111.842 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -103.07 8.64 38.76 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.058 -1.026 . . . . 1.98 112.581 -178.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 56.0 m80 53.17 49.9 18.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 1.32 111.752 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.1 mtt -102.02 152.97 20.33 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.211 -0.931 . . . . 1.38 109.668 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.1 p -71.34 156.52 39.41 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.321 -0.862 . . . . 0.67 109.304 177.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.02 -45.75 79.04 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.276 -0.89 . . . . 0.52 110.366 178.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -68.35 -39.3 81.92 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.063 -1.023 . . . . 2.25 110.267 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.87 -47.78 57.39 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.516 -1.274 . . . . 0.64 110.856 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.25 90.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.56 110.178 -178.439 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.12 91.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.252 -0.905 . . . . 0.46 110.621 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -60.31 -38.39 83.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 1.32 111.249 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -58.49 -49.2 78.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.998 -1.064 . . . . 1.3 111.267 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.3 t -61.5 -44.86 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.834 -1.166 . . . . 0.61 110.321 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.66 -33.24 56.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.556 -0.715 . . . . 0.65 110.403 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -58.5 -41.91 86.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.377 -0.827 . . . . 2.11 110.802 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.36 -30.39 22.26 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.142 -1.504 . . . . 0.83 112.121 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -62.21 -40.6 96.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.523 -1.575 . . . . 1.28 110.252 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.35 -50.59 30.69 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.539 -0.726 . . . . 0.89 111.092 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.1 m -59.63 -39.81 85.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -0.902 . . . . 1.87 110.926 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.19 -42.18 98.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 1.05 111.323 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 80.7 mt -62.27 -29.86 70.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.575 -1.328 . . . . 1.02 111.023 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.91 -21.95 65.97 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.17 -0.956 . . . . 2.04 110.958 179.261 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -74.96 -12.04 60.25 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.019 -0.672 . . . . 1.73 111.412 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.526 HD13 HD13 ' A' ' 123' ' ' LEU . 6.8 mt -87.08 149.22 24.86 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.146 -0.687 . . . . 1.37 109.146 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -102.61 47.49 0.89 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.456 -0.778 . . . . 2.88 111.197 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -124.58 134.5 52.94 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 108.502 -0.925 . . . . 1.58 108.502 179.108 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -57.34 -38.5 74.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.373 -0.829 . . . . 3.04 110.979 178.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -70.88 -49.1 49.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.666 -1.271 . . . . 0.9 110.055 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.526 HD13 HD13 ' A' ' 118' ' ' LEU . 43.8 mt -62.89 -39.14 93.57 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.848 -1.158 . . . . 1.06 109.994 -178.476 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -64.09 -50.18 69.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.627 -1.296 . . . . 2.18 110.149 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.54 -30.14 69.58 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.925 -1.109 . . . . 2.15 109.535 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 130' ' ' VAL . 62.6 ttt180 -64.79 -29.5 70.47 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.959 0.885 . . . . 2.33 109.551 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -60.55 -49.31 78.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.465 -0.894 . . . . 0.82 109.71 178.483 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.27 83.22 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.477 -0.889 . . . . 0.85 110.022 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.55 -35.0 78.07 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.186 0.517 . . . . 1.39 110.839 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 126' ' ' ARG . 30.8 t -69.01 -40.98 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.146 -0.971 . . . . 0.56 110.568 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.487 HH11 ' HG2' ' A' ' 131' ' ' ARG . 24.2 ttt-85 -57.74 -38.57 75.56 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.397 -1.321 . . . . 3.12 109.52 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -60.79 -38.39 85.14 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.421 0.629 . . . . 1.28 110.397 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.25 -39.91 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.252 -0.905 . . . . 0.49 109.821 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.52 -43.76 60.21 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.634 -1.27 . . . . 0.46 110.202 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -57.92 -41.26 82.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.458 -1.025 . . . . 2.71 110.364 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.455 HH11 ' HG2' ' A' ' 136' ' ' ARG . 62.4 mtt-85 -61.7 -43.18 99.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.88 -1.137 . . . . 2.14 110.093 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.7 tp -60.56 -44.9 95.65 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.957 0.884 . . . . 1.05 109.452 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.76 -38.0 83.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.314 -0.866 . . . . 0.52 110.16 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -39.32 85.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 2.35 111.171 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -75.17 -40.86 59.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.872 -1.143 . . . . 1.39 111.008 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.94 -39.77 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.68 110.618 -178.464 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -86.51 -10.07 54.86 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.962 -1.086 . . . . 0.83 111.927 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.39 19.52 71.43 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.992 -1.099 . . . . 0.91 112.634 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 46.2 tp -71.07 140.23 50.64 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.673 -0.898 . . . . 0.95 109.317 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -67.55 150.73 48.44 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.226 -0.921 . . . . 2.43 110.65 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 81.0 mt -106.18 142.11 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.453 -0.944 . . . . 1.1 108.453 178.057 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 23.3 mm -74.56 122.59 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.326 -0.991 . . . . 1.58 108.326 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -95.85 100.65 12.32 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.891 -1.892 . . . . 1.62 105.891 178.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 53.8 mt -73.56 -21.46 60.35 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.295 -0.878 . . . . 0.8 111.396 -177.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 82.5 p -83.97 7.05 19.62 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.443 -0.786 . . . . 1.56 112.169 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.16 17.7 19.26 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.531 0.681 . . . . 0.84 112.212 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.628 HD12 HD21 ' A' ' 172' ' ' ASN . 45.4 mt -74.98 144.49 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.636 -0.665 . . . . 0.82 109.785 179.011 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -120.85 -9.76 9.23 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.359 -0.838 . . . . 2.31 112.522 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -118.77 141.92 48.18 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.963 -0.755 . . . . 1.54 108.963 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.86 124.19 26.42 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.159 0.981 . . . . 1.38 108.791 178.326 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.68 176.84 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.038 -0.727 . . . . 0.69 109.038 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 67.8 mt -91.98 141.59 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.225 -1.028 . . . . 0.53 108.225 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.7 tp -93.95 126.53 39.21 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.851 -1.155 . . . . 0.64 108.447 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 32.3 t -123.42 129.99 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.059 -1.089 . . . . 0.67 108.059 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.83 158.18 27.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.226 -0.921 . . . . 0.78 108.783 179.31 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 162' ' ' ASP . . . -62.05 -39.43 92.34 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.573 -1.33 . . . . 1.0 109.772 178.224 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 55.8 m-20 -168.93 156.63 7.53 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.192 -1.04 . . . . 2.42 108.192 179.187 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 38.4 mt -117.25 139.62 50.57 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.231 -0.918 . . . . 0.75 108.612 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.0 p -95.96 151.02 38.05 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.141 -1.059 . . . . 0.78 108.141 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -39.87 -43.72 3.44 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.779 1.652 . . . . 0.67 113.351 179.355 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 74.8 m -61.28 -50.38 73.23 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.288 -0.882 . . . . 0.7 109.953 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.68 -39.4 88.29 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.409 -0.807 . . . . 1.21 110.153 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.8 p -68.77 -41.08 79.33 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.852 -0.739 . . . . 0.6 110.575 179.551 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.21 -34.86 74.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.07 -1.019 . . . . 0.62 110.531 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -96.97 -1.37 45.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.125 -0.984 . . . . 1.16 112.879 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.46 151.71 31.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.98 -1.075 . . . . 0.73 109.695 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.628 HD21 HD12 ' A' ' 152' ' ' ILE . 25.0 p-10 -92.91 108.13 19.76 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 106.439 -1.689 . . . . 2.24 106.439 178.007 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 173' ' ' LEU . 3.1 mm? -76.96 -18.71 58.07 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.488 -0.757 . . . . 1.43 111.63 -177.728 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -81.1 -25.66 36.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.064 -1.023 . . . . 2.15 112.255 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -102.75 -4.43 25.01 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 113.829 1.048 . . . . 2.04 113.829 -178.046 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 178' ' ' GLY . 63.0 t -101.68 120.1 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.302 -1.74 . . . . 0.55 106.302 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 22.0 tp -84.89 -0.73 55.11 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.657 0.742 . . . . 1.63 111.873 -178.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.492 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.34 169.95 34.09 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.035 -1.626 . . . . 0.47 109.035 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -129.31 137.74 51.18 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.193 -1.18 . . . . 0.54 108.31 179.107 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.541 HG22 HG21 ' A' ' 205' ' ' THR . 93.2 mt -135.67 110.87 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 105.798 -1.927 . . . . 0.69 105.798 178.683 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 203' ' ' VAL . 41.7 p -135.8 179.31 6.42 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.667 -1.27 . . . . 0.82 110.089 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -102.43 55.52 0.78 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 115.91 -0.586 . . . . 2.37 109.735 179.555 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.01 166.55 10.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.663 -0.648 . . . . 1.11 109.448 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.23 -81.93 0.1 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.797 -1.192 . . . . 1.67 111.244 178.272 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.82 -67.53 0.28 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.31 -1.112 . . . . 1.54 111.954 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -61.36 -39.47 90.74 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.378 -1.072 . . . . 4.48 110.143 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.2 p -105.76 13.79 29.17 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.614 -0.679 . . . . 2.63 111.831 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.5 t -86.91 120.46 28.2 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.413 -1.329 . . . . 1.69 107.413 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -60.7 -40.54 92.59 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.696 -0.628 . . . . 1.07 110.767 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 191' ' ' SER . 11.9 t -59.68 -40.03 86.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.916 -1.115 . . . . 1.58 110.29 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.433 ' N ' HG23 ' A' ' 190' ' ' THR . 35.5 t -58.57 -37.56 76.03 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.325 -0.86 . . . . 1.6 110.48 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.81 -38.66 77.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.123 -0.986 . . . . 1.45 110.415 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 74.4 mtp -62.3 -43.63 98.38 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.395 1.093 . . . . 1.05 109.128 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.31 -41.15 83.86 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.223 -0.899 . . . . 0.72 110.464 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.433 HH11 ' HG2' ' A' ' 195' ' ' ARG . 47.0 mtt-85 -60.47 -42.07 95.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.915 -1.115 . . . . 3.05 110.095 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 64.4 m -71.06 -39.31 72.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 0.89 110.305 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.3 mt -91.24 -9.3 45.72 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.841 0.829 . . . . 0.78 112.392 -178.247 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.4 mt-10 52.29 12.5 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.846 1.054 . . . . 1.45 113.846 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.66 147.81 96.58 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 0.67 108.238 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -56.73 139.68 89.11 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.379 1.386 . . . . 0.64 110.134 178.66 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.77 165.85 31.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.518 -1.364 . . . . 0.67 109.798 179.564 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 203' ' ' VAL . 59.6 mt -145.39 156.84 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.656 -1.238 . . . . 0.69 107.656 178.199 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 181' ' ' THR . 8.0 m -137.9 -32.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.162 -0.961 . . . . 0.85 112.942 -179.374 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -72.27 34.03 0.66 Allowed Glycine 0 N--CA 1.486 1.983 0 C-N-CA 120.25 -0.976 . . . . 0.92 113.052 -178.088 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.541 HG21 HG22 ' A' ' 180' ' ' ILE . 54.8 p -58.65 -26.81 64.16 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.198 -1.178 . . . . 0.95 111.074 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.31 -93.54 0.89 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 110.525 -1.03 . . . . 1.04 110.525 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.4 t -126.19 30.56 5.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.848 -0.795 . . . . 1.57 112.269 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 94.7 t -59.62 -34.96 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.525 -1.359 . . . . 0.84 110.23 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 29.4 p -56.13 -24.5 41.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 0.99 111.344 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.6 m -91.97 1.67 57.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.139 -0.975 . . . . 1.7 111.919 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -125.23 -7.25 7.07 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.038 0.755 . . . . 2.2 113.038 -178.256 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 48.8 t -114.97 150.76 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.789 -0.819 . . . . 0.84 108.789 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -120.57 154.1 35.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.354 -0.98 . . . . 2.2 108.354 177.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.435 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 51.4 p-10 -53.56 144.67 16.76 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.988 -1.07 . . . . 2.28 110.797 178.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.9 OUTLIER 81.18 0.11 1.7 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.808 1.41 . . . . 2.35 114.808 179.415 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.0 146.13 55.06 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.382 -1.449 . . . . 1.97 108.473 177.441 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -87.83 120.26 28.99 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.353 -1.351 . . . . 2.65 107.353 178.231 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.56 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 77.1 mt -125.62 145.76 50.01 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.704 0.764 . . . . 0.63 110.055 -179.373 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.91 126.05 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 106.276 -1.75 . . . . 0.62 106.276 177.372 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.454 HD13 HD11 ' A' ' 180' ' ' ILE . 61.3 tp -102.13 119.59 39.05 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.797 -1.557 . . . . 0.64 106.797 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.62 ' O ' ' N ' ' A' ' 223' ' ' VAL . 78.8 m-20 -94.22 -22.85 18.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 2.05 112.238 -178.24 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.922 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.11 14.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 112.508 0.558 . . . . 0.84 112.508 -178.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.3 t -112.31 -59.91 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.279 -0.888 . . . . 1.02 109.857 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -92.21 12.12 23.36 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.52 0.676 . . . . 2.51 110.963 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 60.5 t30 60.22 48.9 7.72 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.262 0.553 . . . . 1.54 111.127 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -147.92 145.38 28.59 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.181 0.991 . . . . 1.95 109.836 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.5 t -117.16 138.82 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.822 -1.177 . . . . 0.71 107.822 177.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -100.13 130.08 46.23 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.913 -1.117 . . . . 1.01 108.235 178.651 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.8 t -109.67 130.03 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.382 -0.969 . . . . 0.82 108.382 179.011 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 25.0 t30 56.62 49.9 4.46 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 114.225 1.194 . . . . 1.54 114.225 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 44.2 Cg_endo -67.88 149.94 78.19 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.41 2.073 . . . . 0.94 110.263 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 45.8 p -72.81 152.71 41.42 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.574 -1.329 . . . . 1.8 109.272 177.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -59.93 -34.51 73.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 2.73 110.308 178.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.77 -40.6 88.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 3.17 110.497 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 67.9 t -70.51 -40.87 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.154 -0.966 . . . . 1.34 109.974 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.2 mt . . . . . 0 C--N 1.303 -1.418 0 O-C-N 121.379 -0.826 . . . . 1.2 110.606 -178.591 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.406 HD13 ' CG2' ' A' ' 208' ' ' VAL . 64.3 mt . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 106.761 -1.57 . . . . 1.07 106.761 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.4 m -104.35 124.76 49.77 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.53 -1.285 . . . . 1.24 107.53 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.22 -159.24 17.2 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 108.46 -1.856 . . . . 1.01 108.46 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 5' ' ' ILE . 97.0 mt -94.44 0.52 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.186 -1.185 . . . . 1.11 112.677 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 51.8 93.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.854 -1.153 . . . . 0.99 112.043 178.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -87.61 -34.41 18.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.832 -1.167 . . . . 0.85 111.12 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 1.2 p -149.55 143.98 17.37 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.59 -1.319 . . . . 1.38 107.96 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.37 145.67 21.42 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.464 2.11 . . . . 0.94 112.758 178.181 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.9 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 148.42 162.08 9.98 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 109.835 -1.306 . . . . 0.81 109.835 178.256 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.3 132.55 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 O-C-N 120.861 -1.376 . . . . 0.83 107.966 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.85 150.12 45.65 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.231 -0.918 . . . . 0.53 109.307 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 7.0 m-85 -123.26 144.03 49.67 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.911 -0.774 . . . . 0.77 108.911 178.278 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.12 169.67 36.55 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.03 -1.557 . . . . 0.51 109.897 177.819 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -76.95 154.79 33.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.542 -0.975 . . . . 1.9 108.786 178.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.605 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.76 125.65 33.4 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.453 -1.314 . . . . 0.66 107.453 178.322 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.3 tp -101.95 107.46 18.61 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.262 -2.125 . . . . 0.83 105.262 177.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -90.28 135.66 33.54 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.839 -1.171 . . . . 0.86 107.839 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.5 mt -100.29 114.34 27.73 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.78 -1.563 . . . . 0.92 106.78 178.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -109.77 137.34 47.71 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.389 -1.337 . . . . 2.03 107.389 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -129.55 144.92 51.48 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.918 -1.114 . . . . 2.66 109.041 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -83.58 136.19 34.34 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.154 -1.054 . . . . 2.32 108.154 177.279 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.99 149.41 44.94 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.278 -0.889 . . . . 2.11 108.627 178.526 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.8 mt -94.68 134.74 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.68 -0.859 . . . . 0.73 108.68 178.268 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.99 131.46 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.757 -1.201 . . . . 0.87 107.757 179.154 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -91.03 144.94 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.08 -0.711 . . . . 0.81 109.08 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -88.97 122.44 32.33 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.633 -1.247 . . . . 1.34 107.633 178.176 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -97.9 16.93 19.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.612 -0.68 . . . . 2.89 112.314 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.51 143.02 56.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.283 -0.885 . . . . 2.09 109.383 179.051 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -90.93 135.73 33.54 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.929 -1.138 . . . . 2.19 107.929 178.086 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.6 pt -97.68 172.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 122.101 0.953 . . . . 0.75 109.889 177.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.44 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 38.2 p -102.85 161.31 13.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.873 -0.788 . . . . 0.91 108.873 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.03 -31.88 19.77 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.996 -1.065 . . . . 0.93 111.947 178.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.44 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 3.5 p-10 -69.99 -40.15 75.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 2.28 110.037 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -77.47 -19.03 56.57 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.363 -0.836 . . . . 1.45 111.413 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.527 HG13 HG22 ' A' ' 93' ' ' ILE . 51.5 t -59.76 -42.56 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.069 -1.019 . . . . 0.81 110.568 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -57.1 -39.96 76.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.808 -1.183 . . . . 1.54 110.841 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.275 -0.891 . . . . 2.36 110.402 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -62.76 -35.34 79.51 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.752 -1.217 . . . . 1.31 110.87 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.69 -40.36 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.61 -1.306 . . . . 0.82 110.21 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -61.4 -39.67 91.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 1.5 109.654 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.504 HH11 ' HG2' ' A' ' 42' ' ' ARG . 21.6 mtt-85 -63.07 -42.96 99.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 2.23 110.06 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -72.12 -54.17 10.55 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 119.838 -0.745 . . . . 0.85 110.138 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.96 -48.05 82.93 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.236 -0.985 . . . . 0.91 110.013 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.543 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.9 t -70.06 -38.68 75.84 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.321 -0.862 . . . . 0.9 110.061 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.78 -43.11 96.68 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.674 -1.37 . . . . 0.69 109.674 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -58.21 -33.34 69.2 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.217 1.008 . . . . 2.88 108.742 179.125 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.06 -46.05 79.06 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.015 0.912 . . . . 0.85 109.274 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -76.81 -43.54 36.16 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.355 -0.841 . . . . 2.35 110.658 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.96 82.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.089 -1.007 . . . . 0.65 109.91 -178.675 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -59.52 -40.0 85.72 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.342 -0.943 . . . . 1.45 109.346 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.81 -48.84 65.1 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.736 -0.602 . . . . 0.63 110.327 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.83 -49.94 75.46 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.356 -1.465 . . . . 1.34 110.566 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.31 -39.31 92.6 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.237 -0.914 . . . . 1.56 109.923 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -59.89 -41.2 91.08 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.017 -0.673 . . . . 1.19 110.543 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.547 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 23.6 m -64.62 -42.57 95.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.405 -0.809 . . . . 0.72 110.273 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.1 mt -59.57 -39.32 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.459 -0.776 . . . . 0.62 110.617 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -51.66 -40.25 59.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.86 -1.15 . . . . 1.05 110.523 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.56 -40.0 73.61 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.328 -0.858 . . . . 0.64 109.974 -179.439 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.547 ' NZ ' HG22 ' A' ' 56' ' ' THR . 61.7 mttp -63.42 -39.01 93.33 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.53 -1.268 . . . . 1.73 108.583 -178.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.37 75.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.568 -0.707 . . . . 0.56 110.112 179.135 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.85 -38.16 10.77 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 119.697 -1.24 . . . . 0.69 111.322 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.46 -23.48 43.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.793 -1.416 . . . . 1.48 110.688 -179.296 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -88.72 -50.42 6.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.088 -1.008 . . . . 0.98 111.067 179.525 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -106.79 -9.5 16.38 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 114.378 1.251 . . . . 1.16 114.378 -177.237 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.36 154.13 12.11 Favored Glycine 0 N--CA 1.502 3.091 0 O-C-N 121.128 -0.982 . . . . 0.85 111.736 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -54.31 -17.15 2.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -1.033 . . . . 3.86 112.544 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -58.38 -35.3 71.79 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.39 -0.819 . . . . 2.35 110.903 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -82.46 -21.99 35.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.741 -1.224 . . . . 1.67 111.708 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.05 -32.91 71.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.9 . . . . 1.45 111.279 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.53 93.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.948 -1.095 . . . . 0.61 110.534 179.078 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.1 mt -68.17 -45.29 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.487 -1.383 . . . . 0.65 110.547 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -69.65 -31.32 69.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.912 -1.117 . . . . 0.66 110.934 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.02 -39.64 86.55 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.295 -0.878 . . . . 1.19 109.974 178.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.96 -38.09 95.06 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.866 -1.294 . . . . 0.53 109.866 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -58.0 -44.03 86.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.414 -1.05 . . . . 1.27 110.001 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.48 -40.59 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.942 -1.099 . . . . 0.54 110.432 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.4 ttt -60.01 -38.95 84.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.271 -0.893 . . . . 1.74 110.108 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -60.96 -50.62 72.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.807 . . . . 0.55 110.201 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.57 -40.44 87.36 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.445 -0.902 . . . . 0.47 110.493 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -88.64 10.54 20.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.645 -0.66 . . . . 1.42 112.68 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -62.93 123.27 18.09 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.035 -1.041 . . . . 1.27 109.151 178.644 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -67.39 -19.13 65.36 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.951 0.882 . . . . 1.35 110.708 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -77.7 -49.65 14.04 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.658 0.742 . . . . 2.22 110.748 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.79 -38.97 90.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.318 -0.864 . . . . 0.62 110.346 -179.419 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -57.83 -46.95 83.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.84 -0.537 . . . . 1.29 110.91 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -61.04 -39.92 91.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.136 -0.977 . . . . 1.52 110.381 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -65.75 -47.2 76.07 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 118.827 -1.149 . . . . 1.3 111.145 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.3 mt -57.56 -44.27 84.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.861 -1.149 . . . . 0.61 110.4 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.7 mt -63.42 -41.54 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.665 0.745 . . . . 0.78 110.967 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.54 -42.08 98.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.82 111.17 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.5 mt -60.43 -45.09 94.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.087 . . . . 0.8 110.536 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.527 HG22 HG13 ' A' ' 36' ' ' VAL . 69.4 mt -60.79 -49.88 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.495 -0.753 . . . . 0.77 110.205 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -77.3 -37.17 53.31 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.59 -0.694 . . . . 2.12 111.776 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -80.71 -46.95 14.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.874 -1.141 . . . . 1.51 112.455 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -100.59 8.33 43.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.964 -1.085 . . . . 1.98 112.677 -178.63 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 37.3 m80 51.94 50.5 18.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.902 -1.124 . . . . 1.32 111.998 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.488 ' O ' HG23 ' A' ' 93' ' ' ILE . 66.4 mtt -107.17 155.54 19.79 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.197 -0.939 . . . . 1.38 109.456 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.2 p -72.23 166.4 22.5 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.609 -0.682 . . . . 0.67 110.51 178.374 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.7 -43.79 97.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.429 -0.794 . . . . 0.52 110.413 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 6.2 p-10 -69.59 -43.41 72.86 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.437 -0.79 . . . . 2.25 109.934 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.08 -47.69 70.51 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.945 -1.102 . . . . 0.64 110.463 -179.333 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.33 98.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.977 -1.077 . . . . 0.56 110.571 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.38 -43.2 92.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.147 -0.971 . . . . 0.46 110.526 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -61.41 -40.21 93.59 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.144 -0.972 . . . . 1.32 111.403 -179.416 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -58.54 -48.43 80.89 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.996 -1.065 . . . . 1.3 111.101 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.3 t -61.04 -46.89 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.205 -0.935 . . . . 0.61 109.816 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -62.24 -32.38 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.271 0.557 . . . . 0.65 110.443 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -55.41 -40.8 71.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 2.11 110.18 179.117 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.12 -27.69 30.29 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.636 -1.268 . . . . 0.83 113.269 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -62.18 -40.35 95.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.404 -1.645 . . . . 1.28 109.67 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.21 -52.15 10.64 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.919 -0.488 . . . . 0.89 111.025 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.2 m -59.51 -39.03 82.49 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.628 -0.829 . . . . 1.87 110.634 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.43 98.18 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.452 -0.78 . . . . 1.05 111.288 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 73.5 mt -63.2 -30.11 71.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.1 -1.0 . . . . 1.02 111.347 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -68.53 -20.21 64.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.956 -1.09 . . . . 2.04 111.006 179.439 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -75.49 -14.24 60.41 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.519 -0.738 . . . . 1.73 111.158 -179.238 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.716 HD13 HD13 ' A' ' 123' ' ' LEU . 12.8 mt -84.35 150.98 25.01 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.439 -0.788 . . . . 1.37 109.015 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -98.21 35.77 1.7 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.954 -1.091 . . . . 2.88 112.468 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -116.0 130.99 57.06 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.667 -0.864 . . . . 1.58 108.667 179.16 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.28 -35.89 74.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 3.04 111.107 178.69 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -69.18 -48.9 60.95 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.499 -1.376 . . . . 0.9 110.289 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.716 HD13 HD13 ' A' ' 118' ' ' LEU . 45.9 mt -62.57 -39.94 95.26 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.011 -1.055 . . . . 1.06 110.854 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 60.2 tttm -62.82 -49.75 73.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.872 -1.143 . . . . 2.18 109.98 178.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.77 -32.44 71.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 2.15 109.637 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 130' ' ' VAL . 66.0 ttt180 -61.31 -29.59 69.97 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.022 -1.071 . . . . 2.33 108.958 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.63 -47.9 83.78 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.838 0.828 . . . . 0.82 109.032 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.87 -47.02 86.9 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.499 -0.88 . . . . 0.85 109.444 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.33 -31.96 72.66 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.469 0.652 . . . . 1.39 109.963 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.2 t -69.66 -41.73 80.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.652 -0.655 . . . . 0.56 110.003 179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -57.51 -40.69 79.27 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.829 -1.169 . . . . 3.12 109.549 179.527 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -60.3 -43.16 96.56 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.621 -0.674 . . . . 1.28 110.535 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.08 -38.28 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.102 -0.999 . . . . 0.49 109.947 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.05 -49.96 37.43 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.846 -1.169 . . . . 0.46 110.406 179.074 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -58.4 -43.36 88.53 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.963 -1.316 . . . . 2.71 110.209 179.428 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.436 ' NH2' ' CB ' ' A' ' 166' ' ' SER . 88.5 mtt180 -62.29 -41.43 98.49 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.705 -1.198 . . . . 2.14 109.22 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.68 -40.72 88.77 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.543 0.687 . . . . 1.05 109.95 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.2 -42.56 95.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.029 . . . . 0.52 110.668 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -59.82 -34.07 72.59 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.428 -0.795 . . . . 2.35 110.614 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -75.03 -42.55 56.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.179 -0.951 . . . . 1.39 110.821 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.9 -39.98 83.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.148 -0.97 . . . . 0.68 110.281 -178.394 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.1 mt -89.94 -12.01 40.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -0.932 . . . . 0.83 112.701 -179.283 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.3 19.72 76.27 Favored Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.569 -1.3 . . . . 0.91 113.066 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.5 150.44 48.95 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.525 -0.985 . . . . 0.95 109.952 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -65.26 148.56 51.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 2.43 109.751 178.105 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.4 mt -106.88 144.13 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.56 -0.904 . . . . 1.1 108.56 178.355 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.1 mm -79.11 120.78 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.885 -1.135 . . . . 1.58 108.388 178.181 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -98.09 96.72 8.32 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.369 -1.715 . . . . 1.62 106.369 179.204 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.6 mt -75.92 -17.51 59.73 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.612 -0.68 . . . . 0.8 111.512 -177.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.6 m -81.19 4.81 18.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.928 -1.108 . . . . 1.56 112.383 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.72 20.83 11.32 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.791 0.805 . . . . 0.84 112.33 -179.241 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 18.0 mt -72.65 139.23 19.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.264 -0.897 . . . . 0.82 108.752 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -116.77 -11.54 10.92 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.491 -0.756 . . . . 2.31 112.885 -178.547 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -115.86 134.09 55.35 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.736 -1.209 . . . . 1.54 107.736 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -72.98 119.28 17.01 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.44 -0.788 . . . . 1.38 108.879 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.0 177.01 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.373 -0.829 . . . . 0.69 109.343 -179.021 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.0 mt -85.87 142.15 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.008 -1.058 . . . . 0.53 109.117 178.147 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.0 tp -95.28 125.17 39.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.155 -0.966 . . . . 0.64 108.613 178.046 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.7 t -124.54 129.69 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.536 -1.283 . . . . 0.67 107.536 179.163 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.33 160.12 29.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 0.78 108.548 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.72 -40.85 89.36 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.275 -1.516 . . . . 1.0 109.521 177.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 9.2 t70 -174.17 158.57 3.04 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.236 -1.024 . . . . 2.42 108.236 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.451 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 35.5 mt -118.3 139.16 51.75 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.149 -1.056 . . . . 0.75 108.149 177.184 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.9 p -90.24 149.36 41.14 Favored Pre-proline 0 N--CA 1.485 1.312 0 N-CA-C 108.293 -1.003 . . . . 0.78 108.293 179.412 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -40.18 -45.23 4.08 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.035 1.824 . . . . 0.67 113.393 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.436 ' CB ' ' NH2' ' A' ' 136' ' ' ARG . 15.3 m -59.94 -50.31 74.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.677 -1.264 . . . . 0.7 110.96 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.94 -40.32 92.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.447 -0.783 . . . . 1.21 109.934 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.5 p -66.41 -39.0 88.72 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.689 0.757 . . . . 0.6 110.141 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.23 85.31 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.358 -0.937 . . . . 0.62 111.11 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -94.8 1.56 55.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.994 -1.066 . . . . 1.16 113.569 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.8 148.74 46.04 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.483 -0.932 . . . . 0.73 108.483 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -95.27 115.01 26.86 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 106.537 -1.653 . . . . 2.24 106.537 177.721 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 26.1 mt -75.46 -14.93 60.46 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.484 -0.76 . . . . 1.43 111.71 -177.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -84.03 -19.67 34.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.081 -1.012 . . . . 2.15 112.276 -178.528 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -102.14 -6.16 23.6 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.327 -0.858 . . . . 2.04 113.033 -177.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 178' ' ' GLY . 85.5 t -110.69 129.57 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.106 -1.442 . . . . 0.55 107.106 179.311 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 tp -90.94 -4.93 56.11 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.985 0.897 . . . . 1.63 112.595 -179.147 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.48 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -179.86 170.46 41.7 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.691 -1.764 . . . . 0.47 108.691 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -125.83 126.18 44.08 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.786 -1.42 . . . . 0.54 107.42 178.22 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.5 mt -125.65 128.61 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 106.913 -1.514 . . . . 0.69 106.913 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 203' ' ' VAL . 74.6 p -139.58 166.78 23.69 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.894 -1.129 . . . . 0.82 109.247 179.052 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 29.0 p-10 -103.16 32.19 3.88 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.397 -0.814 . . . . 2.37 111.504 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -97.02 120.64 37.75 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.091 -1.077 . . . . 1.11 108.091 178.548 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -88.44 27.19 7.19 Favored Glycine 0 N--CA 1.484 1.875 0 C-N-CA 120.15 -1.024 . . . . 1.67 113.515 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -88.1 115.76 4.44 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 107.882 -2.087 . . . . 1.54 107.882 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -58.03 -31.37 66.93 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.525 -0.985 . . . . 4.48 109.287 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.8 p -105.06 37.32 2.2 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.684 0.754 . . . . 2.63 110.265 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.5 t -72.07 146.71 47.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.365 -0.835 . . . . 1.69 109.569 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -58.16 -39.74 79.63 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.245 -0.909 . . . . 1.07 110.999 178.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 56.8 p -57.84 -41.39 82.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.837 -1.164 . . . . 1.58 110.221 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.3 t -61.45 -34.2 75.02 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.333 -0.854 . . . . 1.6 110.163 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.6 mm -60.26 -41.03 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.06 -1.025 . . . . 1.45 110.914 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 60.9 mtp -61.66 -40.46 95.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.565 -1.334 . . . . 1.05 110.103 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.96 -45.74 89.77 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.41 -0.814 . . . . 0.72 111.127 179.372 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -60.7 -42.2 96.74 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.656 -0.817 . . . . 3.05 110.479 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.4 m -69.49 -39.01 77.89 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.328 -0.857 . . . . 0.89 109.942 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.26 -7.29 51.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.234 -0.916 . . . . 0.78 112.753 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 194' ' ' ALA . 89.7 mt-10 53.36 8.53 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.364 1.246 . . . . 1.45 114.364 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.469 ' O ' ' OG ' ' A' ' 8' ' ' SER . 57.2 mt -73.89 147.6 86.44 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.646 -1.284 . . . . 0.67 108.162 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.78 143.43 58.91 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.353 1.369 . . . . 0.64 109.503 178.827 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.82 163.02 37.06 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 117.767 -1.573 . . . . 0.67 109.679 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.47 HD12 HD11 ' A' ' 220' ' ' LEU . 51.2 mt -149.45 151.31 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.654 -1.239 . . . . 0.69 107.654 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 183' ' ' ALA . 15.1 m -136.05 -28.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 120.79 -1.194 . . . . 0.85 112.235 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.39 41.42 3.06 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 120.845 -1.159 . . . . 0.92 112.166 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.6 p -61.58 -17.65 55.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.873 -1.369 . . . . 0.95 111.535 -178.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.12 -93.04 1.8 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.401 -1.08 . . . . 1.04 110.401 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.1 m -133.58 32.84 3.56 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 122.214 -0.58 . . . . 1.57 112.26 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.406 ' CG2' HD13 ' A' ' 2' ' ' ILE . 46.5 t -59.43 -37.69 71.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.324 -1.485 . . . . 0.84 110.527 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 67.5 p -55.34 -28.52 54.3 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.422 -0.911 . . . . 0.99 111.203 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 19.6 m -92.1 0.86 57.47 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.106 -0.996 . . . . 1.7 112.143 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -122.86 -7.19 8.45 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 113.395 0.887 . . . . 2.2 113.395 -177.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.5 t -118.92 151.62 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.59 0.709 . . . . 0.84 109.296 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -117.7 157.12 27.05 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.118 -1.068 . . . . 2.2 108.118 177.649 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.44 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 42.4 t30 -52.48 141.49 19.92 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.871 -1.143 . . . . 2.28 110.805 178.572 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.72 2.75 1.43 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 115.185 1.55 . . . . 2.35 115.185 179.397 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.2 t0 -64.72 148.08 51.81 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.862 -1.148 . . . . 1.97 108.797 177.424 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.522 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 44.3 t80 -88.6 119.38 29.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.544 -1.347 . . . . 2.65 107.664 177.845 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.605 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.7 mt -127.22 148.89 50.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.426 -0.797 . . . . 0.63 110.292 -178.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.4 mt -116.81 123.97 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 106.158 -1.793 . . . . 0.62 106.158 177.124 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.47 HD11 HD12 ' A' ' 202' ' ' ILE . 58.2 tp -99.16 120.12 38.98 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.692 -1.595 . . . . 0.64 106.692 178.625 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.623 ' O ' ' N ' ' A' ' 223' ' ' VAL . 77.8 m-20 -93.84 -29.15 15.47 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.781 -1.168 . . . . 2.05 113.129 -177.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.06 12.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.432 -0.793 . . . . 0.84 112.654 -179.253 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.623 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.4 t -108.53 -61.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.746 -1.222 . . . . 1.02 109.525 179.092 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -94.19 11.59 29.6 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.389 0.614 . . . . 2.51 110.675 179.638 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 61.48 54.53 3.07 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.148 0.499 . . . . 1.54 111.951 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -148.97 143.52 26.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.173 -0.954 . . . . 1.95 109.831 178.604 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.1 t -115.9 136.91 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.077 -1.083 . . . . 0.71 108.077 178.139 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -102.68 131.74 49.28 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.606 -0.887 . . . . 1.01 108.606 178.647 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.41 130.96 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 108.653 -0.869 . . . . 0.82 108.653 178.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.423 ' O ' ' ND2' ' A' ' 230' ' ' ASN . 1.2 t30 52.11 53.69 13.07 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.188 -0.945 . . . . 1.54 113.549 178.309 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.65 151.07 63.73 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 C-N-CA 122.513 2.142 . . . . 0.94 111.069 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.0 m -71.33 157.77 37.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.072 -1.017 . . . . 1.8 108.995 177.478 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -57.31 -40.89 78.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 2.73 109.898 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.85 -39.82 86.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.815 . . . . 3.17 110.692 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.2 t -69.2 -38.05 77.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.23 -0.919 . . . . 1.34 110.818 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 84.4 mt . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 1.2 110.261 179.239 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.4 mt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 112.431 0.53 . . . . 1.07 112.431 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -90.73 115.4 27.79 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.61 -1.626 . . . . 1.24 106.61 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.35 -154.85 22.12 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.081 -2.007 . . . . 1.01 108.081 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 5' ' ' ILE . 72.6 mt -93.92 -4.33 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -1.141 . . . . 1.11 112.64 -178.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 5' ' ' ILE . 38.4 tp 50.61 100.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.831 -1.168 . . . . 0.99 112.235 178.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -89.63 -37.24 14.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.85 111.498 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -145.77 138.75 14.11 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 108.027 -1.101 . . . . 1.38 108.027 -178.257 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.88 148.92 28.73 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.725 2.283 . . . . 0.94 112.505 179.491 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.889 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.85 166.05 13.98 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.891 -1.684 . . . . 0.81 108.891 178.357 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.52 136.11 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.046 -1.267 . . . . 0.83 108.704 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.537 ' HB1' HD22 ' A' ' 177' ' ' LEU . . . -143.06 156.67 44.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.303 -0.873 . . . . 0.53 109.495 179.263 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 23.8 m-85 -124.48 140.74 52.67 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.206 -1.035 . . . . 0.77 108.206 178.247 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.72 168.48 37.39 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 118.551 -1.785 . . . . 0.51 109.906 177.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -78.64 160.22 27.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.427 -1.043 . . . . 1.9 109.547 179.213 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.57 129.71 34.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.791 -1.193 . . . . 0.66 108.195 178.584 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.7 tp -107.53 101.94 11.24 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 105.029 -2.212 . . . . 0.83 105.029 177.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.5 tp -89.88 137.32 32.43 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.173 -1.047 . . . . 0.86 108.173 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.6 mt -100.49 114.79 28.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.592 -1.633 . . . . 0.92 106.592 178.683 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -108.97 131.49 55.0 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.617 -1.253 . . . . 2.03 107.617 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -127.13 149.98 49.7 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.254 -0.904 . . . . 2.66 109.228 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -83.04 135.0 35.01 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.778 -1.193 . . . . 2.32 107.778 177.276 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.39 147.32 48.85 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.592 -0.693 . . . . 2.11 109.315 178.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.423 HD11 ' NH1' ' A' ' 139' ' ' ARG . 61.9 mt -97.7 135.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.166 -0.959 . . . . 0.73 108.72 178.49 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.8 t -107.69 130.88 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.489 -0.93 . . . . 0.87 108.489 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.5 mt -97.56 131.44 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.335 -0.987 . . . . 0.81 108.335 178.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -93.51 123.26 36.7 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.814 -1.179 . . . . 1.34 108.371 178.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -95.81 10.25 37.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.299 -0.876 . . . . 2.89 112.333 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.63 149.22 46.97 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.118 -0.988 . . . . 2.09 109.332 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -89.93 131.02 36.06 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.74 -1.207 . . . . 2.19 107.74 177.52 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 pt -92.53 165.47 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.007 -1.058 . . . . 0.75 110.345 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.3 p -92.51 163.43 13.83 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.446 -0.575 . . . . 0.91 109.446 178.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.39 -17.49 1.94 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.214 -0.929 . . . . 0.93 112.482 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -69.45 -41.78 75.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.355 -0.841 . . . . 2.28 110.685 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -90.75 -5.76 55.28 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.62 -1.3 . . . . 1.45 112.697 -178.898 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.91 -42.29 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.803 -1.186 . . . . 0.81 110.477 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.14 -39.97 88.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.034 -1.041 . . . . 1.54 110.767 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -62.67 -38.13 89.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.509 -0.745 . . . . 2.36 110.845 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -60.19 -40.73 91.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.907 -1.121 . . . . 1.31 110.656 179.248 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -62.43 -41.16 90.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.187 -0.945 . . . . 0.82 110.551 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -60.8 -49.52 77.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.109 -0.995 . . . . 1.5 110.369 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 46' ' ' GLY . 65.1 mtm180 -62.86 -40.35 97.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.231 -0.918 . . . . 2.23 110.09 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -70.04 -54.6 12.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.434 -0.791 . . . . 0.85 110.184 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.49 -49.88 73.63 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.937 -1.105 . . . . 0.91 109.834 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.56 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.9 t -67.81 -39.75 83.95 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.783 0.802 . . . . 0.9 109.91 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 42' ' ' ARG . . . -56.43 -43.25 90.25 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.808 -1.317 . . . . 0.69 109.808 178.614 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -59.54 -31.26 69.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.891 0.853 . . . . 2.88 109.394 178.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.08 -43.2 77.78 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.492 0.663 . . . . 0.85 109.762 178.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -79.07 -42.94 25.21 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.325 -0.95 . . . . 2.35 110.009 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.87 86.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.099 -1.001 . . . . 0.65 110.225 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.0 p -59.98 -41.76 92.71 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.268 1.032 . . . . 1.45 109.241 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.74 90.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.728 -0.669 . . . . 0.63 110.133 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -60.09 -49.8 76.21 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.39 -0.924 . . . . 1.34 110.264 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.59 -42.74 91.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 1.56 110.059 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -59.86 -40.3 88.15 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.736 -0.602 . . . . 1.19 110.47 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.46 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 5.6 m -67.43 -47.69 69.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.06 -1.025 . . . . 0.72 110.18 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.5 mt -61.36 -34.36 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 0.62 110.849 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -51.62 -43.94 62.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.114 -0.991 . . . . 1.05 111.013 179.366 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.9 m -68.97 -39.62 79.35 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.985 -1.072 . . . . 0.64 110.197 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.46 ' NZ ' HG22 ' A' ' 56' ' ' THR . 47.4 mttp -60.11 -40.0 88.17 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.807 -1.157 . . . . 1.73 109.529 179.305 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.41 73.83 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.326 -0.858 . . . . 0.56 109.934 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.59 -37.03 9.87 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.978 -1.106 . . . . 0.69 111.112 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -81.59 -23.94 36.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.092 -1.24 . . . . 1.48 111.001 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.4 m -88.82 -50.37 6.26 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.461 -0.774 . . . . 0.98 110.57 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.591 ' CZ ' ' SD ' ' A' ' 193' ' ' MET . 75.4 m-85 -107.23 -3.67 19.55 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 113.805 1.039 . . . . 1.16 113.805 -177.474 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.1 166.49 34.21 Favored Glycine 0 N--CA 1.495 2.617 0 O-C-N 121.088 -1.007 . . . . 0.85 111.699 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -56.31 -19.54 14.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.558 -0.966 . . . . 3.86 112.787 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -56.74 -41.5 77.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.684 -1.26 . . . . 2.35 110.561 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -89.27 -23.12 22.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.97 -1.081 . . . . 1.67 111.563 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -60.78 -38.93 86.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.502 -0.749 . . . . 1.45 110.745 -179.272 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.1 -39.37 89.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.36 -0.837 . . . . 0.61 110.816 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.6 mt -62.12 -44.24 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.865 -1.147 . . . . 0.65 110.513 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -71.7 -31.65 66.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.856 -1.152 . . . . 0.66 110.701 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.24 -41.17 92.57 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.115 -0.99 . . . . 1.19 109.903 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.88 -36.74 91.53 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.656 -1.259 . . . . 0.53 110.143 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.48 ' N ' ' HD1' ' A' ' 76' ' ' HIS . 1.4 m80 -59.31 -40.83 87.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -1.155 . . . . 1.27 110.492 179.229 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.3 -39.66 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.982 -1.074 . . . . 0.54 110.276 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.8 ttp -59.58 -39.36 83.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.335 -0.853 . . . . 1.74 110.396 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.43 -49.93 73.13 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.466 -0.894 . . . . 0.55 110.105 179.199 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.5 tp -60.45 -46.92 88.3 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.763 0.792 . . . . 0.47 110.272 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -85.74 8.43 19.87 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.034 0.753 . . . . 1.42 113.034 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -62.31 122.06 14.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.878 -1.139 . . . . 1.27 108.581 179.091 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -64.07 -18.67 64.6 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.733 0.777 . . . . 1.35 111.099 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.14 -53.74 7.84 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.74 -0.784 . . . . 2.22 110.253 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.52 -35.12 78.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.551 -0.718 . . . . 0.62 110.495 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -60.01 -48.92 79.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.306 -0.871 . . . . 1.29 110.739 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -62.68 -39.97 95.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 1.52 110.513 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.97 -48.41 76.59 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.292 -0.88 . . . . 1.3 110.152 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -57.89 -43.48 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.291 -0.881 . . . . 0.61 109.879 179.258 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.43 -40.81 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.718 -0.614 . . . . 0.78 110.479 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.19 -45.04 95.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -0.894 . . . . 0.82 110.873 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.91 -39.05 84.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 0.8 110.521 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.8 mt -70.18 -49.73 52.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 0.77 111.066 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -81.78 -36.37 28.54 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.833 -1.167 . . . . 2.12 111.795 -179.212 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 91' ' ' ALA . 24.1 t0 -81.8 -42.43 19.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.83 -1.169 . . . . 1.51 112.132 -178.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -103.38 8.25 38.09 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.212 -0.93 . . . . 1.98 112.452 -178.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.3 m80 51.08 51.17 17.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.14 -0.975 . . . . 1.32 111.804 -179.795 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.6 mtt -104.91 152.07 23.1 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.353 -0.842 . . . . 1.38 108.899 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.1 p -71.92 160.03 33.25 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.577 -0.702 . . . . 0.67 109.292 177.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.7 92.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.149 -0.969 . . . . 0.52 110.571 178.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.579 ' OD2' HD21 ' A' ' 142' ' ' LEU . 81.6 m-20 -67.24 -42.1 84.54 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.044 -1.035 . . . . 2.25 109.925 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.49 -51.0 48.15 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.635 -0.665 . . . . 0.64 111.224 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.31 -45.74 92.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.037 -1.04 . . . . 0.56 110.65 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.7 97.12 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.494 -0.883 . . . . 0.46 110.408 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -60.28 -39.22 86.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 1.32 110.972 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -57.9 -48.72 79.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.949 -1.094 . . . . 1.3 110.567 179.361 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.99 -47.44 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.943 -1.098 . . . . 0.61 110.031 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.0 mm -62.64 -30.95 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.779 -0.576 . . . . 0.65 110.56 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.59 -41.61 86.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.44 -0.788 . . . . 2.11 110.85 179.287 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.75 -34.52 10.05 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.231 -1.462 . . . . 0.83 112.678 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -61.13 -41.68 97.16 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.788 -1.419 . . . . 1.28 110.259 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.39 -54.93 7.99 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.741 0.781 . . . . 0.89 110.29 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 65.3 m -59.97 -38.49 82.67 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.686 -0.634 . . . . 1.87 110.477 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.61 96.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.991 -1.068 . . . . 1.05 110.575 179.599 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.17 -30.14 71.03 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.217 -0.993 . . . . 1.02 110.35 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -66.6 -20.07 65.92 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.164 -0.96 . . . . 2.04 110.986 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -72.63 -10.51 59.87 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.99 0.9 . . . . 1.73 111.02 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 23.2 mt -87.84 144.84 26.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.936 -0.765 . . . . 1.37 108.936 179.323 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -100.19 37.13 1.71 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.132 -0.98 . . . . 2.88 111.787 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -115.22 137.71 51.72 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.179 -0.951 . . . . 1.58 108.81 178.641 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 50.1 mp0 -59.86 -35.24 74.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.67 -0.644 . . . . 3.04 111.089 179.043 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -73.53 -49.74 24.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.926 -1.109 . . . . 0.9 109.848 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.1 mt -63.73 -39.73 95.0 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.281 -0.887 . . . . 1.06 109.604 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -60.96 -45.07 96.21 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.864 0.84 . . . . 2.18 109.67 179.282 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -61.29 -32.78 72.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.812 0.815 . . . . 2.15 109.535 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.416 ' O ' HG23 ' A' ' 130' ' ' VAL . 60.4 ttt180 -62.04 -29.57 70.38 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.996 0.903 . . . . 2.33 109.463 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.93 74.6 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.926 0.87 . . . . 0.82 109.501 178.633 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.56 -41.59 79.53 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.703 0.763 . . . . 0.85 110.08 179.785 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -62.55 -40.47 96.92 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.413 0.625 . . . . 1.39 110.243 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 126' ' ' ARG . 52.1 t -68.96 -38.33 78.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.504 -0.748 . . . . 0.56 109.755 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -58.92 -38.89 79.98 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.057 -1.027 . . . . 3.12 109.715 178.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.498 ' OD2' ' NE ' ' A' ' 136' ' ' ARG . 32.2 t70 -60.12 -39.79 87.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.61 -0.682 . . . . 1.28 110.352 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 57.7 mt -60.05 -39.83 81.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.363 -0.836 . . . . 0.49 109.983 179.401 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.13 -48.3 26.5 Favored Glycine 0 N--CA 1.485 1.943 0 C-N-CA 120.209 -0.995 . . . . 0.46 110.799 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -58.89 -44.16 91.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.039 -1.271 . . . . 2.71 110.202 179.24 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.498 ' NE ' ' OD2' ' A' ' 132' ' ' ASP . 54.3 mtm180 -61.62 -41.48 97.54 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.707 -1.197 . . . . 2.14 109.774 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.45 -41.71 94.65 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.865 -0.734 . . . . 1.05 110.079 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.6 mt -60.57 -43.35 97.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.437 -0.789 . . . . 0.52 110.765 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.423 ' NH1' HD11 ' A' ' 24' ' ' ILE . 48.7 mtt-85 -59.84 -32.81 71.02 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.363 -0.836 . . . . 2.35 111.318 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -75.39 -40.17 58.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.011 -1.056 . . . . 1.39 110.708 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.4 mt -59.58 -40.13 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.227 -0.921 . . . . 0.68 110.972 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.579 HD21 ' OD2' ' A' ' 101' ' ' ASP . 86.2 mt -90.47 -9.2 48.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.916 -1.115 . . . . 0.83 112.926 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.09 23.16 66.8 Favored Glycine 0 N--CA 1.483 1.78 0 C-N-CA 119.91 -1.138 . . . . 0.91 113.112 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.414 HD23 HH11 ' A' ' 139' ' ' ARG . 29.0 tp -63.08 142.21 58.47 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.757 -0.849 . . . . 0.95 109.012 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -66.53 141.35 57.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.239 -0.913 . . . . 2.43 109.378 178.431 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.4 mt -112.18 136.52 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 108.32 -0.993 . . . . 1.1 108.32 178.295 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.561 ' H ' HD12 ' A' ' 147' ' ' ILE . 5.2 mp -76.2 131.07 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 1.58 108.792 178.586 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.09 97.63 11.04 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.721 -1.585 . . . . 1.62 106.721 178.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.455 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 50.4 mt -71.51 -29.45 64.8 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.378 0.609 . . . . 0.8 110.942 -178.146 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.0 t -79.47 -3.29 45.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.35 -0.844 . . . . 1.56 112.297 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -101.27 23.1 11.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.677 -0.64 . . . . 0.84 111.919 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.455 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 16.4 mt -72.1 144.87 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 0.82 109.861 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -118.64 -10.85 9.96 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.979 0.895 . . . . 2.31 112.372 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -118.22 140.36 49.92 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.72 0.772 . . . . 1.54 109.152 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.04 119.8 22.69 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.285 -0.885 . . . . 1.38 108.741 178.621 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.71 175.79 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.578 0.704 . . . . 0.69 109.328 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.5 mt -86.98 140.9 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.805 . . . . 0.53 109.01 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 24.6 tp -98.32 122.3 41.31 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.044 -1.035 . . . . 0.64 108.777 178.365 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.8 t -123.93 133.96 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.337 -0.986 . . . . 0.67 108.337 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.86 157.81 29.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.477 -0.764 . . . . 0.78 109.113 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.449 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.4 -38.7 88.03 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.672 -1.268 . . . . 1.0 109.196 178.185 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.2 t0 -172.45 148.0 1.97 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.524 -0.735 . . . . 2.42 109.02 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.521 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 66.1 mt -119.15 138.98 52.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.243 -0.911 . . . . 0.75 108.555 177.481 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.2 p -93.6 151.6 40.2 Favored Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 108.327 -0.99 . . . . 0.78 108.327 178.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -39.93 -38.72 2.04 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.767 1.645 . . . . 0.67 113.433 179.433 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.5 m -58.92 -42.87 90.7 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.036 -1.065 . . . . 0.7 109.699 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -72.64 -45.1 60.64 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.693 -0.803 . . . . 1.21 110.164 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 20.4 p -66.19 -38.95 89.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.372 -0.83 . . . . 0.6 109.812 -178.652 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.72 87.34 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.677 -0.64 . . . . 0.62 110.844 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -92.96 0.49 57.41 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.126 -0.984 . . . . 1.16 112.738 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.7 tp -65.99 150.26 48.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.729 . . . . 0.73 109.756 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -96.94 117.82 32.0 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.035 -1.469 . . . . 2.24 107.035 177.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 39.1 mt -76.32 -18.07 59.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 1.43 111.404 -178.346 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -82.97 -20.58 34.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.205 -0.935 . . . . 2.15 112.282 -179.208 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -102.69 -6.28 22.86 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.261 -0.899 . . . . 2.04 113.383 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 178' ' ' GLY . 45.5 t -111.7 131.8 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.063 -1.088 . . . . 0.55 108.063 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.739 ' O ' HD23 ' A' ' 177' ' ' LEU . 2.0 tt -86.04 -11.52 52.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.004 -1.06 . . . . 1.63 111.684 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.535 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 174.31 177.39 43.43 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.013 -1.565 . . . . 0.47 109.748 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.64 132.48 46.73 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.405 -1.056 . . . . 0.54 108.199 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 72.6 mt -134.14 109.39 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 106.423 -1.695 . . . . 0.69 106.423 178.439 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 205' ' ' THR . 65.6 p -129.63 170.47 13.75 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.9 -1.125 . . . . 0.82 110.568 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 15.4 p-10 -103.03 49.56 0.83 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.277 0.561 . . . . 2.37 110.423 179.435 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.0 154.46 18.95 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.338 -0.851 . . . . 1.11 109.356 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.91 -80.92 0.06 OUTLIER Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.598 -1.286 . . . . 1.67 111.302 178.433 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.38 -40.74 0.82 Allowed Glycine 0 N--CA 1.492 2.392 0 O-C-N 120.941 -1.329 . . . . 1.54 112.354 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -60.22 -36.25 77.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.947 . . . . 4.48 110.518 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 12.6 p -121.25 26.85 8.69 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.517 -0.74 . . . . 2.63 111.399 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -86.52 109.84 19.37 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.351 -1.351 . . . . 1.69 107.351 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -61.69 -37.83 85.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.588 -0.695 . . . . 1.07 110.727 -178.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 25.8 m -57.24 -40.49 77.7 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.136 -0.977 . . . . 1.58 110.304 179.372 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 50.4 m -60.01 -38.45 82.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 1.6 110.6 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.9 mt -59.36 -41.04 83.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.148 -0.97 . . . . 1.45 110.522 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.591 ' SD ' ' CZ ' ' A' ' 65' ' ' PHE . 7.7 mtm -68.96 -35.07 76.33 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.707 -1.197 . . . . 1.05 109.325 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.26 -44.62 88.44 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.174 -0.61 . . . . 0.72 110.56 179.031 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.474 HH11 ' HG2' ' A' ' 195' ' ' ARG . 32.8 mtt-85 -60.2 -41.27 92.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 3.05 110.448 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.0 m -68.91 -37.46 78.96 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.749 0.785 . . . . 0.89 110.028 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.1 mt -90.4 -5.91 55.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.413 -0.804 . . . . 0.78 112.472 -179.262 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 54.11 8.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.67 0.989 . . . . 1.45 113.67 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 30.8 mt -71.58 150.03 93.5 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.971 -1.081 . . . . 0.67 108.773 178.827 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -55.89 145.79 71.33 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.745 1.63 . . . . 0.64 109.68 178.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.9 158.9 31.69 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.715 -1.241 . . . . 0.67 109.989 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.469 ' CD1' HD11 ' A' ' 220' ' ' LEU . 15.0 mt -149.77 148.03 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.878 -1.156 . . . . 0.69 107.878 178.468 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.2 m -134.11 -32.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.995 -1.066 . . . . 0.85 113.557 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.11 45.32 2.51 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.102 -0.999 . . . . 0.92 112.227 -178.131 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 181' ' ' THR . 32.5 p -67.19 -11.1 56.46 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.189 -1.183 . . . . 0.95 111.328 -179.143 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.0 -97.08 0.81 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.802 -1.189 . . . . 1.04 110.182 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.6 m -127.18 29.07 5.64 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.457 -1.025 . . . . 1.57 112.473 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.53 -37.85 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.595 -1.316 . . . . 0.84 110.7 179.172 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 60.4 p -54.35 -25.1 22.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.001 -1.062 . . . . 0.99 111.36 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.2 t -93.63 -0.2 56.24 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.705 0.764 . . . . 1.7 111.742 -179.389 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -124.37 -2.05 8.06 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 113.291 0.849 . . . . 2.2 113.291 -177.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.4 t -117.12 150.04 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.443 -0.786 . . . . 0.84 109.156 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -122.2 153.07 39.3 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.638 -0.875 . . . . 2.2 108.638 178.01 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 52.3 t30 -52.2 141.53 18.67 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.235 -0.915 . . . . 2.28 110.093 178.518 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 10.0 t0 81.07 -1.76 1.76 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.111 1.152 . . . . 2.35 114.111 179.521 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -61.71 148.56 42.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.796 -1.19 . . . . 1.97 108.578 177.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -90.47 118.97 30.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.116 -1.439 . . . . 2.65 107.116 177.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.527 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 82.9 mt -129.33 148.41 51.25 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.55 -0.719 . . . . 0.63 109.511 -178.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.6 mt -117.54 129.66 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 106.602 -1.629 . . . . 0.62 106.602 177.682 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.469 HD11 ' CD1' ' A' ' 202' ' ' ILE . 61.6 tp -99.75 118.84 37.09 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 106.713 -1.588 . . . . 0.64 106.713 178.632 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 223' ' ' VAL . 50.4 t0 -93.71 -30.94 14.64 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.119 -0.988 . . . . 2.05 112.654 -177.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.889 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.87 20.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.42 0.896 . . . . 0.84 113.42 -178.079 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.7 t -109.62 -62.03 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.839 -1.163 . . . . 1.02 108.788 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -91.83 15.22 13.42 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.024 0.916 . . . . 2.51 110.247 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.3 t30 60.75 51.54 4.8 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.355 -0.839 . . . . 1.54 112.409 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -152.73 156.19 38.66 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.776 -1.202 . . . . 1.95 110.451 178.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 69.9 t -117.97 144.96 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.702 -0.624 . . . . 0.71 109.462 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -101.92 130.34 48.39 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 107.973 -1.121 . . . . 1.01 107.973 177.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.07 129.86 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.22 -0.925 . . . . 0.82 108.815 179.181 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.436 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 44.3 t-20 52.51 49.85 7.2 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.115 -0.991 . . . . 1.54 113.557 178.184 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 40.9 Cg_endo -66.51 149.71 84.3 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.623 2.216 . . . . 0.94 111.432 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.9 m -75.57 154.08 36.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 1.8 109.031 177.546 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 34.0 p-10 -60.74 -35.44 76.38 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.569 -0.707 . . . . 2.73 110.487 179.06 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.497 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 81.0 tt0 -59.47 -43.44 93.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 3.17 110.453 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 99.0 t -71.34 -39.79 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.241 -0.912 . . . . 1.34 110.165 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 1.2 110.512 179.806 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 106.497 -1.668 . . . . 1.07 106.497 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 m -105.94 128.13 53.59 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.762 -1.199 . . . . 1.24 107.762 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.28 -156.98 22.76 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 108.968 -1.653 . . . . 1.01 108.968 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 5' ' ' ILE . 86.6 mt -95.82 -1.81 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.554 -0.968 . . . . 1.11 112.581 -178.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 49.38 99.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.468 0.544 . . . . 0.99 112.468 178.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.89 -52.69 6.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.066 -1.021 . . . . 0.85 110.775 179.383 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.43 146.34 41.76 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 107.449 -1.315 . . . . 1.38 107.449 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -74.07 144.38 33.83 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.866 2.377 . . . . 0.94 112.993 178.92 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.912 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.46 166.81 17.55 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 109.539 -1.425 . . . . 0.81 109.539 178.075 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.7 mt -127.22 134.56 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.302 -1.116 . . . . 0.83 108.225 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.12 155.94 46.77 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.318 -0.864 . . . . 0.53 109.498 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 7.2 m-85 -125.09 143.22 51.03 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.482 -0.761 . . . . 0.77 108.995 178.527 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.32 167.39 34.39 Favored Glycine 0 N--CA 1.499 2.897 0 C-N-CA 118.98 -1.581 . . . . 0.51 110.002 177.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -78.82 157.65 28.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.753 -0.851 . . . . 1.9 109.198 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -81.31 134.84 35.65 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.842 -1.161 . . . . 0.66 108.636 178.035 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.2 tp -116.18 101.19 8.49 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 105.801 -1.925 . . . . 0.83 105.801 178.199 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -93.72 132.97 37.57 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.01 -1.107 . . . . 0.86 108.01 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.6 mt -103.31 118.09 35.99 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 106.802 -1.555 . . . . 0.92 106.802 178.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -110.63 137.72 47.95 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.749 -1.204 . . . . 2.03 107.749 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -121.02 151.33 39.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 2.66 109.703 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -81.92 132.98 35.28 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.941 -1.133 . . . . 2.32 107.941 177.216 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -60.87 148.84 38.09 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.876 -1.14 . . . . 2.11 108.941 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.0 mt -96.9 129.83 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.175 -0.953 . . . . 0.73 108.517 178.41 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.5 129.6 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.005 -1.109 . . . . 0.87 108.005 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.6 mt -91.64 130.91 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.24 -1.022 . . . . 0.81 108.24 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -90.62 116.54 28.59 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.061 -1.459 . . . . 1.34 107.061 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -97.92 17.07 19.06 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.424 -0.797 . . . . 2.89 112.673 -179.217 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -68.42 147.28 52.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 2.09 109.326 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -87.23 128.35 35.15 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.576 -1.268 . . . . 2.19 107.576 178.444 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 pt -93.84 163.97 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.026 -1.046 . . . . 0.75 110.132 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.8 p -92.57 162.03 14.35 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.206 0.527 . . . . 0.91 109.712 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.3 -15.98 1.91 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.046 -1.034 . . . . 0.93 112.011 179.315 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -71.27 -38.95 71.82 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.409 -0.807 . . . . 2.28 110.895 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -92.68 -6.06 50.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.744 -1.222 . . . . 1.45 112.934 -178.236 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -59.67 -40.58 82.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 120.154 -0.618 . . . . 0.81 110.48 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -59.24 -40.19 85.15 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.017 -1.052 . . . . 1.54 110.528 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -62.14 -41.47 98.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.326 -0.859 . . . . 2.36 111.213 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -59.71 -40.27 87.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.316 -0.865 . . . . 1.31 111.047 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.31 -40.63 84.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.169 -0.957 . . . . 0.82 110.982 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -60.37 -48.82 80.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.587 -1.321 . . . . 1.5 110.449 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -62.45 -40.97 98.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.472 -0.767 . . . . 2.23 110.649 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -70.39 -57.6 4.64 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.177 -0.952 . . . . 0.85 109.374 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.39 -48.73 80.53 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.55 -0.86 . . . . 0.91 110.121 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.7 t -68.03 -39.67 83.04 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.106 -0.996 . . . . 0.9 110.074 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.16 -46.67 70.07 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.74 -1.219 . . . . 0.69 110.056 178.615 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -59.96 -29.92 68.75 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.44 -1.035 . . . . 2.88 110.311 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.67 -49.48 77.58 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.671 0.748 . . . . 0.85 109.923 179.187 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -79.27 -41.56 27.85 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.599 -0.688 . . . . 2.35 110.657 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.58 -41.37 90.1 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.05 -1.06 . . . . 0.65 110.206 -178.671 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.2 p -60.78 -40.34 92.23 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.319 1.056 . . . . 1.45 109.246 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.71 -49.63 67.79 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.65 -0.705 . . . . 0.63 110.435 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -59.67 -49.78 76.41 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 118.85 -1.14 . . . . 1.34 110.392 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.94 -40.6 98.15 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.877 0.846 . . . . 1.56 110.164 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -59.93 -41.4 91.7 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.195 -0.94 . . . . 1.19 110.471 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 m -63.89 -43.7 95.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.851 -1.156 . . . . 0.72 110.067 179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.9 mt -60.43 -36.66 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.561 0.696 . . . . 0.62 110.943 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -51.01 -44.09 60.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.401 -0.812 . . . . 1.05 110.81 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -68.98 -38.91 79.61 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.031 -1.043 . . . . 0.64 110.029 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.71 -37.71 87.56 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.887 -1.125 . . . . 1.73 108.873 179.216 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.8 -33.17 75.35 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.887 -0.725 . . . . 0.56 109.818 179.112 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.83 -37.1 12.08 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 120.139 -1.029 . . . . 0.69 111.135 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -81.63 -28.45 33.66 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.787 -1.42 . . . . 1.48 110.723 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.3 m -88.19 -45.45 10.08 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.49 -0.757 . . . . 0.98 111.383 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.89 -7.54 17.04 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 114.102 1.149 . . . . 1.16 114.102 -177.827 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.46 161.27 30.2 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.498 -0.751 . . . . 0.85 111.633 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.87 -25.39 63.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.73 -0.865 . . . . 3.86 112.341 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -57.27 -44.18 83.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.763 -1.211 . . . . 2.35 110.669 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -82.64 -24.29 33.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.554 -1.341 . . . . 1.67 111.405 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.72 -36.84 77.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.531 -0.731 . . . . 1.45 110.981 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.05 83.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.163 -0.961 . . . . 0.61 110.628 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.7 mt -64.74 -41.86 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.913 -1.117 . . . . 0.65 110.178 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -71.42 -32.41 68.36 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.971 -1.081 . . . . 0.66 109.776 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -61.74 -39.19 90.69 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 1.19 109.953 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.71 -40.93 99.04 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.265 -0.969 . . . . 0.53 110.986 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -58.93 -43.07 91.1 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.913 -1.345 . . . . 1.27 110.475 179.435 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.5 mt -60.88 -37.51 76.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.038 -1.039 . . . . 0.54 110.333 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -57.7 -40.27 79.1 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.602 -0.687 . . . . 1.74 110.045 179.12 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 tp -60.31 -50.35 73.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.368 -0.832 . . . . 0.55 110.232 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.01 -41.26 91.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.896 0.855 . . . . 0.47 110.183 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -85.91 5.69 31.83 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.446 -0.784 . . . . 1.42 112.937 -179.392 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -61.59 121.79 13.64 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.204 -0.935 . . . . 1.27 108.491 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.95 -17.26 64.55 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.752 -0.779 . . . . 1.35 110.822 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.77 -51.8 10.73 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.768 -0.773 . . . . 2.22 110.495 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.95 -40.61 93.94 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.48 -0.888 . . . . 0.62 111.204 -179.31 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -57.48 -49.85 74.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.932 . . . . 1.29 110.236 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -61.86 -40.34 95.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 1.52 110.469 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.02 -46.66 77.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.936 -1.102 . . . . 1.3 110.521 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -57.11 -42.87 80.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.049 -1.032 . . . . 0.61 110.065 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.8 -44.51 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.39 -0.819 . . . . 0.78 110.245 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.6 97.33 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.493 -0.754 . . . . 0.82 111.016 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.03 -43.29 99.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.872 -1.142 . . . . 0.8 110.198 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.62 -47.94 89.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.38 -0.825 . . . . 0.77 110.247 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -78.09 -38.76 43.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.125 -0.984 . . . . 2.12 112.059 -179.375 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -82.35 -42.25 18.96 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.964 -1.085 . . . . 1.51 112.359 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -99.04 5.04 47.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.173 -0.955 . . . . 1.98 112.374 -178.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 40.7 m80 51.37 49.11 21.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.0 . . . . 1.32 111.338 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 64.5 mtt -105.82 154.68 20.19 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.14 -0.975 . . . . 1.38 109.711 178.483 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 82.5 p -70.82 160.37 32.87 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.701 -0.624 . . . . 0.67 109.6 177.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.01 86.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.043 -1.035 . . . . 0.52 110.539 179.014 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -67.68 -39.36 84.46 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.318 -0.863 . . . . 2.25 110.568 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.06 67.96 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 120.928 -1.108 . . . . 0.64 111.439 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.76 88.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.56 110.626 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.74 -41.33 86.25 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.234 -0.916 . . . . 0.46 111.148 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -61.13 -40.25 93.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.631 -1.293 . . . . 1.32 110.285 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -59.9 -49.86 76.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.856 -1.152 . . . . 1.3 110.243 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.21 -47.27 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.982 -1.074 . . . . 0.61 110.182 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.3 mm -61.33 -33.26 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.65 110.521 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -57.26 -39.93 76.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.592 -0.693 . . . . 2.11 110.979 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.67 -24.91 44.18 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 118.948 -1.596 . . . . 0.83 113.304 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -63.36 -41.06 98.8 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.527 -1.572 . . . . 1.28 109.702 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.81 63.33 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.018 -0.537 . . . . 0.89 110.759 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.7 p -62.43 -41.14 98.49 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.077 -1.049 . . . . 1.87 109.918 -178.141 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.47 98.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.099 -1.0 . . . . 1.05 110.893 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 87.9 mt -64.92 -29.66 70.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.106 -0.996 . . . . 1.02 110.722 -179.605 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -66.38 -21.59 66.23 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.34 -0.85 . . . . 2.04 110.967 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -71.72 -13.38 61.71 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.222 1.01 . . . . 1.73 110.814 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.8 mt -87.62 136.35 32.98 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.429 -1.323 . . . . 1.37 107.429 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 7.3 t0 -97.01 37.42 1.31 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.556 -0.715 . . . . 2.88 112.266 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -111.96 138.77 48.13 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 107.984 -1.117 . . . . 1.58 107.984 178.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.92 -38.84 76.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.476 -0.765 . . . . 3.04 111.454 179.114 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -73.37 -50.12 23.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.65 -1.281 . . . . 0.9 110.594 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.59 -43.3 97.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.022 -1.049 . . . . 1.06 110.367 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -62.55 -45.11 94.44 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.345 -0.942 . . . . 2.18 109.416 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.84 -31.22 69.54 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.489 -0.885 . . . . 2.15 109.27 179.601 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.473 ' O ' HG23 ' A' ' 130' ' ' VAL . 26.6 ttm180 -61.67 -30.17 70.56 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.308 -0.957 . . . . 2.33 108.832 179.09 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -61.8 -50.51 72.04 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.157 -0.617 . . . . 0.82 110.273 178.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.37 -42.74 78.74 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.843 -0.743 . . . . 0.85 110.38 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.69 -36.84 84.22 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.733 -0.605 . . . . 1.39 110.567 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 126' ' ' ARG . 43.5 t -68.54 -40.94 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.235 -0.986 . . . . 0.56 110.732 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.532 ' HE ' ' NZ ' ' A' ' 135' ' ' LYS . 62.4 ttt180 -59.53 -37.6 78.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.031 -1.043 . . . . 3.12 109.704 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.407 ' CG ' ' NH1' ' A' ' 136' ' ' ARG . 49.2 t0 -60.37 -36.63 78.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.692 -0.63 . . . . 1.28 109.907 179.469 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.99 -39.76 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.729 0.776 . . . . 0.49 109.842 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.16 -42.64 94.25 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 119.567 -1.301 . . . . 0.46 109.973 178.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.532 ' NZ ' ' HE ' ' A' ' 131' ' ' ARG . 40.4 mmtm -59.05 -49.33 78.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.477 -1.014 . . . . 2.71 110.421 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.416 HH11 ' HG3' ' A' ' 136' ' ' ARG . 51.5 mtm-85 -64.96 -40.93 95.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.848 -1.158 . . . . 2.14 109.844 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 35.6 tp -61.09 -39.44 89.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.263 -0.898 . . . . 1.05 110.217 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.7 mt -60.24 -38.6 83.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.56 -0.712 . . . . 0.52 111.074 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 139' ' ' ARG . 56.0 mtt-85 -60.13 -37.83 81.23 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.288 -0.883 . . . . 2.35 110.734 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -75.47 -40.79 56.95 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.62 -0.832 . . . . 1.39 110.581 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -60.37 -39.62 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 0.68 110.17 -178.696 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.2 mt -87.28 -4.33 59.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.955 -1.091 . . . . 0.83 111.522 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.47 29.5 65.85 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 119.62 -1.276 . . . . 0.91 112.819 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 33.2 tp -75.03 151.09 38.76 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.632 0.729 . . . . 0.95 109.136 179.339 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -64.1 146.65 53.83 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.695 -1.253 . . . . 2.43 109.231 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.8 mt -105.27 138.79 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.574 -0.899 . . . . 1.1 108.574 178.633 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.658 ' H ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -81.0 127.32 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.671 -1.233 . . . . 1.58 107.671 178.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -94.7 96.16 9.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.484 -1.672 . . . . 1.62 106.484 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.494 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.9 mt -75.76 -15.77 60.22 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.699 0.762 . . . . 0.8 111.683 -177.758 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.411 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 94.7 p -89.92 8.35 32.68 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.613 -1.305 . . . . 1.56 112.147 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.29 21.21 12.3 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.672 0.99 . . . . 0.84 113.672 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.494 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 3.2 mp -70.51 139.94 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.343 -1.473 . . . . 0.82 108.437 179.302 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -114.65 -20.41 10.69 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.471 -0.768 . . . . 2.31 112.278 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -114.2 139.19 49.57 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.535 -1.284 . . . . 1.54 107.535 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.81 122.97 20.87 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.426 -0.954 . . . . 1.38 108.426 178.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.6 m -144.84 173.87 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 109.071 -0.714 . . . . 0.69 109.071 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.9 mt -85.78 142.87 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.065 -1.022 . . . . 0.53 109.583 178.299 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.2 tp -97.19 124.0 41.13 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.124 -0.985 . . . . 0.64 108.554 178.374 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.6 129.51 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.623 -1.251 . . . . 0.67 107.623 179.357 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.21 152.34 18.66 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.94 -1.1 . . . . 0.78 109.051 179.314 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.83 78.22 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.435 -1.416 . . . . 1.0 109.673 178.081 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 56.1 t0 -171.96 149.79 2.47 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.001 -0.74 . . . . 2.42 109.001 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.464 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 36.1 mt -114.39 140.85 48.33 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.537 -0.727 . . . . 0.75 109.397 177.356 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 81.2 p -90.0 149.02 40.89 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.954 -1.091 . . . . 0.78 109.096 178.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.97 -44.53 12.06 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 C-N-CA 122.159 1.906 . . . . 0.67 113.51 179.305 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.8 m -60.85 -46.54 90.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.834 -1.166 . . . . 0.7 109.742 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -63.81 -39.76 95.0 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.697 -0.801 . . . . 1.21 110.399 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 64.9 p -69.43 -39.4 77.88 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.63 -0.668 . . . . 0.6 110.587 179.616 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.79 78.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.618 -0.676 . . . . 0.62 110.662 179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -95.58 1.3 53.68 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.202 -0.936 . . . . 1.16 112.931 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.4 tp -61.57 151.94 31.82 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.718 -1.238 . . . . 0.73 109.548 179.496 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 150' ' ' SER . 94.3 m-20 -94.65 107.54 19.53 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 106.269 -1.752 . . . . 2.24 106.269 178.102 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.61 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.9 mp -69.36 -25.04 63.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.858 -0.526 . . . . 1.43 111.548 -178.074 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -83.37 -14.25 53.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.251 -0.906 . . . . 2.15 112.925 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -102.98 -1.91 28.52 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.274 0.842 . . . . 2.04 113.274 -177.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 178' ' ' GLY . 96.6 t -111.41 130.26 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.249 -1.019 . . . . 0.55 108.249 179.295 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 27.8 tp -84.54 -10.47 57.39 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.124 -0.985 . . . . 1.63 111.992 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.569 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.45 167.21 35.92 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 108.995 -1.642 . . . . 0.47 108.995 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -121.75 130.15 53.21 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.869 -1.16 . . . . 0.54 107.869 178.375 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 18.8 mt -130.07 130.45 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 107.444 -1.317 . . . . 0.69 107.444 178.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.2 p -140.29 172.33 12.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.936 -1.103 . . . . 0.82 109.818 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 2.8 m-20 -111.95 42.51 1.74 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.338 0.59 . . . . 2.37 110.369 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.55 168.73 9.04 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.783 0.801 . . . . 1.11 110.074 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.17 -6.8 48.55 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 120.107 -1.044 . . . . 1.67 113.086 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 77.6 -52.43 3.5 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.17 -1.194 . . . . 1.54 113.539 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -58.8 -42.37 88.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.817 -1.402 . . . . 4.48 110.986 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 81.8 p -105.38 11.3 32.88 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 120.79 -1.193 . . . . 2.63 112.074 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.5 t -92.18 125.53 36.89 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.839 -0.8 . . . . 1.69 108.839 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -62.08 -32.47 73.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 1.07 110.357 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.6 m -58.66 -38.9 79.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.406 -0.809 . . . . 1.58 110.39 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 93.6 p -59.03 -37.76 77.71 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.38 -0.825 . . . . 1.6 110.085 179.177 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.8 HD13 ' NH2' ' A' ' 195' ' ' ARG . 5.3 mm -58.75 -39.71 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.652 -0.819 . . . . 1.45 110.151 179.375 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 51.1 mtp -62.97 -44.52 95.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.088 -1.008 . . . . 1.05 110.146 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.26 -49.82 76.36 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.08 -0.648 . . . . 0.72 111.484 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.8 ' NH2' HD13 ' A' ' 192' ' ' ILE . 65.0 mtm-85 -62.96 -42.14 99.73 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.188 -0.945 . . . . 3.05 111.199 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.0 m -68.31 -38.75 81.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.173 -0.954 . . . . 0.89 109.855 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.62 -6.95 51.4 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.82 0.674 . . . . 0.78 112.82 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.6 mt-10 53.52 11.26 0.27 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 113.804 1.039 . . . . 1.45 113.804 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.11 144.71 87.73 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.856 -1.153 . . . . 0.67 108.239 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.28 131.2 43.47 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.785 1.657 . . . . 0.64 110.636 178.596 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.6 171.84 16.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.272 -1.371 . . . . 0.67 110.118 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.587 HD12 HD11 ' A' ' 220' ' ' LEU . 10.1 mt -147.03 157.04 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.045 -1.094 . . . . 0.69 108.045 178.335 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 181' ' ' THR . 23.8 m -141.59 -29.05 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.644 -1.285 . . . . 0.85 112.791 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.72 33.18 1.89 Allowed Glycine 0 C--N 1.289 -2.04 0 O-C-N 120.927 -1.108 . . . . 0.92 113.685 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 27.6 p -55.47 -24.79 33.05 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.249 -1.148 . . . . 0.95 111.194 -179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.34 -87.86 1.56 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.825 -0.91 . . . . 1.04 110.825 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 45.2 p -129.02 26.83 5.46 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 121.167 -1.196 . . . . 1.57 113.069 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 30.4 t -57.0 -39.7 67.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.317 -1.489 . . . . 0.84 110.807 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 64.4 p -61.27 -18.95 60.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 0.99 111.93 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 67.4 m -98.83 5.44 47.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 1.7 112.002 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -133.62 -4.19 2.93 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.916 -0.49 . . . . 2.2 112.146 -178.056 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.0 t -121.3 152.95 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 121.504 0.668 . . . . 0.84 109.41 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -117.81 161.21 20.1 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.751 -0.833 . . . . 2.2 108.751 178.175 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.0 p-10 -61.78 149.87 38.68 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.906 -1.117 . . . . 2.28 109.88 177.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.5 t70 82.88 -10.27 1.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.233 1.197 . . . . 2.35 114.233 178.102 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.23 149.44 37.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.534 -1.354 . . . . 1.97 109.276 177.304 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -87.18 123.88 32.68 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.282 -1.377 . . . . 2.65 107.282 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.515 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 74.8 mt -127.51 150.23 49.77 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.017 0.913 . . . . 0.63 110.093 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 88.0 mt -119.05 122.29 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.237 -1.764 . . . . 0.62 106.237 177.114 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.587 HD11 HD12 ' A' ' 202' ' ' ILE . 37.1 tp -98.65 118.01 34.4 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.441 -1.688 . . . . 0.64 106.441 178.434 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 223' ' ' VAL . 87.7 m-20 -94.22 -27.84 15.95 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.502 -1.374 . . . . 2.05 112.917 -177.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.912 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.63 15.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.914 0.709 . . . . 0.84 112.914 -179.159 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.8 t -108.66 -62.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.196 -0.94 . . . . 1.02 109.217 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -94.34 11.31 30.92 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.009 0.909 . . . . 2.51 110.514 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 60.9 54.99 3.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.618 -0.719 . . . . 1.54 112.03 178.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -144.72 146.53 32.24 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.234 1.016 . . . . 1.95 109.586 178.577 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.84 131.32 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.658 -1.238 . . . . 0.71 107.658 177.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -102.05 132.02 48.16 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.846 -1.159 . . . . 1.01 108.483 178.863 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.28 129.94 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 107.998 -1.112 . . . . 0.82 107.998 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.5 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 48.3 t30 59.05 44.01 0.96 Allowed Pre-proline 0 N--CA 1.485 1.309 0 N-CA-C 113.631 0.974 . . . . 1.54 113.631 178.717 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.1 Cg_endo -64.7 149.35 89.88 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.349 2.033 . . . . 0.94 111.56 -179.622 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 36.9 p -77.03 160.18 29.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.475 -0.766 . . . . 1.8 110.255 178.041 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -60.28 -36.73 78.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.753 -0.592 . . . . 2.73 110.385 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.12 -40.34 85.1 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.447 -0.783 . . . . 3.17 110.15 179.332 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 79.4 t -70.15 -39.87 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.824 0.821 . . . . 1.34 110.571 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.3 mt . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.499 -0.751 . . . . 1.2 110.799 -179.894 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.6 mt . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 107.433 -1.321 . . . . 1.07 107.433 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.0 m -100.47 127.48 46.8 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.505 -1.294 . . . . 1.24 107.505 178.862 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -124.5 -163.29 11.64 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.451 -1.86 . . . . 1.01 108.451 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.7 mt -97.91 2.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.984 -1.303 . . . . 1.11 112.593 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tp 51.56 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.762 -1.211 . . . . 0.99 111.825 178.779 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -86.07 -38.83 17.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.914 -1.116 . . . . 0.85 110.939 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.427 ' O ' ' HB1' ' A' ' 222' ' ' ALA . 2.6 m -148.1 144.36 18.78 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.619 -1.301 . . . . 1.38 108.173 -179.376 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.08 145.99 22.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.356 2.037 . . . . 0.94 111.904 178.263 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.922 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.93 171.02 19.27 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.23 -1.548 . . . . 0.81 109.23 178.047 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.1 mt -128.79 135.56 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.208 -1.172 . . . . 0.83 107.919 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.39 152.69 44.55 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.027 -1.046 . . . . 0.53 109.996 179.478 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -125.08 140.28 53.03 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.33 -0.989 . . . . 0.77 108.33 178.171 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.54 170.14 37.38 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 118.216 -1.945 . . . . 0.51 110.473 178.155 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -78.74 157.14 28.57 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.803 -0.822 . . . . 1.9 109.003 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.514 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.89 127.45 35.05 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.257 -1.016 . . . . 0.66 108.257 178.426 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.3 tp -105.07 102.99 12.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.497 -2.038 . . . . 0.83 105.497 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.7 tp -90.62 140.82 29.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.936 -1.102 . . . . 0.86 108.672 -179.68 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.5 mt -97.0 114.22 25.82 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.697 -1.594 . . . . 0.92 106.697 177.62 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -106.23 130.11 54.16 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.317 -1.364 . . . . 2.03 107.317 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -125.31 149.61 47.91 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.476 -0.765 . . . . 2.66 109.527 -179.473 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -82.4 133.28 35.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.079 -1.082 . . . . 2.32 108.079 177.258 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -65.34 146.67 54.62 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.168 -0.957 . . . . 2.11 108.758 178.601 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.1 mt -93.45 136.18 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.694 -0.854 . . . . 0.73 108.694 178.431 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.09 130.27 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.821 -1.177 . . . . 0.87 107.821 179.064 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.7 mt -97.94 135.34 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.181 -1.044 . . . . 0.81 108.181 178.881 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -91.22 122.45 33.87 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.747 -1.205 . . . . 1.34 107.747 178.775 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -95.4 16.96 15.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.201 -0.937 . . . . 2.89 112.216 -179.796 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -73.82 148.57 42.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 2.09 109.728 178.776 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -90.6 135.59 33.61 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.333 -0.988 . . . . 2.19 108.333 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 pt -100.48 166.36 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.131 -0.98 . . . . 0.75 109.976 179.5 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.2 p -95.43 168.68 10.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.501 -0.749 . . . . 0.91 109.583 178.322 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.66 -18.61 21.47 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.078 -1.014 . . . . 0.93 112.476 179.439 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -68.06 -37.54 81.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.881 -1.137 . . . . 2.28 110.711 -179.77 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -92.26 -5.35 52.54 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.634 -1.292 . . . . 1.45 113.132 -179.261 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.28 -43.8 94.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.063 -1.023 . . . . 0.81 110.134 -179.465 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -57.93 -40.76 81.22 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.567 -0.853 . . . . 1.54 110.241 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -63.89 -39.76 94.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.704 -0.623 . . . . 2.36 110.714 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.23 -42.58 95.54 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.157 -0.964 . . . . 1.31 110.913 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.34 -42.22 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.09 -1.006 . . . . 0.82 110.727 -179.801 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -60.96 -42.27 97.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 1.5 109.919 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -60.75 -42.67 97.88 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.466 -0.894 . . . . 2.23 109.803 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -72.84 -56.7 4.84 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.815 0.817 . . . . 0.85 110.231 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 tp -58.47 -47.44 84.03 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.42 -0.912 . . . . 0.91 110.252 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.506 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.8 t -68.73 -39.82 80.18 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.121 -0.987 . . . . 0.9 110.035 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.44 -45.55 94.26 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.434 -1.365 . . . . 0.69 109.783 178.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -58.76 -30.19 67.33 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.516 -0.991 . . . . 2.88 110.28 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.67 -42.14 87.78 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.972 0.891 . . . . 0.85 109.779 179.024 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -81.19 -40.71 23.48 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.412 -0.805 . . . . 2.35 110.73 179.445 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.86 -43.68 90.89 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.747 -0.781 . . . . 0.65 109.938 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.8 m -59.32 -39.93 84.67 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.863 0.84 . . . . 1.45 109.381 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.31 -44.36 71.9 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.629 -0.714 . . . . 0.63 110.587 179.785 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -65.5 -51.57 59.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.004 . . . . 1.34 110.472 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.58 -38.99 86.44 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.371 -0.931 . . . . 1.56 109.874 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -59.99 -40.99 91.06 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.456 -0.777 . . . . 1.19 110.487 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -65.63 -42.33 91.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.72 110.175 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.81 -35.17 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.495 -0.753 . . . . 0.62 110.703 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -52.44 -43.01 64.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.659 -1.275 . . . . 1.05 110.771 179.237 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.13 -37.17 78.18 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.389 -0.819 . . . . 0.64 110.151 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -62.05 -39.54 92.7 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.853 -1.139 . . . . 1.73 109.531 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.83 -32.08 72.37 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.598 -0.689 . . . . 0.56 110.322 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.41 -36.67 16.44 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.242 -1.456 . . . . 0.69 110.478 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.02 -16.43 50.27 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.637 -1.508 . . . . 1.48 111.306 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.2 m -92.94 -51.12 5.22 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.785 -0.572 . . . . 0.98 110.768 -179.597 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -107.82 -19.86 13.39 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.303 -0.873 . . . . 1.16 112.799 -177.996 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.06 160.55 11.1 Favored Glycine 0 N--CA 1.504 3.219 0 O-C-N 120.96 -1.087 . . . . 0.85 112.028 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -56.06 -22.77 29.48 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.983 -0.716 . . . . 3.86 112.727 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -58.14 -35.47 71.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 2.35 111.3 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -81.02 -25.78 36.92 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.721 -1.237 . . . . 1.67 112.315 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.09 -32.41 69.79 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.377 -0.827 . . . . 1.45 110.803 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.43 85.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.019 . . . . 0.61 111.17 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.58 -42.92 87.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.394 -1.441 . . . . 0.65 110.114 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -70.48 -30.69 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.66 110.729 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -59.91 -40.26 88.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.128 -0.982 . . . . 1.19 110.142 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.33 -39.46 97.01 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.537 -1.316 . . . . 0.53 110.47 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -59.1 -41.84 89.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.655 -0.909 . . . . 1.27 111.113 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 77' ' ' ILE . 40.3 mt -60.67 -42.09 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.92 -1.112 . . . . 0.54 110.028 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.5 ttm -60.42 -40.25 90.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.511 -0.743 . . . . 1.74 110.067 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 tp -59.77 -49.82 76.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.422 -0.799 . . . . 0.55 109.872 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.54 -41.85 95.33 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.055 -0.658 . . . . 0.47 110.299 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -85.29 4.96 32.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.5 -0.75 . . . . 1.42 112.972 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -61.54 118.17 6.69 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.627 -1.296 . . . . 1.27 109.191 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -63.69 -16.69 61.7 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.03 0.919 . . . . 1.35 110.904 -179.4 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -77.49 -52.24 9.42 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.95 0.881 . . . . 2.22 110.248 179.74 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.71 -37.79 85.47 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.668 -0.813 . . . . 0.62 110.588 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -59.05 -47.99 83.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 1.29 110.781 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -61.61 -38.0 86.02 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.314 -0.866 . . . . 1.52 111.142 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -64.6 -47.7 77.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.236 -0.915 . . . . 1.3 110.324 179.621 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.1 mt -58.3 -45.05 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.444 -0.785 . . . . 0.61 109.665 179.181 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.1 mt -60.79 -40.59 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.994 0.902 . . . . 0.78 109.862 179.663 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.67 97.32 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.995 -1.065 . . . . 0.82 110.601 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.45 -41.37 97.1 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.426 -0.91 . . . . 0.8 110.245 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.26 -47.99 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.054 -1.029 . . . . 0.77 110.387 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -77.09 -35.77 56.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.508 -0.745 . . . . 2.12 112.121 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -80.7 -44.99 17.85 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.407 -1.433 . . . . 1.51 112.184 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -102.82 12.08 36.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.292 -0.88 . . . . 1.98 112.559 -178.571 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.9 m80 49.23 49.07 20.25 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.026 -1.07 . . . . 1.32 111.56 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.6 mtt -102.57 154.58 18.98 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.146 -0.971 . . . . 1.38 109.715 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.8 p -70.63 159.8 33.73 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.377 0.608 . . . . 0.67 109.412 177.863 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.99 83.39 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.383 -0.823 . . . . 0.52 111.284 178.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -72.07 -44.44 63.29 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.212 -0.93 . . . . 2.25 110.44 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.11 74.39 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.35 -0.94 . . . . 0.64 111.165 -178.235 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.89 93.17 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.182 -0.948 . . . . 0.56 110.945 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.67 86.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 0.46 110.683 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -60.63 -37.94 83.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.925 . . . . 1.32 110.65 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -57.57 -50.01 74.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.821 -1.175 . . . . 1.3 111.078 179.346 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.9 -46.88 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.882 -1.136 . . . . 0.61 109.97 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.02 -33.4 55.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.66 -0.65 . . . . 0.65 110.233 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -58.62 -40.19 82.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.17 -0.956 . . . . 2.11 110.922 179.37 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.41 -35.7 10.4 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.046 -1.55 . . . . 0.83 112.3 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -60.49 -41.16 93.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.394 -1.651 . . . . 1.28 109.889 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.37 -49.82 38.37 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.684 0.754 . . . . 0.89 110.59 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.9 m -60.64 -39.13 87.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 1.87 110.772 -179.432 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.51 -41.9 95.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.423 -0.798 . . . . 1.05 110.847 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.68 -30.35 71.37 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.15 -1.02 . . . . 1.02 110.994 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.0 -20.56 64.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.071 -1.018 . . . . 2.04 111.067 179.783 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.53 -17.84 61.7 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.784 0.802 . . . . 1.73 111.19 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.556 HD13 HD13 ' A' ' 123' ' ' LEU . 29.7 mt -86.34 148.76 25.45 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.396 -0.815 . . . . 1.37 109.285 179.464 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -101.7 41.66 1.19 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.48 -0.763 . . . . 2.88 111.007 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -114.06 130.86 56.54 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.273 -1.01 . . . . 1.58 108.273 178.799 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.6 mp0 -58.71 -33.08 69.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.278 -0.889 . . . . 3.04 110.77 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -71.1 -51.43 25.13 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.689 -1.257 . . . . 0.9 110.318 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.556 HD13 HD13 ' A' ' 118' ' ' LEU . 46.2 mt -67.11 -39.25 86.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.426 -0.796 . . . . 1.06 110.331 -179.312 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 57.2 tttp -61.99 -49.61 75.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.971 -1.08 . . . . 2.18 109.796 179.352 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 187' ' ' THR . 50.5 mt-10 -61.49 -31.66 71.65 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.529 -0.868 . . . . 2.15 109.203 179.699 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 130' ' ' VAL . 22.5 ttp180 -64.75 -28.94 69.93 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.251 1.024 . . . . 2.33 109.091 179.187 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.11 -47.16 86.27 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.575 -0.85 . . . . 0.82 109.54 178.375 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.7 87.59 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.57 -0.852 . . . . 0.85 109.612 179.587 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -63.29 -36.32 83.29 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.189 0.519 . . . . 1.39 110.546 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 126' ' ' ARG . 50.6 t -67.85 -36.59 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.966 -1.084 . . . . 0.56 110.237 179.507 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -59.45 -38.8 81.66 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.869 -1.132 . . . . 3.12 109.109 178.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.571 ' CG ' HH21 ' A' ' 136' ' ' ARG . 58.2 t0 -59.61 -40.34 87.2 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.676 -0.693 . . . . 1.28 109.9 179.114 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -60.83 -33.86 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 0.49 109.7 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.41 -49.74 14.24 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.098 -1.049 . . . . 0.46 111.186 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.474 ' NZ ' ' OD1' ' A' ' 132' ' ' ASP . 5.3 pttm -58.86 -39.46 81.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.998 -1.295 . . . . 2.71 110.649 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.571 HH21 ' CG ' ' A' ' 132' ' ' ASP . 37.0 mtt180 -59.4 -45.22 92.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.947 -1.095 . . . . 2.14 109.936 179.03 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.96 -42.57 98.54 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.66 -0.65 . . . . 1.05 110.427 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 23.8 mt -59.9 -43.48 94.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.577 -0.702 . . . . 0.52 110.566 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -60.47 -34.55 74.19 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.433 -0.792 . . . . 2.35 111.298 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.13 -41.13 51.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.92 -1.112 . . . . 1.39 110.43 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.26 -39.84 83.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 120.83 -1.169 . . . . 0.68 110.887 -178.368 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 76.1 mt -88.53 -10.02 50.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 0.83 112.246 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.0 19.96 71.41 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.887 -1.149 . . . . 0.91 113.261 -179.298 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.9 tp -64.99 143.82 57.7 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.503 -0.998 . . . . 0.95 109.248 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -70.02 151.7 45.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.366 -0.834 . . . . 2.43 109.626 178.113 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.3 mt -105.44 140.19 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.218 -1.03 . . . . 1.1 108.218 178.06 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.3 mm -75.74 136.2 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 1.58 108.973 178.398 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.38 92.55 7.22 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.495 -1.669 . . . . 1.62 106.495 178.526 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 81.3 mt -78.36 -20.86 50.42 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.357 -0.839 . . . . 0.8 111.061 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.6 t -78.86 -6.9 57.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 1.56 112.458 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.39 35.94 1.55 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.597 -0.689 . . . . 0.84 112.489 -178.667 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.1 mm -68.9 149.13 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.865 -1.147 . . . . 0.82 108.986 178.813 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -129.37 -9.12 4.68 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.531 -0.73 . . . . 2.31 112.613 -179.296 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -120.01 145.75 46.52 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.851 -0.796 . . . . 1.54 108.851 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -80.37 114.73 19.48 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.655 -1.239 . . . . 1.38 107.655 177.695 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -148.2 175.45 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 0.69 109.305 -178.911 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.3 mt -93.83 143.33 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.389 -0.967 . . . . 0.53 108.389 178.262 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.8 tp -96.49 129.81 43.78 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.772 -1.205 . . . . 0.64 108.828 178.482 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.84 130.47 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.813 -1.18 . . . . 0.67 107.813 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.06 155.55 23.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.861 -1.149 . . . . 0.78 108.868 179.184 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.01 79.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.492 -1.38 . . . . 1.0 109.712 178.163 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -174.3 148.46 1.28 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.908 -0.775 . . . . 2.42 108.908 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.2 mt -118.15 141.69 48.23 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.585 -0.895 . . . . 0.75 108.585 177.185 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.2 p -90.93 148.9 39.17 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.992 . . . . 0.78 108.671 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -38.81 -41.2 1.64 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.73 1.62 . . . . 0.67 113.542 178.913 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.538 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 25.4 m -62.66 -51.48 67.07 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.878 -1.139 . . . . 0.7 110.508 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.2 -39.09 88.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 1.21 109.855 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.7 p -68.48 -39.18 81.46 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.615 -0.678 . . . . 0.6 110.419 179.332 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.8 -35.73 80.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.051 -1.03 . . . . 0.62 110.761 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -96.21 -1.0 49.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.02 -1.05 . . . . 1.16 112.827 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -60.61 156.41 16.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.929 . . . . 0.73 109.863 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -88.97 106.28 18.32 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.788 -1.56 . . . . 2.24 106.788 178.168 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 50.9 mt -80.49 -17.47 51.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.623 -0.673 . . . . 1.43 112.133 -177.495 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -81.13 -23.05 38.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.381 -0.824 . . . . 2.15 111.769 -178.57 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -105.95 -2.87 22.39 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.614 0.968 . . . . 2.04 113.614 -178.138 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.94 128.4 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 107.74 -1.207 . . . . 0.55 107.74 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.4 tp -90.44 -10.4 43.92 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.246 -0.909 . . . . 1.63 112.251 -178.908 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.22 171.02 41.13 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.116 -1.593 . . . . 0.47 109.116 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -130.77 135.75 48.06 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.563 -1.273 . . . . 0.54 107.563 179.334 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.564 HG22 HG21 ' A' ' 205' ' ' THR . 97.0 mt -133.11 107.94 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 105.938 -1.875 . . . . 0.69 105.938 178.156 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 203' ' ' VAL . 72.2 p -128.82 175.37 8.68 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.676 -1.265 . . . . 0.82 110.746 -178.696 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.7 OUTLIER -100.51 53.92 0.88 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.578 -0.737 . . . . 2.37 110.071 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.93 156.37 16.65 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.091 -1.006 . . . . 1.11 109.773 179.149 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.14 -5.03 57.93 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.769 -1.205 . . . . 1.67 112.397 178.657 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 73.66 -12.37 4.84 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.488 -1.339 . . . . 1.54 115.213 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.406 ' O ' ' OG1' ' A' ' 187' ' ' THR . 79.0 mtm180 -81.8 113.41 19.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.001 -1.481 . . . . 4.48 107.001 178.42 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 22.2 p 48.54 39.96 14.25 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.893 -1.129 . . . . 2.63 111.931 -178.921 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.3 p -82.14 133.67 35.28 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.309 -0.997 . . . . 1.69 108.309 177.7 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -60.15 -40.41 89.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.442 -0.786 . . . . 1.07 110.681 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 87.4 m -60.83 -42.04 96.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 1.58 110.256 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 98.1 p -61.61 -38.58 88.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.945 -1.097 . . . . 1.6 110.411 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.11 -35.32 60.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.431 -0.793 . . . . 1.45 110.833 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.6 mtp -62.64 -42.65 99.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 122.395 1.093 . . . . 1.05 109.202 179.333 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.89 -49.54 77.07 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.552 -0.749 . . . . 0.72 110.789 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -60.38 -44.34 95.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 3.05 110.697 -179.838 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.4 m -69.88 -40.08 75.89 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.295 -0.878 . . . . 0.89 110.315 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.4 mt -90.83 -4.43 56.61 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.1 0.952 . . . . 0.78 112.42 -178.678 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 194' ' ' ALA . 94.1 mt-10 54.56 7.32 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.4 1.259 . . . . 1.45 114.4 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.9 mt -71.46 147.39 92.58 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.948 -1.095 . . . . 0.67 108.092 179.013 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -58.49 141.66 97.42 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.765 1.643 . . . . 0.64 109.714 178.664 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.74 168.39 26.96 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 117.831 -1.548 . . . . 0.67 109.776 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 203' ' ' VAL . 54.8 mt -149.01 159.02 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.519 -1.289 . . . . 0.69 107.519 178.052 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.3 m -140.48 -32.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.702 0 O-C-N 120.647 -1.283 . . . . 0.85 111.951 -179.756 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.3 37.4 0.81 Allowed Glycine 0 N--CA 1.485 1.934 0 C-N-CA 120.497 -0.859 . . . . 0.92 112.865 -178.621 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.564 HG21 HG22 ' A' ' 180' ' ' ILE . 45.6 p -63.94 -20.55 65.94 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.673 -0.898 . . . . 0.95 111.499 -179.098 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.68 -92.43 0.61 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 110.045 -1.222 . . . . 1.04 110.045 179.471 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.631 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 70.4 m -128.16 23.93 6.0 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.275 -1.132 . . . . 1.57 112.696 -178.825 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 79.5 t -51.52 -34.48 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.541 -1.349 . . . . 0.84 110.609 179.085 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.0 p -58.62 -20.91 51.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.58 -0.7 . . . . 0.99 111.58 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.9 t -90.59 -3.16 57.76 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.013 -1.054 . . . . 1.7 111.698 -179.037 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.631 ' NE2' ' O ' ' A' ' 207' ' ' SER . 4.1 mp0 -122.83 -4.42 8.62 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.502 0.668 . . . . 2.2 112.522 -177.892 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 44.6 t -112.85 148.0 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.533 -0.729 . . . . 0.84 109.415 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -121.3 157.08 31.14 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.071 -1.085 . . . . 2.2 108.071 178.055 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.561 HD21 ' C ' ' A' ' 214' ' ' ASN . 0.4 OUTLIER -56.76 140.92 46.06 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.671 -1.268 . . . . 2.28 110.43 178.926 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 m-20 81.57 7.02 1.13 Allowed 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 114.465 1.283 . . . . 2.35 114.465 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -67.48 151.75 46.84 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.424 -1.423 . . . . 1.97 109.945 177.839 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -90.51 115.11 27.4 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.691 -1.596 . . . . 2.65 106.691 177.363 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.514 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 86.8 mt -127.71 141.94 51.46 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.236 -0.915 . . . . 0.63 109.56 -178.641 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 50.8 mt -113.54 127.72 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 106.607 -1.627 . . . . 0.62 106.607 177.439 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.6 tp -102.17 118.47 36.97 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.193 -1.78 . . . . 0.64 106.193 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 223' ' ' VAL . 44.8 p-10 -93.14 -21.04 19.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.042 -1.036 . . . . 2.05 112.297 -178.184 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.922 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.47 17.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.031 0.752 . . . . 0.84 113.031 -179.177 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.5 t -112.77 -62.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 121.807 0.813 . . . . 1.02 109.135 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -90.3 9.62 28.07 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.294 1.045 . . . . 2.51 110.303 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 41.9 t30 60.82 52.37 4.31 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.91 -0.586 . . . . 1.54 111.462 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -150.87 147.89 27.79 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.222 1.011 . . . . 1.95 110.055 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 50.3 t -115.02 138.78 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 107.494 -1.299 . . . . 0.71 107.494 176.818 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -104.53 137.73 41.94 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.096 -1.002 . . . . 1.01 108.602 178.89 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.3 t -109.3 129.4 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 107.638 -1.245 . . . . 0.82 107.638 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.432 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 48.5 t-20 48.15 49.87 8.05 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 113.507 0.929 . . . . 1.54 113.507 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 22.3 Cg_endo -62.53 154.21 66.18 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.141 1.894 . . . . 0.94 110.394 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.6 m -72.77 158.72 35.04 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.987 -1.07 . . . . 1.8 109.272 177.774 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 22.0 p30 -58.59 -38.0 77.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.849 -1.157 . . . . 2.73 110.483 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.51 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 82.1 tt0 -60.93 -39.45 89.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.005 -1.059 . . . . 3.17 110.013 179.355 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.08 -36.84 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 1.34 110.319 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 80.8 mt . . . . . 0 C--N 1.302 -1.475 0 O-C-N 121.397 -0.814 . . . . 1.2 110.252 178.962 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.0 mt . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 107.41 -1.33 . . . . 1.07 107.41 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.4 m -104.8 127.45 52.6 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.791 -1.189 . . . . 1.24 107.791 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.88 -147.79 22.86 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.246 -1.142 . . . . 1.01 110.246 179.42 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 5' ' ' ILE . 80.5 mt -97.6 1.31 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.546 -0.973 . . . . 1.11 112.571 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' ILE . 8.6 tp 50.42 100.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.737 -1.227 . . . . 0.99 112.063 178.458 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.7 -41.4 11.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.924 -1.11 . . . . 0.85 111.791 179.211 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t -146.19 140.98 15.97 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 107.78 -1.193 . . . . 1.38 107.78 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.77 149.73 38.27 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.585 2.19 . . . . 0.94 112.555 178.607 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.88 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 149.66 161.65 9.94 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.367 -1.493 . . . . 0.81 109.367 178.306 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.3 mt -119.95 132.82 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.132 -1.217 . . . . 0.83 107.893 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.16 151.07 47.38 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.216 -0.928 . . . . 0.53 109.03 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -123.16 141.54 51.86 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.577 -0.898 . . . . 0.77 108.577 178.55 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.94 166.2 32.98 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.046 -1.55 . . . . 0.51 109.798 177.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -76.3 158.2 31.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.816 -0.814 . . . . 1.9 109.133 178.756 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.54 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -82.3 123.49 29.11 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.607 -1.257 . . . . 0.66 107.607 178.418 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.2 tp -102.9 99.64 9.57 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.228 -1.768 . . . . 0.83 106.228 178.725 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 tp -87.52 140.92 29.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 0.86 108.962 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.7 mt -96.51 115.66 27.8 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.653 -1.61 . . . . 0.92 106.653 177.497 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -108.84 130.62 55.41 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.816 -1.179 . . . . 2.03 107.816 -179.46 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.425 ' OE1' HD13 ' A' ' 147' ' ' ILE . 72.1 mm-40 -128.4 146.83 50.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 2.66 109.054 179.893 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -80.41 138.89 36.69 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.933 -1.105 . . . . 2.32 108.041 177.278 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -63.48 140.33 58.86 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.612 -0.884 . . . . 2.11 108.612 178.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -89.7 130.16 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.086 -1.079 . . . . 0.73 108.086 178.244 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.6 129.95 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.752 -1.203 . . . . 0.87 107.752 178.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.2 mt -91.25 138.99 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.387 -0.968 . . . . 0.81 108.387 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -88.23 120.73 29.86 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.91 -1.515 . . . . 1.34 106.91 178.96 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -93.57 10.27 33.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.522 -0.736 . . . . 2.89 112.868 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -73.12 143.96 47.14 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.881 -1.137 . . . . 2.09 110.039 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -89.77 132.16 35.36 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.185 -1.043 . . . . 2.19 108.185 177.579 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -93.27 165.01 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.333 -0.854 . . . . 0.75 110.477 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.9 p -93.21 165.12 12.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.772 -0.58 . . . . 0.91 109.713 178.435 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.95 -22.45 15.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.302 -0.874 . . . . 0.93 112.18 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.95 -37.73 81.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.867 -1.146 . . . . 2.28 110.914 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -91.54 -7.26 50.81 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.44 -1.412 . . . . 1.45 112.782 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.3 -41.21 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.218 -0.926 . . . . 0.81 110.56 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -56.42 -39.99 73.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.027 . . . . 1.54 110.602 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -63.47 -41.95 98.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 2.36 111.079 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.96 -41.58 98.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.081 -1.012 . . . . 1.31 110.843 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.6 t -60.66 -40.06 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.611 -0.836 . . . . 0.82 110.217 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -60.85 -43.62 98.08 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.736 -0.786 . . . . 1.5 109.677 179.827 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -62.1 -40.05 94.55 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.909 -0.716 . . . . 2.23 110.325 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -73.16 -54.22 9.02 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.149 -0.969 . . . . 0.85 110.017 179.116 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -60.52 -49.06 79.04 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.002 -1.062 . . . . 0.91 110.306 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.6 t -68.85 -36.92 78.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.361 -0.837 . . . . 0.9 110.02 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.01 -46.3 84.87 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.499 -1.334 . . . . 0.69 109.862 178.495 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -57.92 -31.72 67.07 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.246 -1.149 . . . . 2.88 109.655 178.969 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.31 -51.1 71.2 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.204 -0.998 . . . . 0.85 110.965 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 42.7 pttt -81.9 -42.1 19.99 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.175 -0.953 . . . . 2.35 110.966 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.409 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -60.22 -41.82 93.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.8 . . . . 0.65 110.383 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.1 p -59.46 -41.15 89.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.218 -1.03 . . . . 1.45 108.218 179.181 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.51 -48.65 59.85 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.559 -0.746 . . . . 0.63 109.782 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -62.13 -48.72 78.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.442 -1.411 . . . . 1.34 110.077 -178.442 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.71 -38.9 89.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 1.56 109.81 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -59.62 -40.17 86.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.724 -0.61 . . . . 1.19 110.471 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.519 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 11.2 m -63.65 -39.81 95.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.926 -1.109 . . . . 0.72 110.148 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.71 -40.17 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.468 -0.77 . . . . 0.62 110.573 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -51.75 -40.65 60.64 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.424 -0.798 . . . . 1.05 110.482 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.8 -37.08 73.26 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.11 -0.994 . . . . 0.64 110.348 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.519 ' NZ ' HG22 ' A' ' 56' ' ' THR . 52.4 mttp -63.34 -38.82 92.65 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.669 -1.212 . . . . 1.73 109.025 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.8 -30.14 68.65 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.907 -0.588 . . . . 0.56 110.337 179.281 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.11 -38.88 8.84 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 119.893 -1.146 . . . . 0.69 111.214 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -81.03 -22.69 39.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.856 -1.379 . . . . 1.48 111.282 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.7 m -87.31 -51.56 5.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.656 -0.652 . . . . 0.98 110.687 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -107.21 -7.28 16.84 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.07 1.137 . . . . 1.16 114.07 -177.377 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.45 157.95 17.73 Favored Glycine 0 N--CA 1.5 2.909 0 O-C-N 121.599 -0.688 . . . . 0.85 113.22 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -53.32 -19.06 2.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.592 -0.946 . . . . 3.86 113.341 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -57.41 -33.92 68.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.714 -1.241 . . . . 2.35 110.996 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -80.13 -23.53 41.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.959 -1.088 . . . . 1.67 111.468 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.87 -38.32 81.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.093 -1.004 . . . . 1.45 111.007 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.22 -40.09 84.76 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.954 -1.091 . . . . 0.61 110.999 179.355 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.7 mt -69.3 -47.99 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.665 -1.272 . . . . 0.65 110.13 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -70.52 -29.94 66.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.864 . . . . 0.66 110.62 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.79 -38.63 85.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.275 -0.891 . . . . 1.19 110.403 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.3 -37.25 59.27 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 110.074 -1.211 . . . . 0.53 110.074 179.474 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -59.81 -44.21 94.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.279 -1.13 . . . . 1.27 110.087 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.12 -39.37 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.54 110.045 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.5 ttm -59.88 -39.5 85.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.5 -0.75 . . . . 1.74 110.552 179.46 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.6 tp -58.36 -48.15 81.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.853 . . . . 0.55 110.204 179.028 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.01 -40.29 88.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.602 0.715 . . . . 0.47 110.262 -179.751 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -86.04 5.14 34.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.791 . . . . 1.42 112.75 -179.503 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -61.79 119.18 8.26 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.846 -1.159 . . . . 1.27 108.928 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.85 -17.49 64.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.462 -0.774 . . . . 1.35 110.84 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.83 -47.8 28.54 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.023 -1.071 . . . . 2.22 109.889 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.66 -36.44 82.86 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.301 -0.96 . . . . 0.62 110.011 -178.352 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.77 -48.36 79.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.404 -0.81 . . . . 1.29 110.495 179.05 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.52 -39.49 87.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 1.52 110.492 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.25 -49.88 62.69 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.091 -1.005 . . . . 1.3 110.488 179.435 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.5 mt -56.83 -43.58 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.935 -1.103 . . . . 0.61 110.234 179.402 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.9 -43.2 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.567 -0.708 . . . . 0.78 110.116 179.568 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.81 91.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.409 -0.807 . . . . 0.82 110.574 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.08 -43.6 95.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.113 -0.992 . . . . 0.8 110.254 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.1 mt -65.61 -48.45 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.094 -1.004 . . . . 0.77 110.179 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -78.72 -36.2 43.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.266 -0.896 . . . . 2.12 112.197 -179.414 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -81.74 -40.02 23.33 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.438 -1.414 . . . . 1.51 111.76 -179.405 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -108.59 10.61 27.05 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.211 -0.931 . . . . 1.98 111.965 -178.114 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.0 m80 49.46 50.52 18.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.982 -1.074 . . . . 1.32 111.612 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -104.23 152.89 21.64 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.14 0.971 . . . . 1.38 109.791 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.439 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 23.2 p -72.8 160.8 31.59 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.57 -0.706 . . . . 0.67 109.535 178.009 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.45 -40.09 81.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -0.926 . . . . 0.52 110.914 178.982 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 26.2 p-10 -69.86 -42.1 73.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.051 -1.031 . . . . 2.25 110.519 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.35 61.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.348 -0.845 . . . . 0.64 110.882 -179.251 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.84 93.64 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.265 -0.897 . . . . 0.56 110.696 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.66 -43.75 93.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 0.46 110.943 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -60.19 -40.01 88.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.865 -1.147 . . . . 1.32 111.036 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.73 -48.86 76.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.671 -1.268 . . . . 1.3 110.617 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 83.4 t -62.86 -49.22 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.71 -1.243 . . . . 0.61 110.29 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 mm -61.54 -30.23 47.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.193 0.521 . . . . 0.65 110.538 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -59.87 -40.12 87.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 2.11 110.922 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.95 -31.45 17.6 Favored Glycine 0 N--CA 1.502 3.066 0 C-N-CA 118.668 -1.729 . . . . 0.83 112.925 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -61.49 -40.99 96.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.521 -1.576 . . . . 1.28 110.063 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.22 -48.78 40.3 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.62 -0.675 . . . . 0.89 110.4 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.0 m -61.4 -40.79 95.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 1.87 110.477 -178.185 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.75 97.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.422 -0.799 . . . . 1.05 110.679 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.2 mt -64.57 -30.86 71.89 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.054 -1.029 . . . . 1.02 110.817 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -66.86 -21.11 66.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.945 -1.097 . . . . 2.04 111.158 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -75.0 -12.81 60.42 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.313 -0.867 . . . . 1.73 111.532 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 123' ' ' LEU . 5.3 mt -85.55 144.67 27.77 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.484 -0.76 . . . . 1.37 109.292 179.196 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -100.45 53.03 0.88 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.185 -0.947 . . . . 2.88 110.581 -179.522 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -129.46 138.28 51.33 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.211 -1.033 . . . . 1.58 108.211 179.171 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -58.39 -39.8 80.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.544 -0.722 . . . . 3.04 110.999 179.197 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -71.43 -53.61 13.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.002 -1.061 . . . . 0.9 110.332 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 118' ' ' LEU . 24.5 mt -61.4 -41.09 96.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.339 -0.851 . . . . 1.06 110.506 -179.465 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -62.22 -50.16 72.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.954 -1.091 . . . . 2.18 109.983 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.02 -31.68 70.18 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.309 -0.869 . . . . 2.15 109.644 179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 130' ' ' VAL . 55.7 ttt180 -61.26 -30.43 70.46 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.086 -1.045 . . . . 2.33 108.782 179.241 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.46 -49.58 77.01 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.921 0.867 . . . . 0.82 109.398 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.86 81.7 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.895 -0.722 . . . . 0.85 110.104 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -64.18 -36.69 84.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.347 -0.846 . . . . 1.39 110.52 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 126' ' ' ARG . 38.9 t -67.12 -39.16 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.439 -0.788 . . . . 0.56 109.983 179.793 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -60.4 -38.06 82.78 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.879 0.847 . . . . 3.12 110.009 179.066 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.12 -38.33 82.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.766 -0.584 . . . . 1.28 110.481 179.325 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.7 mt -61.54 -40.17 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.472 -0.767 . . . . 0.49 110.24 179.701 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.27 -42.44 35.15 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 120.078 -1.058 . . . . 0.46 110.993 -179.74 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -58.77 -48.12 82.34 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.072 -1.251 . . . . 2.71 110.484 179.346 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -64.89 -41.25 95.78 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.511 -0.876 . . . . 2.14 109.972 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.05 -39.58 86.45 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.314 -0.866 . . . . 1.05 110.033 179.686 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.14 -41.93 93.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.882 . . . . 0.52 110.902 179.203 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -60.44 -33.08 72.02 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.121 -0.987 . . . . 2.35 110.678 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -77.64 -42.5 34.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 1.39 110.846 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.4 mt -60.99 -38.33 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.231 -0.918 . . . . 0.68 110.344 -178.294 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.7 mt -86.27 -7.43 58.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.31 -0.869 . . . . 0.83 112.276 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.71 19.91 69.69 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.645 -1.264 . . . . 0.91 112.844 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.5 tp -67.22 145.19 55.46 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.815 -0.815 . . . . 0.95 109.163 179.133 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -67.79 149.74 49.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 2.43 108.845 178.169 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.0 mt -109.49 137.38 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.369 -0.974 . . . . 1.1 108.369 178.608 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.67 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.8 mp -80.11 128.59 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.654 -1.239 . . . . 1.58 107.654 178.983 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -94.78 96.08 9.13 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.85 -1.537 . . . . 1.62 106.85 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.41 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 53.1 mt -70.72 -25.23 62.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.337 -0.852 . . . . 0.8 111.12 -178.33 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 p -80.57 0.25 34.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 1.56 111.861 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.14 23.87 9.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.455 -0.778 . . . . 0.84 111.852 -179.757 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.41 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 14.2 mt -72.04 146.33 11.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.234 -0.916 . . . . 0.82 109.457 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -119.41 -14.77 9.15 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.757 0.789 . . . . 2.31 112.756 -178.9 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -115.06 140.51 49.0 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.682 -0.858 . . . . 1.54 108.682 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -77.41 123.52 26.64 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.384 -0.969 . . . . 1.38 108.384 178.005 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.3 m -148.56 175.28 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.608 -0.682 . . . . 0.69 109.266 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.8 mt -88.23 145.05 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.641 -0.874 . . . . 0.53 108.641 178.132 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.1 tp -97.08 126.49 42.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.12 -0.987 . . . . 0.64 108.507 178.355 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.0 t -122.58 128.98 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.573 -1.269 . . . . 0.67 107.573 178.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.39 153.18 21.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.932 . . . . 0.78 108.847 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.66 84.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.701 -1.249 . . . . 1.0 109.65 178.131 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 10.4 t0 -172.37 154.66 3.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.481 -0.933 . . . . 2.42 108.481 179.638 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.501 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 61.6 mt -117.75 139.32 51.21 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.222 -0.924 . . . . 0.75 108.759 177.629 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.2 p -91.2 153.03 44.56 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 107.879 -1.156 . . . . 0.78 107.879 178.66 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -41.81 -44.82 6.82 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.559 1.506 . . . . 0.67 113.375 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 23.9 m -60.26 -48.79 80.23 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.044 -1.035 . . . . 0.7 110.252 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.22 -40.83 98.57 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.204 -0.935 . . . . 1.21 110.177 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 79.5 p -68.33 -38.45 81.53 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.416 -0.802 . . . . 0.6 110.254 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.58 74.52 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.578 -0.701 . . . . 0.62 110.609 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -93.86 -5.87 47.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.166 -0.959 . . . . 1.16 112.734 -179.316 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.73 146.89 51.28 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.959 -1.126 . . . . 0.73 107.959 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.445 ' O ' HG23 ' A' ' 176' ' ' VAL . 55.4 t-20 -97.34 119.73 36.39 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.31 -1.367 . . . . 2.24 107.31 178.075 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.692 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.2 mm? -76.25 -18.24 59.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.77 -0.581 . . . . 1.43 111.526 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -80.99 -25.77 37.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.276 -0.89 . . . . 2.15 111.863 -178.961 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -101.05 -1.69 33.53 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.112 0.782 . . . . 2.04 113.112 -178.272 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 178' ' ' GLY . 58.1 t -107.01 126.44 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 107.556 -1.276 . . . . 0.55 107.556 178.944 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.8 tp -91.27 -2.01 57.53 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.052 -1.03 . . . . 1.63 112.862 -178.729 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.447 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.94 169.83 34.42 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.797 -1.721 . . . . 0.47 108.797 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -127.2 135.43 50.63 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.812 -1.181 . . . . 0.54 107.812 179.278 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 76.1 mt -137.67 106.04 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 105.965 -1.865 . . . . 0.69 105.965 178.339 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 203' ' ' VAL . 68.0 p -131.2 176.98 7.82 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.785 -1.197 . . . . 0.82 110.204 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.552 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.3 OUTLIER -99.29 51.71 0.95 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.736 -0.603 . . . . 2.37 110.843 179.28 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -100.66 145.32 28.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.303 -0.873 . . . . 1.11 108.829 179.642 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -60.05 -32.55 76.06 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 120.15 -1.024 . . . . 1.67 110.897 179.186 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 91.69 -4.37 79.12 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 120.898 -1.354 . . . . 1.54 113.328 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.419 ' O ' ' OG1' ' A' ' 187' ' ' THR . 80.1 mtm180 -90.36 115.65 27.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.243 -1.762 . . . . 4.48 106.243 177.893 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 13.6 p 48.98 31.93 3.57 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.36 -0.837 . . . . 2.63 112.226 -178.667 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.4 t -85.47 142.03 29.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.97 -1.081 . . . . 1.69 109.837 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -58.74 -38.93 79.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 1.07 111.135 178.481 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.3 m -60.38 -39.61 87.9 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.215 -0.928 . . . . 1.58 110.085 179.239 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 70.8 m -60.34 -39.36 86.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 1.6 110.554 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.407 HG12 HH21 ' A' ' 195' ' ' ARG . 96.7 mt -60.8 -39.99 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 1.45 110.959 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.9 mtp -63.76 -44.31 93.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.895 -1.128 . . . . 1.05 109.671 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.12 -49.57 77.11 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.77 -0.65 . . . . 0.72 111.004 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.407 HH21 HG12 ' A' ' 192' ' ' ILE . 81.9 mtm180 -61.73 -41.1 97.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.985 . . . . 3.05 110.946 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 56.0 m -69.36 -39.94 77.79 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.923 -1.111 . . . . 0.89 110.561 -179.696 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.3 mt -89.28 -7.83 54.63 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.819 0.818 . . . . 0.78 112.101 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 194' ' ' ALA . 45.2 mt-10 49.03 15.5 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.876 1.065 . . . . 1.45 113.876 -179.8 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.8 mt -74.75 150.58 86.46 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.022 -1.048 . . . . 0.67 108.607 178.733 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.36 139.05 88.94 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.309 1.339 . . . . 0.64 109.833 178.22 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.92 166.65 25.88 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 117.737 -1.585 . . . . 0.67 109.431 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.5 mt -145.68 147.06 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.681 -1.229 . . . . 0.69 107.681 177.216 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.435 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.8 m -126.99 -34.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 113.302 0.853 . . . . 0.85 113.302 -179.009 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.17 40.83 1.73 Allowed Glycine 0 N--CA 1.489 2.18 0 C-N-CA 120.196 -1.002 . . . . 0.92 111.913 -177.983 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.447 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 58.6 p -60.82 -18.75 57.45 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.273 -1.134 . . . . 0.95 111.371 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.43 -95.82 0.99 Allowed Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.83 -1.176 . . . . 1.04 110.503 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 60.7 m -127.72 31.51 5.13 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.634 -0.921 . . . . 1.57 112.215 -179.03 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.87 -35.33 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.393 -1.442 . . . . 0.84 110.532 179.096 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 46.4 p -61.46 -20.06 62.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.195 -0.94 . . . . 0.99 111.452 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.9 t -93.93 -1.03 55.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -0.951 . . . . 1.7 112.099 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -128.22 -1.66 5.72 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 112.797 0.665 . . . . 2.2 112.797 -177.83 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.04 148.39 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.226 -0.657 . . . . 0.84 109.226 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -119.85 157.18 29.22 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.851 -1.166 . . . . 2.2 107.851 178.062 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.42 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 38.6 p30 -54.12 142.82 24.27 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.049 -1.032 . . . . 2.28 110.813 178.491 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.7 OUTLIER 80.18 1.3 2.01 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 114.905 1.446 . . . . 2.35 114.905 179.183 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -63.46 146.41 53.66 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.765 -1.209 . . . . 1.97 108.371 177.512 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -88.29 118.69 28.07 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.835 -1.542 . . . . 2.65 106.835 177.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 87.3 mt -127.93 142.02 51.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.585 -0.697 . . . . 0.63 109.57 -178.625 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.6 mt -111.16 129.32 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.528 -1.656 . . . . 0.62 106.528 177.529 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 20.4 tp -99.1 119.05 37.19 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.384 -1.71 . . . . 0.64 106.384 178.336 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.0 t0 -94.93 -29.28 14.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.818 -1.176 . . . . 2.05 112.506 -177.631 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.88 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 36.79 20.79 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.773 0.657 . . . . 0.84 112.773 -178.612 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.7 t -109.25 -55.95 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.125 -0.985 . . . . 1.02 109.075 178.335 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.46 14.8 30.02 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.625 -0.716 . . . . 2.51 110.293 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 59.51 55.38 4.14 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.397 0.617 . . . . 1.54 111.21 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -151.49 148.48 28.11 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.254 1.026 . . . . 1.95 109.91 179.596 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 20.0 t -116.09 139.61 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.235 -1.024 . . . . 0.71 108.235 177.251 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -102.01 135.6 43.29 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.057 -1.027 . . . . 1.01 108.739 178.792 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.0 t -112.83 130.24 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-O 121.779 0.8 . . . . 0.82 109.127 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.556 ' O ' ' ND2' ' A' ' 230' ' ' ASN . 1.0 OUTLIER 52.06 48.95 6.14 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 113.577 0.955 . . . . 1.54 113.577 178.092 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.3 Cg_endo -64.5 150.05 88.9 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.585 2.19 . . . . 0.94 110.724 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.1 m -74.77 154.16 38.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.265 -0.897 . . . . 1.8 108.947 177.652 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.55 ' HA ' HD12 ' A' ' 236' ' ' ILE . 16.0 t-20 -52.99 -41.11 64.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 2.73 110.708 178.716 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -59.2 -40.29 85.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 3.17 109.812 179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.04 -38.91 76.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.647 -0.658 . . . . 1.34 110.166 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 233' ' ' ASN . 96.8 mt . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.448 -0.782 . . . . 1.2 110.785 179.198 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 106.856 -1.535 . . . . 1.07 106.856 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -105.31 122.56 46.21 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.391 -1.336 . . . . 1.24 107.391 -179.816 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.95 -150.65 27.15 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.784 -1.326 . . . . 1.01 109.784 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.591 HG22 ' O ' ' A' ' 5' ' ' ILE . 95.4 mt -95.22 1.05 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.408 -1.054 . . . . 1.11 112.942 -179.635 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 tp 49.64 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.801 -1.187 . . . . 0.99 112.867 178.583 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.83 -37.23 14.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.956 -1.09 . . . . 0.85 111.431 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 t -146.34 137.02 12.4 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 107.965 -1.124 . . . . 1.38 107.965 -178.313 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.27 152.56 35.14 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.934 1.756 . . . . 0.94 112.122 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.719 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 147.13 135.41 2.68 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.768 -0.933 . . . . 0.81 110.768 177.683 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -96.15 132.48 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.549 -1.559 . . . . 0.83 108.941 178.968 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.3 148.95 45.2 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.895 -0.78 . . . . 0.53 108.895 179.278 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 3.2 m-85 -121.22 142.75 49.62 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.301 -0.875 . . . . 0.77 109.018 178.474 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.84 168.38 37.32 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.575 -1.774 . . . . 0.51 109.721 177.797 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -78.08 158.68 29.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.763 -0.845 . . . . 1.9 108.799 178.638 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -82.59 123.78 29.54 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.898 -1.149 . . . . 0.66 107.898 178.407 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 tp -102.47 98.86 8.88 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.22 -1.77 . . . . 0.83 106.22 178.619 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.1 tp -86.99 141.1 28.92 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.681 -0.859 . . . . 0.86 108.681 -179.666 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 mt -99.72 107.11 19.11 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.27 -1.381 . . . . 0.92 107.27 178.158 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -110.81 134.23 52.68 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.673 -1.232 . . . . 2.03 107.673 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -131.11 155.12 47.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.211 -0.931 . . . . 2.66 109.163 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -82.11 137.16 35.07 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.907 -1.146 . . . . 2.32 107.907 177.338 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -65.7 148.36 51.89 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.346 -0.847 . . . . 2.11 108.881 178.553 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.6 mt -99.85 134.61 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.359 -0.838 . . . . 0.73 108.799 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.89 130.01 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.571 -1.27 . . . . 0.87 107.571 178.872 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.6 mt -95.83 135.8 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.297 -0.877 . . . . 0.81 108.976 179.257 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -94.45 126.65 39.86 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.265 -1.013 . . . . 1.34 108.265 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.513 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.4 mmt-85 -97.7 15.08 24.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.343 -0.848 . . . . 2.89 112.481 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -63.34 142.32 58.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.004 -1.06 . . . . 2.09 109.117 178.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -88.02 130.82 34.86 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.136 -1.061 . . . . 2.19 108.136 177.628 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -89.37 170.19 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.178 -0.951 . . . . 0.75 110.09 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.3 p -94.64 163.44 13.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.577 -0.702 . . . . 0.91 109.645 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.75 -19.94 4.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 0.93 112.67 179.249 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -68.71 -43.16 76.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.832 -1.167 . . . . 2.28 111.229 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -87.42 -5.79 58.7 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.711 -1.243 . . . . 1.45 112.674 -179.098 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.05 -46.52 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 0.81 110.891 -178.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -56.49 -40.02 74.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.954 . . . . 1.54 110.316 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.61 -39.6 91.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.535 -0.728 . . . . 2.36 110.824 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -60.0 -40.63 89.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.026 -1.046 . . . . 1.31 110.747 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.83 -39.69 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.82 110.38 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -62.87 -48.12 80.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.364 -0.835 . . . . 1.5 110.794 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -62.87 -40.93 99.01 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.917 -1.113 . . . . 2.23 110.256 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -71.13 -52.86 16.85 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.204 -0.935 . . . . 0.85 110.191 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.2 tp -62.3 -47.47 84.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.037 -1.04 . . . . 0.91 109.816 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.522 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.5 t -70.23 -42.46 72.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.472 -0.768 . . . . 0.9 109.697 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.58 -38.08 85.86 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.148 -1.501 . . . . 0.69 109.414 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 20.5 ttm180 -59.32 -32.02 69.69 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.958 0.885 . . . . 2.88 109.095 178.856 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.04 -44.19 91.74 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.787 0.803 . . . . 0.85 109.636 178.985 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -79.63 -40.17 29.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.115 -0.991 . . . . 2.35 110.332 179.752 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.28 -44.9 92.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.468 -0.77 . . . . 0.65 110.132 -178.685 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.5 p -60.45 -38.63 84.76 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.124 0.964 . . . . 1.45 109.313 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.57 99.38 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.126 -0.63 . . . . 0.63 110.661 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -62.0 -50.14 73.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.569 -1.332 . . . . 1.34 110.479 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 54' ' ' LEU . 3.2 mm? -67.63 -40.64 84.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.329 -0.857 . . . . 1.56 110.399 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -59.21 -40.78 86.86 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.389 -0.819 . . . . 1.19 110.467 179.731 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -67.21 -46.93 72.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.084 -1.01 . . . . 0.72 110.671 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.11 -38.16 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.417 -0.802 . . . . 0.62 110.524 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -49.93 -44.72 50.55 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.367 -0.833 . . . . 1.05 111.322 179.183 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -68.16 -40.48 82.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.195 -0.941 . . . . 0.64 109.946 -179.64 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -61.87 -37.98 86.6 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.883 -1.127 . . . . 1.73 109.334 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -33.77 76.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.448 0.642 . . . . 0.56 110.2 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.61 -37.13 12.35 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.771 -1.204 . . . . 0.69 111.255 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.67 -24.41 38.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.07 -1.253 . . . . 1.48 110.755 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.4 m -88.0 -50.77 6.2 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.537 -0.865 . . . . 0.98 110.271 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -107.06 -2.96 20.51 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 113.965 1.098 . . . . 1.16 113.965 -177.572 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.24 155.87 26.88 Favored Glycine 0 N--CA 1.504 3.201 0 O-C-N 120.82 -1.175 . . . . 0.85 113.858 178.311 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.58 -15.55 1.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -1.018 . . . . 3.86 112.979 179.26 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.66 -35.8 71.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 2.35 110.917 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -82.91 -19.03 38.11 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.143 -0.973 . . . . 1.67 111.996 -179.382 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.23 -35.19 74.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.074 -1.016 . . . . 1.45 111.038 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.36 89.18 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.079 -1.013 . . . . 0.61 110.847 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.6 mt -68.64 -42.38 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.943 -1.098 . . . . 0.65 110.098 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -72.05 -31.15 65.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.139 -0.976 . . . . 0.66 110.253 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -59.79 -37.65 79.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.826 . . . . 1.19 110.004 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.92 -40.54 84.42 Favored Glycine 0 N--CA 1.48 1.622 0 C-N-CA 119.733 -1.222 . . . . 0.53 110.277 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -59.93 -47.28 86.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.184 -1.186 . . . . 1.27 110.593 179.506 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.7 mt -60.3 -38.64 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.951 -1.093 . . . . 0.54 110.231 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.9 ttt -59.9 -39.39 85.21 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.365 -0.834 . . . . 1.74 110.904 179.22 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.418 HD11 HE21 ' A' ' 111' ' ' GLN . 9.3 tp -60.31 -50.04 75.2 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.106 -0.996 . . . . 0.55 110.46 179.669 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.31 -39.28 92.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.033 -1.042 . . . . 0.47 110.303 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -87.22 1.5 52.95 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.445 0.906 . . . . 1.42 113.445 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.41 121.45 12.11 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.357 -1.465 . . . . 1.27 108.244 178.805 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -66.36 -16.88 64.41 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.88 0.847 . . . . 1.35 110.964 -178.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.97 -53.35 9.12 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.507 0.67 . . . . 2.22 110.087 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.31 -36.78 81.04 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.568 -0.853 . . . . 0.62 110.485 -179.517 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 47' ' ' ARG . 87.0 tt0 -59.43 -46.84 87.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.203 -0.936 . . . . 1.29 110.918 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.73 -38.56 85.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.393 -0.817 . . . . 1.52 110.701 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.02 -48.7 70.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.831 -1.168 . . . . 1.3 110.872 179.657 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.31 -43.95 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.173 -0.954 . . . . 0.61 110.138 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.5 mt -60.41 -43.96 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.658 -0.651 . . . . 0.78 110.486 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.21 -42.34 98.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.425 -0.797 . . . . 0.82 110.991 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.66 -47.79 83.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.162 -0.961 . . . . 0.8 110.296 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.4 mt -60.89 -44.88 98.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.304 -0.872 . . . . 0.77 110.683 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -84.07 -34.45 24.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.007 -1.058 . . . . 2.12 111.954 -179.71 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 91' ' ' ALA . 44.9 t0 -82.94 -43.62 16.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.809 -1.182 . . . . 1.51 111.445 -178.882 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -101.9 5.79 41.09 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.642 -0.661 . . . . 1.98 112.302 -178.858 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.7 m80 52.09 47.92 23.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 1.32 111.795 -179.524 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.4 mtt -100.34 153.76 19.05 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.146 -0.971 . . . . 1.38 110.018 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.5 p -71.57 161.21 31.38 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.507 -0.746 . . . . 0.67 109.746 178.149 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.22 90.61 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.85 -0.74 . . . . 0.52 110.748 178.84 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.517 ' OD2' HD21 ' A' ' 142' ' ' LEU . 98.1 m-20 -68.49 -40.21 81.0 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.959 -1.088 . . . . 2.25 110.248 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.91 -50.68 54.72 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.855 -0.738 . . . . 0.64 111.064 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.58 -44.23 96.84 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 0.56 110.195 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.97 -44.17 94.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.603 -0.686 . . . . 0.46 110.665 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -61.71 -38.65 88.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 1.32 111.321 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -57.44 -49.77 75.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.675 -1.266 . . . . 1.3 110.888 179.461 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.04 -47.42 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.635 -1.291 . . . . 0.61 110.424 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -61.02 -30.35 47.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.563 -0.711 . . . . 0.65 110.438 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -58.65 -41.27 85.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.358 -0.839 . . . . 2.11 110.776 179.218 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.82 -30.61 23.15 Favored Glycine 0 N--CA 1.498 2.808 0 C-N-CA 119.071 -1.538 . . . . 0.83 112.991 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.418 HE21 HD11 ' A' ' 79' ' ' LEU . 15.2 mm100 -62.09 -42.84 99.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.188 -1.772 . . . . 1.28 110.055 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.41 -52.03 25.26 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.379 -0.825 . . . . 0.89 110.312 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.0 p -60.33 -34.81 74.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.186 -0.946 . . . . 1.87 110.421 -179.365 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.04 -47.02 86.59 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.766 -0.584 . . . . 1.05 110.934 179.576 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.48 -29.94 70.9 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.127 -1.029 . . . . 1.02 111.148 -179.506 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -67.43 -22.29 65.52 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.929 -1.107 . . . . 2.04 111.511 179.455 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -70.59 -18.32 62.89 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.94 -1.104 . . . . 1.73 110.932 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 123' ' ' LEU . 10.7 mt -83.79 145.34 28.74 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.359 -0.838 . . . . 1.37 109.623 179.265 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -101.08 41.93 1.15 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.359 -0.838 . . . . 2.88 110.996 179.83 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -113.13 135.76 53.46 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.961 -1.125 . . . . 1.58 107.961 178.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 25.1 mp0 -59.13 -34.24 71.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.45 -0.781 . . . . 3.04 111.151 179.111 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -74.22 -50.51 18.83 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.108 -0.995 . . . . 0.9 110.51 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 118' ' ' LEU . 30.6 mt -63.4 -36.65 84.44 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.199 -0.938 . . . . 1.06 110.207 -179.354 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -62.56 -49.24 76.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.166 -1.014 . . . . 2.18 109.758 179.209 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -63.04 -28.98 70.46 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.448 -0.901 . . . . 2.15 110.27 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -63.55 -30.38 71.5 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.069 0.937 . . . . 2.33 108.879 178.735 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.1 -48.72 80.56 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.645 0.736 . . . . 0.82 109.665 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.87 91.63 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.847 0.832 . . . . 0.85 109.449 179.663 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.76 -37.61 88.0 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.574 -0.704 . . . . 1.39 110.476 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.75 -39.83 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.407 -0.808 . . . . 0.56 110.202 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -59.1 -38.86 80.54 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.265 -0.974 . . . . 3.12 110.134 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -59.68 -39.74 85.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.557 -0.715 . . . . 1.28 110.469 179.127 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 66.2 mt -60.5 -39.97 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.01 . . . . 0.49 110.1 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.01 -44.96 87.24 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.844 -1.169 . . . . 0.46 110.279 179.552 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -59.54 -40.6 87.75 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.311 -1.111 . . . . 2.71 110.383 179.248 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -61.74 -45.08 95.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.994 -1.066 . . . . 2.14 110.161 179.616 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 50.5 tp -59.92 -43.19 95.06 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.123 -0.986 . . . . 1.05 110.016 179.601 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.89 -44.16 94.4 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.234 -0.916 . . . . 0.52 110.189 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.87 -34.32 74.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.246 -0.909 . . . . 2.35 110.585 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -77.44 -40.5 43.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 1.39 111.058 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.3 -40.05 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.236 -0.915 . . . . 0.68 110.196 -178.498 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.517 HD21 ' OD2' ' A' ' 101' ' ' ASP . 68.7 mt -90.2 -9.42 48.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.91 -1.119 . . . . 0.83 112.041 -179.236 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.37 20.27 77.24 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 120.375 -0.917 . . . . 0.91 112.961 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.2 tp -63.78 149.91 45.78 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.686 0.755 . . . . 0.95 109.408 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.73 146.29 54.99 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.245 -0.909 . . . . 2.43 109.009 178.093 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.82 143.5 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.391 -0.966 . . . . 1.1 108.391 178.393 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 mp -76.23 114.12 16.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.925 -1.11 . . . . 1.58 108.501 178.533 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -98.18 102.13 13.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.441 -1.689 . . . . 1.62 106.441 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.406 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.0 mt -77.37 -18.03 57.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 0.8 111.17 -177.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.3 m -80.11 -1.53 40.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -0.823 . . . . 1.56 112.325 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.61 27.11 5.04 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.807 0.813 . . . . 0.84 111.897 -178.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.406 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 17.5 mt -75.19 139.55 18.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.522 -0.736 . . . . 0.82 109.392 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -111.63 -19.95 12.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.029 0.919 . . . . 2.31 112.535 -178.59 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -119.12 142.88 47.53 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.723 -0.843 . . . . 1.54 108.723 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -73.14 122.42 21.83 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.052 -1.092 . . . . 1.38 108.052 178.042 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.1 m -144.75 175.56 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.594 -0.691 . . . . 0.69 109.253 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 44.9 mt -88.3 143.91 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.282 -0.886 . . . . 0.53 108.802 178.17 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.3 tp -96.8 125.35 41.19 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.06 -1.089 . . . . 0.64 108.06 178.209 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.4 t -123.22 129.93 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.552 -1.277 . . . . 0.67 107.552 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.79 154.21 21.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.159 -0.963 . . . . 0.78 108.678 179.215 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.83 80.6 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.583 -1.323 . . . . 1.0 109.365 178.127 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -171.58 153.9 3.59 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.862 -0.792 . . . . 2.42 108.862 179.675 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.3 mt -118.73 142.26 47.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.932 -0.766 . . . . 0.75 108.932 177.318 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.2 p -92.48 150.56 40.15 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.13 -0.981 . . . . 0.78 108.52 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -42.72 -38.63 6.66 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.857 1.705 . . . . 0.67 113.206 179.329 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 62.1 m -63.52 -50.12 70.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.005 -1.059 . . . . 0.7 109.884 -179.692 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.92 -39.03 90.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.913 . . . . 1.21 110.127 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 70.2 p -68.7 -40.81 79.84 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.827 -0.749 . . . . 0.6 110.328 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.57 77.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.62 110.585 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -95.91 -0.98 50.2 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.949 -1.094 . . . . 1.16 112.921 -179.144 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.95 148.62 46.95 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.72 -1.238 . . . . 0.73 108.49 179.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -97.01 115.3 27.2 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.096 -1.446 . . . . 2.24 107.096 177.852 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.0 mt -73.67 -14.12 61.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.59 -0.694 . . . . 1.43 111.778 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.72 -21.94 32.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.347 -0.845 . . . . 2.15 112.491 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -99.43 -7.06 26.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.129 -0.982 . . . . 2.04 112.549 -178.144 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 178' ' ' GLY . 58.7 t -110.99 131.0 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.198 -1.038 . . . . 0.55 108.198 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.5 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -89.32 -13.87 36.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 1.63 111.275 -179.744 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.423 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -177.14 172.92 45.83 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.889 -1.684 . . . . 0.47 108.889 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -126.56 132.79 51.25 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.947 -1.131 . . . . 0.54 107.947 179.055 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.561 HD11 HD13 ' A' ' 220' ' ' LEU . 67.4 mt -132.66 112.17 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.323 -1.732 . . . . 0.69 106.323 179.052 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 205' ' ' THR . 73.3 p -135.86 173.3 11.86 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.608 -1.308 . . . . 0.82 110.173 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -98.59 54.66 1.05 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.353 0.597 . . . . 2.37 110.546 179.049 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.47 160.62 14.4 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 1.11 109.921 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.93 -82.7 0.07 OUTLIER Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.84 -1.171 . . . . 1.67 111.141 178.165 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 148.47 -38.48 1.01 Allowed Glycine 0 N--CA 1.5 2.942 0 O-C-N 120.582 -1.54 . . . . 1.54 113.223 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -60.05 -39.52 86.22 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.844 -1.386 . . . . 4.48 110.863 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 23.0 p -136.83 38.02 2.6 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.295 -0.878 . . . . 2.63 111.623 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 59.0 m -85.68 124.07 31.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.404 -1.332 . . . . 1.69 107.404 178.94 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -56.69 -37.52 70.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.264 -0.897 . . . . 1.07 110.824 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.3 p -60.88 -38.93 87.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 1.58 110.351 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.0 t -60.21 -40.54 90.47 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.224 -0.923 . . . . 1.6 110.12 179.58 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.55 -35.92 61.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.333 -0.854 . . . . 1.45 110.457 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 59.1 mtp -63.23 -41.44 99.11 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.995 -1.066 . . . . 1.05 109.566 179.639 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.75 -47.09 87.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.701 -0.681 . . . . 0.72 111.021 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -62.17 -43.46 98.77 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.061 -1.024 . . . . 3.05 110.748 -179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.4 m -70.5 -39.78 73.95 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.308 -0.87 . . . . 0.89 110.492 -179.748 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.0 mt -93.3 -4.47 51.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.78 112.817 -178.295 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 53.87 10.84 0.28 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.862 1.06 . . . . 1.45 113.862 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.6 mt -72.36 150.22 91.68 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.871 -1.143 . . . . 0.67 108.904 179.4 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.63 140.81 88.59 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.038 1.159 . . . . 0.64 110.239 178.391 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.94 162.04 31.85 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.049 -1.657 . . . . 0.67 109.479 178.566 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.419 ' CD1' HD11 ' A' ' 220' ' ' LEU . 16.2 mt -147.02 146.6 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.063 -1.088 . . . . 0.69 108.063 177.431 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.2 m -125.93 -28.28 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 O-C-N 121.041 -1.037 . . . . 0.85 113.266 -179.182 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.21 42.2 1.63 Allowed Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.634 -1.27 . . . . 0.92 111.759 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 181' ' ' THR . 45.0 p -65.34 -18.04 65.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.964 -1.315 . . . . 0.95 111.116 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.07 -95.9 0.86 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.833 -1.307 . . . . 1.04 109.833 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 60.8 m -127.46 31.09 5.25 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.709 -0.877 . . . . 1.57 111.866 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 78.2 t -57.06 -35.89 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.32 -1.488 . . . . 0.84 110.593 179.233 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.4 p -59.99 -19.89 54.81 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.939 -1.101 . . . . 0.99 111.974 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 48.9 m -94.56 1.87 55.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.945 . . . . 1.7 112.089 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -128.77 1.67 5.43 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 113.086 0.773 . . . . 2.2 113.086 -178.423 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.53 152.87 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.739 0.781 . . . . 0.84 109.773 -179.663 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -118.82 152.69 35.77 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.044 -1.095 . . . . 2.2 108.044 177.672 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 43.7 p-10 -55.11 143.2 27.88 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.983 -1.073 . . . . 2.28 110.17 178.285 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 80.97 -0.72 1.78 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 114.117 1.155 . . . . 2.35 114.117 179.431 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.14 150.07 43.73 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.646 -1.284 . . . . 1.97 109.338 177.796 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -89.72 120.86 31.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.507 -1.371 . . . . 2.65 107.521 178.175 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 89.8 mt -128.33 146.8 50.66 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.44 -0.788 . . . . 0.63 109.729 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.47 127.88 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.15 -1.426 . . . . 0.62 107.15 177.443 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.561 HD13 HD11 ' A' ' 180' ' ' ILE . 61.8 tp -101.52 118.3 36.67 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 105.883 -1.895 . . . . 0.64 105.883 178.811 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 223' ' ' VAL . 39.4 t0 -91.7 -26.81 18.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.753 -1.217 . . . . 2.05 112.361 -177.903 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.82 19.74 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 113.264 0.839 . . . . 0.84 113.264 -179.25 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.1 t -112.14 -55.74 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.147 0.975 . . . . 1.02 108.981 -179.426 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -100.73 10.89 40.58 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.252 1.025 . . . . 2.51 109.65 -179.169 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 62.03 53.31 3.04 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.317 -0.856 . . . . 1.54 112.05 179.436 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -149.58 146.64 27.44 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.213 1.006 . . . . 1.95 109.792 178.438 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.9 t -116.79 135.37 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.509 -1.293 . . . . 0.71 107.509 178.056 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -102.42 134.77 45.19 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.831 -1.168 . . . . 1.01 108.442 178.673 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.26 129.25 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 107.795 -1.187 . . . . 0.82 107.795 178.738 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.488 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 18.4 t30 56.66 44.88 1.53 Allowed Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 113.467 0.914 . . . . 1.54 113.467 179.092 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 52.2 Cg_endo -68.9 155.47 68.46 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.383 2.055 . . . . 0.94 110.681 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 29.8 p -73.72 162.56 29.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.962 -1.086 . . . . 1.8 110.723 178.544 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.12 -34.04 74.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.507 -0.746 . . . . 2.73 110.337 178.94 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -59.85 -39.53 85.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 3.17 110.747 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.04 -39.07 79.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.217 -0.927 . . . . 1.34 110.405 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 80.5 mt . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.525 -0.734 . . . . 1.2 111.304 179.28 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.6 mt . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 106.318 -1.734 . . . . 1.07 106.318 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 m -105.76 121.02 43.18 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.504 -1.295 . . . . 1.24 107.504 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.01 -149.82 26.15 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.512 -1.035 . . . . 1.01 110.512 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.557 HG22 ' O ' ' A' ' 5' ' ' ILE . 81.3 mt -94.34 0.77 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.783 -0.833 . . . . 1.11 112.086 -179.67 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 50.26 99.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.355 -0.841 . . . . 0.99 112.335 178.646 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.8 -52.97 6.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.108 . . . . 0.85 110.628 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.33 149.41 44.53 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 107.719 -1.215 . . . . 1.38 107.719 -179.541 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.26 144.5 29.48 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 123.029 2.486 . . . . 0.94 112.937 178.815 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.91 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.35 168.67 18.15 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 109.206 -1.558 . . . . 0.81 109.206 178.119 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.87 133.46 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.108 -1.23 . . . . 0.83 108.803 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.33 150.86 43.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.366 -0.834 . . . . 0.53 109.132 179.096 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 22.0 m-85 -117.87 139.78 50.63 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.047 -1.094 . . . . 0.77 108.047 177.703 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.82 167.25 38.52 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.34 -1.886 . . . . 0.51 110.442 178.182 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -78.38 156.62 29.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.768 -0.842 . . . . 1.9 108.774 177.815 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.416 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.67 124.96 32.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.042 -1.095 . . . . 0.66 108.042 178.53 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.2 tp -100.24 101.9 13.03 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 104.721 -2.326 . . . . 0.83 104.721 177.628 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.25 138.48 31.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.21 -1.034 . . . . 0.86 108.21 179.673 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.3 mt -98.98 114.83 27.67 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 106.119 -1.808 . . . . 0.92 106.119 177.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -102.29 129.84 48.83 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.799 -1.186 . . . . 2.03 107.799 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -123.27 144.07 49.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.99 -0.744 . . . . 2.66 108.99 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -81.15 134.34 35.62 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.758 -1.201 . . . . 2.32 107.758 177.284 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.68 145.61 55.39 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.406 -0.809 . . . . 2.11 108.981 178.682 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.9 mt -93.03 132.11 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.263 -1.014 . . . . 0.73 108.263 178.324 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -106.33 129.85 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.169 -1.048 . . . . 0.87 108.169 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.2 mt -97.06 130.34 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.031 -1.1 . . . . 0.81 108.031 178.974 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -89.91 122.51 33.01 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.741 -1.207 . . . . 1.34 107.741 178.896 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mmm-85 -93.58 11.68 27.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.47 -0.768 . . . . 2.89 112.286 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -65.05 150.51 47.98 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.348 -0.845 . . . . 2.09 110.268 178.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -90.08 129.85 36.32 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.148 -1.056 . . . . 2.19 108.148 177.99 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 pt -90.86 164.69 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.962 . . . . 0.75 110.009 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.0 p -94.13 167.25 11.69 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.55 -0.719 . . . . 0.91 110.452 178.893 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.51 -26.89 55.91 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.91 . . . . 0.93 111.929 179.305 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -70.61 -27.98 64.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 2.28 111.012 -179.786 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -93.52 -12.82 28.76 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.416 -0.802 . . . . 1.45 112.151 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.3 t -59.54 -47.79 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.487 0.66 . . . . 0.81 110.205 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.33 -38.27 76.81 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.444 -0.785 . . . . 1.54 110.63 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.28 -38.66 90.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.605 -0.685 . . . . 2.36 110.88 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.466 ' CD ' HH21 ' A' ' 42' ' ' ARG . 79.3 mm-40 -60.35 -41.33 93.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.85 -1.156 . . . . 1.31 110.503 179.573 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.27 -40.41 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.374 -0.828 . . . . 0.82 110.547 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -60.29 -44.91 94.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.128 -0.983 . . . . 1.5 109.882 179.72 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.466 HH21 ' CD ' ' A' ' 39' ' ' GLU . 67.5 mtm180 -63.42 -41.96 98.71 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.929 -1.109 . . . . 2.23 109.74 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -72.25 -54.5 9.41 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.309 -0.869 . . . . 0.85 109.974 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.4 tp -57.79 -48.51 79.48 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.33 -0.948 . . . . 0.91 110.051 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t -68.78 -43.92 74.69 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.121 -0.987 . . . . 0.9 109.489 179.613 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.45 -35.71 73.59 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.348 -1.501 . . . . 0.69 109.348 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' A' ' 47' ' ' ARG . 0.3 OUTLIER -58.62 -33.66 70.28 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.434 1.111 . . . . 2.88 108.819 178.71 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.87 -48.21 82.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.035 -0.984 . . . . 0.85 110.212 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -79.0 -38.6 36.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 2.35 111.261 -179.445 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.76 86.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.65 110.513 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.5 m -61.43 -39.54 91.18 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.042 -1.036 . . . . 1.45 109.893 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.31 92.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.866 -0.521 . . . . 0.63 111.373 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -63.01 -52.16 64.02 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.716 -1.24 . . . . 1.34 111.199 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 54' ' ' LEU . 10.8 mp -64.75 -38.22 90.26 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.804 -1.185 . . . . 1.56 110.401 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.1 -43.33 87.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.737 -0.602 . . . . 1.19 110.781 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.5 m -67.74 -44.65 77.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.784 -1.197 . . . . 0.72 110.311 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.92 -34.92 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.641 -0.662 . . . . 0.62 110.869 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -50.74 -45.55 58.83 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.297 -0.877 . . . . 1.05 110.743 179.369 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -69.58 -34.57 74.33 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.129 -0.982 . . . . 0.64 110.305 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -62.75 -39.62 94.69 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.834 -1.147 . . . . 1.73 109.686 179.455 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.36 73.93 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.683 -0.635 . . . . 0.56 110.427 179.205 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.41 -33.7 21.94 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.8 -1.19 . . . . 0.69 111.042 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.44 -24.58 39.5 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.117 -1.225 . . . . 1.48 111.296 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -86.38 -48.84 8.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.374 -0.828 . . . . 0.98 111.221 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -107.36 -15.36 14.65 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 113.484 0.92 . . . . 1.16 113.484 -177.496 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.85 151.98 8.92 Favored Glycine 0 N--CA 1.501 3.026 0 O-C-N 121.406 -0.809 . . . . 0.85 112.043 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -52.73 -21.22 3.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.53 -0.982 . . . . 3.86 112.417 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.27 -29.89 67.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.974 -1.079 . . . . 2.35 111.689 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -82.82 -17.42 44.07 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.823 -1.173 . . . . 1.67 111.948 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.34 -33.81 72.94 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.419 -0.8 . . . . 1.45 111.109 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.69 -39.97 86.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.086 -1.009 . . . . 0.61 110.701 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.2 mt -66.12 -47.54 84.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.401 -0.92 . . . . 0.65 109.734 179.721 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -71.19 -33.41 69.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.339 -0.851 . . . . 0.66 110.547 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.88 -38.58 86.14 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.139 -0.976 . . . . 1.19 109.854 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.84 95.1 Favored Glycine 0 N--CA 1.483 1.833 0 C-N-CA 120.026 -1.083 . . . . 0.53 110.479 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -58.73 -43.0 90.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.026 -1.279 . . . . 1.27 110.362 179.306 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.33 -40.85 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.083 -1.011 . . . . 0.54 110.081 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.9 ttm -60.57 -41.99 95.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.438 -0.789 . . . . 1.74 110.081 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.1 tp -60.55 -48.09 83.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.417 -0.802 . . . . 0.55 109.995 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.466 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.1 tp -59.83 -39.66 85.87 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.72 0.771 . . . . 0.47 110.248 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -87.06 7.6 27.15 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.725 0.639 . . . . 1.42 112.725 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -63.49 125.2 23.43 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.833 -1.167 . . . . 1.27 108.762 178.952 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.49 -16.72 63.94 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.265 -0.897 . . . . 1.35 111.096 -179.051 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.37 -50.29 19.22 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.274 -0.97 . . . . 2.22 110.623 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.97 -39.72 90.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.379 -0.826 . . . . 0.62 110.631 -179.489 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.84 -48.65 80.84 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.07 -1.019 . . . . 1.29 110.986 179.367 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -62.01 -38.64 89.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 1.52 110.949 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -66.36 -47.98 71.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.899 -1.126 . . . . 1.3 110.319 179.486 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.7 mt -58.33 -46.48 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.968 -1.082 . . . . 0.61 109.991 179.381 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.99 -40.94 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.45 -0.781 . . . . 0.78 110.354 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.43 -46.93 88.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 0.82 111.033 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.8 -42.98 94.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.087 -1.008 . . . . 0.8 110.511 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.8 mt -61.84 -46.77 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.982 . . . . 0.77 110.029 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -82.14 -37.87 25.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 2.12 111.82 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 91' ' ' ALA . 56.3 t0 -81.58 -45.74 15.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.696 -1.253 . . . . 1.51 111.994 -178.681 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -100.01 8.81 43.74 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.991 -1.068 . . . . 1.98 112.61 -178.78 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.0 m170 50.88 50.21 19.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.959 -1.088 . . . . 1.32 111.816 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.9 mtt -107.72 151.45 25.67 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.442 -0.786 . . . . 1.38 109.734 179.486 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.5 p -70.43 163.34 26.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.729 -0.607 . . . . 0.67 109.97 178.351 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.79 -42.29 88.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.933 . . . . 0.52 110.698 178.825 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.518 ' OD2' HD21 ' A' ' 142' ' ' LEU . 84.3 m-20 -67.93 -41.43 82.6 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.042 -1.036 . . . . 2.25 110.205 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.22 -50.87 51.21 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.634 -0.666 . . . . 0.64 111.344 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.71 94.89 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.033 -1.042 . . . . 0.56 110.314 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -43.74 95.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 0.46 110.669 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -61.28 -39.75 91.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 1.32 111.309 -179.481 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -57.63 -49.84 75.12 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.852 -1.155 . . . . 1.3 110.795 179.46 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.14 -46.06 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.047 -1.033 . . . . 0.61 109.974 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -64.93 -31.96 56.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.871 -0.518 . . . . 0.65 110.418 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.21 -41.0 71.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.181 -0.949 . . . . 2.11 110.7 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.01 -30.93 18.97 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 119.142 -1.504 . . . . 0.83 112.452 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -61.21 -39.69 91.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.516 -1.579 . . . . 1.28 109.903 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.14 -48.91 40.07 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.323 0.582 . . . . 0.89 110.755 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.8 t -60.05 -40.34 89.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.319 -0.863 . . . . 1.87 110.433 -178.385 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.07 99.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.382 -0.824 . . . . 1.05 110.745 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.55 -30.11 70.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.814 -1.179 . . . . 1.02 110.733 -179.866 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -66.24 -20.14 66.03 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.78 -1.2 . . . . 2.04 111.039 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.37 -18.77 63.06 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.351 -0.94 . . . . 1.73 110.827 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 15.0 mt -88.88 136.49 32.98 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.843 -1.169 . . . . 1.37 107.843 178.722 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -100.59 42.92 1.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.272 -0.893 . . . . 2.88 111.272 -179.583 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -111.85 142.31 44.39 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.164 -0.96 . . . . 1.58 109.456 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -58.8 -39.27 80.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.228 -0.92 . . . . 3.04 110.797 178.815 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -71.87 -50.58 28.19 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.851 -1.156 . . . . 0.9 109.875 179.568 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt -67.5 -43.28 81.28 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.386 -0.821 . . . . 1.06 110.118 -178.747 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -61.25 -47.87 84.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.16 -0.962 . . . . 2.18 109.787 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.91 -30.92 69.36 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.505 -0.878 . . . . 2.15 109.635 179.594 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 130' ' ' VAL . 57.0 ttt180 -61.68 -30.43 70.73 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.092 0.949 . . . . 2.33 108.696 179.289 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -49.86 74.56 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.071 0.939 . . . . 0.82 109.537 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.65 -43.34 80.52 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.598 0.713 . . . . 0.85 110.078 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -63.21 -33.51 75.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.623 -0.673 . . . . 1.39 110.573 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 126' ' ' ARG . 21.9 t -70.0 -39.28 77.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.472 -0.767 . . . . 0.56 110.105 179.561 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -59.26 -39.92 84.39 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.822 -1.151 . . . . 3.12 109.752 178.653 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.441 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 51.3 t0 -60.12 -40.8 90.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.588 -0.695 . . . . 1.28 110.059 179.437 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.7 mt -61.77 -39.07 82.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.062 -1.023 . . . . 0.49 110.116 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.35 -46.51 20.18 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.655 -1.259 . . . . 0.46 110.486 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -56.62 -41.63 77.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.559 -0.965 . . . . 2.71 110.079 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.443 HH11 ' HG2' ' A' ' 136' ' ' ARG . 40.7 mtt-85 -60.19 -41.52 93.11 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.003 -1.061 . . . . 2.14 109.832 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.9 tp -60.22 -42.78 95.9 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.318 -0.953 . . . . 1.05 109.358 179.462 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.4 mt -59.84 -47.31 86.24 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.828 -0.545 . . . . 0.52 109.949 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -59.88 -35.4 74.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 2.35 111.017 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -73.99 -41.5 61.81 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.026 -1.046 . . . . 1.39 110.684 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.57 -38.89 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -0.925 . . . . 0.68 110.462 -178.388 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.518 HD21 ' OD2' ' A' ' 101' ' ' ASP . 89.7 mt -89.07 -6.96 56.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.093 -1.004 . . . . 0.83 112.099 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.47 30.0 67.31 Favored Glycine 0 N--CA 1.482 1.746 0 C-N-CA 120.065 -1.064 . . . . 0.91 112.075 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.94 148.23 44.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.686 -0.891 . . . . 0.95 109.844 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -68.01 141.29 56.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 2.43 109.27 178.095 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.91 131.5 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.202 -1.036 . . . . 1.1 108.202 178.463 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.775 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.1 mp -77.02 131.02 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.408 -0.808 . . . . 1.58 108.928 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.9 97.93 11.27 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.466 -1.679 . . . . 1.62 106.466 178.623 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.57 ' O ' HD13 ' A' ' 152' ' ' ILE . 77.2 mt -78.84 -6.0 54.91 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 112.72 0.637 . . . . 0.8 112.72 -177.855 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.8 p -88.85 -2.59 58.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.903 -1.123 . . . . 1.56 112.745 -179.123 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -106.17 36.68 2.5 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.147 -0.97 . . . . 0.84 112.414 -177.8 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.5 mp -72.72 139.89 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.575 -1.328 . . . . 0.82 109.406 178.493 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -118.86 -16.73 9.25 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.706 0.765 . . . . 2.31 112.408 -179.097 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -116.03 138.47 51.19 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.771 -1.196 . . . . 1.54 107.771 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -76.12 121.39 22.75 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.284 -1.006 . . . . 1.38 108.284 178.598 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 m -146.28 174.03 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.493 -0.755 . . . . 0.69 109.144 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.7 mt -87.89 140.76 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.53 109.143 178.02 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 42.5 tp -94.8 124.15 38.67 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.98 -1.075 . . . . 0.64 108.183 178.242 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.97 129.18 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 107.604 -1.258 . . . . 0.67 107.604 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.36 153.98 22.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 0.78 108.943 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.65 -34.38 76.96 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.607 -1.308 . . . . 1.0 109.213 178.103 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -173.8 149.77 1.6 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.236 -0.653 . . . . 2.42 109.236 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 58.9 mt -116.03 136.32 53.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.601 -1.259 . . . . 0.75 107.601 177.337 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.9 p -92.2 150.15 39.8 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.164 -0.96 . . . . 0.78 108.786 179.069 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -39.49 -44.38 3.09 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.886 1.724 . . . . 0.67 113.441 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.8 m -58.92 -50.06 75.47 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.835 -1.166 . . . . 0.7 111.014 -179.501 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -62.99 -40.07 96.66 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.253 -0.904 . . . . 1.21 110.212 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 73.0 p -68.58 -39.2 81.07 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.334 -0.854 . . . . 0.6 110.327 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.5 78.17 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.595 -0.842 . . . . 0.62 110.638 179.268 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -94.88 -2.37 50.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.111 -0.993 . . . . 1.16 113.226 -179.014 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.94 149.94 46.14 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.904 -1.123 . . . . 0.73 109.14 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.453 ' O ' HG23 ' A' ' 176' ' ' VAL . 57.5 t-20 -95.63 104.63 16.55 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.056 -1.831 . . . . 2.24 106.056 177.813 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.609 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.6 mp -72.2 -18.3 61.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 1.43 112.054 -177.57 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -77.97 -27.45 49.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.203 -0.936 . . . . 2.15 111.45 -178.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -100.11 6.07 44.91 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.284 -0.885 . . . . 2.04 112.362 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 178' ' ' GLY . 91.5 t -109.75 129.84 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.962 -1.125 . . . . 0.55 107.962 179.683 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 48.9 tp -81.85 -15.47 53.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.815 . . . . 1.63 112.288 -179.068 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.525 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 173.29 179.91 44.27 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.472 -1.451 . . . . 0.47 109.472 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -131.68 138.24 48.63 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.533 -1.284 . . . . 0.54 107.533 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.9 mt -138.21 119.03 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.424 -1.695 . . . . 0.69 106.424 178.524 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 203' ' ' VAL . 60.0 p -132.1 164.53 26.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.087 -1.008 . . . . 0.82 108.952 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 208' ' ' VAL . 1.9 m-20 -104.82 15.98 26.83 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.577 -0.702 . . . . 2.37 112.329 179.047 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -134.12 -51.17 0.82 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 120.808 -1.182 . . . . 1.11 114.0 -177.712 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.54 153.74 0.29 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.199 -1.0 . . . . 1.67 110.84 -176.421 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 152.65 -61.31 0.39 Allowed Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.156 -1.021 . . . . 1.54 112.295 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.83 77.37 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.061 -1.258 . . . . 4.48 109.023 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.6 p 53.67 40.75 31.86 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.672 -0.811 . . . . 2.63 111.596 -178.927 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 38.5 t -79.74 153.99 28.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.816 . . . . 1.69 109.559 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -59.0 -39.91 83.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.859 . . . . 1.07 110.893 178.948 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 33.6 p -56.42 -40.89 75.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 1.58 110.732 179.417 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 82.2 p -62.3 -37.95 87.49 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.066 -1.021 . . . . 1.6 110.485 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.83 -38.7 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.383 -0.823 . . . . 1.45 110.73 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.7 mtp -61.75 -44.86 96.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.84 -1.162 . . . . 1.05 108.905 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.95 -48.6 81.05 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.116 -0.947 . . . . 0.72 111.029 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.47 HH11 ' HG2' ' A' ' 195' ' ' ARG . 23.7 mtt-85 -60.81 -43.48 98.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.099 -1.001 . . . . 3.05 110.751 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 41.5 m -69.88 -41.04 75.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.443 -0.786 . . . . 0.89 110.306 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 13.3 mt -91.75 -6.84 51.19 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.623 0.725 . . . . 0.78 112.284 -178.221 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.5 mt-10 45.52 18.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.529 0.937 . . . . 1.45 113.529 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 18.6 mt -71.84 142.25 85.45 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.953 -1.092 . . . . 0.67 108.372 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -56.24 130.36 39.75 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.678 1.585 . . . . 0.64 110.357 178.475 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.05 175.88 9.05 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 117.911 -1.516 . . . . 0.67 111.517 179.555 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.2 mt -146.63 157.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.632 -1.247 . . . . 0.69 107.632 178.467 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 183' ' ' ALA . 4.6 m -141.8 -23.62 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 120.818 -1.176 . . . . 0.85 113.286 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -104.25 42.3 1.93 Allowed Glycine 0 N--CA 1.503 3.136 0 N-CA-C 110.637 -0.985 . . . . 0.92 110.637 -178.563 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 36.3 p -59.86 -20.76 58.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.056 -1.261 . . . . 0.95 111.841 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.22 -85.37 0.61 Allowed Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.18 -1.01 . . . . 1.04 111.437 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 58.8 p -134.66 32.11 3.32 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 121.008 -1.29 . . . . 1.57 113.331 -178.592 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.527 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 60.2 t -58.84 -34.15 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.223 -1.548 . . . . 0.84 111.076 179.451 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 43.8 p -64.12 -21.73 66.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.835 -1.165 . . . . 0.99 112.199 -179.628 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 53.8 p -96.32 3.16 53.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.943 -1.098 . . . . 1.7 112.339 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -129.76 4.12 4.98 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.684 -0.635 . . . . 2.2 112.691 -178.567 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.1 t -123.04 152.92 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.404 -0.81 . . . . 0.84 109.768 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -118.48 156.76 28.51 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.096 -1.076 . . . . 2.2 108.096 178.032 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.513 ' ND2' ' OD1' ' A' ' 215' ' ' ASP . 46.7 t30 -54.8 139.97 37.89 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.052 -1.03 . . . . 2.28 110.119 178.257 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.513 ' OD1' ' ND2' ' A' ' 214' ' ' ASN . 1.2 m-20 79.56 5.36 2.06 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.281 1.215 . . . . 2.35 114.281 179.58 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -63.39 148.63 47.93 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.385 -0.969 . . . . 1.97 108.385 177.538 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -89.64 119.96 30.51 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.583 -1.636 . . . . 2.65 106.583 178.118 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.416 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 86.7 mt -128.26 146.36 50.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.585 -0.697 . . . . 0.63 109.86 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 47.0 mt -112.13 124.19 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.691 -1.596 . . . . 0.62 106.691 177.519 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.0 tp -97.21 111.58 23.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.981 -1.859 . . . . 0.64 105.981 178.117 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.6 t0 -89.72 -28.95 19.07 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.718 -1.239 . . . . 2.05 111.549 -178.423 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.81 10.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 113.285 0.846 . . . . 0.84 113.285 -179.653 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.625 ' N ' ' O ' ' A' ' 221' ' ' ASP . 39.3 t -110.57 -56.44 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.987 -1.071 . . . . 1.02 109.173 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -92.57 8.87 37.04 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.297 1.046 . . . . 2.51 110.271 -179.097 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 60.51 49.97 6.25 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.026 -0.988 . . . . 1.54 111.632 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -148.47 149.55 31.86 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.608 1.194 . . . . 1.95 109.93 178.842 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.66 135.03 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.653 -1.239 . . . . 0.71 107.653 177.822 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -100.5 130.26 46.55 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.968 -1.123 . . . . 1.01 107.968 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.31 130.01 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.784 -0.821 . . . . 0.82 108.784 179.094 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.412 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 44.2 t-20 49.93 50.59 9.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 113.426 0.898 . . . . 1.54 113.426 178.763 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.7 Cg_endo -69.02 150.29 72.56 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.366 2.044 . . . . 0.94 110.701 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.1 p -73.83 160.29 31.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 1.8 109.821 178.215 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.72 -36.61 72.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.486 -0.759 . . . . 2.73 111.105 179.021 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -59.59 -41.22 89.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 3.17 110.122 179.321 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -71.39 -40.24 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.47 -0.769 . . . . 1.34 110.115 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.487 1.391 0 O-C-N 121.391 -0.818 . . . . 1.2 110.322 -178.549 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.1 mt . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 106.41 -1.7 . . . . 1.07 106.41 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -105.02 120.52 41.68 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.744 -1.206 . . . . 1.24 107.744 -179.418 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.6 -160.37 26.9 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.179 -1.568 . . . . 1.01 109.179 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 5' ' ' ILE . 74.9 mt -96.05 -0.18 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.419 -1.047 . . . . 1.11 112.343 -179.295 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.7 tp 49.24 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.99 112.656 178.577 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.76 -43.55 11.8 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.933 -1.105 . . . . 0.85 111.562 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -141.33 143.51 30.62 Favored Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 107.72 -1.215 . . . . 1.38 107.72 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.32 146.55 22.28 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.616 2.211 . . . . 0.94 112.634 178.665 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.896 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.39 177.98 27.46 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 108.866 -1.694 . . . . 0.81 108.866 177.958 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.9 mt -134.67 140.04 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.041 -1.27 . . . . 0.83 108.345 179.612 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.54 ' HB1' HD22 ' A' ' 177' ' ' LEU . . . -144.94 158.03 43.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -0.984 . . . . 0.53 109.451 178.177 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 11.5 m-85 -127.75 140.54 52.0 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.769 -1.197 . . . . 0.77 107.769 178.223 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.23 166.02 34.41 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 118.38 -1.867 . . . . 0.51 110.411 178.141 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -78.11 158.08 29.25 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.402 -0.962 . . . . 1.9 108.402 178.556 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.16 130.96 35.15 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.743 -0.836 . . . . 0.66 108.743 178.103 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.2 tp -113.35 103.78 11.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 105.604 -1.998 . . . . 0.83 105.604 178.113 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.482 ' O ' ' ND2' ' A' ' 214' ' ' ASN . 13.8 tp -91.84 139.05 31.04 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.66 -0.867 . . . . 0.86 108.66 -179.575 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.2 mt -99.39 120.9 40.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.293 -1.373 . . . . 0.92 107.293 178.318 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -111.12 138.96 46.9 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.995 -1.113 . . . . 2.03 107.995 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -119.78 140.29 50.98 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.172 -0.955 . . . . 2.66 109.245 178.446 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -85.02 133.36 34.25 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.727 -1.212 . . . . 2.32 107.727 177.324 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -60.74 149.1 36.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.07 -1.019 . . . . 2.11 108.732 178.484 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.8 mt -96.99 134.17 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.027 -1.046 . . . . 0.73 108.263 178.325 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.74 129.67 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.586 -1.264 . . . . 0.87 107.586 178.531 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.0 mt -100.62 137.74 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.145 -1.058 . . . . 0.81 108.145 179.546 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -94.33 120.74 35.01 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.324 -0.991 . . . . 1.34 108.324 178.921 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -94.55 15.13 18.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.393 -0.817 . . . . 2.89 112.805 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.98 147.31 53.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.382 -0.824 . . . . 2.09 109.264 178.692 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -88.1 139.42 30.52 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.618 -0.882 . . . . 2.19 108.618 177.718 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 pt -99.77 164.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.857 -1.152 . . . . 0.75 109.912 179.088 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.0 p -93.87 165.95 12.42 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.386 -0.821 . . . . 0.91 109.698 178.472 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -21.24 14.4 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.4 -0.812 . . . . 0.93 112.154 179.242 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -68.15 -39.1 82.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.063 -1.023 . . . . 2.28 110.873 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -91.02 -7.4 52.01 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.814 -1.179 . . . . 1.45 112.744 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.22 -47.44 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.526 -1.358 . . . . 0.81 110.788 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -59.24 -39.15 81.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.124 -0.985 . . . . 1.54 109.972 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -61.36 -37.92 85.1 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.705 -0.798 . . . . 2.36 110.825 179.463 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -59.91 -40.86 90.25 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.17 -1.012 . . . . 1.31 110.639 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.24 -41.77 88.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.165 -0.959 . . . . 0.82 110.504 179.798 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -62.73 -41.39 99.15 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.78 -1.2 . . . . 1.5 110.358 179.821 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -61.05 -41.08 95.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 2.23 110.616 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -75.37 -54.11 7.6 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.844 -1.16 . . . . 0.85 110.463 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.2 tp -57.55 -47.8 81.07 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.721 0.772 . . . . 0.91 110.674 -179.449 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.519 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.0 t -69.06 -40.05 78.75 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.833 0.825 . . . . 0.9 110.346 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.91 -44.6 92.44 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 109.811 -1.316 . . . . 0.69 109.811 179.298 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -60.67 -28.91 68.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.779 -0.836 . . . . 2.88 110.251 179.269 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.5 -49.34 77.7 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.834 0.826 . . . . 0.85 110.604 179.072 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -81.77 -38.62 25.37 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.337 -0.852 . . . . 2.35 110.668 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.6 -42.36 92.42 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.614 -0.834 . . . . 0.65 109.925 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 m -62.08 -39.92 94.06 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.985 0.898 . . . . 1.45 109.582 179.668 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.45 88.83 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.723 -0.791 . . . . 0.63 109.879 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.52 -50.44 69.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.99 -1.069 . . . . 1.34 109.998 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.45 -40.33 94.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.941 -1.1 . . . . 1.56 109.832 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -59.33 -39.89 84.55 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.393 -0.817 . . . . 1.19 110.226 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -62.91 -43.41 98.87 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.388 -0.82 . . . . 0.72 110.277 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.23 -34.43 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.078 -1.014 . . . . 0.62 110.279 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -53.3 -45.55 69.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.45 -0.781 . . . . 1.05 110.877 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -68.87 -39.93 79.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.206 -0.934 . . . . 0.64 109.778 -179.708 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -61.78 -37.58 84.87 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.128 -1.029 . . . . 1.73 109.139 179.675 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.95 79.44 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.308 -0.557 . . . . 0.56 110.193 179.197 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.82 -35.21 16.65 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.8 -1.191 . . . . 0.69 111.267 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -79.9 -25.7 40.48 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.956 -1.32 . . . . 1.48 110.709 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.2 m -86.93 -50.97 6.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.729 -0.607 . . . . 0.98 110.287 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -105.92 -6.14 19.1 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 114.079 1.14 . . . . 1.16 114.079 -177.412 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.57 164.3 27.22 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 120.228 -0.986 . . . . 0.85 112.447 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -56.38 -23.24 36.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.852 -0.793 . . . . 3.86 112.645 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -57.9 -39.0 76.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.356 -1.465 . . . . 2.35 110.515 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -86.99 -25.27 24.36 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.216 -0.928 . . . . 1.67 111.746 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.42 -39.97 85.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.219 -0.925 . . . . 1.45 110.776 -179.424 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.21 84.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.496 -0.752 . . . . 0.61 111.286 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.2 mt -65.41 -44.75 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.622 -1.299 . . . . 0.65 110.649 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -69.87 -31.55 69.44 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.841 -1.162 . . . . 0.66 110.698 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -59.98 -39.33 85.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.064 -1.023 . . . . 1.19 110.94 179.32 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.93 -40.36 93.48 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.535 -1.317 . . . . 0.53 110.863 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -59.35 -40.78 87.5 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.084 -1.245 . . . . 1.27 110.616 179.638 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.7 mt -60.82 -37.55 76.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.202 -0.936 . . . . 0.54 110.497 179.845 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 26.3 ttt -58.64 -38.89 79.07 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.703 -0.799 . . . . 1.74 110.449 179.28 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.05 -49.43 77.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.949 -1.094 . . . . 0.55 110.879 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.6 tp -61.35 -38.81 88.3 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.21 -0.931 . . . . 0.47 110.252 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -86.34 7.65 24.68 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.175 0.806 . . . . 1.42 113.175 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -67.43 116.16 7.87 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 120.793 -1.192 . . . . 1.27 108.655 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -64.37 -20.23 65.99 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.626 0.727 . . . . 1.35 110.946 -179.226 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -71.64 -47.98 50.85 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.991 -1.083 . . . . 2.22 110.364 179.392 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.32 -38.4 89.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.395 -0.816 . . . . 0.62 110.521 -178.544 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -59.54 -41.76 90.81 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.008 -1.058 . . . . 1.29 110.515 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.17 -39.23 85.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.941 -1.099 . . . . 1.52 110.582 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -66.62 -48.06 70.65 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.106 -1.037 . . . . 1.3 110.448 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.59 -43.48 83.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.936 -1.102 . . . . 0.61 110.01 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.73 -44.04 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 0.78 110.685 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.74 -40.89 96.69 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.247 -0.908 . . . . 0.82 110.856 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.0 mt -60.39 -44.77 95.34 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.496 -1.377 . . . . 0.8 110.418 -179.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.64 -47.64 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.907 -1.121 . . . . 0.77 110.812 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -79.75 -35.48 38.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.004 -1.06 . . . . 2.12 111.665 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.78 -43.34 22.67 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.02 -1.05 . . . . 1.51 111.312 -179.001 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -101.13 4.55 42.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.047 -1.033 . . . . 1.98 112.251 -177.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.1 m80 51.48 49.35 21.13 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.238 -0.914 . . . . 1.32 111.646 -179.43 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 70.3 mtm -110.04 157.89 18.85 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.494 -0.754 . . . . 1.38 109.558 178.738 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.8 p -71.51 162.46 29.41 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.296 0.569 . . . . 0.67 110.403 178.247 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.67 -41.11 97.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.53 -0.731 . . . . 0.52 110.827 179.149 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 31.8 p-10 -69.59 -38.59 77.39 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.196 -0.94 . . . . 2.25 109.978 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.527 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -71.27 -52.89 16.43 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.831 -1.148 . . . . 0.64 110.872 179.363 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.25 88.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.56 110.604 -179.349 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.25 93.46 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.026 -0.67 . . . . 0.46 110.878 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -59.76 -41.31 90.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.843 -1.16 . . . . 1.32 111.039 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -56.14 -47.57 77.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.235 -1.54 . . . . 1.3 110.73 179.658 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.53 -44.18 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.548 -1.345 . . . . 0.61 110.22 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.79 -32.31 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.282 -0.886 . . . . 0.65 110.071 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.22 -39.93 92.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.12 -0.987 . . . . 2.11 111.022 179.308 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.9 -30.4 29.11 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.079 -1.534 . . . . 0.83 112.795 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -60.57 -39.68 88.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 119.675 -2.073 . . . . 1.28 109.858 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.53 -48.04 43.45 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.638 0.733 . . . . 0.89 109.696 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.3 p -60.81 -39.73 90.04 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.704 -0.798 . . . . 1.87 110.063 -178.649 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.24 -46.45 89.74 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.954 -1.091 . . . . 1.05 110.821 179.535 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.3 mt -65.44 -29.54 70.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.699 -1.25 . . . . 1.02 111.09 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -64.31 -21.39 66.59 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.975 -1.078 . . . . 2.04 111.426 179.549 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -71.83 -15.51 62.14 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.763 0.792 . . . . 1.73 110.923 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.509 HD13 HD13 ' A' ' 123' ' ' LEU . 36.8 mt -86.9 141.55 28.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.953 -0.758 . . . . 1.37 108.953 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -97.56 41.58 1.12 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.987 -1.071 . . . . 2.88 111.853 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -114.48 140.88 48.37 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.305 -0.872 . . . . 1.58 109.391 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -59.05 -39.39 81.89 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.338 -0.851 . . . . 3.04 111.515 178.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -72.68 -53.01 12.91 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 0.9 110.313 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.509 HD13 HD13 ' A' ' 118' ' ' LEU . 26.4 mt -61.42 -41.32 96.97 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.107 -0.995 . . . . 1.06 110.394 -179.547 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -63.16 -49.05 75.85 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.276 1.036 . . . . 2.18 109.563 179.758 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -63.2 -29.93 71.18 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.092 -1.043 . . . . 2.15 109.968 179.776 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 130' ' ' VAL . 15.2 ttt-85 -60.82 -30.47 70.1 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.741 0.782 . . . . 2.33 108.951 178.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.25 87.28 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.155 0.979 . . . . 0.82 109.001 178.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -43.65 80.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.739 -0.784 . . . . 0.85 109.981 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -64.57 -33.17 75.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.492 -0.755 . . . . 1.39 110.616 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 126' ' ' ARG . 24.5 t -68.19 -39.63 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 0.56 109.834 179.377 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -58.91 -39.67 82.22 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.087 -1.045 . . . . 3.12 109.896 178.94 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -59.35 -38.86 81.48 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.21 -0.45 . . . . 1.28 110.544 179.299 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 54.1 mt -60.72 -40.29 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.673 -1.267 . . . . 0.49 110.116 179.496 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.19 -36.65 60.01 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.395 -1.082 . . . . 0.46 110.395 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -56.63 -48.65 77.05 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.547 -0.972 . . . . 2.71 110.66 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -63.38 -41.03 98.77 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.013 -1.075 . . . . 2.14 110.169 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.9 tp -59.76 -40.37 87.94 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.69 -0.631 . . . . 1.05 110.301 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.2 mt -59.24 -44.3 92.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.094 -1.004 . . . . 0.52 110.463 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -60.62 -33.24 72.48 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.146 -0.971 . . . . 2.35 111.181 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -75.74 -41.4 53.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.909 -1.119 . . . . 1.39 110.867 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.1 mt -60.14 -38.6 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.969 -1.082 . . . . 0.68 110.571 -178.45 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.0 mt -85.35 -7.11 59.14 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.457 -0.777 . . . . 0.83 111.764 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.81 16.42 80.78 Favored Glycine 0 N--CA 1.483 1.82 0 C-N-CA 120.319 -0.943 . . . . 0.91 112.454 -179.666 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.27 149.28 48.37 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.769 -0.842 . . . . 0.95 109.688 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -65.66 150.83 47.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.528 -0.732 . . . . 2.43 109.695 178.259 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.2 mt -104.02 138.43 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.177 -0.952 . . . . 1.1 108.711 178.602 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 mp -82.72 118.84 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.439 -1.319 . . . . 1.58 107.439 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -100.81 102.62 13.74 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.965 -1.865 . . . . 1.62 105.965 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 70.1 mt -74.86 -14.79 60.71 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.563 -0.855 . . . . 0.8 111.505 -178.425 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.2 m -80.09 2.41 24.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.414 -0.804 . . . . 1.56 112.852 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -93.94 21.17 6.92 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.67 0.747 . . . . 0.84 112.325 -179.226 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.2 mt -73.15 140.22 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.811 -0.556 . . . . 0.82 109.672 179.57 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -117.46 -16.37 10.21 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.224 1.011 . . . . 2.31 112.468 -178.715 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -118.03 139.39 51.27 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.288 -1.004 . . . . 1.54 108.288 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -70.87 128.7 36.89 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.826 -1.171 . . . . 1.38 108.294 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.1 m -146.57 175.42 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.92 -0.77 . . . . 0.69 108.92 -179.788 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.28 140.65 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.884 -1.135 . . . . 0.53 108.757 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.6 tp -96.66 123.36 40.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.807 -1.183 . . . . 0.64 108.626 178.271 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.23 130.7 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.431 -0.951 . . . . 0.67 108.431 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 152.01 16.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -0.86 . . . . 0.78 109.157 178.698 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.42 -34.19 74.97 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.897 -1.127 . . . . 1.0 109.344 178.055 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -171.53 153.06 3.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.77 -0.826 . . . . 2.42 108.77 179.455 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 68.9 mt -118.95 142.86 47.4 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.437 -0.79 . . . . 0.75 109.214 177.225 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.4 p -91.81 146.91 33.91 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.275 -0.89 . . . . 0.78 109.071 179.185 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -41.15 -39.23 3.6 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.464 1.443 . . . . 0.67 113.537 178.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.1 m -61.37 -50.17 73.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.764 -1.21 . . . . 0.7 110.208 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.22 -39.13 93.76 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.41 0.624 . . . . 1.21 110.327 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 56.5 p -68.44 -40.03 81.31 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.285 -0.884 . . . . 0.6 110.678 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.78 84.05 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.123 -0.985 . . . . 0.62 110.338 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -94.32 1.85 55.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.791 -1.193 . . . . 1.16 112.991 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.7 149.6 34.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.0 -1.063 . . . . 0.73 109.037 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.02 116.62 29.23 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.621 -1.622 . . . . 2.24 106.621 177.755 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.3 mt -75.66 -13.67 60.33 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.353 0.597 . . . . 1.43 111.717 -177.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -85.76 -22.16 27.86 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.319 0.581 . . . . 2.15 112.072 -179.118 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -102.73 -2.41 28.2 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.884 0.698 . . . . 2.04 112.884 -178.165 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.7 t -112.15 130.04 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 107.65 -1.241 . . . . 0.55 107.65 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.71 ' O ' HD23 ' A' ' 177' ' ' LEU . 1.7 tt -92.96 -11.11 34.09 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.239 1.019 . . . . 1.63 111.735 -179.208 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.89 173.67 42.66 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 109.537 -1.425 . . . . 0.47 109.537 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -126.2 132.49 51.75 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.992 -1.299 . . . . 0.54 107.61 179.17 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.452 HG22 HG21 ' A' ' 205' ' ' THR . 75.0 mt -132.48 106.86 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 106.133 -1.803 . . . . 0.69 106.133 178.366 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.563 ' O ' HG23 ' A' ' 205' ' ' THR . 71.7 p -129.31 170.21 13.9 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 120.497 -1.377 . . . . 0.82 110.018 -178.818 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 20.9 p-10 -99.01 53.23 0.97 Allowed 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 120.118 -0.633 . . . . 2.37 110.881 179.433 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.33 156.14 17.78 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 108.887 -0.783 . . . . 1.11 108.887 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.59 -3.39 58.45 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.431 -1.366 . . . . 1.67 112.821 179.452 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 77.2 -40.22 1.7 Allowed Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.444 -1.36 . . . . 1.54 113.967 179.624 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.49 HH11 ' HG2' ' A' ' 186' ' ' ARG . 14.5 ttt-85 -61.31 127.06 29.69 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.996 -1.297 . . . . 4.48 109.019 179.037 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 10.5 p 46.38 28.94 0.78 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -0.859 . . . . 2.63 112.245 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 42.4 t -83.07 130.04 35.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.922 -1.111 . . . . 1.69 108.089 178.16 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -59.37 -40.74 87.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -0.925 . . . . 1.07 110.625 179.295 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -61.28 -40.72 95.2 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.631 -1.293 . . . . 1.58 110.258 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 91.6 p -60.81 -36.16 78.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.231 -0.918 . . . . 1.6 110.455 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.84 -38.29 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.191 -0.943 . . . . 1.45 110.186 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 67.1 mtp -63.18 -41.85 99.28 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.09 -1.006 . . . . 1.05 109.639 179.392 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.06 -47.13 86.35 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.491 0.662 . . . . 0.72 111.14 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -59.99 -42.6 94.58 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.065 -1.022 . . . . 3.05 110.623 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 31.5 m -70.18 -41.0 74.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.89 110.007 179.788 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -90.44 -9.3 47.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.522 -0.736 . . . . 0.78 111.841 -178.085 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 194' ' ' ALA . 54.3 mt-10 51.38 12.71 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 114.013 1.116 . . . . 1.45 114.013 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 42.9 mt -70.5 162.03 73.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.902 -1.124 . . . . 0.67 108.64 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -68.88 140.67 46.7 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.345 1.363 . . . . 0.64 110.59 178.381 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.82 167.88 27.14 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 117.338 -1.745 . . . . 0.67 110.268 178.727 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 203' ' ' VAL . 75.6 mt -143.48 157.57 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.257 -1.386 . . . . 0.69 107.257 178.213 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.0 m -138.59 -29.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.868 -1.145 . . . . 0.85 112.736 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.25 44.69 2.69 Favored Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.273 -0.892 . . . . 0.92 111.555 -178.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 181' ' ' THR . 33.5 p -66.31 -18.61 65.46 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.961 -1.317 . . . . 0.95 110.841 -179.167 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.35 -94.91 0.74 Allowed Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.51 -1.328 . . . . 1.04 110.123 179.727 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.5 t -126.43 28.19 6.02 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.304 -1.115 . . . . 1.57 112.623 -178.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 84.6 t -59.05 -35.23 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.33 -1.482 . . . . 0.84 110.592 179.323 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.4 p -55.31 -25.24 33.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.058 -1.026 . . . . 0.99 111.378 -179.856 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t -93.89 1.05 56.45 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.141 -0.974 . . . . 1.7 111.992 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -121.03 -6.1 9.51 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.18 0.808 . . . . 2.2 113.18 -178.053 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 29.8 t -114.94 150.15 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.705 -0.622 . . . . 0.84 109.509 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -124.32 160.61 27.66 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.741 -1.207 . . . . 2.2 107.741 177.836 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 10.2 m120 -54.79 140.88 34.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.581 -1.324 . . . . 2.28 110.981 178.541 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.5 m-20 79.03 4.9 2.33 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 114.73 1.381 . . . . 2.35 114.73 179.173 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -65.26 142.55 58.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.702 -1.248 . . . . 1.97 108.479 177.528 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -85.94 115.68 23.71 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.584 -1.265 . . . . 2.65 107.584 177.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 75.9 mt -125.19 143.61 50.85 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.767 0.794 . . . . 0.63 109.849 -178.642 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.2 mt -112.64 128.86 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 106.545 -1.65 . . . . 0.62 106.545 177.622 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.6 tp -103.55 114.48 28.79 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 105.954 -1.869 . . . . 0.64 105.954 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 223' ' ' VAL . 40.8 t0 -90.5 -25.06 20.47 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.945 -1.097 . . . . 2.05 112.704 -177.857 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.896 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.56 14.12 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 113.128 0.788 . . . . 0.84 113.128 -179.051 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 221' ' ' ASP . 34.3 t -110.95 -61.24 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.054 -1.028 . . . . 1.02 109.332 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -89.91 9.28 28.28 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.238 1.018 . . . . 2.51 110.446 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 61.64 51.64 3.91 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.389 -0.823 . . . . 1.54 112.171 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -146.79 151.61 37.41 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.254 1.026 . . . . 1.95 109.789 179.025 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.56 139.09 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.54 -1.282 . . . . 0.71 107.54 177.412 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.76 130.48 49.73 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.06 -1.025 . . . . 1.01 108.292 178.553 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.05 129.57 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.205 -1.035 . . . . 0.82 108.205 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.434 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 10.9 t-20 52.24 51.29 9.42 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 113.365 0.876 . . . . 1.54 113.365 179.128 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.2 Cg_endo -63.48 149.42 91.11 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.367 2.044 . . . . 0.94 111.2 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.7 m -74.41 152.29 39.52 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.055 -1.028 . . . . 1.8 109.098 177.464 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.82 -36.51 76.93 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.162 -0.961 . . . . 2.73 110.302 178.73 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -59.45 -39.83 84.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.674 -0.641 . . . . 3.17 110.293 179.362 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 98.5 t -71.69 -42.93 70.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.887 -1.133 . . . . 1.34 109.867 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.5 mt . . . . . 0 C--N 1.302 -1.46 0 C-N-CA 119.419 -0.912 . . . . 1.2 110.356 -179.033 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.8 mt . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 107.568 -1.271 . . . . 1.07 107.568 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 m -106.59 115.22 29.82 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.346 -1.724 . . . . 1.24 106.346 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.8 -161.06 28.76 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.658 -1.377 . . . . 1.01 109.658 -179.496 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 5' ' ' ILE . 92.7 mt -95.75 1.0 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.415 -1.05 . . . . 1.11 112.69 -179.836 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tp 50.15 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.028 -1.045 . . . . 0.99 112.27 178.596 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -83.43 -47.97 10.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.071 -1.018 . . . . 0.85 111.274 179.15 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -143.53 146.14 34.36 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 107.83 -1.174 . . . . 1.38 107.83 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.13 147.24 29.64 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.099 1.866 . . . . 0.94 112.14 178.549 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.839 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.42 147.31 4.64 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 119.732 -1.223 . . . . 0.81 110.051 178.417 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.9 mt -112.2 130.94 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.797 -1.413 . . . . 0.83 108.352 179.261 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.18 149.65 46.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.88 -0.785 . . . . 0.53 108.88 178.837 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 7.5 m-85 -118.58 139.45 51.46 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 107.652 -1.24 . . . . 0.77 107.652 177.352 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.8 169.53 42.49 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 118.585 -1.769 . . . . 0.51 110.195 178.452 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -78.72 154.84 29.74 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.732 -0.864 . . . . 1.9 109.281 178.042 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -81.88 133.35 35.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.12 -0.988 . . . . 0.66 109.007 178.071 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.5 tp -116.33 99.73 7.4 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.009 -1.848 . . . . 0.83 106.009 178.123 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.521 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 11.7 tp -85.5 137.61 32.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.667 -1.234 . . . . 0.86 107.667 179.659 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.556 HD11 HD11 ' A' ' 158' ' ' LEU . 32.4 mt -102.74 118.31 36.56 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 106.784 -1.561 . . . . 0.92 106.784 178.863 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -111.75 136.74 50.61 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.966 -1.124 . . . . 2.03 107.966 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -126.36 151.28 47.82 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.179 -0.95 . . . . 2.66 109.706 179.009 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -82.44 135.99 35.03 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.622 -1.251 . . . . 2.32 107.622 177.329 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -64.21 149.72 47.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 2.11 109.159 178.792 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mt -88.19 130.1 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.914 -1.143 . . . . 0.73 107.914 177.826 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.2 t -108.57 129.13 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.794 -1.188 . . . . 0.87 107.794 178.711 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.41 136.58 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.157 -1.053 . . . . 0.81 108.157 179.233 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -90.54 120.68 31.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.734 -1.21 . . . . 1.34 107.734 178.8 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.3 mmm-85 -96.17 11.19 35.24 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.198 -0.939 . . . . 2.89 112.667 -179.695 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -64.02 146.07 54.78 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.789 -1.194 . . . . 2.09 109.258 178.683 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.37 139.43 30.5 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.889 -1.152 . . . . 2.19 107.889 177.708 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -100.75 164.39 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 122.014 0.911 . . . . 0.75 109.904 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.6 p -96.64 165.26 12.23 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.3 0.571 . . . . 0.91 109.668 178.369 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.07 -22.13 15.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.93 112.045 179.176 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -68.64 -37.08 79.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.97 -1.081 . . . . 2.28 110.8 -179.881 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -92.68 -5.79 50.62 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.052 -1.03 . . . . 1.45 112.907 -179.315 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.3 t -59.88 -41.45 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.128 -0.982 . . . . 0.81 110.615 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.4 -39.89 84.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.911 -1.118 . . . . 1.54 110.128 179.657 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -60.47 -38.25 83.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.612 -0.68 . . . . 2.36 110.744 179.903 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.62 -40.96 89.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.003 -1.061 . . . . 1.31 110.37 179.319 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.9 t -60.13 -43.6 93.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.158 -0.964 . . . . 0.82 110.322 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -60.55 -43.62 97.02 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.238 -0.914 . . . . 1.5 109.974 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -60.62 -42.92 97.84 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.224 -0.99 . . . . 2.23 109.914 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -73.22 -54.85 7.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.457 -0.777 . . . . 0.85 110.016 179.732 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.6 tp -57.74 -47.76 81.53 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.761 -0.776 . . . . 0.91 109.971 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.517 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.6 t -69.9 -41.17 75.07 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.447 -0.783 . . . . 0.9 109.905 179.764 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.66 -43.11 94.5 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.284 -1.526 . . . . 0.69 109.284 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.401 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.8 ttt-85 -59.97 -29.93 68.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.359 -1.083 . . . . 2.88 109.615 179.002 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.23 -49.93 75.97 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.723 -0.791 . . . . 0.85 111.078 179.309 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -82.62 -38.53 23.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.239 -0.913 . . . . 2.35 110.873 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.11 -44.54 91.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.905 -1.122 . . . . 0.65 109.766 -179.381 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.7 t -60.28 -38.18 82.79 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.212 1.006 . . . . 1.45 109.348 179.603 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.89 78.5 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.845 -0.616 . . . . 0.63 110.326 179.47 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -61.68 -49.76 75.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 1.34 110.365 179.87 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.97 -40.37 93.12 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.985 0.898 . . . . 1.56 109.656 179.777 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.11 -40.82 90.99 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.298 0.57 . . . . 1.19 110.183 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.598 HG22 ' HZ2' ' A' ' 60' ' ' LYS . 14.4 m -67.55 -41.42 84.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.72 110.471 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.4 mt -60.12 -38.35 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.481 -0.762 . . . . 0.62 110.712 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -50.92 -41.6 58.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.853 . . . . 1.05 110.475 179.362 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.71 -37.23 76.49 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.908 -1.12 . . . . 0.64 109.988 -179.672 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.598 ' HZ2' HG22 ' A' ' 56' ' ' THR . 57.8 mttp -62.28 -38.93 91.22 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.343 -0.943 . . . . 1.73 109.505 179.201 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.25 -30.08 68.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.68 -0.638 . . . . 0.56 110.344 179.207 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.95 -37.12 11.86 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.024 -1.084 . . . . 0.69 111.511 179.9 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -80.01 -28.18 39.44 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.071 -1.252 . . . . 1.48 110.895 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.4 m -84.57 -47.57 10.43 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.285 -0.884 . . . . 0.98 111.086 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -107.22 -10.84 15.73 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.547 0.943 . . . . 1.16 113.547 -177.285 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.17 157.99 16.55 Favored Glycine 0 N--CA 1.501 2.968 0 O-C-N 121.269 -0.894 . . . . 0.85 113.051 179.02 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -54.45 -21.66 10.49 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.736 -0.861 . . . . 3.86 112.58 179.491 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -55.93 -36.87 68.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.019 -1.051 . . . . 2.35 111.347 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -80.08 -22.26 42.43 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.1 -1.0 . . . . 1.67 112.446 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.1 -35.66 75.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.806 -1.184 . . . . 1.45 111.39 -179.744 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.26 93.6 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.946 -1.096 . . . . 0.61 111.724 179.767 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.4 mt -66.83 -44.56 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.59 -1.319 . . . . 0.65 110.245 -179.786 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -70.15 -32.87 71.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.074 -1.016 . . . . 0.66 110.207 -179.901 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.72 -36.61 79.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 1.19 110.11 -179.781 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.93 -41.05 83.79 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 120.396 -0.907 . . . . 0.53 110.964 179.401 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -58.68 -44.21 90.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.102 -1.234 . . . . 1.27 110.81 179.562 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.61 -40.09 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.052 -1.03 . . . . 0.54 110.329 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 34.2 ttp -60.21 -38.86 84.64 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.35 -0.844 . . . . 1.74 110.428 179.87 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -58.63 -48.81 79.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.19 -0.944 . . . . 0.55 109.919 179.111 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.01 -40.4 89.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.576 -0.702 . . . . 0.47 110.376 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -86.16 10.85 13.3 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.386 -0.821 . . . . 1.42 112.411 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.14 124.45 21.69 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.038 -1.039 . . . . 1.27 108.659 178.594 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.32 -19.64 65.57 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.746 0.784 . . . . 1.35 110.819 -179.162 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -76.39 -52.96 8.85 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.762 -0.775 . . . . 2.22 110.406 179.919 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -60.62 -41.26 94.46 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.256 -0.977 . . . . 0.62 110.495 -179.455 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -58.18 -48.62 79.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.939 -1.1 . . . . 1.29 110.58 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -62.28 -38.63 90.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.863 -1.148 . . . . 1.52 110.873 -179.913 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.38 -48.37 67.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.989 -1.07 . . . . 1.3 110.999 179.694 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.8 mt -56.21 -43.47 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.066 -1.021 . . . . 0.61 109.735 179.527 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.12 -44.03 99.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.317 0.579 . . . . 0.78 110.515 179.874 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.37 -43.71 98.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 0.82 110.772 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.32 -46.51 90.0 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.083 -1.011 . . . . 0.8 110.483 -179.787 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.65 -43.41 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.77 110.617 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -84.41 -33.68 23.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.729 -0.607 . . . . 2.12 111.549 -179.742 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 91' ' ' ALA . 55.7 t0 -79.76 -42.34 24.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.914 -1.116 . . . . 1.51 111.209 -178.4 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -102.65 5.73 39.24 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 1.98 112.921 -177.946 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.9 m170 52.86 48.99 21.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.987 . . . . 1.32 111.85 -179.495 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.27 158.27 17.62 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.418 -0.801 . . . . 1.38 109.451 178.459 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.4 p -70.96 159.07 35.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.679 -0.638 . . . . 0.67 109.414 177.808 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.2 -41.4 88.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 0.52 110.8 178.743 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.53 ' OD2' HD21 ' A' ' 142' ' ' LEU . 90.0 m-20 -68.27 -38.74 82.03 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.931 -1.106 . . . . 2.25 110.502 -179.82 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.91 -54.53 15.0 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.754 -0.778 . . . . 0.64 111.186 179.691 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.58 94.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.263 -0.898 . . . . 0.56 110.408 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.34 88.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.445 -0.785 . . . . 0.46 110.442 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -60.14 -39.8 87.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 1.32 111.081 -179.936 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.76 -48.0 82.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 1.3 110.69 179.628 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.32 -43.61 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.895 -1.128 . . . . 0.61 110.61 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mm -61.52 -32.38 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.649 -0.657 . . . . 0.65 110.102 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -58.77 -40.66 84.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.51 -0.744 . . . . 2.11 110.469 179.274 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.67 -28.3 27.07 Favored Glycine 0 N--CA 1.499 2.848 0 C-N-CA 119.495 -1.336 . . . . 0.83 113.482 179.724 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -63.68 -42.48 98.01 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.31 -1.7 . . . . 1.28 110.061 -179.841 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.24 -50.61 21.42 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.616 0.722 . . . . 0.89 110.468 -179.961 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.9 t -60.74 -37.53 82.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.314 -0.866 . . . . 1.87 110.627 -179.66 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.24 97.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 1.05 110.901 179.769 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 84.8 mt -66.12 -30.05 70.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.915 -1.116 . . . . 1.02 110.678 -179.748 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -65.71 -22.28 66.6 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.568 -0.707 . . . . 2.04 110.979 179.409 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -70.03 -21.49 63.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.518 -0.739 . . . . 1.73 110.963 179.563 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 123' ' ' LEU . 10.2 mt -82.48 145.66 29.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.786 . . . . 1.37 109.544 178.391 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -100.09 39.9 1.3 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.402 -0.811 . . . . 2.88 111.787 179.766 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -112.72 139.76 48.07 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.102 -0.999 . . . . 1.58 108.923 178.775 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 42.1 mp0 -59.57 -38.9 82.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.558 -0.714 . . . . 3.04 111.064 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -70.96 -55.58 8.05 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.671 -1.268 . . . . 0.9 110.592 179.723 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 118' ' ' LEU . 25.7 mt -59.8 -40.77 89.44 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.034 -1.041 . . . . 1.06 110.371 -179.685 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -64.24 -49.81 70.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.066 . . . . 2.18 109.511 179.599 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -60.37 -32.73 71.57 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.399 -0.921 . . . . 2.15 109.468 179.76 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.413 ' O ' HG23 ' A' ' 130' ' ' VAL . 56.5 ttt180 -63.83 -28.79 70.09 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.385 -0.926 . . . . 2.33 109.529 179.165 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -59.27 -47.31 85.84 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 119.784 -0.766 . . . . 0.82 109.335 178.453 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.55 88.57 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.486 -0.886 . . . . 0.85 110.143 179.718 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.04 -32.39 73.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.821 . . . . 1.39 110.694 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 126' ' ' ARG . 42.8 t -69.24 -39.53 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.56 110.161 179.684 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -55.33 -39.94 70.59 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.514 -1.275 . . . . 3.12 109.17 178.609 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -60.59 -36.1 77.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.746 -0.596 . . . . 1.28 110.433 179.604 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.3 mt -60.33 -39.62 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.328 -0.858 . . . . 0.49 110.389 179.856 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.01 72.31 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.426 -1.369 . . . . 0.46 110.675 178.828 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -59.03 -40.79 86.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.429 -1.042 . . . . 2.71 110.336 179.26 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.528 ' NH1' ' OG ' ' A' ' 166' ' ' SER . 24.7 mtp180 -60.99 -40.53 93.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 2.14 109.693 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.523 ' O ' HD13 ' A' ' 137' ' ' LEU . 0.2 OUTLIER -66.59 -45.52 78.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.714 -0.616 . . . . 1.05 110.279 179.953 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.3 mt -58.43 -41.99 86.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.227 -0.92 . . . . 0.52 110.637 179.671 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -61.03 -32.52 72.12 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.143 -0.973 . . . . 2.35 111.022 -179.854 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -75.37 -43.82 48.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.906 -1.121 . . . . 1.39 111.412 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.21 -35.8 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.68 110.905 -178.071 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.53 HD21 ' OD2' ' A' ' 101' ' ' ASP . 64.9 mt -85.47 -7.86 58.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.074 -1.016 . . . . 0.83 112.119 -179.829 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.27 22.07 78.53 Favored Glycine 0 N--CA 1.479 1.521 0 C-N-CA 119.095 -1.526 . . . . 0.91 113.053 -179.18 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.36 146.41 39.92 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.83 -0.806 . . . . 0.95 110.229 -179.621 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -67.74 148.26 51.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 2.43 108.955 178.913 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 63.2 mt -102.32 139.23 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.785 -1.191 . . . . 1.1 107.785 178.464 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 147' ' ' ILE . 3.8 mp -77.52 132.72 32.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.386 -0.821 . . . . 1.58 108.807 179.169 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -95.17 86.81 4.68 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.242 -1.392 . . . . 1.62 107.242 179.349 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -75.76 -21.73 57.16 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.87 -0.732 . . . . 0.8 111.33 -177.82 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.4 t -80.27 1.08 30.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.369 -0.832 . . . . 1.56 112.445 179.598 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.54 24.72 7.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.561 -0.712 . . . . 0.84 112.372 -179.08 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 15.1 mt -71.42 140.77 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.372 -0.83 . . . . 0.82 109.646 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -114.9 -18.95 11.16 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.582 0.706 . . . . 2.31 112.883 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -115.07 134.28 55.31 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.939 -1.134 . . . . 1.54 107.939 -179.948 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -73.36 126.22 29.65 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.271 -1.011 . . . . 1.38 108.271 178.503 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -148.12 177.08 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.69 109.284 -179.615 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.7 mt -85.74 141.91 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 0.53 108.651 178.111 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.556 HD11 HD11 ' A' ' 19' ' ' LEU . 24.2 tp -96.19 122.84 39.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.23 -0.919 . . . . 0.64 108.886 178.446 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.88 129.96 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.917 -1.142 . . . . 0.67 107.917 179.754 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.439 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.16 155.27 22.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.78 109.048 179.152 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -60.72 -40.59 92.9 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.42 -1.425 . . . . 1.0 109.358 177.992 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -171.04 151.13 3.19 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.739 -0.838 . . . . 2.42 108.739 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 85.2 mt -118.7 139.31 51.74 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.001 -1.111 . . . . 0.75 108.001 177.519 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.9 p -92.8 150.37 39.4 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.238 -0.914 . . . . 0.78 108.77 178.844 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -39.8 -41.65 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.34 2.027 . . . . 0.67 113.686 179.26 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.528 ' OG ' ' NH1' ' A' ' 136' ' ' ARG . 44.1 m -59.97 -48.26 82.43 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.062 -1.024 . . . . 0.7 110.119 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -65.23 -40.06 93.55 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.409 -0.807 . . . . 1.21 110.245 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 43.4 p -67.84 -38.53 83.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.435 -0.791 . . . . 0.6 110.3 179.97 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.61 80.59 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.182 -0.949 . . . . 0.62 110.529 179.624 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -95.05 -0.88 53.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.055 -1.028 . . . . 1.16 113.133 -179.326 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.1 tp -62.98 150.42 42.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.73 109.17 179.801 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -95.31 112.92 24.56 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.146 -1.428 . . . . 2.24 107.146 177.686 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.93 -15.54 61.12 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.139 0.495 . . . . 1.43 112.118 -178.106 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -83.72 -23.03 31.81 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.126 -0.984 . . . . 2.15 112.612 -178.834 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -104.08 3.02 32.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.138 -0.976 . . . . 2.04 112.877 -178.803 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 178' ' ' GLY . 59.1 t -108.78 127.9 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.711 -1.218 . . . . 0.55 107.711 179.556 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 16.1 tp -87.73 -5.47 58.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.504 -0.748 . . . . 1.63 111.895 -179.427 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.508 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.7 175.01 35.82 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.797 -1.721 . . . . 0.47 108.797 -179.367 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -130.58 137.39 49.64 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.814 -1.18 . . . . 0.54 107.814 179.823 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.451 HG22 HG21 ' A' ' 205' ' ' THR . 83.5 mt -137.48 110.86 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 106.688 -1.597 . . . . 0.69 106.688 178.519 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 203' ' ' VAL . 70.7 p -130.59 168.49 17.02 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.831 -1.168 . . . . 0.82 109.829 -179.668 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 25.8 p-10 -101.7 50.42 0.85 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.626 -0.671 . . . . 2.37 110.529 179.841 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.35 147.51 24.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.243 -0.911 . . . . 1.11 109.323 179.333 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.43 -16.03 19.46 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.804 -1.189 . . . . 1.67 112.36 179.204 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 80.7 -19.47 7.32 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 121.402 -1.058 . . . . 1.54 114.474 179.341 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -60.13 -39.88 87.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.161 -1.199 . . . . 4.48 110.569 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 31.1 p -139.84 34.87 1.97 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.587 -0.696 . . . . 2.63 111.195 -179.691 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.0 p -84.02 118.87 24.33 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.974 -1.121 . . . . 1.69 107.974 178.877 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -60.11 -30.6 69.37 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.584 -0.697 . . . . 1.07 110.274 -179.549 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 40.0 m -59.41 -40.9 88.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.497 -0.752 . . . . 1.58 110.392 179.225 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 83.3 p -59.97 -39.05 84.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.995 -1.066 . . . . 1.6 110.074 179.53 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 75.7 mt -59.94 -39.62 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.41 -0.916 . . . . 1.45 110.516 179.41 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 56.5 mtp -62.43 -42.25 99.32 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.293 1.044 . . . . 1.05 109.423 179.473 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.4 -46.28 86.72 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.646 -0.707 . . . . 0.72 110.776 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.429 HH11 ' HG2' ' A' ' 195' ' ' ARG . 46.8 mtt-85 -60.07 -43.78 95.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 3.05 110.518 -179.945 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 51.2 m -68.92 -39.14 79.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.492 -0.755 . . . . 0.89 110.316 -179.86 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.2 mt -90.86 -6.86 53.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.569 -0.707 . . . . 0.78 112.729 -179.148 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 194' ' ' ALA . 43.6 mt-10 53.2 9.8 0.16 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.918 1.081 . . . . 1.45 113.918 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 34.8 mt -71.27 150.79 94.39 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.043 -1.036 . . . . 0.67 108.462 178.997 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.7 141.32 95.5 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.269 1.313 . . . . 0.64 109.465 178.532 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.96 163.79 33.88 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.574 -1.651 . . . . 0.67 110.065 179.899 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.495 ' CD1' HD11 ' A' ' 220' ' ' LEU . 18.6 mt -148.69 152.36 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.919 -1.141 . . . . 0.69 107.919 178.321 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.3 m -135.1 -28.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 O-C-N 120.758 -1.214 . . . . 0.85 111.657 179.568 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.46 40.12 2.56 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.161 -0.962 . . . . 0.92 112.219 -178.993 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.451 HG21 HG22 ' A' ' 180' ' ' ILE . 51.5 p -60.96 -18.73 58.82 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.988 -1.301 . . . . 0.95 111.42 -179.261 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 77.15 -93.41 1.08 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.971 -1.109 . . . . 1.04 110.501 179.539 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 47.8 p -128.8 27.3 5.48 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.472 -1.017 . . . . 1.57 112.597 -178.767 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 83.8 t -59.23 -33.99 52.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.686 -1.259 . . . . 0.84 110.872 179.191 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 44.2 p -59.71 -23.08 62.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.095 -1.003 . . . . 0.99 111.729 -179.813 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 37.6 t -93.27 1.01 57.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 1.7 112.113 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -126.29 0.46 7.05 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.847 0.684 . . . . 2.2 112.847 -178.281 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 32.0 t -116.11 145.55 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.587 -0.696 . . . . 0.84 109.34 179.772 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -119.92 161.33 21.05 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.486 -0.931 . . . . 2.2 108.486 177.938 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 18' ' ' LEU . 73.6 m-80 -59.57 142.27 53.1 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 120.749 -1.219 . . . . 2.28 110.639 179.159 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.6 t70 80.61 1.04 1.87 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.496 1.295 . . . . 2.35 114.496 179.438 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -63.66 148.57 48.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.622 -1.298 . . . . 1.97 108.549 177.706 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -91.69 118.11 30.35 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 106.477 -1.675 . . . . 2.65 106.477 177.698 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.422 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 82.3 mt -126.84 144.64 50.91 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.663 0.744 . . . . 0.63 109.867 -178.536 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.3 mt -114.15 127.37 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.711 -1.588 . . . . 0.62 106.711 177.567 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.495 HD11 ' CD1' ' A' ' 202' ' ' ILE . 59.9 tp -99.58 115.31 29.09 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 105.82 -1.918 . . . . 0.64 105.82 178.272 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 223' ' ' VAL . 28.7 t0 -89.13 -26.95 21.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.024 -1.047 . . . . 2.05 111.701 -178.197 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.28 20.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.598 -0.689 . . . . 0.84 112.666 -179.28 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 221' ' ' ASP . 17.3 t -112.33 -59.77 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 122.065 0.936 . . . . 1.02 109.522 179.573 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -99.58 14.39 30.16 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.933 0.873 . . . . 2.51 110.87 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 45.6 t30 61.22 50.99 4.52 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 116.031 -0.531 . . . . 1.54 112.195 179.163 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -147.06 147.91 31.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.049 -1.032 . . . . 1.95 109.605 178.431 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.05 139.12 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 107.821 -1.177 . . . . 0.71 107.821 178.114 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -99.74 133.29 44.31 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.966 -1.084 . . . . 1.01 108.419 178.394 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.0 t -110.57 130.87 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.589 -0.694 . . . . 0.82 109.381 179.23 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.426 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 58.7 t30 52.23 51.52 9.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 113.596 0.962 . . . . 1.54 113.596 178.117 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 55.9 Cg_endo -69.88 152.51 68.73 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.729 2.286 . . . . 0.94 110.59 179.879 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 232' ' ' THR . 1.3 p -73.64 161.76 29.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.669 -1.269 . . . . 1.8 109.914 178.216 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -59.87 -38.39 82.06 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.192 -0.942 . . . . 2.73 110.216 178.737 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.83 -41.37 91.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.59 -0.694 . . . . 3.17 109.913 179.179 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 86.1 t -70.55 -43.11 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.448 -0.783 . . . . 1.34 110.492 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.6 mt . . . . . 0 N--CA 1.488 1.438 0 C-N-CA 118.803 -1.159 . . . . 1.2 109.829 -178.709 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 106.36 -1.718 . . . . 1.07 106.36 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.7 m -102.5 120.57 40.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.364 -0.976 . . . . 1.24 108.364 -179.717 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.31 -142.82 11.45 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.791 -1.724 . . . . 1.01 108.791 179.498 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 5' ' ' ILE . 81.5 mt -100.53 -1.0 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.984 -1.304 . . . . 1.11 113.399 -178.893 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 tp 49.35 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.659 -1.276 . . . . 0.99 112.312 178.556 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.54 -39.87 16.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.259 -0.9 . . . . 0.85 111.029 179.307 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.06 145.68 19.96 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.105 -1.072 . . . . 1.38 108.105 -179.126 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.95 148.14 31.35 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.849 2.366 . . . . 0.94 112.436 178.585 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.871 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.73 152.13 5.96 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 109.817 -1.313 . . . . 0.81 109.817 178.088 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.4 mt -118.04 130.17 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.199 -1.177 . . . . 0.83 108.072 179.183 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.53 143.89 43.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.315 -0.865 . . . . 0.53 109.024 179.006 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.07 138.27 46.68 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.596 -1.261 . . . . 0.77 107.596 177.346 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.0 169.73 42.45 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 117.708 -2.187 . . . . 0.51 110.4 178.154 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -79.56 159.68 26.76 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.776 -0.824 . . . . 1.9 108.776 177.922 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.449 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.6 130.31 34.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.094 -1.004 . . . . 0.66 109.11 178.152 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.8 tp -109.46 107.51 17.68 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 104.917 -2.253 . . . . 0.83 104.917 176.967 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 tp -94.2 132.79 38.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.105 -0.997 . . . . 0.86 108.977 -179.833 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.3 mt -100.93 122.22 43.1 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.417 -1.327 . . . . 0.92 107.417 178.437 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -108.81 131.31 55.1 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.25 -1.018 . . . . 2.03 108.25 179.521 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.485 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 83.5 tt0 -111.34 140.38 45.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.554 -0.716 . . . . 2.66 109.471 179.073 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -83.87 129.32 34.93 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.412 -1.329 . . . . 2.32 107.412 177.893 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -65.9 143.62 57.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.85 . . . . 2.11 109.153 179.342 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.0 mt -96.55 135.47 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.506 -0.924 . . . . 0.73 108.506 178.587 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.49 130.19 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.376 -0.972 . . . . 0.87 108.376 178.949 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.2 mt -97.57 141.24 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.644 -0.873 . . . . 0.81 108.644 179.325 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -89.77 120.67 31.23 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.755 -1.202 . . . . 1.34 107.755 178.083 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.523 HH11 ' HG2' ' A' ' 28' ' ' ARG . 2.1 mmt-85 -95.19 12.49 28.65 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.256 -0.902 . . . . 2.89 112.605 179.635 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -66.98 146.64 54.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.878 -1.139 . . . . 2.09 109.533 178.879 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -90.18 135.37 33.71 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.964 -1.125 . . . . 2.19 107.964 178.032 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.0 pt -100.43 164.76 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.285 -0.884 . . . . 0.75 110.321 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.5 p -94.86 164.89 12.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.475 -0.565 . . . . 0.91 109.475 178.4 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.85 -20.23 14.7 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.116 -0.99 . . . . 0.93 112.088 179.35 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -68.9 -39.14 79.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.038 -1.039 . . . . 2.28 110.986 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -87.22 -9.24 55.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.62 -1.3 . . . . 1.45 112.423 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.23 -43.2 89.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.186 -0.947 . . . . 0.81 110.557 -179.394 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -56.65 -40.66 75.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.853 -1.154 . . . . 1.54 110.607 179.548 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -65.04 -46.76 79.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.195 -0.94 . . . . 2.36 110.957 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.29 -36.19 79.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.954 -1.092 . . . . 1.31 111.17 -179.772 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.84 -40.81 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.933 -1.104 . . . . 0.82 110.541 179.287 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -61.12 -41.06 96.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.006 -1.059 . . . . 1.5 109.981 179.673 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.418 HH11 ' HG2' ' A' ' 42' ' ' ARG . 46.8 mtt-85 -61.15 -39.32 89.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.844 . . . . 2.23 110.695 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -72.82 -57.04 4.37 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.38 -0.825 . . . . 0.85 110.76 179.517 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.8 tp -59.89 -47.53 85.38 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.314 -0.954 . . . . 0.91 110.088 -179.724 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.554 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.3 t -67.88 -36.17 79.78 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.75 0.786 . . . . 0.9 109.88 179.855 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.19 -43.15 99.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.864 -1.294 . . . . 0.69 109.864 178.856 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -59.54 -30.55 68.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.02 0.915 . . . . 2.88 109.344 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.72 -43.11 90.06 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.814 0.816 . . . . 0.85 109.511 179.056 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -80.34 -45.88 17.05 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.434 -0.791 . . . . 2.35 110.837 179.374 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.64 -41.57 81.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.585 -0.697 . . . . 0.65 110.022 179.997 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.3 p -61.88 -37.16 83.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.119 0.961 . . . . 1.45 109.17 179.765 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.4 -50.2 48.16 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.753 -0.658 . . . . 0.63 110.531 179.454 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -63.53 -48.43 77.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.447 -0.783 . . . . 1.34 110.578 -179.865 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.7 mt -61.2 -38.21 85.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 1.56 110.01 179.977 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -59.78 -39.98 86.72 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.666 -0.646 . . . . 1.19 110.713 179.113 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -65.1 -44.16 89.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.781 -1.2 . . . . 0.72 110.243 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.1 -31.97 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.754 . . . . 0.62 110.186 179.791 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -52.07 -47.08 65.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.604 -0.685 . . . . 1.05 110.61 179.075 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -68.77 -33.78 74.46 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.744 -1.222 . . . . 0.64 109.843 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -62.15 -39.45 92.67 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.531 -1.267 . . . . 1.73 109.363 179.173 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.84 88.9 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.348 -0.845 . . . . 0.56 109.988 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.93 -37.95 42.59 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.573 -1.298 . . . . 0.69 110.476 179.474 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -81.57 -22.46 37.78 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.087 -1.243 . . . . 1.48 111.131 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.8 m -84.74 -46.05 11.8 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.548 -0.72 . . . . 0.98 110.907 179.941 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -106.5 -23.68 12.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.441 -0.787 . . . . 1.16 112.229 -178.981 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.21 168.97 15.28 Favored Glycine 0 N--CA 1.499 2.889 0 CA-C-O 121.785 0.659 . . . . 0.85 111.665 -179.534 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -55.68 -28.2 54.26 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.415 -1.05 . . . . 3.86 112.717 -179.652 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -57.65 -39.91 78.09 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.911 -1.118 . . . . 2.35 111.356 -179.718 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -88.59 -14.53 37.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.618 -1.301 . . . . 1.67 112.385 -178.967 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -60.07 -38.72 83.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.872 . . . . 1.45 110.948 -179.25 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.38 82.97 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.167 -0.958 . . . . 0.61 111.245 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.3 mt -63.14 -43.5 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.572 -1.33 . . . . 0.65 110.475 179.696 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -68.97 -33.28 73.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.968 -1.083 . . . . 0.66 110.001 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.02 -38.84 83.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 1.19 110.114 179.365 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.82 -38.14 94.06 Favored Glycine 0 N--CA 1.486 1.985 0 C-N-CA 120.137 -1.03 . . . . 0.53 110.585 179.552 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -57.16 -42.33 80.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.841 -1.388 . . . . 1.27 110.284 179.368 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.2 mt -60.34 -41.59 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.08 -1.012 . . . . 0.54 109.556 179.641 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.1 ttm -60.19 -39.82 87.88 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 1.74 109.803 179.562 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -58.28 -50.0 75.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.413 -0.804 . . . . 0.55 110.45 178.996 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.67 -40.34 91.75 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.331 -0.856 . . . . 0.47 110.402 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -87.72 5.62 38.97 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.87 0.693 . . . . 1.42 112.87 -179.62 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.31 122.82 15.47 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.911 -1.118 . . . . 1.27 109.581 179.3 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -66.16 -16.29 63.85 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.686 0.755 . . . . 1.35 110.749 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -77.06 -49.17 15.92 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.496 -0.882 . . . . 2.22 110.523 179.94 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.21 -38.29 90.58 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.386 -0.925 . . . . 0.62 110.24 -178.305 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.88 -47.88 83.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.023 -1.048 . . . . 1.29 111.282 179.314 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -60.7 -39.26 87.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.883 -1.136 . . . . 1.52 110.663 -179.721 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.7 -48.48 71.85 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.575 -0.85 . . . . 1.3 110.638 179.692 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.96 -41.6 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.222 -0.991 . . . . 0.61 109.914 179.494 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.81 -42.81 95.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.352 -0.842 . . . . 0.78 110.297 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.88 98.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.82 110.67 -179.965 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.02 -43.06 95.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.8 110.442 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.51 -49.08 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.988 -1.07 . . . . 0.77 110.159 179.817 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -76.66 -35.47 57.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 2.12 111.824 -179.524 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -80.77 -48.25 12.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.887 -1.133 . . . . 1.51 111.98 -179.643 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -101.41 8.69 42.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.227 -0.921 . . . . 1.98 112.994 -178.658 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.5 m80 51.56 49.36 21.06 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.024 -1.071 . . . . 1.32 111.426 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.9 mtt -104.86 149.43 25.69 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.435 1.112 . . . . 1.38 109.052 179.834 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.5 p -72.62 159.63 33.56 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.59 0.709 . . . . 0.67 109.433 177.81 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.33 81.79 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.51 -0.744 . . . . 0.52 110.646 178.627 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.4 p-10 -68.54 -42.31 78.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.977 -1.077 . . . . 2.25 110.268 -179.792 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -70.74 -51.46 27.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.332 -0.855 . . . . 0.64 111.386 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.99 84.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.499 -0.751 . . . . 0.56 110.528 -179.616 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.6 96.53 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.82 -0.752 . . . . 0.46 111.127 179.658 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -60.42 -39.37 87.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.829 -1.169 . . . . 1.32 110.782 179.942 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -54.83 -49.75 70.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.129 -0.982 . . . . 1.3 110.761 179.701 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.1 -42.28 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.718 -1.239 . . . . 0.61 109.853 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.5 mm -61.76 -32.02 52.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.541 -0.724 . . . . 0.65 110.356 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.14 -41.75 89.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 2.11 110.388 179.083 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.09 -31.68 19.47 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.063 -1.542 . . . . 0.83 112.279 -179.896 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -62.16 -41.88 98.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.414 -1.639 . . . . 1.28 109.635 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.59 -51.26 20.48 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.982 0.896 . . . . 0.89 109.713 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.6 t -60.19 -39.93 88.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.358 -0.839 . . . . 1.87 110.176 -179.802 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.32 98.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.176 -0.952 . . . . 1.05 110.454 -179.808 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 88.1 mt -64.84 -30.61 71.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.966 -1.084 . . . . 1.02 110.224 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -66.53 -22.2 66.16 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.342 -0.849 . . . . 2.04 110.877 179.712 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.39 -20.45 64.68 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.415 -0.914 . . . . 1.73 110.625 179.511 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.594 HD13 HD13 ' A' ' 123' ' ' LEU . 38.8 mt -83.15 142.41 31.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.441 -0.787 . . . . 1.37 109.321 178.362 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -101.4 40.01 1.35 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.398 -0.814 . . . . 2.88 111.078 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -112.75 133.48 54.74 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.609 -0.886 . . . . 1.58 108.609 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 5.7 pm0 -60.5 -28.09 68.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.095 -1.003 . . . . 3.04 111.553 179.552 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -74.25 -59.54 2.68 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.072 -1.017 . . . . 0.9 110.027 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.594 HD13 HD13 ' A' ' 118' ' ' LEU . 65.0 mt -66.26 -35.73 81.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 1.06 110.642 -179.554 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -61.81 -48.51 80.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.803 -1.185 . . . . 2.18 110.396 179.466 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -59.74 -30.24 68.71 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.589 -1.244 . . . . 2.15 109.649 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 130' ' ' VAL . 58.6 ttt180 -62.27 -29.19 70.24 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.22 -0.992 . . . . 2.33 109.17 179.306 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -60.17 -49.75 76.39 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.868 0.842 . . . . 0.82 109.805 178.361 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.23 75.92 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.676 -0.809 . . . . 0.85 110.234 179.854 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -61.22 -34.08 74.53 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.635 0.731 . . . . 1.39 110.648 -179.884 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.6 t -68.95 -37.28 77.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.324 -0.86 . . . . 0.56 110.033 179.706 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 131' ' ' ARG . 22.9 ttt-85 -57.93 -38.31 75.69 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.471 -1.292 . . . . 3.12 109.429 178.656 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.498 ' OD1' ' NE ' ' A' ' 136' ' ' ARG . 8.3 t70 -60.11 -40.06 88.35 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.396 0.617 . . . . 1.28 110.568 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 73.1 mt -61.41 -34.68 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.378 -0.826 . . . . 0.49 110.18 -179.611 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -64.91 -51.4 51.66 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.131 -1.033 . . . . 0.46 110.657 178.783 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -57.9 -40.37 80.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.87 -1.371 . . . . 2.71 110.467 179.547 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.498 ' NE ' ' OD1' ' A' ' 132' ' ' ASP . 58.5 mtt-85 -60.5 -43.24 97.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.998 -1.064 . . . . 2.14 110.131 -179.979 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.5 tp -61.26 -44.57 97.03 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.087 -1.008 . . . . 1.05 110.224 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.09 -42.4 90.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.553 -0.717 . . . . 0.52 110.547 179.666 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.485 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 98.1 mtt180 -61.38 -34.42 75.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.159 -0.963 . . . . 2.35 111.206 -179.851 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -74.06 -43.4 57.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.557 -1.339 . . . . 1.39 110.618 179.827 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.4 mt -60.9 -39.38 81.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.52 -0.737 . . . . 0.68 110.455 -178.521 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.4 mt -88.84 -11.65 44.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.532 -0.73 . . . . 0.83 111.996 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.4 22.83 69.44 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 120.323 -0.941 . . . . 0.91 113.581 -179.542 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.39 142.9 58.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.58 -0.953 . . . . 0.95 109.534 179.647 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -68.05 151.94 46.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.894 . . . . 2.43 110.307 178.377 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.7 mt -104.58 136.89 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.033 -1.099 . . . . 1.1 108.033 178.21 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.73 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -81.86 129.62 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.979 -1.119 . . . . 1.58 107.979 179.125 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -95.85 98.68 10.61 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.067 -1.827 . . . . 1.62 106.067 178.873 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.7 mt -77.37 -14.28 59.75 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.529 -0.732 . . . . 0.8 111.775 -177.745 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.6 t -80.1 8.32 7.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.379 -0.826 . . . . 1.56 112.323 -179.574 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.34 17.22 17.91 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.647 0.737 . . . . 0.84 112.315 179.565 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.4 mt -73.22 136.2 25.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.942 -0.762 . . . . 0.82 108.942 179.0 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -124.29 -7.25 7.62 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.547 -0.721 . . . . 2.31 112.651 -178.832 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -110.63 137.5 48.23 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.06 -1.089 . . . . 1.54 108.06 179.794 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -77.25 119.82 21.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.247 -0.908 . . . . 1.38 108.695 178.851 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.2 m -148.12 179.49 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.835 -0.802 . . . . 0.69 108.835 -178.965 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 30.6 mt -88.33 142.86 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.991 -1.068 . . . . 0.53 108.943 178.212 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.0 tp -98.02 120.5 38.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.816 -1.178 . . . . 0.64 108.141 178.251 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.24 130.15 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.418 -0.956 . . . . 0.67 108.418 179.397 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.36 159.14 27.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.243 -0.911 . . . . 0.78 108.752 179.534 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.03 95.6 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.494 -1.378 . . . . 1.0 109.778 177.855 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -172.67 152.65 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.906 -0.775 . . . . 2.42 108.906 -179.744 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 64.9 mt -118.99 141.33 48.77 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.315 -0.866 . . . . 0.75 109.09 177.383 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 168' ' ' THR . 68.9 p -90.55 148.82 39.59 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.182 -0.949 . . . . 0.78 108.919 179.21 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -40.15 -45.52 4.06 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.645 2.23 . . . . 0.67 113.891 179.142 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.0 m -60.09 -46.3 90.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.918 -1.114 . . . . 0.7 110.063 -179.607 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.41 -38.49 91.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.27 -0.894 . . . . 1.21 110.331 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 164' ' ' THR . 23.8 p -67.61 -40.75 84.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 0.6 110.83 179.662 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.3 74.41 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.791 -0.764 . . . . 0.62 110.339 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -93.38 -4.85 50.72 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.007 -1.058 . . . . 1.16 112.862 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.23 153.45 34.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.73 109.631 179.878 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -94.13 117.33 29.96 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.292 -1.744 . . . . 2.24 106.292 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.785 HD22 ' H ' ' A' ' 173' ' ' LEU . 0.7 OUTLIER -82.46 -19.47 38.81 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.472 -0.767 . . . . 1.43 112.396 -177.701 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -84.23 -20.87 31.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.238 -0.913 . . . . 2.15 111.912 -178.569 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -99.96 2.32 43.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.187 -0.946 . . . . 2.04 112.528 -179.254 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.472 HG12 ' H ' ' A' ' 178' ' ' GLY . 61.4 t -112.99 129.95 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 107.873 -1.158 . . . . 0.55 107.873 179.352 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.584 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -82.81 -16.35 48.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.007 -1.058 . . . . 1.63 111.705 -179.541 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.472 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -176.69 171.33 44.27 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.073 -1.611 . . . . 0.47 109.073 179.909 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -125.79 124.56 41.26 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 107.344 -1.354 . . . . 0.54 107.344 178.196 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 180' ' ' ILE . 46.6 mt -123.27 129.75 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 106.952 -1.499 . . . . 0.69 106.952 178.215 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 203' ' ' VAL . 34.2 p -140.61 170.0 16.6 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.907 -1.12 . . . . 0.82 109.802 179.772 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.94 36.08 3.0 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.871 -0.518 . . . . 2.37 111.007 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -96.87 151.53 19.58 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.191 -0.943 . . . . 1.11 110.352 178.75 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -46.33 -28.36 3.23 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 120.162 -1.018 . . . . 1.67 112.609 177.696 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 87.69 -33.12 4.03 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 121.037 -1.272 . . . . 1.54 113.625 179.406 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -60.44 -40.65 91.86 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.007 -1.29 . . . . 4.48 110.346 179.709 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.4 p -118.38 20.18 13.16 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.52 -0.737 . . . . 2.63 111.208 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.3 p -89.11 120.46 30.53 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.772 -1.196 . . . . 1.69 107.772 178.771 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -60.46 -32.27 71.23 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.388 -0.82 . . . . 1.07 110.407 179.827 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 63.0 p -54.68 -41.11 69.82 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.037 -1.039 . . . . 1.58 110.68 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.3 t -60.02 -39.83 87.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.298 -0.876 . . . . 1.6 109.918 179.818 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.1 mm -59.72 -36.36 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.74 . . . . 1.45 110.392 179.119 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 82.5 mtp -63.0 -43.53 98.54 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.225 1.012 . . . . 1.05 109.209 179.509 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -57.38 -45.09 84.83 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.691 -0.631 . . . . 0.72 110.656 179.538 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -63.23 -44.95 93.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.95 -1.093 . . . . 3.05 110.435 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.2 m -70.3 -40.88 74.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.913 . . . . 0.89 110.257 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.8 mt -91.21 -6.36 53.5 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.494 0.664 . . . . 0.78 112.242 -177.145 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 194' ' ' ALA . 98.0 mt-10 50.54 9.42 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.991 1.108 . . . . 1.45 113.991 179.899 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 80.9 mt -71.63 147.67 92.31 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.675 -1.266 . . . . 0.67 108.212 179.113 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.52 138.76 81.37 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.454 1.436 . . . . 0.64 110.227 178.66 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.54 166.67 20.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.312 -1.755 . . . . 0.67 109.865 179.694 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.4 mt -146.25 156.03 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.188 -1.412 . . . . 0.69 107.188 177.541 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.0 m -140.38 -32.37 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 120.742 -1.224 . . . . 0.85 113.035 -179.166 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -95.28 39.87 2.78 Favored Glycine 0 N--CA 1.497 2.744 0 O-C-N 120.942 -1.099 . . . . 0.92 112.076 -177.943 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.505 ' OG1' HG23 ' A' ' 208' ' ' VAL . 23.1 p -59.21 -23.75 62.55 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.089 -1.242 . . . . 0.95 111.799 -179.482 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 101.78 -86.16 0.58 Allowed Glycine 0 N--CA 1.496 2.654 0 C-N-CA 120.396 -0.907 . . . . 1.04 111.345 179.807 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.7 m -132.58 36.56 3.55 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 121.124 -1.221 . . . . 1.57 113.16 -178.529 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.505 HG23 ' OG1' ' A' ' 205' ' ' THR . 93.1 t -53.06 -33.83 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.336 -1.477 . . . . 0.84 110.396 179.252 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.2 p -61.31 -20.62 63.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.99 112.018 -179.675 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.2 m -96.08 2.72 53.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.057 -1.027 . . . . 1.7 112.289 179.63 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -132.05 2.97 4.01 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 112.907 0.706 . . . . 2.2 112.907 -178.281 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 36.0 t -122.54 142.43 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.439 -0.788 . . . . 0.84 109.658 -178.902 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -119.27 149.15 42.25 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.261 -1.014 . . . . 2.2 108.261 177.596 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.464 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 40.3 p-10 -50.73 140.16 15.21 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.876 -1.14 . . . . 2.28 110.023 178.688 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t0 79.62 -2.07 2.13 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.482 1.29 . . . . 2.35 114.482 179.639 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.09 147.0 53.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.532 -1.355 . . . . 1.97 108.233 177.632 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -88.67 120.84 30.43 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.184 -1.413 . . . . 2.65 107.184 178.274 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.449 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 56.6 mt -128.14 146.41 50.72 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.55 -0.719 . . . . 0.63 109.854 -179.56 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.5 mt -114.07 125.02 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 106.788 -1.56 . . . . 0.62 106.788 177.522 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.0 tp -99.86 115.26 29.2 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.315 -1.735 . . . . 0.64 106.315 178.528 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 223' ' ' VAL . 30.0 p-10 -92.72 -25.53 18.17 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.663 -1.215 . . . . 2.05 112.664 -177.848 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.871 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.47 21.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 112.903 0.705 . . . . 0.84 112.903 -178.659 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.3 t -112.79 -59.67 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 121.116 -0.99 . . . . 1.02 109.451 -179.876 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 36.7 m120 -95.79 13.5 26.39 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.148 0.975 . . . . 2.51 110.096 -179.701 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 61.4 t30 60.76 51.82 4.66 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.23 -0.895 . . . . 1.54 111.85 179.326 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.451 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 81.2 mt-30 -149.54 148.17 29.05 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.246 1.022 . . . . 1.95 110.079 178.454 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.54 138.07 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.312 -1.366 . . . . 0.71 107.312 177.887 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -99.58 136.92 38.79 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.933 -1.104 . . . . 1.01 108.516 178.694 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.7 t -109.82 130.18 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 109.001 -0.741 . . . . 0.82 109.001 179.135 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 49.42 55.6 17.31 Favored Pre-proline 0 N--CA 1.498 1.973 0 N-CA-C 113.566 0.95 . . . . 1.54 113.566 178.792 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.08 150.66 82.39 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.474 2.116 . . . . 0.94 110.412 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.504 ' OG1' HG23 ' A' ' 235' ' ' VAL . 31.1 p -72.08 154.55 41.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 1.8 108.915 177.647 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -57.39 -40.14 77.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.058 -1.026 . . . . 2.73 110.8 178.952 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -60.96 -39.04 88.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -0.984 . . . . 3.17 110.332 -179.852 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.504 HG23 ' OG1' ' A' ' 232' ' ' THR . 74.6 t -69.38 -36.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.331 -0.856 . . . . 1.34 110.038 179.413 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 1.2 110.462 178.977 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 106.018 -1.845 . . . . 1.07 106.018 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.3 m -105.85 124.06 48.96 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.661 -1.236 . . . . 1.24 107.661 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.51 -144.44 13.14 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 108.88 -1.688 . . . . 1.01 108.88 179.527 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 5' ' ' ILE . 73.1 mt -97.28 -3.77 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.146 -1.208 . . . . 1.11 112.635 -179.085 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.453 ' H ' HG23 ' A' ' 202' ' ' ILE . 3.8 tp 49.77 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.226 -0.921 . . . . 0.99 112.437 178.947 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -85.58 -40.07 16.67 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.0 . . . . 0.85 112.152 178.967 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 m -147.02 144.9 20.55 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 120.982 -1.074 . . . . 1.38 108.379 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.53 143.95 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.724 2.283 . . . . 0.94 112.127 178.246 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.883 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.08 171.41 21.73 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.319 -1.512 . . . . 0.81 109.319 178.189 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.8 mt -129.92 133.8 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 N-CA-C 107.702 -1.222 . . . . 0.83 107.702 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.38 155.52 47.6 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.564 -0.71 . . . . 0.53 109.119 178.742 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.9 m-85 -126.46 140.18 52.67 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.681 -1.229 . . . . 0.77 107.681 177.97 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.83 170.5 41.78 Favored Glycine 0 N--CA 1.499 2.882 0 C-N-CA 118.382 -1.866 . . . . 0.51 110.297 178.175 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -77.12 154.26 33.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.965 . . . . 1.9 108.938 178.502 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.558 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.03 125.79 33.02 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.233 -1.025 . . . . 0.66 108.233 178.373 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.3 tp -105.49 105.92 16.19 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.458 -2.053 . . . . 0.83 105.458 177.659 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.6 tp -94.18 135.39 35.61 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.957 -1.127 . . . . 0.86 107.957 179.96 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.4 mt -99.36 114.94 28.11 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.832 -1.544 . . . . 0.92 106.832 178.353 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -110.38 124.41 51.65 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.626 -1.62 . . . . 2.03 106.626 -179.88 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -129.77 147.52 51.55 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.418 -0.801 . . . . 2.66 109.39 -179.493 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 27.6 p-10 -81.55 140.9 34.24 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.912 -1.118 . . . . 2.32 109.088 177.807 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -64.69 149.94 48.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.04 -1.038 . . . . 2.11 110.976 178.283 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.9 mt -90.8 133.8 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.15 -0.969 . . . . 0.73 108.811 178.15 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.3 t -109.29 129.79 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.225 -1.028 . . . . 0.87 108.225 179.119 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.0 mt -94.66 137.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.127 -1.064 . . . . 0.81 108.127 178.778 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.95 122.44 35.32 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.977 -1.12 . . . . 1.34 107.977 178.938 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -99.56 18.12 18.72 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.342 -0.849 . . . . 2.89 112.631 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -69.18 146.79 52.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 2.09 109.428 178.738 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -88.98 130.88 35.38 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.329 -0.989 . . . . 2.19 108.329 177.669 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.7 pt -93.33 164.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.751 0.786 . . . . 0.75 110.066 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.2 p -95.41 163.85 13.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.587 -0.695 . . . . 0.91 109.659 178.525 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.8 -22.3 13.9 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.113 -0.992 . . . . 0.93 111.91 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -68.69 -37.06 79.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.932 . . . . 2.28 110.54 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -92.29 -6.31 50.6 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.791 -1.193 . . . . 1.45 113.174 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.31 -42.98 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.055 -1.028 . . . . 0.81 110.576 -179.433 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.36 -37.55 75.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.137 -0.977 . . . . 1.54 110.263 179.726 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -61.93 -43.92 97.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.646 -0.659 . . . . 2.36 110.847 179.906 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.47 -39.12 86.49 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.045 -1.035 . . . . 1.31 111.367 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.26 -40.19 83.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.045 -1.035 . . . . 0.82 110.757 179.429 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -60.95 -48.32 82.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.155 -0.965 . . . . 1.5 110.064 179.663 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -62.17 -38.31 88.55 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.167 -0.958 . . . . 2.23 110.278 179.842 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -74.16 -51.03 16.81 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.858 -1.151 . . . . 0.85 110.285 179.437 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.4 tp -62.81 -49.67 74.0 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.29 -0.964 . . . . 0.91 109.448 -179.622 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.7 t -69.3 -38.77 78.46 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.505 0.669 . . . . 0.9 109.653 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.09 -43.54 93.29 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.601 -1.4 . . . . 0.69 109.601 179.629 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -59.31 -31.74 69.43 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.07 -1.052 . . . . 2.88 109.644 178.871 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -53.78 -47.67 70.53 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.835 -0.746 . . . . 0.85 109.919 179.089 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -77.78 -39.77 42.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 2.35 110.344 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.76 91.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.65 110.049 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.5 p -60.47 -39.6 88.18 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.223 1.011 . . . . 1.45 109.357 179.942 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.12 -46.02 72.06 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.602 -0.727 . . . . 0.63 110.942 179.494 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.5 -50.09 72.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.222 -0.924 . . . . 1.34 110.753 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.21 -36.83 84.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 1.56 109.844 -179.889 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -59.39 -40.24 85.95 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.639 -0.663 . . . . 1.19 110.53 179.155 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.9 m -66.89 -41.69 86.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.047 -1.033 . . . . 0.72 110.324 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.3 -34.03 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.439 -0.788 . . . . 0.62 110.834 -179.703 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -55.93 -45.02 78.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.412 -0.805 . . . . 1.05 111.018 179.301 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.49 -33.44 71.23 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.003 -1.061 . . . . 0.64 110.545 -179.626 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -62.75 -40.27 96.7 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.653 -1.219 . . . . 1.73 109.443 -179.844 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.72 -34.52 78.03 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.776 -0.577 . . . . 0.56 110.363 179.679 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.88 -37.52 25.7 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.536 -1.316 . . . . 0.69 111.41 179.701 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -79.88 -22.31 43.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.036 -1.273 . . . . 1.48 110.815 -179.676 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -89.43 -50.96 5.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.363 -0.836 . . . . 0.98 110.597 179.853 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -108.34 -6.99 16.0 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.143 1.164 . . . . 1.16 114.143 -177.543 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.6 157.48 23.58 Favored Glycine 0 N--CA 1.502 3.072 0 O-C-N 121.056 -1.028 . . . . 0.85 113.473 178.519 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -51.03 -20.69 1.48 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.498 -1.001 . . . . 3.86 112.791 179.197 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.49 -35.31 72.03 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.822 -1.174 . . . . 2.35 111.489 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -84.16 -18.85 35.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.021 -1.049 . . . . 1.67 112.494 -179.555 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.96 -32.71 71.07 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.975 -1.078 . . . . 1.45 110.636 -179.372 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.51 86.88 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.038 -1.039 . . . . 0.61 110.598 179.329 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.0 mt -66.33 -47.66 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.118 -0.989 . . . . 0.65 109.828 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -72.04 -36.54 69.65 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.219 -0.925 . . . . 0.66 110.018 179.822 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.92 -39.11 84.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.493 -0.754 . . . . 1.19 110.074 -179.966 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.01 -35.37 83.92 Favored Glycine 0 N--CA 1.484 1.867 0 C-N-CA 119.795 -1.193 . . . . 0.53 110.491 179.579 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -60.22 -41.27 92.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -1.135 . . . . 1.27 110.542 179.117 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.4 mt -60.96 -41.94 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.025 -1.047 . . . . 0.54 110.423 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.0 ttm -59.77 -40.57 88.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -0.866 . . . . 1.74 110.576 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -60.39 -46.32 90.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.914 -1.116 . . . . 0.55 110.032 179.799 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.0 tp -59.0 -40.36 84.65 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.402 -0.811 . . . . 0.47 110.487 179.81 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -87.08 8.01 25.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.506 -0.746 . . . . 1.42 112.685 -179.887 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -60.26 118.94 7.01 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.185 -0.947 . . . . 1.27 109.61 179.609 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.57 -18.36 63.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.772 0.796 . . . . 1.35 110.954 -179.532 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.82 -52.79 8.33 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.747 -0.781 . . . . 2.22 110.401 -179.918 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.4 mt -61.24 -37.87 84.62 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.18 -1.008 . . . . 0.62 110.441 -179.529 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -58.88 -48.6 80.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 1.29 110.497 179.216 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.4 -38.81 91.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.285 -0.884 . . . . 1.52 110.476 179.814 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.78 -48.17 72.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.991 -1.068 . . . . 1.3 110.503 179.713 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 93.1 mt -58.29 -42.09 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.252 -0.905 . . . . 0.61 109.973 179.419 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.2 mt -63.43 -41.39 92.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.466 -0.772 . . . . 0.78 110.167 179.797 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.93 99.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.426 -0.796 . . . . 0.82 110.664 -179.778 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.0 mt -59.66 -43.72 93.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.8 110.492 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.56 -48.2 89.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.051 -1.031 . . . . 0.77 109.911 179.72 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.94 -36.23 41.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.783 . . . . 2.12 111.709 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -78.94 -48.29 14.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.709 -1.244 . . . . 1.51 111.315 -178.985 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -101.32 8.65 42.27 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.311 -0.868 . . . . 1.98 112.358 -177.685 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m80 50.67 51.31 17.18 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.972 -1.091 . . . . 1.32 111.568 179.892 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.9 mtp -107.79 157.0 18.51 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.55 -0.719 . . . . 1.38 109.239 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.2 p -73.95 158.76 33.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.606 -0.684 . . . . 0.67 109.407 177.784 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.75 91.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.485 -0.76 . . . . 0.52 110.613 179.347 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 28.8 p-10 -68.05 -42.84 79.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.953 -1.092 . . . . 2.25 110.014 179.314 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -68.28 -50.64 52.34 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.461 -0.896 . . . . 0.64 110.734 -179.885 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.24 88.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 0.56 110.592 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.69 -45.65 91.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 0.46 111.39 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -60.45 -39.24 86.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.792 -1.192 . . . . 1.32 111.539 -179.686 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.49 -47.89 78.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.693 -1.255 . . . . 1.3 111.031 179.597 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.18 -44.25 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.723 -1.235 . . . . 0.61 109.742 179.854 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -62.74 -34.7 67.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.631 -0.668 . . . . 0.65 110.755 179.998 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -56.6 -40.55 75.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.845 . . . . 2.11 111.214 179.469 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.21 -34.07 13.26 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.201 -1.476 . . . . 0.83 112.91 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -59.97 -38.26 82.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.398 -1.648 . . . . 1.28 110.04 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.04 -47.23 38.2 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.722 0.773 . . . . 0.89 110.704 179.599 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.7 m -60.37 -40.17 89.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.092 -1.005 . . . . 1.87 110.599 -178.585 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.6 -47.16 86.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.377 -0.827 . . . . 1.05 110.929 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.12 -29.76 69.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.881 -1.137 . . . . 1.02 110.837 -179.829 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -65.06 -22.35 66.96 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.342 -0.849 . . . . 2.04 110.571 179.437 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -71.1 -12.94 61.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.909 0.862 . . . . 1.73 110.815 179.87 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.5 mt -88.49 135.86 33.27 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.806 -1.183 . . . . 1.37 107.806 178.712 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 45.6 t0 -97.99 40.99 1.14 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.388 -0.82 . . . . 2.88 111.98 -179.381 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -114.53 140.38 48.81 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 121.007 -1.058 . . . . 1.58 108.966 178.987 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.07 -40.35 73.46 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.871 -0.732 . . . . 3.04 110.816 178.557 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -71.23 -56.88 5.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.102 -0.999 . . . . 0.9 110.59 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.62 -40.5 83.51 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.19 -0.944 . . . . 1.06 110.41 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -63.31 -47.77 80.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.02 -1.05 . . . . 2.18 109.794 179.866 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -60.17 -31.15 69.85 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.213 -0.929 . . . . 2.15 110.092 179.715 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -61.66 -30.07 70.48 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.552 -1.259 . . . . 2.33 109.262 179.269 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.78 -50.38 73.69 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.74 -0.784 . . . . 0.82 109.423 178.682 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.55 -43.42 80.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.679 0.752 . . . . 0.85 110.315 179.769 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -62.8 -32.7 73.94 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.671 0.748 . . . . 1.39 110.283 -179.691 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 t -68.69 -39.63 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.419 -0.801 . . . . 0.56 110.097 179.589 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -59.48 -37.45 78.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.057 -1.027 . . . . 3.12 109.764 178.852 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -59.92 -40.16 87.93 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.484 0.659 . . . . 1.28 110.259 179.436 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.6 mt -59.57 -39.8 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.49 110.456 179.598 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.33 -45.51 69.09 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 110.54 -1.024 . . . . 0.46 110.54 179.388 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -59.15 -46.77 87.5 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.059 -1.259 . . . . 2.71 110.208 179.41 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 64.4 mtt-85 -62.22 -38.89 90.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.888 -1.132 . . . . 2.14 110.273 179.751 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.0 tp -60.15 -41.02 91.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.682 -0.637 . . . . 1.05 109.852 178.911 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.3 mt -59.66 -40.05 86.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.606 -0.684 . . . . 0.52 110.58 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -60.28 -39.21 86.08 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.206 -0.934 . . . . 2.35 111.256 179.942 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -73.56 -41.62 62.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.108 . . . . 1.39 110.985 -179.866 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.33 -40.08 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.849 . . . . 0.68 110.548 -178.436 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.3 mt -89.32 -8.0 54.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.031 -1.043 . . . . 0.83 111.891 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.57 23.22 70.79 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.761 -1.209 . . . . 0.91 113.518 -179.511 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 18.6 tp -67.23 139.91 57.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.934 -0.745 . . . . 0.95 109.115 179.578 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -70.03 146.97 50.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.421 -0.799 . . . . 2.43 109.357 177.892 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 79.7 mt -108.68 138.67 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 121.128 -0.982 . . . . 1.1 108.619 178.746 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.719 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -78.66 131.65 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.702 -1.249 . . . . 1.58 108.808 178.888 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -94.51 97.37 10.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.396 -1.705 . . . . 1.62 106.396 178.686 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 mt -77.58 -13.37 59.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.473 -0.767 . . . . 0.8 111.916 -177.861 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.8 t -82.9 3.33 30.27 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.906 -1.121 . . . . 1.56 112.584 -179.734 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.5 15.26 22.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.316 -0.865 . . . . 0.84 112.31 179.451 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 24.6 mt -71.93 140.05 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.565 -0.71 . . . . 0.82 109.591 178.801 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -127.91 -6.71 5.56 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.717 0.77 . . . . 2.31 112.323 -179.436 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -110.2 140.21 44.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.571 -0.9 . . . . 1.54 108.571 179.459 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -71.61 120.84 17.77 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.589 -0.893 . . . . 1.38 108.589 178.403 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.51 171.74 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.985 -0.746 . . . . 0.69 108.985 -179.864 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.3 mt -93.18 141.12 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.295 -1.002 . . . . 0.53 108.295 178.275 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 26.8 tp -96.79 120.98 38.13 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.0 -1.063 . . . . 0.64 108.627 178.46 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.42 HG12 HG22 ' A' ' 209' ' ' THR . 44.6 t -121.21 131.15 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 107.816 -1.179 . . . . 0.67 107.816 179.781 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.403 ' C ' HG21 ' A' ' 209' ' ' THR . . . -162.94 157.98 21.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.018 . . . . 0.78 108.785 179.084 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.404 ' N ' HG21 ' A' ' 209' ' ' THR . . . -61.35 -34.45 75.31 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.303 -1.498 . . . . 1.0 109.474 178.079 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -173.04 154.91 2.91 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.827 -0.805 . . . . 2.42 108.827 179.574 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 69.0 mt -121.64 137.81 54.59 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.375 -1.343 . . . . 0.75 107.375 177.519 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.8 p -93.45 148.24 35.17 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.843 -1.161 . . . . 0.78 108.676 179.529 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -39.72 -40.99 2.52 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 122.066 1.844 . . . . 0.67 113.485 178.811 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.4 m -60.98 -50.23 74.22 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.254 -0.903 . . . . 0.7 110.238 -179.727 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -61.61 -38.55 88.0 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.952 -1.093 . . . . 1.21 109.704 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.4 p -68.61 -36.93 79.32 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.335 0.588 . . . . 0.6 110.639 179.524 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.36 -35.02 79.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.402 -0.811 . . . . 0.62 110.64 179.869 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -97.26 -0.6 46.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.477 -0.764 . . . . 1.16 112.503 -179.08 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.6 tp -64.21 153.72 37.12 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.735 -0.603 . . . . 0.73 109.646 179.749 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -97.13 113.15 24.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 106.848 -1.538 . . . . 2.24 106.848 177.615 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.36 -17.0 60.88 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.873 -0.517 . . . . 1.43 112.356 -178.018 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -84.63 -15.43 45.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.105 -0.997 . . . . 2.15 112.421 -178.574 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -103.69 -9.7 18.93 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.685 0.994 . . . . 2.04 113.685 -178.032 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 178' ' ' GLY . 59.3 t -109.51 129.98 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.768 -0.827 . . . . 0.55 108.768 179.666 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.582 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -88.07 -11.56 46.78 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.075 -1.016 . . . . 1.63 111.827 -179.428 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.427 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -173.8 167.78 40.43 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.292 -1.523 . . . . 0.47 109.292 179.807 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -124.15 131.99 53.59 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.218 -1.166 . . . . 0.54 107.995 178.586 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.5 mt -131.49 132.14 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.019 -1.104 . . . . 0.69 108.019 178.795 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 203' ' ' VAL . 55.5 p -135.5 163.37 30.23 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.192 -1.04 . . . . 0.82 108.192 178.08 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.452 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 17.6 m-20 -106.51 12.35 29.65 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.248 -0.908 . . . . 2.37 112.133 179.065 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 184' ' ' GLY . . . -134.66 -62.5 0.73 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.154 -0.966 . . . . 1.11 113.184 -177.068 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 183' ' ' ALA . . . -38.27 151.22 0.04 OUTLIER Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.453 -0.659 . . . . 1.67 111.453 -176.443 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 172.2 -70.3 0.11 Allowed Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.194 -1.479 . . . . 1.54 112.516 179.343 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.509 ' O ' HG23 ' A' ' 187' ' ' THR . 57.7 mtp180 -54.61 -42.2 70.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -1.223 . . . . 4.48 110.755 -178.915 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 186' ' ' ARG . 31.2 p -159.08 45.73 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.825 . . . . 2.63 111.114 -179.498 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.0 p -78.85 136.94 37.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.908 -1.12 . . . . 1.69 109.355 -179.476 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -60.14 -30.86 69.57 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.627 -0.671 . . . . 1.07 110.492 178.863 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.4 m -59.43 -39.6 84.05 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.152 -0.968 . . . . 1.58 110.028 179.424 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 87.0 p -59.52 -37.56 78.68 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.271 -0.893 . . . . 1.6 110.281 179.366 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.09 -39.75 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 1.45 110.493 179.48 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 45.0 mtp -61.74 -44.31 97.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.994 -1.067 . . . . 1.05 109.524 179.484 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.72 -50.58 72.91 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.373 -0.83 . . . . 0.72 111.187 179.992 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -60.57 -42.75 97.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.025 -1.047 . . . . 3.05 110.886 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.7 m -69.98 -38.44 76.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.932 -1.105 . . . . 0.89 110.521 179.968 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.9 mt -91.66 -8.48 47.0 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.686 0.755 . . . . 0.78 112.918 -179.222 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 194' ' ' ALA . 93.8 mt-10 56.75 9.88 0.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.244 1.201 . . . . 1.45 114.244 179.725 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.7 mt -71.41 149.49 93.8 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.945 -1.097 . . . . 0.67 108.086 179.167 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.76 140.22 94.09 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.376 1.384 . . . . 0.64 109.86 178.741 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.26 163.66 35.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.206 -1.559 . . . . 0.67 110.132 179.881 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.462 ' CD1' HD11 ' A' ' 220' ' ' LEU . 11.8 mt -150.25 158.15 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.343 -1.354 . . . . 0.69 107.343 178.17 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 181' ' ' THR . 7.0 m -146.78 -25.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 O-C-N 119.958 -1.714 . . . . 0.85 113.672 -179.578 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -100.93 43.64 1.7 Allowed Glycine 0 N--CA 1.5 2.948 0 O-C-N 120.886 -1.134 . . . . 0.92 110.564 -178.679 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.452 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 33.5 p -63.05 -21.02 65.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.08 -1.247 . . . . 0.95 111.658 -179.651 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.84 -83.01 0.51 Allowed Glycine 0 N--CA 1.499 2.88 0 O-C-N 121.518 -0.739 . . . . 1.04 111.32 179.148 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 77.7 p -134.82 31.67 3.31 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.843 -1.386 . . . . 1.57 113.256 -178.58 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.447 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 78.8 t -60.05 -37.92 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.173 -1.58 . . . . 0.84 110.645 179.576 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.42 HG22 HG12 ' A' ' 159' ' ' VAL . 51.9 p -60.12 -18.97 51.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.174 -0.954 . . . . 0.99 112.474 -179.623 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.7 m -94.31 -0.27 55.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 1.7 112.213 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -131.53 8.35 4.58 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.627 -0.671 . . . . 2.2 112.545 -178.161 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.85 148.63 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.601 -0.687 . . . . 0.84 109.625 -179.146 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -119.01 150.25 40.26 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.939 -1.134 . . . . 2.2 107.939 177.857 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 49.6 p-10 -55.68 142.69 33.17 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.899 -1.125 . . . . 2.28 110.374 178.414 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 m-20 80.34 -1.8 1.95 Allowed 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 114.276 1.213 . . . . 2.35 114.276 179.289 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.14 147.63 50.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.921 -1.112 . . . . 1.97 108.816 177.718 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -88.64 118.35 28.25 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.362 -1.461 . . . . 2.65 107.274 177.782 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.558 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.2 mt -128.22 150.34 50.07 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.837 -0.539 . . . . 0.63 109.788 -179.26 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.37 127.92 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 106.964 -1.495 . . . . 0.62 106.964 177.79 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.462 HD11 ' CD1' ' A' ' 202' ' ' ILE . 44.7 tp -100.35 119.92 39.16 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.005 -1.48 . . . . 0.64 107.005 178.478 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.638 ' O ' ' N ' ' A' ' 223' ' ' VAL . 34.4 t0 -92.35 -25.37 18.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.771 -1.206 . . . . 2.05 112.258 -177.873 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.883 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.34 11.11 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.025 0.75 . . . . 0.84 113.025 -179.077 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.6 t -110.45 -62.27 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 120.836 -1.165 . . . . 1.02 109.108 179.776 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -88.52 5.9 40.44 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.213 1.006 . . . . 2.51 110.23 -179.804 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 47.3 t30 62.73 52.39 2.8 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.208 -0.905 . . . . 1.54 112.184 179.355 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -145.54 150.51 36.55 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.279 1.038 . . . . 1.95 109.973 178.111 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.11 138.23 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.29 -1.374 . . . . 0.71 107.29 178.261 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -103.51 130.92 50.99 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.174 -1.047 . . . . 1.01 108.174 178.463 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 30.2 t -109.2 129.8 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 107.789 -1.189 . . . . 0.82 107.789 178.815 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.466 ' O ' ' ND2' ' A' ' 230' ' ' ASN . 0.2 OUTLIER 54.26 49.98 6.27 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 1.54 113.47 178.764 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.4 Cg_endo -68.4 150.27 75.68 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.847 2.365 . . . . 0.94 110.608 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.8 p -73.74 160.59 31.3 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.805 -1.184 . . . . 1.8 110.137 178.238 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.37 -41.62 89.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.537 -0.727 . . . . 2.73 110.702 179.046 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -61.94 -34.93 77.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.257 -0.902 . . . . 3.17 110.586 -179.804 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.21 -37.4 76.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.965 -1.084 . . . . 1.34 109.865 179.386 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--N 1.3 -1.57 0 O-C-N 121.127 -0.983 . . . . 1.2 110.386 179.066 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 105.869 -1.9 . . . . 1.07 105.869 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.8 m -106.93 120.28 41.62 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.929 -1.137 . . . . 1.24 107.929 -179.358 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.94 -156.21 27.25 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.602 -1.799 . . . . 1.01 108.602 179.496 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 5' ' ' ILE . 67.4 mt -96.88 1.41 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -1.209 . . . . 1.11 112.713 -179.507 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 tp 48.82 98.11 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.044 -1.035 . . . . 0.99 112.674 178.565 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -87.28 -39.16 15.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 0.85 110.842 179.364 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -146.55 144.66 21.19 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.049 -1.093 . . . . 1.38 108.049 -179.454 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.87 145.32 25.17 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.396 2.064 . . . . 0.94 111.917 178.307 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.931 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.96 174.36 23.28 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.803 -1.719 . . . . 0.81 108.803 178.116 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.9 mt -131.28 139.59 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.846 -1.168 . . . . 0.83 107.846 179.759 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.52 148.54 42.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.662 -1.274 . . . . 0.53 108.963 178.402 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -119.23 135.7 54.57 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 107.575 -1.269 . . . . 0.77 107.575 177.348 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.1 168.41 40.23 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 118.304 -1.903 . . . . 0.51 110.112 178.239 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -77.39 159.32 29.55 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.836 -0.802 . . . . 1.9 108.836 178.12 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -83.85 120.26 25.85 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.766 -1.209 . . . . 0.66 108.011 178.557 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.0 tp -102.46 102.66 12.98 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 105.266 -2.124 . . . . 0.83 105.266 178.138 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.8 tp -88.96 130.03 35.52 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.735 -1.209 . . . . 0.86 107.735 179.427 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.43 119.54 35.1 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.994 -1.484 . . . . 0.92 106.994 178.389 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -110.19 137.57 47.75 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.465 -1.309 . . . . 2.03 107.465 -179.787 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -116.22 139.31 50.48 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.111 -0.993 . . . . 2.66 108.843 179.004 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -81.66 130.2 34.97 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.599 -1.26 . . . . 2.32 107.599 177.758 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.35 141.17 58.87 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.575 -0.898 . . . . 2.11 108.575 178.847 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.4 mt -95.73 132.55 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.275 -1.009 . . . . 0.73 108.275 178.289 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.95 129.56 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.686 -1.227 . . . . 0.87 107.686 178.87 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.99 137.55 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.541 -0.911 . . . . 0.81 108.541 179.302 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -92.34 125.18 36.89 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.944 -1.097 . . . . 1.34 108.25 178.751 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -96.98 18.09 15.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -0.853 . . . . 2.89 112.1 -179.722 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -66.9 152.63 45.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.17 -0.956 . . . . 2.09 110.377 179.307 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -93.71 134.6 35.86 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.87 -0.789 . . . . 2.19 108.87 177.975 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -95.92 169.26 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.526 -0.733 . . . . 0.75 109.784 179.336 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.0 p -94.25 161.93 14.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 0.91 109.932 178.494 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.65 -23.08 15.69 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.799 -1.188 . . . . 0.93 111.891 179.137 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -69.29 -37.41 77.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.424 -0.798 . . . . 2.28 111.016 -179.47 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -88.47 -7.92 55.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.898 -1.126 . . . . 1.45 112.854 -179.852 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.75 -41.18 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.329 -0.857 . . . . 0.81 110.219 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.4 -39.3 82.94 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.104 -0.998 . . . . 1.54 110.157 179.243 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -62.29 -40.28 95.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.622 -0.674 . . . . 2.36 110.922 -179.993 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.63 -39.58 88.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 1.31 110.771 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.12 -41.53 86.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.246 -0.982 . . . . 0.82 110.111 179.275 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -61.54 -48.36 81.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.847 -1.158 . . . . 1.5 109.938 179.594 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.527 HH11 ' HG2' ' A' ' 42' ' ' ARG . 14.9 mtt-85 -60.52 -39.5 88.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.123 -0.986 . . . . 2.23 109.628 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -73.39 -52.85 12.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.979 -1.076 . . . . 0.85 110.029 179.23 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.97 -45.12 95.06 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.121 -1.032 . . . . 0.91 109.643 -179.868 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 9.3 t -67.99 -35.23 77.98 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.957 0.884 . . . . 0.9 109.812 -179.761 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.84 -44.49 94.28 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.758 -1.337 . . . . 0.69 109.758 178.733 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.416 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 38.1 ttm-85 -57.25 -32.29 66.41 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.065 0.936 . . . . 2.88 109.495 178.869 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.76 -44.39 86.12 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.884 0.849 . . . . 0.85 109.947 179.251 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -83.47 -43.92 15.29 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.59 -0.694 . . . . 2.35 110.964 179.347 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -42.96 89.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 0.65 110.244 -179.898 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.415 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 22.9 t -62.89 -40.72 98.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.331 -0.856 . . . . 1.45 109.362 179.772 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.46 -48.79 54.18 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.411 0.624 . . . . 0.63 110.915 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -61.82 -47.75 83.67 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.581 -1.324 . . . . 1.34 110.727 -178.592 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.69 -39.2 91.02 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.202 -0.936 . . . . 1.56 110.34 -179.611 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 51' ' ' SER . 32.8 mm-40 -60.01 -40.55 89.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.807 -0.558 . . . . 1.19 110.724 179.3 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.8 m -64.49 -41.56 96.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.72 110.964 -179.887 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.78 -38.83 77.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.379 -0.826 . . . . 0.62 110.97 -179.873 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -52.92 -43.53 66.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 1.05 110.945 179.305 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -70.2 -38.32 75.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.912 -1.117 . . . . 0.64 110.279 -179.638 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -62.26 -39.13 91.87 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 118.637 -1.225 . . . . 1.73 109.427 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.24 -28.88 65.6 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.438 -0.789 . . . . 0.56 110.768 179.52 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.4 -35.69 13.87 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.423 -1.37 . . . . 0.69 110.815 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -81.34 -23.62 37.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.127 -1.219 . . . . 1.48 111.261 -179.91 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -88.66 -48.87 7.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.902 -0.499 . . . . 0.98 111.182 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -108.34 -8.05 15.75 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.996 1.11 . . . . 1.16 113.996 -177.759 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.06 156.89 19.27 Favored Glycine 0 N--CA 1.501 2.987 0 O-C-N 121.369 -0.832 . . . . 0.85 113.577 178.452 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -50.7 -21.73 1.75 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.573 -0.957 . . . . 3.86 112.536 179.072 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -54.3 -38.15 65.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.785 -1.197 . . . . 2.35 111.814 -179.972 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -80.18 -19.24 47.55 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.747 -1.221 . . . . 1.67 112.443 -178.989 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -61.08 -35.5 77.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.984 -1.072 . . . . 1.45 110.811 -179.47 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.79 88.01 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.107 -0.996 . . . . 0.61 111.364 179.773 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt -67.91 -46.86 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.465 -1.397 . . . . 0.65 110.178 179.771 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -72.25 -28.57 63.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.87 . . . . 0.66 111.129 -179.885 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -60.92 -40.56 93.64 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.679 -0.808 . . . . 1.19 109.888 179.565 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.22 -42.17 91.25 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.192 -1.163 . . . . 0.53 110.192 179.857 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -59.58 -45.99 90.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.472 -1.017 . . . . 1.27 110.79 179.39 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.6 mt -61.21 -40.48 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.663 -1.273 . . . . 0.54 110.504 -179.945 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.4 ttm -60.29 -38.35 83.31 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.295 -0.878 . . . . 1.74 110.214 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.5 tp -59.3 -45.77 90.37 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.055 -1.028 . . . . 0.55 110.358 179.208 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.416 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 60.0 tp -60.56 -42.38 96.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.526 -0.734 . . . . 0.47 110.225 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -84.81 4.87 31.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.304 -0.872 . . . . 1.42 112.849 -179.55 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -59.84 125.96 25.71 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.829 -1.169 . . . . 1.27 110.087 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.2 -19.14 65.13 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.542 -0.724 . . . . 1.35 111.351 -179.332 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.61 -53.36 9.52 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.144 -1.023 . . . . 2.22 110.687 179.946 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.3 mt -62.48 -39.28 92.93 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.32 -0.862 . . . . 0.62 110.753 -179.524 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -58.56 -47.0 85.69 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.152 -0.967 . . . . 1.29 110.822 179.338 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -63.12 -40.48 97.73 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.282 -0.886 . . . . 1.52 110.683 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -66.3 -48.3 70.8 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.939 -1.105 . . . . 1.3 110.646 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.38 -44.79 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.636 -1.29 . . . . 0.61 110.028 179.632 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.1 -43.85 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.457 -0.777 . . . . 0.78 110.486 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.4 -44.52 94.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 0.82 111.027 -179.673 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -60.04 -40.25 88.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.075 -1.016 . . . . 0.8 110.735 -179.716 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.55 -47.31 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.056 -1.027 . . . . 0.77 110.57 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -83.31 -31.73 26.69 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.327 -0.858 . . . . 2.12 112.035 -179.786 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -78.05 -47.85 17.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.511 -1.368 . . . . 1.51 110.9 -178.365 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -104.55 11.45 34.28 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 119.672 -0.811 . . . . 1.98 111.796 -178.05 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.3 m80 52.0 47.56 24.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.043 -1.036 . . . . 1.32 111.913 179.809 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 64.5 mtt -98.39 159.85 14.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.141 -0.975 . . . . 1.38 109.796 178.656 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.5 p -76.24 160.81 29.32 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.591 -0.693 . . . . 0.67 109.894 178.173 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.23 -42.75 86.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.368 -0.832 . . . . 0.52 110.989 178.786 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.535 ' OD2' HD21 ' A' ' 142' ' ' LEU . 92.6 m-20 -70.04 -38.97 75.99 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.658 -1.276 . . . . 2.25 110.19 -179.997 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.85 -51.56 39.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.859 -1.151 . . . . 0.64 111.589 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.96 92.26 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.792 -1.163 . . . . 0.56 110.811 -179.813 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.35 95.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.798 -0.564 . . . . 0.46 110.988 179.832 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -60.78 -40.25 91.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.629 -1.294 . . . . 1.32 111.236 -179.514 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.27 -49.87 76.19 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.843 -1.16 . . . . 1.3 111.4 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -59.43 -45.75 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.924 -1.11 . . . . 0.61 109.99 179.929 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.6 mm -62.72 -30.45 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-O 121.388 0.613 . . . . 0.65 110.329 179.768 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -57.36 -40.22 77.64 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.793 -0.763 . . . . 2.11 110.509 179.16 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.16 -30.67 22.05 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 119.249 -1.453 . . . . 0.83 112.877 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -61.34 -41.54 97.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.383 -1.657 . . . . 1.28 110.293 -179.914 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.7 -46.91 51.32 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 119.805 -0.758 . . . . 0.89 110.524 -179.975 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 50.4 p -62.99 -35.67 80.98 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.33 -0.856 . . . . 1.87 110.782 -178.447 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.97 87.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.604 -0.685 . . . . 1.05 110.898 179.951 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 mt -65.33 -28.74 69.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.868 -1.145 . . . . 1.02 111.271 -179.509 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -66.43 -19.69 65.86 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.355 -0.938 . . . . 2.04 110.671 179.179 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -72.42 -11.22 60.59 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.471 -0.891 . . . . 1.73 110.654 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.499 HD13 HD13 ' A' ' 123' ' ' LEU . 69.4 mt -86.44 141.61 29.0 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.522 0.677 . . . . 1.37 109.213 179.535 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -98.13 38.14 1.35 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.193 -0.942 . . . . 2.88 112.206 179.48 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -113.79 137.7 51.28 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.26 -1.015 . . . . 1.58 108.26 178.873 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 28.2 mp0 -59.12 -39.86 83.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.972 -1.08 . . . . 3.04 111.076 179.182 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -71.24 -52.92 16.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.743 -1.223 . . . . 0.9 110.531 179.774 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.499 HD13 HD13 ' A' ' 118' ' ' LEU . 36.2 mt -59.98 -40.39 88.97 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.865 -1.147 . . . . 1.06 110.384 -179.595 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -59.1 -45.72 90.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.893 -1.129 . . . . 2.18 110.2 179.483 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.48 -31.98 70.98 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.369 -0.933 . . . . 2.15 109.906 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 130' ' ' VAL . 34.8 ttm180 -60.6 -31.2 70.37 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.829 -1.148 . . . . 2.33 109.106 178.896 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.61 76.44 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.556 0.693 . . . . 0.82 110.249 179.026 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.98 78.03 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.126 -0.63 . . . . 0.85 110.138 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.34 -34.84 78.58 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.629 0.728 . . . . 1.39 110.673 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 126' ' ' ARG . 29.6 t -68.23 -41.02 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.128 -0.982 . . . . 0.56 110.3 179.723 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -57.9 -38.73 76.34 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.445 -1.302 . . . . 3.12 109.429 179.121 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -59.79 -37.58 79.51 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 120.124 -0.631 . . . . 1.28 110.181 179.199 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.99 -39.81 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 0.49 109.591 179.355 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.93 -46.03 77.56 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.885 -1.15 . . . . 0.46 110.408 179.082 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -57.38 -41.85 81.01 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.356 -1.085 . . . . 2.71 110.163 179.299 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' A' ' 136' ' ' ARG . 50.7 mtt-85 -61.52 -42.98 99.62 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.251 -0.979 . . . . 2.14 110.006 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.77 -42.33 97.25 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.782 -0.767 . . . . 1.05 109.536 179.78 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.5 mt -60.05 -43.78 95.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.526 -0.734 . . . . 0.52 110.404 179.698 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.468 ' NH1' HD23 ' A' ' 144' ' ' LEU . 49.8 mtt-85 -60.54 -36.41 78.36 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.622 -0.674 . . . . 2.35 110.703 -179.974 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -73.94 -40.36 63.12 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.32 -0.863 . . . . 1.39 111.011 179.719 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.463 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.8 mt -60.55 -40.38 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.889 -1.132 . . . . 0.68 110.614 -178.815 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.535 HD21 ' OD2' ' A' ' 101' ' ' ASP . 81.4 mt -87.51 -11.17 49.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.669 -1.27 . . . . 0.83 111.855 -178.951 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.79 18.61 74.9 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.763 -1.208 . . . . 0.91 112.402 -179.71 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.468 HD23 ' NH1' ' A' ' 139' ' ' ARG . 47.8 tp -63.74 145.32 55.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.921 -0.752 . . . . 0.95 109.194 179.218 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -69.02 147.27 51.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.51 -0.744 . . . . 2.43 109.534 178.508 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.0 mt -106.84 141.21 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.383 -0.969 . . . . 1.1 108.383 178.143 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.555 ' H ' HD12 ' A' ' 147' ' ' ILE . 5.3 mp -76.01 123.72 32.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.357 -0.979 . . . . 1.58 108.357 178.238 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -99.62 100.52 11.53 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 106.064 -1.828 . . . . 1.62 106.064 178.98 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.4 mt -75.2 -14.26 60.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.313 -0.867 . . . . 0.8 111.759 -177.885 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.6 p -78.42 3.07 16.78 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.317 1.055 . . . . 1.56 112.153 -179.331 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.28 19.83 14.7 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.125 -0.984 . . . . 0.84 112.744 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 22.6 mt -74.1 137.42 23.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.907 -1.121 . . . . 0.82 109.241 179.172 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -115.52 -14.27 11.53 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.856 0.836 . . . . 2.31 112.558 -178.717 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -113.47 136.35 52.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.502 -1.295 . . . . 1.54 107.502 179.932 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -73.67 124.55 26.19 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.588 -0.893 . . . . 1.38 108.588 178.689 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -146.45 175.58 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.46 -0.775 . . . . 0.69 109.404 -179.69 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.1 mt -87.53 148.49 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.53 108.975 178.135 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -99.75 120.54 39.89 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.055 -1.091 . . . . 0.64 108.055 178.114 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -121.58 129.59 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 N-CA-C 107.718 -1.215 . . . . 0.67 107.718 179.391 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.1 155.97 21.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.968 -1.083 . . . . 0.78 108.863 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.454 ' O ' ' CG ' ' A' ' 162' ' ' ASP . . . -60.59 -37.58 81.81 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.395 -1.441 . . . . 1.0 109.674 178.131 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 161' ' ' ALA . 58.0 m-20 -167.81 153.86 7.51 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.733 -0.839 . . . . 2.42 108.733 179.179 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.8 mt -116.46 139.91 49.94 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 108.374 -0.972 . . . . 0.75 108.374 177.76 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.5 p -96.85 148.97 35.2 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.22 -0.925 . . . . 0.78 108.892 179.402 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.68 -40.01 7.53 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.747 1.632 . . . . 0.67 113.599 179.092 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.6 m -61.75 -49.69 75.39 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.024 -1.047 . . . . 0.7 109.922 -179.336 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -61.87 -39.96 93.71 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.085 -1.01 . . . . 1.21 110.077 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.8 p -67.67 -37.62 82.63 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.417 -0.802 . . . . 0.6 110.267 179.506 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.22 -36.05 82.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.402 -0.811 . . . . 0.62 111.322 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -98.44 -0.47 43.47 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.351 -0.843 . . . . 1.16 112.795 -179.276 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.7 tp -64.14 154.88 33.31 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.951 -0.7 . . . . 0.73 109.906 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -97.41 118.76 34.62 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.984 -1.487 . . . . 2.24 106.984 177.427 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.9 mt -76.52 -19.6 57.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.512 -0.742 . . . . 1.43 111.953 -178.126 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -82.39 -19.86 38.27 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.06 -1.025 . . . . 2.15 112.455 -178.904 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -102.44 -0.76 31.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.46 -0.775 . . . . 2.04 113.065 -178.012 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 178' ' ' GLY . 46.9 t -109.23 121.22 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.591 -1.262 . . . . 0.55 107.591 179.049 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.1 tp -84.74 -4.04 58.86 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.144 -0.972 . . . . 1.63 111.821 -179.434 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.491 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.96 171.29 36.82 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.872 -1.691 . . . . 0.47 108.872 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 3.6 m-85 -125.0 129.69 50.82 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.941 -1.133 . . . . 0.54 107.941 178.463 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.444 ' CG2' HG21 ' A' ' 205' ' ' THR . 30.1 mt -129.92 121.43 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 106.173 -1.788 . . . . 0.69 106.173 177.908 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 203' ' ' VAL . 39.4 p -139.88 172.31 12.96 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.631 -1.293 . . . . 0.82 110.355 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.487 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 4.8 m-20 -105.29 51.96 0.75 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.529 -0.732 . . . . 2.37 109.676 179.382 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -103.93 153.94 20.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.366 -0.834 . . . . 1.11 109.709 179.617 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -58.88 -36.2 86.38 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 120.212 -0.994 . . . . 1.67 110.712 178.517 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 96.52 -17.86 58.52 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 121.164 -1.198 . . . . 1.54 114.157 179.458 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.405 ' HG2' ' NH1' ' A' ' 186' ' ' ARG . 59.4 mtt-85 -58.67 -41.13 85.45 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.835 -1.391 . . . . 4.48 110.212 179.289 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 75.5 p -140.83 36.29 1.78 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.539 -0.726 . . . . 2.63 111.212 -179.391 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 69.9 m -81.9 123.06 28.51 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.553 -1.277 . . . . 1.69 107.553 179.489 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -60.5 -37.58 81.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.669 -0.645 . . . . 1.07 110.741 -179.828 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 23.0 m -52.96 -42.51 65.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 1.58 110.439 179.253 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.8 m -59.65 -40.43 87.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.03 -1.044 . . . . 1.6 110.107 179.463 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.34 -35.69 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.593 -0.692 . . . . 1.45 110.848 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 57.1 mtp -62.6 -40.81 98.1 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.093 0.949 . . . . 1.05 109.453 179.481 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.0 -41.73 92.71 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.589 -0.732 . . . . 0.72 110.515 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -59.8 -44.93 93.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 3.05 110.712 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.1 m -71.19 -39.35 71.88 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.002 -1.061 . . . . 0.89 110.164 -179.843 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.1 mt -90.98 -7.94 50.6 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 112.712 0.634 . . . . 0.78 112.712 -178.124 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 54.29 9.03 0.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.207 1.188 . . . . 1.45 114.207 179.836 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 39.5 mt -71.37 148.92 93.77 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 108.326 -0.99 . . . . 0.67 108.326 179.133 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.45 144.25 92.29 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.456 1.438 . . . . 0.64 109.368 178.608 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -157.9 160.67 37.88 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.086 -1.446 . . . . 0.67 109.65 179.647 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.587 HD12 HD11 ' A' ' 220' ' ' LEU . 14.8 mt -150.78 149.07 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.862 -1.162 . . . . 0.69 107.862 178.386 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.5 m -134.21 -32.18 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.245 -0.909 . . . . 0.85 112.811 -179.755 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.51 33.56 0.83 Allowed Glycine 0 N--CA 1.483 1.792 0 O-C-N 121.183 -0.948 . . . . 0.92 113.037 -178.135 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.487 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 35.0 p -59.67 -26.95 65.97 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 121.465 -1.021 . . . . 0.95 111.085 -179.199 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 79.53 -93.38 1.35 Allowed Glycine 0 N--CA 1.488 2.102 0 C-N-CA 120.181 -1.009 . . . . 1.04 110.952 179.386 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.5 m -123.54 29.74 6.49 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.246 0.832 . . . . 1.57 113.246 -178.798 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 70.3 t -59.84 -33.59 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.824 -1.172 . . . . 0.84 110.237 179.027 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 58.8 p -59.33 -23.23 62.32 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.087 -1.008 . . . . 0.99 111.459 179.947 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.1 t -92.27 -0.38 57.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.914 -1.116 . . . . 1.7 111.428 -179.288 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -124.47 -7.22 7.51 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.617 -0.72 . . . . 2.2 112.681 -177.938 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.43 141.82 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.164 -0.68 . . . . 0.84 109.164 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -116.72 151.44 36.38 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.1 -1.074 . . . . 2.2 108.1 178.296 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 48.2 t30 -53.25 143.29 18.79 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.279 -0.968 . . . . 2.28 110.44 178.318 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.1 t0 82.2 -6.99 1.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.099 1.148 . . . . 2.35 114.099 179.524 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 16' ' ' ALA . 87.6 m-20 -63.18 143.23 57.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.636 -1.29 . . . . 1.97 108.288 177.466 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -88.23 119.1 28.31 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.388 -1.338 . . . . 2.65 107.388 178.124 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.438 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 42.4 mt -127.83 144.51 51.09 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.137 -0.69 . . . . 0.63 109.137 -179.04 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.9 mt -111.94 128.61 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 106.918 -1.512 . . . . 0.62 106.918 177.72 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.587 HD11 HD12 ' A' ' 202' ' ' ILE . 44.1 tp -99.97 118.67 36.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.975 -1.861 . . . . 0.64 105.975 178.35 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 223' ' ' VAL . 35.0 p-10 -92.65 -22.19 19.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 2.05 112.736 -177.558 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.931 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.75 16.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 112.756 0.65 . . . . 0.84 112.756 -179.206 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.632 ' N ' ' O ' ' A' ' 221' ' ' ASP . 15.7 t -111.21 -63.81 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.056 -1.027 . . . . 1.02 108.78 179.694 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -90.22 9.15 29.65 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.245 1.021 . . . . 2.51 110.463 -179.779 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 61.62 52.8 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.067 -0.97 . . . . 1.54 112.157 179.61 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -148.29 153.46 38.7 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.409 1.1 . . . . 1.95 110.25 179.131 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.4 135.48 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.542 -1.281 . . . . 0.71 107.542 177.465 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -101.15 136.93 40.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.987 -1.071 . . . . 1.01 108.719 178.744 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.7 t -109.84 130.04 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.171 -1.048 . . . . 0.82 108.171 179.104 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.451 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 60.7 t30 48.44 50.32 8.86 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.914 . . . . 1.54 113.292 178.913 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.7 Cg_endo -63.41 151.66 83.82 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.32 2.013 . . . . 0.94 110.712 -179.904 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.9 m -73.97 156.79 37.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.795 -1.191 . . . . 1.8 109.226 177.65 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.407 ' HA ' HD12 ' A' ' 236' ' ' ILE . 29.8 m120 -56.79 -40.05 75.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.033 -1.042 . . . . 2.73 111.133 179.054 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.448 ' H ' ' CD ' ' A' ' 234' ' ' GLU . 45.2 mp0 -59.12 -39.52 82.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.044 -1.035 . . . . 3.17 110.288 179.687 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.8 -37.94 78.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.759 0.79 . . . . 1.34 110.097 179.732 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 233' ' ' ASN . 84.5 mt . . . . . 0 N--CA 1.488 1.46 0 O-C-N 121.133 -0.979 . . . . 1.2 110.398 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.246 -0.65 . . . . 3.07 109.246 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.2 mt -91.92 112.36 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.468 -1.679 . . . . 1.07 106.468 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.0 m -105.98 119.99 40.62 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.652 -1.24 . . . . 1.24 107.652 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.17 -160.96 23.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.531 -1.827 . . . . 1.01 108.531 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 5' ' ' ILE . 95.6 mt -95.98 1.29 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.447 -1.031 . . . . 1.11 113.076 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 tp 51.8 93.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.536 -1.353 . . . . 0.99 112.297 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -88.75 -34.11 17.25 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.052 -1.03 . . . . 0.85 111.001 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 201' ' ' ALA . 1.9 p -149.8 140.89 14.46 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 107.682 -1.229 . . . . 1.38 107.682 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.28 146.99 22.76 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.518 2.145 . . . . 0.94 112.173 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.945 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.15 173.69 22.71 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 108.722 -1.751 . . . . 0.81 108.722 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.0 mt -132.12 136.42 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.073 -1.251 . . . . 0.83 107.683 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.34 155.92 45.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.004 -1.06 . . . . 0.53 109.429 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.606 ' CE1' ' NH2' ' A' ' 240' ' ' ARG . 4.6 m-85 -128.38 140.19 51.98 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.391 -0.966 . . . . 0.77 108.391 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.36 172.01 39.86 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 118.546 -1.788 . . . . 0.51 110.061 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -76.02 156.07 34.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.86 -0.788 . . . . 1.9 109.144 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -84.52 122.87 29.61 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.454 -1.313 . . . . 0.66 107.454 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.4 tp -100.2 106.97 18.7 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 105.558 -2.016 . . . . 0.83 105.558 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.4 tp -91.04 131.36 36.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.917 -1.142 . . . . 0.86 107.917 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 158' ' ' LEU . 44.4 mt -99.52 118.04 35.23 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.878 -1.527 . . . . 0.92 106.878 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -110.15 136.09 49.92 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.79 -1.189 . . . . 2.03 107.79 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -128.56 151.21 49.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.08 -1.013 . . . . 2.66 109.748 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -81.52 135.61 35.6 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.816 -1.179 . . . . 2.32 107.816 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -63.67 147.89 50.43 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.743 -0.836 . . . . 2.11 108.743 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.2 mt -93.23 125.48 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.728 -1.212 . . . . 0.73 107.728 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.2 t -109.96 129.95 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.43 -0.952 . . . . 0.87 108.43 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.9 mt -95.02 141.44 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.152 -0.968 . . . . 0.81 108.612 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -90.53 122.68 33.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.033 . . . . 1.34 108.414 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.531 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.6 mmt-85 -94.46 17.02 13.82 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.37 -0.831 . . . . 2.89 111.983 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -74.85 140.42 43.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.259 -0.901 . . . . 2.09 109.006 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -90.97 129.55 36.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.958 -1.089 . . . . 2.19 108.074 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 pt -89.31 166.19 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.75 110.835 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.8 p -96.81 167.19 11.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.405 -0.81 . . . . 0.91 109.653 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -15.16 2.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.922 -1.111 . . . . 0.93 112.39 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -70.33 -39.61 74.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 2.28 110.824 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -94.61 -4.73 47.23 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.635 -1.291 . . . . 1.45 113.029 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.71 -41.38 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.272 -0.893 . . . . 0.81 110.358 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -56.09 -40.1 73.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 1.54 110.189 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -63.16 -36.12 82.58 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.335 -0.853 . . . . 2.36 110.688 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 42' ' ' ARG . 78.6 mm-40 -60.23 -42.06 94.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 1.31 110.398 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.98 -46.0 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.387 -0.821 . . . . 0.82 110.731 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.24 -50.01 74.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.058 -1.026 . . . . 1.5 110.392 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 76.6 mtm180 -62.41 -41.0 98.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -0.897 . . . . 2.23 110.231 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -70.26 -55.33 9.51 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.383 -0.823 . . . . 0.85 109.566 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.25 -47.67 85.0 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.797 0.808 . . . . 0.91 110.361 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 12.2 t -68.67 -38.19 80.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.303 -0.873 . . . . 0.9 110.208 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.61 -46.57 88.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.775 -1.33 . . . . 0.69 109.775 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -59.91 -29.31 68.28 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.405 -1.056 . . . . 2.88 110.311 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.33 -48.86 80.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.808 -0.557 . . . . 0.85 110.97 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -82.55 -35.93 26.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.833 -1.167 . . . . 2.35 110.084 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -45.33 89.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.369 -0.832 . . . . 0.65 109.95 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 t -61.73 -39.8 92.84 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.917 0.865 . . . . 1.45 109.558 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.03 -49.86 63.87 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.287 -0.565 . . . . 0.63 110.873 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -61.7 -51.0 70.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.97 -1.081 . . . . 1.34 110.955 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.72 -38.94 89.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.241 -0.912 . . . . 1.56 110.483 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -58.68 -40.09 82.57 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.059 -0.656 . . . . 1.19 110.654 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 m -63.08 -41.75 99.49 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.839 -1.163 . . . . 0.72 110.247 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.11 -36.32 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.571 -0.706 . . . . 0.62 110.778 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -52.97 -42.56 65.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 1.05 110.76 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.31 -36.12 76.67 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.139 -0.975 . . . . 0.64 110.21 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -62.14 -39.34 92.24 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.246 -0.981 . . . . 1.73 109.454 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.02 -34.74 78.78 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.342 0.591 . . . . 0.56 110.113 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.43 19.02 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.749 -1.215 . . . . 0.69 111.355 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.26 -23.32 35.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -1.183 . . . . 1.48 111.406 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.5 m -86.6 -49.71 7.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.793 -0.567 . . . . 0.98 110.649 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.527 ' CZ ' ' SD ' ' A' ' 193' ' ' MET . 72.2 m-85 -108.43 -6.65 16.08 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 113.954 1.094 . . . . 1.16 113.954 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.0 168.03 29.4 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.115 -1.04 . . . . 0.85 111.745 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.94 -20.49 38.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.273 -1.134 . . . . 3.86 112.603 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.47 -42.03 73.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.618 -1.301 . . . . 2.35 110.945 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -88.43 -25.18 22.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.017 -1.052 . . . . 1.67 111.998 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -59.99 -37.28 79.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 1.45 111.356 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.36 84.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.61 111.299 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.8 mt -65.2 -43.98 95.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.494 -1.379 . . . . 0.65 110.303 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -70.63 -34.53 72.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.938 -1.102 . . . . 0.66 110.423 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.49 -38.55 84.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.3 -0.875 . . . . 1.19 110.491 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.94 -41.15 88.53 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.972 -1.108 . . . . 0.53 110.938 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -59.36 -43.21 92.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.417 -1.049 . . . . 1.27 110.56 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.48 -37.17 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.161 -0.962 . . . . 0.54 110.564 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.2 ttt -59.26 -39.75 83.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.531 -0.731 . . . . 1.74 110.558 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.8 tp -59.6 -48.21 82.54 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.454 -0.898 . . . . 0.55 109.612 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.44 -39.72 88.53 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.541 0.686 . . . . 0.47 110.049 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.62 -1.52 54.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.451 -0.781 . . . . 1.42 112.902 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -58.68 123.88 17.85 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.14 -1.424 . . . . 1.27 110.584 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.36 -16.57 62.51 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.751 -1.218 . . . . 1.35 111.355 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -77.46 -50.08 13.43 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.407 -0.917 . . . . 2.22 111.148 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.09 -39.46 92.55 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.28 -0.888 . . . . 0.62 110.577 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -59.84 -45.71 91.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 1.29 110.348 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -62.72 -39.98 95.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 1.52 110.837 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -64.84 -48.31 74.8 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.798 -1.189 . . . . 1.3 110.273 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.2 mt -55.84 -44.19 76.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.169 -0.957 . . . . 0.61 110.048 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.36 -41.58 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.443 0.64 . . . . 0.78 110.453 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.51 95.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.682 -0.636 . . . . 0.82 110.977 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.86 -42.26 97.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.866 -1.146 . . . . 0.8 110.783 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.21 -49.72 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.857 -1.152 . . . . 0.77 109.931 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -78.0 -35.42 50.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.399 -0.813 . . . . 2.12 111.645 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.12 -42.09 27.07 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.499 -1.375 . . . . 1.51 111.767 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -105.8 7.92 32.6 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.92 -1.112 . . . . 1.98 112.422 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.8 m80 50.77 47.85 23.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.858 -1.151 . . . . 1.32 111.285 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.6 mtt -105.28 154.02 20.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.598 -0.689 . . . . 1.38 109.567 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.9 p -71.32 162.98 28.55 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.79 -0.569 . . . . 0.67 110.034 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.51 -39.84 94.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.964 -1.085 . . . . 0.52 110.856 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -68.5 -42.76 78.14 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 120.807 -1.183 . . . . 2.25 109.971 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.35 -48.06 62.45 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.508 0.671 . . . . 0.64 110.606 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.28 94.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.56 110.494 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.34 86.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.651 -0.656 . . . . 0.46 110.552 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -60.08 -38.57 83.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.17 -0.956 . . . . 1.32 110.937 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.14 -49.46 76.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.9 -1.125 . . . . 1.3 111.174 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.68 -49.5 84.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.402 -1.319 . . . . 0.61 109.714 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.0 mm -60.09 -32.73 51.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.605 0.717 . . . . 0.65 110.149 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -54.84 -40.78 69.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.266 -0.896 . . . . 2.11 110.627 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.49 -34.65 10.15 Favored Glycine 0 N--CA 1.5 2.919 0 C-N-CA 119.618 -1.277 . . . . 0.83 112.236 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -61.86 -42.77 99.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.499 -1.589 . . . . 1.28 109.914 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.11 -49.84 32.95 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.948 -0.701 . . . . 0.89 110.107 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.0 p -61.79 -36.94 82.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.173 -0.954 . . . . 1.87 110.411 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.91 98.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 1.05 110.633 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 95.5 mt -66.37 -29.39 69.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.083 -1.011 . . . . 1.02 110.715 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -67.04 -23.73 65.92 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.383 -0.823 . . . . 2.04 110.961 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -71.56 -15.39 62.28 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.06 -1.025 . . . . 1.73 111.227 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.6 mt -88.45 141.07 28.83 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.829 -0.804 . . . . 1.37 108.829 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -98.1 40.78 1.16 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.146 -0.971 . . . . 2.88 112.048 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -112.39 138.57 48.94 Favored 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 108.174 -1.047 . . . . 1.58 108.174 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 47.7 mp0 -58.58 -36.6 74.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 3.04 111.016 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -73.59 -51.15 17.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.677 -1.264 . . . . 0.9 109.99 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.96 -43.08 96.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.96 -1.087 . . . . 1.06 110.215 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -63.05 -50.22 71.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.913 . . . . 2.18 110.198 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -61.55 -30.5 70.69 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.076 0.941 . . . . 2.15 109.589 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 130' ' ' VAL . 37.9 ttp180 -64.7 -29.55 70.54 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.082 0.944 . . . . 2.33 109.274 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -59.95 -48.22 82.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.708 0.766 . . . . 0.82 109.484 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.06 84.58 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.527 -0.869 . . . . 0.85 109.986 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -64.45 -35.49 81.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.516 -0.74 . . . . 1.39 110.348 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 126' ' ' ARG . 38.2 t -67.59 -39.51 82.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.106 -0.996 . . . . 0.56 109.58 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -58.91 -37.1 75.86 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.895 -1.122 . . . . 3.12 109.214 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -60.25 -37.68 81.12 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.899 -0.591 . . . . 1.28 110.418 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.6 mt -60.48 -40.04 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.318 -0.864 . . . . 0.49 109.71 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.82 -39.97 32.34 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.098 -1.201 . . . . 0.46 110.098 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.72 -46.29 84.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -1.129 . . . . 2.71 109.996 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -63.63 -40.1 96.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.788 -1.195 . . . . 2.14 109.8 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.29 -41.94 90.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.49 -0.756 . . . . 1.05 109.7 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 54.7 mt -59.94 -44.83 94.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.599 -0.84 . . . . 0.52 110.014 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -60.6 -33.84 73.34 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.488 -0.758 . . . . 2.35 110.17 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -74.01 -43.11 59.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.662 -0.649 . . . . 1.39 110.167 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.92 -37.32 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.68 110.741 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 56.4 mt -86.23 -4.8 59.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.156 -0.965 . . . . 0.83 112.148 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.06 23.36 69.08 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 120.175 -1.012 . . . . 0.91 113.22 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.5 tp -73.52 137.51 44.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.531 -0.982 . . . . 0.95 108.932 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -68.41 149.79 48.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.17 -0.956 . . . . 2.43 109.757 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.4 mt -104.07 140.35 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.504 -0.924 . . . . 1.1 108.504 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.751 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.5 mp -77.34 128.23 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.86 -1.163 . . . . 1.58 107.86 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -96.8 100.08 11.63 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 105.861 -1.903 . . . . 1.62 105.861 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.0 mt -75.56 -15.52 60.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.508 -0.745 . . . . 0.8 111.437 -177.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.5 t -78.19 -1.45 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 1.56 112.088 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.35 22.4 10.68 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.735 0.778 . . . . 0.84 111.744 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.461 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 18.0 mt -72.0 135.76 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.742 . . . . 0.82 109.1 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -121.67 -6.82 9.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.571 -0.706 . . . . 2.31 112.343 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -112.71 135.45 53.43 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.957 -1.127 . . . . 1.54 107.957 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.85 113.98 17.4 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.695 -0.854 . . . . 1.38 108.695 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.9 m -148.29 178.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.303 -0.873 . . . . 0.69 109.224 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.0 mt -87.31 144.45 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.046 -0.724 . . . . 0.53 109.046 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 19' ' ' LEU . 30.4 tp -94.76 125.81 39.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.981 -1.118 . . . . 0.64 107.981 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.19 129.9 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.981 -1.118 . . . . 0.67 107.981 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.409 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.78 153.44 22.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.156 -0.965 . . . . 0.78 109.667 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.3 73.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.663 -1.273 . . . . 1.0 109.413 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -173.22 151.2 2.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.882 -0.785 . . . . 2.42 108.882 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.0 mt -119.85 140.79 50.27 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.049 -0.722 . . . . 0.75 109.049 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 56.5 p -90.8 148.1 37.56 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.048 -1.033 . . . . 0.78 108.79 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.9 -40.59 6.03 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.919 1.746 . . . . 0.67 113.342 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.0 m -63.53 -46.22 87.03 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.052 -1.03 . . . . 0.7 110.134 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -65.26 -38.33 90.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 1.21 110.332 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 69.2 p -68.7 -41.43 79.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.492 -0.755 . . . . 0.6 110.585 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.11 83.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.685 -0.635 . . . . 0.62 110.768 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -93.63 2.46 56.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.001 -1.062 . . . . 1.16 112.543 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 171' ' ' LEU . 35.1 tp -61.82 150.39 37.31 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.341 -0.849 . . . . 0.73 109.857 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -95.89 116.19 28.55 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.52 -1.289 . . . . 2.24 107.52 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 75.1 mt -80.04 -11.25 59.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.607 -0.683 . . . . 1.43 112.368 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -83.86 -26.83 29.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 2.15 112.218 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -102.76 -3.88 25.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.305 -0.872 . . . . 2.04 113.245 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.39 126.93 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.462 -1.31 . . . . 0.55 107.462 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 28.8 tp -90.4 -7.17 53.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.788 -1.195 . . . . 1.63 112.349 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.54 173.95 41.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.367 -1.493 . . . . 0.47 109.367 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -128.88 130.65 47.13 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.138 -1.06 . . . . 0.54 108.138 179.233 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.547 HG22 HG21 ' A' ' 205' ' ' THR . 94.8 mt -134.12 105.54 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 105.83 -1.915 . . . . 0.69 105.83 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 39.1 p -126.99 176.11 7.58 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.954 -1.091 . . . . 0.82 110.991 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.581 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -104.02 56.33 0.73 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 115.931 -0.577 . . . . 2.37 109.841 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -100.59 144.37 29.65 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.15 -0.969 . . . . 1.11 109.31 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.6 -32.91 25.09 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.098 -1.049 . . . . 1.67 110.907 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 98.15 0.11 58.61 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.302 -1.117 . . . . 1.54 113.692 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.43 ' O ' ' OG1' ' A' ' 187' ' ' THR . 35.6 ttm180 -87.75 112.6 22.58 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.892 -1.521 . . . . 4.48 106.892 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 20.9 p 49.52 44.74 24.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 2.63 112.291 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.3 m -78.35 126.81 31.3 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.679 -1.23 . . . . 1.69 107.679 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -58.94 -40.8 85.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.227 -0.92 . . . . 1.07 110.292 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -59.94 -48.44 81.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.113 -0.992 . . . . 1.58 110.284 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.7 p -61.39 -38.74 88.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.473 -0.767 . . . . 1.6 110.576 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.475 HG12 HH21 ' A' ' 195' ' ' ARG . 85.5 mt -60.71 -42.42 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.095 -1.003 . . . . 1.45 110.903 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.527 ' SD ' ' CZ ' ' A' ' 65' ' ' PHE . 9.5 mtm -66.74 -36.92 83.6 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.502 -1.374 . . . . 1.05 109.461 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.76 -48.66 80.78 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.843 -0.617 . . . . 0.72 111.006 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.475 HH21 HG12 ' A' ' 192' ' ' ILE . 85.3 mtm180 -60.0 -40.45 89.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 3.05 110.409 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.3 m -64.46 -37.84 88.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 0.89 109.902 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.5 mt -89.21 -1.1 57.94 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.459 0.647 . . . . 0.78 112.045 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 54.82 8.31 0.22 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.059 1.133 . . . . 1.45 114.059 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.3 mt -71.5 149.25 93.52 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.073 -1.084 . . . . 0.67 108.073 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -59.1 144.95 99.17 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.653 1.569 . . . . 0.64 109.948 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -160.89 159.58 29.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.442 -1.411 . . . . 0.67 109.852 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 203' ' ' VAL . 73.0 mt -148.1 155.65 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.059 -1.089 . . . . 0.69 108.059 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.427 ' N ' HG22 ' A' ' 202' ' ' ILE . 2.9 m -137.75 -28.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.145 -0.972 . . . . 0.85 111.758 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.87 41.32 1.71 Allowed Glycine 0 N--CA 1.487 2.034 0 C-N-CA 120.332 -0.937 . . . . 0.92 111.846 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.547 HG21 HG22 ' A' ' 180' ' ' ILE . 75.7 p -63.45 -20.92 65.98 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.341 -1.094 . . . . 0.95 110.938 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.25 -95.88 1.33 Allowed Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.669 -1.253 . . . . 1.04 109.978 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.0 t -129.03 30.65 5.02 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.444 -1.033 . . . . 1.57 111.868 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.03 -38.34 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.701 -1.249 . . . . 0.84 110.829 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 67.6 p -57.49 -24.84 58.17 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.442 -0.903 . . . . 0.99 112.02 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.2 m -93.31 0.72 57.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.017 -1.052 . . . . 1.7 111.974 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -122.96 -4.8 8.53 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 113.082 0.771 . . . . 2.2 113.082 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 52.0 t -119.38 149.11 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 121.568 0.699 . . . . 0.84 109.723 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -116.81 158.56 23.73 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.809 -1.182 . . . . 2.2 107.809 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 45.3 p-10 -55.01 145.17 21.11 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.986 -1.071 . . . . 2.28 110.572 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t70 80.61 2.52 1.81 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 114.803 1.409 . . . . 2.35 114.803 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 62.8 t0 -65.85 146.62 54.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.941 -1.1 . . . . 1.97 108.37 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.499 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 43.3 t80 -88.18 120.64 29.73 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.993 -1.484 . . . . 2.65 106.993 178.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.591 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 79.0 mt -127.75 150.01 49.99 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.527 -0.733 . . . . 0.63 109.92 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.5 mt -118.41 123.59 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 106.691 -1.596 . . . . 0.62 106.691 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.5 tp -99.32 114.87 27.97 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.639 -1.615 . . . . 0.64 106.639 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 223' ' ' VAL . 37.2 t0 -91.36 -25.06 19.57 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.849 -1.157 . . . . 2.05 112.325 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.945 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.65 19.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.667 0.617 . . . . 0.84 112.667 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.0 t -110.94 -61.22 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.097 0.951 . . . . 1.02 108.924 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -93.19 8.72 39.03 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.7 0.762 . . . . 2.51 110.489 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 60.1 t30 62.98 52.35 2.62 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.483 0.658 . . . . 1.54 111.704 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -147.49 147.81 30.57 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.272 1.034 . . . . 1.95 109.453 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 52.0 t -117.45 139.74 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.293 -1.002 . . . . 0.71 108.293 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -103.84 132.59 49.95 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.983 -1.073 . . . . 1.01 109.01 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.9 130.04 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.953 -1.129 . . . . 0.82 107.953 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.473 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 17.9 t-20 54.05 48.09 4.4 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.241 -0.912 . . . . 1.54 113.015 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 56.1 Cg_endo -69.6 150.75 69.58 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.845 2.363 . . . . 0.94 110.921 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 68.2 p -77.75 163.03 26.49 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.314 -0.866 . . . . 1.8 110.562 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -60.47 -35.21 75.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.945 . . . . 2.73 110.56 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -59.14 -39.34 82.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.166 -0.959 . . . . 3.17 110.385 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.8 t -70.88 -42.06 77.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.175 -1.01 . . . . 1.34 110.219 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 67.0 mt -60.31 -44.61 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.769 0.795 . . . . 1.2 109.822 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.98 -40.76 90.22 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.499 -0.751 . . . . 2.7 110.81 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -62.57 -47.41 83.95 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.993 -1.067 . . . . 2.59 110.885 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.6 mtp -69.45 -36.52 76.68 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.316 -0.865 . . . . 1.38 110.677 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.606 ' NH2' ' CE1' ' A' ' 13' ' ' PHE . 1.7 mmp_? -58.01 -39.5 78.48 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.943 -1.098 . . . . 2.84 111.156 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.17 -59.4 2.76 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.131 -0.98 . . . . 1.88 111.259 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 61.4 t -60.74 -46.5 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 2.4 110.993 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -59.8 -52.19 66.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.938 . . . . 3.52 111.08 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.14 -29.57 68.5 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.231 -0.988 . . . . 1.88 111.095 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -60.1 -32.48 71.03 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.495 -0.882 . . . . 3.01 109.845 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.32 -46.72 83.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.636 -0.826 . . . . 2.45 110.012 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.83 92.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.586 -0.696 . . . . 2.75 110.427 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.7 p -68.58 -31.57 70.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.369 -0.832 . . . . 3.16 110.827 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -63.4 -40.75 98.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.431 -0.793 . . . . 3.57 110.339 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -68.46 -29.74 68.44 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.395 -0.815 . . . . 4.3 111.057 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -68.76 -23.69 64.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.941 . . . . 4.45 111.725 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -67.13 -31.6 72.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.914 -1.116 . . . . 5.97 110.948 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.407 HD11 ' O ' ' A' ' 258' ' ' ASP . 61.5 tp -63.33 -48.8 76.49 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.693 -1.255 . . . . 6.18 110.48 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -81.09 0.68 34.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.415 -0.803 . . . . 6.66 112.965 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -81.96 -44.13 17.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.941 -1.099 . . . . 8.2 111.073 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 95.1 mt -88.42 -98.82 0.09 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.044 -1.095 . . . . 8.07 108.044 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -127.03 -94.0 0.46 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.224 -1.028 . . . . 9.45 108.224 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.407 ' O ' HD11 ' A' ' 253' ' ' LEU . 95.7 m-20 -118.63 12.7 13.19 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 116.075 -0.512 . . . . 10.12 110.667 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 . . . . . 0 N--CA 1.5 2.032 0 CA-C-O 117.937 -1.03 . . . . 11.49 109.223 -179.254 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 108.97 -0.752 . . . . 3.07 108.97 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.9 mt -87.61 117.25 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.497 -1.297 . . . . 1.07 107.497 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -102.56 128.43 49.22 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.209 -1.034 . . . . 1.24 108.209 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.53 -152.39 11.51 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 108.536 -1.826 . . . . 1.01 108.536 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 5' ' ' ILE . 81.5 mt -97.23 -3.22 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.293 -1.122 . . . . 1.11 113.027 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.8 tp 49.49 95.62 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.07 -1.019 . . . . 0.99 112.126 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -85.26 -40.16 16.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.11 -0.994 . . . . 0.85 110.587 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -147.12 141.8 16.29 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.706 -1.22 . . . . 1.38 107.706 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.33 149.69 40.51 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.575 2.183 . . . . 0.94 112.144 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.897 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.13 166.16 13.51 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.885 -1.686 . . . . 0.81 108.885 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.8 mt -123.76 135.18 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.232 -1.158 . . . . 0.83 108.424 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.48 44.6 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.963 -1.086 . . . . 0.53 109.293 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -121.86 139.66 53.35 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.841 -1.17 . . . . 0.77 107.841 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.72 165.47 31.75 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 118.356 -1.878 . . . . 0.51 110.254 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -76.03 158.66 31.63 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.938 -0.742 . . . . 1.9 109.262 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.46 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -87.08 123.25 31.95 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.526 -1.287 . . . . 0.66 107.526 178.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.4 tp -100.85 108.73 20.59 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 105.28 -2.118 . . . . 0.83 105.28 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.5 tp -90.41 137.42 32.36 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.847 -1.168 . . . . 0.86 107.847 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.492 HD12 ' HB2' ' A' ' 160' ' ' ALA . 39.9 mt -101.87 120.01 39.7 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 107.714 -1.217 . . . . 0.92 107.714 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -110.97 140.15 45.72 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.056 -1.09 . . . . 2.03 108.056 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.58 139.43 53.6 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.071 -1.018 . . . . 2.66 108.758 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -84.87 133.36 34.31 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.682 -1.229 . . . . 2.32 107.682 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -64.38 146.38 54.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.074 -1.016 . . . . 2.11 109.264 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.5 mt -95.53 132.81 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.278 -0.889 . . . . 0.73 108.691 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -106.42 128.98 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.84 -1.17 . . . . 0.87 107.84 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 mt -98.17 140.17 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.714 -0.847 . . . . 0.81 108.714 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -89.35 119.95 30.26 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.626 -1.25 . . . . 1.34 107.626 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -96.73 15.68 21.22 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.187 -0.946 . . . . 2.89 112.227 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -69.22 151.09 46.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.971 -1.081 . . . . 2.09 110.35 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -90.12 131.87 35.74 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.176 -1.046 . . . . 2.19 108.176 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.2 pt -96.1 168.5 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.577 0.703 . . . . 0.75 110.499 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.9 p -92.48 166.19 12.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.474 -0.766 . . . . 0.91 110.252 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.6 -22.78 47.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.335 -0.853 . . . . 0.93 112.142 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.02 -36.65 80.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.919 -1.113 . . . . 2.28 111.026 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -85.85 -5.5 59.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.574 -1.329 . . . . 1.45 112.501 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.93 -44.55 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.218 -0.926 . . . . 0.81 110.478 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -58.73 -40.35 83.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.082 -1.011 . . . . 1.54 110.247 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.64 -40.78 96.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.484 -0.76 . . . . 2.36 110.965 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -60.72 -39.99 90.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.102 -0.999 . . . . 1.31 110.613 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.36 -40.83 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.956 -1.09 . . . . 0.82 110.242 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -62.23 -40.82 97.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.941 -1.099 . . . . 1.5 110.365 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 42' ' ' ARG . 45.6 mtt-85 -62.01 -41.75 98.42 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.194 -0.941 . . . . 2.23 110.131 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -76.12 -51.4 12.27 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.319 -0.863 . . . . 0.85 109.973 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.03 -49.03 79.44 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.741 -0.784 . . . . 0.91 109.606 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.9 t -70.55 -40.84 73.16 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.59 -0.694 . . . . 0.9 109.962 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.67 -44.51 96.83 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.118 -1.593 . . . . 0.69 109.118 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -57.75 -31.46 66.5 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.498 -1.001 . . . . 2.88 109.548 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.27 -45.63 92.63 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.589 0.709 . . . . 0.85 110.194 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -80.23 -40.82 26.3 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.474 -0.767 . . . . 2.35 111.035 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.64 90.03 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.56 0.695 . . . . 0.65 109.928 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.9 t -60.71 -40.01 90.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.244 1.021 . . . . 1.45 109.238 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.5 78.51 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.824 -0.626 . . . . 0.63 109.804 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -61.27 -50.32 73.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.056 -1.028 . . . . 1.34 110.193 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.86 -39.36 91.63 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.309 -0.869 . . . . 1.56 109.897 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -60.21 -41.33 92.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.802 -0.562 . . . . 1.19 110.915 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.3 m -67.13 -43.0 83.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.94 -1.1 . . . . 0.72 110.244 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.0 mt -59.87 -38.44 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.467 -0.771 . . . . 0.62 110.59 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -53.04 -42.5 65.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 1.05 110.865 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -69.87 -33.05 71.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.982 -1.074 . . . . 0.64 110.383 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -63.22 -39.95 96.08 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.175 -1.01 . . . . 1.73 109.818 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.78 78.31 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.366 -0.834 . . . . 0.56 110.021 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.52 -35.32 29.46 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 119.55 -1.31 . . . . 0.69 110.613 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.45 -19.79 38.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.121 -1.223 . . . . 1.48 111.016 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.9 m -89.59 -55.3 3.7 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.852 -0.53 . . . . 0.98 110.274 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.51 -2.74 20.1 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 113.807 1.04 . . . . 1.16 113.807 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.05 160.95 26.49 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.746 -0.74 . . . . 0.85 112.559 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -52.93 -18.95 2.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.458 -1.025 . . . . 3.86 112.697 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 68' ' ' GLU . 4.9 pt-20 -56.99 -44.18 82.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.049 -1.032 . . . . 2.35 110.842 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -84.57 -21.01 30.57 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.606 -1.309 . . . . 1.67 111.534 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -59.83 -38.61 82.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.567 -0.708 . . . . 1.45 110.956 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.98 82.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.457 -0.777 . . . . 0.61 111.693 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 72' ' ' ILE . 22.9 mt -63.72 -45.01 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.586 -1.321 . . . . 0.65 110.518 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -69.23 -32.37 71.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.66 110.508 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -62.36 -40.11 95.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.532 -0.867 . . . . 1.19 110.597 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.55 -39.88 98.42 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 120.133 -1.032 . . . . 0.53 110.713 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -58.68 -41.69 86.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.295 -1.12 . . . . 1.27 110.44 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.3 mt -60.04 -36.46 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.932 -1.105 . . . . 0.54 110.448 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.3 ttm -59.8 -39.43 84.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.852 . . . . 1.74 110.61 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 tp -60.82 -48.79 80.2 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.591 -0.844 . . . . 0.55 110.007 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.46 -42.59 96.48 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.458 0.647 . . . . 0.47 110.949 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -87.56 5.65 38.28 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.271 -0.893 . . . . 1.42 113.05 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -60.59 121.19 11.57 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.689 -1.257 . . . . 1.27 108.585 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.15 -18.55 65.4 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.875 0.845 . . . . 1.35 110.631 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -75.16 -52.63 10.49 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.675 -0.81 . . . . 2.22 110.079 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.32 -37.0 79.22 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.688 -0.805 . . . . 0.62 110.525 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -57.59 -47.86 80.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.199 -0.938 . . . . 1.29 110.992 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.7 -37.27 81.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.436 -0.79 . . . . 1.52 110.635 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.58 -48.8 68.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.71 -1.244 . . . . 1.3 110.26 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.2 mt -56.57 -45.96 82.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.923 -1.11 . . . . 0.61 109.947 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.0 mt -60.77 -41.9 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.541 0.686 . . . . 0.78 110.36 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.7 98.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.905 . . . . 0.82 110.711 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.67 -42.49 97.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.048 -1.032 . . . . 0.8 110.679 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.41 -45.59 98.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.204 -0.935 . . . . 0.77 110.323 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -83.67 -34.5 24.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 2.12 112.132 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -80.86 -44.86 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.693 -1.254 . . . . 1.51 111.856 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -102.53 8.36 39.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.593 -0.692 . . . . 1.98 112.318 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.0 m170 49.66 49.02 20.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 1.32 111.641 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.4 mtp -101.68 156.58 17.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.583 -0.698 . . . . 1.38 109.397 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.3 p -74.14 160.16 31.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.573 -0.529 . . . . 0.67 109.573 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.14 -40.52 81.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.155 -0.966 . . . . 0.52 110.301 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.544 ' OD2' HD21 ' A' ' 142' ' ' LEU . 73.6 m-20 -68.08 -44.09 77.05 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.905 0.86 . . . . 2.25 110.241 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.06 -49.09 63.5 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.625 -0.83 . . . . 0.64 110.955 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.13 87.91 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.267 -0.896 . . . . 0.56 110.181 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.54 95.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.46 110.539 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -60.29 -36.18 77.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 1.32 111.423 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.05 -50.21 74.63 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.039 -1.038 . . . . 1.3 110.954 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -60.24 -48.01 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.552 -1.343 . . . . 0.61 109.947 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -60.92 -31.86 50.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 121.599 -0.688 . . . . 0.65 110.331 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -57.08 -41.04 78.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.123 -0.986 . . . . 2.11 111.175 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.73 -35.36 11.67 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.231 -1.462 . . . . 0.83 112.191 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -59.99 -40.9 90.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.504 -1.586 . . . . 1.28 110.241 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.48 -51.49 14.65 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.892 0.853 . . . . 0.89 110.224 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.2 m -59.31 -39.85 84.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.307 -0.871 . . . . 1.87 110.619 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.79 98.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -0.784 . . . . 1.05 111.064 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 80.9 mt -63.93 -31.11 72.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.725 -1.234 . . . . 1.02 110.961 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -66.43 -22.65 66.22 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.923 -1.111 . . . . 2.04 110.915 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -72.5 -12.41 61.07 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.676 0.751 . . . . 1.73 111.059 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.507 HD13 HD13 ' A' ' 123' ' ' LEU . 82.9 mt -86.53 149.54 24.88 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.363 0.602 . . . . 1.37 109.426 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -103.02 39.11 1.61 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.127 -0.983 . . . . 2.88 111.769 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.509 ' CB ' HD12 ' A' ' 123' ' ' LEU . 51.2 t0 -115.78 139.07 50.53 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 121.141 -0.975 . . . . 1.58 108.77 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.06 -40.16 84.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 3.04 110.97 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -72.46 -48.82 37.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.846 -1.159 . . . . 0.9 111.068 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.509 HD12 ' CB ' ' A' ' 120' ' ' ASP . 19.3 mt -61.5 -43.43 98.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.878 -1.138 . . . . 1.06 110.116 -178.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -63.79 -50.09 70.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.954 . . . . 2.18 110.06 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -59.9 -32.89 71.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.415 -0.803 . . . . 2.15 110.122 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -63.79 -28.17 69.68 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.716 -1.194 . . . . 2.33 109.343 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -59.06 -47.82 83.86 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.684 0.754 . . . . 0.82 109.685 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.95 -42.35 97.33 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.222 -0.991 . . . . 0.85 109.509 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.48 -31.31 71.96 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.313 0.577 . . . . 1.39 110.26 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.3 t -68.1 -44.97 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 0.56 109.942 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -59.36 -36.15 75.2 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.071 -1.018 . . . . 3.12 110.099 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -60.0 -39.69 86.65 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.067 -0.515 . . . . 1.28 110.579 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.48 -40.02 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.206 -0.934 . . . . 0.49 109.936 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.02 -41.75 31.53 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 119.838 -1.172 . . . . 0.46 110.691 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.457 ' HG2' ' HZ2' ' A' ' 135' ' ' LYS . 16.6 ttpp -58.29 -41.94 85.49 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.305 -1.115 . . . . 2.71 110.355 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HG2' ' NH1' ' A' ' 136' ' ' ARG . 63.7 mtt-85 -63.31 -44.58 94.58 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.478 -0.889 . . . . 2.14 110.019 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 32.2 tp -60.84 -42.06 97.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.625 -0.672 . . . . 1.05 110.084 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.1 mt -59.76 -40.83 89.46 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.377 -0.827 . . . . 0.52 110.367 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -61.33 -36.16 79.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.188 -0.945 . . . . 2.35 110.806 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -74.31 -41.36 61.28 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.218 -0.993 . . . . 1.39 110.698 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.484 HG21 ' OD1' ' A' ' 101' ' ' ASP . 88.5 mt -60.48 -39.02 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.335 -0.853 . . . . 0.68 110.454 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.544 HD21 ' OD2' ' A' ' 101' ' ' ASP . 70.0 mt -85.09 -8.01 58.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.968 -1.082 . . . . 0.83 112.263 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.12 15.6 80.14 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 120.334 -0.936 . . . . 0.91 112.314 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 27.7 tp -70.0 142.37 52.8 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.715 0.769 . . . . 0.95 109.474 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -68.35 151.27 47.11 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.313 -0.867 . . . . 2.43 110.205 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.1 mt -104.61 135.17 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.261 -1.014 . . . . 1.1 108.261 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.726 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -78.49 117.91 24.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.696 -0.853 . . . . 1.58 108.696 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -99.35 103.32 15.13 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.263 -1.755 . . . . 1.62 106.263 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -74.12 -15.21 61.05 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.604 -0.685 . . . . 0.8 111.573 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -81.59 1.8 32.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.224 -0.922 . . . . 1.56 112.279 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.44 23.85 8.02 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.317 -0.864 . . . . 0.84 112.546 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.5 mt -72.41 139.92 18.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.102 -0.999 . . . . 0.82 108.923 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -110.52 -18.88 13.1 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.865 0.841 . . . . 2.31 112.611 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -114.33 134.17 55.15 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.802 -1.185 . . . . 1.54 107.802 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.54 127.57 33.2 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.039 -1.038 . . . . 1.38 108.402 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.84 173.49 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.014 -0.736 . . . . 0.69 109.014 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 29.6 mt -86.75 139.58 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.396 -0.965 . . . . 0.53 108.396 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.5 tp -94.7 122.94 37.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.119 -0.988 . . . . 0.64 108.681 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.48 131.17 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.091 -1.077 . . . . 0.67 108.091 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.492 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -160.7 153.7 21.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 0.78 108.73 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.471 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -62.5 -36.29 82.09 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.502 -1.374 . . . . 1.0 109.411 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 57.7 t0 -170.86 150.54 3.21 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.651 -0.87 . . . . 2.42 108.651 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.468 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 79.8 mt -119.19 143.21 47.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.27 -0.894 . . . . 0.75 109.261 177.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.4 p -91.83 146.49 33.09 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 120.988 -1.07 . . . . 0.78 108.625 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -39.31 -42.62 2.48 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.216 1.944 . . . . 0.67 114.045 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.3 m -59.81 -48.33 82.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 0.7 110.154 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -64.5 -39.95 94.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.002 -1.061 . . . . 1.21 110.284 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 35.0 p -68.47 -35.0 76.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.608 -0.683 . . . . 0.6 110.659 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.68 88.36 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.424 -0.798 . . . . 0.62 110.364 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -93.21 -1.21 56.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.318 -0.864 . . . . 1.16 112.597 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 171' ' ' LEU . 39.0 tp -61.71 150.87 35.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.342 -0.849 . . . . 0.73 109.361 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -94.76 115.03 27.01 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 107.331 -1.359 . . . . 2.24 107.331 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 23.1 mt -73.83 -20.39 60.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.864 -0.523 . . . . 1.43 111.459 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -83.03 -23.04 33.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 2.15 112.252 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -100.88 -1.88 33.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.263 0.838 . . . . 2.04 113.263 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 178' ' ' GLY . 60.4 t -108.38 125.52 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.648 -1.241 . . . . 0.55 107.648 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 13.0 tp -84.25 -4.1 58.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 1.63 111.796 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.604 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.83 170.31 30.59 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.858 -1.697 . . . . 0.47 108.858 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.09 129.33 47.76 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 107.785 -1.191 . . . . 0.54 107.785 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.464 HG22 HG21 ' A' ' 205' ' ' THR . 87.2 mt -130.99 109.85 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 106.409 -1.7 . . . . 0.69 106.409 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 205' ' ' THR . 66.9 p -127.39 169.86 13.15 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.974 -1.079 . . . . 0.82 109.586 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 21.4 p-10 -101.67 53.43 0.82 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.719 -0.613 . . . . 2.37 110.643 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -99.53 133.37 43.95 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.371 -0.974 . . . . 1.11 108.371 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.4 3.17 4.82 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.733 -1.222 . . . . 1.67 112.638 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 92.92 -4.68 75.43 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.247 -1.149 . . . . 1.54 113.198 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.448 ' CG ' ' O ' ' A' ' 186' ' ' ARG . 26.2 ptt180 -81.63 118.36 22.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.813 -1.551 . . . . 4.48 106.813 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 73.5 p 46.95 40.28 9.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.763 -1.211 . . . . 2.63 111.881 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 82.0 p -84.34 109.44 17.83 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.029 -1.471 . . . . 1.69 107.029 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -61.54 -32.97 73.06 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.509 -0.744 . . . . 1.07 110.811 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.3 p -57.13 -40.3 76.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.748 -1.22 . . . . 1.58 110.218 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.0 t -60.17 -39.62 87.11 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.018 -1.051 . . . . 1.6 109.892 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.1 mm -59.88 -40.13 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 1.45 110.351 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.4 mtp -65.06 -42.74 93.92 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.339 1.066 . . . . 1.05 109.605 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.28 -47.42 86.06 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.797 -0.638 . . . . 0.72 110.979 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -61.38 -42.79 99.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.977 -1.077 . . . . 3.05 110.436 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 72.4 m -70.59 -42.73 70.63 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.956 0.884 . . . . 0.89 110.127 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.2 mt -91.84 -8.14 47.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.46 -0.775 . . . . 0.78 112.182 -177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 54.43 9.78 0.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.912 1.078 . . . . 1.45 113.912 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 37.7 mt -70.14 164.97 48.0 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.079 -1.013 . . . . 0.67 109.283 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -70.68 144.28 48.69 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.7 1.6 . . . . 0.64 110.444 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -160.91 166.11 28.95 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.701 -1.6 . . . . 0.67 109.611 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 65.0 mt -146.9 156.48 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.447 -1.316 . . . . 0.69 107.447 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.5 m -140.94 -31.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 O-C-N 120.687 -1.258 . . . . 0.85 112.366 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.05 43.29 2.44 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.007 -1.058 . . . . 0.92 111.997 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 181' ' ' THR . 30.6 p -63.03 -16.73 60.85 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.134 -1.216 . . . . 0.95 111.202 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.96 -94.71 1.0 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 110.14 -1.184 . . . . 1.04 110.14 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 86.8 p -129.07 30.92 4.97 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.607 -0.937 . . . . 1.57 111.716 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.13 -38.18 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.506 -1.371 . . . . 0.84 110.165 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 76.2 p -52.86 -25.81 12.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.99 111.379 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.9 p -96.27 6.2 49.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 1.7 111.814 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -128.82 -4.17 5.19 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 113.136 0.791 . . . . 2.2 113.136 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 13.4 t -117.96 149.51 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.675 0.75 . . . . 0.84 109.784 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -118.46 152.53 35.73 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.079 -1.082 . . . . 2.2 108.079 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 40.4 p-10 -54.31 146.3 15.85 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.932 -1.107 . . . . 2.28 110.113 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 t70 81.07 -3.42 1.74 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 114.304 1.224 . . . . 2.35 114.304 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.76 146.16 53.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.948 -1.095 . . . . 1.97 108.74 177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -88.78 120.22 29.99 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.003 -1.48 . . . . 2.65 107.003 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.46 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.1 mt -126.67 143.39 51.25 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.274 -0.891 . . . . 0.63 109.846 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.7 mt -109.53 121.37 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.859 -1.534 . . . . 0.62 106.859 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 32.8 tp -98.91 109.79 22.49 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.12 -1.807 . . . . 0.64 106.12 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.9 p30 -93.76 -22.52 18.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.907 -1.121 . . . . 2.05 112.958 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.897 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.64 19.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.58 0.705 . . . . 0.84 112.804 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.7 t -108.42 -60.14 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.015 -1.053 . . . . 1.02 108.837 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -88.7 8.25 29.62 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.159 0.98 . . . . 2.51 110.028 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 65.86 49.55 1.65 Allowed 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.9 -1.045 . . . . 1.54 111.944 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -154.65 156.34 36.3 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.642 1.21 . . . . 1.95 110.873 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 54.8 t -118.14 141.58 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 115.176 -0.92 . . . . 0.71 108.626 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -100.98 139.09 37.16 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.961 -1.087 . . . . 1.01 108.431 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.1 t -111.11 129.71 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 107.945 -1.132 . . . . 0.82 107.945 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.429 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 4.1 t30 49.57 50.17 8.66 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 113.4 0.889 . . . . 1.54 113.4 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 29.8 Cg_endo -65.14 151.71 84.68 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.42 2.08 . . . . 0.94 110.41 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 35.9 p -73.4 159.63 33.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.053 -1.029 . . . . 1.8 108.84 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -63.26 -33.81 76.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.365 -0.834 . . . . 2.73 111.143 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.22 -39.25 82.11 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.081 -1.012 . . . . 3.17 110.699 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 98.2 t -71.94 -39.34 66.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.264 -0.897 . . . . 1.34 110.77 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.0 mt -58.11 -46.79 88.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.178 -0.951 . . . . 1.2 110.154 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.01 -42.62 94.7 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.58 -0.848 . . . . 2.7 110.748 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -61.98 -42.66 99.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.006 -1.058 . . . . 2.59 110.892 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 86.6 mtp -70.42 -38.45 74.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 1.38 110.87 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.432 ' NH1' ' HG3' ' A' ' 240' ' ' ARG . 22.5 mmm-85 -59.19 -39.75 83.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.849 -1.157 . . . . 2.84 110.963 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -71.29 -57.12 4.77 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.523 -0.736 . . . . 1.88 110.682 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.13 -42.29 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.076 -1.015 . . . . 2.4 111.101 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.74 -54.28 47.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.896 -1.128 . . . . 3.52 110.621 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.19 -30.97 72.0 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.928 -1.107 . . . . 1.88 110.244 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -60.81 -31.03 70.44 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.437 -0.905 . . . . 3.01 109.459 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.79 -45.63 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.46 -0.896 . . . . 2.45 109.717 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.35 98.88 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.47 0.652 . . . . 2.75 110.174 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.0 t -70.26 -32.42 70.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 3.16 110.811 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.92 -39.91 93.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.16 -0.963 . . . . 3.57 111.117 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -64.98 -37.89 89.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.954 -1.091 . . . . 4.3 110.648 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -68.03 -34.26 76.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 4.45 110.681 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -69.57 -30.84 68.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 5.97 111.304 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.744 HD13 ' C ' ' A' ' 253' ' ' LEU . 2.7 tm? -60.71 -46.79 89.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.913 -1.117 . . . . 6.18 110.627 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -69.26 -37.14 77.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.097 -1.002 . . . . 6.66 110.399 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -89.48 25.09 2.06 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.166 0.802 . . . . 8.2 113.166 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.494 ' O ' HD23 ' A' ' 256' ' ' LEU . 0.7 OUTLIER -78.47 -3.97 46.13 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.177 -0.952 . . . . 8.07 112.2 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -84.41 -14.01 50.57 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.784 -1.197 . . . . 9.45 112.545 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -101.79 -28.78 12.25 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.072 -1.018 . . . . 10.12 112.828 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.859 -1.067 . . . . 11.49 109.686 -177.929 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.2 mtm . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 109.387 -0.598 . . . . 3.07 109.387 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.9 mt -93.88 111.41 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 106.564 -1.643 . . . . 1.07 106.564 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.1 m -104.9 120.57 41.75 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.004 -1.11 . . . . 1.24 108.004 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.08 -158.5 22.21 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.74 -1.744 . . . . 1.01 108.74 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 5' ' ' ILE . 84.4 mt -96.26 -0.59 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.303 -1.116 . . . . 1.11 113.002 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tp 50.06 98.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.925 -1.109 . . . . 0.99 112.583 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.13 -45.12 12.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.106 -0.996 . . . . 0.85 110.849 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -146.58 140.87 15.62 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 107.639 -1.245 . . . . 1.38 107.639 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.38 150.75 41.86 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.506 2.138 . . . . 0.94 112.345 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.947 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.41 170.34 18.8 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 108.992 -1.643 . . . . 0.81 108.992 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.564 ' O ' ' NE2' ' A' ' 243' ' ' GLN . 98.5 mt -129.86 138.8 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.026 -1.279 . . . . 0.83 108.288 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.35 149.88 38.36 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.054 -1.029 . . . . 0.53 109.417 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.3 m-85 -122.04 139.83 53.23 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.969 -1.123 . . . . 0.77 107.969 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.24 171.21 41.34 Favored Glycine 0 N--CA 1.499 2.848 0 C-N-CA 118.746 -1.692 . . . . 0.51 110.213 178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -76.4 158.77 31.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.604 -0.939 . . . . 1.9 108.742 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.59 132.83 33.8 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.225 -0.922 . . . . 0.66 108.827 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.6 tp -110.63 102.69 11.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.78 -1.933 . . . . 0.83 105.78 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.8 tp -91.51 136.84 32.83 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.078 -1.082 . . . . 0.86 108.078 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.5 mt -102.34 116.23 32.2 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.947 -1.501 . . . . 0.92 106.947 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -111.18 137.88 48.32 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.656 -1.238 . . . . 2.03 107.656 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -125.65 149.66 48.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.089 -1.007 . . . . 2.66 108.864 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -85.21 137.56 32.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.736 -1.209 . . . . 2.32 107.736 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -63.3 148.29 48.7 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.599 -0.84 . . . . 2.11 108.818 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -92.55 135.38 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.403 -0.962 . . . . 0.73 108.403 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.7 t -104.4 130.16 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.061 -1.089 . . . . 0.87 108.061 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.1 mt -98.32 135.22 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.278 -1.008 . . . . 0.81 108.278 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -90.64 119.23 30.71 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 106.948 -1.501 . . . . 1.34 106.948 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.451 HH11 ' HG3' ' A' ' 28' ' ' ARG . 19.1 mmm-85 -96.81 11.74 34.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 2.89 112.111 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -72.01 152.26 42.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.176 -0.952 . . . . 2.09 109.619 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -91.71 135.14 34.12 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.54 -0.911 . . . . 2.19 108.54 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -94.64 167.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.886 -1.133 . . . . 0.75 109.957 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.5 p -93.8 166.06 12.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.112 -0.993 . . . . 0.91 109.332 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.06 -19.81 34.57 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.876 -1.14 . . . . 0.93 112.814 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 60.1 t0 -70.01 -38.06 75.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.784 -1.197 . . . . 2.28 110.749 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -86.38 -11.0 53.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.809 -1.182 . . . . 1.45 112.202 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.34 -43.94 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.003 -1.061 . . . . 0.81 110.362 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.1 -39.81 83.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.357 -0.839 . . . . 1.54 110.621 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -63.68 -42.66 98.0 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.25 -0.907 . . . . 2.36 111.019 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -61.53 -38.78 88.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.986 -1.071 . . . . 1.31 110.901 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.4 t -60.0 -45.4 95.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.155 -0.965 . . . . 0.82 110.329 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -61.55 -45.49 93.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.975 . . . . 1.5 110.081 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.65 -43.31 97.77 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.387 -0.821 . . . . 2.23 110.286 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -71.41 -56.94 4.97 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.185 -0.947 . . . . 0.85 109.987 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.6 tp -58.18 -47.46 83.34 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.203 -0.999 . . . . 0.91 109.786 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.4 t -69.95 -37.47 75.86 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.141 -0.975 . . . . 0.9 109.997 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.45 -46.89 91.43 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.912 -1.137 . . . . 0.69 110.366 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -59.83 -30.6 69.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.406 -1.056 . . . . 2.88 109.437 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.16 -45.2 87.87 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.163 -0.615 . . . . 0.85 109.868 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -80.8 -42.26 22.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 2.35 110.885 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.43 85.5 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.599 -0.841 . . . . 0.65 109.42 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 t -60.68 -41.13 94.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.217 1.008 . . . . 1.45 109.077 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.47 -46.07 77.59 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.62 -0.718 . . . . 0.63 110.144 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -62.92 -49.98 72.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.092 -1.005 . . . . 1.34 109.997 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.1 mt -61.69 -40.01 93.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.163 -0.96 . . . . 1.56 109.978 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -60.15 -40.02 88.41 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.93 -0.481 . . . . 1.19 110.497 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.53 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 16.2 m -65.59 -45.01 84.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.924 -1.11 . . . . 0.72 110.043 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.57 -37.84 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 0.62 110.3 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.42 ' NZ ' ' OE2' ' A' ' 70' ' ' GLU . 9.0 ttpp -49.25 -43.4 42.83 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.968 -0.693 . . . . 1.05 110.915 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -69.54 -38.99 77.72 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.581 -0.699 . . . . 0.64 109.659 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.53 ' NZ ' HG22 ' A' ' 56' ' ' THR . 62.1 mttp -61.01 -40.32 93.09 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.46 -1.296 . . . . 1.73 108.996 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.24 77.73 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.922 -0.711 . . . . 0.56 109.835 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.47 -36.74 19.42 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.704 -1.236 . . . . 0.69 110.939 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -80.79 -27.28 36.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.041 -1.27 . . . . 1.48 111.125 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -83.9 -49.87 8.6 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.565 -0.709 . . . . 0.98 111.021 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.87 -5.08 18.55 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.031 1.123 . . . . 1.16 114.031 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.88 163.84 28.97 Favored Glycine 0 N--CA 1.502 3.096 0 O-C-N 121.291 -0.881 . . . . 0.85 111.82 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -56.49 -24.34 45.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.685 -0.891 . . . . 3.86 112.218 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.6 -39.93 68.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 2.35 110.715 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -87.72 -25.03 23.66 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.931 -1.106 . . . . 1.67 111.386 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.42 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 71.1 tt0 -59.72 -37.31 78.54 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.489 0.661 . . . . 1.45 110.647 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.96 74.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.61 111.341 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.55 -42.37 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.634 -1.291 . . . . 0.65 110.517 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -70.13 -31.66 69.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.392 -0.817 . . . . 0.66 110.252 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -59.99 -38.44 82.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.042 -1.036 . . . . 1.19 110.278 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.48 -39.87 86.85 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.004 -1.238 . . . . 0.53 110.004 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -60.21 -45.72 92.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.273 -1.133 . . . . 1.27 110.312 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.5 mt -60.92 -39.34 81.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.193 -0.942 . . . . 0.54 110.318 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.7 ttm -56.9 -40.55 76.47 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.594 -0.842 . . . . 1.74 110.101 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -59.52 -50.05 75.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 0.55 109.992 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.4 tp -61.88 -41.04 97.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.502 -0.748 . . . . 0.47 110.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -86.38 8.05 23.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.506 -0.746 . . . . 1.42 112.518 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -65.5 125.69 25.98 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.448 -1.407 . . . . 1.27 108.346 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.0 -18.73 65.52 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.107 0.956 . . . . 1.35 110.711 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -76.46 -54.65 6.42 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.752 -0.779 . . . . 2.22 110.428 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.68 -35.15 75.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.408 -0.807 . . . . 0.62 110.962 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -59.93 -49.19 78.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.416 -0.802 . . . . 1.29 110.522 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -61.6 -35.72 78.65 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.61 -0.681 . . . . 1.52 110.625 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.82 -46.87 73.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.02 . . . . 1.3 110.619 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.8 mt -59.51 -46.52 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.146 -0.971 . . . . 0.61 109.718 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.7 mt -62.18 -41.25 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.446 0.641 . . . . 0.78 110.529 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.5 -44.24 97.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.103 -0.998 . . . . 0.82 110.741 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.58 -42.31 96.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.045 -1.034 . . . . 0.8 110.434 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.58 -49.43 83.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.034 -1.041 . . . . 0.77 110.386 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -82.8 -31.48 28.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.157 -0.965 . . . . 2.12 111.644 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 91' ' ' ALA . 35.8 t0 -83.03 -45.83 13.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.735 -1.228 . . . . 1.51 111.886 -178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -103.26 11.24 37.06 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.307 -0.87 . . . . 1.98 111.998 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.2 m80 51.3 51.95 15.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.441 -0.787 . . . . 1.32 111.999 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -105.89 151.93 23.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.456 -0.777 . . . . 1.38 109.178 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.7 p -71.61 161.92 30.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.43 -0.794 . . . . 0.67 109.583 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.95 -44.4 91.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.261 -0.899 . . . . 0.52 110.875 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 21.0 p-10 -68.71 -39.25 80.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.996 -1.065 . . . . 2.25 110.133 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -48.21 63.78 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.727 -0.789 . . . . 0.64 111.176 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.35 77.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.242 -0.911 . . . . 0.56 110.577 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.7 89.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.448 -0.783 . . . . 0.46 110.656 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.9 -39.48 89.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.852 -1.155 . . . . 1.32 110.937 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.53 -48.74 79.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.857 -1.152 . . . . 1.3 110.742 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.9 t -59.74 -47.91 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.707 -1.246 . . . . 0.61 109.877 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.0 mm -61.71 -35.64 68.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.934 -0.479 . . . . 0.65 110.617 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -56.58 -40.2 74.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.893 -1.129 . . . . 2.11 111.073 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.36 -28.89 23.67 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.346 -1.407 . . . . 0.83 113.185 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -62.35 -39.94 94.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.466 -1.608 . . . . 1.28 109.973 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.03 -48.49 35.72 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.787 0.803 . . . . 0.89 110.517 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.4 m -61.45 -40.62 95.14 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.208 -0.597 . . . . 1.87 110.239 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.55 95.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.503 -0.748 . . . . 1.05 110.63 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.46 -28.28 69.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.903 -1.123 . . . . 1.02 110.826 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -66.34 -23.24 66.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.561 0.696 . . . . 2.04 110.917 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -76.33 -11.0 59.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.728 -0.608 . . . . 1.73 111.438 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.669 HD13 HD13 ' A' ' 123' ' ' LEU . 4.0 mt -87.27 138.78 31.19 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.038 -1.097 . . . . 1.37 108.038 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 14.2 t70 -96.24 62.52 2.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.308 -0.87 . . . . 2.88 110.48 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -138.36 135.96 35.87 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 107.574 -1.269 . . . . 1.58 107.574 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -59.18 -37.26 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 3.04 110.837 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -71.21 -55.68 7.62 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.809 -1.182 . . . . 0.9 110.402 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.669 HD13 HD13 ' A' ' 118' ' ' LEU . 29.9 mt -60.83 -38.41 85.4 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.109 -0.994 . . . . 1.06 110.704 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -60.7 -49.53 77.12 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.952 -1.099 . . . . 2.18 109.507 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -60.21 -30.41 69.36 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.49 -0.884 . . . . 2.15 109.431 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 130' ' ' VAL . 57.6 ttt180 -62.26 -29.86 70.71 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.06 -1.056 . . . . 2.33 109.03 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.98 75.47 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.939 0.876 . . . . 0.82 109.32 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -42.55 77.26 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.881 -0.6 . . . . 0.85 110.513 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -62.78 -36.52 83.38 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.626 0.727 . . . . 1.39 110.25 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 126' ' ' ARG . 41.7 t -69.21 -39.41 79.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.406 -0.809 . . . . 0.56 110.14 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.414 ' HG3' HH11 ' A' ' 131' ' ' ARG . 38.9 ttm-85 -56.4 -38.96 72.22 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 118.912 -1.115 . . . . 3.12 109.489 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -60.02 -38.6 83.18 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.391 0.615 . . . . 1.28 110.121 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.3 mt -60.33 -39.93 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.703 -0.623 . . . . 0.49 110.027 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.85 -43.79 40.45 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.925 -1.131 . . . . 0.46 110.734 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -57.19 -42.5 81.33 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.145 -1.209 . . . . 2.71 110.099 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 -62.95 -40.69 98.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.13 -0.981 . . . . 2.14 109.815 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.84 -45.95 92.45 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.534 -0.729 . . . . 1.05 110.122 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.69 -42.17 92.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.585 -0.697 . . . . 0.52 110.62 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -60.27 -37.59 80.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.518 -0.739 . . . . 2.35 110.831 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -75.28 -41.38 57.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 1.39 111.191 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.02 -42.17 88.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.991 -1.068 . . . . 0.68 110.292 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.2 -11.0 36.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.926 -1.109 . . . . 0.83 112.276 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.07 26.82 61.29 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 119.611 -1.281 . . . . 0.91 113.11 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 22.3 tp -62.57 149.83 42.1 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.713 -0.875 . . . . 0.95 108.96 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -64.55 149.02 49.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 2.43 109.603 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 70.4 mt -106.7 142.73 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.547 -0.908 . . . . 1.1 108.547 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.762 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -78.75 129.82 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.001 -1.062 . . . . 1.58 108.253 178.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -97.8 87.17 3.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.221 -1.029 . . . . 1.62 108.221 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.97 -24.92 60.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.369 -0.832 . . . . 0.8 111.302 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.5 t -82.01 -0.54 44.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 1.56 112.1 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.49 25.74 7.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.546 -0.721 . . . . 0.84 111.6 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 mt -70.96 139.98 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.138 -0.976 . . . . 0.82 109.439 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -112.02 -20.18 12.06 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.645 0.735 . . . . 2.31 112.073 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -117.63 137.75 52.42 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.704 -1.221 . . . . 1.54 107.704 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.25 128.34 35.37 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.977 -1.119 . . . . 1.38 107.977 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.0 m -148.33 176.76 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.064 -0.717 . . . . 0.69 109.064 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 44.4 mt -88.17 143.72 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.138 -0.976 . . . . 0.53 109.007 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.5 tp -95.93 120.21 35.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.014 -1.054 . . . . 0.64 108.61 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.0 t -120.15 129.58 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 107.506 -1.294 . . . . 0.67 107.506 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.69 151.65 16.9 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.174 -0.954 . . . . 0.78 109.084 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.74 -32.46 72.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.358 -1.464 . . . . 1.0 109.616 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -173.42 152.01 2.09 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.655 -0.868 . . . . 2.42 108.655 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 41.7 mt -112.73 140.27 47.64 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.382 -0.824 . . . . 0.75 108.965 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.9 p -91.11 146.87 34.44 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.072 -1.018 . . . . 0.78 108.852 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -39.19 -43.02 2.43 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 122.173 1.915 . . . . 0.67 113.405 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.6 m -60.16 -48.5 81.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.066 . . . . 0.7 110.234 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -64.68 -39.91 94.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.019 -1.051 . . . . 1.21 109.9 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 43.2 p -65.47 -43.32 90.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.602 -0.686 . . . . 0.6 110.978 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.75 82.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.62 110.617 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -95.87 -1.14 50.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.171 -0.955 . . . . 1.16 112.79 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.74 145.85 51.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.973 -1.079 . . . . 0.73 108.181 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -94.99 117.49 30.22 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 106.979 -1.489 . . . . 2.24 106.979 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.729 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -72.93 -18.59 61.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.781 -0.574 . . . . 1.43 111.151 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -84.06 -16.17 44.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 2.15 112.222 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -103.38 -11.97 17.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.538 -0.726 . . . . 2.04 112.812 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 178' ' ' GLY . 94.9 t -106.15 128.49 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 107.888 -1.153 . . . . 0.55 107.888 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.62 -8.41 58.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.031 -1.043 . . . . 1.63 112.326 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.552 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 177.22 173.94 43.19 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.437 -1.465 . . . . 0.47 109.437 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -127.48 131.62 50.12 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 107.79 -1.189 . . . . 0.54 107.79 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.533 HD11 HD13 ' A' ' 220' ' ' LEU . 62.5 mt -137.18 118.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 105.932 -1.877 . . . . 0.69 105.932 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 203' ' ' VAL . 62.9 p -140.46 170.81 15.11 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.693 -1.254 . . . . 0.82 110.08 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -104.09 65.36 0.8 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.791 -0.568 . . . . 2.37 109.627 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -104.33 152.22 22.51 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.494 -0.754 . . . . 1.11 109.484 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.45 -38.47 70.04 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 120.222 -0.99 . . . . 1.67 110.864 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.63 -2.37 64.67 Favored Glycine 0 N--CA 1.494 2.561 0 O-C-N 121.094 -1.239 . . . . 1.54 113.292 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.437 HH11 ' HG2' ' A' ' 186' ' ' ARG . 3.5 ptt-85 -88.83 101.45 14.05 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.624 -1.991 . . . . 4.48 105.624 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 p 53.4 47.64 23.7 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.993 -1.067 . . . . 2.63 112.001 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 59.1 m -83.63 135.86 34.44 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.697 -1.223 . . . . 1.69 107.697 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -59.36 -39.92 84.81 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.286 -0.884 . . . . 1.07 111.026 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.0 m -59.62 -40.33 87.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.898 -1.126 . . . . 1.58 110.089 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.2 p -61.88 -35.04 77.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 1.6 110.652 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 32.0 mm -59.99 -39.29 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.519 -0.738 . . . . 1.45 110.656 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.4 mtp -62.23 -43.16 99.46 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 122.319 1.057 . . . . 1.05 109.595 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.89 -47.76 83.82 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.717 -0.614 . . . . 0.72 110.504 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.516 HH11 ' HG2' ' A' ' 195' ' ' ARG . 33.8 mtt-85 -60.12 -41.34 92.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 3.05 110.586 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.7 m -70.13 -41.53 73.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.182 -0.949 . . . . 0.89 110.079 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.83 -8.18 50.28 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.577 0.703 . . . . 0.78 112.49 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 194' ' ' ALA . 94.5 mt-10 49.6 12.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.82 1.045 . . . . 1.45 113.82 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.57 149.06 93.31 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 107.872 -1.159 . . . . 0.67 107.872 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.34 135.86 71.0 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 120.948 1.099 . . . . 0.64 110.017 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.75 163.11 34.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.31 -1.494 . . . . 0.67 109.397 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.419 ' CD1' HD11 ' A' ' 220' ' ' LEU . 32.2 mt -146.79 147.51 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.639 -1.245 . . . . 0.69 107.639 177.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.5 m -125.24 -31.55 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.146 -0.971 . . . . 0.85 113.052 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.1 45.01 2.46 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 119.542 -1.313 . . . . 0.92 111.016 -178.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 181' ' ' THR . 58.6 p -61.86 -19.54 62.73 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.537 -0.978 . . . . 0.95 111.372 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.65 -90.7 0.86 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.48 -1.048 . . . . 1.04 110.48 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.3 p -130.62 28.69 4.87 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.503 -0.998 . . . . 1.57 113.288 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.31 -40.02 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.44 -1.412 . . . . 0.84 110.603 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.2 p -58.28 -22.72 53.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.968 -1.082 . . . . 0.99 111.707 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.5 p -94.15 -1.88 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.424 -0.797 . . . . 1.7 112.183 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -125.88 3.07 7.37 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.645 0.736 . . . . 2.2 112.436 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 22.4 t -116.13 146.54 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.528 -0.733 . . . . 0.84 109.263 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -119.81 160.45 22.61 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.998 -1.112 . . . . 2.2 107.998 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 3.7 m120 -57.36 139.81 51.96 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.85 -1.156 . . . . 2.28 110.812 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 79.11 5.55 2.23 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.193 1.182 . . . . 2.35 114.193 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 61.0 t0 -66.08 149.08 50.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.911 -1.118 . . . . 1.97 108.437 177.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.496 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 36.3 t80 -89.82 122.18 32.65 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.916 -1.513 . . . . 2.65 106.916 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.4 mt -129.52 147.53 51.34 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.035 0.922 . . . . 0.63 110.105 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 21.0 mt -119.92 130.75 73.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.408 -1.33 . . . . 0.62 107.408 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.533 HD13 HD11 ' A' ' 180' ' ' ILE . 60.8 tp -99.65 120.2 39.31 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.407 -1.331 . . . . 0.64 107.407 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 223' ' ' VAL . 33.5 t0 -89.77 -35.78 15.52 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.976 -1.077 . . . . 2.05 111.431 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.947 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.78 17.75 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.566 0.698 . . . . 0.84 112.459 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.1 t -109.15 -58.25 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.168 -0.957 . . . . 1.02 109.33 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -95.69 14.72 22.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.961 0.886 . . . . 2.51 110.598 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.0 t30 61.93 52.27 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.608 -0.724 . . . . 1.54 112.834 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -151.93 157.13 41.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.031 -1.043 . . . . 1.95 110.168 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.35 135.19 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.071 -1.085 . . . . 0.71 108.071 177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -103.24 130.01 50.36 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.065 -1.022 . . . . 1.01 108.588 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.9 t -110.53 129.85 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.991 -1.114 . . . . 0.82 107.991 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.443 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 61.8 t30 53.59 48.75 5.26 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 113.434 0.902 . . . . 1.54 113.434 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 37.0 Cg_endo -65.73 153.5 77.88 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.656 2.237 . . . . 0.94 110.911 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.0 p -72.17 160.21 32.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.997 -1.065 . . . . 1.8 110.134 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -60.19 -37.96 81.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.216 -0.928 . . . . 2.73 110.642 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.98 -39.16 84.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 3.17 110.558 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.7 -35.71 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.207 -0.933 . . . . 1.34 110.176 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.71 -45.28 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.351 -0.843 . . . . 1.2 110.598 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -59.24 -41.07 87.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.975 -1.078 . . . . 2.7 110.585 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -65.87 -42.97 89.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.509 -0.745 . . . . 2.59 110.97 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.2 mtp -71.28 -39.39 71.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.955 . . . . 1.38 111.01 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -57.0 -38.67 73.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.867 -1.145 . . . . 2.84 110.375 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 245' ' ' GLN . . . -70.33 -39.32 74.8 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.506 -0.746 . . . . 1.88 111.137 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 98.7 t -56.43 -49.57 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.915 -1.116 . . . . 2.4 111.17 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.564 ' NE2' ' O ' ' A' ' 11' ' ' ILE . 39.5 tt0 -64.14 -50.85 66.58 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.761 -1.212 . . . . 3.52 109.954 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.47 -31.91 72.72 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.617 -0.719 . . . . 1.88 110.414 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 241' ' ' ALA . 63.5 tt0 -60.67 -32.18 71.39 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.827 -1.149 . . . . 3.01 109.19 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 88.0 t -62.46 -45.48 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 119.583 -0.847 . . . . 2.45 109.787 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.02 81.36 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.666 0.746 . . . . 2.75 110.024 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.9 t -68.25 -32.18 72.18 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.767 -0.583 . . . . 3.16 110.739 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -61.36 -49.75 75.68 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.295 -0.962 . . . . 3.57 110.298 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -70.38 -34.15 72.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.373 -0.829 . . . . 4.3 110.054 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.9 0.71 17.33 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 113.121 0.786 . . . . 4.45 113.121 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -62.67 -23.9 67.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.175 -0.953 . . . . 5.97 111.668 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.73 -21.56 63.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.28 -0.888 . . . . 6.18 111.667 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.12 97.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 6.66 111.36 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -82.25 -4.51 57.26 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.86 -1.15 . . . . 8.2 112.779 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.24 44.15 1.16 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.937 -1.102 . . . . 8.07 111.463 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -78.82 2.67 19.14 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.789 -0.765 . . . . 9.45 112.164 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -91.85 14.23 16.12 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.525 0.679 . . . . 10.12 112.152 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.249 -0.881 . . . . 11.49 108.704 179.34 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.596 0.712 . . . . 3.07 109.718 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.5 mt -95.68 112.43 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 106.544 -1.65 . . . . 1.07 106.544 176.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.8 m -102.09 124.51 47.82 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.634 -1.247 . . . . 1.24 107.634 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' A' ' 225' ' ' ASN . . . -118.42 -160.72 11.6 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.77 -1.732 . . . . 1.01 108.77 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 5' ' ' ILE . 90.2 mt -95.8 1.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.372 -1.075 . . . . 1.11 112.711 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.91 97.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 0.99 112.195 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -86.41 -37.4 18.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.36 -0.837 . . . . 0.85 111.477 179.404 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -150.6 145.71 18.75 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 120.682 -1.261 . . . . 1.38 107.738 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.45 144.77 23.08 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 122.647 2.231 . . . . 0.94 112.121 178.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.924 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.65 170.69 20.7 Favored Glycine 0 N--CA 1.504 3.197 0 N-CA-C 109.556 -1.417 . . . . 0.81 109.556 178.032 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.5 mt -133.24 133.68 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 107.71 -1.219 . . . . 0.83 107.71 179.716 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.0 151.94 41.4 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.19 -0.944 . . . . 0.53 109.305 179.034 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 11.2 m-85 -119.25 140.82 49.62 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.668 -0.864 . . . . 0.77 108.668 177.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.19 169.22 41.4 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 118.586 -1.769 . . . . 0.51 110.472 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -77.76 158.18 29.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.688 -0.889 . . . . 1.9 109.076 177.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.42 126.74 33.53 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.957 -1.089 . . . . 0.66 108.291 178.479 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.0 tp -110.11 102.27 10.99 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.621 -1.992 . . . . 0.83 105.621 178.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 tp -88.42 140.33 29.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.937 -1.102 . . . . 0.86 108.922 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.46 HD11 HD11 ' A' ' 158' ' ' LEU . 44.8 mt -99.86 119.72 38.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.923 -1.111 . . . . 0.92 108.061 178.106 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -110.31 141.01 43.91 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.22 -1.029 . . . . 2.03 108.22 179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -118.67 141.32 48.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.103 -0.998 . . . . 2.66 109.281 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -82.91 133.68 35.11 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.746 -1.205 . . . . 2.32 107.746 177.307 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -62.95 149.13 45.52 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.759 -0.83 . . . . 2.11 108.759 178.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.6 mt -95.15 133.79 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.584 -0.895 . . . . 0.73 108.584 178.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 t -103.6 130.14 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.936 -1.135 . . . . 0.87 107.936 178.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.0 mt -98.31 133.12 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.287 -1.005 . . . . 0.81 108.287 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -87.28 119.51 27.61 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.249 -1.389 . . . . 1.34 107.249 178.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -101.37 20.02 16.68 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.86 -0.525 . . . . 2.89 111.619 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -63.27 149.89 44.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.254 -0.904 . . . . 2.09 110.154 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -91.33 125.38 36.08 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.47 -1.307 . . . . 2.19 107.47 177.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 pt -97.07 166.5 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.338 -0.852 . . . . 0.75 110.15 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.8 p -99.3 164.3 12.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.595 -0.69 . . . . 0.91 109.697 178.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.89 -28.38 36.05 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.052 -1.03 . . . . 0.93 111.18 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -69.23 -34.11 74.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.009 . . . . 2.28 110.393 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -87.61 -15.32 37.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.136 -0.978 . . . . 1.45 112.193 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.76 -41.34 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.977 -1.077 . . . . 0.81 110.367 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.32 -40.07 81.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.828 -1.17 . . . . 1.54 110.841 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -61.24 -42.27 98.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.569 -0.707 . . . . 2.36 111.245 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.08 -38.02 81.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.827 -1.17 . . . . 1.31 111.154 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.54 -44.78 93.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.976 -1.077 . . . . 0.82 110.26 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -62.36 -44.64 96.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.201 -0.937 . . . . 1.5 110.266 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -62.15 -41.51 98.35 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.154 -0.966 . . . . 2.23 109.638 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 32.1 t80 -74.06 -51.99 14.07 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.262 -0.899 . . . . 0.85 109.249 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.01 -47.72 85.11 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 117.924 -1.511 . . . . 0.91 110.367 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.605 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.4 t -69.57 -40.63 76.63 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.362 0.601 . . . . 0.9 110.172 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.56 -44.67 90.71 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.292 -1.432 . . . . 0.69 110.079 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.403 HH11 ' HB3' ' A' ' 47' ' ' ARG . 1.7 ttt-85 -59.37 -30.86 68.72 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.573 -0.957 . . . . 2.88 109.36 178.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.72 -45.64 85.51 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.745 -0.661 . . . . 0.85 109.773 178.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -80.11 -45.03 18.92 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.452 0.644 . . . . 2.35 110.427 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.66 -41.98 91.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.317 -0.864 . . . . 0.65 110.156 -178.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.6 t -60.02 -41.54 92.41 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 122.45 1.119 . . . . 1.45 109.098 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.47 -46.57 79.29 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.265 -0.88 . . . . 0.63 110.209 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -62.55 -50.38 71.58 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.117 -0.989 . . . . 1.34 110.063 179.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 66.4 mt -61.23 -36.78 80.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.214 -0.929 . . . . 1.56 110.192 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.81 -41.12 95.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.791 -0.568 . . . . 1.19 110.819 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.59 HG22 ' HZ2' ' A' ' 60' ' ' LYS . 18.6 m -64.74 -42.67 95.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.813 -1.179 . . . . 0.72 110.009 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.51 -38.29 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.818 -0.551 . . . . 0.62 110.672 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -50.32 -45.75 55.01 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 120.122 -0.631 . . . . 1.05 111.182 179.179 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -68.32 -32.56 72.78 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.937 -1.102 . . . . 0.64 109.91 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.59 ' HZ2' HG22 ' A' ' 56' ' ' THR . 54.0 mttp -61.64 -39.88 92.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.617 -1.233 . . . . 1.73 109.295 179.402 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.9 -34.9 78.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.516 -0.74 . . . . 0.56 110.097 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.61 -35.09 23.53 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.856 -1.164 . . . . 0.69 111.364 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -83.33 -18.47 38.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.017 -1.284 . . . . 1.48 111.679 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -87.83 -53.17 4.89 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.747 -0.66 . . . . 0.98 110.3 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -106.95 -17.21 14.25 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 113.275 0.843 . . . . 1.16 113.275 -176.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.59 158.98 10.53 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 120.893 -0.67 . . . . 0.85 111.83 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -55.24 -25.8 35.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.721 -0.87 . . . . 3.86 112.763 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.4 -35.25 71.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.781 -1.199 . . . . 2.35 111.226 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -82.16 -26.38 33.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.055 -1.028 . . . . 1.67 111.702 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -59.82 -33.8 72.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.758 -0.589 . . . . 1.45 111.401 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.07 83.7 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.432 -0.793 . . . . 0.61 111.563 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -65.62 -42.78 93.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.365 -1.459 . . . . 0.65 110.156 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -70.93 -30.86 67.3 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.828 -1.17 . . . . 0.66 110.895 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -61.36 -39.14 89.54 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.61 -0.836 . . . . 1.19 109.955 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.67 -39.53 90.42 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 120.225 -0.988 . . . . 0.53 110.793 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -57.39 -46.86 82.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.623 -1.516 . . . . 1.27 110.804 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.6 mt -59.9 -38.11 74.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.011 -1.056 . . . . 0.54 110.703 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.2 ttp -58.95 -39.4 81.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.915 -1.116 . . . . 1.74 110.308 179.202 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 tp -59.92 -49.62 76.99 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.994 -1.066 . . . . 0.55 109.783 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.9 tp -60.46 -43.72 96.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.066 0.936 . . . . 0.47 110.341 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -87.67 9.65 20.73 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 112.783 0.66 . . . . 1.42 112.783 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -65.27 123.82 20.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.737 -1.227 . . . . 1.27 108.428 178.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.78 -18.44 65.33 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.842 0.829 . . . . 1.35 110.854 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -74.11 -52.37 12.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.564 -0.854 . . . . 2.22 110.167 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.0 -37.85 86.42 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.443 -0.903 . . . . 0.62 110.897 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.78 -45.97 81.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.743 -1.223 . . . . 1.29 110.545 179.303 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -60.73 -36.86 79.93 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.486 -0.759 . . . . 1.52 110.665 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -67.01 -46.86 73.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.183 -1.007 . . . . 1.3 110.574 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.06 -43.77 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.428 -0.795 . . . . 0.61 110.024 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.6 mt -59.78 -42.26 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.531 -0.73 . . . . 0.78 110.589 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.52 -43.86 98.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.638 -0.663 . . . . 0.82 111.007 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.18 -44.47 97.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.741 -1.224 . . . . 0.8 110.474 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 93' ' ' ILE . 68.4 mt -62.99 -47.5 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.954 -1.091 . . . . 0.77 110.466 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -83.63 -31.3 26.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.195 -0.94 . . . . 2.12 111.655 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 91' ' ' ALA . 51.0 t0 -80.79 -45.84 16.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.81 -1.181 . . . . 1.51 111.399 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -100.78 7.04 44.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.626 -0.671 . . . . 1.98 112.328 -178.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.3 m80 51.96 49.72 20.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.181 -0.95 . . . . 1.32 112.153 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 91.1 mtp -109.64 160.74 16.03 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.223 -0.923 . . . . 1.38 109.341 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.5 p -71.21 159.34 34.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.619 -0.676 . . . . 0.67 109.852 178.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.59 93.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.52 110.415 178.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.481 ' OD2' HD21 ' A' ' 142' ' ' LEU . 91.9 m-20 -66.85 -39.72 87.7 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.282 -0.967 . . . . 2.25 109.727 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.83 -50.9 46.18 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.118 -1.033 . . . . 0.64 110.851 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.42 -41.03 96.52 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.061 -1.056 . . . . 0.56 110.569 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.48 87.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.689 -0.632 . . . . 0.46 110.703 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -60.56 -39.63 88.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 1.32 110.965 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -59.7 -48.87 79.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.011 -1.056 . . . . 1.3 111.055 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.29 -44.34 98.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.149 -0.969 . . . . 0.61 110.229 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.17 -32.97 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.803 -0.56 . . . . 0.65 110.475 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -59.83 -39.81 86.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.593 -0.692 . . . . 2.11 110.688 179.263 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.38 -29.73 26.71 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.331 -1.414 . . . . 0.83 113.097 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -61.03 -40.51 93.86 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.186 -1.773 . . . . 1.28 109.309 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.49 -50.02 42.3 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.82 0.819 . . . . 0.89 109.905 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.7 p -60.14 -39.72 87.28 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.725 . . . . 1.87 110.357 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.31 -43.75 96.06 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.231 -0.918 . . . . 1.05 110.194 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.78 -28.48 69.05 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.03 -1.044 . . . . 1.02 111.295 -179.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -67.15 -23.0 65.74 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.754 -0.591 . . . . 2.04 110.833 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -74.17 -11.83 60.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.696 0.76 . . . . 1.73 111.232 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.627 HD13 HD13 ' A' ' 123' ' ' LEU . 15.5 mt -86.37 141.91 28.84 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.157 -0.682 . . . . 1.37 109.157 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -99.41 55.26 0.97 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.029 -1.045 . . . . 2.88 111.058 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -130.77 142.15 50.39 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.293 -0.88 . . . . 1.58 109.202 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.33 -40.28 81.72 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.739 -0.601 . . . . 3.04 110.938 178.148 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -72.8 -54.99 7.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.942 -1.099 . . . . 0.9 111.034 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.627 HD13 HD13 ' A' ' 118' ' ' LEU . 45.5 mt -59.83 -40.33 88.1 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.069 -1.019 . . . . 1.06 110.616 -179.464 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -62.53 -49.42 75.41 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.67 -1.269 . . . . 2.18 110.084 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.6 -31.03 70.2 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.04 0.924 . . . . 2.15 109.717 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -61.99 -30.97 71.3 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.159 -1.016 . . . . 2.33 109.558 179.316 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.84 -48.9 79.81 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.588 -0.845 . . . . 0.82 109.434 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.58 -44.11 75.09 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.647 -0.821 . . . . 0.85 110.251 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.37 -31.78 73.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.106 -0.997 . . . . 1.39 110.272 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.0 t -67.98 -39.35 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.76 -0.776 . . . . 0.56 109.922 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.432 ' HG3' HH11 ' A' ' 131' ' ' ARG . 28.4 ttm-85 -56.97 -39.51 74.75 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.022 -1.071 . . . . 3.12 109.311 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -59.8 -39.23 84.28 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.499 -0.75 . . . . 1.28 110.379 179.106 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.5 mt -61.54 -39.15 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.542 -0.724 . . . . 0.49 109.968 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.45 -47.04 53.28 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 120.011 -1.09 . . . . 0.46 110.6 179.389 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -57.46 -39.79 77.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.156 -1.203 . . . . 2.71 110.496 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.446 HH11 ' HG2' ' A' ' 136' ' ' ARG . 45.5 mtt-85 -61.52 -44.31 97.29 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.247 -0.981 . . . . 2.14 109.944 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.85 -44.73 96.6 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.327 -0.858 . . . . 1.05 109.972 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.6 mt -59.47 -46.25 89.32 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.468 -0.77 . . . . 0.52 110.389 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -59.94 -33.73 72.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.427 -0.795 . . . . 2.35 110.669 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.43 -41.91 45.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.606 -0.684 . . . . 1.39 111.004 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.68 -38.31 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.68 110.78 -178.155 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.481 HD21 ' OD2' ' A' ' 101' ' ' ASP . 89.2 mt -83.97 -4.39 58.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.83 112.294 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.25 20.31 79.12 Favored Glycine 0 N--CA 1.484 1.871 0 C-N-CA 119.265 -1.445 . . . . 0.91 113.112 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.7 tp -66.97 148.43 51.97 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.665 0.745 . . . . 0.95 109.312 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -67.21 149.64 50.17 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.14 -0.975 . . . . 2.43 109.374 178.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 65.5 mt -105.23 139.94 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.12 -1.066 . . . . 1.1 108.12 178.074 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.682 ' H ' HD12 ' A' ' 147' ' ' ILE . 3.6 mp -75.66 126.05 35.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.313 -0.995 . . . . 1.58 108.313 178.327 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -96.22 98.03 9.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.877 -1.527 . . . . 1.62 106.877 179.289 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 64.5 mt -74.83 -11.51 60.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.272 -0.893 . . . . 0.8 111.582 -177.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.6 t -91.41 11.24 24.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.776 -0.577 . . . . 1.56 112.3 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.74 17.54 14.86 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 113.658 0.985 . . . . 0.84 113.658 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.706 HD12 ' N ' ' A' ' 152' ' ' ILE . 2.4 mp -72.77 140.84 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.299 -1.5 . . . . 0.82 109.599 178.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -119.24 -11.99 9.5 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.065 0.936 . . . . 2.31 111.998 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -112.89 149.18 33.51 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.616 -0.883 . . . . 1.54 108.616 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -76.32 123.23 25.61 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.527 -0.916 . . . . 1.38 108.527 178.244 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.0 m -148.51 174.46 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.469 -0.769 . . . . 0.69 109.308 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.9 mt -93.08 142.52 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.804 -0.813 . . . . 0.53 108.804 178.217 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.46 HD11 HD11 ' A' ' 19' ' ' LEU . 23.8 tp -95.07 125.81 39.98 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.753 -1.217 . . . . 0.64 108.022 178.282 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.91 129.96 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 107.68 -1.229 . . . . 0.67 107.68 179.04 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.44 151.52 17.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.511 -1.368 . . . . 0.78 108.838 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.49 -35.94 79.09 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.01 -1.056 . . . . 1.0 109.475 178.154 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -173.09 151.84 2.2 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.734 -0.839 . . . . 2.42 108.734 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.5 mt -115.86 139.59 50.06 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.774 -0.825 . . . . 0.75 108.774 177.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.3 p -89.39 149.26 42.32 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.965 -1.084 . . . . 0.78 108.762 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -41.3 -42.1 5.14 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.563 2.175 . . . . 0.67 113.627 179.162 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.7 m -62.87 -51.41 67.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 0.7 110.121 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -60.94 -39.39 89.28 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.32 -0.862 . . . . 1.21 110.115 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.4 p -67.92 -41.01 83.26 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.372 -0.83 . . . . 0.6 110.464 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.03 -37.03 81.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.304 -0.873 . . . . 0.62 110.819 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -97.22 3.18 51.54 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.027 -1.046 . . . . 1.16 112.685 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 46.2 tp -59.65 149.62 29.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.076 -1.015 . . . . 0.73 109.217 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -95.42 111.17 23.1 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.763 -1.569 . . . . 2.24 106.763 177.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 73.9 mt -80.74 -10.07 59.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.643 -0.66 . . . . 1.43 112.615 -177.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -80.29 -29.63 38.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.15 -0.969 . . . . 2.15 111.935 -178.422 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -100.5 -0.92 36.96 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.126 -0.984 . . . . 2.04 113.417 -178.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 40.0 t -108.45 129.02 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 107.749 -1.204 . . . . 0.55 107.749 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.55 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -90.21 -16.09 30.12 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.366 1.079 . . . . 1.63 111.446 -179.223 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.86 173.33 45.94 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.852 -1.699 . . . . 0.47 108.852 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -130.16 131.32 45.59 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 107.784 -1.191 . . . . 0.54 107.784 179.392 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.48 HD11 HD13 ' A' ' 220' ' ' LEU . 94.8 mt -126.77 115.3 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 106.388 -1.708 . . . . 0.69 106.388 178.169 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 203' ' ' VAL . 70.6 p -132.92 169.61 16.54 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.104 -0.997 . . . . 0.82 109.599 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.455 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 2.8 m-20 -101.86 36.01 2.19 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.563 -0.711 . . . . 2.37 110.711 179.074 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -97.88 175.64 6.07 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.766 -1.209 . . . . 1.11 109.983 177.428 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 183' ' ' ALA . . . -61.13 -132.41 0.01 OUTLIER Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.577 -1.409 . . . . 1.67 109.577 179.145 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.44 -32.89 0.1 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.63 -1.271 . . . . 1.54 113.73 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.46 ' HG3' HH11 ' A' ' 186' ' ' ARG . 36.6 mtm-85 -56.24 -39.2 72.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.678 -1.483 . . . . 4.48 110.318 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.7 p -137.72 29.27 2.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.691 -0.63 . . . . 2.63 111.686 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.1 p -82.04 139.24 34.6 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.878 0.847 . . . . 1.69 109.204 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -59.08 -38.83 80.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 1.07 110.777 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 33.8 p -59.76 -39.78 85.94 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.268 -0.973 . . . . 1.58 110.37 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.8 m -60.16 -37.63 80.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.382 -0.824 . . . . 1.6 110.42 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 37.3 mm -60.1 -37.25 72.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.576 -0.702 . . . . 1.45 110.603 179.462 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.8 mtp -62.21 -44.22 97.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.567 1.175 . . . . 1.05 109.418 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.48 -47.34 85.87 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.473 -0.785 . . . . 0.72 110.802 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -61.64 -42.58 99.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.214 -0.929 . . . . 3.05 110.804 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 20.4 m -69.46 -39.82 77.5 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.38 -0.928 . . . . 0.89 110.204 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.7 mt -90.37 -7.56 52.91 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.512 0.672 . . . . 0.78 112.451 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 194' ' ' ALA . 99.0 mt-10 53.72 8.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 113.853 1.057 . . . . 1.45 113.853 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 66.1 mt -71.5 149.99 93.69 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 0.67 108.419 178.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.92 143.03 99.75 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.459 1.439 . . . . 0.64 109.602 178.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.73 167.44 28.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.361 -1.462 . . . . 0.67 110.194 179.604 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.6 mt -150.58 150.53 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.626 -1.25 . . . . 0.69 107.626 178.101 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.2 m -141.54 -28.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.7 0 O-C-N 120.383 -1.448 . . . . 0.85 113.156 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.34 35.12 3.64 Favored Glycine 0 N--CA 1.488 2.107 0 O-C-N 120.961 -1.087 . . . . 0.92 112.627 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.455 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 20.1 p -59.7 -34.4 72.84 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.462 -1.611 . . . . 0.95 110.23 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 94.26 -78.55 0.97 Allowed Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.196 -1.002 . . . . 1.04 112.445 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.1 p -117.51 23.25 11.89 Favored 'General case' 0 N--CA 1.517 2.919 0 CA-C-N 119.262 1.531 . . . . 1.57 114.061 -178.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.419 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 4.8 t -55.08 -30.97 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 119.479 -2.013 . . . . 0.84 110.572 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.9 p -58.83 -28.66 66.26 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.929 -1.108 . . . . 0.99 111.421 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 13.8 m -94.26 5.28 52.26 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.885 -1.134 . . . . 1.7 112.32 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -129.5 -7.12 4.68 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 113.404 0.89 . . . . 2.2 113.404 -178.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 17.2 t -118.96 139.56 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.564 -0.902 . . . . 0.84 108.564 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -120.16 157.46 28.99 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.087 -1.079 . . . . 2.2 108.087 178.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 37.6 t30 -57.74 140.83 50.56 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.964 -1.094 . . . . 2.28 110.538 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.7 t0 80.1 0.54 2.04 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.451 1.278 . . . . 2.35 114.451 179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -66.21 147.35 53.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.552 -1.342 . . . . 1.97 108.374 177.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -90.18 118.5 29.75 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.054 -1.832 . . . . 2.65 106.054 177.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.3 mt -127.05 143.8 51.19 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.459 0.647 . . . . 0.63 109.48 -178.307 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 61.2 mt -111.36 127.59 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 106.399 -1.704 . . . . 0.62 106.399 177.551 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.48 HD13 HD11 ' A' ' 180' ' ' ILE . 62.9 tp -100.86 120.12 39.67 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.428 -1.323 . . . . 0.64 107.428 179.135 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.587 ' O ' ' N ' ' A' ' 223' ' ' VAL . 52.3 t0 -93.94 -23.68 17.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.872 -1.143 . . . . 2.05 112.777 -178.689 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.924 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.94 18.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.098 0.777 . . . . 0.84 113.098 -178.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.9 t -108.14 -60.3 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.924 -1.11 . . . . 1.02 109.037 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -100.15 16.3 24.6 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.53 0.681 . . . . 2.51 110.345 -179.436 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 4' ' ' GLY . 4.1 t-20 61.2 51.61 4.27 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.362 0.601 . . . . 1.54 111.771 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -145.83 144.87 30.52 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.277 1.036 . . . . 1.95 110.193 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.61 145.16 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.948 -0.76 . . . . 0.71 108.948 178.02 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -101.95 136.58 41.54 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.208 -1.034 . . . . 1.01 108.208 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.62 129.93 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.004 -0.739 . . . . 0.82 109.004 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 42.6 t30 49.63 58.63 17.52 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 113.79 1.033 . . . . 1.54 113.79 178.153 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.66 141.51 38.0 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 121.96 1.773 . . . . 0.94 110.791 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.4 p -74.08 156.72 37.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.942 -1.099 . . . . 1.8 109.277 177.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -58.49 -37.73 76.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.333 -0.854 . . . . 2.73 110.472 178.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.16 -40.98 82.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.452 -0.78 . . . . 3.17 110.223 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 96.6 t -71.06 -42.99 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.386 -0.821 . . . . 1.34 109.979 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.48 -48.23 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.556 -0.715 . . . . 1.2 110.084 -179.043 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -58.91 -41.37 87.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.991 -1.068 . . . . 2.7 109.931 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -62.42 -42.15 99.23 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.597 0.713 . . . . 2.59 110.177 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 243' ' ' GLN . 81.5 mtp -72.3 -39.7 68.08 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.475 -0.766 . . . . 1.38 110.923 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -52.91 -39.22 62.58 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.487 -1.383 . . . . 2.84 110.925 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.56 -56.76 4.47 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.045 -1.062 . . . . 1.88 110.567 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.12 -44.07 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.58 0.705 . . . . 2.4 111.268 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 239' ' ' MET . 1.6 tm0? -60.63 -47.9 84.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.512 -1.368 . . . . 3.52 111.002 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -61.55 -31.33 71.36 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.656 -1.278 . . . . 1.88 109.945 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -59.93 -31.17 69.59 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.139 -1.024 . . . . 3.01 109.317 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 82.4 t -62.01 -41.88 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.734 0.778 . . . . 2.45 109.406 179.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.95 89.0 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.157 -0.617 . . . . 2.75 110.115 179.391 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 25.8 p -70.55 -29.43 65.89 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.441 0.639 . . . . 3.16 110.522 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.59 -32.54 74.04 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.192 -0.942 . . . . 3.57 110.311 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -65.53 -30.27 71.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.403 -0.81 . . . . 4.3 110.764 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.05 -19.2 65.64 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.377 -0.827 . . . . 4.45 111.314 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -69.58 -18.91 63.67 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.313 -0.867 . . . . 5.97 111.281 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.786 ' O ' HD23 ' A' ' 253' ' ' LEU . 7.2 tt -62.21 -30.65 71.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.484 -0.76 . . . . 6.18 110.051 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -72.48 0.67 9.69 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.089 -1.007 . . . . 6.66 112.36 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -80.9 32.17 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.087 0.946 . . . . 8.2 112.411 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 90.5 mt -82.89 11.51 5.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.772 -1.205 . . . . 8.07 111.783 179.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -84.28 5.73 25.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.255 -0.903 . . . . 9.45 112.409 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -91.39 4.5 52.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.124 -0.985 . . . . 10.12 112.416 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 . . . . . 0 N--CA 1.498 1.954 0 O-C-N 121.051 -1.031 . . . . 11.49 109.106 179.947 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.3 mmm . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.518 -0.549 . . . . 3.07 109.518 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt -103.34 122.65 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.654 -1.239 . . . . 1.07 107.654 177.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.2 m -105.73 123.3 47.72 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.784 -1.191 . . . . 1.24 107.784 178.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.22 -162.94 11.64 Favored Glycine 0 N--CA 1.499 2.884 0 N-CA-C 108.274 -1.93 . . . . 1.01 108.274 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 5' ' ' ILE . 90.9 mt -100.59 2.28 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.174 -1.191 . . . . 1.11 112.671 -179.542 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 5' ' ' ILE . 12.3 tp 50.71 101.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.078 -1.014 . . . . 0.99 112.134 179.166 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -87.87 -41.55 13.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.939 -1.1 . . . . 0.85 111.549 179.419 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 t -145.19 146.17 29.52 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.045 -1.095 . . . . 1.38 108.045 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.59 143.85 21.89 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.815 2.343 . . . . 0.94 112.377 178.389 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.922 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.19 -177.47 29.16 Favored Glycine 0 N--CA 1.503 3.129 0 N-CA-C 109.658 -1.377 . . . . 0.81 109.658 177.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.9 mt -137.81 140.75 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.25 -1.147 . . . . 0.83 108.578 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.48 149.99 43.22 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.317 -0.865 . . . . 0.53 109.005 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -119.56 139.8 51.56 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.713 -1.217 . . . . 0.77 107.713 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.49 163.95 27.92 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 118.125 -1.988 . . . . 0.51 110.485 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -76.48 160.68 29.29 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.506 -0.997 . . . . 1.9 109.837 179.146 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -84.15 122.29 28.64 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.965 -1.124 . . . . 0.66 107.965 178.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.7 tp -101.71 101.97 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.089 -2.189 . . . . 0.83 105.089 177.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.6 tp -88.25 140.37 29.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.176 -0.952 . . . . 0.86 108.632 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.9 mt -98.28 118.5 35.06 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 106.271 -1.752 . . . . 0.92 106.271 177.179 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -111.01 134.07 52.91 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.201 -1.037 . . . . 2.03 108.201 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -125.95 140.8 52.33 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.584 -0.895 . . . . 2.66 108.584 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -81.81 138.01 35.2 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.371 -0.974 . . . . 2.32 108.371 177.446 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -63.29 143.63 57.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -0.773 . . . . 2.11 108.991 178.74 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 87.9 mt -94.53 132.13 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.174 -1.047 . . . . 0.73 108.174 178.251 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.16 130.19 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.233 -1.025 . . . . 0.87 108.233 179.047 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.8 mt -94.07 138.13 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.374 -0.973 . . . . 0.81 108.374 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -92.19 122.23 34.48 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.572 -1.27 . . . . 1.34 107.572 178.557 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -93.54 10.93 30.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.289 -0.882 . . . . 2.89 112.651 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -71.57 153.01 42.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.706 -1.246 . . . . 2.09 109.349 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -92.18 140.04 30.02 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 109.102 -0.703 . . . . 2.19 109.102 178.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -92.39 175.29 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.229 -0.919 . . . . 0.75 109.915 177.369 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.473 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 6.3 p -103.5 166.62 10.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.522 -0.736 . . . . 0.91 109.549 179.459 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.56 -35.26 67.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.488 -0.758 . . . . 0.93 111.519 178.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.473 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 10.9 p-10 -69.86 -22.23 63.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.846 -1.159 . . . . 2.28 110.626 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -94.02 -20.44 19.96 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.492 0.663 . . . . 1.45 112.213 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.84 -46.4 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.626 -0.671 . . . . 0.81 110.236 -178.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -58.86 -40.36 84.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.323 -0.861 . . . . 1.54 110.658 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -64.0 -45.32 89.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 2.36 110.808 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -60.82 -37.74 83.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.256 -0.903 . . . . 1.31 110.945 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -59.13 -40.07 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.176 -0.953 . . . . 0.82 110.082 179.274 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.72 -41.74 95.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.072 -1.018 . . . . 1.5 109.645 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -63.1 -39.16 93.88 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.343 -0.848 . . . . 2.23 110.094 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -72.11 -54.52 9.52 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.411 -0.806 . . . . 0.85 110.06 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.7 tp -60.78 -50.14 74.65 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.969 0.89 . . . . 0.91 109.74 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.0 t -67.41 -38.91 85.35 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.422 -0.799 . . . . 0.9 110.247 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.58 90.85 Favored Glycine 0 N--CA 1.485 1.934 0 C-N-CA 119.648 -1.263 . . . . 0.69 110.056 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.4 HH12 ' CG ' ' A' ' 86' ' ' GLU . 39.3 ttm180 -59.94 -31.65 70.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.24 -1.153 . . . . 2.88 109.63 178.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.89 -42.63 90.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.619 0.723 . . . . 0.85 109.764 179.063 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -80.52 -48.65 12.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 2.35 110.85 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.99 79.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.515 -0.741 . . . . 0.65 110.102 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.4 p -61.68 -38.56 88.28 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.867 0.842 . . . . 1.45 109.343 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.82 -46.19 69.25 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.948 -0.569 . . . . 0.63 110.313 179.289 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.74 -49.35 75.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.633 -1.292 . . . . 1.34 110.122 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.9 mt -61.34 -40.0 92.62 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.034 0.921 . . . . 1.56 109.513 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -60.64 -39.73 89.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.577 -0.702 . . . . 1.19 110.105 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.0 m -62.06 -42.89 99.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.866 . . . . 0.72 110.366 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.0 -36.94 70.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.609 -0.682 . . . . 0.62 110.645 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -51.1 -43.5 61.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.938 . . . . 1.05 110.443 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -70.27 -36.42 74.41 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.926 -1.109 . . . . 0.64 110.009 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -62.69 -39.34 93.68 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.819 -1.153 . . . . 1.73 109.316 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.74 81.74 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.852 -0.613 . . . . 0.56 110.091 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.78 -35.86 23.97 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.467 -1.349 . . . . 0.69 110.964 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.03 -17.59 46.22 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.17 -1.194 . . . . 1.48 111.575 -179.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.7 m -93.46 -52.73 4.37 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.716 -0.615 . . . . 0.98 110.672 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -107.65 -6.23 17.0 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 114.004 1.112 . . . . 1.16 114.004 -178.076 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.96 149.88 11.85 Favored Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.375 -0.828 . . . . 0.85 112.432 178.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.47 -15.35 0.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.386 -1.067 . . . . 3.86 112.464 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.46 -31.32 69.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.395 -0.816 . . . . 2.35 111.291 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -83.35 -16.93 44.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.807 -1.183 . . . . 1.67 112.109 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.16 -30.76 69.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.888 -1.133 . . . . 1.45 111.228 -179.094 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.32 90.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.61 110.767 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.6 mt -67.5 -41.48 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.842 -1.161 . . . . 0.65 109.337 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -71.39 -29.88 65.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.66 110.734 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.25 -39.88 88.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.869 . . . . 1.19 110.046 179.584 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.44 -44.31 74.02 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.745 -0.942 . . . . 0.53 110.745 179.337 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -60.0 -48.06 83.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.934 -1.333 . . . . 1.27 110.726 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.5 mt -62.41 -39.49 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 120.9 -1.125 . . . . 0.54 110.016 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.8 ttp -60.28 -39.98 88.79 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.806 -0.758 . . . . 1.74 110.506 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.1 tp -59.37 -48.52 81.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.55 110.355 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.05 -41.24 91.9 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.861 0.838 . . . . 0.47 110.144 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -85.93 4.17 38.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.607 -0.683 . . . . 1.42 112.496 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -59.7 124.54 20.46 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.182 -0.949 . . . . 1.27 110.894 -178.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.02 -16.42 63.42 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.418 -0.801 . . . . 1.35 111.226 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -76.94 -54.31 6.73 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.769 0.795 . . . . 2.22 110.568 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.84 -38.24 87.49 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.386 -0.821 . . . . 0.62 110.923 -179.325 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' CG ' HH12 ' A' ' 47' ' ' ARG . 88.3 tt0 -59.0 -49.58 77.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.073 -1.017 . . . . 1.29 110.786 179.147 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.67 -39.48 94.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.027 -1.046 . . . . 1.52 110.708 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.95 -49.42 61.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 1.3 110.87 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.11 -45.64 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.836 -1.165 . . . . 0.61 110.097 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.45 -41.92 91.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.515 0.674 . . . . 0.78 110.43 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.95 95.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.258 -0.901 . . . . 0.82 111.036 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.29 -39.56 87.32 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.254 -0.904 . . . . 0.8 110.332 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.0 -51.18 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.77 110.365 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.86 -33.99 62.19 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.382 -0.824 . . . . 2.12 111.493 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -80.42 -45.92 16.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.139 -0.976 . . . . 1.51 111.842 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -103.07 8.64 38.76 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.058 -1.026 . . . . 1.98 112.581 -178.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 56.0 m80 53.17 49.9 18.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 1.32 111.752 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.1 mtt -102.02 152.97 20.33 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.211 -0.931 . . . . 1.38 109.668 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.1 p -71.34 156.52 39.41 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.321 -0.862 . . . . 0.67 109.304 177.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.02 -45.75 79.04 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.276 -0.89 . . . . 0.52 110.366 178.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -68.35 -39.3 81.92 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.063 -1.023 . . . . 2.25 110.267 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.87 -47.78 57.39 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.516 -1.274 . . . . 0.64 110.856 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.25 90.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.56 110.178 -178.439 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.12 91.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.252 -0.905 . . . . 0.46 110.621 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -60.31 -38.39 83.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 1.32 111.249 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -58.49 -49.2 78.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.998 -1.064 . . . . 1.3 111.267 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.3 t -61.5 -44.86 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.834 -1.166 . . . . 0.61 110.321 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.66 -33.24 56.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.556 -0.715 . . . . 0.65 110.403 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -58.5 -41.91 86.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.377 -0.827 . . . . 2.11 110.802 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.36 -30.39 22.26 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.142 -1.504 . . . . 0.83 112.121 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -62.21 -40.6 96.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.523 -1.575 . . . . 1.28 110.252 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.35 -50.59 30.69 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.539 -0.726 . . . . 0.89 111.092 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.1 m -59.63 -39.81 85.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -0.902 . . . . 1.87 110.926 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.19 -42.18 98.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 1.05 111.323 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 80.7 mt -62.27 -29.86 70.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.575 -1.328 . . . . 1.02 111.023 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.91 -21.95 65.97 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.17 -0.956 . . . . 2.04 110.958 179.261 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -74.96 -12.04 60.25 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.019 -0.672 . . . . 1.73 111.412 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.526 HD13 HD13 ' A' ' 123' ' ' LEU . 6.8 mt -87.08 149.22 24.86 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.146 -0.687 . . . . 1.37 109.146 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -102.61 47.49 0.89 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.456 -0.778 . . . . 2.88 111.197 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -124.58 134.5 52.94 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 108.502 -0.925 . . . . 1.58 108.502 179.108 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -57.34 -38.5 74.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.373 -0.829 . . . . 3.04 110.979 178.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -70.88 -49.1 49.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.666 -1.271 . . . . 0.9 110.055 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.526 HD13 HD13 ' A' ' 118' ' ' LEU . 43.8 mt -62.89 -39.14 93.57 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.848 -1.158 . . . . 1.06 109.994 -178.476 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -64.09 -50.18 69.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.627 -1.296 . . . . 2.18 110.149 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.54 -30.14 69.58 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.925 -1.109 . . . . 2.15 109.535 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 130' ' ' VAL . 62.6 ttt180 -64.79 -29.5 70.47 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.959 0.885 . . . . 2.33 109.551 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -60.55 -49.31 78.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.465 -0.894 . . . . 0.82 109.71 178.483 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.27 83.22 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.477 -0.889 . . . . 0.85 110.022 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.55 -35.0 78.07 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.186 0.517 . . . . 1.39 110.839 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 126' ' ' ARG . 30.8 t -69.01 -40.98 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.146 -0.971 . . . . 0.56 110.568 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.487 HH11 ' HG2' ' A' ' 131' ' ' ARG . 24.2 ttt-85 -57.74 -38.57 75.56 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.397 -1.321 . . . . 3.12 109.52 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -60.79 -38.39 85.14 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.421 0.629 . . . . 1.28 110.397 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.25 -39.91 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.252 -0.905 . . . . 0.49 109.821 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.52 -43.76 60.21 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.634 -1.27 . . . . 0.46 110.202 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -57.92 -41.26 82.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.458 -1.025 . . . . 2.71 110.364 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.455 HH11 ' HG2' ' A' ' 136' ' ' ARG . 62.4 mtt-85 -61.7 -43.18 99.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.88 -1.137 . . . . 2.14 110.093 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.7 tp -60.56 -44.9 95.65 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.957 0.884 . . . . 1.05 109.452 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.76 -38.0 83.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.314 -0.866 . . . . 0.52 110.16 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -39.32 85.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 2.35 111.171 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -75.17 -40.86 59.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.872 -1.143 . . . . 1.39 111.008 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.94 -39.77 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.68 110.618 -178.464 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -86.51 -10.07 54.86 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.962 -1.086 . . . . 0.83 111.927 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.39 19.52 71.43 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.992 -1.099 . . . . 0.91 112.634 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 46.2 tp -71.07 140.23 50.64 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.673 -0.898 . . . . 0.95 109.317 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -67.55 150.73 48.44 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.226 -0.921 . . . . 2.43 110.65 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 81.0 mt -106.18 142.11 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.453 -0.944 . . . . 1.1 108.453 178.057 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 23.3 mm -74.56 122.59 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.326 -0.991 . . . . 1.58 108.326 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -95.85 100.65 12.32 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.891 -1.892 . . . . 1.62 105.891 178.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 53.8 mt -73.56 -21.46 60.35 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.295 -0.878 . . . . 0.8 111.396 -177.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 82.5 p -83.97 7.05 19.62 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.443 -0.786 . . . . 1.56 112.169 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.16 17.7 19.26 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.531 0.681 . . . . 0.84 112.212 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.628 HD12 HD21 ' A' ' 172' ' ' ASN . 45.4 mt -74.98 144.49 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.636 -0.665 . . . . 0.82 109.785 179.011 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -120.85 -9.76 9.23 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.359 -0.838 . . . . 2.31 112.522 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -118.77 141.92 48.18 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.963 -0.755 . . . . 1.54 108.963 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.86 124.19 26.42 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.159 0.981 . . . . 1.38 108.791 178.326 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.68 176.84 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.038 -0.727 . . . . 0.69 109.038 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 67.8 mt -91.98 141.59 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.225 -1.028 . . . . 0.53 108.225 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.7 tp -93.95 126.53 39.21 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.851 -1.155 . . . . 0.64 108.447 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 32.3 t -123.42 129.99 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.059 -1.089 . . . . 0.67 108.059 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.83 158.18 27.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.226 -0.921 . . . . 0.78 108.783 179.31 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 162' ' ' ASP . . . -62.05 -39.43 92.34 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.573 -1.33 . . . . 1.0 109.772 178.224 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 55.8 m-20 -168.93 156.63 7.53 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.192 -1.04 . . . . 2.42 108.192 179.187 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 38.4 mt -117.25 139.62 50.57 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.231 -0.918 . . . . 0.75 108.612 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.0 p -95.96 151.02 38.05 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.141 -1.059 . . . . 0.78 108.141 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -39.87 -43.72 3.44 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.779 1.652 . . . . 0.67 113.351 179.355 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 74.8 m -61.28 -50.38 73.23 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.288 -0.882 . . . . 0.7 109.953 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.68 -39.4 88.29 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.409 -0.807 . . . . 1.21 110.153 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.8 p -68.77 -41.08 79.33 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.852 -0.739 . . . . 0.6 110.575 179.551 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.21 -34.86 74.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.07 -1.019 . . . . 0.62 110.531 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -96.97 -1.37 45.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.125 -0.984 . . . . 1.16 112.879 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.46 151.71 31.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.98 -1.075 . . . . 0.73 109.695 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.628 HD21 HD12 ' A' ' 152' ' ' ILE . 25.0 p-10 -92.91 108.13 19.76 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 106.439 -1.689 . . . . 2.24 106.439 178.007 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 173' ' ' LEU . 3.1 mm? -76.96 -18.71 58.07 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.488 -0.757 . . . . 1.43 111.63 -177.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -81.1 -25.66 36.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.064 -1.023 . . . . 2.15 112.255 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -102.75 -4.43 25.01 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 113.829 1.048 . . . . 2.04 113.829 -178.046 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 178' ' ' GLY . 63.0 t -101.68 120.1 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.302 -1.74 . . . . 0.55 106.302 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 22.0 tp -84.89 -0.73 55.11 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.657 0.742 . . . . 1.63 111.873 -178.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.492 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.34 169.95 34.09 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.035 -1.626 . . . . 0.47 109.035 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -129.31 137.74 51.18 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.193 -1.18 . . . . 0.54 108.31 179.107 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.541 HG22 HG21 ' A' ' 205' ' ' THR . 93.2 mt -135.67 110.87 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 105.798 -1.927 . . . . 0.69 105.798 178.683 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 203' ' ' VAL . 41.7 p -135.8 179.31 6.42 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.667 -1.27 . . . . 0.82 110.089 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -102.43 55.52 0.78 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 115.91 -0.586 . . . . 2.37 109.735 179.555 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.01 166.55 10.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.663 -0.648 . . . . 1.11 109.448 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.23 -81.93 0.1 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.797 -1.192 . . . . 1.67 111.244 178.272 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.82 -67.53 0.28 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.31 -1.112 . . . . 1.54 111.954 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -61.36 -39.47 90.74 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.378 -1.072 . . . . 4.48 110.143 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.2 p -105.76 13.79 29.17 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.614 -0.679 . . . . 2.63 111.831 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.5 t -86.91 120.46 28.2 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.413 -1.329 . . . . 1.69 107.413 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -60.7 -40.54 92.59 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.696 -0.628 . . . . 1.07 110.767 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 191' ' ' SER . 11.9 t -59.68 -40.03 86.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.916 -1.115 . . . . 1.58 110.29 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.433 ' N ' HG23 ' A' ' 190' ' ' THR . 35.5 t -58.57 -37.56 76.03 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.325 -0.86 . . . . 1.6 110.48 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.81 -38.66 77.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.123 -0.986 . . . . 1.45 110.415 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 74.4 mtp -62.3 -43.63 98.38 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.395 1.093 . . . . 1.05 109.128 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.31 -41.15 83.86 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.223 -0.899 . . . . 0.72 110.464 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.433 HH11 ' HG2' ' A' ' 195' ' ' ARG . 47.0 mtt-85 -60.47 -42.07 95.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.915 -1.115 . . . . 3.05 110.095 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 64.4 m -71.06 -39.31 72.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 0.89 110.305 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.3 mt -91.24 -9.3 45.72 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.841 0.829 . . . . 0.78 112.392 -178.247 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.4 mt-10 52.29 12.5 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.846 1.054 . . . . 1.45 113.846 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.66 147.81 96.58 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 0.67 108.238 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -56.73 139.68 89.11 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.379 1.386 . . . . 0.64 110.134 178.66 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.77 165.85 31.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.518 -1.364 . . . . 0.67 109.798 179.564 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 203' ' ' VAL . 59.6 mt -145.39 156.84 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.656 -1.238 . . . . 0.69 107.656 178.199 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 181' ' ' THR . 8.0 m -137.9 -32.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.162 -0.961 . . . . 0.85 112.942 -179.374 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -72.27 34.03 0.66 Allowed Glycine 0 N--CA 1.486 1.983 0 C-N-CA 120.25 -0.976 . . . . 0.92 113.052 -178.088 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.541 HG21 HG22 ' A' ' 180' ' ' ILE . 54.8 p -58.65 -26.81 64.16 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.198 -1.178 . . . . 0.95 111.074 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.31 -93.54 0.89 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 110.525 -1.03 . . . . 1.04 110.525 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.4 t -126.19 30.56 5.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.848 -0.795 . . . . 1.57 112.269 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 94.7 t -59.62 -34.96 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.525 -1.359 . . . . 0.84 110.23 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 29.4 p -56.13 -24.5 41.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 0.99 111.344 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.6 m -91.97 1.67 57.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.139 -0.975 . . . . 1.7 111.919 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -125.23 -7.25 7.07 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.038 0.755 . . . . 2.2 113.038 -178.256 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 48.8 t -114.97 150.76 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.789 -0.819 . . . . 0.84 108.789 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -120.57 154.1 35.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.354 -0.98 . . . . 2.2 108.354 177.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.435 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 51.4 p-10 -53.56 144.67 16.76 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.988 -1.07 . . . . 2.28 110.797 178.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.9 OUTLIER 81.18 0.11 1.7 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.808 1.41 . . . . 2.35 114.808 179.415 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.0 146.13 55.06 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.382 -1.449 . . . . 1.97 108.473 177.441 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -87.83 120.26 28.99 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.353 -1.351 . . . . 2.65 107.353 178.231 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.56 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 77.1 mt -125.62 145.76 50.01 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.704 0.764 . . . . 0.63 110.055 -179.373 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.91 126.05 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 106.276 -1.75 . . . . 0.62 106.276 177.372 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.454 HD13 HD11 ' A' ' 180' ' ' ILE . 61.3 tp -102.13 119.59 39.05 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.797 -1.557 . . . . 0.64 106.797 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.62 ' O ' ' N ' ' A' ' 223' ' ' VAL . 78.8 m-20 -94.22 -22.85 18.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 2.05 112.238 -178.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.922 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.11 14.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 112.508 0.558 . . . . 0.84 112.508 -178.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.3 t -112.31 -59.91 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.279 -0.888 . . . . 1.02 109.857 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -92.21 12.12 23.36 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.52 0.676 . . . . 2.51 110.963 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 60.5 t30 60.22 48.9 7.72 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.262 0.553 . . . . 1.54 111.127 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -147.92 145.38 28.59 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.181 0.991 . . . . 1.95 109.836 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.5 t -117.16 138.82 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.822 -1.177 . . . . 0.71 107.822 177.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -100.13 130.08 46.23 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.913 -1.117 . . . . 1.01 108.235 178.651 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.8 t -109.67 130.03 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.382 -0.969 . . . . 0.82 108.382 179.011 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 25.0 t30 56.62 49.9 4.46 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 114.225 1.194 . . . . 1.54 114.225 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 44.2 Cg_endo -67.88 149.94 78.19 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.41 2.073 . . . . 0.94 110.263 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 45.8 p -72.81 152.71 41.42 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.574 -1.329 . . . . 1.8 109.272 177.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -59.93 -34.51 73.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 2.73 110.308 178.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.77 -40.6 88.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 3.17 110.497 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 67.9 t -70.51 -40.87 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.154 -0.966 . . . . 1.34 109.974 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.2 mt -59.06 -46.55 91.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.379 -0.826 . . . . 1.2 110.606 -178.591 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -60.14 -44.25 95.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.283 -0.886 . . . . 2.7 110.534 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -61.16 -40.19 92.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.647 -0.658 . . . . 2.59 110.288 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.443 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 90.2 mtp -71.47 -36.04 71.06 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.293 -0.879 . . . . 1.38 110.739 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.409 ' NH1' ' HG3' ' A' ' 240' ' ' ARG . 20.8 mmm-85 -53.2 -45.22 68.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.545 -1.347 . . . . 2.84 110.31 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.61 -57.59 3.73 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.191 -0.943 . . . . 1.88 110.629 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.31 -46.84 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.302 -0.873 . . . . 2.4 111.339 -179.202 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.495 ' HA ' HE21 ' A' ' 243' ' ' GLN . 3.2 tp60 -60.46 -48.98 79.38 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.628 -1.295 . . . . 3.52 110.338 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -59.58 -32.83 70.73 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.507 -1.37 . . . . 1.88 109.62 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -60.95 -28.33 68.89 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.33 -0.948 . . . . 3.01 109.761 179.264 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 97.2 t -59.83 -40.61 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.131 -1.028 . . . . 2.45 109.101 178.461 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.96 -48.65 80.85 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.348 -0.941 . . . . 2.75 109.578 179.267 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 11.2 t -74.01 -28.81 61.63 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.527 -0.733 . . . . 3.16 111.162 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -60.76 -31.67 70.99 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.269 0.557 . . . . 3.57 110.668 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -61.25 -38.99 88.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.254 -0.904 . . . . 4.3 110.745 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -68.22 -38.6 82.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.955 . . . . 4.45 110.31 179.475 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -71.85 -26.44 62.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.307 -0.871 . . . . 5.97 111.571 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.708 ' O ' HD23 ' A' ' 253' ' ' LEU . 1.9 tt -66.07 -19.85 65.98 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.291 -0.881 . . . . 6.18 111.487 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -66.36 -26.75 67.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.72 -1.237 . . . . 6.66 112.232 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -79.2 -9.53 59.59 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.801 -1.187 . . . . 8.2 112.693 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 81.9 mt -83.23 -1.89 54.22 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.216 -0.927 . . . . 8.07 112.359 -179.063 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -84.71 -10.13 57.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 9.45 111.599 -178.292 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -99.48 -4.97 30.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.595 -0.691 . . . . 10.12 112.814 -178.085 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 117.859 -1.067 . . . . 11.49 109.042 -178.579 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 110.111 -0.329 . . . . 3.07 110.111 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.406 HD13 ' CG2' ' A' ' 208' ' ' VAL . 64.3 mt -94.44 111.71 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.761 -1.57 . . . . 1.07 106.761 176.716 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.4 m -104.35 124.76 49.77 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.53 -1.285 . . . . 1.24 107.53 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.22 -159.24 17.2 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 108.46 -1.856 . . . . 1.01 108.46 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 5' ' ' ILE . 97.0 mt -94.44 0.52 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.186 -1.185 . . . . 1.11 112.677 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 51.8 93.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.854 -1.153 . . . . 0.99 112.043 178.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -87.61 -34.41 18.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.832 -1.167 . . . . 0.85 111.12 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 1.2 p -149.55 143.98 17.37 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.59 -1.319 . . . . 1.38 107.96 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.37 145.67 21.42 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.464 2.11 . . . . 0.94 112.758 178.181 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.9 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 148.42 162.08 9.98 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 109.835 -1.306 . . . . 0.81 109.835 178.256 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.3 132.55 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 O-C-N 120.861 -1.376 . . . . 0.83 107.966 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.85 150.12 45.65 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.231 -0.918 . . . . 0.53 109.307 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 7.0 m-85 -123.26 144.03 49.67 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.911 -0.774 . . . . 0.77 108.911 178.278 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.12 169.67 36.55 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.03 -1.557 . . . . 0.51 109.897 177.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -76.95 154.79 33.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.542 -0.975 . . . . 1.9 108.786 178.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.605 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.76 125.65 33.4 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.453 -1.314 . . . . 0.66 107.453 178.322 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.3 tp -101.95 107.46 18.61 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.262 -2.125 . . . . 0.83 105.262 177.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -90.28 135.66 33.54 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.839 -1.171 . . . . 0.86 107.839 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.5 mt -100.29 114.34 27.73 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.78 -1.563 . . . . 0.92 106.78 178.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -109.77 137.34 47.71 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.389 -1.337 . . . . 2.03 107.389 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -129.55 144.92 51.48 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.918 -1.114 . . . . 2.66 109.041 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -83.58 136.19 34.34 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.154 -1.054 . . . . 2.32 108.154 177.279 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.99 149.41 44.94 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.278 -0.889 . . . . 2.11 108.627 178.526 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.8 mt -94.68 134.74 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.68 -0.859 . . . . 0.73 108.68 178.268 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.99 131.46 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.757 -1.201 . . . . 0.87 107.757 179.154 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -91.03 144.94 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.08 -0.711 . . . . 0.81 109.08 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -88.97 122.44 32.33 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.633 -1.247 . . . . 1.34 107.633 178.176 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -97.9 16.93 19.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.612 -0.68 . . . . 2.89 112.314 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.51 143.02 56.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.283 -0.885 . . . . 2.09 109.383 179.051 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -90.93 135.73 33.54 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.929 -1.138 . . . . 2.19 107.929 178.086 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.6 pt -97.68 172.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 122.101 0.953 . . . . 0.75 109.889 177.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.44 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 38.2 p -102.85 161.31 13.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.873 -0.788 . . . . 0.91 108.873 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.03 -31.88 19.77 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.996 -1.065 . . . . 0.93 111.947 178.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.44 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 3.5 p-10 -69.99 -40.15 75.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 2.28 110.037 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -77.47 -19.03 56.57 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.363 -0.836 . . . . 1.45 111.413 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.527 HG13 HG22 ' A' ' 93' ' ' ILE . 51.5 t -59.76 -42.56 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.069 -1.019 . . . . 0.81 110.568 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -57.1 -39.96 76.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.808 -1.183 . . . . 1.54 110.841 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.275 -0.891 . . . . 2.36 110.402 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -62.76 -35.34 79.51 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.752 -1.217 . . . . 1.31 110.87 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.69 -40.36 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.61 -1.306 . . . . 0.82 110.21 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -61.4 -39.67 91.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 1.5 109.654 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.504 HH11 ' HG2' ' A' ' 42' ' ' ARG . 21.6 mtt-85 -63.07 -42.96 99.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 2.23 110.06 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -72.12 -54.17 10.55 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 119.838 -0.745 . . . . 0.85 110.138 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.96 -48.05 82.93 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.236 -0.985 . . . . 0.91 110.013 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.543 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.9 t -70.06 -38.68 75.84 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.321 -0.862 . . . . 0.9 110.061 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.78 -43.11 96.68 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.674 -1.37 . . . . 0.69 109.674 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -58.21 -33.34 69.2 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.217 1.008 . . . . 2.88 108.742 179.125 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.06 -46.05 79.06 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.015 0.912 . . . . 0.85 109.274 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -76.81 -43.54 36.16 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.355 -0.841 . . . . 2.35 110.658 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.96 82.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.089 -1.007 . . . . 0.65 109.91 -178.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -59.52 -40.0 85.72 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.342 -0.943 . . . . 1.45 109.346 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.81 -48.84 65.1 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.736 -0.602 . . . . 0.63 110.327 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.83 -49.94 75.46 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.356 -1.465 . . . . 1.34 110.566 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.31 -39.31 92.6 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.237 -0.914 . . . . 1.56 109.923 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -59.89 -41.2 91.08 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.017 -0.673 . . . . 1.19 110.543 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.547 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 23.6 m -64.62 -42.57 95.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.405 -0.809 . . . . 0.72 110.273 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.1 mt -59.57 -39.32 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.459 -0.776 . . . . 0.62 110.617 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -51.66 -40.25 59.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.86 -1.15 . . . . 1.05 110.523 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.56 -40.0 73.61 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.328 -0.858 . . . . 0.64 109.974 -179.439 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.547 ' NZ ' HG22 ' A' ' 56' ' ' THR . 61.7 mttp -63.42 -39.01 93.33 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.53 -1.268 . . . . 1.73 108.583 -178.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.37 75.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.568 -0.707 . . . . 0.56 110.112 179.135 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.85 -38.16 10.77 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 119.697 -1.24 . . . . 0.69 111.322 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.46 -23.48 43.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.793 -1.416 . . . . 1.48 110.688 -179.296 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -88.72 -50.42 6.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.088 -1.008 . . . . 0.98 111.067 179.525 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -106.79 -9.5 16.38 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 114.378 1.251 . . . . 1.16 114.378 -177.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.36 154.13 12.11 Favored Glycine 0 N--CA 1.502 3.091 0 O-C-N 121.128 -0.982 . . . . 0.85 111.736 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -54.31 -17.15 2.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -1.033 . . . . 3.86 112.544 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -58.38 -35.3 71.79 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.39 -0.819 . . . . 2.35 110.903 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -82.46 -21.99 35.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.741 -1.224 . . . . 1.67 111.708 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.05 -32.91 71.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.9 . . . . 1.45 111.279 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.53 93.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.948 -1.095 . . . . 0.61 110.534 179.078 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.1 mt -68.17 -45.29 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.487 -1.383 . . . . 0.65 110.547 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -69.65 -31.32 69.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.912 -1.117 . . . . 0.66 110.934 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.02 -39.64 86.55 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.295 -0.878 . . . . 1.19 109.974 178.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.96 -38.09 95.06 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.866 -1.294 . . . . 0.53 109.866 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -58.0 -44.03 86.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.414 -1.05 . . . . 1.27 110.001 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.48 -40.59 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.942 -1.099 . . . . 0.54 110.432 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.4 ttt -60.01 -38.95 84.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.271 -0.893 . . . . 1.74 110.108 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -60.96 -50.62 72.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.807 . . . . 0.55 110.201 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.57 -40.44 87.36 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.445 -0.902 . . . . 0.47 110.493 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -88.64 10.54 20.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.645 -0.66 . . . . 1.42 112.68 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -62.93 123.27 18.09 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.035 -1.041 . . . . 1.27 109.151 178.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -67.39 -19.13 65.36 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.951 0.882 . . . . 1.35 110.708 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -77.7 -49.65 14.04 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.658 0.742 . . . . 2.22 110.748 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.79 -38.97 90.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.318 -0.864 . . . . 0.62 110.346 -179.419 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -57.83 -46.95 83.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.84 -0.537 . . . . 1.29 110.91 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -61.04 -39.92 91.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.136 -0.977 . . . . 1.52 110.381 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -65.75 -47.2 76.07 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 118.827 -1.149 . . . . 1.3 111.145 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.3 mt -57.56 -44.27 84.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.861 -1.149 . . . . 0.61 110.4 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.7 mt -63.42 -41.54 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.665 0.745 . . . . 0.78 110.967 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.54 -42.08 98.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.82 111.17 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.5 mt -60.43 -45.09 94.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.087 . . . . 0.8 110.536 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.527 HG22 HG13 ' A' ' 36' ' ' VAL . 69.4 mt -60.79 -49.88 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.495 -0.753 . . . . 0.77 110.205 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -77.3 -37.17 53.31 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.59 -0.694 . . . . 2.12 111.776 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -80.71 -46.95 14.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.874 -1.141 . . . . 1.51 112.455 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -100.59 8.33 43.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.964 -1.085 . . . . 1.98 112.677 -178.63 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 37.3 m80 51.94 50.5 18.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.902 -1.124 . . . . 1.32 111.998 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.488 ' O ' HG23 ' A' ' 93' ' ' ILE . 66.4 mtt -107.17 155.54 19.79 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.197 -0.939 . . . . 1.38 109.456 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.2 p -72.23 166.4 22.5 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.609 -0.682 . . . . 0.67 110.51 178.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.7 -43.79 97.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.429 -0.794 . . . . 0.52 110.413 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 6.2 p-10 -69.59 -43.41 72.86 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.437 -0.79 . . . . 2.25 109.934 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.08 -47.69 70.51 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.945 -1.102 . . . . 0.64 110.463 -179.333 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.33 98.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.977 -1.077 . . . . 0.56 110.571 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.38 -43.2 92.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.147 -0.971 . . . . 0.46 110.526 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -61.41 -40.21 93.59 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.144 -0.972 . . . . 1.32 111.403 -179.416 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -58.54 -48.43 80.89 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.996 -1.065 . . . . 1.3 111.101 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.3 t -61.04 -46.89 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.205 -0.935 . . . . 0.61 109.816 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -62.24 -32.38 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.271 0.557 . . . . 0.65 110.443 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -55.41 -40.8 71.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 2.11 110.18 179.117 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.12 -27.69 30.29 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.636 -1.268 . . . . 0.83 113.269 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -62.18 -40.35 95.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.404 -1.645 . . . . 1.28 109.67 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.21 -52.15 10.64 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.919 -0.488 . . . . 0.89 111.025 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.2 m -59.51 -39.03 82.49 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.628 -0.829 . . . . 1.87 110.634 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.43 98.18 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.452 -0.78 . . . . 1.05 111.288 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 73.5 mt -63.2 -30.11 71.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.1 -1.0 . . . . 1.02 111.347 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -68.53 -20.21 64.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.956 -1.09 . . . . 2.04 111.006 179.439 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -75.49 -14.24 60.41 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.519 -0.738 . . . . 1.73 111.158 -179.238 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.716 HD13 HD13 ' A' ' 123' ' ' LEU . 12.8 mt -84.35 150.98 25.01 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.439 -0.788 . . . . 1.37 109.015 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -98.21 35.77 1.7 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.954 -1.091 . . . . 2.88 112.468 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -116.0 130.99 57.06 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.667 -0.864 . . . . 1.58 108.667 179.16 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.28 -35.89 74.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 3.04 111.107 178.69 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -69.18 -48.9 60.95 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.499 -1.376 . . . . 0.9 110.289 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.716 HD13 HD13 ' A' ' 118' ' ' LEU . 45.9 mt -62.57 -39.94 95.26 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.011 -1.055 . . . . 1.06 110.854 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 60.2 tttm -62.82 -49.75 73.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.872 -1.143 . . . . 2.18 109.98 178.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.77 -32.44 71.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 2.15 109.637 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 130' ' ' VAL . 66.0 ttt180 -61.31 -29.59 69.97 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.022 -1.071 . . . . 2.33 108.958 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.63 -47.9 83.78 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.838 0.828 . . . . 0.82 109.032 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.87 -47.02 86.9 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.499 -0.88 . . . . 0.85 109.444 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.33 -31.96 72.66 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.469 0.652 . . . . 1.39 109.963 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.2 t -69.66 -41.73 80.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.652 -0.655 . . . . 0.56 110.003 179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -57.51 -40.69 79.27 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.829 -1.169 . . . . 3.12 109.549 179.527 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -60.3 -43.16 96.56 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.621 -0.674 . . . . 1.28 110.535 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.08 -38.28 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.102 -0.999 . . . . 0.49 109.947 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.05 -49.96 37.43 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.846 -1.169 . . . . 0.46 110.406 179.074 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -58.4 -43.36 88.53 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.963 -1.316 . . . . 2.71 110.209 179.428 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.436 ' NH2' ' CB ' ' A' ' 166' ' ' SER . 88.5 mtt180 -62.29 -41.43 98.49 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.705 -1.198 . . . . 2.14 109.22 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.68 -40.72 88.77 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.543 0.687 . . . . 1.05 109.95 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.2 -42.56 95.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.029 . . . . 0.52 110.668 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -59.82 -34.07 72.59 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.428 -0.795 . . . . 2.35 110.614 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -75.03 -42.55 56.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.179 -0.951 . . . . 1.39 110.821 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.9 -39.98 83.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.148 -0.97 . . . . 0.68 110.281 -178.394 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.1 mt -89.94 -12.01 40.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -0.932 . . . . 0.83 112.701 -179.283 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.3 19.72 76.27 Favored Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.569 -1.3 . . . . 0.91 113.066 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.5 150.44 48.95 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.525 -0.985 . . . . 0.95 109.952 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -65.26 148.56 51.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 2.43 109.751 178.105 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.4 mt -106.88 144.13 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.56 -0.904 . . . . 1.1 108.56 178.355 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.1 mm -79.11 120.78 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.885 -1.135 . . . . 1.58 108.388 178.181 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -98.09 96.72 8.32 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.369 -1.715 . . . . 1.62 106.369 179.204 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.6 mt -75.92 -17.51 59.73 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.612 -0.68 . . . . 0.8 111.512 -177.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.6 m -81.19 4.81 18.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.928 -1.108 . . . . 1.56 112.383 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.72 20.83 11.32 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.791 0.805 . . . . 0.84 112.33 -179.241 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 18.0 mt -72.65 139.23 19.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.264 -0.897 . . . . 0.82 108.752 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -116.77 -11.54 10.92 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.491 -0.756 . . . . 2.31 112.885 -178.547 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -115.86 134.09 55.35 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.736 -1.209 . . . . 1.54 107.736 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -72.98 119.28 17.01 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.44 -0.788 . . . . 1.38 108.879 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.0 177.01 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.373 -0.829 . . . . 0.69 109.343 -179.021 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.0 mt -85.87 142.15 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.008 -1.058 . . . . 0.53 109.117 178.147 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.0 tp -95.28 125.17 39.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.155 -0.966 . . . . 0.64 108.613 178.046 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.7 t -124.54 129.69 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.536 -1.283 . . . . 0.67 107.536 179.163 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.33 160.12 29.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 0.78 108.548 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.72 -40.85 89.36 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.275 -1.516 . . . . 1.0 109.521 177.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 9.2 t70 -174.17 158.57 3.04 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.236 -1.024 . . . . 2.42 108.236 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.451 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 35.5 mt -118.3 139.16 51.75 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.149 -1.056 . . . . 0.75 108.149 177.184 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.9 p -90.24 149.36 41.14 Favored Pre-proline 0 N--CA 1.485 1.312 0 N-CA-C 108.293 -1.003 . . . . 0.78 108.293 179.412 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -40.18 -45.23 4.08 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.035 1.824 . . . . 0.67 113.393 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.436 ' CB ' ' NH2' ' A' ' 136' ' ' ARG . 15.3 m -59.94 -50.31 74.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.677 -1.264 . . . . 0.7 110.96 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.94 -40.32 92.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.447 -0.783 . . . . 1.21 109.934 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.5 p -66.41 -39.0 88.72 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.689 0.757 . . . . 0.6 110.141 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.23 85.31 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.358 -0.937 . . . . 0.62 111.11 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -94.8 1.56 55.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.994 -1.066 . . . . 1.16 113.569 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.8 148.74 46.04 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.483 -0.932 . . . . 0.73 108.483 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -95.27 115.01 26.86 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 106.537 -1.653 . . . . 2.24 106.537 177.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 26.1 mt -75.46 -14.93 60.46 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.484 -0.76 . . . . 1.43 111.71 -177.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -84.03 -19.67 34.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.081 -1.012 . . . . 2.15 112.276 -178.528 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -102.14 -6.16 23.6 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.327 -0.858 . . . . 2.04 113.033 -177.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 178' ' ' GLY . 85.5 t -110.69 129.57 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.106 -1.442 . . . . 0.55 107.106 179.311 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 tp -90.94 -4.93 56.11 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.985 0.897 . . . . 1.63 112.595 -179.147 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.48 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -179.86 170.46 41.7 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.691 -1.764 . . . . 0.47 108.691 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -125.83 126.18 44.08 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.786 -1.42 . . . . 0.54 107.42 178.22 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.5 mt -125.65 128.61 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 106.913 -1.514 . . . . 0.69 106.913 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 203' ' ' VAL . 74.6 p -139.58 166.78 23.69 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.894 -1.129 . . . . 0.82 109.247 179.052 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 29.0 p-10 -103.16 32.19 3.88 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.397 -0.814 . . . . 2.37 111.504 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -97.02 120.64 37.75 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.091 -1.077 . . . . 1.11 108.091 178.548 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -88.44 27.19 7.19 Favored Glycine 0 N--CA 1.484 1.875 0 C-N-CA 120.15 -1.024 . . . . 1.67 113.515 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -88.1 115.76 4.44 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 107.882 -2.087 . . . . 1.54 107.882 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -58.03 -31.37 66.93 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.525 -0.985 . . . . 4.48 109.287 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.8 p -105.06 37.32 2.2 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.684 0.754 . . . . 2.63 110.265 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.5 t -72.07 146.71 47.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.365 -0.835 . . . . 1.69 109.569 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -58.16 -39.74 79.63 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.245 -0.909 . . . . 1.07 110.999 178.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 56.8 p -57.84 -41.39 82.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.837 -1.164 . . . . 1.58 110.221 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.3 t -61.45 -34.2 75.02 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.333 -0.854 . . . . 1.6 110.163 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.6 mm -60.26 -41.03 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.06 -1.025 . . . . 1.45 110.914 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 60.9 mtp -61.66 -40.46 95.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.565 -1.334 . . . . 1.05 110.103 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.96 -45.74 89.77 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.41 -0.814 . . . . 0.72 111.127 179.372 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -60.7 -42.2 96.74 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.656 -0.817 . . . . 3.05 110.479 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.4 m -69.49 -39.01 77.89 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.328 -0.857 . . . . 0.89 109.942 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.26 -7.29 51.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.234 -0.916 . . . . 0.78 112.753 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 194' ' ' ALA . 89.7 mt-10 53.36 8.53 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.364 1.246 . . . . 1.45 114.364 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.469 ' O ' ' OG ' ' A' ' 8' ' ' SER . 57.2 mt -73.89 147.6 86.44 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.646 -1.284 . . . . 0.67 108.162 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.78 143.43 58.91 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.353 1.369 . . . . 0.64 109.503 178.827 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.82 163.02 37.06 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 117.767 -1.573 . . . . 0.67 109.679 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.47 HD12 HD11 ' A' ' 220' ' ' LEU . 51.2 mt -149.45 151.31 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.654 -1.239 . . . . 0.69 107.654 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 183' ' ' ALA . 15.1 m -136.05 -28.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 120.79 -1.194 . . . . 0.85 112.235 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.39 41.42 3.06 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 120.845 -1.159 . . . . 0.92 112.166 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.6 p -61.58 -17.65 55.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.873 -1.369 . . . . 0.95 111.535 -178.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.12 -93.04 1.8 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.401 -1.08 . . . . 1.04 110.401 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.1 m -133.58 32.84 3.56 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 122.214 -0.58 . . . . 1.57 112.26 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.406 ' CG2' HD13 ' A' ' 2' ' ' ILE . 46.5 t -59.43 -37.69 71.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.324 -1.485 . . . . 0.84 110.527 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 67.5 p -55.34 -28.52 54.3 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.422 -0.911 . . . . 0.99 111.203 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 19.6 m -92.1 0.86 57.47 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.106 -0.996 . . . . 1.7 112.143 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -122.86 -7.19 8.45 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 113.395 0.887 . . . . 2.2 113.395 -177.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.5 t -118.92 151.62 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.59 0.709 . . . . 0.84 109.296 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -117.7 157.12 27.05 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.118 -1.068 . . . . 2.2 108.118 177.649 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.44 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 42.4 t30 -52.48 141.49 19.92 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.871 -1.143 . . . . 2.28 110.805 178.572 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.72 2.75 1.43 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 115.185 1.55 . . . . 2.35 115.185 179.397 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.2 t0 -64.72 148.08 51.81 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.862 -1.148 . . . . 1.97 108.797 177.424 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.522 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 44.3 t80 -88.6 119.38 29.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.544 -1.347 . . . . 2.65 107.664 177.845 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.605 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.7 mt -127.22 148.89 50.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.426 -0.797 . . . . 0.63 110.292 -178.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.4 mt -116.81 123.97 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 106.158 -1.793 . . . . 0.62 106.158 177.124 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.47 HD11 HD12 ' A' ' 202' ' ' ILE . 58.2 tp -99.16 120.12 38.98 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.692 -1.595 . . . . 0.64 106.692 178.625 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.623 ' O ' ' N ' ' A' ' 223' ' ' VAL . 77.8 m-20 -93.84 -29.15 15.47 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.781 -1.168 . . . . 2.05 113.129 -177.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.06 12.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.432 -0.793 . . . . 0.84 112.654 -179.253 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.623 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.4 t -108.53 -61.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.746 -1.222 . . . . 1.02 109.525 179.092 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -94.19 11.59 29.6 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.389 0.614 . . . . 2.51 110.675 179.638 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 61.48 54.53 3.07 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.148 0.499 . . . . 1.54 111.951 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -148.97 143.52 26.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.173 -0.954 . . . . 1.95 109.831 178.604 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.1 t -115.9 136.91 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.077 -1.083 . . . . 0.71 108.077 178.139 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -102.68 131.74 49.28 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.606 -0.887 . . . . 1.01 108.606 178.647 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.41 130.96 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 108.653 -0.869 . . . . 0.82 108.653 178.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.423 ' O ' ' ND2' ' A' ' 230' ' ' ASN . 1.2 t30 52.11 53.69 13.07 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.188 -0.945 . . . . 1.54 113.549 178.309 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.65 151.07 63.73 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 C-N-CA 122.513 2.142 . . . . 0.94 111.069 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.0 m -71.33 157.77 37.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.072 -1.017 . . . . 1.8 108.995 177.478 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -57.31 -40.89 78.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 2.73 109.898 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.85 -39.82 86.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.815 . . . . 3.17 110.692 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.2 t -69.2 -38.05 77.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.23 -0.919 . . . . 1.34 110.818 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 84.4 mt -58.3 -49.13 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 1.2 110.261 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -59.33 -39.32 82.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.322 -0.861 . . . . 2.7 110.828 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -61.92 -47.41 85.03 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.366 -0.834 . . . . 2.59 110.901 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 66.8 mtp -71.1 -36.63 72.27 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.849 -1.157 . . . . 1.38 111.005 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.1 mmm-85 -58.46 -39.63 80.42 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 120.091 -0.643 . . . . 2.84 110.975 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.68 -38.72 80.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 1.88 110.959 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 89.0 t -57.6 -50.09 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.444 -1.41 . . . . 2.4 112.128 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -66.12 -49.88 65.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.539 -1.351 . . . . 3.52 109.709 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -61.24 -35.9 78.51 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.456 -0.777 . . . . 1.88 110.119 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.86 -30.31 68.88 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.662 -1.274 . . . . 3.01 109.958 179.277 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.56 -39.32 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.469 -0.892 . . . . 2.45 110.042 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.29 -41.65 89.44 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.096 -1.042 . . . . 2.75 110.462 178.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 14.3 p -70.18 -28.67 65.5 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.153 -0.967 . . . . 3.16 110.095 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -63.22 -33.55 75.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.587 -0.696 . . . . 3.57 110.842 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -62.08 -30.42 70.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.18 -0.95 . . . . 4.3 110.651 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -66.36 -14.42 62.06 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.362 -0.836 . . . . 4.45 111.451 179.635 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -75.38 -3.87 36.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 5.97 112.612 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.639 HD12 ' C ' ' A' ' 253' ' ' LEU . 4.5 pp -64.05 -12.79 41.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.999 -1.063 . . . . 6.18 111.803 -178.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.586 ' N ' HD12 ' A' ' 253' ' ' LEU . . . -72.33 -11.8 60.86 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.158 -0.964 . . . . 6.66 111.372 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -86.42 5.48 34.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.472 -0.767 . . . . 8.2 111.982 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 256' ' ' LEU . 3.3 mm? -83.46 33.07 0.46 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 8.07 112.869 -179.279 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.424 ' NZ ' ' O ' ' A' ' 254' ' ' ALA . 58.6 mttp -81.18 -2.99 50.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.158 -0.964 . . . . 9.45 112.356 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -96.41 8.07 44.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.449 -0.782 . . . . 10.12 112.254 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 117.812 -1.089 . . . . 11.49 108.779 -179.634 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtt . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 109.341 -0.614 . . . . 3.07 109.341 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.4 mt 51.01 73.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 1.07 112.431 176.644 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -90.73 115.4 27.79 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.61 -1.626 . . . . 1.24 106.61 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.35 -154.85 22.12 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.081 -2.007 . . . . 1.01 108.081 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 5' ' ' ILE . 72.6 mt -93.92 -4.33 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -1.141 . . . . 1.11 112.64 -178.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 5' ' ' ILE . 38.4 tp 50.61 100.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.831 -1.168 . . . . 0.99 112.235 178.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -89.63 -37.24 14.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.85 111.498 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -145.77 138.75 14.11 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 108.027 -1.101 . . . . 1.38 108.027 -178.257 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.88 148.92 28.73 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.725 2.283 . . . . 0.94 112.505 179.491 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.889 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.85 166.05 13.98 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.891 -1.684 . . . . 0.81 108.891 178.357 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.4 HG21 ' NE2' ' A' ' 243' ' ' GLN . 70.8 mt -128.52 136.11 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.046 -1.267 . . . . 0.83 108.704 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.537 ' HB1' HD22 ' A' ' 177' ' ' LEU . . . -143.06 156.67 44.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.303 -0.873 . . . . 0.53 109.495 179.263 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 23.8 m-85 -124.48 140.74 52.67 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.206 -1.035 . . . . 0.77 108.206 178.247 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.72 168.48 37.39 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 118.551 -1.785 . . . . 0.51 109.906 177.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -78.64 160.22 27.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.427 -1.043 . . . . 1.9 109.547 179.213 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.57 129.71 34.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.791 -1.193 . . . . 0.66 108.195 178.584 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.7 tp -107.53 101.94 11.24 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 105.029 -2.212 . . . . 0.83 105.029 177.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.5 tp -89.88 137.32 32.43 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.173 -1.047 . . . . 0.86 108.173 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.6 mt -100.49 114.79 28.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.592 -1.633 . . . . 0.92 106.592 178.683 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -108.97 131.49 55.0 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.617 -1.253 . . . . 2.03 107.617 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -127.13 149.98 49.7 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.254 -0.904 . . . . 2.66 109.228 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -83.04 135.0 35.01 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.778 -1.193 . . . . 2.32 107.778 177.276 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.39 147.32 48.85 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.592 -0.693 . . . . 2.11 109.315 178.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.423 HD11 ' NH1' ' A' ' 139' ' ' ARG . 61.9 mt -97.7 135.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.166 -0.959 . . . . 0.73 108.72 178.49 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.8 t -107.69 130.88 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.489 -0.93 . . . . 0.87 108.489 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.5 mt -97.56 131.44 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.335 -0.987 . . . . 0.81 108.335 178.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -93.51 123.26 36.7 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.814 -1.179 . . . . 1.34 108.371 178.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -95.81 10.25 37.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.299 -0.876 . . . . 2.89 112.333 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.63 149.22 46.97 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.118 -0.988 . . . . 2.09 109.332 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -89.93 131.02 36.06 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.74 -1.207 . . . . 2.19 107.74 177.52 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 pt -92.53 165.47 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.007 -1.058 . . . . 0.75 110.345 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.3 p -92.51 163.43 13.83 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.446 -0.575 . . . . 0.91 109.446 178.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.39 -17.49 1.94 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.214 -0.929 . . . . 0.93 112.482 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -69.45 -41.78 75.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.355 -0.841 . . . . 2.28 110.685 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -90.75 -5.76 55.28 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.62 -1.3 . . . . 1.45 112.697 -178.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.91 -42.29 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.803 -1.186 . . . . 0.81 110.477 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.14 -39.97 88.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.034 -1.041 . . . . 1.54 110.767 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -62.67 -38.13 89.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.509 -0.745 . . . . 2.36 110.845 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -60.19 -40.73 91.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.907 -1.121 . . . . 1.31 110.656 179.248 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -62.43 -41.16 90.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.187 -0.945 . . . . 0.82 110.551 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -60.8 -49.52 77.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.109 -0.995 . . . . 1.5 110.369 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 46' ' ' GLY . 65.1 mtm180 -62.86 -40.35 97.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.231 -0.918 . . . . 2.23 110.09 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -70.04 -54.6 12.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.434 -0.791 . . . . 0.85 110.184 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.49 -49.88 73.63 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.937 -1.105 . . . . 0.91 109.834 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.56 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.9 t -67.81 -39.75 83.95 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.783 0.802 . . . . 0.9 109.91 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 42' ' ' ARG . . . -56.43 -43.25 90.25 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.808 -1.317 . . . . 0.69 109.808 178.614 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -59.54 -31.26 69.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.891 0.853 . . . . 2.88 109.394 178.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.08 -43.2 77.78 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.492 0.663 . . . . 0.85 109.762 178.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -79.07 -42.94 25.21 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.325 -0.95 . . . . 2.35 110.009 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.87 86.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.099 -1.001 . . . . 0.65 110.225 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.0 p -59.98 -41.76 92.71 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.268 1.032 . . . . 1.45 109.241 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.74 90.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.728 -0.669 . . . . 0.63 110.133 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -60.09 -49.8 76.21 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.39 -0.924 . . . . 1.34 110.264 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.59 -42.74 91.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 1.56 110.059 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -59.86 -40.3 88.15 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.736 -0.602 . . . . 1.19 110.47 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.46 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 5.6 m -67.43 -47.69 69.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.06 -1.025 . . . . 0.72 110.18 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.5 mt -61.36 -34.36 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 0.62 110.849 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -51.62 -43.94 62.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.114 -0.991 . . . . 1.05 111.013 179.366 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.9 m -68.97 -39.62 79.35 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.985 -1.072 . . . . 0.64 110.197 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' NZ ' HG22 ' A' ' 56' ' ' THR . 47.4 mttp -60.11 -40.0 88.17 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.807 -1.157 . . . . 1.73 109.529 179.305 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.41 73.83 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.326 -0.858 . . . . 0.56 109.934 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.59 -37.03 9.87 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.978 -1.106 . . . . 0.69 111.112 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -81.59 -23.94 36.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.092 -1.24 . . . . 1.48 111.001 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.4 m -88.82 -50.37 6.26 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.461 -0.774 . . . . 0.98 110.57 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.591 ' CZ ' ' SD ' ' A' ' 193' ' ' MET . 75.4 m-85 -107.23 -3.67 19.55 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 113.805 1.039 . . . . 1.16 113.805 -177.474 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.1 166.49 34.21 Favored Glycine 0 N--CA 1.495 2.617 0 O-C-N 121.088 -1.007 . . . . 0.85 111.699 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -56.31 -19.54 14.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.558 -0.966 . . . . 3.86 112.787 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -56.74 -41.5 77.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.684 -1.26 . . . . 2.35 110.561 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -89.27 -23.12 22.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.97 -1.081 . . . . 1.67 111.563 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -60.78 -38.93 86.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.502 -0.749 . . . . 1.45 110.745 -179.272 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.1 -39.37 89.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.36 -0.837 . . . . 0.61 110.816 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.6 mt -62.12 -44.24 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.865 -1.147 . . . . 0.65 110.513 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -71.7 -31.65 66.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.856 -1.152 . . . . 0.66 110.701 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.24 -41.17 92.57 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.115 -0.99 . . . . 1.19 109.903 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.88 -36.74 91.53 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.656 -1.259 . . . . 0.53 110.143 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.48 ' N ' ' HD1' ' A' ' 76' ' ' HIS . 1.4 m80 -59.31 -40.83 87.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -1.155 . . . . 1.27 110.492 179.229 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.3 -39.66 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.982 -1.074 . . . . 0.54 110.276 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.8 ttp -59.58 -39.36 83.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.335 -0.853 . . . . 1.74 110.396 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.43 -49.93 73.13 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.466 -0.894 . . . . 0.55 110.105 179.199 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.5 tp -60.45 -46.92 88.3 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.763 0.792 . . . . 0.47 110.272 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -85.74 8.43 19.87 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.034 0.753 . . . . 1.42 113.034 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -62.31 122.06 14.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.878 -1.139 . . . . 1.27 108.581 179.091 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -64.07 -18.67 64.6 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.733 0.777 . . . . 1.35 111.099 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.14 -53.74 7.84 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.74 -0.784 . . . . 2.22 110.253 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.52 -35.12 78.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.551 -0.718 . . . . 0.62 110.495 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -60.01 -48.92 79.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.306 -0.871 . . . . 1.29 110.739 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -62.68 -39.97 95.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 1.52 110.513 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.97 -48.41 76.59 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.292 -0.88 . . . . 1.3 110.152 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -57.89 -43.48 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.291 -0.881 . . . . 0.61 109.879 179.258 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.43 -40.81 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.718 -0.614 . . . . 0.78 110.479 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.19 -45.04 95.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -0.894 . . . . 0.82 110.873 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.91 -39.05 84.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 0.8 110.521 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.8 mt -70.18 -49.73 52.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 0.77 111.066 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -81.78 -36.37 28.54 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.833 -1.167 . . . . 2.12 111.795 -179.212 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 91' ' ' ALA . 24.1 t0 -81.8 -42.43 19.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.83 -1.169 . . . . 1.51 112.132 -178.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -103.38 8.25 38.09 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.212 -0.93 . . . . 1.98 112.452 -178.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.3 m80 51.08 51.17 17.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.14 -0.975 . . . . 1.32 111.804 -179.795 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.6 mtt -104.91 152.07 23.1 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.353 -0.842 . . . . 1.38 108.899 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.1 p -71.92 160.03 33.25 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.577 -0.702 . . . . 0.67 109.292 177.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.7 92.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.149 -0.969 . . . . 0.52 110.571 178.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.579 ' OD2' HD21 ' A' ' 142' ' ' LEU . 81.6 m-20 -67.24 -42.1 84.54 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.044 -1.035 . . . . 2.25 109.925 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.49 -51.0 48.15 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.635 -0.665 . . . . 0.64 111.224 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.31 -45.74 92.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.037 -1.04 . . . . 0.56 110.65 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.7 97.12 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.494 -0.883 . . . . 0.46 110.408 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -60.28 -39.22 86.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 1.32 110.972 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -57.9 -48.72 79.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.949 -1.094 . . . . 1.3 110.567 179.361 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.99 -47.44 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.943 -1.098 . . . . 0.61 110.031 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.0 mm -62.64 -30.95 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.779 -0.576 . . . . 0.65 110.56 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.59 -41.61 86.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.44 -0.788 . . . . 2.11 110.85 179.287 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.75 -34.52 10.05 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.231 -1.462 . . . . 0.83 112.678 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -61.13 -41.68 97.16 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.788 -1.419 . . . . 1.28 110.259 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.39 -54.93 7.99 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.741 0.781 . . . . 0.89 110.29 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 65.3 m -59.97 -38.49 82.67 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.686 -0.634 . . . . 1.87 110.477 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.61 96.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.991 -1.068 . . . . 1.05 110.575 179.599 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.17 -30.14 71.03 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.217 -0.993 . . . . 1.02 110.35 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -66.6 -20.07 65.92 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.164 -0.96 . . . . 2.04 110.986 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -72.63 -10.51 59.87 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.99 0.9 . . . . 1.73 111.02 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 23.2 mt -87.84 144.84 26.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.936 -0.765 . . . . 1.37 108.936 179.323 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -100.19 37.13 1.71 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.132 -0.98 . . . . 2.88 111.787 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -115.22 137.71 51.72 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.179 -0.951 . . . . 1.58 108.81 178.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 50.1 mp0 -59.86 -35.24 74.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.67 -0.644 . . . . 3.04 111.089 179.043 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -73.53 -49.74 24.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.926 -1.109 . . . . 0.9 109.848 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.1 mt -63.73 -39.73 95.0 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.281 -0.887 . . . . 1.06 109.604 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -60.96 -45.07 96.21 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.864 0.84 . . . . 2.18 109.67 179.282 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -61.29 -32.78 72.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.812 0.815 . . . . 2.15 109.535 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.416 ' O ' HG23 ' A' ' 130' ' ' VAL . 60.4 ttt180 -62.04 -29.57 70.38 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.996 0.903 . . . . 2.33 109.463 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.93 74.6 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.926 0.87 . . . . 0.82 109.501 178.633 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.56 -41.59 79.53 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.703 0.763 . . . . 0.85 110.08 179.785 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -62.55 -40.47 96.92 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.413 0.625 . . . . 1.39 110.243 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 126' ' ' ARG . 52.1 t -68.96 -38.33 78.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.504 -0.748 . . . . 0.56 109.755 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -58.92 -38.89 79.98 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.057 -1.027 . . . . 3.12 109.715 178.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.498 ' OD2' ' NE ' ' A' ' 136' ' ' ARG . 32.2 t70 -60.12 -39.79 87.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.61 -0.682 . . . . 1.28 110.352 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 57.7 mt -60.05 -39.83 81.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.363 -0.836 . . . . 0.49 109.983 179.401 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.13 -48.3 26.5 Favored Glycine 0 N--CA 1.485 1.943 0 C-N-CA 120.209 -0.995 . . . . 0.46 110.799 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -58.89 -44.16 91.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.039 -1.271 . . . . 2.71 110.202 179.24 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.498 ' NE ' ' OD2' ' A' ' 132' ' ' ASP . 54.3 mtm180 -61.62 -41.48 97.54 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.707 -1.197 . . . . 2.14 109.774 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.45 -41.71 94.65 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.865 -0.734 . . . . 1.05 110.079 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.6 mt -60.57 -43.35 97.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.437 -0.789 . . . . 0.52 110.765 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.423 ' NH1' HD11 ' A' ' 24' ' ' ILE . 48.7 mtt-85 -59.84 -32.81 71.02 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.363 -0.836 . . . . 2.35 111.318 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -75.39 -40.17 58.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.011 -1.056 . . . . 1.39 110.708 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.4 mt -59.58 -40.13 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.227 -0.921 . . . . 0.68 110.972 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.579 HD21 ' OD2' ' A' ' 101' ' ' ASP . 86.2 mt -90.47 -9.2 48.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.916 -1.115 . . . . 0.83 112.926 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.09 23.16 66.8 Favored Glycine 0 N--CA 1.483 1.78 0 C-N-CA 119.91 -1.138 . . . . 0.91 113.112 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.414 HD23 HH11 ' A' ' 139' ' ' ARG . 29.0 tp -63.08 142.21 58.47 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.757 -0.849 . . . . 0.95 109.012 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -66.53 141.35 57.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.239 -0.913 . . . . 2.43 109.378 178.431 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.4 mt -112.18 136.52 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 108.32 -0.993 . . . . 1.1 108.32 178.295 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.561 ' H ' HD12 ' A' ' 147' ' ' ILE . 5.2 mp -76.2 131.07 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 1.58 108.792 178.586 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.09 97.63 11.04 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.721 -1.585 . . . . 1.62 106.721 178.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.455 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 50.4 mt -71.51 -29.45 64.8 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.378 0.609 . . . . 0.8 110.942 -178.146 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.0 t -79.47 -3.29 45.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.35 -0.844 . . . . 1.56 112.297 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -101.27 23.1 11.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.677 -0.64 . . . . 0.84 111.919 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.455 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 16.4 mt -72.1 144.87 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 0.82 109.861 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -118.64 -10.85 9.96 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.979 0.895 . . . . 2.31 112.372 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -118.22 140.36 49.92 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.72 0.772 . . . . 1.54 109.152 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.04 119.8 22.69 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.285 -0.885 . . . . 1.38 108.741 178.621 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.71 175.79 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.578 0.704 . . . . 0.69 109.328 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.5 mt -86.98 140.9 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.805 . . . . 0.53 109.01 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 24.6 tp -98.32 122.3 41.31 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.044 -1.035 . . . . 0.64 108.777 178.365 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.8 t -123.93 133.96 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.337 -0.986 . . . . 0.67 108.337 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.86 157.81 29.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.477 -0.764 . . . . 0.78 109.113 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.449 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.4 -38.7 88.03 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.672 -1.268 . . . . 1.0 109.196 178.185 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.2 t0 -172.45 148.0 1.97 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.524 -0.735 . . . . 2.42 109.02 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.521 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 66.1 mt -119.15 138.98 52.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.243 -0.911 . . . . 0.75 108.555 177.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.2 p -93.6 151.6 40.2 Favored Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 108.327 -0.99 . . . . 0.78 108.327 178.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -39.93 -38.72 2.04 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.767 1.645 . . . . 0.67 113.433 179.433 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.5 m -58.92 -42.87 90.7 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.036 -1.065 . . . . 0.7 109.699 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -72.64 -45.1 60.64 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.693 -0.803 . . . . 1.21 110.164 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 20.4 p -66.19 -38.95 89.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.372 -0.83 . . . . 0.6 109.812 -178.652 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.72 87.34 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.677 -0.64 . . . . 0.62 110.844 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -92.96 0.49 57.41 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.126 -0.984 . . . . 1.16 112.738 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.7 tp -65.99 150.26 48.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.729 . . . . 0.73 109.756 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -96.94 117.82 32.0 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.035 -1.469 . . . . 2.24 107.035 177.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 39.1 mt -76.32 -18.07 59.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 1.43 111.404 -178.346 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -82.97 -20.58 34.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.205 -0.935 . . . . 2.15 112.282 -179.208 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -102.69 -6.28 22.86 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.261 -0.899 . . . . 2.04 113.383 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 178' ' ' GLY . 45.5 t -111.7 131.8 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.063 -1.088 . . . . 0.55 108.063 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.739 ' O ' HD23 ' A' ' 177' ' ' LEU . 2.0 tt -86.04 -11.52 52.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.004 -1.06 . . . . 1.63 111.684 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.535 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 174.31 177.39 43.43 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.013 -1.565 . . . . 0.47 109.748 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.64 132.48 46.73 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.405 -1.056 . . . . 0.54 108.199 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 72.6 mt -134.14 109.39 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 106.423 -1.695 . . . . 0.69 106.423 178.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 205' ' ' THR . 65.6 p -129.63 170.47 13.75 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.9 -1.125 . . . . 0.82 110.568 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 15.4 p-10 -103.03 49.56 0.83 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.277 0.561 . . . . 2.37 110.423 179.435 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.0 154.46 18.95 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.338 -0.851 . . . . 1.11 109.356 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.91 -80.92 0.06 OUTLIER Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.598 -1.286 . . . . 1.67 111.302 178.433 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.38 -40.74 0.82 Allowed Glycine 0 N--CA 1.492 2.392 0 O-C-N 120.941 -1.329 . . . . 1.54 112.354 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -60.22 -36.25 77.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.947 . . . . 4.48 110.518 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 12.6 p -121.25 26.85 8.69 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.517 -0.74 . . . . 2.63 111.399 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -86.52 109.84 19.37 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.351 -1.351 . . . . 1.69 107.351 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -61.69 -37.83 85.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.588 -0.695 . . . . 1.07 110.727 -178.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 25.8 m -57.24 -40.49 77.7 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.136 -0.977 . . . . 1.58 110.304 179.372 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 50.4 m -60.01 -38.45 82.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 1.6 110.6 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.9 mt -59.36 -41.04 83.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.148 -0.97 . . . . 1.45 110.522 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.591 ' SD ' ' CZ ' ' A' ' 65' ' ' PHE . 7.7 mtm -68.96 -35.07 76.33 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.707 -1.197 . . . . 1.05 109.325 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.26 -44.62 88.44 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.174 -0.61 . . . . 0.72 110.56 179.031 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.474 HH11 ' HG2' ' A' ' 195' ' ' ARG . 32.8 mtt-85 -60.2 -41.27 92.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 3.05 110.448 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.0 m -68.91 -37.46 78.96 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.749 0.785 . . . . 0.89 110.028 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.1 mt -90.4 -5.91 55.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.413 -0.804 . . . . 0.78 112.472 -179.262 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 54.11 8.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.67 0.989 . . . . 1.45 113.67 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 30.8 mt -71.58 150.03 93.5 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.971 -1.081 . . . . 0.67 108.773 178.827 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -55.89 145.79 71.33 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.745 1.63 . . . . 0.64 109.68 178.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.9 158.9 31.69 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.715 -1.241 . . . . 0.67 109.989 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.469 ' CD1' HD11 ' A' ' 220' ' ' LEU . 15.0 mt -149.77 148.03 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.878 -1.156 . . . . 0.69 107.878 178.468 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.2 m -134.11 -32.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.995 -1.066 . . . . 0.85 113.557 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.11 45.32 2.51 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.102 -0.999 . . . . 0.92 112.227 -178.131 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 181' ' ' THR . 32.5 p -67.19 -11.1 56.46 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.189 -1.183 . . . . 0.95 111.328 -179.143 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.0 -97.08 0.81 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.802 -1.189 . . . . 1.04 110.182 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.6 m -127.18 29.07 5.64 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.457 -1.025 . . . . 1.57 112.473 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.53 -37.85 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.595 -1.316 . . . . 0.84 110.7 179.172 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 60.4 p -54.35 -25.1 22.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.001 -1.062 . . . . 0.99 111.36 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.2 t -93.63 -0.2 56.24 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.705 0.764 . . . . 1.7 111.742 -179.389 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -124.37 -2.05 8.06 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 113.291 0.849 . . . . 2.2 113.291 -177.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.4 t -117.12 150.04 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.443 -0.786 . . . . 0.84 109.156 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -122.2 153.07 39.3 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.638 -0.875 . . . . 2.2 108.638 178.01 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 52.3 t30 -52.2 141.53 18.67 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.235 -0.915 . . . . 2.28 110.093 178.518 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 10.0 t0 81.07 -1.76 1.76 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.111 1.152 . . . . 2.35 114.111 179.521 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -61.71 148.56 42.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.796 -1.19 . . . . 1.97 108.578 177.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -90.47 118.97 30.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.116 -1.439 . . . . 2.65 107.116 177.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.527 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 82.9 mt -129.33 148.41 51.25 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.55 -0.719 . . . . 0.63 109.511 -178.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.6 mt -117.54 129.66 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 106.602 -1.629 . . . . 0.62 106.602 177.682 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.469 HD11 ' CD1' ' A' ' 202' ' ' ILE . 61.6 tp -99.75 118.84 37.09 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 106.713 -1.588 . . . . 0.64 106.713 178.632 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 223' ' ' VAL . 50.4 t0 -93.71 -30.94 14.64 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.119 -0.988 . . . . 2.05 112.654 -177.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.889 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.87 20.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.42 0.896 . . . . 0.84 113.42 -178.079 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.7 t -109.62 -62.03 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.839 -1.163 . . . . 1.02 108.788 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -91.83 15.22 13.42 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.024 0.916 . . . . 2.51 110.247 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.3 t30 60.75 51.54 4.8 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.355 -0.839 . . . . 1.54 112.409 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -152.73 156.19 38.66 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.776 -1.202 . . . . 1.95 110.451 178.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 69.9 t -117.97 144.96 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.702 -0.624 . . . . 0.71 109.462 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -101.92 130.34 48.39 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 107.973 -1.121 . . . . 1.01 107.973 177.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.07 129.86 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.22 -0.925 . . . . 0.82 108.815 179.181 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.436 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 44.3 t-20 52.51 49.85 7.2 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.115 -0.991 . . . . 1.54 113.557 178.184 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 40.9 Cg_endo -66.51 149.71 84.3 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.623 2.216 . . . . 0.94 111.432 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.9 m -75.57 154.08 36.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 1.8 109.031 177.546 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 34.0 p-10 -60.74 -35.44 76.38 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.569 -0.707 . . . . 2.73 110.487 179.06 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.497 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 81.0 tt0 -59.47 -43.44 93.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 3.17 110.453 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 99.0 t -71.34 -39.79 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.241 -0.912 . . . . 1.34 110.165 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.494 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 96.3 mt -58.54 -46.73 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 1.2 110.512 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -59.86 -41.14 90.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.501 -0.75 . . . . 2.7 110.275 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -60.81 -41.88 96.55 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.513 -0.742 . . . . 2.59 110.455 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.463 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 87.1 mtp -73.09 -40.38 65.06 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.524 -0.735 . . . . 1.38 110.674 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.522 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.1 OUTLIER -53.93 -41.8 68.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.031 -1.043 . . . . 2.84 110.516 -178.59 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.61 -59.21 2.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.635 -1.291 . . . . 1.88 110.471 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 63.1 t -64.52 -46.72 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.347 -0.845 . . . . 2.4 111.321 -179.204 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' A' ' 239' ' ' MET . 0.9 OUTLIER -59.16 -48.95 79.72 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.723 -1.236 . . . . 3.52 110.92 179.959 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -60.78 -31.64 71.0 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.789 -1.194 . . . . 1.88 110.365 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.23 -31.82 70.54 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.254 -0.904 . . . . 3.01 109.209 178.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 90.6 t -62.56 -39.87 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 121.794 0.807 . . . . 2.45 109.863 179.261 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.76 91.86 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.403 0.62 . . . . 2.75 110.538 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 11.7 m -69.52 -40.69 76.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.482 -0.762 . . . . 3.16 110.326 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -61.39 -34.46 75.37 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.924 -0.71 . . . . 3.57 110.216 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -63.34 -35.78 81.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.935 . . . . 4.3 110.212 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -65.48 -30.32 71.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.606 -0.684 . . . . 4.45 110.635 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -71.45 -11.12 60.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.214 -0.929 . . . . 5.97 111.963 -179.659 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 31.3 tp -64.37 -27.87 69.31 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.938 -1.101 . . . . 6.18 111.17 -179.357 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -67.29 -4.98 12.18 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.554 -0.716 . . . . 6.66 112.552 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -83.12 12.33 5.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.449 -0.782 . . . . 8.2 112.436 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 3.7 pp -77.1 -4.52 44.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.788 -1.195 . . . . 8.07 112.388 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -85.2 -5.03 59.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.193 -0.942 . . . . 9.45 112.247 -179.155 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -94.17 4.86 53.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.496 -0.752 . . . . 10.12 112.559 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 117.991 -1.004 . . . . 11.49 110.108 -179.38 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mmt . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 108.591 -0.892 . . . . 3.07 108.591 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.85 111.51 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.497 -1.668 . . . . 1.07 106.497 176.477 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 m -105.94 128.13 53.59 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.762 -1.199 . . . . 1.24 107.762 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.28 -156.98 22.76 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 108.968 -1.653 . . . . 1.01 108.968 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 5' ' ' ILE . 86.6 mt -95.82 -1.81 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.554 -0.968 . . . . 1.11 112.581 -178.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 49.38 99.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.468 0.544 . . . . 0.99 112.468 178.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.89 -52.69 6.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.066 -1.021 . . . . 0.85 110.775 179.383 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.43 146.34 41.76 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 107.449 -1.315 . . . . 1.38 107.449 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -74.07 144.38 33.83 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.866 2.377 . . . . 0.94 112.993 178.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.912 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.46 166.81 17.55 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 109.539 -1.425 . . . . 0.81 109.539 178.075 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.446 HD12 ' HG2' ' A' ' 243' ' ' GLN . 85.7 mt -127.22 134.56 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.302 -1.116 . . . . 0.83 108.225 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.12 155.94 46.77 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.318 -0.864 . . . . 0.53 109.498 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 7.2 m-85 -125.09 143.22 51.03 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.482 -0.761 . . . . 0.77 108.995 178.527 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.32 167.39 34.39 Favored Glycine 0 N--CA 1.499 2.897 0 C-N-CA 118.98 -1.581 . . . . 0.51 110.002 177.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -78.82 157.65 28.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.753 -0.851 . . . . 1.9 109.198 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -81.31 134.84 35.65 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.842 -1.161 . . . . 0.66 108.636 178.035 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.2 tp -116.18 101.19 8.49 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 105.801 -1.925 . . . . 0.83 105.801 178.199 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -93.72 132.97 37.57 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.01 -1.107 . . . . 0.86 108.01 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.6 mt -103.31 118.09 35.99 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 106.802 -1.555 . . . . 0.92 106.802 178.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -110.63 137.72 47.95 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.749 -1.204 . . . . 2.03 107.749 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -121.02 151.33 39.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 2.66 109.703 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -81.92 132.98 35.28 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.941 -1.133 . . . . 2.32 107.941 177.216 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -60.87 148.84 38.09 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.876 -1.14 . . . . 2.11 108.941 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.0 mt -96.9 129.83 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.175 -0.953 . . . . 0.73 108.517 178.41 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.5 129.6 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.005 -1.109 . . . . 0.87 108.005 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.6 mt -91.64 130.91 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.24 -1.022 . . . . 0.81 108.24 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -90.62 116.54 28.59 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.061 -1.459 . . . . 1.34 107.061 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -97.92 17.07 19.06 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.424 -0.797 . . . . 2.89 112.673 -179.217 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -68.42 147.28 52.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 2.09 109.326 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -87.23 128.35 35.15 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.576 -1.268 . . . . 2.19 107.576 178.444 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 pt -93.84 163.97 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.026 -1.046 . . . . 0.75 110.132 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.8 p -92.57 162.03 14.35 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.206 0.527 . . . . 0.91 109.712 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.3 -15.98 1.91 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.046 -1.034 . . . . 0.93 112.011 179.315 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -71.27 -38.95 71.82 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.409 -0.807 . . . . 2.28 110.895 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -92.68 -6.06 50.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.744 -1.222 . . . . 1.45 112.934 -178.236 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -59.67 -40.58 82.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 120.154 -0.618 . . . . 0.81 110.48 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -59.24 -40.19 85.15 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.017 -1.052 . . . . 1.54 110.528 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -62.14 -41.47 98.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.326 -0.859 . . . . 2.36 111.213 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -59.71 -40.27 87.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.316 -0.865 . . . . 1.31 111.047 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.31 -40.63 84.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.169 -0.957 . . . . 0.82 110.982 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -60.37 -48.82 80.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.587 -1.321 . . . . 1.5 110.449 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -62.45 -40.97 98.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.472 -0.767 . . . . 2.23 110.649 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -70.39 -57.6 4.64 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.177 -0.952 . . . . 0.85 109.374 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.39 -48.73 80.53 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.55 -0.86 . . . . 0.91 110.121 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.7 t -68.03 -39.67 83.04 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.106 -0.996 . . . . 0.9 110.074 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.16 -46.67 70.07 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.74 -1.219 . . . . 0.69 110.056 178.615 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -59.96 -29.92 68.75 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.44 -1.035 . . . . 2.88 110.311 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.67 -49.48 77.58 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.671 0.748 . . . . 0.85 109.923 179.187 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -79.27 -41.56 27.85 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.599 -0.688 . . . . 2.35 110.657 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.58 -41.37 90.1 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.05 -1.06 . . . . 0.65 110.206 -178.671 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.2 p -60.78 -40.34 92.23 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.319 1.056 . . . . 1.45 109.246 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.71 -49.63 67.79 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.65 -0.705 . . . . 0.63 110.435 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -59.67 -49.78 76.41 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 118.85 -1.14 . . . . 1.34 110.392 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.94 -40.6 98.15 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.877 0.846 . . . . 1.56 110.164 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -59.93 -41.4 91.7 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.195 -0.94 . . . . 1.19 110.471 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 m -63.89 -43.7 95.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.851 -1.156 . . . . 0.72 110.067 179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.9 mt -60.43 -36.66 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.561 0.696 . . . . 0.62 110.943 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -51.01 -44.09 60.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.401 -0.812 . . . . 1.05 110.81 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -68.98 -38.91 79.61 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.031 -1.043 . . . . 0.64 110.029 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.71 -37.71 87.56 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.887 -1.125 . . . . 1.73 108.873 179.216 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.8 -33.17 75.35 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.887 -0.725 . . . . 0.56 109.818 179.112 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.83 -37.1 12.08 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 120.139 -1.029 . . . . 0.69 111.135 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -81.63 -28.45 33.66 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.787 -1.42 . . . . 1.48 110.723 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.3 m -88.19 -45.45 10.08 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.49 -0.757 . . . . 0.98 111.383 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.89 -7.54 17.04 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 114.102 1.149 . . . . 1.16 114.102 -177.827 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.46 161.27 30.2 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.498 -0.751 . . . . 0.85 111.633 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.87 -25.39 63.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.73 -0.865 . . . . 3.86 112.341 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -57.27 -44.18 83.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.763 -1.211 . . . . 2.35 110.669 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -82.64 -24.29 33.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.554 -1.341 . . . . 1.67 111.405 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.72 -36.84 77.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.531 -0.731 . . . . 1.45 110.981 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.05 83.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.163 -0.961 . . . . 0.61 110.628 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.7 mt -64.74 -41.86 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.913 -1.117 . . . . 0.65 110.178 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -71.42 -32.41 68.36 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.971 -1.081 . . . . 0.66 109.776 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -61.74 -39.19 90.69 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 1.19 109.953 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.71 -40.93 99.04 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.265 -0.969 . . . . 0.53 110.986 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -58.93 -43.07 91.1 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.913 -1.345 . . . . 1.27 110.475 179.435 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.5 mt -60.88 -37.51 76.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.038 -1.039 . . . . 0.54 110.333 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -57.7 -40.27 79.1 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.602 -0.687 . . . . 1.74 110.045 179.12 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 tp -60.31 -50.35 73.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.368 -0.832 . . . . 0.55 110.232 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.01 -41.26 91.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.896 0.855 . . . . 0.47 110.183 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -85.91 5.69 31.83 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.446 -0.784 . . . . 1.42 112.937 -179.392 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -61.59 121.79 13.64 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.204 -0.935 . . . . 1.27 108.491 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.95 -17.26 64.55 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.752 -0.779 . . . . 1.35 110.822 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.77 -51.8 10.73 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.768 -0.773 . . . . 2.22 110.495 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.95 -40.61 93.94 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.48 -0.888 . . . . 0.62 111.204 -179.31 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -57.48 -49.85 74.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.932 . . . . 1.29 110.236 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -61.86 -40.34 95.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 1.52 110.469 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.02 -46.66 77.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.936 -1.102 . . . . 1.3 110.521 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -57.11 -42.87 80.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.049 -1.032 . . . . 0.61 110.065 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.8 -44.51 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.39 -0.819 . . . . 0.78 110.245 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.6 97.33 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.493 -0.754 . . . . 0.82 111.016 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.03 -43.29 99.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.872 -1.142 . . . . 0.8 110.198 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.62 -47.94 89.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.38 -0.825 . . . . 0.77 110.247 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -78.09 -38.76 43.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.125 -0.984 . . . . 2.12 112.059 -179.375 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -82.35 -42.25 18.96 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.964 -1.085 . . . . 1.51 112.359 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -99.04 5.04 47.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.173 -0.955 . . . . 1.98 112.374 -178.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 40.7 m80 51.37 49.11 21.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.0 . . . . 1.32 111.338 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 64.5 mtt -105.82 154.68 20.19 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.14 -0.975 . . . . 1.38 109.711 178.483 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 82.5 p -70.82 160.37 32.87 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.701 -0.624 . . . . 0.67 109.6 177.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.01 86.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.043 -1.035 . . . . 0.52 110.539 179.014 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -67.68 -39.36 84.46 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.318 -0.863 . . . . 2.25 110.568 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.06 67.96 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 120.928 -1.108 . . . . 0.64 111.439 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.76 88.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.56 110.626 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.74 -41.33 86.25 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.234 -0.916 . . . . 0.46 111.148 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -61.13 -40.25 93.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.631 -1.293 . . . . 1.32 110.285 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -59.9 -49.86 76.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.856 -1.152 . . . . 1.3 110.243 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.21 -47.27 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.982 -1.074 . . . . 0.61 110.182 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.3 mm -61.33 -33.26 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.65 110.521 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -57.26 -39.93 76.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.592 -0.693 . . . . 2.11 110.979 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.67 -24.91 44.18 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 118.948 -1.596 . . . . 0.83 113.304 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -63.36 -41.06 98.8 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.527 -1.572 . . . . 1.28 109.702 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.81 63.33 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.018 -0.537 . . . . 0.89 110.759 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.7 p -62.43 -41.14 98.49 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.077 -1.049 . . . . 1.87 109.918 -178.141 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.47 98.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.099 -1.0 . . . . 1.05 110.893 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 87.9 mt -64.92 -29.66 70.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.106 -0.996 . . . . 1.02 110.722 -179.605 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -66.38 -21.59 66.23 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.34 -0.85 . . . . 2.04 110.967 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -71.72 -13.38 61.71 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.222 1.01 . . . . 1.73 110.814 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.8 mt -87.62 136.35 32.98 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.429 -1.323 . . . . 1.37 107.429 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 7.3 t0 -97.01 37.42 1.31 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.556 -0.715 . . . . 2.88 112.266 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -111.96 138.77 48.13 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 107.984 -1.117 . . . . 1.58 107.984 178.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.92 -38.84 76.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.476 -0.765 . . . . 3.04 111.454 179.114 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -73.37 -50.12 23.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.65 -1.281 . . . . 0.9 110.594 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.59 -43.3 97.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.022 -1.049 . . . . 1.06 110.367 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -62.55 -45.11 94.44 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.345 -0.942 . . . . 2.18 109.416 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.84 -31.22 69.54 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.489 -0.885 . . . . 2.15 109.27 179.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.473 ' O ' HG23 ' A' ' 130' ' ' VAL . 26.6 ttm180 -61.67 -30.17 70.56 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.308 -0.957 . . . . 2.33 108.832 179.09 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -61.8 -50.51 72.04 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.157 -0.617 . . . . 0.82 110.273 178.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.37 -42.74 78.74 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.843 -0.743 . . . . 0.85 110.38 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.69 -36.84 84.22 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.733 -0.605 . . . . 1.39 110.567 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 126' ' ' ARG . 43.5 t -68.54 -40.94 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.235 -0.986 . . . . 0.56 110.732 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.532 ' HE ' ' NZ ' ' A' ' 135' ' ' LYS . 62.4 ttt180 -59.53 -37.6 78.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.031 -1.043 . . . . 3.12 109.704 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.407 ' CG ' ' NH1' ' A' ' 136' ' ' ARG . 49.2 t0 -60.37 -36.63 78.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.692 -0.63 . . . . 1.28 109.907 179.469 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.99 -39.76 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.729 0.776 . . . . 0.49 109.842 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.16 -42.64 94.25 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 119.567 -1.301 . . . . 0.46 109.973 178.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.532 ' NZ ' ' HE ' ' A' ' 131' ' ' ARG . 40.4 mmtm -59.05 -49.33 78.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.477 -1.014 . . . . 2.71 110.421 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.416 HH11 ' HG3' ' A' ' 136' ' ' ARG . 51.5 mtm-85 -64.96 -40.93 95.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.848 -1.158 . . . . 2.14 109.844 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 35.6 tp -61.09 -39.44 89.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.263 -0.898 . . . . 1.05 110.217 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.7 mt -60.24 -38.6 83.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.56 -0.712 . . . . 0.52 111.074 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 139' ' ' ARG . 56.0 mtt-85 -60.13 -37.83 81.23 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.288 -0.883 . . . . 2.35 110.734 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -75.47 -40.79 56.95 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.62 -0.832 . . . . 1.39 110.581 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -60.37 -39.62 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 0.68 110.17 -178.696 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.2 mt -87.28 -4.33 59.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.955 -1.091 . . . . 0.83 111.522 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.47 29.5 65.85 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 119.62 -1.276 . . . . 0.91 112.819 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 33.2 tp -75.03 151.09 38.76 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.632 0.729 . . . . 0.95 109.136 179.339 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -64.1 146.65 53.83 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.695 -1.253 . . . . 2.43 109.231 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.8 mt -105.27 138.79 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.574 -0.899 . . . . 1.1 108.574 178.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.658 ' H ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -81.0 127.32 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.671 -1.233 . . . . 1.58 107.671 178.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -94.7 96.16 9.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.484 -1.672 . . . . 1.62 106.484 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.494 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.9 mt -75.76 -15.77 60.22 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.699 0.762 . . . . 0.8 111.683 -177.758 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.411 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 94.7 p -89.92 8.35 32.68 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.613 -1.305 . . . . 1.56 112.147 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.29 21.21 12.3 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.672 0.99 . . . . 0.84 113.672 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.494 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 3.2 mp -70.51 139.94 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.343 -1.473 . . . . 0.82 108.437 179.302 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -114.65 -20.41 10.69 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.471 -0.768 . . . . 2.31 112.278 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -114.2 139.19 49.57 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.535 -1.284 . . . . 1.54 107.535 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.81 122.97 20.87 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.426 -0.954 . . . . 1.38 108.426 178.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.6 m -144.84 173.87 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 109.071 -0.714 . . . . 0.69 109.071 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.9 mt -85.78 142.87 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.065 -1.022 . . . . 0.53 109.583 178.299 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.2 tp -97.19 124.0 41.13 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.124 -0.985 . . . . 0.64 108.554 178.374 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.6 129.51 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.623 -1.251 . . . . 0.67 107.623 179.357 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.21 152.34 18.66 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.94 -1.1 . . . . 0.78 109.051 179.314 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.83 78.22 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.435 -1.416 . . . . 1.0 109.673 178.081 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 56.1 t0 -171.96 149.79 2.47 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.001 -0.74 . . . . 2.42 109.001 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.464 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 36.1 mt -114.39 140.85 48.33 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.537 -0.727 . . . . 0.75 109.397 177.356 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 81.2 p -90.0 149.02 40.89 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.954 -1.091 . . . . 0.78 109.096 178.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.97 -44.53 12.06 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 C-N-CA 122.159 1.906 . . . . 0.67 113.51 179.305 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.8 m -60.85 -46.54 90.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.834 -1.166 . . . . 0.7 109.742 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -63.81 -39.76 95.0 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.697 -0.801 . . . . 1.21 110.399 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 64.9 p -69.43 -39.4 77.88 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.63 -0.668 . . . . 0.6 110.587 179.616 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.79 78.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.618 -0.676 . . . . 0.62 110.662 179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -95.58 1.3 53.68 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.202 -0.936 . . . . 1.16 112.931 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.4 tp -61.57 151.94 31.82 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.718 -1.238 . . . . 0.73 109.548 179.496 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 150' ' ' SER . 94.3 m-20 -94.65 107.54 19.53 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 106.269 -1.752 . . . . 2.24 106.269 178.102 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.61 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.9 mp -69.36 -25.04 63.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.858 -0.526 . . . . 1.43 111.548 -178.074 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -83.37 -14.25 53.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.251 -0.906 . . . . 2.15 112.925 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -102.98 -1.91 28.52 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.274 0.842 . . . . 2.04 113.274 -177.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 178' ' ' GLY . 96.6 t -111.41 130.26 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.249 -1.019 . . . . 0.55 108.249 179.295 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 27.8 tp -84.54 -10.47 57.39 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.124 -0.985 . . . . 1.63 111.992 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.569 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.45 167.21 35.92 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 108.995 -1.642 . . . . 0.47 108.995 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -121.75 130.15 53.21 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.869 -1.16 . . . . 0.54 107.869 178.375 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 18.8 mt -130.07 130.45 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 107.444 -1.317 . . . . 0.69 107.444 178.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.2 p -140.29 172.33 12.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.936 -1.103 . . . . 0.82 109.818 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 2.8 m-20 -111.95 42.51 1.74 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.338 0.59 . . . . 2.37 110.369 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.55 168.73 9.04 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.783 0.801 . . . . 1.11 110.074 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.17 -6.8 48.55 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 120.107 -1.044 . . . . 1.67 113.086 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 77.6 -52.43 3.5 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.17 -1.194 . . . . 1.54 113.539 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -58.8 -42.37 88.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.817 -1.402 . . . . 4.48 110.986 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 81.8 p -105.38 11.3 32.88 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 120.79 -1.193 . . . . 2.63 112.074 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.5 t -92.18 125.53 36.89 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.839 -0.8 . . . . 1.69 108.839 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -62.08 -32.47 73.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 1.07 110.357 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.6 m -58.66 -38.9 79.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.406 -0.809 . . . . 1.58 110.39 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 93.6 p -59.03 -37.76 77.71 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.38 -0.825 . . . . 1.6 110.085 179.177 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.8 HD13 ' NH2' ' A' ' 195' ' ' ARG . 5.3 mm -58.75 -39.71 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.652 -0.819 . . . . 1.45 110.151 179.375 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 51.1 mtp -62.97 -44.52 95.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.088 -1.008 . . . . 1.05 110.146 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.26 -49.82 76.36 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.08 -0.648 . . . . 0.72 111.484 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.8 ' NH2' HD13 ' A' ' 192' ' ' ILE . 65.0 mtm-85 -62.96 -42.14 99.73 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.188 -0.945 . . . . 3.05 111.199 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.0 m -68.31 -38.75 81.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.173 -0.954 . . . . 0.89 109.855 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.62 -6.95 51.4 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.82 0.674 . . . . 0.78 112.82 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.6 mt-10 53.52 11.26 0.27 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 113.804 1.039 . . . . 1.45 113.804 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.11 144.71 87.73 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.856 -1.153 . . . . 0.67 108.239 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.28 131.2 43.47 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.785 1.657 . . . . 0.64 110.636 178.596 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.6 171.84 16.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.272 -1.371 . . . . 0.67 110.118 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.587 HD12 HD11 ' A' ' 220' ' ' LEU . 10.1 mt -147.03 157.04 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.045 -1.094 . . . . 0.69 108.045 178.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 181' ' ' THR . 23.8 m -141.59 -29.05 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.644 -1.285 . . . . 0.85 112.791 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.72 33.18 1.89 Allowed Glycine 0 C--N 1.289 -2.04 0 O-C-N 120.927 -1.108 . . . . 0.92 113.685 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 27.6 p -55.47 -24.79 33.05 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.249 -1.148 . . . . 0.95 111.194 -179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.34 -87.86 1.56 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.825 -0.91 . . . . 1.04 110.825 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 45.2 p -129.02 26.83 5.46 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 121.167 -1.196 . . . . 1.57 113.069 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 30.4 t -57.0 -39.7 67.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.317 -1.489 . . . . 0.84 110.807 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 64.4 p -61.27 -18.95 60.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 0.99 111.93 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 67.4 m -98.83 5.44 47.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 1.7 112.002 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -133.62 -4.19 2.93 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.916 -0.49 . . . . 2.2 112.146 -178.056 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.0 t -121.3 152.95 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 121.504 0.668 . . . . 0.84 109.41 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -117.81 161.21 20.1 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.751 -0.833 . . . . 2.2 108.751 178.175 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.0 p-10 -61.78 149.87 38.68 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.906 -1.117 . . . . 2.28 109.88 177.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.5 t70 82.88 -10.27 1.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.233 1.197 . . . . 2.35 114.233 178.102 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.23 149.44 37.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.534 -1.354 . . . . 1.97 109.276 177.304 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -87.18 123.88 32.68 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.282 -1.377 . . . . 2.65 107.282 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.515 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 74.8 mt -127.51 150.23 49.77 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.017 0.913 . . . . 0.63 110.093 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 88.0 mt -119.05 122.29 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.237 -1.764 . . . . 0.62 106.237 177.114 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.587 HD11 HD12 ' A' ' 202' ' ' ILE . 37.1 tp -98.65 118.01 34.4 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.441 -1.688 . . . . 0.64 106.441 178.434 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 223' ' ' VAL . 87.7 m-20 -94.22 -27.84 15.95 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.502 -1.374 . . . . 2.05 112.917 -177.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.912 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.63 15.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.914 0.709 . . . . 0.84 112.914 -179.159 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.8 t -108.66 -62.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.196 -0.94 . . . . 1.02 109.217 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -94.34 11.31 30.92 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.009 0.909 . . . . 2.51 110.514 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 60.9 54.99 3.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.618 -0.719 . . . . 1.54 112.03 178.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -144.72 146.53 32.24 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.234 1.016 . . . . 1.95 109.586 178.577 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.84 131.32 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.658 -1.238 . . . . 0.71 107.658 177.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -102.05 132.02 48.16 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.846 -1.159 . . . . 1.01 108.483 178.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.28 129.94 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 107.998 -1.112 . . . . 0.82 107.998 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.5 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 48.3 t30 59.05 44.01 0.96 Allowed Pre-proline 0 N--CA 1.485 1.309 0 N-CA-C 113.631 0.974 . . . . 1.54 113.631 178.717 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.1 Cg_endo -64.7 149.35 89.88 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.349 2.033 . . . . 0.94 111.56 -179.622 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 36.9 p -77.03 160.18 29.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.475 -0.766 . . . . 1.8 110.255 178.041 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -60.28 -36.73 78.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.753 -0.592 . . . . 2.73 110.385 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.12 -40.34 85.1 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.447 -0.783 . . . . 3.17 110.15 179.332 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 79.4 t -70.15 -39.87 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.824 0.821 . . . . 1.34 110.571 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.3 mt -60.4 -45.84 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.499 -0.751 . . . . 1.2 110.799 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -59.86 -41.37 91.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.181 -0.949 . . . . 2.7 110.441 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -63.0 -43.23 99.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 2.59 110.902 -179.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.6 mtp -70.92 -39.49 72.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 1.38 110.936 -179.53 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -57.55 -41.28 80.69 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.053 -1.029 . . . . 2.84 110.025 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.79 -57.47 4.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.766 -0.584 . . . . 1.88 110.707 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.29 -44.2 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.943 -1.098 . . . . 2.4 110.737 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.446 ' HG2' HD12 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -60.3 -52.77 63.85 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.636 -1.29 . . . . 3.52 111.119 179.858 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.0 -30.27 71.36 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.232 -0.918 . . . . 1.88 110.64 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -59.37 -33.27 70.97 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.969 -1.092 . . . . 3.01 109.058 178.654 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 95.3 t -64.17 -40.81 90.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 122.102 0.953 . . . . 2.45 109.433 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.36 -40.11 85.41 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.402 0.62 . . . . 2.75 110.895 179.43 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.9 t -62.98 -33.81 76.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.544 -0.722 . . . . 3.16 110.78 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -62.14 -39.09 91.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.12 -0.987 . . . . 3.57 110.028 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -68.16 -29.95 68.96 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.359 -0.838 . . . . 4.3 110.841 179.494 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -65.96 -15.76 63.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.481 -0.762 . . . . 4.45 112.265 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -64.62 -30.78 71.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.927 -1.108 . . . . 5.97 110.626 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 30.1 tp -61.93 -24.39 66.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.346 -0.846 . . . . 6.18 111.077 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -68.19 -4.83 15.21 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.247 -0.908 . . . . 6.66 112.692 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -78.18 1.36 21.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.978 -1.076 . . . . 8.2 112.686 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 256' ' ' LEU . 6.8 tt -79.85 -9.73 59.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.448 -0.783 . . . . 8.07 112.505 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -85.66 -1.89 57.62 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.232 -0.917 . . . . 9.45 112.124 -178.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -92.94 8.38 40.01 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.239 -0.913 . . . . 10.12 112.583 -178.712 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 259' ' ' ARG . 31.7 ttm-85 . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 117.934 -1.032 . . . . 11.49 110.614 -179.434 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 121.126 0.489 . . . . 3.07 109.783 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.6 mt -109.98 120.02 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 107.433 -1.321 . . . . 1.07 107.433 178.155 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.0 m -100.47 127.48 46.8 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.505 -1.294 . . . . 1.24 107.505 178.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -124.5 -163.29 11.64 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.451 -1.86 . . . . 1.01 108.451 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.7 mt -97.91 2.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.984 -1.303 . . . . 1.11 112.593 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tp 51.56 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.762 -1.211 . . . . 0.99 111.825 178.779 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -86.07 -38.83 17.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.914 -1.116 . . . . 0.85 110.939 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.427 ' O ' ' HB1' ' A' ' 222' ' ' ALA . 2.6 m -148.1 144.36 18.78 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.619 -1.301 . . . . 1.38 108.173 -179.376 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.08 145.99 22.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.356 2.037 . . . . 0.94 111.904 178.263 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.922 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.93 171.02 19.27 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.23 -1.548 . . . . 0.81 109.23 178.047 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.1 mt -128.79 135.56 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.208 -1.172 . . . . 0.83 107.919 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.39 152.69 44.55 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.027 -1.046 . . . . 0.53 109.996 179.478 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -125.08 140.28 53.03 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.33 -0.989 . . . . 0.77 108.33 178.171 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.54 170.14 37.38 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 118.216 -1.945 . . . . 0.51 110.473 178.155 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -78.74 157.14 28.57 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.803 -0.822 . . . . 1.9 109.003 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.514 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.89 127.45 35.05 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.257 -1.016 . . . . 0.66 108.257 178.426 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.3 tp -105.07 102.99 12.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.497 -2.038 . . . . 0.83 105.497 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.7 tp -90.62 140.82 29.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.936 -1.102 . . . . 0.86 108.672 -179.68 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.5 mt -97.0 114.22 25.82 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.697 -1.594 . . . . 0.92 106.697 177.62 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -106.23 130.11 54.16 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.317 -1.364 . . . . 2.03 107.317 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -125.31 149.61 47.91 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.476 -0.765 . . . . 2.66 109.527 -179.473 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -82.4 133.28 35.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.079 -1.082 . . . . 2.32 108.079 177.258 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -65.34 146.67 54.62 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.168 -0.957 . . . . 2.11 108.758 178.601 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.1 mt -93.45 136.18 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.694 -0.854 . . . . 0.73 108.694 178.431 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.09 130.27 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.821 -1.177 . . . . 0.87 107.821 179.064 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.7 mt -97.94 135.34 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.181 -1.044 . . . . 0.81 108.181 178.881 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -91.22 122.45 33.87 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.747 -1.205 . . . . 1.34 107.747 178.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -95.4 16.96 15.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.201 -0.937 . . . . 2.89 112.216 -179.796 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -73.82 148.57 42.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 2.09 109.728 178.776 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -90.6 135.59 33.61 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.333 -0.988 . . . . 2.19 108.333 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 pt -100.48 166.36 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.131 -0.98 . . . . 0.75 109.976 179.5 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.2 p -95.43 168.68 10.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.501 -0.749 . . . . 0.91 109.583 178.322 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.66 -18.61 21.47 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.078 -1.014 . . . . 0.93 112.476 179.439 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -68.06 -37.54 81.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.881 -1.137 . . . . 2.28 110.711 -179.77 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -92.26 -5.35 52.54 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.634 -1.292 . . . . 1.45 113.132 -179.261 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.28 -43.8 94.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.063 -1.023 . . . . 0.81 110.134 -179.465 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -57.93 -40.76 81.22 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.567 -0.853 . . . . 1.54 110.241 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -63.89 -39.76 94.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.704 -0.623 . . . . 2.36 110.714 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.23 -42.58 95.54 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.157 -0.964 . . . . 1.31 110.913 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.34 -42.22 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.09 -1.006 . . . . 0.82 110.727 -179.801 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -60.96 -42.27 97.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 1.5 109.919 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -60.75 -42.67 97.88 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.466 -0.894 . . . . 2.23 109.803 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -72.84 -56.7 4.84 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.815 0.817 . . . . 0.85 110.231 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 tp -58.47 -47.44 84.03 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.42 -0.912 . . . . 0.91 110.252 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.506 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.8 t -68.73 -39.82 80.18 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.121 -0.987 . . . . 0.9 110.035 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.44 -45.55 94.26 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.434 -1.365 . . . . 0.69 109.783 178.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -58.76 -30.19 67.33 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.516 -0.991 . . . . 2.88 110.28 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.67 -42.14 87.78 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.972 0.891 . . . . 0.85 109.779 179.024 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -81.19 -40.71 23.48 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.412 -0.805 . . . . 2.35 110.73 179.445 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.86 -43.68 90.89 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.747 -0.781 . . . . 0.65 109.938 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.8 m -59.32 -39.93 84.67 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.863 0.84 . . . . 1.45 109.381 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.31 -44.36 71.9 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.629 -0.714 . . . . 0.63 110.587 179.785 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -65.5 -51.57 59.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.004 . . . . 1.34 110.472 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.58 -38.99 86.44 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.371 -0.931 . . . . 1.56 109.874 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -59.99 -40.99 91.06 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.456 -0.777 . . . . 1.19 110.487 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -65.63 -42.33 91.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.72 110.175 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.81 -35.17 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.495 -0.753 . . . . 0.62 110.703 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -52.44 -43.01 64.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.659 -1.275 . . . . 1.05 110.771 179.237 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.13 -37.17 78.18 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.389 -0.819 . . . . 0.64 110.151 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -62.05 -39.54 92.7 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.853 -1.139 . . . . 1.73 109.531 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.83 -32.08 72.37 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.598 -0.689 . . . . 0.56 110.322 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.41 -36.67 16.44 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.242 -1.456 . . . . 0.69 110.478 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.02 -16.43 50.27 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.637 -1.508 . . . . 1.48 111.306 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.2 m -92.94 -51.12 5.22 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.785 -0.572 . . . . 0.98 110.768 -179.597 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -107.82 -19.86 13.39 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.303 -0.873 . . . . 1.16 112.799 -177.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.06 160.55 11.1 Favored Glycine 0 N--CA 1.504 3.219 0 O-C-N 120.96 -1.087 . . . . 0.85 112.028 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -56.06 -22.77 29.48 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.983 -0.716 . . . . 3.86 112.727 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -58.14 -35.47 71.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 2.35 111.3 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -81.02 -25.78 36.92 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.721 -1.237 . . . . 1.67 112.315 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.09 -32.41 69.79 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.377 -0.827 . . . . 1.45 110.803 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.43 85.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.019 . . . . 0.61 111.17 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.58 -42.92 87.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.394 -1.441 . . . . 0.65 110.114 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -70.48 -30.69 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.66 110.729 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -59.91 -40.26 88.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.128 -0.982 . . . . 1.19 110.142 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.33 -39.46 97.01 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.537 -1.316 . . . . 0.53 110.47 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -59.1 -41.84 89.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.655 -0.909 . . . . 1.27 111.113 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 77' ' ' ILE . 40.3 mt -60.67 -42.09 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.92 -1.112 . . . . 0.54 110.028 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.5 ttm -60.42 -40.25 90.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.511 -0.743 . . . . 1.74 110.067 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 tp -59.77 -49.82 76.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.422 -0.799 . . . . 0.55 109.872 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.54 -41.85 95.33 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.055 -0.658 . . . . 0.47 110.299 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -85.29 4.96 32.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.5 -0.75 . . . . 1.42 112.972 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -61.54 118.17 6.69 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.627 -1.296 . . . . 1.27 109.191 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -63.69 -16.69 61.7 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.03 0.919 . . . . 1.35 110.904 -179.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -77.49 -52.24 9.42 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.95 0.881 . . . . 2.22 110.248 179.74 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.71 -37.79 85.47 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.668 -0.813 . . . . 0.62 110.588 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -59.05 -47.99 83.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 1.29 110.781 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -61.61 -38.0 86.02 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.314 -0.866 . . . . 1.52 111.142 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -64.6 -47.7 77.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.236 -0.915 . . . . 1.3 110.324 179.621 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.1 mt -58.3 -45.05 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.444 -0.785 . . . . 0.61 109.665 179.181 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.1 mt -60.79 -40.59 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.994 0.902 . . . . 0.78 109.862 179.663 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.67 97.32 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.995 -1.065 . . . . 0.82 110.601 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.45 -41.37 97.1 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.426 -0.91 . . . . 0.8 110.245 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.26 -47.99 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.054 -1.029 . . . . 0.77 110.387 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -77.09 -35.77 56.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.508 -0.745 . . . . 2.12 112.121 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -80.7 -44.99 17.85 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.407 -1.433 . . . . 1.51 112.184 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -102.82 12.08 36.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.292 -0.88 . . . . 1.98 112.559 -178.571 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.9 m80 49.23 49.07 20.25 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.026 -1.07 . . . . 1.32 111.56 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.6 mtt -102.57 154.58 18.98 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.146 -0.971 . . . . 1.38 109.715 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.8 p -70.63 159.8 33.73 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.377 0.608 . . . . 0.67 109.412 177.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.99 83.39 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.383 -0.823 . . . . 0.52 111.284 178.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -72.07 -44.44 63.29 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.212 -0.93 . . . . 2.25 110.44 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.11 74.39 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.35 -0.94 . . . . 0.64 111.165 -178.235 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.89 93.17 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.182 -0.948 . . . . 0.56 110.945 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.67 86.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 0.46 110.683 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -60.63 -37.94 83.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.925 . . . . 1.32 110.65 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -57.57 -50.01 74.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.821 -1.175 . . . . 1.3 111.078 179.346 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.9 -46.88 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.882 -1.136 . . . . 0.61 109.97 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.02 -33.4 55.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.66 -0.65 . . . . 0.65 110.233 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -58.62 -40.19 82.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.17 -0.956 . . . . 2.11 110.922 179.37 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.41 -35.7 10.4 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.046 -1.55 . . . . 0.83 112.3 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -60.49 -41.16 93.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.394 -1.651 . . . . 1.28 109.889 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.37 -49.82 38.37 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.684 0.754 . . . . 0.89 110.59 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.9 m -60.64 -39.13 87.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 1.87 110.772 -179.432 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.51 -41.9 95.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.423 -0.798 . . . . 1.05 110.847 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.68 -30.35 71.37 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.15 -1.02 . . . . 1.02 110.994 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.0 -20.56 64.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.071 -1.018 . . . . 2.04 111.067 179.783 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.53 -17.84 61.7 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.784 0.802 . . . . 1.73 111.19 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.556 HD13 HD13 ' A' ' 123' ' ' LEU . 29.7 mt -86.34 148.76 25.45 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.396 -0.815 . . . . 1.37 109.285 179.464 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -101.7 41.66 1.19 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.48 -0.763 . . . . 2.88 111.007 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -114.06 130.86 56.54 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.273 -1.01 . . . . 1.58 108.273 178.799 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.6 mp0 -58.71 -33.08 69.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.278 -0.889 . . . . 3.04 110.77 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -71.1 -51.43 25.13 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.689 -1.257 . . . . 0.9 110.318 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.556 HD13 HD13 ' A' ' 118' ' ' LEU . 46.2 mt -67.11 -39.25 86.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.426 -0.796 . . . . 1.06 110.331 -179.312 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 57.2 tttp -61.99 -49.61 75.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.971 -1.08 . . . . 2.18 109.796 179.352 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 187' ' ' THR . 50.5 mt-10 -61.49 -31.66 71.65 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.529 -0.868 . . . . 2.15 109.203 179.699 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 130' ' ' VAL . 22.5 ttp180 -64.75 -28.94 69.93 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.251 1.024 . . . . 2.33 109.091 179.187 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.11 -47.16 86.27 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.575 -0.85 . . . . 0.82 109.54 178.375 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.7 87.59 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.57 -0.852 . . . . 0.85 109.612 179.587 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -63.29 -36.32 83.29 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.189 0.519 . . . . 1.39 110.546 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 126' ' ' ARG . 50.6 t -67.85 -36.59 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.966 -1.084 . . . . 0.56 110.237 179.507 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -59.45 -38.8 81.66 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.869 -1.132 . . . . 3.12 109.109 178.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.571 ' CG ' HH21 ' A' ' 136' ' ' ARG . 58.2 t0 -59.61 -40.34 87.2 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.676 -0.693 . . . . 1.28 109.9 179.114 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -60.83 -33.86 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 0.49 109.7 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.41 -49.74 14.24 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.098 -1.049 . . . . 0.46 111.186 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.474 ' NZ ' ' OD1' ' A' ' 132' ' ' ASP . 5.3 pttm -58.86 -39.46 81.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.998 -1.295 . . . . 2.71 110.649 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.571 HH21 ' CG ' ' A' ' 132' ' ' ASP . 37.0 mtt180 -59.4 -45.22 92.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.947 -1.095 . . . . 2.14 109.936 179.03 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.96 -42.57 98.54 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.66 -0.65 . . . . 1.05 110.427 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 23.8 mt -59.9 -43.48 94.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.577 -0.702 . . . . 0.52 110.566 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -60.47 -34.55 74.19 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.433 -0.792 . . . . 2.35 111.298 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.13 -41.13 51.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.92 -1.112 . . . . 1.39 110.43 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.26 -39.84 83.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 120.83 -1.169 . . . . 0.68 110.887 -178.368 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 76.1 mt -88.53 -10.02 50.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 0.83 112.246 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.0 19.96 71.41 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.887 -1.149 . . . . 0.91 113.261 -179.298 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.9 tp -64.99 143.82 57.7 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.503 -0.998 . . . . 0.95 109.248 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -70.02 151.7 45.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.366 -0.834 . . . . 2.43 109.626 178.113 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.3 mt -105.44 140.19 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.218 -1.03 . . . . 1.1 108.218 178.06 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.3 mm -75.74 136.2 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 1.58 108.973 178.398 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.38 92.55 7.22 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.495 -1.669 . . . . 1.62 106.495 178.526 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 81.3 mt -78.36 -20.86 50.42 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.357 -0.839 . . . . 0.8 111.061 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.6 t -78.86 -6.9 57.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 1.56 112.458 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.39 35.94 1.55 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.597 -0.689 . . . . 0.84 112.489 -178.667 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.1 mm -68.9 149.13 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.865 -1.147 . . . . 0.82 108.986 178.813 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -129.37 -9.12 4.68 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.531 -0.73 . . . . 2.31 112.613 -179.296 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -120.01 145.75 46.52 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.851 -0.796 . . . . 1.54 108.851 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -80.37 114.73 19.48 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.655 -1.239 . . . . 1.38 107.655 177.695 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -148.2 175.45 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 0.69 109.305 -178.911 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.3 mt -93.83 143.33 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.389 -0.967 . . . . 0.53 108.389 178.262 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.8 tp -96.49 129.81 43.78 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.772 -1.205 . . . . 0.64 108.828 178.482 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.84 130.47 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.813 -1.18 . . . . 0.67 107.813 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.06 155.55 23.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.861 -1.149 . . . . 0.78 108.868 179.184 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.01 79.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.492 -1.38 . . . . 1.0 109.712 178.163 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -174.3 148.46 1.28 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.908 -0.775 . . . . 2.42 108.908 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.2 mt -118.15 141.69 48.23 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.585 -0.895 . . . . 0.75 108.585 177.185 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.2 p -90.93 148.9 39.17 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.992 . . . . 0.78 108.671 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -38.81 -41.2 1.64 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.73 1.62 . . . . 0.67 113.542 178.913 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.538 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 25.4 m -62.66 -51.48 67.07 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.878 -1.139 . . . . 0.7 110.508 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.2 -39.09 88.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 1.21 109.855 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.7 p -68.48 -39.18 81.46 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.615 -0.678 . . . . 0.6 110.419 179.332 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.8 -35.73 80.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.051 -1.03 . . . . 0.62 110.761 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -96.21 -1.0 49.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.02 -1.05 . . . . 1.16 112.827 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -60.61 156.41 16.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.929 . . . . 0.73 109.863 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -88.97 106.28 18.32 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.788 -1.56 . . . . 2.24 106.788 178.168 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 50.9 mt -80.49 -17.47 51.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.623 -0.673 . . . . 1.43 112.133 -177.495 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -81.13 -23.05 38.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.381 -0.824 . . . . 2.15 111.769 -178.57 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -105.95 -2.87 22.39 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.614 0.968 . . . . 2.04 113.614 -178.138 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.94 128.4 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 107.74 -1.207 . . . . 0.55 107.74 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.4 tp -90.44 -10.4 43.92 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.246 -0.909 . . . . 1.63 112.251 -178.908 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.22 171.02 41.13 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.116 -1.593 . . . . 0.47 109.116 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -130.77 135.75 48.06 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.563 -1.273 . . . . 0.54 107.563 179.334 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.564 HG22 HG21 ' A' ' 205' ' ' THR . 97.0 mt -133.11 107.94 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 105.938 -1.875 . . . . 0.69 105.938 178.156 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 203' ' ' VAL . 72.2 p -128.82 175.37 8.68 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.676 -1.265 . . . . 0.82 110.746 -178.696 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.7 OUTLIER -100.51 53.92 0.88 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.578 -0.737 . . . . 2.37 110.071 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.93 156.37 16.65 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.091 -1.006 . . . . 1.11 109.773 179.149 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.14 -5.03 57.93 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.769 -1.205 . . . . 1.67 112.397 178.657 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 73.66 -12.37 4.84 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.488 -1.339 . . . . 1.54 115.213 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.406 ' O ' ' OG1' ' A' ' 187' ' ' THR . 79.0 mtm180 -81.8 113.41 19.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.001 -1.481 . . . . 4.48 107.001 178.42 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 22.2 p 48.54 39.96 14.25 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.893 -1.129 . . . . 2.63 111.931 -178.921 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.3 p -82.14 133.67 35.28 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.309 -0.997 . . . . 1.69 108.309 177.7 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -60.15 -40.41 89.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.442 -0.786 . . . . 1.07 110.681 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 87.4 m -60.83 -42.04 96.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 1.58 110.256 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 98.1 p -61.61 -38.58 88.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.945 -1.097 . . . . 1.6 110.411 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.11 -35.32 60.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.431 -0.793 . . . . 1.45 110.833 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.6 mtp -62.64 -42.65 99.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 122.395 1.093 . . . . 1.05 109.202 179.333 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.89 -49.54 77.07 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.552 -0.749 . . . . 0.72 110.789 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -60.38 -44.34 95.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 3.05 110.697 -179.838 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.4 m -69.88 -40.08 75.89 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.295 -0.878 . . . . 0.89 110.315 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.4 mt -90.83 -4.43 56.61 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.1 0.952 . . . . 0.78 112.42 -178.678 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 194' ' ' ALA . 94.1 mt-10 54.56 7.32 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.4 1.259 . . . . 1.45 114.4 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.9 mt -71.46 147.39 92.58 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.948 -1.095 . . . . 0.67 108.092 179.013 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -58.49 141.66 97.42 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.765 1.643 . . . . 0.64 109.714 178.664 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.74 168.39 26.96 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 117.831 -1.548 . . . . 0.67 109.776 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 203' ' ' VAL . 54.8 mt -149.01 159.02 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.519 -1.289 . . . . 0.69 107.519 178.052 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.3 m -140.48 -32.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.702 0 O-C-N 120.647 -1.283 . . . . 0.85 111.951 -179.756 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.3 37.4 0.81 Allowed Glycine 0 N--CA 1.485 1.934 0 C-N-CA 120.497 -0.859 . . . . 0.92 112.865 -178.621 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.564 HG21 HG22 ' A' ' 180' ' ' ILE . 45.6 p -63.94 -20.55 65.94 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.673 -0.898 . . . . 0.95 111.499 -179.098 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.68 -92.43 0.61 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 110.045 -1.222 . . . . 1.04 110.045 179.471 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.631 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 70.4 m -128.16 23.93 6.0 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.275 -1.132 . . . . 1.57 112.696 -178.825 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 79.5 t -51.52 -34.48 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.541 -1.349 . . . . 0.84 110.609 179.085 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.0 p -58.62 -20.91 51.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.58 -0.7 . . . . 0.99 111.58 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.9 t -90.59 -3.16 57.76 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.013 -1.054 . . . . 1.7 111.698 -179.037 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.631 ' NE2' ' O ' ' A' ' 207' ' ' SER . 4.1 mp0 -122.83 -4.42 8.62 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.502 0.668 . . . . 2.2 112.522 -177.892 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 44.6 t -112.85 148.0 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.533 -0.729 . . . . 0.84 109.415 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -121.3 157.08 31.14 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.071 -1.085 . . . . 2.2 108.071 178.055 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.561 HD21 ' C ' ' A' ' 214' ' ' ASN . 0.4 OUTLIER -56.76 140.92 46.06 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.671 -1.268 . . . . 2.28 110.43 178.926 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 m-20 81.57 7.02 1.13 Allowed 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 114.465 1.283 . . . . 2.35 114.465 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -67.48 151.75 46.84 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.424 -1.423 . . . . 1.97 109.945 177.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -90.51 115.11 27.4 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.691 -1.596 . . . . 2.65 106.691 177.363 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.514 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 86.8 mt -127.71 141.94 51.46 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.236 -0.915 . . . . 0.63 109.56 -178.641 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 50.8 mt -113.54 127.72 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 106.607 -1.627 . . . . 0.62 106.607 177.439 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.6 tp -102.17 118.47 36.97 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.193 -1.78 . . . . 0.64 106.193 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 223' ' ' VAL . 44.8 p-10 -93.14 -21.04 19.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.042 -1.036 . . . . 2.05 112.297 -178.184 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.922 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.47 17.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.031 0.752 . . . . 0.84 113.031 -179.177 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.5 t -112.77 -62.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 121.807 0.813 . . . . 1.02 109.135 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -90.3 9.62 28.07 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.294 1.045 . . . . 2.51 110.303 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 41.9 t30 60.82 52.37 4.31 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.91 -0.586 . . . . 1.54 111.462 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -150.87 147.89 27.79 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.222 1.011 . . . . 1.95 110.055 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 50.3 t -115.02 138.78 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 107.494 -1.299 . . . . 0.71 107.494 176.818 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -104.53 137.73 41.94 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.096 -1.002 . . . . 1.01 108.602 178.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.3 t -109.3 129.4 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 107.638 -1.245 . . . . 0.82 107.638 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.432 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 48.5 t-20 48.15 49.87 8.05 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 113.507 0.929 . . . . 1.54 113.507 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 22.3 Cg_endo -62.53 154.21 66.18 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.141 1.894 . . . . 0.94 110.394 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.6 m -72.77 158.72 35.04 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.987 -1.07 . . . . 1.8 109.272 177.774 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 22.0 p30 -58.59 -38.0 77.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.849 -1.157 . . . . 2.73 110.483 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.51 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 82.1 tt0 -60.93 -39.45 89.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.005 -1.059 . . . . 3.17 110.013 179.355 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.08 -36.84 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 1.34 110.319 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.462 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 80.8 mt -58.7 -43.61 88.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.397 -0.814 . . . . 1.2 110.252 178.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -59.45 -38.74 81.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.001 -1.062 . . . . 2.7 110.277 179.57 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -60.88 -49.26 78.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.507 -0.746 . . . . 2.59 110.591 179.546 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.5 mtp -70.56 -39.2 74.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.524 -0.735 . . . . 1.38 110.601 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.508 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -57.85 -40.27 79.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 2.84 110.545 179.949 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 245' ' ' GLN . . . -71.45 -42.21 68.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 1.88 111.3 -179.598 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 76.8 t -54.48 -50.31 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.84 -1.163 . . . . 2.4 111.968 -178.314 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -66.97 -49.65 64.75 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.557 -1.339 . . . . 3.52 110.039 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -64.73 -31.44 72.66 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.132 -0.627 . . . . 1.88 110.618 -179.709 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 241' ' ' ALA . 31.6 tt0 -60.11 -31.25 69.88 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 118.7 -1.2 . . . . 3.01 109.164 179.278 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 84.9 t -66.43 -42.01 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.4 -0.92 . . . . 2.45 109.375 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.72 -40.32 91.89 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.664 0.745 . . . . 2.75 110.558 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.8 t -69.98 -39.14 76.13 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.106 -0.996 . . . . 3.16 110.919 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -61.14 -31.49 71.21 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.67 0.748 . . . . 3.57 111.044 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -68.77 -29.73 68.17 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.331 -0.855 . . . . 4.3 111.592 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -61.89 -12.37 17.55 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.13 -0.981 . . . . 4.45 112.629 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -75.22 6.15 4.69 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.319 -0.863 . . . . 5.97 112.934 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.721 HD22 ' C ' ' A' ' 253' ' ' LEU . 0.0 OUTLIER -62.99 -12.03 22.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.388 -0.82 . . . . 6.18 111.882 179.814 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.452 ' N ' HD22 ' A' ' 253' ' ' LEU . . . -71.29 -4.41 25.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.692 -0.63 . . . . 6.66 112.226 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.53 23.47 0.51 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.255 0.835 . . . . 8.2 113.255 -179.201 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.547 ' O ' HD23 ' A' ' 256' ' ' LEU . 7.0 tt -79.68 -7.1 58.37 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.044 -1.035 . . . . 8.07 112.446 179.112 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -83.64 8.72 13.46 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.989 -1.069 . . . . 9.45 112.626 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -89.83 4.03 51.08 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.202 -0.936 . . . . 10.12 112.597 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 107.472 -1.307 . . . . 11.49 107.472 179.738 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mpp? . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.484 -0.561 . . . . 3.07 109.484 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.0 mt -88.21 111.22 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.41 -1.33 . . . . 1.07 107.41 177.489 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.4 m -104.8 127.45 52.6 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.791 -1.189 . . . . 1.24 107.791 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.88 -147.79 22.86 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.246 -1.142 . . . . 1.01 110.246 179.42 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 5' ' ' ILE . 80.5 mt -97.6 1.31 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.546 -0.973 . . . . 1.11 112.571 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' ILE . 8.6 tp 50.42 100.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.737 -1.227 . . . . 0.99 112.063 178.458 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.7 -41.4 11.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.924 -1.11 . . . . 0.85 111.791 179.211 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t -146.19 140.98 15.97 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 107.78 -1.193 . . . . 1.38 107.78 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.77 149.73 38.27 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.585 2.19 . . . . 0.94 112.555 178.607 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.88 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 149.66 161.65 9.94 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.367 -1.493 . . . . 0.81 109.367 178.306 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.521 ' O ' ' NE2' ' A' ' 243' ' ' GLN . 94.3 mt -119.95 132.82 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.132 -1.217 . . . . 0.83 107.893 179.58 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.16 151.07 47.38 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.216 -0.928 . . . . 0.53 109.03 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -123.16 141.54 51.86 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.577 -0.898 . . . . 0.77 108.577 178.55 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.94 166.2 32.98 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.046 -1.55 . . . . 0.51 109.798 177.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -76.3 158.2 31.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.816 -0.814 . . . . 1.9 109.133 178.756 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -82.3 123.49 29.11 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.607 -1.257 . . . . 0.66 107.607 178.418 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.2 tp -102.9 99.64 9.57 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.228 -1.768 . . . . 0.83 106.228 178.725 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 tp -87.52 140.92 29.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 0.86 108.962 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.7 mt -96.51 115.66 27.8 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.653 -1.61 . . . . 0.92 106.653 177.497 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -108.84 130.62 55.41 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.816 -1.179 . . . . 2.03 107.816 -179.46 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.425 ' OE1' HD13 ' A' ' 147' ' ' ILE . 72.1 mm-40 -128.4 146.83 50.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 2.66 109.054 179.893 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -80.41 138.89 36.69 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.933 -1.105 . . . . 2.32 108.041 177.278 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -63.48 140.33 58.86 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.612 -0.884 . . . . 2.11 108.612 178.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -89.7 130.16 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.086 -1.079 . . . . 0.73 108.086 178.244 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.6 129.95 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.752 -1.203 . . . . 0.87 107.752 178.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.2 mt -91.25 138.99 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.387 -0.968 . . . . 0.81 108.387 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -88.23 120.73 29.86 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.91 -1.515 . . . . 1.34 106.91 178.96 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -93.57 10.27 33.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.522 -0.736 . . . . 2.89 112.868 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -73.12 143.96 47.14 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.881 -1.137 . . . . 2.09 110.039 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -89.77 132.16 35.36 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.185 -1.043 . . . . 2.19 108.185 177.579 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -93.27 165.01 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.333 -0.854 . . . . 0.75 110.477 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.9 p -93.21 165.12 12.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.772 -0.58 . . . . 0.91 109.713 178.435 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.95 -22.45 15.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.302 -0.874 . . . . 0.93 112.18 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.95 -37.73 81.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.867 -1.146 . . . . 2.28 110.914 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -91.54 -7.26 50.81 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.44 -1.412 . . . . 1.45 112.782 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.3 -41.21 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.218 -0.926 . . . . 0.81 110.56 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -56.42 -39.99 73.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.027 . . . . 1.54 110.602 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -63.47 -41.95 98.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 2.36 111.079 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.96 -41.58 98.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.081 -1.012 . . . . 1.31 110.843 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.6 t -60.66 -40.06 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.611 -0.836 . . . . 0.82 110.217 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -60.85 -43.62 98.08 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.736 -0.786 . . . . 1.5 109.677 179.827 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -62.1 -40.05 94.55 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.909 -0.716 . . . . 2.23 110.325 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -73.16 -54.22 9.02 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.149 -0.969 . . . . 0.85 110.017 179.116 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -60.52 -49.06 79.04 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.002 -1.062 . . . . 0.91 110.306 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.6 t -68.85 -36.92 78.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.361 -0.837 . . . . 0.9 110.02 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.01 -46.3 84.87 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.499 -1.334 . . . . 0.69 109.862 178.495 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -57.92 -31.72 67.07 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.246 -1.149 . . . . 2.88 109.655 178.969 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.31 -51.1 71.2 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.204 -0.998 . . . . 0.85 110.965 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 42.7 pttt -81.9 -42.1 19.99 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.175 -0.953 . . . . 2.35 110.966 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.409 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -60.22 -41.82 93.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.8 . . . . 0.65 110.383 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.1 p -59.46 -41.15 89.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.218 -1.03 . . . . 1.45 108.218 179.181 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.51 -48.65 59.85 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.559 -0.746 . . . . 0.63 109.782 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -62.13 -48.72 78.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.442 -1.411 . . . . 1.34 110.077 -178.442 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.71 -38.9 89.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 1.56 109.81 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -59.62 -40.17 86.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.724 -0.61 . . . . 1.19 110.471 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.519 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 11.2 m -63.65 -39.81 95.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.926 -1.109 . . . . 0.72 110.148 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.71 -40.17 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.468 -0.77 . . . . 0.62 110.573 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -51.75 -40.65 60.64 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.424 -0.798 . . . . 1.05 110.482 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.8 -37.08 73.26 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.11 -0.994 . . . . 0.64 110.348 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.519 ' NZ ' HG22 ' A' ' 56' ' ' THR . 52.4 mttp -63.34 -38.82 92.65 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.669 -1.212 . . . . 1.73 109.025 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.8 -30.14 68.65 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.907 -0.588 . . . . 0.56 110.337 179.281 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.11 -38.88 8.84 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 119.893 -1.146 . . . . 0.69 111.214 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -81.03 -22.69 39.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.856 -1.379 . . . . 1.48 111.282 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.7 m -87.31 -51.56 5.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.656 -0.652 . . . . 0.98 110.687 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -107.21 -7.28 16.84 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.07 1.137 . . . . 1.16 114.07 -177.377 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.45 157.95 17.73 Favored Glycine 0 N--CA 1.5 2.909 0 O-C-N 121.599 -0.688 . . . . 0.85 113.22 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -53.32 -19.06 2.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.592 -0.946 . . . . 3.86 113.341 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -57.41 -33.92 68.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.714 -1.241 . . . . 2.35 110.996 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -80.13 -23.53 41.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.959 -1.088 . . . . 1.67 111.468 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.87 -38.32 81.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.093 -1.004 . . . . 1.45 111.007 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.22 -40.09 84.76 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.954 -1.091 . . . . 0.61 110.999 179.355 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.7 mt -69.3 -47.99 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.665 -1.272 . . . . 0.65 110.13 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -70.52 -29.94 66.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.864 . . . . 0.66 110.62 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.79 -38.63 85.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.275 -0.891 . . . . 1.19 110.403 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.3 -37.25 59.27 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 110.074 -1.211 . . . . 0.53 110.074 179.474 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -59.81 -44.21 94.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.279 -1.13 . . . . 1.27 110.087 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.12 -39.37 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.54 110.045 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.5 ttm -59.88 -39.5 85.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.5 -0.75 . . . . 1.74 110.552 179.46 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.6 tp -58.36 -48.15 81.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.853 . . . . 0.55 110.204 179.028 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.01 -40.29 88.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.602 0.715 . . . . 0.47 110.262 -179.751 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -86.04 5.14 34.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.791 . . . . 1.42 112.75 -179.503 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -61.79 119.18 8.26 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.846 -1.159 . . . . 1.27 108.928 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.85 -17.49 64.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.462 -0.774 . . . . 1.35 110.84 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.83 -47.8 28.54 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.023 -1.071 . . . . 2.22 109.889 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.66 -36.44 82.86 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.301 -0.96 . . . . 0.62 110.011 -178.352 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.77 -48.36 79.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.404 -0.81 . . . . 1.29 110.495 179.05 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.52 -39.49 87.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 1.52 110.492 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.25 -49.88 62.69 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.091 -1.005 . . . . 1.3 110.488 179.435 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.5 mt -56.83 -43.58 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.935 -1.103 . . . . 0.61 110.234 179.402 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.9 -43.2 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.567 -0.708 . . . . 0.78 110.116 179.568 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.81 91.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.409 -0.807 . . . . 0.82 110.574 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.08 -43.6 95.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.113 -0.992 . . . . 0.8 110.254 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.1 mt -65.61 -48.45 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.094 -1.004 . . . . 0.77 110.179 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -78.72 -36.2 43.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.266 -0.896 . . . . 2.12 112.197 -179.414 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -81.74 -40.02 23.33 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.438 -1.414 . . . . 1.51 111.76 -179.405 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -108.59 10.61 27.05 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.211 -0.931 . . . . 1.98 111.965 -178.114 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.0 m80 49.46 50.52 18.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.982 -1.074 . . . . 1.32 111.612 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -104.23 152.89 21.64 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.14 0.971 . . . . 1.38 109.791 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.439 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 23.2 p -72.8 160.8 31.59 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.57 -0.706 . . . . 0.67 109.535 178.009 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.45 -40.09 81.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -0.926 . . . . 0.52 110.914 178.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 26.2 p-10 -69.86 -42.1 73.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.051 -1.031 . . . . 2.25 110.519 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.35 61.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.348 -0.845 . . . . 0.64 110.882 -179.251 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.84 93.64 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.265 -0.897 . . . . 0.56 110.696 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.66 -43.75 93.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 0.46 110.943 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -60.19 -40.01 88.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.865 -1.147 . . . . 1.32 111.036 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.73 -48.86 76.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.671 -1.268 . . . . 1.3 110.617 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 83.4 t -62.86 -49.22 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.71 -1.243 . . . . 0.61 110.29 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 mm -61.54 -30.23 47.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.193 0.521 . . . . 0.65 110.538 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -59.87 -40.12 87.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 2.11 110.922 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.95 -31.45 17.6 Favored Glycine 0 N--CA 1.502 3.066 0 C-N-CA 118.668 -1.729 . . . . 0.83 112.925 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -61.49 -40.99 96.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.521 -1.576 . . . . 1.28 110.063 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.22 -48.78 40.3 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.62 -0.675 . . . . 0.89 110.4 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.0 m -61.4 -40.79 95.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 1.87 110.477 -178.185 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.75 97.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.422 -0.799 . . . . 1.05 110.679 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.2 mt -64.57 -30.86 71.89 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.054 -1.029 . . . . 1.02 110.817 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -66.86 -21.11 66.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.945 -1.097 . . . . 2.04 111.158 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -75.0 -12.81 60.42 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.313 -0.867 . . . . 1.73 111.532 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 123' ' ' LEU . 5.3 mt -85.55 144.67 27.77 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.484 -0.76 . . . . 1.37 109.292 179.196 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -100.45 53.03 0.88 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.185 -0.947 . . . . 2.88 110.581 -179.522 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -129.46 138.28 51.33 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.211 -1.033 . . . . 1.58 108.211 179.171 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -58.39 -39.8 80.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.544 -0.722 . . . . 3.04 110.999 179.197 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -71.43 -53.61 13.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.002 -1.061 . . . . 0.9 110.332 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 118' ' ' LEU . 24.5 mt -61.4 -41.09 96.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.339 -0.851 . . . . 1.06 110.506 -179.465 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -62.22 -50.16 72.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.954 -1.091 . . . . 2.18 109.983 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.02 -31.68 70.18 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.309 -0.869 . . . . 2.15 109.644 179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 130' ' ' VAL . 55.7 ttt180 -61.26 -30.43 70.46 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.086 -1.045 . . . . 2.33 108.782 179.241 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.46 -49.58 77.01 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.921 0.867 . . . . 0.82 109.398 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.86 81.7 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.895 -0.722 . . . . 0.85 110.104 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -64.18 -36.69 84.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.347 -0.846 . . . . 1.39 110.52 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 126' ' ' ARG . 38.9 t -67.12 -39.16 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.439 -0.788 . . . . 0.56 109.983 179.793 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -60.4 -38.06 82.78 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.879 0.847 . . . . 3.12 110.009 179.066 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.12 -38.33 82.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.766 -0.584 . . . . 1.28 110.481 179.325 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.7 mt -61.54 -40.17 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.472 -0.767 . . . . 0.49 110.24 179.701 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.27 -42.44 35.15 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 120.078 -1.058 . . . . 0.46 110.993 -179.74 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -58.77 -48.12 82.34 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.072 -1.251 . . . . 2.71 110.484 179.346 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -64.89 -41.25 95.78 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.511 -0.876 . . . . 2.14 109.972 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.05 -39.58 86.45 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.314 -0.866 . . . . 1.05 110.033 179.686 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.14 -41.93 93.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.882 . . . . 0.52 110.902 179.203 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -60.44 -33.08 72.02 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.121 -0.987 . . . . 2.35 110.678 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -77.64 -42.5 34.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 1.39 110.846 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.4 mt -60.99 -38.33 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.231 -0.918 . . . . 0.68 110.344 -178.294 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.7 mt -86.27 -7.43 58.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.31 -0.869 . . . . 0.83 112.276 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.71 19.91 69.69 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.645 -1.264 . . . . 0.91 112.844 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.5 tp -67.22 145.19 55.46 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.815 -0.815 . . . . 0.95 109.163 179.133 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -67.79 149.74 49.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 2.43 108.845 178.169 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.0 mt -109.49 137.38 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.369 -0.974 . . . . 1.1 108.369 178.608 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.67 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.8 mp -80.11 128.59 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.654 -1.239 . . . . 1.58 107.654 178.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -94.78 96.08 9.13 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.85 -1.537 . . . . 1.62 106.85 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.41 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 53.1 mt -70.72 -25.23 62.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.337 -0.852 . . . . 0.8 111.12 -178.33 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 p -80.57 0.25 34.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 1.56 111.861 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.14 23.87 9.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.455 -0.778 . . . . 0.84 111.852 -179.757 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.41 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 14.2 mt -72.04 146.33 11.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.234 -0.916 . . . . 0.82 109.457 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -119.41 -14.77 9.15 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.757 0.789 . . . . 2.31 112.756 -178.9 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -115.06 140.51 49.0 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.682 -0.858 . . . . 1.54 108.682 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -77.41 123.52 26.64 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.384 -0.969 . . . . 1.38 108.384 178.005 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.3 m -148.56 175.28 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.608 -0.682 . . . . 0.69 109.266 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.8 mt -88.23 145.05 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.641 -0.874 . . . . 0.53 108.641 178.132 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.1 tp -97.08 126.49 42.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.12 -0.987 . . . . 0.64 108.507 178.355 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.0 t -122.58 128.98 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.573 -1.269 . . . . 0.67 107.573 178.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.39 153.18 21.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.932 . . . . 0.78 108.847 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.66 84.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.701 -1.249 . . . . 1.0 109.65 178.131 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 10.4 t0 -172.37 154.66 3.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.481 -0.933 . . . . 2.42 108.481 179.638 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.501 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 61.6 mt -117.75 139.32 51.21 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.222 -0.924 . . . . 0.75 108.759 177.629 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.2 p -91.2 153.03 44.56 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 107.879 -1.156 . . . . 0.78 107.879 178.66 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -41.81 -44.82 6.82 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.559 1.506 . . . . 0.67 113.375 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 23.9 m -60.26 -48.79 80.23 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.044 -1.035 . . . . 0.7 110.252 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.22 -40.83 98.57 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.204 -0.935 . . . . 1.21 110.177 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 79.5 p -68.33 -38.45 81.53 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.416 -0.802 . . . . 0.6 110.254 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.58 74.52 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.578 -0.701 . . . . 0.62 110.609 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -93.86 -5.87 47.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.166 -0.959 . . . . 1.16 112.734 -179.316 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.73 146.89 51.28 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.959 -1.126 . . . . 0.73 107.959 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.445 ' O ' HG23 ' A' ' 176' ' ' VAL . 55.4 t-20 -97.34 119.73 36.39 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.31 -1.367 . . . . 2.24 107.31 178.075 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.692 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.2 mm? -76.25 -18.24 59.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.77 -0.581 . . . . 1.43 111.526 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -80.99 -25.77 37.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.276 -0.89 . . . . 2.15 111.863 -178.961 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -101.05 -1.69 33.53 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.112 0.782 . . . . 2.04 113.112 -178.272 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 178' ' ' GLY . 58.1 t -107.01 126.44 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 107.556 -1.276 . . . . 0.55 107.556 178.944 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.8 tp -91.27 -2.01 57.53 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.052 -1.03 . . . . 1.63 112.862 -178.729 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.447 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.94 169.83 34.42 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.797 -1.721 . . . . 0.47 108.797 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -127.2 135.43 50.63 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.812 -1.181 . . . . 0.54 107.812 179.278 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 76.1 mt -137.67 106.04 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 105.965 -1.865 . . . . 0.69 105.965 178.339 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 203' ' ' VAL . 68.0 p -131.2 176.98 7.82 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.785 -1.197 . . . . 0.82 110.204 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.552 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.3 OUTLIER -99.29 51.71 0.95 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.736 -0.603 . . . . 2.37 110.843 179.28 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -100.66 145.32 28.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.303 -0.873 . . . . 1.11 108.829 179.642 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -60.05 -32.55 76.06 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 120.15 -1.024 . . . . 1.67 110.897 179.186 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 91.69 -4.37 79.12 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 120.898 -1.354 . . . . 1.54 113.328 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.419 ' O ' ' OG1' ' A' ' 187' ' ' THR . 80.1 mtm180 -90.36 115.65 27.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.243 -1.762 . . . . 4.48 106.243 177.893 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 13.6 p 48.98 31.93 3.57 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.36 -0.837 . . . . 2.63 112.226 -178.667 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.4 t -85.47 142.03 29.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.97 -1.081 . . . . 1.69 109.837 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -58.74 -38.93 79.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 1.07 111.135 178.481 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.3 m -60.38 -39.61 87.9 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.215 -0.928 . . . . 1.58 110.085 179.239 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 70.8 m -60.34 -39.36 86.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 1.6 110.554 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.407 HG12 HH21 ' A' ' 195' ' ' ARG . 96.7 mt -60.8 -39.99 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 1.45 110.959 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.9 mtp -63.76 -44.31 93.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.895 -1.128 . . . . 1.05 109.671 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.12 -49.57 77.11 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.77 -0.65 . . . . 0.72 111.004 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.407 HH21 HG12 ' A' ' 192' ' ' ILE . 81.9 mtm180 -61.73 -41.1 97.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.985 . . . . 3.05 110.946 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 56.0 m -69.36 -39.94 77.79 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.923 -1.111 . . . . 0.89 110.561 -179.696 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.3 mt -89.28 -7.83 54.63 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.819 0.818 . . . . 0.78 112.101 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 194' ' ' ALA . 45.2 mt-10 49.03 15.5 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.876 1.065 . . . . 1.45 113.876 -179.8 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.8 mt -74.75 150.58 86.46 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.022 -1.048 . . . . 0.67 108.607 178.733 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.36 139.05 88.94 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.309 1.339 . . . . 0.64 109.833 178.22 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.92 166.65 25.88 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 117.737 -1.585 . . . . 0.67 109.431 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.5 mt -145.68 147.06 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.681 -1.229 . . . . 0.69 107.681 177.216 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.435 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.8 m -126.99 -34.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 113.302 0.853 . . . . 0.85 113.302 -179.009 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.17 40.83 1.73 Allowed Glycine 0 N--CA 1.489 2.18 0 C-N-CA 120.196 -1.002 . . . . 0.92 111.913 -177.983 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.447 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 58.6 p -60.82 -18.75 57.45 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.273 -1.134 . . . . 0.95 111.371 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.43 -95.82 0.99 Allowed Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.83 -1.176 . . . . 1.04 110.503 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 60.7 m -127.72 31.51 5.13 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.634 -0.921 . . . . 1.57 112.215 -179.03 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.87 -35.33 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.393 -1.442 . . . . 0.84 110.532 179.096 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 46.4 p -61.46 -20.06 62.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.195 -0.94 . . . . 0.99 111.452 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.9 t -93.93 -1.03 55.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -0.951 . . . . 1.7 112.099 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -128.22 -1.66 5.72 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 112.797 0.665 . . . . 2.2 112.797 -177.83 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.04 148.39 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.226 -0.657 . . . . 0.84 109.226 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -119.85 157.18 29.22 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.851 -1.166 . . . . 2.2 107.851 178.062 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.42 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 38.6 p30 -54.12 142.82 24.27 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.049 -1.032 . . . . 2.28 110.813 178.491 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.7 OUTLIER 80.18 1.3 2.01 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 114.905 1.446 . . . . 2.35 114.905 179.183 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -63.46 146.41 53.66 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.765 -1.209 . . . . 1.97 108.371 177.512 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -88.29 118.69 28.07 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.835 -1.542 . . . . 2.65 106.835 177.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 87.3 mt -127.93 142.02 51.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.585 -0.697 . . . . 0.63 109.57 -178.625 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.6 mt -111.16 129.32 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.528 -1.656 . . . . 0.62 106.528 177.529 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 20.4 tp -99.1 119.05 37.19 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.384 -1.71 . . . . 0.64 106.384 178.336 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.0 t0 -94.93 -29.28 14.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.818 -1.176 . . . . 2.05 112.506 -177.631 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.88 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 36.79 20.79 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.773 0.657 . . . . 0.84 112.773 -178.612 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.7 t -109.25 -55.95 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.125 -0.985 . . . . 1.02 109.075 178.335 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.46 14.8 30.02 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.625 -0.716 . . . . 2.51 110.293 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 59.51 55.38 4.14 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.397 0.617 . . . . 1.54 111.21 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -151.49 148.48 28.11 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.254 1.026 . . . . 1.95 109.91 179.596 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 20.0 t -116.09 139.61 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.235 -1.024 . . . . 0.71 108.235 177.251 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -102.01 135.6 43.29 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.057 -1.027 . . . . 1.01 108.739 178.792 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.0 t -112.83 130.24 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-O 121.779 0.8 . . . . 0.82 109.127 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.556 ' O ' ' ND2' ' A' ' 230' ' ' ASN . 1.0 OUTLIER 52.06 48.95 6.14 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 113.577 0.955 . . . . 1.54 113.577 178.092 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.3 Cg_endo -64.5 150.05 88.9 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.585 2.19 . . . . 0.94 110.724 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.1 m -74.77 154.16 38.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.265 -0.897 . . . . 1.8 108.947 177.652 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.55 ' HA ' HD12 ' A' ' 236' ' ' ILE . 16.0 t-20 -52.99 -41.11 64.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 2.73 110.708 178.716 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -59.2 -40.29 85.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 3.17 109.812 179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.04 -38.91 76.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.647 -0.658 . . . . 1.34 110.166 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 233' ' ' ASN . 96.8 mt -58.31 -46.83 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.448 -0.782 . . . . 1.2 110.785 179.198 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -59.14 -40.69 86.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.947 -1.096 . . . . 2.7 110.406 179.703 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -60.76 -41.52 95.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.384 -0.822 . . . . 2.59 110.305 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 47.3 mtp -71.51 -36.75 71.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.354 -0.841 . . . . 1.38 110.593 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.541 HH12 ' CG2' ' A' ' 236' ' ' ILE . 0.3 OUTLIER -57.88 -41.03 81.69 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.137 -0.977 . . . . 2.84 110.286 179.734 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.84 -37.58 73.16 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.375 -0.828 . . . . 1.88 111.047 -179.685 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.44 -56.35 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.708 -1.245 . . . . 2.4 111.919 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 11' ' ' ILE . 50.5 tt0 -62.89 -49.39 75.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.6 -1.313 . . . . 3.52 109.751 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.37 -33.26 72.2 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.648 -0.658 . . . . 1.88 110.523 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -60.63 -30.0 69.59 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.774 -1.17 . . . . 3.01 109.358 179.058 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.55 -47.27 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 121.898 0.856 . . . . 2.45 109.509 179.17 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.97 91.07 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.783 -0.767 . . . . 2.75 110.046 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 20.9 t -70.22 -40.23 74.65 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.523 -0.735 . . . . 3.16 110.541 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -62.74 -40.79 98.34 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.427 -0.796 . . . . 3.57 110.19 -178.43 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -67.98 -39.56 83.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 4.3 110.614 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -66.57 -40.57 89.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 4.45 110.636 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -70.04 -27.91 65.04 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.206 -0.934 . . . . 5.97 111.44 -179.544 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.33 -40.38 94.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 6.18 110.437 179.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -78.42 -7.92 57.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.019 -1.051 . . . . 6.66 112.156 -179.274 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -77.25 -54.66 6.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.345 -0.847 . . . . 8.2 111.386 -179.284 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.578 ' CD2' ' H ' ' A' ' 256' ' ' LEU . 1.3 pt? -82.9 -14.18 54.68 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.868 -1.145 . . . . 8.07 112.95 -178.267 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -96.33 51.53 1.2 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.77 -1.206 . . . . 9.45 110.924 -178.725 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -91.47 -7.92 49.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.309 -0.869 . . . . 10.12 112.663 -178.485 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.958 -1.02 . . . . 11.49 109.286 -178.788 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.199 -0.667 . . . . 3.07 109.199 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt -99.14 98.14 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 106.856 -1.535 . . . . 1.07 106.856 177.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -105.31 122.56 46.21 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.391 -1.336 . . . . 1.24 107.391 -179.816 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.95 -150.65 27.15 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.784 -1.326 . . . . 1.01 109.784 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.591 HG22 ' O ' ' A' ' 5' ' ' ILE . 95.4 mt -95.22 1.05 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.408 -1.054 . . . . 1.11 112.942 -179.635 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 tp 49.64 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.801 -1.187 . . . . 0.99 112.867 178.583 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.83 -37.23 14.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.956 -1.09 . . . . 0.85 111.431 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 t -146.34 137.02 12.4 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 107.965 -1.124 . . . . 1.38 107.965 -178.313 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.27 152.56 35.14 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.934 1.756 . . . . 0.94 112.122 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.719 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 147.13 135.41 2.68 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.768 -0.933 . . . . 0.81 110.768 177.683 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -96.15 132.48 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.549 -1.559 . . . . 0.83 108.941 178.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.3 148.95 45.2 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.895 -0.78 . . . . 0.53 108.895 179.278 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 3.2 m-85 -121.22 142.75 49.62 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.301 -0.875 . . . . 0.77 109.018 178.474 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.84 168.38 37.32 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.575 -1.774 . . . . 0.51 109.721 177.797 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -78.08 158.68 29.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.763 -0.845 . . . . 1.9 108.799 178.638 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -82.59 123.78 29.54 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.898 -1.149 . . . . 0.66 107.898 178.407 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 tp -102.47 98.86 8.88 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.22 -1.77 . . . . 0.83 106.22 178.619 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.1 tp -86.99 141.1 28.92 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.681 -0.859 . . . . 0.86 108.681 -179.666 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 mt -99.72 107.11 19.11 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.27 -1.381 . . . . 0.92 107.27 178.158 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -110.81 134.23 52.68 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.673 -1.232 . . . . 2.03 107.673 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -131.11 155.12 47.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.211 -0.931 . . . . 2.66 109.163 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -82.11 137.16 35.07 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.907 -1.146 . . . . 2.32 107.907 177.338 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -65.7 148.36 51.89 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.346 -0.847 . . . . 2.11 108.881 178.553 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.6 mt -99.85 134.61 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.359 -0.838 . . . . 0.73 108.799 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.89 130.01 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.571 -1.27 . . . . 0.87 107.571 178.872 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.6 mt -95.83 135.8 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.297 -0.877 . . . . 0.81 108.976 179.257 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -94.45 126.65 39.86 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.265 -1.013 . . . . 1.34 108.265 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.513 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.4 mmt-85 -97.7 15.08 24.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.343 -0.848 . . . . 2.89 112.481 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -63.34 142.32 58.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.004 -1.06 . . . . 2.09 109.117 178.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -88.02 130.82 34.86 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.136 -1.061 . . . . 2.19 108.136 177.628 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -89.37 170.19 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.178 -0.951 . . . . 0.75 110.09 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.3 p -94.64 163.44 13.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.577 -0.702 . . . . 0.91 109.645 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.75 -19.94 4.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 0.93 112.67 179.249 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -68.71 -43.16 76.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.832 -1.167 . . . . 2.28 111.229 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -87.42 -5.79 58.7 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.711 -1.243 . . . . 1.45 112.674 -179.098 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.05 -46.52 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 0.81 110.891 -178.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -56.49 -40.02 74.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.954 . . . . 1.54 110.316 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.61 -39.6 91.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.535 -0.728 . . . . 2.36 110.824 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -60.0 -40.63 89.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.026 -1.046 . . . . 1.31 110.747 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.83 -39.69 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.82 110.38 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -62.87 -48.12 80.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.364 -0.835 . . . . 1.5 110.794 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -62.87 -40.93 99.01 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.917 -1.113 . . . . 2.23 110.256 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -71.13 -52.86 16.85 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.204 -0.935 . . . . 0.85 110.191 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.2 tp -62.3 -47.47 84.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.037 -1.04 . . . . 0.91 109.816 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.522 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.5 t -70.23 -42.46 72.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.472 -0.768 . . . . 0.9 109.697 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.58 -38.08 85.86 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.148 -1.501 . . . . 0.69 109.414 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 20.5 ttm180 -59.32 -32.02 69.69 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.958 0.885 . . . . 2.88 109.095 178.856 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.04 -44.19 91.74 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.787 0.803 . . . . 0.85 109.636 178.985 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -79.63 -40.17 29.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.115 -0.991 . . . . 2.35 110.332 179.752 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.28 -44.9 92.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.468 -0.77 . . . . 0.65 110.132 -178.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.5 p -60.45 -38.63 84.76 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.124 0.964 . . . . 1.45 109.313 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.57 99.38 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.126 -0.63 . . . . 0.63 110.661 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -62.0 -50.14 73.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.569 -1.332 . . . . 1.34 110.479 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 54' ' ' LEU . 3.2 mm? -67.63 -40.64 84.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.329 -0.857 . . . . 1.56 110.399 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -59.21 -40.78 86.86 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.389 -0.819 . . . . 1.19 110.467 179.731 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -67.21 -46.93 72.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.084 -1.01 . . . . 0.72 110.671 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.11 -38.16 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.417 -0.802 . . . . 0.62 110.524 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -49.93 -44.72 50.55 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.367 -0.833 . . . . 1.05 111.322 179.183 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -68.16 -40.48 82.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.195 -0.941 . . . . 0.64 109.946 -179.64 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -61.87 -37.98 86.6 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.883 -1.127 . . . . 1.73 109.334 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -33.77 76.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.448 0.642 . . . . 0.56 110.2 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.61 -37.13 12.35 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.771 -1.204 . . . . 0.69 111.255 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.67 -24.41 38.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.07 -1.253 . . . . 1.48 110.755 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.4 m -88.0 -50.77 6.2 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.537 -0.865 . . . . 0.98 110.271 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -107.06 -2.96 20.51 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 113.965 1.098 . . . . 1.16 113.965 -177.572 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.24 155.87 26.88 Favored Glycine 0 N--CA 1.504 3.201 0 O-C-N 120.82 -1.175 . . . . 0.85 113.858 178.311 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.58 -15.55 1.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -1.018 . . . . 3.86 112.979 179.26 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.66 -35.8 71.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 2.35 110.917 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -82.91 -19.03 38.11 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.143 -0.973 . . . . 1.67 111.996 -179.382 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.23 -35.19 74.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.074 -1.016 . . . . 1.45 111.038 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.36 89.18 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.079 -1.013 . . . . 0.61 110.847 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.6 mt -68.64 -42.38 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.943 -1.098 . . . . 0.65 110.098 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -72.05 -31.15 65.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.139 -0.976 . . . . 0.66 110.253 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -59.79 -37.65 79.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.826 . . . . 1.19 110.004 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.92 -40.54 84.42 Favored Glycine 0 N--CA 1.48 1.622 0 C-N-CA 119.733 -1.222 . . . . 0.53 110.277 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -59.93 -47.28 86.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.184 -1.186 . . . . 1.27 110.593 179.506 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.7 mt -60.3 -38.64 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.951 -1.093 . . . . 0.54 110.231 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.9 ttt -59.9 -39.39 85.21 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.365 -0.834 . . . . 1.74 110.904 179.22 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.418 HD11 HE21 ' A' ' 111' ' ' GLN . 9.3 tp -60.31 -50.04 75.2 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.106 -0.996 . . . . 0.55 110.46 179.669 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.31 -39.28 92.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.033 -1.042 . . . . 0.47 110.303 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -87.22 1.5 52.95 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.445 0.906 . . . . 1.42 113.445 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.41 121.45 12.11 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.357 -1.465 . . . . 1.27 108.244 178.805 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -66.36 -16.88 64.41 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.88 0.847 . . . . 1.35 110.964 -178.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.97 -53.35 9.12 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.507 0.67 . . . . 2.22 110.087 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.31 -36.78 81.04 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.568 -0.853 . . . . 0.62 110.485 -179.517 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 47' ' ' ARG . 87.0 tt0 -59.43 -46.84 87.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.203 -0.936 . . . . 1.29 110.918 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.73 -38.56 85.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.393 -0.817 . . . . 1.52 110.701 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.02 -48.7 70.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.831 -1.168 . . . . 1.3 110.872 179.657 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.31 -43.95 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.173 -0.954 . . . . 0.61 110.138 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.5 mt -60.41 -43.96 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.658 -0.651 . . . . 0.78 110.486 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.21 -42.34 98.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.425 -0.797 . . . . 0.82 110.991 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.66 -47.79 83.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.162 -0.961 . . . . 0.8 110.296 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.4 mt -60.89 -44.88 98.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.304 -0.872 . . . . 0.77 110.683 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -84.07 -34.45 24.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.007 -1.058 . . . . 2.12 111.954 -179.71 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 91' ' ' ALA . 44.9 t0 -82.94 -43.62 16.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.809 -1.182 . . . . 1.51 111.445 -178.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -101.9 5.79 41.09 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.642 -0.661 . . . . 1.98 112.302 -178.858 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.7 m80 52.09 47.92 23.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 1.32 111.795 -179.524 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.4 mtt -100.34 153.76 19.05 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.146 -0.971 . . . . 1.38 110.018 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.5 p -71.57 161.21 31.38 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.507 -0.746 . . . . 0.67 109.746 178.149 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.22 90.61 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.85 -0.74 . . . . 0.52 110.748 178.84 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.517 ' OD2' HD21 ' A' ' 142' ' ' LEU . 98.1 m-20 -68.49 -40.21 81.0 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.959 -1.088 . . . . 2.25 110.248 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.91 -50.68 54.72 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.855 -0.738 . . . . 0.64 111.064 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.58 -44.23 96.84 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 0.56 110.195 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.97 -44.17 94.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.603 -0.686 . . . . 0.46 110.665 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -61.71 -38.65 88.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 1.32 111.321 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -57.44 -49.77 75.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.675 -1.266 . . . . 1.3 110.888 179.461 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.04 -47.42 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.635 -1.291 . . . . 0.61 110.424 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -61.02 -30.35 47.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.563 -0.711 . . . . 0.65 110.438 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -58.65 -41.27 85.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.358 -0.839 . . . . 2.11 110.776 179.218 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.82 -30.61 23.15 Favored Glycine 0 N--CA 1.498 2.808 0 C-N-CA 119.071 -1.538 . . . . 0.83 112.991 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.418 HE21 HD11 ' A' ' 79' ' ' LEU . 15.2 mm100 -62.09 -42.84 99.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.188 -1.772 . . . . 1.28 110.055 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.41 -52.03 25.26 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.379 -0.825 . . . . 0.89 110.312 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.0 p -60.33 -34.81 74.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.186 -0.946 . . . . 1.87 110.421 -179.365 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.04 -47.02 86.59 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.766 -0.584 . . . . 1.05 110.934 179.576 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.48 -29.94 70.9 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.127 -1.029 . . . . 1.02 111.148 -179.506 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -67.43 -22.29 65.52 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.929 -1.107 . . . . 2.04 111.511 179.455 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -70.59 -18.32 62.89 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.94 -1.104 . . . . 1.73 110.932 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 123' ' ' LEU . 10.7 mt -83.79 145.34 28.74 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.359 -0.838 . . . . 1.37 109.623 179.265 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -101.08 41.93 1.15 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.359 -0.838 . . . . 2.88 110.996 179.83 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -113.13 135.76 53.46 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.961 -1.125 . . . . 1.58 107.961 178.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 25.1 mp0 -59.13 -34.24 71.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.45 -0.781 . . . . 3.04 111.151 179.111 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -74.22 -50.51 18.83 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.108 -0.995 . . . . 0.9 110.51 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 118' ' ' LEU . 30.6 mt -63.4 -36.65 84.44 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.199 -0.938 . . . . 1.06 110.207 -179.354 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -62.56 -49.24 76.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.166 -1.014 . . . . 2.18 109.758 179.209 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -63.04 -28.98 70.46 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.448 -0.901 . . . . 2.15 110.27 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -63.55 -30.38 71.5 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.069 0.937 . . . . 2.33 108.879 178.735 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.1 -48.72 80.56 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.645 0.736 . . . . 0.82 109.665 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.87 91.63 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.847 0.832 . . . . 0.85 109.449 179.663 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.76 -37.61 88.0 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.574 -0.704 . . . . 1.39 110.476 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.75 -39.83 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.407 -0.808 . . . . 0.56 110.202 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -59.1 -38.86 80.54 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.265 -0.974 . . . . 3.12 110.134 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -59.68 -39.74 85.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.557 -0.715 . . . . 1.28 110.469 179.127 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 66.2 mt -60.5 -39.97 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.01 . . . . 0.49 110.1 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.01 -44.96 87.24 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.844 -1.169 . . . . 0.46 110.279 179.552 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -59.54 -40.6 87.75 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.311 -1.111 . . . . 2.71 110.383 179.248 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -61.74 -45.08 95.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.994 -1.066 . . . . 2.14 110.161 179.616 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 50.5 tp -59.92 -43.19 95.06 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.123 -0.986 . . . . 1.05 110.016 179.601 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.89 -44.16 94.4 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.234 -0.916 . . . . 0.52 110.189 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.87 -34.32 74.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.246 -0.909 . . . . 2.35 110.585 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -77.44 -40.5 43.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 1.39 111.058 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.3 -40.05 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.236 -0.915 . . . . 0.68 110.196 -178.498 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.517 HD21 ' OD2' ' A' ' 101' ' ' ASP . 68.7 mt -90.2 -9.42 48.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.91 -1.119 . . . . 0.83 112.041 -179.236 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.37 20.27 77.24 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 120.375 -0.917 . . . . 0.91 112.961 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.2 tp -63.78 149.91 45.78 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.686 0.755 . . . . 0.95 109.408 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.73 146.29 54.99 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.245 -0.909 . . . . 2.43 109.009 178.093 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.82 143.5 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.391 -0.966 . . . . 1.1 108.391 178.393 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 mp -76.23 114.12 16.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.925 -1.11 . . . . 1.58 108.501 178.533 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -98.18 102.13 13.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.441 -1.689 . . . . 1.62 106.441 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.406 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.0 mt -77.37 -18.03 57.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 0.8 111.17 -177.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.3 m -80.11 -1.53 40.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -0.823 . . . . 1.56 112.325 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.61 27.11 5.04 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.807 0.813 . . . . 0.84 111.897 -178.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.406 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 17.5 mt -75.19 139.55 18.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.522 -0.736 . . . . 0.82 109.392 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -111.63 -19.95 12.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.029 0.919 . . . . 2.31 112.535 -178.59 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -119.12 142.88 47.53 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.723 -0.843 . . . . 1.54 108.723 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -73.14 122.42 21.83 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.052 -1.092 . . . . 1.38 108.052 178.042 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.1 m -144.75 175.56 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.594 -0.691 . . . . 0.69 109.253 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 44.9 mt -88.3 143.91 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.282 -0.886 . . . . 0.53 108.802 178.17 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.3 tp -96.8 125.35 41.19 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.06 -1.089 . . . . 0.64 108.06 178.209 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.4 t -123.22 129.93 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.552 -1.277 . . . . 0.67 107.552 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.79 154.21 21.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.159 -0.963 . . . . 0.78 108.678 179.215 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.83 80.6 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.583 -1.323 . . . . 1.0 109.365 178.127 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -171.58 153.9 3.59 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.862 -0.792 . . . . 2.42 108.862 179.675 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.3 mt -118.73 142.26 47.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.932 -0.766 . . . . 0.75 108.932 177.318 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.2 p -92.48 150.56 40.15 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.13 -0.981 . . . . 0.78 108.52 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -42.72 -38.63 6.66 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.857 1.705 . . . . 0.67 113.206 179.329 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 62.1 m -63.52 -50.12 70.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.005 -1.059 . . . . 0.7 109.884 -179.692 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.92 -39.03 90.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.913 . . . . 1.21 110.127 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 70.2 p -68.7 -40.81 79.84 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.827 -0.749 . . . . 0.6 110.328 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.57 77.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.62 110.585 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -95.91 -0.98 50.2 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.949 -1.094 . . . . 1.16 112.921 -179.144 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.95 148.62 46.95 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.72 -1.238 . . . . 0.73 108.49 179.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -97.01 115.3 27.2 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.096 -1.446 . . . . 2.24 107.096 177.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.0 mt -73.67 -14.12 61.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.59 -0.694 . . . . 1.43 111.778 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.72 -21.94 32.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.347 -0.845 . . . . 2.15 112.491 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -99.43 -7.06 26.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.129 -0.982 . . . . 2.04 112.549 -178.144 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 178' ' ' GLY . 58.7 t -110.99 131.0 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.198 -1.038 . . . . 0.55 108.198 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.5 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -89.32 -13.87 36.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 1.63 111.275 -179.744 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.423 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -177.14 172.92 45.83 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.889 -1.684 . . . . 0.47 108.889 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -126.56 132.79 51.25 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.947 -1.131 . . . . 0.54 107.947 179.055 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.561 HD11 HD13 ' A' ' 220' ' ' LEU . 67.4 mt -132.66 112.17 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.323 -1.732 . . . . 0.69 106.323 179.052 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 205' ' ' THR . 73.3 p -135.86 173.3 11.86 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.608 -1.308 . . . . 0.82 110.173 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -98.59 54.66 1.05 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.353 0.597 . . . . 2.37 110.546 179.049 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.47 160.62 14.4 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 1.11 109.921 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.93 -82.7 0.07 OUTLIER Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.84 -1.171 . . . . 1.67 111.141 178.165 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 148.47 -38.48 1.01 Allowed Glycine 0 N--CA 1.5 2.942 0 O-C-N 120.582 -1.54 . . . . 1.54 113.223 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -60.05 -39.52 86.22 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.844 -1.386 . . . . 4.48 110.863 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 23.0 p -136.83 38.02 2.6 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.295 -0.878 . . . . 2.63 111.623 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 59.0 m -85.68 124.07 31.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.404 -1.332 . . . . 1.69 107.404 178.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -56.69 -37.52 70.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.264 -0.897 . . . . 1.07 110.824 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.3 p -60.88 -38.93 87.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 1.58 110.351 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.0 t -60.21 -40.54 90.47 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.224 -0.923 . . . . 1.6 110.12 179.58 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.55 -35.92 61.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.333 -0.854 . . . . 1.45 110.457 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 59.1 mtp -63.23 -41.44 99.11 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.995 -1.066 . . . . 1.05 109.566 179.639 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.75 -47.09 87.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.701 -0.681 . . . . 0.72 111.021 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -62.17 -43.46 98.77 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.061 -1.024 . . . . 3.05 110.748 -179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.4 m -70.5 -39.78 73.95 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.308 -0.87 . . . . 0.89 110.492 -179.748 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.0 mt -93.3 -4.47 51.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.78 112.817 -178.295 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 53.87 10.84 0.28 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.862 1.06 . . . . 1.45 113.862 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.6 mt -72.36 150.22 91.68 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.871 -1.143 . . . . 0.67 108.904 179.4 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.63 140.81 88.59 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.038 1.159 . . . . 0.64 110.239 178.391 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.94 162.04 31.85 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.049 -1.657 . . . . 0.67 109.479 178.566 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.419 ' CD1' HD11 ' A' ' 220' ' ' LEU . 16.2 mt -147.02 146.6 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.063 -1.088 . . . . 0.69 108.063 177.431 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.2 m -125.93 -28.28 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 O-C-N 121.041 -1.037 . . . . 0.85 113.266 -179.182 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.21 42.2 1.63 Allowed Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.634 -1.27 . . . . 0.92 111.759 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 181' ' ' THR . 45.0 p -65.34 -18.04 65.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.964 -1.315 . . . . 0.95 111.116 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.07 -95.9 0.86 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.833 -1.307 . . . . 1.04 109.833 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 60.8 m -127.46 31.09 5.25 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.709 -0.877 . . . . 1.57 111.866 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 78.2 t -57.06 -35.89 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.32 -1.488 . . . . 0.84 110.593 179.233 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.4 p -59.99 -19.89 54.81 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.939 -1.101 . . . . 0.99 111.974 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 48.9 m -94.56 1.87 55.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.945 . . . . 1.7 112.089 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -128.77 1.67 5.43 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 113.086 0.773 . . . . 2.2 113.086 -178.423 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.53 152.87 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.739 0.781 . . . . 0.84 109.773 -179.663 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -118.82 152.69 35.77 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.044 -1.095 . . . . 2.2 108.044 177.672 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 43.7 p-10 -55.11 143.2 27.88 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.983 -1.073 . . . . 2.28 110.17 178.285 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 80.97 -0.72 1.78 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 114.117 1.155 . . . . 2.35 114.117 179.431 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.14 150.07 43.73 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.646 -1.284 . . . . 1.97 109.338 177.796 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -89.72 120.86 31.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.507 -1.371 . . . . 2.65 107.521 178.175 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 89.8 mt -128.33 146.8 50.66 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.44 -0.788 . . . . 0.63 109.729 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.47 127.88 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.15 -1.426 . . . . 0.62 107.15 177.443 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.561 HD13 HD11 ' A' ' 180' ' ' ILE . 61.8 tp -101.52 118.3 36.67 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 105.883 -1.895 . . . . 0.64 105.883 178.811 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 223' ' ' VAL . 39.4 t0 -91.7 -26.81 18.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.753 -1.217 . . . . 2.05 112.361 -177.903 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.82 19.74 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 113.264 0.839 . . . . 0.84 113.264 -179.25 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.1 t -112.14 -55.74 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.147 0.975 . . . . 1.02 108.981 -179.426 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -100.73 10.89 40.58 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.252 1.025 . . . . 2.51 109.65 -179.169 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 62.03 53.31 3.04 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.317 -0.856 . . . . 1.54 112.05 179.436 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -149.58 146.64 27.44 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.213 1.006 . . . . 1.95 109.792 178.438 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.9 t -116.79 135.37 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.509 -1.293 . . . . 0.71 107.509 178.056 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -102.42 134.77 45.19 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.831 -1.168 . . . . 1.01 108.442 178.673 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.26 129.25 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 107.795 -1.187 . . . . 0.82 107.795 178.738 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.488 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 18.4 t30 56.66 44.88 1.53 Allowed Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 113.467 0.914 . . . . 1.54 113.467 179.092 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 52.2 Cg_endo -68.9 155.47 68.46 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.383 2.055 . . . . 0.94 110.681 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 29.8 p -73.72 162.56 29.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.962 -1.086 . . . . 1.8 110.723 178.544 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.12 -34.04 74.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.507 -0.746 . . . . 2.73 110.337 178.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -59.85 -39.53 85.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 3.17 110.747 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.04 -39.07 79.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.217 -0.927 . . . . 1.34 110.405 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 80.5 mt -59.74 -48.37 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.525 -0.734 . . . . 1.2 111.304 179.28 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -59.06 -40.17 84.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.892 -1.13 . . . . 2.7 110.824 -179.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -62.69 -47.49 83.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.256 -0.903 . . . . 2.59 110.76 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 87.6 mtp -71.29 -39.1 71.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.384 -0.823 . . . . 1.38 110.89 -179.647 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -56.23 -39.93 73.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.866 -1.146 . . . . 2.84 110.751 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.91 -45.89 63.48 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.014 -1.054 . . . . 1.88 111.122 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.12 -48.59 84.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.648 -1.282 . . . . 2.4 110.895 -178.573 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -60.07 -50.73 72.57 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.647 -1.283 . . . . 3.52 111.124 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.57 -36.78 85.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.761 -0.587 . . . . 1.88 111.108 -179.4 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -61.98 -26.32 68.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.424 -1.31 . . . . 3.01 110.428 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 77.5 t -69.49 -49.26 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 119.354 -0.939 . . . . 2.45 110.308 179.013 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.13 97.02 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.17 -0.956 . . . . 2.75 110.023 -179.766 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.5 t -69.94 -39.81 75.86 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.701 -0.625 . . . . 3.16 110.794 -179.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -62.54 -46.6 87.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.344 -0.847 . . . . 3.57 110.833 -179.441 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 254' ' ' ALA . 3.7 ttmp? -70.19 -29.19 65.99 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.426 -0.796 . . . . 4.3 111.09 -179.576 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.24 -69.35 0.6 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.886 -1.134 . . . . 4.45 111.636 179.378 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -78.45 -53.72 6.94 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.316 -0.865 . . . . 5.97 113.03 -178.336 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 66.1 mt -68.4 -12.27 60.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.443 -1.411 . . . . 6.18 112.887 -178.211 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 250' ' ' LYS . . . -62.85 -28.29 69.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.371 -1.456 . . . . 6.66 111.144 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -82.08 -11.37 58.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.917 -1.115 . . . . 8.2 112.454 -179.816 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.578 HD22 ' N ' ' A' ' 256' ' ' LEU . 3.6 mm? -92.05 16.65 10.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.014 -1.054 . . . . 8.07 112.28 -179.682 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.404 ' NZ ' ' CB ' ' A' ' 257' ' ' LYS . 9.3 mtmp? -85.75 11.27 11.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.059 -1.025 . . . . 9.45 112.802 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -85.16 -8.14 58.74 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.856 -1.152 . . . . 10.12 112.422 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 51.2 mtt-85 . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.1 -1.0 . . . . 11.49 109.302 -178.111 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.293 0.568 . . . . 3.07 109.519 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.6 mt -92.93 106.94 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.318 -1.734 . . . . 1.07 106.318 177.666 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 m -105.76 121.02 43.18 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.504 -1.295 . . . . 1.24 107.504 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.01 -149.82 26.15 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.512 -1.035 . . . . 1.01 110.512 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.557 HG22 ' O ' ' A' ' 5' ' ' ILE . 81.3 mt -94.34 0.77 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.783 -0.833 . . . . 1.11 112.086 -179.67 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 50.26 99.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.355 -0.841 . . . . 0.99 112.335 178.646 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.8 -52.97 6.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.108 . . . . 0.85 110.628 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.33 149.41 44.53 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 107.719 -1.215 . . . . 1.38 107.719 -179.541 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.26 144.5 29.48 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 123.029 2.486 . . . . 0.94 112.937 178.815 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.91 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.35 168.67 18.15 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 109.206 -1.558 . . . . 0.81 109.206 178.119 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.87 133.46 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.108 -1.23 . . . . 0.83 108.803 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.33 150.86 43.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.366 -0.834 . . . . 0.53 109.132 179.096 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 22.0 m-85 -117.87 139.78 50.63 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.047 -1.094 . . . . 0.77 108.047 177.703 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.82 167.25 38.52 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.34 -1.886 . . . . 0.51 110.442 178.182 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -78.38 156.62 29.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.768 -0.842 . . . . 1.9 108.774 177.815 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.416 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.67 124.96 32.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.042 -1.095 . . . . 0.66 108.042 178.53 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.2 tp -100.24 101.9 13.03 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 104.721 -2.326 . . . . 0.83 104.721 177.628 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.25 138.48 31.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.21 -1.034 . . . . 0.86 108.21 179.673 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.3 mt -98.98 114.83 27.67 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 106.119 -1.808 . . . . 0.92 106.119 177.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -102.29 129.84 48.83 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.799 -1.186 . . . . 2.03 107.799 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -123.27 144.07 49.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.99 -0.744 . . . . 2.66 108.99 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -81.15 134.34 35.62 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.758 -1.201 . . . . 2.32 107.758 177.284 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.68 145.61 55.39 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.406 -0.809 . . . . 2.11 108.981 178.682 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.9 mt -93.03 132.11 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.263 -1.014 . . . . 0.73 108.263 178.324 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -106.33 129.85 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.169 -1.048 . . . . 0.87 108.169 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.2 mt -97.06 130.34 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.031 -1.1 . . . . 0.81 108.031 178.974 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -89.91 122.51 33.01 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.741 -1.207 . . . . 1.34 107.741 178.896 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mmm-85 -93.58 11.68 27.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.47 -0.768 . . . . 2.89 112.286 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -65.05 150.51 47.98 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.348 -0.845 . . . . 2.09 110.268 178.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -90.08 129.85 36.32 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.148 -1.056 . . . . 2.19 108.148 177.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 pt -90.86 164.69 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.962 . . . . 0.75 110.009 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.0 p -94.13 167.25 11.69 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.55 -0.719 . . . . 0.91 110.452 178.893 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.51 -26.89 55.91 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.91 . . . . 0.93 111.929 179.305 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -70.61 -27.98 64.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 2.28 111.012 -179.786 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -93.52 -12.82 28.76 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.416 -0.802 . . . . 1.45 112.151 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.3 t -59.54 -47.79 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.487 0.66 . . . . 0.81 110.205 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.33 -38.27 76.81 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.444 -0.785 . . . . 1.54 110.63 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.28 -38.66 90.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.605 -0.685 . . . . 2.36 110.88 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.466 ' CD ' HH21 ' A' ' 42' ' ' ARG . 79.3 mm-40 -60.35 -41.33 93.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.85 -1.156 . . . . 1.31 110.503 179.573 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.27 -40.41 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.374 -0.828 . . . . 0.82 110.547 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -60.29 -44.91 94.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.128 -0.983 . . . . 1.5 109.882 179.72 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.466 HH21 ' CD ' ' A' ' 39' ' ' GLU . 67.5 mtm180 -63.42 -41.96 98.71 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.929 -1.109 . . . . 2.23 109.74 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -72.25 -54.5 9.41 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.309 -0.869 . . . . 0.85 109.974 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.4 tp -57.79 -48.51 79.48 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.33 -0.948 . . . . 0.91 110.051 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t -68.78 -43.92 74.69 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.121 -0.987 . . . . 0.9 109.489 179.613 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.45 -35.71 73.59 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.348 -1.501 . . . . 0.69 109.348 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' A' ' 47' ' ' ARG . 0.3 OUTLIER -58.62 -33.66 70.28 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.434 1.111 . . . . 2.88 108.819 178.71 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.87 -48.21 82.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.035 -0.984 . . . . 0.85 110.212 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -79.0 -38.6 36.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 2.35 111.261 -179.445 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.76 86.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.65 110.513 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.5 m -61.43 -39.54 91.18 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.042 -1.036 . . . . 1.45 109.893 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.31 92.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.866 -0.521 . . . . 0.63 111.373 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -63.01 -52.16 64.02 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.716 -1.24 . . . . 1.34 111.199 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 54' ' ' LEU . 10.8 mp -64.75 -38.22 90.26 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.804 -1.185 . . . . 1.56 110.401 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.1 -43.33 87.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.737 -0.602 . . . . 1.19 110.781 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.5 m -67.74 -44.65 77.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.784 -1.197 . . . . 0.72 110.311 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.92 -34.92 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.641 -0.662 . . . . 0.62 110.869 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -50.74 -45.55 58.83 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.297 -0.877 . . . . 1.05 110.743 179.369 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -69.58 -34.57 74.33 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.129 -0.982 . . . . 0.64 110.305 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -62.75 -39.62 94.69 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.834 -1.147 . . . . 1.73 109.686 179.455 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.36 73.93 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.683 -0.635 . . . . 0.56 110.427 179.205 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.41 -33.7 21.94 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.8 -1.19 . . . . 0.69 111.042 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.44 -24.58 39.5 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.117 -1.225 . . . . 1.48 111.296 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -86.38 -48.84 8.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.374 -0.828 . . . . 0.98 111.221 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -107.36 -15.36 14.65 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 113.484 0.92 . . . . 1.16 113.484 -177.496 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.85 151.98 8.92 Favored Glycine 0 N--CA 1.501 3.026 0 O-C-N 121.406 -0.809 . . . . 0.85 112.043 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -52.73 -21.22 3.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.53 -0.982 . . . . 3.86 112.417 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.27 -29.89 67.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.974 -1.079 . . . . 2.35 111.689 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -82.82 -17.42 44.07 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.823 -1.173 . . . . 1.67 111.948 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.34 -33.81 72.94 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.419 -0.8 . . . . 1.45 111.109 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.69 -39.97 86.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.086 -1.009 . . . . 0.61 110.701 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.2 mt -66.12 -47.54 84.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.401 -0.92 . . . . 0.65 109.734 179.721 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -71.19 -33.41 69.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.339 -0.851 . . . . 0.66 110.547 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.88 -38.58 86.14 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.139 -0.976 . . . . 1.19 109.854 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.84 95.1 Favored Glycine 0 N--CA 1.483 1.833 0 C-N-CA 120.026 -1.083 . . . . 0.53 110.479 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -58.73 -43.0 90.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.026 -1.279 . . . . 1.27 110.362 179.306 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.33 -40.85 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.083 -1.011 . . . . 0.54 110.081 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.9 ttm -60.57 -41.99 95.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.438 -0.789 . . . . 1.74 110.081 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.1 tp -60.55 -48.09 83.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.417 -0.802 . . . . 0.55 109.995 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.466 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.1 tp -59.83 -39.66 85.87 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.72 0.771 . . . . 0.47 110.248 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -87.06 7.6 27.15 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.725 0.639 . . . . 1.42 112.725 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -63.49 125.2 23.43 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.833 -1.167 . . . . 1.27 108.762 178.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.49 -16.72 63.94 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.265 -0.897 . . . . 1.35 111.096 -179.051 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.37 -50.29 19.22 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.274 -0.97 . . . . 2.22 110.623 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.97 -39.72 90.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.379 -0.826 . . . . 0.62 110.631 -179.489 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.84 -48.65 80.84 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.07 -1.019 . . . . 1.29 110.986 179.367 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -62.01 -38.64 89.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 1.52 110.949 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -66.36 -47.98 71.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.899 -1.126 . . . . 1.3 110.319 179.486 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.7 mt -58.33 -46.48 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.968 -1.082 . . . . 0.61 109.991 179.381 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.99 -40.94 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.45 -0.781 . . . . 0.78 110.354 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.43 -46.93 88.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 0.82 111.033 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.8 -42.98 94.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.087 -1.008 . . . . 0.8 110.511 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.8 mt -61.84 -46.77 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.982 . . . . 0.77 110.029 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -82.14 -37.87 25.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 2.12 111.82 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 91' ' ' ALA . 56.3 t0 -81.58 -45.74 15.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.696 -1.253 . . . . 1.51 111.994 -178.681 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -100.01 8.81 43.74 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.991 -1.068 . . . . 1.98 112.61 -178.78 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.0 m170 50.88 50.21 19.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.959 -1.088 . . . . 1.32 111.816 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.9 mtt -107.72 151.45 25.67 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.442 -0.786 . . . . 1.38 109.734 179.486 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.5 p -70.43 163.34 26.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.729 -0.607 . . . . 0.67 109.97 178.351 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.79 -42.29 88.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.933 . . . . 0.52 110.698 178.825 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.518 ' OD2' HD21 ' A' ' 142' ' ' LEU . 84.3 m-20 -67.93 -41.43 82.6 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.042 -1.036 . . . . 2.25 110.205 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.22 -50.87 51.21 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.634 -0.666 . . . . 0.64 111.344 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.71 94.89 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.033 -1.042 . . . . 0.56 110.314 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -43.74 95.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 0.46 110.669 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -61.28 -39.75 91.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 1.32 111.309 -179.481 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -57.63 -49.84 75.12 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.852 -1.155 . . . . 1.3 110.795 179.46 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.14 -46.06 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.047 -1.033 . . . . 0.61 109.974 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -64.93 -31.96 56.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.871 -0.518 . . . . 0.65 110.418 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.21 -41.0 71.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.181 -0.949 . . . . 2.11 110.7 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.01 -30.93 18.97 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 119.142 -1.504 . . . . 0.83 112.452 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -61.21 -39.69 91.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.516 -1.579 . . . . 1.28 109.903 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.14 -48.91 40.07 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.323 0.582 . . . . 0.89 110.755 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.8 t -60.05 -40.34 89.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.319 -0.863 . . . . 1.87 110.433 -178.385 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.07 99.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.382 -0.824 . . . . 1.05 110.745 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.55 -30.11 70.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.814 -1.179 . . . . 1.02 110.733 -179.866 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -66.24 -20.14 66.03 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.78 -1.2 . . . . 2.04 111.039 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.37 -18.77 63.06 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.351 -0.94 . . . . 1.73 110.827 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 15.0 mt -88.88 136.49 32.98 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.843 -1.169 . . . . 1.37 107.843 178.722 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -100.59 42.92 1.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.272 -0.893 . . . . 2.88 111.272 -179.583 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -111.85 142.31 44.39 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.164 -0.96 . . . . 1.58 109.456 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -58.8 -39.27 80.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.228 -0.92 . . . . 3.04 110.797 178.815 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -71.87 -50.58 28.19 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.851 -1.156 . . . . 0.9 109.875 179.568 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt -67.5 -43.28 81.28 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.386 -0.821 . . . . 1.06 110.118 -178.747 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -61.25 -47.87 84.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.16 -0.962 . . . . 2.18 109.787 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.91 -30.92 69.36 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.505 -0.878 . . . . 2.15 109.635 179.594 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 130' ' ' VAL . 57.0 ttt180 -61.68 -30.43 70.73 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.092 0.949 . . . . 2.33 108.696 179.289 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -49.86 74.56 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.071 0.939 . . . . 0.82 109.537 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.65 -43.34 80.52 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.598 0.713 . . . . 0.85 110.078 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -63.21 -33.51 75.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.623 -0.673 . . . . 1.39 110.573 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 126' ' ' ARG . 21.9 t -70.0 -39.28 77.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.472 -0.767 . . . . 0.56 110.105 179.561 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -59.26 -39.92 84.39 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.822 -1.151 . . . . 3.12 109.752 178.653 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.441 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 51.3 t0 -60.12 -40.8 90.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.588 -0.695 . . . . 1.28 110.059 179.437 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.7 mt -61.77 -39.07 82.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.062 -1.023 . . . . 0.49 110.116 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.35 -46.51 20.18 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.655 -1.259 . . . . 0.46 110.486 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -56.62 -41.63 77.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.559 -0.965 . . . . 2.71 110.079 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.443 HH11 ' HG2' ' A' ' 136' ' ' ARG . 40.7 mtt-85 -60.19 -41.52 93.11 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.003 -1.061 . . . . 2.14 109.832 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.9 tp -60.22 -42.78 95.9 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.318 -0.953 . . . . 1.05 109.358 179.462 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.4 mt -59.84 -47.31 86.24 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.828 -0.545 . . . . 0.52 109.949 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -59.88 -35.4 74.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 2.35 111.017 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -73.99 -41.5 61.81 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.026 -1.046 . . . . 1.39 110.684 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.57 -38.89 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -0.925 . . . . 0.68 110.462 -178.388 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.518 HD21 ' OD2' ' A' ' 101' ' ' ASP . 89.7 mt -89.07 -6.96 56.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.093 -1.004 . . . . 0.83 112.099 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.47 30.0 67.31 Favored Glycine 0 N--CA 1.482 1.746 0 C-N-CA 120.065 -1.064 . . . . 0.91 112.075 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.94 148.23 44.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.686 -0.891 . . . . 0.95 109.844 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -68.01 141.29 56.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 2.43 109.27 178.095 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.91 131.5 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.202 -1.036 . . . . 1.1 108.202 178.463 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.775 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.1 mp -77.02 131.02 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.408 -0.808 . . . . 1.58 108.928 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.9 97.93 11.27 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.466 -1.679 . . . . 1.62 106.466 178.623 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.57 ' O ' HD13 ' A' ' 152' ' ' ILE . 77.2 mt -78.84 -6.0 54.91 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 112.72 0.637 . . . . 0.8 112.72 -177.855 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.8 p -88.85 -2.59 58.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.903 -1.123 . . . . 1.56 112.745 -179.123 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -106.17 36.68 2.5 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.147 -0.97 . . . . 0.84 112.414 -177.8 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.5 mp -72.72 139.89 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.575 -1.328 . . . . 0.82 109.406 178.493 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -118.86 -16.73 9.25 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.706 0.765 . . . . 2.31 112.408 -179.097 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -116.03 138.47 51.19 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.771 -1.196 . . . . 1.54 107.771 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -76.12 121.39 22.75 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.284 -1.006 . . . . 1.38 108.284 178.598 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 m -146.28 174.03 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.493 -0.755 . . . . 0.69 109.144 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.7 mt -87.89 140.76 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.53 109.143 178.02 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 42.5 tp -94.8 124.15 38.67 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.98 -1.075 . . . . 0.64 108.183 178.242 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.97 129.18 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 107.604 -1.258 . . . . 0.67 107.604 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.36 153.98 22.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 0.78 108.943 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.65 -34.38 76.96 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.607 -1.308 . . . . 1.0 109.213 178.103 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -173.8 149.77 1.6 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.236 -0.653 . . . . 2.42 109.236 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 58.9 mt -116.03 136.32 53.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.601 -1.259 . . . . 0.75 107.601 177.337 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.9 p -92.2 150.15 39.8 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.164 -0.96 . . . . 0.78 108.786 179.069 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -39.49 -44.38 3.09 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.886 1.724 . . . . 0.67 113.441 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.8 m -58.92 -50.06 75.47 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.835 -1.166 . . . . 0.7 111.014 -179.501 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -62.99 -40.07 96.66 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.253 -0.904 . . . . 1.21 110.212 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 73.0 p -68.58 -39.2 81.07 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.334 -0.854 . . . . 0.6 110.327 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.5 78.17 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.595 -0.842 . . . . 0.62 110.638 179.268 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -94.88 -2.37 50.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.111 -0.993 . . . . 1.16 113.226 -179.014 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.94 149.94 46.14 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.904 -1.123 . . . . 0.73 109.14 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.453 ' O ' HG23 ' A' ' 176' ' ' VAL . 57.5 t-20 -95.63 104.63 16.55 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.056 -1.831 . . . . 2.24 106.056 177.813 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.609 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.6 mp -72.2 -18.3 61.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 1.43 112.054 -177.57 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -77.97 -27.45 49.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.203 -0.936 . . . . 2.15 111.45 -178.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -100.11 6.07 44.91 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.284 -0.885 . . . . 2.04 112.362 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 178' ' ' GLY . 91.5 t -109.75 129.84 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.962 -1.125 . . . . 0.55 107.962 179.683 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 48.9 tp -81.85 -15.47 53.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.815 . . . . 1.63 112.288 -179.068 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.525 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 173.29 179.91 44.27 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.472 -1.451 . . . . 0.47 109.472 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -131.68 138.24 48.63 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.533 -1.284 . . . . 0.54 107.533 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.9 mt -138.21 119.03 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.424 -1.695 . . . . 0.69 106.424 178.524 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 203' ' ' VAL . 60.0 p -132.1 164.53 26.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.087 -1.008 . . . . 0.82 108.952 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 208' ' ' VAL . 1.9 m-20 -104.82 15.98 26.83 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.577 -0.702 . . . . 2.37 112.329 179.047 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -134.12 -51.17 0.82 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 120.808 -1.182 . . . . 1.11 114.0 -177.712 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.54 153.74 0.29 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.199 -1.0 . . . . 1.67 110.84 -176.421 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 152.65 -61.31 0.39 Allowed Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.156 -1.021 . . . . 1.54 112.295 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.83 77.37 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.061 -1.258 . . . . 4.48 109.023 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.6 p 53.67 40.75 31.86 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.672 -0.811 . . . . 2.63 111.596 -178.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 38.5 t -79.74 153.99 28.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.816 . . . . 1.69 109.559 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -59.0 -39.91 83.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.859 . . . . 1.07 110.893 178.948 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 33.6 p -56.42 -40.89 75.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 1.58 110.732 179.417 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 82.2 p -62.3 -37.95 87.49 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.066 -1.021 . . . . 1.6 110.485 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.83 -38.7 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.383 -0.823 . . . . 1.45 110.73 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.7 mtp -61.75 -44.86 96.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.84 -1.162 . . . . 1.05 108.905 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.95 -48.6 81.05 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.116 -0.947 . . . . 0.72 111.029 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.47 HH11 ' HG2' ' A' ' 195' ' ' ARG . 23.7 mtt-85 -60.81 -43.48 98.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.099 -1.001 . . . . 3.05 110.751 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 41.5 m -69.88 -41.04 75.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.443 -0.786 . . . . 0.89 110.306 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 13.3 mt -91.75 -6.84 51.19 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.623 0.725 . . . . 0.78 112.284 -178.221 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.5 mt-10 45.52 18.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.529 0.937 . . . . 1.45 113.529 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 18.6 mt -71.84 142.25 85.45 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.953 -1.092 . . . . 0.67 108.372 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -56.24 130.36 39.75 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.678 1.585 . . . . 0.64 110.357 178.475 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.05 175.88 9.05 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 117.911 -1.516 . . . . 0.67 111.517 179.555 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.2 mt -146.63 157.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.632 -1.247 . . . . 0.69 107.632 178.467 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 183' ' ' ALA . 4.6 m -141.8 -23.62 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 120.818 -1.176 . . . . 0.85 113.286 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -104.25 42.3 1.93 Allowed Glycine 0 N--CA 1.503 3.136 0 N-CA-C 110.637 -0.985 . . . . 0.92 110.637 -178.563 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 36.3 p -59.86 -20.76 58.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.056 -1.261 . . . . 0.95 111.841 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.22 -85.37 0.61 Allowed Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.18 -1.01 . . . . 1.04 111.437 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 58.8 p -134.66 32.11 3.32 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 121.008 -1.29 . . . . 1.57 113.331 -178.592 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.527 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 60.2 t -58.84 -34.15 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.223 -1.548 . . . . 0.84 111.076 179.451 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 43.8 p -64.12 -21.73 66.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.835 -1.165 . . . . 0.99 112.199 -179.628 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 53.8 p -96.32 3.16 53.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.943 -1.098 . . . . 1.7 112.339 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -129.76 4.12 4.98 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.684 -0.635 . . . . 2.2 112.691 -178.567 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.1 t -123.04 152.92 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.404 -0.81 . . . . 0.84 109.768 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -118.48 156.76 28.51 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.096 -1.076 . . . . 2.2 108.096 178.032 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.513 ' ND2' ' OD1' ' A' ' 215' ' ' ASP . 46.7 t30 -54.8 139.97 37.89 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.052 -1.03 . . . . 2.28 110.119 178.257 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.513 ' OD1' ' ND2' ' A' ' 214' ' ' ASN . 1.2 m-20 79.56 5.36 2.06 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.281 1.215 . . . . 2.35 114.281 179.58 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -63.39 148.63 47.93 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.385 -0.969 . . . . 1.97 108.385 177.538 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -89.64 119.96 30.51 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.583 -1.636 . . . . 2.65 106.583 178.118 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.416 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 86.7 mt -128.26 146.36 50.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.585 -0.697 . . . . 0.63 109.86 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 47.0 mt -112.13 124.19 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.691 -1.596 . . . . 0.62 106.691 177.519 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.0 tp -97.21 111.58 23.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.981 -1.859 . . . . 0.64 105.981 178.117 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.6 t0 -89.72 -28.95 19.07 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.718 -1.239 . . . . 2.05 111.549 -178.423 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.81 10.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 113.285 0.846 . . . . 0.84 113.285 -179.653 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.625 ' N ' ' O ' ' A' ' 221' ' ' ASP . 39.3 t -110.57 -56.44 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.987 -1.071 . . . . 1.02 109.173 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -92.57 8.87 37.04 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.297 1.046 . . . . 2.51 110.271 -179.097 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 60.51 49.97 6.25 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.026 -0.988 . . . . 1.54 111.632 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -148.47 149.55 31.86 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.608 1.194 . . . . 1.95 109.93 178.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.66 135.03 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.653 -1.239 . . . . 0.71 107.653 177.822 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -100.5 130.26 46.55 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.968 -1.123 . . . . 1.01 107.968 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.31 130.01 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.784 -0.821 . . . . 0.82 108.784 179.094 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.412 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 44.2 t-20 49.93 50.59 9.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 113.426 0.898 . . . . 1.54 113.426 178.763 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.7 Cg_endo -69.02 150.29 72.56 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.366 2.044 . . . . 0.94 110.701 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.1 p -73.83 160.29 31.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 1.8 109.821 178.215 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.72 -36.61 72.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.486 -0.759 . . . . 2.73 111.105 179.021 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -59.59 -41.22 89.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 3.17 110.122 179.321 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -71.39 -40.24 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.47 -0.769 . . . . 1.34 110.115 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.606 ' CG2' HH12 ' A' ' 240' ' ' ARG . 87.6 mt -60.53 -47.02 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.391 -0.818 . . . . 1.2 110.322 -178.549 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.12 -39.86 87.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.047 -1.033 . . . . 2.7 110.303 179.591 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -60.61 -40.96 93.78 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.558 -0.713 . . . . 2.59 110.063 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 72.8 mtp -72.15 -38.32 69.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.041 -1.037 . . . . 1.38 110.94 -179.577 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.606 HH12 ' CG2' ' A' ' 236' ' ' ILE . 0.0 OUTLIER -57.45 -42.16 81.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.128 -0.982 . . . . 2.84 110.891 179.946 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.54 -50.41 21.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 1.88 110.585 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 90.1 t -63.89 -46.69 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.343 -0.848 . . . . 2.4 110.934 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.78 -51.48 69.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.075 -1.015 . . . . 3.52 111.318 -179.716 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -62.58 -33.7 75.48 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.124 -0.985 . . . . 1.88 110.363 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -61.12 -30.27 70.27 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.992 -1.083 . . . . 3.01 109.641 179.129 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.46 -40.71 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.894 -0.723 . . . . 2.45 109.949 179.342 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.79 87.78 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.583 -0.847 . . . . 2.75 110.181 179.619 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.2 p -71.77 -44.67 63.62 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.294 -0.879 . . . . 3.16 110.91 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -63.48 -32.54 74.02 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.656 -0.652 . . . . 3.57 110.661 -177.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -67.8 -28.76 67.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -0.952 . . . . 4.3 111.007 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.81 98.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 4.45 110.106 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -70.15 -37.7 75.31 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.322 -0.861 . . . . 5.97 110.303 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 35.0 tp -69.3 -26.41 64.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.617 -0.677 . . . . 6.18 111.302 -179.407 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -69.17 -6.76 30.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.377 -0.827 . . . . 6.66 113.17 -179.56 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -69.67 -30.71 68.45 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.035 -1.041 . . . . 8.2 110.917 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 86.2 mt -87.13 -10.89 51.65 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.942 -1.099 . . . . 8.07 112.607 -179.52 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -93.52 33.8 1.23 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.984 -1.073 . . . . 9.45 112.297 -178.544 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -88.88 2.92 52.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.938 -1.101 . . . . 10.12 112.353 179.775 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.977 -1.011 . . . . 11.49 108.936 179.998 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.218 -0.66 . . . . 3.07 109.218 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.1 mt -99.24 109.7 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 106.41 -1.7 . . . . 1.07 106.41 177.669 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -105.02 120.52 41.68 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.744 -1.206 . . . . 1.24 107.744 -179.418 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.6 -160.37 26.9 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.179 -1.568 . . . . 1.01 109.179 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 5' ' ' ILE . 74.9 mt -96.05 -0.18 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.419 -1.047 . . . . 1.11 112.343 -179.295 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.7 tp 49.24 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.99 112.656 178.577 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.76 -43.55 11.8 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.933 -1.105 . . . . 0.85 111.562 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -141.33 143.51 30.62 Favored Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 107.72 -1.215 . . . . 1.38 107.72 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.32 146.55 22.28 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.616 2.211 . . . . 0.94 112.634 178.665 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.896 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.39 177.98 27.46 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 108.866 -1.694 . . . . 0.81 108.866 177.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.9 mt -134.67 140.04 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.041 -1.27 . . . . 0.83 108.345 179.612 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.54 ' HB1' HD22 ' A' ' 177' ' ' LEU . . . -144.94 158.03 43.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -0.984 . . . . 0.53 109.451 178.177 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 11.5 m-85 -127.75 140.54 52.0 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.769 -1.197 . . . . 0.77 107.769 178.223 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.23 166.02 34.41 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 118.38 -1.867 . . . . 0.51 110.411 178.141 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -78.11 158.08 29.25 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.402 -0.962 . . . . 1.9 108.402 178.556 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.16 130.96 35.15 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.743 -0.836 . . . . 0.66 108.743 178.103 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.2 tp -113.35 103.78 11.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 105.604 -1.998 . . . . 0.83 105.604 178.113 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.482 ' O ' ' ND2' ' A' ' 214' ' ' ASN . 13.8 tp -91.84 139.05 31.04 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.66 -0.867 . . . . 0.86 108.66 -179.575 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.2 mt -99.39 120.9 40.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.293 -1.373 . . . . 0.92 107.293 178.318 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -111.12 138.96 46.9 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.995 -1.113 . . . . 2.03 107.995 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -119.78 140.29 50.98 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.172 -0.955 . . . . 2.66 109.245 178.446 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -85.02 133.36 34.25 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.727 -1.212 . . . . 2.32 107.727 177.324 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -60.74 149.1 36.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.07 -1.019 . . . . 2.11 108.732 178.484 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.8 mt -96.99 134.17 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.027 -1.046 . . . . 0.73 108.263 178.325 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.74 129.67 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.586 -1.264 . . . . 0.87 107.586 178.531 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.0 mt -100.62 137.74 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.145 -1.058 . . . . 0.81 108.145 179.546 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -94.33 120.74 35.01 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.324 -0.991 . . . . 1.34 108.324 178.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -94.55 15.13 18.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.393 -0.817 . . . . 2.89 112.805 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.98 147.31 53.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.382 -0.824 . . . . 2.09 109.264 178.692 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -88.1 139.42 30.52 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.618 -0.882 . . . . 2.19 108.618 177.718 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 pt -99.77 164.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.857 -1.152 . . . . 0.75 109.912 179.088 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.0 p -93.87 165.95 12.42 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.386 -0.821 . . . . 0.91 109.698 178.472 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -21.24 14.4 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.4 -0.812 . . . . 0.93 112.154 179.242 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -68.15 -39.1 82.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.063 -1.023 . . . . 2.28 110.873 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -91.02 -7.4 52.01 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.814 -1.179 . . . . 1.45 112.744 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.22 -47.44 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.526 -1.358 . . . . 0.81 110.788 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -59.24 -39.15 81.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.124 -0.985 . . . . 1.54 109.972 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -61.36 -37.92 85.1 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.705 -0.798 . . . . 2.36 110.825 179.463 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -59.91 -40.86 90.25 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.17 -1.012 . . . . 1.31 110.639 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.24 -41.77 88.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.165 -0.959 . . . . 0.82 110.504 179.798 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -62.73 -41.39 99.15 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.78 -1.2 . . . . 1.5 110.358 179.821 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -61.05 -41.08 95.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 2.23 110.616 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -75.37 -54.11 7.6 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.844 -1.16 . . . . 0.85 110.463 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.2 tp -57.55 -47.8 81.07 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.721 0.772 . . . . 0.91 110.674 -179.449 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.519 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.0 t -69.06 -40.05 78.75 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.833 0.825 . . . . 0.9 110.346 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.91 -44.6 92.44 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 109.811 -1.316 . . . . 0.69 109.811 179.298 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -60.67 -28.91 68.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.779 -0.836 . . . . 2.88 110.251 179.269 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.5 -49.34 77.7 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.834 0.826 . . . . 0.85 110.604 179.072 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -81.77 -38.62 25.37 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.337 -0.852 . . . . 2.35 110.668 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.6 -42.36 92.42 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.614 -0.834 . . . . 0.65 109.925 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 m -62.08 -39.92 94.06 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.985 0.898 . . . . 1.45 109.582 179.668 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.45 88.83 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.723 -0.791 . . . . 0.63 109.879 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.52 -50.44 69.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.99 -1.069 . . . . 1.34 109.998 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.45 -40.33 94.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.941 -1.1 . . . . 1.56 109.832 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -59.33 -39.89 84.55 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.393 -0.817 . . . . 1.19 110.226 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -62.91 -43.41 98.87 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.388 -0.82 . . . . 0.72 110.277 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.23 -34.43 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.078 -1.014 . . . . 0.62 110.279 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -53.3 -45.55 69.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.45 -0.781 . . . . 1.05 110.877 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -68.87 -39.93 79.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.206 -0.934 . . . . 0.64 109.778 -179.708 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -61.78 -37.58 84.87 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.128 -1.029 . . . . 1.73 109.139 179.675 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.95 79.44 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.308 -0.557 . . . . 0.56 110.193 179.197 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.82 -35.21 16.65 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.8 -1.191 . . . . 0.69 111.267 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -79.9 -25.7 40.48 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.956 -1.32 . . . . 1.48 110.709 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.2 m -86.93 -50.97 6.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.729 -0.607 . . . . 0.98 110.287 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -105.92 -6.14 19.1 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 114.079 1.14 . . . . 1.16 114.079 -177.412 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.57 164.3 27.22 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 120.228 -0.986 . . . . 0.85 112.447 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -56.38 -23.24 36.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.852 -0.793 . . . . 3.86 112.645 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -57.9 -39.0 76.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.356 -1.465 . . . . 2.35 110.515 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -86.99 -25.27 24.36 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.216 -0.928 . . . . 1.67 111.746 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.42 -39.97 85.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.219 -0.925 . . . . 1.45 110.776 -179.424 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.21 84.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.496 -0.752 . . . . 0.61 111.286 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.2 mt -65.41 -44.75 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.622 -1.299 . . . . 0.65 110.649 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -69.87 -31.55 69.44 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.841 -1.162 . . . . 0.66 110.698 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -59.98 -39.33 85.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.064 -1.023 . . . . 1.19 110.94 179.32 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.93 -40.36 93.48 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.535 -1.317 . . . . 0.53 110.863 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -59.35 -40.78 87.5 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.084 -1.245 . . . . 1.27 110.616 179.638 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.7 mt -60.82 -37.55 76.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.202 -0.936 . . . . 0.54 110.497 179.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 26.3 ttt -58.64 -38.89 79.07 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.703 -0.799 . . . . 1.74 110.449 179.28 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.05 -49.43 77.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.949 -1.094 . . . . 0.55 110.879 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.6 tp -61.35 -38.81 88.3 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.21 -0.931 . . . . 0.47 110.252 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -86.34 7.65 24.68 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.175 0.806 . . . . 1.42 113.175 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -67.43 116.16 7.87 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 120.793 -1.192 . . . . 1.27 108.655 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -64.37 -20.23 65.99 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.626 0.727 . . . . 1.35 110.946 -179.226 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -71.64 -47.98 50.85 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.991 -1.083 . . . . 2.22 110.364 179.392 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.32 -38.4 89.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.395 -0.816 . . . . 0.62 110.521 -178.544 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -59.54 -41.76 90.81 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.008 -1.058 . . . . 1.29 110.515 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.17 -39.23 85.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.941 -1.099 . . . . 1.52 110.582 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -66.62 -48.06 70.65 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.106 -1.037 . . . . 1.3 110.448 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.59 -43.48 83.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.936 -1.102 . . . . 0.61 110.01 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.73 -44.04 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 0.78 110.685 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.74 -40.89 96.69 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.247 -0.908 . . . . 0.82 110.856 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.0 mt -60.39 -44.77 95.34 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.496 -1.377 . . . . 0.8 110.418 -179.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.64 -47.64 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.907 -1.121 . . . . 0.77 110.812 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -79.75 -35.48 38.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.004 -1.06 . . . . 2.12 111.665 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.78 -43.34 22.67 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.02 -1.05 . . . . 1.51 111.312 -179.001 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -101.13 4.55 42.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.047 -1.033 . . . . 1.98 112.251 -177.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.1 m80 51.48 49.35 21.13 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.238 -0.914 . . . . 1.32 111.646 -179.43 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 70.3 mtm -110.04 157.89 18.85 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.494 -0.754 . . . . 1.38 109.558 178.738 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.8 p -71.51 162.46 29.41 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.296 0.569 . . . . 0.67 110.403 178.247 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.67 -41.11 97.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.53 -0.731 . . . . 0.52 110.827 179.149 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 31.8 p-10 -69.59 -38.59 77.39 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.196 -0.94 . . . . 2.25 109.978 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.527 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -71.27 -52.89 16.43 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.831 -1.148 . . . . 0.64 110.872 179.363 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.25 88.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.56 110.604 -179.349 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.25 93.46 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.026 -0.67 . . . . 0.46 110.878 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -59.76 -41.31 90.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.843 -1.16 . . . . 1.32 111.039 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -56.14 -47.57 77.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.235 -1.54 . . . . 1.3 110.73 179.658 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.53 -44.18 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.548 -1.345 . . . . 0.61 110.22 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.79 -32.31 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.282 -0.886 . . . . 0.65 110.071 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.22 -39.93 92.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.12 -0.987 . . . . 2.11 111.022 179.308 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.9 -30.4 29.11 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.079 -1.534 . . . . 0.83 112.795 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -60.57 -39.68 88.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 119.675 -2.073 . . . . 1.28 109.858 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.53 -48.04 43.45 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.638 0.733 . . . . 0.89 109.696 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.3 p -60.81 -39.73 90.04 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.704 -0.798 . . . . 1.87 110.063 -178.649 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.24 -46.45 89.74 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.954 -1.091 . . . . 1.05 110.821 179.535 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.3 mt -65.44 -29.54 70.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.699 -1.25 . . . . 1.02 111.09 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -64.31 -21.39 66.59 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.975 -1.078 . . . . 2.04 111.426 179.549 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -71.83 -15.51 62.14 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.763 0.792 . . . . 1.73 110.923 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.509 HD13 HD13 ' A' ' 123' ' ' LEU . 36.8 mt -86.9 141.55 28.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.953 -0.758 . . . . 1.37 108.953 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -97.56 41.58 1.12 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.987 -1.071 . . . . 2.88 111.853 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -114.48 140.88 48.37 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.305 -0.872 . . . . 1.58 109.391 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -59.05 -39.39 81.89 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.338 -0.851 . . . . 3.04 111.515 178.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -72.68 -53.01 12.91 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 0.9 110.313 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.509 HD13 HD13 ' A' ' 118' ' ' LEU . 26.4 mt -61.42 -41.32 96.97 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.107 -0.995 . . . . 1.06 110.394 -179.547 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -63.16 -49.05 75.85 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.276 1.036 . . . . 2.18 109.563 179.758 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -63.2 -29.93 71.18 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.092 -1.043 . . . . 2.15 109.968 179.776 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 130' ' ' VAL . 15.2 ttt-85 -60.82 -30.47 70.1 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.741 0.782 . . . . 2.33 108.951 178.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.25 87.28 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.155 0.979 . . . . 0.82 109.001 178.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -43.65 80.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.739 -0.784 . . . . 0.85 109.981 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -64.57 -33.17 75.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.492 -0.755 . . . . 1.39 110.616 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 126' ' ' ARG . 24.5 t -68.19 -39.63 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 0.56 109.834 179.377 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -58.91 -39.67 82.22 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.087 -1.045 . . . . 3.12 109.896 178.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -59.35 -38.86 81.48 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.21 -0.45 . . . . 1.28 110.544 179.299 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 54.1 mt -60.72 -40.29 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.673 -1.267 . . . . 0.49 110.116 179.496 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.19 -36.65 60.01 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.395 -1.082 . . . . 0.46 110.395 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -56.63 -48.65 77.05 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.547 -0.972 . . . . 2.71 110.66 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -63.38 -41.03 98.77 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.013 -1.075 . . . . 2.14 110.169 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.9 tp -59.76 -40.37 87.94 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.69 -0.631 . . . . 1.05 110.301 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.2 mt -59.24 -44.3 92.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.094 -1.004 . . . . 0.52 110.463 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -60.62 -33.24 72.48 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.146 -0.971 . . . . 2.35 111.181 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -75.74 -41.4 53.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.909 -1.119 . . . . 1.39 110.867 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.1 mt -60.14 -38.6 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.969 -1.082 . . . . 0.68 110.571 -178.45 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.0 mt -85.35 -7.11 59.14 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.457 -0.777 . . . . 0.83 111.764 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.81 16.42 80.78 Favored Glycine 0 N--CA 1.483 1.82 0 C-N-CA 120.319 -0.943 . . . . 0.91 112.454 -179.666 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.27 149.28 48.37 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.769 -0.842 . . . . 0.95 109.688 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -65.66 150.83 47.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.528 -0.732 . . . . 2.43 109.695 178.259 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.2 mt -104.02 138.43 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.177 -0.952 . . . . 1.1 108.711 178.602 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 mp -82.72 118.84 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.439 -1.319 . . . . 1.58 107.439 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -100.81 102.62 13.74 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.965 -1.865 . . . . 1.62 105.965 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 70.1 mt -74.86 -14.79 60.71 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.563 -0.855 . . . . 0.8 111.505 -178.425 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.2 m -80.09 2.41 24.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.414 -0.804 . . . . 1.56 112.852 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -93.94 21.17 6.92 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.67 0.747 . . . . 0.84 112.325 -179.226 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.2 mt -73.15 140.22 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.811 -0.556 . . . . 0.82 109.672 179.57 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -117.46 -16.37 10.21 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.224 1.011 . . . . 2.31 112.468 -178.715 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -118.03 139.39 51.27 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.288 -1.004 . . . . 1.54 108.288 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -70.87 128.7 36.89 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.826 -1.171 . . . . 1.38 108.294 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.1 m -146.57 175.42 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.92 -0.77 . . . . 0.69 108.92 -179.788 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.28 140.65 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.884 -1.135 . . . . 0.53 108.757 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.6 tp -96.66 123.36 40.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.807 -1.183 . . . . 0.64 108.626 178.271 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.23 130.7 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.431 -0.951 . . . . 0.67 108.431 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 152.01 16.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -0.86 . . . . 0.78 109.157 178.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.42 -34.19 74.97 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.897 -1.127 . . . . 1.0 109.344 178.055 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -171.53 153.06 3.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.77 -0.826 . . . . 2.42 108.77 179.455 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 68.9 mt -118.95 142.86 47.4 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.437 -0.79 . . . . 0.75 109.214 177.225 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.4 p -91.81 146.91 33.91 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.275 -0.89 . . . . 0.78 109.071 179.185 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -41.15 -39.23 3.6 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.464 1.443 . . . . 0.67 113.537 178.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.1 m -61.37 -50.17 73.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.764 -1.21 . . . . 0.7 110.208 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.22 -39.13 93.76 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.41 0.624 . . . . 1.21 110.327 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 56.5 p -68.44 -40.03 81.31 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.285 -0.884 . . . . 0.6 110.678 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.78 84.05 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.123 -0.985 . . . . 0.62 110.338 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -94.32 1.85 55.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.791 -1.193 . . . . 1.16 112.991 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.7 149.6 34.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.0 -1.063 . . . . 0.73 109.037 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.02 116.62 29.23 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.621 -1.622 . . . . 2.24 106.621 177.755 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.3 mt -75.66 -13.67 60.33 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.353 0.597 . . . . 1.43 111.717 -177.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -85.76 -22.16 27.86 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.319 0.581 . . . . 2.15 112.072 -179.118 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -102.73 -2.41 28.2 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.884 0.698 . . . . 2.04 112.884 -178.165 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.7 t -112.15 130.04 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 107.65 -1.241 . . . . 0.55 107.65 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.71 ' O ' HD23 ' A' ' 177' ' ' LEU . 1.7 tt -92.96 -11.11 34.09 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.239 1.019 . . . . 1.63 111.735 -179.208 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.89 173.67 42.66 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 109.537 -1.425 . . . . 0.47 109.537 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -126.2 132.49 51.75 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.992 -1.299 . . . . 0.54 107.61 179.17 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.452 HG22 HG21 ' A' ' 205' ' ' THR . 75.0 mt -132.48 106.86 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 106.133 -1.803 . . . . 0.69 106.133 178.366 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.563 ' O ' HG23 ' A' ' 205' ' ' THR . 71.7 p -129.31 170.21 13.9 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 120.497 -1.377 . . . . 0.82 110.018 -178.818 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 20.9 p-10 -99.01 53.23 0.97 Allowed 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 120.118 -0.633 . . . . 2.37 110.881 179.433 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.33 156.14 17.78 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 108.887 -0.783 . . . . 1.11 108.887 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.59 -3.39 58.45 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.431 -1.366 . . . . 1.67 112.821 179.452 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 77.2 -40.22 1.7 Allowed Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.444 -1.36 . . . . 1.54 113.967 179.624 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.49 HH11 ' HG2' ' A' ' 186' ' ' ARG . 14.5 ttt-85 -61.31 127.06 29.69 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.996 -1.297 . . . . 4.48 109.019 179.037 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 10.5 p 46.38 28.94 0.78 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -0.859 . . . . 2.63 112.245 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 42.4 t -83.07 130.04 35.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.922 -1.111 . . . . 1.69 108.089 178.16 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -59.37 -40.74 87.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -0.925 . . . . 1.07 110.625 179.295 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -61.28 -40.72 95.2 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.631 -1.293 . . . . 1.58 110.258 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 91.6 p -60.81 -36.16 78.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.231 -0.918 . . . . 1.6 110.455 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.84 -38.29 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.191 -0.943 . . . . 1.45 110.186 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 67.1 mtp -63.18 -41.85 99.28 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.09 -1.006 . . . . 1.05 109.639 179.392 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.06 -47.13 86.35 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.491 0.662 . . . . 0.72 111.14 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -59.99 -42.6 94.58 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.065 -1.022 . . . . 3.05 110.623 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 31.5 m -70.18 -41.0 74.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.89 110.007 179.788 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -90.44 -9.3 47.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.522 -0.736 . . . . 0.78 111.841 -178.085 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 194' ' ' ALA . 54.3 mt-10 51.38 12.71 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 114.013 1.116 . . . . 1.45 114.013 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 42.9 mt -70.5 162.03 73.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.902 -1.124 . . . . 0.67 108.64 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -68.88 140.67 46.7 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.345 1.363 . . . . 0.64 110.59 178.381 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.82 167.88 27.14 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 117.338 -1.745 . . . . 0.67 110.268 178.727 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 203' ' ' VAL . 75.6 mt -143.48 157.57 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.257 -1.386 . . . . 0.69 107.257 178.213 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.0 m -138.59 -29.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.868 -1.145 . . . . 0.85 112.736 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.25 44.69 2.69 Favored Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.273 -0.892 . . . . 0.92 111.555 -178.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 181' ' ' THR . 33.5 p -66.31 -18.61 65.46 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.961 -1.317 . . . . 0.95 110.841 -179.167 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.35 -94.91 0.74 Allowed Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.51 -1.328 . . . . 1.04 110.123 179.727 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.5 t -126.43 28.19 6.02 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.304 -1.115 . . . . 1.57 112.623 -178.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 84.6 t -59.05 -35.23 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.33 -1.482 . . . . 0.84 110.592 179.323 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.4 p -55.31 -25.24 33.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.058 -1.026 . . . . 0.99 111.378 -179.856 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t -93.89 1.05 56.45 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.141 -0.974 . . . . 1.7 111.992 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -121.03 -6.1 9.51 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.18 0.808 . . . . 2.2 113.18 -178.053 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 29.8 t -114.94 150.15 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.705 -0.622 . . . . 0.84 109.509 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -124.32 160.61 27.66 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.741 -1.207 . . . . 2.2 107.741 177.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 10.2 m120 -54.79 140.88 34.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.581 -1.324 . . . . 2.28 110.981 178.541 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.5 m-20 79.03 4.9 2.33 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 114.73 1.381 . . . . 2.35 114.73 179.173 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -65.26 142.55 58.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.702 -1.248 . . . . 1.97 108.479 177.528 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -85.94 115.68 23.71 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.584 -1.265 . . . . 2.65 107.584 177.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 75.9 mt -125.19 143.61 50.85 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.767 0.794 . . . . 0.63 109.849 -178.642 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.2 mt -112.64 128.86 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 106.545 -1.65 . . . . 0.62 106.545 177.622 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.6 tp -103.55 114.48 28.79 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 105.954 -1.869 . . . . 0.64 105.954 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 223' ' ' VAL . 40.8 t0 -90.5 -25.06 20.47 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.945 -1.097 . . . . 2.05 112.704 -177.857 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.896 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.56 14.12 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 113.128 0.788 . . . . 0.84 113.128 -179.051 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 221' ' ' ASP . 34.3 t -110.95 -61.24 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.054 -1.028 . . . . 1.02 109.332 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -89.91 9.28 28.28 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.238 1.018 . . . . 2.51 110.446 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 61.64 51.64 3.91 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.389 -0.823 . . . . 1.54 112.171 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -146.79 151.61 37.41 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.254 1.026 . . . . 1.95 109.789 179.025 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.56 139.09 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.54 -1.282 . . . . 0.71 107.54 177.412 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.76 130.48 49.73 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.06 -1.025 . . . . 1.01 108.292 178.553 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.05 129.57 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.205 -1.035 . . . . 0.82 108.205 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.434 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 10.9 t-20 52.24 51.29 9.42 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 113.365 0.876 . . . . 1.54 113.365 179.128 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.2 Cg_endo -63.48 149.42 91.11 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.367 2.044 . . . . 0.94 111.2 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.7 m -74.41 152.29 39.52 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.055 -1.028 . . . . 1.8 109.098 177.464 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.82 -36.51 76.93 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.162 -0.961 . . . . 2.73 110.302 178.73 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -59.45 -39.83 84.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.674 -0.641 . . . . 3.17 110.293 179.362 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 98.5 t -71.69 -42.93 70.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.887 -1.133 . . . . 1.34 109.867 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.584 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 89.5 mt -58.54 -47.8 87.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.419 -0.912 . . . . 1.2 110.356 -179.033 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.81 -42.15 92.82 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.184 -0.948 . . . . 2.7 110.631 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -61.52 -45.05 95.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.29 -0.881 . . . . 2.59 110.079 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.464 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 90.6 mtp -70.26 -38.03 75.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.398 -0.814 . . . . 1.38 111.046 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -53.36 -42.18 66.57 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.822 -1.174 . . . . 2.84 110.767 -179.897 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.22 -59.99 2.55 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.163 -0.961 . . . . 1.88 110.691 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.05 -46.46 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.178 -0.951 . . . . 2.4 111.747 -179.049 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.464 ' CB ' ' O ' ' A' ' 239' ' ' MET . 42.4 tp60 -60.46 -47.75 84.76 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.976 -1.09 . . . . 3.52 110.393 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.32 -30.91 70.79 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.195 -1.402 . . . . 1.88 109.853 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.72 -30.2 69.82 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.945 -1.102 . . . . 3.01 109.498 178.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 95.9 t -61.75 -42.46 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.45 -0.9 . . . . 2.45 109.36 178.84 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.91 91.37 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.784 -0.766 . . . . 2.75 110.057 179.758 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.1 t -69.86 -36.83 75.83 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.996 0.903 . . . . 3.16 110.134 -179.789 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -63.94 -28.22 69.68 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.44 -0.787 . . . . 3.57 110.956 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -59.58 -40.6 87.94 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.848 -0.532 . . . . 4.3 110.246 179.14 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.93 -33.27 74.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 4.45 109.972 179.782 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -72.74 -11.2 60.52 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.763 -0.585 . . . . 5.97 111.998 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 51.8 tp -60.36 -30.3 69.47 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.288 -0.882 . . . . 6.18 110.421 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -69.52 7.1 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.015 0.746 . . . . 6.66 113.015 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -81.72 11.31 4.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.421 -0.8 . . . . 8.2 112.691 179.606 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 77.0 mt -78.8 -12.86 60.04 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.251 -0.906 . . . . 8.07 111.627 -179.588 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -87.3 -29.3 21.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.578 -0.701 . . . . 9.45 111.78 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -95.05 -6.65 41.66 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.303 0.853 . . . . 10.12 113.303 -178.122 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 117.758 -1.115 . . . . 11.49 109.09 -178.444 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.249 -0.649 . . . . 3.07 109.249 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.8 mt -106.27 87.9 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 107.568 -1.271 . . . . 1.07 107.568 179.394 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 m -106.59 115.22 29.82 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.346 -1.724 . . . . 1.24 106.346 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.8 -161.06 28.76 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.658 -1.377 . . . . 1.01 109.658 -179.496 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 5' ' ' ILE . 92.7 mt -95.75 1.0 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.415 -1.05 . . . . 1.11 112.69 -179.836 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tp 50.15 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.028 -1.045 . . . . 0.99 112.27 178.596 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -83.43 -47.97 10.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.071 -1.018 . . . . 0.85 111.274 179.15 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -143.53 146.14 34.36 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 107.83 -1.174 . . . . 1.38 107.83 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.13 147.24 29.64 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.099 1.866 . . . . 0.94 112.14 178.549 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.839 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.42 147.31 4.64 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 119.732 -1.223 . . . . 0.81 110.051 178.417 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.9 mt -112.2 130.94 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.797 -1.413 . . . . 0.83 108.352 179.261 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.18 149.65 46.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.88 -0.785 . . . . 0.53 108.88 178.837 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 7.5 m-85 -118.58 139.45 51.46 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 107.652 -1.24 . . . . 0.77 107.652 177.352 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.8 169.53 42.49 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 118.585 -1.769 . . . . 0.51 110.195 178.452 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -78.72 154.84 29.74 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.732 -0.864 . . . . 1.9 109.281 178.042 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -81.88 133.35 35.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.12 -0.988 . . . . 0.66 109.007 178.071 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.5 tp -116.33 99.73 7.4 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.009 -1.848 . . . . 0.83 106.009 178.123 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.521 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 11.7 tp -85.5 137.61 32.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.667 -1.234 . . . . 0.86 107.667 179.659 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.556 HD11 HD11 ' A' ' 158' ' ' LEU . 32.4 mt -102.74 118.31 36.56 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 106.784 -1.561 . . . . 0.92 106.784 178.863 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -111.75 136.74 50.61 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.966 -1.124 . . . . 2.03 107.966 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -126.36 151.28 47.82 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.179 -0.95 . . . . 2.66 109.706 179.009 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -82.44 135.99 35.03 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.622 -1.251 . . . . 2.32 107.622 177.329 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -64.21 149.72 47.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 2.11 109.159 178.792 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mt -88.19 130.1 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.914 -1.143 . . . . 0.73 107.914 177.826 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.2 t -108.57 129.13 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.794 -1.188 . . . . 0.87 107.794 178.711 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.41 136.58 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.157 -1.053 . . . . 0.81 108.157 179.233 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -90.54 120.68 31.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.734 -1.21 . . . . 1.34 107.734 178.8 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.3 mmm-85 -96.17 11.19 35.24 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.198 -0.939 . . . . 2.89 112.667 -179.695 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -64.02 146.07 54.78 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.789 -1.194 . . . . 2.09 109.258 178.683 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.37 139.43 30.5 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.889 -1.152 . . . . 2.19 107.889 177.708 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -100.75 164.39 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 122.014 0.911 . . . . 0.75 109.904 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.6 p -96.64 165.26 12.23 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.3 0.571 . . . . 0.91 109.668 178.369 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.07 -22.13 15.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.93 112.045 179.176 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -68.64 -37.08 79.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.97 -1.081 . . . . 2.28 110.8 -179.881 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -92.68 -5.79 50.62 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.052 -1.03 . . . . 1.45 112.907 -179.315 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.3 t -59.88 -41.45 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.128 -0.982 . . . . 0.81 110.615 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.4 -39.89 84.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.911 -1.118 . . . . 1.54 110.128 179.657 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -60.47 -38.25 83.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.612 -0.68 . . . . 2.36 110.744 179.903 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.62 -40.96 89.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.003 -1.061 . . . . 1.31 110.37 179.319 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.9 t -60.13 -43.6 93.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.158 -0.964 . . . . 0.82 110.322 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -60.55 -43.62 97.02 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.238 -0.914 . . . . 1.5 109.974 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -60.62 -42.92 97.84 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.224 -0.99 . . . . 2.23 109.914 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -73.22 -54.85 7.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.457 -0.777 . . . . 0.85 110.016 179.732 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.6 tp -57.74 -47.76 81.53 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.761 -0.776 . . . . 0.91 109.971 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.517 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.6 t -69.9 -41.17 75.07 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.447 -0.783 . . . . 0.9 109.905 179.764 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.66 -43.11 94.5 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.284 -1.526 . . . . 0.69 109.284 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.401 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.8 ttt-85 -59.97 -29.93 68.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.359 -1.083 . . . . 2.88 109.615 179.002 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.23 -49.93 75.97 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.723 -0.791 . . . . 0.85 111.078 179.309 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -82.62 -38.53 23.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.239 -0.913 . . . . 2.35 110.873 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.11 -44.54 91.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.905 -1.122 . . . . 0.65 109.766 -179.381 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.7 t -60.28 -38.18 82.79 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.212 1.006 . . . . 1.45 109.348 179.603 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.89 78.5 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.845 -0.616 . . . . 0.63 110.326 179.47 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -61.68 -49.76 75.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 1.34 110.365 179.87 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.97 -40.37 93.12 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.985 0.898 . . . . 1.56 109.656 179.777 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.11 -40.82 90.99 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.298 0.57 . . . . 1.19 110.183 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.598 HG22 ' HZ2' ' A' ' 60' ' ' LYS . 14.4 m -67.55 -41.42 84.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.72 110.471 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.4 mt -60.12 -38.35 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.481 -0.762 . . . . 0.62 110.712 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -50.92 -41.6 58.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.853 . . . . 1.05 110.475 179.362 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.71 -37.23 76.49 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.908 -1.12 . . . . 0.64 109.988 -179.672 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.598 ' HZ2' HG22 ' A' ' 56' ' ' THR . 57.8 mttp -62.28 -38.93 91.22 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.343 -0.943 . . . . 1.73 109.505 179.201 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.25 -30.08 68.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.68 -0.638 . . . . 0.56 110.344 179.207 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.95 -37.12 11.86 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.024 -1.084 . . . . 0.69 111.511 179.9 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -80.01 -28.18 39.44 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.071 -1.252 . . . . 1.48 110.895 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.4 m -84.57 -47.57 10.43 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.285 -0.884 . . . . 0.98 111.086 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -107.22 -10.84 15.73 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.547 0.943 . . . . 1.16 113.547 -177.285 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.17 157.99 16.55 Favored Glycine 0 N--CA 1.501 2.968 0 O-C-N 121.269 -0.894 . . . . 0.85 113.051 179.02 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -54.45 -21.66 10.49 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.736 -0.861 . . . . 3.86 112.58 179.491 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -55.93 -36.87 68.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.019 -1.051 . . . . 2.35 111.347 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -80.08 -22.26 42.43 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.1 -1.0 . . . . 1.67 112.446 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.1 -35.66 75.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.806 -1.184 . . . . 1.45 111.39 -179.744 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.26 93.6 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.946 -1.096 . . . . 0.61 111.724 179.767 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.4 mt -66.83 -44.56 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.59 -1.319 . . . . 0.65 110.245 -179.786 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -70.15 -32.87 71.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.074 -1.016 . . . . 0.66 110.207 -179.901 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.72 -36.61 79.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 1.19 110.11 -179.781 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.93 -41.05 83.79 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 120.396 -0.907 . . . . 0.53 110.964 179.401 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -58.68 -44.21 90.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.102 -1.234 . . . . 1.27 110.81 179.562 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.61 -40.09 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.052 -1.03 . . . . 0.54 110.329 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 34.2 ttp -60.21 -38.86 84.64 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.35 -0.844 . . . . 1.74 110.428 179.87 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -58.63 -48.81 79.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.19 -0.944 . . . . 0.55 109.919 179.111 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.01 -40.4 89.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.576 -0.702 . . . . 0.47 110.376 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -86.16 10.85 13.3 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.386 -0.821 . . . . 1.42 112.411 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.14 124.45 21.69 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.038 -1.039 . . . . 1.27 108.659 178.594 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.32 -19.64 65.57 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.746 0.784 . . . . 1.35 110.819 -179.162 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -76.39 -52.96 8.85 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.762 -0.775 . . . . 2.22 110.406 179.919 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -60.62 -41.26 94.46 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.256 -0.977 . . . . 0.62 110.495 -179.455 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -58.18 -48.62 79.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.939 -1.1 . . . . 1.29 110.58 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -62.28 -38.63 90.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.863 -1.148 . . . . 1.52 110.873 -179.913 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.38 -48.37 67.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.989 -1.07 . . . . 1.3 110.999 179.694 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.8 mt -56.21 -43.47 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.066 -1.021 . . . . 0.61 109.735 179.527 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.12 -44.03 99.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.317 0.579 . . . . 0.78 110.515 179.874 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.37 -43.71 98.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 0.82 110.772 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.32 -46.51 90.0 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.083 -1.011 . . . . 0.8 110.483 -179.787 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.65 -43.41 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.77 110.617 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -84.41 -33.68 23.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.729 -0.607 . . . . 2.12 111.549 -179.742 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 91' ' ' ALA . 55.7 t0 -79.76 -42.34 24.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.914 -1.116 . . . . 1.51 111.209 -178.4 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -102.65 5.73 39.24 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 1.98 112.921 -177.946 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.9 m170 52.86 48.99 21.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.987 . . . . 1.32 111.85 -179.495 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.27 158.27 17.62 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.418 -0.801 . . . . 1.38 109.451 178.459 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.4 p -70.96 159.07 35.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.679 -0.638 . . . . 0.67 109.414 177.808 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.2 -41.4 88.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 0.52 110.8 178.743 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.53 ' OD2' HD21 ' A' ' 142' ' ' LEU . 90.0 m-20 -68.27 -38.74 82.03 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.931 -1.106 . . . . 2.25 110.502 -179.82 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.91 -54.53 15.0 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.754 -0.778 . . . . 0.64 111.186 179.691 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.58 94.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.263 -0.898 . . . . 0.56 110.408 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.34 88.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.445 -0.785 . . . . 0.46 110.442 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -60.14 -39.8 87.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 1.32 111.081 -179.936 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.76 -48.0 82.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 1.3 110.69 179.628 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.32 -43.61 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.895 -1.128 . . . . 0.61 110.61 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mm -61.52 -32.38 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.649 -0.657 . . . . 0.65 110.102 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -58.77 -40.66 84.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.51 -0.744 . . . . 2.11 110.469 179.274 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.67 -28.3 27.07 Favored Glycine 0 N--CA 1.499 2.848 0 C-N-CA 119.495 -1.336 . . . . 0.83 113.482 179.724 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -63.68 -42.48 98.01 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.31 -1.7 . . . . 1.28 110.061 -179.841 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.24 -50.61 21.42 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.616 0.722 . . . . 0.89 110.468 -179.961 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.9 t -60.74 -37.53 82.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.314 -0.866 . . . . 1.87 110.627 -179.66 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.24 97.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 1.05 110.901 179.769 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 84.8 mt -66.12 -30.05 70.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.915 -1.116 . . . . 1.02 110.678 -179.748 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -65.71 -22.28 66.6 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.568 -0.707 . . . . 2.04 110.979 179.409 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -70.03 -21.49 63.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.518 -0.739 . . . . 1.73 110.963 179.563 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 123' ' ' LEU . 10.2 mt -82.48 145.66 29.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.786 . . . . 1.37 109.544 178.391 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -100.09 39.9 1.3 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.402 -0.811 . . . . 2.88 111.787 179.766 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -112.72 139.76 48.07 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.102 -0.999 . . . . 1.58 108.923 178.775 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 42.1 mp0 -59.57 -38.9 82.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.558 -0.714 . . . . 3.04 111.064 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -70.96 -55.58 8.05 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.671 -1.268 . . . . 0.9 110.592 179.723 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 118' ' ' LEU . 25.7 mt -59.8 -40.77 89.44 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.034 -1.041 . . . . 1.06 110.371 -179.685 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -64.24 -49.81 70.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.066 . . . . 2.18 109.511 179.599 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -60.37 -32.73 71.57 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.399 -0.921 . . . . 2.15 109.468 179.76 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.413 ' O ' HG23 ' A' ' 130' ' ' VAL . 56.5 ttt180 -63.83 -28.79 70.09 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.385 -0.926 . . . . 2.33 109.529 179.165 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -59.27 -47.31 85.84 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 119.784 -0.766 . . . . 0.82 109.335 178.453 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.55 88.57 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.486 -0.886 . . . . 0.85 110.143 179.718 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.04 -32.39 73.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.821 . . . . 1.39 110.694 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 126' ' ' ARG . 42.8 t -69.24 -39.53 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.56 110.161 179.684 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -55.33 -39.94 70.59 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.514 -1.275 . . . . 3.12 109.17 178.609 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -60.59 -36.1 77.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.746 -0.596 . . . . 1.28 110.433 179.604 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.3 mt -60.33 -39.62 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.328 -0.858 . . . . 0.49 110.389 179.856 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.01 72.31 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.426 -1.369 . . . . 0.46 110.675 178.828 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -59.03 -40.79 86.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.429 -1.042 . . . . 2.71 110.336 179.26 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.528 ' NH1' ' OG ' ' A' ' 166' ' ' SER . 24.7 mtp180 -60.99 -40.53 93.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 2.14 109.693 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.523 ' O ' HD13 ' A' ' 137' ' ' LEU . 0.2 OUTLIER -66.59 -45.52 78.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.714 -0.616 . . . . 1.05 110.279 179.953 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.3 mt -58.43 -41.99 86.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.227 -0.92 . . . . 0.52 110.637 179.671 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -61.03 -32.52 72.12 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.143 -0.973 . . . . 2.35 111.022 -179.854 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -75.37 -43.82 48.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.906 -1.121 . . . . 1.39 111.412 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.21 -35.8 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.68 110.905 -178.071 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.53 HD21 ' OD2' ' A' ' 101' ' ' ASP . 64.9 mt -85.47 -7.86 58.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.074 -1.016 . . . . 0.83 112.119 -179.829 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.27 22.07 78.53 Favored Glycine 0 N--CA 1.479 1.521 0 C-N-CA 119.095 -1.526 . . . . 0.91 113.053 -179.18 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.36 146.41 39.92 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.83 -0.806 . . . . 0.95 110.229 -179.621 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -67.74 148.26 51.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 2.43 108.955 178.913 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 63.2 mt -102.32 139.23 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.785 -1.191 . . . . 1.1 107.785 178.464 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 147' ' ' ILE . 3.8 mp -77.52 132.72 32.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.386 -0.821 . . . . 1.58 108.807 179.169 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -95.17 86.81 4.68 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.242 -1.392 . . . . 1.62 107.242 179.349 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -75.76 -21.73 57.16 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.87 -0.732 . . . . 0.8 111.33 -177.82 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.4 t -80.27 1.08 30.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.369 -0.832 . . . . 1.56 112.445 179.598 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.54 24.72 7.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.561 -0.712 . . . . 0.84 112.372 -179.08 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 15.1 mt -71.42 140.77 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.372 -0.83 . . . . 0.82 109.646 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -114.9 -18.95 11.16 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.582 0.706 . . . . 2.31 112.883 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -115.07 134.28 55.31 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.939 -1.134 . . . . 1.54 107.939 -179.948 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -73.36 126.22 29.65 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.271 -1.011 . . . . 1.38 108.271 178.503 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -148.12 177.08 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.69 109.284 -179.615 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.7 mt -85.74 141.91 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 0.53 108.651 178.111 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.556 HD11 HD11 ' A' ' 19' ' ' LEU . 24.2 tp -96.19 122.84 39.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.23 -0.919 . . . . 0.64 108.886 178.446 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.88 129.96 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.917 -1.142 . . . . 0.67 107.917 179.754 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.439 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.16 155.27 22.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.78 109.048 179.152 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -60.72 -40.59 92.9 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.42 -1.425 . . . . 1.0 109.358 177.992 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -171.04 151.13 3.19 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.739 -0.838 . . . . 2.42 108.739 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 85.2 mt -118.7 139.31 51.74 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.001 -1.111 . . . . 0.75 108.001 177.519 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.9 p -92.8 150.37 39.4 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.238 -0.914 . . . . 0.78 108.77 178.844 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -39.8 -41.65 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.34 2.027 . . . . 0.67 113.686 179.26 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.528 ' OG ' ' NH1' ' A' ' 136' ' ' ARG . 44.1 m -59.97 -48.26 82.43 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.062 -1.024 . . . . 0.7 110.119 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -65.23 -40.06 93.55 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.409 -0.807 . . . . 1.21 110.245 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 43.4 p -67.84 -38.53 83.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.435 -0.791 . . . . 0.6 110.3 179.97 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.61 80.59 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.182 -0.949 . . . . 0.62 110.529 179.624 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -95.05 -0.88 53.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.055 -1.028 . . . . 1.16 113.133 -179.326 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.1 tp -62.98 150.42 42.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.73 109.17 179.801 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -95.31 112.92 24.56 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.146 -1.428 . . . . 2.24 107.146 177.686 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.93 -15.54 61.12 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.139 0.495 . . . . 1.43 112.118 -178.106 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -83.72 -23.03 31.81 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.126 -0.984 . . . . 2.15 112.612 -178.834 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -104.08 3.02 32.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.138 -0.976 . . . . 2.04 112.877 -178.803 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 178' ' ' GLY . 59.1 t -108.78 127.9 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.711 -1.218 . . . . 0.55 107.711 179.556 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 16.1 tp -87.73 -5.47 58.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.504 -0.748 . . . . 1.63 111.895 -179.427 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.508 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.7 175.01 35.82 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.797 -1.721 . . . . 0.47 108.797 -179.367 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -130.58 137.39 49.64 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.814 -1.18 . . . . 0.54 107.814 179.823 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.451 HG22 HG21 ' A' ' 205' ' ' THR . 83.5 mt -137.48 110.86 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 106.688 -1.597 . . . . 0.69 106.688 178.519 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 203' ' ' VAL . 70.7 p -130.59 168.49 17.02 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.831 -1.168 . . . . 0.82 109.829 -179.668 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 25.8 p-10 -101.7 50.42 0.85 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.626 -0.671 . . . . 2.37 110.529 179.841 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.35 147.51 24.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.243 -0.911 . . . . 1.11 109.323 179.333 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.43 -16.03 19.46 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.804 -1.189 . . . . 1.67 112.36 179.204 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 80.7 -19.47 7.32 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 121.402 -1.058 . . . . 1.54 114.474 179.341 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -60.13 -39.88 87.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.161 -1.199 . . . . 4.48 110.569 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 31.1 p -139.84 34.87 1.97 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.587 -0.696 . . . . 2.63 111.195 -179.691 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.0 p -84.02 118.87 24.33 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.974 -1.121 . . . . 1.69 107.974 178.877 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -60.11 -30.6 69.37 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.584 -0.697 . . . . 1.07 110.274 -179.549 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 40.0 m -59.41 -40.9 88.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.497 -0.752 . . . . 1.58 110.392 179.225 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 83.3 p -59.97 -39.05 84.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.995 -1.066 . . . . 1.6 110.074 179.53 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 75.7 mt -59.94 -39.62 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.41 -0.916 . . . . 1.45 110.516 179.41 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 56.5 mtp -62.43 -42.25 99.32 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.293 1.044 . . . . 1.05 109.423 179.473 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.4 -46.28 86.72 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.646 -0.707 . . . . 0.72 110.776 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.429 HH11 ' HG2' ' A' ' 195' ' ' ARG . 46.8 mtt-85 -60.07 -43.78 95.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 3.05 110.518 -179.945 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 51.2 m -68.92 -39.14 79.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.492 -0.755 . . . . 0.89 110.316 -179.86 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.2 mt -90.86 -6.86 53.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.569 -0.707 . . . . 0.78 112.729 -179.148 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 194' ' ' ALA . 43.6 mt-10 53.2 9.8 0.16 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.918 1.081 . . . . 1.45 113.918 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 34.8 mt -71.27 150.79 94.39 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.043 -1.036 . . . . 0.67 108.462 178.997 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.7 141.32 95.5 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.269 1.313 . . . . 0.64 109.465 178.532 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.96 163.79 33.88 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.574 -1.651 . . . . 0.67 110.065 179.899 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.495 ' CD1' HD11 ' A' ' 220' ' ' LEU . 18.6 mt -148.69 152.36 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.919 -1.141 . . . . 0.69 107.919 178.321 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.3 m -135.1 -28.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 O-C-N 120.758 -1.214 . . . . 0.85 111.657 179.568 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.46 40.12 2.56 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.161 -0.962 . . . . 0.92 112.219 -178.993 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.451 HG21 HG22 ' A' ' 180' ' ' ILE . 51.5 p -60.96 -18.73 58.82 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.988 -1.301 . . . . 0.95 111.42 -179.261 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 77.15 -93.41 1.08 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.971 -1.109 . . . . 1.04 110.501 179.539 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 47.8 p -128.8 27.3 5.48 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.472 -1.017 . . . . 1.57 112.597 -178.767 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 83.8 t -59.23 -33.99 52.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.686 -1.259 . . . . 0.84 110.872 179.191 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 44.2 p -59.71 -23.08 62.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.095 -1.003 . . . . 0.99 111.729 -179.813 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 37.6 t -93.27 1.01 57.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 1.7 112.113 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -126.29 0.46 7.05 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.847 0.684 . . . . 2.2 112.847 -178.281 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 32.0 t -116.11 145.55 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.587 -0.696 . . . . 0.84 109.34 179.772 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -119.92 161.33 21.05 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.486 -0.931 . . . . 2.2 108.486 177.938 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 18' ' ' LEU . 73.6 m-80 -59.57 142.27 53.1 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 120.749 -1.219 . . . . 2.28 110.639 179.159 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.6 t70 80.61 1.04 1.87 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.496 1.295 . . . . 2.35 114.496 179.438 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -63.66 148.57 48.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.622 -1.298 . . . . 1.97 108.549 177.706 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -91.69 118.11 30.35 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 106.477 -1.675 . . . . 2.65 106.477 177.698 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.422 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 82.3 mt -126.84 144.64 50.91 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.663 0.744 . . . . 0.63 109.867 -178.536 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.3 mt -114.15 127.37 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.711 -1.588 . . . . 0.62 106.711 177.567 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.495 HD11 ' CD1' ' A' ' 202' ' ' ILE . 59.9 tp -99.58 115.31 29.09 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 105.82 -1.918 . . . . 0.64 105.82 178.272 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 223' ' ' VAL . 28.7 t0 -89.13 -26.95 21.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.024 -1.047 . . . . 2.05 111.701 -178.197 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.28 20.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.598 -0.689 . . . . 0.84 112.666 -179.28 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 221' ' ' ASP . 17.3 t -112.33 -59.77 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 122.065 0.936 . . . . 1.02 109.522 179.573 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -99.58 14.39 30.16 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.933 0.873 . . . . 2.51 110.87 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 45.6 t30 61.22 50.99 4.52 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 116.031 -0.531 . . . . 1.54 112.195 179.163 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -147.06 147.91 31.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.049 -1.032 . . . . 1.95 109.605 178.431 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.05 139.12 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 107.821 -1.177 . . . . 0.71 107.821 178.114 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -99.74 133.29 44.31 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.966 -1.084 . . . . 1.01 108.419 178.394 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.0 t -110.57 130.87 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.589 -0.694 . . . . 0.82 109.381 179.23 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.426 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 58.7 t30 52.23 51.52 9.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 113.596 0.962 . . . . 1.54 113.596 178.117 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 55.9 Cg_endo -69.88 152.51 68.73 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.729 2.286 . . . . 0.94 110.59 179.879 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 232' ' ' THR . 1.3 p -73.64 161.76 29.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.669 -1.269 . . . . 1.8 109.914 178.216 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -59.87 -38.39 82.06 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.192 -0.942 . . . . 2.73 110.216 178.737 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.83 -41.37 91.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.59 -0.694 . . . . 3.17 109.913 179.179 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 86.1 t -70.55 -43.11 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.448 -0.783 . . . . 1.34 110.492 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.563 ' CG2' HH12 ' A' ' 240' ' ' ARG . 73.6 mt -58.33 -48.56 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 118.803 -1.159 . . . . 1.2 109.829 -178.709 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -59.83 -40.9 90.04 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.726 -0.79 . . . . 2.7 109.824 179.392 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -61.82 -41.56 97.94 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.415 -0.803 . . . . 2.59 110.18 179.827 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 72.5 mtp -71.55 -32.14 67.79 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.34 -0.85 . . . . 1.38 110.548 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -55.81 -40.66 73.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 2.84 109.863 179.587 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 245' ' ' GLN . . . -72.59 -39.64 67.19 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.551 -0.718 . . . . 1.88 110.917 -179.884 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 79.5 t -51.0 -51.97 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.743 -1.223 . . . . 2.4 111.705 -179.34 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -63.47 -50.0 71.43 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.748 -1.22 . . . . 3.52 109.566 179.916 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -61.65 -35.6 78.41 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.631 -0.827 . . . . 1.88 110.252 -179.876 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 249' ' ' GLU . 80.2 mt-30 -65.45 -27.81 68.78 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.403 -0.919 . . . . 3.01 110.291 179.18 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 52.6 t -60.41 -42.67 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 119.187 -1.005 . . . . 2.45 109.554 178.927 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.3 -44.91 88.77 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.606 -1.238 . . . . 2.75 109.055 179.071 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.2 t -77.21 -25.08 51.33 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.453 0.644 . . . . 3.16 111.058 -179.9 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 245' ' ' GLN . 29.3 tp10 -61.96 -30.05 70.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.659 -0.65 . . . . 3.57 111.479 -179.791 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -61.41 -38.67 87.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.023 -1.048 . . . . 4.3 110.244 179.565 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.67 -19.87 63.59 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.113 -0.992 . . . . 4.45 111.341 179.605 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -71.66 -13.07 61.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.822 -0.549 . . . . 5.97 111.979 -179.432 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.94 -30.67 70.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.993 -1.067 . . . . 6.18 110.826 -179.434 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -69.9 -14.19 62.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.11 -0.994 . . . . 6.66 112.08 179.935 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -89.11 26.02 1.7 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.437 -0.789 . . . . 8.2 113.031 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 15.0 tp -74.34 -10.97 60.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 8.07 112.414 179.211 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -87.92 1.92 52.89 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.571 -1.33 . . . . 9.45 112.498 -179.846 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.5 -0.99 57.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.855 -1.153 . . . . 10.12 112.59 -179.467 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.939 -1.029 . . . . 11.49 108.78 -178.25 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.0 mtp . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 110.129 -0.323 . . . . 3.07 110.129 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 93.0 mt -96.66 112.94 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.36 -1.718 . . . . 1.07 106.36 176.66 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.7 m -102.5 120.57 40.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.364 -0.976 . . . . 1.24 108.364 -179.717 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.31 -142.82 11.45 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.791 -1.724 . . . . 1.01 108.791 179.498 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 5' ' ' ILE . 81.5 mt -100.53 -1.0 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.984 -1.304 . . . . 1.11 113.399 -178.893 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 tp 49.35 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.659 -1.276 . . . . 0.99 112.312 178.556 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.54 -39.87 16.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.259 -0.9 . . . . 0.85 111.029 179.307 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.06 145.68 19.96 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.105 -1.072 . . . . 1.38 108.105 -179.126 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.95 148.14 31.35 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.849 2.366 . . . . 0.94 112.436 178.585 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.871 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.73 152.13 5.96 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 109.817 -1.313 . . . . 0.81 109.817 178.088 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.4 mt -118.04 130.17 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.199 -1.177 . . . . 0.83 108.072 179.183 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.53 143.89 43.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.315 -0.865 . . . . 0.53 109.024 179.006 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.557 ' CE2' ' OE1' ' A' ' 243' ' ' GLN . 45.6 m-85 -110.07 138.27 46.68 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.596 -1.261 . . . . 0.77 107.596 177.346 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.0 169.73 42.45 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 117.708 -2.187 . . . . 0.51 110.4 178.154 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -79.56 159.68 26.76 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.776 -0.824 . . . . 1.9 108.776 177.922 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.449 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.6 130.31 34.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.094 -1.004 . . . . 0.66 109.11 178.152 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.8 tp -109.46 107.51 17.68 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 104.917 -2.253 . . . . 0.83 104.917 176.967 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 tp -94.2 132.79 38.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.105 -0.997 . . . . 0.86 108.977 -179.833 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.3 mt -100.93 122.22 43.1 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.417 -1.327 . . . . 0.92 107.417 178.437 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -108.81 131.31 55.1 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.25 -1.018 . . . . 2.03 108.25 179.521 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.485 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 83.5 tt0 -111.34 140.38 45.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.554 -0.716 . . . . 2.66 109.471 179.073 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -83.87 129.32 34.93 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.412 -1.329 . . . . 2.32 107.412 177.893 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -65.9 143.62 57.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.85 . . . . 2.11 109.153 179.342 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.0 mt -96.55 135.47 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.506 -0.924 . . . . 0.73 108.506 178.587 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.49 130.19 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.376 -0.972 . . . . 0.87 108.376 178.949 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.2 mt -97.57 141.24 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.644 -0.873 . . . . 0.81 108.644 179.325 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -89.77 120.67 31.23 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.755 -1.202 . . . . 1.34 107.755 178.083 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.523 HH11 ' HG2' ' A' ' 28' ' ' ARG . 2.1 mmt-85 -95.19 12.49 28.65 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.256 -0.902 . . . . 2.89 112.605 179.635 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -66.98 146.64 54.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.878 -1.139 . . . . 2.09 109.533 178.879 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -90.18 135.37 33.71 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.964 -1.125 . . . . 2.19 107.964 178.032 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.0 pt -100.43 164.76 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.285 -0.884 . . . . 0.75 110.321 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.5 p -94.86 164.89 12.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.475 -0.565 . . . . 0.91 109.475 178.4 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.85 -20.23 14.7 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.116 -0.99 . . . . 0.93 112.088 179.35 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -68.9 -39.14 79.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.038 -1.039 . . . . 2.28 110.986 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -87.22 -9.24 55.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.62 -1.3 . . . . 1.45 112.423 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.23 -43.2 89.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.186 -0.947 . . . . 0.81 110.557 -179.394 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -56.65 -40.66 75.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.853 -1.154 . . . . 1.54 110.607 179.548 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -65.04 -46.76 79.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.195 -0.94 . . . . 2.36 110.957 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.29 -36.19 79.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.954 -1.092 . . . . 1.31 111.17 -179.772 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.84 -40.81 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.933 -1.104 . . . . 0.82 110.541 179.287 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -61.12 -41.06 96.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.006 -1.059 . . . . 1.5 109.981 179.673 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.418 HH11 ' HG2' ' A' ' 42' ' ' ARG . 46.8 mtt-85 -61.15 -39.32 89.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.844 . . . . 2.23 110.695 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -72.82 -57.04 4.37 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.38 -0.825 . . . . 0.85 110.76 179.517 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.8 tp -59.89 -47.53 85.38 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.314 -0.954 . . . . 0.91 110.088 -179.724 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.554 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.3 t -67.88 -36.17 79.78 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.75 0.786 . . . . 0.9 109.88 179.855 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.19 -43.15 99.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.864 -1.294 . . . . 0.69 109.864 178.856 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -59.54 -30.55 68.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.02 0.915 . . . . 2.88 109.344 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.72 -43.11 90.06 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.814 0.816 . . . . 0.85 109.511 179.056 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -80.34 -45.88 17.05 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.434 -0.791 . . . . 2.35 110.837 179.374 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.64 -41.57 81.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.585 -0.697 . . . . 0.65 110.022 179.997 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.3 p -61.88 -37.16 83.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.119 0.961 . . . . 1.45 109.17 179.765 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.4 -50.2 48.16 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.753 -0.658 . . . . 0.63 110.531 179.454 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -63.53 -48.43 77.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.447 -0.783 . . . . 1.34 110.578 -179.865 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.7 mt -61.2 -38.21 85.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 1.56 110.01 179.977 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -59.78 -39.98 86.72 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.666 -0.646 . . . . 1.19 110.713 179.113 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -65.1 -44.16 89.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.781 -1.2 . . . . 0.72 110.243 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.1 -31.97 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.754 . . . . 0.62 110.186 179.791 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -52.07 -47.08 65.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.604 -0.685 . . . . 1.05 110.61 179.075 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -68.77 -33.78 74.46 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.744 -1.222 . . . . 0.64 109.843 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -62.15 -39.45 92.67 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.531 -1.267 . . . . 1.73 109.363 179.173 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.84 88.9 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.348 -0.845 . . . . 0.56 109.988 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.93 -37.95 42.59 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.573 -1.298 . . . . 0.69 110.476 179.474 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -81.57 -22.46 37.78 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.087 -1.243 . . . . 1.48 111.131 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.8 m -84.74 -46.05 11.8 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.548 -0.72 . . . . 0.98 110.907 179.941 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -106.5 -23.68 12.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.441 -0.787 . . . . 1.16 112.229 -178.981 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.21 168.97 15.28 Favored Glycine 0 N--CA 1.499 2.889 0 CA-C-O 121.785 0.659 . . . . 0.85 111.665 -179.534 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -55.68 -28.2 54.26 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.415 -1.05 . . . . 3.86 112.717 -179.652 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -57.65 -39.91 78.09 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.911 -1.118 . . . . 2.35 111.356 -179.718 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -88.59 -14.53 37.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.618 -1.301 . . . . 1.67 112.385 -178.967 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -60.07 -38.72 83.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.872 . . . . 1.45 110.948 -179.25 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.38 82.97 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.167 -0.958 . . . . 0.61 111.245 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.3 mt -63.14 -43.5 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.572 -1.33 . . . . 0.65 110.475 179.696 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -68.97 -33.28 73.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.968 -1.083 . . . . 0.66 110.001 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.02 -38.84 83.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 1.19 110.114 179.365 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.82 -38.14 94.06 Favored Glycine 0 N--CA 1.486 1.985 0 C-N-CA 120.137 -1.03 . . . . 0.53 110.585 179.552 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -57.16 -42.33 80.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.841 -1.388 . . . . 1.27 110.284 179.368 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.2 mt -60.34 -41.59 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.08 -1.012 . . . . 0.54 109.556 179.641 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.1 ttm -60.19 -39.82 87.88 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 1.74 109.803 179.562 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -58.28 -50.0 75.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.413 -0.804 . . . . 0.55 110.45 178.996 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.67 -40.34 91.75 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.331 -0.856 . . . . 0.47 110.402 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -87.72 5.62 38.97 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.87 0.693 . . . . 1.42 112.87 -179.62 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.31 122.82 15.47 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.911 -1.118 . . . . 1.27 109.581 179.3 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -66.16 -16.29 63.85 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.686 0.755 . . . . 1.35 110.749 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -77.06 -49.17 15.92 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.496 -0.882 . . . . 2.22 110.523 179.94 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.21 -38.29 90.58 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.386 -0.925 . . . . 0.62 110.24 -178.305 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.88 -47.88 83.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.023 -1.048 . . . . 1.29 111.282 179.314 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -60.7 -39.26 87.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.883 -1.136 . . . . 1.52 110.663 -179.721 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.7 -48.48 71.85 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.575 -0.85 . . . . 1.3 110.638 179.692 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.96 -41.6 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.222 -0.991 . . . . 0.61 109.914 179.494 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.81 -42.81 95.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.352 -0.842 . . . . 0.78 110.297 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.88 98.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.82 110.67 -179.965 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.02 -43.06 95.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.8 110.442 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.51 -49.08 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.988 -1.07 . . . . 0.77 110.159 179.817 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -76.66 -35.47 57.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 2.12 111.824 -179.524 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -80.77 -48.25 12.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.887 -1.133 . . . . 1.51 111.98 -179.643 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -101.41 8.69 42.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.227 -0.921 . . . . 1.98 112.994 -178.658 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.5 m80 51.56 49.36 21.06 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.024 -1.071 . . . . 1.32 111.426 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.9 mtt -104.86 149.43 25.69 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.435 1.112 . . . . 1.38 109.052 179.834 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.5 p -72.62 159.63 33.56 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.59 0.709 . . . . 0.67 109.433 177.81 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.33 81.79 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.51 -0.744 . . . . 0.52 110.646 178.627 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.4 p-10 -68.54 -42.31 78.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.977 -1.077 . . . . 2.25 110.268 -179.792 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -70.74 -51.46 27.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.332 -0.855 . . . . 0.64 111.386 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.99 84.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.499 -0.751 . . . . 0.56 110.528 -179.616 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.6 96.53 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.82 -0.752 . . . . 0.46 111.127 179.658 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -60.42 -39.37 87.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.829 -1.169 . . . . 1.32 110.782 179.942 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -54.83 -49.75 70.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.129 -0.982 . . . . 1.3 110.761 179.701 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.1 -42.28 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.718 -1.239 . . . . 0.61 109.853 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.5 mm -61.76 -32.02 52.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.541 -0.724 . . . . 0.65 110.356 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.14 -41.75 89.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 2.11 110.388 179.083 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.09 -31.68 19.47 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.063 -1.542 . . . . 0.83 112.279 -179.896 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -62.16 -41.88 98.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.414 -1.639 . . . . 1.28 109.635 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.59 -51.26 20.48 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.982 0.896 . . . . 0.89 109.713 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.6 t -60.19 -39.93 88.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.358 -0.839 . . . . 1.87 110.176 -179.802 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.32 98.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.176 -0.952 . . . . 1.05 110.454 -179.808 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 88.1 mt -64.84 -30.61 71.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.966 -1.084 . . . . 1.02 110.224 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -66.53 -22.2 66.16 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.342 -0.849 . . . . 2.04 110.877 179.712 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.39 -20.45 64.68 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.415 -0.914 . . . . 1.73 110.625 179.511 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.594 HD13 HD13 ' A' ' 123' ' ' LEU . 38.8 mt -83.15 142.41 31.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.441 -0.787 . . . . 1.37 109.321 178.362 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -101.4 40.01 1.35 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.398 -0.814 . . . . 2.88 111.078 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -112.75 133.48 54.74 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.609 -0.886 . . . . 1.58 108.609 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 5.7 pm0 -60.5 -28.09 68.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.095 -1.003 . . . . 3.04 111.553 179.552 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -74.25 -59.54 2.68 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.072 -1.017 . . . . 0.9 110.027 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.594 HD13 HD13 ' A' ' 118' ' ' LEU . 65.0 mt -66.26 -35.73 81.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 1.06 110.642 -179.554 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -61.81 -48.51 80.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.803 -1.185 . . . . 2.18 110.396 179.466 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -59.74 -30.24 68.71 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.589 -1.244 . . . . 2.15 109.649 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 130' ' ' VAL . 58.6 ttt180 -62.27 -29.19 70.24 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.22 -0.992 . . . . 2.33 109.17 179.306 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -60.17 -49.75 76.39 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.868 0.842 . . . . 0.82 109.805 178.361 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.23 75.92 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.676 -0.809 . . . . 0.85 110.234 179.854 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -61.22 -34.08 74.53 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.635 0.731 . . . . 1.39 110.648 -179.884 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.6 t -68.95 -37.28 77.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.324 -0.86 . . . . 0.56 110.033 179.706 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 131' ' ' ARG . 22.9 ttt-85 -57.93 -38.31 75.69 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.471 -1.292 . . . . 3.12 109.429 178.656 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.498 ' OD1' ' NE ' ' A' ' 136' ' ' ARG . 8.3 t70 -60.11 -40.06 88.35 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.396 0.617 . . . . 1.28 110.568 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 73.1 mt -61.41 -34.68 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.378 -0.826 . . . . 0.49 110.18 -179.611 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -64.91 -51.4 51.66 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.131 -1.033 . . . . 0.46 110.657 178.783 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -57.9 -40.37 80.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.87 -1.371 . . . . 2.71 110.467 179.547 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.498 ' NE ' ' OD1' ' A' ' 132' ' ' ASP . 58.5 mtt-85 -60.5 -43.24 97.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.998 -1.064 . . . . 2.14 110.131 -179.979 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.5 tp -61.26 -44.57 97.03 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.087 -1.008 . . . . 1.05 110.224 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.09 -42.4 90.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.553 -0.717 . . . . 0.52 110.547 179.666 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.485 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 98.1 mtt180 -61.38 -34.42 75.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.159 -0.963 . . . . 2.35 111.206 -179.851 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -74.06 -43.4 57.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.557 -1.339 . . . . 1.39 110.618 179.827 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.4 mt -60.9 -39.38 81.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.52 -0.737 . . . . 0.68 110.455 -178.521 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.4 mt -88.84 -11.65 44.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.532 -0.73 . . . . 0.83 111.996 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.4 22.83 69.44 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 120.323 -0.941 . . . . 0.91 113.581 -179.542 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.39 142.9 58.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.58 -0.953 . . . . 0.95 109.534 179.647 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -68.05 151.94 46.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.894 . . . . 2.43 110.307 178.377 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.7 mt -104.58 136.89 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.033 -1.099 . . . . 1.1 108.033 178.21 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.73 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -81.86 129.62 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.979 -1.119 . . . . 1.58 107.979 179.125 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -95.85 98.68 10.61 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.067 -1.827 . . . . 1.62 106.067 178.873 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.7 mt -77.37 -14.28 59.75 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.529 -0.732 . . . . 0.8 111.775 -177.745 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.6 t -80.1 8.32 7.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.379 -0.826 . . . . 1.56 112.323 -179.574 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.34 17.22 17.91 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.647 0.737 . . . . 0.84 112.315 179.565 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.4 mt -73.22 136.2 25.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.942 -0.762 . . . . 0.82 108.942 179.0 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -124.29 -7.25 7.62 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.547 -0.721 . . . . 2.31 112.651 -178.832 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -110.63 137.5 48.23 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.06 -1.089 . . . . 1.54 108.06 179.794 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -77.25 119.82 21.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.247 -0.908 . . . . 1.38 108.695 178.851 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.2 m -148.12 179.49 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.835 -0.802 . . . . 0.69 108.835 -178.965 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 30.6 mt -88.33 142.86 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.991 -1.068 . . . . 0.53 108.943 178.212 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.0 tp -98.02 120.5 38.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.816 -1.178 . . . . 0.64 108.141 178.251 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.24 130.15 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.418 -0.956 . . . . 0.67 108.418 179.397 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.36 159.14 27.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.243 -0.911 . . . . 0.78 108.752 179.534 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.03 95.6 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.494 -1.378 . . . . 1.0 109.778 177.855 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -172.67 152.65 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.906 -0.775 . . . . 2.42 108.906 -179.744 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 64.9 mt -118.99 141.33 48.77 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.315 -0.866 . . . . 0.75 109.09 177.383 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 168' ' ' THR . 68.9 p -90.55 148.82 39.59 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.182 -0.949 . . . . 0.78 108.919 179.21 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -40.15 -45.52 4.06 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.645 2.23 . . . . 0.67 113.891 179.142 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.0 m -60.09 -46.3 90.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.918 -1.114 . . . . 0.7 110.063 -179.607 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.41 -38.49 91.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.27 -0.894 . . . . 1.21 110.331 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 164' ' ' THR . 23.8 p -67.61 -40.75 84.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 0.6 110.83 179.662 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.3 74.41 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.791 -0.764 . . . . 0.62 110.339 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -93.38 -4.85 50.72 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.007 -1.058 . . . . 1.16 112.862 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.23 153.45 34.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.73 109.631 179.878 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -94.13 117.33 29.96 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.292 -1.744 . . . . 2.24 106.292 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.785 HD22 ' H ' ' A' ' 173' ' ' LEU . 0.7 OUTLIER -82.46 -19.47 38.81 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.472 -0.767 . . . . 1.43 112.396 -177.701 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -84.23 -20.87 31.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.238 -0.913 . . . . 2.15 111.912 -178.569 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -99.96 2.32 43.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.187 -0.946 . . . . 2.04 112.528 -179.254 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.472 HG12 ' H ' ' A' ' 178' ' ' GLY . 61.4 t -112.99 129.95 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 107.873 -1.158 . . . . 0.55 107.873 179.352 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.584 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -82.81 -16.35 48.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.007 -1.058 . . . . 1.63 111.705 -179.541 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.472 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -176.69 171.33 44.27 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.073 -1.611 . . . . 0.47 109.073 179.909 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -125.79 124.56 41.26 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 107.344 -1.354 . . . . 0.54 107.344 178.196 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 180' ' ' ILE . 46.6 mt -123.27 129.75 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 106.952 -1.499 . . . . 0.69 106.952 178.215 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 203' ' ' VAL . 34.2 p -140.61 170.0 16.6 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.907 -1.12 . . . . 0.82 109.802 179.772 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.94 36.08 3.0 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.871 -0.518 . . . . 2.37 111.007 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -96.87 151.53 19.58 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.191 -0.943 . . . . 1.11 110.352 178.75 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -46.33 -28.36 3.23 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 120.162 -1.018 . . . . 1.67 112.609 177.696 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 87.69 -33.12 4.03 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 121.037 -1.272 . . . . 1.54 113.625 179.406 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -60.44 -40.65 91.86 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.007 -1.29 . . . . 4.48 110.346 179.709 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.4 p -118.38 20.18 13.16 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.52 -0.737 . . . . 2.63 111.208 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.3 p -89.11 120.46 30.53 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.772 -1.196 . . . . 1.69 107.772 178.771 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -60.46 -32.27 71.23 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.388 -0.82 . . . . 1.07 110.407 179.827 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 63.0 p -54.68 -41.11 69.82 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.037 -1.039 . . . . 1.58 110.68 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.3 t -60.02 -39.83 87.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.298 -0.876 . . . . 1.6 109.918 179.818 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.1 mm -59.72 -36.36 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.74 . . . . 1.45 110.392 179.119 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 82.5 mtp -63.0 -43.53 98.54 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.225 1.012 . . . . 1.05 109.209 179.509 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -57.38 -45.09 84.83 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.691 -0.631 . . . . 0.72 110.656 179.538 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -63.23 -44.95 93.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.95 -1.093 . . . . 3.05 110.435 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.2 m -70.3 -40.88 74.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.913 . . . . 0.89 110.257 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.8 mt -91.21 -6.36 53.5 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.494 0.664 . . . . 0.78 112.242 -177.145 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 194' ' ' ALA . 98.0 mt-10 50.54 9.42 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.991 1.108 . . . . 1.45 113.991 179.899 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 80.9 mt -71.63 147.67 92.31 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.675 -1.266 . . . . 0.67 108.212 179.113 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.52 138.76 81.37 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.454 1.436 . . . . 0.64 110.227 178.66 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.54 166.67 20.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.312 -1.755 . . . . 0.67 109.865 179.694 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.4 mt -146.25 156.03 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.188 -1.412 . . . . 0.69 107.188 177.541 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.0 m -140.38 -32.37 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 120.742 -1.224 . . . . 0.85 113.035 -179.166 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -95.28 39.87 2.78 Favored Glycine 0 N--CA 1.497 2.744 0 O-C-N 120.942 -1.099 . . . . 0.92 112.076 -177.943 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.505 ' OG1' HG23 ' A' ' 208' ' ' VAL . 23.1 p -59.21 -23.75 62.55 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.089 -1.242 . . . . 0.95 111.799 -179.482 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 101.78 -86.16 0.58 Allowed Glycine 0 N--CA 1.496 2.654 0 C-N-CA 120.396 -0.907 . . . . 1.04 111.345 179.807 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.7 m -132.58 36.56 3.55 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 121.124 -1.221 . . . . 1.57 113.16 -178.529 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.505 HG23 ' OG1' ' A' ' 205' ' ' THR . 93.1 t -53.06 -33.83 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.336 -1.477 . . . . 0.84 110.396 179.252 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.2 p -61.31 -20.62 63.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.99 112.018 -179.675 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.2 m -96.08 2.72 53.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.057 -1.027 . . . . 1.7 112.289 179.63 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -132.05 2.97 4.01 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 112.907 0.706 . . . . 2.2 112.907 -178.281 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 36.0 t -122.54 142.43 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.439 -0.788 . . . . 0.84 109.658 -178.902 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -119.27 149.15 42.25 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.261 -1.014 . . . . 2.2 108.261 177.596 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.464 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 40.3 p-10 -50.73 140.16 15.21 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.876 -1.14 . . . . 2.28 110.023 178.688 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t0 79.62 -2.07 2.13 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.482 1.29 . . . . 2.35 114.482 179.639 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.09 147.0 53.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.532 -1.355 . . . . 1.97 108.233 177.632 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -88.67 120.84 30.43 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.184 -1.413 . . . . 2.65 107.184 178.274 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.449 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 56.6 mt -128.14 146.41 50.72 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.55 -0.719 . . . . 0.63 109.854 -179.56 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.53 HD13 ' SD ' ' A' ' 239' ' ' MET . 84.5 mt -114.07 125.02 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 106.788 -1.56 . . . . 0.62 106.788 177.522 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.0 tp -99.86 115.26 29.2 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.315 -1.735 . . . . 0.64 106.315 178.528 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 223' ' ' VAL . 30.0 p-10 -92.72 -25.53 18.17 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.663 -1.215 . . . . 2.05 112.664 -177.848 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.871 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.47 21.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 112.903 0.705 . . . . 0.84 112.903 -178.659 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.3 t -112.79 -59.67 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 121.116 -0.99 . . . . 1.02 109.451 -179.876 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 36.7 m120 -95.79 13.5 26.39 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.148 0.975 . . . . 2.51 110.096 -179.701 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 61.4 t30 60.76 51.82 4.66 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.23 -0.895 . . . . 1.54 111.85 179.326 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.451 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 81.2 mt-30 -149.54 148.17 29.05 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.246 1.022 . . . . 1.95 110.079 178.454 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.54 138.07 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.312 -1.366 . . . . 0.71 107.312 177.887 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -99.58 136.92 38.79 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.933 -1.104 . . . . 1.01 108.516 178.694 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.7 t -109.82 130.18 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 109.001 -0.741 . . . . 0.82 109.001 179.135 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 49.42 55.6 17.31 Favored Pre-proline 0 N--CA 1.498 1.973 0 N-CA-C 113.566 0.95 . . . . 1.54 113.566 178.792 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.08 150.66 82.39 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.474 2.116 . . . . 0.94 110.412 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.504 ' OG1' HG23 ' A' ' 235' ' ' VAL . 31.1 p -72.08 154.55 41.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 1.8 108.915 177.647 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -57.39 -40.14 77.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.058 -1.026 . . . . 2.73 110.8 178.952 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -60.96 -39.04 88.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -0.984 . . . . 3.17 110.332 -179.852 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.504 HG23 ' OG1' ' A' ' 232' ' ' THR . 74.6 t -69.38 -36.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.331 -0.856 . . . . 1.34 110.038 179.413 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.41 ' CG2' HH12 ' A' ' 240' ' ' ARG . 95.5 mt -59.16 -46.01 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 1.2 110.462 178.977 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -59.66 -40.56 88.16 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.07 -1.052 . . . . 2.7 109.969 179.491 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -61.17 -40.08 92.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.527 -0.733 . . . . 2.59 110.221 179.834 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.53 ' SD ' HD13 ' A' ' 219' ' ' ILE . 76.9 mtp -70.84 -33.78 71.01 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.36 -0.838 . . . . 1.38 110.5 -179.807 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.55 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.1 OUTLIER -56.46 -41.14 76.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.942 -1.098 . . . . 2.84 109.364 179.619 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.05 -42.52 66.18 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.677 -0.639 . . . . 1.88 110.209 179.794 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 72.9 t -59.69 -48.76 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.388 -0.82 . . . . 2.4 110.452 -178.265 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 13' ' ' PHE . 51.5 tt0 -59.98 -50.59 73.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.622 -1.298 . . . . 3.52 110.591 179.816 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.05 -31.08 72.13 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.188 -1.005 . . . . 1.88 109.711 -179.747 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -62.81 -30.29 71.36 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.512 -0.875 . . . . 3.01 109.138 178.755 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.24 -40.08 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.406 -0.917 . . . . 2.45 109.192 178.792 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.6 -38.15 71.64 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.871 -1.132 . . . . 2.75 109.357 179.029 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.3 t -68.12 -30.45 69.61 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.42 0.629 . . . . 3.16 109.645 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -63.48 -29.28 70.58 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.524 0.678 . . . . 3.57 110.85 179.555 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -61.54 -28.38 69.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.425 -0.797 . . . . 4.3 111.172 179.479 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -65.67 -10.76 39.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 4.45 111.879 179.634 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.16 -7.97 52.11 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.277 -0.889 . . . . 5.97 112.529 -179.396 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 34.4 tp -63.74 -24.64 67.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.125 -0.984 . . . . 6.18 111.265 -179.258 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -70.12 -1.25 9.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.154 -0.966 . . . . 6.66 112.657 179.844 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -82.04 11.85 4.76 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.181 -0.949 . . . . 8.2 112.488 -179.346 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.528 ' CD2' ' H ' ' A' ' 256' ' ' LEU . 0.7 OUTLIER -82.09 9.4 8.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.117 -0.99 . . . . 8.07 112.454 179.626 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -81.86 -2.3 50.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.989 . . . . 9.45 111.919 -179.796 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -93.91 -1.6 54.5 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.301 -0.874 . . . . 10.12 112.628 -177.993 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 42.9 mtm-85 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.094 -0.955 . . . . 11.49 109.202 -178.839 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.087 -0.708 . . . . 3.07 109.087 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.0 mt -102.24 109.53 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.018 -1.845 . . . . 1.07 106.018 176.481 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.3 m -105.85 124.06 48.96 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.661 -1.236 . . . . 1.24 107.661 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.51 -144.44 13.14 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 108.88 -1.688 . . . . 1.01 108.88 179.527 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 5' ' ' ILE . 73.1 mt -97.28 -3.77 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.146 -1.208 . . . . 1.11 112.635 -179.085 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.453 ' H ' HG23 ' A' ' 202' ' ' ILE . 3.8 tp 49.77 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.226 -0.921 . . . . 0.99 112.437 178.947 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -85.58 -40.07 16.67 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.0 . . . . 0.85 112.152 178.967 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 m -147.02 144.9 20.55 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 120.982 -1.074 . . . . 1.38 108.379 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.53 143.95 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.724 2.283 . . . . 0.94 112.127 178.246 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.883 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.08 171.41 21.73 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.319 -1.512 . . . . 0.81 109.319 178.189 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.8 mt -129.92 133.8 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 N-CA-C 107.702 -1.222 . . . . 0.83 107.702 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.38 155.52 47.6 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.564 -0.71 . . . . 0.53 109.119 178.742 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.9 m-85 -126.46 140.18 52.67 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.681 -1.229 . . . . 0.77 107.681 177.97 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.83 170.5 41.78 Favored Glycine 0 N--CA 1.499 2.882 0 C-N-CA 118.382 -1.866 . . . . 0.51 110.297 178.175 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -77.12 154.26 33.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.965 . . . . 1.9 108.938 178.502 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.558 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.03 125.79 33.02 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.233 -1.025 . . . . 0.66 108.233 178.373 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.3 tp -105.49 105.92 16.19 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.458 -2.053 . . . . 0.83 105.458 177.659 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.6 tp -94.18 135.39 35.61 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.957 -1.127 . . . . 0.86 107.957 179.96 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.4 mt -99.36 114.94 28.11 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.832 -1.544 . . . . 0.92 106.832 178.353 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -110.38 124.41 51.65 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.626 -1.62 . . . . 2.03 106.626 -179.88 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -129.77 147.52 51.55 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.418 -0.801 . . . . 2.66 109.39 -179.493 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 27.6 p-10 -81.55 140.9 34.24 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.912 -1.118 . . . . 2.32 109.088 177.807 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -64.69 149.94 48.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.04 -1.038 . . . . 2.11 110.976 178.283 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.9 mt -90.8 133.8 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.15 -0.969 . . . . 0.73 108.811 178.15 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.3 t -109.29 129.79 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.225 -1.028 . . . . 0.87 108.225 179.119 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.0 mt -94.66 137.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.127 -1.064 . . . . 0.81 108.127 178.778 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.95 122.44 35.32 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.977 -1.12 . . . . 1.34 107.977 178.938 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -99.56 18.12 18.72 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.342 -0.849 . . . . 2.89 112.631 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -69.18 146.79 52.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 2.09 109.428 178.738 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -88.98 130.88 35.38 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.329 -0.989 . . . . 2.19 108.329 177.669 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.7 pt -93.33 164.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.751 0.786 . . . . 0.75 110.066 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.2 p -95.41 163.85 13.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.587 -0.695 . . . . 0.91 109.659 178.525 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.8 -22.3 13.9 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.113 -0.992 . . . . 0.93 111.91 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -68.69 -37.06 79.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.932 . . . . 2.28 110.54 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -92.29 -6.31 50.6 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.791 -1.193 . . . . 1.45 113.174 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.31 -42.98 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.055 -1.028 . . . . 0.81 110.576 -179.433 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.36 -37.55 75.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.137 -0.977 . . . . 1.54 110.263 179.726 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -61.93 -43.92 97.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.646 -0.659 . . . . 2.36 110.847 179.906 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.47 -39.12 86.49 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.045 -1.035 . . . . 1.31 111.367 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.26 -40.19 83.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.045 -1.035 . . . . 0.82 110.757 179.429 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -60.95 -48.32 82.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.155 -0.965 . . . . 1.5 110.064 179.663 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -62.17 -38.31 88.55 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.167 -0.958 . . . . 2.23 110.278 179.842 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -74.16 -51.03 16.81 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.858 -1.151 . . . . 0.85 110.285 179.437 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.4 tp -62.81 -49.67 74.0 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.29 -0.964 . . . . 0.91 109.448 -179.622 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.7 t -69.3 -38.77 78.46 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.505 0.669 . . . . 0.9 109.653 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.09 -43.54 93.29 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.601 -1.4 . . . . 0.69 109.601 179.629 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -59.31 -31.74 69.43 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.07 -1.052 . . . . 2.88 109.644 178.871 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -53.78 -47.67 70.53 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.835 -0.746 . . . . 0.85 109.919 179.089 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -77.78 -39.77 42.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 2.35 110.344 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.76 91.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.65 110.049 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.5 p -60.47 -39.6 88.18 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.223 1.011 . . . . 1.45 109.357 179.942 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.12 -46.02 72.06 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.602 -0.727 . . . . 0.63 110.942 179.494 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.5 -50.09 72.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.222 -0.924 . . . . 1.34 110.753 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.21 -36.83 84.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 1.56 109.844 -179.889 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -59.39 -40.24 85.95 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.639 -0.663 . . . . 1.19 110.53 179.155 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.9 m -66.89 -41.69 86.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.047 -1.033 . . . . 0.72 110.324 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.3 -34.03 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.439 -0.788 . . . . 0.62 110.834 -179.703 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -55.93 -45.02 78.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.412 -0.805 . . . . 1.05 111.018 179.301 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.49 -33.44 71.23 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.003 -1.061 . . . . 0.64 110.545 -179.626 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -62.75 -40.27 96.7 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.653 -1.219 . . . . 1.73 109.443 -179.844 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.72 -34.52 78.03 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.776 -0.577 . . . . 0.56 110.363 179.679 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.88 -37.52 25.7 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.536 -1.316 . . . . 0.69 111.41 179.701 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -79.88 -22.31 43.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.036 -1.273 . . . . 1.48 110.815 -179.676 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -89.43 -50.96 5.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.363 -0.836 . . . . 0.98 110.597 179.853 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -108.34 -6.99 16.0 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.143 1.164 . . . . 1.16 114.143 -177.543 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.6 157.48 23.58 Favored Glycine 0 N--CA 1.502 3.072 0 O-C-N 121.056 -1.028 . . . . 0.85 113.473 178.519 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -51.03 -20.69 1.48 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.498 -1.001 . . . . 3.86 112.791 179.197 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.49 -35.31 72.03 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.822 -1.174 . . . . 2.35 111.489 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -84.16 -18.85 35.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.021 -1.049 . . . . 1.67 112.494 -179.555 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.96 -32.71 71.07 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.975 -1.078 . . . . 1.45 110.636 -179.372 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.51 86.88 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.038 -1.039 . . . . 0.61 110.598 179.329 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.0 mt -66.33 -47.66 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.118 -0.989 . . . . 0.65 109.828 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -72.04 -36.54 69.65 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.219 -0.925 . . . . 0.66 110.018 179.822 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.92 -39.11 84.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.493 -0.754 . . . . 1.19 110.074 -179.966 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.01 -35.37 83.92 Favored Glycine 0 N--CA 1.484 1.867 0 C-N-CA 119.795 -1.193 . . . . 0.53 110.491 179.579 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -60.22 -41.27 92.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -1.135 . . . . 1.27 110.542 179.117 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.4 mt -60.96 -41.94 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.025 -1.047 . . . . 0.54 110.423 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.0 ttm -59.77 -40.57 88.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -0.866 . . . . 1.74 110.576 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -60.39 -46.32 90.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.914 -1.116 . . . . 0.55 110.032 179.799 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.0 tp -59.0 -40.36 84.65 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.402 -0.811 . . . . 0.47 110.487 179.81 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -87.08 8.01 25.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.506 -0.746 . . . . 1.42 112.685 -179.887 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -60.26 118.94 7.01 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.185 -0.947 . . . . 1.27 109.61 179.609 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.57 -18.36 63.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.772 0.796 . . . . 1.35 110.954 -179.532 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.82 -52.79 8.33 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.747 -0.781 . . . . 2.22 110.401 -179.918 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.4 mt -61.24 -37.87 84.62 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.18 -1.008 . . . . 0.62 110.441 -179.529 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -58.88 -48.6 80.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 1.29 110.497 179.216 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.4 -38.81 91.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.285 -0.884 . . . . 1.52 110.476 179.814 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.78 -48.17 72.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.991 -1.068 . . . . 1.3 110.503 179.713 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 93.1 mt -58.29 -42.09 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.252 -0.905 . . . . 0.61 109.973 179.419 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.2 mt -63.43 -41.39 92.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.466 -0.772 . . . . 0.78 110.167 179.797 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.93 99.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.426 -0.796 . . . . 0.82 110.664 -179.778 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.0 mt -59.66 -43.72 93.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.8 110.492 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.56 -48.2 89.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.051 -1.031 . . . . 0.77 109.911 179.72 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.94 -36.23 41.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.783 . . . . 2.12 111.709 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -78.94 -48.29 14.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.709 -1.244 . . . . 1.51 111.315 -178.985 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -101.32 8.65 42.27 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.311 -0.868 . . . . 1.98 112.358 -177.685 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m80 50.67 51.31 17.18 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.972 -1.091 . . . . 1.32 111.568 179.892 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.9 mtp -107.79 157.0 18.51 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.55 -0.719 . . . . 1.38 109.239 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.2 p -73.95 158.76 33.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.606 -0.684 . . . . 0.67 109.407 177.784 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.75 91.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.485 -0.76 . . . . 0.52 110.613 179.347 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 28.8 p-10 -68.05 -42.84 79.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.953 -1.092 . . . . 2.25 110.014 179.314 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -68.28 -50.64 52.34 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.461 -0.896 . . . . 0.64 110.734 -179.885 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.24 88.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 0.56 110.592 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.69 -45.65 91.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 0.46 111.39 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -60.45 -39.24 86.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.792 -1.192 . . . . 1.32 111.539 -179.686 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.49 -47.89 78.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.693 -1.255 . . . . 1.3 111.031 179.597 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.18 -44.25 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.723 -1.235 . . . . 0.61 109.742 179.854 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -62.74 -34.7 67.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.631 -0.668 . . . . 0.65 110.755 179.998 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -56.6 -40.55 75.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.845 . . . . 2.11 111.214 179.469 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.21 -34.07 13.26 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.201 -1.476 . . . . 0.83 112.91 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -59.97 -38.26 82.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.398 -1.648 . . . . 1.28 110.04 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.04 -47.23 38.2 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.722 0.773 . . . . 0.89 110.704 179.599 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.7 m -60.37 -40.17 89.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.092 -1.005 . . . . 1.87 110.599 -178.585 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.6 -47.16 86.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.377 -0.827 . . . . 1.05 110.929 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.12 -29.76 69.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.881 -1.137 . . . . 1.02 110.837 -179.829 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -65.06 -22.35 66.96 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.342 -0.849 . . . . 2.04 110.571 179.437 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -71.1 -12.94 61.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.909 0.862 . . . . 1.73 110.815 179.87 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.5 mt -88.49 135.86 33.27 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.806 -1.183 . . . . 1.37 107.806 178.712 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 45.6 t0 -97.99 40.99 1.14 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.388 -0.82 . . . . 2.88 111.98 -179.381 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -114.53 140.38 48.81 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 121.007 -1.058 . . . . 1.58 108.966 178.987 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.07 -40.35 73.46 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.871 -0.732 . . . . 3.04 110.816 178.557 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -71.23 -56.88 5.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.102 -0.999 . . . . 0.9 110.59 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.62 -40.5 83.51 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.19 -0.944 . . . . 1.06 110.41 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -63.31 -47.77 80.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.02 -1.05 . . . . 2.18 109.794 179.866 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -60.17 -31.15 69.85 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.213 -0.929 . . . . 2.15 110.092 179.715 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -61.66 -30.07 70.48 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.552 -1.259 . . . . 2.33 109.262 179.269 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.78 -50.38 73.69 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.74 -0.784 . . . . 0.82 109.423 178.682 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.55 -43.42 80.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.679 0.752 . . . . 0.85 110.315 179.769 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -62.8 -32.7 73.94 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.671 0.748 . . . . 1.39 110.283 -179.691 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 t -68.69 -39.63 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.419 -0.801 . . . . 0.56 110.097 179.589 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -59.48 -37.45 78.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.057 -1.027 . . . . 3.12 109.764 178.852 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -59.92 -40.16 87.93 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.484 0.659 . . . . 1.28 110.259 179.436 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.6 mt -59.57 -39.8 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.49 110.456 179.598 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.33 -45.51 69.09 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 110.54 -1.024 . . . . 0.46 110.54 179.388 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -59.15 -46.77 87.5 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.059 -1.259 . . . . 2.71 110.208 179.41 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 64.4 mtt-85 -62.22 -38.89 90.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.888 -1.132 . . . . 2.14 110.273 179.751 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.0 tp -60.15 -41.02 91.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.682 -0.637 . . . . 1.05 109.852 178.911 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.3 mt -59.66 -40.05 86.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.606 -0.684 . . . . 0.52 110.58 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -60.28 -39.21 86.08 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.206 -0.934 . . . . 2.35 111.256 179.942 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -73.56 -41.62 62.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.108 . . . . 1.39 110.985 -179.866 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.33 -40.08 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.849 . . . . 0.68 110.548 -178.436 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.3 mt -89.32 -8.0 54.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.031 -1.043 . . . . 0.83 111.891 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.57 23.22 70.79 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.761 -1.209 . . . . 0.91 113.518 -179.511 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 18.6 tp -67.23 139.91 57.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.934 -0.745 . . . . 0.95 109.115 179.578 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -70.03 146.97 50.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.421 -0.799 . . . . 2.43 109.357 177.892 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 79.7 mt -108.68 138.67 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 121.128 -0.982 . . . . 1.1 108.619 178.746 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.719 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -78.66 131.65 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.702 -1.249 . . . . 1.58 108.808 178.888 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -94.51 97.37 10.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.396 -1.705 . . . . 1.62 106.396 178.686 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 mt -77.58 -13.37 59.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.473 -0.767 . . . . 0.8 111.916 -177.861 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.8 t -82.9 3.33 30.27 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.906 -1.121 . . . . 1.56 112.584 -179.734 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.5 15.26 22.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.316 -0.865 . . . . 0.84 112.31 179.451 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 24.6 mt -71.93 140.05 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.565 -0.71 . . . . 0.82 109.591 178.801 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -127.91 -6.71 5.56 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.717 0.77 . . . . 2.31 112.323 -179.436 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -110.2 140.21 44.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.571 -0.9 . . . . 1.54 108.571 179.459 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -71.61 120.84 17.77 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.589 -0.893 . . . . 1.38 108.589 178.403 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.51 171.74 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.985 -0.746 . . . . 0.69 108.985 -179.864 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.3 mt -93.18 141.12 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.295 -1.002 . . . . 0.53 108.295 178.275 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 26.8 tp -96.79 120.98 38.13 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.0 -1.063 . . . . 0.64 108.627 178.46 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.42 HG12 HG22 ' A' ' 209' ' ' THR . 44.6 t -121.21 131.15 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 107.816 -1.179 . . . . 0.67 107.816 179.781 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.403 ' C ' HG21 ' A' ' 209' ' ' THR . . . -162.94 157.98 21.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.018 . . . . 0.78 108.785 179.084 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.404 ' N ' HG21 ' A' ' 209' ' ' THR . . . -61.35 -34.45 75.31 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.303 -1.498 . . . . 1.0 109.474 178.079 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -173.04 154.91 2.91 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.827 -0.805 . . . . 2.42 108.827 179.574 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 69.0 mt -121.64 137.81 54.59 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.375 -1.343 . . . . 0.75 107.375 177.519 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.8 p -93.45 148.24 35.17 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.843 -1.161 . . . . 0.78 108.676 179.529 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -39.72 -40.99 2.52 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 122.066 1.844 . . . . 0.67 113.485 178.811 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.4 m -60.98 -50.23 74.22 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.254 -0.903 . . . . 0.7 110.238 -179.727 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -61.61 -38.55 88.0 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.952 -1.093 . . . . 1.21 109.704 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.4 p -68.61 -36.93 79.32 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.335 0.588 . . . . 0.6 110.639 179.524 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.36 -35.02 79.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.402 -0.811 . . . . 0.62 110.64 179.869 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -97.26 -0.6 46.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.477 -0.764 . . . . 1.16 112.503 -179.08 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.6 tp -64.21 153.72 37.12 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.735 -0.603 . . . . 0.73 109.646 179.749 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -97.13 113.15 24.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 106.848 -1.538 . . . . 2.24 106.848 177.615 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.36 -17.0 60.88 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.873 -0.517 . . . . 1.43 112.356 -178.018 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -84.63 -15.43 45.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.105 -0.997 . . . . 2.15 112.421 -178.574 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -103.69 -9.7 18.93 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.685 0.994 . . . . 2.04 113.685 -178.032 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 178' ' ' GLY . 59.3 t -109.51 129.98 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.768 -0.827 . . . . 0.55 108.768 179.666 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.582 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -88.07 -11.56 46.78 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.075 -1.016 . . . . 1.63 111.827 -179.428 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.427 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -173.8 167.78 40.43 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.292 -1.523 . . . . 0.47 109.292 179.807 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -124.15 131.99 53.59 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.218 -1.166 . . . . 0.54 107.995 178.586 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.5 mt -131.49 132.14 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.019 -1.104 . . . . 0.69 108.019 178.795 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 203' ' ' VAL . 55.5 p -135.5 163.37 30.23 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.192 -1.04 . . . . 0.82 108.192 178.08 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.452 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 17.6 m-20 -106.51 12.35 29.65 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.248 -0.908 . . . . 2.37 112.133 179.065 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 184' ' ' GLY . . . -134.66 -62.5 0.73 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.154 -0.966 . . . . 1.11 113.184 -177.068 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 183' ' ' ALA . . . -38.27 151.22 0.04 OUTLIER Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.453 -0.659 . . . . 1.67 111.453 -176.443 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 172.2 -70.3 0.11 Allowed Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.194 -1.479 . . . . 1.54 112.516 179.343 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.509 ' O ' HG23 ' A' ' 187' ' ' THR . 57.7 mtp180 -54.61 -42.2 70.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -1.223 . . . . 4.48 110.755 -178.915 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 186' ' ' ARG . 31.2 p -159.08 45.73 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.825 . . . . 2.63 111.114 -179.498 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.0 p -78.85 136.94 37.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.908 -1.12 . . . . 1.69 109.355 -179.476 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -60.14 -30.86 69.57 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.627 -0.671 . . . . 1.07 110.492 178.863 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.4 m -59.43 -39.6 84.05 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.152 -0.968 . . . . 1.58 110.028 179.424 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 87.0 p -59.52 -37.56 78.68 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.271 -0.893 . . . . 1.6 110.281 179.366 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.09 -39.75 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 1.45 110.493 179.48 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 45.0 mtp -61.74 -44.31 97.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.994 -1.067 . . . . 1.05 109.524 179.484 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.72 -50.58 72.91 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.373 -0.83 . . . . 0.72 111.187 179.992 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -60.57 -42.75 97.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.025 -1.047 . . . . 3.05 110.886 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.7 m -69.98 -38.44 76.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.932 -1.105 . . . . 0.89 110.521 179.968 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.9 mt -91.66 -8.48 47.0 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.686 0.755 . . . . 0.78 112.918 -179.222 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 194' ' ' ALA . 93.8 mt-10 56.75 9.88 0.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.244 1.201 . . . . 1.45 114.244 179.725 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.7 mt -71.41 149.49 93.8 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.945 -1.097 . . . . 0.67 108.086 179.167 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.76 140.22 94.09 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.376 1.384 . . . . 0.64 109.86 178.741 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.26 163.66 35.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.206 -1.559 . . . . 0.67 110.132 179.881 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.462 ' CD1' HD11 ' A' ' 220' ' ' LEU . 11.8 mt -150.25 158.15 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.343 -1.354 . . . . 0.69 107.343 178.17 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 181' ' ' THR . 7.0 m -146.78 -25.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 O-C-N 119.958 -1.714 . . . . 0.85 113.672 -179.578 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -100.93 43.64 1.7 Allowed Glycine 0 N--CA 1.5 2.948 0 O-C-N 120.886 -1.134 . . . . 0.92 110.564 -178.679 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.452 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 33.5 p -63.05 -21.02 65.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.08 -1.247 . . . . 0.95 111.658 -179.651 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.84 -83.01 0.51 Allowed Glycine 0 N--CA 1.499 2.88 0 O-C-N 121.518 -0.739 . . . . 1.04 111.32 179.148 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 77.7 p -134.82 31.67 3.31 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.843 -1.386 . . . . 1.57 113.256 -178.58 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.447 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 78.8 t -60.05 -37.92 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.173 -1.58 . . . . 0.84 110.645 179.576 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.42 HG22 HG12 ' A' ' 159' ' ' VAL . 51.9 p -60.12 -18.97 51.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.174 -0.954 . . . . 0.99 112.474 -179.623 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.7 m -94.31 -0.27 55.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 1.7 112.213 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -131.53 8.35 4.58 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.627 -0.671 . . . . 2.2 112.545 -178.161 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.85 148.63 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.601 -0.687 . . . . 0.84 109.625 -179.146 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -119.01 150.25 40.26 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.939 -1.134 . . . . 2.2 107.939 177.857 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 49.6 p-10 -55.68 142.69 33.17 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.899 -1.125 . . . . 2.28 110.374 178.414 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 m-20 80.34 -1.8 1.95 Allowed 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 114.276 1.213 . . . . 2.35 114.276 179.289 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.14 147.63 50.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.921 -1.112 . . . . 1.97 108.816 177.718 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -88.64 118.35 28.25 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.362 -1.461 . . . . 2.65 107.274 177.782 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.558 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.2 mt -128.22 150.34 50.07 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.837 -0.539 . . . . 0.63 109.788 -179.26 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.37 127.92 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 106.964 -1.495 . . . . 0.62 106.964 177.79 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.462 HD11 ' CD1' ' A' ' 202' ' ' ILE . 44.7 tp -100.35 119.92 39.16 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.005 -1.48 . . . . 0.64 107.005 178.478 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.638 ' O ' ' N ' ' A' ' 223' ' ' VAL . 34.4 t0 -92.35 -25.37 18.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.771 -1.206 . . . . 2.05 112.258 -177.873 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.883 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.34 11.11 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.025 0.75 . . . . 0.84 113.025 -179.077 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.6 t -110.45 -62.27 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 120.836 -1.165 . . . . 1.02 109.108 179.776 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -88.52 5.9 40.44 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.213 1.006 . . . . 2.51 110.23 -179.804 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 47.3 t30 62.73 52.39 2.8 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.208 -0.905 . . . . 1.54 112.184 179.355 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -145.54 150.51 36.55 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.279 1.038 . . . . 1.95 109.973 178.111 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.11 138.23 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.29 -1.374 . . . . 0.71 107.29 178.261 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -103.51 130.92 50.99 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.174 -1.047 . . . . 1.01 108.174 178.463 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 30.2 t -109.2 129.8 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 107.789 -1.189 . . . . 0.82 107.789 178.815 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.466 ' O ' ' ND2' ' A' ' 230' ' ' ASN . 0.2 OUTLIER 54.26 49.98 6.27 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 1.54 113.47 178.764 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.4 Cg_endo -68.4 150.27 75.68 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.847 2.365 . . . . 0.94 110.608 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.8 p -73.74 160.59 31.3 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.805 -1.184 . . . . 1.8 110.137 178.238 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.37 -41.62 89.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.537 -0.727 . . . . 2.73 110.702 179.046 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -61.94 -34.93 77.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.257 -0.902 . . . . 3.17 110.586 -179.804 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.21 -37.4 76.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.965 -1.084 . . . . 1.34 109.865 179.386 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.4 mt -58.29 -45.19 89.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.127 -0.983 . . . . 1.2 110.386 179.066 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -58.48 -39.98 81.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 2.7 110.489 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -61.63 -45.52 93.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.4 -0.813 . . . . 2.59 110.664 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 75.5 mtp -72.3 -35.52 68.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.036 -1.04 . . . . 1.38 110.596 -179.697 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -57.46 -37.62 73.15 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.125 -0.985 . . . . 2.84 110.664 -179.904 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -69.27 -46.08 68.13 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.44 -0.904 . . . . 1.88 110.669 179.748 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 95.9 t -59.88 -47.72 90.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.111 -0.993 . . . . 2.4 111.817 -179.445 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.64 -49.32 78.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.765 -1.209 . . . . 3.52 111.191 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.51 -36.63 84.39 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.21 -0.931 . . . . 1.88 111.692 -179.455 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -61.22 -28.76 69.38 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.076 -1.449 . . . . 3.01 110.041 179.426 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.04 -41.83 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.762 -0.775 . . . . 2.45 110.368 178.941 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.09 -38.64 83.54 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.749 0.785 . . . . 2.75 110.233 179.566 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.8 t -68.69 -31.01 69.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.381 -0.824 . . . . 3.16 110.863 179.761 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -62.24 -41.39 98.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.094 -1.004 . . . . 3.57 110.507 179.631 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -68.52 -38.58 81.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 4.3 110.491 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.49 -3.28 33.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.432 -0.793 . . . . 4.45 112.368 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -70.85 -14.4 62.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.26 -0.9 . . . . 5.97 112.034 -178.527 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.06 -39.62 86.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.673 -1.267 . . . . 6.18 109.939 -179.9 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -71.5 -24.7 62.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 6.66 110.832 179.97 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -88.45 32.95 0.76 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.135 0.969 . . . . 8.2 112.153 -179.865 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.33 6.79 7.56 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.748 0.785 . . . . 8.07 112.529 -179.675 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -81.24 -3.27 51.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 9.45 112.399 179.809 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -96.83 -54.73 3.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.206 -0.934 . . . . 10.12 111.05 -179.438 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 117.928 -1.034 . . . . 11.49 108.806 -178.996 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.2 mtp . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.891 -0.411 . . . . 3.07 109.891 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.8 mt -93.08 107.86 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 105.869 -1.9 . . . . 1.07 105.869 177.315 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.8 m -106.93 120.28 41.62 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.929 -1.137 . . . . 1.24 107.929 -179.358 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.94 -156.21 27.25 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.602 -1.799 . . . . 1.01 108.602 179.496 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 5' ' ' ILE . 67.4 mt -96.88 1.41 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -1.209 . . . . 1.11 112.713 -179.507 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 tp 48.82 98.11 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.044 -1.035 . . . . 0.99 112.674 178.565 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -87.28 -39.16 15.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 0.85 110.842 179.364 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -146.55 144.66 21.19 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.049 -1.093 . . . . 1.38 108.049 -179.454 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.87 145.32 25.17 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.396 2.064 . . . . 0.94 111.917 178.307 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.931 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.96 174.36 23.28 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.803 -1.719 . . . . 0.81 108.803 178.116 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.9 mt -131.28 139.59 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.846 -1.168 . . . . 0.83 107.846 179.759 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.52 148.54 42.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.662 -1.274 . . . . 0.53 108.963 178.402 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -119.23 135.7 54.57 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 107.575 -1.269 . . . . 0.77 107.575 177.348 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.1 168.41 40.23 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 118.304 -1.903 . . . . 0.51 110.112 178.239 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -77.39 159.32 29.55 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.836 -0.802 . . . . 1.9 108.836 178.12 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -83.85 120.26 25.85 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.766 -1.209 . . . . 0.66 108.011 178.557 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.0 tp -102.46 102.66 12.98 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 105.266 -2.124 . . . . 0.83 105.266 178.138 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.8 tp -88.96 130.03 35.52 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.735 -1.209 . . . . 0.86 107.735 179.427 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.43 119.54 35.1 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.994 -1.484 . . . . 0.92 106.994 178.389 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -110.19 137.57 47.75 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.465 -1.309 . . . . 2.03 107.465 -179.787 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -116.22 139.31 50.48 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.111 -0.993 . . . . 2.66 108.843 179.004 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -81.66 130.2 34.97 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.599 -1.26 . . . . 2.32 107.599 177.758 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.35 141.17 58.87 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.575 -0.898 . . . . 2.11 108.575 178.847 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.4 mt -95.73 132.55 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.275 -1.009 . . . . 0.73 108.275 178.289 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.95 129.56 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.686 -1.227 . . . . 0.87 107.686 178.87 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.99 137.55 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.541 -0.911 . . . . 0.81 108.541 179.302 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -92.34 125.18 36.89 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.944 -1.097 . . . . 1.34 108.25 178.751 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -96.98 18.09 15.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -0.853 . . . . 2.89 112.1 -179.722 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -66.9 152.63 45.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.17 -0.956 . . . . 2.09 110.377 179.307 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -93.71 134.6 35.86 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.87 -0.789 . . . . 2.19 108.87 177.975 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -95.92 169.26 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.526 -0.733 . . . . 0.75 109.784 179.336 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.0 p -94.25 161.93 14.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 0.91 109.932 178.494 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.65 -23.08 15.69 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.799 -1.188 . . . . 0.93 111.891 179.137 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -69.29 -37.41 77.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.424 -0.798 . . . . 2.28 111.016 -179.47 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -88.47 -7.92 55.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.898 -1.126 . . . . 1.45 112.854 -179.852 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.75 -41.18 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.329 -0.857 . . . . 0.81 110.219 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.4 -39.3 82.94 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.104 -0.998 . . . . 1.54 110.157 179.243 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -62.29 -40.28 95.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.622 -0.674 . . . . 2.36 110.922 -179.993 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.63 -39.58 88.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 1.31 110.771 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.12 -41.53 86.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.246 -0.982 . . . . 0.82 110.111 179.275 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -61.54 -48.36 81.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.847 -1.158 . . . . 1.5 109.938 179.594 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.527 HH11 ' HG2' ' A' ' 42' ' ' ARG . 14.9 mtt-85 -60.52 -39.5 88.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.123 -0.986 . . . . 2.23 109.628 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -73.39 -52.85 12.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.979 -1.076 . . . . 0.85 110.029 179.23 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.97 -45.12 95.06 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.121 -1.032 . . . . 0.91 109.643 -179.868 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 9.3 t -67.99 -35.23 77.98 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.957 0.884 . . . . 0.9 109.812 -179.761 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.84 -44.49 94.28 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.758 -1.337 . . . . 0.69 109.758 178.733 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.416 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 38.1 ttm-85 -57.25 -32.29 66.41 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.065 0.936 . . . . 2.88 109.495 178.869 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.76 -44.39 86.12 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.884 0.849 . . . . 0.85 109.947 179.251 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -83.47 -43.92 15.29 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.59 -0.694 . . . . 2.35 110.964 179.347 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -42.96 89.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 0.65 110.244 -179.898 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.415 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 22.9 t -62.89 -40.72 98.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.331 -0.856 . . . . 1.45 109.362 179.772 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.46 -48.79 54.18 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.411 0.624 . . . . 0.63 110.915 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -61.82 -47.75 83.67 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.581 -1.324 . . . . 1.34 110.727 -178.592 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.69 -39.2 91.02 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.202 -0.936 . . . . 1.56 110.34 -179.611 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 51' ' ' SER . 32.8 mm-40 -60.01 -40.55 89.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.807 -0.558 . . . . 1.19 110.724 179.3 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.8 m -64.49 -41.56 96.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.72 110.964 -179.887 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.78 -38.83 77.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.379 -0.826 . . . . 0.62 110.97 -179.873 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -52.92 -43.53 66.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 1.05 110.945 179.305 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -70.2 -38.32 75.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.912 -1.117 . . . . 0.64 110.279 -179.638 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -62.26 -39.13 91.87 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 118.637 -1.225 . . . . 1.73 109.427 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.24 -28.88 65.6 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.438 -0.789 . . . . 0.56 110.768 179.52 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.4 -35.69 13.87 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.423 -1.37 . . . . 0.69 110.815 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -81.34 -23.62 37.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.127 -1.219 . . . . 1.48 111.261 -179.91 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -88.66 -48.87 7.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.902 -0.499 . . . . 0.98 111.182 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -108.34 -8.05 15.75 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.996 1.11 . . . . 1.16 113.996 -177.759 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.06 156.89 19.27 Favored Glycine 0 N--CA 1.501 2.987 0 O-C-N 121.369 -0.832 . . . . 0.85 113.577 178.452 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -50.7 -21.73 1.75 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.573 -0.957 . . . . 3.86 112.536 179.072 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -54.3 -38.15 65.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.785 -1.197 . . . . 2.35 111.814 -179.972 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -80.18 -19.24 47.55 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.747 -1.221 . . . . 1.67 112.443 -178.989 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -61.08 -35.5 77.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.984 -1.072 . . . . 1.45 110.811 -179.47 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.79 88.01 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.107 -0.996 . . . . 0.61 111.364 179.773 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt -67.91 -46.86 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.465 -1.397 . . . . 0.65 110.178 179.771 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -72.25 -28.57 63.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.87 . . . . 0.66 111.129 -179.885 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -60.92 -40.56 93.64 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.679 -0.808 . . . . 1.19 109.888 179.565 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.22 -42.17 91.25 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.192 -1.163 . . . . 0.53 110.192 179.857 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -59.58 -45.99 90.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.472 -1.017 . . . . 1.27 110.79 179.39 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.6 mt -61.21 -40.48 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.663 -1.273 . . . . 0.54 110.504 -179.945 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.4 ttm -60.29 -38.35 83.31 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.295 -0.878 . . . . 1.74 110.214 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.5 tp -59.3 -45.77 90.37 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.055 -1.028 . . . . 0.55 110.358 179.208 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.416 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 60.0 tp -60.56 -42.38 96.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.526 -0.734 . . . . 0.47 110.225 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -84.81 4.87 31.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.304 -0.872 . . . . 1.42 112.849 -179.55 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -59.84 125.96 25.71 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.829 -1.169 . . . . 1.27 110.087 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.2 -19.14 65.13 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.542 -0.724 . . . . 1.35 111.351 -179.332 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.61 -53.36 9.52 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.144 -1.023 . . . . 2.22 110.687 179.946 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.3 mt -62.48 -39.28 92.93 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.32 -0.862 . . . . 0.62 110.753 -179.524 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -58.56 -47.0 85.69 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.152 -0.967 . . . . 1.29 110.822 179.338 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -63.12 -40.48 97.73 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.282 -0.886 . . . . 1.52 110.683 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -66.3 -48.3 70.8 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.939 -1.105 . . . . 1.3 110.646 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.38 -44.79 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.636 -1.29 . . . . 0.61 110.028 179.632 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.1 -43.85 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.457 -0.777 . . . . 0.78 110.486 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.4 -44.52 94.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 0.82 111.027 -179.673 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -60.04 -40.25 88.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.075 -1.016 . . . . 0.8 110.735 -179.716 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.55 -47.31 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.056 -1.027 . . . . 0.77 110.57 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -83.31 -31.73 26.69 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.327 -0.858 . . . . 2.12 112.035 -179.786 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -78.05 -47.85 17.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.511 -1.368 . . . . 1.51 110.9 -178.365 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -104.55 11.45 34.28 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 119.672 -0.811 . . . . 1.98 111.796 -178.05 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.3 m80 52.0 47.56 24.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.043 -1.036 . . . . 1.32 111.913 179.809 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 64.5 mtt -98.39 159.85 14.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.141 -0.975 . . . . 1.38 109.796 178.656 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.5 p -76.24 160.81 29.32 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.591 -0.693 . . . . 0.67 109.894 178.173 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.23 -42.75 86.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.368 -0.832 . . . . 0.52 110.989 178.786 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.535 ' OD2' HD21 ' A' ' 142' ' ' LEU . 92.6 m-20 -70.04 -38.97 75.99 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.658 -1.276 . . . . 2.25 110.19 -179.997 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.85 -51.56 39.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.859 -1.151 . . . . 0.64 111.589 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.96 92.26 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.792 -1.163 . . . . 0.56 110.811 -179.813 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.35 95.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.798 -0.564 . . . . 0.46 110.988 179.832 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -60.78 -40.25 91.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.629 -1.294 . . . . 1.32 111.236 -179.514 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.27 -49.87 76.19 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.843 -1.16 . . . . 1.3 111.4 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -59.43 -45.75 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.924 -1.11 . . . . 0.61 109.99 179.929 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.6 mm -62.72 -30.45 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-O 121.388 0.613 . . . . 0.65 110.329 179.768 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -57.36 -40.22 77.64 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.793 -0.763 . . . . 2.11 110.509 179.16 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.16 -30.67 22.05 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 119.249 -1.453 . . . . 0.83 112.877 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -61.34 -41.54 97.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.383 -1.657 . . . . 1.28 110.293 -179.914 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.7 -46.91 51.32 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 119.805 -0.758 . . . . 0.89 110.524 -179.975 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 50.4 p -62.99 -35.67 80.98 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.33 -0.856 . . . . 1.87 110.782 -178.447 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.97 87.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.604 -0.685 . . . . 1.05 110.898 179.951 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 mt -65.33 -28.74 69.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.868 -1.145 . . . . 1.02 111.271 -179.509 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -66.43 -19.69 65.86 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.355 -0.938 . . . . 2.04 110.671 179.179 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -72.42 -11.22 60.59 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.471 -0.891 . . . . 1.73 110.654 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.499 HD13 HD13 ' A' ' 123' ' ' LEU . 69.4 mt -86.44 141.61 29.0 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.522 0.677 . . . . 1.37 109.213 179.535 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -98.13 38.14 1.35 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.193 -0.942 . . . . 2.88 112.206 179.48 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -113.79 137.7 51.28 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.26 -1.015 . . . . 1.58 108.26 178.873 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 28.2 mp0 -59.12 -39.86 83.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.972 -1.08 . . . . 3.04 111.076 179.182 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -71.24 -52.92 16.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.743 -1.223 . . . . 0.9 110.531 179.774 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.499 HD13 HD13 ' A' ' 118' ' ' LEU . 36.2 mt -59.98 -40.39 88.97 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.865 -1.147 . . . . 1.06 110.384 -179.595 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -59.1 -45.72 90.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.893 -1.129 . . . . 2.18 110.2 179.483 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.48 -31.98 70.98 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.369 -0.933 . . . . 2.15 109.906 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 130' ' ' VAL . 34.8 ttm180 -60.6 -31.2 70.37 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.829 -1.148 . . . . 2.33 109.106 178.896 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.61 76.44 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.556 0.693 . . . . 0.82 110.249 179.026 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.98 78.03 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.126 -0.63 . . . . 0.85 110.138 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.34 -34.84 78.58 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.629 0.728 . . . . 1.39 110.673 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 126' ' ' ARG . 29.6 t -68.23 -41.02 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.128 -0.982 . . . . 0.56 110.3 179.723 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -57.9 -38.73 76.34 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.445 -1.302 . . . . 3.12 109.429 179.121 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -59.79 -37.58 79.51 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 120.124 -0.631 . . . . 1.28 110.181 179.199 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.99 -39.81 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 0.49 109.591 179.355 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.93 -46.03 77.56 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.885 -1.15 . . . . 0.46 110.408 179.082 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -57.38 -41.85 81.01 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.356 -1.085 . . . . 2.71 110.163 179.299 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' A' ' 136' ' ' ARG . 50.7 mtt-85 -61.52 -42.98 99.62 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.251 -0.979 . . . . 2.14 110.006 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.77 -42.33 97.25 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.782 -0.767 . . . . 1.05 109.536 179.78 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.5 mt -60.05 -43.78 95.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.526 -0.734 . . . . 0.52 110.404 179.698 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.468 ' NH1' HD23 ' A' ' 144' ' ' LEU . 49.8 mtt-85 -60.54 -36.41 78.36 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.622 -0.674 . . . . 2.35 110.703 -179.974 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -73.94 -40.36 63.12 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.32 -0.863 . . . . 1.39 111.011 179.719 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.463 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.8 mt -60.55 -40.38 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.889 -1.132 . . . . 0.68 110.614 -178.815 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.535 HD21 ' OD2' ' A' ' 101' ' ' ASP . 81.4 mt -87.51 -11.17 49.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.669 -1.27 . . . . 0.83 111.855 -178.951 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.79 18.61 74.9 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.763 -1.208 . . . . 0.91 112.402 -179.71 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.468 HD23 ' NH1' ' A' ' 139' ' ' ARG . 47.8 tp -63.74 145.32 55.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.921 -0.752 . . . . 0.95 109.194 179.218 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -69.02 147.27 51.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.51 -0.744 . . . . 2.43 109.534 178.508 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.0 mt -106.84 141.21 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.383 -0.969 . . . . 1.1 108.383 178.143 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.555 ' H ' HD12 ' A' ' 147' ' ' ILE . 5.3 mp -76.01 123.72 32.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.357 -0.979 . . . . 1.58 108.357 178.238 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -99.62 100.52 11.53 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 106.064 -1.828 . . . . 1.62 106.064 178.98 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.4 mt -75.2 -14.26 60.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.313 -0.867 . . . . 0.8 111.759 -177.885 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.6 p -78.42 3.07 16.78 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.317 1.055 . . . . 1.56 112.153 -179.331 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.28 19.83 14.7 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.125 -0.984 . . . . 0.84 112.744 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 22.6 mt -74.1 137.42 23.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.907 -1.121 . . . . 0.82 109.241 179.172 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -115.52 -14.27 11.53 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.856 0.836 . . . . 2.31 112.558 -178.717 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -113.47 136.35 52.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.502 -1.295 . . . . 1.54 107.502 179.932 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -73.67 124.55 26.19 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.588 -0.893 . . . . 1.38 108.588 178.689 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -146.45 175.58 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.46 -0.775 . . . . 0.69 109.404 -179.69 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.1 mt -87.53 148.49 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.53 108.975 178.135 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -99.75 120.54 39.89 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.055 -1.091 . . . . 0.64 108.055 178.114 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -121.58 129.59 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 N-CA-C 107.718 -1.215 . . . . 0.67 107.718 179.391 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.1 155.97 21.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.968 -1.083 . . . . 0.78 108.863 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.454 ' O ' ' CG ' ' A' ' 162' ' ' ASP . . . -60.59 -37.58 81.81 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.395 -1.441 . . . . 1.0 109.674 178.131 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 161' ' ' ALA . 58.0 m-20 -167.81 153.86 7.51 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.733 -0.839 . . . . 2.42 108.733 179.179 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.8 mt -116.46 139.91 49.94 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 108.374 -0.972 . . . . 0.75 108.374 177.76 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.5 p -96.85 148.97 35.2 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.22 -0.925 . . . . 0.78 108.892 179.402 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.68 -40.01 7.53 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.747 1.632 . . . . 0.67 113.599 179.092 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.6 m -61.75 -49.69 75.39 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.024 -1.047 . . . . 0.7 109.922 -179.336 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -61.87 -39.96 93.71 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.085 -1.01 . . . . 1.21 110.077 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.8 p -67.67 -37.62 82.63 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.417 -0.802 . . . . 0.6 110.267 179.506 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.22 -36.05 82.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.402 -0.811 . . . . 0.62 111.322 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -98.44 -0.47 43.47 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.351 -0.843 . . . . 1.16 112.795 -179.276 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.7 tp -64.14 154.88 33.31 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.951 -0.7 . . . . 0.73 109.906 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -97.41 118.76 34.62 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.984 -1.487 . . . . 2.24 106.984 177.427 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.9 mt -76.52 -19.6 57.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.512 -0.742 . . . . 1.43 111.953 -178.126 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -82.39 -19.86 38.27 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.06 -1.025 . . . . 2.15 112.455 -178.904 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -102.44 -0.76 31.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.46 -0.775 . . . . 2.04 113.065 -178.012 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 178' ' ' GLY . 46.9 t -109.23 121.22 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.591 -1.262 . . . . 0.55 107.591 179.049 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.1 tp -84.74 -4.04 58.86 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.144 -0.972 . . . . 1.63 111.821 -179.434 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.491 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.96 171.29 36.82 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.872 -1.691 . . . . 0.47 108.872 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 3.6 m-85 -125.0 129.69 50.82 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.941 -1.133 . . . . 0.54 107.941 178.463 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.444 ' CG2' HG21 ' A' ' 205' ' ' THR . 30.1 mt -129.92 121.43 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 106.173 -1.788 . . . . 0.69 106.173 177.908 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 203' ' ' VAL . 39.4 p -139.88 172.31 12.96 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.631 -1.293 . . . . 0.82 110.355 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.487 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 4.8 m-20 -105.29 51.96 0.75 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.529 -0.732 . . . . 2.37 109.676 179.382 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -103.93 153.94 20.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.366 -0.834 . . . . 1.11 109.709 179.617 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -58.88 -36.2 86.38 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 120.212 -0.994 . . . . 1.67 110.712 178.517 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 96.52 -17.86 58.52 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 121.164 -1.198 . . . . 1.54 114.157 179.458 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.405 ' HG2' ' NH1' ' A' ' 186' ' ' ARG . 59.4 mtt-85 -58.67 -41.13 85.45 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.835 -1.391 . . . . 4.48 110.212 179.289 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 75.5 p -140.83 36.29 1.78 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.539 -0.726 . . . . 2.63 111.212 -179.391 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 69.9 m -81.9 123.06 28.51 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.553 -1.277 . . . . 1.69 107.553 179.489 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -60.5 -37.58 81.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.669 -0.645 . . . . 1.07 110.741 -179.828 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 23.0 m -52.96 -42.51 65.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 1.58 110.439 179.253 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.8 m -59.65 -40.43 87.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.03 -1.044 . . . . 1.6 110.107 179.463 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.34 -35.69 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.593 -0.692 . . . . 1.45 110.848 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 57.1 mtp -62.6 -40.81 98.1 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.093 0.949 . . . . 1.05 109.453 179.481 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.0 -41.73 92.71 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.589 -0.732 . . . . 0.72 110.515 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -59.8 -44.93 93.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 3.05 110.712 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.1 m -71.19 -39.35 71.88 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.002 -1.061 . . . . 0.89 110.164 -179.843 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.1 mt -90.98 -7.94 50.6 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 112.712 0.634 . . . . 0.78 112.712 -178.124 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 54.29 9.03 0.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.207 1.188 . . . . 1.45 114.207 179.836 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 39.5 mt -71.37 148.92 93.77 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 108.326 -0.99 . . . . 0.67 108.326 179.133 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.45 144.25 92.29 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.456 1.438 . . . . 0.64 109.368 178.608 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -157.9 160.67 37.88 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.086 -1.446 . . . . 0.67 109.65 179.647 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.587 HD12 HD11 ' A' ' 220' ' ' LEU . 14.8 mt -150.78 149.07 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.862 -1.162 . . . . 0.69 107.862 178.386 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.5 m -134.21 -32.18 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.245 -0.909 . . . . 0.85 112.811 -179.755 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.51 33.56 0.83 Allowed Glycine 0 N--CA 1.483 1.792 0 O-C-N 121.183 -0.948 . . . . 0.92 113.037 -178.135 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.487 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 35.0 p -59.67 -26.95 65.97 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 121.465 -1.021 . . . . 0.95 111.085 -179.199 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 79.53 -93.38 1.35 Allowed Glycine 0 N--CA 1.488 2.102 0 C-N-CA 120.181 -1.009 . . . . 1.04 110.952 179.386 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.5 m -123.54 29.74 6.49 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.246 0.832 . . . . 1.57 113.246 -178.798 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 70.3 t -59.84 -33.59 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.824 -1.172 . . . . 0.84 110.237 179.027 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 58.8 p -59.33 -23.23 62.32 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.087 -1.008 . . . . 0.99 111.459 179.947 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.1 t -92.27 -0.38 57.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.914 -1.116 . . . . 1.7 111.428 -179.288 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -124.47 -7.22 7.51 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.617 -0.72 . . . . 2.2 112.681 -177.938 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.43 141.82 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.164 -0.68 . . . . 0.84 109.164 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -116.72 151.44 36.38 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.1 -1.074 . . . . 2.2 108.1 178.296 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 48.2 t30 -53.25 143.29 18.79 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.279 -0.968 . . . . 2.28 110.44 178.318 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.1 t0 82.2 -6.99 1.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.099 1.148 . . . . 2.35 114.099 179.524 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 16' ' ' ALA . 87.6 m-20 -63.18 143.23 57.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.636 -1.29 . . . . 1.97 108.288 177.466 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -88.23 119.1 28.31 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.388 -1.338 . . . . 2.65 107.388 178.124 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.438 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 42.4 mt -127.83 144.51 51.09 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.137 -0.69 . . . . 0.63 109.137 -179.04 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.9 mt -111.94 128.61 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 106.918 -1.512 . . . . 0.62 106.918 177.72 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.587 HD11 HD12 ' A' ' 202' ' ' ILE . 44.1 tp -99.97 118.67 36.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.975 -1.861 . . . . 0.64 105.975 178.35 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 223' ' ' VAL . 35.0 p-10 -92.65 -22.19 19.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 2.05 112.736 -177.558 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.931 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.75 16.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 112.756 0.65 . . . . 0.84 112.756 -179.206 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.632 ' N ' ' O ' ' A' ' 221' ' ' ASP . 15.7 t -111.21 -63.81 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.056 -1.027 . . . . 1.02 108.78 179.694 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -90.22 9.15 29.65 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.245 1.021 . . . . 2.51 110.463 -179.779 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 61.62 52.8 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.067 -0.97 . . . . 1.54 112.157 179.61 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -148.29 153.46 38.7 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.409 1.1 . . . . 1.95 110.25 179.131 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.4 135.48 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.542 -1.281 . . . . 0.71 107.542 177.465 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -101.15 136.93 40.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.987 -1.071 . . . . 1.01 108.719 178.744 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.7 t -109.84 130.04 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.171 -1.048 . . . . 0.82 108.171 179.104 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.451 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 60.7 t30 48.44 50.32 8.86 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.914 . . . . 1.54 113.292 178.913 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.7 Cg_endo -63.41 151.66 83.82 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.32 2.013 . . . . 0.94 110.712 -179.904 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.9 m -73.97 156.79 37.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.795 -1.191 . . . . 1.8 109.226 177.65 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.407 ' HA ' HD12 ' A' ' 236' ' ' ILE . 29.8 m120 -56.79 -40.05 75.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.033 -1.042 . . . . 2.73 111.133 179.054 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.448 ' H ' ' CD ' ' A' ' 234' ' ' GLU . 45.2 mp0 -59.12 -39.52 82.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.044 -1.035 . . . . 3.17 110.288 179.687 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.8 -37.94 78.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.759 0.79 . . . . 1.34 110.097 179.732 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 233' ' ' ASN . 84.5 mt -58.09 -43.77 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.133 -0.979 . . . . 1.2 110.398 179.292 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.73 -39.7 85.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 2.7 110.768 179.822 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -61.72 -41.45 97.63 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.909 -1.119 . . . . 2.59 110.78 179.873 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.5 mtp -73.36 -36.5 66.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.325 -0.859 . . . . 1.38 111.013 -179.419 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -59.73 -38.54 81.98 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.249 -0.907 . . . . 2.84 110.765 -179.729 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.52 -44.53 67.37 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.834 -1.166 . . . . 1.88 111.157 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 97.6 t -58.87 -51.02 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.551 -1.343 . . . . 2.4 111.557 -178.258 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -62.1 -49.88 74.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.054 -1.029 . . . . 3.52 110.555 -179.921 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.43 -35.64 78.12 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.433 -0.792 . . . . 1.88 110.87 -179.489 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.81 -29.32 69.39 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.569 -1.253 . . . . 3.01 109.995 179.325 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.36 -47.63 88.76 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 C-N-CA 118.894 -1.122 . . . . 2.45 109.529 178.81 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.03 -36.46 81.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 2.75 110.456 -179.943 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.7 t -66.94 -36.26 81.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.47 -0.769 . . . . 3.16 110.582 179.657 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -62.18 -45.62 92.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 3.57 110.244 179.65 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -68.8 -39.3 80.17 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.797 0.808 . . . . 4.3 110.33 -179.868 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.16 23.98 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.389 -0.819 . . . . 4.45 112.815 -179.808 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.68 -38.03 83.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.964 -1.085 . . . . 5.97 111.113 -179.226 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.08 -32.84 74.55 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.837 -1.164 . . . . 6.18 110.432 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -75.15 -8.88 57.82 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.474 -0.766 . . . . 6.66 112.872 -179.765 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -80.14 0.59 31.54 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.058 -1.026 . . . . 8.2 112.927 -178.969 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.552 HD22 ' N ' ' A' ' 256' ' ' LEU . 3.0 mm? -82.34 -5.47 58.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.778 -1.202 . . . . 8.07 112.319 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -87.43 0.54 55.35 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.221 -0.924 . . . . 9.45 112.925 -178.473 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -92.97 -40.91 10.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.355 -0.841 . . . . 10.12 112.046 -178.961 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 . . . . . 0 N--CA 1.498 1.929 0 O-C-N 120.966 -1.084 . . . . 11.49 110.15 -177.324 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.2 mt . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 106.468 -1.679 . . . . 1.0700000000000001 106.468 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.0 m -105.98 119.99 40.62 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.652 -1.24 . . . . 1.24 107.652 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.17 -160.96 23.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.531 -1.827 . . . . 1.01 108.531 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 5' ' ' ILE . 95.6 mt -95.98 1.29 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.447 -1.031 . . . . 1.1100000000000001 113.076 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 tp 51.8 93.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.536 -1.353 . . . . 0.98999999999999999 112.297 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -88.75 -34.11 17.25 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.052 -1.03 . . . . 0.84999999999999998 111.001 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 201' ' ' ALA . 1.9 p -149.8 140.89 14.46 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 107.682 -1.229 . . . . 1.3799999999999999 107.682 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.28 146.99 22.76 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.518 2.145 . . . . 0.93999999999999995 112.173 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.945 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.15 173.69 22.71 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 108.722 -1.751 . . . . 0.81000000000000005 108.722 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.0 mt -132.12 136.42 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.073 -1.251 . . . . 0.82999999999999996 107.683 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.34 155.92 45.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.004 -1.06 . . . . 0.53000000000000003 109.429 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 4.6 m-85 -128.38 140.19 51.98 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.391 -0.966 . . . . 0.77000000000000002 108.391 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.36 172.01 39.86 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 118.546 -1.788 . . . . 0.51000000000000001 110.061 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -76.02 156.07 34.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.86 -0.788 . . . . 1.8999999999999999 109.144 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -84.52 122.87 29.61 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.454 -1.313 . . . . 0.66000000000000003 107.454 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.4 tp -100.2 106.97 18.7 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 105.558 -2.016 . . . . 0.82999999999999996 105.558 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.4 tp -91.04 131.36 36.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.917 -1.142 . . . . 0.85999999999999999 107.917 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 158' ' ' LEU . 44.4 mt -99.52 118.04 35.23 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.878 -1.527 . . . . 0.92000000000000004 106.878 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -110.15 136.09 49.92 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.79 -1.189 . . . . 2.0299999999999998 107.79 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -128.56 151.21 49.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.08 -1.013 . . . . 2.6600000000000001 109.748 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -81.52 135.61 35.6 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.816 -1.179 . . . . 2.3199999999999998 107.816 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -63.67 147.89 50.43 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.743 -0.836 . . . . 2.1099999999999999 108.743 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.2 mt -93.23 125.48 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.728 -1.212 . . . . 0.72999999999999998 107.728 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.2 t -109.96 129.95 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.43 -0.952 . . . . 0.87 108.43 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.9 mt -95.02 141.44 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.152 -0.968 . . . . 0.81000000000000005 108.612 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -90.53 122.68 33.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.033 . . . . 1.3400000000000001 108.414 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.531 ' HG2' HH11 ' A' ' 28' ' ' ARG . 4.6 mmt-85 -94.46 17.02 13.82 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.37 -0.831 . . . . 2.8900000000000001 111.983 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -74.85 140.42 43.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.259 -0.901 . . . . 2.0899999999999999 109.006 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -90.97 129.55 36.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.958 -1.089 . . . . 2.1899999999999999 108.074 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 pt -89.31 166.19 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.75 110.835 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.8 p -96.81 167.19 11.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.405 -0.81 . . . . 0.91000000000000003 109.653 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -15.16 2.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.922 -1.111 . . . . 0.93000000000000005 112.39 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -70.33 -39.61 74.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 2.2799999999999998 110.824 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -94.61 -4.73 47.23 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.635 -1.291 . . . . 1.45 113.029 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.71 -41.38 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.272 -0.893 . . . . 0.81000000000000005 110.358 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -56.09 -40.1 73.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 1.54 110.189 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -63.16 -36.12 82.58 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.335 -0.853 . . . . 2.3599999999999999 110.688 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 42' ' ' ARG . 78.6 mm-40 -60.23 -42.06 94.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 1.3100000000000001 110.398 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.98 -46.0 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.387 -0.821 . . . . 0.81999999999999995 110.731 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.24 -50.01 74.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.058 -1.026 . . . . 1.5 110.392 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 76.6 mtm180 -62.41 -41.0 98.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -0.897 . . . . 2.23 110.231 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -70.26 -55.33 9.51 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.383 -0.823 . . . . 0.84999999999999998 109.566 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.25 -47.67 85.0 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.797 0.808 . . . . 0.91000000000000003 110.361 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 12.2 t -68.67 -38.19 80.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.303 -0.873 . . . . 0.90000000000000002 110.208 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.61 -46.57 88.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.775 -1.33 . . . . 0.68999999999999995 109.775 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -59.91 -29.31 68.28 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.405 -1.056 . . . . 2.8799999999999999 110.311 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.33 -48.86 80.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.808 -0.557 . . . . 0.84999999999999998 110.97 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -82.55 -35.93 26.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.833 -1.167 . . . . 2.3500000000000001 110.084 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -45.33 89.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.369 -0.832 . . . . 0.65000000000000002 109.95 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 t -61.73 -39.8 92.84 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.917 0.865 . . . . 1.45 109.558 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.03 -49.86 63.87 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.287 -0.565 . . . . 0.63 110.873 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -61.7 -51.0 70.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.97 -1.081 . . . . 1.3400000000000001 110.955 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.72 -38.94 89.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.241 -0.912 . . . . 1.5600000000000001 110.483 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -58.68 -40.09 82.57 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.059 -0.656 . . . . 1.1899999999999999 110.654 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 m -63.08 -41.75 99.49 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.839 -1.163 . . . . 0.71999999999999997 110.247 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.11 -36.32 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.571 -0.706 . . . . 0.62 110.778 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -52.97 -42.56 65.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 1.05 110.76 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.31 -36.12 76.67 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.139 -0.975 . . . . 0.64000000000000001 110.21 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -62.14 -39.34 92.24 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.246 -0.981 . . . . 1.73 109.454 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.02 -34.74 78.78 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.342 0.591 . . . . 0.56000000000000005 110.113 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.43 19.02 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.749 -1.215 . . . . 0.68999999999999995 111.355 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.26 -23.32 35.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -1.183 . . . . 1.48 111.406 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.5 m -86.6 -49.71 7.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.793 -0.567 . . . . 0.97999999999999998 110.649 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.527 ' CZ ' ' SD ' ' A' ' 193' ' ' MET . 72.2 m-85 -108.43 -6.65 16.08 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 113.954 1.094 . . . . 1.1599999999999999 113.954 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.0 168.03 29.4 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.115 -1.04 . . . . 0.84999999999999998 111.745 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.94 -20.49 38.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.273 -1.134 . . . . 3.8599999999999999 112.603 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.47 -42.03 73.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.618 -1.301 . . . . 2.3500000000000001 110.945 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -88.43 -25.18 22.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.017 -1.052 . . . . 1.6699999999999999 111.998 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -59.99 -37.28 79.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 1.45 111.356 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.36 84.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.60999999999999999 111.299 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.8 mt -65.2 -43.98 95.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.494 -1.379 . . . . 0.65000000000000002 110.303 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -70.63 -34.53 72.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.938 -1.102 . . . . 0.66000000000000003 110.423 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.49 -38.55 84.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.3 -0.875 . . . . 1.1899999999999999 110.491 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.94 -41.15 88.53 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.972 -1.108 . . . . 0.53000000000000003 110.938 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -59.36 -43.21 92.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.417 -1.049 . . . . 1.27 110.56 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.48 -37.17 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.161 -0.962 . . . . 0.54000000000000004 110.564 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.2 ttt -59.26 -39.75 83.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.531 -0.731 . . . . 1.74 110.558 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.8 tp -59.6 -48.21 82.54 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.454 -0.898 . . . . 0.55000000000000004 109.612 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.44 -39.72 88.53 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.541 0.686 . . . . 0.46999999999999997 110.049 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.62 -1.52 54.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.451 -0.781 . . . . 1.4199999999999999 112.902 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -58.68 123.88 17.85 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.14 -1.424 . . . . 1.27 110.584 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.36 -16.57 62.51 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.751 -1.218 . . . . 1.3500000000000001 111.355 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -77.46 -50.08 13.43 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.407 -0.917 . . . . 2.2200000000000002 111.148 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.09 -39.46 92.55 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.28 -0.888 . . . . 0.62 110.577 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -59.84 -45.71 91.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 1.29 110.348 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -62.72 -39.98 95.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 1.52 110.837 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -64.84 -48.31 74.8 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.798 -1.189 . . . . 1.3 110.273 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.2 mt -55.84 -44.19 76.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.169 -0.957 . . . . 0.60999999999999999 110.048 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.36 -41.58 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.443 0.64 . . . . 0.78000000000000003 110.453 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.51 95.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.682 -0.636 . . . . 0.81999999999999995 110.977 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.86 -42.26 97.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.866 -1.146 . . . . 0.80000000000000004 110.783 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.21 -49.72 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.857 -1.152 . . . . 0.77000000000000002 109.931 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -78.0 -35.42 50.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.399 -0.813 . . . . 2.1200000000000001 111.645 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.12 -42.09 27.07 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.499 -1.375 . . . . 1.51 111.767 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -105.8 7.92 32.6 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.92 -1.112 . . . . 1.98 112.422 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.8 m80 50.77 47.85 23.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.858 -1.151 . . . . 1.3200000000000001 111.285 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.6 mtt -105.28 154.02 20.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.598 -0.689 . . . . 1.3799999999999999 109.567 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.9 p -71.32 162.98 28.55 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.79 -0.569 . . . . 0.67000000000000004 110.034 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.51 -39.84 94.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.964 -1.085 . . . . 0.52000000000000002 110.856 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -68.5 -42.76 78.14 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 120.807 -1.183 . . . . 2.25 109.971 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.35 -48.06 62.45 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.508 0.671 . . . . 0.64000000000000001 110.606 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.28 94.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.56000000000000005 110.494 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.34 86.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.651 -0.656 . . . . 0.46000000000000002 110.552 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -60.08 -38.57 83.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.17 -0.956 . . . . 1.3200000000000001 110.937 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.14 -49.46 76.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.9 -1.125 . . . . 1.3 111.174 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.68 -49.5 84.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.402 -1.319 . . . . 0.60999999999999999 109.714 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.0 mm -60.09 -32.73 51.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.605 0.717 . . . . 0.65000000000000002 110.149 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -54.84 -40.78 69.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.266 -0.896 . . . . 2.1099999999999999 110.627 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.49 -34.65 10.15 Favored Glycine 0 N--CA 1.5 2.919 0 C-N-CA 119.618 -1.277 . . . . 0.82999999999999996 112.236 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -61.86 -42.77 99.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.499 -1.589 . . . . 1.28 109.914 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.11 -49.84 32.95 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.948 -0.701 . . . . 0.89000000000000001 110.107 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.0 p -61.79 -36.94 82.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.173 -0.954 . . . . 1.8700000000000001 110.411 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.91 98.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 1.05 110.633 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 95.5 mt -66.37 -29.39 69.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.083 -1.011 . . . . 1.02 110.715 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -67.04 -23.73 65.92 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.383 -0.823 . . . . 2.04 110.961 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -71.56 -15.39 62.28 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.06 -1.025 . . . . 1.73 111.227 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.6 mt -88.45 141.07 28.83 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.829 -0.804 . . . . 1.3700000000000001 108.829 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -98.1 40.78 1.16 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.146 -0.971 . . . . 2.8799999999999999 112.048 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -112.39 138.57 48.94 Favored 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 108.174 -1.047 . . . . 1.5800000000000001 108.174 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.541 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 47.7 mp0 -58.58 -36.6 74.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 3.04 111.016 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -73.59 -51.15 17.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.677 -1.264 . . . . 0.90000000000000002 109.99 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.96 -43.08 96.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.96 -1.087 . . . . 1.0600000000000001 110.215 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -63.05 -50.22 71.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.913 . . . . 2.1800000000000002 110.198 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -61.55 -30.5 70.69 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.076 0.941 . . . . 2.1499999999999999 109.589 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 130' ' ' VAL . 37.9 ttp180 -64.7 -29.55 70.54 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.082 0.944 . . . . 2.3300000000000001 109.274 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -59.95 -48.22 82.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.708 0.766 . . . . 0.81999999999999995 109.484 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.06 84.58 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.527 -0.869 . . . . 0.84999999999999998 109.986 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -64.45 -35.49 81.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.516 -0.74 . . . . 1.3899999999999999 110.348 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 126' ' ' ARG . 38.2 t -67.59 -39.51 82.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.106 -0.996 . . . . 0.56000000000000005 109.58 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -58.91 -37.1 75.86 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.895 -1.122 . . . . 3.1200000000000001 109.214 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -60.25 -37.68 81.12 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.899 -0.591 . . . . 1.28 110.418 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.6 mt -60.48 -40.04 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.318 -0.864 . . . . 0.48999999999999999 109.71 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.82 -39.97 32.34 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.098 -1.201 . . . . 0.46000000000000002 110.098 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.72 -46.29 84.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -1.129 . . . . 2.71 109.996 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -63.63 -40.1 96.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.788 -1.195 . . . . 2.1400000000000001 109.8 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.29 -41.94 90.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.49 -0.756 . . . . 1.05 109.7 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 54.7 mt -59.94 -44.83 94.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.599 -0.84 . . . . 0.52000000000000002 110.014 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -60.6 -33.84 73.34 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.488 -0.758 . . . . 2.3500000000000001 110.17 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -74.01 -43.11 59.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.662 -0.649 . . . . 1.3899999999999999 110.167 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.92 -37.32 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.68000000000000005 110.741 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 56.4 mt -86.23 -4.8 59.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.156 -0.965 . . . . 0.82999999999999996 112.148 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.06 23.36 69.08 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 120.175 -1.012 . . . . 0.91000000000000003 113.22 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.5 tp -73.52 137.51 44.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.531 -0.982 . . . . 0.94999999999999996 108.932 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -68.41 149.79 48.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.17 -0.956 . . . . 2.4300000000000002 109.757 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.4 mt -104.07 140.35 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.504 -0.924 . . . . 1.1000000000000001 108.504 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.751 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.5 mp -77.34 128.23 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.86 -1.163 . . . . 1.5800000000000001 107.86 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -96.8 100.08 11.63 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 105.861 -1.903 . . . . 1.6200000000000001 105.861 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.0 mt -75.56 -15.52 60.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.508 -0.745 . . . . 0.80000000000000004 111.437 -177.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.5 t -78.19 -1.45 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 1.5600000000000001 112.088 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.35 22.4 10.68 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.735 0.778 . . . . 0.83999999999999997 111.744 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.461 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 18.0 mt -72.0 135.76 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.742 . . . . 0.81999999999999995 109.1 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -121.67 -6.82 9.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.571 -0.706 . . . . 2.3100000000000001 112.343 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -112.71 135.45 53.43 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.957 -1.127 . . . . 1.54 107.957 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.85 113.98 17.4 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.695 -0.854 . . . . 1.3799999999999999 108.695 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.9 m -148.29 178.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.303 -0.873 . . . . 0.68999999999999995 109.224 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.0 mt -87.31 144.45 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.046 -0.724 . . . . 0.53000000000000003 109.046 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 19' ' ' LEU . 30.4 tp -94.76 125.81 39.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.981 -1.118 . . . . 0.64000000000000001 107.981 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.19 129.9 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.981 -1.118 . . . . 0.67000000000000004 107.981 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.409 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.78 153.44 22.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.156 -0.965 . . . . 0.78000000000000003 109.667 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.3 73.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.663 -1.273 . . . . 1.0 109.413 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -173.22 151.2 2.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.882 -0.785 . . . . 2.4199999999999999 108.882 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.0 mt -119.85 140.79 50.27 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.049 -0.722 . . . . 0.75 109.049 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 56.5 p -90.8 148.1 37.56 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.048 -1.033 . . . . 0.78000000000000003 108.79 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.9 -40.59 6.03 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.919 1.746 . . . . 0.67000000000000004 113.342 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.0 m -63.53 -46.22 87.03 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.052 -1.03 . . . . 0.69999999999999996 110.134 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -65.26 -38.33 90.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 1.21 110.332 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 69.2 p -68.7 -41.43 79.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.492 -0.755 . . . . 0.59999999999999998 110.585 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.11 83.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.685 -0.635 . . . . 0.62 110.768 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -93.63 2.46 56.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.001 -1.062 . . . . 1.1599999999999999 112.543 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 171' ' ' LEU . 35.1 tp -61.82 150.39 37.31 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.341 -0.849 . . . . 0.72999999999999998 109.857 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -95.89 116.19 28.55 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.52 -1.289 . . . . 2.2400000000000002 107.52 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 75.1 mt -80.04 -11.25 59.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.607 -0.683 . . . . 1.4299999999999999 112.368 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -83.86 -26.83 29.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 2.1499999999999999 112.218 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -102.76 -3.88 25.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.305 -0.872 . . . . 2.04 113.245 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.39 126.93 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.462 -1.31 . . . . 0.55000000000000004 107.462 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 28.8 tp -90.4 -7.17 53.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.788 -1.195 . . . . 1.6299999999999999 112.349 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.54 173.95 41.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.367 -1.493 . . . . 0.46999999999999997 109.367 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -128.88 130.65 47.13 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.138 -1.06 . . . . 0.54000000000000004 108.138 179.233 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.547 HG22 HG21 ' A' ' 205' ' ' THR . 94.8 mt -134.12 105.54 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 105.83 -1.915 . . . . 0.68999999999999995 105.83 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 39.1 p -126.99 176.11 7.58 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.954 -1.091 . . . . 0.81999999999999995 110.991 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.581 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -104.02 56.33 0.73 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 115.931 -0.577 . . . . 2.3700000000000001 109.841 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -100.59 144.37 29.65 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.15 -0.969 . . . . 1.1100000000000001 109.31 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.6 -32.91 25.09 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.098 -1.049 . . . . 1.6699999999999999 110.907 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 98.15 0.11 58.61 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.302 -1.117 . . . . 1.54 113.692 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.43 ' O ' ' OG1' ' A' ' 187' ' ' THR . 35.6 ttm180 -87.75 112.6 22.58 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.892 -1.521 . . . . 4.4800000000000004 106.892 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 20.9 p 49.52 44.74 24.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 2.6299999999999999 112.291 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.3 m -78.35 126.81 31.3 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.679 -1.23 . . . . 1.6899999999999999 107.679 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -58.94 -40.8 85.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.227 -0.92 . . . . 1.0700000000000001 110.292 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -59.94 -48.44 81.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.113 -0.992 . . . . 1.5800000000000001 110.284 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.7 p -61.39 -38.74 88.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.473 -0.767 . . . . 1.6000000000000001 110.576 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.475 HG12 HH21 ' A' ' 195' ' ' ARG . 85.5 mt -60.71 -42.42 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.095 -1.003 . . . . 1.45 110.903 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.527 ' SD ' ' CZ ' ' A' ' 65' ' ' PHE . 9.5 mtm -66.74 -36.92 83.6 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.502 -1.374 . . . . 1.05 109.461 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.76 -48.66 80.78 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.843 -0.617 . . . . 0.71999999999999997 111.006 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.475 HH21 HG12 ' A' ' 192' ' ' ILE . 85.3 mtm180 -60.0 -40.45 89.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 3.0499999999999998 110.409 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.3 m -64.46 -37.84 88.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 0.89000000000000001 109.902 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.5 mt -89.21 -1.1 57.94 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.459 0.647 . . . . 0.78000000000000003 112.045 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 54.82 8.31 0.22 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.059 1.133 . . . . 1.45 114.059 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.3 mt -71.5 149.25 93.52 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.073 -1.084 . . . . 0.67000000000000004 108.073 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -59.1 144.95 99.17 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.653 1.569 . . . . 0.64000000000000001 109.948 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -160.89 159.58 29.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.442 -1.411 . . . . 0.67000000000000004 109.852 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 203' ' ' VAL . 73.0 mt -148.1 155.65 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.059 -1.089 . . . . 0.68999999999999995 108.059 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.427 ' N ' HG22 ' A' ' 202' ' ' ILE . 2.9 m -137.75 -28.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.145 -0.972 . . . . 0.84999999999999998 111.758 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.87 41.32 1.71 Allowed Glycine 0 N--CA 1.487 2.034 0 C-N-CA 120.332 -0.937 . . . . 0.92000000000000004 111.846 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.547 HG21 HG22 ' A' ' 180' ' ' ILE . 75.7 p -63.45 -20.92 65.98 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.341 -1.094 . . . . 0.94999999999999996 110.938 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.25 -95.88 1.33 Allowed Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.669 -1.253 . . . . 1.04 109.978 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.0 t -129.03 30.65 5.02 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.444 -1.033 . . . . 1.5700000000000001 111.868 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.03 -38.34 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.701 -1.249 . . . . 0.83999999999999997 110.829 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 67.6 p -57.49 -24.84 58.17 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.442 -0.903 . . . . 0.98999999999999999 112.02 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.2 m -93.31 0.72 57.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.017 -1.052 . . . . 1.7 111.974 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -122.96 -4.8 8.53 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 113.082 0.771 . . . . 2.2000000000000002 113.082 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 52.0 t -119.38 149.11 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 121.568 0.699 . . . . 0.83999999999999997 109.723 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -116.81 158.56 23.73 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.809 -1.182 . . . . 2.2000000000000002 107.809 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 45.3 p-10 -55.01 145.17 21.11 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.986 -1.071 . . . . 2.2799999999999998 110.572 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t70 80.61 2.52 1.81 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 114.803 1.409 . . . . 2.3500000000000001 114.803 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 62.8 t0 -65.85 146.62 54.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.941 -1.1 . . . . 1.97 108.37 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.499 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 43.3 t80 -88.18 120.64 29.73 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.993 -1.484 . . . . 2.6499999999999999 106.993 178.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.591 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 79.0 mt -127.75 150.01 49.99 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.527 -0.733 . . . . 0.63 109.92 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.5 mt -118.41 123.59 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 106.691 -1.596 . . . . 0.62 106.691 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.5 tp -99.32 114.87 27.97 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.639 -1.615 . . . . 0.64000000000000001 106.639 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 223' ' ' VAL . 37.2 t0 -91.36 -25.06 19.57 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.849 -1.157 . . . . 2.0499999999999998 112.325 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.945 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.65 19.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.667 0.617 . . . . 0.83999999999999997 112.667 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.0 t -110.94 -61.22 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.097 0.951 . . . . 1.02 108.924 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -93.19 8.72 39.03 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.7 0.762 . . . . 2.5099999999999998 110.489 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 60.1 t30 62.98 52.35 2.62 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.483 0.658 . . . . 1.54 111.704 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -147.49 147.81 30.57 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.272 1.034 . . . . 1.95 109.453 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 52.0 t -117.45 139.74 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.293 -1.002 . . . . 0.70999999999999996 108.293 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -103.84 132.59 49.95 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.983 -1.073 . . . . 1.01 109.01 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.9 130.04 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.953 -1.129 . . . . 0.81999999999999995 107.953 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.473 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 17.9 t-20 54.05 48.09 4.4 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.241 -0.912 . . . . 1.54 113.015 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 56.1 Cg_endo -69.6 150.75 69.58 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.845 2.363 . . . . 0.93999999999999995 110.921 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 68.2 p -77.75 163.03 26.49 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.314 -0.866 . . . . 1.8 110.562 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -60.47 -35.21 75.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.945 . . . . 2.73 110.56 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -59.14 -39.34 82.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.166 -0.959 . . . . 3.1699999999999999 110.385 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.8 t -70.88 -42.06 77.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.175 -1.01 . . . . 1.3400000000000001 110.219 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 67.0 mt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.769 0.795 . . . . 1.2 109.822 -178.605 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.9 mt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 107.497 -1.297 . . . . 1.0700000000000001 107.497 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -102.56 128.43 49.22 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.209 -1.034 . . . . 1.24 108.209 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.53 -152.39 11.51 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 108.536 -1.826 . . . . 1.01 108.536 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 5' ' ' ILE . 81.5 mt -97.23 -3.22 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.293 -1.122 . . . . 1.1100000000000001 113.027 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.8 tp 49.49 95.62 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.07 -1.019 . . . . 0.98999999999999999 112.126 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -85.26 -40.16 16.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.11 -0.994 . . . . 0.84999999999999998 110.587 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -147.12 141.8 16.29 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.706 -1.22 . . . . 1.3799999999999999 107.706 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.33 149.69 40.51 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.575 2.183 . . . . 0.93999999999999995 112.144 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.897 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.13 166.16 13.51 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.885 -1.686 . . . . 0.81000000000000005 108.885 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.8 mt -123.76 135.18 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.232 -1.158 . . . . 0.82999999999999996 108.424 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.48 44.6 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.963 -1.086 . . . . 0.53000000000000003 109.293 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -121.86 139.66 53.35 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.841 -1.17 . . . . 0.77000000000000002 107.841 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.72 165.47 31.75 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 118.356 -1.878 . . . . 0.51000000000000001 110.254 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -76.03 158.66 31.63 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.938 -0.742 . . . . 1.8999999999999999 109.262 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.46 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -87.08 123.25 31.95 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.526 -1.287 . . . . 0.66000000000000003 107.526 178.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.4 tp -100.85 108.73 20.59 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 105.28 -2.118 . . . . 0.82999999999999996 105.28 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.5 tp -90.41 137.42 32.36 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.847 -1.168 . . . . 0.85999999999999999 107.847 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.492 HD12 ' HB2' ' A' ' 160' ' ' ALA . 39.9 mt -101.87 120.01 39.7 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 107.714 -1.217 . . . . 0.92000000000000004 107.714 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -110.97 140.15 45.72 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.056 -1.09 . . . . 2.0299999999999998 108.056 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.58 139.43 53.6 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.071 -1.018 . . . . 2.6600000000000001 108.758 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -84.87 133.36 34.31 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.682 -1.229 . . . . 2.3199999999999998 107.682 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -64.38 146.38 54.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.074 -1.016 . . . . 2.1099999999999999 109.264 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.5 mt -95.53 132.81 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.278 -0.889 . . . . 0.72999999999999998 108.691 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -106.42 128.98 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.84 -1.17 . . . . 0.87 107.84 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 mt -98.17 140.17 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.714 -0.847 . . . . 0.81000000000000005 108.714 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -89.35 119.95 30.26 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.626 -1.25 . . . . 1.3400000000000001 107.626 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -96.73 15.68 21.22 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.187 -0.946 . . . . 2.8900000000000001 112.227 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -69.22 151.09 46.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.971 -1.081 . . . . 2.0899999999999999 110.35 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -90.12 131.87 35.74 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.176 -1.046 . . . . 2.1899999999999999 108.176 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.2 pt -96.1 168.5 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.577 0.703 . . . . 0.75 110.499 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.9 p -92.48 166.19 12.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.474 -0.766 . . . . 0.91000000000000003 110.252 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.6 -22.78 47.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.335 -0.853 . . . . 0.93000000000000005 112.142 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.02 -36.65 80.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.919 -1.113 . . . . 2.2799999999999998 111.026 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -85.85 -5.5 59.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.574 -1.329 . . . . 1.45 112.501 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.93 -44.55 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.218 -0.926 . . . . 0.81000000000000005 110.478 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -58.73 -40.35 83.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.082 -1.011 . . . . 1.54 110.247 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -64.64 -40.78 96.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.484 -0.76 . . . . 2.3599999999999999 110.965 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -60.72 -39.99 90.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.102 -0.999 . . . . 1.3100000000000001 110.613 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.36 -40.83 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.956 -1.09 . . . . 0.81999999999999995 110.242 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -62.23 -40.82 97.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.941 -1.099 . . . . 1.5 110.365 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.422 ' HG2' HH11 ' A' ' 42' ' ' ARG . 45.6 mtt-85 -62.01 -41.75 98.42 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.194 -0.941 . . . . 2.23 110.131 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -76.12 -51.4 12.27 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.319 -0.863 . . . . 0.84999999999999998 109.973 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.03 -49.03 79.44 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.741 -0.784 . . . . 0.91000000000000003 109.606 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.9 t -70.55 -40.84 73.16 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.59 -0.694 . . . . 0.90000000000000002 109.962 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.67 -44.51 96.83 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.118 -1.593 . . . . 0.68999999999999995 109.118 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -57.75 -31.46 66.5 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.498 -1.001 . . . . 2.8799999999999999 109.548 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.27 -45.63 92.63 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.589 0.709 . . . . 0.84999999999999998 110.194 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -80.23 -40.82 26.3 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.474 -0.767 . . . . 2.3500000000000001 111.035 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.64 90.03 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.56 0.695 . . . . 0.65000000000000002 109.928 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.9 t -60.71 -40.01 90.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.244 1.021 . . . . 1.45 109.238 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.5 78.51 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.824 -0.626 . . . . 0.63 109.804 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -61.27 -50.32 73.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.056 -1.028 . . . . 1.3400000000000001 110.193 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.86 -39.36 91.63 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.309 -0.869 . . . . 1.5600000000000001 109.897 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -60.21 -41.33 92.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.802 -0.562 . . . . 1.1899999999999999 110.915 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.3 m -67.13 -43.0 83.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.94 -1.1 . . . . 0.71999999999999997 110.244 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.0 mt -59.87 -38.44 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.467 -0.771 . . . . 0.62 110.59 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -53.04 -42.5 65.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 1.05 110.865 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -69.87 -33.05 71.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.982 -1.074 . . . . 0.64000000000000001 110.383 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -63.22 -39.95 96.08 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.175 -1.01 . . . . 1.73 109.818 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.78 78.31 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.366 -0.834 . . . . 0.56000000000000005 110.021 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.52 -35.32 29.46 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 119.55 -1.31 . . . . 0.68999999999999995 110.613 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.45 -19.79 38.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.121 -1.223 . . . . 1.48 111.016 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.9 m -89.59 -55.3 3.7 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.852 -0.53 . . . . 0.97999999999999998 110.274 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.51 -2.74 20.1 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 113.807 1.04 . . . . 1.1599999999999999 113.807 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.05 160.95 26.49 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.746 -0.74 . . . . 0.84999999999999998 112.559 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -52.93 -18.95 2.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.458 -1.025 . . . . 3.8599999999999999 112.697 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 68' ' ' GLU . 4.9 pt-20 -56.99 -44.18 82.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.049 -1.032 . . . . 2.3500000000000001 110.842 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -84.57 -21.01 30.57 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.606 -1.309 . . . . 1.6699999999999999 111.534 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -59.83 -38.61 82.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.567 -0.708 . . . . 1.45 110.956 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.98 82.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.457 -0.777 . . . . 0.60999999999999999 111.693 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 72' ' ' ILE . 22.9 mt -63.72 -45.01 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.586 -1.321 . . . . 0.65000000000000002 110.518 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -69.23 -32.37 71.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.66000000000000003 110.508 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -62.36 -40.11 95.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.532 -0.867 . . . . 1.1899999999999999 110.597 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.55 -39.88 98.42 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 120.133 -1.032 . . . . 0.53000000000000003 110.713 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -58.68 -41.69 86.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.295 -1.12 . . . . 1.27 110.44 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.3 mt -60.04 -36.46 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.932 -1.105 . . . . 0.54000000000000004 110.448 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.3 ttm -59.8 -39.43 84.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.852 . . . . 1.74 110.61 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 tp -60.82 -48.79 80.2 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.591 -0.844 . . . . 0.55000000000000004 110.007 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.46 -42.59 96.48 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.458 0.647 . . . . 0.46999999999999997 110.949 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -87.56 5.65 38.28 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.271 -0.893 . . . . 1.4199999999999999 113.05 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -60.59 121.19 11.57 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.689 -1.257 . . . . 1.27 108.585 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.15 -18.55 65.4 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.875 0.845 . . . . 1.3500000000000001 110.631 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -75.16 -52.63 10.49 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.675 -0.81 . . . . 2.2200000000000002 110.079 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.32 -37.0 79.22 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.688 -0.805 . . . . 0.62 110.525 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -57.59 -47.86 80.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.199 -0.938 . . . . 1.29 110.992 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.7 -37.27 81.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.436 -0.79 . . . . 1.52 110.635 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.58 -48.8 68.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.71 -1.244 . . . . 1.3 110.26 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.2 mt -56.57 -45.96 82.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.923 -1.11 . . . . 0.60999999999999999 109.947 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.0 mt -60.77 -41.9 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.541 0.686 . . . . 0.78000000000000003 110.36 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.7 98.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.905 . . . . 0.81999999999999995 110.711 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.67 -42.49 97.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.048 -1.032 . . . . 0.80000000000000004 110.679 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.41 -45.59 98.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.204 -0.935 . . . . 0.77000000000000002 110.323 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -83.67 -34.5 24.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 2.1200000000000001 112.132 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -80.86 -44.86 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.693 -1.254 . . . . 1.51 111.856 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -102.53 8.36 39.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.593 -0.692 . . . . 1.98 112.318 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.0 m170 49.66 49.02 20.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 1.3200000000000001 111.641 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.4 mtp -101.68 156.58 17.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.583 -0.698 . . . . 1.3799999999999999 109.397 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.3 p -74.14 160.16 31.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.573 -0.529 . . . . 0.67000000000000004 109.573 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.14 -40.52 81.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.155 -0.966 . . . . 0.52000000000000002 110.301 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.544 ' OD2' HD21 ' A' ' 142' ' ' LEU . 73.6 m-20 -68.08 -44.09 77.05 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.905 0.86 . . . . 2.25 110.241 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.06 -49.09 63.5 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.625 -0.83 . . . . 0.64000000000000001 110.955 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.13 87.91 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.267 -0.896 . . . . 0.56000000000000005 110.181 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.54 95.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.46000000000000002 110.539 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -60.29 -36.18 77.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 1.3200000000000001 111.423 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.05 -50.21 74.63 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.039 -1.038 . . . . 1.3 110.954 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -60.24 -48.01 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.552 -1.343 . . . . 0.60999999999999999 109.947 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -60.92 -31.86 50.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 121.599 -0.688 . . . . 0.65000000000000002 110.331 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -57.08 -41.04 78.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.123 -0.986 . . . . 2.1099999999999999 111.175 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.73 -35.36 11.67 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.231 -1.462 . . . . 0.82999999999999996 112.191 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -59.99 -40.9 90.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.504 -1.586 . . . . 1.28 110.241 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.48 -51.49 14.65 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.892 0.853 . . . . 0.89000000000000001 110.224 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.2 m -59.31 -39.85 84.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.307 -0.871 . . . . 1.8700000000000001 110.619 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.79 98.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -0.784 . . . . 1.05 111.064 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 80.9 mt -63.93 -31.11 72.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.725 -1.234 . . . . 1.02 110.961 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -66.43 -22.65 66.22 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.923 -1.111 . . . . 2.04 110.915 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -72.5 -12.41 61.07 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.676 0.751 . . . . 1.73 111.059 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.507 HD13 HD13 ' A' ' 123' ' ' LEU . 82.9 mt -86.53 149.54 24.88 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.363 0.602 . . . . 1.3700000000000001 109.426 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -103.02 39.11 1.61 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.127 -0.983 . . . . 2.8799999999999999 111.769 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.509 ' CB ' HD12 ' A' ' 123' ' ' LEU . 51.2 t0 -115.78 139.07 50.53 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 121.141 -0.975 . . . . 1.5800000000000001 108.77 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.06 -40.16 84.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 3.04 110.97 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -72.46 -48.82 37.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.846 -1.159 . . . . 0.90000000000000002 111.068 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.509 HD12 ' CB ' ' A' ' 120' ' ' ASP . 19.3 mt -61.5 -43.43 98.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.878 -1.138 . . . . 1.0600000000000001 110.116 -178.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -63.79 -50.09 70.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.954 . . . . 2.1800000000000002 110.06 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -59.9 -32.89 71.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.415 -0.803 . . . . 2.1499999999999999 110.122 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -63.79 -28.17 69.68 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.716 -1.194 . . . . 2.3300000000000001 109.343 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -59.06 -47.82 83.86 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.684 0.754 . . . . 0.81999999999999995 109.685 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.95 -42.35 97.33 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.222 -0.991 . . . . 0.84999999999999998 109.509 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.48 -31.31 71.96 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.313 0.577 . . . . 1.3899999999999999 110.26 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.3 t -68.1 -44.97 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 0.56000000000000005 109.942 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -59.36 -36.15 75.2 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.071 -1.018 . . . . 3.1200000000000001 110.099 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -60.0 -39.69 86.65 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.067 -0.515 . . . . 1.28 110.579 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.48 -40.02 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.206 -0.934 . . . . 0.48999999999999999 109.936 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.02 -41.75 31.53 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 119.838 -1.172 . . . . 0.46000000000000002 110.691 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.457 ' HG2' ' HZ2' ' A' ' 135' ' ' LYS . 16.6 ttpp -58.29 -41.94 85.49 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.305 -1.115 . . . . 2.71 110.355 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.419 ' NH1' ' HG2' ' A' ' 136' ' ' ARG . 63.7 mtt-85 -63.31 -44.58 94.58 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.478 -0.889 . . . . 2.1400000000000001 110.019 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 32.2 tp -60.84 -42.06 97.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.625 -0.672 . . . . 1.05 110.084 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.1 mt -59.76 -40.83 89.46 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.377 -0.827 . . . . 0.52000000000000002 110.367 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -61.33 -36.16 79.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.188 -0.945 . . . . 2.3500000000000001 110.806 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -74.31 -41.36 61.28 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.218 -0.993 . . . . 1.3899999999999999 110.698 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.484 HG21 ' OD1' ' A' ' 101' ' ' ASP . 88.5 mt -60.48 -39.02 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.335 -0.853 . . . . 0.68000000000000005 110.454 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.544 HD21 ' OD2' ' A' ' 101' ' ' ASP . 70.0 mt -85.09 -8.01 58.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.968 -1.082 . . . . 0.82999999999999996 112.263 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.12 15.6 80.14 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 120.334 -0.936 . . . . 0.91000000000000003 112.314 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 27.7 tp -70.0 142.37 52.8 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.715 0.769 . . . . 0.94999999999999996 109.474 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -68.35 151.27 47.11 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.313 -0.867 . . . . 2.4300000000000002 110.205 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.1 mt -104.61 135.17 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.261 -1.014 . . . . 1.1000000000000001 108.261 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.726 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -78.49 117.91 24.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.696 -0.853 . . . . 1.5800000000000001 108.696 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -99.35 103.32 15.13 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.263 -1.755 . . . . 1.6200000000000001 106.263 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -74.12 -15.21 61.05 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.604 -0.685 . . . . 0.80000000000000004 111.573 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -81.59 1.8 32.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.224 -0.922 . . . . 1.5600000000000001 112.279 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.44 23.85 8.02 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.317 -0.864 . . . . 0.83999999999999997 112.546 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.5 mt -72.41 139.92 18.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.102 -0.999 . . . . 0.81999999999999995 108.923 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -110.52 -18.88 13.1 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.865 0.841 . . . . 2.3100000000000001 112.611 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -114.33 134.17 55.15 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.802 -1.185 . . . . 1.54 107.802 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.54 127.57 33.2 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.039 -1.038 . . . . 1.3799999999999999 108.402 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.84 173.49 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.014 -0.736 . . . . 0.68999999999999995 109.014 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 29.6 mt -86.75 139.58 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.396 -0.965 . . . . 0.53000000000000003 108.396 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.5 tp -94.7 122.94 37.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.119 -0.988 . . . . 0.64000000000000001 108.681 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.48 131.17 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.091 -1.077 . . . . 0.67000000000000004 108.091 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.492 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -160.7 153.7 21.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 0.78000000000000003 108.73 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.471 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -62.5 -36.29 82.09 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.502 -1.374 . . . . 1.0 109.411 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 57.7 t0 -170.86 150.54 3.21 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.651 -0.87 . . . . 2.4199999999999999 108.651 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.468 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 79.8 mt -119.19 143.21 47.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.27 -0.894 . . . . 0.75 109.261 177.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.4 p -91.83 146.49 33.09 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 120.988 -1.07 . . . . 0.78000000000000003 108.625 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -39.31 -42.62 2.48 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.216 1.944 . . . . 0.67000000000000004 114.045 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.3 m -59.81 -48.33 82.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 0.69999999999999996 110.154 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -64.5 -39.95 94.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.002 -1.061 . . . . 1.21 110.284 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 35.0 p -68.47 -35.0 76.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.608 -0.683 . . . . 0.59999999999999998 110.659 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.68 88.36 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.424 -0.798 . . . . 0.62 110.364 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -93.21 -1.21 56.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.318 -0.864 . . . . 1.1599999999999999 112.597 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 171' ' ' LEU . 39.0 tp -61.71 150.87 35.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.342 -0.849 . . . . 0.72999999999999998 109.361 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -94.76 115.03 27.01 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 107.331 -1.359 . . . . 2.2400000000000002 107.331 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 23.1 mt -73.83 -20.39 60.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.864 -0.523 . . . . 1.4299999999999999 111.459 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -83.03 -23.04 33.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 2.1499999999999999 112.252 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -100.88 -1.88 33.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.263 0.838 . . . . 2.04 113.263 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 178' ' ' GLY . 60.4 t -108.38 125.52 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.648 -1.241 . . . . 0.55000000000000004 107.648 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 13.0 tp -84.25 -4.1 58.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 1.6299999999999999 111.796 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.604 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.83 170.31 30.59 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.858 -1.697 . . . . 0.46999999999999997 108.858 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.09 129.33 47.76 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 107.785 -1.191 . . . . 0.54000000000000004 107.785 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.464 HG22 HG21 ' A' ' 205' ' ' THR . 87.2 mt -130.99 109.85 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 106.409 -1.7 . . . . 0.68999999999999995 106.409 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 205' ' ' THR . 66.9 p -127.39 169.86 13.15 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.974 -1.079 . . . . 0.81999999999999995 109.586 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 21.4 p-10 -101.67 53.43 0.82 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.719 -0.613 . . . . 2.3700000000000001 110.643 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -99.53 133.37 43.95 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.371 -0.974 . . . . 1.1100000000000001 108.371 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.4 3.17 4.82 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.733 -1.222 . . . . 1.6699999999999999 112.638 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 92.92 -4.68 75.43 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.247 -1.149 . . . . 1.54 113.198 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.448 ' O ' ' CG ' ' A' ' 186' ' ' ARG . 26.2 ptt180 -81.63 118.36 22.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.813 -1.551 . . . . 4.4800000000000004 106.813 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 73.5 p 46.95 40.28 9.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.763 -1.211 . . . . 2.6299999999999999 111.881 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 82.0 p -84.34 109.44 17.83 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.029 -1.471 . . . . 1.6899999999999999 107.029 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -61.54 -32.97 73.06 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.509 -0.744 . . . . 1.0700000000000001 110.811 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.3 p -57.13 -40.3 76.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.748 -1.22 . . . . 1.5800000000000001 110.218 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.0 t -60.17 -39.62 87.11 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.018 -1.051 . . . . 1.6000000000000001 109.892 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.1 mm -59.88 -40.13 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 1.45 110.351 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.4 mtp -65.06 -42.74 93.92 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.339 1.066 . . . . 1.05 109.605 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.28 -47.42 86.06 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.797 -0.638 . . . . 0.71999999999999997 110.979 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -61.38 -42.79 99.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.977 -1.077 . . . . 3.0499999999999998 110.436 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 72.4 m -70.59 -42.73 70.63 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.956 0.884 . . . . 0.89000000000000001 110.127 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.2 mt -91.84 -8.14 47.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.46 -0.775 . . . . 0.78000000000000003 112.182 -177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 54.43 9.78 0.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.912 1.078 . . . . 1.45 113.912 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 37.7 mt -70.14 164.97 48.0 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.079 -1.013 . . . . 0.67000000000000004 109.283 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -70.68 144.28 48.69 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.7 1.6 . . . . 0.64000000000000001 110.444 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -160.91 166.11 28.95 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.701 -1.6 . . . . 0.67000000000000004 109.611 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 65.0 mt -146.9 156.48 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.447 -1.316 . . . . 0.68999999999999995 107.447 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.5 m -140.94 -31.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 O-C-N 120.687 -1.258 . . . . 0.84999999999999998 112.366 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.05 43.29 2.44 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.007 -1.058 . . . . 0.92000000000000004 111.997 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 181' ' ' THR . 30.6 p -63.03 -16.73 60.85 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.134 -1.216 . . . . 0.94999999999999996 111.202 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.96 -94.71 1.0 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 110.14 -1.184 . . . . 1.04 110.14 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 86.8 p -129.07 30.92 4.97 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.607 -0.937 . . . . 1.5700000000000001 111.716 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.13 -38.18 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.506 -1.371 . . . . 0.83999999999999997 110.165 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 76.2 p -52.86 -25.81 12.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.98999999999999999 111.379 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.9 p -96.27 6.2 49.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 1.7 111.814 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -128.82 -4.17 5.19 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 113.136 0.791 . . . . 2.2000000000000002 113.136 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 13.4 t -117.96 149.51 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.675 0.75 . . . . 0.83999999999999997 109.784 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -118.46 152.53 35.73 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.079 -1.082 . . . . 2.2000000000000002 108.079 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 40.4 p-10 -54.31 146.3 15.85 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.932 -1.107 . . . . 2.2799999999999998 110.113 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 t70 81.07 -3.42 1.74 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 114.304 1.224 . . . . 2.3500000000000001 114.304 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.76 146.16 53.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.948 -1.095 . . . . 1.97 108.74 177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -88.78 120.22 29.99 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.003 -1.48 . . . . 2.6499999999999999 107.003 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.46 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.1 mt -126.67 143.39 51.25 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.274 -0.891 . . . . 0.63 109.846 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.7 mt -109.53 121.37 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.859 -1.534 . . . . 0.62 106.859 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 32.8 tp -98.91 109.79 22.49 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.12 -1.807 . . . . 0.64000000000000001 106.12 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.9 p30 -93.76 -22.52 18.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.907 -1.121 . . . . 2.0499999999999998 112.958 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.897 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.64 19.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.58 0.705 . . . . 0.83999999999999997 112.804 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.7 t -108.42 -60.14 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.015 -1.053 . . . . 1.02 108.837 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -88.7 8.25 29.62 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.159 0.98 . . . . 2.5099999999999998 110.028 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 65.86 49.55 1.65 Allowed 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.9 -1.045 . . . . 1.54 111.944 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.51 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 16.8 pt20 -154.65 156.34 36.3 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.642 1.21 . . . . 1.95 110.873 178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 54.8 t -118.14 141.58 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 115.176 -0.92 . . . . 0.70999999999999996 108.626 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.51 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 94.8 m-85 -100.98 139.09 37.16 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.961 -1.087 . . . . 1.01 108.431 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.1 t -111.11 129.71 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 107.945 -1.132 . . . . 0.81999999999999995 107.945 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.429 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 4.1 t30 49.57 50.17 8.66 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 113.4 0.889 . . . . 1.54 113.4 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 29.8 Cg_endo -65.14 151.71 84.68 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.42 2.08 . . . . 0.93999999999999995 110.41 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 35.9 p -73.4 159.63 33.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.053 -1.029 . . . . 1.8 108.84 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -63.26 -33.81 76.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.365 -0.834 . . . . 2.73 111.143 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.22 -39.25 82.11 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.081 -1.012 . . . . 3.1699999999999999 110.699 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 98.2 t -71.94 -39.34 66.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.264 -0.897 . . . . 1.3400000000000001 110.77 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.0 mt . . . . . 0 C--N 1.302 -1.471 0 O-C-N 121.178 -0.951 . . . . 1.2 110.154 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 106.564 -1.643 . . . . 1.0700000000000001 106.564 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.1 m -104.9 120.57 41.75 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.004 -1.11 . . . . 1.24 108.004 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.08 -158.5 22.21 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.74 -1.744 . . . . 1.01 108.74 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 5' ' ' ILE . 84.4 mt -96.26 -0.59 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.303 -1.116 . . . . 1.1100000000000001 113.002 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tp 50.06 98.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.925 -1.109 . . . . 0.98999999999999999 112.583 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.13 -45.12 12.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.106 -0.996 . . . . 0.84999999999999998 110.849 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -146.58 140.87 15.62 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 107.639 -1.245 . . . . 1.3799999999999999 107.639 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.38 150.75 41.86 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.506 2.138 . . . . 0.93999999999999995 112.345 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.947 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.41 170.34 18.8 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 108.992 -1.643 . . . . 0.81000000000000005 108.992 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.5 mt -129.86 138.8 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.026 -1.279 . . . . 0.82999999999999996 108.288 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.35 149.88 38.36 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.054 -1.029 . . . . 0.53000000000000003 109.417 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.3 m-85 -122.04 139.83 53.23 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.969 -1.123 . . . . 0.77000000000000002 107.969 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.24 171.21 41.34 Favored Glycine 0 N--CA 1.499 2.848 0 C-N-CA 118.746 -1.692 . . . . 0.51000000000000001 110.213 178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -76.4 158.77 31.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.604 -0.939 . . . . 1.8999999999999999 108.742 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.59 132.83 33.8 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.225 -0.922 . . . . 0.66000000000000003 108.827 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.6 tp -110.63 102.69 11.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.78 -1.933 . . . . 0.82999999999999996 105.78 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.8 tp -91.51 136.84 32.83 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.078 -1.082 . . . . 0.85999999999999999 108.078 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.5 mt -102.34 116.23 32.2 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.947 -1.501 . . . . 0.92000000000000004 106.947 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -111.18 137.88 48.32 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.656 -1.238 . . . . 2.0299999999999998 107.656 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -125.65 149.66 48.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.089 -1.007 . . . . 2.6600000000000001 108.864 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -85.21 137.56 32.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.736 -1.209 . . . . 2.3199999999999998 107.736 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -63.3 148.29 48.7 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.599 -0.84 . . . . 2.1099999999999999 108.818 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -92.55 135.38 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.403 -0.962 . . . . 0.72999999999999998 108.403 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.7 t -104.4 130.16 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.061 -1.089 . . . . 0.87 108.061 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.1 mt -98.32 135.22 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.278 -1.008 . . . . 0.81000000000000005 108.278 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -90.64 119.23 30.71 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 106.948 -1.501 . . . . 1.3400000000000001 106.948 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.451 HH11 ' HG3' ' A' ' 28' ' ' ARG . 19.1 mmm-85 -96.81 11.74 34.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 2.8900000000000001 112.111 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -72.01 152.26 42.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.176 -0.952 . . . . 2.0899999999999999 109.619 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -91.71 135.14 34.12 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.54 -0.911 . . . . 2.1899999999999999 108.54 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -94.64 167.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.886 -1.133 . . . . 0.75 109.957 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.5 p -93.8 166.06 12.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.112 -0.993 . . . . 0.91000000000000003 109.332 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.06 -19.81 34.57 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.876 -1.14 . . . . 0.93000000000000005 112.814 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 60.1 t0 -70.01 -38.06 75.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.784 -1.197 . . . . 2.2799999999999998 110.749 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -86.38 -11.0 53.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.809 -1.182 . . . . 1.45 112.202 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.34 -43.94 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.003 -1.061 . . . . 0.81000000000000005 110.362 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.1 -39.81 83.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.357 -0.839 . . . . 1.54 110.621 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -63.68 -42.66 98.0 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.25 -0.907 . . . . 2.3599999999999999 111.019 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -61.53 -38.78 88.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.986 -1.071 . . . . 1.3100000000000001 110.901 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.4 t -60.0 -45.4 95.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.155 -0.965 . . . . 0.81999999999999995 110.329 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -61.55 -45.49 93.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.975 . . . . 1.5 110.081 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.65 -43.31 97.77 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.387 -0.821 . . . . 2.23 110.286 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -71.41 -56.94 4.97 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.185 -0.947 . . . . 0.84999999999999998 109.987 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.6 tp -58.18 -47.46 83.34 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.203 -0.999 . . . . 0.91000000000000003 109.786 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.4 t -69.95 -37.47 75.86 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.141 -0.975 . . . . 0.90000000000000002 109.997 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.45 -46.89 91.43 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.912 -1.137 . . . . 0.68999999999999995 110.366 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -59.83 -30.6 69.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.406 -1.056 . . . . 2.8799999999999999 109.437 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.16 -45.2 87.87 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.163 -0.615 . . . . 0.84999999999999998 109.868 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -80.8 -42.26 22.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 2.3500000000000001 110.885 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.43 85.5 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.599 -0.841 . . . . 0.65000000000000002 109.42 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 t -60.68 -41.13 94.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.217 1.008 . . . . 1.45 109.077 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.47 -46.07 77.59 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.62 -0.718 . . . . 0.63 110.144 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -62.92 -49.98 72.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.092 -1.005 . . . . 1.3400000000000001 109.997 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.1 mt -61.69 -40.01 93.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.163 -0.96 . . . . 1.5600000000000001 109.978 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -60.15 -40.02 88.41 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.93 -0.481 . . . . 1.1899999999999999 110.497 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.53 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 16.2 m -65.59 -45.01 84.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.924 -1.11 . . . . 0.71999999999999997 110.043 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.57 -37.84 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 0.62 110.3 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.42 ' NZ ' ' OE2' ' A' ' 70' ' ' GLU . 9.0 ttpp -49.25 -43.4 42.83 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.968 -0.693 . . . . 1.05 110.915 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -69.54 -38.99 77.72 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.581 -0.699 . . . . 0.64000000000000001 109.659 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.53 ' NZ ' HG22 ' A' ' 56' ' ' THR . 62.1 mttp -61.01 -40.32 93.09 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.46 -1.296 . . . . 1.73 108.996 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.24 77.73 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.922 -0.711 . . . . 0.56000000000000005 109.835 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.47 -36.74 19.42 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.704 -1.236 . . . . 0.68999999999999995 110.939 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -80.79 -27.28 36.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.041 -1.27 . . . . 1.48 111.125 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -83.9 -49.87 8.6 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.565 -0.709 . . . . 0.97999999999999998 111.021 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.87 -5.08 18.55 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.031 1.123 . . . . 1.1599999999999999 114.031 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.88 163.84 28.97 Favored Glycine 0 N--CA 1.502 3.096 0 O-C-N 121.291 -0.881 . . . . 0.84999999999999998 111.82 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -56.49 -24.34 45.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.685 -0.891 . . . . 3.8599999999999999 112.218 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.6 -39.93 68.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 2.3500000000000001 110.715 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -87.72 -25.03 23.66 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.931 -1.106 . . . . 1.6699999999999999 111.386 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.42 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 71.1 tt0 -59.72 -37.31 78.54 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.489 0.661 . . . . 1.45 110.647 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.96 74.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.60999999999999999 111.341 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.55 -42.37 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.634 -1.291 . . . . 0.65000000000000002 110.517 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -70.13 -31.66 69.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.392 -0.817 . . . . 0.66000000000000003 110.252 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -59.99 -38.44 82.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.042 -1.036 . . . . 1.1899999999999999 110.278 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.48 -39.87 86.85 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.004 -1.238 . . . . 0.53000000000000003 110.004 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -60.21 -45.72 92.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.273 -1.133 . . . . 1.27 110.312 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.5 mt -60.92 -39.34 81.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.193 -0.942 . . . . 0.54000000000000004 110.318 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.7 ttm -56.9 -40.55 76.47 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.594 -0.842 . . . . 1.74 110.101 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -59.52 -50.05 75.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 0.55000000000000004 109.992 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.4 tp -61.88 -41.04 97.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.502 -0.748 . . . . 0.46999999999999997 110.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -86.38 8.05 23.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.506 -0.746 . . . . 1.4199999999999999 112.518 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -65.5 125.69 25.98 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.448 -1.407 . . . . 1.27 108.346 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.0 -18.73 65.52 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.107 0.956 . . . . 1.3500000000000001 110.711 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -76.46 -54.65 6.42 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.752 -0.779 . . . . 2.2200000000000002 110.428 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.68 -35.15 75.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.408 -0.807 . . . . 0.62 110.962 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -59.93 -49.19 78.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.416 -0.802 . . . . 1.29 110.522 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -61.6 -35.72 78.65 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.61 -0.681 . . . . 1.52 110.625 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.82 -46.87 73.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.02 . . . . 1.3 110.619 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.8 mt -59.51 -46.52 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.146 -0.971 . . . . 0.60999999999999999 109.718 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.7 mt -62.18 -41.25 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.446 0.641 . . . . 0.78000000000000003 110.529 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.5 -44.24 97.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.103 -0.998 . . . . 0.81999999999999995 110.741 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.58 -42.31 96.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.045 -1.034 . . . . 0.80000000000000004 110.434 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.58 -49.43 83.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.034 -1.041 . . . . 0.77000000000000002 110.386 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -82.8 -31.48 28.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.157 -0.965 . . . . 2.1200000000000001 111.644 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 91' ' ' ALA . 35.8 t0 -83.03 -45.83 13.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.735 -1.228 . . . . 1.51 111.886 -178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -103.26 11.24 37.06 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.307 -0.87 . . . . 1.98 111.998 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.2 m80 51.3 51.95 15.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.441 -0.787 . . . . 1.3200000000000001 111.999 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -105.89 151.93 23.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.456 -0.777 . . . . 1.3799999999999999 109.178 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.7 p -71.61 161.92 30.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.43 -0.794 . . . . 0.67000000000000004 109.583 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.95 -44.4 91.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.261 -0.899 . . . . 0.52000000000000002 110.875 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 21.0 p-10 -68.71 -39.25 80.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.996 -1.065 . . . . 2.25 110.133 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -48.21 63.78 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.727 -0.789 . . . . 0.64000000000000001 111.176 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.35 77.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.242 -0.911 . . . . 0.56000000000000005 110.577 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.7 89.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.448 -0.783 . . . . 0.46000000000000002 110.656 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.9 -39.48 89.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.852 -1.155 . . . . 1.3200000000000001 110.937 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.53 -48.74 79.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.857 -1.152 . . . . 1.3 110.742 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.9 t -59.74 -47.91 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.707 -1.246 . . . . 0.60999999999999999 109.877 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.0 mm -61.71 -35.64 68.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.934 -0.479 . . . . 0.65000000000000002 110.617 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -56.58 -40.2 74.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.893 -1.129 . . . . 2.1099999999999999 111.073 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.36 -28.89 23.67 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.346 -1.407 . . . . 0.82999999999999996 113.185 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -62.35 -39.94 94.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.466 -1.608 . . . . 1.28 109.973 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.03 -48.49 35.72 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.787 0.803 . . . . 0.89000000000000001 110.517 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.4 m -61.45 -40.62 95.14 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.208 -0.597 . . . . 1.8700000000000001 110.239 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.55 95.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.503 -0.748 . . . . 1.05 110.63 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.46 -28.28 69.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.903 -1.123 . . . . 1.02 110.826 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -66.34 -23.24 66.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.561 0.696 . . . . 2.04 110.917 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -76.33 -11.0 59.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.728 -0.608 . . . . 1.73 111.438 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.669 HD13 HD13 ' A' ' 123' ' ' LEU . 4.0 mt -87.27 138.78 31.19 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.038 -1.097 . . . . 1.3700000000000001 108.038 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 14.2 t70 -96.24 62.52 2.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.308 -0.87 . . . . 2.8799999999999999 110.48 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -138.36 135.96 35.87 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 107.574 -1.269 . . . . 1.5800000000000001 107.574 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -59.18 -37.26 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 3.04 110.837 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -71.21 -55.68 7.62 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.809 -1.182 . . . . 0.90000000000000002 110.402 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.669 HD13 HD13 ' A' ' 118' ' ' LEU . 29.9 mt -60.83 -38.41 85.4 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.109 -0.994 . . . . 1.0600000000000001 110.704 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -60.7 -49.53 77.12 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.952 -1.099 . . . . 2.1800000000000002 109.507 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -60.21 -30.41 69.36 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.49 -0.884 . . . . 2.1499999999999999 109.431 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 130' ' ' VAL . 57.6 ttt180 -62.26 -29.86 70.71 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.06 -1.056 . . . . 2.3300000000000001 109.03 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.98 75.47 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.939 0.876 . . . . 0.81999999999999995 109.32 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -42.55 77.26 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.881 -0.6 . . . . 0.84999999999999998 110.513 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -62.78 -36.52 83.38 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.626 0.727 . . . . 1.3899999999999999 110.25 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 126' ' ' ARG . 41.7 t -69.21 -39.41 79.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.406 -0.809 . . . . 0.56000000000000005 110.14 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.414 HH11 ' HG3' ' A' ' 131' ' ' ARG . 38.9 ttm-85 -56.4 -38.96 72.22 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 118.912 -1.115 . . . . 3.1200000000000001 109.489 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -60.02 -38.6 83.18 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.391 0.615 . . . . 1.28 110.121 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.3 mt -60.33 -39.93 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.703 -0.623 . . . . 0.48999999999999999 110.027 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.85 -43.79 40.45 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.925 -1.131 . . . . 0.46000000000000002 110.734 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -57.19 -42.5 81.33 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.145 -1.209 . . . . 2.71 110.099 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 -62.95 -40.69 98.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.13 -0.981 . . . . 2.1400000000000001 109.815 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.84 -45.95 92.45 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.534 -0.729 . . . . 1.05 110.122 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.69 -42.17 92.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.585 -0.697 . . . . 0.52000000000000002 110.62 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -60.27 -37.59 80.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.518 -0.739 . . . . 2.3500000000000001 110.831 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -75.28 -41.38 57.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 1.3899999999999999 111.191 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.02 -42.17 88.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.991 -1.068 . . . . 0.68000000000000005 110.292 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.2 -11.0 36.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.926 -1.109 . . . . 0.82999999999999996 112.276 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.07 26.82 61.29 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 119.611 -1.281 . . . . 0.91000000000000003 113.11 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 22.3 tp -62.57 149.83 42.1 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.713 -0.875 . . . . 0.94999999999999996 108.96 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -64.55 149.02 49.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 2.4300000000000002 109.603 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 70.4 mt -106.7 142.73 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.547 -0.908 . . . . 1.1000000000000001 108.547 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.762 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -78.75 129.82 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.001 -1.062 . . . . 1.5800000000000001 108.253 178.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -97.8 87.17 3.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.221 -1.029 . . . . 1.6200000000000001 108.221 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.97 -24.92 60.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.369 -0.832 . . . . 0.80000000000000004 111.302 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' A' ' 172' ' ' ASN . 34.5 t -82.01 -0.54 44.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 1.5600000000000001 112.1 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.49 25.74 7.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.546 -0.721 . . . . 0.83999999999999997 111.6 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 mt -70.96 139.98 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.138 -0.976 . . . . 0.81999999999999995 109.439 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -112.02 -20.18 12.06 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.645 0.735 . . . . 2.3100000000000001 112.073 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -117.63 137.75 52.42 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.704 -1.221 . . . . 1.54 107.704 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.25 128.34 35.37 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.977 -1.119 . . . . 1.3799999999999999 107.977 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.0 m -148.33 176.76 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.064 -0.717 . . . . 0.68999999999999995 109.064 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 44.4 mt -88.17 143.72 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.138 -0.976 . . . . 0.53000000000000003 109.007 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.5 tp -95.93 120.21 35.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.014 -1.054 . . . . 0.64000000000000001 108.61 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.0 t -120.15 129.58 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 107.506 -1.294 . . . . 0.67000000000000004 107.506 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.69 151.65 16.9 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.174 -0.954 . . . . 0.78000000000000003 109.084 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.74 -32.46 72.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.358 -1.464 . . . . 1.0 109.616 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -173.42 152.01 2.09 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.655 -0.868 . . . . 2.4199999999999999 108.655 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 41.7 mt -112.73 140.27 47.64 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.382 -0.824 . . . . 0.75 108.965 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.9 p -91.11 146.87 34.44 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.072 -1.018 . . . . 0.78000000000000003 108.852 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -39.19 -43.02 2.43 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 122.173 1.915 . . . . 0.67000000000000004 113.405 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.6 m -60.16 -48.5 81.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.066 . . . . 0.69999999999999996 110.234 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -64.68 -39.91 94.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.019 -1.051 . . . . 1.21 109.9 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 43.2 p -65.47 -43.32 90.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.602 -0.686 . . . . 0.59999999999999998 110.978 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.75 82.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.62 110.617 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -95.87 -1.14 50.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.171 -0.955 . . . . 1.1599999999999999 112.79 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.74 145.85 51.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.973 -1.079 . . . . 0.72999999999999998 108.181 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' A' ' 150' ' ' SER . 97.6 m-20 -94.99 117.49 30.22 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 106.979 -1.489 . . . . 2.2400000000000002 106.979 177.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.729 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -72.93 -18.59 61.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.781 -0.574 . . . . 1.4299999999999999 111.151 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -84.06 -16.17 44.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 2.1499999999999999 112.222 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -103.38 -11.97 17.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.538 -0.726 . . . . 2.04 112.812 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 178' ' ' GLY . 94.9 t -106.15 128.49 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 107.888 -1.153 . . . . 0.55000000000000004 107.888 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.62 -8.41 58.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.031 -1.043 . . . . 1.6299999999999999 112.326 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.552 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 177.22 173.94 43.19 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.437 -1.465 . . . . 0.46999999999999997 109.437 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -127.48 131.62 50.12 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 107.79 -1.189 . . . . 0.54000000000000004 107.79 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.533 HD11 HD13 ' A' ' 220' ' ' LEU . 62.5 mt -137.18 118.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 105.932 -1.877 . . . . 0.68999999999999995 105.932 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 203' ' ' VAL . 62.9 p -140.46 170.81 15.11 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.693 -1.254 . . . . 0.81999999999999995 110.08 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -104.09 65.36 0.8 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.791 -0.568 . . . . 2.3700000000000001 109.627 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -104.33 152.22 22.51 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.494 -0.754 . . . . 1.1100000000000001 109.484 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.45 -38.47 70.04 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 120.222 -0.99 . . . . 1.6699999999999999 110.864 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.63 -2.37 64.67 Favored Glycine 0 N--CA 1.494 2.561 0 O-C-N 121.094 -1.239 . . . . 1.54 113.292 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.437 HH11 ' HG2' ' A' ' 186' ' ' ARG . 3.5 ptt-85 -88.83 101.45 14.05 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.624 -1.991 . . . . 4.4800000000000004 105.624 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 p 53.4 47.64 23.7 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.993 -1.067 . . . . 2.6299999999999999 112.001 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 59.1 m -83.63 135.86 34.44 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.697 -1.223 . . . . 1.6899999999999999 107.697 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -59.36 -39.92 84.81 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.286 -0.884 . . . . 1.0700000000000001 111.026 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.0 m -59.62 -40.33 87.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.898 -1.126 . . . . 1.5800000000000001 110.089 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.2 p -61.88 -35.04 77.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 1.6000000000000001 110.652 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 32.0 mm -59.99 -39.29 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.519 -0.738 . . . . 1.45 110.656 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.4 mtp -62.23 -43.16 99.46 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 122.319 1.057 . . . . 1.05 109.595 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.89 -47.76 83.82 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.717 -0.614 . . . . 0.71999999999999997 110.504 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.516 ' HG2' HH11 ' A' ' 195' ' ' ARG . 33.8 mtt-85 -60.12 -41.34 92.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 3.0499999999999998 110.586 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.7 m -70.13 -41.53 73.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.182 -0.949 . . . . 0.89000000000000001 110.079 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.83 -8.18 50.28 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.577 0.703 . . . . 0.78000000000000003 112.49 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 194' ' ' ALA . 94.5 mt-10 49.6 12.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.82 1.045 . . . . 1.45 113.82 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.57 149.06 93.31 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 107.872 -1.159 . . . . 0.67000000000000004 107.872 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.34 135.86 71.0 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 120.948 1.099 . . . . 0.64000000000000001 110.017 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.75 163.11 34.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.31 -1.494 . . . . 0.67000000000000004 109.397 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.419 ' CD1' HD11 ' A' ' 220' ' ' LEU . 32.2 mt -146.79 147.51 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.639 -1.245 . . . . 0.68999999999999995 107.639 177.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.5 m -125.24 -31.55 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.146 -0.971 . . . . 0.84999999999999998 113.052 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.1 45.01 2.46 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 119.542 -1.313 . . . . 0.92000000000000004 111.016 -178.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 181' ' ' THR . 58.6 p -61.86 -19.54 62.73 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.537 -0.978 . . . . 0.94999999999999996 111.372 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.65 -90.7 0.86 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.48 -1.048 . . . . 1.04 110.48 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.3 p -130.62 28.69 4.87 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.503 -0.998 . . . . 1.5700000000000001 113.288 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.31 -40.02 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.44 -1.412 . . . . 0.83999999999999997 110.603 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.2 p -58.28 -22.72 53.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.968 -1.082 . . . . 0.98999999999999999 111.707 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.5 p -94.15 -1.88 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.424 -0.797 . . . . 1.7 112.183 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -125.88 3.07 7.37 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.645 0.736 . . . . 2.2000000000000002 112.436 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 22.4 t -116.13 146.54 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.528 -0.733 . . . . 0.83999999999999997 109.263 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -119.81 160.45 22.61 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.998 -1.112 . . . . 2.2000000000000002 107.998 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 3.7 m120 -57.36 139.81 51.96 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.85 -1.156 . . . . 2.2799999999999998 110.812 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 79.11 5.55 2.23 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.193 1.182 . . . . 2.3500000000000001 114.193 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 61.0 t0 -66.08 149.08 50.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.911 -1.118 . . . . 1.97 108.437 177.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.496 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 36.3 t80 -89.82 122.18 32.65 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.916 -1.513 . . . . 2.6499999999999999 106.916 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.4 mt -129.52 147.53 51.34 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.035 0.922 . . . . 0.63 110.105 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 21.0 mt -119.92 130.75 73.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.408 -1.33 . . . . 0.62 107.408 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.533 HD13 HD11 ' A' ' 180' ' ' ILE . 60.8 tp -99.65 120.2 39.31 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.407 -1.331 . . . . 0.64000000000000001 107.407 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 223' ' ' VAL . 33.5 t0 -89.77 -35.78 15.52 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.976 -1.077 . . . . 2.0499999999999998 111.431 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.947 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.78 17.75 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.566 0.698 . . . . 0.83999999999999997 112.459 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.1 t -109.15 -58.25 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.168 -0.957 . . . . 1.02 109.33 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.485 HD22 ' NE2' ' A' ' 226' ' ' GLN . 56.6 t30 -95.69 14.72 22.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.961 0.886 . . . . 2.5099999999999998 110.598 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.93 52.27 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.608 -0.724 . . . . 1.54 112.834 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.52 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 28.8 pt20 -151.93 157.13 41.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.031 -1.043 . . . . 1.95 110.168 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.35 135.19 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.071 -1.085 . . . . 0.70999999999999996 108.071 177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.52 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 83.4 m-85 -103.24 130.01 50.36 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.065 -1.022 . . . . 1.01 108.588 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.9 t -110.53 129.85 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.991 -1.114 . . . . 0.81999999999999995 107.991 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.443 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 61.8 t30 53.59 48.75 5.26 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 113.434 0.902 . . . . 1.54 113.434 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 37.0 Cg_endo -65.73 153.5 77.88 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.656 2.237 . . . . 0.93999999999999995 110.911 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.0 p -72.17 160.21 32.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.997 -1.065 . . . . 1.8 110.134 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -60.19 -37.96 81.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.216 -0.928 . . . . 2.73 110.642 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.98 -39.16 84.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 3.1699999999999999 110.558 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.7 -35.71 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.207 -0.933 . . . . 1.3400000000000001 110.176 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.488 1.459 0 O-C-N 121.351 -0.843 . . . . 1.2 110.598 179.175 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 106.544 -1.65 . . . . 1.0700000000000001 106.544 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.8 m -102.09 124.51 47.82 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.634 -1.247 . . . . 1.24 107.634 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' A' ' 225' ' ' ASN . . . -118.42 -160.72 11.6 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.77 -1.732 . . . . 1.01 108.77 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 5' ' ' ILE . 90.2 mt -95.8 1.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.372 -1.075 . . . . 1.1100000000000001 112.711 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.91 97.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 0.98999999999999999 112.195 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -86.41 -37.4 18.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.36 -0.837 . . . . 0.84999999999999998 111.477 179.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -150.6 145.71 18.75 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 120.682 -1.261 . . . . 1.3799999999999999 107.738 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.45 144.77 23.08 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 122.647 2.231 . . . . 0.93999999999999995 112.121 178.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.924 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.65 170.69 20.7 Favored Glycine 0 N--CA 1.504 3.197 0 N-CA-C 109.556 -1.417 . . . . 0.81000000000000005 109.556 178.032 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.5 mt -133.24 133.68 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 107.71 -1.219 . . . . 0.82999999999999996 107.71 179.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.0 151.94 41.4 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.19 -0.944 . . . . 0.53000000000000003 109.305 179.034 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.48 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 11.2 m-85 -119.25 140.82 49.62 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.668 -0.864 . . . . 0.77000000000000002 108.668 177.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.19 169.22 41.4 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 118.586 -1.769 . . . . 0.51000000000000001 110.472 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -77.76 158.18 29.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.688 -0.889 . . . . 1.8999999999999999 109.076 177.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.42 126.74 33.53 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.957 -1.089 . . . . 0.66000000000000003 108.291 178.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.0 tp -110.11 102.27 10.99 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.621 -1.992 . . . . 0.82999999999999996 105.621 178.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 tp -88.42 140.33 29.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.937 -1.102 . . . . 0.85999999999999999 108.922 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.46 HD11 HD11 ' A' ' 158' ' ' LEU . 44.8 mt -99.86 119.72 38.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.923 -1.111 . . . . 0.92000000000000004 108.061 178.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -110.31 141.01 43.91 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.22 -1.029 . . . . 2.0299999999999998 108.22 179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -118.67 141.32 48.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.103 -0.998 . . . . 2.6600000000000001 109.281 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -82.91 133.68 35.11 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.746 -1.205 . . . . 2.3199999999999998 107.746 177.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -62.95 149.13 45.52 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.759 -0.83 . . . . 2.1099999999999999 108.759 178.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.6 mt -95.15 133.79 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.584 -0.895 . . . . 0.72999999999999998 108.584 178.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 t -103.6 130.14 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.936 -1.135 . . . . 0.87 107.936 178.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.0 mt -98.31 133.12 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.287 -1.005 . . . . 0.81000000000000005 108.287 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -87.28 119.51 27.61 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.249 -1.389 . . . . 1.3400000000000001 107.249 178.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -101.37 20.02 16.68 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.86 -0.525 . . . . 2.8900000000000001 111.619 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -63.27 149.89 44.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.254 -0.904 . . . . 2.0899999999999999 110.154 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -91.33 125.38 36.08 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.47 -1.307 . . . . 2.1899999999999999 107.47 177.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 pt -97.07 166.5 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.338 -0.852 . . . . 0.75 110.15 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.8 p -99.3 164.3 12.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.595 -0.69 . . . . 0.91000000000000003 109.697 178.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.89 -28.38 36.05 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.052 -1.03 . . . . 0.93000000000000005 111.18 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -69.23 -34.11 74.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.009 . . . . 2.2799999999999998 110.393 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -87.61 -15.32 37.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.136 -0.978 . . . . 1.45 112.193 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.76 -41.34 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.977 -1.077 . . . . 0.81000000000000005 110.367 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.32 -40.07 81.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.828 -1.17 . . . . 1.54 110.841 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -61.24 -42.27 98.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.569 -0.707 . . . . 2.3599999999999999 111.245 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.08 -38.02 81.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.827 -1.17 . . . . 1.3100000000000001 111.154 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.54 -44.78 93.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.976 -1.077 . . . . 0.81999999999999995 110.26 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -62.36 -44.64 96.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.201 -0.937 . . . . 1.5 110.266 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -62.15 -41.51 98.35 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.154 -0.966 . . . . 2.23 109.638 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 32.1 t80 -74.06 -51.99 14.07 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.262 -0.899 . . . . 0.84999999999999998 109.249 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.01 -47.72 85.11 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 117.924 -1.511 . . . . 0.91000000000000003 110.367 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.605 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.4 t -69.57 -40.63 76.63 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.362 0.601 . . . . 0.90000000000000002 110.172 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.56 -44.67 90.71 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.292 -1.432 . . . . 0.68999999999999995 110.079 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.403 ' HB3' HH11 ' A' ' 47' ' ' ARG . 1.7 ttt-85 -59.37 -30.86 68.72 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.573 -0.957 . . . . 2.8799999999999999 109.36 178.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.72 -45.64 85.51 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.745 -0.661 . . . . 0.84999999999999998 109.773 178.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -80.11 -45.03 18.92 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.452 0.644 . . . . 2.3500000000000001 110.427 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.66 -41.98 91.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.317 -0.864 . . . . 0.65000000000000002 110.156 -178.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.6 t -60.02 -41.54 92.41 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 122.45 1.119 . . . . 1.45 109.098 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.47 -46.57 79.29 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.265 -0.88 . . . . 0.63 110.209 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -62.55 -50.38 71.58 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.117 -0.989 . . . . 1.3400000000000001 110.063 179.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 66.4 mt -61.23 -36.78 80.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.214 -0.929 . . . . 1.5600000000000001 110.192 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.81 -41.12 95.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.791 -0.568 . . . . 1.1899999999999999 110.819 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.59 HG22 ' HZ2' ' A' ' 60' ' ' LYS . 18.6 m -64.74 -42.67 95.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.813 -1.179 . . . . 0.71999999999999997 110.009 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.51 -38.29 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.818 -0.551 . . . . 0.62 110.672 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -50.32 -45.75 55.01 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 120.122 -0.631 . . . . 1.05 111.182 179.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -68.32 -32.56 72.78 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.937 -1.102 . . . . 0.64000000000000001 109.91 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.59 ' HZ2' HG22 ' A' ' 56' ' ' THR . 54.0 mttp -61.64 -39.88 92.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.617 -1.233 . . . . 1.73 109.295 179.402 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.9 -34.9 78.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.516 -0.74 . . . . 0.56000000000000005 110.097 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.61 -35.09 23.53 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.856 -1.164 . . . . 0.68999999999999995 111.364 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -83.33 -18.47 38.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.017 -1.284 . . . . 1.48 111.679 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -87.83 -53.17 4.89 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.747 -0.66 . . . . 0.97999999999999998 110.3 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -106.95 -17.21 14.25 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 113.275 0.843 . . . . 1.1599999999999999 113.275 -176.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.59 158.98 10.53 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 120.893 -0.67 . . . . 0.84999999999999998 111.83 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -55.24 -25.8 35.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.721 -0.87 . . . . 3.8599999999999999 112.763 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.4 -35.25 71.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.781 -1.199 . . . . 2.3500000000000001 111.226 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -82.16 -26.38 33.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.055 -1.028 . . . . 1.6699999999999999 111.702 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -59.82 -33.8 72.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.758 -0.589 . . . . 1.45 111.401 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.07 83.7 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.432 -0.793 . . . . 0.60999999999999999 111.563 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -65.62 -42.78 93.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.365 -1.459 . . . . 0.65000000000000002 110.156 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -70.93 -30.86 67.3 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.828 -1.17 . . . . 0.66000000000000003 110.895 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -61.36 -39.14 89.54 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.61 -0.836 . . . . 1.1899999999999999 109.955 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.67 -39.53 90.42 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 120.225 -0.988 . . . . 0.53000000000000003 110.793 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -57.39 -46.86 82.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.623 -1.516 . . . . 1.27 110.804 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.6 mt -59.9 -38.11 74.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.011 -1.056 . . . . 0.54000000000000004 110.703 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.2 ttp -58.95 -39.4 81.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.915 -1.116 . . . . 1.74 110.308 179.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 tp -59.92 -49.62 76.99 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.994 -1.066 . . . . 0.55000000000000004 109.783 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.9 tp -60.46 -43.72 96.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.066 0.936 . . . . 0.46999999999999997 110.341 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -87.67 9.65 20.73 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 112.783 0.66 . . . . 1.4199999999999999 112.783 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -65.27 123.82 20.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.737 -1.227 . . . . 1.27 108.428 178.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.78 -18.44 65.33 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.842 0.829 . . . . 1.3500000000000001 110.854 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -74.11 -52.37 12.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.564 -0.854 . . . . 2.2200000000000002 110.167 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.0 -37.85 86.42 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.443 -0.903 . . . . 0.62 110.897 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.78 -45.97 81.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.743 -1.223 . . . . 1.29 110.545 179.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -60.73 -36.86 79.93 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.486 -0.759 . . . . 1.52 110.665 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -67.01 -46.86 73.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.183 -1.007 . . . . 1.3 110.574 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.06 -43.77 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.428 -0.795 . . . . 0.60999999999999999 110.024 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.6 mt -59.78 -42.26 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.531 -0.73 . . . . 0.78000000000000003 110.589 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.52 -43.86 98.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.638 -0.663 . . . . 0.81999999999999995 111.007 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.18 -44.47 97.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.741 -1.224 . . . . 0.80000000000000004 110.474 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 93' ' ' ILE . 68.4 mt -62.99 -47.5 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.954 -1.091 . . . . 0.77000000000000002 110.466 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -83.63 -31.3 26.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.195 -0.94 . . . . 2.1200000000000001 111.655 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 91' ' ' ALA . 51.0 t0 -80.79 -45.84 16.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.81 -1.181 . . . . 1.51 111.399 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -100.78 7.04 44.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.626 -0.671 . . . . 1.98 112.328 -178.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.3 m80 51.96 49.72 20.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.181 -0.95 . . . . 1.3200000000000001 112.153 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 91.1 mtp -109.64 160.74 16.03 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.223 -0.923 . . . . 1.3799999999999999 109.341 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.5 p -71.21 159.34 34.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.619 -0.676 . . . . 0.67000000000000004 109.852 178.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.59 93.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.52000000000000002 110.415 178.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.481 ' OD2' HD21 ' A' ' 142' ' ' LEU . 91.9 m-20 -66.85 -39.72 87.7 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.282 -0.967 . . . . 2.25 109.727 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.83 -50.9 46.18 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.118 -1.033 . . . . 0.64000000000000001 110.851 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.42 -41.03 96.52 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.061 -1.056 . . . . 0.56000000000000005 110.569 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.48 87.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.689 -0.632 . . . . 0.46000000000000002 110.703 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -60.56 -39.63 88.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 1.3200000000000001 110.965 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -59.7 -48.87 79.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.011 -1.056 . . . . 1.3 111.055 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.29 -44.34 98.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.149 -0.969 . . . . 0.60999999999999999 110.229 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.17 -32.97 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.803 -0.56 . . . . 0.65000000000000002 110.475 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -59.83 -39.81 86.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.593 -0.692 . . . . 2.1099999999999999 110.688 179.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.38 -29.73 26.71 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.331 -1.414 . . . . 0.82999999999999996 113.097 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -61.03 -40.51 93.86 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.186 -1.773 . . . . 1.28 109.309 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.49 -50.02 42.3 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.82 0.819 . . . . 0.89000000000000001 109.905 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.7 p -60.14 -39.72 87.28 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.725 . . . . 1.8700000000000001 110.357 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.31 -43.75 96.06 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.231 -0.918 . . . . 1.05 110.194 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.78 -28.48 69.05 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.03 -1.044 . . . . 1.02 111.295 -179.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -67.15 -23.0 65.74 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.754 -0.591 . . . . 2.04 110.833 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -74.17 -11.83 60.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.696 0.76 . . . . 1.73 111.232 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.627 HD13 HD13 ' A' ' 123' ' ' LEU . 15.5 mt -86.37 141.91 28.84 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.157 -0.682 . . . . 1.3700000000000001 109.157 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -99.41 55.26 0.97 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.029 -1.045 . . . . 2.8799999999999999 111.058 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -130.77 142.15 50.39 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.293 -0.88 . . . . 1.5800000000000001 109.202 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.33 -40.28 81.72 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.739 -0.601 . . . . 3.04 110.938 178.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -72.8 -54.99 7.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.942 -1.099 . . . . 0.90000000000000002 111.034 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.627 HD13 HD13 ' A' ' 118' ' ' LEU . 45.5 mt -59.83 -40.33 88.1 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.069 -1.019 . . . . 1.0600000000000001 110.616 -179.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -62.53 -49.42 75.41 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.67 -1.269 . . . . 2.1800000000000002 110.084 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.6 -31.03 70.2 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.04 0.924 . . . . 2.1499999999999999 109.717 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -61.99 -30.97 71.3 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.159 -1.016 . . . . 2.3300000000000001 109.558 179.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.84 -48.9 79.81 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.588 -0.845 . . . . 0.81999999999999995 109.434 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.58 -44.11 75.09 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.647 -0.821 . . . . 0.84999999999999998 110.251 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.37 -31.78 73.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.106 -0.997 . . . . 1.3899999999999999 110.272 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.0 t -67.98 -39.35 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.76 -0.776 . . . . 0.56000000000000005 109.922 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.432 HH11 ' HG3' ' A' ' 131' ' ' ARG . 28.4 ttm-85 -56.97 -39.51 74.75 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.022 -1.071 . . . . 3.1200000000000001 109.311 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -59.8 -39.23 84.28 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.499 -0.75 . . . . 1.28 110.379 179.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.5 mt -61.54 -39.15 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.542 -0.724 . . . . 0.48999999999999999 109.968 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.45 -47.04 53.28 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 120.011 -1.09 . . . . 0.46000000000000002 110.6 179.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -57.46 -39.79 77.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.156 -1.203 . . . . 2.71 110.496 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.446 ' HG2' HH11 ' A' ' 136' ' ' ARG . 45.5 mtt-85 -61.52 -44.31 97.29 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.247 -0.981 . . . . 2.1400000000000001 109.944 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.85 -44.73 96.6 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.327 -0.858 . . . . 1.05 109.972 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.6 mt -59.47 -46.25 89.32 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.468 -0.77 . . . . 0.52000000000000002 110.389 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -59.94 -33.73 72.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.427 -0.795 . . . . 2.3500000000000001 110.669 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.43 -41.91 45.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.606 -0.684 . . . . 1.3899999999999999 111.004 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.68 -38.31 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.68000000000000005 110.78 -178.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.481 HD21 ' OD2' ' A' ' 101' ' ' ASP . 89.2 mt -83.97 -4.39 58.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.82999999999999996 112.294 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.25 20.31 79.12 Favored Glycine 0 N--CA 1.484 1.871 0 C-N-CA 119.265 -1.445 . . . . 0.91000000000000003 113.112 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.7 tp -66.97 148.43 51.97 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.665 0.745 . . . . 0.94999999999999996 109.312 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -67.21 149.64 50.17 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.14 -0.975 . . . . 2.4300000000000002 109.374 178.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 65.5 mt -105.23 139.94 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.12 -1.066 . . . . 1.1000000000000001 108.12 178.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.682 HD12 ' H ' ' A' ' 147' ' ' ILE . 3.6 mp -75.66 126.05 35.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.313 -0.995 . . . . 1.5800000000000001 108.313 178.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -96.22 98.03 9.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.877 -1.527 . . . . 1.6200000000000001 106.877 179.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 64.5 mt -74.83 -11.51 60.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.272 -0.893 . . . . 0.80000000000000004 111.582 -177.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.6 t -91.41 11.24 24.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.776 -0.577 . . . . 1.5600000000000001 112.3 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.74 17.54 14.86 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 113.658 0.985 . . . . 0.83999999999999997 113.658 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.706 ' N ' HD12 ' A' ' 152' ' ' ILE . 2.4 mp -72.77 140.84 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.299 -1.5 . . . . 0.81999999999999995 109.599 178.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -119.24 -11.99 9.5 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.065 0.936 . . . . 2.3100000000000001 111.998 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -112.89 149.18 33.51 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.616 -0.883 . . . . 1.54 108.616 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -76.32 123.23 25.61 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.527 -0.916 . . . . 1.3799999999999999 108.527 178.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.0 m -148.51 174.46 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.469 -0.769 . . . . 0.68999999999999995 109.308 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.9 mt -93.08 142.52 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.804 -0.813 . . . . 0.53000000000000003 108.804 178.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.46 HD11 HD11 ' A' ' 19' ' ' LEU . 23.8 tp -95.07 125.81 39.98 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.753 -1.217 . . . . 0.64000000000000001 108.022 178.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.91 129.96 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 107.68 -1.229 . . . . 0.67000000000000004 107.68 179.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.44 151.52 17.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.511 -1.368 . . . . 0.78000000000000003 108.838 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.49 -35.94 79.09 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.01 -1.056 . . . . 1.0 109.475 178.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -173.09 151.84 2.2 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.734 -0.839 . . . . 2.4199999999999999 108.734 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.5 mt -115.86 139.59 50.06 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.774 -0.825 . . . . 0.75 108.774 177.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.3 p -89.39 149.26 42.32 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.965 -1.084 . . . . 0.78000000000000003 108.762 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -41.3 -42.1 5.14 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.563 2.175 . . . . 0.67000000000000004 113.627 179.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.7 m -62.87 -51.41 67.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 0.69999999999999996 110.121 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -60.94 -39.39 89.28 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.32 -0.862 . . . . 1.21 110.115 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.4 p -67.92 -41.01 83.26 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.372 -0.83 . . . . 0.59999999999999998 110.464 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.03 -37.03 81.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.304 -0.873 . . . . 0.62 110.819 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -97.22 3.18 51.54 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.027 -1.046 . . . . 1.1599999999999999 112.685 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 46.2 tp -59.65 149.62 29.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.076 -1.015 . . . . 0.72999999999999998 109.217 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -95.42 111.17 23.1 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.763 -1.569 . . . . 2.2400000000000002 106.763 177.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 73.9 mt -80.74 -10.07 59.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.643 -0.66 . . . . 1.4299999999999999 112.615 -177.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -80.29 -29.63 38.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.15 -0.969 . . . . 2.1499999999999999 111.935 -178.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -100.5 -0.92 36.96 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.126 -0.984 . . . . 2.04 113.417 -178.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 40.0 t -108.45 129.02 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 107.749 -1.204 . . . . 0.55000000000000004 107.749 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -90.21 -16.09 30.12 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.366 1.079 . . . . 1.6299999999999999 111.446 -179.223 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.86 173.33 45.94 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.852 -1.699 . . . . 0.46999999999999997 108.852 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -130.16 131.32 45.59 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 107.784 -1.191 . . . . 0.54000000000000004 107.784 179.392 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.48 HD11 HD13 ' A' ' 220' ' ' LEU . 94.8 mt -126.77 115.3 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 106.388 -1.708 . . . . 0.68999999999999995 106.388 178.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 203' ' ' VAL . 70.6 p -132.92 169.61 16.54 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.104 -0.997 . . . . 0.81999999999999995 109.599 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.455 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 2.8 m-20 -101.86 36.01 2.19 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.563 -0.711 . . . . 2.3700000000000001 110.711 179.074 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -97.88 175.64 6.07 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.766 -1.209 . . . . 1.1100000000000001 109.983 177.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 183' ' ' ALA . . . -61.13 -132.41 0.01 OUTLIER Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.577 -1.409 . . . . 1.6699999999999999 109.577 179.145 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.44 -32.89 0.1 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.63 -1.271 . . . . 1.54 113.73 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.46 HH11 ' HG3' ' A' ' 186' ' ' ARG . 36.6 mtm-85 -56.24 -39.2 72.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.678 -1.483 . . . . 4.4800000000000004 110.318 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.7 p -137.72 29.27 2.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.691 -0.63 . . . . 2.6299999999999999 111.686 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.1 p -82.04 139.24 34.6 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.878 0.847 . . . . 1.6899999999999999 109.204 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -59.08 -38.83 80.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 1.0700000000000001 110.777 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 33.8 p -59.76 -39.78 85.94 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.268 -0.973 . . . . 1.5800000000000001 110.37 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.8 m -60.16 -37.63 80.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.382 -0.824 . . . . 1.6000000000000001 110.42 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 37.3 mm -60.1 -37.25 72.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.576 -0.702 . . . . 1.45 110.603 179.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.8 mtp -62.21 -44.22 97.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.567 1.175 . . . . 1.05 109.418 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.48 -47.34 85.87 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.473 -0.785 . . . . 0.71999999999999997 110.802 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -61.64 -42.58 99.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.214 -0.929 . . . . 3.0499999999999998 110.804 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 20.4 m -69.46 -39.82 77.5 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.38 -0.928 . . . . 0.89000000000000001 110.204 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.7 mt -90.37 -7.56 52.91 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.512 0.672 . . . . 0.78000000000000003 112.451 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 194' ' ' ALA . 99.0 mt-10 53.72 8.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 113.853 1.057 . . . . 1.45 113.853 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 66.1 mt -71.5 149.99 93.69 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 0.67000000000000004 108.419 178.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.92 143.03 99.75 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.459 1.439 . . . . 0.64000000000000001 109.602 178.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.73 167.44 28.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.361 -1.462 . . . . 0.67000000000000004 110.194 179.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.6 mt -150.58 150.53 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.626 -1.25 . . . . 0.68999999999999995 107.626 178.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.2 m -141.54 -28.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.7 0 O-C-N 120.383 -1.448 . . . . 0.84999999999999998 113.156 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.34 35.12 3.64 Favored Glycine 0 N--CA 1.488 2.107 0 O-C-N 120.961 -1.087 . . . . 0.92000000000000004 112.627 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.455 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 20.1 p -59.7 -34.4 72.84 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.462 -1.611 . . . . 0.94999999999999996 110.23 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 94.26 -78.55 0.97 Allowed Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.196 -1.002 . . . . 1.04 112.445 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.1 p -117.51 23.25 11.89 Favored 'General case' 0 N--CA 1.517 2.919 0 CA-C-N 119.262 1.531 . . . . 1.5700000000000001 114.061 -178.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.419 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 4.8 t -55.08 -30.97 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 119.479 -2.013 . . . . 0.83999999999999997 110.572 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.9 p -58.83 -28.66 66.26 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.929 -1.108 . . . . 0.98999999999999999 111.421 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 13.8 m -94.26 5.28 52.26 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.885 -1.134 . . . . 1.7 112.32 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -129.5 -7.12 4.68 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 113.404 0.89 . . . . 2.2000000000000002 113.404 -178.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 17.2 t -118.96 139.56 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.564 -0.902 . . . . 0.83999999999999997 108.564 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -120.16 157.46 28.99 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.087 -1.079 . . . . 2.2000000000000002 108.087 178.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 2.7 t-20 -57.74 140.83 50.56 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.964 -1.094 . . . . 2.2799999999999998 110.538 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.7 t0 80.1 0.54 2.04 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.451 1.278 . . . . 2.3500000000000001 114.451 179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -66.21 147.35 53.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.552 -1.342 . . . . 1.97 108.374 177.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -90.18 118.5 29.75 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.054 -1.832 . . . . 2.6499999999999999 106.054 177.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.3 mt -127.05 143.8 51.19 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.459 0.647 . . . . 0.63 109.48 -178.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 61.2 mt -111.36 127.59 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 106.399 -1.704 . . . . 0.62 106.399 177.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.48 HD13 HD11 ' A' ' 180' ' ' ILE . 62.9 tp -100.86 120.12 39.67 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.428 -1.323 . . . . 0.64000000000000001 107.428 179.135 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.587 ' O ' ' N ' ' A' ' 223' ' ' VAL . 52.3 t0 -93.94 -23.68 17.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.872 -1.143 . . . . 2.0499999999999998 112.777 -178.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.924 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.94 18.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.098 0.777 . . . . 0.83999999999999997 113.098 -178.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.9 t -108.14 -60.3 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.924 -1.11 . . . . 1.02 109.037 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -100.15 16.3 24.6 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.53 0.681 . . . . 2.5099999999999998 110.345 -179.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 4' ' ' GLY . 4.1 t-20 61.2 51.61 4.27 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.362 0.601 . . . . 1.54 111.771 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -145.83 144.87 30.52 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.277 1.036 . . . . 1.95 110.193 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.61 145.16 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.948 -0.76 . . . . 0.70999999999999996 108.948 178.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -101.95 136.58 41.54 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.208 -1.034 . . . . 1.01 108.208 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.62 129.93 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.004 -0.739 . . . . 0.81999999999999995 109.004 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 42.6 t30 49.63 58.63 17.52 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 113.79 1.033 . . . . 1.54 113.79 178.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.66 141.51 38.0 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 121.96 1.773 . . . . 0.93999999999999995 110.791 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.4 p -74.08 156.72 37.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.942 -1.099 . . . . 1.8 109.277 177.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -58.49 -37.73 76.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.333 -0.854 . . . . 2.73 110.472 178.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.16 -40.98 82.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.452 -0.78 . . . . 3.1699999999999999 110.223 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 96.6 t -71.06 -42.99 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.386 -0.821 . . . . 1.3400000000000001 109.979 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.3 mt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.556 -0.715 . . . . 1.2 110.084 -179.043 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 107.654 -1.239 . . . . 1.0700000000000001 107.654 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.2 m -105.73 123.3 47.72 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.784 -1.191 . . . . 1.24 107.784 178.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.22 -162.94 11.64 Favored Glycine 0 N--CA 1.499 2.884 0 N-CA-C 108.274 -1.93 . . . . 1.01 108.274 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 5' ' ' ILE . 90.9 mt -100.59 2.28 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.174 -1.191 . . . . 1.1100000000000001 112.671 -179.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 5' ' ' ILE . 12.3 tp 50.71 101.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.078 -1.014 . . . . 0.98999999999999999 112.134 179.166 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -87.87 -41.55 13.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.939 -1.1 . . . . 0.84999999999999998 111.549 179.419 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 t -145.19 146.17 29.52 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.045 -1.095 . . . . 1.3799999999999999 108.045 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.59 143.85 21.89 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.815 2.343 . . . . 0.93999999999999995 112.377 178.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.922 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.19 -177.47 29.16 Favored Glycine 0 N--CA 1.503 3.129 0 N-CA-C 109.658 -1.377 . . . . 0.81000000000000005 109.658 177.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.9 mt -137.81 140.75 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.25 -1.147 . . . . 0.82999999999999996 108.578 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.48 149.99 43.22 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.317 -0.865 . . . . 0.53000000000000003 109.005 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -119.56 139.8 51.56 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.713 -1.217 . . . . 0.77000000000000002 107.713 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.49 163.95 27.92 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 118.125 -1.988 . . . . 0.51000000000000001 110.485 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -76.48 160.68 29.29 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.506 -0.997 . . . . 1.8999999999999999 109.837 179.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -84.15 122.29 28.64 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.965 -1.124 . . . . 0.66000000000000003 107.965 178.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.7 tp -101.71 101.97 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.089 -2.189 . . . . 0.82999999999999996 105.089 177.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.6 tp -88.25 140.37 29.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.176 -0.952 . . . . 0.85999999999999999 108.632 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.9 mt -98.28 118.5 35.06 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 106.271 -1.752 . . . . 0.92000000000000004 106.271 177.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -111.01 134.07 52.91 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.201 -1.037 . . . . 2.0299999999999998 108.201 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -125.95 140.8 52.33 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.584 -0.895 . . . . 2.6600000000000001 108.584 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -81.81 138.01 35.2 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.371 -0.974 . . . . 2.3199999999999998 108.371 177.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -63.29 143.63 57.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -0.773 . . . . 2.1099999999999999 108.991 178.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 87.9 mt -94.53 132.13 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.174 -1.047 . . . . 0.72999999999999998 108.174 178.251 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.16 130.19 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.233 -1.025 . . . . 0.87 108.233 179.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.8 mt -94.07 138.13 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.374 -0.973 . . . . 0.81000000000000005 108.374 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -92.19 122.23 34.48 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.572 -1.27 . . . . 1.3400000000000001 107.572 178.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -93.54 10.93 30.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.289 -0.882 . . . . 2.8900000000000001 112.651 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -71.57 153.01 42.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.706 -1.246 . . . . 2.0899999999999999 109.349 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -92.18 140.04 30.02 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 109.102 -0.703 . . . . 2.1899999999999999 109.102 178.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -92.39 175.29 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.229 -0.919 . . . . 0.75 109.915 177.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.473 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 6.3 p -103.5 166.62 10.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.522 -0.736 . . . . 0.91000000000000003 109.549 179.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.56 -35.26 67.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.488 -0.758 . . . . 0.93000000000000005 111.519 178.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.473 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 10.9 p-10 -69.86 -22.23 63.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.846 -1.159 . . . . 2.2799999999999998 110.626 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -94.02 -20.44 19.96 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.492 0.663 . . . . 1.45 112.213 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.84 -46.4 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.626 -0.671 . . . . 0.81000000000000005 110.236 -178.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -58.86 -40.36 84.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.323 -0.861 . . . . 1.54 110.658 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -64.0 -45.32 89.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 2.3599999999999999 110.808 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -60.82 -37.74 83.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.256 -0.903 . . . . 1.3100000000000001 110.945 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -59.13 -40.07 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.176 -0.953 . . . . 0.81999999999999995 110.082 179.274 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.72 -41.74 95.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.072 -1.018 . . . . 1.5 109.645 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -63.1 -39.16 93.88 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.343 -0.848 . . . . 2.23 110.094 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -72.11 -54.52 9.52 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.411 -0.806 . . . . 0.84999999999999998 110.06 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.7 tp -60.78 -50.14 74.65 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.969 0.89 . . . . 0.91000000000000003 109.74 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.0 t -67.41 -38.91 85.35 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.422 -0.799 . . . . 0.90000000000000002 110.247 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.58 90.85 Favored Glycine 0 N--CA 1.485 1.934 0 C-N-CA 119.648 -1.263 . . . . 0.68999999999999995 110.056 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.4 HH12 ' CG ' ' A' ' 86' ' ' GLU . 39.3 ttm180 -59.94 -31.65 70.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.24 -1.153 . . . . 2.8799999999999999 109.63 178.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.89 -42.63 90.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.619 0.723 . . . . 0.84999999999999998 109.764 179.063 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -80.52 -48.65 12.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 2.3500000000000001 110.85 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.99 79.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.515 -0.741 . . . . 0.65000000000000002 110.102 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.4 p -61.68 -38.56 88.28 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.867 0.842 . . . . 1.45 109.343 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.82 -46.19 69.25 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.948 -0.569 . . . . 0.63 110.313 179.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.74 -49.35 75.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.633 -1.292 . . . . 1.3400000000000001 110.122 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.9 mt -61.34 -40.0 92.62 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.034 0.921 . . . . 1.5600000000000001 109.513 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -60.64 -39.73 89.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.577 -0.702 . . . . 1.1899999999999999 110.105 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.0 m -62.06 -42.89 99.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.866 . . . . 0.71999999999999997 110.366 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.0 -36.94 70.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.609 -0.682 . . . . 0.62 110.645 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -51.1 -43.5 61.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.938 . . . . 1.05 110.443 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -70.27 -36.42 74.41 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.926 -1.109 . . . . 0.64000000000000001 110.009 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -62.69 -39.34 93.68 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.819 -1.153 . . . . 1.73 109.316 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.74 81.74 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.852 -0.613 . . . . 0.56000000000000005 110.091 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.78 -35.86 23.97 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.467 -1.349 . . . . 0.68999999999999995 110.964 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.03 -17.59 46.22 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.17 -1.194 . . . . 1.48 111.575 -179.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.7 m -93.46 -52.73 4.37 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.716 -0.615 . . . . 0.97999999999999998 110.672 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -107.65 -6.23 17.0 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 114.004 1.112 . . . . 1.1599999999999999 114.004 -178.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.96 149.88 11.85 Favored Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.375 -0.828 . . . . 0.84999999999999998 112.432 178.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.47 -15.35 0.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.386 -1.067 . . . . 3.8599999999999999 112.464 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.46 -31.32 69.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.395 -0.816 . . . . 2.3500000000000001 111.291 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -83.35 -16.93 44.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.807 -1.183 . . . . 1.6699999999999999 112.109 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.16 -30.76 69.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.888 -1.133 . . . . 1.45 111.228 -179.094 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.32 90.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.60999999999999999 110.767 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.6 mt -67.5 -41.48 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.842 -1.161 . . . . 0.65000000000000002 109.337 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -71.39 -29.88 65.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.66000000000000003 110.734 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.25 -39.88 88.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.869 . . . . 1.1899999999999999 110.046 179.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.44 -44.31 74.02 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.745 -0.942 . . . . 0.53000000000000003 110.745 179.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -60.0 -48.06 83.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.934 -1.333 . . . . 1.27 110.726 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.5 mt -62.41 -39.49 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 120.9 -1.125 . . . . 0.54000000000000004 110.016 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.8 ttp -60.28 -39.98 88.79 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.806 -0.758 . . . . 1.74 110.506 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.1 tp -59.37 -48.52 81.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.55000000000000004 110.355 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.05 -41.24 91.9 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.861 0.838 . . . . 0.46999999999999997 110.144 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -85.93 4.17 38.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.607 -0.683 . . . . 1.4199999999999999 112.496 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -59.7 124.54 20.46 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.182 -0.949 . . . . 1.27 110.894 -178.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.02 -16.42 63.42 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.418 -0.801 . . . . 1.3500000000000001 111.226 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -76.94 -54.31 6.73 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.769 0.795 . . . . 2.2200000000000002 110.568 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.84 -38.24 87.49 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.386 -0.821 . . . . 0.62 110.923 -179.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.4 ' CG ' HH12 ' A' ' 47' ' ' ARG . 88.3 tt0 -59.0 -49.58 77.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.073 -1.017 . . . . 1.29 110.786 179.147 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.67 -39.48 94.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.027 -1.046 . . . . 1.52 110.708 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.95 -49.42 61.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 1.3 110.87 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.11 -45.64 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.836 -1.165 . . . . 0.60999999999999999 110.097 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.45 -41.92 91.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.515 0.674 . . . . 0.78000000000000003 110.43 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.95 95.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.258 -0.901 . . . . 0.81999999999999995 111.036 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.29 -39.56 87.32 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.254 -0.904 . . . . 0.80000000000000004 110.332 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.0 -51.18 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.77000000000000002 110.365 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.86 -33.99 62.19 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.382 -0.824 . . . . 2.1200000000000001 111.493 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -80.42 -45.92 16.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.139 -0.976 . . . . 1.51 111.842 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -103.07 8.64 38.76 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.058 -1.026 . . . . 1.98 112.581 -178.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 56.0 m80 53.17 49.9 18.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 1.3200000000000001 111.752 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.1 mtt -102.02 152.97 20.33 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.211 -0.931 . . . . 1.3799999999999999 109.668 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.1 p -71.34 156.52 39.41 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.321 -0.862 . . . . 0.67000000000000004 109.304 177.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.02 -45.75 79.04 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.276 -0.89 . . . . 0.52000000000000002 110.366 178.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -68.35 -39.3 81.92 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.063 -1.023 . . . . 2.25 110.267 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.87 -47.78 57.39 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.516 -1.274 . . . . 0.64000000000000001 110.856 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.25 90.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.56000000000000005 110.178 -178.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.12 91.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.252 -0.905 . . . . 0.46000000000000002 110.621 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -60.31 -38.39 83.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 1.3200000000000001 111.249 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -58.49 -49.2 78.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.998 -1.064 . . . . 1.3 111.267 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.3 t -61.5 -44.86 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.834 -1.166 . . . . 0.60999999999999999 110.321 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.66 -33.24 56.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.556 -0.715 . . . . 0.65000000000000002 110.403 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -58.5 -41.91 86.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.377 -0.827 . . . . 2.1099999999999999 110.802 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.36 -30.39 22.26 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.142 -1.504 . . . . 0.82999999999999996 112.121 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -62.21 -40.6 96.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.523 -1.575 . . . . 1.28 110.252 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.35 -50.59 30.69 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.539 -0.726 . . . . 0.89000000000000001 111.092 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.1 m -59.63 -39.81 85.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -0.902 . . . . 1.8700000000000001 110.926 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.19 -42.18 98.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 1.05 111.323 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 80.7 mt -62.27 -29.86 70.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.575 -1.328 . . . . 1.02 111.023 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.91 -21.95 65.97 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.17 -0.956 . . . . 2.04 110.958 179.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -74.96 -12.04 60.25 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.019 -0.672 . . . . 1.73 111.412 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.526 HD13 HD13 ' A' ' 123' ' ' LEU . 6.8 mt -87.08 149.22 24.86 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.146 -0.687 . . . . 1.3700000000000001 109.146 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -102.61 47.49 0.89 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.456 -0.778 . . . . 2.8799999999999999 111.197 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -124.58 134.5 52.94 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 108.502 -0.925 . . . . 1.5800000000000001 108.502 179.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -57.34 -38.5 74.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.373 -0.829 . . . . 3.04 110.979 178.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -70.88 -49.1 49.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.666 -1.271 . . . . 0.90000000000000002 110.055 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.526 HD13 HD13 ' A' ' 118' ' ' LEU . 43.8 mt -62.89 -39.14 93.57 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.848 -1.158 . . . . 1.0600000000000001 109.994 -178.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -64.09 -50.18 69.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.627 -1.296 . . . . 2.1800000000000002 110.149 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.54 -30.14 69.58 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.925 -1.109 . . . . 2.1499999999999999 109.535 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 130' ' ' VAL . 62.6 ttt180 -64.79 -29.5 70.47 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.959 0.885 . . . . 2.3300000000000001 109.551 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -60.55 -49.31 78.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.465 -0.894 . . . . 0.81999999999999995 109.71 178.483 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.27 83.22 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.477 -0.889 . . . . 0.84999999999999998 110.022 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.55 -35.0 78.07 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.186 0.517 . . . . 1.3899999999999999 110.839 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 126' ' ' ARG . 30.8 t -69.01 -40.98 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.146 -0.971 . . . . 0.56000000000000005 110.568 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.487 ' HG2' HH11 ' A' ' 131' ' ' ARG . 24.2 ttt-85 -57.74 -38.57 75.56 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.397 -1.321 . . . . 3.1200000000000001 109.52 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -60.79 -38.39 85.14 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.421 0.629 . . . . 1.28 110.397 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.25 -39.91 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.252 -0.905 . . . . 0.48999999999999999 109.821 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.52 -43.76 60.21 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.634 -1.27 . . . . 0.46000000000000002 110.202 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -57.92 -41.26 82.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.458 -1.025 . . . . 2.71 110.364 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.455 ' HG2' HH11 ' A' ' 136' ' ' ARG . 62.4 mtt-85 -61.7 -43.18 99.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.88 -1.137 . . . . 2.1400000000000001 110.093 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.7 tp -60.56 -44.9 95.65 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.957 0.884 . . . . 1.05 109.452 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.76 -38.0 83.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.314 -0.866 . . . . 0.52000000000000002 110.16 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -39.32 85.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 2.3500000000000001 111.171 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -75.17 -40.86 59.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.872 -1.143 . . . . 1.3899999999999999 111.008 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.94 -39.77 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.68000000000000005 110.618 -178.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -86.51 -10.07 54.86 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.962 -1.086 . . . . 0.82999999999999996 111.927 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.39 19.52 71.43 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.992 -1.099 . . . . 0.91000000000000003 112.634 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 46.2 tp -71.07 140.23 50.64 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.673 -0.898 . . . . 0.94999999999999996 109.317 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -67.55 150.73 48.44 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.226 -0.921 . . . . 2.4300000000000002 110.65 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 81.0 mt -106.18 142.11 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.453 -0.944 . . . . 1.1000000000000001 108.453 178.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 23.3 mm -74.56 122.59 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.326 -0.991 . . . . 1.5800000000000001 108.326 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -95.85 100.65 12.32 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.891 -1.892 . . . . 1.6200000000000001 105.891 178.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 53.8 mt -73.56 -21.46 60.35 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.295 -0.878 . . . . 0.80000000000000004 111.396 -177.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 82.5 p -83.97 7.05 19.62 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.443 -0.786 . . . . 1.5600000000000001 112.169 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.16 17.7 19.26 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.531 0.681 . . . . 0.83999999999999997 112.212 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.628 HD12 HD21 ' A' ' 172' ' ' ASN . 45.4 mt -74.98 144.49 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.636 -0.665 . . . . 0.81999999999999995 109.785 179.011 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -120.85 -9.76 9.23 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.359 -0.838 . . . . 2.3100000000000001 112.522 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -118.77 141.92 48.18 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.963 -0.755 . . . . 1.54 108.963 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.86 124.19 26.42 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.159 0.981 . . . . 1.3799999999999999 108.791 178.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.68 176.84 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.038 -0.727 . . . . 0.68999999999999995 109.038 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 67.8 mt -91.98 141.59 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.225 -1.028 . . . . 0.53000000000000003 108.225 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.7 tp -93.95 126.53 39.21 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.851 -1.155 . . . . 0.64000000000000001 108.447 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 32.3 t -123.42 129.99 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.059 -1.089 . . . . 0.67000000000000004 108.059 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.83 158.18 27.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.226 -0.921 . . . . 0.78000000000000003 108.783 179.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 162' ' ' ASP . . . -62.05 -39.43 92.34 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.573 -1.33 . . . . 1.0 109.772 178.224 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 55.8 m-20 -168.93 156.63 7.53 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.192 -1.04 . . . . 2.4199999999999999 108.192 179.187 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 38.4 mt -117.25 139.62 50.57 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.231 -0.918 . . . . 0.75 108.612 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.0 p -95.96 151.02 38.05 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.141 -1.059 . . . . 0.78000000000000003 108.141 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -39.87 -43.72 3.44 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.779 1.652 . . . . 0.67000000000000004 113.351 179.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 74.8 m -61.28 -50.38 73.23 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.288 -0.882 . . . . 0.69999999999999996 109.953 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.68 -39.4 88.29 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.409 -0.807 . . . . 1.21 110.153 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.8 p -68.77 -41.08 79.33 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.852 -0.739 . . . . 0.59999999999999998 110.575 179.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.21 -34.86 74.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.07 -1.019 . . . . 0.62 110.531 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -96.97 -1.37 45.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.125 -0.984 . . . . 1.1599999999999999 112.879 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.46 151.71 31.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.98 -1.075 . . . . 0.72999999999999998 109.695 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.628 HD21 HD12 ' A' ' 152' ' ' ILE . 25.0 p-10 -92.91 108.13 19.76 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 106.439 -1.689 . . . . 2.2400000000000002 106.439 178.007 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 173' ' ' LEU . 3.1 mm? -76.96 -18.71 58.07 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.488 -0.757 . . . . 1.4299999999999999 111.63 -177.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -81.1 -25.66 36.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.064 -1.023 . . . . 2.1499999999999999 112.255 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -102.75 -4.43 25.01 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 113.829 1.048 . . . . 2.04 113.829 -178.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 178' ' ' GLY . 63.0 t -101.68 120.1 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.302 -1.74 . . . . 0.55000000000000004 106.302 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 22.0 tp -84.89 -0.73 55.11 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.657 0.742 . . . . 1.6299999999999999 111.873 -178.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.492 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.34 169.95 34.09 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.035 -1.626 . . . . 0.46999999999999997 109.035 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -129.31 137.74 51.18 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.193 -1.18 . . . . 0.54000000000000004 108.31 179.107 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.541 HG22 HG21 ' A' ' 205' ' ' THR . 93.2 mt -135.67 110.87 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 105.798 -1.927 . . . . 0.68999999999999995 105.798 178.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 203' ' ' VAL . 41.7 p -135.8 179.31 6.42 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.667 -1.27 . . . . 0.81999999999999995 110.089 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -102.43 55.52 0.78 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 115.91 -0.586 . . . . 2.3700000000000001 109.735 179.555 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.01 166.55 10.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.663 -0.648 . . . . 1.1100000000000001 109.448 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.23 -81.93 0.1 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.797 -1.192 . . . . 1.6699999999999999 111.244 178.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.82 -67.53 0.28 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.31 -1.112 . . . . 1.54 111.954 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -61.36 -39.47 90.74 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.378 -1.072 . . . . 4.4800000000000004 110.143 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.2 p -105.76 13.79 29.17 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.614 -0.679 . . . . 2.6299999999999999 111.831 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.5 t -86.91 120.46 28.2 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.413 -1.329 . . . . 1.6899999999999999 107.413 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -60.7 -40.54 92.59 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.696 -0.628 . . . . 1.0700000000000001 110.767 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 191' ' ' SER . 11.9 t -59.68 -40.03 86.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.916 -1.115 . . . . 1.5800000000000001 110.29 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.433 ' N ' HG23 ' A' ' 190' ' ' THR . 35.5 t -58.57 -37.56 76.03 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.325 -0.86 . . . . 1.6000000000000001 110.48 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.81 -38.66 77.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.123 -0.986 . . . . 1.45 110.415 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 74.4 mtp -62.3 -43.63 98.38 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.395 1.093 . . . . 1.05 109.128 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.31 -41.15 83.86 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.223 -0.899 . . . . 0.71999999999999997 110.464 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.433 ' HG2' HH11 ' A' ' 195' ' ' ARG . 47.0 mtt-85 -60.47 -42.07 95.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.915 -1.115 . . . . 3.0499999999999998 110.095 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 64.4 m -71.06 -39.31 72.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 0.89000000000000001 110.305 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.3 mt -91.24 -9.3 45.72 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.841 0.829 . . . . 0.78000000000000003 112.392 -178.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.4 mt-10 52.29 12.5 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.846 1.054 . . . . 1.45 113.846 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.66 147.81 96.58 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 0.67000000000000004 108.238 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -56.73 139.68 89.11 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.379 1.386 . . . . 0.64000000000000001 110.134 178.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.77 165.85 31.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.518 -1.364 . . . . 0.67000000000000004 109.798 179.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 203' ' ' VAL . 59.6 mt -145.39 156.84 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.656 -1.238 . . . . 0.68999999999999995 107.656 178.199 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 181' ' ' THR . 8.0 m -137.9 -32.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.162 -0.961 . . . . 0.84999999999999998 112.942 -179.374 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -72.27 34.03 0.66 Allowed Glycine 0 N--CA 1.486 1.983 0 C-N-CA 120.25 -0.976 . . . . 0.92000000000000004 113.052 -178.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.541 HG21 HG22 ' A' ' 180' ' ' ILE . 54.8 p -58.65 -26.81 64.16 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.198 -1.178 . . . . 0.94999999999999996 111.074 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.31 -93.54 0.89 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 110.525 -1.03 . . . . 1.04 110.525 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.4 t -126.19 30.56 5.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.848 -0.795 . . . . 1.5700000000000001 112.269 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 94.7 t -59.62 -34.96 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.525 -1.359 . . . . 0.83999999999999997 110.23 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 29.4 p -56.13 -24.5 41.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 0.98999999999999999 111.344 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.6 m -91.97 1.67 57.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.139 -0.975 . . . . 1.7 111.919 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -125.23 -7.25 7.07 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.038 0.755 . . . . 2.2000000000000002 113.038 -178.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 48.8 t -114.97 150.76 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.789 -0.819 . . . . 0.83999999999999997 108.789 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -120.57 154.1 35.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.354 -0.98 . . . . 2.2000000000000002 108.354 177.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.435 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 51.4 p-10 -53.56 144.67 16.76 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.988 -1.07 . . . . 2.2799999999999998 110.797 178.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.9 OUTLIER 81.18 0.11 1.7 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.808 1.41 . . . . 2.3500000000000001 114.808 179.415 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.0 146.13 55.06 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.382 -1.449 . . . . 1.97 108.473 177.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -87.83 120.26 28.99 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.353 -1.351 . . . . 2.6499999999999999 107.353 178.231 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.56 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 77.1 mt -125.62 145.76 50.01 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.704 0.764 . . . . 0.63 110.055 -179.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.91 126.05 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 106.276 -1.75 . . . . 0.62 106.276 177.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.454 HD13 HD11 ' A' ' 180' ' ' ILE . 61.3 tp -102.13 119.59 39.05 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.797 -1.557 . . . . 0.64000000000000001 106.797 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.62 ' O ' ' N ' ' A' ' 223' ' ' VAL . 78.8 m-20 -94.22 -22.85 18.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 2.0499999999999998 112.238 -178.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.922 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.11 14.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 112.508 0.558 . . . . 0.83999999999999997 112.508 -178.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.3 t -112.31 -59.91 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.279 -0.888 . . . . 1.02 109.857 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -92.21 12.12 23.36 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.52 0.676 . . . . 2.5099999999999998 110.963 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 60.22 48.9 7.72 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.262 0.553 . . . . 1.54 111.127 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -147.92 145.38 28.59 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.181 0.991 . . . . 1.95 109.836 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.5 t -117.16 138.82 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.822 -1.177 . . . . 0.70999999999999996 107.822 177.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -100.13 130.08 46.23 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.913 -1.117 . . . . 1.01 108.235 178.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.8 t -109.67 130.03 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.382 -0.969 . . . . 0.81999999999999995 108.382 179.011 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 25.0 t30 56.62 49.9 4.46 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 114.225 1.194 . . . . 1.54 114.225 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 44.2 Cg_endo -67.88 149.94 78.19 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.41 2.073 . . . . 0.93999999999999995 110.263 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 45.8 p -72.81 152.71 41.42 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.574 -1.329 . . . . 1.8 109.272 177.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -59.93 -34.51 73.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 2.73 110.308 178.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.77 -40.6 88.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 3.1699999999999999 110.497 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 67.9 t -70.51 -40.87 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.154 -0.966 . . . . 1.3400000000000001 109.974 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.2 mt . . . . . 0 C--N 1.303 -1.418 0 O-C-N 121.379 -0.826 . . . . 1.2 110.606 -178.591 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.406 HD13 ' CG2' ' A' ' 208' ' ' VAL . 64.3 mt . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 106.761 -1.57 . . . . 1.0700000000000001 106.761 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.4 m -104.35 124.76 49.77 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.53 -1.285 . . . . 1.24 107.53 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.22 -159.24 17.2 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 108.46 -1.856 . . . . 1.01 108.46 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 5' ' ' ILE . 97.0 mt -94.44 0.52 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.186 -1.185 . . . . 1.1100000000000001 112.677 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 51.8 93.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.854 -1.153 . . . . 0.98999999999999999 112.043 178.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -87.61 -34.41 18.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.832 -1.167 . . . . 0.84999999999999998 111.12 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 1.2 p -149.55 143.98 17.37 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.59 -1.319 . . . . 1.3799999999999999 107.96 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.37 145.67 21.42 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.464 2.11 . . . . 0.93999999999999995 112.758 178.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.9 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 148.42 162.08 9.98 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 109.835 -1.306 . . . . 0.81000000000000005 109.835 178.256 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.3 132.55 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 O-C-N 120.861 -1.376 . . . . 0.82999999999999996 107.966 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.85 150.12 45.65 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.231 -0.918 . . . . 0.53000000000000003 109.307 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.0 m-85 -123.26 144.03 49.67 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.911 -0.774 . . . . 0.77000000000000002 108.911 178.278 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.12 169.67 36.55 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.03 -1.557 . . . . 0.51000000000000001 109.897 177.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -76.95 154.79 33.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.542 -0.975 . . . . 1.8999999999999999 108.786 178.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.605 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.76 125.65 33.4 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.453 -1.314 . . . . 0.66000000000000003 107.453 178.322 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.3 tp -101.95 107.46 18.61 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.262 -2.125 . . . . 0.82999999999999996 105.262 177.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -90.28 135.66 33.54 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.839 -1.171 . . . . 0.85999999999999999 107.839 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.5 mt -100.29 114.34 27.73 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.78 -1.563 . . . . 0.92000000000000004 106.78 178.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -109.77 137.34 47.71 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.389 -1.337 . . . . 2.0299999999999998 107.389 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -129.55 144.92 51.48 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.918 -1.114 . . . . 2.6600000000000001 109.041 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -83.58 136.19 34.34 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.154 -1.054 . . . . 2.3199999999999998 108.154 177.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.99 149.41 44.94 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.278 -0.889 . . . . 2.1099999999999999 108.627 178.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.8 mt -94.68 134.74 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.68 -0.859 . . . . 0.72999999999999998 108.68 178.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.99 131.46 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.757 -1.201 . . . . 0.87 107.757 179.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -91.03 144.94 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.08 -0.711 . . . . 0.81000000000000005 109.08 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -88.97 122.44 32.33 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.633 -1.247 . . . . 1.3400000000000001 107.633 178.176 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -97.9 16.93 19.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.612 -0.68 . . . . 2.8900000000000001 112.314 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.51 143.02 56.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.283 -0.885 . . . . 2.0899999999999999 109.383 179.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -90.93 135.73 33.54 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.929 -1.138 . . . . 2.1899999999999999 107.929 178.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.6 pt -97.68 172.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 122.101 0.953 . . . . 0.75 109.889 177.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.44 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 38.2 p -102.85 161.31 13.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.873 -0.788 . . . . 0.91000000000000003 108.873 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.03 -31.88 19.77 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.996 -1.065 . . . . 0.93000000000000005 111.947 178.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.44 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 3.5 p-10 -69.99 -40.15 75.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 2.2799999999999998 110.037 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -77.47 -19.03 56.57 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.363 -0.836 . . . . 1.45 111.413 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.527 HG13 HG22 ' A' ' 93' ' ' ILE . 51.5 t -59.76 -42.56 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.069 -1.019 . . . . 0.81000000000000005 110.568 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -57.1 -39.96 76.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.808 -1.183 . . . . 1.54 110.841 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.275 -0.891 . . . . 2.3599999999999999 110.402 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -62.76 -35.34 79.51 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.752 -1.217 . . . . 1.3100000000000001 110.87 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.69 -40.36 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.61 -1.306 . . . . 0.81999999999999995 110.21 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -61.4 -39.67 91.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 1.5 109.654 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.504 ' HG2' HH11 ' A' ' 42' ' ' ARG . 21.6 mtt-85 -63.07 -42.96 99.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 2.23 110.06 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -72.12 -54.17 10.55 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 119.838 -0.745 . . . . 0.84999999999999998 110.138 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.96 -48.05 82.93 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.236 -0.985 . . . . 0.91000000000000003 110.013 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.543 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.9 t -70.06 -38.68 75.84 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.321 -0.862 . . . . 0.90000000000000002 110.061 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.78 -43.11 96.68 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.674 -1.37 . . . . 0.68999999999999995 109.674 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -58.21 -33.34 69.2 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.217 1.008 . . . . 2.8799999999999999 108.742 179.125 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.06 -46.05 79.06 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.015 0.912 . . . . 0.84999999999999998 109.274 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.533 ' HZ2' ' NE2' ' A' ' 53' ' ' GLN . 25.8 ttpp -76.81 -43.54 36.16 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.355 -0.841 . . . . 2.3500000000000001 110.658 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.96 82.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.089 -1.007 . . . . 0.65000000000000002 109.91 -178.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -59.52 -40.0 85.72 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.342 -0.943 . . . . 1.45 109.346 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.81 -48.84 65.1 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.736 -0.602 . . . . 0.63 110.327 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.533 ' NE2' ' HZ2' ' A' ' 49' ' ' LYS . 93.4 mt-30 -60.83 -49.94 75.46 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.356 -1.465 . . . . 1.3400000000000001 110.566 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.31 -39.31 92.6 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.237 -0.914 . . . . 1.5600000000000001 109.923 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -59.89 -41.2 91.08 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.017 -0.673 . . . . 1.1899999999999999 110.543 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.547 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 23.6 m -64.62 -42.57 95.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.405 -0.809 . . . . 0.71999999999999997 110.273 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.1 mt -59.57 -39.32 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.459 -0.776 . . . . 0.62 110.617 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -51.66 -40.25 59.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.86 -1.15 . . . . 1.05 110.523 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.56 -40.0 73.61 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.328 -0.858 . . . . 0.64000000000000001 109.974 -179.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.547 ' NZ ' HG22 ' A' ' 56' ' ' THR . 61.7 mttp -63.42 -39.01 93.33 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.53 -1.268 . . . . 1.73 108.583 -178.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.37 75.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.568 -0.707 . . . . 0.56000000000000005 110.112 179.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.85 -38.16 10.77 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 119.697 -1.24 . . . . 0.68999999999999995 111.322 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.46 -23.48 43.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.793 -1.416 . . . . 1.48 110.688 -179.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -88.72 -50.42 6.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.088 -1.008 . . . . 0.97999999999999998 111.067 179.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -106.79 -9.5 16.38 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 114.378 1.251 . . . . 1.1599999999999999 114.378 -177.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.36 154.13 12.11 Favored Glycine 0 N--CA 1.502 3.091 0 O-C-N 121.128 -0.982 . . . . 0.84999999999999998 111.736 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -54.31 -17.15 2.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -1.033 . . . . 3.8599999999999999 112.544 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -58.38 -35.3 71.79 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.39 -0.819 . . . . 2.3500000000000001 110.903 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -82.46 -21.99 35.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.741 -1.224 . . . . 1.6699999999999999 111.708 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.05 -32.91 71.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.9 . . . . 1.45 111.279 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.53 93.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.948 -1.095 . . . . 0.60999999999999999 110.534 179.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.1 mt -68.17 -45.29 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.487 -1.383 . . . . 0.65000000000000002 110.547 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -69.65 -31.32 69.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.912 -1.117 . . . . 0.66000000000000003 110.934 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.02 -39.64 86.55 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.295 -0.878 . . . . 1.1899999999999999 109.974 178.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.96 -38.09 95.06 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.866 -1.294 . . . . 0.53000000000000003 109.866 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -58.0 -44.03 86.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.414 -1.05 . . . . 1.27 110.001 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.48 -40.59 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.942 -1.099 . . . . 0.54000000000000004 110.432 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.4 ttt -60.01 -38.95 84.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.271 -0.893 . . . . 1.74 110.108 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -60.96 -50.62 72.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.807 . . . . 0.55000000000000004 110.201 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.57 -40.44 87.36 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.445 -0.902 . . . . 0.46999999999999997 110.493 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -88.64 10.54 20.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.645 -0.66 . . . . 1.4199999999999999 112.68 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -62.93 123.27 18.09 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.035 -1.041 . . . . 1.27 109.151 178.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -67.39 -19.13 65.36 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.951 0.882 . . . . 1.3500000000000001 110.708 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -77.7 -49.65 14.04 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.658 0.742 . . . . 2.2200000000000002 110.748 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.79 -38.97 90.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.318 -0.864 . . . . 0.62 110.346 -179.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -57.83 -46.95 83.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.84 -0.537 . . . . 1.29 110.91 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -61.04 -39.92 91.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.136 -0.977 . . . . 1.52 110.381 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -65.75 -47.2 76.07 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 118.827 -1.149 . . . . 1.3 111.145 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.3 mt -57.56 -44.27 84.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.861 -1.149 . . . . 0.60999999999999999 110.4 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.7 mt -63.42 -41.54 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.665 0.745 . . . . 0.78000000000000003 110.967 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.54 -42.08 98.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.81999999999999995 111.17 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.5 mt -60.43 -45.09 94.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.087 . . . . 0.80000000000000004 110.536 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.527 HG22 HG13 ' A' ' 36' ' ' VAL . 69.4 mt -60.79 -49.88 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.495 -0.753 . . . . 0.77000000000000002 110.205 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -77.3 -37.17 53.31 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.59 -0.694 . . . . 2.1200000000000001 111.776 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -80.71 -46.95 14.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.874 -1.141 . . . . 1.51 112.455 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -100.59 8.33 43.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.964 -1.085 . . . . 1.98 112.677 -178.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 37.3 m80 51.94 50.5 18.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.902 -1.124 . . . . 1.3200000000000001 111.998 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.488 ' O ' HG23 ' A' ' 93' ' ' ILE . 66.4 mtt -107.17 155.54 19.79 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.197 -0.939 . . . . 1.3799999999999999 109.456 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.2 p -72.23 166.4 22.5 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.609 -0.682 . . . . 0.67000000000000004 110.51 178.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.7 -43.79 97.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.429 -0.794 . . . . 0.52000000000000002 110.413 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 6.2 p-10 -69.59 -43.41 72.86 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.437 -0.79 . . . . 2.25 109.934 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.08 -47.69 70.51 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.945 -1.102 . . . . 0.64000000000000001 110.463 -179.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.33 98.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.977 -1.077 . . . . 0.56000000000000005 110.571 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.38 -43.2 92.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.147 -0.971 . . . . 0.46000000000000002 110.526 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -61.41 -40.21 93.59 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.144 -0.972 . . . . 1.3200000000000001 111.403 -179.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -58.54 -48.43 80.89 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.996 -1.065 . . . . 1.3 111.101 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.3 t -61.04 -46.89 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.205 -0.935 . . . . 0.60999999999999999 109.816 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -62.24 -32.38 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.271 0.557 . . . . 0.65000000000000002 110.443 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -55.41 -40.8 71.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 2.1099999999999999 110.18 179.117 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.12 -27.69 30.29 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.636 -1.268 . . . . 0.82999999999999996 113.269 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -62.18 -40.35 95.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.404 -1.645 . . . . 1.28 109.67 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.21 -52.15 10.64 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.919 -0.488 . . . . 0.89000000000000001 111.025 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.2 m -59.51 -39.03 82.49 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.628 -0.829 . . . . 1.8700000000000001 110.634 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.43 98.18 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.452 -0.78 . . . . 1.05 111.288 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 73.5 mt -63.2 -30.11 71.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.1 -1.0 . . . . 1.02 111.347 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -68.53 -20.21 64.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.956 -1.09 . . . . 2.04 111.006 179.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -75.49 -14.24 60.41 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.519 -0.738 . . . . 1.73 111.158 -179.238 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.716 HD13 HD13 ' A' ' 123' ' ' LEU . 12.8 mt -84.35 150.98 25.01 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.439 -0.788 . . . . 1.3700000000000001 109.015 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -98.21 35.77 1.7 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.954 -1.091 . . . . 2.8799999999999999 112.468 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -116.0 130.99 57.06 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.667 -0.864 . . . . 1.5800000000000001 108.667 179.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.28 -35.89 74.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 3.04 111.107 178.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -69.18 -48.9 60.95 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.499 -1.376 . . . . 0.90000000000000002 110.289 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.716 HD13 HD13 ' A' ' 118' ' ' LEU . 45.9 mt -62.57 -39.94 95.26 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.011 -1.055 . . . . 1.0600000000000001 110.854 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 60.2 tttm -62.82 -49.75 73.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.872 -1.143 . . . . 2.1800000000000002 109.98 178.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.77 -32.44 71.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 2.1499999999999999 109.637 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 130' ' ' VAL . 66.0 ttt180 -61.31 -29.59 69.97 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.022 -1.071 . . . . 2.3300000000000001 108.958 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.63 -47.9 83.78 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.838 0.828 . . . . 0.81999999999999995 109.032 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.87 -47.02 86.9 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.499 -0.88 . . . . 0.84999999999999998 109.444 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.33 -31.96 72.66 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.469 0.652 . . . . 1.3899999999999999 109.963 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.2 t -69.66 -41.73 80.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.652 -0.655 . . . . 0.56000000000000005 110.003 179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -57.51 -40.69 79.27 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.829 -1.169 . . . . 3.1200000000000001 109.549 179.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -60.3 -43.16 96.56 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.621 -0.674 . . . . 1.28 110.535 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.08 -38.28 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.102 -0.999 . . . . 0.48999999999999999 109.947 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.05 -49.96 37.43 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.846 -1.169 . . . . 0.46000000000000002 110.406 179.074 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -58.4 -43.36 88.53 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.963 -1.316 . . . . 2.71 110.209 179.428 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.436 ' NH2' ' CB ' ' A' ' 166' ' ' SER . 88.5 mtt180 -62.29 -41.43 98.49 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.705 -1.198 . . . . 2.1400000000000001 109.22 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.68 -40.72 88.77 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.543 0.687 . . . . 1.05 109.95 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.2 -42.56 95.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.029 . . . . 0.52000000000000002 110.668 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -59.82 -34.07 72.59 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.428 -0.795 . . . . 2.3500000000000001 110.614 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -75.03 -42.55 56.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.179 -0.951 . . . . 1.3899999999999999 110.821 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.9 -39.98 83.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.148 -0.97 . . . . 0.68000000000000005 110.281 -178.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.1 mt -89.94 -12.01 40.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -0.932 . . . . 0.82999999999999996 112.701 -179.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.3 19.72 76.27 Favored Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.569 -1.3 . . . . 0.91000000000000003 113.066 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.5 150.44 48.95 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.525 -0.985 . . . . 0.94999999999999996 109.952 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -65.26 148.56 51.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 2.4300000000000002 109.751 178.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.4 mt -106.88 144.13 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.56 -0.904 . . . . 1.1000000000000001 108.56 178.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.1 mm -79.11 120.78 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.885 -1.135 . . . . 1.5800000000000001 108.388 178.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -98.09 96.72 8.32 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.369 -1.715 . . . . 1.6200000000000001 106.369 179.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.6 mt -75.92 -17.51 59.73 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.612 -0.68 . . . . 0.80000000000000004 111.512 -177.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.6 m -81.19 4.81 18.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.928 -1.108 . . . . 1.5600000000000001 112.383 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.72 20.83 11.32 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.791 0.805 . . . . 0.83999999999999997 112.33 -179.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 18.0 mt -72.65 139.23 19.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.264 -0.897 . . . . 0.81999999999999995 108.752 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -116.77 -11.54 10.92 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.491 -0.756 . . . . 2.3100000000000001 112.885 -178.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -115.86 134.09 55.35 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.736 -1.209 . . . . 1.54 107.736 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -72.98 119.28 17.01 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.44 -0.788 . . . . 1.3799999999999999 108.879 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.0 177.01 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.373 -0.829 . . . . 0.68999999999999995 109.343 -179.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.0 mt -85.87 142.15 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.008 -1.058 . . . . 0.53000000000000003 109.117 178.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.0 tp -95.28 125.17 39.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.155 -0.966 . . . . 0.64000000000000001 108.613 178.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.7 t -124.54 129.69 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.536 -1.283 . . . . 0.67000000000000004 107.536 179.163 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.33 160.12 29.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 0.78000000000000003 108.548 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.72 -40.85 89.36 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.275 -1.516 . . . . 1.0 109.521 177.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 9.2 t70 -174.17 158.57 3.04 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.236 -1.024 . . . . 2.4199999999999999 108.236 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.451 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 35.5 mt -118.3 139.16 51.75 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.149 -1.056 . . . . 0.75 108.149 177.184 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.9 p -90.24 149.36 41.14 Favored Pre-proline 0 N--CA 1.485 1.312 0 N-CA-C 108.293 -1.003 . . . . 0.78000000000000003 108.293 179.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -40.18 -45.23 4.08 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.035 1.824 . . . . 0.67000000000000004 113.393 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.436 ' CB ' ' NH2' ' A' ' 136' ' ' ARG . 15.3 m -59.94 -50.31 74.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.677 -1.264 . . . . 0.69999999999999996 110.96 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.94 -40.32 92.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.447 -0.783 . . . . 1.21 109.934 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.5 p -66.41 -39.0 88.72 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.689 0.757 . . . . 0.59999999999999998 110.141 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.23 85.31 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.358 -0.937 . . . . 0.62 111.11 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -94.8 1.56 55.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.994 -1.066 . . . . 1.1599999999999999 113.569 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.8 148.74 46.04 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.483 -0.932 . . . . 0.72999999999999998 108.483 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -95.27 115.01 26.86 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 106.537 -1.653 . . . . 2.2400000000000002 106.537 177.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 26.1 mt -75.46 -14.93 60.46 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.484 -0.76 . . . . 1.4299999999999999 111.71 -177.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -84.03 -19.67 34.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.081 -1.012 . . . . 2.1499999999999999 112.276 -178.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -102.14 -6.16 23.6 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.327 -0.858 . . . . 2.04 113.033 -177.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 178' ' ' GLY . 85.5 t -110.69 129.57 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.106 -1.442 . . . . 0.55000000000000004 107.106 179.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 tp -90.94 -4.93 56.11 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.985 0.897 . . . . 1.6299999999999999 112.595 -179.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.48 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -179.86 170.46 41.7 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.691 -1.764 . . . . 0.46999999999999997 108.691 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -125.83 126.18 44.08 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.786 -1.42 . . . . 0.54000000000000004 107.42 178.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.5 mt -125.65 128.61 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 106.913 -1.514 . . . . 0.68999999999999995 106.913 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 203' ' ' VAL . 74.6 p -139.58 166.78 23.69 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.894 -1.129 . . . . 0.81999999999999995 109.247 179.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 29.0 p-10 -103.16 32.19 3.88 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.397 -0.814 . . . . 2.3700000000000001 111.504 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -97.02 120.64 37.75 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.091 -1.077 . . . . 1.1100000000000001 108.091 178.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -88.44 27.19 7.19 Favored Glycine 0 N--CA 1.484 1.875 0 C-N-CA 120.15 -1.024 . . . . 1.6699999999999999 113.515 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -88.1 115.76 4.44 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 107.882 -2.087 . . . . 1.54 107.882 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -58.03 -31.37 66.93 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.525 -0.985 . . . . 4.4800000000000004 109.287 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.8 p -105.06 37.32 2.2 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.684 0.754 . . . . 2.6299999999999999 110.265 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.5 t -72.07 146.71 47.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.365 -0.835 . . . . 1.6899999999999999 109.569 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -58.16 -39.74 79.63 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.245 -0.909 . . . . 1.0700000000000001 110.999 178.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 56.8 p -57.84 -41.39 82.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.837 -1.164 . . . . 1.5800000000000001 110.221 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.3 t -61.45 -34.2 75.02 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.333 -0.854 . . . . 1.6000000000000001 110.163 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.6 mm -60.26 -41.03 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.06 -1.025 . . . . 1.45 110.914 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 60.9 mtp -61.66 -40.46 95.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.565 -1.334 . . . . 1.05 110.103 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.96 -45.74 89.77 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.41 -0.814 . . . . 0.71999999999999997 111.127 179.372 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -60.7 -42.2 96.74 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.656 -0.817 . . . . 3.0499999999999998 110.479 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.4 m -69.49 -39.01 77.89 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.328 -0.857 . . . . 0.89000000000000001 109.942 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.26 -7.29 51.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.234 -0.916 . . . . 0.78000000000000003 112.753 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 194' ' ' ALA . 89.7 mt-10 53.36 8.53 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.364 1.246 . . . . 1.45 114.364 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.469 ' O ' ' OG ' ' A' ' 8' ' ' SER . 57.2 mt -73.89 147.6 86.44 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.646 -1.284 . . . . 0.67000000000000004 108.162 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.78 143.43 58.91 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.353 1.369 . . . . 0.64000000000000001 109.503 178.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.82 163.02 37.06 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 117.767 -1.573 . . . . 0.67000000000000004 109.679 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.47 HD12 HD11 ' A' ' 220' ' ' LEU . 51.2 mt -149.45 151.31 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.654 -1.239 . . . . 0.68999999999999995 107.654 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 183' ' ' ALA . 15.1 m -136.05 -28.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 120.79 -1.194 . . . . 0.84999999999999998 112.235 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.39 41.42 3.06 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 120.845 -1.159 . . . . 0.92000000000000004 112.166 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.6 p -61.58 -17.65 55.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.873 -1.369 . . . . 0.94999999999999996 111.535 -178.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.12 -93.04 1.8 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.401 -1.08 . . . . 1.04 110.401 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.1 m -133.58 32.84 3.56 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 122.214 -0.58 . . . . 1.5700000000000001 112.26 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.406 ' CG2' HD13 ' A' ' 2' ' ' ILE . 46.5 t -59.43 -37.69 71.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.324 -1.485 . . . . 0.83999999999999997 110.527 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 67.5 p -55.34 -28.52 54.3 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.422 -0.911 . . . . 0.98999999999999999 111.203 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 19.6 m -92.1 0.86 57.47 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.106 -0.996 . . . . 1.7 112.143 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -122.86 -7.19 8.45 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 113.395 0.887 . . . . 2.2000000000000002 113.395 -177.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.5 t -118.92 151.62 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.59 0.709 . . . . 0.83999999999999997 109.296 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -117.7 157.12 27.05 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.118 -1.068 . . . . 2.2000000000000002 108.118 177.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.588 HD22 ' H ' ' A' ' 215' ' ' ASP . 1.6 t-20 -52.48 141.49 19.92 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.871 -1.143 . . . . 2.2799999999999998 110.805 178.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.588 ' H ' HD22 ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.72 2.75 1.43 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 115.185 1.55 . . . . 2.3500000000000001 115.185 179.397 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.2 t0 -64.72 148.08 51.81 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.862 -1.148 . . . . 1.97 108.797 177.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.522 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 44.3 t80 -88.6 119.38 29.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.544 -1.347 . . . . 2.6499999999999999 107.664 177.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.605 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.7 mt -127.22 148.89 50.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.426 -0.797 . . . . 0.63 110.292 -178.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.4 mt -116.81 123.97 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 106.158 -1.793 . . . . 0.62 106.158 177.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.47 HD11 HD12 ' A' ' 202' ' ' ILE . 58.2 tp -99.16 120.12 38.98 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.692 -1.595 . . . . 0.64000000000000001 106.692 178.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.623 ' O ' ' N ' ' A' ' 223' ' ' VAL . 77.8 m-20 -93.84 -29.15 15.47 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.781 -1.168 . . . . 2.0499999999999998 113.129 -177.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.06 12.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.432 -0.793 . . . . 0.83999999999999997 112.654 -179.253 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.623 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.4 t -108.53 -61.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.746 -1.222 . . . . 1.02 109.525 179.092 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -94.19 11.59 29.6 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.389 0.614 . . . . 2.5099999999999998 110.675 179.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 61.48 54.53 3.07 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.148 0.499 . . . . 1.54 111.951 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -148.97 143.52 26.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.173 -0.954 . . . . 1.95 109.831 178.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.1 t -115.9 136.91 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.077 -1.083 . . . . 0.70999999999999996 108.077 178.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -102.68 131.74 49.28 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.606 -0.887 . . . . 1.01 108.606 178.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.41 130.96 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 108.653 -0.869 . . . . 0.81999999999999995 108.653 178.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 52.11 53.69 13.07 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.188 -0.945 . . . . 1.54 113.549 178.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.65 151.07 63.73 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 C-N-CA 122.513 2.142 . . . . 0.93999999999999995 111.069 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.0 m -71.33 157.77 37.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.072 -1.017 . . . . 1.8 108.995 177.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -57.31 -40.89 78.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 2.73 109.898 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.85 -39.82 86.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.815 . . . . 3.1699999999999999 110.692 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.2 t -69.2 -38.05 77.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.23 -0.919 . . . . 1.3400000000000001 110.818 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 84.4 mt . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 1.2 110.261 179.239 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.4 mt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 112.431 0.53 . . . . 1.0700000000000001 112.431 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -90.73 115.4 27.79 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.61 -1.626 . . . . 1.24 106.61 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.35 -154.85 22.12 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.081 -2.007 . . . . 1.01 108.081 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 5' ' ' ILE . 72.6 mt -93.92 -4.33 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -1.141 . . . . 1.1100000000000001 112.64 -178.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 5' ' ' ILE . 38.4 tp 50.61 100.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.831 -1.168 . . . . 0.98999999999999999 112.235 178.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -89.63 -37.24 14.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.84999999999999998 111.498 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -145.77 138.75 14.11 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 108.027 -1.101 . . . . 1.3799999999999999 108.027 -178.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.88 148.92 28.73 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.725 2.283 . . . . 0.93999999999999995 112.505 179.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.889 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.85 166.05 13.98 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.891 -1.684 . . . . 0.81000000000000005 108.891 178.357 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.52 136.11 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.046 -1.267 . . . . 0.82999999999999996 108.704 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.537 ' HB1' HD22 ' A' ' 177' ' ' LEU . . . -143.06 156.67 44.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.303 -0.873 . . . . 0.53000000000000003 109.495 179.263 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 23.8 m-85 -124.48 140.74 52.67 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.206 -1.035 . . . . 0.77000000000000002 108.206 178.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.72 168.48 37.39 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 118.551 -1.785 . . . . 0.51000000000000001 109.906 177.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -78.64 160.22 27.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.427 -1.043 . . . . 1.8999999999999999 109.547 179.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.57 129.71 34.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.791 -1.193 . . . . 0.66000000000000003 108.195 178.584 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.7 tp -107.53 101.94 11.24 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 105.029 -2.212 . . . . 0.82999999999999996 105.029 177.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.5 tp -89.88 137.32 32.43 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.173 -1.047 . . . . 0.85999999999999999 108.173 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.6 mt -100.49 114.79 28.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.592 -1.633 . . . . 0.92000000000000004 106.592 178.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -108.97 131.49 55.0 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.617 -1.253 . . . . 2.0299999999999998 107.617 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -127.13 149.98 49.7 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.254 -0.904 . . . . 2.6600000000000001 109.228 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -83.04 135.0 35.01 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.778 -1.193 . . . . 2.3199999999999998 107.778 177.276 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.39 147.32 48.85 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.592 -0.693 . . . . 2.1099999999999999 109.315 178.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.423 HD11 ' NH1' ' A' ' 139' ' ' ARG . 61.9 mt -97.7 135.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.166 -0.959 . . . . 0.72999999999999998 108.72 178.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.8 t -107.69 130.88 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.489 -0.93 . . . . 0.87 108.489 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.5 mt -97.56 131.44 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.335 -0.987 . . . . 0.81000000000000005 108.335 178.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -93.51 123.26 36.7 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.814 -1.179 . . . . 1.3400000000000001 108.371 178.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -95.81 10.25 37.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.299 -0.876 . . . . 2.8900000000000001 112.333 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.63 149.22 46.97 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.118 -0.988 . . . . 2.0899999999999999 109.332 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -89.93 131.02 36.06 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.74 -1.207 . . . . 2.1899999999999999 107.74 177.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 pt -92.53 165.47 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.007 -1.058 . . . . 0.75 110.345 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.3 p -92.51 163.43 13.83 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.446 -0.575 . . . . 0.91000000000000003 109.446 178.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.39 -17.49 1.94 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.214 -0.929 . . . . 0.93000000000000005 112.482 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -69.45 -41.78 75.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.355 -0.841 . . . . 2.2799999999999998 110.685 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -90.75 -5.76 55.28 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.62 -1.3 . . . . 1.45 112.697 -178.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.91 -42.29 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.803 -1.186 . . . . 0.81000000000000005 110.477 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.14 -39.97 88.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.034 -1.041 . . . . 1.54 110.767 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -62.67 -38.13 89.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.509 -0.745 . . . . 2.3599999999999999 110.845 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -60.19 -40.73 91.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.907 -1.121 . . . . 1.3100000000000001 110.656 179.248 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -62.43 -41.16 90.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.187 -0.945 . . . . 0.81999999999999995 110.551 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -60.8 -49.52 77.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.109 -0.995 . . . . 1.5 110.369 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 46' ' ' GLY . 65.1 mtm180 -62.86 -40.35 97.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.231 -0.918 . . . . 2.23 110.09 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -70.04 -54.6 12.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.434 -0.791 . . . . 0.84999999999999998 110.184 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.49 -49.88 73.63 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.937 -1.105 . . . . 0.91000000000000003 109.834 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.56 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.9 t -67.81 -39.75 83.95 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.783 0.802 . . . . 0.90000000000000002 109.91 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 42' ' ' ARG . . . -56.43 -43.25 90.25 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.808 -1.317 . . . . 0.68999999999999995 109.808 178.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -59.54 -31.26 69.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.891 0.853 . . . . 2.8799999999999999 109.394 178.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.08 -43.2 77.78 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.492 0.663 . . . . 0.84999999999999998 109.762 178.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -79.07 -42.94 25.21 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.325 -0.95 . . . . 2.3500000000000001 110.009 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.87 86.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.099 -1.001 . . . . 0.65000000000000002 110.225 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.0 p -59.98 -41.76 92.71 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.268 1.032 . . . . 1.45 109.241 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.74 90.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.728 -0.669 . . . . 0.63 110.133 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -60.09 -49.8 76.21 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.39 -0.924 . . . . 1.3400000000000001 110.264 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.59 -42.74 91.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 1.5600000000000001 110.059 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -59.86 -40.3 88.15 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.736 -0.602 . . . . 1.1899999999999999 110.47 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.46 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 5.6 m -67.43 -47.69 69.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.06 -1.025 . . . . 0.71999999999999997 110.18 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.5 mt -61.36 -34.36 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 0.62 110.849 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -51.62 -43.94 62.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.114 -0.991 . . . . 1.05 111.013 179.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.9 m -68.97 -39.62 79.35 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.985 -1.072 . . . . 0.64000000000000001 110.197 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.46 ' NZ ' HG22 ' A' ' 56' ' ' THR . 47.4 mttp -60.11 -40.0 88.17 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.807 -1.157 . . . . 1.73 109.529 179.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.41 73.83 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.326 -0.858 . . . . 0.56000000000000005 109.934 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.59 -37.03 9.87 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.978 -1.106 . . . . 0.68999999999999995 111.112 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -81.59 -23.94 36.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.092 -1.24 . . . . 1.48 111.001 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.4 m -88.82 -50.37 6.26 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.461 -0.774 . . . . 0.97999999999999998 110.57 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.591 ' CZ ' ' SD ' ' A' ' 193' ' ' MET . 75.4 m-85 -107.23 -3.67 19.55 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 113.805 1.039 . . . . 1.1599999999999999 113.805 -177.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.1 166.49 34.21 Favored Glycine 0 N--CA 1.495 2.617 0 O-C-N 121.088 -1.007 . . . . 0.84999999999999998 111.699 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -56.31 -19.54 14.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.558 -0.966 . . . . 3.8599999999999999 112.787 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -56.74 -41.5 77.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.684 -1.26 . . . . 2.3500000000000001 110.561 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -89.27 -23.12 22.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.97 -1.081 . . . . 1.6699999999999999 111.563 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -60.78 -38.93 86.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.502 -0.749 . . . . 1.45 110.745 -179.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.1 -39.37 89.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.36 -0.837 . . . . 0.60999999999999999 110.816 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.6 mt -62.12 -44.24 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.865 -1.147 . . . . 0.65000000000000002 110.513 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -71.7 -31.65 66.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.856 -1.152 . . . . 0.66000000000000003 110.701 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.24 -41.17 92.57 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.115 -0.99 . . . . 1.1899999999999999 109.903 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.88 -36.74 91.53 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.656 -1.259 . . . . 0.53000000000000003 110.143 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.48 ' N ' ' HD1' ' A' ' 76' ' ' HIS . 1.4 m80 -59.31 -40.83 87.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -1.155 . . . . 1.27 110.492 179.229 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.3 -39.66 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.982 -1.074 . . . . 0.54000000000000004 110.276 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.8 ttp -59.58 -39.36 83.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.335 -0.853 . . . . 1.74 110.396 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.43 -49.93 73.13 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.466 -0.894 . . . . 0.55000000000000004 110.105 179.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.5 tp -60.45 -46.92 88.3 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.763 0.792 . . . . 0.46999999999999997 110.272 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -85.74 8.43 19.87 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.034 0.753 . . . . 1.4199999999999999 113.034 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -62.31 122.06 14.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.878 -1.139 . . . . 1.27 108.581 179.091 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -64.07 -18.67 64.6 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.733 0.777 . . . . 1.3500000000000001 111.099 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.14 -53.74 7.84 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.74 -0.784 . . . . 2.2200000000000002 110.253 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.52 -35.12 78.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.551 -0.718 . . . . 0.62 110.495 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -60.01 -48.92 79.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.306 -0.871 . . . . 1.29 110.739 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -62.68 -39.97 95.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 1.52 110.513 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.97 -48.41 76.59 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.292 -0.88 . . . . 1.3 110.152 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -57.89 -43.48 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.291 -0.881 . . . . 0.60999999999999999 109.879 179.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.43 -40.81 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.718 -0.614 . . . . 0.78000000000000003 110.479 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.19 -45.04 95.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -0.894 . . . . 0.81999999999999995 110.873 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.91 -39.05 84.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 0.80000000000000004 110.521 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.8 mt -70.18 -49.73 52.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 0.77000000000000002 111.066 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -81.78 -36.37 28.54 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.833 -1.167 . . . . 2.1200000000000001 111.795 -179.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 91' ' ' ALA . 24.1 t0 -81.8 -42.43 19.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.83 -1.169 . . . . 1.51 112.132 -178.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -103.38 8.25 38.09 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.212 -0.93 . . . . 1.98 112.452 -178.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.3 m80 51.08 51.17 17.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.14 -0.975 . . . . 1.3200000000000001 111.804 -179.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.6 mtt -104.91 152.07 23.1 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.353 -0.842 . . . . 1.3799999999999999 108.899 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.1 p -71.92 160.03 33.25 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.577 -0.702 . . . . 0.67000000000000004 109.292 177.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.7 92.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.149 -0.969 . . . . 0.52000000000000002 110.571 178.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.579 ' OD2' HD21 ' A' ' 142' ' ' LEU . 81.6 m-20 -67.24 -42.1 84.54 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.044 -1.035 . . . . 2.25 109.925 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.49 -51.0 48.15 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.635 -0.665 . . . . 0.64000000000000001 111.224 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.31 -45.74 92.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.037 -1.04 . . . . 0.56000000000000005 110.65 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.7 97.12 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.494 -0.883 . . . . 0.46000000000000002 110.408 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -60.28 -39.22 86.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 1.3200000000000001 110.972 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -57.9 -48.72 79.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.949 -1.094 . . . . 1.3 110.567 179.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.99 -47.44 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.943 -1.098 . . . . 0.60999999999999999 110.031 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.0 mm -62.64 -30.95 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.779 -0.576 . . . . 0.65000000000000002 110.56 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.59 -41.61 86.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.44 -0.788 . . . . 2.1099999999999999 110.85 179.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.75 -34.52 10.05 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.231 -1.462 . . . . 0.82999999999999996 112.678 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -61.13 -41.68 97.16 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.788 -1.419 . . . . 1.28 110.259 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.39 -54.93 7.99 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.741 0.781 . . . . 0.89000000000000001 110.29 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 65.3 m -59.97 -38.49 82.67 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.686 -0.634 . . . . 1.8700000000000001 110.477 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.61 96.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.991 -1.068 . . . . 1.05 110.575 179.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.17 -30.14 71.03 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.217 -0.993 . . . . 1.02 110.35 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -66.6 -20.07 65.92 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.164 -0.96 . . . . 2.04 110.986 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -72.63 -10.51 59.87 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.99 0.9 . . . . 1.73 111.02 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 23.2 mt -87.84 144.84 26.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.936 -0.765 . . . . 1.3700000000000001 108.936 179.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -100.19 37.13 1.71 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.132 -0.98 . . . . 2.8799999999999999 111.787 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -115.22 137.71 51.72 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.179 -0.951 . . . . 1.5800000000000001 108.81 178.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 50.1 mp0 -59.86 -35.24 74.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.67 -0.644 . . . . 3.04 111.089 179.043 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -73.53 -49.74 24.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.926 -1.109 . . . . 0.90000000000000002 109.848 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.1 mt -63.73 -39.73 95.0 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.281 -0.887 . . . . 1.0600000000000001 109.604 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -60.96 -45.07 96.21 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.864 0.84 . . . . 2.1800000000000002 109.67 179.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -61.29 -32.78 72.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.812 0.815 . . . . 2.1499999999999999 109.535 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.416 ' O ' HG23 ' A' ' 130' ' ' VAL . 60.4 ttt180 -62.04 -29.57 70.38 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.996 0.903 . . . . 2.3300000000000001 109.463 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.93 74.6 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.926 0.87 . . . . 0.81999999999999995 109.501 178.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.56 -41.59 79.53 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.703 0.763 . . . . 0.84999999999999998 110.08 179.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -62.55 -40.47 96.92 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.413 0.625 . . . . 1.3899999999999999 110.243 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 126' ' ' ARG . 52.1 t -68.96 -38.33 78.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.504 -0.748 . . . . 0.56000000000000005 109.755 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -58.92 -38.89 79.98 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.057 -1.027 . . . . 3.1200000000000001 109.715 178.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.498 ' OD2' ' NE ' ' A' ' 136' ' ' ARG . 32.2 t70 -60.12 -39.79 87.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.61 -0.682 . . . . 1.28 110.352 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 57.7 mt -60.05 -39.83 81.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.363 -0.836 . . . . 0.48999999999999999 109.983 179.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.13 -48.3 26.5 Favored Glycine 0 N--CA 1.485 1.943 0 C-N-CA 120.209 -0.995 . . . . 0.46000000000000002 110.799 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -58.89 -44.16 91.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.039 -1.271 . . . . 2.71 110.202 179.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.498 ' NE ' ' OD2' ' A' ' 132' ' ' ASP . 54.3 mtm180 -61.62 -41.48 97.54 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.707 -1.197 . . . . 2.1400000000000001 109.774 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.45 -41.71 94.65 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.865 -0.734 . . . . 1.05 110.079 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.6 mt -60.57 -43.35 97.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.437 -0.789 . . . . 0.52000000000000002 110.765 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.423 ' NH1' HD11 ' A' ' 24' ' ' ILE . 48.7 mtt-85 -59.84 -32.81 71.02 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.363 -0.836 . . . . 2.3500000000000001 111.318 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -75.39 -40.17 58.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.011 -1.056 . . . . 1.3899999999999999 110.708 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.4 mt -59.58 -40.13 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.227 -0.921 . . . . 0.68000000000000005 110.972 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.579 HD21 ' OD2' ' A' ' 101' ' ' ASP . 86.2 mt -90.47 -9.2 48.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.916 -1.115 . . . . 0.82999999999999996 112.926 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.09 23.16 66.8 Favored Glycine 0 N--CA 1.483 1.78 0 C-N-CA 119.91 -1.138 . . . . 0.91000000000000003 113.112 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.414 HD23 HH11 ' A' ' 139' ' ' ARG . 29.0 tp -63.08 142.21 58.47 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.757 -0.849 . . . . 0.94999999999999996 109.012 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -66.53 141.35 57.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.239 -0.913 . . . . 2.4300000000000002 109.378 178.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.4 mt -112.18 136.52 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 108.32 -0.993 . . . . 1.1000000000000001 108.32 178.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.561 HD12 ' H ' ' A' ' 147' ' ' ILE . 5.2 mp -76.2 131.07 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 1.5800000000000001 108.792 178.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.09 97.63 11.04 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.721 -1.585 . . . . 1.6200000000000001 106.721 178.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.455 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 50.4 mt -71.51 -29.45 64.8 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.378 0.609 . . . . 0.80000000000000004 110.942 -178.146 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.0 t -79.47 -3.29 45.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.35 -0.844 . . . . 1.5600000000000001 112.297 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -101.27 23.1 11.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.677 -0.64 . . . . 0.83999999999999997 111.919 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.455 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 16.4 mt -72.1 144.87 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 0.81999999999999995 109.861 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -118.64 -10.85 9.96 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.979 0.895 . . . . 2.3100000000000001 112.372 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -118.22 140.36 49.92 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.72 0.772 . . . . 1.54 109.152 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.04 119.8 22.69 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.285 -0.885 . . . . 1.3799999999999999 108.741 178.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.71 175.79 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.578 0.704 . . . . 0.68999999999999995 109.328 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.5 mt -86.98 140.9 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.805 . . . . 0.53000000000000003 109.01 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 24.6 tp -98.32 122.3 41.31 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.044 -1.035 . . . . 0.64000000000000001 108.777 178.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.8 t -123.93 133.96 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.337 -0.986 . . . . 0.67000000000000004 108.337 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.86 157.81 29.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.477 -0.764 . . . . 0.78000000000000003 109.113 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.449 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.4 -38.7 88.03 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.672 -1.268 . . . . 1.0 109.196 178.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.2 t0 -172.45 148.0 1.97 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.524 -0.735 . . . . 2.4199999999999999 109.02 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.521 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 66.1 mt -119.15 138.98 52.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.243 -0.911 . . . . 0.75 108.555 177.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.2 p -93.6 151.6 40.2 Favored Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 108.327 -0.99 . . . . 0.78000000000000003 108.327 178.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -39.93 -38.72 2.04 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.767 1.645 . . . . 0.67000000000000004 113.433 179.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.5 m -58.92 -42.87 90.7 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.036 -1.065 . . . . 0.69999999999999996 109.699 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -72.64 -45.1 60.64 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.693 -0.803 . . . . 1.21 110.164 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 20.4 p -66.19 -38.95 89.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.372 -0.83 . . . . 0.59999999999999998 109.812 -178.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.72 87.34 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.677 -0.64 . . . . 0.62 110.844 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -92.96 0.49 57.41 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.126 -0.984 . . . . 1.1599999999999999 112.738 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.7 tp -65.99 150.26 48.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.729 . . . . 0.72999999999999998 109.756 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -96.94 117.82 32.0 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.035 -1.469 . . . . 2.2400000000000002 107.035 177.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 39.1 mt -76.32 -18.07 59.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 1.4299999999999999 111.404 -178.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -82.97 -20.58 34.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.205 -0.935 . . . . 2.1499999999999999 112.282 -179.208 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -102.69 -6.28 22.86 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.261 -0.899 . . . . 2.04 113.383 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 178' ' ' GLY . 45.5 t -111.7 131.8 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.063 -1.088 . . . . 0.55000000000000004 108.063 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.739 ' O ' HD23 ' A' ' 177' ' ' LEU . 2.0 tt -86.04 -11.52 52.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.004 -1.06 . . . . 1.6299999999999999 111.684 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.535 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 174.31 177.39 43.43 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.013 -1.565 . . . . 0.46999999999999997 109.748 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.64 132.48 46.73 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.405 -1.056 . . . . 0.54000000000000004 108.199 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 72.6 mt -134.14 109.39 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 106.423 -1.695 . . . . 0.68999999999999995 106.423 178.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 205' ' ' THR . 65.6 p -129.63 170.47 13.75 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.9 -1.125 . . . . 0.81999999999999995 110.568 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 15.4 p-10 -103.03 49.56 0.83 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.277 0.561 . . . . 2.3700000000000001 110.423 179.435 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.0 154.46 18.95 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.338 -0.851 . . . . 1.1100000000000001 109.356 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.91 -80.92 0.06 OUTLIER Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.598 -1.286 . . . . 1.6699999999999999 111.302 178.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.38 -40.74 0.82 Allowed Glycine 0 N--CA 1.492 2.392 0 O-C-N 120.941 -1.329 . . . . 1.54 112.354 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -60.22 -36.25 77.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.947 . . . . 4.4800000000000004 110.518 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 12.6 p -121.25 26.85 8.69 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.517 -0.74 . . . . 2.6299999999999999 111.399 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -86.52 109.84 19.37 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.351 -1.351 . . . . 1.6899999999999999 107.351 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -61.69 -37.83 85.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.588 -0.695 . . . . 1.0700000000000001 110.727 -178.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 25.8 m -57.24 -40.49 77.7 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.136 -0.977 . . . . 1.5800000000000001 110.304 179.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 50.4 m -60.01 -38.45 82.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 1.6000000000000001 110.6 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.9 mt -59.36 -41.04 83.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.148 -0.97 . . . . 1.45 110.522 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.591 ' SD ' ' CZ ' ' A' ' 65' ' ' PHE . 7.7 mtm -68.96 -35.07 76.33 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.707 -1.197 . . . . 1.05 109.325 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.26 -44.62 88.44 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.174 -0.61 . . . . 0.71999999999999997 110.56 179.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.474 ' HG2' HH11 ' A' ' 195' ' ' ARG . 32.8 mtt-85 -60.2 -41.27 92.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 3.0499999999999998 110.448 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.0 m -68.91 -37.46 78.96 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.749 0.785 . . . . 0.89000000000000001 110.028 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.1 mt -90.4 -5.91 55.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.413 -0.804 . . . . 0.78000000000000003 112.472 -179.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 54.11 8.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.67 0.989 . . . . 1.45 113.67 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 30.8 mt -71.58 150.03 93.5 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.971 -1.081 . . . . 0.67000000000000004 108.773 178.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -55.89 145.79 71.33 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.745 1.63 . . . . 0.64000000000000001 109.68 178.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.9 158.9 31.69 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.715 -1.241 . . . . 0.67000000000000004 109.989 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.469 ' CD1' HD11 ' A' ' 220' ' ' LEU . 15.0 mt -149.77 148.03 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.878 -1.156 . . . . 0.68999999999999995 107.878 178.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.2 m -134.11 -32.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.995 -1.066 . . . . 0.84999999999999998 113.557 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.11 45.32 2.51 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.102 -0.999 . . . . 0.92000000000000004 112.227 -178.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 181' ' ' THR . 32.5 p -67.19 -11.1 56.46 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.189 -1.183 . . . . 0.94999999999999996 111.328 -179.143 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.0 -97.08 0.81 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.802 -1.189 . . . . 1.04 110.182 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.6 m -127.18 29.07 5.64 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.457 -1.025 . . . . 1.5700000000000001 112.473 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.53 -37.85 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.595 -1.316 . . . . 0.83999999999999997 110.7 179.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 60.4 p -54.35 -25.1 22.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.001 -1.062 . . . . 0.98999999999999999 111.36 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.2 t -93.63 -0.2 56.24 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.705 0.764 . . . . 1.7 111.742 -179.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -124.37 -2.05 8.06 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 113.291 0.849 . . . . 2.2000000000000002 113.291 -177.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.4 t -117.12 150.04 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.443 -0.786 . . . . 0.83999999999999997 109.156 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -122.2 153.07 39.3 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.638 -0.875 . . . . 2.2000000000000002 108.638 178.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 52.3 t30 -52.2 141.53 18.67 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.235 -0.915 . . . . 2.2799999999999998 110.093 178.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 10.0 t0 81.07 -1.76 1.76 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.111 1.152 . . . . 2.3500000000000001 114.111 179.521 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -61.71 148.56 42.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.796 -1.19 . . . . 1.97 108.578 177.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -90.47 118.97 30.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.116 -1.439 . . . . 2.6499999999999999 107.116 177.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.527 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 82.9 mt -129.33 148.41 51.25 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.55 -0.719 . . . . 0.63 109.511 -178.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.6 mt -117.54 129.66 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 106.602 -1.629 . . . . 0.62 106.602 177.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.469 HD11 ' CD1' ' A' ' 202' ' ' ILE . 61.6 tp -99.75 118.84 37.09 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 106.713 -1.588 . . . . 0.64000000000000001 106.713 178.632 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 223' ' ' VAL . 50.4 t0 -93.71 -30.94 14.64 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.119 -0.988 . . . . 2.0499999999999998 112.654 -177.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.889 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.87 20.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.42 0.896 . . . . 0.83999999999999997 113.42 -178.079 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.7 t -109.62 -62.03 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.839 -1.163 . . . . 1.02 108.788 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -91.83 15.22 13.42 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.024 0.916 . . . . 2.5099999999999998 110.247 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.3 t30 60.75 51.54 4.8 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.355 -0.839 . . . . 1.54 112.409 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.475 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 15.4 pt20 -152.73 156.19 38.66 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.776 -1.202 . . . . 1.95 110.451 178.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 69.9 t -117.97 144.96 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.702 -0.624 . . . . 0.70999999999999996 109.462 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.475 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 93.8 m-85 -101.92 130.34 48.39 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 107.973 -1.121 . . . . 1.01 107.973 177.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.07 129.86 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.22 -0.925 . . . . 0.81999999999999995 108.815 179.181 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.436 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 0.4 OUTLIER 52.51 49.85 7.2 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.115 -0.991 . . . . 1.54 113.557 178.184 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 40.9 Cg_endo -66.51 149.71 84.3 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.623 2.216 . . . . 0.93999999999999995 111.432 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.9 m -75.57 154.08 36.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 1.8 109.031 177.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 34.0 p-10 -60.74 -35.44 76.38 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.569 -0.707 . . . . 2.73 110.487 179.06 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.497 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 81.0 tt0 -59.47 -43.44 93.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 3.1699999999999999 110.453 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 99.0 t -71.34 -39.79 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.241 -0.912 . . . . 1.3400000000000001 110.165 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 1.2 110.512 179.806 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 106.497 -1.668 . . . . 1.0700000000000001 106.497 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 m -105.94 128.13 53.59 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.762 -1.199 . . . . 1.24 107.762 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.28 -156.98 22.76 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 108.968 -1.653 . . . . 1.01 108.968 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 5' ' ' ILE . 86.6 mt -95.82 -1.81 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.554 -0.968 . . . . 1.1100000000000001 112.581 -178.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 49.38 99.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.468 0.544 . . . . 0.98999999999999999 112.468 178.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.89 -52.69 6.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.066 -1.021 . . . . 0.84999999999999998 110.775 179.383 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.43 146.34 41.76 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 107.449 -1.315 . . . . 1.3799999999999999 107.449 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -74.07 144.38 33.83 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.866 2.377 . . . . 0.93999999999999995 112.993 178.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.912 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.46 166.81 17.55 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 109.539 -1.425 . . . . 0.81000000000000005 109.539 178.075 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.7 mt -127.22 134.56 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.302 -1.116 . . . . 0.82999999999999996 108.225 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.12 155.94 46.77 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.318 -0.864 . . . . 0.53000000000000003 109.498 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.2 m-85 -125.09 143.22 51.03 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.482 -0.761 . . . . 0.77000000000000002 108.995 178.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.32 167.39 34.39 Favored Glycine 0 N--CA 1.499 2.897 0 C-N-CA 118.98 -1.581 . . . . 0.51000000000000001 110.002 177.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -78.82 157.65 28.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.753 -0.851 . . . . 1.8999999999999999 109.198 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -81.31 134.84 35.65 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.842 -1.161 . . . . 0.66000000000000003 108.636 178.035 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.2 tp -116.18 101.19 8.49 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 105.801 -1.925 . . . . 0.82999999999999996 105.801 178.199 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -93.72 132.97 37.57 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.01 -1.107 . . . . 0.85999999999999999 108.01 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.6 mt -103.31 118.09 35.99 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 106.802 -1.555 . . . . 0.92000000000000004 106.802 178.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -110.63 137.72 47.95 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.749 -1.204 . . . . 2.0299999999999998 107.749 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -121.02 151.33 39.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 2.6600000000000001 109.703 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -81.92 132.98 35.28 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.941 -1.133 . . . . 2.3199999999999998 107.941 177.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -60.87 148.84 38.09 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.876 -1.14 . . . . 2.1099999999999999 108.941 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.0 mt -96.9 129.83 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.175 -0.953 . . . . 0.72999999999999998 108.517 178.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.5 129.6 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.005 -1.109 . . . . 0.87 108.005 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.6 mt -91.64 130.91 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.24 -1.022 . . . . 0.81000000000000005 108.24 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -90.62 116.54 28.59 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.061 -1.459 . . . . 1.3400000000000001 107.061 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -97.92 17.07 19.06 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.424 -0.797 . . . . 2.8900000000000001 112.673 -179.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -68.42 147.28 52.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 2.0899999999999999 109.326 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -87.23 128.35 35.15 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.576 -1.268 . . . . 2.1899999999999999 107.576 178.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 pt -93.84 163.97 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.026 -1.046 . . . . 0.75 110.132 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.8 p -92.57 162.03 14.35 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.206 0.527 . . . . 0.91000000000000003 109.712 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.3 -15.98 1.91 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.046 -1.034 . . . . 0.93000000000000005 112.011 179.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -71.27 -38.95 71.82 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.409 -0.807 . . . . 2.2799999999999998 110.895 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -92.68 -6.06 50.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.744 -1.222 . . . . 1.45 112.934 -178.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -59.67 -40.58 82.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 120.154 -0.618 . . . . 0.81000000000000005 110.48 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -59.24 -40.19 85.15 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.017 -1.052 . . . . 1.54 110.528 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -62.14 -41.47 98.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.326 -0.859 . . . . 2.3599999999999999 111.213 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -59.71 -40.27 87.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.316 -0.865 . . . . 1.3100000000000001 111.047 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.31 -40.63 84.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.169 -0.957 . . . . 0.81999999999999995 110.982 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -60.37 -48.82 80.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.587 -1.321 . . . . 1.5 110.449 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -62.45 -40.97 98.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.472 -0.767 . . . . 2.23 110.649 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -70.39 -57.6 4.64 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.177 -0.952 . . . . 0.84999999999999998 109.374 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.39 -48.73 80.53 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.55 -0.86 . . . . 0.91000000000000003 110.121 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.7 t -68.03 -39.67 83.04 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.106 -0.996 . . . . 0.90000000000000002 110.074 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.16 -46.67 70.07 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.74 -1.219 . . . . 0.68999999999999995 110.056 178.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -59.96 -29.92 68.75 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.44 -1.035 . . . . 2.8799999999999999 110.311 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.67 -49.48 77.58 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.671 0.748 . . . . 0.84999999999999998 109.923 179.187 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -79.27 -41.56 27.85 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.599 -0.688 . . . . 2.3500000000000001 110.657 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.58 -41.37 90.1 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.05 -1.06 . . . . 0.65000000000000002 110.206 -178.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.2 p -60.78 -40.34 92.23 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.319 1.056 . . . . 1.45 109.246 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.71 -49.63 67.79 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.65 -0.705 . . . . 0.63 110.435 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.67 -49.78 76.41 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 118.85 -1.14 . . . . 1.3400000000000001 110.392 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.94 -40.6 98.15 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.877 0.846 . . . . 1.5600000000000001 110.164 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -59.93 -41.4 91.7 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.195 -0.94 . . . . 1.1899999999999999 110.471 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 m -63.89 -43.7 95.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.851 -1.156 . . . . 0.71999999999999997 110.067 179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.9 mt -60.43 -36.66 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.561 0.696 . . . . 0.62 110.943 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -51.01 -44.09 60.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.401 -0.812 . . . . 1.05 110.81 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -68.98 -38.91 79.61 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.031 -1.043 . . . . 0.64000000000000001 110.029 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.71 -37.71 87.56 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.887 -1.125 . . . . 1.73 108.873 179.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.8 -33.17 75.35 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.887 -0.725 . . . . 0.56000000000000005 109.818 179.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.83 -37.1 12.08 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 120.139 -1.029 . . . . 0.68999999999999995 111.135 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -81.63 -28.45 33.66 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.787 -1.42 . . . . 1.48 110.723 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.3 m -88.19 -45.45 10.08 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.49 -0.757 . . . . 0.97999999999999998 111.383 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.89 -7.54 17.04 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 114.102 1.149 . . . . 1.1599999999999999 114.102 -177.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.46 161.27 30.2 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.498 -0.751 . . . . 0.84999999999999998 111.633 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.87 -25.39 63.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.73 -0.865 . . . . 3.8599999999999999 112.341 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -57.27 -44.18 83.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.763 -1.211 . . . . 2.3500000000000001 110.669 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -82.64 -24.29 33.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.554 -1.341 . . . . 1.6699999999999999 111.405 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.72 -36.84 77.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.531 -0.731 . . . . 1.45 110.981 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.05 83.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.163 -0.961 . . . . 0.60999999999999999 110.628 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.7 mt -64.74 -41.86 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.913 -1.117 . . . . 0.65000000000000002 110.178 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -71.42 -32.41 68.36 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.971 -1.081 . . . . 0.66000000000000003 109.776 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -61.74 -39.19 90.69 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 1.1899999999999999 109.953 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.71 -40.93 99.04 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.265 -0.969 . . . . 0.53000000000000003 110.986 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -58.93 -43.07 91.1 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.913 -1.345 . . . . 1.27 110.475 179.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.5 mt -60.88 -37.51 76.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.038 -1.039 . . . . 0.54000000000000004 110.333 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -57.7 -40.27 79.1 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.602 -0.687 . . . . 1.74 110.045 179.12 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 tp -60.31 -50.35 73.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.368 -0.832 . . . . 0.55000000000000004 110.232 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.01 -41.26 91.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.896 0.855 . . . . 0.46999999999999997 110.183 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -85.91 5.69 31.83 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.446 -0.784 . . . . 1.4199999999999999 112.937 -179.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -61.59 121.79 13.64 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.204 -0.935 . . . . 1.27 108.491 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.95 -17.26 64.55 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.752 -0.779 . . . . 1.3500000000000001 110.822 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.77 -51.8 10.73 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.768 -0.773 . . . . 2.2200000000000002 110.495 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.95 -40.61 93.94 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.48 -0.888 . . . . 0.62 111.204 -179.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -57.48 -49.85 74.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.932 . . . . 1.29 110.236 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -61.86 -40.34 95.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 1.52 110.469 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.02 -46.66 77.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.936 -1.102 . . . . 1.3 110.521 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -57.11 -42.87 80.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.049 -1.032 . . . . 0.60999999999999999 110.065 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.8 -44.51 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.39 -0.819 . . . . 0.78000000000000003 110.245 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.6 97.33 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.493 -0.754 . . . . 0.81999999999999995 111.016 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.03 -43.29 99.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.872 -1.142 . . . . 0.80000000000000004 110.198 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.62 -47.94 89.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.38 -0.825 . . . . 0.77000000000000002 110.247 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -78.09 -38.76 43.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.125 -0.984 . . . . 2.1200000000000001 112.059 -179.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -82.35 -42.25 18.96 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.964 -1.085 . . . . 1.51 112.359 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -99.04 5.04 47.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.173 -0.955 . . . . 1.98 112.374 -178.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 40.7 m80 51.37 49.11 21.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.0 . . . . 1.3200000000000001 111.338 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 64.5 mtt -105.82 154.68 20.19 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.14 -0.975 . . . . 1.3799999999999999 109.711 178.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 82.5 p -70.82 160.37 32.87 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.701 -0.624 . . . . 0.67000000000000004 109.6 177.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.01 86.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.043 -1.035 . . . . 0.52000000000000002 110.539 179.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -67.68 -39.36 84.46 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.318 -0.863 . . . . 2.25 110.568 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.06 67.96 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 120.928 -1.108 . . . . 0.64000000000000001 111.439 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.76 88.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.56000000000000005 110.626 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.74 -41.33 86.25 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.234 -0.916 . . . . 0.46000000000000002 111.148 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -61.13 -40.25 93.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.631 -1.293 . . . . 1.3200000000000001 110.285 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -59.9 -49.86 76.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.856 -1.152 . . . . 1.3 110.243 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.21 -47.27 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.982 -1.074 . . . . 0.60999999999999999 110.182 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.3 mm -61.33 -33.26 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.65000000000000002 110.521 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -57.26 -39.93 76.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.592 -0.693 . . . . 2.1099999999999999 110.979 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.67 -24.91 44.18 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 118.948 -1.596 . . . . 0.82999999999999996 113.304 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -63.36 -41.06 98.8 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.527 -1.572 . . . . 1.28 109.702 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.81 63.33 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.018 -0.537 . . . . 0.89000000000000001 110.759 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.7 p -62.43 -41.14 98.49 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.077 -1.049 . . . . 1.8700000000000001 109.918 -178.141 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.47 98.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.099 -1.0 . . . . 1.05 110.893 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 87.9 mt -64.92 -29.66 70.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.106 -0.996 . . . . 1.02 110.722 -179.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -66.38 -21.59 66.23 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.34 -0.85 . . . . 2.04 110.967 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -71.72 -13.38 61.71 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.222 1.01 . . . . 1.73 110.814 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.8 mt -87.62 136.35 32.98 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.429 -1.323 . . . . 1.3700000000000001 107.429 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 7.3 t0 -97.01 37.42 1.31 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.556 -0.715 . . . . 2.8799999999999999 112.266 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -111.96 138.77 48.13 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 107.984 -1.117 . . . . 1.5800000000000001 107.984 178.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.92 -38.84 76.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.476 -0.765 . . . . 3.04 111.454 179.114 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -73.37 -50.12 23.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.65 -1.281 . . . . 0.90000000000000002 110.594 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.59 -43.3 97.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.022 -1.049 . . . . 1.0600000000000001 110.367 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -62.55 -45.11 94.44 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.345 -0.942 . . . . 2.1800000000000002 109.416 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.84 -31.22 69.54 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.489 -0.885 . . . . 2.1499999999999999 109.27 179.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.473 ' O ' HG23 ' A' ' 130' ' ' VAL . 26.6 ttm180 -61.67 -30.17 70.56 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.308 -0.957 . . . . 2.3300000000000001 108.832 179.09 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -61.8 -50.51 72.04 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.157 -0.617 . . . . 0.81999999999999995 110.273 178.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.37 -42.74 78.74 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.843 -0.743 . . . . 0.84999999999999998 110.38 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.69 -36.84 84.22 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.733 -0.605 . . . . 1.3899999999999999 110.567 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 126' ' ' ARG . 43.5 t -68.54 -40.94 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.235 -0.986 . . . . 0.56000000000000005 110.732 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.532 ' HE ' ' NZ ' ' A' ' 135' ' ' LYS . 62.4 ttt180 -59.53 -37.6 78.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.031 -1.043 . . . . 3.1200000000000001 109.704 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.407 ' CG ' ' NH1' ' A' ' 136' ' ' ARG . 49.2 t0 -60.37 -36.63 78.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.692 -0.63 . . . . 1.28 109.907 179.469 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.99 -39.76 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.729 0.776 . . . . 0.48999999999999999 109.842 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.16 -42.64 94.25 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 119.567 -1.301 . . . . 0.46000000000000002 109.973 178.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.532 ' NZ ' ' HE ' ' A' ' 131' ' ' ARG . 40.4 mmtm -59.05 -49.33 78.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.477 -1.014 . . . . 2.71 110.421 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.416 ' HG3' HH11 ' A' ' 136' ' ' ARG . 51.5 mtm-85 -64.96 -40.93 95.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.848 -1.158 . . . . 2.1400000000000001 109.844 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 35.6 tp -61.09 -39.44 89.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.263 -0.898 . . . . 1.05 110.217 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.7 mt -60.24 -38.6 83.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.56 -0.712 . . . . 0.52000000000000002 111.074 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.401 ' HG2' HH11 ' A' ' 139' ' ' ARG . 56.0 mtt-85 -60.13 -37.83 81.23 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.288 -0.883 . . . . 2.3500000000000001 110.734 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -75.47 -40.79 56.95 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.62 -0.832 . . . . 1.3899999999999999 110.581 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -60.37 -39.62 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 0.68000000000000005 110.17 -178.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.2 mt -87.28 -4.33 59.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.955 -1.091 . . . . 0.82999999999999996 111.522 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.47 29.5 65.85 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 119.62 -1.276 . . . . 0.91000000000000003 112.819 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 33.2 tp -75.03 151.09 38.76 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.632 0.729 . . . . 0.94999999999999996 109.136 179.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -64.1 146.65 53.83 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.695 -1.253 . . . . 2.4300000000000002 109.231 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.8 mt -105.27 138.79 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.574 -0.899 . . . . 1.1000000000000001 108.574 178.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.658 HD12 ' H ' ' A' ' 147' ' ' ILE . 2.9 mp -81.0 127.32 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.671 -1.233 . . . . 1.5800000000000001 107.671 178.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -94.7 96.16 9.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.484 -1.672 . . . . 1.6200000000000001 106.484 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.494 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.9 mt -75.76 -15.77 60.22 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.699 0.762 . . . . 0.80000000000000004 111.683 -177.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.411 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 94.7 p -89.92 8.35 32.68 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.613 -1.305 . . . . 1.5600000000000001 112.147 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.29 21.21 12.3 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.672 0.99 . . . . 0.83999999999999997 113.672 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.494 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 3.2 mp -70.51 139.94 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.343 -1.473 . . . . 0.81999999999999995 108.437 179.302 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -114.65 -20.41 10.69 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.471 -0.768 . . . . 2.3100000000000001 112.278 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -114.2 139.19 49.57 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.535 -1.284 . . . . 1.54 107.535 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.81 122.97 20.87 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.426 -0.954 . . . . 1.3799999999999999 108.426 178.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.6 m -144.84 173.87 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 109.071 -0.714 . . . . 0.68999999999999995 109.071 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.9 mt -85.78 142.87 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.065 -1.022 . . . . 0.53000000000000003 109.583 178.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.2 tp -97.19 124.0 41.13 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.124 -0.985 . . . . 0.64000000000000001 108.554 178.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.6 129.51 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.623 -1.251 . . . . 0.67000000000000004 107.623 179.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.21 152.34 18.66 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.94 -1.1 . . . . 0.78000000000000003 109.051 179.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.83 78.22 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.435 -1.416 . . . . 1.0 109.673 178.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 56.1 t0 -171.96 149.79 2.47 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.001 -0.74 . . . . 2.4199999999999999 109.001 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.464 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 36.1 mt -114.39 140.85 48.33 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.537 -0.727 . . . . 0.75 109.397 177.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 81.2 p -90.0 149.02 40.89 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.954 -1.091 . . . . 0.78000000000000003 109.096 178.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.97 -44.53 12.06 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 C-N-CA 122.159 1.906 . . . . 0.67000000000000004 113.51 179.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.8 m -60.85 -46.54 90.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.834 -1.166 . . . . 0.69999999999999996 109.742 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -63.81 -39.76 95.0 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.697 -0.801 . . . . 1.21 110.399 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 64.9 p -69.43 -39.4 77.88 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.63 -0.668 . . . . 0.59999999999999998 110.587 179.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.79 78.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.618 -0.676 . . . . 0.62 110.662 179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -95.58 1.3 53.68 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.202 -0.936 . . . . 1.1599999999999999 112.931 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.4 tp -61.57 151.94 31.82 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.718 -1.238 . . . . 0.72999999999999998 109.548 179.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 150' ' ' SER . 94.3 m-20 -94.65 107.54 19.53 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 106.269 -1.752 . . . . 2.2400000000000002 106.269 178.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.61 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.9 mp -69.36 -25.04 63.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.858 -0.526 . . . . 1.4299999999999999 111.548 -178.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -83.37 -14.25 53.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.251 -0.906 . . . . 2.1499999999999999 112.925 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -102.98 -1.91 28.52 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.274 0.842 . . . . 2.04 113.274 -177.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 178' ' ' GLY . 96.6 t -111.41 130.26 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.249 -1.019 . . . . 0.55000000000000004 108.249 179.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 27.8 tp -84.54 -10.47 57.39 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.124 -0.985 . . . . 1.6299999999999999 111.992 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.569 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.45 167.21 35.92 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 108.995 -1.642 . . . . 0.46999999999999997 108.995 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -121.75 130.15 53.21 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.869 -1.16 . . . . 0.54000000000000004 107.869 178.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 18.8 mt -130.07 130.45 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 107.444 -1.317 . . . . 0.68999999999999995 107.444 178.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.2 p -140.29 172.33 12.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.936 -1.103 . . . . 0.81999999999999995 109.818 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 2.8 m-20 -111.95 42.51 1.74 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.338 0.59 . . . . 2.3700000000000001 110.369 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.55 168.73 9.04 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.783 0.801 . . . . 1.1100000000000001 110.074 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.17 -6.8 48.55 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 120.107 -1.044 . . . . 1.6699999999999999 113.086 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 77.6 -52.43 3.5 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.17 -1.194 . . . . 1.54 113.539 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -58.8 -42.37 88.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.817 -1.402 . . . . 4.4800000000000004 110.986 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 81.8 p -105.38 11.3 32.88 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 120.79 -1.193 . . . . 2.6299999999999999 112.074 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.5 t -92.18 125.53 36.89 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.839 -0.8 . . . . 1.6899999999999999 108.839 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -62.08 -32.47 73.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 1.0700000000000001 110.357 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.6 m -58.66 -38.9 79.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.406 -0.809 . . . . 1.5800000000000001 110.39 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 93.6 p -59.03 -37.76 77.71 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.38 -0.825 . . . . 1.6000000000000001 110.085 179.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.8 HD13 ' NH2' ' A' ' 195' ' ' ARG . 5.3 mm -58.75 -39.71 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.652 -0.819 . . . . 1.45 110.151 179.375 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 51.1 mtp -62.97 -44.52 95.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.088 -1.008 . . . . 1.05 110.146 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.26 -49.82 76.36 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.08 -0.648 . . . . 0.71999999999999997 111.484 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.8 ' NH2' HD13 ' A' ' 192' ' ' ILE . 65.0 mtm-85 -62.96 -42.14 99.73 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.188 -0.945 . . . . 3.0499999999999998 111.199 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.0 m -68.31 -38.75 81.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.173 -0.954 . . . . 0.89000000000000001 109.855 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.62 -6.95 51.4 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.82 0.674 . . . . 0.78000000000000003 112.82 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.6 mt-10 53.52 11.26 0.27 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 113.804 1.039 . . . . 1.45 113.804 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.11 144.71 87.73 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.856 -1.153 . . . . 0.67000000000000004 108.239 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.28 131.2 43.47 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.785 1.657 . . . . 0.64000000000000001 110.636 178.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.6 171.84 16.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.272 -1.371 . . . . 0.67000000000000004 110.118 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.587 HD12 HD11 ' A' ' 220' ' ' LEU . 10.1 mt -147.03 157.04 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.045 -1.094 . . . . 0.68999999999999995 108.045 178.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 181' ' ' THR . 23.8 m -141.59 -29.05 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.644 -1.285 . . . . 0.84999999999999998 112.791 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.72 33.18 1.89 Allowed Glycine 0 C--N 1.289 -2.04 0 O-C-N 120.927 -1.108 . . . . 0.92000000000000004 113.685 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 27.6 p -55.47 -24.79 33.05 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.249 -1.148 . . . . 0.94999999999999996 111.194 -179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.34 -87.86 1.56 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.825 -0.91 . . . . 1.04 110.825 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 45.2 p -129.02 26.83 5.46 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 121.167 -1.196 . . . . 1.5700000000000001 113.069 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 30.4 t -57.0 -39.7 67.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.317 -1.489 . . . . 0.83999999999999997 110.807 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 64.4 p -61.27 -18.95 60.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 0.98999999999999999 111.93 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 67.4 m -98.83 5.44 47.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 1.7 112.002 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -133.62 -4.19 2.93 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.916 -0.49 . . . . 2.2000000000000002 112.146 -178.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.0 t -121.3 152.95 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 121.504 0.668 . . . . 0.83999999999999997 109.41 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -117.81 161.21 20.1 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.751 -0.833 . . . . 2.2000000000000002 108.751 178.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.0 p-10 -61.78 149.87 38.68 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.906 -1.117 . . . . 2.2799999999999998 109.88 177.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.5 t70 82.88 -10.27 1.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.233 1.197 . . . . 2.3500000000000001 114.233 178.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.23 149.44 37.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.534 -1.354 . . . . 1.97 109.276 177.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -87.18 123.88 32.68 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.282 -1.377 . . . . 2.6499999999999999 107.282 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.515 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 74.8 mt -127.51 150.23 49.77 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.017 0.913 . . . . 0.63 110.093 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 88.0 mt -119.05 122.29 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.237 -1.764 . . . . 0.62 106.237 177.114 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.587 HD11 HD12 ' A' ' 202' ' ' ILE . 37.1 tp -98.65 118.01 34.4 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.441 -1.688 . . . . 0.64000000000000001 106.441 178.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 223' ' ' VAL . 87.7 m-20 -94.22 -27.84 15.95 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.502 -1.374 . . . . 2.0499999999999998 112.917 -177.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.912 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.63 15.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.914 0.709 . . . . 0.83999999999999997 112.914 -179.159 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.8 t -108.66 -62.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.196 -0.94 . . . . 1.02 109.217 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -94.34 11.31 30.92 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.009 0.909 . . . . 2.5099999999999998 110.514 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 60.9 54.99 3.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.618 -0.719 . . . . 1.54 112.03 178.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -144.72 146.53 32.24 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.234 1.016 . . . . 1.95 109.586 178.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.84 131.32 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.658 -1.238 . . . . 0.70999999999999996 107.658 177.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -102.05 132.02 48.16 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.846 -1.159 . . . . 1.01 108.483 178.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.28 129.94 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 107.998 -1.112 . . . . 0.81999999999999995 107.998 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.5 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 48.3 t30 59.05 44.01 0.96 Allowed Pre-proline 0 N--CA 1.485 1.309 0 N-CA-C 113.631 0.974 . . . . 1.54 113.631 178.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.1 Cg_endo -64.7 149.35 89.88 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.349 2.033 . . . . 0.93999999999999995 111.56 -179.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 36.9 p -77.03 160.18 29.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.475 -0.766 . . . . 1.8 110.255 178.041 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -60.28 -36.73 78.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.753 -0.592 . . . . 2.73 110.385 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.12 -40.34 85.1 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.447 -0.783 . . . . 3.1699999999999999 110.15 179.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 79.4 t -70.15 -39.87 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.824 0.821 . . . . 1.3400000000000001 110.571 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.3 mt . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.499 -0.751 . . . . 1.2 110.799 -179.894 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.6 mt . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 107.433 -1.321 . . . . 1.0700000000000001 107.433 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.0 m -100.47 127.48 46.8 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.505 -1.294 . . . . 1.24 107.505 178.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -124.5 -163.29 11.64 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.451 -1.86 . . . . 1.01 108.451 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.7 mt -97.91 2.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.984 -1.303 . . . . 1.1100000000000001 112.593 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tp 51.56 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.762 -1.211 . . . . 0.98999999999999999 111.825 178.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -86.07 -38.83 17.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.914 -1.116 . . . . 0.84999999999999998 110.939 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.427 ' O ' ' HB1' ' A' ' 222' ' ' ALA . 2.6 m -148.1 144.36 18.78 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.619 -1.301 . . . . 1.3799999999999999 108.173 -179.376 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.08 145.99 22.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.356 2.037 . . . . 0.93999999999999995 111.904 178.263 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.922 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.93 171.02 19.27 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.23 -1.548 . . . . 0.81000000000000005 109.23 178.047 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.1 mt -128.79 135.56 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.208 -1.172 . . . . 0.82999999999999996 107.919 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.39 152.69 44.55 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.027 -1.046 . . . . 0.53000000000000003 109.996 179.478 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -125.08 140.28 53.03 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.33 -0.989 . . . . 0.77000000000000002 108.33 178.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.54 170.14 37.38 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 118.216 -1.945 . . . . 0.51000000000000001 110.473 178.155 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -78.74 157.14 28.57 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.803 -0.822 . . . . 1.8999999999999999 109.003 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.514 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.89 127.45 35.05 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.257 -1.016 . . . . 0.66000000000000003 108.257 178.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.3 tp -105.07 102.99 12.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.497 -2.038 . . . . 0.82999999999999996 105.497 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.7 tp -90.62 140.82 29.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.936 -1.102 . . . . 0.85999999999999999 108.672 -179.68 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.5 mt -97.0 114.22 25.82 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.697 -1.594 . . . . 0.92000000000000004 106.697 177.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -106.23 130.11 54.16 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.317 -1.364 . . . . 2.0299999999999998 107.317 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -125.31 149.61 47.91 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.476 -0.765 . . . . 2.6600000000000001 109.527 -179.473 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -82.4 133.28 35.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.079 -1.082 . . . . 2.3199999999999998 108.079 177.258 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -65.34 146.67 54.62 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.168 -0.957 . . . . 2.1099999999999999 108.758 178.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.1 mt -93.45 136.18 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.694 -0.854 . . . . 0.72999999999999998 108.694 178.431 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.09 130.27 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.821 -1.177 . . . . 0.87 107.821 179.064 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.7 mt -97.94 135.34 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.181 -1.044 . . . . 0.81000000000000005 108.181 178.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -91.22 122.45 33.87 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.747 -1.205 . . . . 1.3400000000000001 107.747 178.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -95.4 16.96 15.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.201 -0.937 . . . . 2.8900000000000001 112.216 -179.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -73.82 148.57 42.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 2.0899999999999999 109.728 178.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -90.6 135.59 33.61 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.333 -0.988 . . . . 2.1899999999999999 108.333 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 pt -100.48 166.36 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.131 -0.98 . . . . 0.75 109.976 179.5 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.2 p -95.43 168.68 10.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.501 -0.749 . . . . 0.91000000000000003 109.583 178.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.66 -18.61 21.47 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.078 -1.014 . . . . 0.93000000000000005 112.476 179.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -68.06 -37.54 81.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.881 -1.137 . . . . 2.2799999999999998 110.711 -179.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -92.26 -5.35 52.54 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.634 -1.292 . . . . 1.45 113.132 -179.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.28 -43.8 94.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.063 -1.023 . . . . 0.81000000000000005 110.134 -179.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -57.93 -40.76 81.22 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.567 -0.853 . . . . 1.54 110.241 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -63.89 -39.76 94.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.704 -0.623 . . . . 2.3599999999999999 110.714 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.23 -42.58 95.54 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.157 -0.964 . . . . 1.3100000000000001 110.913 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.34 -42.22 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.09 -1.006 . . . . 0.81999999999999995 110.727 -179.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -60.96 -42.27 97.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 1.5 109.919 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -60.75 -42.67 97.88 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.466 -0.894 . . . . 2.23 109.803 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -72.84 -56.7 4.84 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.815 0.817 . . . . 0.84999999999999998 110.231 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 tp -58.47 -47.44 84.03 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.42 -0.912 . . . . 0.91000000000000003 110.252 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.506 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.8 t -68.73 -39.82 80.18 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.121 -0.987 . . . . 0.90000000000000002 110.035 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.44 -45.55 94.26 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.434 -1.365 . . . . 0.68999999999999995 109.783 178.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -58.76 -30.19 67.33 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.516 -0.991 . . . . 2.8799999999999999 110.28 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.67 -42.14 87.78 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.972 0.891 . . . . 0.84999999999999998 109.779 179.024 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -81.19 -40.71 23.48 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.412 -0.805 . . . . 2.3500000000000001 110.73 179.445 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.86 -43.68 90.89 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.747 -0.781 . . . . 0.65000000000000002 109.938 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.8 m -59.32 -39.93 84.67 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.863 0.84 . . . . 1.45 109.381 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.31 -44.36 71.9 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.629 -0.714 . . . . 0.63 110.587 179.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.5 -51.57 59.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.004 . . . . 1.3400000000000001 110.472 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.58 -38.99 86.44 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.371 -0.931 . . . . 1.5600000000000001 109.874 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -59.99 -40.99 91.06 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.456 -0.777 . . . . 1.1899999999999999 110.487 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -65.63 -42.33 91.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.71999999999999997 110.175 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.81 -35.17 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.495 -0.753 . . . . 0.62 110.703 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -52.44 -43.01 64.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.659 -1.275 . . . . 1.05 110.771 179.237 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.13 -37.17 78.18 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.389 -0.819 . . . . 0.64000000000000001 110.151 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -62.05 -39.54 92.7 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.853 -1.139 . . . . 1.73 109.531 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.83 -32.08 72.37 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.598 -0.689 . . . . 0.56000000000000005 110.322 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.41 -36.67 16.44 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.242 -1.456 . . . . 0.68999999999999995 110.478 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.02 -16.43 50.27 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.637 -1.508 . . . . 1.48 111.306 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.2 m -92.94 -51.12 5.22 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.785 -0.572 . . . . 0.97999999999999998 110.768 -179.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -107.82 -19.86 13.39 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.303 -0.873 . . . . 1.1599999999999999 112.799 -177.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.06 160.55 11.1 Favored Glycine 0 N--CA 1.504 3.219 0 O-C-N 120.96 -1.087 . . . . 0.84999999999999998 112.028 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -56.06 -22.77 29.48 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.983 -0.716 . . . . 3.8599999999999999 112.727 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -58.14 -35.47 71.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 2.3500000000000001 111.3 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -81.02 -25.78 36.92 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.721 -1.237 . . . . 1.6699999999999999 112.315 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.09 -32.41 69.79 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.377 -0.827 . . . . 1.45 110.803 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.43 85.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.019 . . . . 0.60999999999999999 111.17 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.58 -42.92 87.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.394 -1.441 . . . . 0.65000000000000002 110.114 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -70.48 -30.69 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.66000000000000003 110.729 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -59.91 -40.26 88.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.128 -0.982 . . . . 1.1899999999999999 110.142 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.33 -39.46 97.01 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.537 -1.316 . . . . 0.53000000000000003 110.47 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -59.1 -41.84 89.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.655 -0.909 . . . . 1.27 111.113 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 77' ' ' ILE . 40.3 mt -60.67 -42.09 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.92 -1.112 . . . . 0.54000000000000004 110.028 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.5 ttm -60.42 -40.25 90.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.511 -0.743 . . . . 1.74 110.067 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 tp -59.77 -49.82 76.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.422 -0.799 . . . . 0.55000000000000004 109.872 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.54 -41.85 95.33 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.055 -0.658 . . . . 0.46999999999999997 110.299 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -85.29 4.96 32.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.5 -0.75 . . . . 1.4199999999999999 112.972 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -61.54 118.17 6.69 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.627 -1.296 . . . . 1.27 109.191 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -63.69 -16.69 61.7 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.03 0.919 . . . . 1.3500000000000001 110.904 -179.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -77.49 -52.24 9.42 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.95 0.881 . . . . 2.2200000000000002 110.248 179.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.71 -37.79 85.47 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.668 -0.813 . . . . 0.62 110.588 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -59.05 -47.99 83.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 1.29 110.781 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -61.61 -38.0 86.02 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.314 -0.866 . . . . 1.52 111.142 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -64.6 -47.7 77.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.236 -0.915 . . . . 1.3 110.324 179.621 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.1 mt -58.3 -45.05 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.444 -0.785 . . . . 0.60999999999999999 109.665 179.181 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.1 mt -60.79 -40.59 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.994 0.902 . . . . 0.78000000000000003 109.862 179.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.67 97.32 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.995 -1.065 . . . . 0.81999999999999995 110.601 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.45 -41.37 97.1 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.426 -0.91 . . . . 0.80000000000000004 110.245 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.26 -47.99 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.054 -1.029 . . . . 0.77000000000000002 110.387 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -77.09 -35.77 56.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.508 -0.745 . . . . 2.1200000000000001 112.121 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -80.7 -44.99 17.85 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.407 -1.433 . . . . 1.51 112.184 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -102.82 12.08 36.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.292 -0.88 . . . . 1.98 112.559 -178.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.9 m80 49.23 49.07 20.25 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.026 -1.07 . . . . 1.3200000000000001 111.56 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.6 mtt -102.57 154.58 18.98 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.146 -0.971 . . . . 1.3799999999999999 109.715 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.8 p -70.63 159.8 33.73 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.377 0.608 . . . . 0.67000000000000004 109.412 177.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.99 83.39 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.383 -0.823 . . . . 0.52000000000000002 111.284 178.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -72.07 -44.44 63.29 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.212 -0.93 . . . . 2.25 110.44 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.11 74.39 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.35 -0.94 . . . . 0.64000000000000001 111.165 -178.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.89 93.17 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.182 -0.948 . . . . 0.56000000000000005 110.945 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.67 86.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 0.46000000000000002 110.683 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -60.63 -37.94 83.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.925 . . . . 1.3200000000000001 110.65 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -57.57 -50.01 74.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.821 -1.175 . . . . 1.3 111.078 179.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.9 -46.88 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.882 -1.136 . . . . 0.60999999999999999 109.97 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.02 -33.4 55.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.66 -0.65 . . . . 0.65000000000000002 110.233 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -58.62 -40.19 82.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.17 -0.956 . . . . 2.1099999999999999 110.922 179.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.41 -35.7 10.4 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.046 -1.55 . . . . 0.82999999999999996 112.3 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -60.49 -41.16 93.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.394 -1.651 . . . . 1.28 109.889 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.37 -49.82 38.37 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.684 0.754 . . . . 0.89000000000000001 110.59 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.9 m -60.64 -39.13 87.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 1.8700000000000001 110.772 -179.432 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.51 -41.9 95.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.423 -0.798 . . . . 1.05 110.847 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.68 -30.35 71.37 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.15 -1.02 . . . . 1.02 110.994 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.0 -20.56 64.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.071 -1.018 . . . . 2.04 111.067 179.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.53 -17.84 61.7 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.784 0.802 . . . . 1.73 111.19 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.556 HD13 HD13 ' A' ' 123' ' ' LEU . 29.7 mt -86.34 148.76 25.45 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.396 -0.815 . . . . 1.3700000000000001 109.285 179.464 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -101.7 41.66 1.19 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.48 -0.763 . . . . 2.8799999999999999 111.007 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -114.06 130.86 56.54 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.273 -1.01 . . . . 1.5800000000000001 108.273 178.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.548 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.6 mp0 -58.71 -33.08 69.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.278 -0.889 . . . . 3.04 110.77 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -71.1 -51.43 25.13 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.689 -1.257 . . . . 0.90000000000000002 110.318 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.556 HD13 HD13 ' A' ' 118' ' ' LEU . 46.2 mt -67.11 -39.25 86.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.426 -0.796 . . . . 1.0600000000000001 110.331 -179.312 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 57.2 tttp -61.99 -49.61 75.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.971 -1.08 . . . . 2.1800000000000002 109.796 179.352 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 187' ' ' THR . 50.5 mt-10 -61.49 -31.66 71.65 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.529 -0.868 . . . . 2.1499999999999999 109.203 179.699 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 130' ' ' VAL . 22.5 ttp180 -64.75 -28.94 69.93 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.251 1.024 . . . . 2.3300000000000001 109.091 179.187 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.11 -47.16 86.27 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.575 -0.85 . . . . 0.81999999999999995 109.54 178.375 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.7 87.59 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.57 -0.852 . . . . 0.84999999999999998 109.612 179.587 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -63.29 -36.32 83.29 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.189 0.519 . . . . 1.3899999999999999 110.546 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 126' ' ' ARG . 50.6 t -67.85 -36.59 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.966 -1.084 . . . . 0.56000000000000005 110.237 179.507 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -59.45 -38.8 81.66 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.869 -1.132 . . . . 3.1200000000000001 109.109 178.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.571 ' CG ' HH21 ' A' ' 136' ' ' ARG . 58.2 t0 -59.61 -40.34 87.2 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.676 -0.693 . . . . 1.28 109.9 179.114 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -60.83 -33.86 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 0.48999999999999999 109.7 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.41 -49.74 14.24 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.098 -1.049 . . . . 0.46000000000000002 111.186 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.474 ' NZ ' ' OD1' ' A' ' 132' ' ' ASP . 5.3 pttm -58.86 -39.46 81.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.998 -1.295 . . . . 2.71 110.649 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.571 HH21 ' CG ' ' A' ' 132' ' ' ASP . 37.0 mtt180 -59.4 -45.22 92.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.947 -1.095 . . . . 2.1400000000000001 109.936 179.03 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.96 -42.57 98.54 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.66 -0.65 . . . . 1.05 110.427 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 23.8 mt -59.9 -43.48 94.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.577 -0.702 . . . . 0.52000000000000002 110.566 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -60.47 -34.55 74.19 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.433 -0.792 . . . . 2.3500000000000001 111.298 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -76.13 -41.13 51.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.92 -1.112 . . . . 1.3899999999999999 110.43 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.26 -39.84 83.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 120.83 -1.169 . . . . 0.68000000000000005 110.887 -178.368 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 76.1 mt -88.53 -10.02 50.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 0.82999999999999996 112.246 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.0 19.96 71.41 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.887 -1.149 . . . . 0.91000000000000003 113.261 -179.298 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.9 tp -64.99 143.82 57.7 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.503 -0.998 . . . . 0.94999999999999996 109.248 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -70.02 151.7 45.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.366 -0.834 . . . . 2.4300000000000002 109.626 178.113 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.3 mt -105.44 140.19 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.218 -1.03 . . . . 1.1000000000000001 108.218 178.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.3 mm -75.74 136.2 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 1.5800000000000001 108.973 178.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.38 92.55 7.22 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.495 -1.669 . . . . 1.6200000000000001 106.495 178.526 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 81.3 mt -78.36 -20.86 50.42 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.357 -0.839 . . . . 0.80000000000000004 111.061 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.6 t -78.86 -6.9 57.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 1.5600000000000001 112.458 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.39 35.94 1.55 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.597 -0.689 . . . . 0.83999999999999997 112.489 -178.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.1 mm -68.9 149.13 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.865 -1.147 . . . . 0.81999999999999995 108.986 178.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -129.37 -9.12 4.68 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.531 -0.73 . . . . 2.3100000000000001 112.613 -179.296 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -120.01 145.75 46.52 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.851 -0.796 . . . . 1.54 108.851 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -80.37 114.73 19.48 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.655 -1.239 . . . . 1.3799999999999999 107.655 177.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -148.2 175.45 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 0.68999999999999995 109.305 -178.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.3 mt -93.83 143.33 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.389 -0.967 . . . . 0.53000000000000003 108.389 178.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.8 tp -96.49 129.81 43.78 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.772 -1.205 . . . . 0.64000000000000001 108.828 178.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.84 130.47 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.813 -1.18 . . . . 0.67000000000000004 107.813 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.06 155.55 23.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.861 -1.149 . . . . 0.78000000000000003 108.868 179.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.01 79.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.492 -1.38 . . . . 1.0 109.712 178.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -174.3 148.46 1.28 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.908 -0.775 . . . . 2.4199999999999999 108.908 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.2 mt -118.15 141.69 48.23 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.585 -0.895 . . . . 0.75 108.585 177.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.2 p -90.93 148.9 39.17 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.992 . . . . 0.78000000000000003 108.671 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -38.81 -41.2 1.64 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.73 1.62 . . . . 0.67000000000000004 113.542 178.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.538 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 25.4 m -62.66 -51.48 67.07 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.878 -1.139 . . . . 0.69999999999999996 110.508 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.2 -39.09 88.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 1.21 109.855 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.7 p -68.48 -39.18 81.46 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.615 -0.678 . . . . 0.59999999999999998 110.419 179.332 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.8 -35.73 80.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.051 -1.03 . . . . 0.62 110.761 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -96.21 -1.0 49.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.02 -1.05 . . . . 1.1599999999999999 112.827 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -60.61 156.41 16.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.929 . . . . 0.72999999999999998 109.863 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -88.97 106.28 18.32 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.788 -1.56 . . . . 2.2400000000000002 106.788 178.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 50.9 mt -80.49 -17.47 51.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.623 -0.673 . . . . 1.4299999999999999 112.133 -177.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -81.13 -23.05 38.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.381 -0.824 . . . . 2.1499999999999999 111.769 -178.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -105.95 -2.87 22.39 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.614 0.968 . . . . 2.04 113.614 -178.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.94 128.4 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 107.74 -1.207 . . . . 0.55000000000000004 107.74 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.4 tp -90.44 -10.4 43.92 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.246 -0.909 . . . . 1.6299999999999999 112.251 -178.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.22 171.02 41.13 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.116 -1.593 . . . . 0.46999999999999997 109.116 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.585 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -130.77 135.75 48.06 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.563 -1.273 . . . . 0.54000000000000004 107.563 179.334 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.564 HG22 HG21 ' A' ' 205' ' ' THR . 97.0 mt -133.11 107.94 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 105.938 -1.875 . . . . 0.68999999999999995 105.938 178.156 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 203' ' ' VAL . 72.2 p -128.82 175.37 8.68 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.676 -1.265 . . . . 0.81999999999999995 110.746 -178.696 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.7 OUTLIER -100.51 53.92 0.88 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.578 -0.737 . . . . 2.3700000000000001 110.071 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.93 156.37 16.65 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.091 -1.006 . . . . 1.1100000000000001 109.773 179.149 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.14 -5.03 57.93 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.769 -1.205 . . . . 1.6699999999999999 112.397 178.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 73.66 -12.37 4.84 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.488 -1.339 . . . . 1.54 115.213 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.406 ' O ' ' OG1' ' A' ' 187' ' ' THR . 79.0 mtm180 -81.8 113.41 19.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.001 -1.481 . . . . 4.4800000000000004 107.001 178.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 22.2 p 48.54 39.96 14.25 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.893 -1.129 . . . . 2.6299999999999999 111.931 -178.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.3 p -82.14 133.67 35.28 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.309 -0.997 . . . . 1.6899999999999999 108.309 177.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -60.15 -40.41 89.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.442 -0.786 . . . . 1.0700000000000001 110.681 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 87.4 m -60.83 -42.04 96.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 1.5800000000000001 110.256 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 98.1 p -61.61 -38.58 88.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.945 -1.097 . . . . 1.6000000000000001 110.411 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.11 -35.32 60.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.431 -0.793 . . . . 1.45 110.833 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.6 mtp -62.64 -42.65 99.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 122.395 1.093 . . . . 1.05 109.202 179.333 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.89 -49.54 77.07 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.552 -0.749 . . . . 0.71999999999999997 110.789 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -60.38 -44.34 95.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 3.0499999999999998 110.697 -179.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.4 m -69.88 -40.08 75.89 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.295 -0.878 . . . . 0.89000000000000001 110.315 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.4 mt -90.83 -4.43 56.61 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.1 0.952 . . . . 0.78000000000000003 112.42 -178.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 194' ' ' ALA . 94.1 mt-10 54.56 7.32 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.4 1.259 . . . . 1.45 114.4 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.9 mt -71.46 147.39 92.58 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.948 -1.095 . . . . 0.67000000000000004 108.092 179.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -58.49 141.66 97.42 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.765 1.643 . . . . 0.64000000000000001 109.714 178.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.74 168.39 26.96 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 117.831 -1.548 . . . . 0.67000000000000004 109.776 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 203' ' ' VAL . 54.8 mt -149.01 159.02 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.519 -1.289 . . . . 0.68999999999999995 107.519 178.052 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.3 m -140.48 -32.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.702 0 O-C-N 120.647 -1.283 . . . . 0.84999999999999998 111.951 -179.756 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.3 37.4 0.81 Allowed Glycine 0 N--CA 1.485 1.934 0 C-N-CA 120.497 -0.859 . . . . 0.92000000000000004 112.865 -178.621 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.564 HG21 HG22 ' A' ' 180' ' ' ILE . 45.6 p -63.94 -20.55 65.94 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.673 -0.898 . . . . 0.94999999999999996 111.499 -179.098 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.68 -92.43 0.61 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 110.045 -1.222 . . . . 1.04 110.045 179.471 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.481 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 70.4 m -128.16 23.93 6.0 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.275 -1.132 . . . . 1.5700000000000001 112.696 -178.825 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 79.5 t -51.52 -34.48 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.541 -1.349 . . . . 0.83999999999999997 110.609 179.085 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.0 p -58.62 -20.91 51.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.58 -0.7 . . . . 0.98999999999999999 111.58 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.9 t -90.59 -3.16 57.76 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.013 -1.054 . . . . 1.7 111.698 -179.037 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.481 ' OE1' ' O ' ' A' ' 207' ' ' SER . 24.6 mp0 -122.83 -4.42 8.62 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.502 0.668 . . . . 2.2000000000000002 112.522 -177.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 44.6 t -112.85 148.0 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.533 -0.729 . . . . 0.83999999999999997 109.415 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -121.3 157.08 31.14 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.071 -1.085 . . . . 2.2000000000000002 108.071 178.055 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 19.1 p30 -56.76 140.92 46.06 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.671 -1.268 . . . . 2.2799999999999998 110.43 178.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 m-20 81.57 7.02 1.13 Allowed 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 114.465 1.283 . . . . 2.3500000000000001 114.465 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -67.48 151.75 46.84 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.424 -1.423 . . . . 1.97 109.945 177.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -90.51 115.11 27.4 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.691 -1.596 . . . . 2.6499999999999999 106.691 177.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.514 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 86.8 mt -127.71 141.94 51.46 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.236 -0.915 . . . . 0.63 109.56 -178.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 50.8 mt -113.54 127.72 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 106.607 -1.627 . . . . 0.62 106.607 177.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.6 tp -102.17 118.47 36.97 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.193 -1.78 . . . . 0.64000000000000001 106.193 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 223' ' ' VAL . 44.8 p-10 -93.14 -21.04 19.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.042 -1.036 . . . . 2.0499999999999998 112.297 -178.184 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.922 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.47 17.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.031 0.752 . . . . 0.83999999999999997 113.031 -179.177 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.5 t -112.77 -62.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 121.807 0.813 . . . . 1.02 109.135 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -90.3 9.62 28.07 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.294 1.045 . . . . 2.5099999999999998 110.303 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 41.9 t30 60.82 52.37 4.31 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.91 -0.586 . . . . 1.54 111.462 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -150.87 147.89 27.79 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.222 1.011 . . . . 1.95 110.055 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 50.3 t -115.02 138.78 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 107.494 -1.299 . . . . 0.70999999999999996 107.494 176.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -104.53 137.73 41.94 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.096 -1.002 . . . . 1.01 108.602 178.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.3 t -109.3 129.4 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 107.638 -1.245 . . . . 0.81999999999999995 107.638 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.432 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 48.5 t-20 48.15 49.87 8.05 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 113.507 0.929 . . . . 1.54 113.507 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 22.3 Cg_endo -62.53 154.21 66.18 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.141 1.894 . . . . 0.93999999999999995 110.394 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.6 m -72.77 158.72 35.04 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.987 -1.07 . . . . 1.8 109.272 177.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 22.0 p30 -58.59 -38.0 77.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.849 -1.157 . . . . 2.73 110.483 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.51 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 82.1 tt0 -60.93 -39.45 89.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.005 -1.059 . . . . 3.1699999999999999 110.013 179.355 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.08 -36.84 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 1.3400000000000001 110.319 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 80.8 mt . . . . . 0 C--N 1.302 -1.475 0 O-C-N 121.397 -0.814 . . . . 1.2 110.252 178.962 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.0 mt . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 107.41 -1.33 . . . . 1.0700000000000001 107.41 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.4 m -104.8 127.45 52.6 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.791 -1.189 . . . . 1.24 107.791 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.403 ' N ' HD21 ' A' ' 225' ' ' ASN . . . -97.88 -147.79 22.86 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.246 -1.142 . . . . 1.01 110.246 179.42 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 5' ' ' ILE . 80.5 mt -97.6 1.31 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.546 -0.973 . . . . 1.1100000000000001 112.571 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' ILE . 8.6 tp 50.42 100.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.737 -1.227 . . . . 0.98999999999999999 112.063 178.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.7 -41.4 11.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.924 -1.11 . . . . 0.84999999999999998 111.791 179.211 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t -146.19 140.98 15.97 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 107.78 -1.193 . . . . 1.3799999999999999 107.78 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.77 149.73 38.27 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.585 2.19 . . . . 0.93999999999999995 112.555 178.607 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.88 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 149.66 161.65 9.94 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.367 -1.493 . . . . 0.81000000000000005 109.367 178.306 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.3 mt -119.95 132.82 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.132 -1.217 . . . . 0.82999999999999996 107.893 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.16 151.07 47.38 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.216 -0.928 . . . . 0.53000000000000003 109.03 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -123.16 141.54 51.86 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.577 -0.898 . . . . 0.77000000000000002 108.577 178.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.94 166.2 32.98 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.046 -1.55 . . . . 0.51000000000000001 109.798 177.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -76.3 158.2 31.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.816 -0.814 . . . . 1.8999999999999999 109.133 178.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.54 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -82.3 123.49 29.11 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.607 -1.257 . . . . 0.66000000000000003 107.607 178.418 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.2 tp -102.9 99.64 9.57 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.228 -1.768 . . . . 0.82999999999999996 106.228 178.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 tp -87.52 140.92 29.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 0.85999999999999999 108.962 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.7 mt -96.51 115.66 27.8 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.653 -1.61 . . . . 0.92000000000000004 106.653 177.497 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -108.84 130.62 55.41 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.816 -1.179 . . . . 2.0299999999999998 107.816 -179.46 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.425 ' OE1' HD13 ' A' ' 147' ' ' ILE . 72.1 mm-40 -128.4 146.83 50.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 2.6600000000000001 109.054 179.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -80.41 138.89 36.69 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.933 -1.105 . . . . 2.3199999999999998 108.041 177.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -63.48 140.33 58.86 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.612 -0.884 . . . . 2.1099999999999999 108.612 178.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -89.7 130.16 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.086 -1.079 . . . . 0.72999999999999998 108.086 178.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.6 129.95 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.752 -1.203 . . . . 0.87 107.752 178.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.2 mt -91.25 138.99 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.387 -0.968 . . . . 0.81000000000000005 108.387 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -88.23 120.73 29.86 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.91 -1.515 . . . . 1.3400000000000001 106.91 178.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -93.57 10.27 33.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.522 -0.736 . . . . 2.8900000000000001 112.868 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -73.12 143.96 47.14 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.881 -1.137 . . . . 2.0899999999999999 110.039 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -89.77 132.16 35.36 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.185 -1.043 . . . . 2.1899999999999999 108.185 177.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -93.27 165.01 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.333 -0.854 . . . . 0.75 110.477 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.9 p -93.21 165.12 12.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.772 -0.58 . . . . 0.91000000000000003 109.713 178.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.95 -22.45 15.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.302 -0.874 . . . . 0.93000000000000005 112.18 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.95 -37.73 81.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.867 -1.146 . . . . 2.2799999999999998 110.914 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -91.54 -7.26 50.81 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.44 -1.412 . . . . 1.45 112.782 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.3 -41.21 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.218 -0.926 . . . . 0.81000000000000005 110.56 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -56.42 -39.99 73.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.027 . . . . 1.54 110.602 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -63.47 -41.95 98.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 2.3599999999999999 111.079 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.96 -41.58 98.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.081 -1.012 . . . . 1.3100000000000001 110.843 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.6 t -60.66 -40.06 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.611 -0.836 . . . . 0.81999999999999995 110.217 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -60.85 -43.62 98.08 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.736 -0.786 . . . . 1.5 109.677 179.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -62.1 -40.05 94.55 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.909 -0.716 . . . . 2.23 110.325 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -73.16 -54.22 9.02 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.149 -0.969 . . . . 0.84999999999999998 110.017 179.116 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -60.52 -49.06 79.04 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.002 -1.062 . . . . 0.91000000000000003 110.306 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.6 t -68.85 -36.92 78.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.361 -0.837 . . . . 0.90000000000000002 110.02 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.01 -46.3 84.87 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.499 -1.334 . . . . 0.68999999999999995 109.862 178.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -57.92 -31.72 67.07 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.246 -1.149 . . . . 2.8799999999999999 109.655 178.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.31 -51.1 71.2 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.204 -0.998 . . . . 0.84999999999999998 110.965 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 42.7 pttt -81.9 -42.1 19.99 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.175 -0.953 . . . . 2.3500000000000001 110.966 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.409 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -60.22 -41.82 93.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.8 . . . . 0.65000000000000002 110.383 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.1 p -59.46 -41.15 89.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.218 -1.03 . . . . 1.45 108.218 179.181 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.51 -48.65 59.85 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.559 -0.746 . . . . 0.63 109.782 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -62.13 -48.72 78.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.442 -1.411 . . . . 1.3400000000000001 110.077 -178.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.71 -38.9 89.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 1.5600000000000001 109.81 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -59.62 -40.17 86.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.724 -0.61 . . . . 1.1899999999999999 110.471 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.519 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 11.2 m -63.65 -39.81 95.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.926 -1.109 . . . . 0.71999999999999997 110.148 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.71 -40.17 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.468 -0.77 . . . . 0.62 110.573 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -51.75 -40.65 60.64 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.424 -0.798 . . . . 1.05 110.482 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.8 -37.08 73.26 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.11 -0.994 . . . . 0.64000000000000001 110.348 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.519 ' NZ ' HG22 ' A' ' 56' ' ' THR . 52.4 mttp -63.34 -38.82 92.65 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.669 -1.212 . . . . 1.73 109.025 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.8 -30.14 68.65 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.907 -0.588 . . . . 0.56000000000000005 110.337 179.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.11 -38.88 8.84 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 119.893 -1.146 . . . . 0.68999999999999995 111.214 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -81.03 -22.69 39.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.856 -1.379 . . . . 1.48 111.282 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.7 m -87.31 -51.56 5.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.656 -0.652 . . . . 0.97999999999999998 110.687 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -107.21 -7.28 16.84 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.07 1.137 . . . . 1.1599999999999999 114.07 -177.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.45 157.95 17.73 Favored Glycine 0 N--CA 1.5 2.909 0 O-C-N 121.599 -0.688 . . . . 0.84999999999999998 113.22 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -53.32 -19.06 2.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.592 -0.946 . . . . 3.8599999999999999 113.341 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -57.41 -33.92 68.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.714 -1.241 . . . . 2.3500000000000001 110.996 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -80.13 -23.53 41.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.959 -1.088 . . . . 1.6699999999999999 111.468 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.87 -38.32 81.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.093 -1.004 . . . . 1.45 111.007 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.22 -40.09 84.76 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.954 -1.091 . . . . 0.60999999999999999 110.999 179.355 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.7 mt -69.3 -47.99 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.665 -1.272 . . . . 0.65000000000000002 110.13 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -70.52 -29.94 66.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.864 . . . . 0.66000000000000003 110.62 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.79 -38.63 85.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.275 -0.891 . . . . 1.1899999999999999 110.403 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.3 -37.25 59.27 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 110.074 -1.211 . . . . 0.53000000000000003 110.074 179.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -59.81 -44.21 94.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.279 -1.13 . . . . 1.27 110.087 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.12 -39.37 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.54000000000000004 110.045 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.5 ttm -59.88 -39.5 85.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.5 -0.75 . . . . 1.74 110.552 179.46 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.6 tp -58.36 -48.15 81.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.853 . . . . 0.55000000000000004 110.204 179.028 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.01 -40.29 88.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.602 0.715 . . . . 0.46999999999999997 110.262 -179.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -86.04 5.14 34.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.791 . . . . 1.4199999999999999 112.75 -179.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -61.79 119.18 8.26 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.846 -1.159 . . . . 1.27 108.928 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.85 -17.49 64.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.462 -0.774 . . . . 1.3500000000000001 110.84 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.83 -47.8 28.54 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.023 -1.071 . . . . 2.2200000000000002 109.889 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.66 -36.44 82.86 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.301 -0.96 . . . . 0.62 110.011 -178.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.77 -48.36 79.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.404 -0.81 . . . . 1.29 110.495 179.05 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.52 -39.49 87.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 1.52 110.492 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.25 -49.88 62.69 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.091 -1.005 . . . . 1.3 110.488 179.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.5 mt -56.83 -43.58 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.935 -1.103 . . . . 0.60999999999999999 110.234 179.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.9 -43.2 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.567 -0.708 . . . . 0.78000000000000003 110.116 179.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.81 91.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.409 -0.807 . . . . 0.81999999999999995 110.574 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.08 -43.6 95.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.113 -0.992 . . . . 0.80000000000000004 110.254 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.1 mt -65.61 -48.45 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.094 -1.004 . . . . 0.77000000000000002 110.179 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -78.72 -36.2 43.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.266 -0.896 . . . . 2.1200000000000001 112.197 -179.414 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -81.74 -40.02 23.33 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.438 -1.414 . . . . 1.51 111.76 -179.405 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -108.59 10.61 27.05 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.211 -0.931 . . . . 1.98 111.965 -178.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.0 m80 49.46 50.52 18.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.982 -1.074 . . . . 1.3200000000000001 111.612 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -104.23 152.89 21.64 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.14 0.971 . . . . 1.3799999999999999 109.791 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.439 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 23.2 p -72.8 160.8 31.59 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.57 -0.706 . . . . 0.67000000000000004 109.535 178.009 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.45 -40.09 81.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -0.926 . . . . 0.52000000000000002 110.914 178.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 26.2 p-10 -69.86 -42.1 73.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.051 -1.031 . . . . 2.25 110.519 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.35 61.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.348 -0.845 . . . . 0.64000000000000001 110.882 -179.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.84 93.64 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.265 -0.897 . . . . 0.56000000000000005 110.696 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.66 -43.75 93.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 0.46000000000000002 110.943 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -60.19 -40.01 88.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.865 -1.147 . . . . 1.3200000000000001 111.036 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.73 -48.86 76.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.671 -1.268 . . . . 1.3 110.617 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 83.4 t -62.86 -49.22 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.71 -1.243 . . . . 0.60999999999999999 110.29 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 mm -61.54 -30.23 47.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.193 0.521 . . . . 0.65000000000000002 110.538 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -59.87 -40.12 87.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 2.1099999999999999 110.922 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.95 -31.45 17.6 Favored Glycine 0 N--CA 1.502 3.066 0 C-N-CA 118.668 -1.729 . . . . 0.82999999999999996 112.925 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -61.49 -40.99 96.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.521 -1.576 . . . . 1.28 110.063 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.22 -48.78 40.3 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.62 -0.675 . . . . 0.89000000000000001 110.4 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.0 m -61.4 -40.79 95.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 1.8700000000000001 110.477 -178.185 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.75 97.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.422 -0.799 . . . . 1.05 110.679 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.2 mt -64.57 -30.86 71.89 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.054 -1.029 . . . . 1.02 110.817 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -66.86 -21.11 66.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.945 -1.097 . . . . 2.04 111.158 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -75.0 -12.81 60.42 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.313 -0.867 . . . . 1.73 111.532 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 123' ' ' LEU . 5.3 mt -85.55 144.67 27.77 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.484 -0.76 . . . . 1.3700000000000001 109.292 179.196 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -100.45 53.03 0.88 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.185 -0.947 . . . . 2.8799999999999999 110.581 -179.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -129.46 138.28 51.33 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.211 -1.033 . . . . 1.5800000000000001 108.211 179.171 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -58.39 -39.8 80.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.544 -0.722 . . . . 3.04 110.999 179.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -71.43 -53.61 13.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.002 -1.061 . . . . 0.90000000000000002 110.332 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 118' ' ' LEU . 24.5 mt -61.4 -41.09 96.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.339 -0.851 . . . . 1.0600000000000001 110.506 -179.465 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -62.22 -50.16 72.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.954 -1.091 . . . . 2.1800000000000002 109.983 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.02 -31.68 70.18 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.309 -0.869 . . . . 2.1499999999999999 109.644 179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 130' ' ' VAL . 55.7 ttt180 -61.26 -30.43 70.46 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.086 -1.045 . . . . 2.3300000000000001 108.782 179.241 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.46 -49.58 77.01 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.921 0.867 . . . . 0.81999999999999995 109.398 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.86 81.7 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.895 -0.722 . . . . 0.84999999999999998 110.104 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -64.18 -36.69 84.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.347 -0.846 . . . . 1.3899999999999999 110.52 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 126' ' ' ARG . 38.9 t -67.12 -39.16 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.439 -0.788 . . . . 0.56000000000000005 109.983 179.793 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -60.4 -38.06 82.78 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.879 0.847 . . . . 3.1200000000000001 110.009 179.066 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.12 -38.33 82.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.766 -0.584 . . . . 1.28 110.481 179.325 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.7 mt -61.54 -40.17 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.472 -0.767 . . . . 0.48999999999999999 110.24 179.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.27 -42.44 35.15 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 120.078 -1.058 . . . . 0.46000000000000002 110.993 -179.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -58.77 -48.12 82.34 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.072 -1.251 . . . . 2.71 110.484 179.346 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -64.89 -41.25 95.78 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.511 -0.876 . . . . 2.1400000000000001 109.972 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.05 -39.58 86.45 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.314 -0.866 . . . . 1.05 110.033 179.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.14 -41.93 93.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.882 . . . . 0.52000000000000002 110.902 179.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -60.44 -33.08 72.02 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.121 -0.987 . . . . 2.3500000000000001 110.678 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -77.64 -42.5 34.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 1.3899999999999999 110.846 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.4 mt -60.99 -38.33 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.231 -0.918 . . . . 0.68000000000000005 110.344 -178.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.7 mt -86.27 -7.43 58.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.31 -0.869 . . . . 0.82999999999999996 112.276 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.71 19.91 69.69 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.645 -1.264 . . . . 0.91000000000000003 112.844 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.5 tp -67.22 145.19 55.46 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.815 -0.815 . . . . 0.94999999999999996 109.163 179.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -67.79 149.74 49.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 2.4300000000000002 108.845 178.169 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.0 mt -109.49 137.38 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.369 -0.974 . . . . 1.1000000000000001 108.369 178.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.67 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.8 mp -80.11 128.59 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.654 -1.239 . . . . 1.5800000000000001 107.654 178.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -94.78 96.08 9.13 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.85 -1.537 . . . . 1.6200000000000001 106.85 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.41 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 53.1 mt -70.72 -25.23 62.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.337 -0.852 . . . . 0.80000000000000004 111.12 -178.33 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 p -80.57 0.25 34.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 1.5600000000000001 111.861 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.14 23.87 9.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.455 -0.778 . . . . 0.83999999999999997 111.852 -179.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.41 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 14.2 mt -72.04 146.33 11.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.234 -0.916 . . . . 0.81999999999999995 109.457 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -119.41 -14.77 9.15 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.757 0.789 . . . . 2.3100000000000001 112.756 -178.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -115.06 140.51 49.0 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.682 -0.858 . . . . 1.54 108.682 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -77.41 123.52 26.64 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.384 -0.969 . . . . 1.3799999999999999 108.384 178.005 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.3 m -148.56 175.28 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.608 -0.682 . . . . 0.68999999999999995 109.266 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.8 mt -88.23 145.05 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.641 -0.874 . . . . 0.53000000000000003 108.641 178.132 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.1 tp -97.08 126.49 42.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.12 -0.987 . . . . 0.64000000000000001 108.507 178.355 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.0 t -122.58 128.98 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.573 -1.269 . . . . 0.67000000000000004 107.573 178.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.39 153.18 21.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.932 . . . . 0.78000000000000003 108.847 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.66 84.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.701 -1.249 . . . . 1.0 109.65 178.131 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 10.4 t0 -172.37 154.66 3.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.481 -0.933 . . . . 2.4199999999999999 108.481 179.638 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.501 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 61.6 mt -117.75 139.32 51.21 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.222 -0.924 . . . . 0.75 108.759 177.629 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.2 p -91.2 153.03 44.56 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 107.879 -1.156 . . . . 0.78000000000000003 107.879 178.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -41.81 -44.82 6.82 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.559 1.506 . . . . 0.67000000000000004 113.375 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 23.9 m -60.26 -48.79 80.23 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.044 -1.035 . . . . 0.69999999999999996 110.252 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.22 -40.83 98.57 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.204 -0.935 . . . . 1.21 110.177 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 79.5 p -68.33 -38.45 81.53 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.416 -0.802 . . . . 0.59999999999999998 110.254 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.58 74.52 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.578 -0.701 . . . . 0.62 110.609 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -93.86 -5.87 47.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.166 -0.959 . . . . 1.1599999999999999 112.734 -179.316 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.73 146.89 51.28 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.959 -1.126 . . . . 0.72999999999999998 107.959 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.445 ' O ' HG23 ' A' ' 176' ' ' VAL . 55.4 t-20 -97.34 119.73 36.39 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.31 -1.367 . . . . 2.2400000000000002 107.31 178.075 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.692 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.2 mm? -76.25 -18.24 59.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.77 -0.581 . . . . 1.4299999999999999 111.526 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -80.99 -25.77 37.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.276 -0.89 . . . . 2.1499999999999999 111.863 -178.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -101.05 -1.69 33.53 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.112 0.782 . . . . 2.04 113.112 -178.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 178' ' ' GLY . 58.1 t -107.01 126.44 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 107.556 -1.276 . . . . 0.55000000000000004 107.556 178.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.8 tp -91.27 -2.01 57.53 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.052 -1.03 . . . . 1.6299999999999999 112.862 -178.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.447 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.94 169.83 34.42 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.797 -1.721 . . . . 0.46999999999999997 108.797 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -127.2 135.43 50.63 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.812 -1.181 . . . . 0.54000000000000004 107.812 179.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 76.1 mt -137.67 106.04 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 105.965 -1.865 . . . . 0.68999999999999995 105.965 178.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 203' ' ' VAL . 68.0 p -131.2 176.98 7.82 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.785 -1.197 . . . . 0.81999999999999995 110.204 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.552 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.3 OUTLIER -99.29 51.71 0.95 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.736 -0.603 . . . . 2.3700000000000001 110.843 179.28 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -100.66 145.32 28.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.303 -0.873 . . . . 1.1100000000000001 108.829 179.642 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -60.05 -32.55 76.06 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 120.15 -1.024 . . . . 1.6699999999999999 110.897 179.186 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 91.69 -4.37 79.12 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 120.898 -1.354 . . . . 1.54 113.328 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.419 ' O ' ' OG1' ' A' ' 187' ' ' THR . 80.1 mtm180 -90.36 115.65 27.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.243 -1.762 . . . . 4.4800000000000004 106.243 177.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 13.6 p 48.98 31.93 3.57 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.36 -0.837 . . . . 2.6299999999999999 112.226 -178.667 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.4 t -85.47 142.03 29.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.97 -1.081 . . . . 1.6899999999999999 109.837 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -58.74 -38.93 79.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 1.0700000000000001 111.135 178.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.3 m -60.38 -39.61 87.9 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.215 -0.928 . . . . 1.5800000000000001 110.085 179.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 70.8 m -60.34 -39.36 86.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 1.6000000000000001 110.554 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.407 HG12 HH21 ' A' ' 195' ' ' ARG . 96.7 mt -60.8 -39.99 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 1.45 110.959 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.9 mtp -63.76 -44.31 93.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.895 -1.128 . . . . 1.05 109.671 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.12 -49.57 77.11 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.77 -0.65 . . . . 0.71999999999999997 111.004 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.407 HH21 HG12 ' A' ' 192' ' ' ILE . 81.9 mtm180 -61.73 -41.1 97.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.985 . . . . 3.0499999999999998 110.946 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 56.0 m -69.36 -39.94 77.79 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.923 -1.111 . . . . 0.89000000000000001 110.561 -179.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.3 mt -89.28 -7.83 54.63 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.819 0.818 . . . . 0.78000000000000003 112.101 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 194' ' ' ALA . 45.2 mt-10 49.03 15.5 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.876 1.065 . . . . 1.45 113.876 -179.8 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.8 mt -74.75 150.58 86.46 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.022 -1.048 . . . . 0.67000000000000004 108.607 178.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.36 139.05 88.94 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.309 1.339 . . . . 0.64000000000000001 109.833 178.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.92 166.65 25.88 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 117.737 -1.585 . . . . 0.67000000000000004 109.431 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.5 mt -145.68 147.06 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.681 -1.229 . . . . 0.68999999999999995 107.681 177.216 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.435 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.8 m -126.99 -34.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 113.302 0.853 . . . . 0.84999999999999998 113.302 -179.009 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.17 40.83 1.73 Allowed Glycine 0 N--CA 1.489 2.18 0 C-N-CA 120.196 -1.002 . . . . 0.92000000000000004 111.913 -177.983 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.447 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 58.6 p -60.82 -18.75 57.45 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.273 -1.134 . . . . 0.94999999999999996 111.371 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.43 -95.82 0.99 Allowed Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.83 -1.176 . . . . 1.04 110.503 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 60.7 m -127.72 31.51 5.13 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.634 -0.921 . . . . 1.5700000000000001 112.215 -179.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.87 -35.33 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.393 -1.442 . . . . 0.83999999999999997 110.532 179.096 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 46.4 p -61.46 -20.06 62.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.195 -0.94 . . . . 0.98999999999999999 111.452 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.9 t -93.93 -1.03 55.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -0.951 . . . . 1.7 112.099 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -128.22 -1.66 5.72 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 112.797 0.665 . . . . 2.2000000000000002 112.797 -177.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.04 148.39 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.226 -0.657 . . . . 0.83999999999999997 109.226 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -119.85 157.18 29.22 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.851 -1.166 . . . . 2.2000000000000002 107.851 178.062 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.42 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 38.6 p30 -54.12 142.82 24.27 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.049 -1.032 . . . . 2.2799999999999998 110.813 178.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.7 OUTLIER 80.18 1.3 2.01 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 114.905 1.446 . . . . 2.3500000000000001 114.905 179.183 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -63.46 146.41 53.66 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.765 -1.209 . . . . 1.97 108.371 177.512 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -88.29 118.69 28.07 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.835 -1.542 . . . . 2.6499999999999999 106.835 177.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 87.3 mt -127.93 142.02 51.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.585 -0.697 . . . . 0.63 109.57 -178.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.6 mt -111.16 129.32 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.528 -1.656 . . . . 0.62 106.528 177.529 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 20.4 tp -99.1 119.05 37.19 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.384 -1.71 . . . . 0.64000000000000001 106.384 178.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.0 t0 -94.93 -29.28 14.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.818 -1.176 . . . . 2.0499999999999998 112.506 -177.631 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.88 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 36.79 20.79 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.773 0.657 . . . . 0.83999999999999997 112.773 -178.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.7 t -109.25 -55.95 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.125 -0.985 . . . . 1.02 109.075 178.335 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.46 14.8 30.02 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.625 -0.716 . . . . 2.5099999999999998 110.293 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.403 HD21 ' N ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER 59.51 55.38 4.14 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.397 0.617 . . . . 1.54 111.21 179.67 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -151.49 148.48 28.11 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.254 1.026 . . . . 1.95 109.91 179.596 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 20.0 t -116.09 139.61 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.235 -1.024 . . . . 0.70999999999999996 108.235 177.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -102.01 135.6 43.29 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.057 -1.027 . . . . 1.01 108.739 178.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.0 t -112.83 130.24 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-O 121.779 0.8 . . . . 0.81999999999999995 109.127 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.439 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 13.6 t-20 52.06 48.95 6.14 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 113.577 0.955 . . . . 1.54 113.577 178.092 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.3 Cg_endo -64.5 150.05 88.9 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.585 2.19 . . . . 0.93999999999999995 110.724 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.1 m -74.77 154.16 38.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.265 -0.897 . . . . 1.8 108.947 177.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.55 ' HA ' HD12 ' A' ' 236' ' ' ILE . 16.0 t-20 -52.99 -41.11 64.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 2.73 110.708 178.716 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -59.2 -40.29 85.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 3.1699999999999999 109.812 179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.04 -38.91 76.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.647 -0.658 . . . . 1.3400000000000001 110.166 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 233' ' ' ASN . 96.8 mt . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.448 -0.782 . . . . 1.2 110.785 179.198 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 106.856 -1.535 . . . . 1.0700000000000001 106.856 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -105.31 122.56 46.21 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.391 -1.336 . . . . 1.24 107.391 -179.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.95 -150.65 27.15 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.784 -1.326 . . . . 1.01 109.784 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.591 HG22 ' O ' ' A' ' 5' ' ' ILE . 95.4 mt -95.22 1.05 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.408 -1.054 . . . . 1.1100000000000001 112.942 -179.635 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 tp 49.64 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.801 -1.187 . . . . 0.98999999999999999 112.867 178.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.83 -37.23 14.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.956 -1.09 . . . . 0.84999999999999998 111.431 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 t -146.34 137.02 12.4 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 107.965 -1.124 . . . . 1.3799999999999999 107.965 -178.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.27 152.56 35.14 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.934 1.756 . . . . 0.93999999999999995 112.122 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.719 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 147.13 135.41 2.68 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.768 -0.933 . . . . 0.81000000000000005 110.768 177.683 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -96.15 132.48 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.549 -1.559 . . . . 0.82999999999999996 108.941 178.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.3 148.95 45.2 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.895 -0.78 . . . . 0.53000000000000003 108.895 179.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 3.2 m-85 -121.22 142.75 49.62 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.301 -0.875 . . . . 0.77000000000000002 109.018 178.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.84 168.38 37.32 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.575 -1.774 . . . . 0.51000000000000001 109.721 177.797 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -78.08 158.68 29.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.763 -0.845 . . . . 1.8999999999999999 108.799 178.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -82.59 123.78 29.54 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.898 -1.149 . . . . 0.66000000000000003 107.898 178.407 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 tp -102.47 98.86 8.88 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.22 -1.77 . . . . 0.82999999999999996 106.22 178.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.1 tp -86.99 141.1 28.92 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.681 -0.859 . . . . 0.85999999999999999 108.681 -179.666 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 mt -99.72 107.11 19.11 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.27 -1.381 . . . . 0.92000000000000004 107.27 178.158 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -110.81 134.23 52.68 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.673 -1.232 . . . . 2.0299999999999998 107.673 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -131.11 155.12 47.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.211 -0.931 . . . . 2.6600000000000001 109.163 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -82.11 137.16 35.07 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.907 -1.146 . . . . 2.3199999999999998 107.907 177.338 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -65.7 148.36 51.89 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.346 -0.847 . . . . 2.1099999999999999 108.881 178.553 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.6 mt -99.85 134.61 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.359 -0.838 . . . . 0.72999999999999998 108.799 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.89 130.01 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.571 -1.27 . . . . 0.87 107.571 178.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.6 mt -95.83 135.8 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.297 -0.877 . . . . 0.81000000000000005 108.976 179.257 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -94.45 126.65 39.86 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.265 -1.013 . . . . 1.3400000000000001 108.265 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.513 ' HG2' HH11 ' A' ' 28' ' ' ARG . 4.4 mmt-85 -97.7 15.08 24.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.343 -0.848 . . . . 2.8900000000000001 112.481 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -63.34 142.32 58.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.004 -1.06 . . . . 2.0899999999999999 109.117 178.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -88.02 130.82 34.86 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.136 -1.061 . . . . 2.1899999999999999 108.136 177.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -89.37 170.19 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.178 -0.951 . . . . 0.75 110.09 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.3 p -94.64 163.44 13.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.577 -0.702 . . . . 0.91000000000000003 109.645 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.75 -19.94 4.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 0.93000000000000005 112.67 179.249 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -68.71 -43.16 76.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.832 -1.167 . . . . 2.2799999999999998 111.229 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -87.42 -5.79 58.7 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.711 -1.243 . . . . 1.45 112.674 -179.098 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.05 -46.52 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 0.81000000000000005 110.891 -178.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -56.49 -40.02 74.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.954 . . . . 1.54 110.316 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.61 -39.6 91.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.535 -0.728 . . . . 2.3599999999999999 110.824 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -60.0 -40.63 89.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.026 -1.046 . . . . 1.3100000000000001 110.747 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.83 -39.69 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.81999999999999995 110.38 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -62.87 -48.12 80.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.364 -0.835 . . . . 1.5 110.794 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -62.87 -40.93 99.01 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.917 -1.113 . . . . 2.23 110.256 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -71.13 -52.86 16.85 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.204 -0.935 . . . . 0.84999999999999998 110.191 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.2 tp -62.3 -47.47 84.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.037 -1.04 . . . . 0.91000000000000003 109.816 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.522 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.5 t -70.23 -42.46 72.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.472 -0.768 . . . . 0.90000000000000002 109.697 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.58 -38.08 85.86 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.148 -1.501 . . . . 0.68999999999999995 109.414 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 20.5 ttm180 -59.32 -32.02 69.69 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.958 0.885 . . . . 2.8799999999999999 109.095 178.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.04 -44.19 91.74 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.787 0.803 . . . . 0.84999999999999998 109.636 178.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -79.63 -40.17 29.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.115 -0.991 . . . . 2.3500000000000001 110.332 179.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.28 -44.9 92.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.468 -0.77 . . . . 0.65000000000000002 110.132 -178.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.5 p -60.45 -38.63 84.76 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.124 0.964 . . . . 1.45 109.313 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.57 99.38 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.126 -0.63 . . . . 0.63 110.661 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -62.0 -50.14 73.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.569 -1.332 . . . . 1.3400000000000001 110.479 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 54' ' ' LEU . 3.2 mm? -67.63 -40.64 84.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.329 -0.857 . . . . 1.5600000000000001 110.399 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -59.21 -40.78 86.86 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.389 -0.819 . . . . 1.1899999999999999 110.467 179.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -67.21 -46.93 72.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.084 -1.01 . . . . 0.71999999999999997 110.671 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.11 -38.16 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.417 -0.802 . . . . 0.62 110.524 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -49.93 -44.72 50.55 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.367 -0.833 . . . . 1.05 111.322 179.183 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -68.16 -40.48 82.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.195 -0.941 . . . . 0.64000000000000001 109.946 -179.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -61.87 -37.98 86.6 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.883 -1.127 . . . . 1.73 109.334 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -33.77 76.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.448 0.642 . . . . 0.56000000000000005 110.2 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.61 -37.13 12.35 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.771 -1.204 . . . . 0.68999999999999995 111.255 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.67 -24.41 38.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.07 -1.253 . . . . 1.48 110.755 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.4 m -88.0 -50.77 6.2 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.537 -0.865 . . . . 0.97999999999999998 110.271 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -107.06 -2.96 20.51 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 113.965 1.098 . . . . 1.1599999999999999 113.965 -177.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.24 155.87 26.88 Favored Glycine 0 N--CA 1.504 3.201 0 O-C-N 120.82 -1.175 . . . . 0.84999999999999998 113.858 178.311 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.58 -15.55 1.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -1.018 . . . . 3.8599999999999999 112.979 179.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.66 -35.8 71.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 2.3500000000000001 110.917 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -82.91 -19.03 38.11 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.143 -0.973 . . . . 1.6699999999999999 111.996 -179.382 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.23 -35.19 74.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.074 -1.016 . . . . 1.45 111.038 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.36 89.18 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.079 -1.013 . . . . 0.60999999999999999 110.847 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.6 mt -68.64 -42.38 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.943 -1.098 . . . . 0.65000000000000002 110.098 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -72.05 -31.15 65.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.139 -0.976 . . . . 0.66000000000000003 110.253 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -59.79 -37.65 79.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.826 . . . . 1.1899999999999999 110.004 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.92 -40.54 84.42 Favored Glycine 0 N--CA 1.48 1.622 0 C-N-CA 119.733 -1.222 . . . . 0.53000000000000003 110.277 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -59.93 -47.28 86.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.184 -1.186 . . . . 1.27 110.593 179.506 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.7 mt -60.3 -38.64 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.951 -1.093 . . . . 0.54000000000000004 110.231 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.9 ttt -59.9 -39.39 85.21 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.365 -0.834 . . . . 1.74 110.904 179.22 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.418 HD11 HE21 ' A' ' 111' ' ' GLN . 9.3 tp -60.31 -50.04 75.2 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.106 -0.996 . . . . 0.55000000000000004 110.46 179.669 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.31 -39.28 92.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.033 -1.042 . . . . 0.46999999999999997 110.303 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -87.22 1.5 52.95 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.445 0.906 . . . . 1.4199999999999999 113.445 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.41 121.45 12.11 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.357 -1.465 . . . . 1.27 108.244 178.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -66.36 -16.88 64.41 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.88 0.847 . . . . 1.3500000000000001 110.964 -178.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.97 -53.35 9.12 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.507 0.67 . . . . 2.2200000000000002 110.087 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.31 -36.78 81.04 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.568 -0.853 . . . . 0.62 110.485 -179.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 47' ' ' ARG . 87.0 tt0 -59.43 -46.84 87.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.203 -0.936 . . . . 1.29 110.918 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.73 -38.56 85.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.393 -0.817 . . . . 1.52 110.701 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.02 -48.7 70.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.831 -1.168 . . . . 1.3 110.872 179.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.31 -43.95 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.173 -0.954 . . . . 0.60999999999999999 110.138 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.5 mt -60.41 -43.96 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.658 -0.651 . . . . 0.78000000000000003 110.486 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.21 -42.34 98.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.425 -0.797 . . . . 0.81999999999999995 110.991 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.66 -47.79 83.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.162 -0.961 . . . . 0.80000000000000004 110.296 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.4 mt -60.89 -44.88 98.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.304 -0.872 . . . . 0.77000000000000002 110.683 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -84.07 -34.45 24.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.007 -1.058 . . . . 2.1200000000000001 111.954 -179.71 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 91' ' ' ALA . 44.9 t0 -82.94 -43.62 16.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.809 -1.182 . . . . 1.51 111.445 -178.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -101.9 5.79 41.09 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.642 -0.661 . . . . 1.98 112.302 -178.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.7 m80 52.09 47.92 23.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 1.3200000000000001 111.795 -179.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.4 mtt -100.34 153.76 19.05 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.146 -0.971 . . . . 1.3799999999999999 110.018 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.5 p -71.57 161.21 31.38 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.507 -0.746 . . . . 0.67000000000000004 109.746 178.149 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.22 90.61 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.85 -0.74 . . . . 0.52000000000000002 110.748 178.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.517 ' OD2' HD21 ' A' ' 142' ' ' LEU . 98.1 m-20 -68.49 -40.21 81.0 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.959 -1.088 . . . . 2.25 110.248 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.91 -50.68 54.72 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.855 -0.738 . . . . 0.64000000000000001 111.064 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.58 -44.23 96.84 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 0.56000000000000005 110.195 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.97 -44.17 94.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.603 -0.686 . . . . 0.46000000000000002 110.665 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -61.71 -38.65 88.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 1.3200000000000001 111.321 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -57.44 -49.77 75.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.675 -1.266 . . . . 1.3 110.888 179.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.04 -47.42 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.635 -1.291 . . . . 0.60999999999999999 110.424 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -61.02 -30.35 47.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.563 -0.711 . . . . 0.65000000000000002 110.438 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -58.65 -41.27 85.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.358 -0.839 . . . . 2.1099999999999999 110.776 179.218 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.82 -30.61 23.15 Favored Glycine 0 N--CA 1.498 2.808 0 C-N-CA 119.071 -1.538 . . . . 0.82999999999999996 112.991 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.418 HE21 HD11 ' A' ' 79' ' ' LEU . 15.2 mm100 -62.09 -42.84 99.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.188 -1.772 . . . . 1.28 110.055 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.41 -52.03 25.26 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.379 -0.825 . . . . 0.89000000000000001 110.312 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.0 p -60.33 -34.81 74.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.186 -0.946 . . . . 1.8700000000000001 110.421 -179.365 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.04 -47.02 86.59 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.766 -0.584 . . . . 1.05 110.934 179.576 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.48 -29.94 70.9 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.127 -1.029 . . . . 1.02 111.148 -179.506 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -67.43 -22.29 65.52 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.929 -1.107 . . . . 2.04 111.511 179.455 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -70.59 -18.32 62.89 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.94 -1.104 . . . . 1.73 110.932 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 123' ' ' LEU . 10.7 mt -83.79 145.34 28.74 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.359 -0.838 . . . . 1.3700000000000001 109.623 179.265 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -101.08 41.93 1.15 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.359 -0.838 . . . . 2.8799999999999999 110.996 179.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -113.13 135.76 53.46 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.961 -1.125 . . . . 1.5800000000000001 107.961 178.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.495 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 25.1 mp0 -59.13 -34.24 71.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.45 -0.781 . . . . 3.04 111.151 179.111 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -74.22 -50.51 18.83 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.108 -0.995 . . . . 0.90000000000000002 110.51 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 118' ' ' LEU . 30.6 mt -63.4 -36.65 84.44 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.199 -0.938 . . . . 1.0600000000000001 110.207 -179.354 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -62.56 -49.24 76.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.166 -1.014 . . . . 2.1800000000000002 109.758 179.209 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -63.04 -28.98 70.46 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.448 -0.901 . . . . 2.1499999999999999 110.27 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -63.55 -30.38 71.5 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.069 0.937 . . . . 2.3300000000000001 108.879 178.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.1 -48.72 80.56 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.645 0.736 . . . . 0.81999999999999995 109.665 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.87 91.63 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.847 0.832 . . . . 0.84999999999999998 109.449 179.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.76 -37.61 88.0 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.574 -0.704 . . . . 1.3899999999999999 110.476 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.75 -39.83 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.407 -0.808 . . . . 0.56000000000000005 110.202 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -59.1 -38.86 80.54 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.265 -0.974 . . . . 3.1200000000000001 110.134 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -59.68 -39.74 85.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.557 -0.715 . . . . 1.28 110.469 179.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 66.2 mt -60.5 -39.97 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.01 . . . . 0.48999999999999999 110.1 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.01 -44.96 87.24 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.844 -1.169 . . . . 0.46000000000000002 110.279 179.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -59.54 -40.6 87.75 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.311 -1.111 . . . . 2.71 110.383 179.248 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -61.74 -45.08 95.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.994 -1.066 . . . . 2.1400000000000001 110.161 179.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 50.5 tp -59.92 -43.19 95.06 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.123 -0.986 . . . . 1.05 110.016 179.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.89 -44.16 94.4 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.234 -0.916 . . . . 0.52000000000000002 110.189 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.87 -34.32 74.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.246 -0.909 . . . . 2.3500000000000001 110.585 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.541 HD21 HD11 ' A' ' 146' ' ' ILE . 5.3 m120 -77.44 -40.5 43.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 1.3899999999999999 111.058 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.3 -40.05 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.236 -0.915 . . . . 0.68000000000000005 110.196 -178.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.517 HD21 ' OD2' ' A' ' 101' ' ' ASP . 68.7 mt -90.2 -9.42 48.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.91 -1.119 . . . . 0.82999999999999996 112.041 -179.236 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.37 20.27 77.24 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 120.375 -0.917 . . . . 0.91000000000000003 112.961 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.2 tp -63.78 149.91 45.78 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.686 0.755 . . . . 0.94999999999999996 109.408 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.73 146.29 54.99 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.245 -0.909 . . . . 2.4300000000000002 109.009 178.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.541 HD11 HD21 ' A' ' 140' ' ' ASN . 62.5 mt -108.82 143.5 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.391 -0.966 . . . . 1.1000000000000001 108.391 178.393 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 mp -76.23 114.12 16.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.925 -1.11 . . . . 1.5800000000000001 108.501 178.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -98.18 102.13 13.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.441 -1.689 . . . . 1.6200000000000001 106.441 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.406 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.0 mt -77.37 -18.03 57.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 0.80000000000000004 111.17 -177.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.3 m -80.11 -1.53 40.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -0.823 . . . . 1.5600000000000001 112.325 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.61 27.11 5.04 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.807 0.813 . . . . 0.83999999999999997 111.897 -178.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.406 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 17.5 mt -75.19 139.55 18.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.522 -0.736 . . . . 0.81999999999999995 109.392 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -111.63 -19.95 12.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.029 0.919 . . . . 2.3100000000000001 112.535 -178.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -119.12 142.88 47.53 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.723 -0.843 . . . . 1.54 108.723 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -73.14 122.42 21.83 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.052 -1.092 . . . . 1.3799999999999999 108.052 178.042 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.1 m -144.75 175.56 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.594 -0.691 . . . . 0.68999999999999995 109.253 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 44.9 mt -88.3 143.91 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.282 -0.886 . . . . 0.53000000000000003 108.802 178.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.3 tp -96.8 125.35 41.19 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.06 -1.089 . . . . 0.64000000000000001 108.06 178.209 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.4 t -123.22 129.93 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.552 -1.277 . . . . 0.67000000000000004 107.552 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.79 154.21 21.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.159 -0.963 . . . . 0.78000000000000003 108.678 179.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.83 80.6 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.583 -1.323 . . . . 1.0 109.365 178.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -171.58 153.9 3.59 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.862 -0.792 . . . . 2.4199999999999999 108.862 179.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.3 mt -118.73 142.26 47.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.932 -0.766 . . . . 0.75 108.932 177.318 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.2 p -92.48 150.56 40.15 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.13 -0.981 . . . . 0.78000000000000003 108.52 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -42.72 -38.63 6.66 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.857 1.705 . . . . 0.67000000000000004 113.206 179.329 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 62.1 m -63.52 -50.12 70.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.005 -1.059 . . . . 0.69999999999999996 109.884 -179.692 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.92 -39.03 90.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.913 . . . . 1.21 110.127 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 70.2 p -68.7 -40.81 79.84 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.827 -0.749 . . . . 0.59999999999999998 110.328 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.57 77.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.62 110.585 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -95.91 -0.98 50.2 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.949 -1.094 . . . . 1.1599999999999999 112.921 -179.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.95 148.62 46.95 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.72 -1.238 . . . . 0.72999999999999998 108.49 179.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -97.01 115.3 27.2 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.096 -1.446 . . . . 2.2400000000000002 107.096 177.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.0 mt -73.67 -14.12 61.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.59 -0.694 . . . . 1.4299999999999999 111.778 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.72 -21.94 32.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.347 -0.845 . . . . 2.1499999999999999 112.491 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -99.43 -7.06 26.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.129 -0.982 . . . . 2.04 112.549 -178.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 178' ' ' GLY . 58.7 t -110.99 131.0 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.198 -1.038 . . . . 0.55000000000000004 108.198 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -89.32 -13.87 36.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 1.6299999999999999 111.275 -179.744 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.423 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -177.14 172.92 45.83 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.889 -1.684 . . . . 0.46999999999999997 108.889 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -126.56 132.79 51.25 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.947 -1.131 . . . . 0.54000000000000004 107.947 179.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.561 HD11 HD13 ' A' ' 220' ' ' LEU . 67.4 mt -132.66 112.17 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.323 -1.732 . . . . 0.68999999999999995 106.323 179.052 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 205' ' ' THR . 73.3 p -135.86 173.3 11.86 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.608 -1.308 . . . . 0.81999999999999995 110.173 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -98.59 54.66 1.05 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.353 0.597 . . . . 2.3700000000000001 110.546 179.049 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.47 160.62 14.4 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 1.1100000000000001 109.921 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.93 -82.7 0.07 OUTLIER Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.84 -1.171 . . . . 1.6699999999999999 111.141 178.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 148.47 -38.48 1.01 Allowed Glycine 0 N--CA 1.5 2.942 0 O-C-N 120.582 -1.54 . . . . 1.54 113.223 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -60.05 -39.52 86.22 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.844 -1.386 . . . . 4.4800000000000004 110.863 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 23.0 p -136.83 38.02 2.6 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.295 -0.878 . . . . 2.6299999999999999 111.623 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 59.0 m -85.68 124.07 31.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.404 -1.332 . . . . 1.6899999999999999 107.404 178.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -56.69 -37.52 70.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.264 -0.897 . . . . 1.0700000000000001 110.824 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.3 p -60.88 -38.93 87.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 1.5800000000000001 110.351 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.0 t -60.21 -40.54 90.47 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.224 -0.923 . . . . 1.6000000000000001 110.12 179.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.55 -35.92 61.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.333 -0.854 . . . . 1.45 110.457 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 59.1 mtp -63.23 -41.44 99.11 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.995 -1.066 . . . . 1.05 109.566 179.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.75 -47.09 87.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.701 -0.681 . . . . 0.71999999999999997 111.021 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -62.17 -43.46 98.77 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.061 -1.024 . . . . 3.0499999999999998 110.748 -179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.4 m -70.5 -39.78 73.95 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.308 -0.87 . . . . 0.89000000000000001 110.492 -179.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.0 mt -93.3 -4.47 51.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.78000000000000003 112.817 -178.295 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 53.87 10.84 0.28 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.862 1.06 . . . . 1.45 113.862 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.6 mt -72.36 150.22 91.68 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.871 -1.143 . . . . 0.67000000000000004 108.904 179.4 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.63 140.81 88.59 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.038 1.159 . . . . 0.64000000000000001 110.239 178.391 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.94 162.04 31.85 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.049 -1.657 . . . . 0.67000000000000004 109.479 178.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.419 ' CD1' HD11 ' A' ' 220' ' ' LEU . 16.2 mt -147.02 146.6 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.063 -1.088 . . . . 0.68999999999999995 108.063 177.431 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.2 m -125.93 -28.28 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 O-C-N 121.041 -1.037 . . . . 0.84999999999999998 113.266 -179.182 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.21 42.2 1.63 Allowed Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.634 -1.27 . . . . 0.92000000000000004 111.759 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 181' ' ' THR . 45.0 p -65.34 -18.04 65.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.964 -1.315 . . . . 0.94999999999999996 111.116 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.07 -95.9 0.86 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.833 -1.307 . . . . 1.04 109.833 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 60.8 m -127.46 31.09 5.25 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.709 -0.877 . . . . 1.5700000000000001 111.866 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 78.2 t -57.06 -35.89 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.32 -1.488 . . . . 0.83999999999999997 110.593 179.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.4 p -59.99 -19.89 54.81 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.939 -1.101 . . . . 0.98999999999999999 111.974 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 48.9 m -94.56 1.87 55.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.945 . . . . 1.7 112.089 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -128.77 1.67 5.43 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 113.086 0.773 . . . . 2.2000000000000002 113.086 -178.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.53 152.87 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.739 0.781 . . . . 0.83999999999999997 109.773 -179.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -118.82 152.69 35.77 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.044 -1.095 . . . . 2.2000000000000002 108.044 177.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 43.7 p-10 -55.11 143.2 27.88 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.983 -1.073 . . . . 2.2799999999999998 110.17 178.285 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 80.97 -0.72 1.78 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 114.117 1.155 . . . . 2.3500000000000001 114.117 179.431 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.14 150.07 43.73 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.646 -1.284 . . . . 1.97 109.338 177.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -89.72 120.86 31.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.507 -1.371 . . . . 2.6499999999999999 107.521 178.175 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 89.8 mt -128.33 146.8 50.66 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.44 -0.788 . . . . 0.63 109.729 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.47 127.88 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.15 -1.426 . . . . 0.62 107.15 177.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.561 HD13 HD11 ' A' ' 180' ' ' ILE . 61.8 tp -101.52 118.3 36.67 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 105.883 -1.895 . . . . 0.64000000000000001 105.883 178.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 223' ' ' VAL . 39.4 t0 -91.7 -26.81 18.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.753 -1.217 . . . . 2.0499999999999998 112.361 -177.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.82 19.74 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 113.264 0.839 . . . . 0.83999999999999997 113.264 -179.25 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.1 t -112.14 -55.74 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.147 0.975 . . . . 1.02 108.981 -179.426 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -100.73 10.89 40.58 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.252 1.025 . . . . 2.5099999999999998 109.65 -179.169 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 62.03 53.31 3.04 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.317 -0.856 . . . . 1.54 112.05 179.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -149.58 146.64 27.44 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.213 1.006 . . . . 1.95 109.792 178.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.9 t -116.79 135.37 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.509 -1.293 . . . . 0.70999999999999996 107.509 178.056 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -102.42 134.77 45.19 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.831 -1.168 . . . . 1.01 108.442 178.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.26 129.25 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 107.795 -1.187 . . . . 0.81999999999999995 107.795 178.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.488 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 18.4 t30 56.66 44.88 1.53 Allowed Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 113.467 0.914 . . . . 1.54 113.467 179.092 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 52.2 Cg_endo -68.9 155.47 68.46 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.383 2.055 . . . . 0.93999999999999995 110.681 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 29.8 p -73.72 162.56 29.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.962 -1.086 . . . . 1.8 110.723 178.544 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.12 -34.04 74.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.507 -0.746 . . . . 2.73 110.337 178.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -59.85 -39.53 85.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 3.1699999999999999 110.747 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.04 -39.07 79.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.217 -0.927 . . . . 1.3400000000000001 110.405 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 80.5 mt . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.525 -0.734 . . . . 1.2 111.304 179.28 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.6 mt . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 106.318 -1.734 . . . . 1.0700000000000001 106.318 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 m -105.76 121.02 43.18 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.504 -1.295 . . . . 1.24 107.504 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.01 -149.82 26.15 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.512 -1.035 . . . . 1.01 110.512 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.557 HG22 ' O ' ' A' ' 5' ' ' ILE . 81.3 mt -94.34 0.77 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.783 -0.833 . . . . 1.1100000000000001 112.086 -179.67 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 50.26 99.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.355 -0.841 . . . . 0.98999999999999999 112.335 178.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.8 -52.97 6.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.108 . . . . 0.84999999999999998 110.628 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.33 149.41 44.53 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 107.719 -1.215 . . . . 1.3799999999999999 107.719 -179.541 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.26 144.5 29.48 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 123.029 2.486 . . . . 0.93999999999999995 112.937 178.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.91 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.35 168.67 18.15 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 109.206 -1.558 . . . . 0.81000000000000005 109.206 178.119 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.87 133.46 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.108 -1.23 . . . . 0.82999999999999996 108.803 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.33 150.86 43.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.366 -0.834 . . . . 0.53000000000000003 109.132 179.096 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.418 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 22.0 m-85 -117.87 139.78 50.63 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.047 -1.094 . . . . 0.77000000000000002 108.047 177.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.82 167.25 38.52 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.34 -1.886 . . . . 0.51000000000000001 110.442 178.182 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -78.38 156.62 29.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.768 -0.842 . . . . 1.8999999999999999 108.774 177.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.416 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.67 124.96 32.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.042 -1.095 . . . . 0.66000000000000003 108.042 178.53 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.2 tp -100.24 101.9 13.03 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 104.721 -2.326 . . . . 0.82999999999999996 104.721 177.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.25 138.48 31.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.21 -1.034 . . . . 0.85999999999999999 108.21 179.673 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.3 mt -98.98 114.83 27.67 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 106.119 -1.808 . . . . 0.92000000000000004 106.119 177.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -102.29 129.84 48.83 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.799 -1.186 . . . . 2.0299999999999998 107.799 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -123.27 144.07 49.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.99 -0.744 . . . . 2.6600000000000001 108.99 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -81.15 134.34 35.62 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.758 -1.201 . . . . 2.3199999999999998 107.758 177.284 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.68 145.61 55.39 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.406 -0.809 . . . . 2.1099999999999999 108.981 178.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.9 mt -93.03 132.11 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.263 -1.014 . . . . 0.72999999999999998 108.263 178.324 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -106.33 129.85 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.169 -1.048 . . . . 0.87 108.169 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.2 mt -97.06 130.34 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.031 -1.1 . . . . 0.81000000000000005 108.031 178.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -89.91 122.51 33.01 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.741 -1.207 . . . . 1.3400000000000001 107.741 178.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mmm-85 -93.58 11.68 27.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.47 -0.768 . . . . 2.8900000000000001 112.286 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -65.05 150.51 47.98 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.348 -0.845 . . . . 2.0899999999999999 110.268 178.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -90.08 129.85 36.32 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.148 -1.056 . . . . 2.1899999999999999 108.148 177.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 pt -90.86 164.69 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.962 . . . . 0.75 110.009 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.0 p -94.13 167.25 11.69 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.55 -0.719 . . . . 0.91000000000000003 110.452 178.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.51 -26.89 55.91 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.91 . . . . 0.93000000000000005 111.929 179.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -70.61 -27.98 64.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 2.2799999999999998 111.012 -179.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -93.52 -12.82 28.76 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.416 -0.802 . . . . 1.45 112.151 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.3 t -59.54 -47.79 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.487 0.66 . . . . 0.81000000000000005 110.205 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.33 -38.27 76.81 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.444 -0.785 . . . . 1.54 110.63 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.28 -38.66 90.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.605 -0.685 . . . . 2.3599999999999999 110.88 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.466 ' CD ' HH21 ' A' ' 42' ' ' ARG . 79.3 mm-40 -60.35 -41.33 93.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.85 -1.156 . . . . 1.3100000000000001 110.503 179.573 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.27 -40.41 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.374 -0.828 . . . . 0.81999999999999995 110.547 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -60.29 -44.91 94.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.128 -0.983 . . . . 1.5 109.882 179.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.466 HH21 ' CD ' ' A' ' 39' ' ' GLU . 67.5 mtm180 -63.42 -41.96 98.71 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.929 -1.109 . . . . 2.23 109.74 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -72.25 -54.5 9.41 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.309 -0.869 . . . . 0.84999999999999998 109.974 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.4 tp -57.79 -48.51 79.48 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.33 -0.948 . . . . 0.91000000000000003 110.051 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t -68.78 -43.92 74.69 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.121 -0.987 . . . . 0.90000000000000002 109.489 179.613 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.45 -35.71 73.59 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.348 -1.501 . . . . 0.68999999999999995 109.348 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' A' ' 47' ' ' ARG . 0.3 OUTLIER -58.62 -33.66 70.28 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.434 1.111 . . . . 2.8799999999999999 108.819 178.71 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.87 -48.21 82.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.035 -0.984 . . . . 0.84999999999999998 110.212 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -79.0 -38.6 36.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 2.3500000000000001 111.261 -179.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.76 86.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.65000000000000002 110.513 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.5 m -61.43 -39.54 91.18 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.042 -1.036 . . . . 1.45 109.893 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.31 92.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.866 -0.521 . . . . 0.63 111.373 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -63.01 -52.16 64.02 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.716 -1.24 . . . . 1.3400000000000001 111.199 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 54' ' ' LEU . 10.8 mp -64.75 -38.22 90.26 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.804 -1.185 . . . . 1.5600000000000001 110.401 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.1 -43.33 87.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.737 -0.602 . . . . 1.1899999999999999 110.781 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.5 m -67.74 -44.65 77.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.784 -1.197 . . . . 0.71999999999999997 110.311 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.92 -34.92 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.641 -0.662 . . . . 0.62 110.869 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -50.74 -45.55 58.83 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.297 -0.877 . . . . 1.05 110.743 179.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -69.58 -34.57 74.33 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.129 -0.982 . . . . 0.64000000000000001 110.305 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -62.75 -39.62 94.69 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.834 -1.147 . . . . 1.73 109.686 179.455 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.36 73.93 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.683 -0.635 . . . . 0.56000000000000005 110.427 179.205 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.41 -33.7 21.94 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.8 -1.19 . . . . 0.68999999999999995 111.042 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.44 -24.58 39.5 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.117 -1.225 . . . . 1.48 111.296 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -86.38 -48.84 8.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.374 -0.828 . . . . 0.97999999999999998 111.221 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -107.36 -15.36 14.65 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 113.484 0.92 . . . . 1.1599999999999999 113.484 -177.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.85 151.98 8.92 Favored Glycine 0 N--CA 1.501 3.026 0 O-C-N 121.406 -0.809 . . . . 0.84999999999999998 112.043 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -52.73 -21.22 3.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.53 -0.982 . . . . 3.8599999999999999 112.417 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.27 -29.89 67.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.974 -1.079 . . . . 2.3500000000000001 111.689 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -82.82 -17.42 44.07 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.823 -1.173 . . . . 1.6699999999999999 111.948 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.34 -33.81 72.94 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.419 -0.8 . . . . 1.45 111.109 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.69 -39.97 86.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.086 -1.009 . . . . 0.60999999999999999 110.701 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.2 mt -66.12 -47.54 84.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.401 -0.92 . . . . 0.65000000000000002 109.734 179.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -71.19 -33.41 69.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.339 -0.851 . . . . 0.66000000000000003 110.547 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.88 -38.58 86.14 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.139 -0.976 . . . . 1.1899999999999999 109.854 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.84 95.1 Favored Glycine 0 N--CA 1.483 1.833 0 C-N-CA 120.026 -1.083 . . . . 0.53000000000000003 110.479 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -58.73 -43.0 90.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.026 -1.279 . . . . 1.27 110.362 179.306 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.33 -40.85 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.083 -1.011 . . . . 0.54000000000000004 110.081 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.9 ttm -60.57 -41.99 95.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.438 -0.789 . . . . 1.74 110.081 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.1 tp -60.55 -48.09 83.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.417 -0.802 . . . . 0.55000000000000004 109.995 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.466 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.1 tp -59.83 -39.66 85.87 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.72 0.771 . . . . 0.46999999999999997 110.248 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -87.06 7.6 27.15 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.725 0.639 . . . . 1.4199999999999999 112.725 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -63.49 125.2 23.43 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.833 -1.167 . . . . 1.27 108.762 178.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.49 -16.72 63.94 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.265 -0.897 . . . . 1.3500000000000001 111.096 -179.051 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.37 -50.29 19.22 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.274 -0.97 . . . . 2.2200000000000002 110.623 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.97 -39.72 90.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.379 -0.826 . . . . 0.62 110.631 -179.489 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.84 -48.65 80.84 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.07 -1.019 . . . . 1.29 110.986 179.367 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -62.01 -38.64 89.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 1.52 110.949 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -66.36 -47.98 71.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.899 -1.126 . . . . 1.3 110.319 179.486 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.7 mt -58.33 -46.48 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.968 -1.082 . . . . 0.60999999999999999 109.991 179.381 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.99 -40.94 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.45 -0.781 . . . . 0.78000000000000003 110.354 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.43 -46.93 88.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 0.81999999999999995 111.033 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.8 -42.98 94.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.087 -1.008 . . . . 0.80000000000000004 110.511 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.8 mt -61.84 -46.77 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.982 . . . . 0.77000000000000002 110.029 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -82.14 -37.87 25.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 2.1200000000000001 111.82 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 91' ' ' ALA . 56.3 t0 -81.58 -45.74 15.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.696 -1.253 . . . . 1.51 111.994 -178.681 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -100.01 8.81 43.74 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.991 -1.068 . . . . 1.98 112.61 -178.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.0 m170 50.88 50.21 19.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.959 -1.088 . . . . 1.3200000000000001 111.816 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.9 mtt -107.72 151.45 25.67 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.442 -0.786 . . . . 1.3799999999999999 109.734 179.486 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.5 p -70.43 163.34 26.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.729 -0.607 . . . . 0.67000000000000004 109.97 178.351 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.79 -42.29 88.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.933 . . . . 0.52000000000000002 110.698 178.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.518 ' OD2' HD21 ' A' ' 142' ' ' LEU . 84.3 m-20 -67.93 -41.43 82.6 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.042 -1.036 . . . . 2.25 110.205 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.22 -50.87 51.21 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.634 -0.666 . . . . 0.64000000000000001 111.344 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.71 94.89 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.033 -1.042 . . . . 0.56000000000000005 110.314 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -43.74 95.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 0.46000000000000002 110.669 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -61.28 -39.75 91.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 1.3200000000000001 111.309 -179.481 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -57.63 -49.84 75.12 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.852 -1.155 . . . . 1.3 110.795 179.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.14 -46.06 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.047 -1.033 . . . . 0.60999999999999999 109.974 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -64.93 -31.96 56.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.871 -0.518 . . . . 0.65000000000000002 110.418 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.21 -41.0 71.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.181 -0.949 . . . . 2.1099999999999999 110.7 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.01 -30.93 18.97 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 119.142 -1.504 . . . . 0.82999999999999996 112.452 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -61.21 -39.69 91.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.516 -1.579 . . . . 1.28 109.903 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.14 -48.91 40.07 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.323 0.582 . . . . 0.89000000000000001 110.755 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.8 t -60.05 -40.34 89.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.319 -0.863 . . . . 1.8700000000000001 110.433 -178.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.07 99.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.382 -0.824 . . . . 1.05 110.745 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.55 -30.11 70.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.814 -1.179 . . . . 1.02 110.733 -179.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -66.24 -20.14 66.03 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.78 -1.2 . . . . 2.04 111.039 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.37 -18.77 63.06 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.351 -0.94 . . . . 1.73 110.827 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 15.0 mt -88.88 136.49 32.98 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.843 -1.169 . . . . 1.3700000000000001 107.843 178.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -100.59 42.92 1.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.272 -0.893 . . . . 2.8799999999999999 111.272 -179.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -111.85 142.31 44.39 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.164 -0.96 . . . . 1.5800000000000001 109.456 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -58.8 -39.27 80.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.228 -0.92 . . . . 3.04 110.797 178.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -71.87 -50.58 28.19 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.851 -1.156 . . . . 0.90000000000000002 109.875 179.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt -67.5 -43.28 81.28 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.386 -0.821 . . . . 1.0600000000000001 110.118 -178.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -61.25 -47.87 84.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.16 -0.962 . . . . 2.1800000000000002 109.787 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.91 -30.92 69.36 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.505 -0.878 . . . . 2.1499999999999999 109.635 179.594 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 130' ' ' VAL . 57.0 ttt180 -61.68 -30.43 70.73 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.092 0.949 . . . . 2.3300000000000001 108.696 179.289 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -49.86 74.56 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.071 0.939 . . . . 0.81999999999999995 109.537 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.65 -43.34 80.52 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.598 0.713 . . . . 0.84999999999999998 110.078 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -63.21 -33.51 75.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.623 -0.673 . . . . 1.3899999999999999 110.573 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 126' ' ' ARG . 21.9 t -70.0 -39.28 77.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.472 -0.767 . . . . 0.56000000000000005 110.105 179.561 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -59.26 -39.92 84.39 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.822 -1.151 . . . . 3.1200000000000001 109.752 178.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.441 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 51.3 t0 -60.12 -40.8 90.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.588 -0.695 . . . . 1.28 110.059 179.437 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.7 mt -61.77 -39.07 82.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.062 -1.023 . . . . 0.48999999999999999 110.116 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.35 -46.51 20.18 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.655 -1.259 . . . . 0.46000000000000002 110.486 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -56.62 -41.63 77.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.559 -0.965 . . . . 2.71 110.079 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 136' ' ' ARG . 40.7 mtt-85 -60.19 -41.52 93.11 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.003 -1.061 . . . . 2.1400000000000001 109.832 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.9 tp -60.22 -42.78 95.9 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.318 -0.953 . . . . 1.05 109.358 179.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.4 mt -59.84 -47.31 86.24 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.828 -0.545 . . . . 0.52000000000000002 109.949 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -59.88 -35.4 74.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 2.3500000000000001 111.017 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -73.99 -41.5 61.81 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.026 -1.046 . . . . 1.3899999999999999 110.684 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.57 -38.89 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -0.925 . . . . 0.68000000000000005 110.462 -178.388 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.518 HD21 ' OD2' ' A' ' 101' ' ' ASP . 89.7 mt -89.07 -6.96 56.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.093 -1.004 . . . . 0.82999999999999996 112.099 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.47 30.0 67.31 Favored Glycine 0 N--CA 1.482 1.746 0 C-N-CA 120.065 -1.064 . . . . 0.91000000000000003 112.075 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.94 148.23 44.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.686 -0.891 . . . . 0.94999999999999996 109.844 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -68.01 141.29 56.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 2.4300000000000002 109.27 178.095 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.91 131.5 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.202 -1.036 . . . . 1.1000000000000001 108.202 178.463 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.775 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.1 mp -77.02 131.02 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.408 -0.808 . . . . 1.5800000000000001 108.928 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.9 97.93 11.27 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.466 -1.679 . . . . 1.6200000000000001 106.466 178.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.57 ' O ' HD13 ' A' ' 152' ' ' ILE . 77.2 mt -78.84 -6.0 54.91 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 112.72 0.637 . . . . 0.80000000000000004 112.72 -177.855 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.8 p -88.85 -2.59 58.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.903 -1.123 . . . . 1.5600000000000001 112.745 -179.123 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -106.17 36.68 2.5 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.147 -0.97 . . . . 0.83999999999999997 112.414 -177.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.616 ' N ' HD12 ' A' ' 152' ' ' ILE . 1.5 mp -72.72 139.89 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.575 -1.328 . . . . 0.81999999999999995 109.406 178.493 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -118.86 -16.73 9.25 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.706 0.765 . . . . 2.3100000000000001 112.408 -179.097 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -116.03 138.47 51.19 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.771 -1.196 . . . . 1.54 107.771 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -76.12 121.39 22.75 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.284 -1.006 . . . . 1.3799999999999999 108.284 178.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 m -146.28 174.03 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.493 -0.755 . . . . 0.68999999999999995 109.144 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.7 mt -87.89 140.76 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.53000000000000003 109.143 178.02 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 42.5 tp -94.8 124.15 38.67 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.98 -1.075 . . . . 0.64000000000000001 108.183 178.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.97 129.18 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 107.604 -1.258 . . . . 0.67000000000000004 107.604 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.36 153.98 22.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 0.78000000000000003 108.943 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.65 -34.38 76.96 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.607 -1.308 . . . . 1.0 109.213 178.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -173.8 149.77 1.6 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.236 -0.653 . . . . 2.4199999999999999 109.236 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 58.9 mt -116.03 136.32 53.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.601 -1.259 . . . . 0.75 107.601 177.337 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.9 p -92.2 150.15 39.8 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.164 -0.96 . . . . 0.78000000000000003 108.786 179.069 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -39.49 -44.38 3.09 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.886 1.724 . . . . 0.67000000000000004 113.441 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.8 m -58.92 -50.06 75.47 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.835 -1.166 . . . . 0.69999999999999996 111.014 -179.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -62.99 -40.07 96.66 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.253 -0.904 . . . . 1.21 110.212 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 73.0 p -68.58 -39.2 81.07 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.334 -0.854 . . . . 0.59999999999999998 110.327 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.5 78.17 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.595 -0.842 . . . . 0.62 110.638 179.268 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -94.88 -2.37 50.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.111 -0.993 . . . . 1.1599999999999999 113.226 -179.014 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.94 149.94 46.14 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.904 -1.123 . . . . 0.72999999999999998 109.14 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.453 ' O ' HG23 ' A' ' 176' ' ' VAL . 57.5 t-20 -95.63 104.63 16.55 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.056 -1.831 . . . . 2.2400000000000002 106.056 177.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.609 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.6 mp -72.2 -18.3 61.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 1.4299999999999999 112.054 -177.57 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -77.97 -27.45 49.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.203 -0.936 . . . . 2.1499999999999999 111.45 -178.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -100.11 6.07 44.91 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.284 -0.885 . . . . 2.04 112.362 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 178' ' ' GLY . 91.5 t -109.75 129.84 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.962 -1.125 . . . . 0.55000000000000004 107.962 179.683 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 48.9 tp -81.85 -15.47 53.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.815 . . . . 1.6299999999999999 112.288 -179.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.525 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 173.29 179.91 44.27 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.472 -1.451 . . . . 0.46999999999999997 109.472 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -131.68 138.24 48.63 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.533 -1.284 . . . . 0.54000000000000004 107.533 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.9 mt -138.21 119.03 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.424 -1.695 . . . . 0.68999999999999995 106.424 178.524 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 203' ' ' VAL . 60.0 p -132.1 164.53 26.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.087 -1.008 . . . . 0.81999999999999995 108.952 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 208' ' ' VAL . 1.9 m-20 -104.82 15.98 26.83 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.577 -0.702 . . . . 2.3700000000000001 112.329 179.047 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -134.12 -51.17 0.82 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 120.808 -1.182 . . . . 1.1100000000000001 114.0 -177.712 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.54 153.74 0.29 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.199 -1.0 . . . . 1.6699999999999999 110.84 -176.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 152.65 -61.31 0.39 Allowed Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.156 -1.021 . . . . 1.54 112.295 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.83 77.37 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.061 -1.258 . . . . 4.4800000000000004 109.023 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.6 p 53.67 40.75 31.86 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.672 -0.811 . . . . 2.6299999999999999 111.596 -178.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 38.5 t -79.74 153.99 28.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.816 . . . . 1.6899999999999999 109.559 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -59.0 -39.91 83.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.859 . . . . 1.0700000000000001 110.893 178.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 33.6 p -56.42 -40.89 75.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 1.5800000000000001 110.732 179.417 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 82.2 p -62.3 -37.95 87.49 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.066 -1.021 . . . . 1.6000000000000001 110.485 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.83 -38.7 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.383 -0.823 . . . . 1.45 110.73 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.7 mtp -61.75 -44.86 96.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.84 -1.162 . . . . 1.05 108.905 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.95 -48.6 81.05 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.116 -0.947 . . . . 0.71999999999999997 111.029 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 195' ' ' ARG . 23.7 mtt-85 -60.81 -43.48 98.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.099 -1.001 . . . . 3.0499999999999998 110.751 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 41.5 m -69.88 -41.04 75.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.443 -0.786 . . . . 0.89000000000000001 110.306 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 13.3 mt -91.75 -6.84 51.19 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.623 0.725 . . . . 0.78000000000000003 112.284 -178.221 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.5 mt-10 45.52 18.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.529 0.937 . . . . 1.45 113.529 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 18.6 mt -71.84 142.25 85.45 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.953 -1.092 . . . . 0.67000000000000004 108.372 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -56.24 130.36 39.75 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.678 1.585 . . . . 0.64000000000000001 110.357 178.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.05 175.88 9.05 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 117.911 -1.516 . . . . 0.67000000000000004 111.517 179.555 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.2 mt -146.63 157.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.632 -1.247 . . . . 0.68999999999999995 107.632 178.467 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 183' ' ' ALA . 4.6 m -141.8 -23.62 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 120.818 -1.176 . . . . 0.84999999999999998 113.286 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -104.25 42.3 1.93 Allowed Glycine 0 N--CA 1.503 3.136 0 N-CA-C 110.637 -0.985 . . . . 0.92000000000000004 110.637 -178.563 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 36.3 p -59.86 -20.76 58.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.056 -1.261 . . . . 0.94999999999999996 111.841 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.22 -85.37 0.61 Allowed Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.18 -1.01 . . . . 1.04 111.437 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 58.8 p -134.66 32.11 3.32 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 121.008 -1.29 . . . . 1.5700000000000001 113.331 -178.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.527 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 60.2 t -58.84 -34.15 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.223 -1.548 . . . . 0.83999999999999997 111.076 179.451 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 43.8 p -64.12 -21.73 66.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.835 -1.165 . . . . 0.98999999999999999 112.199 -179.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 53.8 p -96.32 3.16 53.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.943 -1.098 . . . . 1.7 112.339 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -129.76 4.12 4.98 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.684 -0.635 . . . . 2.2000000000000002 112.691 -178.567 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.1 t -123.04 152.92 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.404 -0.81 . . . . 0.83999999999999997 109.768 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -118.48 156.76 28.51 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.096 -1.076 . . . . 2.2000000000000002 108.096 178.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.513 ' ND2' ' OD1' ' A' ' 215' ' ' ASP . 46.7 t30 -54.8 139.97 37.89 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.052 -1.03 . . . . 2.2799999999999998 110.119 178.257 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.513 ' OD1' ' ND2' ' A' ' 214' ' ' ASN . 1.2 m-20 79.56 5.36 2.06 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.281 1.215 . . . . 2.3500000000000001 114.281 179.58 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -63.39 148.63 47.93 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.385 -0.969 . . . . 1.97 108.385 177.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -89.64 119.96 30.51 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.583 -1.636 . . . . 2.6499999999999999 106.583 178.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.416 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 86.7 mt -128.26 146.36 50.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.585 -0.697 . . . . 0.63 109.86 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 47.0 mt -112.13 124.19 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.691 -1.596 . . . . 0.62 106.691 177.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.0 tp -97.21 111.58 23.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.981 -1.859 . . . . 0.64000000000000001 105.981 178.117 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.6 t0 -89.72 -28.95 19.07 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.718 -1.239 . . . . 2.0499999999999998 111.549 -178.423 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.81 10.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 113.285 0.846 . . . . 0.83999999999999997 113.285 -179.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.625 ' N ' ' O ' ' A' ' 221' ' ' ASP . 39.3 t -110.57 -56.44 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.987 -1.071 . . . . 1.02 109.173 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -92.57 8.87 37.04 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.297 1.046 . . . . 2.5099999999999998 110.271 -179.097 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 60.51 49.97 6.25 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.026 -0.988 . . . . 1.54 111.632 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -148.47 149.55 31.86 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.608 1.194 . . . . 1.95 109.93 178.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.66 135.03 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.653 -1.239 . . . . 0.70999999999999996 107.653 177.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -100.5 130.26 46.55 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.968 -1.123 . . . . 1.01 107.968 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.31 130.01 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.784 -0.821 . . . . 0.81999999999999995 108.784 179.094 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.412 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 0.7 OUTLIER 49.93 50.59 9.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 113.426 0.898 . . . . 1.54 113.426 178.763 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.7 Cg_endo -69.02 150.29 72.56 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.366 2.044 . . . . 0.93999999999999995 110.701 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.1 p -73.83 160.29 31.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 1.8 109.821 178.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.72 -36.61 72.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.486 -0.759 . . . . 2.73 111.105 179.021 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -59.59 -41.22 89.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 3.1699999999999999 110.122 179.321 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -71.39 -40.24 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.47 -0.769 . . . . 1.3400000000000001 110.115 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.487 1.391 0 O-C-N 121.391 -0.818 . . . . 1.2 110.322 -178.549 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.1 mt . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 106.41 -1.7 . . . . 1.0700000000000001 106.41 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -105.02 120.52 41.68 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.744 -1.206 . . . . 1.24 107.744 -179.418 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.6 -160.37 26.9 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.179 -1.568 . . . . 1.01 109.179 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 5' ' ' ILE . 74.9 mt -96.05 -0.18 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.419 -1.047 . . . . 1.1100000000000001 112.343 -179.295 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.7 tp 49.24 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.98999999999999999 112.656 178.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.76 -43.55 11.8 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.933 -1.105 . . . . 0.84999999999999998 111.562 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -141.33 143.51 30.62 Favored Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 107.72 -1.215 . . . . 1.3799999999999999 107.72 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.32 146.55 22.28 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.616 2.211 . . . . 0.93999999999999995 112.634 178.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.896 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.39 177.98 27.46 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 108.866 -1.694 . . . . 0.81000000000000005 108.866 177.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.9 mt -134.67 140.04 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.041 -1.27 . . . . 0.82999999999999996 108.345 179.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.54 ' HB1' HD22 ' A' ' 177' ' ' LEU . . . -144.94 158.03 43.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -0.984 . . . . 0.53000000000000003 109.451 178.177 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 11.5 m-85 -127.75 140.54 52.0 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.769 -1.197 . . . . 0.77000000000000002 107.769 178.223 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.23 166.02 34.41 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 118.38 -1.867 . . . . 0.51000000000000001 110.411 178.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -78.11 158.08 29.25 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.402 -0.962 . . . . 1.8999999999999999 108.402 178.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.16 130.96 35.15 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.743 -0.836 . . . . 0.66000000000000003 108.743 178.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.2 tp -113.35 103.78 11.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 105.604 -1.998 . . . . 0.82999999999999996 105.604 178.113 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.482 ' O ' ' ND2' ' A' ' 214' ' ' ASN . 13.8 tp -91.84 139.05 31.04 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.66 -0.867 . . . . 0.85999999999999999 108.66 -179.575 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.2 mt -99.39 120.9 40.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.293 -1.373 . . . . 0.92000000000000004 107.293 178.318 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -111.12 138.96 46.9 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.995 -1.113 . . . . 2.0299999999999998 107.995 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -119.78 140.29 50.98 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.172 -0.955 . . . . 2.6600000000000001 109.245 178.446 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -85.02 133.36 34.25 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.727 -1.212 . . . . 2.3199999999999998 107.727 177.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -60.74 149.1 36.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.07 -1.019 . . . . 2.1099999999999999 108.732 178.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.8 mt -96.99 134.17 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.027 -1.046 . . . . 0.72999999999999998 108.263 178.325 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.74 129.67 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.586 -1.264 . . . . 0.87 107.586 178.531 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.0 mt -100.62 137.74 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.145 -1.058 . . . . 0.81000000000000005 108.145 179.546 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -94.33 120.74 35.01 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.324 -0.991 . . . . 1.3400000000000001 108.324 178.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -94.55 15.13 18.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.393 -0.817 . . . . 2.8900000000000001 112.805 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.98 147.31 53.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.382 -0.824 . . . . 2.0899999999999999 109.264 178.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -88.1 139.42 30.52 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.618 -0.882 . . . . 2.1899999999999999 108.618 177.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 pt -99.77 164.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.857 -1.152 . . . . 0.75 109.912 179.088 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.0 p -93.87 165.95 12.42 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.386 -0.821 . . . . 0.91000000000000003 109.698 178.472 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -21.24 14.4 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.4 -0.812 . . . . 0.93000000000000005 112.154 179.242 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -68.15 -39.1 82.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.063 -1.023 . . . . 2.2799999999999998 110.873 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -91.02 -7.4 52.01 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.814 -1.179 . . . . 1.45 112.744 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.22 -47.44 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.526 -1.358 . . . . 0.81000000000000005 110.788 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -59.24 -39.15 81.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.124 -0.985 . . . . 1.54 109.972 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -61.36 -37.92 85.1 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.705 -0.798 . . . . 2.3599999999999999 110.825 179.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -59.91 -40.86 90.25 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.17 -1.012 . . . . 1.3100000000000001 110.639 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.24 -41.77 88.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.165 -0.959 . . . . 0.81999999999999995 110.504 179.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -62.73 -41.39 99.15 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.78 -1.2 . . . . 1.5 110.358 179.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -61.05 -41.08 95.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 2.23 110.616 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -75.37 -54.11 7.6 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.844 -1.16 . . . . 0.84999999999999998 110.463 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.2 tp -57.55 -47.8 81.07 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.721 0.772 . . . . 0.91000000000000003 110.674 -179.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.519 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.0 t -69.06 -40.05 78.75 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.833 0.825 . . . . 0.90000000000000002 110.346 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.91 -44.6 92.44 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 109.811 -1.316 . . . . 0.68999999999999995 109.811 179.298 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -60.67 -28.91 68.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.779 -0.836 . . . . 2.8799999999999999 110.251 179.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.5 -49.34 77.7 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.834 0.826 . . . . 0.84999999999999998 110.604 179.072 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -81.77 -38.62 25.37 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.337 -0.852 . . . . 2.3500000000000001 110.668 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.6 -42.36 92.42 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.614 -0.834 . . . . 0.65000000000000002 109.925 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 m -62.08 -39.92 94.06 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.985 0.898 . . . . 1.45 109.582 179.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.45 88.83 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.723 -0.791 . . . . 0.63 109.879 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.52 -50.44 69.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.99 -1.069 . . . . 1.3400000000000001 109.998 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.45 -40.33 94.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.941 -1.1 . . . . 1.5600000000000001 109.832 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -59.33 -39.89 84.55 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.393 -0.817 . . . . 1.1899999999999999 110.226 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -62.91 -43.41 98.87 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.388 -0.82 . . . . 0.71999999999999997 110.277 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.23 -34.43 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.078 -1.014 . . . . 0.62 110.279 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -53.3 -45.55 69.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.45 -0.781 . . . . 1.05 110.877 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -68.87 -39.93 79.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.206 -0.934 . . . . 0.64000000000000001 109.778 -179.708 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -61.78 -37.58 84.87 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.128 -1.029 . . . . 1.73 109.139 179.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.95 79.44 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.308 -0.557 . . . . 0.56000000000000005 110.193 179.197 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.82 -35.21 16.65 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.8 -1.191 . . . . 0.68999999999999995 111.267 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -79.9 -25.7 40.48 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.956 -1.32 . . . . 1.48 110.709 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.2 m -86.93 -50.97 6.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.729 -0.607 . . . . 0.97999999999999998 110.287 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -105.92 -6.14 19.1 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 114.079 1.14 . . . . 1.1599999999999999 114.079 -177.412 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.57 164.3 27.22 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 120.228 -0.986 . . . . 0.84999999999999998 112.447 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -56.38 -23.24 36.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.852 -0.793 . . . . 3.8599999999999999 112.645 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -57.9 -39.0 76.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.356 -1.465 . . . . 2.3500000000000001 110.515 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -86.99 -25.27 24.36 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.216 -0.928 . . . . 1.6699999999999999 111.746 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.42 -39.97 85.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.219 -0.925 . . . . 1.45 110.776 -179.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.21 84.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.496 -0.752 . . . . 0.60999999999999999 111.286 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.2 mt -65.41 -44.75 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.622 -1.299 . . . . 0.65000000000000002 110.649 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -69.87 -31.55 69.44 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.841 -1.162 . . . . 0.66000000000000003 110.698 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -59.98 -39.33 85.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.064 -1.023 . . . . 1.1899999999999999 110.94 179.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.93 -40.36 93.48 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.535 -1.317 . . . . 0.53000000000000003 110.863 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -59.35 -40.78 87.5 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.084 -1.245 . . . . 1.27 110.616 179.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.7 mt -60.82 -37.55 76.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.202 -0.936 . . . . 0.54000000000000004 110.497 179.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 26.3 ttt -58.64 -38.89 79.07 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.703 -0.799 . . . . 1.74 110.449 179.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.05 -49.43 77.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.949 -1.094 . . . . 0.55000000000000004 110.879 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.6 tp -61.35 -38.81 88.3 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.21 -0.931 . . . . 0.46999999999999997 110.252 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -86.34 7.65 24.68 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.175 0.806 . . . . 1.4199999999999999 113.175 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -67.43 116.16 7.87 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 120.793 -1.192 . . . . 1.27 108.655 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -64.37 -20.23 65.99 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.626 0.727 . . . . 1.3500000000000001 110.946 -179.226 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -71.64 -47.98 50.85 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.991 -1.083 . . . . 2.2200000000000002 110.364 179.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.32 -38.4 89.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.395 -0.816 . . . . 0.62 110.521 -178.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -59.54 -41.76 90.81 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.008 -1.058 . . . . 1.29 110.515 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.17 -39.23 85.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.941 -1.099 . . . . 1.52 110.582 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -66.62 -48.06 70.65 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.106 -1.037 . . . . 1.3 110.448 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.59 -43.48 83.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.936 -1.102 . . . . 0.60999999999999999 110.01 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.73 -44.04 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 0.78000000000000003 110.685 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.74 -40.89 96.69 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.247 -0.908 . . . . 0.81999999999999995 110.856 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.0 mt -60.39 -44.77 95.34 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.496 -1.377 . . . . 0.80000000000000004 110.418 -179.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.64 -47.64 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.907 -1.121 . . . . 0.77000000000000002 110.812 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -79.75 -35.48 38.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.004 -1.06 . . . . 2.1200000000000001 111.665 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.78 -43.34 22.67 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.02 -1.05 . . . . 1.51 111.312 -179.001 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -101.13 4.55 42.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.047 -1.033 . . . . 1.98 112.251 -177.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.1 m80 51.48 49.35 21.13 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.238 -0.914 . . . . 1.3200000000000001 111.646 -179.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 70.3 mtm -110.04 157.89 18.85 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.494 -0.754 . . . . 1.3799999999999999 109.558 178.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.8 p -71.51 162.46 29.41 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.296 0.569 . . . . 0.67000000000000004 110.403 178.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.67 -41.11 97.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.53 -0.731 . . . . 0.52000000000000002 110.827 179.149 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 31.8 p-10 -69.59 -38.59 77.39 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.196 -0.94 . . . . 2.25 109.978 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.527 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -71.27 -52.89 16.43 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.831 -1.148 . . . . 0.64000000000000001 110.872 179.363 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.25 88.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.56000000000000005 110.604 -179.349 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.25 93.46 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.026 -0.67 . . . . 0.46000000000000002 110.878 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -59.76 -41.31 90.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.843 -1.16 . . . . 1.3200000000000001 111.039 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -56.14 -47.57 77.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.235 -1.54 . . . . 1.3 110.73 179.658 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.53 -44.18 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.548 -1.345 . . . . 0.60999999999999999 110.22 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.79 -32.31 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.282 -0.886 . . . . 0.65000000000000002 110.071 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.22 -39.93 92.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.12 -0.987 . . . . 2.1099999999999999 111.022 179.308 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.9 -30.4 29.11 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.079 -1.534 . . . . 0.82999999999999996 112.795 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -60.57 -39.68 88.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 119.675 -2.073 . . . . 1.28 109.858 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.53 -48.04 43.45 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.638 0.733 . . . . 0.89000000000000001 109.696 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.3 p -60.81 -39.73 90.04 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.704 -0.798 . . . . 1.8700000000000001 110.063 -178.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.24 -46.45 89.74 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.954 -1.091 . . . . 1.05 110.821 179.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.3 mt -65.44 -29.54 70.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.699 -1.25 . . . . 1.02 111.09 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -64.31 -21.39 66.59 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.975 -1.078 . . . . 2.04 111.426 179.549 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -71.83 -15.51 62.14 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.763 0.792 . . . . 1.73 110.923 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.509 HD13 HD13 ' A' ' 123' ' ' LEU . 36.8 mt -86.9 141.55 28.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.953 -0.758 . . . . 1.3700000000000001 108.953 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -97.56 41.58 1.12 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.987 -1.071 . . . . 2.8799999999999999 111.853 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -114.48 140.88 48.37 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.305 -0.872 . . . . 1.5800000000000001 109.391 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -59.05 -39.39 81.89 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.338 -0.851 . . . . 3.04 111.515 178.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -72.68 -53.01 12.91 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 0.90000000000000002 110.313 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.509 HD13 HD13 ' A' ' 118' ' ' LEU . 26.4 mt -61.42 -41.32 96.97 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.107 -0.995 . . . . 1.0600000000000001 110.394 -179.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -63.16 -49.05 75.85 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.276 1.036 . . . . 2.1800000000000002 109.563 179.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -63.2 -29.93 71.18 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.092 -1.043 . . . . 2.1499999999999999 109.968 179.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 130' ' ' VAL . 15.2 ttt-85 -60.82 -30.47 70.1 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.741 0.782 . . . . 2.3300000000000001 108.951 178.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.25 87.28 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.155 0.979 . . . . 0.81999999999999995 109.001 178.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -43.65 80.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.739 -0.784 . . . . 0.84999999999999998 109.981 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -64.57 -33.17 75.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.492 -0.755 . . . . 1.3899999999999999 110.616 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 126' ' ' ARG . 24.5 t -68.19 -39.63 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 0.56000000000000005 109.834 179.377 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -58.91 -39.67 82.22 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.087 -1.045 . . . . 3.1200000000000001 109.896 178.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -59.35 -38.86 81.48 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.21 -0.45 . . . . 1.28 110.544 179.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 54.1 mt -60.72 -40.29 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.673 -1.267 . . . . 0.48999999999999999 110.116 179.496 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.19 -36.65 60.01 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.395 -1.082 . . . . 0.46000000000000002 110.395 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -56.63 -48.65 77.05 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.547 -0.972 . . . . 2.71 110.66 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -63.38 -41.03 98.77 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.013 -1.075 . . . . 2.1400000000000001 110.169 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.9 tp -59.76 -40.37 87.94 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.69 -0.631 . . . . 1.05 110.301 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.2 mt -59.24 -44.3 92.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.094 -1.004 . . . . 0.52000000000000002 110.463 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -60.62 -33.24 72.48 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.146 -0.971 . . . . 2.3500000000000001 111.181 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -75.74 -41.4 53.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.909 -1.119 . . . . 1.3899999999999999 110.867 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.1 mt -60.14 -38.6 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.969 -1.082 . . . . 0.68000000000000005 110.571 -178.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.0 mt -85.35 -7.11 59.14 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.457 -0.777 . . . . 0.82999999999999996 111.764 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.81 16.42 80.78 Favored Glycine 0 N--CA 1.483 1.82 0 C-N-CA 120.319 -0.943 . . . . 0.91000000000000003 112.454 -179.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.27 149.28 48.37 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.769 -0.842 . . . . 0.94999999999999996 109.688 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -65.66 150.83 47.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.528 -0.732 . . . . 2.4300000000000002 109.695 178.259 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.2 mt -104.02 138.43 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.177 -0.952 . . . . 1.1000000000000001 108.711 178.602 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 mp -82.72 118.84 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.439 -1.319 . . . . 1.5800000000000001 107.439 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -100.81 102.62 13.74 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.965 -1.865 . . . . 1.6200000000000001 105.965 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 70.1 mt -74.86 -14.79 60.71 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.563 -0.855 . . . . 0.80000000000000004 111.505 -178.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.2 m -80.09 2.41 24.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.414 -0.804 . . . . 1.5600000000000001 112.852 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -93.94 21.17 6.92 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.67 0.747 . . . . 0.83999999999999997 112.325 -179.226 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.2 mt -73.15 140.22 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.811 -0.556 . . . . 0.81999999999999995 109.672 179.57 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -117.46 -16.37 10.21 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.224 1.011 . . . . 2.3100000000000001 112.468 -178.715 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -118.03 139.39 51.27 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.288 -1.004 . . . . 1.54 108.288 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -70.87 128.7 36.89 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.826 -1.171 . . . . 1.3799999999999999 108.294 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.1 m -146.57 175.42 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.92 -0.77 . . . . 0.68999999999999995 108.92 -179.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.28 140.65 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.884 -1.135 . . . . 0.53000000000000003 108.757 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.6 tp -96.66 123.36 40.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.807 -1.183 . . . . 0.64000000000000001 108.626 178.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.23 130.7 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.431 -0.951 . . . . 0.67000000000000004 108.431 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 152.01 16.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -0.86 . . . . 0.78000000000000003 109.157 178.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.42 -34.19 74.97 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.897 -1.127 . . . . 1.0 109.344 178.055 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -171.53 153.06 3.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.77 -0.826 . . . . 2.4199999999999999 108.77 179.455 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 68.9 mt -118.95 142.86 47.4 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.437 -0.79 . . . . 0.75 109.214 177.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.4 p -91.81 146.91 33.91 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.275 -0.89 . . . . 0.78000000000000003 109.071 179.185 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -41.15 -39.23 3.6 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.464 1.443 . . . . 0.67000000000000004 113.537 178.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.1 m -61.37 -50.17 73.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.764 -1.21 . . . . 0.69999999999999996 110.208 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.22 -39.13 93.76 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.41 0.624 . . . . 1.21 110.327 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 56.5 p -68.44 -40.03 81.31 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.285 -0.884 . . . . 0.59999999999999998 110.678 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.78 84.05 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.123 -0.985 . . . . 0.62 110.338 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -94.32 1.85 55.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.791 -1.193 . . . . 1.1599999999999999 112.991 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.7 149.6 34.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.0 -1.063 . . . . 0.72999999999999998 109.037 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.02 116.62 29.23 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.621 -1.622 . . . . 2.2400000000000002 106.621 177.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.3 mt -75.66 -13.67 60.33 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.353 0.597 . . . . 1.4299999999999999 111.717 -177.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -85.76 -22.16 27.86 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.319 0.581 . . . . 2.1499999999999999 112.072 -179.118 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -102.73 -2.41 28.2 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.884 0.698 . . . . 2.04 112.884 -178.165 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.7 t -112.15 130.04 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 107.65 -1.241 . . . . 0.55000000000000004 107.65 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.71 ' O ' HD23 ' A' ' 177' ' ' LEU . 1.7 tt -92.96 -11.11 34.09 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.239 1.019 . . . . 1.6299999999999999 111.735 -179.208 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.89 173.67 42.66 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 109.537 -1.425 . . . . 0.46999999999999997 109.537 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -126.2 132.49 51.75 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.992 -1.299 . . . . 0.54000000000000004 107.61 179.17 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.452 HG22 HG21 ' A' ' 205' ' ' THR . 75.0 mt -132.48 106.86 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 106.133 -1.803 . . . . 0.68999999999999995 106.133 178.366 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.563 ' O ' HG23 ' A' ' 205' ' ' THR . 71.7 p -129.31 170.21 13.9 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 120.497 -1.377 . . . . 0.81999999999999995 110.018 -178.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 20.9 p-10 -99.01 53.23 0.97 Allowed 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 120.118 -0.633 . . . . 2.3700000000000001 110.881 179.433 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.33 156.14 17.78 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 108.887 -0.783 . . . . 1.1100000000000001 108.887 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.59 -3.39 58.45 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.431 -1.366 . . . . 1.6699999999999999 112.821 179.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 77.2 -40.22 1.7 Allowed Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.444 -1.36 . . . . 1.54 113.967 179.624 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.49 HH11 ' HG2' ' A' ' 186' ' ' ARG . 14.5 ttt-85 -61.31 127.06 29.69 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.996 -1.297 . . . . 4.4800000000000004 109.019 179.037 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 10.5 p 46.38 28.94 0.78 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -0.859 . . . . 2.6299999999999999 112.245 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 42.4 t -83.07 130.04 35.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.922 -1.111 . . . . 1.6899999999999999 108.089 178.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -59.37 -40.74 87.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -0.925 . . . . 1.0700000000000001 110.625 179.295 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -61.28 -40.72 95.2 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.631 -1.293 . . . . 1.5800000000000001 110.258 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 91.6 p -60.81 -36.16 78.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.231 -0.918 . . . . 1.6000000000000001 110.455 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.84 -38.29 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.191 -0.943 . . . . 1.45 110.186 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 67.1 mtp -63.18 -41.85 99.28 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.09 -1.006 . . . . 1.05 109.639 179.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.06 -47.13 86.35 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.491 0.662 . . . . 0.71999999999999997 111.14 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -59.99 -42.6 94.58 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.065 -1.022 . . . . 3.0499999999999998 110.623 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 31.5 m -70.18 -41.0 74.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.89000000000000001 110.007 179.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -90.44 -9.3 47.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.522 -0.736 . . . . 0.78000000000000003 111.841 -178.085 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 194' ' ' ALA . 54.3 mt-10 51.38 12.71 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 114.013 1.116 . . . . 1.45 114.013 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 42.9 mt -70.5 162.03 73.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.902 -1.124 . . . . 0.67000000000000004 108.64 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -68.88 140.67 46.7 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.345 1.363 . . . . 0.64000000000000001 110.59 178.381 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.82 167.88 27.14 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 117.338 -1.745 . . . . 0.67000000000000004 110.268 178.727 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 203' ' ' VAL . 75.6 mt -143.48 157.57 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.257 -1.386 . . . . 0.68999999999999995 107.257 178.213 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.0 m -138.59 -29.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.868 -1.145 . . . . 0.84999999999999998 112.736 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.25 44.69 2.69 Favored Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.273 -0.892 . . . . 0.92000000000000004 111.555 -178.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 181' ' ' THR . 33.5 p -66.31 -18.61 65.46 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.961 -1.317 . . . . 0.94999999999999996 110.841 -179.167 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.35 -94.91 0.74 Allowed Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.51 -1.328 . . . . 1.04 110.123 179.727 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.5 t -126.43 28.19 6.02 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.304 -1.115 . . . . 1.5700000000000001 112.623 -178.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 84.6 t -59.05 -35.23 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.33 -1.482 . . . . 0.83999999999999997 110.592 179.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.4 p -55.31 -25.24 33.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.058 -1.026 . . . . 0.98999999999999999 111.378 -179.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t -93.89 1.05 56.45 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.141 -0.974 . . . . 1.7 111.992 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -121.03 -6.1 9.51 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.18 0.808 . . . . 2.2000000000000002 113.18 -178.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 29.8 t -114.94 150.15 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.705 -0.622 . . . . 0.83999999999999997 109.509 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -124.32 160.61 27.66 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.741 -1.207 . . . . 2.2000000000000002 107.741 177.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 10.2 m120 -54.79 140.88 34.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.581 -1.324 . . . . 2.2799999999999998 110.981 178.541 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.5 m-20 79.03 4.9 2.33 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 114.73 1.381 . . . . 2.3500000000000001 114.73 179.173 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -65.26 142.55 58.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.702 -1.248 . . . . 1.97 108.479 177.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -85.94 115.68 23.71 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.584 -1.265 . . . . 2.6499999999999999 107.584 177.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 75.9 mt -125.19 143.61 50.85 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.767 0.794 . . . . 0.63 109.849 -178.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.2 mt -112.64 128.86 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 106.545 -1.65 . . . . 0.62 106.545 177.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.6 tp -103.55 114.48 28.79 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 105.954 -1.869 . . . . 0.64000000000000001 105.954 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 223' ' ' VAL . 40.8 t0 -90.5 -25.06 20.47 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.945 -1.097 . . . . 2.0499999999999998 112.704 -177.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.896 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.56 14.12 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 113.128 0.788 . . . . 0.83999999999999997 113.128 -179.051 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 221' ' ' ASP . 34.3 t -110.95 -61.24 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.054 -1.028 . . . . 1.02 109.332 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -89.91 9.28 28.28 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.238 1.018 . . . . 2.5099999999999998 110.446 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.64 51.64 3.91 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.389 -0.823 . . . . 1.54 112.171 179.293 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -146.79 151.61 37.41 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.254 1.026 . . . . 1.95 109.789 179.025 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.56 139.09 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.54 -1.282 . . . . 0.70999999999999996 107.54 177.412 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.76 130.48 49.73 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.06 -1.025 . . . . 1.01 108.292 178.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.05 129.57 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.205 -1.035 . . . . 0.81999999999999995 108.205 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.434 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 10.9 t-20 52.24 51.29 9.42 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 113.365 0.876 . . . . 1.54 113.365 179.128 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.2 Cg_endo -63.48 149.42 91.11 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.367 2.044 . . . . 0.93999999999999995 111.2 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.7 m -74.41 152.29 39.52 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.055 -1.028 . . . . 1.8 109.098 177.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.82 -36.51 76.93 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.162 -0.961 . . . . 2.73 110.302 178.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -59.45 -39.83 84.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.674 -0.641 . . . . 3.1699999999999999 110.293 179.362 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 98.5 t -71.69 -42.93 70.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.887 -1.133 . . . . 1.3400000000000001 109.867 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.5 mt . . . . . 0 C--N 1.302 -1.46 0 C-N-CA 119.419 -0.912 . . . . 1.2 110.356 -179.033 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.8 mt . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 107.568 -1.271 . . . . 1.0700000000000001 107.568 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 m -106.59 115.22 29.82 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.346 -1.724 . . . . 1.24 106.346 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.8 -161.06 28.76 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.658 -1.377 . . . . 1.01 109.658 -179.496 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 5' ' ' ILE . 92.7 mt -95.75 1.0 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.415 -1.05 . . . . 1.1100000000000001 112.69 -179.836 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tp 50.15 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.028 -1.045 . . . . 0.98999999999999999 112.27 178.596 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -83.43 -47.97 10.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.071 -1.018 . . . . 0.84999999999999998 111.274 179.15 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -143.53 146.14 34.36 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 107.83 -1.174 . . . . 1.3799999999999999 107.83 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.13 147.24 29.64 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.099 1.866 . . . . 0.93999999999999995 112.14 178.549 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.839 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.42 147.31 4.64 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 119.732 -1.223 . . . . 0.81000000000000005 110.051 178.417 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.9 mt -112.2 130.94 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.797 -1.413 . . . . 0.82999999999999996 108.352 179.261 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.18 149.65 46.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.88 -0.785 . . . . 0.53000000000000003 108.88 178.837 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.5 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.5 m-85 -118.58 139.45 51.46 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 107.652 -1.24 . . . . 0.77000000000000002 107.652 177.352 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.8 169.53 42.49 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 118.585 -1.769 . . . . 0.51000000000000001 110.195 178.452 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -78.72 154.84 29.74 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.732 -0.864 . . . . 1.8999999999999999 109.281 178.042 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -81.88 133.35 35.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.12 -0.988 . . . . 0.66000000000000003 109.007 178.071 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.5 tp -116.33 99.73 7.4 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.009 -1.848 . . . . 0.82999999999999996 106.009 178.123 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.521 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 11.7 tp -85.5 137.61 32.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.667 -1.234 . . . . 0.85999999999999999 107.667 179.659 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.556 HD11 HD11 ' A' ' 158' ' ' LEU . 32.4 mt -102.74 118.31 36.56 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 106.784 -1.561 . . . . 0.92000000000000004 106.784 178.863 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -111.75 136.74 50.61 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.966 -1.124 . . . . 2.0299999999999998 107.966 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -126.36 151.28 47.82 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.179 -0.95 . . . . 2.6600000000000001 109.706 179.009 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -82.44 135.99 35.03 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.622 -1.251 . . . . 2.3199999999999998 107.622 177.329 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -64.21 149.72 47.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 2.1099999999999999 109.159 178.792 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mt -88.19 130.1 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.914 -1.143 . . . . 0.72999999999999998 107.914 177.826 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.2 t -108.57 129.13 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.794 -1.188 . . . . 0.87 107.794 178.711 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.41 136.58 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.157 -1.053 . . . . 0.81000000000000005 108.157 179.233 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -90.54 120.68 31.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.734 -1.21 . . . . 1.3400000000000001 107.734 178.8 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.3 mmm-85 -96.17 11.19 35.24 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.198 -0.939 . . . . 2.8900000000000001 112.667 -179.695 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -64.02 146.07 54.78 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.789 -1.194 . . . . 2.0899999999999999 109.258 178.683 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.37 139.43 30.5 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.889 -1.152 . . . . 2.1899999999999999 107.889 177.708 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -100.75 164.39 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 122.014 0.911 . . . . 0.75 109.904 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.6 p -96.64 165.26 12.23 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.3 0.571 . . . . 0.91000000000000003 109.668 178.369 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.07 -22.13 15.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.93000000000000005 112.045 179.176 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -68.64 -37.08 79.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.97 -1.081 . . . . 2.2799999999999998 110.8 -179.881 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -92.68 -5.79 50.62 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.052 -1.03 . . . . 1.45 112.907 -179.315 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.3 t -59.88 -41.45 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.128 -0.982 . . . . 0.81000000000000005 110.615 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.4 -39.89 84.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.911 -1.118 . . . . 1.54 110.128 179.657 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -60.47 -38.25 83.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.612 -0.68 . . . . 2.3599999999999999 110.744 179.903 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.62 -40.96 89.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.003 -1.061 . . . . 1.3100000000000001 110.37 179.319 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.9 t -60.13 -43.6 93.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.158 -0.964 . . . . 0.81999999999999995 110.322 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -60.55 -43.62 97.02 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.238 -0.914 . . . . 1.5 109.974 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -60.62 -42.92 97.84 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.224 -0.99 . . . . 2.23 109.914 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -73.22 -54.85 7.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.457 -0.777 . . . . 0.84999999999999998 110.016 179.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.6 tp -57.74 -47.76 81.53 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.761 -0.776 . . . . 0.91000000000000003 109.971 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.517 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.6 t -69.9 -41.17 75.07 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.447 -0.783 . . . . 0.90000000000000002 109.905 179.764 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.66 -43.11 94.5 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.284 -1.526 . . . . 0.68999999999999995 109.284 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.401 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.8 ttt-85 -59.97 -29.93 68.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.359 -1.083 . . . . 2.8799999999999999 109.615 179.002 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.23 -49.93 75.97 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.723 -0.791 . . . . 0.84999999999999998 111.078 179.309 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -82.62 -38.53 23.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.239 -0.913 . . . . 2.3500000000000001 110.873 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.11 -44.54 91.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.905 -1.122 . . . . 0.65000000000000002 109.766 -179.381 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.7 t -60.28 -38.18 82.79 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.212 1.006 . . . . 1.45 109.348 179.603 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.89 78.5 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.845 -0.616 . . . . 0.63 110.326 179.47 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -61.68 -49.76 75.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 1.3400000000000001 110.365 179.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.97 -40.37 93.12 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.985 0.898 . . . . 1.5600000000000001 109.656 179.777 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.11 -40.82 90.99 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.298 0.57 . . . . 1.1899999999999999 110.183 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.598 HG22 ' HZ2' ' A' ' 60' ' ' LYS . 14.4 m -67.55 -41.42 84.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.71999999999999997 110.471 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.4 mt -60.12 -38.35 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.481 -0.762 . . . . 0.62 110.712 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -50.92 -41.6 58.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.853 . . . . 1.05 110.475 179.362 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.71 -37.23 76.49 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.908 -1.12 . . . . 0.64000000000000001 109.988 -179.672 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.598 ' HZ2' HG22 ' A' ' 56' ' ' THR . 57.8 mttp -62.28 -38.93 91.22 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.343 -0.943 . . . . 1.73 109.505 179.201 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.25 -30.08 68.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.68 -0.638 . . . . 0.56000000000000005 110.344 179.207 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.95 -37.12 11.86 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.024 -1.084 . . . . 0.68999999999999995 111.511 179.9 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -80.01 -28.18 39.44 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.071 -1.252 . . . . 1.48 110.895 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.4 m -84.57 -47.57 10.43 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.285 -0.884 . . . . 0.97999999999999998 111.086 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -107.22 -10.84 15.73 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.547 0.943 . . . . 1.1599999999999999 113.547 -177.285 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.17 157.99 16.55 Favored Glycine 0 N--CA 1.501 2.968 0 O-C-N 121.269 -0.894 . . . . 0.84999999999999998 113.051 179.02 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -54.45 -21.66 10.49 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.736 -0.861 . . . . 3.8599999999999999 112.58 179.491 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -55.93 -36.87 68.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.019 -1.051 . . . . 2.3500000000000001 111.347 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -80.08 -22.26 42.43 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.1 -1.0 . . . . 1.6699999999999999 112.446 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.1 -35.66 75.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.806 -1.184 . . . . 1.45 111.39 -179.744 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.26 93.6 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.946 -1.096 . . . . 0.60999999999999999 111.724 179.767 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.4 mt -66.83 -44.56 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.59 -1.319 . . . . 0.65000000000000002 110.245 -179.786 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -70.15 -32.87 71.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.074 -1.016 . . . . 0.66000000000000003 110.207 -179.901 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.72 -36.61 79.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 1.1899999999999999 110.11 -179.781 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.93 -41.05 83.79 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 120.396 -0.907 . . . . 0.53000000000000003 110.964 179.401 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -58.68 -44.21 90.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.102 -1.234 . . . . 1.27 110.81 179.562 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.61 -40.09 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.052 -1.03 . . . . 0.54000000000000004 110.329 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 34.2 ttp -60.21 -38.86 84.64 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.35 -0.844 . . . . 1.74 110.428 179.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -58.63 -48.81 79.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.19 -0.944 . . . . 0.55000000000000004 109.919 179.111 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.01 -40.4 89.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.576 -0.702 . . . . 0.46999999999999997 110.376 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -86.16 10.85 13.3 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.386 -0.821 . . . . 1.4199999999999999 112.411 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.14 124.45 21.69 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.038 -1.039 . . . . 1.27 108.659 178.594 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.32 -19.64 65.57 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.746 0.784 . . . . 1.3500000000000001 110.819 -179.162 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -76.39 -52.96 8.85 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.762 -0.775 . . . . 2.2200000000000002 110.406 179.919 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -60.62 -41.26 94.46 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.256 -0.977 . . . . 0.62 110.495 -179.455 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -58.18 -48.62 79.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.939 -1.1 . . . . 1.29 110.58 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -62.28 -38.63 90.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.863 -1.148 . . . . 1.52 110.873 -179.913 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.38 -48.37 67.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.989 -1.07 . . . . 1.3 110.999 179.694 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.8 mt -56.21 -43.47 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.066 -1.021 . . . . 0.60999999999999999 109.735 179.527 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.12 -44.03 99.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.317 0.579 . . . . 0.78000000000000003 110.515 179.874 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.37 -43.71 98.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 0.81999999999999995 110.772 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.32 -46.51 90.0 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.083 -1.011 . . . . 0.80000000000000004 110.483 -179.787 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.65 -43.41 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.77000000000000002 110.617 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -84.41 -33.68 23.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.729 -0.607 . . . . 2.1200000000000001 111.549 -179.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 91' ' ' ALA . 55.7 t0 -79.76 -42.34 24.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.914 -1.116 . . . . 1.51 111.209 -178.4 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -102.65 5.73 39.24 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 1.98 112.921 -177.946 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.9 m170 52.86 48.99 21.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.987 . . . . 1.3200000000000001 111.85 -179.495 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.27 158.27 17.62 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.418 -0.801 . . . . 1.3799999999999999 109.451 178.459 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.4 p -70.96 159.07 35.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.679 -0.638 . . . . 0.67000000000000004 109.414 177.808 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.2 -41.4 88.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 0.52000000000000002 110.8 178.743 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.53 ' OD2' HD21 ' A' ' 142' ' ' LEU . 90.0 m-20 -68.27 -38.74 82.03 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.931 -1.106 . . . . 2.25 110.502 -179.82 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.91 -54.53 15.0 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.754 -0.778 . . . . 0.64000000000000001 111.186 179.691 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.58 94.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.263 -0.898 . . . . 0.56000000000000005 110.408 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.34 88.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.445 -0.785 . . . . 0.46000000000000002 110.442 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -60.14 -39.8 87.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 1.3200000000000001 111.081 -179.936 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.76 -48.0 82.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 1.3 110.69 179.628 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.32 -43.61 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.895 -1.128 . . . . 0.60999999999999999 110.61 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mm -61.52 -32.38 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.649 -0.657 . . . . 0.65000000000000002 110.102 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -58.77 -40.66 84.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.51 -0.744 . . . . 2.1099999999999999 110.469 179.274 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.67 -28.3 27.07 Favored Glycine 0 N--CA 1.499 2.848 0 C-N-CA 119.495 -1.336 . . . . 0.82999999999999996 113.482 179.724 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -63.68 -42.48 98.01 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.31 -1.7 . . . . 1.28 110.061 -179.841 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.24 -50.61 21.42 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.616 0.722 . . . . 0.89000000000000001 110.468 -179.961 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.9 t -60.74 -37.53 82.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.314 -0.866 . . . . 1.8700000000000001 110.627 -179.66 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.24 97.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 1.05 110.901 179.769 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 84.8 mt -66.12 -30.05 70.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.915 -1.116 . . . . 1.02 110.678 -179.748 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -65.71 -22.28 66.6 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.568 -0.707 . . . . 2.04 110.979 179.409 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -70.03 -21.49 63.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.518 -0.739 . . . . 1.73 110.963 179.563 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 123' ' ' LEU . 10.2 mt -82.48 145.66 29.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.786 . . . . 1.3700000000000001 109.544 178.391 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -100.09 39.9 1.3 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.402 -0.811 . . . . 2.8799999999999999 111.787 179.766 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -112.72 139.76 48.07 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.102 -0.999 . . . . 1.5800000000000001 108.923 178.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.536 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 42.1 mp0 -59.57 -38.9 82.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.558 -0.714 . . . . 3.04 111.064 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -70.96 -55.58 8.05 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.671 -1.268 . . . . 0.90000000000000002 110.592 179.723 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 118' ' ' LEU . 25.7 mt -59.8 -40.77 89.44 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.034 -1.041 . . . . 1.0600000000000001 110.371 -179.685 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -64.24 -49.81 70.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.066 . . . . 2.1800000000000002 109.511 179.599 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -60.37 -32.73 71.57 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.399 -0.921 . . . . 2.1499999999999999 109.468 179.76 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.413 ' O ' HG23 ' A' ' 130' ' ' VAL . 56.5 ttt180 -63.83 -28.79 70.09 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.385 -0.926 . . . . 2.3300000000000001 109.529 179.165 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -59.27 -47.31 85.84 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 119.784 -0.766 . . . . 0.81999999999999995 109.335 178.453 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.55 88.57 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.486 -0.886 . . . . 0.84999999999999998 110.143 179.718 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.04 -32.39 73.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.821 . . . . 1.3899999999999999 110.694 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 126' ' ' ARG . 42.8 t -69.24 -39.53 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.56000000000000005 110.161 179.684 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -55.33 -39.94 70.59 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.514 -1.275 . . . . 3.1200000000000001 109.17 178.609 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -60.59 -36.1 77.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.746 -0.596 . . . . 1.28 110.433 179.604 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.3 mt -60.33 -39.62 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.328 -0.858 . . . . 0.48999999999999999 110.389 179.856 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.01 72.31 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.426 -1.369 . . . . 0.46000000000000002 110.675 178.828 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -59.03 -40.79 86.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.429 -1.042 . . . . 2.71 110.336 179.26 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.528 ' NH1' ' OG ' ' A' ' 166' ' ' SER . 24.7 mtp180 -60.99 -40.53 93.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 2.1400000000000001 109.693 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.523 HD13 ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -66.59 -45.52 78.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.714 -0.616 . . . . 1.05 110.279 179.953 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.3 mt -58.43 -41.99 86.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.227 -0.92 . . . . 0.52000000000000002 110.637 179.671 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -61.03 -32.52 72.12 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.143 -0.973 . . . . 2.3500000000000001 111.022 -179.854 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -75.37 -43.82 48.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.906 -1.121 . . . . 1.3899999999999999 111.412 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.21 -35.8 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.68000000000000005 110.905 -178.071 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.53 HD21 ' OD2' ' A' ' 101' ' ' ASP . 64.9 mt -85.47 -7.86 58.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.074 -1.016 . . . . 0.82999999999999996 112.119 -179.829 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.27 22.07 78.53 Favored Glycine 0 N--CA 1.479 1.521 0 C-N-CA 119.095 -1.526 . . . . 0.91000000000000003 113.053 -179.18 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.36 146.41 39.92 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.83 -0.806 . . . . 0.94999999999999996 110.229 -179.621 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -67.74 148.26 51.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 2.4300000000000002 108.955 178.913 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 63.2 mt -102.32 139.23 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.785 -1.191 . . . . 1.1000000000000001 107.785 178.464 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.467 HD12 ' H ' ' A' ' 147' ' ' ILE . 3.8 mp -77.52 132.72 32.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.386 -0.821 . . . . 1.5800000000000001 108.807 179.169 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -95.17 86.81 4.68 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.242 -1.392 . . . . 1.6200000000000001 107.242 179.349 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -75.76 -21.73 57.16 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.87 -0.732 . . . . 0.80000000000000004 111.33 -177.82 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.424 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 32.4 t -80.27 1.08 30.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.369 -0.832 . . . . 1.5600000000000001 112.445 179.598 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.54 24.72 7.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.561 -0.712 . . . . 0.83999999999999997 112.372 -179.08 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 15.1 mt -71.42 140.77 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.372 -0.83 . . . . 0.81999999999999995 109.646 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -114.9 -18.95 11.16 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.582 0.706 . . . . 2.3100000000000001 112.883 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -115.07 134.28 55.31 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.939 -1.134 . . . . 1.54 107.939 -179.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -73.36 126.22 29.65 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.271 -1.011 . . . . 1.3799999999999999 108.271 178.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -148.12 177.08 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.68999999999999995 109.284 -179.615 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.7 mt -85.74 141.91 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 0.53000000000000003 108.651 178.111 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.556 HD11 HD11 ' A' ' 19' ' ' LEU . 24.2 tp -96.19 122.84 39.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.23 -0.919 . . . . 0.64000000000000001 108.886 178.446 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.88 129.96 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.917 -1.142 . . . . 0.67000000000000004 107.917 179.754 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.439 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.16 155.27 22.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.78000000000000003 109.048 179.152 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -60.72 -40.59 92.9 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.42 -1.425 . . . . 1.0 109.358 177.992 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -171.04 151.13 3.19 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.739 -0.838 . . . . 2.4199999999999999 108.739 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 85.2 mt -118.7 139.31 51.74 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.001 -1.111 . . . . 0.75 108.001 177.519 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.9 p -92.8 150.37 39.4 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.238 -0.914 . . . . 0.78000000000000003 108.77 178.844 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -39.8 -41.65 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.34 2.027 . . . . 0.67000000000000004 113.686 179.26 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.528 ' OG ' ' NH1' ' A' ' 136' ' ' ARG . 44.1 m -59.97 -48.26 82.43 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.062 -1.024 . . . . 0.69999999999999996 110.119 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -65.23 -40.06 93.55 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.409 -0.807 . . . . 1.21 110.245 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 43.4 p -67.84 -38.53 83.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.435 -0.791 . . . . 0.59999999999999998 110.3 179.97 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.61 80.59 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.182 -0.949 . . . . 0.62 110.529 179.624 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -95.05 -0.88 53.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.055 -1.028 . . . . 1.1599999999999999 113.133 -179.326 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.1 tp -62.98 150.42 42.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.72999999999999998 109.17 179.801 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 150' ' ' SER . 71.4 m-20 -95.31 112.92 24.56 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.146 -1.428 . . . . 2.2400000000000002 107.146 177.686 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.93 -15.54 61.12 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.139 0.495 . . . . 1.4299999999999999 112.118 -178.106 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -83.72 -23.03 31.81 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.126 -0.984 . . . . 2.1499999999999999 112.612 -178.834 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -104.08 3.02 32.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.138 -0.976 . . . . 2.04 112.877 -178.803 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 178' ' ' GLY . 59.1 t -108.78 127.9 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.711 -1.218 . . . . 0.55000000000000004 107.711 179.556 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 16.1 tp -87.73 -5.47 58.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.504 -0.748 . . . . 1.6299999999999999 111.895 -179.427 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.508 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.7 175.01 35.82 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.797 -1.721 . . . . 0.46999999999999997 108.797 -179.367 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -130.58 137.39 49.64 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.814 -1.18 . . . . 0.54000000000000004 107.814 179.823 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.451 HG22 HG21 ' A' ' 205' ' ' THR . 83.5 mt -137.48 110.86 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 106.688 -1.597 . . . . 0.68999999999999995 106.688 178.519 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 203' ' ' VAL . 70.7 p -130.59 168.49 17.02 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.831 -1.168 . . . . 0.81999999999999995 109.829 -179.668 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 25.8 p-10 -101.7 50.42 0.85 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.626 -0.671 . . . . 2.3700000000000001 110.529 179.841 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.35 147.51 24.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.243 -0.911 . . . . 1.1100000000000001 109.323 179.333 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.43 -16.03 19.46 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.804 -1.189 . . . . 1.6699999999999999 112.36 179.204 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 80.7 -19.47 7.32 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 121.402 -1.058 . . . . 1.54 114.474 179.341 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -60.13 -39.88 87.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.161 -1.199 . . . . 4.4800000000000004 110.569 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 31.1 p -139.84 34.87 1.97 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.587 -0.696 . . . . 2.6299999999999999 111.195 -179.691 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.0 p -84.02 118.87 24.33 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.974 -1.121 . . . . 1.6899999999999999 107.974 178.877 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -60.11 -30.6 69.37 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.584 -0.697 . . . . 1.0700000000000001 110.274 -179.549 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 40.0 m -59.41 -40.9 88.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.497 -0.752 . . . . 1.5800000000000001 110.392 179.225 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 83.3 p -59.97 -39.05 84.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.995 -1.066 . . . . 1.6000000000000001 110.074 179.53 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 75.7 mt -59.94 -39.62 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.41 -0.916 . . . . 1.45 110.516 179.41 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 56.5 mtp -62.43 -42.25 99.32 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.293 1.044 . . . . 1.05 109.423 179.473 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.4 -46.28 86.72 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.646 -0.707 . . . . 0.71999999999999997 110.776 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.429 ' HG2' HH11 ' A' ' 195' ' ' ARG . 46.8 mtt-85 -60.07 -43.78 95.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 3.0499999999999998 110.518 -179.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 51.2 m -68.92 -39.14 79.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.492 -0.755 . . . . 0.89000000000000001 110.316 -179.86 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.2 mt -90.86 -6.86 53.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.569 -0.707 . . . . 0.78000000000000003 112.729 -179.148 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 194' ' ' ALA . 43.6 mt-10 53.2 9.8 0.16 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.918 1.081 . . . . 1.45 113.918 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 34.8 mt -71.27 150.79 94.39 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.043 -1.036 . . . . 0.67000000000000004 108.462 178.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.7 141.32 95.5 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.269 1.313 . . . . 0.64000000000000001 109.465 178.532 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.96 163.79 33.88 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.574 -1.651 . . . . 0.67000000000000004 110.065 179.899 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.495 ' CD1' HD11 ' A' ' 220' ' ' LEU . 18.6 mt -148.69 152.36 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.919 -1.141 . . . . 0.68999999999999995 107.919 178.321 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.3 m -135.1 -28.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 O-C-N 120.758 -1.214 . . . . 0.84999999999999998 111.657 179.568 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.46 40.12 2.56 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.161 -0.962 . . . . 0.92000000000000004 112.219 -178.993 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.451 HG21 HG22 ' A' ' 180' ' ' ILE . 51.5 p -60.96 -18.73 58.82 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.988 -1.301 . . . . 0.94999999999999996 111.42 -179.261 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 77.15 -93.41 1.08 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.971 -1.109 . . . . 1.04 110.501 179.539 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 47.8 p -128.8 27.3 5.48 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.472 -1.017 . . . . 1.5700000000000001 112.597 -178.767 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 83.8 t -59.23 -33.99 52.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.686 -1.259 . . . . 0.83999999999999997 110.872 179.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 44.2 p -59.71 -23.08 62.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.095 -1.003 . . . . 0.98999999999999999 111.729 -179.813 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 37.6 t -93.27 1.01 57.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 1.7 112.113 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -126.29 0.46 7.05 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.847 0.684 . . . . 2.2000000000000002 112.847 -178.281 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 32.0 t -116.11 145.55 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.587 -0.696 . . . . 0.83999999999999997 109.34 179.772 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -119.92 161.33 21.05 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.486 -0.931 . . . . 2.2000000000000002 108.486 177.938 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 18' ' ' LEU . 73.6 m-80 -59.57 142.27 53.1 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 120.749 -1.219 . . . . 2.2799999999999998 110.639 179.159 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.6 t70 80.61 1.04 1.87 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.496 1.295 . . . . 2.3500000000000001 114.496 179.438 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -63.66 148.57 48.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.622 -1.298 . . . . 1.97 108.549 177.706 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -91.69 118.11 30.35 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 106.477 -1.675 . . . . 2.6499999999999999 106.477 177.698 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.422 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 82.3 mt -126.84 144.64 50.91 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.663 0.744 . . . . 0.63 109.867 -178.536 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.3 mt -114.15 127.37 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.711 -1.588 . . . . 0.62 106.711 177.567 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.495 HD11 ' CD1' ' A' ' 202' ' ' ILE . 59.9 tp -99.58 115.31 29.09 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 105.82 -1.918 . . . . 0.64000000000000001 105.82 178.272 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 223' ' ' VAL . 28.7 t0 -89.13 -26.95 21.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.024 -1.047 . . . . 2.0499999999999998 111.701 -178.197 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.28 20.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.598 -0.689 . . . . 0.83999999999999997 112.666 -179.28 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 221' ' ' ASP . 17.3 t -112.33 -59.77 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 122.065 0.936 . . . . 1.02 109.522 179.573 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -99.58 14.39 30.16 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.933 0.873 . . . . 2.5099999999999998 110.87 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 45.6 t30 61.22 50.99 4.52 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 116.031 -0.531 . . . . 1.54 112.195 179.163 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -147.06 147.91 31.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.049 -1.032 . . . . 1.95 109.605 178.431 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.05 139.12 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 107.821 -1.177 . . . . 0.70999999999999996 107.821 178.114 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -99.74 133.29 44.31 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.966 -1.084 . . . . 1.01 108.419 178.394 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.0 t -110.57 130.87 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.589 -0.694 . . . . 0.81999999999999995 109.381 179.23 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.426 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 58.7 t30 52.23 51.52 9.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 113.596 0.962 . . . . 1.54 113.596 178.117 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 55.9 Cg_endo -69.88 152.51 68.73 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.729 2.286 . . . . 0.93999999999999995 110.59 179.879 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 232' ' ' THR . 1.3 p -73.64 161.76 29.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.669 -1.269 . . . . 1.8 109.914 178.216 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -59.87 -38.39 82.06 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.192 -0.942 . . . . 2.73 110.216 178.737 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.83 -41.37 91.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.59 -0.694 . . . . 3.1699999999999999 109.913 179.179 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 86.1 t -70.55 -43.11 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.448 -0.783 . . . . 1.3400000000000001 110.492 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.6 mt . . . . . 0 N--CA 1.488 1.438 0 C-N-CA 118.803 -1.159 . . . . 1.2 109.829 -178.709 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 106.36 -1.718 . . . . 1.0700000000000001 106.36 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.7 m -102.5 120.57 40.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.364 -0.976 . . . . 1.24 108.364 -179.717 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.31 -142.82 11.45 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.791 -1.724 . . . . 1.01 108.791 179.498 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 5' ' ' ILE . 81.5 mt -100.53 -1.0 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.984 -1.304 . . . . 1.1100000000000001 113.399 -178.893 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 tp 49.35 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.659 -1.276 . . . . 0.98999999999999999 112.312 178.556 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.54 -39.87 16.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.259 -0.9 . . . . 0.84999999999999998 111.029 179.307 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.06 145.68 19.96 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.105 -1.072 . . . . 1.3799999999999999 108.105 -179.126 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.95 148.14 31.35 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.849 2.366 . . . . 0.93999999999999995 112.436 178.585 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.871 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.73 152.13 5.96 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 109.817 -1.313 . . . . 0.81000000000000005 109.817 178.088 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.4 mt -118.04 130.17 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.199 -1.177 . . . . 0.82999999999999996 108.072 179.183 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.53 143.89 43.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.315 -0.865 . . . . 0.53000000000000003 109.024 179.006 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.07 138.27 46.68 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.596 -1.261 . . . . 0.77000000000000002 107.596 177.346 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.0 169.73 42.45 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 117.708 -2.187 . . . . 0.51000000000000001 110.4 178.154 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -79.56 159.68 26.76 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.776 -0.824 . . . . 1.8999999999999999 108.776 177.922 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.449 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.6 130.31 34.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.094 -1.004 . . . . 0.66000000000000003 109.11 178.152 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.8 tp -109.46 107.51 17.68 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 104.917 -2.253 . . . . 0.82999999999999996 104.917 176.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 tp -94.2 132.79 38.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.105 -0.997 . . . . 0.85999999999999999 108.977 -179.833 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.3 mt -100.93 122.22 43.1 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.417 -1.327 . . . . 0.92000000000000004 107.417 178.437 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -108.81 131.31 55.1 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.25 -1.018 . . . . 2.0299999999999998 108.25 179.521 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.485 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 83.5 tt0 -111.34 140.38 45.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.554 -0.716 . . . . 2.6600000000000001 109.471 179.073 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -83.87 129.32 34.93 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.412 -1.329 . . . . 2.3199999999999998 107.412 177.893 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -65.9 143.62 57.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.85 . . . . 2.1099999999999999 109.153 179.342 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.0 mt -96.55 135.47 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.506 -0.924 . . . . 0.72999999999999998 108.506 178.587 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.49 130.19 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.376 -0.972 . . . . 0.87 108.376 178.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.2 mt -97.57 141.24 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.644 -0.873 . . . . 0.81000000000000005 108.644 179.325 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -89.77 120.67 31.23 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.755 -1.202 . . . . 1.3400000000000001 107.755 178.083 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.523 ' HG2' HH11 ' A' ' 28' ' ' ARG . 2.1 mmt-85 -95.19 12.49 28.65 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.256 -0.902 . . . . 2.8900000000000001 112.605 179.635 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -66.98 146.64 54.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.878 -1.139 . . . . 2.0899999999999999 109.533 178.879 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -90.18 135.37 33.71 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.964 -1.125 . . . . 2.1899999999999999 107.964 178.032 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.0 pt -100.43 164.76 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.285 -0.884 . . . . 0.75 110.321 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.5 p -94.86 164.89 12.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.475 -0.565 . . . . 0.91000000000000003 109.475 178.4 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.85 -20.23 14.7 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.116 -0.99 . . . . 0.93000000000000005 112.088 179.35 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -68.9 -39.14 79.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.038 -1.039 . . . . 2.2799999999999998 110.986 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -87.22 -9.24 55.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.62 -1.3 . . . . 1.45 112.423 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.23 -43.2 89.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.186 -0.947 . . . . 0.81000000000000005 110.557 -179.394 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -56.65 -40.66 75.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.853 -1.154 . . . . 1.54 110.607 179.548 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -65.04 -46.76 79.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.195 -0.94 . . . . 2.3599999999999999 110.957 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.29 -36.19 79.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.954 -1.092 . . . . 1.3100000000000001 111.17 -179.772 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.84 -40.81 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.933 -1.104 . . . . 0.81999999999999995 110.541 179.287 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -61.12 -41.06 96.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.006 -1.059 . . . . 1.5 109.981 179.673 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.418 ' HG2' HH11 ' A' ' 42' ' ' ARG . 46.8 mtt-85 -61.15 -39.32 89.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.844 . . . . 2.23 110.695 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -72.82 -57.04 4.37 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.38 -0.825 . . . . 0.84999999999999998 110.76 179.517 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.8 tp -59.89 -47.53 85.38 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.314 -0.954 . . . . 0.91000000000000003 110.088 -179.724 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.554 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.3 t -67.88 -36.17 79.78 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.75 0.786 . . . . 0.90000000000000002 109.88 179.855 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.19 -43.15 99.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.864 -1.294 . . . . 0.68999999999999995 109.864 178.856 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -59.54 -30.55 68.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.02 0.915 . . . . 2.8799999999999999 109.344 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.72 -43.11 90.06 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.814 0.816 . . . . 0.84999999999999998 109.511 179.056 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.405 ' HZ3' ' NE2' ' A' ' 53' ' ' GLN . 24.1 ttpp -80.34 -45.88 17.05 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.434 -0.791 . . . . 2.3500000000000001 110.837 179.374 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.64 -41.57 81.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.585 -0.697 . . . . 0.65000000000000002 110.022 179.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.3 p -61.88 -37.16 83.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.119 0.961 . . . . 1.45 109.17 179.765 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.4 -50.2 48.16 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.753 -0.658 . . . . 0.63 110.531 179.454 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' NE2' ' HZ3' ' A' ' 49' ' ' LYS . 96.0 mt-30 -63.53 -48.43 77.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.447 -0.783 . . . . 1.3400000000000001 110.578 -179.865 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.7 mt -61.2 -38.21 85.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 1.5600000000000001 110.01 179.977 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -59.78 -39.98 86.72 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.666 -0.646 . . . . 1.1899999999999999 110.713 179.113 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -65.1 -44.16 89.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.781 -1.2 . . . . 0.71999999999999997 110.243 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.1 -31.97 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.754 . . . . 0.62 110.186 179.791 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -52.07 -47.08 65.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.604 -0.685 . . . . 1.05 110.61 179.075 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -68.77 -33.78 74.46 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.744 -1.222 . . . . 0.64000000000000001 109.843 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -62.15 -39.45 92.67 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.531 -1.267 . . . . 1.73 109.363 179.173 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.84 88.9 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.348 -0.845 . . . . 0.56000000000000005 109.988 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.93 -37.95 42.59 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.573 -1.298 . . . . 0.68999999999999995 110.476 179.474 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -81.57 -22.46 37.78 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.087 -1.243 . . . . 1.48 111.131 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.8 m -84.74 -46.05 11.8 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.548 -0.72 . . . . 0.97999999999999998 110.907 179.941 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -106.5 -23.68 12.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.441 -0.787 . . . . 1.1599999999999999 112.229 -178.981 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.21 168.97 15.28 Favored Glycine 0 N--CA 1.499 2.889 0 CA-C-O 121.785 0.659 . . . . 0.84999999999999998 111.665 -179.534 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -55.68 -28.2 54.26 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.415 -1.05 . . . . 3.8599999999999999 112.717 -179.652 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -57.65 -39.91 78.09 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.911 -1.118 . . . . 2.3500000000000001 111.356 -179.718 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -88.59 -14.53 37.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.618 -1.301 . . . . 1.6699999999999999 112.385 -178.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -60.07 -38.72 83.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.872 . . . . 1.45 110.948 -179.25 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.38 82.97 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.167 -0.958 . . . . 0.60999999999999999 111.245 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.3 mt -63.14 -43.5 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.572 -1.33 . . . . 0.65000000000000002 110.475 179.696 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -68.97 -33.28 73.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.968 -1.083 . . . . 0.66000000000000003 110.001 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.02 -38.84 83.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 1.1899999999999999 110.114 179.365 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.82 -38.14 94.06 Favored Glycine 0 N--CA 1.486 1.985 0 C-N-CA 120.137 -1.03 . . . . 0.53000000000000003 110.585 179.552 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -57.16 -42.33 80.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.841 -1.388 . . . . 1.27 110.284 179.368 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.2 mt -60.34 -41.59 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.08 -1.012 . . . . 0.54000000000000004 109.556 179.641 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.1 ttm -60.19 -39.82 87.88 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 1.74 109.803 179.562 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -58.28 -50.0 75.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.413 -0.804 . . . . 0.55000000000000004 110.45 178.996 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.67 -40.34 91.75 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.331 -0.856 . . . . 0.46999999999999997 110.402 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -87.72 5.62 38.97 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.87 0.693 . . . . 1.4199999999999999 112.87 -179.62 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.31 122.82 15.47 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.911 -1.118 . . . . 1.27 109.581 179.3 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -66.16 -16.29 63.85 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.686 0.755 . . . . 1.3500000000000001 110.749 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -77.06 -49.17 15.92 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.496 -0.882 . . . . 2.2200000000000002 110.523 179.94 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.21 -38.29 90.58 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.386 -0.925 . . . . 0.62 110.24 -178.305 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.88 -47.88 83.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.023 -1.048 . . . . 1.29 111.282 179.314 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -60.7 -39.26 87.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.883 -1.136 . . . . 1.52 110.663 -179.721 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.7 -48.48 71.85 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.575 -0.85 . . . . 1.3 110.638 179.692 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.96 -41.6 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.222 -0.991 . . . . 0.60999999999999999 109.914 179.494 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.81 -42.81 95.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.352 -0.842 . . . . 0.78000000000000003 110.297 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.88 98.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.81999999999999995 110.67 -179.965 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.02 -43.06 95.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.80000000000000004 110.442 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.51 -49.08 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.988 -1.07 . . . . 0.77000000000000002 110.159 179.817 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -76.66 -35.47 57.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 2.1200000000000001 111.824 -179.524 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -80.77 -48.25 12.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.887 -1.133 . . . . 1.51 111.98 -179.643 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -101.41 8.69 42.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.227 -0.921 . . . . 1.98 112.994 -178.658 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.5 m80 51.56 49.36 21.06 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.024 -1.071 . . . . 1.3200000000000001 111.426 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.9 mtt -104.86 149.43 25.69 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.435 1.112 . . . . 1.3799999999999999 109.052 179.834 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.5 p -72.62 159.63 33.56 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.59 0.709 . . . . 0.67000000000000004 109.433 177.81 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.33 81.79 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.51 -0.744 . . . . 0.52000000000000002 110.646 178.627 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.4 p-10 -68.54 -42.31 78.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.977 -1.077 . . . . 2.25 110.268 -179.792 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -70.74 -51.46 27.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.332 -0.855 . . . . 0.64000000000000001 111.386 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.99 84.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.499 -0.751 . . . . 0.56000000000000005 110.528 -179.616 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.6 96.53 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.82 -0.752 . . . . 0.46000000000000002 111.127 179.658 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -60.42 -39.37 87.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.829 -1.169 . . . . 1.3200000000000001 110.782 179.942 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -54.83 -49.75 70.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.129 -0.982 . . . . 1.3 110.761 179.701 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.1 -42.28 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.718 -1.239 . . . . 0.60999999999999999 109.853 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.5 mm -61.76 -32.02 52.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.541 -0.724 . . . . 0.65000000000000002 110.356 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.14 -41.75 89.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 2.1099999999999999 110.388 179.083 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.09 -31.68 19.47 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.063 -1.542 . . . . 0.82999999999999996 112.279 -179.896 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -62.16 -41.88 98.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.414 -1.639 . . . . 1.28 109.635 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.59 -51.26 20.48 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.982 0.896 . . . . 0.89000000000000001 109.713 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.6 t -60.19 -39.93 88.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.358 -0.839 . . . . 1.8700000000000001 110.176 -179.802 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.32 98.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.176 -0.952 . . . . 1.05 110.454 -179.808 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 88.1 mt -64.84 -30.61 71.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.966 -1.084 . . . . 1.02 110.224 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -66.53 -22.2 66.16 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.342 -0.849 . . . . 2.04 110.877 179.712 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.39 -20.45 64.68 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.415 -0.914 . . . . 1.73 110.625 179.511 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.594 HD13 HD13 ' A' ' 123' ' ' LEU . 38.8 mt -83.15 142.41 31.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.441 -0.787 . . . . 1.3700000000000001 109.321 178.362 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -101.4 40.01 1.35 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.398 -0.814 . . . . 2.8799999999999999 111.078 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -112.75 133.48 54.74 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.609 -0.886 . . . . 1.5800000000000001 108.609 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.626 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 5.7 pm0 -60.5 -28.09 68.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.095 -1.003 . . . . 3.04 111.553 179.552 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -74.25 -59.54 2.68 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.072 -1.017 . . . . 0.90000000000000002 110.027 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.594 HD13 HD13 ' A' ' 118' ' ' LEU . 65.0 mt -66.26 -35.73 81.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 1.0600000000000001 110.642 -179.554 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -61.81 -48.51 80.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.803 -1.185 . . . . 2.1800000000000002 110.396 179.466 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -59.74 -30.24 68.71 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.589 -1.244 . . . . 2.1499999999999999 109.649 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 130' ' ' VAL . 58.6 ttt180 -62.27 -29.19 70.24 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.22 -0.992 . . . . 2.3300000000000001 109.17 179.306 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -60.17 -49.75 76.39 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.868 0.842 . . . . 0.81999999999999995 109.805 178.361 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.23 75.92 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.676 -0.809 . . . . 0.84999999999999998 110.234 179.854 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -61.22 -34.08 74.53 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.635 0.731 . . . . 1.3899999999999999 110.648 -179.884 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.6 t -68.95 -37.28 77.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.324 -0.86 . . . . 0.56000000000000005 110.033 179.706 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.426 ' HG2' HH11 ' A' ' 131' ' ' ARG . 22.9 ttt-85 -57.93 -38.31 75.69 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.471 -1.292 . . . . 3.1200000000000001 109.429 178.656 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.498 ' OD1' ' NE ' ' A' ' 136' ' ' ARG . 8.3 t70 -60.11 -40.06 88.35 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.396 0.617 . . . . 1.28 110.568 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 73.1 mt -61.41 -34.68 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.378 -0.826 . . . . 0.48999999999999999 110.18 -179.611 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -64.91 -51.4 51.66 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.131 -1.033 . . . . 0.46000000000000002 110.657 178.783 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -57.9 -40.37 80.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.87 -1.371 . . . . 2.71 110.467 179.547 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.498 ' NE ' ' OD1' ' A' ' 132' ' ' ASP . 58.5 mtt-85 -60.5 -43.24 97.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.998 -1.064 . . . . 2.1400000000000001 110.131 -179.979 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.5 tp -61.26 -44.57 97.03 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.087 -1.008 . . . . 1.05 110.224 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.09 -42.4 90.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.553 -0.717 . . . . 0.52000000000000002 110.547 179.666 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.485 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 98.1 mtt180 -61.38 -34.42 75.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.159 -0.963 . . . . 2.3500000000000001 111.206 -179.851 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -74.06 -43.4 57.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.557 -1.339 . . . . 1.3899999999999999 110.618 179.827 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.4 mt -60.9 -39.38 81.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.52 -0.737 . . . . 0.68000000000000005 110.455 -178.521 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.4 mt -88.84 -11.65 44.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.532 -0.73 . . . . 0.82999999999999996 111.996 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.4 22.83 69.44 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 120.323 -0.941 . . . . 0.91000000000000003 113.581 -179.542 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.39 142.9 58.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.58 -0.953 . . . . 0.94999999999999996 109.534 179.647 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -68.05 151.94 46.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.894 . . . . 2.4300000000000002 110.307 178.377 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.7 mt -104.58 136.89 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.033 -1.099 . . . . 1.1000000000000001 108.033 178.21 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.73 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -81.86 129.62 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.979 -1.119 . . . . 1.5800000000000001 107.979 179.125 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -95.85 98.68 10.61 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.067 -1.827 . . . . 1.6200000000000001 106.067 178.873 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.7 mt -77.37 -14.28 59.75 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.529 -0.732 . . . . 0.80000000000000004 111.775 -177.745 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.6 t -80.1 8.32 7.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.379 -0.826 . . . . 1.5600000000000001 112.323 -179.574 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.34 17.22 17.91 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.647 0.737 . . . . 0.83999999999999997 112.315 179.565 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.4 mt -73.22 136.2 25.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.942 -0.762 . . . . 0.81999999999999995 108.942 179.0 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -124.29 -7.25 7.62 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.547 -0.721 . . . . 2.3100000000000001 112.651 -178.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -110.63 137.5 48.23 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.06 -1.089 . . . . 1.54 108.06 179.794 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -77.25 119.82 21.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.247 -0.908 . . . . 1.3799999999999999 108.695 178.851 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.2 m -148.12 179.49 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.835 -0.802 . . . . 0.68999999999999995 108.835 -178.965 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 30.6 mt -88.33 142.86 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.991 -1.068 . . . . 0.53000000000000003 108.943 178.212 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.0 tp -98.02 120.5 38.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.816 -1.178 . . . . 0.64000000000000001 108.141 178.251 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.24 130.15 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.418 -0.956 . . . . 0.67000000000000004 108.418 179.397 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.36 159.14 27.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.243 -0.911 . . . . 0.78000000000000003 108.752 179.534 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.03 95.6 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.494 -1.378 . . . . 1.0 109.778 177.855 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -172.67 152.65 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.906 -0.775 . . . . 2.4199999999999999 108.906 -179.744 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 64.9 mt -118.99 141.33 48.77 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.315 -0.866 . . . . 0.75 109.09 177.383 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 168' ' ' THR . 68.9 p -90.55 148.82 39.59 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.182 -0.949 . . . . 0.78000000000000003 108.919 179.21 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -40.15 -45.52 4.06 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.645 2.23 . . . . 0.67000000000000004 113.891 179.142 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.0 m -60.09 -46.3 90.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.918 -1.114 . . . . 0.69999999999999996 110.063 -179.607 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.41 -38.49 91.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.27 -0.894 . . . . 1.21 110.331 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 164' ' ' THR . 23.8 p -67.61 -40.75 84.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 0.59999999999999998 110.83 179.662 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.3 74.41 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.791 -0.764 . . . . 0.62 110.339 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -93.38 -4.85 50.72 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.007 -1.058 . . . . 1.1599999999999999 112.862 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.23 153.45 34.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.72999999999999998 109.631 179.878 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -94.13 117.33 29.96 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.292 -1.744 . . . . 2.2400000000000002 106.292 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.785 ' H ' HD22 ' A' ' 173' ' ' LEU . 0.7 OUTLIER -82.46 -19.47 38.81 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.472 -0.767 . . . . 1.4299999999999999 112.396 -177.701 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -84.23 -20.87 31.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.238 -0.913 . . . . 2.1499999999999999 111.912 -178.569 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -99.96 2.32 43.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.187 -0.946 . . . . 2.04 112.528 -179.254 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.472 HG12 ' H ' ' A' ' 178' ' ' GLY . 61.4 t -112.99 129.95 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 107.873 -1.158 . . . . 0.55000000000000004 107.873 179.352 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.584 HD13 ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -82.81 -16.35 48.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.007 -1.058 . . . . 1.6299999999999999 111.705 -179.541 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.472 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -176.69 171.33 44.27 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.073 -1.611 . . . . 0.46999999999999997 109.073 179.909 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -125.79 124.56 41.26 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 107.344 -1.354 . . . . 0.54000000000000004 107.344 178.196 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 180' ' ' ILE . 46.6 mt -123.27 129.75 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 106.952 -1.499 . . . . 0.68999999999999995 106.952 178.215 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 203' ' ' VAL . 34.2 p -140.61 170.0 16.6 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.907 -1.12 . . . . 0.81999999999999995 109.802 179.772 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.94 36.08 3.0 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.871 -0.518 . . . . 2.3700000000000001 111.007 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -96.87 151.53 19.58 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.191 -0.943 . . . . 1.1100000000000001 110.352 178.75 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -46.33 -28.36 3.23 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 120.162 -1.018 . . . . 1.6699999999999999 112.609 177.696 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 87.69 -33.12 4.03 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 121.037 -1.272 . . . . 1.54 113.625 179.406 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -60.44 -40.65 91.86 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.007 -1.29 . . . . 4.4800000000000004 110.346 179.709 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.4 p -118.38 20.18 13.16 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.52 -0.737 . . . . 2.6299999999999999 111.208 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.3 p -89.11 120.46 30.53 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.772 -1.196 . . . . 1.6899999999999999 107.772 178.771 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -60.46 -32.27 71.23 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.388 -0.82 . . . . 1.0700000000000001 110.407 179.827 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 63.0 p -54.68 -41.11 69.82 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.037 -1.039 . . . . 1.5800000000000001 110.68 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.3 t -60.02 -39.83 87.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.298 -0.876 . . . . 1.6000000000000001 109.918 179.818 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.1 mm -59.72 -36.36 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.74 . . . . 1.45 110.392 179.119 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 82.5 mtp -63.0 -43.53 98.54 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.225 1.012 . . . . 1.05 109.209 179.509 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -57.38 -45.09 84.83 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.691 -0.631 . . . . 0.71999999999999997 110.656 179.538 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -63.23 -44.95 93.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.95 -1.093 . . . . 3.0499999999999998 110.435 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.2 m -70.3 -40.88 74.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.913 . . . . 0.89000000000000001 110.257 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.8 mt -91.21 -6.36 53.5 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.494 0.664 . . . . 0.78000000000000003 112.242 -177.145 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 194' ' ' ALA . 98.0 mt-10 50.54 9.42 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.991 1.108 . . . . 1.45 113.991 179.899 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 80.9 mt -71.63 147.67 92.31 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.675 -1.266 . . . . 0.67000000000000004 108.212 179.113 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.52 138.76 81.37 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.454 1.436 . . . . 0.64000000000000001 110.227 178.66 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.54 166.67 20.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.312 -1.755 . . . . 0.67000000000000004 109.865 179.694 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.4 mt -146.25 156.03 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.188 -1.412 . . . . 0.68999999999999995 107.188 177.541 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.0 m -140.38 -32.37 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 120.742 -1.224 . . . . 0.84999999999999998 113.035 -179.166 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -95.28 39.87 2.78 Favored Glycine 0 N--CA 1.497 2.744 0 O-C-N 120.942 -1.099 . . . . 0.92000000000000004 112.076 -177.943 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.505 ' OG1' HG23 ' A' ' 208' ' ' VAL . 23.1 p -59.21 -23.75 62.55 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.089 -1.242 . . . . 0.94999999999999996 111.799 -179.482 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 101.78 -86.16 0.58 Allowed Glycine 0 N--CA 1.496 2.654 0 C-N-CA 120.396 -0.907 . . . . 1.04 111.345 179.807 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.7 m -132.58 36.56 3.55 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 121.124 -1.221 . . . . 1.5700000000000001 113.16 -178.529 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.505 HG23 ' OG1' ' A' ' 205' ' ' THR . 93.1 t -53.06 -33.83 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.336 -1.477 . . . . 0.83999999999999997 110.396 179.252 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.2 p -61.31 -20.62 63.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.98999999999999999 112.018 -179.675 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.2 m -96.08 2.72 53.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.057 -1.027 . . . . 1.7 112.289 179.63 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -132.05 2.97 4.01 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 112.907 0.706 . . . . 2.2000000000000002 112.907 -178.281 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 36.0 t -122.54 142.43 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.439 -0.788 . . . . 0.83999999999999997 109.658 -178.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -119.27 149.15 42.25 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.261 -1.014 . . . . 2.2000000000000002 108.261 177.596 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.464 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 40.3 p-10 -50.73 140.16 15.21 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.876 -1.14 . . . . 2.2799999999999998 110.023 178.688 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t0 79.62 -2.07 2.13 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.482 1.29 . . . . 2.3500000000000001 114.482 179.639 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.09 147.0 53.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.532 -1.355 . . . . 1.97 108.233 177.632 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -88.67 120.84 30.43 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.184 -1.413 . . . . 2.6499999999999999 107.184 178.274 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.449 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 56.6 mt -128.14 146.41 50.72 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.55 -0.719 . . . . 0.63 109.854 -179.56 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.5 mt -114.07 125.02 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 106.788 -1.56 . . . . 0.62 106.788 177.522 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.0 tp -99.86 115.26 29.2 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.315 -1.735 . . . . 0.64000000000000001 106.315 178.528 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 223' ' ' VAL . 30.0 p-10 -92.72 -25.53 18.17 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.663 -1.215 . . . . 2.0499999999999998 112.664 -177.848 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.871 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.47 21.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 112.903 0.705 . . . . 0.83999999999999997 112.903 -178.659 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.3 t -112.79 -59.67 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 121.116 -0.99 . . . . 1.02 109.451 -179.876 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 36.7 m120 -95.79 13.5 26.39 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.148 0.975 . . . . 2.5099999999999998 110.096 -179.701 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 60.76 51.82 4.66 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.23 -0.895 . . . . 1.54 111.85 179.326 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.451 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 81.2 mt-30 -149.54 148.17 29.05 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.246 1.022 . . . . 1.95 110.079 178.454 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.54 138.07 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.312 -1.366 . . . . 0.70999999999999996 107.312 177.887 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -99.58 136.92 38.79 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.933 -1.104 . . . . 1.01 108.516 178.694 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.7 t -109.82 130.18 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 109.001 -0.741 . . . . 0.81999999999999995 109.001 179.135 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 49.42 55.6 17.31 Favored Pre-proline 0 N--CA 1.498 1.973 0 N-CA-C 113.566 0.95 . . . . 1.54 113.566 178.792 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.08 150.66 82.39 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.474 2.116 . . . . 0.93999999999999995 110.412 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.504 ' OG1' HG23 ' A' ' 235' ' ' VAL . 31.1 p -72.08 154.55 41.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 1.8 108.915 177.647 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -57.39 -40.14 77.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.058 -1.026 . . . . 2.73 110.8 178.952 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -60.96 -39.04 88.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -0.984 . . . . 3.1699999999999999 110.332 -179.852 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.504 HG23 ' OG1' ' A' ' 232' ' ' THR . 74.6 t -69.38 -36.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.331 -0.856 . . . . 1.3400000000000001 110.038 179.413 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 1.2 110.462 178.977 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 106.018 -1.845 . . . . 1.0700000000000001 106.018 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.3 m -105.85 124.06 48.96 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.661 -1.236 . . . . 1.24 107.661 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.593 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -104.51 -144.44 13.14 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 108.88 -1.688 . . . . 1.01 108.88 179.527 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 5' ' ' ILE . 73.1 mt -97.28 -3.77 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.146 -1.208 . . . . 1.1100000000000001 112.635 -179.085 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.453 ' H ' HG23 ' A' ' 202' ' ' ILE . 3.8 tp 49.77 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.226 -0.921 . . . . 0.98999999999999999 112.437 178.947 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -85.58 -40.07 16.67 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.0 . . . . 0.84999999999999998 112.152 178.967 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 m -147.02 144.9 20.55 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 120.982 -1.074 . . . . 1.3799999999999999 108.379 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.53 143.95 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.724 2.283 . . . . 0.93999999999999995 112.127 178.246 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.883 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.08 171.41 21.73 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.319 -1.512 . . . . 0.81000000000000005 109.319 178.189 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.8 mt -129.92 133.8 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 N-CA-C 107.702 -1.222 . . . . 0.82999999999999996 107.702 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.38 155.52 47.6 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.564 -0.71 . . . . 0.53000000000000003 109.119 178.742 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.571 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.9 m-85 -126.46 140.18 52.67 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.681 -1.229 . . . . 0.77000000000000002 107.681 177.97 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.83 170.5 41.78 Favored Glycine 0 N--CA 1.499 2.882 0 C-N-CA 118.382 -1.866 . . . . 0.51000000000000001 110.297 178.175 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -77.12 154.26 33.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.965 . . . . 1.8999999999999999 108.938 178.502 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.558 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.03 125.79 33.02 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.233 -1.025 . . . . 0.66000000000000003 108.233 178.373 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.3 tp -105.49 105.92 16.19 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.458 -2.053 . . . . 0.82999999999999996 105.458 177.659 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.6 tp -94.18 135.39 35.61 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.957 -1.127 . . . . 0.85999999999999999 107.957 179.96 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.4 mt -99.36 114.94 28.11 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.832 -1.544 . . . . 0.92000000000000004 106.832 178.353 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -110.38 124.41 51.65 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.626 -1.62 . . . . 2.0299999999999998 106.626 -179.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -129.77 147.52 51.55 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.418 -0.801 . . . . 2.6600000000000001 109.39 -179.493 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 27.6 p-10 -81.55 140.9 34.24 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.912 -1.118 . . . . 2.3199999999999998 109.088 177.807 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -64.69 149.94 48.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.04 -1.038 . . . . 2.1099999999999999 110.976 178.283 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.9 mt -90.8 133.8 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.15 -0.969 . . . . 0.72999999999999998 108.811 178.15 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.3 t -109.29 129.79 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.225 -1.028 . . . . 0.87 108.225 179.119 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.0 mt -94.66 137.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.127 -1.064 . . . . 0.81000000000000005 108.127 178.778 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.95 122.44 35.32 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.977 -1.12 . . . . 1.3400000000000001 107.977 178.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -99.56 18.12 18.72 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.342 -0.849 . . . . 2.8900000000000001 112.631 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -69.18 146.79 52.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 2.0899999999999999 109.428 178.738 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -88.98 130.88 35.38 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.329 -0.989 . . . . 2.1899999999999999 108.329 177.669 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.7 pt -93.33 164.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.751 0.786 . . . . 0.75 110.066 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.2 p -95.41 163.85 13.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.587 -0.695 . . . . 0.91000000000000003 109.659 178.525 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.8 -22.3 13.9 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.113 -0.992 . . . . 0.93000000000000005 111.91 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -68.69 -37.06 79.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.932 . . . . 2.2799999999999998 110.54 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -92.29 -6.31 50.6 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.791 -1.193 . . . . 1.45 113.174 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.31 -42.98 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.055 -1.028 . . . . 0.81000000000000005 110.576 -179.433 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.36 -37.55 75.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.137 -0.977 . . . . 1.54 110.263 179.726 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -61.93 -43.92 97.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.646 -0.659 . . . . 2.3599999999999999 110.847 179.906 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.47 -39.12 86.49 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.045 -1.035 . . . . 1.3100000000000001 111.367 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.26 -40.19 83.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.045 -1.035 . . . . 0.81999999999999995 110.757 179.429 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -60.95 -48.32 82.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.155 -0.965 . . . . 1.5 110.064 179.663 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -62.17 -38.31 88.55 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.167 -0.958 . . . . 2.23 110.278 179.842 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -74.16 -51.03 16.81 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.858 -1.151 . . . . 0.84999999999999998 110.285 179.437 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.4 tp -62.81 -49.67 74.0 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.29 -0.964 . . . . 0.91000000000000003 109.448 -179.622 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.7 t -69.3 -38.77 78.46 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.505 0.669 . . . . 0.90000000000000002 109.653 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.09 -43.54 93.29 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.601 -1.4 . . . . 0.68999999999999995 109.601 179.629 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -59.31 -31.74 69.43 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.07 -1.052 . . . . 2.8799999999999999 109.644 178.871 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -53.78 -47.67 70.53 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.835 -0.746 . . . . 0.84999999999999998 109.919 179.089 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -77.78 -39.77 42.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 2.3500000000000001 110.344 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.76 91.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.65000000000000002 110.049 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.5 p -60.47 -39.6 88.18 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.223 1.011 . . . . 1.45 109.357 179.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.12 -46.02 72.06 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.602 -0.727 . . . . 0.63 110.942 179.494 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.5 -50.09 72.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.222 -0.924 . . . . 1.3400000000000001 110.753 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.21 -36.83 84.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 1.5600000000000001 109.844 -179.889 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -59.39 -40.24 85.95 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.639 -0.663 . . . . 1.1899999999999999 110.53 179.155 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.9 m -66.89 -41.69 86.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.047 -1.033 . . . . 0.71999999999999997 110.324 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.3 -34.03 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.439 -0.788 . . . . 0.62 110.834 -179.703 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -55.93 -45.02 78.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.412 -0.805 . . . . 1.05 111.018 179.301 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.49 -33.44 71.23 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.003 -1.061 . . . . 0.64000000000000001 110.545 -179.626 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -62.75 -40.27 96.7 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.653 -1.219 . . . . 1.73 109.443 -179.844 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.72 -34.52 78.03 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.776 -0.577 . . . . 0.56000000000000005 110.363 179.679 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.88 -37.52 25.7 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.536 -1.316 . . . . 0.68999999999999995 111.41 179.701 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -79.88 -22.31 43.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.036 -1.273 . . . . 1.48 110.815 -179.676 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -89.43 -50.96 5.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.363 -0.836 . . . . 0.97999999999999998 110.597 179.853 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -108.34 -6.99 16.0 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.143 1.164 . . . . 1.1599999999999999 114.143 -177.543 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.6 157.48 23.58 Favored Glycine 0 N--CA 1.502 3.072 0 O-C-N 121.056 -1.028 . . . . 0.84999999999999998 113.473 178.519 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -51.03 -20.69 1.48 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.498 -1.001 . . . . 3.8599999999999999 112.791 179.197 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.49 -35.31 72.03 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.822 -1.174 . . . . 2.3500000000000001 111.489 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -84.16 -18.85 35.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.021 -1.049 . . . . 1.6699999999999999 112.494 -179.555 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.96 -32.71 71.07 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.975 -1.078 . . . . 1.45 110.636 -179.372 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.51 86.88 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.038 -1.039 . . . . 0.60999999999999999 110.598 179.329 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.0 mt -66.33 -47.66 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.118 -0.989 . . . . 0.65000000000000002 109.828 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -72.04 -36.54 69.65 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.219 -0.925 . . . . 0.66000000000000003 110.018 179.822 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.92 -39.11 84.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.493 -0.754 . . . . 1.1899999999999999 110.074 -179.966 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.01 -35.37 83.92 Favored Glycine 0 N--CA 1.484 1.867 0 C-N-CA 119.795 -1.193 . . . . 0.53000000000000003 110.491 179.579 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -60.22 -41.27 92.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -1.135 . . . . 1.27 110.542 179.117 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.4 mt -60.96 -41.94 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.025 -1.047 . . . . 0.54000000000000004 110.423 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.0 ttm -59.77 -40.57 88.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -0.866 . . . . 1.74 110.576 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -60.39 -46.32 90.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.914 -1.116 . . . . 0.55000000000000004 110.032 179.799 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.0 tp -59.0 -40.36 84.65 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.402 -0.811 . . . . 0.46999999999999997 110.487 179.81 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -87.08 8.01 25.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.506 -0.746 . . . . 1.4199999999999999 112.685 -179.887 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -60.26 118.94 7.01 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.185 -0.947 . . . . 1.27 109.61 179.609 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.57 -18.36 63.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.772 0.796 . . . . 1.3500000000000001 110.954 -179.532 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.82 -52.79 8.33 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.747 -0.781 . . . . 2.2200000000000002 110.401 -179.918 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.4 mt -61.24 -37.87 84.62 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.18 -1.008 . . . . 0.62 110.441 -179.529 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -58.88 -48.6 80.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 1.29 110.497 179.216 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.4 -38.81 91.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.285 -0.884 . . . . 1.52 110.476 179.814 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.78 -48.17 72.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.991 -1.068 . . . . 1.3 110.503 179.713 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 93.1 mt -58.29 -42.09 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.252 -0.905 . . . . 0.60999999999999999 109.973 179.419 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.2 mt -63.43 -41.39 92.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.466 -0.772 . . . . 0.78000000000000003 110.167 179.797 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.93 99.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.426 -0.796 . . . . 0.81999999999999995 110.664 -179.778 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.0 mt -59.66 -43.72 93.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.80000000000000004 110.492 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.56 -48.2 89.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.051 -1.031 . . . . 0.77000000000000002 109.911 179.72 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.94 -36.23 41.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.783 . . . . 2.1200000000000001 111.709 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -78.94 -48.29 14.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.709 -1.244 . . . . 1.51 111.315 -178.985 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -101.32 8.65 42.27 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.311 -0.868 . . . . 1.98 112.358 -177.685 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m80 50.67 51.31 17.18 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.972 -1.091 . . . . 1.3200000000000001 111.568 179.892 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.9 mtp -107.79 157.0 18.51 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.55 -0.719 . . . . 1.3799999999999999 109.239 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.2 p -73.95 158.76 33.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.606 -0.684 . . . . 0.67000000000000004 109.407 177.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.75 91.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.485 -0.76 . . . . 0.52000000000000002 110.613 179.347 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 28.8 p-10 -68.05 -42.84 79.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.953 -1.092 . . . . 2.25 110.014 179.314 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -68.28 -50.64 52.34 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.461 -0.896 . . . . 0.64000000000000001 110.734 -179.885 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.24 88.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 0.56000000000000005 110.592 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.69 -45.65 91.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 0.46000000000000002 111.39 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -60.45 -39.24 86.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.792 -1.192 . . . . 1.3200000000000001 111.539 -179.686 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.49 -47.89 78.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.693 -1.255 . . . . 1.3 111.031 179.597 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.18 -44.25 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.723 -1.235 . . . . 0.60999999999999999 109.742 179.854 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -62.74 -34.7 67.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.631 -0.668 . . . . 0.65000000000000002 110.755 179.998 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -56.6 -40.55 75.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.845 . . . . 2.1099999999999999 111.214 179.469 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.21 -34.07 13.26 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.201 -1.476 . . . . 0.82999999999999996 112.91 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -59.97 -38.26 82.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.398 -1.648 . . . . 1.28 110.04 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.04 -47.23 38.2 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.722 0.773 . . . . 0.89000000000000001 110.704 179.599 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.7 m -60.37 -40.17 89.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.092 -1.005 . . . . 1.8700000000000001 110.599 -178.585 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.6 -47.16 86.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.377 -0.827 . . . . 1.05 110.929 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.12 -29.76 69.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.881 -1.137 . . . . 1.02 110.837 -179.829 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -65.06 -22.35 66.96 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.342 -0.849 . . . . 2.04 110.571 179.437 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -71.1 -12.94 61.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.909 0.862 . . . . 1.73 110.815 179.87 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.5 mt -88.49 135.86 33.27 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.806 -1.183 . . . . 1.3700000000000001 107.806 178.712 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 45.6 t0 -97.99 40.99 1.14 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.388 -0.82 . . . . 2.8799999999999999 111.98 -179.381 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -114.53 140.38 48.81 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 121.007 -1.058 . . . . 1.5800000000000001 108.966 178.987 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.07 -40.35 73.46 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.871 -0.732 . . . . 3.04 110.816 178.557 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -71.23 -56.88 5.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.102 -0.999 . . . . 0.90000000000000002 110.59 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.62 -40.5 83.51 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.19 -0.944 . . . . 1.0600000000000001 110.41 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -63.31 -47.77 80.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.02 -1.05 . . . . 2.1800000000000002 109.794 179.866 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -60.17 -31.15 69.85 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.213 -0.929 . . . . 2.1499999999999999 110.092 179.715 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -61.66 -30.07 70.48 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.552 -1.259 . . . . 2.3300000000000001 109.262 179.269 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.78 -50.38 73.69 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.74 -0.784 . . . . 0.81999999999999995 109.423 178.682 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.55 -43.42 80.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.679 0.752 . . . . 0.84999999999999998 110.315 179.769 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -62.8 -32.7 73.94 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.671 0.748 . . . . 1.3899999999999999 110.283 -179.691 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 t -68.69 -39.63 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.419 -0.801 . . . . 0.56000000000000005 110.097 179.589 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -59.48 -37.45 78.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.057 -1.027 . . . . 3.1200000000000001 109.764 178.852 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -59.92 -40.16 87.93 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.484 0.659 . . . . 1.28 110.259 179.436 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.6 mt -59.57 -39.8 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.48999999999999999 110.456 179.598 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.33 -45.51 69.09 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 110.54 -1.024 . . . . 0.46000000000000002 110.54 179.388 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -59.15 -46.77 87.5 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.059 -1.259 . . . . 2.71 110.208 179.41 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 64.4 mtt-85 -62.22 -38.89 90.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.888 -1.132 . . . . 2.1400000000000001 110.273 179.751 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.0 tp -60.15 -41.02 91.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.682 -0.637 . . . . 1.05 109.852 178.911 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.3 mt -59.66 -40.05 86.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.606 -0.684 . . . . 0.52000000000000002 110.58 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -60.28 -39.21 86.08 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.206 -0.934 . . . . 2.3500000000000001 111.256 179.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -73.56 -41.62 62.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.108 . . . . 1.3899999999999999 110.985 -179.866 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.33 -40.08 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.849 . . . . 0.68000000000000005 110.548 -178.436 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.3 mt -89.32 -8.0 54.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.031 -1.043 . . . . 0.82999999999999996 111.891 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.57 23.22 70.79 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.761 -1.209 . . . . 0.91000000000000003 113.518 -179.511 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 18.6 tp -67.23 139.91 57.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.934 -0.745 . . . . 0.94999999999999996 109.115 179.578 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -70.03 146.97 50.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.421 -0.799 . . . . 2.4300000000000002 109.357 177.892 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 79.7 mt -108.68 138.67 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 121.128 -0.982 . . . . 1.1000000000000001 108.619 178.746 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.719 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -78.66 131.65 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.702 -1.249 . . . . 1.5800000000000001 108.808 178.888 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -94.51 97.37 10.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.396 -1.705 . . . . 1.6200000000000001 106.396 178.686 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 mt -77.58 -13.37 59.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.473 -0.767 . . . . 0.80000000000000004 111.916 -177.861 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.8 t -82.9 3.33 30.27 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.906 -1.121 . . . . 1.5600000000000001 112.584 -179.734 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.5 15.26 22.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.316 -0.865 . . . . 0.83999999999999997 112.31 179.451 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 24.6 mt -71.93 140.05 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.565 -0.71 . . . . 0.81999999999999995 109.591 178.801 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -127.91 -6.71 5.56 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.717 0.77 . . . . 2.3100000000000001 112.323 -179.436 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -110.2 140.21 44.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.571 -0.9 . . . . 1.54 108.571 179.459 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -71.61 120.84 17.77 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.589 -0.893 . . . . 1.3799999999999999 108.589 178.403 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.51 171.74 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.985 -0.746 . . . . 0.68999999999999995 108.985 -179.864 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.3 mt -93.18 141.12 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.295 -1.002 . . . . 0.53000000000000003 108.295 178.275 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 26.8 tp -96.79 120.98 38.13 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.0 -1.063 . . . . 0.64000000000000001 108.627 178.46 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.42 HG12 HG22 ' A' ' 209' ' ' THR . 44.6 t -121.21 131.15 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 107.816 -1.179 . . . . 0.67000000000000004 107.816 179.781 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.403 ' C ' HG21 ' A' ' 209' ' ' THR . . . -162.94 157.98 21.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.018 . . . . 0.78000000000000003 108.785 179.084 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.404 ' N ' HG21 ' A' ' 209' ' ' THR . . . -61.35 -34.45 75.31 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.303 -1.498 . . . . 1.0 109.474 178.079 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -173.04 154.91 2.91 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.827 -0.805 . . . . 2.4199999999999999 108.827 179.574 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 69.0 mt -121.64 137.81 54.59 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.375 -1.343 . . . . 0.75 107.375 177.519 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.8 p -93.45 148.24 35.17 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.843 -1.161 . . . . 0.78000000000000003 108.676 179.529 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -39.72 -40.99 2.52 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 122.066 1.844 . . . . 0.67000000000000004 113.485 178.811 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.4 m -60.98 -50.23 74.22 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.254 -0.903 . . . . 0.69999999999999996 110.238 -179.727 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -61.61 -38.55 88.0 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.952 -1.093 . . . . 1.21 109.704 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.4 p -68.61 -36.93 79.32 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.335 0.588 . . . . 0.59999999999999998 110.639 179.524 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.36 -35.02 79.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.402 -0.811 . . . . 0.62 110.64 179.869 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -97.26 -0.6 46.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.477 -0.764 . . . . 1.1599999999999999 112.503 -179.08 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.6 tp -64.21 153.72 37.12 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.735 -0.603 . . . . 0.72999999999999998 109.646 179.749 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.13 113.15 24.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 106.848 -1.538 . . . . 2.2400000000000002 106.848 177.615 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.36 -17.0 60.88 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.873 -0.517 . . . . 1.4299999999999999 112.356 -178.018 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -84.63 -15.43 45.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.105 -0.997 . . . . 2.1499999999999999 112.421 -178.574 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -103.69 -9.7 18.93 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.685 0.994 . . . . 2.04 113.685 -178.032 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 178' ' ' GLY . 59.3 t -109.51 129.98 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.768 -0.827 . . . . 0.55000000000000004 108.768 179.666 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.582 HD13 ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -88.07 -11.56 46.78 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.075 -1.016 . . . . 1.6299999999999999 111.827 -179.428 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.427 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -173.8 167.78 40.43 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.292 -1.523 . . . . 0.46999999999999997 109.292 179.807 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -124.15 131.99 53.59 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.218 -1.166 . . . . 0.54000000000000004 107.995 178.586 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.5 mt -131.49 132.14 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.019 -1.104 . . . . 0.68999999999999995 108.019 178.795 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 203' ' ' VAL . 55.5 p -135.5 163.37 30.23 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.192 -1.04 . . . . 0.81999999999999995 108.192 178.08 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.452 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 17.6 m-20 -106.51 12.35 29.65 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.248 -0.908 . . . . 2.3700000000000001 112.133 179.065 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 184' ' ' GLY . . . -134.66 -62.5 0.73 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.154 -0.966 . . . . 1.1100000000000001 113.184 -177.068 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 183' ' ' ALA . . . -38.27 151.22 0.04 OUTLIER Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.453 -0.659 . . . . 1.6699999999999999 111.453 -176.443 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 172.2 -70.3 0.11 Allowed Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.194 -1.479 . . . . 1.54 112.516 179.343 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.509 ' O ' HG23 ' A' ' 187' ' ' THR . 57.7 mtp180 -54.61 -42.2 70.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -1.223 . . . . 4.4800000000000004 110.755 -178.915 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 186' ' ' ARG . 31.2 p -159.08 45.73 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.825 . . . . 2.6299999999999999 111.114 -179.498 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.0 p -78.85 136.94 37.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.908 -1.12 . . . . 1.6899999999999999 109.355 -179.476 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -60.14 -30.86 69.57 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.627 -0.671 . . . . 1.0700000000000001 110.492 178.863 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.4 m -59.43 -39.6 84.05 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.152 -0.968 . . . . 1.5800000000000001 110.028 179.424 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 87.0 p -59.52 -37.56 78.68 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.271 -0.893 . . . . 1.6000000000000001 110.281 179.366 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.09 -39.75 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 1.45 110.493 179.48 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 45.0 mtp -61.74 -44.31 97.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.994 -1.067 . . . . 1.05 109.524 179.484 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.72 -50.58 72.91 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.373 -0.83 . . . . 0.71999999999999997 111.187 179.992 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -60.57 -42.75 97.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.025 -1.047 . . . . 3.0499999999999998 110.886 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.7 m -69.98 -38.44 76.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.932 -1.105 . . . . 0.89000000000000001 110.521 179.968 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.9 mt -91.66 -8.48 47.0 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.686 0.755 . . . . 0.78000000000000003 112.918 -179.222 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 194' ' ' ALA . 93.8 mt-10 56.75 9.88 0.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.244 1.201 . . . . 1.45 114.244 179.725 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.7 mt -71.41 149.49 93.8 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.945 -1.097 . . . . 0.67000000000000004 108.086 179.167 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.76 140.22 94.09 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.376 1.384 . . . . 0.64000000000000001 109.86 178.741 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.26 163.66 35.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.206 -1.559 . . . . 0.67000000000000004 110.132 179.881 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.462 ' CD1' HD11 ' A' ' 220' ' ' LEU . 11.8 mt -150.25 158.15 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.343 -1.354 . . . . 0.68999999999999995 107.343 178.17 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 181' ' ' THR . 7.0 m -146.78 -25.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 O-C-N 119.958 -1.714 . . . . 0.84999999999999998 113.672 -179.578 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -100.93 43.64 1.7 Allowed Glycine 0 N--CA 1.5 2.948 0 O-C-N 120.886 -1.134 . . . . 0.92000000000000004 110.564 -178.679 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.452 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 33.5 p -63.05 -21.02 65.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.08 -1.247 . . . . 0.94999999999999996 111.658 -179.651 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.84 -83.01 0.51 Allowed Glycine 0 N--CA 1.499 2.88 0 O-C-N 121.518 -0.739 . . . . 1.04 111.32 179.148 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 77.7 p -134.82 31.67 3.31 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.843 -1.386 . . . . 1.5700000000000001 113.256 -178.58 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.447 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 78.8 t -60.05 -37.92 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.173 -1.58 . . . . 0.83999999999999997 110.645 179.576 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.42 HG22 HG12 ' A' ' 159' ' ' VAL . 51.9 p -60.12 -18.97 51.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.174 -0.954 . . . . 0.98999999999999999 112.474 -179.623 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.7 m -94.31 -0.27 55.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 1.7 112.213 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -131.53 8.35 4.58 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.627 -0.671 . . . . 2.2000000000000002 112.545 -178.161 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.85 148.63 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.601 -0.687 . . . . 0.83999999999999997 109.625 -179.146 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -119.01 150.25 40.26 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.939 -1.134 . . . . 2.2000000000000002 107.939 177.857 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 49.6 p-10 -55.68 142.69 33.17 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.899 -1.125 . . . . 2.2799999999999998 110.374 178.414 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 m-20 80.34 -1.8 1.95 Allowed 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 114.276 1.213 . . . . 2.3500000000000001 114.276 179.289 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.14 147.63 50.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.921 -1.112 . . . . 1.97 108.816 177.718 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -88.64 118.35 28.25 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.362 -1.461 . . . . 2.6499999999999999 107.274 177.782 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.558 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.2 mt -128.22 150.34 50.07 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.837 -0.539 . . . . 0.63 109.788 -179.26 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.37 127.92 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 106.964 -1.495 . . . . 0.62 106.964 177.79 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.462 HD11 ' CD1' ' A' ' 202' ' ' ILE . 44.7 tp -100.35 119.92 39.16 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.005 -1.48 . . . . 0.64000000000000001 107.005 178.478 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.638 ' O ' ' N ' ' A' ' 223' ' ' VAL . 34.4 t0 -92.35 -25.37 18.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.771 -1.206 . . . . 2.0499999999999998 112.258 -177.873 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.883 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.34 11.11 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.025 0.75 . . . . 0.83999999999999997 113.025 -179.077 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.6 t -110.45 -62.27 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 120.836 -1.165 . . . . 1.02 109.108 179.776 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -88.52 5.9 40.44 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.213 1.006 . . . . 2.5099999999999998 110.23 -179.804 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.593 HD21 ' H ' ' A' ' 4' ' ' GLY . 1.0 OUTLIER 62.73 52.39 2.8 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.208 -0.905 . . . . 1.54 112.184 179.355 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -145.54 150.51 36.55 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.279 1.038 . . . . 1.95 109.973 178.111 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.11 138.23 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.29 -1.374 . . . . 0.70999999999999996 107.29 178.261 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -103.51 130.92 50.99 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.174 -1.047 . . . . 1.01 108.174 178.463 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 30.2 t -109.2 129.8 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 107.789 -1.189 . . . . 0.81999999999999995 107.789 178.815 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.442 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 19.4 t-20 54.26 49.98 6.27 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 1.54 113.47 178.764 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.4 Cg_endo -68.4 150.27 75.68 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.847 2.365 . . . . 0.93999999999999995 110.608 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.8 p -73.74 160.59 31.3 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.805 -1.184 . . . . 1.8 110.137 178.238 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.37 -41.62 89.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.537 -0.727 . . . . 2.73 110.702 179.046 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -61.94 -34.93 77.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.257 -0.902 . . . . 3.1699999999999999 110.586 -179.804 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.21 -37.4 76.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.965 -1.084 . . . . 1.3400000000000001 109.865 179.386 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--N 1.3 -1.57 0 O-C-N 121.127 -0.983 . . . . 1.2 110.386 179.066 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 105.869 -1.9 . . . . 1.0700000000000001 105.869 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.8 m -106.93 120.28 41.62 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.929 -1.137 . . . . 1.24 107.929 -179.358 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.698 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -100.94 -156.21 27.25 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.602 -1.799 . . . . 1.01 108.602 179.496 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 5' ' ' ILE . 67.4 mt -96.88 1.41 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -1.209 . . . . 1.1100000000000001 112.713 -179.507 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 tp 48.82 98.11 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.044 -1.035 . . . . 0.98999999999999999 112.674 178.565 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -87.28 -39.16 15.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 0.84999999999999998 110.842 179.364 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -146.55 144.66 21.19 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.049 -1.093 . . . . 1.3799999999999999 108.049 -179.454 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.87 145.32 25.17 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.396 2.064 . . . . 0.93999999999999995 111.917 178.307 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.931 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.96 174.36 23.28 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.803 -1.719 . . . . 0.81000000000000005 108.803 178.116 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.9 mt -131.28 139.59 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.846 -1.168 . . . . 0.82999999999999996 107.846 179.759 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.52 148.54 42.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.662 -1.274 . . . . 0.53000000000000003 108.963 178.402 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -119.23 135.7 54.57 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 107.575 -1.269 . . . . 0.77000000000000002 107.575 177.348 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.1 168.41 40.23 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 118.304 -1.903 . . . . 0.51000000000000001 110.112 178.239 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -77.39 159.32 29.55 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.836 -0.802 . . . . 1.8999999999999999 108.836 178.12 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -83.85 120.26 25.85 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.766 -1.209 . . . . 0.66000000000000003 108.011 178.557 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.0 tp -102.46 102.66 12.98 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 105.266 -2.124 . . . . 0.82999999999999996 105.266 178.138 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.8 tp -88.96 130.03 35.52 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.735 -1.209 . . . . 0.85999999999999999 107.735 179.427 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.43 119.54 35.1 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.994 -1.484 . . . . 0.92000000000000004 106.994 178.389 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -110.19 137.57 47.75 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.465 -1.309 . . . . 2.0299999999999998 107.465 -179.787 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -116.22 139.31 50.48 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.111 -0.993 . . . . 2.6600000000000001 108.843 179.004 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -81.66 130.2 34.97 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.599 -1.26 . . . . 2.3199999999999998 107.599 177.758 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.35 141.17 58.87 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.575 -0.898 . . . . 2.1099999999999999 108.575 178.847 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.4 mt -95.73 132.55 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.275 -1.009 . . . . 0.72999999999999998 108.275 178.289 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.95 129.56 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.686 -1.227 . . . . 0.87 107.686 178.87 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.99 137.55 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.541 -0.911 . . . . 0.81000000000000005 108.541 179.302 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -92.34 125.18 36.89 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.944 -1.097 . . . . 1.3400000000000001 108.25 178.751 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -96.98 18.09 15.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -0.853 . . . . 2.8900000000000001 112.1 -179.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -66.9 152.63 45.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.17 -0.956 . . . . 2.0899999999999999 110.377 179.307 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -93.71 134.6 35.86 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.87 -0.789 . . . . 2.1899999999999999 108.87 177.975 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -95.92 169.26 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.526 -0.733 . . . . 0.75 109.784 179.336 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.0 p -94.25 161.93 14.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 0.91000000000000003 109.932 178.494 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.65 -23.08 15.69 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.799 -1.188 . . . . 0.93000000000000005 111.891 179.137 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -69.29 -37.41 77.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.424 -0.798 . . . . 2.2799999999999998 111.016 -179.47 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -88.47 -7.92 55.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.898 -1.126 . . . . 1.45 112.854 -179.852 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.75 -41.18 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.329 -0.857 . . . . 0.81000000000000005 110.219 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.4 -39.3 82.94 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.104 -0.998 . . . . 1.54 110.157 179.243 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -62.29 -40.28 95.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.622 -0.674 . . . . 2.3599999999999999 110.922 -179.993 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.63 -39.58 88.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 1.3100000000000001 110.771 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.12 -41.53 86.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.246 -0.982 . . . . 0.81999999999999995 110.111 179.275 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -61.54 -48.36 81.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.847 -1.158 . . . . 1.5 109.938 179.594 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.527 ' HG2' HH11 ' A' ' 42' ' ' ARG . 14.9 mtt-85 -60.52 -39.5 88.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.123 -0.986 . . . . 2.23 109.628 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -73.39 -52.85 12.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.979 -1.076 . . . . 0.84999999999999998 110.029 179.23 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.97 -45.12 95.06 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.121 -1.032 . . . . 0.91000000000000003 109.643 -179.868 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 9.3 t -67.99 -35.23 77.98 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.957 0.884 . . . . 0.90000000000000002 109.812 -179.761 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.84 -44.49 94.28 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.758 -1.337 . . . . 0.68999999999999995 109.758 178.733 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.416 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 38.1 ttm-85 -57.25 -32.29 66.41 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.065 0.936 . . . . 2.8799999999999999 109.495 178.869 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.76 -44.39 86.12 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.884 0.849 . . . . 0.84999999999999998 109.947 179.251 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -83.47 -43.92 15.29 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.59 -0.694 . . . . 2.3500000000000001 110.964 179.347 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -42.96 89.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 0.65000000000000002 110.244 -179.898 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.415 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 22.9 t -62.89 -40.72 98.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.331 -0.856 . . . . 1.45 109.362 179.772 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.46 -48.79 54.18 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.411 0.624 . . . . 0.63 110.915 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -61.82 -47.75 83.67 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.581 -1.324 . . . . 1.3400000000000001 110.727 -178.592 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.69 -39.2 91.02 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.202 -0.936 . . . . 1.5600000000000001 110.34 -179.611 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 51' ' ' SER . 32.8 mm-40 -60.01 -40.55 89.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.807 -0.558 . . . . 1.1899999999999999 110.724 179.3 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.8 m -64.49 -41.56 96.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.71999999999999997 110.964 -179.887 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.78 -38.83 77.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.379 -0.826 . . . . 0.62 110.97 -179.873 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -52.92 -43.53 66.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 1.05 110.945 179.305 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -70.2 -38.32 75.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.912 -1.117 . . . . 0.64000000000000001 110.279 -179.638 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -62.26 -39.13 91.87 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 118.637 -1.225 . . . . 1.73 109.427 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.24 -28.88 65.6 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.438 -0.789 . . . . 0.56000000000000005 110.768 179.52 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.4 -35.69 13.87 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.423 -1.37 . . . . 0.68999999999999995 110.815 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -81.34 -23.62 37.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.127 -1.219 . . . . 1.48 111.261 -179.91 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -88.66 -48.87 7.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.902 -0.499 . . . . 0.97999999999999998 111.182 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -108.34 -8.05 15.75 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.996 1.11 . . . . 1.1599999999999999 113.996 -177.759 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.06 156.89 19.27 Favored Glycine 0 N--CA 1.501 2.987 0 O-C-N 121.369 -0.832 . . . . 0.84999999999999998 113.577 178.452 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -50.7 -21.73 1.75 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.573 -0.957 . . . . 3.8599999999999999 112.536 179.072 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -54.3 -38.15 65.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.785 -1.197 . . . . 2.3500000000000001 111.814 -179.972 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -80.18 -19.24 47.55 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.747 -1.221 . . . . 1.6699999999999999 112.443 -178.989 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -61.08 -35.5 77.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.984 -1.072 . . . . 1.45 110.811 -179.47 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.79 88.01 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.107 -0.996 . . . . 0.60999999999999999 111.364 179.773 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt -67.91 -46.86 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.465 -1.397 . . . . 0.65000000000000002 110.178 179.771 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -72.25 -28.57 63.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.87 . . . . 0.66000000000000003 111.129 -179.885 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -60.92 -40.56 93.64 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.679 -0.808 . . . . 1.1899999999999999 109.888 179.565 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.22 -42.17 91.25 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.192 -1.163 . . . . 0.53000000000000003 110.192 179.857 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -59.58 -45.99 90.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.472 -1.017 . . . . 1.27 110.79 179.39 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.6 mt -61.21 -40.48 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.663 -1.273 . . . . 0.54000000000000004 110.504 -179.945 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.4 ttm -60.29 -38.35 83.31 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.295 -0.878 . . . . 1.74 110.214 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.5 tp -59.3 -45.77 90.37 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.055 -1.028 . . . . 0.55000000000000004 110.358 179.208 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.416 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 60.0 tp -60.56 -42.38 96.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.526 -0.734 . . . . 0.46999999999999997 110.225 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -84.81 4.87 31.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.304 -0.872 . . . . 1.4199999999999999 112.849 -179.55 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -59.84 125.96 25.71 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.829 -1.169 . . . . 1.27 110.087 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.2 -19.14 65.13 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.542 -0.724 . . . . 1.3500000000000001 111.351 -179.332 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.61 -53.36 9.52 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.144 -1.023 . . . . 2.2200000000000002 110.687 179.946 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.3 mt -62.48 -39.28 92.93 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.32 -0.862 . . . . 0.62 110.753 -179.524 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -58.56 -47.0 85.69 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.152 -0.967 . . . . 1.29 110.822 179.338 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -63.12 -40.48 97.73 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.282 -0.886 . . . . 1.52 110.683 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -66.3 -48.3 70.8 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.939 -1.105 . . . . 1.3 110.646 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.38 -44.79 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.636 -1.29 . . . . 0.60999999999999999 110.028 179.632 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.1 -43.85 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.457 -0.777 . . . . 0.78000000000000003 110.486 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.4 -44.52 94.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 0.81999999999999995 111.027 -179.673 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -60.04 -40.25 88.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.075 -1.016 . . . . 0.80000000000000004 110.735 -179.716 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.55 -47.31 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.056 -1.027 . . . . 0.77000000000000002 110.57 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -83.31 -31.73 26.69 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.327 -0.858 . . . . 2.1200000000000001 112.035 -179.786 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -78.05 -47.85 17.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.511 -1.368 . . . . 1.51 110.9 -178.365 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -104.55 11.45 34.28 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 119.672 -0.811 . . . . 1.98 111.796 -178.05 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.3 m80 52.0 47.56 24.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.043 -1.036 . . . . 1.3200000000000001 111.913 179.809 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 64.5 mtt -98.39 159.85 14.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.141 -0.975 . . . . 1.3799999999999999 109.796 178.656 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.5 p -76.24 160.81 29.32 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.591 -0.693 . . . . 0.67000000000000004 109.894 178.173 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.23 -42.75 86.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.368 -0.832 . . . . 0.52000000000000002 110.989 178.786 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.535 ' OD2' HD21 ' A' ' 142' ' ' LEU . 92.6 m-20 -70.04 -38.97 75.99 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.658 -1.276 . . . . 2.25 110.19 -179.997 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.85 -51.56 39.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.859 -1.151 . . . . 0.64000000000000001 111.589 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.96 92.26 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.792 -1.163 . . . . 0.56000000000000005 110.811 -179.813 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.35 95.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.798 -0.564 . . . . 0.46000000000000002 110.988 179.832 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -60.78 -40.25 91.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.629 -1.294 . . . . 1.3200000000000001 111.236 -179.514 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.27 -49.87 76.19 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.843 -1.16 . . . . 1.3 111.4 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -59.43 -45.75 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.924 -1.11 . . . . 0.60999999999999999 109.99 179.929 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.6 mm -62.72 -30.45 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-O 121.388 0.613 . . . . 0.65000000000000002 110.329 179.768 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -57.36 -40.22 77.64 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.793 -0.763 . . . . 2.1099999999999999 110.509 179.16 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.16 -30.67 22.05 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 119.249 -1.453 . . . . 0.82999999999999996 112.877 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -61.34 -41.54 97.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.383 -1.657 . . . . 1.28 110.293 -179.914 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.7 -46.91 51.32 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 119.805 -0.758 . . . . 0.89000000000000001 110.524 -179.975 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 50.4 p -62.99 -35.67 80.98 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.33 -0.856 . . . . 1.8700000000000001 110.782 -178.447 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.97 87.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.604 -0.685 . . . . 1.05 110.898 179.951 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 mt -65.33 -28.74 69.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.868 -1.145 . . . . 1.02 111.271 -179.509 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -66.43 -19.69 65.86 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.355 -0.938 . . . . 2.04 110.671 179.179 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -72.42 -11.22 60.59 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.471 -0.891 . . . . 1.73 110.654 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.499 HD13 HD13 ' A' ' 123' ' ' LEU . 69.4 mt -86.44 141.61 29.0 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.522 0.677 . . . . 1.3700000000000001 109.213 179.535 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -98.13 38.14 1.35 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.193 -0.942 . . . . 2.8799999999999999 112.206 179.48 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -113.79 137.7 51.28 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.26 -1.015 . . . . 1.5800000000000001 108.26 178.873 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.63 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 28.2 mp0 -59.12 -39.86 83.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.972 -1.08 . . . . 3.04 111.076 179.182 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -71.24 -52.92 16.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.743 -1.223 . . . . 0.90000000000000002 110.531 179.774 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.499 HD13 HD13 ' A' ' 118' ' ' LEU . 36.2 mt -59.98 -40.39 88.97 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.865 -1.147 . . . . 1.0600000000000001 110.384 -179.595 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -59.1 -45.72 90.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.893 -1.129 . . . . 2.1800000000000002 110.2 179.483 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.48 -31.98 70.98 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.369 -0.933 . . . . 2.1499999999999999 109.906 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 130' ' ' VAL . 34.8 ttm180 -60.6 -31.2 70.37 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.829 -1.148 . . . . 2.3300000000000001 109.106 178.896 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.61 76.44 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.556 0.693 . . . . 0.81999999999999995 110.249 179.026 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.98 78.03 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.126 -0.63 . . . . 0.84999999999999998 110.138 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.34 -34.84 78.58 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.629 0.728 . . . . 1.3899999999999999 110.673 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 126' ' ' ARG . 29.6 t -68.23 -41.02 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.128 -0.982 . . . . 0.56000000000000005 110.3 179.723 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -57.9 -38.73 76.34 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.445 -1.302 . . . . 3.1200000000000001 109.429 179.121 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -59.79 -37.58 79.51 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 120.124 -0.631 . . . . 1.28 110.181 179.199 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.99 -39.81 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 0.48999999999999999 109.591 179.355 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.93 -46.03 77.56 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.885 -1.15 . . . . 0.46000000000000002 110.408 179.082 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -57.38 -41.85 81.01 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.356 -1.085 . . . . 2.71 110.163 179.299 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.442 ' HG2' HH11 ' A' ' 136' ' ' ARG . 50.7 mtt-85 -61.52 -42.98 99.62 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.251 -0.979 . . . . 2.1400000000000001 110.006 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.77 -42.33 97.25 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.782 -0.767 . . . . 1.05 109.536 179.78 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.5 mt -60.05 -43.78 95.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.526 -0.734 . . . . 0.52000000000000002 110.404 179.698 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.468 ' NH1' HD23 ' A' ' 144' ' ' LEU . 49.8 mtt-85 -60.54 -36.41 78.36 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.622 -0.674 . . . . 2.3500000000000001 110.703 -179.974 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -73.94 -40.36 63.12 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.32 -0.863 . . . . 1.3899999999999999 111.011 179.719 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.463 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.8 mt -60.55 -40.38 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.889 -1.132 . . . . 0.68000000000000005 110.614 -178.815 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.535 HD21 ' OD2' ' A' ' 101' ' ' ASP . 81.4 mt -87.51 -11.17 49.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.669 -1.27 . . . . 0.82999999999999996 111.855 -178.951 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.79 18.61 74.9 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.763 -1.208 . . . . 0.91000000000000003 112.402 -179.71 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.468 HD23 ' NH1' ' A' ' 139' ' ' ARG . 47.8 tp -63.74 145.32 55.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.921 -0.752 . . . . 0.94999999999999996 109.194 179.218 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -69.02 147.27 51.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.51 -0.744 . . . . 2.4300000000000002 109.534 178.508 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.0 mt -106.84 141.21 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.383 -0.969 . . . . 1.1000000000000001 108.383 178.143 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.555 HD12 ' H ' ' A' ' 147' ' ' ILE . 5.3 mp -76.01 123.72 32.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.357 -0.979 . . . . 1.5800000000000001 108.357 178.238 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -99.62 100.52 11.53 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 106.064 -1.828 . . . . 1.6200000000000001 106.064 178.98 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.4 mt -75.2 -14.26 60.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.313 -0.867 . . . . 0.80000000000000004 111.759 -177.885 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.6 p -78.42 3.07 16.78 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.317 1.055 . . . . 1.5600000000000001 112.153 -179.331 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.28 19.83 14.7 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.125 -0.984 . . . . 0.83999999999999997 112.744 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 22.6 mt -74.1 137.42 23.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.907 -1.121 . . . . 0.81999999999999995 109.241 179.172 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -115.52 -14.27 11.53 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.856 0.836 . . . . 2.3100000000000001 112.558 -178.717 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -113.47 136.35 52.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.502 -1.295 . . . . 1.54 107.502 179.932 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -73.67 124.55 26.19 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.588 -0.893 . . . . 1.3799999999999999 108.588 178.689 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -146.45 175.58 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.46 -0.775 . . . . 0.68999999999999995 109.404 -179.69 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.1 mt -87.53 148.49 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.53000000000000003 108.975 178.135 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -99.75 120.54 39.89 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.055 -1.091 . . . . 0.64000000000000001 108.055 178.114 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -121.58 129.59 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 N-CA-C 107.718 -1.215 . . . . 0.67000000000000004 107.718 179.391 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.1 155.97 21.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.968 -1.083 . . . . 0.78000000000000003 108.863 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.454 ' O ' ' CG ' ' A' ' 162' ' ' ASP . . . -60.59 -37.58 81.81 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.395 -1.441 . . . . 1.0 109.674 178.131 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 161' ' ' ALA . 58.0 m-20 -167.81 153.86 7.51 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.733 -0.839 . . . . 2.4199999999999999 108.733 179.179 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.8 mt -116.46 139.91 49.94 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 108.374 -0.972 . . . . 0.75 108.374 177.76 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.5 p -96.85 148.97 35.2 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.22 -0.925 . . . . 0.78000000000000003 108.892 179.402 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.68 -40.01 7.53 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.747 1.632 . . . . 0.67000000000000004 113.599 179.092 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.6 m -61.75 -49.69 75.39 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.024 -1.047 . . . . 0.69999999999999996 109.922 -179.336 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -61.87 -39.96 93.71 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.085 -1.01 . . . . 1.21 110.077 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.8 p -67.67 -37.62 82.63 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.417 -0.802 . . . . 0.59999999999999998 110.267 179.506 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.22 -36.05 82.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.402 -0.811 . . . . 0.62 111.322 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -98.44 -0.47 43.47 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.351 -0.843 . . . . 1.1599999999999999 112.795 -179.276 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.7 tp -64.14 154.88 33.31 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.951 -0.7 . . . . 0.72999999999999998 109.906 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.631 HD22 ' N ' ' A' ' 173' ' ' LEU . 0.3 OUTLIER -97.41 118.76 34.62 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.984 -1.487 . . . . 2.2400000000000002 106.984 177.427 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.631 ' N ' HD22 ' A' ' 172' ' ' ASN . 44.9 mt -76.52 -19.6 57.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.512 -0.742 . . . . 1.4299999999999999 111.953 -178.126 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.609 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 66.3 mttm -82.39 -19.86 38.27 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.06 -1.025 . . . . 2.1499999999999999 112.455 -178.904 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -102.44 -0.76 31.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.46 -0.775 . . . . 2.04 113.065 -178.012 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 178' ' ' GLY . 46.9 t -109.23 121.22 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.591 -1.262 . . . . 0.55000000000000004 107.591 179.049 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.1 tp -84.74 -4.04 58.86 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.144 -0.972 . . . . 1.6299999999999999 111.821 -179.434 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.491 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.96 171.29 36.82 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.872 -1.691 . . . . 0.46999999999999997 108.872 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 3.6 m-85 -125.0 129.69 50.82 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.941 -1.133 . . . . 0.54000000000000004 107.941 178.463 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.444 ' CG2' HG21 ' A' ' 205' ' ' THR . 30.1 mt -129.92 121.43 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 106.173 -1.788 . . . . 0.68999999999999995 106.173 177.908 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 203' ' ' VAL . 39.4 p -139.88 172.31 12.96 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.631 -1.293 . . . . 0.81999999999999995 110.355 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.487 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 4.8 m-20 -105.29 51.96 0.75 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.529 -0.732 . . . . 2.3700000000000001 109.676 179.382 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -103.93 153.94 20.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.366 -0.834 . . . . 1.1100000000000001 109.709 179.617 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -58.88 -36.2 86.38 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 120.212 -0.994 . . . . 1.6699999999999999 110.712 178.517 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 96.52 -17.86 58.52 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 121.164 -1.198 . . . . 1.54 114.157 179.458 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.405 ' HG2' ' NH1' ' A' ' 186' ' ' ARG . 59.4 mtt-85 -58.67 -41.13 85.45 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.835 -1.391 . . . . 4.4800000000000004 110.212 179.289 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 75.5 p -140.83 36.29 1.78 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.539 -0.726 . . . . 2.6299999999999999 111.212 -179.391 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 69.9 m -81.9 123.06 28.51 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.553 -1.277 . . . . 1.6899999999999999 107.553 179.489 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -60.5 -37.58 81.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.669 -0.645 . . . . 1.0700000000000001 110.741 -179.828 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 23.0 m -52.96 -42.51 65.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 1.5800000000000001 110.439 179.253 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.8 m -59.65 -40.43 87.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.03 -1.044 . . . . 1.6000000000000001 110.107 179.463 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.34 -35.69 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.593 -0.692 . . . . 1.45 110.848 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 57.1 mtp -62.6 -40.81 98.1 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.093 0.949 . . . . 1.05 109.453 179.481 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.0 -41.73 92.71 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.589 -0.732 . . . . 0.71999999999999997 110.515 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -59.8 -44.93 93.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 3.0499999999999998 110.712 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.1 m -71.19 -39.35 71.88 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.002 -1.061 . . . . 0.89000000000000001 110.164 -179.843 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.1 mt -90.98 -7.94 50.6 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 112.712 0.634 . . . . 0.78000000000000003 112.712 -178.124 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 54.29 9.03 0.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.207 1.188 . . . . 1.45 114.207 179.836 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 39.5 mt -71.37 148.92 93.77 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 108.326 -0.99 . . . . 0.67000000000000004 108.326 179.133 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.45 144.25 92.29 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.456 1.438 . . . . 0.64000000000000001 109.368 178.608 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -157.9 160.67 37.88 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.086 -1.446 . . . . 0.67000000000000004 109.65 179.647 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.587 HD12 HD11 ' A' ' 220' ' ' LEU . 14.8 mt -150.78 149.07 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.862 -1.162 . . . . 0.68999999999999995 107.862 178.386 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.5 m -134.21 -32.18 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.245 -0.909 . . . . 0.84999999999999998 112.811 -179.755 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.51 33.56 0.83 Allowed Glycine 0 N--CA 1.483 1.792 0 O-C-N 121.183 -0.948 . . . . 0.92000000000000004 113.037 -178.135 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.487 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 35.0 p -59.67 -26.95 65.97 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 121.465 -1.021 . . . . 0.94999999999999996 111.085 -179.199 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 79.53 -93.38 1.35 Allowed Glycine 0 N--CA 1.488 2.102 0 C-N-CA 120.181 -1.009 . . . . 1.04 110.952 179.386 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.5 m -123.54 29.74 6.49 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.246 0.832 . . . . 1.5700000000000001 113.246 -178.798 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 70.3 t -59.84 -33.59 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.824 -1.172 . . . . 0.83999999999999997 110.237 179.027 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 58.8 p -59.33 -23.23 62.32 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.087 -1.008 . . . . 0.98999999999999999 111.459 179.947 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.1 t -92.27 -0.38 57.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.914 -1.116 . . . . 1.7 111.428 -179.288 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -124.47 -7.22 7.51 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.617 -0.72 . . . . 2.2000000000000002 112.681 -177.938 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.43 141.82 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.164 -0.68 . . . . 0.83999999999999997 109.164 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -116.72 151.44 36.38 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.1 -1.074 . . . . 2.2000000000000002 108.1 178.296 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 48.2 t30 -53.25 143.29 18.79 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.279 -0.968 . . . . 2.2799999999999998 110.44 178.318 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.1 t0 82.2 -6.99 1.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.099 1.148 . . . . 2.3500000000000001 114.099 179.524 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 16' ' ' ALA . 87.6 m-20 -63.18 143.23 57.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.636 -1.29 . . . . 1.97 108.288 177.466 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -88.23 119.1 28.31 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.388 -1.338 . . . . 2.6499999999999999 107.388 178.124 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.438 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 42.4 mt -127.83 144.51 51.09 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.137 -0.69 . . . . 0.63 109.137 -179.04 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.9 mt -111.94 128.61 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 106.918 -1.512 . . . . 0.62 106.918 177.72 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.587 HD11 HD12 ' A' ' 202' ' ' ILE . 44.1 tp -99.97 118.67 36.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.975 -1.861 . . . . 0.64000000000000001 105.975 178.35 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 223' ' ' VAL . 35.0 p-10 -92.65 -22.19 19.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 2.0499999999999998 112.736 -177.558 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.931 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.75 16.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 112.756 0.65 . . . . 0.83999999999999997 112.756 -179.206 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.632 ' N ' ' O ' ' A' ' 221' ' ' ASP . 15.7 t -111.21 -63.81 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.056 -1.027 . . . . 1.02 108.78 179.694 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -90.22 9.15 29.65 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.245 1.021 . . . . 2.5099999999999998 110.463 -179.779 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.698 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.8 OUTLIER 61.62 52.8 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.067 -0.97 . . . . 1.54 112.157 179.61 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -148.29 153.46 38.7 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.409 1.1 . . . . 1.95 110.25 179.131 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.4 135.48 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.542 -1.281 . . . . 0.70999999999999996 107.542 177.465 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -101.15 136.93 40.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.987 -1.071 . . . . 1.01 108.719 178.744 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.7 t -109.84 130.04 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.171 -1.048 . . . . 0.81999999999999995 108.171 179.104 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.451 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 60.7 t30 48.44 50.32 8.86 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.914 . . . . 1.54 113.292 178.913 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.7 Cg_endo -63.41 151.66 83.82 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.32 2.013 . . . . 0.93999999999999995 110.712 -179.904 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.9 m -73.97 156.79 37.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.795 -1.191 . . . . 1.8 109.226 177.65 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.407 ' HA ' HD12 ' A' ' 236' ' ' ILE . 29.8 m120 -56.79 -40.05 75.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.033 -1.042 . . . . 2.73 111.133 179.054 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.448 ' H ' ' CD ' ' A' ' 234' ' ' GLU . 45.2 mp0 -59.12 -39.52 82.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.044 -1.035 . . . . 3.1699999999999999 110.288 179.687 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.8 -37.94 78.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.759 0.79 . . . . 1.3400000000000001 110.097 179.732 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 233' ' ' ASN . 84.5 mt . . . . . 0 N--CA 1.488 1.46 0 O-C-N 121.133 -0.979 . . . . 1.2 110.398 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.246 -0.65 . . . . 3.0699999999999998 109.246 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.2 mt -91.92 112.36 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.468 -1.679 . . . . 1.0700000000000001 106.468 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.0 m -105.98 119.99 40.62 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.652 -1.24 . . . . 1.24 107.652 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.17 -160.96 23.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.531 -1.827 . . . . 1.01 108.531 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 5' ' ' ILE . 95.6 mt -95.98 1.29 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.447 -1.031 . . . . 1.1100000000000001 113.076 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 tp 51.8 93.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.536 -1.353 . . . . 0.98999999999999999 112.297 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -88.75 -34.11 17.25 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.052 -1.03 . . . . 0.84999999999999998 111.001 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 201' ' ' ALA . 1.9 p -149.8 140.89 14.46 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 107.682 -1.229 . . . . 1.3799999999999999 107.682 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.28 146.99 22.76 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.518 2.145 . . . . 0.93999999999999995 112.173 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.945 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.15 173.69 22.71 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 108.722 -1.751 . . . . 0.81000000000000005 108.722 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.0 mt -132.12 136.42 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.073 -1.251 . . . . 0.82999999999999996 107.683 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.34 155.92 45.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.004 -1.06 . . . . 0.53000000000000003 109.429 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.606 ' CE1' ' NH2' ' A' ' 240' ' ' ARG . 4.6 m-85 -128.38 140.19 51.98 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.391 -0.966 . . . . 0.77000000000000002 108.391 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.36 172.01 39.86 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 118.546 -1.788 . . . . 0.51000000000000001 110.061 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -76.02 156.07 34.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.86 -0.788 . . . . 1.8999999999999999 109.144 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -84.52 122.87 29.61 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.454 -1.313 . . . . 0.66000000000000003 107.454 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.4 tp -100.2 106.97 18.7 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 105.558 -2.016 . . . . 0.82999999999999996 105.558 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.4 tp -91.04 131.36 36.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.917 -1.142 . . . . 0.85999999999999999 107.917 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 158' ' ' LEU . 44.4 mt -99.52 118.04 35.23 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.878 -1.527 . . . . 0.92000000000000004 106.878 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -110.15 136.09 49.92 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.79 -1.189 . . . . 2.0299999999999998 107.79 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -128.56 151.21 49.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.08 -1.013 . . . . 2.6600000000000001 109.748 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -81.52 135.61 35.6 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.816 -1.179 . . . . 2.3199999999999998 107.816 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -63.67 147.89 50.43 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.743 -0.836 . . . . 2.1099999999999999 108.743 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.2 mt -93.23 125.48 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.728 -1.212 . . . . 0.72999999999999998 107.728 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.2 t -109.96 129.95 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.43 -0.952 . . . . 0.87 108.43 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.9 mt -95.02 141.44 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.152 -0.968 . . . . 0.81000000000000005 108.612 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -90.53 122.68 33.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.033 . . . . 1.3400000000000001 108.414 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.531 ' HG2' HH11 ' A' ' 28' ' ' ARG . 4.6 mmt-85 -94.46 17.02 13.82 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.37 -0.831 . . . . 2.8900000000000001 111.983 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -74.85 140.42 43.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.259 -0.901 . . . . 2.0899999999999999 109.006 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -90.97 129.55 36.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.958 -1.089 . . . . 2.1899999999999999 108.074 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 pt -89.31 166.19 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.75 110.835 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.8 p -96.81 167.19 11.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.405 -0.81 . . . . 0.91000000000000003 109.653 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -15.16 2.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.922 -1.111 . . . . 0.93000000000000005 112.39 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -70.33 -39.61 74.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 2.2799999999999998 110.824 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -94.61 -4.73 47.23 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.635 -1.291 . . . . 1.45 113.029 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.71 -41.38 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.272 -0.893 . . . . 0.81000000000000005 110.358 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -56.09 -40.1 73.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 1.54 110.189 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -63.16 -36.12 82.58 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.335 -0.853 . . . . 2.3599999999999999 110.688 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 42' ' ' ARG . 78.6 mm-40 -60.23 -42.06 94.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 1.3100000000000001 110.398 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.98 -46.0 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.387 -0.821 . . . . 0.81999999999999995 110.731 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.24 -50.01 74.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.058 -1.026 . . . . 1.5 110.392 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 76.6 mtm180 -62.41 -41.0 98.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -0.897 . . . . 2.23 110.231 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -70.26 -55.33 9.51 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.383 -0.823 . . . . 0.84999999999999998 109.566 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.25 -47.67 85.0 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.797 0.808 . . . . 0.91000000000000003 110.361 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 12.2 t -68.67 -38.19 80.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.303 -0.873 . . . . 0.90000000000000002 110.208 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.61 -46.57 88.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.775 -1.33 . . . . 0.68999999999999995 109.775 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -59.91 -29.31 68.28 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.405 -1.056 . . . . 2.8799999999999999 110.311 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.33 -48.86 80.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.808 -0.557 . . . . 0.84999999999999998 110.97 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -82.55 -35.93 26.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.833 -1.167 . . . . 2.3500000000000001 110.084 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -45.33 89.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.369 -0.832 . . . . 0.65000000000000002 109.95 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 t -61.73 -39.8 92.84 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.917 0.865 . . . . 1.45 109.558 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.03 -49.86 63.87 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.287 -0.565 . . . . 0.63 110.873 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -61.7 -51.0 70.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.97 -1.081 . . . . 1.3400000000000001 110.955 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.72 -38.94 89.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.241 -0.912 . . . . 1.5600000000000001 110.483 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -58.68 -40.09 82.57 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.059 -0.656 . . . . 1.1899999999999999 110.654 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 m -63.08 -41.75 99.49 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.839 -1.163 . . . . 0.71999999999999997 110.247 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.11 -36.32 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.571 -0.706 . . . . 0.62 110.778 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -52.97 -42.56 65.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 1.05 110.76 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.31 -36.12 76.67 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.139 -0.975 . . . . 0.64000000000000001 110.21 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -62.14 -39.34 92.24 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.246 -0.981 . . . . 1.73 109.454 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.02 -34.74 78.78 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.342 0.591 . . . . 0.56000000000000005 110.113 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.43 19.02 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.749 -1.215 . . . . 0.68999999999999995 111.355 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.26 -23.32 35.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -1.183 . . . . 1.48 111.406 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.5 m -86.6 -49.71 7.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.793 -0.567 . . . . 0.97999999999999998 110.649 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.527 ' CZ ' ' SD ' ' A' ' 193' ' ' MET . 72.2 m-85 -108.43 -6.65 16.08 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 113.954 1.094 . . . . 1.1599999999999999 113.954 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.0 168.03 29.4 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.115 -1.04 . . . . 0.84999999999999998 111.745 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.94 -20.49 38.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.273 -1.134 . . . . 3.8599999999999999 112.603 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.47 -42.03 73.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.618 -1.301 . . . . 2.3500000000000001 110.945 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -88.43 -25.18 22.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.017 -1.052 . . . . 1.6699999999999999 111.998 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -59.99 -37.28 79.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 1.45 111.356 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.36 84.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.60999999999999999 111.299 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.8 mt -65.2 -43.98 95.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.494 -1.379 . . . . 0.65000000000000002 110.303 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -70.63 -34.53 72.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.938 -1.102 . . . . 0.66000000000000003 110.423 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.49 -38.55 84.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.3 -0.875 . . . . 1.1899999999999999 110.491 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.94 -41.15 88.53 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.972 -1.108 . . . . 0.53000000000000003 110.938 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -59.36 -43.21 92.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.417 -1.049 . . . . 1.27 110.56 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.48 -37.17 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.161 -0.962 . . . . 0.54000000000000004 110.564 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.2 ttt -59.26 -39.75 83.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.531 -0.731 . . . . 1.74 110.558 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.8 tp -59.6 -48.21 82.54 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.454 -0.898 . . . . 0.55000000000000004 109.612 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.44 -39.72 88.53 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.541 0.686 . . . . 0.46999999999999997 110.049 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.62 -1.52 54.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.451 -0.781 . . . . 1.4199999999999999 112.902 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -58.68 123.88 17.85 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.14 -1.424 . . . . 1.27 110.584 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.36 -16.57 62.51 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.751 -1.218 . . . . 1.3500000000000001 111.355 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -77.46 -50.08 13.43 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.407 -0.917 . . . . 2.2200000000000002 111.148 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.09 -39.46 92.55 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.28 -0.888 . . . . 0.62 110.577 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -59.84 -45.71 91.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 1.29 110.348 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -62.72 -39.98 95.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 1.52 110.837 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -64.84 -48.31 74.8 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.798 -1.189 . . . . 1.3 110.273 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.2 mt -55.84 -44.19 76.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.169 -0.957 . . . . 0.60999999999999999 110.048 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.36 -41.58 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.443 0.64 . . . . 0.78000000000000003 110.453 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.51 95.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.682 -0.636 . . . . 0.81999999999999995 110.977 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.86 -42.26 97.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.866 -1.146 . . . . 0.80000000000000004 110.783 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.21 -49.72 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.857 -1.152 . . . . 0.77000000000000002 109.931 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -78.0 -35.42 50.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.399 -0.813 . . . . 2.1200000000000001 111.645 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.12 -42.09 27.07 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.499 -1.375 . . . . 1.51 111.767 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -105.8 7.92 32.6 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.92 -1.112 . . . . 1.98 112.422 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.8 m80 50.77 47.85 23.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.858 -1.151 . . . . 1.3200000000000001 111.285 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.6 mtt -105.28 154.02 20.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.598 -0.689 . . . . 1.3799999999999999 109.567 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.9 p -71.32 162.98 28.55 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.79 -0.569 . . . . 0.67000000000000004 110.034 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.51 -39.84 94.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.964 -1.085 . . . . 0.52000000000000002 110.856 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -68.5 -42.76 78.14 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 120.807 -1.183 . . . . 2.25 109.971 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.35 -48.06 62.45 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.508 0.671 . . . . 0.64000000000000001 110.606 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.28 94.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.56000000000000005 110.494 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.34 86.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.651 -0.656 . . . . 0.46000000000000002 110.552 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -60.08 -38.57 83.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.17 -0.956 . . . . 1.3200000000000001 110.937 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.14 -49.46 76.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.9 -1.125 . . . . 1.3 111.174 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.68 -49.5 84.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.402 -1.319 . . . . 0.60999999999999999 109.714 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.0 mm -60.09 -32.73 51.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.605 0.717 . . . . 0.65000000000000002 110.149 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -54.84 -40.78 69.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.266 -0.896 . . . . 2.1099999999999999 110.627 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.49 -34.65 10.15 Favored Glycine 0 N--CA 1.5 2.919 0 C-N-CA 119.618 -1.277 . . . . 0.82999999999999996 112.236 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -61.86 -42.77 99.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.499 -1.589 . . . . 1.28 109.914 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.11 -49.84 32.95 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.948 -0.701 . . . . 0.89000000000000001 110.107 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.0 p -61.79 -36.94 82.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.173 -0.954 . . . . 1.8700000000000001 110.411 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.91 98.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 1.05 110.633 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 95.5 mt -66.37 -29.39 69.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.083 -1.011 . . . . 1.02 110.715 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -67.04 -23.73 65.92 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.383 -0.823 . . . . 2.04 110.961 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -71.56 -15.39 62.28 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.06 -1.025 . . . . 1.73 111.227 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.6 mt -88.45 141.07 28.83 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.829 -0.804 . . . . 1.3700000000000001 108.829 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -98.1 40.78 1.16 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.146 -0.971 . . . . 2.8799999999999999 112.048 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -112.39 138.57 48.94 Favored 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 108.174 -1.047 . . . . 1.5800000000000001 108.174 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.541 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 47.7 mp0 -58.58 -36.6 74.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 3.04 111.016 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -73.59 -51.15 17.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.677 -1.264 . . . . 0.90000000000000002 109.99 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.96 -43.08 96.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.96 -1.087 . . . . 1.0600000000000001 110.215 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -63.05 -50.22 71.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.913 . . . . 2.1800000000000002 110.198 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -61.55 -30.5 70.69 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.076 0.941 . . . . 2.1499999999999999 109.589 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 130' ' ' VAL . 37.9 ttp180 -64.7 -29.55 70.54 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.082 0.944 . . . . 2.3300000000000001 109.274 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -59.95 -48.22 82.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.708 0.766 . . . . 0.81999999999999995 109.484 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.06 84.58 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.527 -0.869 . . . . 0.84999999999999998 109.986 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -64.45 -35.49 81.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.516 -0.74 . . . . 1.3899999999999999 110.348 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 126' ' ' ARG . 38.2 t -67.59 -39.51 82.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.106 -0.996 . . . . 0.56000000000000005 109.58 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -58.91 -37.1 75.86 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.895 -1.122 . . . . 3.1200000000000001 109.214 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -60.25 -37.68 81.12 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.899 -0.591 . . . . 1.28 110.418 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.6 mt -60.48 -40.04 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.318 -0.864 . . . . 0.48999999999999999 109.71 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.82 -39.97 32.34 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.098 -1.201 . . . . 0.46000000000000002 110.098 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.72 -46.29 84.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -1.129 . . . . 2.71 109.996 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -63.63 -40.1 96.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.788 -1.195 . . . . 2.1400000000000001 109.8 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.29 -41.94 90.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.49 -0.756 . . . . 1.05 109.7 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 54.7 mt -59.94 -44.83 94.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.599 -0.84 . . . . 0.52000000000000002 110.014 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -60.6 -33.84 73.34 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.488 -0.758 . . . . 2.3500000000000001 110.17 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -74.01 -43.11 59.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.662 -0.649 . . . . 1.3899999999999999 110.167 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.92 -37.32 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.68000000000000005 110.741 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 56.4 mt -86.23 -4.8 59.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.156 -0.965 . . . . 0.82999999999999996 112.148 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.06 23.36 69.08 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 120.175 -1.012 . . . . 0.91000000000000003 113.22 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.5 tp -73.52 137.51 44.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.531 -0.982 . . . . 0.94999999999999996 108.932 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -68.41 149.79 48.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.17 -0.956 . . . . 2.4300000000000002 109.757 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.4 mt -104.07 140.35 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.504 -0.924 . . . . 1.1000000000000001 108.504 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.751 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.5 mp -77.34 128.23 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.86 -1.163 . . . . 1.5800000000000001 107.86 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -96.8 100.08 11.63 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 105.861 -1.903 . . . . 1.6200000000000001 105.861 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.0 mt -75.56 -15.52 60.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.508 -0.745 . . . . 0.80000000000000004 111.437 -177.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.5 t -78.19 -1.45 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 1.5600000000000001 112.088 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.35 22.4 10.68 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.735 0.778 . . . . 0.83999999999999997 111.744 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.461 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 18.0 mt -72.0 135.76 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.742 . . . . 0.81999999999999995 109.1 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -121.67 -6.82 9.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.571 -0.706 . . . . 2.3100000000000001 112.343 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -112.71 135.45 53.43 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.957 -1.127 . . . . 1.54 107.957 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.85 113.98 17.4 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.695 -0.854 . . . . 1.3799999999999999 108.695 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.9 m -148.29 178.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.303 -0.873 . . . . 0.68999999999999995 109.224 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.0 mt -87.31 144.45 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.046 -0.724 . . . . 0.53000000000000003 109.046 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 19' ' ' LEU . 30.4 tp -94.76 125.81 39.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.981 -1.118 . . . . 0.64000000000000001 107.981 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.19 129.9 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 107.981 -1.118 . . . . 0.67000000000000004 107.981 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.409 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.78 153.44 22.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.156 -0.965 . . . . 0.78000000000000003 109.667 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.3 73.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.663 -1.273 . . . . 1.0 109.413 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -173.22 151.2 2.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.882 -0.785 . . . . 2.4199999999999999 108.882 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.0 mt -119.85 140.79 50.27 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.049 -0.722 . . . . 0.75 109.049 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 56.5 p -90.8 148.1 37.56 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.048 -1.033 . . . . 0.78000000000000003 108.79 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.9 -40.59 6.03 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.919 1.746 . . . . 0.67000000000000004 113.342 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.0 m -63.53 -46.22 87.03 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.052 -1.03 . . . . 0.69999999999999996 110.134 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -65.26 -38.33 90.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 1.21 110.332 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 69.2 p -68.7 -41.43 79.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.492 -0.755 . . . . 0.59999999999999998 110.585 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.11 83.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.685 -0.635 . . . . 0.62 110.768 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -93.63 2.46 56.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.001 -1.062 . . . . 1.1599999999999999 112.543 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 171' ' ' LEU . 35.1 tp -61.82 150.39 37.31 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.341 -0.849 . . . . 0.72999999999999998 109.857 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -95.89 116.19 28.55 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.52 -1.289 . . . . 2.2400000000000002 107.52 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 75.1 mt -80.04 -11.25 59.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.607 -0.683 . . . . 1.4299999999999999 112.368 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -83.86 -26.83 29.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 2.1499999999999999 112.218 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -102.76 -3.88 25.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.305 -0.872 . . . . 2.04 113.245 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.39 126.93 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.462 -1.31 . . . . 0.55000000000000004 107.462 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 28.8 tp -90.4 -7.17 53.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.788 -1.195 . . . . 1.6299999999999999 112.349 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.54 173.95 41.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.367 -1.493 . . . . 0.46999999999999997 109.367 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -128.88 130.65 47.13 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.138 -1.06 . . . . 0.54000000000000004 108.138 179.233 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.547 HG22 HG21 ' A' ' 205' ' ' THR . 94.8 mt -134.12 105.54 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 105.83 -1.915 . . . . 0.68999999999999995 105.83 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 39.1 p -126.99 176.11 7.58 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.954 -1.091 . . . . 0.81999999999999995 110.991 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.581 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -104.02 56.33 0.73 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 115.931 -0.577 . . . . 2.3700000000000001 109.841 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -100.59 144.37 29.65 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.15 -0.969 . . . . 1.1100000000000001 109.31 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.6 -32.91 25.09 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.098 -1.049 . . . . 1.6699999999999999 110.907 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 98.15 0.11 58.61 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.302 -1.117 . . . . 1.54 113.692 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.43 ' O ' ' OG1' ' A' ' 187' ' ' THR . 35.6 ttm180 -87.75 112.6 22.58 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.892 -1.521 . . . . 4.4800000000000004 106.892 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 20.9 p 49.52 44.74 24.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 2.6299999999999999 112.291 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.3 m -78.35 126.81 31.3 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.679 -1.23 . . . . 1.6899999999999999 107.679 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -58.94 -40.8 85.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.227 -0.92 . . . . 1.0700000000000001 110.292 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -59.94 -48.44 81.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.113 -0.992 . . . . 1.5800000000000001 110.284 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.7 p -61.39 -38.74 88.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.473 -0.767 . . . . 1.6000000000000001 110.576 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.475 HG12 HH21 ' A' ' 195' ' ' ARG . 85.5 mt -60.71 -42.42 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.095 -1.003 . . . . 1.45 110.903 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.527 ' SD ' ' CZ ' ' A' ' 65' ' ' PHE . 9.5 mtm -66.74 -36.92 83.6 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.502 -1.374 . . . . 1.05 109.461 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.76 -48.66 80.78 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.843 -0.617 . . . . 0.71999999999999997 111.006 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.475 HH21 HG12 ' A' ' 192' ' ' ILE . 85.3 mtm180 -60.0 -40.45 89.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 3.0499999999999998 110.409 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.3 m -64.46 -37.84 88.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 0.89000000000000001 109.902 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.5 mt -89.21 -1.1 57.94 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.459 0.647 . . . . 0.78000000000000003 112.045 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 54.82 8.31 0.22 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.059 1.133 . . . . 1.45 114.059 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.3 mt -71.5 149.25 93.52 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.073 -1.084 . . . . 0.67000000000000004 108.073 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -59.1 144.95 99.17 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.653 1.569 . . . . 0.64000000000000001 109.948 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -160.89 159.58 29.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.442 -1.411 . . . . 0.67000000000000004 109.852 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 203' ' ' VAL . 73.0 mt -148.1 155.65 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.059 -1.089 . . . . 0.68999999999999995 108.059 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.427 ' N ' HG22 ' A' ' 202' ' ' ILE . 2.9 m -137.75 -28.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.145 -0.972 . . . . 0.84999999999999998 111.758 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.87 41.32 1.71 Allowed Glycine 0 N--CA 1.487 2.034 0 C-N-CA 120.332 -0.937 . . . . 0.92000000000000004 111.846 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.547 HG21 HG22 ' A' ' 180' ' ' ILE . 75.7 p -63.45 -20.92 65.98 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.341 -1.094 . . . . 0.94999999999999996 110.938 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.25 -95.88 1.33 Allowed Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.669 -1.253 . . . . 1.04 109.978 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.0 t -129.03 30.65 5.02 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.444 -1.033 . . . . 1.5700000000000001 111.868 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.03 -38.34 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.701 -1.249 . . . . 0.83999999999999997 110.829 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 67.6 p -57.49 -24.84 58.17 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.442 -0.903 . . . . 0.98999999999999999 112.02 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.2 m -93.31 0.72 57.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.017 -1.052 . . . . 1.7 111.974 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -122.96 -4.8 8.53 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 113.082 0.771 . . . . 2.2000000000000002 113.082 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 52.0 t -119.38 149.11 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 121.568 0.699 . . . . 0.83999999999999997 109.723 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -116.81 158.56 23.73 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.809 -1.182 . . . . 2.2000000000000002 107.809 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 45.3 p-10 -55.01 145.17 21.11 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.986 -1.071 . . . . 2.2799999999999998 110.572 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t70 80.61 2.52 1.81 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 114.803 1.409 . . . . 2.3500000000000001 114.803 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 62.8 t0 -65.85 146.62 54.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.941 -1.1 . . . . 1.97 108.37 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.499 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 43.3 t80 -88.18 120.64 29.73 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.993 -1.484 . . . . 2.6499999999999999 106.993 178.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.591 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 79.0 mt -127.75 150.01 49.99 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.527 -0.733 . . . . 0.63 109.92 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.5 mt -118.41 123.59 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 106.691 -1.596 . . . . 0.62 106.691 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.5 tp -99.32 114.87 27.97 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.639 -1.615 . . . . 0.64000000000000001 106.639 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 223' ' ' VAL . 37.2 t0 -91.36 -25.06 19.57 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.849 -1.157 . . . . 2.0499999999999998 112.325 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.945 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.65 19.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.667 0.617 . . . . 0.83999999999999997 112.667 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.0 t -110.94 -61.22 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.097 0.951 . . . . 1.02 108.924 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -93.19 8.72 39.03 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.7 0.762 . . . . 2.5099999999999998 110.489 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 60.1 t30 62.98 52.35 2.62 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.483 0.658 . . . . 1.54 111.704 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -147.49 147.81 30.57 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.272 1.034 . . . . 1.95 109.453 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 52.0 t -117.45 139.74 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.293 -1.002 . . . . 0.70999999999999996 108.293 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -103.84 132.59 49.95 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.983 -1.073 . . . . 1.01 109.01 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.9 130.04 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.953 -1.129 . . . . 0.81999999999999995 107.953 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.473 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 17.9 t-20 54.05 48.09 4.4 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.241 -0.912 . . . . 1.54 113.015 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 56.1 Cg_endo -69.6 150.75 69.58 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.845 2.363 . . . . 0.93999999999999995 110.921 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 68.2 p -77.75 163.03 26.49 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.314 -0.866 . . . . 1.8 110.562 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -60.47 -35.21 75.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.945 . . . . 2.73 110.56 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -59.14 -39.34 82.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.166 -0.959 . . . . 3.1699999999999999 110.385 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.8 t -70.88 -42.06 77.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.175 -1.01 . . . . 1.3400000000000001 110.219 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 67.0 mt -60.31 -44.61 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.769 0.795 . . . . 1.2 109.822 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.98 -40.76 90.22 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.499 -0.751 . . . . 2.7000000000000002 110.81 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -62.57 -47.41 83.95 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.993 -1.067 . . . . 2.5899999999999999 110.885 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.6 mtp -69.45 -36.52 76.68 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.316 -0.865 . . . . 1.3799999999999999 110.677 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.606 ' NH2' ' CE1' ' A' ' 13' ' ' PHE . 1.7 mmp_? -58.01 -39.5 78.48 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.943 -1.098 . . . . 2.8399999999999999 111.156 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.17 -59.4 2.76 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.131 -0.98 . . . . 1.8799999999999999 111.259 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 61.4 t -60.74 -46.5 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 2.3999999999999999 110.993 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.481 HE21 HH21 ' A' ' 240' ' ' ARG . 1.0 OUTLIER -59.8 -52.19 66.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.938 . . . . 3.52 111.08 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.14 -29.57 68.5 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.231 -0.988 . . . . 1.8799999999999999 111.095 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -60.1 -32.48 71.03 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.495 -0.882 . . . . 3.0099999999999998 109.845 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.32 -46.72 83.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.636 -0.826 . . . . 2.4500000000000002 110.012 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.83 92.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.586 -0.696 . . . . 2.75 110.427 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.7 p -68.58 -31.57 70.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.369 -0.832 . . . . 3.1600000000000001 110.827 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -63.4 -40.75 98.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.431 -0.793 . . . . 3.5699999999999998 110.339 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -68.46 -29.74 68.44 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.395 -0.815 . . . . 4.2999999999999998 111.057 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -68.76 -23.69 64.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.941 . . . . 4.4500000000000002 111.725 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -67.13 -31.6 72.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.914 -1.116 . . . . 5.9699999999999998 110.948 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.407 HD11 ' O ' ' A' ' 258' ' ' ASP . 61.5 tp -63.33 -48.8 76.49 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.693 -1.255 . . . . 6.1799999999999997 110.48 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -81.09 0.68 34.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.415 -0.803 . . . . 6.6600000000000001 112.965 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -81.96 -44.13 17.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.941 -1.099 . . . . 8.1999999999999993 111.073 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 95.1 mt -88.42 -98.82 0.09 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.044 -1.095 . . . . 8.0700000000000003 108.044 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -127.03 -94.0 0.46 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.224 -1.028 . . . . 9.4499999999999993 108.224 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.407 ' O ' HD11 ' A' ' 253' ' ' LEU . 95.7 m-20 -118.63 12.7 13.19 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 116.075 -0.512 . . . . 10.119999999999999 110.667 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 . . . . . 0 N--CA 1.5 2.032 0 CA-C-O 117.937 -1.03 . . . . 11.49 109.223 -179.254 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 108.97 -0.752 . . . . 3.0699999999999998 108.97 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.9 mt -87.61 117.25 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.497 -1.297 . . . . 1.0700000000000001 107.497 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -102.56 128.43 49.22 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.209 -1.034 . . . . 1.24 108.209 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.53 -152.39 11.51 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 108.536 -1.826 . . . . 1.01 108.536 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 5' ' ' ILE . 81.5 mt -97.23 -3.22 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.293 -1.122 . . . . 1.1100000000000001 113.027 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.8 tp 49.49 95.62 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.07 -1.019 . . . . 0.98999999999999999 112.126 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -85.26 -40.16 16.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.11 -0.994 . . . . 0.84999999999999998 110.587 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -147.12 141.8 16.29 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.706 -1.22 . . . . 1.3799999999999999 107.706 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.33 149.69 40.51 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.575 2.183 . . . . 0.93999999999999995 112.144 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.897 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.13 166.16 13.51 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.885 -1.686 . . . . 0.81000000000000005 108.885 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.8 mt -123.76 135.18 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.232 -1.158 . . . . 0.82999999999999996 108.424 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.48 44.6 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.963 -1.086 . . . . 0.53000000000000003 109.293 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -121.86 139.66 53.35 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.841 -1.17 . . . . 0.77000000000000002 107.841 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.72 165.47 31.75 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 118.356 -1.878 . . . . 0.51000000000000001 110.254 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -76.03 158.66 31.63 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.938 -0.742 . . . . 1.8999999999999999 109.262 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.46 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -87.08 123.25 31.95 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.526 -1.287 . . . . 0.66000000000000003 107.526 178.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.4 tp -100.85 108.73 20.59 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 105.28 -2.118 . . . . 0.82999999999999996 105.28 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.5 tp -90.41 137.42 32.36 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.847 -1.168 . . . . 0.85999999999999999 107.847 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.492 HD12 ' HB2' ' A' ' 160' ' ' ALA . 39.9 mt -101.87 120.01 39.7 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 107.714 -1.217 . . . . 0.92000000000000004 107.714 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -110.97 140.15 45.72 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.056 -1.09 . . . . 2.0299999999999998 108.056 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.58 139.43 53.6 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.071 -1.018 . . . . 2.6600000000000001 108.758 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -84.87 133.36 34.31 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.682 -1.229 . . . . 2.3199999999999998 107.682 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -64.38 146.38 54.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.074 -1.016 . . . . 2.1099999999999999 109.264 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.5 mt -95.53 132.81 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.278 -0.889 . . . . 0.72999999999999998 108.691 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -106.42 128.98 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.84 -1.17 . . . . 0.87 107.84 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 mt -98.17 140.17 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.714 -0.847 . . . . 0.81000000000000005 108.714 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -89.35 119.95 30.26 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.626 -1.25 . . . . 1.3400000000000001 107.626 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -96.73 15.68 21.22 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.187 -0.946 . . . . 2.8900000000000001 112.227 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -69.22 151.09 46.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.971 -1.081 . . . . 2.0899999999999999 110.35 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -90.12 131.87 35.74 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.176 -1.046 . . . . 2.1899999999999999 108.176 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.2 pt -96.1 168.5 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.577 0.703 . . . . 0.75 110.499 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.9 p -92.48 166.19 12.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.474 -0.766 . . . . 0.91000000000000003 110.252 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.6 -22.78 47.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.335 -0.853 . . . . 0.93000000000000005 112.142 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.02 -36.65 80.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.919 -1.113 . . . . 2.2799999999999998 111.026 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -85.85 -5.5 59.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.574 -1.329 . . . . 1.45 112.501 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.93 -44.55 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.218 -0.926 . . . . 0.81000000000000005 110.478 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -58.73 -40.35 83.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.082 -1.011 . . . . 1.54 110.247 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -64.64 -40.78 96.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.484 -0.76 . . . . 2.3599999999999999 110.965 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -60.72 -39.99 90.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.102 -0.999 . . . . 1.3100000000000001 110.613 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.36 -40.83 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.956 -1.09 . . . . 0.81999999999999995 110.242 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -62.23 -40.82 97.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.941 -1.099 . . . . 1.5 110.365 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.422 ' HG2' HH11 ' A' ' 42' ' ' ARG . 45.6 mtt-85 -62.01 -41.75 98.42 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.194 -0.941 . . . . 2.23 110.131 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -76.12 -51.4 12.27 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.319 -0.863 . . . . 0.84999999999999998 109.973 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.03 -49.03 79.44 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.741 -0.784 . . . . 0.91000000000000003 109.606 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.9 t -70.55 -40.84 73.16 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.59 -0.694 . . . . 0.90000000000000002 109.962 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.67 -44.51 96.83 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.118 -1.593 . . . . 0.68999999999999995 109.118 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -57.75 -31.46 66.5 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.498 -1.001 . . . . 2.8799999999999999 109.548 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.27 -45.63 92.63 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.589 0.709 . . . . 0.84999999999999998 110.194 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -80.23 -40.82 26.3 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.474 -0.767 . . . . 2.3500000000000001 111.035 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.64 90.03 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.56 0.695 . . . . 0.65000000000000002 109.928 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.9 t -60.71 -40.01 90.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.244 1.021 . . . . 1.45 109.238 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.5 78.51 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.824 -0.626 . . . . 0.63 109.804 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -61.27 -50.32 73.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.056 -1.028 . . . . 1.3400000000000001 110.193 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.86 -39.36 91.63 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.309 -0.869 . . . . 1.5600000000000001 109.897 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -60.21 -41.33 92.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.802 -0.562 . . . . 1.1899999999999999 110.915 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.3 m -67.13 -43.0 83.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.94 -1.1 . . . . 0.71999999999999997 110.244 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.0 mt -59.87 -38.44 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.467 -0.771 . . . . 0.62 110.59 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -53.04 -42.5 65.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 1.05 110.865 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -69.87 -33.05 71.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.982 -1.074 . . . . 0.64000000000000001 110.383 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -63.22 -39.95 96.08 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.175 -1.01 . . . . 1.73 109.818 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.78 78.31 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.366 -0.834 . . . . 0.56000000000000005 110.021 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.52 -35.32 29.46 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 119.55 -1.31 . . . . 0.68999999999999995 110.613 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.45 -19.79 38.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.121 -1.223 . . . . 1.48 111.016 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.9 m -89.59 -55.3 3.7 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.852 -0.53 . . . . 0.97999999999999998 110.274 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.51 -2.74 20.1 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 113.807 1.04 . . . . 1.1599999999999999 113.807 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.05 160.95 26.49 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.746 -0.74 . . . . 0.84999999999999998 112.559 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -52.93 -18.95 2.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.458 -1.025 . . . . 3.8599999999999999 112.697 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 68' ' ' GLU . 4.9 pt-20 -56.99 -44.18 82.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.049 -1.032 . . . . 2.3500000000000001 110.842 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -84.57 -21.01 30.57 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.606 -1.309 . . . . 1.6699999999999999 111.534 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -59.83 -38.61 82.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.567 -0.708 . . . . 1.45 110.956 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.98 82.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.457 -0.777 . . . . 0.60999999999999999 111.693 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 72' ' ' ILE . 22.9 mt -63.72 -45.01 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.586 -1.321 . . . . 0.65000000000000002 110.518 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -69.23 -32.37 71.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.66000000000000003 110.508 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -62.36 -40.11 95.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.532 -0.867 . . . . 1.1899999999999999 110.597 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.55 -39.88 98.42 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 120.133 -1.032 . . . . 0.53000000000000003 110.713 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -58.68 -41.69 86.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.295 -1.12 . . . . 1.27 110.44 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.3 mt -60.04 -36.46 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.932 -1.105 . . . . 0.54000000000000004 110.448 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.3 ttm -59.8 -39.43 84.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.852 . . . . 1.74 110.61 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 tp -60.82 -48.79 80.2 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.591 -0.844 . . . . 0.55000000000000004 110.007 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.46 -42.59 96.48 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.458 0.647 . . . . 0.46999999999999997 110.949 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -87.56 5.65 38.28 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.271 -0.893 . . . . 1.4199999999999999 113.05 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -60.59 121.19 11.57 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.689 -1.257 . . . . 1.27 108.585 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.15 -18.55 65.4 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.875 0.845 . . . . 1.3500000000000001 110.631 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -75.16 -52.63 10.49 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.675 -0.81 . . . . 2.2200000000000002 110.079 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.32 -37.0 79.22 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.688 -0.805 . . . . 0.62 110.525 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -57.59 -47.86 80.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.199 -0.938 . . . . 1.29 110.992 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.7 -37.27 81.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.436 -0.79 . . . . 1.52 110.635 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.58 -48.8 68.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.71 -1.244 . . . . 1.3 110.26 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.2 mt -56.57 -45.96 82.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.923 -1.11 . . . . 0.60999999999999999 109.947 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.0 mt -60.77 -41.9 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.541 0.686 . . . . 0.78000000000000003 110.36 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.7 98.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.905 . . . . 0.81999999999999995 110.711 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.67 -42.49 97.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.048 -1.032 . . . . 0.80000000000000004 110.679 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.41 -45.59 98.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.204 -0.935 . . . . 0.77000000000000002 110.323 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -83.67 -34.5 24.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 2.1200000000000001 112.132 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -80.86 -44.86 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.693 -1.254 . . . . 1.51 111.856 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -102.53 8.36 39.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.593 -0.692 . . . . 1.98 112.318 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.0 m170 49.66 49.02 20.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 1.3200000000000001 111.641 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.4 mtp -101.68 156.58 17.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.583 -0.698 . . . . 1.3799999999999999 109.397 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.3 p -74.14 160.16 31.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.573 -0.529 . . . . 0.67000000000000004 109.573 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.14 -40.52 81.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.155 -0.966 . . . . 0.52000000000000002 110.301 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.544 ' OD2' HD21 ' A' ' 142' ' ' LEU . 73.6 m-20 -68.08 -44.09 77.05 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.905 0.86 . . . . 2.25 110.241 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.06 -49.09 63.5 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.625 -0.83 . . . . 0.64000000000000001 110.955 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.13 87.91 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.267 -0.896 . . . . 0.56000000000000005 110.181 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.54 95.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.46000000000000002 110.539 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -60.29 -36.18 77.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 1.3200000000000001 111.423 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.05 -50.21 74.63 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.039 -1.038 . . . . 1.3 110.954 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -60.24 -48.01 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.552 -1.343 . . . . 0.60999999999999999 109.947 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -60.92 -31.86 50.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 121.599 -0.688 . . . . 0.65000000000000002 110.331 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -57.08 -41.04 78.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.123 -0.986 . . . . 2.1099999999999999 111.175 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.73 -35.36 11.67 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.231 -1.462 . . . . 0.82999999999999996 112.191 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -59.99 -40.9 90.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.504 -1.586 . . . . 1.28 110.241 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.48 -51.49 14.65 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.892 0.853 . . . . 0.89000000000000001 110.224 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.2 m -59.31 -39.85 84.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.307 -0.871 . . . . 1.8700000000000001 110.619 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.79 98.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -0.784 . . . . 1.05 111.064 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 80.9 mt -63.93 -31.11 72.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.725 -1.234 . . . . 1.02 110.961 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -66.43 -22.65 66.22 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.923 -1.111 . . . . 2.04 110.915 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -72.5 -12.41 61.07 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.676 0.751 . . . . 1.73 111.059 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.507 HD13 HD13 ' A' ' 123' ' ' LEU . 82.9 mt -86.53 149.54 24.88 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.363 0.602 . . . . 1.3700000000000001 109.426 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -103.02 39.11 1.61 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.127 -0.983 . . . . 2.8799999999999999 111.769 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.509 ' CB ' HD12 ' A' ' 123' ' ' LEU . 51.2 t0 -115.78 139.07 50.53 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 121.141 -0.975 . . . . 1.5800000000000001 108.77 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -59.06 -40.16 84.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 3.04 110.97 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -72.46 -48.82 37.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.846 -1.159 . . . . 0.90000000000000002 111.068 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.509 HD12 ' CB ' ' A' ' 120' ' ' ASP . 19.3 mt -61.5 -43.43 98.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.878 -1.138 . . . . 1.0600000000000001 110.116 -178.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -63.79 -50.09 70.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.954 . . . . 2.1800000000000002 110.06 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -59.9 -32.89 71.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.415 -0.803 . . . . 2.1499999999999999 110.122 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -63.79 -28.17 69.68 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.716 -1.194 . . . . 2.3300000000000001 109.343 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -59.06 -47.82 83.86 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.684 0.754 . . . . 0.81999999999999995 109.685 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.95 -42.35 97.33 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.222 -0.991 . . . . 0.84999999999999998 109.509 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.48 -31.31 71.96 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.313 0.577 . . . . 1.3899999999999999 110.26 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.3 t -68.1 -44.97 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 0.56000000000000005 109.942 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -59.36 -36.15 75.2 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.071 -1.018 . . . . 3.1200000000000001 110.099 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -60.0 -39.69 86.65 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.067 -0.515 . . . . 1.28 110.579 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.48 -40.02 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.206 -0.934 . . . . 0.48999999999999999 109.936 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.02 -41.75 31.53 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 119.838 -1.172 . . . . 0.46000000000000002 110.691 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.457 ' HG2' ' HZ2' ' A' ' 135' ' ' LYS . 16.6 ttpp -58.29 -41.94 85.49 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.305 -1.115 . . . . 2.71 110.355 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' NH1' ' HG2' ' A' ' 136' ' ' ARG . 63.7 mtt-85 -63.31 -44.58 94.58 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.478 -0.889 . . . . 2.1400000000000001 110.019 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 32.2 tp -60.84 -42.06 97.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.625 -0.672 . . . . 1.05 110.084 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.1 mt -59.76 -40.83 89.46 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.377 -0.827 . . . . 0.52000000000000002 110.367 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -61.33 -36.16 79.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.188 -0.945 . . . . 2.3500000000000001 110.806 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -74.31 -41.36 61.28 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.218 -0.993 . . . . 1.3899999999999999 110.698 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.484 HG21 ' OD1' ' A' ' 101' ' ' ASP . 88.5 mt -60.48 -39.02 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.335 -0.853 . . . . 0.68000000000000005 110.454 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.544 HD21 ' OD2' ' A' ' 101' ' ' ASP . 70.0 mt -85.09 -8.01 58.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.968 -1.082 . . . . 0.82999999999999996 112.263 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.12 15.6 80.14 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 120.334 -0.936 . . . . 0.91000000000000003 112.314 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 27.7 tp -70.0 142.37 52.8 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.715 0.769 . . . . 0.94999999999999996 109.474 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -68.35 151.27 47.11 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.313 -0.867 . . . . 2.4300000000000002 110.205 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.1 mt -104.61 135.17 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.261 -1.014 . . . . 1.1000000000000001 108.261 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.726 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -78.49 117.91 24.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.696 -0.853 . . . . 1.5800000000000001 108.696 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -99.35 103.32 15.13 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.263 -1.755 . . . . 1.6200000000000001 106.263 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -74.12 -15.21 61.05 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.604 -0.685 . . . . 0.80000000000000004 111.573 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -81.59 1.8 32.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.224 -0.922 . . . . 1.5600000000000001 112.279 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.44 23.85 8.02 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.317 -0.864 . . . . 0.83999999999999997 112.546 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.5 mt -72.41 139.92 18.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.102 -0.999 . . . . 0.81999999999999995 108.923 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -110.52 -18.88 13.1 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.865 0.841 . . . . 2.3100000000000001 112.611 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -114.33 134.17 55.15 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.802 -1.185 . . . . 1.54 107.802 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.54 127.57 33.2 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.039 -1.038 . . . . 1.3799999999999999 108.402 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.84 173.49 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.014 -0.736 . . . . 0.68999999999999995 109.014 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 29.6 mt -86.75 139.58 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.396 -0.965 . . . . 0.53000000000000003 108.396 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.5 tp -94.7 122.94 37.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.119 -0.988 . . . . 0.64000000000000001 108.681 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.48 131.17 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.091 -1.077 . . . . 0.67000000000000004 108.091 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.492 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -160.7 153.7 21.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 0.78000000000000003 108.73 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.471 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -62.5 -36.29 82.09 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.502 -1.374 . . . . 1.0 109.411 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 57.7 t0 -170.86 150.54 3.21 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.651 -0.87 . . . . 2.4199999999999999 108.651 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.468 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 79.8 mt -119.19 143.21 47.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.27 -0.894 . . . . 0.75 109.261 177.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.4 p -91.83 146.49 33.09 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 120.988 -1.07 . . . . 0.78000000000000003 108.625 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -39.31 -42.62 2.48 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.216 1.944 . . . . 0.67000000000000004 114.045 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.3 m -59.81 -48.33 82.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 0.69999999999999996 110.154 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -64.5 -39.95 94.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.002 -1.061 . . . . 1.21 110.284 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 35.0 p -68.47 -35.0 76.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.608 -0.683 . . . . 0.59999999999999998 110.659 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.68 88.36 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.424 -0.798 . . . . 0.62 110.364 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -93.21 -1.21 56.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.318 -0.864 . . . . 1.1599999999999999 112.597 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 171' ' ' LEU . 39.0 tp -61.71 150.87 35.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.342 -0.849 . . . . 0.72999999999999998 109.361 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -94.76 115.03 27.01 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 107.331 -1.359 . . . . 2.2400000000000002 107.331 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 23.1 mt -73.83 -20.39 60.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.864 -0.523 . . . . 1.4299999999999999 111.459 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -83.03 -23.04 33.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.169 -0.957 . . . . 2.1499999999999999 112.252 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -100.88 -1.88 33.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.263 0.838 . . . . 2.04 113.263 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 178' ' ' GLY . 60.4 t -108.38 125.52 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.648 -1.241 . . . . 0.55000000000000004 107.648 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 13.0 tp -84.25 -4.1 58.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 1.6299999999999999 111.796 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.604 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.83 170.31 30.59 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.858 -1.697 . . . . 0.46999999999999997 108.858 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.09 129.33 47.76 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 107.785 -1.191 . . . . 0.54000000000000004 107.785 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.464 HG22 HG21 ' A' ' 205' ' ' THR . 87.2 mt -130.99 109.85 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 106.409 -1.7 . . . . 0.68999999999999995 106.409 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 205' ' ' THR . 66.9 p -127.39 169.86 13.15 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.974 -1.079 . . . . 0.81999999999999995 109.586 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 21.4 p-10 -101.67 53.43 0.82 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.719 -0.613 . . . . 2.3700000000000001 110.643 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -99.53 133.37 43.95 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.371 -0.974 . . . . 1.1100000000000001 108.371 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.4 3.17 4.82 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.733 -1.222 . . . . 1.6699999999999999 112.638 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 92.92 -4.68 75.43 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.247 -1.149 . . . . 1.54 113.198 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.448 ' O ' ' CG ' ' A' ' 186' ' ' ARG . 26.2 ptt180 -81.63 118.36 22.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.813 -1.551 . . . . 4.4800000000000004 106.813 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 73.5 p 46.95 40.28 9.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.763 -1.211 . . . . 2.6299999999999999 111.881 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 82.0 p -84.34 109.44 17.83 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.029 -1.471 . . . . 1.6899999999999999 107.029 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -61.54 -32.97 73.06 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.509 -0.744 . . . . 1.0700000000000001 110.811 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.3 p -57.13 -40.3 76.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.748 -1.22 . . . . 1.5800000000000001 110.218 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.0 t -60.17 -39.62 87.11 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.018 -1.051 . . . . 1.6000000000000001 109.892 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.1 mm -59.88 -40.13 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 1.45 110.351 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.4 mtp -65.06 -42.74 93.92 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.339 1.066 . . . . 1.05 109.605 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.28 -47.42 86.06 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.797 -0.638 . . . . 0.71999999999999997 110.979 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -61.38 -42.79 99.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.977 -1.077 . . . . 3.0499999999999998 110.436 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 72.4 m -70.59 -42.73 70.63 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.956 0.884 . . . . 0.89000000000000001 110.127 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.2 mt -91.84 -8.14 47.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.46 -0.775 . . . . 0.78000000000000003 112.182 -177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 54.43 9.78 0.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.912 1.078 . . . . 1.45 113.912 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 37.7 mt -70.14 164.97 48.0 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.079 -1.013 . . . . 0.67000000000000004 109.283 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -70.68 144.28 48.69 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.7 1.6 . . . . 0.64000000000000001 110.444 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -160.91 166.11 28.95 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.701 -1.6 . . . . 0.67000000000000004 109.611 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 65.0 mt -146.9 156.48 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.447 -1.316 . . . . 0.68999999999999995 107.447 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.5 m -140.94 -31.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 O-C-N 120.687 -1.258 . . . . 0.84999999999999998 112.366 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.05 43.29 2.44 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.007 -1.058 . . . . 0.92000000000000004 111.997 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 181' ' ' THR . 30.6 p -63.03 -16.73 60.85 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.134 -1.216 . . . . 0.94999999999999996 111.202 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.96 -94.71 1.0 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 110.14 -1.184 . . . . 1.04 110.14 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 86.8 p -129.07 30.92 4.97 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.607 -0.937 . . . . 1.5700000000000001 111.716 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.13 -38.18 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.506 -1.371 . . . . 0.83999999999999997 110.165 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 76.2 p -52.86 -25.81 12.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.98999999999999999 111.379 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.9 p -96.27 6.2 49.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 1.7 111.814 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -128.82 -4.17 5.19 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 113.136 0.791 . . . . 2.2000000000000002 113.136 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 13.4 t -117.96 149.51 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.675 0.75 . . . . 0.83999999999999997 109.784 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -118.46 152.53 35.73 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.079 -1.082 . . . . 2.2000000000000002 108.079 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 40.4 p-10 -54.31 146.3 15.85 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.932 -1.107 . . . . 2.2799999999999998 110.113 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 t70 81.07 -3.42 1.74 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 114.304 1.224 . . . . 2.3500000000000001 114.304 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.76 146.16 53.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.948 -1.095 . . . . 1.97 108.74 177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -88.78 120.22 29.99 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.003 -1.48 . . . . 2.6499999999999999 107.003 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.46 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.1 mt -126.67 143.39 51.25 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.274 -0.891 . . . . 0.63 109.846 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.7 mt -109.53 121.37 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.859 -1.534 . . . . 0.62 106.859 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 32.8 tp -98.91 109.79 22.49 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.12 -1.807 . . . . 0.64000000000000001 106.12 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.9 p30 -93.76 -22.52 18.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.907 -1.121 . . . . 2.0499999999999998 112.958 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.897 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.64 19.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.58 0.705 . . . . 0.83999999999999997 112.804 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.7 t -108.42 -60.14 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.015 -1.053 . . . . 1.02 108.837 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -88.7 8.25 29.62 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.159 0.98 . . . . 2.5099999999999998 110.028 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 65.86 49.55 1.65 Allowed 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.9 -1.045 . . . . 1.54 111.944 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.51 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 16.8 pt20 -154.65 156.34 36.3 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.642 1.21 . . . . 1.95 110.873 178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 54.8 t -118.14 141.58 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 115.176 -0.92 . . . . 0.70999999999999996 108.626 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.51 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 94.8 m-85 -100.98 139.09 37.16 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.961 -1.087 . . . . 1.01 108.431 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.1 t -111.11 129.71 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 107.945 -1.132 . . . . 0.81999999999999995 107.945 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.429 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 4.1 t30 49.57 50.17 8.66 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 113.4 0.889 . . . . 1.54 113.4 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 29.8 Cg_endo -65.14 151.71 84.68 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.42 2.08 . . . . 0.93999999999999995 110.41 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 35.9 p -73.4 159.63 33.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.053 -1.029 . . . . 1.8 108.84 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -63.26 -33.81 76.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.365 -0.834 . . . . 2.73 111.143 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.22 -39.25 82.11 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.081 -1.012 . . . . 3.1699999999999999 110.699 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 98.2 t -71.94 -39.34 66.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.264 -0.897 . . . . 1.3400000000000001 110.77 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.0 mt -58.11 -46.79 88.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.178 -0.951 . . . . 1.2 110.154 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.01 -42.62 94.7 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.58 -0.848 . . . . 2.7000000000000002 110.748 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -61.98 -42.66 99.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.006 -1.058 . . . . 2.5899999999999999 110.892 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 86.6 mtp -70.42 -38.45 74.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 1.3799999999999999 110.87 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.432 ' HG3' ' NH1' ' A' ' 240' ' ' ARG . 22.5 mmm-85 -59.19 -39.75 83.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.849 -1.157 . . . . 2.8399999999999999 110.963 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -71.29 -57.12 4.77 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.523 -0.736 . . . . 1.8799999999999999 110.682 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.13 -42.29 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.076 -1.015 . . . . 2.3999999999999999 111.101 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.74 -54.28 47.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.896 -1.128 . . . . 3.52 110.621 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.19 -30.97 72.0 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.928 -1.107 . . . . 1.8799999999999999 110.244 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -60.81 -31.03 70.44 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.437 -0.905 . . . . 3.0099999999999998 109.459 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.79 -45.63 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.46 -0.896 . . . . 2.4500000000000002 109.717 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.35 98.88 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.47 0.652 . . . . 2.75 110.174 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.0 t -70.26 -32.42 70.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 3.1600000000000001 110.811 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.92 -39.91 93.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.16 -0.963 . . . . 3.5699999999999998 111.117 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -64.98 -37.89 89.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.954 -1.091 . . . . 4.2999999999999998 110.648 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -68.03 -34.26 76.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 4.4500000000000002 110.681 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -69.57 -30.84 68.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 5.9699999999999998 111.304 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.744 ' C ' HD13 ' A' ' 253' ' ' LEU . 2.7 tm? -60.71 -46.79 89.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.913 -1.117 . . . . 6.1799999999999997 110.627 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -69.26 -37.14 77.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.097 -1.002 . . . . 6.6600000000000001 110.399 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -89.48 25.09 2.06 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.166 0.802 . . . . 8.1999999999999993 113.166 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 256' ' ' LEU . 0.7 OUTLIER -78.47 -3.97 46.13 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.177 -0.952 . . . . 8.0700000000000003 112.2 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -84.41 -14.01 50.57 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.784 -1.197 . . . . 9.4499999999999993 112.545 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -101.79 -28.78 12.25 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.072 -1.018 . . . . 10.119999999999999 112.828 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.859 -1.067 . . . . 11.49 109.686 -177.929 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.2 mtm . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 109.387 -0.598 . . . . 3.0699999999999998 109.387 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.9 mt -93.88 111.41 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 106.564 -1.643 . . . . 1.0700000000000001 106.564 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.1 m -104.9 120.57 41.75 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.004 -1.11 . . . . 1.24 108.004 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.08 -158.5 22.21 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.74 -1.744 . . . . 1.01 108.74 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 5' ' ' ILE . 84.4 mt -96.26 -0.59 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.303 -1.116 . . . . 1.1100000000000001 113.002 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tp 50.06 98.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.925 -1.109 . . . . 0.98999999999999999 112.583 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.13 -45.12 12.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.106 -0.996 . . . . 0.84999999999999998 110.849 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -146.58 140.87 15.62 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 107.639 -1.245 . . . . 1.3799999999999999 107.639 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.38 150.75 41.86 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.506 2.138 . . . . 0.93999999999999995 112.345 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.947 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.41 170.34 18.8 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 108.992 -1.643 . . . . 0.81000000000000005 108.992 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.564 ' O ' ' NE2' ' A' ' 243' ' ' GLN . 98.5 mt -129.86 138.8 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.026 -1.279 . . . . 0.82999999999999996 108.288 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.35 149.88 38.36 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.054 -1.029 . . . . 0.53000000000000003 109.417 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.3 m-85 -122.04 139.83 53.23 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.969 -1.123 . . . . 0.77000000000000002 107.969 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.24 171.21 41.34 Favored Glycine 0 N--CA 1.499 2.848 0 C-N-CA 118.746 -1.692 . . . . 0.51000000000000001 110.213 178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -76.4 158.77 31.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.604 -0.939 . . . . 1.8999999999999999 108.742 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.59 132.83 33.8 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.225 -0.922 . . . . 0.66000000000000003 108.827 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.6 tp -110.63 102.69 11.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.78 -1.933 . . . . 0.82999999999999996 105.78 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.8 tp -91.51 136.84 32.83 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.078 -1.082 . . . . 0.85999999999999999 108.078 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.5 mt -102.34 116.23 32.2 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.947 -1.501 . . . . 0.92000000000000004 106.947 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -111.18 137.88 48.32 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.656 -1.238 . . . . 2.0299999999999998 107.656 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -125.65 149.66 48.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.089 -1.007 . . . . 2.6600000000000001 108.864 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -85.21 137.56 32.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.736 -1.209 . . . . 2.3199999999999998 107.736 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -63.3 148.29 48.7 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.599 -0.84 . . . . 2.1099999999999999 108.818 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -92.55 135.38 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.403 -0.962 . . . . 0.72999999999999998 108.403 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.7 t -104.4 130.16 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.061 -1.089 . . . . 0.87 108.061 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.1 mt -98.32 135.22 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.278 -1.008 . . . . 0.81000000000000005 108.278 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -90.64 119.23 30.71 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 106.948 -1.501 . . . . 1.3400000000000001 106.948 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.451 HH11 ' HG3' ' A' ' 28' ' ' ARG . 19.1 mmm-85 -96.81 11.74 34.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 2.8900000000000001 112.111 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -72.01 152.26 42.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.176 -0.952 . . . . 2.0899999999999999 109.619 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -91.71 135.14 34.12 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.54 -0.911 . . . . 2.1899999999999999 108.54 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -94.64 167.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.886 -1.133 . . . . 0.75 109.957 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.5 p -93.8 166.06 12.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.112 -0.993 . . . . 0.91000000000000003 109.332 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.06 -19.81 34.57 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.876 -1.14 . . . . 0.93000000000000005 112.814 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 60.1 t0 -70.01 -38.06 75.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.784 -1.197 . . . . 2.2799999999999998 110.749 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -86.38 -11.0 53.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.809 -1.182 . . . . 1.45 112.202 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.34 -43.94 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.003 -1.061 . . . . 0.81000000000000005 110.362 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.1 -39.81 83.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.357 -0.839 . . . . 1.54 110.621 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -63.68 -42.66 98.0 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.25 -0.907 . . . . 2.3599999999999999 111.019 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -61.53 -38.78 88.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.986 -1.071 . . . . 1.3100000000000001 110.901 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.4 t -60.0 -45.4 95.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.155 -0.965 . . . . 0.81999999999999995 110.329 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -61.55 -45.49 93.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.975 . . . . 1.5 110.081 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.65 -43.31 97.77 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.387 -0.821 . . . . 2.23 110.286 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -71.41 -56.94 4.97 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.185 -0.947 . . . . 0.84999999999999998 109.987 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.6 tp -58.18 -47.46 83.34 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.203 -0.999 . . . . 0.91000000000000003 109.786 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.4 t -69.95 -37.47 75.86 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.141 -0.975 . . . . 0.90000000000000002 109.997 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.45 -46.89 91.43 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.912 -1.137 . . . . 0.68999999999999995 110.366 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -59.83 -30.6 69.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.406 -1.056 . . . . 2.8799999999999999 109.437 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.16 -45.2 87.87 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.163 -0.615 . . . . 0.84999999999999998 109.868 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -80.8 -42.26 22.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 2.3500000000000001 110.885 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.43 85.5 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.599 -0.841 . . . . 0.65000000000000002 109.42 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 t -60.68 -41.13 94.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.217 1.008 . . . . 1.45 109.077 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.47 -46.07 77.59 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.62 -0.718 . . . . 0.63 110.144 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -62.92 -49.98 72.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.092 -1.005 . . . . 1.3400000000000001 109.997 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.1 mt -61.69 -40.01 93.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.163 -0.96 . . . . 1.5600000000000001 109.978 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -60.15 -40.02 88.41 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.93 -0.481 . . . . 1.1899999999999999 110.497 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.53 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 16.2 m -65.59 -45.01 84.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.924 -1.11 . . . . 0.71999999999999997 110.043 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.57 -37.84 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 0.62 110.3 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.42 ' NZ ' ' OE2' ' A' ' 70' ' ' GLU . 9.0 ttpp -49.25 -43.4 42.83 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.968 -0.693 . . . . 1.05 110.915 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -69.54 -38.99 77.72 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.581 -0.699 . . . . 0.64000000000000001 109.659 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.53 ' NZ ' HG22 ' A' ' 56' ' ' THR . 62.1 mttp -61.01 -40.32 93.09 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.46 -1.296 . . . . 1.73 108.996 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.24 77.73 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.922 -0.711 . . . . 0.56000000000000005 109.835 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.47 -36.74 19.42 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.704 -1.236 . . . . 0.68999999999999995 110.939 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -80.79 -27.28 36.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.041 -1.27 . . . . 1.48 111.125 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -83.9 -49.87 8.6 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.565 -0.709 . . . . 0.97999999999999998 111.021 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.87 -5.08 18.55 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.031 1.123 . . . . 1.1599999999999999 114.031 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.88 163.84 28.97 Favored Glycine 0 N--CA 1.502 3.096 0 O-C-N 121.291 -0.881 . . . . 0.84999999999999998 111.82 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -56.49 -24.34 45.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.685 -0.891 . . . . 3.8599999999999999 112.218 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.6 -39.93 68.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 2.3500000000000001 110.715 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -87.72 -25.03 23.66 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.931 -1.106 . . . . 1.6699999999999999 111.386 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.42 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 71.1 tt0 -59.72 -37.31 78.54 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.489 0.661 . . . . 1.45 110.647 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.96 74.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.60999999999999999 111.341 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.55 -42.37 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.634 -1.291 . . . . 0.65000000000000002 110.517 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -70.13 -31.66 69.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.392 -0.817 . . . . 0.66000000000000003 110.252 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -59.99 -38.44 82.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.042 -1.036 . . . . 1.1899999999999999 110.278 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.48 -39.87 86.85 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.004 -1.238 . . . . 0.53000000000000003 110.004 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -60.21 -45.72 92.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.273 -1.133 . . . . 1.27 110.312 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.5 mt -60.92 -39.34 81.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.193 -0.942 . . . . 0.54000000000000004 110.318 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.7 ttm -56.9 -40.55 76.47 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.594 -0.842 . . . . 1.74 110.101 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -59.52 -50.05 75.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 0.55000000000000004 109.992 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.4 tp -61.88 -41.04 97.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.502 -0.748 . . . . 0.46999999999999997 110.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -86.38 8.05 23.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.506 -0.746 . . . . 1.4199999999999999 112.518 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -65.5 125.69 25.98 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.448 -1.407 . . . . 1.27 108.346 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.0 -18.73 65.52 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.107 0.956 . . . . 1.3500000000000001 110.711 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -76.46 -54.65 6.42 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.752 -0.779 . . . . 2.2200000000000002 110.428 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.68 -35.15 75.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.408 -0.807 . . . . 0.62 110.962 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -59.93 -49.19 78.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.416 -0.802 . . . . 1.29 110.522 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -61.6 -35.72 78.65 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.61 -0.681 . . . . 1.52 110.625 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.82 -46.87 73.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.02 . . . . 1.3 110.619 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.8 mt -59.51 -46.52 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.146 -0.971 . . . . 0.60999999999999999 109.718 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.7 mt -62.18 -41.25 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.446 0.641 . . . . 0.78000000000000003 110.529 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.5 -44.24 97.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.103 -0.998 . . . . 0.81999999999999995 110.741 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.58 -42.31 96.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.045 -1.034 . . . . 0.80000000000000004 110.434 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.58 -49.43 83.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.034 -1.041 . . . . 0.77000000000000002 110.386 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -82.8 -31.48 28.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.157 -0.965 . . . . 2.1200000000000001 111.644 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 91' ' ' ALA . 35.8 t0 -83.03 -45.83 13.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.735 -1.228 . . . . 1.51 111.886 -178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -103.26 11.24 37.06 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.307 -0.87 . . . . 1.98 111.998 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.2 m80 51.3 51.95 15.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.441 -0.787 . . . . 1.3200000000000001 111.999 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -105.89 151.93 23.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.456 -0.777 . . . . 1.3799999999999999 109.178 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.7 p -71.61 161.92 30.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.43 -0.794 . . . . 0.67000000000000004 109.583 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.95 -44.4 91.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.261 -0.899 . . . . 0.52000000000000002 110.875 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 21.0 p-10 -68.71 -39.25 80.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.996 -1.065 . . . . 2.25 110.133 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -48.21 63.78 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.727 -0.789 . . . . 0.64000000000000001 111.176 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.35 77.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.242 -0.911 . . . . 0.56000000000000005 110.577 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.7 89.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.448 -0.783 . . . . 0.46000000000000002 110.656 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.9 -39.48 89.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.852 -1.155 . . . . 1.3200000000000001 110.937 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.53 -48.74 79.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.857 -1.152 . . . . 1.3 110.742 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.9 t -59.74 -47.91 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.707 -1.246 . . . . 0.60999999999999999 109.877 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.0 mm -61.71 -35.64 68.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.934 -0.479 . . . . 0.65000000000000002 110.617 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -56.58 -40.2 74.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.893 -1.129 . . . . 2.1099999999999999 111.073 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.36 -28.89 23.67 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.346 -1.407 . . . . 0.82999999999999996 113.185 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -62.35 -39.94 94.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.466 -1.608 . . . . 1.28 109.973 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.03 -48.49 35.72 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.787 0.803 . . . . 0.89000000000000001 110.517 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.4 m -61.45 -40.62 95.14 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.208 -0.597 . . . . 1.8700000000000001 110.239 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.55 95.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.503 -0.748 . . . . 1.05 110.63 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.46 -28.28 69.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.903 -1.123 . . . . 1.02 110.826 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -66.34 -23.24 66.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.561 0.696 . . . . 2.04 110.917 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -76.33 -11.0 59.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.728 -0.608 . . . . 1.73 111.438 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.669 HD13 HD13 ' A' ' 123' ' ' LEU . 4.0 mt -87.27 138.78 31.19 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.038 -1.097 . . . . 1.3700000000000001 108.038 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 14.2 t70 -96.24 62.52 2.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.308 -0.87 . . . . 2.8799999999999999 110.48 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -138.36 135.96 35.87 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 107.574 -1.269 . . . . 1.5800000000000001 107.574 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -59.18 -37.26 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 3.04 110.837 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -71.21 -55.68 7.62 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.809 -1.182 . . . . 0.90000000000000002 110.402 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.669 HD13 HD13 ' A' ' 118' ' ' LEU . 29.9 mt -60.83 -38.41 85.4 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.109 -0.994 . . . . 1.0600000000000001 110.704 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -60.7 -49.53 77.12 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.952 -1.099 . . . . 2.1800000000000002 109.507 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -60.21 -30.41 69.36 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.49 -0.884 . . . . 2.1499999999999999 109.431 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 130' ' ' VAL . 57.6 ttt180 -62.26 -29.86 70.71 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.06 -1.056 . . . . 2.3300000000000001 109.03 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.98 75.47 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.939 0.876 . . . . 0.81999999999999995 109.32 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -42.55 77.26 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.881 -0.6 . . . . 0.84999999999999998 110.513 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -62.78 -36.52 83.38 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.626 0.727 . . . . 1.3899999999999999 110.25 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 126' ' ' ARG . 41.7 t -69.21 -39.41 79.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.406 -0.809 . . . . 0.56000000000000005 110.14 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.414 HH11 ' HG3' ' A' ' 131' ' ' ARG . 38.9 ttm-85 -56.4 -38.96 72.22 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 118.912 -1.115 . . . . 3.1200000000000001 109.489 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -60.02 -38.6 83.18 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.391 0.615 . . . . 1.28 110.121 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.3 mt -60.33 -39.93 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.703 -0.623 . . . . 0.48999999999999999 110.027 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.85 -43.79 40.45 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.925 -1.131 . . . . 0.46000000000000002 110.734 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -57.19 -42.5 81.33 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.145 -1.209 . . . . 2.71 110.099 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 -62.95 -40.69 98.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.13 -0.981 . . . . 2.1400000000000001 109.815 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.84 -45.95 92.45 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.534 -0.729 . . . . 1.05 110.122 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.69 -42.17 92.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.585 -0.697 . . . . 0.52000000000000002 110.62 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -60.27 -37.59 80.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.518 -0.739 . . . . 2.3500000000000001 110.831 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -75.28 -41.38 57.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 1.3899999999999999 111.191 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.02 -42.17 88.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.991 -1.068 . . . . 0.68000000000000005 110.292 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.2 -11.0 36.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.926 -1.109 . . . . 0.82999999999999996 112.276 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.07 26.82 61.29 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 119.611 -1.281 . . . . 0.91000000000000003 113.11 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 22.3 tp -62.57 149.83 42.1 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.713 -0.875 . . . . 0.94999999999999996 108.96 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -64.55 149.02 49.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 2.4300000000000002 109.603 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 70.4 mt -106.7 142.73 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.547 -0.908 . . . . 1.1000000000000001 108.547 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.762 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -78.75 129.82 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.001 -1.062 . . . . 1.5800000000000001 108.253 178.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -97.8 87.17 3.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.221 -1.029 . . . . 1.6200000000000001 108.221 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.97 -24.92 60.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.369 -0.832 . . . . 0.80000000000000004 111.302 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' A' ' 172' ' ' ASN . 34.5 t -82.01 -0.54 44.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 1.5600000000000001 112.1 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.49 25.74 7.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.546 -0.721 . . . . 0.83999999999999997 111.6 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.8 mt -70.96 139.98 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.138 -0.976 . . . . 0.81999999999999995 109.439 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -112.02 -20.18 12.06 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.645 0.735 . . . . 2.3100000000000001 112.073 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -117.63 137.75 52.42 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.704 -1.221 . . . . 1.54 107.704 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.25 128.34 35.37 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.977 -1.119 . . . . 1.3799999999999999 107.977 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.0 m -148.33 176.76 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.064 -0.717 . . . . 0.68999999999999995 109.064 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 44.4 mt -88.17 143.72 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.138 -0.976 . . . . 0.53000000000000003 109.007 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.5 tp -95.93 120.21 35.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.014 -1.054 . . . . 0.64000000000000001 108.61 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.0 t -120.15 129.58 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 107.506 -1.294 . . . . 0.67000000000000004 107.506 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.69 151.65 16.9 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.174 -0.954 . . . . 0.78000000000000003 109.084 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.74 -32.46 72.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.358 -1.464 . . . . 1.0 109.616 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -173.42 152.01 2.09 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.655 -0.868 . . . . 2.4199999999999999 108.655 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 41.7 mt -112.73 140.27 47.64 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.382 -0.824 . . . . 0.75 108.965 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.9 p -91.11 146.87 34.44 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.072 -1.018 . . . . 0.78000000000000003 108.852 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -39.19 -43.02 2.43 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 122.173 1.915 . . . . 0.67000000000000004 113.405 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.6 m -60.16 -48.5 81.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.066 . . . . 0.69999999999999996 110.234 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -64.68 -39.91 94.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.019 -1.051 . . . . 1.21 109.9 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 43.2 p -65.47 -43.32 90.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.602 -0.686 . . . . 0.59999999999999998 110.978 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.75 82.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.62 110.617 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -95.87 -1.14 50.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.171 -0.955 . . . . 1.1599999999999999 112.79 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.74 145.85 51.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.973 -1.079 . . . . 0.72999999999999998 108.181 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' A' ' 150' ' ' SER . 97.6 m-20 -94.99 117.49 30.22 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 106.979 -1.489 . . . . 2.2400000000000002 106.979 177.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.729 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -72.93 -18.59 61.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.781 -0.574 . . . . 1.4299999999999999 111.151 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -84.06 -16.17 44.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 2.1499999999999999 112.222 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -103.38 -11.97 17.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.538 -0.726 . . . . 2.04 112.812 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 178' ' ' GLY . 94.9 t -106.15 128.49 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 107.888 -1.153 . . . . 0.55000000000000004 107.888 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.62 -8.41 58.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.031 -1.043 . . . . 1.6299999999999999 112.326 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.552 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 177.22 173.94 43.19 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.437 -1.465 . . . . 0.46999999999999997 109.437 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -127.48 131.62 50.12 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 107.79 -1.189 . . . . 0.54000000000000004 107.79 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.533 HD11 HD13 ' A' ' 220' ' ' LEU . 62.5 mt -137.18 118.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 105.932 -1.877 . . . . 0.68999999999999995 105.932 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 203' ' ' VAL . 62.9 p -140.46 170.81 15.11 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.693 -1.254 . . . . 0.81999999999999995 110.08 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -104.09 65.36 0.8 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.791 -0.568 . . . . 2.3700000000000001 109.627 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -104.33 152.22 22.51 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.494 -0.754 . . . . 1.1100000000000001 109.484 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.45 -38.47 70.04 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 120.222 -0.99 . . . . 1.6699999999999999 110.864 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.63 -2.37 64.67 Favored Glycine 0 N--CA 1.494 2.561 0 O-C-N 121.094 -1.239 . . . . 1.54 113.292 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.437 HH11 ' HG2' ' A' ' 186' ' ' ARG . 3.5 ptt-85 -88.83 101.45 14.05 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.624 -1.991 . . . . 4.4800000000000004 105.624 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 p 53.4 47.64 23.7 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.993 -1.067 . . . . 2.6299999999999999 112.001 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 59.1 m -83.63 135.86 34.44 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.697 -1.223 . . . . 1.6899999999999999 107.697 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -59.36 -39.92 84.81 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.286 -0.884 . . . . 1.0700000000000001 111.026 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.0 m -59.62 -40.33 87.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.898 -1.126 . . . . 1.5800000000000001 110.089 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.2 p -61.88 -35.04 77.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 1.6000000000000001 110.652 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 32.0 mm -59.99 -39.29 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.519 -0.738 . . . . 1.45 110.656 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.4 mtp -62.23 -43.16 99.46 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 122.319 1.057 . . . . 1.05 109.595 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.89 -47.76 83.82 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.717 -0.614 . . . . 0.71999999999999997 110.504 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.516 ' HG2' HH11 ' A' ' 195' ' ' ARG . 33.8 mtt-85 -60.12 -41.34 92.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 3.0499999999999998 110.586 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.7 m -70.13 -41.53 73.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.182 -0.949 . . . . 0.89000000000000001 110.079 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.83 -8.18 50.28 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.577 0.703 . . . . 0.78000000000000003 112.49 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 194' ' ' ALA . 94.5 mt-10 49.6 12.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.82 1.045 . . . . 1.45 113.82 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.57 149.06 93.31 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 107.872 -1.159 . . . . 0.67000000000000004 107.872 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.34 135.86 71.0 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 120.948 1.099 . . . . 0.64000000000000001 110.017 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.75 163.11 34.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.31 -1.494 . . . . 0.67000000000000004 109.397 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.419 ' CD1' HD11 ' A' ' 220' ' ' LEU . 32.2 mt -146.79 147.51 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.639 -1.245 . . . . 0.68999999999999995 107.639 177.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.5 m -125.24 -31.55 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.146 -0.971 . . . . 0.84999999999999998 113.052 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.1 45.01 2.46 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 119.542 -1.313 . . . . 0.92000000000000004 111.016 -178.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 181' ' ' THR . 58.6 p -61.86 -19.54 62.73 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.537 -0.978 . . . . 0.94999999999999996 111.372 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.65 -90.7 0.86 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.48 -1.048 . . . . 1.04 110.48 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.3 p -130.62 28.69 4.87 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.503 -0.998 . . . . 1.5700000000000001 113.288 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.31 -40.02 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.44 -1.412 . . . . 0.83999999999999997 110.603 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.2 p -58.28 -22.72 53.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.968 -1.082 . . . . 0.98999999999999999 111.707 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.5 p -94.15 -1.88 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.424 -0.797 . . . . 1.7 112.183 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -125.88 3.07 7.37 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.645 0.736 . . . . 2.2000000000000002 112.436 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 22.4 t -116.13 146.54 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.528 -0.733 . . . . 0.83999999999999997 109.263 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -119.81 160.45 22.61 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.998 -1.112 . . . . 2.2000000000000002 107.998 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 3.7 m120 -57.36 139.81 51.96 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.85 -1.156 . . . . 2.2799999999999998 110.812 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 79.11 5.55 2.23 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.193 1.182 . . . . 2.3500000000000001 114.193 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 61.0 t0 -66.08 149.08 50.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.911 -1.118 . . . . 1.97 108.437 177.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.496 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 36.3 t80 -89.82 122.18 32.65 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.916 -1.513 . . . . 2.6499999999999999 106.916 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.4 mt -129.52 147.53 51.34 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.035 0.922 . . . . 0.63 110.105 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 21.0 mt -119.92 130.75 73.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.408 -1.33 . . . . 0.62 107.408 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.533 HD13 HD11 ' A' ' 180' ' ' ILE . 60.8 tp -99.65 120.2 39.31 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.407 -1.331 . . . . 0.64000000000000001 107.407 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 223' ' ' VAL . 33.5 t0 -89.77 -35.78 15.52 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.976 -1.077 . . . . 2.0499999999999998 111.431 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.947 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.78 17.75 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.566 0.698 . . . . 0.83999999999999997 112.459 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.1 t -109.15 -58.25 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.168 -0.957 . . . . 1.02 109.33 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.485 HD22 ' NE2' ' A' ' 226' ' ' GLN . 56.6 t30 -95.69 14.72 22.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.961 0.886 . . . . 2.5099999999999998 110.598 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.93 52.27 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.608 -0.724 . . . . 1.54 112.834 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.52 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 28.8 pt20 -151.93 157.13 41.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.031 -1.043 . . . . 1.95 110.168 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.35 135.19 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.071 -1.085 . . . . 0.70999999999999996 108.071 177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.52 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 83.4 m-85 -103.24 130.01 50.36 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.065 -1.022 . . . . 1.01 108.588 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.9 t -110.53 129.85 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.991 -1.114 . . . . 0.81999999999999995 107.991 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.443 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 61.8 t30 53.59 48.75 5.26 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 113.434 0.902 . . . . 1.54 113.434 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 37.0 Cg_endo -65.73 153.5 77.88 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.656 2.237 . . . . 0.93999999999999995 110.911 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.0 p -72.17 160.21 32.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.997 -1.065 . . . . 1.8 110.134 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -60.19 -37.96 81.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.216 -0.928 . . . . 2.73 110.642 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.98 -39.16 84.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 3.1699999999999999 110.558 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.7 -35.71 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.207 -0.933 . . . . 1.3400000000000001 110.176 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.71 -45.28 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.351 -0.843 . . . . 1.2 110.598 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -59.24 -41.07 87.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.975 -1.078 . . . . 2.7000000000000002 110.585 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -65.87 -42.97 89.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.509 -0.745 . . . . 2.5899999999999999 110.97 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.2 mtp -71.28 -39.39 71.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.955 . . . . 1.3799999999999999 111.01 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -57.0 -38.67 73.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.867 -1.145 . . . . 2.8399999999999999 110.375 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 245' ' ' GLN . . . -70.33 -39.32 74.8 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.506 -0.746 . . . . 1.8799999999999999 111.137 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 98.7 t -56.43 -49.57 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.915 -1.116 . . . . 2.3999999999999999 111.17 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.564 ' NE2' ' O ' ' A' ' 11' ' ' ILE . 39.5 tt0 -64.14 -50.85 66.58 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.761 -1.212 . . . . 3.52 109.954 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.47 -31.91 72.72 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.617 -0.719 . . . . 1.8799999999999999 110.414 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 241' ' ' ALA . 63.5 tt0 -60.67 -32.18 71.39 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.827 -1.149 . . . . 3.0099999999999998 109.19 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 88.0 t -62.46 -45.48 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 119.583 -0.847 . . . . 2.4500000000000002 109.787 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.02 81.36 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.666 0.746 . . . . 2.75 110.024 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.9 t -68.25 -32.18 72.18 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.767 -0.583 . . . . 3.1600000000000001 110.739 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -61.36 -49.75 75.68 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.295 -0.962 . . . . 3.5699999999999998 110.298 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -70.38 -34.15 72.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.373 -0.829 . . . . 4.2999999999999998 110.054 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.9 0.71 17.33 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 113.121 0.786 . . . . 4.4500000000000002 113.121 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -62.67 -23.9 67.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.175 -0.953 . . . . 5.9699999999999998 111.668 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.73 -21.56 63.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.28 -0.888 . . . . 6.1799999999999997 111.667 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.12 97.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 6.6600000000000001 111.36 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -82.25 -4.51 57.26 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.86 -1.15 . . . . 8.1999999999999993 112.779 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.24 44.15 1.16 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.937 -1.102 . . . . 8.0700000000000003 111.463 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -78.82 2.67 19.14 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.789 -0.765 . . . . 9.4499999999999993 112.164 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -91.85 14.23 16.12 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.525 0.679 . . . . 10.119999999999999 112.152 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.249 -0.881 . . . . 11.49 108.704 179.34 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.596 0.712 . . . . 3.0699999999999998 109.718 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.5 mt -95.68 112.43 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 106.544 -1.65 . . . . 1.0700000000000001 106.544 176.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.8 m -102.09 124.51 47.82 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.634 -1.247 . . . . 1.24 107.634 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' A' ' 225' ' ' ASN . . . -118.42 -160.72 11.6 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.77 -1.732 . . . . 1.01 108.77 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 5' ' ' ILE . 90.2 mt -95.8 1.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.372 -1.075 . . . . 1.1100000000000001 112.711 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.91 97.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 0.98999999999999999 112.195 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -86.41 -37.4 18.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.36 -0.837 . . . . 0.84999999999999998 111.477 179.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -150.6 145.71 18.75 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 120.682 -1.261 . . . . 1.3799999999999999 107.738 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.45 144.77 23.08 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 122.647 2.231 . . . . 0.93999999999999995 112.121 178.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.924 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.65 170.69 20.7 Favored Glycine 0 N--CA 1.504 3.197 0 N-CA-C 109.556 -1.417 . . . . 0.81000000000000005 109.556 178.032 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.5 mt -133.24 133.68 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 107.71 -1.219 . . . . 0.82999999999999996 107.71 179.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.0 151.94 41.4 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.19 -0.944 . . . . 0.53000000000000003 109.305 179.034 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.48 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 11.2 m-85 -119.25 140.82 49.62 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.668 -0.864 . . . . 0.77000000000000002 108.668 177.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.19 169.22 41.4 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 118.586 -1.769 . . . . 0.51000000000000001 110.472 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -77.76 158.18 29.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.688 -0.889 . . . . 1.8999999999999999 109.076 177.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.42 126.74 33.53 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.957 -1.089 . . . . 0.66000000000000003 108.291 178.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.0 tp -110.11 102.27 10.99 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.621 -1.992 . . . . 0.82999999999999996 105.621 178.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 tp -88.42 140.33 29.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.937 -1.102 . . . . 0.85999999999999999 108.922 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.46 HD11 HD11 ' A' ' 158' ' ' LEU . 44.8 mt -99.86 119.72 38.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.923 -1.111 . . . . 0.92000000000000004 108.061 178.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -110.31 141.01 43.91 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.22 -1.029 . . . . 2.0299999999999998 108.22 179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -118.67 141.32 48.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.103 -0.998 . . . . 2.6600000000000001 109.281 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -82.91 133.68 35.11 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.746 -1.205 . . . . 2.3199999999999998 107.746 177.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -62.95 149.13 45.52 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.759 -0.83 . . . . 2.1099999999999999 108.759 178.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.6 mt -95.15 133.79 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.584 -0.895 . . . . 0.72999999999999998 108.584 178.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 t -103.6 130.14 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.936 -1.135 . . . . 0.87 107.936 178.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.0 mt -98.31 133.12 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.287 -1.005 . . . . 0.81000000000000005 108.287 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -87.28 119.51 27.61 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.249 -1.389 . . . . 1.3400000000000001 107.249 178.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -101.37 20.02 16.68 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.86 -0.525 . . . . 2.8900000000000001 111.619 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -63.27 149.89 44.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.254 -0.904 . . . . 2.0899999999999999 110.154 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -91.33 125.38 36.08 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.47 -1.307 . . . . 2.1899999999999999 107.47 177.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 pt -97.07 166.5 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.338 -0.852 . . . . 0.75 110.15 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.8 p -99.3 164.3 12.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.595 -0.69 . . . . 0.91000000000000003 109.697 178.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.89 -28.38 36.05 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.052 -1.03 . . . . 0.93000000000000005 111.18 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -69.23 -34.11 74.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.009 . . . . 2.2799999999999998 110.393 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -87.61 -15.32 37.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.136 -0.978 . . . . 1.45 112.193 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.76 -41.34 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.977 -1.077 . . . . 0.81000000000000005 110.367 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.32 -40.07 81.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.828 -1.17 . . . . 1.54 110.841 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -61.24 -42.27 98.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.569 -0.707 . . . . 2.3599999999999999 111.245 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.08 -38.02 81.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.827 -1.17 . . . . 1.3100000000000001 111.154 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.54 -44.78 93.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.976 -1.077 . . . . 0.81999999999999995 110.26 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -62.36 -44.64 96.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.201 -0.937 . . . . 1.5 110.266 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -62.15 -41.51 98.35 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.154 -0.966 . . . . 2.23 109.638 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 32.1 t80 -74.06 -51.99 14.07 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.262 -0.899 . . . . 0.84999999999999998 109.249 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.01 -47.72 85.11 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 117.924 -1.511 . . . . 0.91000000000000003 110.367 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.605 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.4 t -69.57 -40.63 76.63 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.362 0.601 . . . . 0.90000000000000002 110.172 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.56 -44.67 90.71 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.292 -1.432 . . . . 0.68999999999999995 110.079 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.403 ' HB3' HH11 ' A' ' 47' ' ' ARG . 1.7 ttt-85 -59.37 -30.86 68.72 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.573 -0.957 . . . . 2.8799999999999999 109.36 178.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.72 -45.64 85.51 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.745 -0.661 . . . . 0.84999999999999998 109.773 178.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -80.11 -45.03 18.92 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.452 0.644 . . . . 2.3500000000000001 110.427 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.66 -41.98 91.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.317 -0.864 . . . . 0.65000000000000002 110.156 -178.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.6 t -60.02 -41.54 92.41 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 122.45 1.119 . . . . 1.45 109.098 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.47 -46.57 79.29 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.265 -0.88 . . . . 0.63 110.209 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -62.55 -50.38 71.58 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.117 -0.989 . . . . 1.3400000000000001 110.063 179.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 66.4 mt -61.23 -36.78 80.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.214 -0.929 . . . . 1.5600000000000001 110.192 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.81 -41.12 95.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.791 -0.568 . . . . 1.1899999999999999 110.819 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.59 HG22 ' HZ2' ' A' ' 60' ' ' LYS . 18.6 m -64.74 -42.67 95.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.813 -1.179 . . . . 0.71999999999999997 110.009 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.51 -38.29 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.818 -0.551 . . . . 0.62 110.672 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -50.32 -45.75 55.01 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 120.122 -0.631 . . . . 1.05 111.182 179.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -68.32 -32.56 72.78 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.937 -1.102 . . . . 0.64000000000000001 109.91 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.59 ' HZ2' HG22 ' A' ' 56' ' ' THR . 54.0 mttp -61.64 -39.88 92.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.617 -1.233 . . . . 1.73 109.295 179.402 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.9 -34.9 78.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.516 -0.74 . . . . 0.56000000000000005 110.097 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.61 -35.09 23.53 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.856 -1.164 . . . . 0.68999999999999995 111.364 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -83.33 -18.47 38.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.017 -1.284 . . . . 1.48 111.679 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -87.83 -53.17 4.89 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.747 -0.66 . . . . 0.97999999999999998 110.3 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -106.95 -17.21 14.25 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 113.275 0.843 . . . . 1.1599999999999999 113.275 -176.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.59 158.98 10.53 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 120.893 -0.67 . . . . 0.84999999999999998 111.83 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -55.24 -25.8 35.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.721 -0.87 . . . . 3.8599999999999999 112.763 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.4 -35.25 71.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.781 -1.199 . . . . 2.3500000000000001 111.226 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -82.16 -26.38 33.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.055 -1.028 . . . . 1.6699999999999999 111.702 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -59.82 -33.8 72.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.758 -0.589 . . . . 1.45 111.401 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.07 83.7 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.432 -0.793 . . . . 0.60999999999999999 111.563 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -65.62 -42.78 93.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.365 -1.459 . . . . 0.65000000000000002 110.156 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -70.93 -30.86 67.3 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.828 -1.17 . . . . 0.66000000000000003 110.895 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -61.36 -39.14 89.54 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.61 -0.836 . . . . 1.1899999999999999 109.955 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.67 -39.53 90.42 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 120.225 -0.988 . . . . 0.53000000000000003 110.793 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -57.39 -46.86 82.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.623 -1.516 . . . . 1.27 110.804 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.6 mt -59.9 -38.11 74.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.011 -1.056 . . . . 0.54000000000000004 110.703 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.2 ttp -58.95 -39.4 81.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.915 -1.116 . . . . 1.74 110.308 179.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 tp -59.92 -49.62 76.99 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.994 -1.066 . . . . 0.55000000000000004 109.783 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.9 tp -60.46 -43.72 96.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.066 0.936 . . . . 0.46999999999999997 110.341 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -87.67 9.65 20.73 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 112.783 0.66 . . . . 1.4199999999999999 112.783 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -65.27 123.82 20.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.737 -1.227 . . . . 1.27 108.428 178.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.78 -18.44 65.33 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.842 0.829 . . . . 1.3500000000000001 110.854 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -74.11 -52.37 12.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.564 -0.854 . . . . 2.2200000000000002 110.167 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.0 -37.85 86.42 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.443 -0.903 . . . . 0.62 110.897 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.78 -45.97 81.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.743 -1.223 . . . . 1.29 110.545 179.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -60.73 -36.86 79.93 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.486 -0.759 . . . . 1.52 110.665 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -67.01 -46.86 73.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.183 -1.007 . . . . 1.3 110.574 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.06 -43.77 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.428 -0.795 . . . . 0.60999999999999999 110.024 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.6 mt -59.78 -42.26 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.531 -0.73 . . . . 0.78000000000000003 110.589 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.52 -43.86 98.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.638 -0.663 . . . . 0.81999999999999995 111.007 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.18 -44.47 97.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.741 -1.224 . . . . 0.80000000000000004 110.474 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 93' ' ' ILE . 68.4 mt -62.99 -47.5 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.954 -1.091 . . . . 0.77000000000000002 110.466 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -83.63 -31.3 26.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.195 -0.94 . . . . 2.1200000000000001 111.655 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 91' ' ' ALA . 51.0 t0 -80.79 -45.84 16.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.81 -1.181 . . . . 1.51 111.399 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -100.78 7.04 44.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.626 -0.671 . . . . 1.98 112.328 -178.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.3 m80 51.96 49.72 20.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.181 -0.95 . . . . 1.3200000000000001 112.153 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 91.1 mtp -109.64 160.74 16.03 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.223 -0.923 . . . . 1.3799999999999999 109.341 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.5 p -71.21 159.34 34.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.619 -0.676 . . . . 0.67000000000000004 109.852 178.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.59 93.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.52000000000000002 110.415 178.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.481 ' OD2' HD21 ' A' ' 142' ' ' LEU . 91.9 m-20 -66.85 -39.72 87.7 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.282 -0.967 . . . . 2.25 109.727 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.83 -50.9 46.18 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.118 -1.033 . . . . 0.64000000000000001 110.851 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.42 -41.03 96.52 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.061 -1.056 . . . . 0.56000000000000005 110.569 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.48 87.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.689 -0.632 . . . . 0.46000000000000002 110.703 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -60.56 -39.63 88.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 1.3200000000000001 110.965 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -59.7 -48.87 79.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.011 -1.056 . . . . 1.3 111.055 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.29 -44.34 98.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.149 -0.969 . . . . 0.60999999999999999 110.229 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.17 -32.97 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.803 -0.56 . . . . 0.65000000000000002 110.475 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -59.83 -39.81 86.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.593 -0.692 . . . . 2.1099999999999999 110.688 179.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.38 -29.73 26.71 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.331 -1.414 . . . . 0.82999999999999996 113.097 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -61.03 -40.51 93.86 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.186 -1.773 . . . . 1.28 109.309 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.49 -50.02 42.3 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.82 0.819 . . . . 0.89000000000000001 109.905 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.7 p -60.14 -39.72 87.28 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.725 . . . . 1.8700000000000001 110.357 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.31 -43.75 96.06 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.231 -0.918 . . . . 1.05 110.194 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.78 -28.48 69.05 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.03 -1.044 . . . . 1.02 111.295 -179.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -67.15 -23.0 65.74 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.754 -0.591 . . . . 2.04 110.833 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -74.17 -11.83 60.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.696 0.76 . . . . 1.73 111.232 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.627 HD13 HD13 ' A' ' 123' ' ' LEU . 15.5 mt -86.37 141.91 28.84 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.157 -0.682 . . . . 1.3700000000000001 109.157 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -99.41 55.26 0.97 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.029 -1.045 . . . . 2.8799999999999999 111.058 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -130.77 142.15 50.39 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.293 -0.88 . . . . 1.5800000000000001 109.202 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.33 -40.28 81.72 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.739 -0.601 . . . . 3.04 110.938 178.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -72.8 -54.99 7.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.942 -1.099 . . . . 0.90000000000000002 111.034 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.627 HD13 HD13 ' A' ' 118' ' ' LEU . 45.5 mt -59.83 -40.33 88.1 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.069 -1.019 . . . . 1.0600000000000001 110.616 -179.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -62.53 -49.42 75.41 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.67 -1.269 . . . . 2.1800000000000002 110.084 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.6 -31.03 70.2 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.04 0.924 . . . . 2.1499999999999999 109.717 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -61.99 -30.97 71.3 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.159 -1.016 . . . . 2.3300000000000001 109.558 179.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.84 -48.9 79.81 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.588 -0.845 . . . . 0.81999999999999995 109.434 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.58 -44.11 75.09 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.647 -0.821 . . . . 0.84999999999999998 110.251 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.37 -31.78 73.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.106 -0.997 . . . . 1.3899999999999999 110.272 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.0 t -67.98 -39.35 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.76 -0.776 . . . . 0.56000000000000005 109.922 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.432 HH11 ' HG3' ' A' ' 131' ' ' ARG . 28.4 ttm-85 -56.97 -39.51 74.75 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.022 -1.071 . . . . 3.1200000000000001 109.311 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -59.8 -39.23 84.28 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.499 -0.75 . . . . 1.28 110.379 179.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.5 mt -61.54 -39.15 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.542 -0.724 . . . . 0.48999999999999999 109.968 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.45 -47.04 53.28 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 120.011 -1.09 . . . . 0.46000000000000002 110.6 179.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -57.46 -39.79 77.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.156 -1.203 . . . . 2.71 110.496 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.446 ' HG2' HH11 ' A' ' 136' ' ' ARG . 45.5 mtt-85 -61.52 -44.31 97.29 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.247 -0.981 . . . . 2.1400000000000001 109.944 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.85 -44.73 96.6 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.327 -0.858 . . . . 1.05 109.972 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.6 mt -59.47 -46.25 89.32 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.468 -0.77 . . . . 0.52000000000000002 110.389 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -59.94 -33.73 72.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.427 -0.795 . . . . 2.3500000000000001 110.669 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -76.43 -41.91 45.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.606 -0.684 . . . . 1.3899999999999999 111.004 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.68 -38.31 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.68000000000000005 110.78 -178.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.481 HD21 ' OD2' ' A' ' 101' ' ' ASP . 89.2 mt -83.97 -4.39 58.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.82999999999999996 112.294 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.25 20.31 79.12 Favored Glycine 0 N--CA 1.484 1.871 0 C-N-CA 119.265 -1.445 . . . . 0.91000000000000003 113.112 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.7 tp -66.97 148.43 51.97 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.665 0.745 . . . . 0.94999999999999996 109.312 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -67.21 149.64 50.17 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.14 -0.975 . . . . 2.4300000000000002 109.374 178.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 65.5 mt -105.23 139.94 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.12 -1.066 . . . . 1.1000000000000001 108.12 178.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.682 HD12 ' H ' ' A' ' 147' ' ' ILE . 3.6 mp -75.66 126.05 35.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.313 -0.995 . . . . 1.5800000000000001 108.313 178.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -96.22 98.03 9.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.877 -1.527 . . . . 1.6200000000000001 106.877 179.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 64.5 mt -74.83 -11.51 60.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.272 -0.893 . . . . 0.80000000000000004 111.582 -177.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.6 t -91.41 11.24 24.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.776 -0.577 . . . . 1.5600000000000001 112.3 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.74 17.54 14.86 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 113.658 0.985 . . . . 0.83999999999999997 113.658 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.706 ' N ' HD12 ' A' ' 152' ' ' ILE . 2.4 mp -72.77 140.84 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.299 -1.5 . . . . 0.81999999999999995 109.599 178.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -119.24 -11.99 9.5 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.065 0.936 . . . . 2.3100000000000001 111.998 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -112.89 149.18 33.51 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.616 -0.883 . . . . 1.54 108.616 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -76.32 123.23 25.61 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.527 -0.916 . . . . 1.3799999999999999 108.527 178.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.0 m -148.51 174.46 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.469 -0.769 . . . . 0.68999999999999995 109.308 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.9 mt -93.08 142.52 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.804 -0.813 . . . . 0.53000000000000003 108.804 178.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.46 HD11 HD11 ' A' ' 19' ' ' LEU . 23.8 tp -95.07 125.81 39.98 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.753 -1.217 . . . . 0.64000000000000001 108.022 178.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.91 129.96 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 107.68 -1.229 . . . . 0.67000000000000004 107.68 179.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.44 151.52 17.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.511 -1.368 . . . . 0.78000000000000003 108.838 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.49 -35.94 79.09 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.01 -1.056 . . . . 1.0 109.475 178.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -173.09 151.84 2.2 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.734 -0.839 . . . . 2.4199999999999999 108.734 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.5 mt -115.86 139.59 50.06 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.774 -0.825 . . . . 0.75 108.774 177.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.3 p -89.39 149.26 42.32 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.965 -1.084 . . . . 0.78000000000000003 108.762 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -41.3 -42.1 5.14 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.563 2.175 . . . . 0.67000000000000004 113.627 179.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.7 m -62.87 -51.41 67.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 0.69999999999999996 110.121 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -60.94 -39.39 89.28 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.32 -0.862 . . . . 1.21 110.115 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.4 p -67.92 -41.01 83.26 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.372 -0.83 . . . . 0.59999999999999998 110.464 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.03 -37.03 81.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.304 -0.873 . . . . 0.62 110.819 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -97.22 3.18 51.54 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.027 -1.046 . . . . 1.1599999999999999 112.685 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 46.2 tp -59.65 149.62 29.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.076 -1.015 . . . . 0.72999999999999998 109.217 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -95.42 111.17 23.1 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.763 -1.569 . . . . 2.2400000000000002 106.763 177.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 73.9 mt -80.74 -10.07 59.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.643 -0.66 . . . . 1.4299999999999999 112.615 -177.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -80.29 -29.63 38.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.15 -0.969 . . . . 2.1499999999999999 111.935 -178.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -100.5 -0.92 36.96 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.126 -0.984 . . . . 2.04 113.417 -178.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 40.0 t -108.45 129.02 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 107.749 -1.204 . . . . 0.55000000000000004 107.749 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -90.21 -16.09 30.12 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.366 1.079 . . . . 1.6299999999999999 111.446 -179.223 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.86 173.33 45.94 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.852 -1.699 . . . . 0.46999999999999997 108.852 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -130.16 131.32 45.59 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 107.784 -1.191 . . . . 0.54000000000000004 107.784 179.392 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.48 HD11 HD13 ' A' ' 220' ' ' LEU . 94.8 mt -126.77 115.3 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 106.388 -1.708 . . . . 0.68999999999999995 106.388 178.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 203' ' ' VAL . 70.6 p -132.92 169.61 16.54 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.104 -0.997 . . . . 0.81999999999999995 109.599 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.455 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 2.8 m-20 -101.86 36.01 2.19 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.563 -0.711 . . . . 2.3700000000000001 110.711 179.074 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -97.88 175.64 6.07 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.766 -1.209 . . . . 1.1100000000000001 109.983 177.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 183' ' ' ALA . . . -61.13 -132.41 0.01 OUTLIER Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.577 -1.409 . . . . 1.6699999999999999 109.577 179.145 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.44 -32.89 0.1 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.63 -1.271 . . . . 1.54 113.73 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.46 HH11 ' HG3' ' A' ' 186' ' ' ARG . 36.6 mtm-85 -56.24 -39.2 72.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.678 -1.483 . . . . 4.4800000000000004 110.318 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.7 p -137.72 29.27 2.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.691 -0.63 . . . . 2.6299999999999999 111.686 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.1 p -82.04 139.24 34.6 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.878 0.847 . . . . 1.6899999999999999 109.204 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -59.08 -38.83 80.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 1.0700000000000001 110.777 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 33.8 p -59.76 -39.78 85.94 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.268 -0.973 . . . . 1.5800000000000001 110.37 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.8 m -60.16 -37.63 80.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.382 -0.824 . . . . 1.6000000000000001 110.42 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 37.3 mm -60.1 -37.25 72.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.576 -0.702 . . . . 1.45 110.603 179.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.8 mtp -62.21 -44.22 97.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.567 1.175 . . . . 1.05 109.418 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.48 -47.34 85.87 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.473 -0.785 . . . . 0.71999999999999997 110.802 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -61.64 -42.58 99.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.214 -0.929 . . . . 3.0499999999999998 110.804 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 20.4 m -69.46 -39.82 77.5 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.38 -0.928 . . . . 0.89000000000000001 110.204 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.7 mt -90.37 -7.56 52.91 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.512 0.672 . . . . 0.78000000000000003 112.451 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 194' ' ' ALA . 99.0 mt-10 53.72 8.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 113.853 1.057 . . . . 1.45 113.853 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 66.1 mt -71.5 149.99 93.69 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 0.67000000000000004 108.419 178.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.92 143.03 99.75 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.459 1.439 . . . . 0.64000000000000001 109.602 178.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.73 167.44 28.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.361 -1.462 . . . . 0.67000000000000004 110.194 179.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.6 mt -150.58 150.53 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.626 -1.25 . . . . 0.68999999999999995 107.626 178.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.2 m -141.54 -28.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.7 0 O-C-N 120.383 -1.448 . . . . 0.84999999999999998 113.156 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.34 35.12 3.64 Favored Glycine 0 N--CA 1.488 2.107 0 O-C-N 120.961 -1.087 . . . . 0.92000000000000004 112.627 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.455 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 20.1 p -59.7 -34.4 72.84 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.462 -1.611 . . . . 0.94999999999999996 110.23 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 94.26 -78.55 0.97 Allowed Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.196 -1.002 . . . . 1.04 112.445 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.1 p -117.51 23.25 11.89 Favored 'General case' 0 N--CA 1.517 2.919 0 CA-C-N 119.262 1.531 . . . . 1.5700000000000001 114.061 -178.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.419 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 4.8 t -55.08 -30.97 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 119.479 -2.013 . . . . 0.83999999999999997 110.572 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.9 p -58.83 -28.66 66.26 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.929 -1.108 . . . . 0.98999999999999999 111.421 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 13.8 m -94.26 5.28 52.26 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.885 -1.134 . . . . 1.7 112.32 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -129.5 -7.12 4.68 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 113.404 0.89 . . . . 2.2000000000000002 113.404 -178.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 17.2 t -118.96 139.56 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.564 -0.902 . . . . 0.83999999999999997 108.564 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -120.16 157.46 28.99 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.087 -1.079 . . . . 2.2000000000000002 108.087 178.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 2.7 t-20 -57.74 140.83 50.56 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.964 -1.094 . . . . 2.2799999999999998 110.538 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.7 t0 80.1 0.54 2.04 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.451 1.278 . . . . 2.3500000000000001 114.451 179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -66.21 147.35 53.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.552 -1.342 . . . . 1.97 108.374 177.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -90.18 118.5 29.75 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.054 -1.832 . . . . 2.6499999999999999 106.054 177.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.3 mt -127.05 143.8 51.19 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.459 0.647 . . . . 0.63 109.48 -178.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 61.2 mt -111.36 127.59 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 106.399 -1.704 . . . . 0.62 106.399 177.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.48 HD13 HD11 ' A' ' 180' ' ' ILE . 62.9 tp -100.86 120.12 39.67 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.428 -1.323 . . . . 0.64000000000000001 107.428 179.135 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.587 ' O ' ' N ' ' A' ' 223' ' ' VAL . 52.3 t0 -93.94 -23.68 17.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.872 -1.143 . . . . 2.0499999999999998 112.777 -178.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.924 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.94 18.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.098 0.777 . . . . 0.83999999999999997 113.098 -178.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.9 t -108.14 -60.3 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.924 -1.11 . . . . 1.02 109.037 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -100.15 16.3 24.6 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.53 0.681 . . . . 2.5099999999999998 110.345 -179.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 4' ' ' GLY . 4.1 t-20 61.2 51.61 4.27 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.362 0.601 . . . . 1.54 111.771 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -145.83 144.87 30.52 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.277 1.036 . . . . 1.95 110.193 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.61 145.16 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.948 -0.76 . . . . 0.70999999999999996 108.948 178.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -101.95 136.58 41.54 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.208 -1.034 . . . . 1.01 108.208 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.62 129.93 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.004 -0.739 . . . . 0.81999999999999995 109.004 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 42.6 t30 49.63 58.63 17.52 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 113.79 1.033 . . . . 1.54 113.79 178.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.66 141.51 38.0 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 121.96 1.773 . . . . 0.93999999999999995 110.791 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.4 p -74.08 156.72 37.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.942 -1.099 . . . . 1.8 109.277 177.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -58.49 -37.73 76.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.333 -0.854 . . . . 2.73 110.472 178.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.16 -40.98 82.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.452 -0.78 . . . . 3.1699999999999999 110.223 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 96.6 t -71.06 -42.99 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.386 -0.821 . . . . 1.3400000000000001 109.979 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.48 -48.23 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.556 -0.715 . . . . 1.2 110.084 -179.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -58.91 -41.37 87.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.991 -1.068 . . . . 2.7000000000000002 109.931 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -62.42 -42.15 99.23 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.597 0.713 . . . . 2.5899999999999999 110.177 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 243' ' ' GLN . 81.5 mtp -72.3 -39.7 68.08 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.475 -0.766 . . . . 1.3799999999999999 110.923 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -52.91 -39.22 62.58 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.487 -1.383 . . . . 2.8399999999999999 110.925 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.56 -56.76 4.47 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.045 -1.062 . . . . 1.8799999999999999 110.567 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.12 -44.07 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.58 0.705 . . . . 2.3999999999999999 111.268 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 239' ' ' MET . 1.6 tm0? -60.63 -47.9 84.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.512 -1.368 . . . . 3.52 111.002 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -61.55 -31.33 71.36 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.656 -1.278 . . . . 1.8799999999999999 109.945 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -59.93 -31.17 69.59 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.139 -1.024 . . . . 3.0099999999999998 109.317 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 82.4 t -62.01 -41.88 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.734 0.778 . . . . 2.4500000000000002 109.406 179.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.95 89.0 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.157 -0.617 . . . . 2.75 110.115 179.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 25.8 p -70.55 -29.43 65.89 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.441 0.639 . . . . 3.1600000000000001 110.522 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.59 -32.54 74.04 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.192 -0.942 . . . . 3.5699999999999998 110.311 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -65.53 -30.27 71.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.403 -0.81 . . . . 4.2999999999999998 110.764 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.05 -19.2 65.64 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.377 -0.827 . . . . 4.4500000000000002 111.314 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -69.58 -18.91 63.67 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.313 -0.867 . . . . 5.9699999999999998 111.281 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 253' ' ' LEU . 7.2 tt -62.21 -30.65 71.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.484 -0.76 . . . . 6.1799999999999997 110.051 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -72.48 0.67 9.69 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.089 -1.007 . . . . 6.6600000000000001 112.36 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -80.9 32.17 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.087 0.946 . . . . 8.1999999999999993 112.411 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 90.5 mt -82.89 11.51 5.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.772 -1.205 . . . . 8.0700000000000003 111.783 179.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -84.28 5.73 25.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.255 -0.903 . . . . 9.4499999999999993 112.409 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -91.39 4.5 52.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.124 -0.985 . . . . 10.119999999999999 112.416 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 . . . . . 0 N--CA 1.498 1.954 0 O-C-N 121.051 -1.031 . . . . 11.49 109.106 179.947 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.3 mmm . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.518 -0.549 . . . . 3.0699999999999998 109.518 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt -103.34 122.65 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.654 -1.239 . . . . 1.0700000000000001 107.654 177.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.2 m -105.73 123.3 47.72 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.784 -1.191 . . . . 1.24 107.784 178.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.22 -162.94 11.64 Favored Glycine 0 N--CA 1.499 2.884 0 N-CA-C 108.274 -1.93 . . . . 1.01 108.274 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 5' ' ' ILE . 90.9 mt -100.59 2.28 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.174 -1.191 . . . . 1.1100000000000001 112.671 -179.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 5' ' ' ILE . 12.3 tp 50.71 101.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.078 -1.014 . . . . 0.98999999999999999 112.134 179.166 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -87.87 -41.55 13.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.939 -1.1 . . . . 0.84999999999999998 111.549 179.419 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 t -145.19 146.17 29.52 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.045 -1.095 . . . . 1.3799999999999999 108.045 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.59 143.85 21.89 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.815 2.343 . . . . 0.93999999999999995 112.377 178.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.922 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.19 -177.47 29.16 Favored Glycine 0 N--CA 1.503 3.129 0 N-CA-C 109.658 -1.377 . . . . 0.81000000000000005 109.658 177.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.9 mt -137.81 140.75 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.25 -1.147 . . . . 0.82999999999999996 108.578 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.48 149.99 43.22 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.317 -0.865 . . . . 0.53000000000000003 109.005 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -119.56 139.8 51.56 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.713 -1.217 . . . . 0.77000000000000002 107.713 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.49 163.95 27.92 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 118.125 -1.988 . . . . 0.51000000000000001 110.485 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -76.48 160.68 29.29 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.506 -0.997 . . . . 1.8999999999999999 109.837 179.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -84.15 122.29 28.64 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.965 -1.124 . . . . 0.66000000000000003 107.965 178.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.7 tp -101.71 101.97 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.089 -2.189 . . . . 0.82999999999999996 105.089 177.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.6 tp -88.25 140.37 29.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.176 -0.952 . . . . 0.85999999999999999 108.632 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.9 mt -98.28 118.5 35.06 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 106.271 -1.752 . . . . 0.92000000000000004 106.271 177.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -111.01 134.07 52.91 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.201 -1.037 . . . . 2.0299999999999998 108.201 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -125.95 140.8 52.33 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.584 -0.895 . . . . 2.6600000000000001 108.584 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -81.81 138.01 35.2 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.371 -0.974 . . . . 2.3199999999999998 108.371 177.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -63.29 143.63 57.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -0.773 . . . . 2.1099999999999999 108.991 178.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 87.9 mt -94.53 132.13 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.174 -1.047 . . . . 0.72999999999999998 108.174 178.251 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.16 130.19 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.233 -1.025 . . . . 0.87 108.233 179.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.8 mt -94.07 138.13 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.374 -0.973 . . . . 0.81000000000000005 108.374 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -92.19 122.23 34.48 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.572 -1.27 . . . . 1.3400000000000001 107.572 178.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -93.54 10.93 30.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.289 -0.882 . . . . 2.8900000000000001 112.651 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -71.57 153.01 42.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.706 -1.246 . . . . 2.0899999999999999 109.349 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -92.18 140.04 30.02 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 109.102 -0.703 . . . . 2.1899999999999999 109.102 178.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -92.39 175.29 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.229 -0.919 . . . . 0.75 109.915 177.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.473 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 6.3 p -103.5 166.62 10.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.522 -0.736 . . . . 0.91000000000000003 109.549 179.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.56 -35.26 67.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.488 -0.758 . . . . 0.93000000000000005 111.519 178.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.473 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 10.9 p-10 -69.86 -22.23 63.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.846 -1.159 . . . . 2.2799999999999998 110.626 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -94.02 -20.44 19.96 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.492 0.663 . . . . 1.45 112.213 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.84 -46.4 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.626 -0.671 . . . . 0.81000000000000005 110.236 -178.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -58.86 -40.36 84.06 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.323 -0.861 . . . . 1.54 110.658 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -64.0 -45.32 89.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 2.3599999999999999 110.808 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -60.82 -37.74 83.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.256 -0.903 . . . . 1.3100000000000001 110.945 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -59.13 -40.07 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.176 -0.953 . . . . 0.81999999999999995 110.082 179.274 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.72 -41.74 95.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.072 -1.018 . . . . 1.5 109.645 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -63.1 -39.16 93.88 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.343 -0.848 . . . . 2.23 110.094 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -72.11 -54.52 9.52 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.411 -0.806 . . . . 0.84999999999999998 110.06 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.7 tp -60.78 -50.14 74.65 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.969 0.89 . . . . 0.91000000000000003 109.74 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.0 t -67.41 -38.91 85.35 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.422 -0.799 . . . . 0.90000000000000002 110.247 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.58 90.85 Favored Glycine 0 N--CA 1.485 1.934 0 C-N-CA 119.648 -1.263 . . . . 0.68999999999999995 110.056 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.4 HH12 ' CG ' ' A' ' 86' ' ' GLU . 39.3 ttm180 -59.94 -31.65 70.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.24 -1.153 . . . . 2.8799999999999999 109.63 178.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.89 -42.63 90.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.619 0.723 . . . . 0.84999999999999998 109.764 179.063 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -80.52 -48.65 12.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 2.3500000000000001 110.85 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.99 79.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.515 -0.741 . . . . 0.65000000000000002 110.102 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.4 p -61.68 -38.56 88.28 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.867 0.842 . . . . 1.45 109.343 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.82 -46.19 69.25 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.948 -0.569 . . . . 0.63 110.313 179.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.74 -49.35 75.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.633 -1.292 . . . . 1.3400000000000001 110.122 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.9 mt -61.34 -40.0 92.62 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.034 0.921 . . . . 1.5600000000000001 109.513 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -60.64 -39.73 89.37 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.577 -0.702 . . . . 1.1899999999999999 110.105 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.0 m -62.06 -42.89 99.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.866 . . . . 0.71999999999999997 110.366 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.0 -36.94 70.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.609 -0.682 . . . . 0.62 110.645 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -51.1 -43.5 61.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.938 . . . . 1.05 110.443 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -70.27 -36.42 74.41 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.926 -1.109 . . . . 0.64000000000000001 110.009 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -62.69 -39.34 93.68 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.819 -1.153 . . . . 1.73 109.316 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.74 81.74 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.852 -0.613 . . . . 0.56000000000000005 110.091 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.78 -35.86 23.97 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.467 -1.349 . . . . 0.68999999999999995 110.964 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.03 -17.59 46.22 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.17 -1.194 . . . . 1.48 111.575 -179.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.7 m -93.46 -52.73 4.37 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.716 -0.615 . . . . 0.97999999999999998 110.672 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -107.65 -6.23 17.0 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 114.004 1.112 . . . . 1.1599999999999999 114.004 -178.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.96 149.88 11.85 Favored Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.375 -0.828 . . . . 0.84999999999999998 112.432 178.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.47 -15.35 0.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.386 -1.067 . . . . 3.8599999999999999 112.464 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.46 -31.32 69.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.395 -0.816 . . . . 2.3500000000000001 111.291 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -83.35 -16.93 44.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.807 -1.183 . . . . 1.6699999999999999 112.109 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.16 -30.76 69.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.888 -1.133 . . . . 1.45 111.228 -179.094 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.32 90.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.60999999999999999 110.767 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.6 mt -67.5 -41.48 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.842 -1.161 . . . . 0.65000000000000002 109.337 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -71.39 -29.88 65.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.66000000000000003 110.734 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.25 -39.88 88.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.869 . . . . 1.1899999999999999 110.046 179.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.44 -44.31 74.02 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.745 -0.942 . . . . 0.53000000000000003 110.745 179.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -60.0 -48.06 83.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.934 -1.333 . . . . 1.27 110.726 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.5 mt -62.41 -39.49 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 120.9 -1.125 . . . . 0.54000000000000004 110.016 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.8 ttp -60.28 -39.98 88.79 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.806 -0.758 . . . . 1.74 110.506 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.1 tp -59.37 -48.52 81.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.55000000000000004 110.355 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.05 -41.24 91.9 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.861 0.838 . . . . 0.46999999999999997 110.144 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -85.93 4.17 38.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.607 -0.683 . . . . 1.4199999999999999 112.496 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -59.7 124.54 20.46 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.182 -0.949 . . . . 1.27 110.894 -178.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.02 -16.42 63.42 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.418 -0.801 . . . . 1.3500000000000001 111.226 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -76.94 -54.31 6.73 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.769 0.795 . . . . 2.2200000000000002 110.568 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.84 -38.24 87.49 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.386 -0.821 . . . . 0.62 110.923 -179.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' CG ' HH12 ' A' ' 47' ' ' ARG . 88.3 tt0 -59.0 -49.58 77.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.073 -1.017 . . . . 1.29 110.786 179.147 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.67 -39.48 94.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.027 -1.046 . . . . 1.52 110.708 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.95 -49.42 61.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 1.3 110.87 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.11 -45.64 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.836 -1.165 . . . . 0.60999999999999999 110.097 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -61.45 -41.92 91.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.515 0.674 . . . . 0.78000000000000003 110.43 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.95 95.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.258 -0.901 . . . . 0.81999999999999995 111.036 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.29 -39.56 87.32 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.254 -0.904 . . . . 0.80000000000000004 110.332 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.0 -51.18 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.77000000000000002 110.365 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.86 -33.99 62.19 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.382 -0.824 . . . . 2.1200000000000001 111.493 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -80.42 -45.92 16.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.139 -0.976 . . . . 1.51 111.842 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -103.07 8.64 38.76 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.058 -1.026 . . . . 1.98 112.581 -178.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 56.0 m80 53.17 49.9 18.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 1.3200000000000001 111.752 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.1 mtt -102.02 152.97 20.33 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.211 -0.931 . . . . 1.3799999999999999 109.668 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.1 p -71.34 156.52 39.41 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.321 -0.862 . . . . 0.67000000000000004 109.304 177.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.02 -45.75 79.04 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.276 -0.89 . . . . 0.52000000000000002 110.366 178.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -68.35 -39.3 81.92 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.063 -1.023 . . . . 2.25 110.267 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.87 -47.78 57.39 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.516 -1.274 . . . . 0.64000000000000001 110.856 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.25 90.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.56000000000000005 110.178 -178.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.12 91.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.252 -0.905 . . . . 0.46000000000000002 110.621 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -60.31 -38.39 83.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 1.3200000000000001 111.249 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -58.49 -49.2 78.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.998 -1.064 . . . . 1.3 111.267 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.3 t -61.5 -44.86 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.834 -1.166 . . . . 0.60999999999999999 110.321 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.66 -33.24 56.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.556 -0.715 . . . . 0.65000000000000002 110.403 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -58.5 -41.91 86.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.377 -0.827 . . . . 2.1099999999999999 110.802 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.36 -30.39 22.26 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.142 -1.504 . . . . 0.82999999999999996 112.121 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -62.21 -40.6 96.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.523 -1.575 . . . . 1.28 110.252 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.35 -50.59 30.69 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.539 -0.726 . . . . 0.89000000000000001 111.092 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.1 m -59.63 -39.81 85.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -0.902 . . . . 1.8700000000000001 110.926 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.19 -42.18 98.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 1.05 111.323 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 80.7 mt -62.27 -29.86 70.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.575 -1.328 . . . . 1.02 111.023 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.91 -21.95 65.97 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.17 -0.956 . . . . 2.04 110.958 179.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -74.96 -12.04 60.25 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.019 -0.672 . . . . 1.73 111.412 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.526 HD13 HD13 ' A' ' 123' ' ' LEU . 6.8 mt -87.08 149.22 24.86 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.146 -0.687 . . . . 1.3700000000000001 109.146 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -102.61 47.49 0.89 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.456 -0.778 . . . . 2.8799999999999999 111.197 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -124.58 134.5 52.94 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 108.502 -0.925 . . . . 1.5800000000000001 108.502 179.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -57.34 -38.5 74.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.373 -0.829 . . . . 3.04 110.979 178.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -70.88 -49.1 49.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.666 -1.271 . . . . 0.90000000000000002 110.055 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.526 HD13 HD13 ' A' ' 118' ' ' LEU . 43.8 mt -62.89 -39.14 93.57 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.848 -1.158 . . . . 1.0600000000000001 109.994 -178.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -64.09 -50.18 69.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.627 -1.296 . . . . 2.1800000000000002 110.149 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.54 -30.14 69.58 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.925 -1.109 . . . . 2.1499999999999999 109.535 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 130' ' ' VAL . 62.6 ttt180 -64.79 -29.5 70.47 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.959 0.885 . . . . 2.3300000000000001 109.551 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -60.55 -49.31 78.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.465 -0.894 . . . . 0.81999999999999995 109.71 178.483 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.27 83.22 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.477 -0.889 . . . . 0.84999999999999998 110.022 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.55 -35.0 78.07 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.186 0.517 . . . . 1.3899999999999999 110.839 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 126' ' ' ARG . 30.8 t -69.01 -40.98 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.146 -0.971 . . . . 0.56000000000000005 110.568 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.487 ' HG2' HH11 ' A' ' 131' ' ' ARG . 24.2 ttt-85 -57.74 -38.57 75.56 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.397 -1.321 . . . . 3.1200000000000001 109.52 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -60.79 -38.39 85.14 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.421 0.629 . . . . 1.28 110.397 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.25 -39.91 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.252 -0.905 . . . . 0.48999999999999999 109.821 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.52 -43.76 60.21 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.634 -1.27 . . . . 0.46000000000000002 110.202 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -57.92 -41.26 82.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.458 -1.025 . . . . 2.71 110.364 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.455 ' HG2' HH11 ' A' ' 136' ' ' ARG . 62.4 mtt-85 -61.7 -43.18 99.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.88 -1.137 . . . . 2.1400000000000001 110.093 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.7 tp -60.56 -44.9 95.65 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.957 0.884 . . . . 1.05 109.452 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.76 -38.0 83.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.314 -0.866 . . . . 0.52000000000000002 110.16 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -39.32 85.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 2.3500000000000001 111.171 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -75.17 -40.86 59.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.872 -1.143 . . . . 1.3899999999999999 111.008 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.94 -39.77 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.68000000000000005 110.618 -178.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.3 mt -86.51 -10.07 54.86 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.962 -1.086 . . . . 0.82999999999999996 111.927 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.39 19.52 71.43 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.992 -1.099 . . . . 0.91000000000000003 112.634 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 46.2 tp -71.07 140.23 50.64 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.673 -0.898 . . . . 0.94999999999999996 109.317 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -67.55 150.73 48.44 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.226 -0.921 . . . . 2.4300000000000002 110.65 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 81.0 mt -106.18 142.11 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.453 -0.944 . . . . 1.1000000000000001 108.453 178.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 23.3 mm -74.56 122.59 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.326 -0.991 . . . . 1.5800000000000001 108.326 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -95.85 100.65 12.32 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.891 -1.892 . . . . 1.6200000000000001 105.891 178.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 53.8 mt -73.56 -21.46 60.35 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.295 -0.878 . . . . 0.80000000000000004 111.396 -177.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 82.5 p -83.97 7.05 19.62 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.443 -0.786 . . . . 1.5600000000000001 112.169 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.16 17.7 19.26 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.531 0.681 . . . . 0.83999999999999997 112.212 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.628 HD12 HD21 ' A' ' 172' ' ' ASN . 45.4 mt -74.98 144.49 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.636 -0.665 . . . . 0.81999999999999995 109.785 179.011 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -120.85 -9.76 9.23 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.359 -0.838 . . . . 2.3100000000000001 112.522 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -118.77 141.92 48.18 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.963 -0.755 . . . . 1.54 108.963 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.86 124.19 26.42 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.159 0.981 . . . . 1.3799999999999999 108.791 178.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.68 176.84 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.038 -0.727 . . . . 0.68999999999999995 109.038 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 67.8 mt -91.98 141.59 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.225 -1.028 . . . . 0.53000000000000003 108.225 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.7 tp -93.95 126.53 39.21 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.851 -1.155 . . . . 0.64000000000000001 108.447 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 32.3 t -123.42 129.99 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.059 -1.089 . . . . 0.67000000000000004 108.059 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.83 158.18 27.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.226 -0.921 . . . . 0.78000000000000003 108.783 179.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 162' ' ' ASP . . . -62.05 -39.43 92.34 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.573 -1.33 . . . . 1.0 109.772 178.224 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 55.8 m-20 -168.93 156.63 7.53 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.192 -1.04 . . . . 2.4199999999999999 108.192 179.187 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 38.4 mt -117.25 139.62 50.57 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.231 -0.918 . . . . 0.75 108.612 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.0 p -95.96 151.02 38.05 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.141 -1.059 . . . . 0.78000000000000003 108.141 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -39.87 -43.72 3.44 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.779 1.652 . . . . 0.67000000000000004 113.351 179.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 74.8 m -61.28 -50.38 73.23 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.288 -0.882 . . . . 0.69999999999999996 109.953 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.68 -39.4 88.29 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.409 -0.807 . . . . 1.21 110.153 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.8 p -68.77 -41.08 79.33 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.852 -0.739 . . . . 0.59999999999999998 110.575 179.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.21 -34.86 74.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.07 -1.019 . . . . 0.62 110.531 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -96.97 -1.37 45.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.125 -0.984 . . . . 1.1599999999999999 112.879 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.46 151.71 31.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.98 -1.075 . . . . 0.72999999999999998 109.695 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.628 HD21 HD12 ' A' ' 152' ' ' ILE . 25.0 p-10 -92.91 108.13 19.76 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 106.439 -1.689 . . . . 2.2400000000000002 106.439 178.007 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 173' ' ' LEU . 3.1 mm? -76.96 -18.71 58.07 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.488 -0.757 . . . . 1.4299999999999999 111.63 -177.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -81.1 -25.66 36.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.064 -1.023 . . . . 2.1499999999999999 112.255 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -102.75 -4.43 25.01 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 113.829 1.048 . . . . 2.04 113.829 -178.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 178' ' ' GLY . 63.0 t -101.68 120.1 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.302 -1.74 . . . . 0.55000000000000004 106.302 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 22.0 tp -84.89 -0.73 55.11 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.657 0.742 . . . . 1.6299999999999999 111.873 -178.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.492 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.34 169.95 34.09 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.035 -1.626 . . . . 0.46999999999999997 109.035 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -129.31 137.74 51.18 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.193 -1.18 . . . . 0.54000000000000004 108.31 179.107 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.541 HG22 HG21 ' A' ' 205' ' ' THR . 93.2 mt -135.67 110.87 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 105.798 -1.927 . . . . 0.68999999999999995 105.798 178.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 203' ' ' VAL . 41.7 p -135.8 179.31 6.42 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.667 -1.27 . . . . 0.81999999999999995 110.089 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -102.43 55.52 0.78 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 115.91 -0.586 . . . . 2.3700000000000001 109.735 179.555 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.01 166.55 10.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.663 -0.648 . . . . 1.1100000000000001 109.448 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.23 -81.93 0.1 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.797 -1.192 . . . . 1.6699999999999999 111.244 178.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.82 -67.53 0.28 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.31 -1.112 . . . . 1.54 111.954 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -61.36 -39.47 90.74 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.378 -1.072 . . . . 4.4800000000000004 110.143 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.2 p -105.76 13.79 29.17 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.614 -0.679 . . . . 2.6299999999999999 111.831 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.5 t -86.91 120.46 28.2 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.413 -1.329 . . . . 1.6899999999999999 107.413 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -60.7 -40.54 92.59 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.696 -0.628 . . . . 1.0700000000000001 110.767 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 191' ' ' SER . 11.9 t -59.68 -40.03 86.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.916 -1.115 . . . . 1.5800000000000001 110.29 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.433 ' N ' HG23 ' A' ' 190' ' ' THR . 35.5 t -58.57 -37.56 76.03 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.325 -0.86 . . . . 1.6000000000000001 110.48 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.81 -38.66 77.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.123 -0.986 . . . . 1.45 110.415 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 74.4 mtp -62.3 -43.63 98.38 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.395 1.093 . . . . 1.05 109.128 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.31 -41.15 83.86 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.223 -0.899 . . . . 0.71999999999999997 110.464 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.433 ' HG2' HH11 ' A' ' 195' ' ' ARG . 47.0 mtt-85 -60.47 -42.07 95.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.915 -1.115 . . . . 3.0499999999999998 110.095 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 64.4 m -71.06 -39.31 72.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 0.89000000000000001 110.305 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.3 mt -91.24 -9.3 45.72 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.841 0.829 . . . . 0.78000000000000003 112.392 -178.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.4 mt-10 52.29 12.5 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.846 1.054 . . . . 1.45 113.846 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.66 147.81 96.58 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 0.67000000000000004 108.238 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -56.73 139.68 89.11 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.379 1.386 . . . . 0.64000000000000001 110.134 178.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.77 165.85 31.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.518 -1.364 . . . . 0.67000000000000004 109.798 179.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 203' ' ' VAL . 59.6 mt -145.39 156.84 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.656 -1.238 . . . . 0.68999999999999995 107.656 178.199 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 181' ' ' THR . 8.0 m -137.9 -32.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.162 -0.961 . . . . 0.84999999999999998 112.942 -179.374 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -72.27 34.03 0.66 Allowed Glycine 0 N--CA 1.486 1.983 0 C-N-CA 120.25 -0.976 . . . . 0.92000000000000004 113.052 -178.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.541 HG21 HG22 ' A' ' 180' ' ' ILE . 54.8 p -58.65 -26.81 64.16 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.198 -1.178 . . . . 0.94999999999999996 111.074 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.31 -93.54 0.89 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 110.525 -1.03 . . . . 1.04 110.525 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.4 t -126.19 30.56 5.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.848 -0.795 . . . . 1.5700000000000001 112.269 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 94.7 t -59.62 -34.96 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.525 -1.359 . . . . 0.83999999999999997 110.23 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 29.4 p -56.13 -24.5 41.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 0.98999999999999999 111.344 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.6 m -91.97 1.67 57.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.139 -0.975 . . . . 1.7 111.919 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -125.23 -7.25 7.07 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.038 0.755 . . . . 2.2000000000000002 113.038 -178.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 48.8 t -114.97 150.76 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.789 -0.819 . . . . 0.83999999999999997 108.789 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -120.57 154.1 35.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.354 -0.98 . . . . 2.2000000000000002 108.354 177.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.435 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 51.4 p-10 -53.56 144.67 16.76 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.988 -1.07 . . . . 2.2799999999999998 110.797 178.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.9 OUTLIER 81.18 0.11 1.7 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.808 1.41 . . . . 2.3500000000000001 114.808 179.415 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.0 146.13 55.06 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.382 -1.449 . . . . 1.97 108.473 177.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -87.83 120.26 28.99 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.353 -1.351 . . . . 2.6499999999999999 107.353 178.231 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.56 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 77.1 mt -125.62 145.76 50.01 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.704 0.764 . . . . 0.63 110.055 -179.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.91 126.05 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 106.276 -1.75 . . . . 0.62 106.276 177.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.454 HD13 HD11 ' A' ' 180' ' ' ILE . 61.3 tp -102.13 119.59 39.05 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.797 -1.557 . . . . 0.64000000000000001 106.797 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.62 ' O ' ' N ' ' A' ' 223' ' ' VAL . 78.8 m-20 -94.22 -22.85 18.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 2.0499999999999998 112.238 -178.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.922 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.11 14.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 112.508 0.558 . . . . 0.83999999999999997 112.508 -178.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.3 t -112.31 -59.91 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.279 -0.888 . . . . 1.02 109.857 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -92.21 12.12 23.36 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.52 0.676 . . . . 2.5099999999999998 110.963 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 60.22 48.9 7.72 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.262 0.553 . . . . 1.54 111.127 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -147.92 145.38 28.59 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.181 0.991 . . . . 1.95 109.836 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.5 t -117.16 138.82 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.822 -1.177 . . . . 0.70999999999999996 107.822 177.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -100.13 130.08 46.23 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.913 -1.117 . . . . 1.01 108.235 178.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.8 t -109.67 130.03 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.382 -0.969 . . . . 0.81999999999999995 108.382 179.011 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 25.0 t30 56.62 49.9 4.46 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 114.225 1.194 . . . . 1.54 114.225 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 44.2 Cg_endo -67.88 149.94 78.19 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.41 2.073 . . . . 0.93999999999999995 110.263 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 45.8 p -72.81 152.71 41.42 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.574 -1.329 . . . . 1.8 109.272 177.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -59.93 -34.51 73.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 2.73 110.308 178.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.77 -40.6 88.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 3.1699999999999999 110.497 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 67.9 t -70.51 -40.87 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.154 -0.966 . . . . 1.3400000000000001 109.974 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.2 mt -59.06 -46.55 91.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.379 -0.826 . . . . 1.2 110.606 -178.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -60.14 -44.25 95.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.283 -0.886 . . . . 2.7000000000000002 110.534 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -61.16 -40.19 92.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.647 -0.658 . . . . 2.5899999999999999 110.288 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.443 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 90.2 mtp -71.47 -36.04 71.06 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.293 -0.879 . . . . 1.3799999999999999 110.739 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.409 ' NH1' ' HG3' ' A' ' 240' ' ' ARG . 20.8 mmm-85 -53.2 -45.22 68.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.545 -1.347 . . . . 2.8399999999999999 110.31 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.61 -57.59 3.73 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.191 -0.943 . . . . 1.8799999999999999 110.629 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.31 -46.84 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.302 -0.873 . . . . 2.3999999999999999 111.339 -179.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.443 ' CB ' ' O ' ' A' ' 239' ' ' MET . 2.2 tp-100 -60.46 -48.98 79.38 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.628 -1.295 . . . . 3.52 110.338 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -59.58 -32.83 70.73 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.507 -1.37 . . . . 1.8799999999999999 109.62 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -60.95 -28.33 68.89 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.33 -0.948 . . . . 3.0099999999999998 109.761 179.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 97.2 t -59.83 -40.61 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.131 -1.028 . . . . 2.4500000000000002 109.101 178.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.96 -48.65 80.85 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.348 -0.941 . . . . 2.75 109.578 179.267 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 11.2 t -74.01 -28.81 61.63 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.527 -0.733 . . . . 3.1600000000000001 111.162 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -60.76 -31.67 70.99 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.269 0.557 . . . . 3.5699999999999998 110.668 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -61.25 -38.99 88.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.254 -0.904 . . . . 4.2999999999999998 110.745 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -68.22 -38.6 82.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.955 . . . . 4.4500000000000002 110.31 179.475 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -71.85 -26.44 62.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.307 -0.871 . . . . 5.9699999999999998 111.571 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 253' ' ' LEU . 1.9 tt -66.07 -19.85 65.98 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.291 -0.881 . . . . 6.1799999999999997 111.487 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -66.36 -26.75 67.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.72 -1.237 . . . . 6.6600000000000001 112.232 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -79.2 -9.53 59.59 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.801 -1.187 . . . . 8.1999999999999993 112.693 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 81.9 mt -83.23 -1.89 54.22 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.216 -0.927 . . . . 8.0700000000000003 112.359 -179.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -84.71 -10.13 57.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 9.4499999999999993 111.599 -178.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -99.48 -4.97 30.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.595 -0.691 . . . . 10.119999999999999 112.814 -178.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 117.859 -1.067 . . . . 11.49 109.042 -178.579 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 110.111 -0.329 . . . . 3.0699999999999998 110.111 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.406 HD13 ' CG2' ' A' ' 208' ' ' VAL . 64.3 mt -94.44 111.71 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.761 -1.57 . . . . 1.0700000000000001 106.761 176.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.4 m -104.35 124.76 49.77 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.53 -1.285 . . . . 1.24 107.53 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.22 -159.24 17.2 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 108.46 -1.856 . . . . 1.01 108.46 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 5' ' ' ILE . 97.0 mt -94.44 0.52 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.186 -1.185 . . . . 1.1100000000000001 112.677 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 51.8 93.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.854 -1.153 . . . . 0.98999999999999999 112.043 178.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -87.61 -34.41 18.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.832 -1.167 . . . . 0.84999999999999998 111.12 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 1.2 p -149.55 143.98 17.37 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.59 -1.319 . . . . 1.3799999999999999 107.96 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.37 145.67 21.42 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.464 2.11 . . . . 0.93999999999999995 112.758 178.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.9 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 148.42 162.08 9.98 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 109.835 -1.306 . . . . 0.81000000000000005 109.835 178.256 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.3 132.55 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 O-C-N 120.861 -1.376 . . . . 0.82999999999999996 107.966 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.85 150.12 45.65 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.231 -0.918 . . . . 0.53000000000000003 109.307 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.0 m-85 -123.26 144.03 49.67 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.911 -0.774 . . . . 0.77000000000000002 108.911 178.278 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.12 169.67 36.55 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.03 -1.557 . . . . 0.51000000000000001 109.897 177.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -76.95 154.79 33.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.542 -0.975 . . . . 1.8999999999999999 108.786 178.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.605 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.76 125.65 33.4 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.453 -1.314 . . . . 0.66000000000000003 107.453 178.322 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.3 tp -101.95 107.46 18.61 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.262 -2.125 . . . . 0.82999999999999996 105.262 177.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -90.28 135.66 33.54 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.839 -1.171 . . . . 0.85999999999999999 107.839 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.5 mt -100.29 114.34 27.73 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.78 -1.563 . . . . 0.92000000000000004 106.78 178.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -109.77 137.34 47.71 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.389 -1.337 . . . . 2.0299999999999998 107.389 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -129.55 144.92 51.48 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.918 -1.114 . . . . 2.6600000000000001 109.041 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -83.58 136.19 34.34 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.154 -1.054 . . . . 2.3199999999999998 108.154 177.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.99 149.41 44.94 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.278 -0.889 . . . . 2.1099999999999999 108.627 178.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.8 mt -94.68 134.74 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.68 -0.859 . . . . 0.72999999999999998 108.68 178.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.99 131.46 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.757 -1.201 . . . . 0.87 107.757 179.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -91.03 144.94 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.08 -0.711 . . . . 0.81000000000000005 109.08 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -88.97 122.44 32.33 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.633 -1.247 . . . . 1.3400000000000001 107.633 178.176 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -97.9 16.93 19.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.612 -0.68 . . . . 2.8900000000000001 112.314 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.51 143.02 56.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.283 -0.885 . . . . 2.0899999999999999 109.383 179.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -90.93 135.73 33.54 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.929 -1.138 . . . . 2.1899999999999999 107.929 178.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.6 pt -97.68 172.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 122.101 0.953 . . . . 0.75 109.889 177.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.44 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 38.2 p -102.85 161.31 13.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.873 -0.788 . . . . 0.91000000000000003 108.873 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.03 -31.88 19.77 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.996 -1.065 . . . . 0.93000000000000005 111.947 178.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.44 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 3.5 p-10 -69.99 -40.15 75.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 2.2799999999999998 110.037 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -77.47 -19.03 56.57 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.363 -0.836 . . . . 1.45 111.413 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.527 HG13 HG22 ' A' ' 93' ' ' ILE . 51.5 t -59.76 -42.56 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.069 -1.019 . . . . 0.81000000000000005 110.568 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -57.1 -39.96 76.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.808 -1.183 . . . . 1.54 110.841 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.275 -0.891 . . . . 2.3599999999999999 110.402 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -62.76 -35.34 79.51 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.752 -1.217 . . . . 1.3100000000000001 110.87 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.69 -40.36 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.61 -1.306 . . . . 0.81999999999999995 110.21 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -61.4 -39.67 91.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 1.5 109.654 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.504 ' HG2' HH11 ' A' ' 42' ' ' ARG . 21.6 mtt-85 -63.07 -42.96 99.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.789 . . . . 2.23 110.06 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -72.12 -54.17 10.55 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 119.838 -0.745 . . . . 0.84999999999999998 110.138 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.96 -48.05 82.93 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.236 -0.985 . . . . 0.91000000000000003 110.013 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.543 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.9 t -70.06 -38.68 75.84 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.321 -0.862 . . . . 0.90000000000000002 110.061 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.78 -43.11 96.68 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.674 -1.37 . . . . 0.68999999999999995 109.674 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -58.21 -33.34 69.2 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.217 1.008 . . . . 2.8799999999999999 108.742 179.125 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.06 -46.05 79.06 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.015 0.912 . . . . 0.84999999999999998 109.274 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.533 ' HZ2' ' NE2' ' A' ' 53' ' ' GLN . 25.8 ttpp -76.81 -43.54 36.16 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.355 -0.841 . . . . 2.3500000000000001 110.658 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.96 82.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.089 -1.007 . . . . 0.65000000000000002 109.91 -178.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -59.52 -40.0 85.72 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.342 -0.943 . . . . 1.45 109.346 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.81 -48.84 65.1 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.736 -0.602 . . . . 0.63 110.327 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.533 ' NE2' ' HZ2' ' A' ' 49' ' ' LYS . 93.4 mt-30 -60.83 -49.94 75.46 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.356 -1.465 . . . . 1.3400000000000001 110.566 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.31 -39.31 92.6 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.237 -0.914 . . . . 1.5600000000000001 109.923 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -59.89 -41.2 91.08 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.017 -0.673 . . . . 1.1899999999999999 110.543 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.547 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 23.6 m -64.62 -42.57 95.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.405 -0.809 . . . . 0.71999999999999997 110.273 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.1 mt -59.57 -39.32 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.459 -0.776 . . . . 0.62 110.617 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -51.66 -40.25 59.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.86 -1.15 . . . . 1.05 110.523 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.56 -40.0 73.61 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.328 -0.858 . . . . 0.64000000000000001 109.974 -179.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.547 ' NZ ' HG22 ' A' ' 56' ' ' THR . 61.7 mttp -63.42 -39.01 93.33 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.53 -1.268 . . . . 1.73 108.583 -178.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.37 75.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.568 -0.707 . . . . 0.56000000000000005 110.112 179.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.85 -38.16 10.77 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 119.697 -1.24 . . . . 0.68999999999999995 111.322 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.46 -23.48 43.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.793 -1.416 . . . . 1.48 110.688 -179.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -88.72 -50.42 6.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.088 -1.008 . . . . 0.97999999999999998 111.067 179.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -106.79 -9.5 16.38 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 114.378 1.251 . . . . 1.1599999999999999 114.378 -177.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.36 154.13 12.11 Favored Glycine 0 N--CA 1.502 3.091 0 O-C-N 121.128 -0.982 . . . . 0.84999999999999998 111.736 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -54.31 -17.15 2.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -1.033 . . . . 3.8599999999999999 112.544 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -58.38 -35.3 71.79 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.39 -0.819 . . . . 2.3500000000000001 110.903 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -82.46 -21.99 35.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.741 -1.224 . . . . 1.6699999999999999 111.708 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.05 -32.91 71.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.9 . . . . 1.45 111.279 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.53 93.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.948 -1.095 . . . . 0.60999999999999999 110.534 179.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.1 mt -68.17 -45.29 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.487 -1.383 . . . . 0.65000000000000002 110.547 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -69.65 -31.32 69.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.912 -1.117 . . . . 0.66000000000000003 110.934 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.02 -39.64 86.55 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.295 -0.878 . . . . 1.1899999999999999 109.974 178.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.96 -38.09 95.06 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.866 -1.294 . . . . 0.53000000000000003 109.866 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -58.0 -44.03 86.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.414 -1.05 . . . . 1.27 110.001 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.48 -40.59 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.942 -1.099 . . . . 0.54000000000000004 110.432 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.4 ttt -60.01 -38.95 84.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.271 -0.893 . . . . 1.74 110.108 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -60.96 -50.62 72.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.807 . . . . 0.55000000000000004 110.201 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.57 -40.44 87.36 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.445 -0.902 . . . . 0.46999999999999997 110.493 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -88.64 10.54 20.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.645 -0.66 . . . . 1.4199999999999999 112.68 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -62.93 123.27 18.09 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.035 -1.041 . . . . 1.27 109.151 178.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -67.39 -19.13 65.36 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.951 0.882 . . . . 1.3500000000000001 110.708 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -77.7 -49.65 14.04 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.658 0.742 . . . . 2.2200000000000002 110.748 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.79 -38.97 90.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.318 -0.864 . . . . 0.62 110.346 -179.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -57.83 -46.95 83.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.84 -0.537 . . . . 1.29 110.91 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -61.04 -39.92 91.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.136 -0.977 . . . . 1.52 110.381 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -65.75 -47.2 76.07 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 118.827 -1.149 . . . . 1.3 111.145 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.3 mt -57.56 -44.27 84.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.861 -1.149 . . . . 0.60999999999999999 110.4 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.7 mt -63.42 -41.54 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.665 0.745 . . . . 0.78000000000000003 110.967 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.54 -42.08 98.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.81999999999999995 111.17 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.5 mt -60.43 -45.09 94.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.087 . . . . 0.80000000000000004 110.536 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.527 HG22 HG13 ' A' ' 36' ' ' VAL . 69.4 mt -60.79 -49.88 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.495 -0.753 . . . . 0.77000000000000002 110.205 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -77.3 -37.17 53.31 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.59 -0.694 . . . . 2.1200000000000001 111.776 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -80.71 -46.95 14.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.874 -1.141 . . . . 1.51 112.455 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -100.59 8.33 43.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.964 -1.085 . . . . 1.98 112.677 -178.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 37.3 m80 51.94 50.5 18.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.902 -1.124 . . . . 1.3200000000000001 111.998 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.488 ' O ' HG23 ' A' ' 93' ' ' ILE . 66.4 mtt -107.17 155.54 19.79 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.197 -0.939 . . . . 1.3799999999999999 109.456 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.2 p -72.23 166.4 22.5 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.609 -0.682 . . . . 0.67000000000000004 110.51 178.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.7 -43.79 97.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.429 -0.794 . . . . 0.52000000000000002 110.413 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 6.2 p-10 -69.59 -43.41 72.86 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.437 -0.79 . . . . 2.25 109.934 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.08 -47.69 70.51 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.945 -1.102 . . . . 0.64000000000000001 110.463 -179.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.33 98.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.977 -1.077 . . . . 0.56000000000000005 110.571 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.38 -43.2 92.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.147 -0.971 . . . . 0.46000000000000002 110.526 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -61.41 -40.21 93.59 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.144 -0.972 . . . . 1.3200000000000001 111.403 -179.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -58.54 -48.43 80.89 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.996 -1.065 . . . . 1.3 111.101 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.3 t -61.04 -46.89 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.205 -0.935 . . . . 0.60999999999999999 109.816 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -62.24 -32.38 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.271 0.557 . . . . 0.65000000000000002 110.443 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -55.41 -40.8 71.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 2.1099999999999999 110.18 179.117 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.12 -27.69 30.29 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.636 -1.268 . . . . 0.82999999999999996 113.269 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -62.18 -40.35 95.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.404 -1.645 . . . . 1.28 109.67 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.21 -52.15 10.64 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.919 -0.488 . . . . 0.89000000000000001 111.025 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.2 m -59.51 -39.03 82.49 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.628 -0.829 . . . . 1.8700000000000001 110.634 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.43 98.18 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.452 -0.78 . . . . 1.05 111.288 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 73.5 mt -63.2 -30.11 71.32 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.1 -1.0 . . . . 1.02 111.347 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -68.53 -20.21 64.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.956 -1.09 . . . . 2.04 111.006 179.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -75.49 -14.24 60.41 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.519 -0.738 . . . . 1.73 111.158 -179.238 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.716 HD13 HD13 ' A' ' 123' ' ' LEU . 12.8 mt -84.35 150.98 25.01 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.439 -0.788 . . . . 1.3700000000000001 109.015 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -98.21 35.77 1.7 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.954 -1.091 . . . . 2.8799999999999999 112.468 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -116.0 130.99 57.06 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 108.667 -0.864 . . . . 1.5800000000000001 108.667 179.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.28 -35.89 74.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 3.04 111.107 178.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -69.18 -48.9 60.95 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.499 -1.376 . . . . 0.90000000000000002 110.289 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.716 HD13 HD13 ' A' ' 118' ' ' LEU . 45.9 mt -62.57 -39.94 95.26 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.011 -1.055 . . . . 1.0600000000000001 110.854 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 60.2 tttm -62.82 -49.75 73.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.872 -1.143 . . . . 2.1800000000000002 109.98 178.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.77 -32.44 71.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 2.1499999999999999 109.637 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 130' ' ' VAL . 66.0 ttt180 -61.31 -29.59 69.97 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.022 -1.071 . . . . 2.3300000000000001 108.958 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.63 -47.9 83.78 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.838 0.828 . . . . 0.81999999999999995 109.032 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.87 -47.02 86.9 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.499 -0.88 . . . . 0.84999999999999998 109.444 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.33 -31.96 72.66 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.469 0.652 . . . . 1.3899999999999999 109.963 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.2 t -69.66 -41.73 80.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.652 -0.655 . . . . 0.56000000000000005 110.003 179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -57.51 -40.69 79.27 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.829 -1.169 . . . . 3.1200000000000001 109.549 179.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -60.3 -43.16 96.56 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.621 -0.674 . . . . 1.28 110.535 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.08 -38.28 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.102 -0.999 . . . . 0.48999999999999999 109.947 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.05 -49.96 37.43 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.846 -1.169 . . . . 0.46000000000000002 110.406 179.074 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -58.4 -43.36 88.53 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.963 -1.316 . . . . 2.71 110.209 179.428 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.436 ' NH2' ' CB ' ' A' ' 166' ' ' SER . 88.5 mtt180 -62.29 -41.43 98.49 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.705 -1.198 . . . . 2.1400000000000001 109.22 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.68 -40.72 88.77 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.543 0.687 . . . . 1.05 109.95 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.2 -42.56 95.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.029 . . . . 0.52000000000000002 110.668 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -59.82 -34.07 72.59 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.428 -0.795 . . . . 2.3500000000000001 110.614 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -75.03 -42.55 56.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.179 -0.951 . . . . 1.3899999999999999 110.821 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.9 -39.98 83.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.148 -0.97 . . . . 0.68000000000000005 110.281 -178.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.1 mt -89.94 -12.01 40.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -0.932 . . . . 0.82999999999999996 112.701 -179.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.3 19.72 76.27 Favored Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.569 -1.3 . . . . 0.91000000000000003 113.066 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.5 150.44 48.95 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.525 -0.985 . . . . 0.94999999999999996 109.952 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -65.26 148.56 51.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 2.4300000000000002 109.751 178.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.4 mt -106.88 144.13 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.56 -0.904 . . . . 1.1000000000000001 108.56 178.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.1 mm -79.11 120.78 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.885 -1.135 . . . . 1.5800000000000001 108.388 178.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -98.09 96.72 8.32 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.369 -1.715 . . . . 1.6200000000000001 106.369 179.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.6 mt -75.92 -17.51 59.73 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.612 -0.68 . . . . 0.80000000000000004 111.512 -177.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.6 m -81.19 4.81 18.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.928 -1.108 . . . . 1.5600000000000001 112.383 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.72 20.83 11.32 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.791 0.805 . . . . 0.83999999999999997 112.33 -179.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 18.0 mt -72.65 139.23 19.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.264 -0.897 . . . . 0.81999999999999995 108.752 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -116.77 -11.54 10.92 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.491 -0.756 . . . . 2.3100000000000001 112.885 -178.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -115.86 134.09 55.35 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.736 -1.209 . . . . 1.54 107.736 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -72.98 119.28 17.01 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.44 -0.788 . . . . 1.3799999999999999 108.879 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.0 177.01 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.373 -0.829 . . . . 0.68999999999999995 109.343 -179.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.0 mt -85.87 142.15 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.008 -1.058 . . . . 0.53000000000000003 109.117 178.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.0 tp -95.28 125.17 39.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.155 -0.966 . . . . 0.64000000000000001 108.613 178.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.7 t -124.54 129.69 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.536 -1.283 . . . . 0.67000000000000004 107.536 179.163 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.33 160.12 29.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 0.78000000000000003 108.548 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.72 -40.85 89.36 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.275 -1.516 . . . . 1.0 109.521 177.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 9.2 t70 -174.17 158.57 3.04 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.236 -1.024 . . . . 2.4199999999999999 108.236 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.451 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 35.5 mt -118.3 139.16 51.75 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.149 -1.056 . . . . 0.75 108.149 177.184 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.9 p -90.24 149.36 41.14 Favored Pre-proline 0 N--CA 1.485 1.312 0 N-CA-C 108.293 -1.003 . . . . 0.78000000000000003 108.293 179.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -40.18 -45.23 4.08 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.035 1.824 . . . . 0.67000000000000004 113.393 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.436 ' CB ' ' NH2' ' A' ' 136' ' ' ARG . 15.3 m -59.94 -50.31 74.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.677 -1.264 . . . . 0.69999999999999996 110.96 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.94 -40.32 92.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.447 -0.783 . . . . 1.21 109.934 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.5 p -66.41 -39.0 88.72 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.689 0.757 . . . . 0.59999999999999998 110.141 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.23 85.31 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.358 -0.937 . . . . 0.62 111.11 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -94.8 1.56 55.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.994 -1.066 . . . . 1.1599999999999999 113.569 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.8 148.74 46.04 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.483 -0.932 . . . . 0.72999999999999998 108.483 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -95.27 115.01 26.86 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 106.537 -1.653 . . . . 2.2400000000000002 106.537 177.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 26.1 mt -75.46 -14.93 60.46 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.484 -0.76 . . . . 1.4299999999999999 111.71 -177.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -84.03 -19.67 34.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.081 -1.012 . . . . 2.1499999999999999 112.276 -178.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -102.14 -6.16 23.6 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.327 -0.858 . . . . 2.04 113.033 -177.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 178' ' ' GLY . 85.5 t -110.69 129.57 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.106 -1.442 . . . . 0.55000000000000004 107.106 179.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 tp -90.94 -4.93 56.11 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.985 0.897 . . . . 1.6299999999999999 112.595 -179.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.48 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -179.86 170.46 41.7 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.691 -1.764 . . . . 0.46999999999999997 108.691 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -125.83 126.18 44.08 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.786 -1.42 . . . . 0.54000000000000004 107.42 178.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.5 mt -125.65 128.61 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 106.913 -1.514 . . . . 0.68999999999999995 106.913 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 203' ' ' VAL . 74.6 p -139.58 166.78 23.69 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.894 -1.129 . . . . 0.81999999999999995 109.247 179.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 29.0 p-10 -103.16 32.19 3.88 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.397 -0.814 . . . . 2.3700000000000001 111.504 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -97.02 120.64 37.75 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.091 -1.077 . . . . 1.1100000000000001 108.091 178.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -88.44 27.19 7.19 Favored Glycine 0 N--CA 1.484 1.875 0 C-N-CA 120.15 -1.024 . . . . 1.6699999999999999 113.515 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -88.1 115.76 4.44 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 107.882 -2.087 . . . . 1.54 107.882 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -58.03 -31.37 66.93 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.525 -0.985 . . . . 4.4800000000000004 109.287 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.8 p -105.06 37.32 2.2 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.684 0.754 . . . . 2.6299999999999999 110.265 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.5 t -72.07 146.71 47.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.365 -0.835 . . . . 1.6899999999999999 109.569 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -58.16 -39.74 79.63 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.245 -0.909 . . . . 1.0700000000000001 110.999 178.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 56.8 p -57.84 -41.39 82.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.837 -1.164 . . . . 1.5800000000000001 110.221 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.3 t -61.45 -34.2 75.02 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.333 -0.854 . . . . 1.6000000000000001 110.163 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.6 mm -60.26 -41.03 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.06 -1.025 . . . . 1.45 110.914 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 60.9 mtp -61.66 -40.46 95.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.565 -1.334 . . . . 1.05 110.103 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.96 -45.74 89.77 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.41 -0.814 . . . . 0.71999999999999997 111.127 179.372 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -60.7 -42.2 96.74 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.656 -0.817 . . . . 3.0499999999999998 110.479 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.4 m -69.49 -39.01 77.89 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.328 -0.857 . . . . 0.89000000000000001 109.942 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.26 -7.29 51.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.234 -0.916 . . . . 0.78000000000000003 112.753 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 194' ' ' ALA . 89.7 mt-10 53.36 8.53 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.364 1.246 . . . . 1.45 114.364 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.469 ' O ' ' OG ' ' A' ' 8' ' ' SER . 57.2 mt -73.89 147.6 86.44 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.646 -1.284 . . . . 0.67000000000000004 108.162 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.78 143.43 58.91 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.353 1.369 . . . . 0.64000000000000001 109.503 178.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.82 163.02 37.06 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 117.767 -1.573 . . . . 0.67000000000000004 109.679 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.47 HD12 HD11 ' A' ' 220' ' ' LEU . 51.2 mt -149.45 151.31 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.654 -1.239 . . . . 0.68999999999999995 107.654 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 183' ' ' ALA . 15.1 m -136.05 -28.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 120.79 -1.194 . . . . 0.84999999999999998 112.235 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.39 41.42 3.06 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 120.845 -1.159 . . . . 0.92000000000000004 112.166 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.6 p -61.58 -17.65 55.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.873 -1.369 . . . . 0.94999999999999996 111.535 -178.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.12 -93.04 1.8 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.401 -1.08 . . . . 1.04 110.401 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.1 m -133.58 32.84 3.56 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 122.214 -0.58 . . . . 1.5700000000000001 112.26 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.406 ' CG2' HD13 ' A' ' 2' ' ' ILE . 46.5 t -59.43 -37.69 71.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.324 -1.485 . . . . 0.83999999999999997 110.527 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 67.5 p -55.34 -28.52 54.3 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.422 -0.911 . . . . 0.98999999999999999 111.203 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 19.6 m -92.1 0.86 57.47 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.106 -0.996 . . . . 1.7 112.143 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -122.86 -7.19 8.45 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 113.395 0.887 . . . . 2.2000000000000002 113.395 -177.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.5 t -118.92 151.62 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.59 0.709 . . . . 0.83999999999999997 109.296 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -117.7 157.12 27.05 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.118 -1.068 . . . . 2.2000000000000002 108.118 177.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.588 HD22 ' H ' ' A' ' 215' ' ' ASP . 1.6 t-20 -52.48 141.49 19.92 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.871 -1.143 . . . . 2.2799999999999998 110.805 178.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.588 ' H ' HD22 ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.72 2.75 1.43 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 115.185 1.55 . . . . 2.3500000000000001 115.185 179.397 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.2 t0 -64.72 148.08 51.81 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.862 -1.148 . . . . 1.97 108.797 177.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.522 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 44.3 t80 -88.6 119.38 29.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.544 -1.347 . . . . 2.6499999999999999 107.664 177.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.605 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.7 mt -127.22 148.89 50.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.426 -0.797 . . . . 0.63 110.292 -178.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.4 mt -116.81 123.97 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 106.158 -1.793 . . . . 0.62 106.158 177.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.47 HD11 HD12 ' A' ' 202' ' ' ILE . 58.2 tp -99.16 120.12 38.98 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.692 -1.595 . . . . 0.64000000000000001 106.692 178.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.623 ' O ' ' N ' ' A' ' 223' ' ' VAL . 77.8 m-20 -93.84 -29.15 15.47 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.781 -1.168 . . . . 2.0499999999999998 113.129 -177.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.06 12.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.432 -0.793 . . . . 0.83999999999999997 112.654 -179.253 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.623 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.4 t -108.53 -61.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.746 -1.222 . . . . 1.02 109.525 179.092 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -94.19 11.59 29.6 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.389 0.614 . . . . 2.5099999999999998 110.675 179.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 61.48 54.53 3.07 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.148 0.499 . . . . 1.54 111.951 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -148.97 143.52 26.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.173 -0.954 . . . . 1.95 109.831 178.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.1 t -115.9 136.91 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.077 -1.083 . . . . 0.70999999999999996 108.077 178.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -102.68 131.74 49.28 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.606 -0.887 . . . . 1.01 108.606 178.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.41 130.96 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 108.653 -0.869 . . . . 0.81999999999999995 108.653 178.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 52.11 53.69 13.07 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.188 -0.945 . . . . 1.54 113.549 178.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.65 151.07 63.73 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 C-N-CA 122.513 2.142 . . . . 0.93999999999999995 111.069 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.0 m -71.33 157.77 37.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.072 -1.017 . . . . 1.8 108.995 177.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -57.31 -40.89 78.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 2.73 109.898 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.85 -39.82 86.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.815 . . . . 3.1699999999999999 110.692 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.2 t -69.2 -38.05 77.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.23 -0.919 . . . . 1.3400000000000001 110.818 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 84.4 mt -58.3 -49.13 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 1.2 110.261 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -59.33 -39.32 82.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.322 -0.861 . . . . 2.7000000000000002 110.828 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -61.92 -47.41 85.03 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.366 -0.834 . . . . 2.5899999999999999 110.901 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 66.8 mtp -71.1 -36.63 72.27 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.849 -1.157 . . . . 1.3799999999999999 111.005 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.1 mmm-85 -58.46 -39.63 80.42 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 120.091 -0.643 . . . . 2.8399999999999999 110.975 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.68 -38.72 80.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 1.8799999999999999 110.959 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 89.0 t -57.6 -50.09 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.444 -1.41 . . . . 2.3999999999999999 112.128 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -66.12 -49.88 65.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.539 -1.351 . . . . 3.52 109.709 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -61.24 -35.9 78.51 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.456 -0.777 . . . . 1.8799999999999999 110.119 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.86 -30.31 68.88 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.662 -1.274 . . . . 3.0099999999999998 109.958 179.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.56 -39.32 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.469 -0.892 . . . . 2.4500000000000002 110.042 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.29 -41.65 89.44 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.096 -1.042 . . . . 2.75 110.462 178.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 14.3 p -70.18 -28.67 65.5 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.153 -0.967 . . . . 3.1600000000000001 110.095 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -63.22 -33.55 75.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.587 -0.696 . . . . 3.5699999999999998 110.842 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -62.08 -30.42 70.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.18 -0.95 . . . . 4.2999999999999998 110.651 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -66.36 -14.42 62.06 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.362 -0.836 . . . . 4.4500000000000002 111.451 179.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -75.38 -3.87 36.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 5.9699999999999998 112.612 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.639 ' C ' HD12 ' A' ' 253' ' ' LEU . 4.5 pp -64.05 -12.79 41.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.999 -1.063 . . . . 6.1799999999999997 111.803 -178.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.586 ' N ' HD12 ' A' ' 253' ' ' LEU . . . -72.33 -11.8 60.86 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.158 -0.964 . . . . 6.6600000000000001 111.372 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -86.42 5.48 34.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.472 -0.767 . . . . 8.1999999999999993 111.982 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.496 ' N ' ' CD2' ' A' ' 256' ' ' LEU . 3.3 mm? -83.46 33.07 0.46 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 8.0700000000000003 112.869 -179.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.424 ' NZ ' ' O ' ' A' ' 254' ' ' ALA . 58.6 mttp -81.18 -2.99 50.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.158 -0.964 . . . . 9.4499999999999993 112.356 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -96.41 8.07 44.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.449 -0.782 . . . . 10.119999999999999 112.254 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 117.812 -1.089 . . . . 11.49 108.779 -179.634 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtt . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 109.341 -0.614 . . . . 3.0699999999999998 109.341 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.4 mt 51.01 73.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 1.0700000000000001 112.431 176.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -90.73 115.4 27.79 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.61 -1.626 . . . . 1.24 106.61 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.35 -154.85 22.12 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.081 -2.007 . . . . 1.01 108.081 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 5' ' ' ILE . 72.6 mt -93.92 -4.33 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -1.141 . . . . 1.1100000000000001 112.64 -178.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 5' ' ' ILE . 38.4 tp 50.61 100.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.831 -1.168 . . . . 0.98999999999999999 112.235 178.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -89.63 -37.24 14.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.84999999999999998 111.498 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -145.77 138.75 14.11 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 108.027 -1.101 . . . . 1.3799999999999999 108.027 -178.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.88 148.92 28.73 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.725 2.283 . . . . 0.93999999999999995 112.505 179.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.889 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.85 166.05 13.98 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.891 -1.684 . . . . 0.81000000000000005 108.891 178.357 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.4 HG21 ' NE2' ' A' ' 243' ' ' GLN . 70.8 mt -128.52 136.11 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.046 -1.267 . . . . 0.82999999999999996 108.704 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.537 ' HB1' HD22 ' A' ' 177' ' ' LEU . . . -143.06 156.67 44.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.303 -0.873 . . . . 0.53000000000000003 109.495 179.263 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 23.8 m-85 -124.48 140.74 52.67 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.206 -1.035 . . . . 0.77000000000000002 108.206 178.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.72 168.48 37.39 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 118.551 -1.785 . . . . 0.51000000000000001 109.906 177.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -78.64 160.22 27.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.427 -1.043 . . . . 1.8999999999999999 109.547 179.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.57 129.71 34.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.791 -1.193 . . . . 0.66000000000000003 108.195 178.584 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.7 tp -107.53 101.94 11.24 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 105.029 -2.212 . . . . 0.82999999999999996 105.029 177.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.5 tp -89.88 137.32 32.43 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.173 -1.047 . . . . 0.85999999999999999 108.173 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.6 mt -100.49 114.79 28.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.592 -1.633 . . . . 0.92000000000000004 106.592 178.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -108.97 131.49 55.0 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.617 -1.253 . . . . 2.0299999999999998 107.617 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -127.13 149.98 49.7 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.254 -0.904 . . . . 2.6600000000000001 109.228 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -83.04 135.0 35.01 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.778 -1.193 . . . . 2.3199999999999998 107.778 177.276 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.39 147.32 48.85 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.592 -0.693 . . . . 2.1099999999999999 109.315 178.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.423 HD11 ' NH1' ' A' ' 139' ' ' ARG . 61.9 mt -97.7 135.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.166 -0.959 . . . . 0.72999999999999998 108.72 178.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.8 t -107.69 130.88 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.489 -0.93 . . . . 0.87 108.489 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.5 mt -97.56 131.44 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.335 -0.987 . . . . 0.81000000000000005 108.335 178.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -93.51 123.26 36.7 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.814 -1.179 . . . . 1.3400000000000001 108.371 178.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -95.81 10.25 37.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.299 -0.876 . . . . 2.8900000000000001 112.333 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.63 149.22 46.97 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.118 -0.988 . . . . 2.0899999999999999 109.332 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -89.93 131.02 36.06 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.74 -1.207 . . . . 2.1899999999999999 107.74 177.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 pt -92.53 165.47 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.007 -1.058 . . . . 0.75 110.345 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.3 p -92.51 163.43 13.83 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.446 -0.575 . . . . 0.91000000000000003 109.446 178.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.39 -17.49 1.94 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.214 -0.929 . . . . 0.93000000000000005 112.482 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -69.45 -41.78 75.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.355 -0.841 . . . . 2.2799999999999998 110.685 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -90.75 -5.76 55.28 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.62 -1.3 . . . . 1.45 112.697 -178.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.91 -42.29 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.803 -1.186 . . . . 0.81000000000000005 110.477 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.14 -39.97 88.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.034 -1.041 . . . . 1.54 110.767 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -62.67 -38.13 89.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.509 -0.745 . . . . 2.3599999999999999 110.845 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -60.19 -40.73 91.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.907 -1.121 . . . . 1.3100000000000001 110.656 179.248 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -62.43 -41.16 90.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.187 -0.945 . . . . 0.81999999999999995 110.551 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -60.8 -49.52 77.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.109 -0.995 . . . . 1.5 110.369 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 46' ' ' GLY . 65.1 mtm180 -62.86 -40.35 97.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.231 -0.918 . . . . 2.23 110.09 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -70.04 -54.6 12.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.434 -0.791 . . . . 0.84999999999999998 110.184 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.49 -49.88 73.63 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.937 -1.105 . . . . 0.91000000000000003 109.834 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.56 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.9 t -67.81 -39.75 83.95 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.783 0.802 . . . . 0.90000000000000002 109.91 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 42' ' ' ARG . . . -56.43 -43.25 90.25 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.808 -1.317 . . . . 0.68999999999999995 109.808 178.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -59.54 -31.26 69.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.891 0.853 . . . . 2.8799999999999999 109.394 178.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.08 -43.2 77.78 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.492 0.663 . . . . 0.84999999999999998 109.762 178.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -79.07 -42.94 25.21 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.325 -0.95 . . . . 2.3500000000000001 110.009 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.87 86.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.099 -1.001 . . . . 0.65000000000000002 110.225 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.0 p -59.98 -41.76 92.71 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.268 1.032 . . . . 1.45 109.241 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.74 90.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.728 -0.669 . . . . 0.63 110.133 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -60.09 -49.8 76.21 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.39 -0.924 . . . . 1.3400000000000001 110.264 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.59 -42.74 91.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 1.5600000000000001 110.059 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -59.86 -40.3 88.15 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.736 -0.602 . . . . 1.1899999999999999 110.47 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.46 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 5.6 m -67.43 -47.69 69.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.06 -1.025 . . . . 0.71999999999999997 110.18 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.5 mt -61.36 -34.36 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 0.62 110.849 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -51.62 -43.94 62.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.114 -0.991 . . . . 1.05 111.013 179.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.9 m -68.97 -39.62 79.35 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.985 -1.072 . . . . 0.64000000000000001 110.197 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' NZ ' HG22 ' A' ' 56' ' ' THR . 47.4 mttp -60.11 -40.0 88.17 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.807 -1.157 . . . . 1.73 109.529 179.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.41 73.83 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.326 -0.858 . . . . 0.56000000000000005 109.934 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.59 -37.03 9.87 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.978 -1.106 . . . . 0.68999999999999995 111.112 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -81.59 -23.94 36.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.092 -1.24 . . . . 1.48 111.001 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.4 m -88.82 -50.37 6.26 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.461 -0.774 . . . . 0.97999999999999998 110.57 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.591 ' CZ ' ' SD ' ' A' ' 193' ' ' MET . 75.4 m-85 -107.23 -3.67 19.55 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 113.805 1.039 . . . . 1.1599999999999999 113.805 -177.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.1 166.49 34.21 Favored Glycine 0 N--CA 1.495 2.617 0 O-C-N 121.088 -1.007 . . . . 0.84999999999999998 111.699 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -56.31 -19.54 14.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.558 -0.966 . . . . 3.8599999999999999 112.787 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -56.74 -41.5 77.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.684 -1.26 . . . . 2.3500000000000001 110.561 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -89.27 -23.12 22.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.97 -1.081 . . . . 1.6699999999999999 111.563 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -60.78 -38.93 86.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.502 -0.749 . . . . 1.45 110.745 -179.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.1 -39.37 89.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.36 -0.837 . . . . 0.60999999999999999 110.816 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.6 mt -62.12 -44.24 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.865 -1.147 . . . . 0.65000000000000002 110.513 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -71.7 -31.65 66.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.856 -1.152 . . . . 0.66000000000000003 110.701 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.24 -41.17 92.57 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.115 -0.99 . . . . 1.1899999999999999 109.903 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.88 -36.74 91.53 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.656 -1.259 . . . . 0.53000000000000003 110.143 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.48 ' N ' ' HD1' ' A' ' 76' ' ' HIS . 1.4 m80 -59.31 -40.83 87.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -1.155 . . . . 1.27 110.492 179.229 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.3 -39.66 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.982 -1.074 . . . . 0.54000000000000004 110.276 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.8 ttp -59.58 -39.36 83.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.335 -0.853 . . . . 1.74 110.396 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.43 -49.93 73.13 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.466 -0.894 . . . . 0.55000000000000004 110.105 179.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.5 tp -60.45 -46.92 88.3 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.763 0.792 . . . . 0.46999999999999997 110.272 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -85.74 8.43 19.87 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.034 0.753 . . . . 1.4199999999999999 113.034 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -62.31 122.06 14.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.878 -1.139 . . . . 1.27 108.581 179.091 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -64.07 -18.67 64.6 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.733 0.777 . . . . 1.3500000000000001 111.099 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.14 -53.74 7.84 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.74 -0.784 . . . . 2.2200000000000002 110.253 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.52 -35.12 78.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.551 -0.718 . . . . 0.62 110.495 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -60.01 -48.92 79.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.306 -0.871 . . . . 1.29 110.739 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -62.68 -39.97 95.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 1.52 110.513 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.97 -48.41 76.59 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.292 -0.88 . . . . 1.3 110.152 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -57.89 -43.48 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.291 -0.881 . . . . 0.60999999999999999 109.879 179.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.43 -40.81 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.718 -0.614 . . . . 0.78000000000000003 110.479 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.19 -45.04 95.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -0.894 . . . . 0.81999999999999995 110.873 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.91 -39.05 84.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 0.80000000000000004 110.521 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.8 mt -70.18 -49.73 52.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 0.77000000000000002 111.066 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -81.78 -36.37 28.54 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.833 -1.167 . . . . 2.1200000000000001 111.795 -179.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 91' ' ' ALA . 24.1 t0 -81.8 -42.43 19.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.83 -1.169 . . . . 1.51 112.132 -178.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -103.38 8.25 38.09 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.212 -0.93 . . . . 1.98 112.452 -178.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.3 m80 51.08 51.17 17.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.14 -0.975 . . . . 1.3200000000000001 111.804 -179.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.6 mtt -104.91 152.07 23.1 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.353 -0.842 . . . . 1.3799999999999999 108.899 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.1 p -71.92 160.03 33.25 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.577 -0.702 . . . . 0.67000000000000004 109.292 177.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.7 92.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.149 -0.969 . . . . 0.52000000000000002 110.571 178.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.579 ' OD2' HD21 ' A' ' 142' ' ' LEU . 81.6 m-20 -67.24 -42.1 84.54 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.044 -1.035 . . . . 2.25 109.925 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.49 -51.0 48.15 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.635 -0.665 . . . . 0.64000000000000001 111.224 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.31 -45.74 92.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.037 -1.04 . . . . 0.56000000000000005 110.65 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.7 97.12 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.494 -0.883 . . . . 0.46000000000000002 110.408 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -60.28 -39.22 86.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 1.3200000000000001 110.972 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -57.9 -48.72 79.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.949 -1.094 . . . . 1.3 110.567 179.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.99 -47.44 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.943 -1.098 . . . . 0.60999999999999999 110.031 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.0 mm -62.64 -30.95 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.779 -0.576 . . . . 0.65000000000000002 110.56 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.59 -41.61 86.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.44 -0.788 . . . . 2.1099999999999999 110.85 179.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.75 -34.52 10.05 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.231 -1.462 . . . . 0.82999999999999996 112.678 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -61.13 -41.68 97.16 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.788 -1.419 . . . . 1.28 110.259 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.39 -54.93 7.99 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.741 0.781 . . . . 0.89000000000000001 110.29 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 65.3 m -59.97 -38.49 82.67 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.686 -0.634 . . . . 1.8700000000000001 110.477 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.61 96.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.991 -1.068 . . . . 1.05 110.575 179.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.17 -30.14 71.03 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.217 -0.993 . . . . 1.02 110.35 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -66.6 -20.07 65.92 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.164 -0.96 . . . . 2.04 110.986 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -72.63 -10.51 59.87 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.99 0.9 . . . . 1.73 111.02 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 23.2 mt -87.84 144.84 26.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.936 -0.765 . . . . 1.3700000000000001 108.936 179.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -100.19 37.13 1.71 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.132 -0.98 . . . . 2.8799999999999999 111.787 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -115.22 137.71 51.72 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.179 -0.951 . . . . 1.5800000000000001 108.81 178.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 50.1 mp0 -59.86 -35.24 74.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.67 -0.644 . . . . 3.04 111.089 179.043 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -73.53 -49.74 24.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.926 -1.109 . . . . 0.90000000000000002 109.848 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.1 mt -63.73 -39.73 95.0 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.281 -0.887 . . . . 1.0600000000000001 109.604 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -60.96 -45.07 96.21 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.864 0.84 . . . . 2.1800000000000002 109.67 179.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -61.29 -32.78 72.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.812 0.815 . . . . 2.1499999999999999 109.535 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.416 ' O ' HG23 ' A' ' 130' ' ' VAL . 60.4 ttt180 -62.04 -29.57 70.38 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.996 0.903 . . . . 2.3300000000000001 109.463 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.93 74.6 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.926 0.87 . . . . 0.81999999999999995 109.501 178.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.56 -41.59 79.53 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.703 0.763 . . . . 0.84999999999999998 110.08 179.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -62.55 -40.47 96.92 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.413 0.625 . . . . 1.3899999999999999 110.243 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 126' ' ' ARG . 52.1 t -68.96 -38.33 78.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.504 -0.748 . . . . 0.56000000000000005 109.755 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -58.92 -38.89 79.98 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.057 -1.027 . . . . 3.1200000000000001 109.715 178.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.498 ' OD2' ' NE ' ' A' ' 136' ' ' ARG . 32.2 t70 -60.12 -39.79 87.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.61 -0.682 . . . . 1.28 110.352 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 57.7 mt -60.05 -39.83 81.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.363 -0.836 . . . . 0.48999999999999999 109.983 179.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.13 -48.3 26.5 Favored Glycine 0 N--CA 1.485 1.943 0 C-N-CA 120.209 -0.995 . . . . 0.46000000000000002 110.799 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -58.89 -44.16 91.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.039 -1.271 . . . . 2.71 110.202 179.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.498 ' NE ' ' OD2' ' A' ' 132' ' ' ASP . 54.3 mtm180 -61.62 -41.48 97.54 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.707 -1.197 . . . . 2.1400000000000001 109.774 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.45 -41.71 94.65 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.865 -0.734 . . . . 1.05 110.079 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.6 mt -60.57 -43.35 97.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.437 -0.789 . . . . 0.52000000000000002 110.765 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.423 ' NH1' HD11 ' A' ' 24' ' ' ILE . 48.7 mtt-85 -59.84 -32.81 71.02 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.363 -0.836 . . . . 2.3500000000000001 111.318 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -75.39 -40.17 58.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.011 -1.056 . . . . 1.3899999999999999 110.708 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.4 mt -59.58 -40.13 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.227 -0.921 . . . . 0.68000000000000005 110.972 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.579 HD21 ' OD2' ' A' ' 101' ' ' ASP . 86.2 mt -90.47 -9.2 48.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.916 -1.115 . . . . 0.82999999999999996 112.926 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.09 23.16 66.8 Favored Glycine 0 N--CA 1.483 1.78 0 C-N-CA 119.91 -1.138 . . . . 0.91000000000000003 113.112 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.414 HD23 HH11 ' A' ' 139' ' ' ARG . 29.0 tp -63.08 142.21 58.47 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.757 -0.849 . . . . 0.94999999999999996 109.012 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -66.53 141.35 57.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.239 -0.913 . . . . 2.4300000000000002 109.378 178.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.4 mt -112.18 136.52 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 108.32 -0.993 . . . . 1.1000000000000001 108.32 178.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.561 HD12 ' H ' ' A' ' 147' ' ' ILE . 5.2 mp -76.2 131.07 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 1.5800000000000001 108.792 178.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.09 97.63 11.04 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.721 -1.585 . . . . 1.6200000000000001 106.721 178.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.455 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 50.4 mt -71.51 -29.45 64.8 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.378 0.609 . . . . 0.80000000000000004 110.942 -178.146 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.0 t -79.47 -3.29 45.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.35 -0.844 . . . . 1.5600000000000001 112.297 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -101.27 23.1 11.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.677 -0.64 . . . . 0.83999999999999997 111.919 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.455 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 16.4 mt -72.1 144.87 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 0.81999999999999995 109.861 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -118.64 -10.85 9.96 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.979 0.895 . . . . 2.3100000000000001 112.372 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -118.22 140.36 49.92 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.72 0.772 . . . . 1.54 109.152 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.04 119.8 22.69 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.285 -0.885 . . . . 1.3799999999999999 108.741 178.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.71 175.79 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.578 0.704 . . . . 0.68999999999999995 109.328 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.5 mt -86.98 140.9 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.805 . . . . 0.53000000000000003 109.01 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 24.6 tp -98.32 122.3 41.31 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.044 -1.035 . . . . 0.64000000000000001 108.777 178.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.8 t -123.93 133.96 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.337 -0.986 . . . . 0.67000000000000004 108.337 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.86 157.81 29.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.477 -0.764 . . . . 0.78000000000000003 109.113 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.449 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.4 -38.7 88.03 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.672 -1.268 . . . . 1.0 109.196 178.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.2 t0 -172.45 148.0 1.97 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.524 -0.735 . . . . 2.4199999999999999 109.02 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.521 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 66.1 mt -119.15 138.98 52.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.243 -0.911 . . . . 0.75 108.555 177.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.2 p -93.6 151.6 40.2 Favored Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 108.327 -0.99 . . . . 0.78000000000000003 108.327 178.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -39.93 -38.72 2.04 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.767 1.645 . . . . 0.67000000000000004 113.433 179.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.5 m -58.92 -42.87 90.7 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.036 -1.065 . . . . 0.69999999999999996 109.699 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -72.64 -45.1 60.64 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.693 -0.803 . . . . 1.21 110.164 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 20.4 p -66.19 -38.95 89.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.372 -0.83 . . . . 0.59999999999999998 109.812 -178.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.72 87.34 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.677 -0.64 . . . . 0.62 110.844 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -92.96 0.49 57.41 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.126 -0.984 . . . . 1.1599999999999999 112.738 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.7 tp -65.99 150.26 48.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.729 . . . . 0.72999999999999998 109.756 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -96.94 117.82 32.0 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.035 -1.469 . . . . 2.2400000000000002 107.035 177.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 39.1 mt -76.32 -18.07 59.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 1.4299999999999999 111.404 -178.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -82.97 -20.58 34.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.205 -0.935 . . . . 2.1499999999999999 112.282 -179.208 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -102.69 -6.28 22.86 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.261 -0.899 . . . . 2.04 113.383 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 178' ' ' GLY . 45.5 t -111.7 131.8 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.063 -1.088 . . . . 0.55000000000000004 108.063 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.739 ' O ' HD23 ' A' ' 177' ' ' LEU . 2.0 tt -86.04 -11.52 52.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.004 -1.06 . . . . 1.6299999999999999 111.684 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.535 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 174.31 177.39 43.43 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.013 -1.565 . . . . 0.46999999999999997 109.748 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.64 132.48 46.73 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.405 -1.056 . . . . 0.54000000000000004 108.199 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 72.6 mt -134.14 109.39 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 106.423 -1.695 . . . . 0.68999999999999995 106.423 178.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 205' ' ' THR . 65.6 p -129.63 170.47 13.75 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.9 -1.125 . . . . 0.81999999999999995 110.568 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 15.4 p-10 -103.03 49.56 0.83 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.277 0.561 . . . . 2.3700000000000001 110.423 179.435 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.0 154.46 18.95 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.338 -0.851 . . . . 1.1100000000000001 109.356 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.91 -80.92 0.06 OUTLIER Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.598 -1.286 . . . . 1.6699999999999999 111.302 178.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.38 -40.74 0.82 Allowed Glycine 0 N--CA 1.492 2.392 0 O-C-N 120.941 -1.329 . . . . 1.54 112.354 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -60.22 -36.25 77.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.947 . . . . 4.4800000000000004 110.518 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 12.6 p -121.25 26.85 8.69 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.517 -0.74 . . . . 2.6299999999999999 111.399 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -86.52 109.84 19.37 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.351 -1.351 . . . . 1.6899999999999999 107.351 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -61.69 -37.83 85.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.588 -0.695 . . . . 1.0700000000000001 110.727 -178.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 25.8 m -57.24 -40.49 77.7 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.136 -0.977 . . . . 1.5800000000000001 110.304 179.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 50.4 m -60.01 -38.45 82.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 1.6000000000000001 110.6 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.9 mt -59.36 -41.04 83.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.148 -0.97 . . . . 1.45 110.522 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.591 ' SD ' ' CZ ' ' A' ' 65' ' ' PHE . 7.7 mtm -68.96 -35.07 76.33 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.707 -1.197 . . . . 1.05 109.325 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.26 -44.62 88.44 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.174 -0.61 . . . . 0.71999999999999997 110.56 179.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.474 ' HG2' HH11 ' A' ' 195' ' ' ARG . 32.8 mtt-85 -60.2 -41.27 92.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 3.0499999999999998 110.448 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.0 m -68.91 -37.46 78.96 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.749 0.785 . . . . 0.89000000000000001 110.028 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.1 mt -90.4 -5.91 55.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.413 -0.804 . . . . 0.78000000000000003 112.472 -179.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 54.11 8.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.67 0.989 . . . . 1.45 113.67 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 30.8 mt -71.58 150.03 93.5 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.971 -1.081 . . . . 0.67000000000000004 108.773 178.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -55.89 145.79 71.33 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.745 1.63 . . . . 0.64000000000000001 109.68 178.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.9 158.9 31.69 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.715 -1.241 . . . . 0.67000000000000004 109.989 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.469 ' CD1' HD11 ' A' ' 220' ' ' LEU . 15.0 mt -149.77 148.03 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.878 -1.156 . . . . 0.68999999999999995 107.878 178.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.2 m -134.11 -32.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.995 -1.066 . . . . 0.84999999999999998 113.557 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.11 45.32 2.51 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.102 -0.999 . . . . 0.92000000000000004 112.227 -178.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 181' ' ' THR . 32.5 p -67.19 -11.1 56.46 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.189 -1.183 . . . . 0.94999999999999996 111.328 -179.143 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.0 -97.08 0.81 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.802 -1.189 . . . . 1.04 110.182 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.6 m -127.18 29.07 5.64 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.457 -1.025 . . . . 1.5700000000000001 112.473 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.53 -37.85 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.595 -1.316 . . . . 0.83999999999999997 110.7 179.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 60.4 p -54.35 -25.1 22.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.001 -1.062 . . . . 0.98999999999999999 111.36 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.2 t -93.63 -0.2 56.24 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.705 0.764 . . . . 1.7 111.742 -179.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -124.37 -2.05 8.06 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 113.291 0.849 . . . . 2.2000000000000002 113.291 -177.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.4 t -117.12 150.04 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.443 -0.786 . . . . 0.83999999999999997 109.156 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -122.2 153.07 39.3 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.638 -0.875 . . . . 2.2000000000000002 108.638 178.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 52.3 t30 -52.2 141.53 18.67 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.235 -0.915 . . . . 2.2799999999999998 110.093 178.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 10.0 t0 81.07 -1.76 1.76 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.111 1.152 . . . . 2.3500000000000001 114.111 179.521 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -61.71 148.56 42.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.796 -1.19 . . . . 1.97 108.578 177.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -90.47 118.97 30.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.116 -1.439 . . . . 2.6499999999999999 107.116 177.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.527 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 82.9 mt -129.33 148.41 51.25 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.55 -0.719 . . . . 0.63 109.511 -178.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.6 mt -117.54 129.66 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 106.602 -1.629 . . . . 0.62 106.602 177.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.469 HD11 ' CD1' ' A' ' 202' ' ' ILE . 61.6 tp -99.75 118.84 37.09 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 106.713 -1.588 . . . . 0.64000000000000001 106.713 178.632 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 223' ' ' VAL . 50.4 t0 -93.71 -30.94 14.64 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.119 -0.988 . . . . 2.0499999999999998 112.654 -177.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.889 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.87 20.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.42 0.896 . . . . 0.83999999999999997 113.42 -178.079 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.7 t -109.62 -62.03 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.839 -1.163 . . . . 1.02 108.788 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -91.83 15.22 13.42 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.024 0.916 . . . . 2.5099999999999998 110.247 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.3 t30 60.75 51.54 4.8 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.355 -0.839 . . . . 1.54 112.409 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.475 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 15.4 pt20 -152.73 156.19 38.66 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.776 -1.202 . . . . 1.95 110.451 178.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 69.9 t -117.97 144.96 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.702 -0.624 . . . . 0.70999999999999996 109.462 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.475 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 93.8 m-85 -101.92 130.34 48.39 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 107.973 -1.121 . . . . 1.01 107.973 177.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.07 129.86 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.22 -0.925 . . . . 0.81999999999999995 108.815 179.181 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.436 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 0.4 OUTLIER 52.51 49.85 7.2 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.115 -0.991 . . . . 1.54 113.557 178.184 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 40.9 Cg_endo -66.51 149.71 84.3 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.623 2.216 . . . . 0.93999999999999995 111.432 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.9 m -75.57 154.08 36.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 1.8 109.031 177.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 34.0 p-10 -60.74 -35.44 76.38 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.569 -0.707 . . . . 2.73 110.487 179.06 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.497 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 81.0 tt0 -59.47 -43.44 93.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 3.1699999999999999 110.453 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 99.0 t -71.34 -39.79 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.241 -0.912 . . . . 1.3400000000000001 110.165 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.494 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 96.3 mt -58.54 -46.73 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 1.2 110.512 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -59.86 -41.14 90.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.501 -0.75 . . . . 2.7000000000000002 110.275 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -60.81 -41.88 96.55 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.513 -0.742 . . . . 2.5899999999999999 110.455 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.463 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 87.1 mtp -73.09 -40.38 65.06 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.524 -0.735 . . . . 1.3799999999999999 110.674 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.522 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.1 OUTLIER -53.93 -41.8 68.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.031 -1.043 . . . . 2.8399999999999999 110.516 -178.59 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.61 -59.21 2.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.635 -1.291 . . . . 1.8799999999999999 110.471 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 63.1 t -64.52 -46.72 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.347 -0.845 . . . . 2.3999999999999999 111.321 -179.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' A' ' 239' ' ' MET . 0.9 OUTLIER -59.16 -48.95 79.72 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.723 -1.236 . . . . 3.52 110.92 179.959 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -60.78 -31.64 71.0 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.789 -1.194 . . . . 1.8799999999999999 110.365 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -60.23 -31.82 70.54 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.254 -0.904 . . . . 3.0099999999999998 109.209 178.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 90.6 t -62.56 -39.87 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 121.794 0.807 . . . . 2.4500000000000002 109.863 179.261 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.76 91.86 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.403 0.62 . . . . 2.75 110.538 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 11.7 m -69.52 -40.69 76.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.482 -0.762 . . . . 3.1600000000000001 110.326 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -61.39 -34.46 75.37 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.924 -0.71 . . . . 3.5699999999999998 110.216 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -63.34 -35.78 81.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.935 . . . . 4.2999999999999998 110.212 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -65.48 -30.32 71.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.606 -0.684 . . . . 4.4500000000000002 110.635 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -71.45 -11.12 60.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.214 -0.929 . . . . 5.9699999999999998 111.963 -179.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 31.3 tp -64.37 -27.87 69.31 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.938 -1.101 . . . . 6.1799999999999997 111.17 -179.357 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -67.29 -4.98 12.18 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.554 -0.716 . . . . 6.6600000000000001 112.552 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -83.12 12.33 5.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.449 -0.782 . . . . 8.1999999999999993 112.436 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 3.7 pp -77.1 -4.52 44.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.788 -1.195 . . . . 8.0700000000000003 112.388 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -85.2 -5.03 59.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.193 -0.942 . . . . 9.4499999999999993 112.247 -179.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -94.17 4.86 53.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.496 -0.752 . . . . 10.119999999999999 112.559 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 117.991 -1.004 . . . . 11.49 110.108 -179.38 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mmt . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 108.591 -0.892 . . . . 3.0699999999999998 108.591 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.85 111.51 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.497 -1.668 . . . . 1.0700000000000001 106.497 176.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 m -105.94 128.13 53.59 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.762 -1.199 . . . . 1.24 107.762 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.28 -156.98 22.76 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 108.968 -1.653 . . . . 1.01 108.968 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 5' ' ' ILE . 86.6 mt -95.82 -1.81 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.554 -0.968 . . . . 1.1100000000000001 112.581 -178.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 49.38 99.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.468 0.544 . . . . 0.98999999999999999 112.468 178.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.89 -52.69 6.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.066 -1.021 . . . . 0.84999999999999998 110.775 179.383 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.43 146.34 41.76 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 107.449 -1.315 . . . . 1.3799999999999999 107.449 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -74.07 144.38 33.83 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.866 2.377 . . . . 0.93999999999999995 112.993 178.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.912 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.46 166.81 17.55 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 109.539 -1.425 . . . . 0.81000000000000005 109.539 178.075 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.446 HD12 ' HG2' ' A' ' 243' ' ' GLN . 85.7 mt -127.22 134.56 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.302 -1.116 . . . . 0.82999999999999996 108.225 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.12 155.94 46.77 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.318 -0.864 . . . . 0.53000000000000003 109.498 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.2 m-85 -125.09 143.22 51.03 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.482 -0.761 . . . . 0.77000000000000002 108.995 178.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.32 167.39 34.39 Favored Glycine 0 N--CA 1.499 2.897 0 C-N-CA 118.98 -1.581 . . . . 0.51000000000000001 110.002 177.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -78.82 157.65 28.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.753 -0.851 . . . . 1.8999999999999999 109.198 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -81.31 134.84 35.65 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.842 -1.161 . . . . 0.66000000000000003 108.636 178.035 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.2 tp -116.18 101.19 8.49 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 105.801 -1.925 . . . . 0.82999999999999996 105.801 178.199 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -93.72 132.97 37.57 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.01 -1.107 . . . . 0.85999999999999999 108.01 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.6 mt -103.31 118.09 35.99 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 106.802 -1.555 . . . . 0.92000000000000004 106.802 178.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -110.63 137.72 47.95 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.749 -1.204 . . . . 2.0299999999999998 107.749 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -121.02 151.33 39.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 2.6600000000000001 109.703 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -81.92 132.98 35.28 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.941 -1.133 . . . . 2.3199999999999998 107.941 177.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -60.87 148.84 38.09 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.876 -1.14 . . . . 2.1099999999999999 108.941 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.0 mt -96.9 129.83 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.175 -0.953 . . . . 0.72999999999999998 108.517 178.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.5 129.6 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.005 -1.109 . . . . 0.87 108.005 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.6 mt -91.64 130.91 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.24 -1.022 . . . . 0.81000000000000005 108.24 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -90.62 116.54 28.59 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.061 -1.459 . . . . 1.3400000000000001 107.061 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -97.92 17.07 19.06 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.424 -0.797 . . . . 2.8900000000000001 112.673 -179.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -68.42 147.28 52.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 2.0899999999999999 109.326 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -87.23 128.35 35.15 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.576 -1.268 . . . . 2.1899999999999999 107.576 178.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 pt -93.84 163.97 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.026 -1.046 . . . . 0.75 110.132 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.8 p -92.57 162.03 14.35 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.206 0.527 . . . . 0.91000000000000003 109.712 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.3 -15.98 1.91 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.046 -1.034 . . . . 0.93000000000000005 112.011 179.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -71.27 -38.95 71.82 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.409 -0.807 . . . . 2.2799999999999998 110.895 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -92.68 -6.06 50.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.744 -1.222 . . . . 1.45 112.934 -178.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -59.67 -40.58 82.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 120.154 -0.618 . . . . 0.81000000000000005 110.48 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -59.24 -40.19 85.15 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.017 -1.052 . . . . 1.54 110.528 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -62.14 -41.47 98.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.326 -0.859 . . . . 2.3599999999999999 111.213 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -59.71 -40.27 87.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.316 -0.865 . . . . 1.3100000000000001 111.047 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.31 -40.63 84.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.169 -0.957 . . . . 0.81999999999999995 110.982 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -60.37 -48.82 80.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.587 -1.321 . . . . 1.5 110.449 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -62.45 -40.97 98.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.472 -0.767 . . . . 2.23 110.649 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -70.39 -57.6 4.64 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.177 -0.952 . . . . 0.84999999999999998 109.374 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.39 -48.73 80.53 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.55 -0.86 . . . . 0.91000000000000003 110.121 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.7 t -68.03 -39.67 83.04 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.106 -0.996 . . . . 0.90000000000000002 110.074 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.16 -46.67 70.07 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.74 -1.219 . . . . 0.68999999999999995 110.056 178.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -59.96 -29.92 68.75 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.44 -1.035 . . . . 2.8799999999999999 110.311 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.67 -49.48 77.58 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.671 0.748 . . . . 0.84999999999999998 109.923 179.187 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -79.27 -41.56 27.85 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.599 -0.688 . . . . 2.3500000000000001 110.657 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.58 -41.37 90.1 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.05 -1.06 . . . . 0.65000000000000002 110.206 -178.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.2 p -60.78 -40.34 92.23 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.319 1.056 . . . . 1.45 109.246 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.71 -49.63 67.79 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.65 -0.705 . . . . 0.63 110.435 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.67 -49.78 76.41 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 118.85 -1.14 . . . . 1.3400000000000001 110.392 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.94 -40.6 98.15 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.877 0.846 . . . . 1.5600000000000001 110.164 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -59.93 -41.4 91.7 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.195 -0.94 . . . . 1.1899999999999999 110.471 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 m -63.89 -43.7 95.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.851 -1.156 . . . . 0.71999999999999997 110.067 179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.9 mt -60.43 -36.66 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.561 0.696 . . . . 0.62 110.943 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -51.01 -44.09 60.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.401 -0.812 . . . . 1.05 110.81 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -68.98 -38.91 79.61 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.031 -1.043 . . . . 0.64000000000000001 110.029 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.71 -37.71 87.56 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.887 -1.125 . . . . 1.73 108.873 179.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.8 -33.17 75.35 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.887 -0.725 . . . . 0.56000000000000005 109.818 179.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.83 -37.1 12.08 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 120.139 -1.029 . . . . 0.68999999999999995 111.135 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -81.63 -28.45 33.66 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.787 -1.42 . . . . 1.48 110.723 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.3 m -88.19 -45.45 10.08 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.49 -0.757 . . . . 0.97999999999999998 111.383 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.89 -7.54 17.04 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 114.102 1.149 . . . . 1.1599999999999999 114.102 -177.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.46 161.27 30.2 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.498 -0.751 . . . . 0.84999999999999998 111.633 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.87 -25.39 63.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.73 -0.865 . . . . 3.8599999999999999 112.341 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -57.27 -44.18 83.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.763 -1.211 . . . . 2.3500000000000001 110.669 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -82.64 -24.29 33.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.554 -1.341 . . . . 1.6699999999999999 111.405 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.72 -36.84 77.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.531 -0.731 . . . . 1.45 110.981 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.05 83.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.163 -0.961 . . . . 0.60999999999999999 110.628 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.7 mt -64.74 -41.86 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.913 -1.117 . . . . 0.65000000000000002 110.178 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -71.42 -32.41 68.36 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.971 -1.081 . . . . 0.66000000000000003 109.776 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -61.74 -39.19 90.69 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 1.1899999999999999 109.953 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.71 -40.93 99.04 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.265 -0.969 . . . . 0.53000000000000003 110.986 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -58.93 -43.07 91.1 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.913 -1.345 . . . . 1.27 110.475 179.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.5 mt -60.88 -37.51 76.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.038 -1.039 . . . . 0.54000000000000004 110.333 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -57.7 -40.27 79.1 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.602 -0.687 . . . . 1.74 110.045 179.12 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 tp -60.31 -50.35 73.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.368 -0.832 . . . . 0.55000000000000004 110.232 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.01 -41.26 91.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.896 0.855 . . . . 0.46999999999999997 110.183 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -85.91 5.69 31.83 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.446 -0.784 . . . . 1.4199999999999999 112.937 -179.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -61.59 121.79 13.64 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.204 -0.935 . . . . 1.27 108.491 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.95 -17.26 64.55 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.752 -0.779 . . . . 1.3500000000000001 110.822 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.77 -51.8 10.73 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.768 -0.773 . . . . 2.2200000000000002 110.495 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.95 -40.61 93.94 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.48 -0.888 . . . . 0.62 111.204 -179.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -57.48 -49.85 74.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.932 . . . . 1.29 110.236 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -61.86 -40.34 95.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 1.52 110.469 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.02 -46.66 77.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.936 -1.102 . . . . 1.3 110.521 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -57.11 -42.87 80.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.049 -1.032 . . . . 0.60999999999999999 110.065 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.8 -44.51 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.39 -0.819 . . . . 0.78000000000000003 110.245 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.6 97.33 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.493 -0.754 . . . . 0.81999999999999995 111.016 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.03 -43.29 99.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.872 -1.142 . . . . 0.80000000000000004 110.198 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.62 -47.94 89.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.38 -0.825 . . . . 0.77000000000000002 110.247 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -78.09 -38.76 43.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.125 -0.984 . . . . 2.1200000000000001 112.059 -179.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -82.35 -42.25 18.96 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.964 -1.085 . . . . 1.51 112.359 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -99.04 5.04 47.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.173 -0.955 . . . . 1.98 112.374 -178.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 40.7 m80 51.37 49.11 21.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.0 . . . . 1.3200000000000001 111.338 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 64.5 mtt -105.82 154.68 20.19 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.14 -0.975 . . . . 1.3799999999999999 109.711 178.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 82.5 p -70.82 160.37 32.87 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.701 -0.624 . . . . 0.67000000000000004 109.6 177.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.01 86.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.043 -1.035 . . . . 0.52000000000000002 110.539 179.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -67.68 -39.36 84.46 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.318 -0.863 . . . . 2.25 110.568 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.06 67.96 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 120.928 -1.108 . . . . 0.64000000000000001 111.439 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.76 88.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.56000000000000005 110.626 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.74 -41.33 86.25 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.234 -0.916 . . . . 0.46000000000000002 111.148 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -61.13 -40.25 93.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.631 -1.293 . . . . 1.3200000000000001 110.285 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -59.9 -49.86 76.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.856 -1.152 . . . . 1.3 110.243 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.21 -47.27 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.982 -1.074 . . . . 0.60999999999999999 110.182 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.3 mm -61.33 -33.26 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.65000000000000002 110.521 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -57.26 -39.93 76.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.592 -0.693 . . . . 2.1099999999999999 110.979 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.67 -24.91 44.18 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 118.948 -1.596 . . . . 0.82999999999999996 113.304 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -63.36 -41.06 98.8 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.527 -1.572 . . . . 1.28 109.702 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.81 63.33 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.018 -0.537 . . . . 0.89000000000000001 110.759 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.7 p -62.43 -41.14 98.49 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.077 -1.049 . . . . 1.8700000000000001 109.918 -178.141 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.47 98.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.099 -1.0 . . . . 1.05 110.893 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 87.9 mt -64.92 -29.66 70.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.106 -0.996 . . . . 1.02 110.722 -179.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -66.38 -21.59 66.23 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.34 -0.85 . . . . 2.04 110.967 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -71.72 -13.38 61.71 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.222 1.01 . . . . 1.73 110.814 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.8 mt -87.62 136.35 32.98 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.429 -1.323 . . . . 1.3700000000000001 107.429 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 7.3 t0 -97.01 37.42 1.31 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.556 -0.715 . . . . 2.8799999999999999 112.266 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -111.96 138.77 48.13 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 107.984 -1.117 . . . . 1.5800000000000001 107.984 178.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.92 -38.84 76.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.476 -0.765 . . . . 3.04 111.454 179.114 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -73.37 -50.12 23.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.65 -1.281 . . . . 0.90000000000000002 110.594 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.59 -43.3 97.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.022 -1.049 . . . . 1.0600000000000001 110.367 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -62.55 -45.11 94.44 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.345 -0.942 . . . . 2.1800000000000002 109.416 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.84 -31.22 69.54 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.489 -0.885 . . . . 2.1499999999999999 109.27 179.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.473 ' O ' HG23 ' A' ' 130' ' ' VAL . 26.6 ttm180 -61.67 -30.17 70.56 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.308 -0.957 . . . . 2.3300000000000001 108.832 179.09 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -61.8 -50.51 72.04 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.157 -0.617 . . . . 0.81999999999999995 110.273 178.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.37 -42.74 78.74 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.843 -0.743 . . . . 0.84999999999999998 110.38 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.69 -36.84 84.22 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.733 -0.605 . . . . 1.3899999999999999 110.567 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 126' ' ' ARG . 43.5 t -68.54 -40.94 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.235 -0.986 . . . . 0.56000000000000005 110.732 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.532 ' HE ' ' NZ ' ' A' ' 135' ' ' LYS . 62.4 ttt180 -59.53 -37.6 78.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.031 -1.043 . . . . 3.1200000000000001 109.704 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.407 ' CG ' ' NH1' ' A' ' 136' ' ' ARG . 49.2 t0 -60.37 -36.63 78.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.692 -0.63 . . . . 1.28 109.907 179.469 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.99 -39.76 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.729 0.776 . . . . 0.48999999999999999 109.842 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.16 -42.64 94.25 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 119.567 -1.301 . . . . 0.46000000000000002 109.973 178.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.532 ' NZ ' ' HE ' ' A' ' 131' ' ' ARG . 40.4 mmtm -59.05 -49.33 78.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.477 -1.014 . . . . 2.71 110.421 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.416 ' HG3' HH11 ' A' ' 136' ' ' ARG . 51.5 mtm-85 -64.96 -40.93 95.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.848 -1.158 . . . . 2.1400000000000001 109.844 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 35.6 tp -61.09 -39.44 89.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.263 -0.898 . . . . 1.05 110.217 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.7 mt -60.24 -38.6 83.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.56 -0.712 . . . . 0.52000000000000002 111.074 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.401 ' HG2' HH11 ' A' ' 139' ' ' ARG . 56.0 mtt-85 -60.13 -37.83 81.23 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.288 -0.883 . . . . 2.3500000000000001 110.734 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -75.47 -40.79 56.95 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.62 -0.832 . . . . 1.3899999999999999 110.581 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -60.37 -39.62 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 0.68000000000000005 110.17 -178.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.2 mt -87.28 -4.33 59.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.955 -1.091 . . . . 0.82999999999999996 111.522 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.47 29.5 65.85 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 119.62 -1.276 . . . . 0.91000000000000003 112.819 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 33.2 tp -75.03 151.09 38.76 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.632 0.729 . . . . 0.94999999999999996 109.136 179.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -64.1 146.65 53.83 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.695 -1.253 . . . . 2.4300000000000002 109.231 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.8 mt -105.27 138.79 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.574 -0.899 . . . . 1.1000000000000001 108.574 178.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.658 HD12 ' H ' ' A' ' 147' ' ' ILE . 2.9 mp -81.0 127.32 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.671 -1.233 . . . . 1.5800000000000001 107.671 178.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -94.7 96.16 9.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.484 -1.672 . . . . 1.6200000000000001 106.484 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.494 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.9 mt -75.76 -15.77 60.22 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.699 0.762 . . . . 0.80000000000000004 111.683 -177.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.411 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 94.7 p -89.92 8.35 32.68 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.613 -1.305 . . . . 1.5600000000000001 112.147 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.29 21.21 12.3 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.672 0.99 . . . . 0.83999999999999997 113.672 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.494 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 3.2 mp -70.51 139.94 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.343 -1.473 . . . . 0.81999999999999995 108.437 179.302 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -114.65 -20.41 10.69 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.471 -0.768 . . . . 2.3100000000000001 112.278 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -114.2 139.19 49.57 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.535 -1.284 . . . . 1.54 107.535 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.81 122.97 20.87 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.426 -0.954 . . . . 1.3799999999999999 108.426 178.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.6 m -144.84 173.87 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 109.071 -0.714 . . . . 0.68999999999999995 109.071 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.9 mt -85.78 142.87 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.065 -1.022 . . . . 0.53000000000000003 109.583 178.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.2 tp -97.19 124.0 41.13 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.124 -0.985 . . . . 0.64000000000000001 108.554 178.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.6 129.51 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.623 -1.251 . . . . 0.67000000000000004 107.623 179.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.21 152.34 18.66 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.94 -1.1 . . . . 0.78000000000000003 109.051 179.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.83 78.22 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.435 -1.416 . . . . 1.0 109.673 178.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 56.1 t0 -171.96 149.79 2.47 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.001 -0.74 . . . . 2.4199999999999999 109.001 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.464 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 36.1 mt -114.39 140.85 48.33 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.537 -0.727 . . . . 0.75 109.397 177.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 81.2 p -90.0 149.02 40.89 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.954 -1.091 . . . . 0.78000000000000003 109.096 178.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.97 -44.53 12.06 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 C-N-CA 122.159 1.906 . . . . 0.67000000000000004 113.51 179.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.8 m -60.85 -46.54 90.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.834 -1.166 . . . . 0.69999999999999996 109.742 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -63.81 -39.76 95.0 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.697 -0.801 . . . . 1.21 110.399 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 64.9 p -69.43 -39.4 77.88 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.63 -0.668 . . . . 0.59999999999999998 110.587 179.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.79 78.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.618 -0.676 . . . . 0.62 110.662 179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -95.58 1.3 53.68 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.202 -0.936 . . . . 1.1599999999999999 112.931 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.4 tp -61.57 151.94 31.82 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.718 -1.238 . . . . 0.72999999999999998 109.548 179.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 150' ' ' SER . 94.3 m-20 -94.65 107.54 19.53 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 106.269 -1.752 . . . . 2.2400000000000002 106.269 178.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.61 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.9 mp -69.36 -25.04 63.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.858 -0.526 . . . . 1.4299999999999999 111.548 -178.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -83.37 -14.25 53.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.251 -0.906 . . . . 2.1499999999999999 112.925 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -102.98 -1.91 28.52 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.274 0.842 . . . . 2.04 113.274 -177.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 178' ' ' GLY . 96.6 t -111.41 130.26 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.249 -1.019 . . . . 0.55000000000000004 108.249 179.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 27.8 tp -84.54 -10.47 57.39 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.124 -0.985 . . . . 1.6299999999999999 111.992 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.569 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.45 167.21 35.92 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 108.995 -1.642 . . . . 0.46999999999999997 108.995 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -121.75 130.15 53.21 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.869 -1.16 . . . . 0.54000000000000004 107.869 178.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 18.8 mt -130.07 130.45 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 107.444 -1.317 . . . . 0.68999999999999995 107.444 178.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.2 p -140.29 172.33 12.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.936 -1.103 . . . . 0.81999999999999995 109.818 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 2.8 m-20 -111.95 42.51 1.74 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.338 0.59 . . . . 2.3700000000000001 110.369 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.55 168.73 9.04 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.783 0.801 . . . . 1.1100000000000001 110.074 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.17 -6.8 48.55 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 120.107 -1.044 . . . . 1.6699999999999999 113.086 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 77.6 -52.43 3.5 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.17 -1.194 . . . . 1.54 113.539 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -58.8 -42.37 88.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.817 -1.402 . . . . 4.4800000000000004 110.986 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 81.8 p -105.38 11.3 32.88 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 120.79 -1.193 . . . . 2.6299999999999999 112.074 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.5 t -92.18 125.53 36.89 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.839 -0.8 . . . . 1.6899999999999999 108.839 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -62.08 -32.47 73.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 1.0700000000000001 110.357 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.6 m -58.66 -38.9 79.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.406 -0.809 . . . . 1.5800000000000001 110.39 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 93.6 p -59.03 -37.76 77.71 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.38 -0.825 . . . . 1.6000000000000001 110.085 179.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.8 HD13 ' NH2' ' A' ' 195' ' ' ARG . 5.3 mm -58.75 -39.71 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.652 -0.819 . . . . 1.45 110.151 179.375 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 51.1 mtp -62.97 -44.52 95.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.088 -1.008 . . . . 1.05 110.146 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.26 -49.82 76.36 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.08 -0.648 . . . . 0.71999999999999997 111.484 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.8 ' NH2' HD13 ' A' ' 192' ' ' ILE . 65.0 mtm-85 -62.96 -42.14 99.73 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.188 -0.945 . . . . 3.0499999999999998 111.199 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.0 m -68.31 -38.75 81.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.173 -0.954 . . . . 0.89000000000000001 109.855 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.62 -6.95 51.4 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.82 0.674 . . . . 0.78000000000000003 112.82 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.6 mt-10 53.52 11.26 0.27 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 113.804 1.039 . . . . 1.45 113.804 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.11 144.71 87.73 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.856 -1.153 . . . . 0.67000000000000004 108.239 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.28 131.2 43.47 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.785 1.657 . . . . 0.64000000000000001 110.636 178.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.6 171.84 16.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.272 -1.371 . . . . 0.67000000000000004 110.118 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.587 HD12 HD11 ' A' ' 220' ' ' LEU . 10.1 mt -147.03 157.04 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.045 -1.094 . . . . 0.68999999999999995 108.045 178.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 181' ' ' THR . 23.8 m -141.59 -29.05 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.644 -1.285 . . . . 0.84999999999999998 112.791 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.72 33.18 1.89 Allowed Glycine 0 C--N 1.289 -2.04 0 O-C-N 120.927 -1.108 . . . . 0.92000000000000004 113.685 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 27.6 p -55.47 -24.79 33.05 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.249 -1.148 . . . . 0.94999999999999996 111.194 -179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.34 -87.86 1.56 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.825 -0.91 . . . . 1.04 110.825 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 45.2 p -129.02 26.83 5.46 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 121.167 -1.196 . . . . 1.5700000000000001 113.069 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 30.4 t -57.0 -39.7 67.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.317 -1.489 . . . . 0.83999999999999997 110.807 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 64.4 p -61.27 -18.95 60.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 0.98999999999999999 111.93 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 67.4 m -98.83 5.44 47.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 1.7 112.002 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -133.62 -4.19 2.93 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.916 -0.49 . . . . 2.2000000000000002 112.146 -178.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.0 t -121.3 152.95 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 121.504 0.668 . . . . 0.83999999999999997 109.41 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -117.81 161.21 20.1 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.751 -0.833 . . . . 2.2000000000000002 108.751 178.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.0 p-10 -61.78 149.87 38.68 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.906 -1.117 . . . . 2.2799999999999998 109.88 177.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.5 t70 82.88 -10.27 1.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.233 1.197 . . . . 2.3500000000000001 114.233 178.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.23 149.44 37.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.534 -1.354 . . . . 1.97 109.276 177.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -87.18 123.88 32.68 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.282 -1.377 . . . . 2.6499999999999999 107.282 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.515 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 74.8 mt -127.51 150.23 49.77 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.017 0.913 . . . . 0.63 110.093 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 88.0 mt -119.05 122.29 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.237 -1.764 . . . . 0.62 106.237 177.114 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.587 HD11 HD12 ' A' ' 202' ' ' ILE . 37.1 tp -98.65 118.01 34.4 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.441 -1.688 . . . . 0.64000000000000001 106.441 178.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 223' ' ' VAL . 87.7 m-20 -94.22 -27.84 15.95 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.502 -1.374 . . . . 2.0499999999999998 112.917 -177.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.912 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.63 15.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.914 0.709 . . . . 0.83999999999999997 112.914 -179.159 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.8 t -108.66 -62.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.196 -0.94 . . . . 1.02 109.217 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -94.34 11.31 30.92 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.009 0.909 . . . . 2.5099999999999998 110.514 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 60.9 54.99 3.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.618 -0.719 . . . . 1.54 112.03 178.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -144.72 146.53 32.24 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.234 1.016 . . . . 1.95 109.586 178.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.84 131.32 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.658 -1.238 . . . . 0.70999999999999996 107.658 177.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -102.05 132.02 48.16 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.846 -1.159 . . . . 1.01 108.483 178.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.28 129.94 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 107.998 -1.112 . . . . 0.81999999999999995 107.998 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.5 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 48.3 t30 59.05 44.01 0.96 Allowed Pre-proline 0 N--CA 1.485 1.309 0 N-CA-C 113.631 0.974 . . . . 1.54 113.631 178.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.1 Cg_endo -64.7 149.35 89.88 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.349 2.033 . . . . 0.93999999999999995 111.56 -179.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 36.9 p -77.03 160.18 29.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.475 -0.766 . . . . 1.8 110.255 178.041 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -60.28 -36.73 78.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.753 -0.592 . . . . 2.73 110.385 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.12 -40.34 85.1 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.447 -0.783 . . . . 3.1699999999999999 110.15 179.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 79.4 t -70.15 -39.87 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.824 0.821 . . . . 1.3400000000000001 110.571 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.3 mt -60.4 -45.84 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.499 -0.751 . . . . 1.2 110.799 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -59.86 -41.37 91.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.181 -0.949 . . . . 2.7000000000000002 110.441 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -63.0 -43.23 99.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 2.5899999999999999 110.902 -179.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.6 mtp -70.92 -39.49 72.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 1.3799999999999999 110.936 -179.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -57.55 -41.28 80.69 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.053 -1.029 . . . . 2.8399999999999999 110.025 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.79 -57.47 4.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.766 -0.584 . . . . 1.8799999999999999 110.707 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.29 -44.2 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.943 -1.098 . . . . 2.3999999999999999 110.737 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.446 ' HG2' HD12 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -60.3 -52.77 63.85 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.636 -1.29 . . . . 3.52 111.119 179.858 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.0 -30.27 71.36 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.232 -0.918 . . . . 1.8799999999999999 110.64 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -59.37 -33.27 70.97 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.969 -1.092 . . . . 3.0099999999999998 109.058 178.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 95.3 t -64.17 -40.81 90.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 122.102 0.953 . . . . 2.4500000000000002 109.433 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.36 -40.11 85.41 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.402 0.62 . . . . 2.75 110.895 179.43 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.9 t -62.98 -33.81 76.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.544 -0.722 . . . . 3.1600000000000001 110.78 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -62.14 -39.09 91.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.12 -0.987 . . . . 3.5699999999999998 110.028 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -68.16 -29.95 68.96 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.359 -0.838 . . . . 4.2999999999999998 110.841 179.494 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -65.96 -15.76 63.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.481 -0.762 . . . . 4.4500000000000002 112.265 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -64.62 -30.78 71.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.927 -1.108 . . . . 5.9699999999999998 110.626 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 30.1 tp -61.93 -24.39 66.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.346 -0.846 . . . . 6.1799999999999997 111.077 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -68.19 -4.83 15.21 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.247 -0.908 . . . . 6.6600000000000001 112.692 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -78.18 1.36 21.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.978 -1.076 . . . . 8.1999999999999993 112.686 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 256' ' ' LEU . 6.8 tt -79.85 -9.73 59.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.448 -0.783 . . . . 8.0700000000000003 112.505 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -85.66 -1.89 57.62 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.232 -0.917 . . . . 9.4499999999999993 112.124 -178.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -92.94 8.38 40.01 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.239 -0.913 . . . . 10.119999999999999 112.583 -178.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 259' ' ' ARG . 31.7 ttm-85 . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 117.934 -1.032 . . . . 11.49 110.614 -179.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 121.126 0.489 . . . . 3.0699999999999998 109.783 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.6 mt -109.98 120.02 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 107.433 -1.321 . . . . 1.0700000000000001 107.433 178.155 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.0 m -100.47 127.48 46.8 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.505 -1.294 . . . . 1.24 107.505 178.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -124.5 -163.29 11.64 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.451 -1.86 . . . . 1.01 108.451 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.7 mt -97.91 2.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.984 -1.303 . . . . 1.1100000000000001 112.593 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tp 51.56 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.762 -1.211 . . . . 0.98999999999999999 111.825 178.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -86.07 -38.83 17.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.914 -1.116 . . . . 0.84999999999999998 110.939 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.427 ' O ' ' HB1' ' A' ' 222' ' ' ALA . 2.6 m -148.1 144.36 18.78 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.619 -1.301 . . . . 1.3799999999999999 108.173 -179.376 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.08 145.99 22.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.356 2.037 . . . . 0.93999999999999995 111.904 178.263 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.922 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.93 171.02 19.27 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.23 -1.548 . . . . 0.81000000000000005 109.23 178.047 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.1 mt -128.79 135.56 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.208 -1.172 . . . . 0.82999999999999996 107.919 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.39 152.69 44.55 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.027 -1.046 . . . . 0.53000000000000003 109.996 179.478 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -125.08 140.28 53.03 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.33 -0.989 . . . . 0.77000000000000002 108.33 178.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.54 170.14 37.38 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 118.216 -1.945 . . . . 0.51000000000000001 110.473 178.155 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -78.74 157.14 28.57 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.803 -0.822 . . . . 1.8999999999999999 109.003 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.514 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.89 127.45 35.05 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.257 -1.016 . . . . 0.66000000000000003 108.257 178.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.3 tp -105.07 102.99 12.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.497 -2.038 . . . . 0.82999999999999996 105.497 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.7 tp -90.62 140.82 29.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.936 -1.102 . . . . 0.85999999999999999 108.672 -179.68 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.5 mt -97.0 114.22 25.82 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.697 -1.594 . . . . 0.92000000000000004 106.697 177.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -106.23 130.11 54.16 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.317 -1.364 . . . . 2.0299999999999998 107.317 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -125.31 149.61 47.91 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.476 -0.765 . . . . 2.6600000000000001 109.527 -179.473 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -82.4 133.28 35.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.079 -1.082 . . . . 2.3199999999999998 108.079 177.258 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -65.34 146.67 54.62 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.168 -0.957 . . . . 2.1099999999999999 108.758 178.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.1 mt -93.45 136.18 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.694 -0.854 . . . . 0.72999999999999998 108.694 178.431 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.09 130.27 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.821 -1.177 . . . . 0.87 107.821 179.064 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.7 mt -97.94 135.34 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.181 -1.044 . . . . 0.81000000000000005 108.181 178.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -91.22 122.45 33.87 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.747 -1.205 . . . . 1.3400000000000001 107.747 178.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -95.4 16.96 15.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.201 -0.937 . . . . 2.8900000000000001 112.216 -179.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -73.82 148.57 42.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 2.0899999999999999 109.728 178.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -90.6 135.59 33.61 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.333 -0.988 . . . . 2.1899999999999999 108.333 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 pt -100.48 166.36 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.131 -0.98 . . . . 0.75 109.976 179.5 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.2 p -95.43 168.68 10.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.501 -0.749 . . . . 0.91000000000000003 109.583 178.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.66 -18.61 21.47 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.078 -1.014 . . . . 0.93000000000000005 112.476 179.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -68.06 -37.54 81.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.881 -1.137 . . . . 2.2799999999999998 110.711 -179.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -92.26 -5.35 52.54 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.634 -1.292 . . . . 1.45 113.132 -179.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.28 -43.8 94.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.063 -1.023 . . . . 0.81000000000000005 110.134 -179.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -57.93 -40.76 81.22 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.567 -0.853 . . . . 1.54 110.241 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -63.89 -39.76 94.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.704 -0.623 . . . . 2.3599999999999999 110.714 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.23 -42.58 95.54 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.157 -0.964 . . . . 1.3100000000000001 110.913 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.34 -42.22 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.09 -1.006 . . . . 0.81999999999999995 110.727 -179.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -60.96 -42.27 97.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 1.5 109.919 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -60.75 -42.67 97.88 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.466 -0.894 . . . . 2.23 109.803 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -72.84 -56.7 4.84 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.815 0.817 . . . . 0.84999999999999998 110.231 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 tp -58.47 -47.44 84.03 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.42 -0.912 . . . . 0.91000000000000003 110.252 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.506 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.8 t -68.73 -39.82 80.18 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.121 -0.987 . . . . 0.90000000000000002 110.035 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.44 -45.55 94.26 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.434 -1.365 . . . . 0.68999999999999995 109.783 178.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -58.76 -30.19 67.33 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.516 -0.991 . . . . 2.8799999999999999 110.28 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.67 -42.14 87.78 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.972 0.891 . . . . 0.84999999999999998 109.779 179.024 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -81.19 -40.71 23.48 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.412 -0.805 . . . . 2.3500000000000001 110.73 179.445 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.86 -43.68 90.89 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.747 -0.781 . . . . 0.65000000000000002 109.938 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.8 m -59.32 -39.93 84.67 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.863 0.84 . . . . 1.45 109.381 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.31 -44.36 71.9 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.629 -0.714 . . . . 0.63 110.587 179.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.5 -51.57 59.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.004 . . . . 1.3400000000000001 110.472 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.58 -38.99 86.44 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.371 -0.931 . . . . 1.5600000000000001 109.874 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -59.99 -40.99 91.06 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.456 -0.777 . . . . 1.1899999999999999 110.487 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -65.63 -42.33 91.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.71999999999999997 110.175 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.81 -35.17 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.495 -0.753 . . . . 0.62 110.703 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -52.44 -43.01 64.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.659 -1.275 . . . . 1.05 110.771 179.237 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.13 -37.17 78.18 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.389 -0.819 . . . . 0.64000000000000001 110.151 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -62.05 -39.54 92.7 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.853 -1.139 . . . . 1.73 109.531 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.83 -32.08 72.37 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.598 -0.689 . . . . 0.56000000000000005 110.322 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.41 -36.67 16.44 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.242 -1.456 . . . . 0.68999999999999995 110.478 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.02 -16.43 50.27 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.637 -1.508 . . . . 1.48 111.306 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.2 m -92.94 -51.12 5.22 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.785 -0.572 . . . . 0.97999999999999998 110.768 -179.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -107.82 -19.86 13.39 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.303 -0.873 . . . . 1.1599999999999999 112.799 -177.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.06 160.55 11.1 Favored Glycine 0 N--CA 1.504 3.219 0 O-C-N 120.96 -1.087 . . . . 0.84999999999999998 112.028 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -56.06 -22.77 29.48 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.983 -0.716 . . . . 3.8599999999999999 112.727 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -58.14 -35.47 71.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 2.3500000000000001 111.3 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -81.02 -25.78 36.92 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.721 -1.237 . . . . 1.6699999999999999 112.315 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.09 -32.41 69.79 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.377 -0.827 . . . . 1.45 110.803 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.43 85.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.019 . . . . 0.60999999999999999 111.17 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.58 -42.92 87.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.394 -1.441 . . . . 0.65000000000000002 110.114 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -70.48 -30.69 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.66000000000000003 110.729 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -59.91 -40.26 88.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.128 -0.982 . . . . 1.1899999999999999 110.142 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.33 -39.46 97.01 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.537 -1.316 . . . . 0.53000000000000003 110.47 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -59.1 -41.84 89.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.655 -0.909 . . . . 1.27 111.113 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 77' ' ' ILE . 40.3 mt -60.67 -42.09 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.92 -1.112 . . . . 0.54000000000000004 110.028 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.5 ttm -60.42 -40.25 90.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.511 -0.743 . . . . 1.74 110.067 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 tp -59.77 -49.82 76.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.422 -0.799 . . . . 0.55000000000000004 109.872 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.54 -41.85 95.33 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.055 -0.658 . . . . 0.46999999999999997 110.299 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -85.29 4.96 32.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.5 -0.75 . . . . 1.4199999999999999 112.972 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -61.54 118.17 6.69 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.627 -1.296 . . . . 1.27 109.191 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -63.69 -16.69 61.7 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.03 0.919 . . . . 1.3500000000000001 110.904 -179.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -77.49 -52.24 9.42 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.95 0.881 . . . . 2.2200000000000002 110.248 179.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.71 -37.79 85.47 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.668 -0.813 . . . . 0.62 110.588 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -59.05 -47.99 83.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 1.29 110.781 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -61.61 -38.0 86.02 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.314 -0.866 . . . . 1.52 111.142 -179.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -64.6 -47.7 77.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.236 -0.915 . . . . 1.3 110.324 179.621 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.1 mt -58.3 -45.05 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.444 -0.785 . . . . 0.60999999999999999 109.665 179.181 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.1 mt -60.79 -40.59 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.994 0.902 . . . . 0.78000000000000003 109.862 179.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.67 97.32 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.995 -1.065 . . . . 0.81999999999999995 110.601 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.45 -41.37 97.1 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.426 -0.91 . . . . 0.80000000000000004 110.245 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.26 -47.99 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.054 -1.029 . . . . 0.77000000000000002 110.387 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -77.09 -35.77 56.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.508 -0.745 . . . . 2.1200000000000001 112.121 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -80.7 -44.99 17.85 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.407 -1.433 . . . . 1.51 112.184 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -102.82 12.08 36.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.292 -0.88 . . . . 1.98 112.559 -178.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.9 m80 49.23 49.07 20.25 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.026 -1.07 . . . . 1.3200000000000001 111.56 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.6 mtt -102.57 154.58 18.98 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.146 -0.971 . . . . 1.3799999999999999 109.715 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.8 p -70.63 159.8 33.73 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.377 0.608 . . . . 0.67000000000000004 109.412 177.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.99 83.39 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.383 -0.823 . . . . 0.52000000000000002 111.284 178.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -72.07 -44.44 63.29 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.212 -0.93 . . . . 2.25 110.44 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.11 74.39 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.35 -0.94 . . . . 0.64000000000000001 111.165 -178.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.89 93.17 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.182 -0.948 . . . . 0.56000000000000005 110.945 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.67 86.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.478 -0.764 . . . . 0.46000000000000002 110.683 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -60.63 -37.94 83.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.925 . . . . 1.3200000000000001 110.65 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -57.57 -50.01 74.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.821 -1.175 . . . . 1.3 111.078 179.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.9 -46.88 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.882 -1.136 . . . . 0.60999999999999999 109.97 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.02 -33.4 55.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.66 -0.65 . . . . 0.65000000000000002 110.233 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -58.62 -40.19 82.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.17 -0.956 . . . . 2.1099999999999999 110.922 179.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.41 -35.7 10.4 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.046 -1.55 . . . . 0.82999999999999996 112.3 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -60.49 -41.16 93.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.394 -1.651 . . . . 1.28 109.889 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.37 -49.82 38.37 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.684 0.754 . . . . 0.89000000000000001 110.59 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.9 m -60.64 -39.13 87.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 1.8700000000000001 110.772 -179.432 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.51 -41.9 95.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.423 -0.798 . . . . 1.05 110.847 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.68 -30.35 71.37 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.15 -1.02 . . . . 1.02 110.994 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.0 -20.56 64.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.071 -1.018 . . . . 2.04 111.067 179.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.53 -17.84 61.7 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.784 0.802 . . . . 1.73 111.19 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.556 HD13 HD13 ' A' ' 123' ' ' LEU . 29.7 mt -86.34 148.76 25.45 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.396 -0.815 . . . . 1.3700000000000001 109.285 179.464 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -101.7 41.66 1.19 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.48 -0.763 . . . . 2.8799999999999999 111.007 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -114.06 130.86 56.54 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.273 -1.01 . . . . 1.5800000000000001 108.273 178.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.548 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.6 mp0 -58.71 -33.08 69.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.278 -0.889 . . . . 3.04 110.77 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -71.1 -51.43 25.13 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.689 -1.257 . . . . 0.90000000000000002 110.318 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.556 HD13 HD13 ' A' ' 118' ' ' LEU . 46.2 mt -67.11 -39.25 86.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.426 -0.796 . . . . 1.0600000000000001 110.331 -179.312 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 57.2 tttp -61.99 -49.61 75.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.971 -1.08 . . . . 2.1800000000000002 109.796 179.352 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 187' ' ' THR . 50.5 mt-10 -61.49 -31.66 71.65 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.529 -0.868 . . . . 2.1499999999999999 109.203 179.699 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 130' ' ' VAL . 22.5 ttp180 -64.75 -28.94 69.93 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.251 1.024 . . . . 2.3300000000000001 109.091 179.187 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.11 -47.16 86.27 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.575 -0.85 . . . . 0.81999999999999995 109.54 178.375 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.7 87.59 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.57 -0.852 . . . . 0.84999999999999998 109.612 179.587 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -63.29 -36.32 83.29 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.189 0.519 . . . . 1.3899999999999999 110.546 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 126' ' ' ARG . 50.6 t -67.85 -36.59 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.966 -1.084 . . . . 0.56000000000000005 110.237 179.507 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -59.45 -38.8 81.66 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.869 -1.132 . . . . 3.1200000000000001 109.109 178.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.571 ' CG ' HH21 ' A' ' 136' ' ' ARG . 58.2 t0 -59.61 -40.34 87.2 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.676 -0.693 . . . . 1.28 109.9 179.114 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -60.83 -33.86 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 0.48999999999999999 109.7 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.41 -49.74 14.24 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.098 -1.049 . . . . 0.46000000000000002 111.186 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.474 ' NZ ' ' OD1' ' A' ' 132' ' ' ASP . 5.3 pttm -58.86 -39.46 81.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.998 -1.295 . . . . 2.71 110.649 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.571 HH21 ' CG ' ' A' ' 132' ' ' ASP . 37.0 mtt180 -59.4 -45.22 92.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.947 -1.095 . . . . 2.1400000000000001 109.936 179.03 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.96 -42.57 98.54 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.66 -0.65 . . . . 1.05 110.427 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 23.8 mt -59.9 -43.48 94.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.577 -0.702 . . . . 0.52000000000000002 110.566 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -60.47 -34.55 74.19 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.433 -0.792 . . . . 2.3500000000000001 111.298 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -76.13 -41.13 51.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.92 -1.112 . . . . 1.3899999999999999 110.43 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.26 -39.84 83.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 120.83 -1.169 . . . . 0.68000000000000005 110.887 -178.368 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 76.1 mt -88.53 -10.02 50.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 0.82999999999999996 112.246 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.0 19.96 71.41 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.887 -1.149 . . . . 0.91000000000000003 113.261 -179.298 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.9 tp -64.99 143.82 57.7 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.503 -0.998 . . . . 0.94999999999999996 109.248 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -70.02 151.7 45.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.366 -0.834 . . . . 2.4300000000000002 109.626 178.113 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.3 mt -105.44 140.19 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.218 -1.03 . . . . 1.1000000000000001 108.218 178.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.3 mm -75.74 136.2 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 1.5800000000000001 108.973 178.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.38 92.55 7.22 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.495 -1.669 . . . . 1.6200000000000001 106.495 178.526 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 81.3 mt -78.36 -20.86 50.42 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.357 -0.839 . . . . 0.80000000000000004 111.061 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.6 t -78.86 -6.9 57.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 1.5600000000000001 112.458 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.39 35.94 1.55 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.597 -0.689 . . . . 0.83999999999999997 112.489 -178.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.1 mm -68.9 149.13 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.865 -1.147 . . . . 0.81999999999999995 108.986 178.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -129.37 -9.12 4.68 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.531 -0.73 . . . . 2.3100000000000001 112.613 -179.296 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -120.01 145.75 46.52 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.851 -0.796 . . . . 1.54 108.851 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -80.37 114.73 19.48 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.655 -1.239 . . . . 1.3799999999999999 107.655 177.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -148.2 175.45 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 0.68999999999999995 109.305 -178.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.3 mt -93.83 143.33 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.389 -0.967 . . . . 0.53000000000000003 108.389 178.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.8 tp -96.49 129.81 43.78 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.772 -1.205 . . . . 0.64000000000000001 108.828 178.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.84 130.47 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.813 -1.18 . . . . 0.67000000000000004 107.813 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.06 155.55 23.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.861 -1.149 . . . . 0.78000000000000003 108.868 179.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.01 79.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.492 -1.38 . . . . 1.0 109.712 178.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -174.3 148.46 1.28 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.908 -0.775 . . . . 2.4199999999999999 108.908 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.2 mt -118.15 141.69 48.23 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.585 -0.895 . . . . 0.75 108.585 177.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.2 p -90.93 148.9 39.17 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.992 . . . . 0.78000000000000003 108.671 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -38.81 -41.2 1.64 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.73 1.62 . . . . 0.67000000000000004 113.542 178.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.538 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 25.4 m -62.66 -51.48 67.07 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.878 -1.139 . . . . 0.69999999999999996 110.508 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.2 -39.09 88.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 1.21 109.855 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.7 p -68.48 -39.18 81.46 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.615 -0.678 . . . . 0.59999999999999998 110.419 179.332 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.8 -35.73 80.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.051 -1.03 . . . . 0.62 110.761 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -96.21 -1.0 49.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.02 -1.05 . . . . 1.1599999999999999 112.827 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -60.61 156.41 16.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.929 . . . . 0.72999999999999998 109.863 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -88.97 106.28 18.32 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.788 -1.56 . . . . 2.2400000000000002 106.788 178.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 50.9 mt -80.49 -17.47 51.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.623 -0.673 . . . . 1.4299999999999999 112.133 -177.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -81.13 -23.05 38.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.381 -0.824 . . . . 2.1499999999999999 111.769 -178.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -105.95 -2.87 22.39 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.614 0.968 . . . . 2.04 113.614 -178.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.94 128.4 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 107.74 -1.207 . . . . 0.55000000000000004 107.74 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.4 tp -90.44 -10.4 43.92 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.246 -0.909 . . . . 1.6299999999999999 112.251 -178.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.22 171.02 41.13 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.116 -1.593 . . . . 0.46999999999999997 109.116 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.585 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -130.77 135.75 48.06 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.563 -1.273 . . . . 0.54000000000000004 107.563 179.334 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.564 HG22 HG21 ' A' ' 205' ' ' THR . 97.0 mt -133.11 107.94 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 105.938 -1.875 . . . . 0.68999999999999995 105.938 178.156 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 203' ' ' VAL . 72.2 p -128.82 175.37 8.68 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.676 -1.265 . . . . 0.81999999999999995 110.746 -178.696 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.7 OUTLIER -100.51 53.92 0.88 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.578 -0.737 . . . . 2.3700000000000001 110.071 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.93 156.37 16.65 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.091 -1.006 . . . . 1.1100000000000001 109.773 179.149 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.14 -5.03 57.93 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.769 -1.205 . . . . 1.6699999999999999 112.397 178.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 73.66 -12.37 4.84 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.488 -1.339 . . . . 1.54 115.213 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.406 ' O ' ' OG1' ' A' ' 187' ' ' THR . 79.0 mtm180 -81.8 113.41 19.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.001 -1.481 . . . . 4.4800000000000004 107.001 178.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 22.2 p 48.54 39.96 14.25 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.893 -1.129 . . . . 2.6299999999999999 111.931 -178.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.3 p -82.14 133.67 35.28 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.309 -0.997 . . . . 1.6899999999999999 108.309 177.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -60.15 -40.41 89.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.442 -0.786 . . . . 1.0700000000000001 110.681 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 87.4 m -60.83 -42.04 96.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 1.5800000000000001 110.256 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 98.1 p -61.61 -38.58 88.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.945 -1.097 . . . . 1.6000000000000001 110.411 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.11 -35.32 60.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.431 -0.793 . . . . 1.45 110.833 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.6 mtp -62.64 -42.65 99.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 122.395 1.093 . . . . 1.05 109.202 179.333 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.89 -49.54 77.07 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.552 -0.749 . . . . 0.71999999999999997 110.789 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -60.38 -44.34 95.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 3.0499999999999998 110.697 -179.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.4 m -69.88 -40.08 75.89 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.295 -0.878 . . . . 0.89000000000000001 110.315 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.4 mt -90.83 -4.43 56.61 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.1 0.952 . . . . 0.78000000000000003 112.42 -178.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 194' ' ' ALA . 94.1 mt-10 54.56 7.32 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.4 1.259 . . . . 1.45 114.4 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.9 mt -71.46 147.39 92.58 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.948 -1.095 . . . . 0.67000000000000004 108.092 179.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -58.49 141.66 97.42 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.765 1.643 . . . . 0.64000000000000001 109.714 178.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.74 168.39 26.96 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 117.831 -1.548 . . . . 0.67000000000000004 109.776 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 203' ' ' VAL . 54.8 mt -149.01 159.02 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.519 -1.289 . . . . 0.68999999999999995 107.519 178.052 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.3 m -140.48 -32.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.702 0 O-C-N 120.647 -1.283 . . . . 0.84999999999999998 111.951 -179.756 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.3 37.4 0.81 Allowed Glycine 0 N--CA 1.485 1.934 0 C-N-CA 120.497 -0.859 . . . . 0.92000000000000004 112.865 -178.621 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.564 HG21 HG22 ' A' ' 180' ' ' ILE . 45.6 p -63.94 -20.55 65.94 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.673 -0.898 . . . . 0.94999999999999996 111.499 -179.098 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.68 -92.43 0.61 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 110.045 -1.222 . . . . 1.04 110.045 179.471 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.481 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 70.4 m -128.16 23.93 6.0 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.275 -1.132 . . . . 1.5700000000000001 112.696 -178.825 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 79.5 t -51.52 -34.48 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.541 -1.349 . . . . 0.83999999999999997 110.609 179.085 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.0 p -58.62 -20.91 51.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.58 -0.7 . . . . 0.98999999999999999 111.58 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.9 t -90.59 -3.16 57.76 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.013 -1.054 . . . . 1.7 111.698 -179.037 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.481 ' OE1' ' O ' ' A' ' 207' ' ' SER . 24.6 mp0 -122.83 -4.42 8.62 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.502 0.668 . . . . 2.2000000000000002 112.522 -177.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 44.6 t -112.85 148.0 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.533 -0.729 . . . . 0.83999999999999997 109.415 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -121.3 157.08 31.14 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.071 -1.085 . . . . 2.2000000000000002 108.071 178.055 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 19.1 p30 -56.76 140.92 46.06 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.671 -1.268 . . . . 2.2799999999999998 110.43 178.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 m-20 81.57 7.02 1.13 Allowed 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 114.465 1.283 . . . . 2.3500000000000001 114.465 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -67.48 151.75 46.84 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.424 -1.423 . . . . 1.97 109.945 177.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -90.51 115.11 27.4 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.691 -1.596 . . . . 2.6499999999999999 106.691 177.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.514 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 86.8 mt -127.71 141.94 51.46 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.236 -0.915 . . . . 0.63 109.56 -178.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 50.8 mt -113.54 127.72 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 106.607 -1.627 . . . . 0.62 106.607 177.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.6 tp -102.17 118.47 36.97 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.193 -1.78 . . . . 0.64000000000000001 106.193 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 223' ' ' VAL . 44.8 p-10 -93.14 -21.04 19.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.042 -1.036 . . . . 2.0499999999999998 112.297 -178.184 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.922 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.47 17.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.031 0.752 . . . . 0.83999999999999997 113.031 -179.177 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.5 t -112.77 -62.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 121.807 0.813 . . . . 1.02 109.135 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -90.3 9.62 28.07 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.294 1.045 . . . . 2.5099999999999998 110.303 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 41.9 t30 60.82 52.37 4.31 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.91 -0.586 . . . . 1.54 111.462 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -150.87 147.89 27.79 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.222 1.011 . . . . 1.95 110.055 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 50.3 t -115.02 138.78 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 107.494 -1.299 . . . . 0.70999999999999996 107.494 176.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -104.53 137.73 41.94 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.096 -1.002 . . . . 1.01 108.602 178.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.3 t -109.3 129.4 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 107.638 -1.245 . . . . 0.81999999999999995 107.638 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.432 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 48.5 t-20 48.15 49.87 8.05 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 113.507 0.929 . . . . 1.54 113.507 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 22.3 Cg_endo -62.53 154.21 66.18 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.141 1.894 . . . . 0.93999999999999995 110.394 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.6 m -72.77 158.72 35.04 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.987 -1.07 . . . . 1.8 109.272 177.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 22.0 p30 -58.59 -38.0 77.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.849 -1.157 . . . . 2.73 110.483 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.51 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 82.1 tt0 -60.93 -39.45 89.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.005 -1.059 . . . . 3.1699999999999999 110.013 179.355 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.08 -36.84 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 1.3400000000000001 110.319 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.462 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 80.8 mt -58.7 -43.61 88.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.397 -0.814 . . . . 1.2 110.252 178.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -59.45 -38.74 81.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.001 -1.062 . . . . 2.7000000000000002 110.277 179.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -60.88 -49.26 78.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.507 -0.746 . . . . 2.5899999999999999 110.591 179.546 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.5 mtp -70.56 -39.2 74.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.524 -0.735 . . . . 1.3799999999999999 110.601 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.508 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -57.85 -40.27 79.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 2.8399999999999999 110.545 179.949 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 245' ' ' GLN . . . -71.45 -42.21 68.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 1.8799999999999999 111.3 -179.598 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 76.8 t -54.48 -50.31 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.84 -1.163 . . . . 2.3999999999999999 111.968 -178.314 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -66.97 -49.65 64.75 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.557 -1.339 . . . . 3.52 110.039 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -64.73 -31.44 72.66 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.132 -0.627 . . . . 1.8799999999999999 110.618 -179.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 241' ' ' ALA . 31.6 tt0 -60.11 -31.25 69.88 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 118.7 -1.2 . . . . 3.0099999999999998 109.164 179.278 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 84.9 t -66.43 -42.01 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.4 -0.92 . . . . 2.4500000000000002 109.375 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.72 -40.32 91.89 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.664 0.745 . . . . 2.75 110.558 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.8 t -69.98 -39.14 76.13 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.106 -0.996 . . . . 3.1600000000000001 110.919 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -61.14 -31.49 71.21 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.67 0.748 . . . . 3.5699999999999998 111.044 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -68.77 -29.73 68.17 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.331 -0.855 . . . . 4.2999999999999998 111.592 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -61.89 -12.37 17.55 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.13 -0.981 . . . . 4.4500000000000002 112.629 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -75.22 6.15 4.69 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.319 -0.863 . . . . 5.9699999999999998 112.934 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.721 ' C ' HD22 ' A' ' 253' ' ' LEU . 0.0 OUTLIER -62.99 -12.03 22.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.388 -0.82 . . . . 6.1799999999999997 111.882 179.814 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.452 ' N ' HD22 ' A' ' 253' ' ' LEU . . . -71.29 -4.41 25.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.692 -0.63 . . . . 6.6600000000000001 112.226 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.53 23.47 0.51 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.255 0.835 . . . . 8.1999999999999993 113.255 -179.201 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 256' ' ' LEU . 7.0 tt -79.68 -7.1 58.37 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.044 -1.035 . . . . 8.0700000000000003 112.446 179.112 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -83.64 8.72 13.46 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.989 -1.069 . . . . 9.4499999999999993 112.626 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -89.83 4.03 51.08 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.202 -0.936 . . . . 10.119999999999999 112.597 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 107.472 -1.307 . . . . 11.49 107.472 179.738 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.555 ' N ' HE21 ' A' ' 226' ' ' GLN . 5.0 mpp? . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.484 -0.561 . . . . 3.0699999999999998 109.484 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.0 mt -88.21 111.22 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.41 -1.33 . . . . 1.0700000000000001 107.41 177.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.4 m -104.8 127.45 52.6 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.791 -1.189 . . . . 1.24 107.791 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.403 ' N ' HD21 ' A' ' 225' ' ' ASN . . . -97.88 -147.79 22.86 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.246 -1.142 . . . . 1.01 110.246 179.42 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 5' ' ' ILE . 80.5 mt -97.6 1.31 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.546 -0.973 . . . . 1.1100000000000001 112.571 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' ILE . 8.6 tp 50.42 100.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.737 -1.227 . . . . 0.98999999999999999 112.063 178.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.7 -41.4 11.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.924 -1.11 . . . . 0.84999999999999998 111.791 179.211 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t -146.19 140.98 15.97 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 107.78 -1.193 . . . . 1.3799999999999999 107.78 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.77 149.73 38.27 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.585 2.19 . . . . 0.93999999999999995 112.555 178.607 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.88 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 149.66 161.65 9.94 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.367 -1.493 . . . . 0.81000000000000005 109.367 178.306 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.521 ' O ' ' NE2' ' A' ' 243' ' ' GLN . 94.3 mt -119.95 132.82 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.132 -1.217 . . . . 0.82999999999999996 107.893 179.58 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.16 151.07 47.38 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.216 -0.928 . . . . 0.53000000000000003 109.03 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -123.16 141.54 51.86 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.577 -0.898 . . . . 0.77000000000000002 108.577 178.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.94 166.2 32.98 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.046 -1.55 . . . . 0.51000000000000001 109.798 177.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -76.3 158.2 31.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.816 -0.814 . . . . 1.8999999999999999 109.133 178.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -82.3 123.49 29.11 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.607 -1.257 . . . . 0.66000000000000003 107.607 178.418 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.2 tp -102.9 99.64 9.57 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.228 -1.768 . . . . 0.82999999999999996 106.228 178.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 tp -87.52 140.92 29.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 0.85999999999999999 108.962 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.7 mt -96.51 115.66 27.8 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.653 -1.61 . . . . 0.92000000000000004 106.653 177.497 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -108.84 130.62 55.41 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.816 -1.179 . . . . 2.0299999999999998 107.816 -179.46 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.425 ' OE1' HD13 ' A' ' 147' ' ' ILE . 72.1 mm-40 -128.4 146.83 50.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 2.6600000000000001 109.054 179.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -80.41 138.89 36.69 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.933 -1.105 . . . . 2.3199999999999998 108.041 177.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -63.48 140.33 58.86 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.612 -0.884 . . . . 2.1099999999999999 108.612 178.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -89.7 130.16 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.086 -1.079 . . . . 0.72999999999999998 108.086 178.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.6 129.95 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.752 -1.203 . . . . 0.87 107.752 178.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.2 mt -91.25 138.99 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.387 -0.968 . . . . 0.81000000000000005 108.387 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -88.23 120.73 29.86 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.91 -1.515 . . . . 1.3400000000000001 106.91 178.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -93.57 10.27 33.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.522 -0.736 . . . . 2.8900000000000001 112.868 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -73.12 143.96 47.14 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.881 -1.137 . . . . 2.0899999999999999 110.039 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -89.77 132.16 35.36 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.185 -1.043 . . . . 2.1899999999999999 108.185 177.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -93.27 165.01 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.333 -0.854 . . . . 0.75 110.477 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.9 p -93.21 165.12 12.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.772 -0.58 . . . . 0.91000000000000003 109.713 178.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.95 -22.45 15.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.302 -0.874 . . . . 0.93000000000000005 112.18 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.95 -37.73 81.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.867 -1.146 . . . . 2.2799999999999998 110.914 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -91.54 -7.26 50.81 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.44 -1.412 . . . . 1.45 112.782 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.3 -41.21 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.218 -0.926 . . . . 0.81000000000000005 110.56 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -56.42 -39.99 73.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.027 . . . . 1.54 110.602 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -63.47 -41.95 98.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 2.3599999999999999 111.079 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.96 -41.58 98.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.081 -1.012 . . . . 1.3100000000000001 110.843 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.6 t -60.66 -40.06 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.611 -0.836 . . . . 0.81999999999999995 110.217 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -60.85 -43.62 98.08 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.736 -0.786 . . . . 1.5 109.677 179.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -62.1 -40.05 94.55 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.909 -0.716 . . . . 2.23 110.325 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -73.16 -54.22 9.02 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.149 -0.969 . . . . 0.84999999999999998 110.017 179.116 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -60.52 -49.06 79.04 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.002 -1.062 . . . . 0.91000000000000003 110.306 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.6 t -68.85 -36.92 78.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.361 -0.837 . . . . 0.90000000000000002 110.02 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.01 -46.3 84.87 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.499 -1.334 . . . . 0.68999999999999995 109.862 178.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -57.92 -31.72 67.07 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.246 -1.149 . . . . 2.8799999999999999 109.655 178.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.31 -51.1 71.2 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.204 -0.998 . . . . 0.84999999999999998 110.965 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 42.7 pttt -81.9 -42.1 19.99 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.175 -0.953 . . . . 2.3500000000000001 110.966 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.409 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -60.22 -41.82 93.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.8 . . . . 0.65000000000000002 110.383 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.1 p -59.46 -41.15 89.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.218 -1.03 . . . . 1.45 108.218 179.181 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.51 -48.65 59.85 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.559 -0.746 . . . . 0.63 109.782 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -62.13 -48.72 78.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.442 -1.411 . . . . 1.3400000000000001 110.077 -178.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.71 -38.9 89.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 1.5600000000000001 109.81 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -59.62 -40.17 86.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.724 -0.61 . . . . 1.1899999999999999 110.471 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.519 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 11.2 m -63.65 -39.81 95.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.926 -1.109 . . . . 0.71999999999999997 110.148 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.71 -40.17 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.468 -0.77 . . . . 0.62 110.573 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -51.75 -40.65 60.64 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.424 -0.798 . . . . 1.05 110.482 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.8 -37.08 73.26 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.11 -0.994 . . . . 0.64000000000000001 110.348 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.519 ' NZ ' HG22 ' A' ' 56' ' ' THR . 52.4 mttp -63.34 -38.82 92.65 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.669 -1.212 . . . . 1.73 109.025 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.8 -30.14 68.65 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.907 -0.588 . . . . 0.56000000000000005 110.337 179.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.11 -38.88 8.84 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 119.893 -1.146 . . . . 0.68999999999999995 111.214 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -81.03 -22.69 39.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.856 -1.379 . . . . 1.48 111.282 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.7 m -87.31 -51.56 5.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.656 -0.652 . . . . 0.97999999999999998 110.687 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -107.21 -7.28 16.84 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.07 1.137 . . . . 1.1599999999999999 114.07 -177.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.45 157.95 17.73 Favored Glycine 0 N--CA 1.5 2.909 0 O-C-N 121.599 -0.688 . . . . 0.84999999999999998 113.22 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -53.32 -19.06 2.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.592 -0.946 . . . . 3.8599999999999999 113.341 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -57.41 -33.92 68.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.714 -1.241 . . . . 2.3500000000000001 110.996 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -80.13 -23.53 41.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.959 -1.088 . . . . 1.6699999999999999 111.468 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.87 -38.32 81.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.093 -1.004 . . . . 1.45 111.007 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.22 -40.09 84.76 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.954 -1.091 . . . . 0.60999999999999999 110.999 179.355 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.7 mt -69.3 -47.99 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.665 -1.272 . . . . 0.65000000000000002 110.13 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -70.52 -29.94 66.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.864 . . . . 0.66000000000000003 110.62 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.79 -38.63 85.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.275 -0.891 . . . . 1.1899999999999999 110.403 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.3 -37.25 59.27 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 110.074 -1.211 . . . . 0.53000000000000003 110.074 179.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -59.81 -44.21 94.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.279 -1.13 . . . . 1.27 110.087 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.12 -39.37 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.54000000000000004 110.045 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.5 ttm -59.88 -39.5 85.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.5 -0.75 . . . . 1.74 110.552 179.46 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.6 tp -58.36 -48.15 81.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.853 . . . . 0.55000000000000004 110.204 179.028 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.01 -40.29 88.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.602 0.715 . . . . 0.46999999999999997 110.262 -179.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -86.04 5.14 34.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.791 . . . . 1.4199999999999999 112.75 -179.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -61.79 119.18 8.26 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.846 -1.159 . . . . 1.27 108.928 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.85 -17.49 64.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.462 -0.774 . . . . 1.3500000000000001 110.84 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.83 -47.8 28.54 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.023 -1.071 . . . . 2.2200000000000002 109.889 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.66 -36.44 82.86 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.301 -0.96 . . . . 0.62 110.011 -178.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.77 -48.36 79.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.404 -0.81 . . . . 1.29 110.495 179.05 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.52 -39.49 87.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 1.52 110.492 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.25 -49.88 62.69 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.091 -1.005 . . . . 1.3 110.488 179.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.5 mt -56.83 -43.58 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.935 -1.103 . . . . 0.60999999999999999 110.234 179.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.9 -43.2 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.567 -0.708 . . . . 0.78000000000000003 110.116 179.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.81 91.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.409 -0.807 . . . . 0.81999999999999995 110.574 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.08 -43.6 95.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.113 -0.992 . . . . 0.80000000000000004 110.254 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.1 mt -65.61 -48.45 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.094 -1.004 . . . . 0.77000000000000002 110.179 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -78.72 -36.2 43.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.266 -0.896 . . . . 2.1200000000000001 112.197 -179.414 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -81.74 -40.02 23.33 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.438 -1.414 . . . . 1.51 111.76 -179.405 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -108.59 10.61 27.05 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.211 -0.931 . . . . 1.98 111.965 -178.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.0 m80 49.46 50.52 18.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.982 -1.074 . . . . 1.3200000000000001 111.612 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -104.23 152.89 21.64 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.14 0.971 . . . . 1.3799999999999999 109.791 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.439 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 23.2 p -72.8 160.8 31.59 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.57 -0.706 . . . . 0.67000000000000004 109.535 178.009 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.45 -40.09 81.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -0.926 . . . . 0.52000000000000002 110.914 178.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 26.2 p-10 -69.86 -42.1 73.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.051 -1.031 . . . . 2.25 110.519 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.35 61.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.348 -0.845 . . . . 0.64000000000000001 110.882 -179.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.84 93.64 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.265 -0.897 . . . . 0.56000000000000005 110.696 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.66 -43.75 93.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 0.46000000000000002 110.943 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -60.19 -40.01 88.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.865 -1.147 . . . . 1.3200000000000001 111.036 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.73 -48.86 76.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.671 -1.268 . . . . 1.3 110.617 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 83.4 t -62.86 -49.22 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.71 -1.243 . . . . 0.60999999999999999 110.29 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 mm -61.54 -30.23 47.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.193 0.521 . . . . 0.65000000000000002 110.538 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -59.87 -40.12 87.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 2.1099999999999999 110.922 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.95 -31.45 17.6 Favored Glycine 0 N--CA 1.502 3.066 0 C-N-CA 118.668 -1.729 . . . . 0.82999999999999996 112.925 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -61.49 -40.99 96.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.521 -1.576 . . . . 1.28 110.063 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.22 -48.78 40.3 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.62 -0.675 . . . . 0.89000000000000001 110.4 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.0 m -61.4 -40.79 95.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 1.8700000000000001 110.477 -178.185 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.75 97.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.422 -0.799 . . . . 1.05 110.679 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.2 mt -64.57 -30.86 71.89 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.054 -1.029 . . . . 1.02 110.817 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -66.86 -21.11 66.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.945 -1.097 . . . . 2.04 111.158 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -75.0 -12.81 60.42 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.313 -0.867 . . . . 1.73 111.532 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 123' ' ' LEU . 5.3 mt -85.55 144.67 27.77 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.484 -0.76 . . . . 1.3700000000000001 109.292 179.196 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -100.45 53.03 0.88 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.185 -0.947 . . . . 2.8799999999999999 110.581 -179.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -129.46 138.28 51.33 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.211 -1.033 . . . . 1.5800000000000001 108.211 179.171 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -58.39 -39.8 80.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.544 -0.722 . . . . 3.04 110.999 179.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -71.43 -53.61 13.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.002 -1.061 . . . . 0.90000000000000002 110.332 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 118' ' ' LEU . 24.5 mt -61.4 -41.09 96.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.339 -0.851 . . . . 1.0600000000000001 110.506 -179.465 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -62.22 -50.16 72.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.954 -1.091 . . . . 2.1800000000000002 109.983 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.02 -31.68 70.18 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.309 -0.869 . . . . 2.1499999999999999 109.644 179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 130' ' ' VAL . 55.7 ttt180 -61.26 -30.43 70.46 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.086 -1.045 . . . . 2.3300000000000001 108.782 179.241 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.46 -49.58 77.01 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.921 0.867 . . . . 0.81999999999999995 109.398 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.86 81.7 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.895 -0.722 . . . . 0.84999999999999998 110.104 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -64.18 -36.69 84.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.347 -0.846 . . . . 1.3899999999999999 110.52 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 126' ' ' ARG . 38.9 t -67.12 -39.16 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.439 -0.788 . . . . 0.56000000000000005 109.983 179.793 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -60.4 -38.06 82.78 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.879 0.847 . . . . 3.1200000000000001 110.009 179.066 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.12 -38.33 82.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.766 -0.584 . . . . 1.28 110.481 179.325 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.7 mt -61.54 -40.17 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.472 -0.767 . . . . 0.48999999999999999 110.24 179.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.27 -42.44 35.15 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 120.078 -1.058 . . . . 0.46000000000000002 110.993 -179.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -58.77 -48.12 82.34 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.072 -1.251 . . . . 2.71 110.484 179.346 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -64.89 -41.25 95.78 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.511 -0.876 . . . . 2.1400000000000001 109.972 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.05 -39.58 86.45 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.314 -0.866 . . . . 1.05 110.033 179.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.2 mt -60.14 -41.93 93.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.882 . . . . 0.52000000000000002 110.902 179.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -60.44 -33.08 72.02 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.121 -0.987 . . . . 2.3500000000000001 110.678 179.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -77.64 -42.5 34.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 1.3899999999999999 110.846 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.4 mt -60.99 -38.33 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.231 -0.918 . . . . 0.68000000000000005 110.344 -178.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.7 mt -86.27 -7.43 58.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.31 -0.869 . . . . 0.82999999999999996 112.276 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.71 19.91 69.69 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.645 -1.264 . . . . 0.91000000000000003 112.844 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.5 tp -67.22 145.19 55.46 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.815 -0.815 . . . . 0.94999999999999996 109.163 179.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -67.79 149.74 49.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 2.4300000000000002 108.845 178.169 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.0 mt -109.49 137.38 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.369 -0.974 . . . . 1.1000000000000001 108.369 178.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.67 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.8 mp -80.11 128.59 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.654 -1.239 . . . . 1.5800000000000001 107.654 178.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -94.78 96.08 9.13 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.85 -1.537 . . . . 1.6200000000000001 106.85 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.41 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 53.1 mt -70.72 -25.23 62.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.337 -0.852 . . . . 0.80000000000000004 111.12 -178.33 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 p -80.57 0.25 34.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 1.5600000000000001 111.861 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.14 23.87 9.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.455 -0.778 . . . . 0.83999999999999997 111.852 -179.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.41 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 14.2 mt -72.04 146.33 11.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.234 -0.916 . . . . 0.81999999999999995 109.457 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -119.41 -14.77 9.15 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.757 0.789 . . . . 2.3100000000000001 112.756 -178.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -115.06 140.51 49.0 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.682 -0.858 . . . . 1.54 108.682 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -77.41 123.52 26.64 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.384 -0.969 . . . . 1.3799999999999999 108.384 178.005 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.3 m -148.56 175.28 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.608 -0.682 . . . . 0.68999999999999995 109.266 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.8 mt -88.23 145.05 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.641 -0.874 . . . . 0.53000000000000003 108.641 178.132 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.1 tp -97.08 126.49 42.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.12 -0.987 . . . . 0.64000000000000001 108.507 178.355 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.0 t -122.58 128.98 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.573 -1.269 . . . . 0.67000000000000004 107.573 178.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.39 153.18 21.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.932 . . . . 0.78000000000000003 108.847 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.66 84.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.701 -1.249 . . . . 1.0 109.65 178.131 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 10.4 t0 -172.37 154.66 3.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.481 -0.933 . . . . 2.4199999999999999 108.481 179.638 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.501 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 61.6 mt -117.75 139.32 51.21 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.222 -0.924 . . . . 0.75 108.759 177.629 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.2 p -91.2 153.03 44.56 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 107.879 -1.156 . . . . 0.78000000000000003 107.879 178.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -41.81 -44.82 6.82 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.559 1.506 . . . . 0.67000000000000004 113.375 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 23.9 m -60.26 -48.79 80.23 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.044 -1.035 . . . . 0.69999999999999996 110.252 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.22 -40.83 98.57 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.204 -0.935 . . . . 1.21 110.177 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 79.5 p -68.33 -38.45 81.53 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.416 -0.802 . . . . 0.59999999999999998 110.254 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.58 74.52 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.578 -0.701 . . . . 0.62 110.609 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -93.86 -5.87 47.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.166 -0.959 . . . . 1.1599999999999999 112.734 -179.316 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.73 146.89 51.28 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.959 -1.126 . . . . 0.72999999999999998 107.959 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.445 ' O ' HG23 ' A' ' 176' ' ' VAL . 55.4 t-20 -97.34 119.73 36.39 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.31 -1.367 . . . . 2.2400000000000002 107.31 178.075 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.692 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.2 mm? -76.25 -18.24 59.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.77 -0.581 . . . . 1.4299999999999999 111.526 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -80.99 -25.77 37.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.276 -0.89 . . . . 2.1499999999999999 111.863 -178.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -101.05 -1.69 33.53 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.112 0.782 . . . . 2.04 113.112 -178.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 178' ' ' GLY . 58.1 t -107.01 126.44 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 107.556 -1.276 . . . . 0.55000000000000004 107.556 178.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.8 tp -91.27 -2.01 57.53 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.052 -1.03 . . . . 1.6299999999999999 112.862 -178.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.447 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.94 169.83 34.42 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.797 -1.721 . . . . 0.46999999999999997 108.797 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -127.2 135.43 50.63 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.812 -1.181 . . . . 0.54000000000000004 107.812 179.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 76.1 mt -137.67 106.04 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 105.965 -1.865 . . . . 0.68999999999999995 105.965 178.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 203' ' ' VAL . 68.0 p -131.2 176.98 7.82 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.785 -1.197 . . . . 0.81999999999999995 110.204 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.552 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.3 OUTLIER -99.29 51.71 0.95 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.736 -0.603 . . . . 2.3700000000000001 110.843 179.28 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -100.66 145.32 28.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.303 -0.873 . . . . 1.1100000000000001 108.829 179.642 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -60.05 -32.55 76.06 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 120.15 -1.024 . . . . 1.6699999999999999 110.897 179.186 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 91.69 -4.37 79.12 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 120.898 -1.354 . . . . 1.54 113.328 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.419 ' O ' ' OG1' ' A' ' 187' ' ' THR . 80.1 mtm180 -90.36 115.65 27.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.243 -1.762 . . . . 4.4800000000000004 106.243 177.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 13.6 p 48.98 31.93 3.57 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.36 -0.837 . . . . 2.6299999999999999 112.226 -178.667 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.4 t -85.47 142.03 29.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.97 -1.081 . . . . 1.6899999999999999 109.837 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -58.74 -38.93 79.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 1.0700000000000001 111.135 178.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.3 m -60.38 -39.61 87.9 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.215 -0.928 . . . . 1.5800000000000001 110.085 179.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 70.8 m -60.34 -39.36 86.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 1.6000000000000001 110.554 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.407 HG12 HH21 ' A' ' 195' ' ' ARG . 96.7 mt -60.8 -39.99 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 1.45 110.959 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.9 mtp -63.76 -44.31 93.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.895 -1.128 . . . . 1.05 109.671 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.12 -49.57 77.11 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.77 -0.65 . . . . 0.71999999999999997 111.004 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.407 HH21 HG12 ' A' ' 192' ' ' ILE . 81.9 mtm180 -61.73 -41.1 97.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.985 . . . . 3.0499999999999998 110.946 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 56.0 m -69.36 -39.94 77.79 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.923 -1.111 . . . . 0.89000000000000001 110.561 -179.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.3 mt -89.28 -7.83 54.63 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.819 0.818 . . . . 0.78000000000000003 112.101 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 194' ' ' ALA . 45.2 mt-10 49.03 15.5 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.876 1.065 . . . . 1.45 113.876 -179.8 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.8 mt -74.75 150.58 86.46 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.022 -1.048 . . . . 0.67000000000000004 108.607 178.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.36 139.05 88.94 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.309 1.339 . . . . 0.64000000000000001 109.833 178.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.92 166.65 25.88 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 117.737 -1.585 . . . . 0.67000000000000004 109.431 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.5 mt -145.68 147.06 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.681 -1.229 . . . . 0.68999999999999995 107.681 177.216 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.435 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.8 m -126.99 -34.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 113.302 0.853 . . . . 0.84999999999999998 113.302 -179.009 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.17 40.83 1.73 Allowed Glycine 0 N--CA 1.489 2.18 0 C-N-CA 120.196 -1.002 . . . . 0.92000000000000004 111.913 -177.983 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.447 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 58.6 p -60.82 -18.75 57.45 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.273 -1.134 . . . . 0.94999999999999996 111.371 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.43 -95.82 0.99 Allowed Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.83 -1.176 . . . . 1.04 110.503 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 60.7 m -127.72 31.51 5.13 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.634 -0.921 . . . . 1.5700000000000001 112.215 -179.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.87 -35.33 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.393 -1.442 . . . . 0.83999999999999997 110.532 179.096 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 46.4 p -61.46 -20.06 62.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.195 -0.94 . . . . 0.98999999999999999 111.452 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.9 t -93.93 -1.03 55.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -0.951 . . . . 1.7 112.099 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -128.22 -1.66 5.72 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 112.797 0.665 . . . . 2.2000000000000002 112.797 -177.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.04 148.39 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.226 -0.657 . . . . 0.83999999999999997 109.226 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -119.85 157.18 29.22 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.851 -1.166 . . . . 2.2000000000000002 107.851 178.062 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.42 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 38.6 p30 -54.12 142.82 24.27 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.049 -1.032 . . . . 2.2799999999999998 110.813 178.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.7 OUTLIER 80.18 1.3 2.01 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 114.905 1.446 . . . . 2.3500000000000001 114.905 179.183 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -63.46 146.41 53.66 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.765 -1.209 . . . . 1.97 108.371 177.512 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -88.29 118.69 28.07 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.835 -1.542 . . . . 2.6499999999999999 106.835 177.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 87.3 mt -127.93 142.02 51.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.585 -0.697 . . . . 0.63 109.57 -178.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.6 mt -111.16 129.32 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.528 -1.656 . . . . 0.62 106.528 177.529 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 20.4 tp -99.1 119.05 37.19 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.384 -1.71 . . . . 0.64000000000000001 106.384 178.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.0 t0 -94.93 -29.28 14.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.818 -1.176 . . . . 2.0499999999999998 112.506 -177.631 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.88 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 36.79 20.79 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.773 0.657 . . . . 0.83999999999999997 112.773 -178.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.7 t -109.25 -55.95 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.125 -0.985 . . . . 1.02 109.075 178.335 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.46 14.8 30.02 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.625 -0.716 . . . . 2.5099999999999998 110.293 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.403 HD21 ' N ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER 59.51 55.38 4.14 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.397 0.617 . . . . 1.54 111.21 179.67 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.555 HE21 ' N ' ' A' ' 1' ' ' MET . 53.8 tt0 -151.49 148.48 28.11 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.254 1.026 . . . . 1.95 109.91 179.596 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 20.0 t -116.09 139.61 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.235 -1.024 . . . . 0.70999999999999996 108.235 177.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -102.01 135.6 43.29 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.057 -1.027 . . . . 1.01 108.739 178.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.0 t -112.83 130.24 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-O 121.779 0.8 . . . . 0.81999999999999995 109.127 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.439 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 13.6 t-20 52.06 48.95 6.14 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 113.577 0.955 . . . . 1.54 113.577 178.092 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.3 Cg_endo -64.5 150.05 88.9 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.585 2.19 . . . . 0.93999999999999995 110.724 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.1 m -74.77 154.16 38.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.265 -0.897 . . . . 1.8 108.947 177.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.55 ' HA ' HD12 ' A' ' 236' ' ' ILE . 16.0 t-20 -52.99 -41.11 64.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 2.73 110.708 178.716 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -59.2 -40.29 85.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 3.1699999999999999 109.812 179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.04 -38.91 76.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.647 -0.658 . . . . 1.3400000000000001 110.166 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 233' ' ' ASN . 96.8 mt -58.31 -46.83 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.448 -0.782 . . . . 1.2 110.785 179.198 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -59.14 -40.69 86.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.947 -1.096 . . . . 2.7000000000000002 110.406 179.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -60.76 -41.52 95.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.384 -0.822 . . . . 2.5899999999999999 110.305 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 47.3 mtp -71.51 -36.75 71.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.354 -0.841 . . . . 1.3799999999999999 110.593 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.541 HH12 ' CG2' ' A' ' 236' ' ' ILE . 0.3 OUTLIER -57.88 -41.03 81.69 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.137 -0.977 . . . . 2.8399999999999999 110.286 179.734 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.84 -37.58 73.16 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.375 -0.828 . . . . 1.8799999999999999 111.047 -179.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.44 -56.35 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.708 -1.245 . . . . 2.3999999999999999 111.919 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 11' ' ' ILE . 50.5 tt0 -62.89 -49.39 75.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.6 -1.313 . . . . 3.52 109.751 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.37 -33.26 72.2 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.648 -0.658 . . . . 1.8799999999999999 110.523 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -60.63 -30.0 69.59 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.774 -1.17 . . . . 3.0099999999999998 109.358 179.058 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.55 -47.27 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 121.898 0.856 . . . . 2.4500000000000002 109.509 179.17 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.97 91.07 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.783 -0.767 . . . . 2.75 110.046 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 20.9 t -70.22 -40.23 74.65 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.523 -0.735 . . . . 3.1600000000000001 110.541 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -62.74 -40.79 98.34 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.427 -0.796 . . . . 3.5699999999999998 110.19 -178.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -67.98 -39.56 83.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 4.2999999999999998 110.614 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -66.57 -40.57 89.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 4.4500000000000002 110.636 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -70.04 -27.91 65.04 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.206 -0.934 . . . . 5.9699999999999998 111.44 -179.544 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.33 -40.38 94.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 6.1799999999999997 110.437 179.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -78.42 -7.92 57.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.019 -1.051 . . . . 6.6600000000000001 112.156 -179.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -77.25 -54.66 6.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.345 -0.847 . . . . 8.1999999999999993 111.386 -179.284 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.578 ' CD2' ' H ' ' A' ' 256' ' ' LEU . 1.3 pt? -82.9 -14.18 54.68 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.868 -1.145 . . . . 8.0700000000000003 112.95 -178.267 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -96.33 51.53 1.2 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.77 -1.206 . . . . 9.4499999999999993 110.924 -178.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -91.47 -7.92 49.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.309 -0.869 . . . . 10.119999999999999 112.663 -178.485 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.958 -1.02 . . . . 11.49 109.286 -178.788 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.199 -0.667 . . . . 3.0699999999999998 109.199 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt -99.14 98.14 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 106.856 -1.535 . . . . 1.0700000000000001 106.856 177.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -105.31 122.56 46.21 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.391 -1.336 . . . . 1.24 107.391 -179.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.95 -150.65 27.15 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.784 -1.326 . . . . 1.01 109.784 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.591 HG22 ' O ' ' A' ' 5' ' ' ILE . 95.4 mt -95.22 1.05 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.408 -1.054 . . . . 1.1100000000000001 112.942 -179.635 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 tp 49.64 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.801 -1.187 . . . . 0.98999999999999999 112.867 178.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.83 -37.23 14.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.956 -1.09 . . . . 0.84999999999999998 111.431 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 t -146.34 137.02 12.4 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 107.965 -1.124 . . . . 1.3799999999999999 107.965 -178.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.27 152.56 35.14 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.934 1.756 . . . . 0.93999999999999995 112.122 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.719 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 147.13 135.41 2.68 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.768 -0.933 . . . . 0.81000000000000005 110.768 177.683 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -96.15 132.48 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.549 -1.559 . . . . 0.82999999999999996 108.941 178.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.3 148.95 45.2 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.895 -0.78 . . . . 0.53000000000000003 108.895 179.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 3.2 m-85 -121.22 142.75 49.62 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.301 -0.875 . . . . 0.77000000000000002 109.018 178.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.84 168.38 37.32 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.575 -1.774 . . . . 0.51000000000000001 109.721 177.797 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -78.08 158.68 29.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.763 -0.845 . . . . 1.8999999999999999 108.799 178.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -82.59 123.78 29.54 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.898 -1.149 . . . . 0.66000000000000003 107.898 178.407 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 tp -102.47 98.86 8.88 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.22 -1.77 . . . . 0.82999999999999996 106.22 178.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.1 tp -86.99 141.1 28.92 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.681 -0.859 . . . . 0.85999999999999999 108.681 -179.666 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 mt -99.72 107.11 19.11 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.27 -1.381 . . . . 0.92000000000000004 107.27 178.158 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -110.81 134.23 52.68 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.673 -1.232 . . . . 2.0299999999999998 107.673 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -131.11 155.12 47.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.211 -0.931 . . . . 2.6600000000000001 109.163 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -82.11 137.16 35.07 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.907 -1.146 . . . . 2.3199999999999998 107.907 177.338 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -65.7 148.36 51.89 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.346 -0.847 . . . . 2.1099999999999999 108.881 178.553 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.6 mt -99.85 134.61 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.359 -0.838 . . . . 0.72999999999999998 108.799 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.89 130.01 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.571 -1.27 . . . . 0.87 107.571 178.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.6 mt -95.83 135.8 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.297 -0.877 . . . . 0.81000000000000005 108.976 179.257 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -94.45 126.65 39.86 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.265 -1.013 . . . . 1.3400000000000001 108.265 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.513 ' HG2' HH11 ' A' ' 28' ' ' ARG . 4.4 mmt-85 -97.7 15.08 24.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.343 -0.848 . . . . 2.8900000000000001 112.481 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -63.34 142.32 58.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.004 -1.06 . . . . 2.0899999999999999 109.117 178.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -88.02 130.82 34.86 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.136 -1.061 . . . . 2.1899999999999999 108.136 177.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -89.37 170.19 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.178 -0.951 . . . . 0.75 110.09 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.3 p -94.64 163.44 13.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.577 -0.702 . . . . 0.91000000000000003 109.645 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.75 -19.94 4.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 0.93000000000000005 112.67 179.249 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -68.71 -43.16 76.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.832 -1.167 . . . . 2.2799999999999998 111.229 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -87.42 -5.79 58.7 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.711 -1.243 . . . . 1.45 112.674 -179.098 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.05 -46.52 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 0.81000000000000005 110.891 -178.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -56.49 -40.02 74.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.954 . . . . 1.54 110.316 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.61 -39.6 91.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.535 -0.728 . . . . 2.3599999999999999 110.824 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -60.0 -40.63 89.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.026 -1.046 . . . . 1.3100000000000001 110.747 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.83 -39.69 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.81999999999999995 110.38 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -62.87 -48.12 80.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.364 -0.835 . . . . 1.5 110.794 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -62.87 -40.93 99.01 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.917 -1.113 . . . . 2.23 110.256 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -71.13 -52.86 16.85 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.204 -0.935 . . . . 0.84999999999999998 110.191 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.2 tp -62.3 -47.47 84.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.037 -1.04 . . . . 0.91000000000000003 109.816 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.522 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.5 t -70.23 -42.46 72.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.472 -0.768 . . . . 0.90000000000000002 109.697 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.58 -38.08 85.86 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.148 -1.501 . . . . 0.68999999999999995 109.414 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 20.5 ttm180 -59.32 -32.02 69.69 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.958 0.885 . . . . 2.8799999999999999 109.095 178.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.04 -44.19 91.74 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.787 0.803 . . . . 0.84999999999999998 109.636 178.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -79.63 -40.17 29.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.115 -0.991 . . . . 2.3500000000000001 110.332 179.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.28 -44.9 92.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.468 -0.77 . . . . 0.65000000000000002 110.132 -178.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.5 p -60.45 -38.63 84.76 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.124 0.964 . . . . 1.45 109.313 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.57 99.38 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.126 -0.63 . . . . 0.63 110.661 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -62.0 -50.14 73.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.569 -1.332 . . . . 1.3400000000000001 110.479 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 54' ' ' LEU . 3.2 mm? -67.63 -40.64 84.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.329 -0.857 . . . . 1.5600000000000001 110.399 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -59.21 -40.78 86.86 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.389 -0.819 . . . . 1.1899999999999999 110.467 179.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -67.21 -46.93 72.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.084 -1.01 . . . . 0.71999999999999997 110.671 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.11 -38.16 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.417 -0.802 . . . . 0.62 110.524 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -49.93 -44.72 50.55 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.367 -0.833 . . . . 1.05 111.322 179.183 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -68.16 -40.48 82.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.195 -0.941 . . . . 0.64000000000000001 109.946 -179.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -61.87 -37.98 86.6 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.883 -1.127 . . . . 1.73 109.334 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -33.77 76.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.448 0.642 . . . . 0.56000000000000005 110.2 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.61 -37.13 12.35 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.771 -1.204 . . . . 0.68999999999999995 111.255 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.67 -24.41 38.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.07 -1.253 . . . . 1.48 110.755 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.4 m -88.0 -50.77 6.2 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.537 -0.865 . . . . 0.97999999999999998 110.271 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -107.06 -2.96 20.51 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 113.965 1.098 . . . . 1.1599999999999999 113.965 -177.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.24 155.87 26.88 Favored Glycine 0 N--CA 1.504 3.201 0 O-C-N 120.82 -1.175 . . . . 0.84999999999999998 113.858 178.311 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.58 -15.55 1.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -1.018 . . . . 3.8599999999999999 112.979 179.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.66 -35.8 71.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 2.3500000000000001 110.917 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -82.91 -19.03 38.11 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.143 -0.973 . . . . 1.6699999999999999 111.996 -179.382 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.23 -35.19 74.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.074 -1.016 . . . . 1.45 111.038 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.36 89.18 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.079 -1.013 . . . . 0.60999999999999999 110.847 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.6 mt -68.64 -42.38 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.943 -1.098 . . . . 0.65000000000000002 110.098 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -72.05 -31.15 65.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.139 -0.976 . . . . 0.66000000000000003 110.253 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -59.79 -37.65 79.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.826 . . . . 1.1899999999999999 110.004 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.92 -40.54 84.42 Favored Glycine 0 N--CA 1.48 1.622 0 C-N-CA 119.733 -1.222 . . . . 0.53000000000000003 110.277 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -59.93 -47.28 86.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.184 -1.186 . . . . 1.27 110.593 179.506 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.7 mt -60.3 -38.64 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.951 -1.093 . . . . 0.54000000000000004 110.231 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.9 ttt -59.9 -39.39 85.21 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.365 -0.834 . . . . 1.74 110.904 179.22 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.418 HD11 HE21 ' A' ' 111' ' ' GLN . 9.3 tp -60.31 -50.04 75.2 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.106 -0.996 . . . . 0.55000000000000004 110.46 179.669 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.31 -39.28 92.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.033 -1.042 . . . . 0.46999999999999997 110.303 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -87.22 1.5 52.95 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.445 0.906 . . . . 1.4199999999999999 113.445 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.41 121.45 12.11 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.357 -1.465 . . . . 1.27 108.244 178.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -66.36 -16.88 64.41 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.88 0.847 . . . . 1.3500000000000001 110.964 -178.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.97 -53.35 9.12 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.507 0.67 . . . . 2.2200000000000002 110.087 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.31 -36.78 81.04 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.568 -0.853 . . . . 0.62 110.485 -179.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 47' ' ' ARG . 87.0 tt0 -59.43 -46.84 87.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.203 -0.936 . . . . 1.29 110.918 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.73 -38.56 85.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.393 -0.817 . . . . 1.52 110.701 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.02 -48.7 70.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.831 -1.168 . . . . 1.3 110.872 179.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.31 -43.95 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.173 -0.954 . . . . 0.60999999999999999 110.138 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.5 mt -60.41 -43.96 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.658 -0.651 . . . . 0.78000000000000003 110.486 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.21 -42.34 98.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.425 -0.797 . . . . 0.81999999999999995 110.991 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.66 -47.79 83.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.162 -0.961 . . . . 0.80000000000000004 110.296 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.4 mt -60.89 -44.88 98.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.304 -0.872 . . . . 0.77000000000000002 110.683 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -84.07 -34.45 24.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.007 -1.058 . . . . 2.1200000000000001 111.954 -179.71 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 91' ' ' ALA . 44.9 t0 -82.94 -43.62 16.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.809 -1.182 . . . . 1.51 111.445 -178.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -101.9 5.79 41.09 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.642 -0.661 . . . . 1.98 112.302 -178.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.7 m80 52.09 47.92 23.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 1.3200000000000001 111.795 -179.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.4 mtt -100.34 153.76 19.05 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.146 -0.971 . . . . 1.3799999999999999 110.018 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.5 p -71.57 161.21 31.38 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.507 -0.746 . . . . 0.67000000000000004 109.746 178.149 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.22 90.61 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.85 -0.74 . . . . 0.52000000000000002 110.748 178.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.517 ' OD2' HD21 ' A' ' 142' ' ' LEU . 98.1 m-20 -68.49 -40.21 81.0 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.959 -1.088 . . . . 2.25 110.248 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.91 -50.68 54.72 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.855 -0.738 . . . . 0.64000000000000001 111.064 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.58 -44.23 96.84 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 0.56000000000000005 110.195 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.97 -44.17 94.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.603 -0.686 . . . . 0.46000000000000002 110.665 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -61.71 -38.65 88.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 1.3200000000000001 111.321 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -57.44 -49.77 75.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.675 -1.266 . . . . 1.3 110.888 179.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.4 t -60.04 -47.42 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.635 -1.291 . . . . 0.60999999999999999 110.424 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -61.02 -30.35 47.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.563 -0.711 . . . . 0.65000000000000002 110.438 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -58.65 -41.27 85.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.358 -0.839 . . . . 2.1099999999999999 110.776 179.218 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.82 -30.61 23.15 Favored Glycine 0 N--CA 1.498 2.808 0 C-N-CA 119.071 -1.538 . . . . 0.82999999999999996 112.991 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.418 HE21 HD11 ' A' ' 79' ' ' LEU . 15.2 mm100 -62.09 -42.84 99.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.188 -1.772 . . . . 1.28 110.055 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.41 -52.03 25.26 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.379 -0.825 . . . . 0.89000000000000001 110.312 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.0 p -60.33 -34.81 74.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.186 -0.946 . . . . 1.8700000000000001 110.421 -179.365 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.04 -47.02 86.59 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.766 -0.584 . . . . 1.05 110.934 179.576 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.48 -29.94 70.9 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.127 -1.029 . . . . 1.02 111.148 -179.506 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -67.43 -22.29 65.52 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.929 -1.107 . . . . 2.04 111.511 179.455 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -70.59 -18.32 62.89 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.94 -1.104 . . . . 1.73 110.932 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 123' ' ' LEU . 10.7 mt -83.79 145.34 28.74 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.359 -0.838 . . . . 1.3700000000000001 109.623 179.265 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -101.08 41.93 1.15 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.359 -0.838 . . . . 2.8799999999999999 110.996 179.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -113.13 135.76 53.46 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.961 -1.125 . . . . 1.5800000000000001 107.961 178.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.495 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 25.1 mp0 -59.13 -34.24 71.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.45 -0.781 . . . . 3.04 111.151 179.111 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -74.22 -50.51 18.83 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.108 -0.995 . . . . 0.90000000000000002 110.51 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 118' ' ' LEU . 30.6 mt -63.4 -36.65 84.44 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.199 -0.938 . . . . 1.0600000000000001 110.207 -179.354 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -62.56 -49.24 76.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.166 -1.014 . . . . 2.1800000000000002 109.758 179.209 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -63.04 -28.98 70.46 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.448 -0.901 . . . . 2.1499999999999999 110.27 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -63.55 -30.38 71.5 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.069 0.937 . . . . 2.3300000000000001 108.879 178.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.1 -48.72 80.56 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.645 0.736 . . . . 0.81999999999999995 109.665 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.87 91.63 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.847 0.832 . . . . 0.84999999999999998 109.449 179.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.76 -37.61 88.0 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.574 -0.704 . . . . 1.3899999999999999 110.476 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.75 -39.83 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.407 -0.808 . . . . 0.56000000000000005 110.202 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -59.1 -38.86 80.54 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.265 -0.974 . . . . 3.1200000000000001 110.134 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -59.68 -39.74 85.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.557 -0.715 . . . . 1.28 110.469 179.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 66.2 mt -60.5 -39.97 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.01 . . . . 0.48999999999999999 110.1 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.01 -44.96 87.24 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.844 -1.169 . . . . 0.46000000000000002 110.279 179.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -59.54 -40.6 87.75 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.311 -1.111 . . . . 2.71 110.383 179.248 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -61.74 -45.08 95.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.994 -1.066 . . . . 2.1400000000000001 110.161 179.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 50.5 tp -59.92 -43.19 95.06 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.123 -0.986 . . . . 1.05 110.016 179.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.89 -44.16 94.4 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.234 -0.916 . . . . 0.52000000000000002 110.189 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.87 -34.32 74.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.246 -0.909 . . . . 2.3500000000000001 110.585 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.541 HD21 HD11 ' A' ' 146' ' ' ILE . 5.3 m120 -77.44 -40.5 43.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 1.3899999999999999 111.058 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.3 -40.05 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.236 -0.915 . . . . 0.68000000000000005 110.196 -178.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.517 HD21 ' OD2' ' A' ' 101' ' ' ASP . 68.7 mt -90.2 -9.42 48.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.91 -1.119 . . . . 0.82999999999999996 112.041 -179.236 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.37 20.27 77.24 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 120.375 -0.917 . . . . 0.91000000000000003 112.961 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.2 tp -63.78 149.91 45.78 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.686 0.755 . . . . 0.94999999999999996 109.408 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.73 146.29 54.99 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.245 -0.909 . . . . 2.4300000000000002 109.009 178.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.541 HD11 HD21 ' A' ' 140' ' ' ASN . 62.5 mt -108.82 143.5 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.391 -0.966 . . . . 1.1000000000000001 108.391 178.393 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 mp -76.23 114.12 16.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.925 -1.11 . . . . 1.5800000000000001 108.501 178.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -98.18 102.13 13.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.441 -1.689 . . . . 1.6200000000000001 106.441 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.406 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 63.0 mt -77.37 -18.03 57.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 0.80000000000000004 111.17 -177.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.3 m -80.11 -1.53 40.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -0.823 . . . . 1.5600000000000001 112.325 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.61 27.11 5.04 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.807 0.813 . . . . 0.83999999999999997 111.897 -178.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.406 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 17.5 mt -75.19 139.55 18.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.522 -0.736 . . . . 0.81999999999999995 109.392 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -111.63 -19.95 12.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.029 0.919 . . . . 2.3100000000000001 112.535 -178.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -119.12 142.88 47.53 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.723 -0.843 . . . . 1.54 108.723 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -73.14 122.42 21.83 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.052 -1.092 . . . . 1.3799999999999999 108.052 178.042 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.1 m -144.75 175.56 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.594 -0.691 . . . . 0.68999999999999995 109.253 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 44.9 mt -88.3 143.91 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.282 -0.886 . . . . 0.53000000000000003 108.802 178.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.3 tp -96.8 125.35 41.19 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.06 -1.089 . . . . 0.64000000000000001 108.06 178.209 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.4 t -123.22 129.93 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.552 -1.277 . . . . 0.67000000000000004 107.552 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.79 154.21 21.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.159 -0.963 . . . . 0.78000000000000003 108.678 179.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.83 80.6 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.583 -1.323 . . . . 1.0 109.365 178.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -171.58 153.9 3.59 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.862 -0.792 . . . . 2.4199999999999999 108.862 179.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.3 mt -118.73 142.26 47.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.932 -0.766 . . . . 0.75 108.932 177.318 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.2 p -92.48 150.56 40.15 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.13 -0.981 . . . . 0.78000000000000003 108.52 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -42.72 -38.63 6.66 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.857 1.705 . . . . 0.67000000000000004 113.206 179.329 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 62.1 m -63.52 -50.12 70.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.005 -1.059 . . . . 0.69999999999999996 109.884 -179.692 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.92 -39.03 90.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.913 . . . . 1.21 110.127 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 70.2 p -68.7 -40.81 79.84 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.827 -0.749 . . . . 0.59999999999999998 110.328 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.57 77.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.62 110.585 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -95.91 -0.98 50.2 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.949 -1.094 . . . . 1.1599999999999999 112.921 -179.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.95 148.62 46.95 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.72 -1.238 . . . . 0.72999999999999998 108.49 179.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -97.01 115.3 27.2 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.096 -1.446 . . . . 2.2400000000000002 107.096 177.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.0 mt -73.67 -14.12 61.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.59 -0.694 . . . . 1.4299999999999999 111.778 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.72 -21.94 32.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.347 -0.845 . . . . 2.1499999999999999 112.491 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -99.43 -7.06 26.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.129 -0.982 . . . . 2.04 112.549 -178.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 178' ' ' GLY . 58.7 t -110.99 131.0 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.198 -1.038 . . . . 0.55000000000000004 108.198 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -89.32 -13.87 36.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 1.6299999999999999 111.275 -179.744 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.423 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -177.14 172.92 45.83 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.889 -1.684 . . . . 0.46999999999999997 108.889 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -126.56 132.79 51.25 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.947 -1.131 . . . . 0.54000000000000004 107.947 179.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.561 HD11 HD13 ' A' ' 220' ' ' LEU . 67.4 mt -132.66 112.17 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.323 -1.732 . . . . 0.68999999999999995 106.323 179.052 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 205' ' ' THR . 73.3 p -135.86 173.3 11.86 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.608 -1.308 . . . . 0.81999999999999995 110.173 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -98.59 54.66 1.05 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.353 0.597 . . . . 2.3700000000000001 110.546 179.049 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.47 160.62 14.4 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 1.1100000000000001 109.921 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.93 -82.7 0.07 OUTLIER Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.84 -1.171 . . . . 1.6699999999999999 111.141 178.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 148.47 -38.48 1.01 Allowed Glycine 0 N--CA 1.5 2.942 0 O-C-N 120.582 -1.54 . . . . 1.54 113.223 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -60.05 -39.52 86.22 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.844 -1.386 . . . . 4.4800000000000004 110.863 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 23.0 p -136.83 38.02 2.6 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.295 -0.878 . . . . 2.6299999999999999 111.623 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 59.0 m -85.68 124.07 31.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.404 -1.332 . . . . 1.6899999999999999 107.404 178.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -56.69 -37.52 70.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.264 -0.897 . . . . 1.0700000000000001 110.824 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.3 p -60.88 -38.93 87.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 1.5800000000000001 110.351 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.0 t -60.21 -40.54 90.47 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.224 -0.923 . . . . 1.6000000000000001 110.12 179.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.55 -35.92 61.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.333 -0.854 . . . . 1.45 110.457 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 59.1 mtp -63.23 -41.44 99.11 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.995 -1.066 . . . . 1.05 109.566 179.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.75 -47.09 87.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.701 -0.681 . . . . 0.71999999999999997 111.021 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -62.17 -43.46 98.77 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.061 -1.024 . . . . 3.0499999999999998 110.748 -179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.4 m -70.5 -39.78 73.95 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.308 -0.87 . . . . 0.89000000000000001 110.492 -179.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.0 mt -93.3 -4.47 51.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.78000000000000003 112.817 -178.295 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 53.87 10.84 0.28 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.862 1.06 . . . . 1.45 113.862 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.6 mt -72.36 150.22 91.68 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.871 -1.143 . . . . 0.67000000000000004 108.904 179.4 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.63 140.81 88.59 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.038 1.159 . . . . 0.64000000000000001 110.239 178.391 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.94 162.04 31.85 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.049 -1.657 . . . . 0.67000000000000004 109.479 178.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.419 ' CD1' HD11 ' A' ' 220' ' ' LEU . 16.2 mt -147.02 146.6 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.063 -1.088 . . . . 0.68999999999999995 108.063 177.431 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.2 m -125.93 -28.28 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 O-C-N 121.041 -1.037 . . . . 0.84999999999999998 113.266 -179.182 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.21 42.2 1.63 Allowed Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.634 -1.27 . . . . 0.92000000000000004 111.759 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 181' ' ' THR . 45.0 p -65.34 -18.04 65.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.964 -1.315 . . . . 0.94999999999999996 111.116 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.07 -95.9 0.86 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.833 -1.307 . . . . 1.04 109.833 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 60.8 m -127.46 31.09 5.25 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.709 -0.877 . . . . 1.5700000000000001 111.866 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 78.2 t -57.06 -35.89 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.32 -1.488 . . . . 0.83999999999999997 110.593 179.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.4 p -59.99 -19.89 54.81 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.939 -1.101 . . . . 0.98999999999999999 111.974 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 48.9 m -94.56 1.87 55.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.945 . . . . 1.7 112.089 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -128.77 1.67 5.43 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 113.086 0.773 . . . . 2.2000000000000002 113.086 -178.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.53 152.87 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.739 0.781 . . . . 0.83999999999999997 109.773 -179.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -118.82 152.69 35.77 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.044 -1.095 . . . . 2.2000000000000002 108.044 177.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 43.7 p-10 -55.11 143.2 27.88 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.983 -1.073 . . . . 2.2799999999999998 110.17 178.285 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 80.97 -0.72 1.78 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 114.117 1.155 . . . . 2.3500000000000001 114.117 179.431 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.14 150.07 43.73 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.646 -1.284 . . . . 1.97 109.338 177.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -89.72 120.86 31.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.507 -1.371 . . . . 2.6499999999999999 107.521 178.175 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 89.8 mt -128.33 146.8 50.66 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.44 -0.788 . . . . 0.63 109.729 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.47 127.88 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.15 -1.426 . . . . 0.62 107.15 177.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.561 HD13 HD11 ' A' ' 180' ' ' ILE . 61.8 tp -101.52 118.3 36.67 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 105.883 -1.895 . . . . 0.64000000000000001 105.883 178.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 223' ' ' VAL . 39.4 t0 -91.7 -26.81 18.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.753 -1.217 . . . . 2.0499999999999998 112.361 -177.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.82 19.74 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 113.264 0.839 . . . . 0.83999999999999997 113.264 -179.25 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.1 t -112.14 -55.74 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.147 0.975 . . . . 1.02 108.981 -179.426 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -100.73 10.89 40.58 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.252 1.025 . . . . 2.5099999999999998 109.65 -179.169 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 62.03 53.31 3.04 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.317 -0.856 . . . . 1.54 112.05 179.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -149.58 146.64 27.44 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.213 1.006 . . . . 1.95 109.792 178.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.9 t -116.79 135.37 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.509 -1.293 . . . . 0.70999999999999996 107.509 178.056 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -102.42 134.77 45.19 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.831 -1.168 . . . . 1.01 108.442 178.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.26 129.25 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 107.795 -1.187 . . . . 0.81999999999999995 107.795 178.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.488 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 18.4 t30 56.66 44.88 1.53 Allowed Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 113.467 0.914 . . . . 1.54 113.467 179.092 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 52.2 Cg_endo -68.9 155.47 68.46 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.383 2.055 . . . . 0.93999999999999995 110.681 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 29.8 p -73.72 162.56 29.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.962 -1.086 . . . . 1.8 110.723 178.544 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.12 -34.04 74.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.507 -0.746 . . . . 2.73 110.337 178.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -59.85 -39.53 85.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 3.1699999999999999 110.747 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.04 -39.07 79.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.217 -0.927 . . . . 1.3400000000000001 110.405 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 80.5 mt -59.74 -48.37 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.525 -0.734 . . . . 1.2 111.304 179.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -59.06 -40.17 84.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.892 -1.13 . . . . 2.7000000000000002 110.824 -179.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -62.69 -47.49 83.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.256 -0.903 . . . . 2.5899999999999999 110.76 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 87.6 mtp -71.29 -39.1 71.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.384 -0.823 . . . . 1.3799999999999999 110.89 -179.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -56.23 -39.93 73.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.866 -1.146 . . . . 2.8399999999999999 110.751 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.91 -45.89 63.48 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.014 -1.054 . . . . 1.8799999999999999 111.122 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.12 -48.59 84.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.648 -1.282 . . . . 2.3999999999999999 110.895 -178.573 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -60.07 -50.73 72.57 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.647 -1.283 . . . . 3.52 111.124 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.57 -36.78 85.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.761 -0.587 . . . . 1.8799999999999999 111.108 -179.4 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -61.98 -26.32 68.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.424 -1.31 . . . . 3.0099999999999998 110.428 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 77.5 t -69.49 -49.26 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 119.354 -0.939 . . . . 2.4500000000000002 110.308 179.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.13 97.02 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.17 -0.956 . . . . 2.75 110.023 -179.766 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.5 t -69.94 -39.81 75.86 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.701 -0.625 . . . . 3.1600000000000001 110.794 -179.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -62.54 -46.6 87.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.344 -0.847 . . . . 3.5699999999999998 110.833 -179.441 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 254' ' ' ALA . 3.7 ttmp? -70.19 -29.19 65.99 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.426 -0.796 . . . . 4.2999999999999998 111.09 -179.576 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.24 -69.35 0.6 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.886 -1.134 . . . . 4.4500000000000002 111.636 179.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -78.45 -53.72 6.94 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.316 -0.865 . . . . 5.9699999999999998 113.03 -178.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 66.1 mt -68.4 -12.27 60.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.443 -1.411 . . . . 6.1799999999999997 112.887 -178.211 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 250' ' ' LYS . . . -62.85 -28.29 69.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.371 -1.456 . . . . 6.6600000000000001 111.144 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -82.08 -11.37 58.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.917 -1.115 . . . . 8.1999999999999993 112.454 -179.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.578 ' N ' HD22 ' A' ' 256' ' ' LEU . 3.6 mm? -92.05 16.65 10.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.014 -1.054 . . . . 8.0700000000000003 112.28 -179.682 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.404 ' CB ' ' NZ ' ' A' ' 257' ' ' LYS . 9.3 mtmp? -85.75 11.27 11.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.059 -1.025 . . . . 9.4499999999999993 112.802 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -85.16 -8.14 58.74 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.856 -1.152 . . . . 10.119999999999999 112.422 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 51.2 mtt-85 . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.1 -1.0 . . . . 11.49 109.302 -178.111 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.293 0.568 . . . . 3.0699999999999998 109.519 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.6 mt -92.93 106.94 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.318 -1.734 . . . . 1.0700000000000001 106.318 177.666 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 m -105.76 121.02 43.18 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.504 -1.295 . . . . 1.24 107.504 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.01 -149.82 26.15 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.512 -1.035 . . . . 1.01 110.512 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.557 HG22 ' O ' ' A' ' 5' ' ' ILE . 81.3 mt -94.34 0.77 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.783 -0.833 . . . . 1.1100000000000001 112.086 -179.67 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 50.26 99.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.355 -0.841 . . . . 0.98999999999999999 112.335 178.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.8 -52.97 6.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.108 . . . . 0.84999999999999998 110.628 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.33 149.41 44.53 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 107.719 -1.215 . . . . 1.3799999999999999 107.719 -179.541 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.26 144.5 29.48 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 123.029 2.486 . . . . 0.93999999999999995 112.937 178.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.91 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.35 168.67 18.15 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 109.206 -1.558 . . . . 0.81000000000000005 109.206 178.119 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.87 133.46 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.108 -1.23 . . . . 0.82999999999999996 108.803 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.33 150.86 43.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.366 -0.834 . . . . 0.53000000000000003 109.132 179.096 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.418 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 22.0 m-85 -117.87 139.78 50.63 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.047 -1.094 . . . . 0.77000000000000002 108.047 177.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.82 167.25 38.52 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.34 -1.886 . . . . 0.51000000000000001 110.442 178.182 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -78.38 156.62 29.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.768 -0.842 . . . . 1.8999999999999999 108.774 177.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.416 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.67 124.96 32.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.042 -1.095 . . . . 0.66000000000000003 108.042 178.53 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.2 tp -100.24 101.9 13.03 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 104.721 -2.326 . . . . 0.82999999999999996 104.721 177.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.25 138.48 31.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.21 -1.034 . . . . 0.85999999999999999 108.21 179.673 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.3 mt -98.98 114.83 27.67 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 106.119 -1.808 . . . . 0.92000000000000004 106.119 177.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -102.29 129.84 48.83 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.799 -1.186 . . . . 2.0299999999999998 107.799 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -123.27 144.07 49.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.99 -0.744 . . . . 2.6600000000000001 108.99 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -81.15 134.34 35.62 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.758 -1.201 . . . . 2.3199999999999998 107.758 177.284 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.68 145.61 55.39 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.406 -0.809 . . . . 2.1099999999999999 108.981 178.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.9 mt -93.03 132.11 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.263 -1.014 . . . . 0.72999999999999998 108.263 178.324 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -106.33 129.85 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.169 -1.048 . . . . 0.87 108.169 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.2 mt -97.06 130.34 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.031 -1.1 . . . . 0.81000000000000005 108.031 178.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -89.91 122.51 33.01 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.741 -1.207 . . . . 1.3400000000000001 107.741 178.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mmm-85 -93.58 11.68 27.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.47 -0.768 . . . . 2.8900000000000001 112.286 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -65.05 150.51 47.98 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.348 -0.845 . . . . 2.0899999999999999 110.268 178.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -90.08 129.85 36.32 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.148 -1.056 . . . . 2.1899999999999999 108.148 177.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 pt -90.86 164.69 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.962 . . . . 0.75 110.009 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.0 p -94.13 167.25 11.69 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.55 -0.719 . . . . 0.91000000000000003 110.452 178.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.51 -26.89 55.91 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.91 . . . . 0.93000000000000005 111.929 179.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -70.61 -27.98 64.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 2.2799999999999998 111.012 -179.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -93.52 -12.82 28.76 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.416 -0.802 . . . . 1.45 112.151 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.3 t -59.54 -47.79 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.487 0.66 . . . . 0.81000000000000005 110.205 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -58.33 -38.27 76.81 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.444 -0.785 . . . . 1.54 110.63 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.28 -38.66 90.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.605 -0.685 . . . . 2.3599999999999999 110.88 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.466 ' CD ' HH21 ' A' ' 42' ' ' ARG . 79.3 mm-40 -60.35 -41.33 93.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.85 -1.156 . . . . 1.3100000000000001 110.503 179.573 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.27 -40.41 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.374 -0.828 . . . . 0.81999999999999995 110.547 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -60.29 -44.91 94.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.128 -0.983 . . . . 1.5 109.882 179.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.466 HH21 ' CD ' ' A' ' 39' ' ' GLU . 67.5 mtm180 -63.42 -41.96 98.71 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.929 -1.109 . . . . 2.23 109.74 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -72.25 -54.5 9.41 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.309 -0.869 . . . . 0.84999999999999998 109.974 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.4 tp -57.79 -48.51 79.48 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.33 -0.948 . . . . 0.91000000000000003 110.051 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t -68.78 -43.92 74.69 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.121 -0.987 . . . . 0.90000000000000002 109.489 179.613 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.45 -35.71 73.59 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.348 -1.501 . . . . 0.68999999999999995 109.348 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' A' ' 47' ' ' ARG . 0.3 OUTLIER -58.62 -33.66 70.28 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.434 1.111 . . . . 2.8799999999999999 108.819 178.71 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.87 -48.21 82.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.035 -0.984 . . . . 0.84999999999999998 110.212 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -79.0 -38.6 36.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 2.3500000000000001 111.261 -179.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.76 86.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.65000000000000002 110.513 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.5 m -61.43 -39.54 91.18 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.042 -1.036 . . . . 1.45 109.893 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.31 92.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.866 -0.521 . . . . 0.63 111.373 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -63.01 -52.16 64.02 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.716 -1.24 . . . . 1.3400000000000001 111.199 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 54' ' ' LEU . 10.8 mp -64.75 -38.22 90.26 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.804 -1.185 . . . . 1.5600000000000001 110.401 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -58.1 -43.33 87.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.737 -0.602 . . . . 1.1899999999999999 110.781 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.5 m -67.74 -44.65 77.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.784 -1.197 . . . . 0.71999999999999997 110.311 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.92 -34.92 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.641 -0.662 . . . . 0.62 110.869 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -50.74 -45.55 58.83 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.297 -0.877 . . . . 1.05 110.743 179.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -69.58 -34.57 74.33 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.129 -0.982 . . . . 0.64000000000000001 110.305 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -62.75 -39.62 94.69 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.834 -1.147 . . . . 1.73 109.686 179.455 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.36 73.93 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.683 -0.635 . . . . 0.56000000000000005 110.427 179.205 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.41 -33.7 21.94 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.8 -1.19 . . . . 0.68999999999999995 111.042 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.44 -24.58 39.5 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.117 -1.225 . . . . 1.48 111.296 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -86.38 -48.84 8.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.374 -0.828 . . . . 0.97999999999999998 111.221 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -107.36 -15.36 14.65 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 113.484 0.92 . . . . 1.1599999999999999 113.484 -177.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.85 151.98 8.92 Favored Glycine 0 N--CA 1.501 3.026 0 O-C-N 121.406 -0.809 . . . . 0.84999999999999998 112.043 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -52.73 -21.22 3.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.53 -0.982 . . . . 3.8599999999999999 112.417 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.27 -29.89 67.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.974 -1.079 . . . . 2.3500000000000001 111.689 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -82.82 -17.42 44.07 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.823 -1.173 . . . . 1.6699999999999999 111.948 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.34 -33.81 72.94 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.419 -0.8 . . . . 1.45 111.109 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.69 -39.97 86.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.086 -1.009 . . . . 0.60999999999999999 110.701 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.2 mt -66.12 -47.54 84.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.401 -0.92 . . . . 0.65000000000000002 109.734 179.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -71.19 -33.41 69.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.339 -0.851 . . . . 0.66000000000000003 110.547 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.88 -38.58 86.14 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.139 -0.976 . . . . 1.1899999999999999 109.854 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.84 95.1 Favored Glycine 0 N--CA 1.483 1.833 0 C-N-CA 120.026 -1.083 . . . . 0.53000000000000003 110.479 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -58.73 -43.0 90.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.026 -1.279 . . . . 1.27 110.362 179.306 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.33 -40.85 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.083 -1.011 . . . . 0.54000000000000004 110.081 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.9 ttm -60.57 -41.99 95.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.438 -0.789 . . . . 1.74 110.081 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.1 tp -60.55 -48.09 83.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.417 -0.802 . . . . 0.55000000000000004 109.995 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.466 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.1 tp -59.83 -39.66 85.87 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.72 0.771 . . . . 0.46999999999999997 110.248 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -87.06 7.6 27.15 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.725 0.639 . . . . 1.4199999999999999 112.725 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -63.49 125.2 23.43 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.833 -1.167 . . . . 1.27 108.762 178.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.49 -16.72 63.94 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.265 -0.897 . . . . 1.3500000000000001 111.096 -179.051 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.37 -50.29 19.22 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.274 -0.97 . . . . 2.2200000000000002 110.623 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.97 -39.72 90.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.379 -0.826 . . . . 0.62 110.631 -179.489 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.84 -48.65 80.84 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.07 -1.019 . . . . 1.29 110.986 179.367 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -62.01 -38.64 89.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 1.52 110.949 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -66.36 -47.98 71.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.899 -1.126 . . . . 1.3 110.319 179.486 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.7 mt -58.33 -46.48 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.968 -1.082 . . . . 0.60999999999999999 109.991 179.381 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.99 -40.94 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.45 -0.781 . . . . 0.78000000000000003 110.354 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.43 -46.93 88.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -0.771 . . . . 0.81999999999999995 111.033 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.8 -42.98 94.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.087 -1.008 . . . . 0.80000000000000004 110.511 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.8 mt -61.84 -46.77 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.982 . . . . 0.77000000000000002 110.029 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -82.14 -37.87 25.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 2.1200000000000001 111.82 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 91' ' ' ALA . 56.3 t0 -81.58 -45.74 15.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.696 -1.253 . . . . 1.51 111.994 -178.681 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -100.01 8.81 43.74 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.991 -1.068 . . . . 1.98 112.61 -178.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.0 m170 50.88 50.21 19.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.959 -1.088 . . . . 1.3200000000000001 111.816 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.9 mtt -107.72 151.45 25.67 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.442 -0.786 . . . . 1.3799999999999999 109.734 179.486 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.5 p -70.43 163.34 26.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.729 -0.607 . . . . 0.67000000000000004 109.97 178.351 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.79 -42.29 88.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.933 . . . . 0.52000000000000002 110.698 178.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.518 ' OD2' HD21 ' A' ' 142' ' ' LEU . 84.3 m-20 -67.93 -41.43 82.6 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.042 -1.036 . . . . 2.25 110.205 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.22 -50.87 51.21 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.634 -0.666 . . . . 0.64000000000000001 111.344 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.71 94.89 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.033 -1.042 . . . . 0.56000000000000005 110.314 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -43.74 95.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 0.46000000000000002 110.669 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -61.28 -39.75 91.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 1.3200000000000001 111.309 -179.481 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -57.63 -49.84 75.12 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.852 -1.155 . . . . 1.3 110.795 179.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.14 -46.06 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.047 -1.033 . . . . 0.60999999999999999 109.974 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -64.93 -31.96 56.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.871 -0.518 . . . . 0.65000000000000002 110.418 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.21 -41.0 71.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.181 -0.949 . . . . 2.1099999999999999 110.7 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.01 -30.93 18.97 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 119.142 -1.504 . . . . 0.82999999999999996 112.452 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -61.21 -39.69 91.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.516 -1.579 . . . . 1.28 109.903 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.14 -48.91 40.07 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.323 0.582 . . . . 0.89000000000000001 110.755 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.8 t -60.05 -40.34 89.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.319 -0.863 . . . . 1.8700000000000001 110.433 -178.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.07 99.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.382 -0.824 . . . . 1.05 110.745 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.55 -30.11 70.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.814 -1.179 . . . . 1.02 110.733 -179.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -66.24 -20.14 66.03 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.78 -1.2 . . . . 2.04 111.039 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.37 -18.77 63.06 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.351 -0.94 . . . . 1.73 110.827 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 15.0 mt -88.88 136.49 32.98 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.843 -1.169 . . . . 1.3700000000000001 107.843 178.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -100.59 42.92 1.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.272 -0.893 . . . . 2.8799999999999999 111.272 -179.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -111.85 142.31 44.39 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.164 -0.96 . . . . 1.5800000000000001 109.456 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -58.8 -39.27 80.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.228 -0.92 . . . . 3.04 110.797 178.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -71.87 -50.58 28.19 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.851 -1.156 . . . . 0.90000000000000002 109.875 179.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt -67.5 -43.28 81.28 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.386 -0.821 . . . . 1.0600000000000001 110.118 -178.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -61.25 -47.87 84.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.16 -0.962 . . . . 2.1800000000000002 109.787 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.91 -30.92 69.36 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.505 -0.878 . . . . 2.1499999999999999 109.635 179.594 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 130' ' ' VAL . 57.0 ttt180 -61.68 -30.43 70.73 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.092 0.949 . . . . 2.3300000000000001 108.696 179.289 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -49.86 74.56 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.071 0.939 . . . . 0.81999999999999995 109.537 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.65 -43.34 80.52 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.598 0.713 . . . . 0.84999999999999998 110.078 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -63.21 -33.51 75.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.623 -0.673 . . . . 1.3899999999999999 110.573 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 126' ' ' ARG . 21.9 t -70.0 -39.28 77.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.472 -0.767 . . . . 0.56000000000000005 110.105 179.561 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -59.26 -39.92 84.39 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.822 -1.151 . . . . 3.1200000000000001 109.752 178.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.441 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 51.3 t0 -60.12 -40.8 90.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.588 -0.695 . . . . 1.28 110.059 179.437 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.7 mt -61.77 -39.07 82.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.062 -1.023 . . . . 0.48999999999999999 110.116 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.35 -46.51 20.18 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.655 -1.259 . . . . 0.46000000000000002 110.486 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -56.62 -41.63 77.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.559 -0.965 . . . . 2.71 110.079 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 136' ' ' ARG . 40.7 mtt-85 -60.19 -41.52 93.11 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.003 -1.061 . . . . 2.1400000000000001 109.832 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.9 tp -60.22 -42.78 95.9 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.318 -0.953 . . . . 1.05 109.358 179.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.4 mt -59.84 -47.31 86.24 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.828 -0.545 . . . . 0.52000000000000002 109.949 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -59.88 -35.4 74.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 2.3500000000000001 111.017 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -73.99 -41.5 61.81 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.026 -1.046 . . . . 1.3899999999999999 110.684 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.57 -38.89 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -0.925 . . . . 0.68000000000000005 110.462 -178.388 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.518 HD21 ' OD2' ' A' ' 101' ' ' ASP . 89.7 mt -89.07 -6.96 56.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.093 -1.004 . . . . 0.82999999999999996 112.099 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.47 30.0 67.31 Favored Glycine 0 N--CA 1.482 1.746 0 C-N-CA 120.065 -1.064 . . . . 0.91000000000000003 112.075 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.94 148.23 44.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.686 -0.891 . . . . 0.94999999999999996 109.844 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -68.01 141.29 56.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 2.4300000000000002 109.27 178.095 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.91 131.5 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.202 -1.036 . . . . 1.1000000000000001 108.202 178.463 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.775 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.1 mp -77.02 131.02 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.408 -0.808 . . . . 1.5800000000000001 108.928 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.9 97.93 11.27 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.466 -1.679 . . . . 1.6200000000000001 106.466 178.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.57 ' O ' HD13 ' A' ' 152' ' ' ILE . 77.2 mt -78.84 -6.0 54.91 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 112.72 0.637 . . . . 0.80000000000000004 112.72 -177.855 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.8 p -88.85 -2.59 58.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.903 -1.123 . . . . 1.5600000000000001 112.745 -179.123 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -106.17 36.68 2.5 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.147 -0.97 . . . . 0.83999999999999997 112.414 -177.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.616 ' N ' HD12 ' A' ' 152' ' ' ILE . 1.5 mp -72.72 139.89 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.575 -1.328 . . . . 0.81999999999999995 109.406 178.493 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -118.86 -16.73 9.25 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.706 0.765 . . . . 2.3100000000000001 112.408 -179.097 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -116.03 138.47 51.19 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.771 -1.196 . . . . 1.54 107.771 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -76.12 121.39 22.75 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.284 -1.006 . . . . 1.3799999999999999 108.284 178.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 m -146.28 174.03 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.493 -0.755 . . . . 0.68999999999999995 109.144 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.7 mt -87.89 140.76 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.53000000000000003 109.143 178.02 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 42.5 tp -94.8 124.15 38.67 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.98 -1.075 . . . . 0.64000000000000001 108.183 178.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.97 129.18 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 107.604 -1.258 . . . . 0.67000000000000004 107.604 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.36 153.98 22.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 0.78000000000000003 108.943 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.65 -34.38 76.96 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.607 -1.308 . . . . 1.0 109.213 178.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -173.8 149.77 1.6 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.236 -0.653 . . . . 2.4199999999999999 109.236 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 58.9 mt -116.03 136.32 53.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.601 -1.259 . . . . 0.75 107.601 177.337 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.9 p -92.2 150.15 39.8 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.164 -0.96 . . . . 0.78000000000000003 108.786 179.069 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -39.49 -44.38 3.09 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.886 1.724 . . . . 0.67000000000000004 113.441 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.8 m -58.92 -50.06 75.47 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.835 -1.166 . . . . 0.69999999999999996 111.014 -179.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -62.99 -40.07 96.66 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.253 -0.904 . . . . 1.21 110.212 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 73.0 p -68.58 -39.2 81.07 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.334 -0.854 . . . . 0.59999999999999998 110.327 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.5 78.17 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.595 -0.842 . . . . 0.62 110.638 179.268 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -94.88 -2.37 50.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.111 -0.993 . . . . 1.1599999999999999 113.226 -179.014 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.94 149.94 46.14 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.904 -1.123 . . . . 0.72999999999999998 109.14 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.453 ' O ' HG23 ' A' ' 176' ' ' VAL . 57.5 t-20 -95.63 104.63 16.55 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.056 -1.831 . . . . 2.2400000000000002 106.056 177.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.609 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.6 mp -72.2 -18.3 61.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 1.4299999999999999 112.054 -177.57 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -77.97 -27.45 49.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.203 -0.936 . . . . 2.1499999999999999 111.45 -178.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -100.11 6.07 44.91 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.284 -0.885 . . . . 2.04 112.362 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 178' ' ' GLY . 91.5 t -109.75 129.84 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.962 -1.125 . . . . 0.55000000000000004 107.962 179.683 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 48.9 tp -81.85 -15.47 53.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.815 . . . . 1.6299999999999999 112.288 -179.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.525 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 173.29 179.91 44.27 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.472 -1.451 . . . . 0.46999999999999997 109.472 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -131.68 138.24 48.63 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.533 -1.284 . . . . 0.54000000000000004 107.533 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.9 mt -138.21 119.03 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.424 -1.695 . . . . 0.68999999999999995 106.424 178.524 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 203' ' ' VAL . 60.0 p -132.1 164.53 26.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.087 -1.008 . . . . 0.81999999999999995 108.952 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.527 ' OD2' ' N ' ' A' ' 208' ' ' VAL . 1.9 m-20 -104.82 15.98 26.83 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.577 -0.702 . . . . 2.3700000000000001 112.329 179.047 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -134.12 -51.17 0.82 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 120.808 -1.182 . . . . 1.1100000000000001 114.0 -177.712 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.54 153.74 0.29 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.199 -1.0 . . . . 1.6699999999999999 110.84 -176.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 152.65 -61.31 0.39 Allowed Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.156 -1.021 . . . . 1.54 112.295 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.83 77.37 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.061 -1.258 . . . . 4.4800000000000004 109.023 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.6 p 53.67 40.75 31.86 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.672 -0.811 . . . . 2.6299999999999999 111.596 -178.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 38.5 t -79.74 153.99 28.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.816 . . . . 1.6899999999999999 109.559 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -59.0 -39.91 83.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.859 . . . . 1.0700000000000001 110.893 178.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 33.6 p -56.42 -40.89 75.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 1.5800000000000001 110.732 179.417 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 82.2 p -62.3 -37.95 87.49 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.066 -1.021 . . . . 1.6000000000000001 110.485 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.83 -38.7 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.383 -0.823 . . . . 1.45 110.73 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.7 mtp -61.75 -44.86 96.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.84 -1.162 . . . . 1.05 108.905 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.95 -48.6 81.05 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.116 -0.947 . . . . 0.71999999999999997 111.029 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 195' ' ' ARG . 23.7 mtt-85 -60.81 -43.48 98.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.099 -1.001 . . . . 3.0499999999999998 110.751 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 41.5 m -69.88 -41.04 75.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.443 -0.786 . . . . 0.89000000000000001 110.306 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 13.3 mt -91.75 -6.84 51.19 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.623 0.725 . . . . 0.78000000000000003 112.284 -178.221 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.5 mt-10 45.52 18.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.529 0.937 . . . . 1.45 113.529 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 18.6 mt -71.84 142.25 85.45 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.953 -1.092 . . . . 0.67000000000000004 108.372 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -56.24 130.36 39.75 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.678 1.585 . . . . 0.64000000000000001 110.357 178.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.05 175.88 9.05 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 117.911 -1.516 . . . . 0.67000000000000004 111.517 179.555 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.2 mt -146.63 157.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.632 -1.247 . . . . 0.68999999999999995 107.632 178.467 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 183' ' ' ALA . 4.6 m -141.8 -23.62 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 120.818 -1.176 . . . . 0.84999999999999998 113.286 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -104.25 42.3 1.93 Allowed Glycine 0 N--CA 1.503 3.136 0 N-CA-C 110.637 -0.985 . . . . 0.92000000000000004 110.637 -178.563 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 36.3 p -59.86 -20.76 58.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.056 -1.261 . . . . 0.94999999999999996 111.841 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.22 -85.37 0.61 Allowed Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.18 -1.01 . . . . 1.04 111.437 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 58.8 p -134.66 32.11 3.32 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 121.008 -1.29 . . . . 1.5700000000000001 113.331 -178.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.527 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 60.2 t -58.84 -34.15 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.223 -1.548 . . . . 0.83999999999999997 111.076 179.451 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 43.8 p -64.12 -21.73 66.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.835 -1.165 . . . . 0.98999999999999999 112.199 -179.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 53.8 p -96.32 3.16 53.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.943 -1.098 . . . . 1.7 112.339 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -129.76 4.12 4.98 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.684 -0.635 . . . . 2.2000000000000002 112.691 -178.567 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.1 t -123.04 152.92 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.404 -0.81 . . . . 0.83999999999999997 109.768 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -118.48 156.76 28.51 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.096 -1.076 . . . . 2.2000000000000002 108.096 178.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.513 ' ND2' ' OD1' ' A' ' 215' ' ' ASP . 46.7 t30 -54.8 139.97 37.89 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.052 -1.03 . . . . 2.2799999999999998 110.119 178.257 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.513 ' OD1' ' ND2' ' A' ' 214' ' ' ASN . 1.2 m-20 79.56 5.36 2.06 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.281 1.215 . . . . 2.3500000000000001 114.281 179.58 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -63.39 148.63 47.93 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.385 -0.969 . . . . 1.97 108.385 177.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -89.64 119.96 30.51 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.583 -1.636 . . . . 2.6499999999999999 106.583 178.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.416 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 86.7 mt -128.26 146.36 50.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.585 -0.697 . . . . 0.63 109.86 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 47.0 mt -112.13 124.19 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.691 -1.596 . . . . 0.62 106.691 177.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.0 tp -97.21 111.58 23.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.981 -1.859 . . . . 0.64000000000000001 105.981 178.117 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.6 t0 -89.72 -28.95 19.07 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.718 -1.239 . . . . 2.0499999999999998 111.549 -178.423 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.81 10.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 113.285 0.846 . . . . 0.83999999999999997 113.285 -179.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.625 ' N ' ' O ' ' A' ' 221' ' ' ASP . 39.3 t -110.57 -56.44 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.987 -1.071 . . . . 1.02 109.173 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -92.57 8.87 37.04 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.297 1.046 . . . . 2.5099999999999998 110.271 -179.097 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 60.51 49.97 6.25 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.026 -0.988 . . . . 1.54 111.632 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -148.47 149.55 31.86 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.608 1.194 . . . . 1.95 109.93 178.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.66 135.03 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.653 -1.239 . . . . 0.70999999999999996 107.653 177.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -100.5 130.26 46.55 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.968 -1.123 . . . . 1.01 107.968 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.31 130.01 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.784 -0.821 . . . . 0.81999999999999995 108.784 179.094 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.412 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 0.7 OUTLIER 49.93 50.59 9.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 113.426 0.898 . . . . 1.54 113.426 178.763 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.7 Cg_endo -69.02 150.29 72.56 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.366 2.044 . . . . 0.93999999999999995 110.701 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.1 p -73.83 160.29 31.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 1.8 109.821 178.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.72 -36.61 72.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.486 -0.759 . . . . 2.73 111.105 179.021 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -59.59 -41.22 89.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 3.1699999999999999 110.122 179.321 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -71.39 -40.24 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.47 -0.769 . . . . 1.3400000000000001 110.115 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.606 ' CG2' HH12 ' A' ' 240' ' ' ARG . 87.6 mt -60.53 -47.02 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.391 -0.818 . . . . 1.2 110.322 -178.549 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.12 -39.86 87.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.047 -1.033 . . . . 2.7000000000000002 110.303 179.591 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -60.61 -40.96 93.78 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.558 -0.713 . . . . 2.5899999999999999 110.063 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 72.8 mtp -72.15 -38.32 69.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.041 -1.037 . . . . 1.3799999999999999 110.94 -179.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.606 HH12 ' CG2' ' A' ' 236' ' ' ILE . 0.0 OUTLIER -57.45 -42.16 81.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.128 -0.982 . . . . 2.8399999999999999 110.891 179.946 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.54 -50.41 21.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 1.8799999999999999 110.585 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 90.1 t -63.89 -46.69 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.343 -0.848 . . . . 2.3999999999999999 110.934 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.78 -51.48 69.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.075 -1.015 . . . . 3.52 111.318 -179.716 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -62.58 -33.7 75.48 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.124 -0.985 . . . . 1.8799999999999999 110.363 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -61.12 -30.27 70.27 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.992 -1.083 . . . . 3.0099999999999998 109.641 179.129 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.46 -40.71 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.894 -0.723 . . . . 2.4500000000000002 109.949 179.342 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.79 87.78 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.583 -0.847 . . . . 2.75 110.181 179.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.2 p -71.77 -44.67 63.62 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.294 -0.879 . . . . 3.1600000000000001 110.91 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -63.48 -32.54 74.02 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.656 -0.652 . . . . 3.5699999999999998 110.661 -177.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -67.8 -28.76 67.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -0.952 . . . . 4.2999999999999998 111.007 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.81 98.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 4.4500000000000002 110.106 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -70.15 -37.7 75.31 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.322 -0.861 . . . . 5.9699999999999998 110.303 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 35.0 tp -69.3 -26.41 64.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.617 -0.677 . . . . 6.1799999999999997 111.302 -179.407 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -69.17 -6.76 30.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.377 -0.827 . . . . 6.6600000000000001 113.17 -179.56 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -69.67 -30.71 68.45 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.035 -1.041 . . . . 8.1999999999999993 110.917 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 86.2 mt -87.13 -10.89 51.65 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.942 -1.099 . . . . 8.0700000000000003 112.607 -179.52 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -93.52 33.8 1.23 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.984 -1.073 . . . . 9.4499999999999993 112.297 -178.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -88.88 2.92 52.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.938 -1.101 . . . . 10.119999999999999 112.353 179.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.977 -1.011 . . . . 11.49 108.936 179.998 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.218 -0.66 . . . . 3.0699999999999998 109.218 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.1 mt -99.24 109.7 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 106.41 -1.7 . . . . 1.0700000000000001 106.41 177.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -105.02 120.52 41.68 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.744 -1.206 . . . . 1.24 107.744 -179.418 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.6 -160.37 26.9 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.179 -1.568 . . . . 1.01 109.179 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 5' ' ' ILE . 74.9 mt -96.05 -0.18 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.419 -1.047 . . . . 1.1100000000000001 112.343 -179.295 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.7 tp 49.24 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.98999999999999999 112.656 178.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.76 -43.55 11.8 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.933 -1.105 . . . . 0.84999999999999998 111.562 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -141.33 143.51 30.62 Favored Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 107.72 -1.215 . . . . 1.3799999999999999 107.72 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.32 146.55 22.28 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.616 2.211 . . . . 0.93999999999999995 112.634 178.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.896 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.39 177.98 27.46 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 108.866 -1.694 . . . . 0.81000000000000005 108.866 177.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.9 mt -134.67 140.04 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.041 -1.27 . . . . 0.82999999999999996 108.345 179.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.54 ' HB1' HD22 ' A' ' 177' ' ' LEU . . . -144.94 158.03 43.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -0.984 . . . . 0.53000000000000003 109.451 178.177 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 11.5 m-85 -127.75 140.54 52.0 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.769 -1.197 . . . . 0.77000000000000002 107.769 178.223 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.23 166.02 34.41 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 118.38 -1.867 . . . . 0.51000000000000001 110.411 178.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -78.11 158.08 29.25 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.402 -0.962 . . . . 1.8999999999999999 108.402 178.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.16 130.96 35.15 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.743 -0.836 . . . . 0.66000000000000003 108.743 178.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.2 tp -113.35 103.78 11.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 105.604 -1.998 . . . . 0.82999999999999996 105.604 178.113 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.482 ' O ' ' ND2' ' A' ' 214' ' ' ASN . 13.8 tp -91.84 139.05 31.04 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.66 -0.867 . . . . 0.85999999999999999 108.66 -179.575 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.2 mt -99.39 120.9 40.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.293 -1.373 . . . . 0.92000000000000004 107.293 178.318 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -111.12 138.96 46.9 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.995 -1.113 . . . . 2.0299999999999998 107.995 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -119.78 140.29 50.98 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.172 -0.955 . . . . 2.6600000000000001 109.245 178.446 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -85.02 133.36 34.25 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.727 -1.212 . . . . 2.3199999999999998 107.727 177.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -60.74 149.1 36.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.07 -1.019 . . . . 2.1099999999999999 108.732 178.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.8 mt -96.99 134.17 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.027 -1.046 . . . . 0.72999999999999998 108.263 178.325 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.74 129.67 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.586 -1.264 . . . . 0.87 107.586 178.531 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.0 mt -100.62 137.74 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.145 -1.058 . . . . 0.81000000000000005 108.145 179.546 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -94.33 120.74 35.01 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.324 -0.991 . . . . 1.3400000000000001 108.324 178.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -94.55 15.13 18.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.393 -0.817 . . . . 2.8900000000000001 112.805 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.98 147.31 53.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.382 -0.824 . . . . 2.0899999999999999 109.264 178.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -88.1 139.42 30.52 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.618 -0.882 . . . . 2.1899999999999999 108.618 177.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 pt -99.77 164.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.857 -1.152 . . . . 0.75 109.912 179.088 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.0 p -93.87 165.95 12.42 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.386 -0.821 . . . . 0.91000000000000003 109.698 178.472 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -21.24 14.4 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.4 -0.812 . . . . 0.93000000000000005 112.154 179.242 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -68.15 -39.1 82.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.063 -1.023 . . . . 2.2799999999999998 110.873 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -91.02 -7.4 52.01 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.814 -1.179 . . . . 1.45 112.744 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.22 -47.44 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.526 -1.358 . . . . 0.81000000000000005 110.788 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -59.24 -39.15 81.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.124 -0.985 . . . . 1.54 109.972 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -61.36 -37.92 85.1 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.705 -0.798 . . . . 2.3599999999999999 110.825 179.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -59.91 -40.86 90.25 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.17 -1.012 . . . . 1.3100000000000001 110.639 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.24 -41.77 88.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.165 -0.959 . . . . 0.81999999999999995 110.504 179.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -62.73 -41.39 99.15 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.78 -1.2 . . . . 1.5 110.358 179.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -61.05 -41.08 95.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 2.23 110.616 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -75.37 -54.11 7.6 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.844 -1.16 . . . . 0.84999999999999998 110.463 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.2 tp -57.55 -47.8 81.07 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.721 0.772 . . . . 0.91000000000000003 110.674 -179.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.519 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.0 t -69.06 -40.05 78.75 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.833 0.825 . . . . 0.90000000000000002 110.346 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.91 -44.6 92.44 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 109.811 -1.316 . . . . 0.68999999999999995 109.811 179.298 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -60.67 -28.91 68.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.779 -0.836 . . . . 2.8799999999999999 110.251 179.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.5 -49.34 77.7 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.834 0.826 . . . . 0.84999999999999998 110.604 179.072 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -81.77 -38.62 25.37 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.337 -0.852 . . . . 2.3500000000000001 110.668 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.6 -42.36 92.42 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.614 -0.834 . . . . 0.65000000000000002 109.925 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 m -62.08 -39.92 94.06 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.985 0.898 . . . . 1.45 109.582 179.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.45 88.83 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.723 -0.791 . . . . 0.63 109.879 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.52 -50.44 69.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.99 -1.069 . . . . 1.3400000000000001 109.998 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.45 -40.33 94.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.941 -1.1 . . . . 1.5600000000000001 109.832 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -59.33 -39.89 84.55 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.393 -0.817 . . . . 1.1899999999999999 110.226 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -62.91 -43.41 98.87 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.388 -0.82 . . . . 0.71999999999999997 110.277 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.23 -34.43 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.078 -1.014 . . . . 0.62 110.279 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -53.3 -45.55 69.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.45 -0.781 . . . . 1.05 110.877 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -68.87 -39.93 79.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.206 -0.934 . . . . 0.64000000000000001 109.778 -179.708 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -61.78 -37.58 84.87 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.128 -1.029 . . . . 1.73 109.139 179.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.95 79.44 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.308 -0.557 . . . . 0.56000000000000005 110.193 179.197 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.82 -35.21 16.65 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.8 -1.191 . . . . 0.68999999999999995 111.267 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -79.9 -25.7 40.48 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.956 -1.32 . . . . 1.48 110.709 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.2 m -86.93 -50.97 6.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.729 -0.607 . . . . 0.97999999999999998 110.287 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -105.92 -6.14 19.1 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 114.079 1.14 . . . . 1.1599999999999999 114.079 -177.412 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.57 164.3 27.22 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 120.228 -0.986 . . . . 0.84999999999999998 112.447 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -56.38 -23.24 36.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.852 -0.793 . . . . 3.8599999999999999 112.645 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -57.9 -39.0 76.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.356 -1.465 . . . . 2.3500000000000001 110.515 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -86.99 -25.27 24.36 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.216 -0.928 . . . . 1.6699999999999999 111.746 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.42 -39.97 85.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.219 -0.925 . . . . 1.45 110.776 -179.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.21 84.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.496 -0.752 . . . . 0.60999999999999999 111.286 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.2 mt -65.41 -44.75 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.622 -1.299 . . . . 0.65000000000000002 110.649 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -69.87 -31.55 69.44 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.841 -1.162 . . . . 0.66000000000000003 110.698 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -59.98 -39.33 85.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.064 -1.023 . . . . 1.1899999999999999 110.94 179.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.93 -40.36 93.48 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.535 -1.317 . . . . 0.53000000000000003 110.863 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -59.35 -40.78 87.5 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.084 -1.245 . . . . 1.27 110.616 179.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.7 mt -60.82 -37.55 76.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.202 -0.936 . . . . 0.54000000000000004 110.497 179.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 26.3 ttt -58.64 -38.89 79.07 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.703 -0.799 . . . . 1.74 110.449 179.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.05 -49.43 77.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.949 -1.094 . . . . 0.55000000000000004 110.879 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.6 tp -61.35 -38.81 88.3 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.21 -0.931 . . . . 0.46999999999999997 110.252 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -86.34 7.65 24.68 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.175 0.806 . . . . 1.4199999999999999 113.175 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -67.43 116.16 7.87 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 120.793 -1.192 . . . . 1.27 108.655 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -64.37 -20.23 65.99 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.626 0.727 . . . . 1.3500000000000001 110.946 -179.226 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -71.64 -47.98 50.85 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.991 -1.083 . . . . 2.2200000000000002 110.364 179.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.32 -38.4 89.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.395 -0.816 . . . . 0.62 110.521 -178.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -59.54 -41.76 90.81 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.008 -1.058 . . . . 1.29 110.515 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.17 -39.23 85.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.941 -1.099 . . . . 1.52 110.582 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -66.62 -48.06 70.65 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.106 -1.037 . . . . 1.3 110.448 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.59 -43.48 83.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.936 -1.102 . . . . 0.60999999999999999 110.01 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.73 -44.04 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 0.78000000000000003 110.685 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.74 -40.89 96.69 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.247 -0.908 . . . . 0.81999999999999995 110.856 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.0 mt -60.39 -44.77 95.34 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.496 -1.377 . . . . 0.80000000000000004 110.418 -179.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.64 -47.64 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.907 -1.121 . . . . 0.77000000000000002 110.812 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -79.75 -35.48 38.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.004 -1.06 . . . . 2.1200000000000001 111.665 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.78 -43.34 22.67 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.02 -1.05 . . . . 1.51 111.312 -179.001 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -101.13 4.55 42.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.047 -1.033 . . . . 1.98 112.251 -177.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.1 m80 51.48 49.35 21.13 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.238 -0.914 . . . . 1.3200000000000001 111.646 -179.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 70.3 mtm -110.04 157.89 18.85 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.494 -0.754 . . . . 1.3799999999999999 109.558 178.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.8 p -71.51 162.46 29.41 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.296 0.569 . . . . 0.67000000000000004 110.403 178.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.67 -41.11 97.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.53 -0.731 . . . . 0.52000000000000002 110.827 179.149 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 31.8 p-10 -69.59 -38.59 77.39 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.196 -0.94 . . . . 2.25 109.978 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.527 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -71.27 -52.89 16.43 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.831 -1.148 . . . . 0.64000000000000001 110.872 179.363 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.25 88.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.56000000000000005 110.604 -179.349 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.25 93.46 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.026 -0.67 . . . . 0.46000000000000002 110.878 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -59.76 -41.31 90.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.843 -1.16 . . . . 1.3200000000000001 111.039 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -56.14 -47.57 77.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.235 -1.54 . . . . 1.3 110.73 179.658 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.53 -44.18 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.548 -1.345 . . . . 0.60999999999999999 110.22 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.79 -32.31 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.282 -0.886 . . . . 0.65000000000000002 110.071 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.22 -39.93 92.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.12 -0.987 . . . . 2.1099999999999999 111.022 179.308 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.9 -30.4 29.11 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.079 -1.534 . . . . 0.82999999999999996 112.795 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -60.57 -39.68 88.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 119.675 -2.073 . . . . 1.28 109.858 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.53 -48.04 43.45 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.638 0.733 . . . . 0.89000000000000001 109.696 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.3 p -60.81 -39.73 90.04 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.704 -0.798 . . . . 1.8700000000000001 110.063 -178.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.24 -46.45 89.74 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.954 -1.091 . . . . 1.05 110.821 179.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.3 mt -65.44 -29.54 70.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.699 -1.25 . . . . 1.02 111.09 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -64.31 -21.39 66.59 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.975 -1.078 . . . . 2.04 111.426 179.549 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -71.83 -15.51 62.14 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.763 0.792 . . . . 1.73 110.923 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.509 HD13 HD13 ' A' ' 123' ' ' LEU . 36.8 mt -86.9 141.55 28.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.953 -0.758 . . . . 1.3700000000000001 108.953 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -97.56 41.58 1.12 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.987 -1.071 . . . . 2.8799999999999999 111.853 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -114.48 140.88 48.37 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.305 -0.872 . . . . 1.5800000000000001 109.391 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -59.05 -39.39 81.89 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.338 -0.851 . . . . 3.04 111.515 178.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -72.68 -53.01 12.91 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 0.90000000000000002 110.313 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.509 HD13 HD13 ' A' ' 118' ' ' LEU . 26.4 mt -61.42 -41.32 96.97 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.107 -0.995 . . . . 1.0600000000000001 110.394 -179.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -63.16 -49.05 75.85 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.276 1.036 . . . . 2.1800000000000002 109.563 179.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -63.2 -29.93 71.18 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.092 -1.043 . . . . 2.1499999999999999 109.968 179.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 130' ' ' VAL . 15.2 ttt-85 -60.82 -30.47 70.1 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.741 0.782 . . . . 2.3300000000000001 108.951 178.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.25 87.28 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.155 0.979 . . . . 0.81999999999999995 109.001 178.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -43.65 80.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.739 -0.784 . . . . 0.84999999999999998 109.981 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -64.57 -33.17 75.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.492 -0.755 . . . . 1.3899999999999999 110.616 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 126' ' ' ARG . 24.5 t -68.19 -39.63 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 0.56000000000000005 109.834 179.377 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -58.91 -39.67 82.22 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.087 -1.045 . . . . 3.1200000000000001 109.896 178.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -59.35 -38.86 81.48 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.21 -0.45 . . . . 1.28 110.544 179.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 54.1 mt -60.72 -40.29 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.673 -1.267 . . . . 0.48999999999999999 110.116 179.496 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.19 -36.65 60.01 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.395 -1.082 . . . . 0.46000000000000002 110.395 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -56.63 -48.65 77.05 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.547 -0.972 . . . . 2.71 110.66 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -63.38 -41.03 98.77 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.013 -1.075 . . . . 2.1400000000000001 110.169 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.9 tp -59.76 -40.37 87.94 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.69 -0.631 . . . . 1.05 110.301 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.2 mt -59.24 -44.3 92.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.094 -1.004 . . . . 0.52000000000000002 110.463 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -60.62 -33.24 72.48 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.146 -0.971 . . . . 2.3500000000000001 111.181 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -75.74 -41.4 53.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.909 -1.119 . . . . 1.3899999999999999 110.867 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.1 mt -60.14 -38.6 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.969 -1.082 . . . . 0.68000000000000005 110.571 -178.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.0 mt -85.35 -7.11 59.14 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.457 -0.777 . . . . 0.82999999999999996 111.764 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.81 16.42 80.78 Favored Glycine 0 N--CA 1.483 1.82 0 C-N-CA 120.319 -0.943 . . . . 0.91000000000000003 112.454 -179.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.27 149.28 48.37 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.769 -0.842 . . . . 0.94999999999999996 109.688 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -65.66 150.83 47.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.528 -0.732 . . . . 2.4300000000000002 109.695 178.259 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.2 mt -104.02 138.43 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.177 -0.952 . . . . 1.1000000000000001 108.711 178.602 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 mp -82.72 118.84 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.439 -1.319 . . . . 1.5800000000000001 107.439 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -100.81 102.62 13.74 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.965 -1.865 . . . . 1.6200000000000001 105.965 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 70.1 mt -74.86 -14.79 60.71 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.563 -0.855 . . . . 0.80000000000000004 111.505 -178.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.2 m -80.09 2.41 24.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.414 -0.804 . . . . 1.5600000000000001 112.852 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -93.94 21.17 6.92 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.67 0.747 . . . . 0.83999999999999997 112.325 -179.226 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.2 mt -73.15 140.22 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.811 -0.556 . . . . 0.81999999999999995 109.672 179.57 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -117.46 -16.37 10.21 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.224 1.011 . . . . 2.3100000000000001 112.468 -178.715 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -118.03 139.39 51.27 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.288 -1.004 . . . . 1.54 108.288 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -70.87 128.7 36.89 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.826 -1.171 . . . . 1.3799999999999999 108.294 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.1 m -146.57 175.42 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.92 -0.77 . . . . 0.68999999999999995 108.92 -179.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.28 140.65 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.884 -1.135 . . . . 0.53000000000000003 108.757 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.6 tp -96.66 123.36 40.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.807 -1.183 . . . . 0.64000000000000001 108.626 178.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.23 130.7 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.431 -0.951 . . . . 0.67000000000000004 108.431 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 152.01 16.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -0.86 . . . . 0.78000000000000003 109.157 178.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.42 -34.19 74.97 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.897 -1.127 . . . . 1.0 109.344 178.055 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -171.53 153.06 3.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.77 -0.826 . . . . 2.4199999999999999 108.77 179.455 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 68.9 mt -118.95 142.86 47.4 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.437 -0.79 . . . . 0.75 109.214 177.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.4 p -91.81 146.91 33.91 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.275 -0.89 . . . . 0.78000000000000003 109.071 179.185 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -41.15 -39.23 3.6 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.464 1.443 . . . . 0.67000000000000004 113.537 178.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.1 m -61.37 -50.17 73.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.764 -1.21 . . . . 0.69999999999999996 110.208 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.22 -39.13 93.76 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.41 0.624 . . . . 1.21 110.327 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 56.5 p -68.44 -40.03 81.31 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.285 -0.884 . . . . 0.59999999999999998 110.678 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.78 84.05 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.123 -0.985 . . . . 0.62 110.338 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -94.32 1.85 55.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.791 -1.193 . . . . 1.1599999999999999 112.991 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.7 149.6 34.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.0 -1.063 . . . . 0.72999999999999998 109.037 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.02 116.62 29.23 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.621 -1.622 . . . . 2.2400000000000002 106.621 177.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.3 mt -75.66 -13.67 60.33 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.353 0.597 . . . . 1.4299999999999999 111.717 -177.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -85.76 -22.16 27.86 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.319 0.581 . . . . 2.1499999999999999 112.072 -179.118 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -102.73 -2.41 28.2 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.884 0.698 . . . . 2.04 112.884 -178.165 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.7 t -112.15 130.04 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 107.65 -1.241 . . . . 0.55000000000000004 107.65 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.71 ' O ' HD23 ' A' ' 177' ' ' LEU . 1.7 tt -92.96 -11.11 34.09 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.239 1.019 . . . . 1.6299999999999999 111.735 -179.208 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.89 173.67 42.66 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 109.537 -1.425 . . . . 0.46999999999999997 109.537 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.8 OUTLIER -126.2 132.49 51.75 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.992 -1.299 . . . . 0.54000000000000004 107.61 179.17 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.452 HG22 HG21 ' A' ' 205' ' ' THR . 75.0 mt -132.48 106.86 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 106.133 -1.803 . . . . 0.68999999999999995 106.133 178.366 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.563 ' O ' HG23 ' A' ' 205' ' ' THR . 71.7 p -129.31 170.21 13.9 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 120.497 -1.377 . . . . 0.81999999999999995 110.018 -178.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 20.9 p-10 -99.01 53.23 0.97 Allowed 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 120.118 -0.633 . . . . 2.3700000000000001 110.881 179.433 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.33 156.14 17.78 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 108.887 -0.783 . . . . 1.1100000000000001 108.887 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.59 -3.39 58.45 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.431 -1.366 . . . . 1.6699999999999999 112.821 179.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 77.2 -40.22 1.7 Allowed Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.444 -1.36 . . . . 1.54 113.967 179.624 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.49 HH11 ' HG2' ' A' ' 186' ' ' ARG . 14.5 ttt-85 -61.31 127.06 29.69 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.996 -1.297 . . . . 4.4800000000000004 109.019 179.037 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 10.5 p 46.38 28.94 0.78 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -0.859 . . . . 2.6299999999999999 112.245 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 42.4 t -83.07 130.04 35.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.922 -1.111 . . . . 1.6899999999999999 108.089 178.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -59.37 -40.74 87.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -0.925 . . . . 1.0700000000000001 110.625 179.295 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -61.28 -40.72 95.2 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.631 -1.293 . . . . 1.5800000000000001 110.258 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 91.6 p -60.81 -36.16 78.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.231 -0.918 . . . . 1.6000000000000001 110.455 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.84 -38.29 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.191 -0.943 . . . . 1.45 110.186 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 67.1 mtp -63.18 -41.85 99.28 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.09 -1.006 . . . . 1.05 109.639 179.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.06 -47.13 86.35 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.491 0.662 . . . . 0.71999999999999997 111.14 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -59.99 -42.6 94.58 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.065 -1.022 . . . . 3.0499999999999998 110.623 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 31.5 m -70.18 -41.0 74.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.89000000000000001 110.007 179.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -90.44 -9.3 47.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.522 -0.736 . . . . 0.78000000000000003 111.841 -178.085 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 194' ' ' ALA . 54.3 mt-10 51.38 12.71 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 114.013 1.116 . . . . 1.45 114.013 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 42.9 mt -70.5 162.03 73.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.902 -1.124 . . . . 0.67000000000000004 108.64 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -68.88 140.67 46.7 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.345 1.363 . . . . 0.64000000000000001 110.59 178.381 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.82 167.88 27.14 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 117.338 -1.745 . . . . 0.67000000000000004 110.268 178.727 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 203' ' ' VAL . 75.6 mt -143.48 157.57 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.257 -1.386 . . . . 0.68999999999999995 107.257 178.213 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.0 m -138.59 -29.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.868 -1.145 . . . . 0.84999999999999998 112.736 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.25 44.69 2.69 Favored Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.273 -0.892 . . . . 0.92000000000000004 111.555 -178.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 181' ' ' THR . 33.5 p -66.31 -18.61 65.46 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.961 -1.317 . . . . 0.94999999999999996 110.841 -179.167 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.35 -94.91 0.74 Allowed Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.51 -1.328 . . . . 1.04 110.123 179.727 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.5 t -126.43 28.19 6.02 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.304 -1.115 . . . . 1.5700000000000001 112.623 -178.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 84.6 t -59.05 -35.23 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.33 -1.482 . . . . 0.83999999999999997 110.592 179.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.4 p -55.31 -25.24 33.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.058 -1.026 . . . . 0.98999999999999999 111.378 -179.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t -93.89 1.05 56.45 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.141 -0.974 . . . . 1.7 111.992 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -121.03 -6.1 9.51 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.18 0.808 . . . . 2.2000000000000002 113.18 -178.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 29.8 t -114.94 150.15 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.705 -0.622 . . . . 0.83999999999999997 109.509 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -124.32 160.61 27.66 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.741 -1.207 . . . . 2.2000000000000002 107.741 177.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 10.2 m120 -54.79 140.88 34.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.581 -1.324 . . . . 2.2799999999999998 110.981 178.541 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.5 m-20 79.03 4.9 2.33 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 114.73 1.381 . . . . 2.3500000000000001 114.73 179.173 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -65.26 142.55 58.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.702 -1.248 . . . . 1.97 108.479 177.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -85.94 115.68 23.71 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.584 -1.265 . . . . 2.6499999999999999 107.584 177.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 75.9 mt -125.19 143.61 50.85 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.767 0.794 . . . . 0.63 109.849 -178.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.2 mt -112.64 128.86 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 106.545 -1.65 . . . . 0.62 106.545 177.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.6 tp -103.55 114.48 28.79 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 105.954 -1.869 . . . . 0.64000000000000001 105.954 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 223' ' ' VAL . 40.8 t0 -90.5 -25.06 20.47 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.945 -1.097 . . . . 2.0499999999999998 112.704 -177.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.896 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.56 14.12 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 113.128 0.788 . . . . 0.83999999999999997 113.128 -179.051 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 221' ' ' ASP . 34.3 t -110.95 -61.24 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.054 -1.028 . . . . 1.02 109.332 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -89.91 9.28 28.28 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.238 1.018 . . . . 2.5099999999999998 110.446 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.64 51.64 3.91 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.389 -0.823 . . . . 1.54 112.171 179.293 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -146.79 151.61 37.41 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.254 1.026 . . . . 1.95 109.789 179.025 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.56 139.09 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.54 -1.282 . . . . 0.70999999999999996 107.54 177.412 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.76 130.48 49.73 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.06 -1.025 . . . . 1.01 108.292 178.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.05 129.57 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.205 -1.035 . . . . 0.81999999999999995 108.205 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.434 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 10.9 t-20 52.24 51.29 9.42 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 113.365 0.876 . . . . 1.54 113.365 179.128 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.2 Cg_endo -63.48 149.42 91.11 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.367 2.044 . . . . 0.93999999999999995 111.2 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.7 m -74.41 152.29 39.52 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.055 -1.028 . . . . 1.8 109.098 177.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.82 -36.51 76.93 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.162 -0.961 . . . . 2.73 110.302 178.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -59.45 -39.83 84.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.674 -0.641 . . . . 3.1699999999999999 110.293 179.362 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 98.5 t -71.69 -42.93 70.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.887 -1.133 . . . . 1.3400000000000001 109.867 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.584 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 89.5 mt -58.54 -47.8 87.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.419 -0.912 . . . . 1.2 110.356 -179.033 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.81 -42.15 92.82 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.184 -0.948 . . . . 2.7000000000000002 110.631 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -61.52 -45.05 95.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.29 -0.881 . . . . 2.5899999999999999 110.079 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.464 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 90.6 mtp -70.26 -38.03 75.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.398 -0.814 . . . . 1.3799999999999999 111.046 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -53.36 -42.18 66.57 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.822 -1.174 . . . . 2.8399999999999999 110.767 -179.897 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.22 -59.99 2.55 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.163 -0.961 . . . . 1.8799999999999999 110.691 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.05 -46.46 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.178 -0.951 . . . . 2.3999999999999999 111.747 -179.049 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.464 ' CB ' ' O ' ' A' ' 239' ' ' MET . 42.4 tp60 -60.46 -47.75 84.76 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.976 -1.09 . . . . 3.52 110.393 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.32 -30.91 70.79 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.195 -1.402 . . . . 1.8799999999999999 109.853 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.72 -30.2 69.82 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.945 -1.102 . . . . 3.0099999999999998 109.498 178.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 95.9 t -61.75 -42.46 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.45 -0.9 . . . . 2.4500000000000002 109.36 178.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.91 91.37 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.784 -0.766 . . . . 2.75 110.057 179.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.1 t -69.86 -36.83 75.83 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.996 0.903 . . . . 3.1600000000000001 110.134 -179.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -63.94 -28.22 69.68 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.44 -0.787 . . . . 3.5699999999999998 110.956 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -59.58 -40.6 87.94 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.848 -0.532 . . . . 4.2999999999999998 110.246 179.14 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.93 -33.27 74.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 4.4500000000000002 109.972 179.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -72.74 -11.2 60.52 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.763 -0.585 . . . . 5.9699999999999998 111.998 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 51.8 tp -60.36 -30.3 69.47 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.288 -0.882 . . . . 6.1799999999999997 110.421 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -69.52 7.1 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.015 0.746 . . . . 6.6600000000000001 113.015 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -81.72 11.31 4.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.421 -0.8 . . . . 8.1999999999999993 112.691 179.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 77.0 mt -78.8 -12.86 60.04 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.251 -0.906 . . . . 8.0700000000000003 111.627 -179.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -87.3 -29.3 21.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.578 -0.701 . . . . 9.4499999999999993 111.78 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -95.05 -6.65 41.66 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.303 0.853 . . . . 10.119999999999999 113.303 -178.122 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 117.758 -1.115 . . . . 11.49 109.09 -178.444 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.249 -0.649 . . . . 3.0699999999999998 109.249 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.8 mt -106.27 87.9 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 107.568 -1.271 . . . . 1.0700000000000001 107.568 179.394 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 m -106.59 115.22 29.82 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.346 -1.724 . . . . 1.24 106.346 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.8 -161.06 28.76 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.658 -1.377 . . . . 1.01 109.658 -179.496 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 5' ' ' ILE . 92.7 mt -95.75 1.0 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.415 -1.05 . . . . 1.1100000000000001 112.69 -179.836 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tp 50.15 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.028 -1.045 . . . . 0.98999999999999999 112.27 178.596 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -83.43 -47.97 10.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.071 -1.018 . . . . 0.84999999999999998 111.274 179.15 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -143.53 146.14 34.36 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 107.83 -1.174 . . . . 1.3799999999999999 107.83 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.13 147.24 29.64 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.099 1.866 . . . . 0.93999999999999995 112.14 178.549 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.839 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.42 147.31 4.64 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 119.732 -1.223 . . . . 0.81000000000000005 110.051 178.417 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.9 mt -112.2 130.94 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.797 -1.413 . . . . 0.82999999999999996 108.352 179.261 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.18 149.65 46.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.88 -0.785 . . . . 0.53000000000000003 108.88 178.837 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.5 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.5 m-85 -118.58 139.45 51.46 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 107.652 -1.24 . . . . 0.77000000000000002 107.652 177.352 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.8 169.53 42.49 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 118.585 -1.769 . . . . 0.51000000000000001 110.195 178.452 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -78.72 154.84 29.74 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.732 -0.864 . . . . 1.8999999999999999 109.281 178.042 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -81.88 133.35 35.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.12 -0.988 . . . . 0.66000000000000003 109.007 178.071 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.5 tp -116.33 99.73 7.4 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.009 -1.848 . . . . 0.82999999999999996 106.009 178.123 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.521 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 11.7 tp -85.5 137.61 32.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.667 -1.234 . . . . 0.85999999999999999 107.667 179.659 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.556 HD11 HD11 ' A' ' 158' ' ' LEU . 32.4 mt -102.74 118.31 36.56 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 106.784 -1.561 . . . . 0.92000000000000004 106.784 178.863 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -111.75 136.74 50.61 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.966 -1.124 . . . . 2.0299999999999998 107.966 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -126.36 151.28 47.82 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.179 -0.95 . . . . 2.6600000000000001 109.706 179.009 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -82.44 135.99 35.03 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.622 -1.251 . . . . 2.3199999999999998 107.622 177.329 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -64.21 149.72 47.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 2.1099999999999999 109.159 178.792 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mt -88.19 130.1 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.914 -1.143 . . . . 0.72999999999999998 107.914 177.826 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.2 t -108.57 129.13 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.794 -1.188 . . . . 0.87 107.794 178.711 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.41 136.58 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.157 -1.053 . . . . 0.81000000000000005 108.157 179.233 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -90.54 120.68 31.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.734 -1.21 . . . . 1.3400000000000001 107.734 178.8 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.3 mmm-85 -96.17 11.19 35.24 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.198 -0.939 . . . . 2.8900000000000001 112.667 -179.695 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -64.02 146.07 54.78 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.789 -1.194 . . . . 2.0899999999999999 109.258 178.683 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.37 139.43 30.5 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.889 -1.152 . . . . 2.1899999999999999 107.889 177.708 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -100.75 164.39 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 122.014 0.911 . . . . 0.75 109.904 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.6 p -96.64 165.26 12.23 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.3 0.571 . . . . 0.91000000000000003 109.668 178.369 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.07 -22.13 15.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.93000000000000005 112.045 179.176 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -68.64 -37.08 79.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.97 -1.081 . . . . 2.2799999999999998 110.8 -179.881 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -92.68 -5.79 50.62 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.052 -1.03 . . . . 1.45 112.907 -179.315 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.3 t -59.88 -41.45 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.128 -0.982 . . . . 0.81000000000000005 110.615 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.4 -39.89 84.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.911 -1.118 . . . . 1.54 110.128 179.657 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -60.47 -38.25 83.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.612 -0.68 . . . . 2.3599999999999999 110.744 179.903 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.62 -40.96 89.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.003 -1.061 . . . . 1.3100000000000001 110.37 179.319 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.9 t -60.13 -43.6 93.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.158 -0.964 . . . . 0.81999999999999995 110.322 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -60.55 -43.62 97.02 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.238 -0.914 . . . . 1.5 109.974 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -60.62 -42.92 97.84 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.224 -0.99 . . . . 2.23 109.914 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -73.22 -54.85 7.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.457 -0.777 . . . . 0.84999999999999998 110.016 179.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.6 tp -57.74 -47.76 81.53 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.761 -0.776 . . . . 0.91000000000000003 109.971 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.517 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.6 t -69.9 -41.17 75.07 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.447 -0.783 . . . . 0.90000000000000002 109.905 179.764 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.66 -43.11 94.5 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.284 -1.526 . . . . 0.68999999999999995 109.284 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.401 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.8 ttt-85 -59.97 -29.93 68.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.359 -1.083 . . . . 2.8799999999999999 109.615 179.002 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.23 -49.93 75.97 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.723 -0.791 . . . . 0.84999999999999998 111.078 179.309 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -82.62 -38.53 23.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.239 -0.913 . . . . 2.3500000000000001 110.873 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.11 -44.54 91.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.905 -1.122 . . . . 0.65000000000000002 109.766 -179.381 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.7 t -60.28 -38.18 82.79 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.212 1.006 . . . . 1.45 109.348 179.603 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.89 78.5 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.845 -0.616 . . . . 0.63 110.326 179.47 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -61.68 -49.76 75.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.912 . . . . 1.3400000000000001 110.365 179.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.97 -40.37 93.12 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.985 0.898 . . . . 1.5600000000000001 109.656 179.777 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.11 -40.82 90.99 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.298 0.57 . . . . 1.1899999999999999 110.183 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.598 HG22 ' HZ2' ' A' ' 60' ' ' LYS . 14.4 m -67.55 -41.42 84.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.71999999999999997 110.471 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.4 mt -60.12 -38.35 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.481 -0.762 . . . . 0.62 110.712 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -50.92 -41.6 58.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.853 . . . . 1.05 110.475 179.362 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -69.71 -37.23 76.49 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.908 -1.12 . . . . 0.64000000000000001 109.988 -179.672 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.598 ' HZ2' HG22 ' A' ' 56' ' ' THR . 57.8 mttp -62.28 -38.93 91.22 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.343 -0.943 . . . . 1.73 109.505 179.201 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.25 -30.08 68.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.68 -0.638 . . . . 0.56000000000000005 110.344 179.207 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.95 -37.12 11.86 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.024 -1.084 . . . . 0.68999999999999995 111.511 179.9 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -80.01 -28.18 39.44 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.071 -1.252 . . . . 1.48 110.895 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.4 m -84.57 -47.57 10.43 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.285 -0.884 . . . . 0.97999999999999998 111.086 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -107.22 -10.84 15.73 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.547 0.943 . . . . 1.1599999999999999 113.547 -177.285 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.17 157.99 16.55 Favored Glycine 0 N--CA 1.501 2.968 0 O-C-N 121.269 -0.894 . . . . 0.84999999999999998 113.051 179.02 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -54.45 -21.66 10.49 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.736 -0.861 . . . . 3.8599999999999999 112.58 179.491 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -55.93 -36.87 68.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.019 -1.051 . . . . 2.3500000000000001 111.347 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -80.08 -22.26 42.43 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.1 -1.0 . . . . 1.6699999999999999 112.446 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.1 -35.66 75.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.806 -1.184 . . . . 1.45 111.39 -179.744 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.26 93.6 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.946 -1.096 . . . . 0.60999999999999999 111.724 179.767 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.4 mt -66.83 -44.56 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.59 -1.319 . . . . 0.65000000000000002 110.245 -179.786 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -70.15 -32.87 71.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.074 -1.016 . . . . 0.66000000000000003 110.207 -179.901 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.72 -36.61 79.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 1.1899999999999999 110.11 -179.781 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.93 -41.05 83.79 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 120.396 -0.907 . . . . 0.53000000000000003 110.964 179.401 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -58.68 -44.21 90.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.102 -1.234 . . . . 1.27 110.81 179.562 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.61 -40.09 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.052 -1.03 . . . . 0.54000000000000004 110.329 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 34.2 ttp -60.21 -38.86 84.64 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.35 -0.844 . . . . 1.74 110.428 179.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -58.63 -48.81 79.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.19 -0.944 . . . . 0.55000000000000004 109.919 179.111 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.01 -40.4 89.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.576 -0.702 . . . . 0.46999999999999997 110.376 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -86.16 10.85 13.3 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.386 -0.821 . . . . 1.4199999999999999 112.411 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.14 124.45 21.69 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.038 -1.039 . . . . 1.27 108.659 178.594 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.32 -19.64 65.57 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.746 0.784 . . . . 1.3500000000000001 110.819 -179.162 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -76.39 -52.96 8.85 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.762 -0.775 . . . . 2.2200000000000002 110.406 179.919 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -60.62 -41.26 94.46 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.256 -0.977 . . . . 0.62 110.495 -179.455 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -58.18 -48.62 79.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.939 -1.1 . . . . 1.29 110.58 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -62.28 -38.63 90.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.863 -1.148 . . . . 1.52 110.873 -179.913 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.38 -48.37 67.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.989 -1.07 . . . . 1.3 110.999 179.694 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.8 mt -56.21 -43.47 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.066 -1.021 . . . . 0.60999999999999999 109.735 179.527 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.12 -44.03 99.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.317 0.579 . . . . 0.78000000000000003 110.515 179.874 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.37 -43.71 98.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 0.81999999999999995 110.772 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.32 -46.51 90.0 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.083 -1.011 . . . . 0.80000000000000004 110.483 -179.787 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.65 -43.41 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.77000000000000002 110.617 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -84.41 -33.68 23.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.729 -0.607 . . . . 2.1200000000000001 111.549 -179.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 91' ' ' ALA . 55.7 t0 -79.76 -42.34 24.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.914 -1.116 . . . . 1.51 111.209 -178.4 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -102.65 5.73 39.24 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 1.98 112.921 -177.946 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.9 m170 52.86 48.99 21.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.987 . . . . 1.3200000000000001 111.85 -179.495 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.27 158.27 17.62 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.418 -0.801 . . . . 1.3799999999999999 109.451 178.459 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.4 p -70.96 159.07 35.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.679 -0.638 . . . . 0.67000000000000004 109.414 177.808 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.2 -41.4 88.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 0.52000000000000002 110.8 178.743 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.53 ' OD2' HD21 ' A' ' 142' ' ' LEU . 90.0 m-20 -68.27 -38.74 82.03 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.931 -1.106 . . . . 2.25 110.502 -179.82 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.91 -54.53 15.0 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.754 -0.778 . . . . 0.64000000000000001 111.186 179.691 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.58 94.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.263 -0.898 . . . . 0.56000000000000005 110.408 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.34 88.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.445 -0.785 . . . . 0.46000000000000002 110.442 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -60.14 -39.8 87.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 1.3200000000000001 111.081 -179.936 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.76 -48.0 82.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 1.3 110.69 179.628 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.32 -43.61 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.895 -1.128 . . . . 0.60999999999999999 110.61 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mm -61.52 -32.38 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.649 -0.657 . . . . 0.65000000000000002 110.102 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -58.77 -40.66 84.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.51 -0.744 . . . . 2.1099999999999999 110.469 179.274 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.67 -28.3 27.07 Favored Glycine 0 N--CA 1.499 2.848 0 C-N-CA 119.495 -1.336 . . . . 0.82999999999999996 113.482 179.724 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -63.68 -42.48 98.01 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.31 -1.7 . . . . 1.28 110.061 -179.841 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.24 -50.61 21.42 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.616 0.722 . . . . 0.89000000000000001 110.468 -179.961 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.9 t -60.74 -37.53 82.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.314 -0.866 . . . . 1.8700000000000001 110.627 -179.66 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.24 97.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.448 -0.783 . . . . 1.05 110.901 179.769 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 84.8 mt -66.12 -30.05 70.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.915 -1.116 . . . . 1.02 110.678 -179.748 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -65.71 -22.28 66.6 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.568 -0.707 . . . . 2.04 110.979 179.409 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -70.03 -21.49 63.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.518 -0.739 . . . . 1.73 110.963 179.563 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 123' ' ' LEU . 10.2 mt -82.48 145.66 29.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.786 . . . . 1.3700000000000001 109.544 178.391 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -100.09 39.9 1.3 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.402 -0.811 . . . . 2.8799999999999999 111.787 179.766 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -112.72 139.76 48.07 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.102 -0.999 . . . . 1.5800000000000001 108.923 178.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.536 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 42.1 mp0 -59.57 -38.9 82.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.558 -0.714 . . . . 3.04 111.064 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -70.96 -55.58 8.05 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.671 -1.268 . . . . 0.90000000000000002 110.592 179.723 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 118' ' ' LEU . 25.7 mt -59.8 -40.77 89.44 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.034 -1.041 . . . . 1.0600000000000001 110.371 -179.685 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -64.24 -49.81 70.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.066 . . . . 2.1800000000000002 109.511 179.599 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -60.37 -32.73 71.57 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.399 -0.921 . . . . 2.1499999999999999 109.468 179.76 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.413 ' O ' HG23 ' A' ' 130' ' ' VAL . 56.5 ttt180 -63.83 -28.79 70.09 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.385 -0.926 . . . . 2.3300000000000001 109.529 179.165 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -59.27 -47.31 85.84 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 119.784 -0.766 . . . . 0.81999999999999995 109.335 178.453 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.55 88.57 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.486 -0.886 . . . . 0.84999999999999998 110.143 179.718 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.04 -32.39 73.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.821 . . . . 1.3899999999999999 110.694 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 126' ' ' ARG . 42.8 t -69.24 -39.53 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.56000000000000005 110.161 179.684 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -55.33 -39.94 70.59 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.514 -1.275 . . . . 3.1200000000000001 109.17 178.609 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -60.59 -36.1 77.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.746 -0.596 . . . . 1.28 110.433 179.604 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.3 mt -60.33 -39.62 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.328 -0.858 . . . . 0.48999999999999999 110.389 179.856 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.01 72.31 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.426 -1.369 . . . . 0.46000000000000002 110.675 178.828 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -59.03 -40.79 86.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.429 -1.042 . . . . 2.71 110.336 179.26 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.528 ' NH1' ' OG ' ' A' ' 166' ' ' SER . 24.7 mtp180 -60.99 -40.53 93.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 2.1400000000000001 109.693 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.523 HD13 ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -66.59 -45.52 78.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.714 -0.616 . . . . 1.05 110.279 179.953 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.3 mt -58.43 -41.99 86.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.227 -0.92 . . . . 0.52000000000000002 110.637 179.671 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -61.03 -32.52 72.12 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.143 -0.973 . . . . 2.3500000000000001 111.022 -179.854 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -75.37 -43.82 48.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.906 -1.121 . . . . 1.3899999999999999 111.412 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.21 -35.8 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.68000000000000005 110.905 -178.071 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.53 HD21 ' OD2' ' A' ' 101' ' ' ASP . 64.9 mt -85.47 -7.86 58.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.074 -1.016 . . . . 0.82999999999999996 112.119 -179.829 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.27 22.07 78.53 Favored Glycine 0 N--CA 1.479 1.521 0 C-N-CA 119.095 -1.526 . . . . 0.91000000000000003 113.053 -179.18 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.36 146.41 39.92 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.83 -0.806 . . . . 0.94999999999999996 110.229 -179.621 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -67.74 148.26 51.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 2.4300000000000002 108.955 178.913 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 63.2 mt -102.32 139.23 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.785 -1.191 . . . . 1.1000000000000001 107.785 178.464 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.467 HD12 ' H ' ' A' ' 147' ' ' ILE . 3.8 mp -77.52 132.72 32.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.386 -0.821 . . . . 1.5800000000000001 108.807 179.169 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -95.17 86.81 4.68 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.242 -1.392 . . . . 1.6200000000000001 107.242 179.349 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -75.76 -21.73 57.16 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.87 -0.732 . . . . 0.80000000000000004 111.33 -177.82 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.424 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 32.4 t -80.27 1.08 30.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.369 -0.832 . . . . 1.5600000000000001 112.445 179.598 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.54 24.72 7.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.561 -0.712 . . . . 0.83999999999999997 112.372 -179.08 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 15.1 mt -71.42 140.77 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.372 -0.83 . . . . 0.81999999999999995 109.646 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -114.9 -18.95 11.16 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.582 0.706 . . . . 2.3100000000000001 112.883 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -115.07 134.28 55.31 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.939 -1.134 . . . . 1.54 107.939 -179.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -73.36 126.22 29.65 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.271 -1.011 . . . . 1.3799999999999999 108.271 178.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -148.12 177.08 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.68999999999999995 109.284 -179.615 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.7 mt -85.74 141.91 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 0.53000000000000003 108.651 178.111 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.556 HD11 HD11 ' A' ' 19' ' ' LEU . 24.2 tp -96.19 122.84 39.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.23 -0.919 . . . . 0.64000000000000001 108.886 178.446 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.88 129.96 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.917 -1.142 . . . . 0.67000000000000004 107.917 179.754 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.439 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.16 155.27 22.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.78000000000000003 109.048 179.152 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -60.72 -40.59 92.9 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.42 -1.425 . . . . 1.0 109.358 177.992 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -171.04 151.13 3.19 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.739 -0.838 . . . . 2.4199999999999999 108.739 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 85.2 mt -118.7 139.31 51.74 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.001 -1.111 . . . . 0.75 108.001 177.519 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.9 p -92.8 150.37 39.4 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.238 -0.914 . . . . 0.78000000000000003 108.77 178.844 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -39.8 -41.65 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.34 2.027 . . . . 0.67000000000000004 113.686 179.26 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.528 ' OG ' ' NH1' ' A' ' 136' ' ' ARG . 44.1 m -59.97 -48.26 82.43 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.062 -1.024 . . . . 0.69999999999999996 110.119 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -65.23 -40.06 93.55 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.409 -0.807 . . . . 1.21 110.245 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 43.4 p -67.84 -38.53 83.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.435 -0.791 . . . . 0.59999999999999998 110.3 179.97 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.61 80.59 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.182 -0.949 . . . . 0.62 110.529 179.624 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -95.05 -0.88 53.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.055 -1.028 . . . . 1.1599999999999999 113.133 -179.326 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.1 tp -62.98 150.42 42.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.72999999999999998 109.17 179.801 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 150' ' ' SER . 71.4 m-20 -95.31 112.92 24.56 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.146 -1.428 . . . . 2.2400000000000002 107.146 177.686 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.93 -15.54 61.12 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.139 0.495 . . . . 1.4299999999999999 112.118 -178.106 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -83.72 -23.03 31.81 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.126 -0.984 . . . . 2.1499999999999999 112.612 -178.834 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -104.08 3.02 32.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.138 -0.976 . . . . 2.04 112.877 -178.803 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 178' ' ' GLY . 59.1 t -108.78 127.9 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.711 -1.218 . . . . 0.55000000000000004 107.711 179.556 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 16.1 tp -87.73 -5.47 58.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.504 -0.748 . . . . 1.6299999999999999 111.895 -179.427 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.508 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.7 175.01 35.82 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.797 -1.721 . . . . 0.46999999999999997 108.797 -179.367 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -130.58 137.39 49.64 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.814 -1.18 . . . . 0.54000000000000004 107.814 179.823 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.451 HG22 HG21 ' A' ' 205' ' ' THR . 83.5 mt -137.48 110.86 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 106.688 -1.597 . . . . 0.68999999999999995 106.688 178.519 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 203' ' ' VAL . 70.7 p -130.59 168.49 17.02 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.831 -1.168 . . . . 0.81999999999999995 109.829 -179.668 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 25.8 p-10 -101.7 50.42 0.85 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.626 -0.671 . . . . 2.3700000000000001 110.529 179.841 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.35 147.51 24.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.243 -0.911 . . . . 1.1100000000000001 109.323 179.333 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.43 -16.03 19.46 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.804 -1.189 . . . . 1.6699999999999999 112.36 179.204 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 80.7 -19.47 7.32 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 121.402 -1.058 . . . . 1.54 114.474 179.341 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -60.13 -39.88 87.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.161 -1.199 . . . . 4.4800000000000004 110.569 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 31.1 p -139.84 34.87 1.97 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.587 -0.696 . . . . 2.6299999999999999 111.195 -179.691 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.0 p -84.02 118.87 24.33 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.974 -1.121 . . . . 1.6899999999999999 107.974 178.877 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -60.11 -30.6 69.37 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.584 -0.697 . . . . 1.0700000000000001 110.274 -179.549 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 40.0 m -59.41 -40.9 88.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.497 -0.752 . . . . 1.5800000000000001 110.392 179.225 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 83.3 p -59.97 -39.05 84.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.995 -1.066 . . . . 1.6000000000000001 110.074 179.53 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 75.7 mt -59.94 -39.62 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.41 -0.916 . . . . 1.45 110.516 179.41 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 56.5 mtp -62.43 -42.25 99.32 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.293 1.044 . . . . 1.05 109.423 179.473 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.4 -46.28 86.72 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.646 -0.707 . . . . 0.71999999999999997 110.776 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.429 ' HG2' HH11 ' A' ' 195' ' ' ARG . 46.8 mtt-85 -60.07 -43.78 95.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 3.0499999999999998 110.518 -179.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 51.2 m -68.92 -39.14 79.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.492 -0.755 . . . . 0.89000000000000001 110.316 -179.86 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.2 mt -90.86 -6.86 53.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.569 -0.707 . . . . 0.78000000000000003 112.729 -179.148 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 194' ' ' ALA . 43.6 mt-10 53.2 9.8 0.16 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.918 1.081 . . . . 1.45 113.918 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 34.8 mt -71.27 150.79 94.39 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.043 -1.036 . . . . 0.67000000000000004 108.462 178.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.7 141.32 95.5 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.269 1.313 . . . . 0.64000000000000001 109.465 178.532 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.96 163.79 33.88 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.574 -1.651 . . . . 0.67000000000000004 110.065 179.899 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.495 ' CD1' HD11 ' A' ' 220' ' ' LEU . 18.6 mt -148.69 152.36 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.919 -1.141 . . . . 0.68999999999999995 107.919 178.321 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.3 m -135.1 -28.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 O-C-N 120.758 -1.214 . . . . 0.84999999999999998 111.657 179.568 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.46 40.12 2.56 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.161 -0.962 . . . . 0.92000000000000004 112.219 -178.993 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.451 HG21 HG22 ' A' ' 180' ' ' ILE . 51.5 p -60.96 -18.73 58.82 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.988 -1.301 . . . . 0.94999999999999996 111.42 -179.261 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 77.15 -93.41 1.08 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.971 -1.109 . . . . 1.04 110.501 179.539 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 47.8 p -128.8 27.3 5.48 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.472 -1.017 . . . . 1.5700000000000001 112.597 -178.767 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 83.8 t -59.23 -33.99 52.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.686 -1.259 . . . . 0.83999999999999997 110.872 179.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 44.2 p -59.71 -23.08 62.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.095 -1.003 . . . . 0.98999999999999999 111.729 -179.813 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 37.6 t -93.27 1.01 57.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 1.7 112.113 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -126.29 0.46 7.05 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.847 0.684 . . . . 2.2000000000000002 112.847 -178.281 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 32.0 t -116.11 145.55 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.587 -0.696 . . . . 0.83999999999999997 109.34 179.772 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -119.92 161.33 21.05 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.486 -0.931 . . . . 2.2000000000000002 108.486 177.938 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 18' ' ' LEU . 73.6 m-80 -59.57 142.27 53.1 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 120.749 -1.219 . . . . 2.2799999999999998 110.639 179.159 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.6 t70 80.61 1.04 1.87 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.496 1.295 . . . . 2.3500000000000001 114.496 179.438 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -63.66 148.57 48.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.622 -1.298 . . . . 1.97 108.549 177.706 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -91.69 118.11 30.35 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 106.477 -1.675 . . . . 2.6499999999999999 106.477 177.698 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.422 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 82.3 mt -126.84 144.64 50.91 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.663 0.744 . . . . 0.63 109.867 -178.536 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.3 mt -114.15 127.37 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.711 -1.588 . . . . 0.62 106.711 177.567 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.495 HD11 ' CD1' ' A' ' 202' ' ' ILE . 59.9 tp -99.58 115.31 29.09 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 105.82 -1.918 . . . . 0.64000000000000001 105.82 178.272 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 223' ' ' VAL . 28.7 t0 -89.13 -26.95 21.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.024 -1.047 . . . . 2.0499999999999998 111.701 -178.197 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.28 20.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.598 -0.689 . . . . 0.83999999999999997 112.666 -179.28 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 221' ' ' ASP . 17.3 t -112.33 -59.77 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 122.065 0.936 . . . . 1.02 109.522 179.573 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -99.58 14.39 30.16 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.933 0.873 . . . . 2.5099999999999998 110.87 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 45.6 t30 61.22 50.99 4.52 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 116.031 -0.531 . . . . 1.54 112.195 179.163 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -147.06 147.91 31.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.049 -1.032 . . . . 1.95 109.605 178.431 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.05 139.12 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 107.821 -1.177 . . . . 0.70999999999999996 107.821 178.114 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -99.74 133.29 44.31 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.966 -1.084 . . . . 1.01 108.419 178.394 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.0 t -110.57 130.87 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.589 -0.694 . . . . 0.81999999999999995 109.381 179.23 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.426 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 58.7 t30 52.23 51.52 9.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 113.596 0.962 . . . . 1.54 113.596 178.117 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 55.9 Cg_endo -69.88 152.51 68.73 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.729 2.286 . . . . 0.93999999999999995 110.59 179.879 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 232' ' ' THR . 1.3 p -73.64 161.76 29.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.669 -1.269 . . . . 1.8 109.914 178.216 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -59.87 -38.39 82.06 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.192 -0.942 . . . . 2.73 110.216 178.737 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.83 -41.37 91.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.59 -0.694 . . . . 3.1699999999999999 109.913 179.179 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 86.1 t -70.55 -43.11 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.448 -0.783 . . . . 1.3400000000000001 110.492 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.563 ' CG2' HH12 ' A' ' 240' ' ' ARG . 73.6 mt -58.33 -48.56 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 118.803 -1.159 . . . . 1.2 109.829 -178.709 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -59.83 -40.9 90.04 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.726 -0.79 . . . . 2.7000000000000002 109.824 179.392 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -61.82 -41.56 97.94 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.415 -0.803 . . . . 2.5899999999999999 110.18 179.827 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 72.5 mtp -71.55 -32.14 67.79 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.34 -0.85 . . . . 1.3799999999999999 110.548 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -55.81 -40.66 73.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 2.8399999999999999 109.863 179.587 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 245' ' ' GLN . . . -72.59 -39.64 67.19 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.551 -0.718 . . . . 1.8799999999999999 110.917 -179.884 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 79.5 t -51.0 -51.97 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.743 -1.223 . . . . 2.3999999999999999 111.705 -179.34 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -63.47 -50.0 71.43 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.748 -1.22 . . . . 3.52 109.566 179.916 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -61.65 -35.6 78.41 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.631 -0.827 . . . . 1.8799999999999999 110.252 -179.876 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 249' ' ' GLU . 80.2 mt-30 -65.45 -27.81 68.78 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.403 -0.919 . . . . 3.0099999999999998 110.291 179.18 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 52.6 t -60.41 -42.67 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 119.187 -1.005 . . . . 2.4500000000000002 109.554 178.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.3 -44.91 88.77 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.606 -1.238 . . . . 2.75 109.055 179.071 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.2 t -77.21 -25.08 51.33 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.453 0.644 . . . . 3.1600000000000001 111.058 -179.9 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 245' ' ' GLN . 29.3 tp10 -61.96 -30.05 70.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.659 -0.65 . . . . 3.5699999999999998 111.479 -179.791 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -61.41 -38.67 87.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.023 -1.048 . . . . 4.2999999999999998 110.244 179.565 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.67 -19.87 63.59 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.113 -0.992 . . . . 4.4500000000000002 111.341 179.605 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -71.66 -13.07 61.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.822 -0.549 . . . . 5.9699999999999998 111.979 -179.432 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.94 -30.67 70.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.993 -1.067 . . . . 6.1799999999999997 110.826 -179.434 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -69.9 -14.19 62.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.11 -0.994 . . . . 6.6600000000000001 112.08 179.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -89.11 26.02 1.7 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.437 -0.789 . . . . 8.1999999999999993 113.031 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 15.0 tp -74.34 -10.97 60.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 8.0700000000000003 112.414 179.211 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -87.92 1.92 52.89 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.571 -1.33 . . . . 9.4499999999999993 112.498 -179.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.5 -0.99 57.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.855 -1.153 . . . . 10.119999999999999 112.59 -179.467 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.939 -1.029 . . . . 11.49 108.78 -178.25 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.0 mtp . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 110.129 -0.323 . . . . 3.0699999999999998 110.129 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 93.0 mt -96.66 112.94 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.36 -1.718 . . . . 1.0700000000000001 106.36 176.66 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.7 m -102.5 120.57 40.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.364 -0.976 . . . . 1.24 108.364 -179.717 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.31 -142.82 11.45 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.791 -1.724 . . . . 1.01 108.791 179.498 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 5' ' ' ILE . 81.5 mt -100.53 -1.0 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.984 -1.304 . . . . 1.1100000000000001 113.399 -178.893 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 tp 49.35 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.659 -1.276 . . . . 0.98999999999999999 112.312 178.556 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.54 -39.87 16.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.259 -0.9 . . . . 0.84999999999999998 111.029 179.307 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.06 145.68 19.96 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.105 -1.072 . . . . 1.3799999999999999 108.105 -179.126 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.95 148.14 31.35 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.849 2.366 . . . . 0.93999999999999995 112.436 178.585 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.871 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.73 152.13 5.96 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 109.817 -1.313 . . . . 0.81000000000000005 109.817 178.088 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.4 mt -118.04 130.17 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.199 -1.177 . . . . 0.82999999999999996 108.072 179.183 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.53 143.89 43.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.315 -0.865 . . . . 0.53000000000000003 109.024 179.006 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.557 ' CE2' ' OE1' ' A' ' 243' ' ' GLN . 45.6 m-85 -110.07 138.27 46.68 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.596 -1.261 . . . . 0.77000000000000002 107.596 177.346 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.0 169.73 42.45 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 117.708 -2.187 . . . . 0.51000000000000001 110.4 178.154 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -79.56 159.68 26.76 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.776 -0.824 . . . . 1.8999999999999999 108.776 177.922 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.449 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.6 130.31 34.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.094 -1.004 . . . . 0.66000000000000003 109.11 178.152 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.8 tp -109.46 107.51 17.68 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 104.917 -2.253 . . . . 0.82999999999999996 104.917 176.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 tp -94.2 132.79 38.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.105 -0.997 . . . . 0.85999999999999999 108.977 -179.833 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.3 mt -100.93 122.22 43.1 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.417 -1.327 . . . . 0.92000000000000004 107.417 178.437 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -108.81 131.31 55.1 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.25 -1.018 . . . . 2.0299999999999998 108.25 179.521 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.485 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 83.5 tt0 -111.34 140.38 45.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.554 -0.716 . . . . 2.6600000000000001 109.471 179.073 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -83.87 129.32 34.93 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.412 -1.329 . . . . 2.3199999999999998 107.412 177.893 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -65.9 143.62 57.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.85 . . . . 2.1099999999999999 109.153 179.342 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.0 mt -96.55 135.47 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.506 -0.924 . . . . 0.72999999999999998 108.506 178.587 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.49 130.19 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.376 -0.972 . . . . 0.87 108.376 178.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.2 mt -97.57 141.24 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.644 -0.873 . . . . 0.81000000000000005 108.644 179.325 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -89.77 120.67 31.23 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.755 -1.202 . . . . 1.3400000000000001 107.755 178.083 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.523 ' HG2' HH11 ' A' ' 28' ' ' ARG . 2.1 mmt-85 -95.19 12.49 28.65 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.256 -0.902 . . . . 2.8900000000000001 112.605 179.635 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -66.98 146.64 54.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.878 -1.139 . . . . 2.0899999999999999 109.533 178.879 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -90.18 135.37 33.71 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.964 -1.125 . . . . 2.1899999999999999 107.964 178.032 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.0 pt -100.43 164.76 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.285 -0.884 . . . . 0.75 110.321 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.5 p -94.86 164.89 12.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.475 -0.565 . . . . 0.91000000000000003 109.475 178.4 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.85 -20.23 14.7 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.116 -0.99 . . . . 0.93000000000000005 112.088 179.35 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -68.9 -39.14 79.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.038 -1.039 . . . . 2.2799999999999998 110.986 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -87.22 -9.24 55.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.62 -1.3 . . . . 1.45 112.423 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.23 -43.2 89.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.186 -0.947 . . . . 0.81000000000000005 110.557 -179.394 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -56.65 -40.66 75.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.853 -1.154 . . . . 1.54 110.607 179.548 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -65.04 -46.76 79.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.195 -0.94 . . . . 2.3599999999999999 110.957 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.29 -36.19 79.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.954 -1.092 . . . . 1.3100000000000001 111.17 -179.772 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.84 -40.81 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.933 -1.104 . . . . 0.81999999999999995 110.541 179.287 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -61.12 -41.06 96.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.006 -1.059 . . . . 1.5 109.981 179.673 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.418 ' HG2' HH11 ' A' ' 42' ' ' ARG . 46.8 mtt-85 -61.15 -39.32 89.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.844 . . . . 2.23 110.695 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -72.82 -57.04 4.37 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.38 -0.825 . . . . 0.84999999999999998 110.76 179.517 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.8 tp -59.89 -47.53 85.38 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.314 -0.954 . . . . 0.91000000000000003 110.088 -179.724 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.554 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.3 t -67.88 -36.17 79.78 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.75 0.786 . . . . 0.90000000000000002 109.88 179.855 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.19 -43.15 99.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.864 -1.294 . . . . 0.68999999999999995 109.864 178.856 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -59.54 -30.55 68.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.02 0.915 . . . . 2.8799999999999999 109.344 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.72 -43.11 90.06 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.814 0.816 . . . . 0.84999999999999998 109.511 179.056 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.405 ' HZ3' ' NE2' ' A' ' 53' ' ' GLN . 24.1 ttpp -80.34 -45.88 17.05 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.434 -0.791 . . . . 2.3500000000000001 110.837 179.374 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.64 -41.57 81.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.585 -0.697 . . . . 0.65000000000000002 110.022 179.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.3 p -61.88 -37.16 83.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.119 0.961 . . . . 1.45 109.17 179.765 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.4 -50.2 48.16 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.753 -0.658 . . . . 0.63 110.531 179.454 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' NE2' ' HZ3' ' A' ' 49' ' ' LYS . 96.0 mt-30 -63.53 -48.43 77.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.447 -0.783 . . . . 1.3400000000000001 110.578 -179.865 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.7 mt -61.2 -38.21 85.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 1.5600000000000001 110.01 179.977 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -59.78 -39.98 86.72 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.666 -0.646 . . . . 1.1899999999999999 110.713 179.113 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -65.1 -44.16 89.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.781 -1.2 . . . . 0.71999999999999997 110.243 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.1 -31.97 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.754 . . . . 0.62 110.186 179.791 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -52.07 -47.08 65.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.604 -0.685 . . . . 1.05 110.61 179.075 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -68.77 -33.78 74.46 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.744 -1.222 . . . . 0.64000000000000001 109.843 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -62.15 -39.45 92.67 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.531 -1.267 . . . . 1.73 109.363 179.173 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.84 88.9 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.348 -0.845 . . . . 0.56000000000000005 109.988 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.93 -37.95 42.59 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.573 -1.298 . . . . 0.68999999999999995 110.476 179.474 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -81.57 -22.46 37.78 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.087 -1.243 . . . . 1.48 111.131 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.8 m -84.74 -46.05 11.8 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.548 -0.72 . . . . 0.97999999999999998 110.907 179.941 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -106.5 -23.68 12.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.441 -0.787 . . . . 1.1599999999999999 112.229 -178.981 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.21 168.97 15.28 Favored Glycine 0 N--CA 1.499 2.889 0 CA-C-O 121.785 0.659 . . . . 0.84999999999999998 111.665 -179.534 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -55.68 -28.2 54.26 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.415 -1.05 . . . . 3.8599999999999999 112.717 -179.652 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -57.65 -39.91 78.09 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.911 -1.118 . . . . 2.3500000000000001 111.356 -179.718 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -88.59 -14.53 37.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.618 -1.301 . . . . 1.6699999999999999 112.385 -178.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -60.07 -38.72 83.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.872 . . . . 1.45 110.948 -179.25 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.38 82.97 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.167 -0.958 . . . . 0.60999999999999999 111.245 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.3 mt -63.14 -43.5 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.572 -1.33 . . . . 0.65000000000000002 110.475 179.696 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -68.97 -33.28 73.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.968 -1.083 . . . . 0.66000000000000003 110.001 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.02 -38.84 83.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 1.1899999999999999 110.114 179.365 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.82 -38.14 94.06 Favored Glycine 0 N--CA 1.486 1.985 0 C-N-CA 120.137 -1.03 . . . . 0.53000000000000003 110.585 179.552 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -57.16 -42.33 80.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.841 -1.388 . . . . 1.27 110.284 179.368 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.2 mt -60.34 -41.59 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.08 -1.012 . . . . 0.54000000000000004 109.556 179.641 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.1 ttm -60.19 -39.82 87.88 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 1.74 109.803 179.562 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 tp -58.28 -50.0 75.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.413 -0.804 . . . . 0.55000000000000004 110.45 178.996 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.67 -40.34 91.75 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.331 -0.856 . . . . 0.46999999999999997 110.402 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -87.72 5.62 38.97 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.87 0.693 . . . . 1.4199999999999999 112.87 -179.62 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.31 122.82 15.47 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.911 -1.118 . . . . 1.27 109.581 179.3 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -66.16 -16.29 63.85 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.686 0.755 . . . . 1.3500000000000001 110.749 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -77.06 -49.17 15.92 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.496 -0.882 . . . . 2.2200000000000002 110.523 179.94 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.21 -38.29 90.58 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.386 -0.925 . . . . 0.62 110.24 -178.305 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.88 -47.88 83.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.023 -1.048 . . . . 1.29 111.282 179.314 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -60.7 -39.26 87.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.883 -1.136 . . . . 1.52 110.663 -179.721 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.7 -48.48 71.85 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.575 -0.85 . . . . 1.3 110.638 179.692 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.96 -41.6 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.222 -0.991 . . . . 0.60999999999999999 109.914 179.494 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.81 -42.81 95.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.352 -0.842 . . . . 0.78000000000000003 110.297 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.88 98.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.81999999999999995 110.67 -179.965 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.02 -43.06 95.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.80000000000000004 110.442 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.51 -49.08 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.988 -1.07 . . . . 0.77000000000000002 110.159 179.817 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -76.66 -35.47 57.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 2.1200000000000001 111.824 -179.524 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -80.77 -48.25 12.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.887 -1.133 . . . . 1.51 111.98 -179.643 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -101.41 8.69 42.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.227 -0.921 . . . . 1.98 112.994 -178.658 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.5 m80 51.56 49.36 21.06 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.024 -1.071 . . . . 1.3200000000000001 111.426 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.9 mtt -104.86 149.43 25.69 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.435 1.112 . . . . 1.3799999999999999 109.052 179.834 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.5 p -72.62 159.63 33.56 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.59 0.709 . . . . 0.67000000000000004 109.433 177.81 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.33 81.79 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.51 -0.744 . . . . 0.52000000000000002 110.646 178.627 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.4 p-10 -68.54 -42.31 78.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.977 -1.077 . . . . 2.25 110.268 -179.792 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -70.74 -51.46 27.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.332 -0.855 . . . . 0.64000000000000001 111.386 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.99 84.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.499 -0.751 . . . . 0.56000000000000005 110.528 -179.616 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.6 96.53 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.82 -0.752 . . . . 0.46000000000000002 111.127 179.658 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -60.42 -39.37 87.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.829 -1.169 . . . . 1.3200000000000001 110.782 179.942 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -54.83 -49.75 70.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.129 -0.982 . . . . 1.3 110.761 179.701 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.1 -42.28 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.718 -1.239 . . . . 0.60999999999999999 109.853 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.5 mm -61.76 -32.02 52.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.541 -0.724 . . . . 0.65000000000000002 110.356 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.14 -41.75 89.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 2.1099999999999999 110.388 179.083 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.09 -31.68 19.47 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.063 -1.542 . . . . 0.82999999999999996 112.279 -179.896 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -62.16 -41.88 98.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.414 -1.639 . . . . 1.28 109.635 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.59 -51.26 20.48 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.982 0.896 . . . . 0.89000000000000001 109.713 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.6 t -60.19 -39.93 88.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.358 -0.839 . . . . 1.8700000000000001 110.176 -179.802 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.32 98.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.176 -0.952 . . . . 1.05 110.454 -179.808 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 88.1 mt -64.84 -30.61 71.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.966 -1.084 . . . . 1.02 110.224 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -66.53 -22.2 66.16 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.342 -0.849 . . . . 2.04 110.877 179.712 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.39 -20.45 64.68 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.415 -0.914 . . . . 1.73 110.625 179.511 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.594 HD13 HD13 ' A' ' 123' ' ' LEU . 38.8 mt -83.15 142.41 31.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.441 -0.787 . . . . 1.3700000000000001 109.321 178.362 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -101.4 40.01 1.35 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.398 -0.814 . . . . 2.8799999999999999 111.078 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -112.75 133.48 54.74 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.609 -0.886 . . . . 1.5800000000000001 108.609 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.626 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 5.7 pm0 -60.5 -28.09 68.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.095 -1.003 . . . . 3.04 111.553 179.552 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -74.25 -59.54 2.68 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.072 -1.017 . . . . 0.90000000000000002 110.027 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.594 HD13 HD13 ' A' ' 118' ' ' LEU . 65.0 mt -66.26 -35.73 81.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 1.0600000000000001 110.642 -179.554 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -61.81 -48.51 80.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.803 -1.185 . . . . 2.1800000000000002 110.396 179.466 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -59.74 -30.24 68.71 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.589 -1.244 . . . . 2.1499999999999999 109.649 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 130' ' ' VAL . 58.6 ttt180 -62.27 -29.19 70.24 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.22 -0.992 . . . . 2.3300000000000001 109.17 179.306 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -60.17 -49.75 76.39 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.868 0.842 . . . . 0.81999999999999995 109.805 178.361 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.23 75.92 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.676 -0.809 . . . . 0.84999999999999998 110.234 179.854 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -61.22 -34.08 74.53 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.635 0.731 . . . . 1.3899999999999999 110.648 -179.884 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.6 t -68.95 -37.28 77.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.324 -0.86 . . . . 0.56000000000000005 110.033 179.706 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.426 ' HG2' HH11 ' A' ' 131' ' ' ARG . 22.9 ttt-85 -57.93 -38.31 75.69 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.471 -1.292 . . . . 3.1200000000000001 109.429 178.656 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.498 ' OD1' ' NE ' ' A' ' 136' ' ' ARG . 8.3 t70 -60.11 -40.06 88.35 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.396 0.617 . . . . 1.28 110.568 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 73.1 mt -61.41 -34.68 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.378 -0.826 . . . . 0.48999999999999999 110.18 -179.611 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -64.91 -51.4 51.66 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.131 -1.033 . . . . 0.46000000000000002 110.657 178.783 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -57.9 -40.37 80.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.87 -1.371 . . . . 2.71 110.467 179.547 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.498 ' NE ' ' OD1' ' A' ' 132' ' ' ASP . 58.5 mtt-85 -60.5 -43.24 97.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.998 -1.064 . . . . 2.1400000000000001 110.131 -179.979 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.5 tp -61.26 -44.57 97.03 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.087 -1.008 . . . . 1.05 110.224 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.09 -42.4 90.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.553 -0.717 . . . . 0.52000000000000002 110.547 179.666 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.485 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 98.1 mtt180 -61.38 -34.42 75.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.159 -0.963 . . . . 2.3500000000000001 111.206 -179.851 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -74.06 -43.4 57.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.557 -1.339 . . . . 1.3899999999999999 110.618 179.827 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.4 mt -60.9 -39.38 81.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.52 -0.737 . . . . 0.68000000000000005 110.455 -178.521 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.4 mt -88.84 -11.65 44.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.532 -0.73 . . . . 0.82999999999999996 111.996 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.4 22.83 69.44 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 120.323 -0.941 . . . . 0.91000000000000003 113.581 -179.542 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.39 142.9 58.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.58 -0.953 . . . . 0.94999999999999996 109.534 179.647 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -68.05 151.94 46.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.894 . . . . 2.4300000000000002 110.307 178.377 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.7 mt -104.58 136.89 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.033 -1.099 . . . . 1.1000000000000001 108.033 178.21 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.73 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -81.86 129.62 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.979 -1.119 . . . . 1.5800000000000001 107.979 179.125 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -95.85 98.68 10.61 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.067 -1.827 . . . . 1.6200000000000001 106.067 178.873 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.7 mt -77.37 -14.28 59.75 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.529 -0.732 . . . . 0.80000000000000004 111.775 -177.745 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.6 t -80.1 8.32 7.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.379 -0.826 . . . . 1.5600000000000001 112.323 -179.574 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.34 17.22 17.91 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.647 0.737 . . . . 0.83999999999999997 112.315 179.565 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.4 mt -73.22 136.2 25.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.942 -0.762 . . . . 0.81999999999999995 108.942 179.0 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -124.29 -7.25 7.62 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.547 -0.721 . . . . 2.3100000000000001 112.651 -178.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -110.63 137.5 48.23 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.06 -1.089 . . . . 1.54 108.06 179.794 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -77.25 119.82 21.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.247 -0.908 . . . . 1.3799999999999999 108.695 178.851 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.2 m -148.12 179.49 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.835 -0.802 . . . . 0.68999999999999995 108.835 -178.965 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 30.6 mt -88.33 142.86 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.991 -1.068 . . . . 0.53000000000000003 108.943 178.212 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.0 tp -98.02 120.5 38.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.816 -1.178 . . . . 0.64000000000000001 108.141 178.251 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.24 130.15 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.418 -0.956 . . . . 0.67000000000000004 108.418 179.397 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.36 159.14 27.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.243 -0.911 . . . . 0.78000000000000003 108.752 179.534 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.03 95.6 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.494 -1.378 . . . . 1.0 109.778 177.855 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -172.67 152.65 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.906 -0.775 . . . . 2.4199999999999999 108.906 -179.744 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 64.9 mt -118.99 141.33 48.77 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.315 -0.866 . . . . 0.75 109.09 177.383 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 168' ' ' THR . 68.9 p -90.55 148.82 39.59 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.182 -0.949 . . . . 0.78000000000000003 108.919 179.21 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -40.15 -45.52 4.06 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.645 2.23 . . . . 0.67000000000000004 113.891 179.142 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.0 m -60.09 -46.3 90.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.918 -1.114 . . . . 0.69999999999999996 110.063 -179.607 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.41 -38.49 91.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.27 -0.894 . . . . 1.21 110.331 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 164' ' ' THR . 23.8 p -67.61 -40.75 84.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 0.59999999999999998 110.83 179.662 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.3 74.41 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.791 -0.764 . . . . 0.62 110.339 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -93.38 -4.85 50.72 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.007 -1.058 . . . . 1.1599999999999999 112.862 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.23 153.45 34.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.72999999999999998 109.631 179.878 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -94.13 117.33 29.96 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.292 -1.744 . . . . 2.2400000000000002 106.292 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.785 ' H ' HD22 ' A' ' 173' ' ' LEU . 0.7 OUTLIER -82.46 -19.47 38.81 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.472 -0.767 . . . . 1.4299999999999999 112.396 -177.701 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -84.23 -20.87 31.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.238 -0.913 . . . . 2.1499999999999999 111.912 -178.569 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -99.96 2.32 43.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.187 -0.946 . . . . 2.04 112.528 -179.254 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.472 HG12 ' H ' ' A' ' 178' ' ' GLY . 61.4 t -112.99 129.95 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 107.873 -1.158 . . . . 0.55000000000000004 107.873 179.352 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.584 HD13 ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -82.81 -16.35 48.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.007 -1.058 . . . . 1.6299999999999999 111.705 -179.541 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.472 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -176.69 171.33 44.27 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.073 -1.611 . . . . 0.46999999999999997 109.073 179.909 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -125.79 124.56 41.26 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 107.344 -1.354 . . . . 0.54000000000000004 107.344 178.196 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 180' ' ' ILE . 46.6 mt -123.27 129.75 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 106.952 -1.499 . . . . 0.68999999999999995 106.952 178.215 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 203' ' ' VAL . 34.2 p -140.61 170.0 16.6 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.907 -1.12 . . . . 0.81999999999999995 109.802 179.772 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.94 36.08 3.0 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.871 -0.518 . . . . 2.3700000000000001 111.007 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -96.87 151.53 19.58 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.191 -0.943 . . . . 1.1100000000000001 110.352 178.75 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -46.33 -28.36 3.23 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 120.162 -1.018 . . . . 1.6699999999999999 112.609 177.696 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 87.69 -33.12 4.03 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 121.037 -1.272 . . . . 1.54 113.625 179.406 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -60.44 -40.65 91.86 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.007 -1.29 . . . . 4.4800000000000004 110.346 179.709 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.4 p -118.38 20.18 13.16 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.52 -0.737 . . . . 2.6299999999999999 111.208 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.3 p -89.11 120.46 30.53 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.772 -1.196 . . . . 1.6899999999999999 107.772 178.771 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -60.46 -32.27 71.23 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.388 -0.82 . . . . 1.0700000000000001 110.407 179.827 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 63.0 p -54.68 -41.11 69.82 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.037 -1.039 . . . . 1.5800000000000001 110.68 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.3 t -60.02 -39.83 87.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.298 -0.876 . . . . 1.6000000000000001 109.918 179.818 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.1 mm -59.72 -36.36 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.74 . . . . 1.45 110.392 179.119 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 82.5 mtp -63.0 -43.53 98.54 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.225 1.012 . . . . 1.05 109.209 179.509 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -57.38 -45.09 84.83 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.691 -0.631 . . . . 0.71999999999999997 110.656 179.538 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -63.23 -44.95 93.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.95 -1.093 . . . . 3.0499999999999998 110.435 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.2 m -70.3 -40.88 74.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.913 . . . . 0.89000000000000001 110.257 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.8 mt -91.21 -6.36 53.5 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.494 0.664 . . . . 0.78000000000000003 112.242 -177.145 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 194' ' ' ALA . 98.0 mt-10 50.54 9.42 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.991 1.108 . . . . 1.45 113.991 179.899 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 80.9 mt -71.63 147.67 92.31 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.675 -1.266 . . . . 0.67000000000000004 108.212 179.113 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.52 138.76 81.37 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.454 1.436 . . . . 0.64000000000000001 110.227 178.66 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.54 166.67 20.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.312 -1.755 . . . . 0.67000000000000004 109.865 179.694 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.4 mt -146.25 156.03 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.188 -1.412 . . . . 0.68999999999999995 107.188 177.541 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.0 m -140.38 -32.37 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 120.742 -1.224 . . . . 0.84999999999999998 113.035 -179.166 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -95.28 39.87 2.78 Favored Glycine 0 N--CA 1.497 2.744 0 O-C-N 120.942 -1.099 . . . . 0.92000000000000004 112.076 -177.943 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.505 ' OG1' HG23 ' A' ' 208' ' ' VAL . 23.1 p -59.21 -23.75 62.55 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.089 -1.242 . . . . 0.94999999999999996 111.799 -179.482 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 101.78 -86.16 0.58 Allowed Glycine 0 N--CA 1.496 2.654 0 C-N-CA 120.396 -0.907 . . . . 1.04 111.345 179.807 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.7 m -132.58 36.56 3.55 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 121.124 -1.221 . . . . 1.5700000000000001 113.16 -178.529 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.505 HG23 ' OG1' ' A' ' 205' ' ' THR . 93.1 t -53.06 -33.83 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.336 -1.477 . . . . 0.83999999999999997 110.396 179.252 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 81.2 p -61.31 -20.62 63.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.98999999999999999 112.018 -179.675 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.2 m -96.08 2.72 53.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.057 -1.027 . . . . 1.7 112.289 179.63 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -132.05 2.97 4.01 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 112.907 0.706 . . . . 2.2000000000000002 112.907 -178.281 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 36.0 t -122.54 142.43 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.439 -0.788 . . . . 0.83999999999999997 109.658 -178.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -119.27 149.15 42.25 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.261 -1.014 . . . . 2.2000000000000002 108.261 177.596 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.464 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 40.3 p-10 -50.73 140.16 15.21 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.876 -1.14 . . . . 2.2799999999999998 110.023 178.688 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t0 79.62 -2.07 2.13 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.482 1.29 . . . . 2.3500000000000001 114.482 179.639 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.09 147.0 53.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.532 -1.355 . . . . 1.97 108.233 177.632 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -88.67 120.84 30.43 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.184 -1.413 . . . . 2.6499999999999999 107.184 178.274 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.449 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 56.6 mt -128.14 146.41 50.72 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.55 -0.719 . . . . 0.63 109.854 -179.56 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.53 HD13 ' SD ' ' A' ' 239' ' ' MET . 84.5 mt -114.07 125.02 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 106.788 -1.56 . . . . 0.62 106.788 177.522 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.0 tp -99.86 115.26 29.2 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.315 -1.735 . . . . 0.64000000000000001 106.315 178.528 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 223' ' ' VAL . 30.0 p-10 -92.72 -25.53 18.17 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.663 -1.215 . . . . 2.0499999999999998 112.664 -177.848 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.871 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.47 21.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 112.903 0.705 . . . . 0.83999999999999997 112.903 -178.659 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.3 t -112.79 -59.67 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 121.116 -0.99 . . . . 1.02 109.451 -179.876 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 36.7 m120 -95.79 13.5 26.39 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.148 0.975 . . . . 2.5099999999999998 110.096 -179.701 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 60.76 51.82 4.66 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.23 -0.895 . . . . 1.54 111.85 179.326 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.451 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 81.2 mt-30 -149.54 148.17 29.05 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.246 1.022 . . . . 1.95 110.079 178.454 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.54 138.07 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.312 -1.366 . . . . 0.70999999999999996 107.312 177.887 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -99.58 136.92 38.79 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.933 -1.104 . . . . 1.01 108.516 178.694 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.7 t -109.82 130.18 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 109.001 -0.741 . . . . 0.81999999999999995 109.001 179.135 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 49.42 55.6 17.31 Favored Pre-proline 0 N--CA 1.498 1.973 0 N-CA-C 113.566 0.95 . . . . 1.54 113.566 178.792 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.08 150.66 82.39 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.474 2.116 . . . . 0.93999999999999995 110.412 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.504 ' OG1' HG23 ' A' ' 235' ' ' VAL . 31.1 p -72.08 154.55 41.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 1.8 108.915 177.647 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -57.39 -40.14 77.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.058 -1.026 . . . . 2.73 110.8 178.952 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -60.96 -39.04 88.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -0.984 . . . . 3.1699999999999999 110.332 -179.852 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.504 HG23 ' OG1' ' A' ' 232' ' ' THR . 74.6 t -69.38 -36.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.331 -0.856 . . . . 1.3400000000000001 110.038 179.413 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.41 ' CG2' HH12 ' A' ' 240' ' ' ARG . 95.5 mt -59.16 -46.01 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 1.2 110.462 178.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -59.66 -40.56 88.16 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.07 -1.052 . . . . 2.7000000000000002 109.969 179.491 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -61.17 -40.08 92.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.527 -0.733 . . . . 2.5899999999999999 110.221 179.834 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.53 ' SD ' HD13 ' A' ' 219' ' ' ILE . 76.9 mtp -70.84 -33.78 71.01 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.36 -0.838 . . . . 1.3799999999999999 110.5 -179.807 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.55 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.1 OUTLIER -56.46 -41.14 76.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.942 -1.098 . . . . 2.8399999999999999 109.364 179.619 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.05 -42.52 66.18 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.677 -0.639 . . . . 1.8799999999999999 110.209 179.794 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 72.9 t -59.69 -48.76 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.388 -0.82 . . . . 2.3999999999999999 110.452 -178.265 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 13' ' ' PHE . 51.5 tt0 -59.98 -50.59 73.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.622 -1.298 . . . . 3.52 110.591 179.816 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.05 -31.08 72.13 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.188 -1.005 . . . . 1.8799999999999999 109.711 -179.747 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -62.81 -30.29 71.36 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.512 -0.875 . . . . 3.0099999999999998 109.138 178.755 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.24 -40.08 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.406 -0.917 . . . . 2.4500000000000002 109.192 178.792 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.6 -38.15 71.64 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.871 -1.132 . . . . 2.75 109.357 179.029 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.3 t -68.12 -30.45 69.61 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.42 0.629 . . . . 3.1600000000000001 109.645 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -63.48 -29.28 70.58 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.524 0.678 . . . . 3.5699999999999998 110.85 179.555 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -61.54 -28.38 69.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.425 -0.797 . . . . 4.2999999999999998 111.172 179.479 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -65.67 -10.76 39.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 4.4500000000000002 111.879 179.634 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.16 -7.97 52.11 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.277 -0.889 . . . . 5.9699999999999998 112.529 -179.396 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 34.4 tp -63.74 -24.64 67.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.125 -0.984 . . . . 6.1799999999999997 111.265 -179.258 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -70.12 -1.25 9.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.154 -0.966 . . . . 6.6600000000000001 112.657 179.844 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -82.04 11.85 4.76 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.181 -0.949 . . . . 8.1999999999999993 112.488 -179.346 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.528 ' CD2' ' H ' ' A' ' 256' ' ' LEU . 0.7 OUTLIER -82.09 9.4 8.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.117 -0.99 . . . . 8.0700000000000003 112.454 179.626 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -81.86 -2.3 50.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.989 . . . . 9.4499999999999993 111.919 -179.796 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -93.91 -1.6 54.5 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.301 -0.874 . . . . 10.119999999999999 112.628 -177.993 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 42.9 mtm-85 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.094 -0.955 . . . . 11.49 109.202 -178.839 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.087 -0.708 . . . . 3.0699999999999998 109.087 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.0 mt -102.24 109.53 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.018 -1.845 . . . . 1.0700000000000001 106.018 176.481 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.3 m -105.85 124.06 48.96 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.661 -1.236 . . . . 1.24 107.661 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.593 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -104.51 -144.44 13.14 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 108.88 -1.688 . . . . 1.01 108.88 179.527 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 5' ' ' ILE . 73.1 mt -97.28 -3.77 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.146 -1.208 . . . . 1.1100000000000001 112.635 -179.085 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.453 ' H ' HG23 ' A' ' 202' ' ' ILE . 3.8 tp 49.77 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.226 -0.921 . . . . 0.98999999999999999 112.437 178.947 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -85.58 -40.07 16.67 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.099 -1.0 . . . . 0.84999999999999998 112.152 178.967 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 m -147.02 144.9 20.55 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 120.982 -1.074 . . . . 1.3799999999999999 108.379 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.53 143.95 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.724 2.283 . . . . 0.93999999999999995 112.127 178.246 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.883 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.08 171.41 21.73 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.319 -1.512 . . . . 0.81000000000000005 109.319 178.189 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.8 mt -129.92 133.8 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 N-CA-C 107.702 -1.222 . . . . 0.82999999999999996 107.702 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.38 155.52 47.6 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.564 -0.71 . . . . 0.53000000000000003 109.119 178.742 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.571 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.9 m-85 -126.46 140.18 52.67 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.681 -1.229 . . . . 0.77000000000000002 107.681 177.97 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.83 170.5 41.78 Favored Glycine 0 N--CA 1.499 2.882 0 C-N-CA 118.382 -1.866 . . . . 0.51000000000000001 110.297 178.175 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -77.12 154.26 33.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.965 . . . . 1.8999999999999999 108.938 178.502 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.558 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.03 125.79 33.02 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.233 -1.025 . . . . 0.66000000000000003 108.233 178.373 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.3 tp -105.49 105.92 16.19 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.458 -2.053 . . . . 0.82999999999999996 105.458 177.659 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 16.6 tp -94.18 135.39 35.61 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.957 -1.127 . . . . 0.85999999999999999 107.957 179.96 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.4 mt -99.36 114.94 28.11 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.832 -1.544 . . . . 0.92000000000000004 106.832 178.353 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -110.38 124.41 51.65 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.626 -1.62 . . . . 2.0299999999999998 106.626 -179.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -129.77 147.52 51.55 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.418 -0.801 . . . . 2.6600000000000001 109.39 -179.493 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 27.6 p-10 -81.55 140.9 34.24 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.912 -1.118 . . . . 2.3199999999999998 109.088 177.807 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -64.69 149.94 48.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.04 -1.038 . . . . 2.1099999999999999 110.976 178.283 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.9 mt -90.8 133.8 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.15 -0.969 . . . . 0.72999999999999998 108.811 178.15 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.3 t -109.29 129.79 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.225 -1.028 . . . . 0.87 108.225 179.119 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.0 mt -94.66 137.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.127 -1.064 . . . . 0.81000000000000005 108.127 178.778 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.95 122.44 35.32 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.977 -1.12 . . . . 1.3400000000000001 107.977 178.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -99.56 18.12 18.72 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.342 -0.849 . . . . 2.8900000000000001 112.631 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -69.18 146.79 52.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 2.0899999999999999 109.428 178.738 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -88.98 130.88 35.38 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.329 -0.989 . . . . 2.1899999999999999 108.329 177.669 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.7 pt -93.33 164.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.751 0.786 . . . . 0.75 110.066 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.2 p -95.41 163.85 13.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.587 -0.695 . . . . 0.91000000000000003 109.659 178.525 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.8 -22.3 13.9 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.113 -0.992 . . . . 0.93000000000000005 111.91 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -68.69 -37.06 79.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.932 . . . . 2.2799999999999998 110.54 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -92.29 -6.31 50.6 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.791 -1.193 . . . . 1.45 113.174 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.31 -42.98 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.055 -1.028 . . . . 0.81000000000000005 110.576 -179.433 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -58.36 -37.55 75.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.137 -0.977 . . . . 1.54 110.263 179.726 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -61.93 -43.92 97.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.646 -0.659 . . . . 2.3599999999999999 110.847 179.906 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.47 -39.12 86.49 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.045 -1.035 . . . . 1.3100000000000001 111.367 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.26 -40.19 83.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.045 -1.035 . . . . 0.81999999999999995 110.757 179.429 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -60.95 -48.32 82.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.155 -0.965 . . . . 1.5 110.064 179.663 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -62.17 -38.31 88.55 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.167 -0.958 . . . . 2.23 110.278 179.842 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -74.16 -51.03 16.81 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.858 -1.151 . . . . 0.84999999999999998 110.285 179.437 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.4 tp -62.81 -49.67 74.0 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.29 -0.964 . . . . 0.91000000000000003 109.448 -179.622 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.7 t -69.3 -38.77 78.46 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.505 0.669 . . . . 0.90000000000000002 109.653 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.09 -43.54 93.29 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.601 -1.4 . . . . 0.68999999999999995 109.601 179.629 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -59.31 -31.74 69.43 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.07 -1.052 . . . . 2.8799999999999999 109.644 178.871 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -53.78 -47.67 70.53 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.835 -0.746 . . . . 0.84999999999999998 109.919 179.089 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -77.78 -39.77 42.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 2.3500000000000001 110.344 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.76 91.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.65000000000000002 110.049 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.5 p -60.47 -39.6 88.18 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.223 1.011 . . . . 1.45 109.357 179.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.12 -46.02 72.06 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.602 -0.727 . . . . 0.63 110.942 179.494 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.5 -50.09 72.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.222 -0.924 . . . . 1.3400000000000001 110.753 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.21 -36.83 84.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 1.5600000000000001 109.844 -179.889 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -59.39 -40.24 85.95 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.639 -0.663 . . . . 1.1899999999999999 110.53 179.155 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.9 m -66.89 -41.69 86.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.047 -1.033 . . . . 0.71999999999999997 110.324 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.3 -34.03 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.439 -0.788 . . . . 0.62 110.834 -179.703 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -55.93 -45.02 78.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.412 -0.805 . . . . 1.05 111.018 179.301 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.49 -33.44 71.23 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.003 -1.061 . . . . 0.64000000000000001 110.545 -179.626 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -62.75 -40.27 96.7 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.653 -1.219 . . . . 1.73 109.443 -179.844 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.72 -34.52 78.03 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.776 -0.577 . . . . 0.56000000000000005 110.363 179.679 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.88 -37.52 25.7 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.536 -1.316 . . . . 0.68999999999999995 111.41 179.701 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -79.88 -22.31 43.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.036 -1.273 . . . . 1.48 110.815 -179.676 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -89.43 -50.96 5.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.363 -0.836 . . . . 0.97999999999999998 110.597 179.853 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -108.34 -6.99 16.0 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.143 1.164 . . . . 1.1599999999999999 114.143 -177.543 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.6 157.48 23.58 Favored Glycine 0 N--CA 1.502 3.072 0 O-C-N 121.056 -1.028 . . . . 0.84999999999999998 113.473 178.519 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -51.03 -20.69 1.48 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.498 -1.001 . . . . 3.8599999999999999 112.791 179.197 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.49 -35.31 72.03 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.822 -1.174 . . . . 2.3500000000000001 111.489 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -84.16 -18.85 35.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.021 -1.049 . . . . 1.6699999999999999 112.494 -179.555 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.96 -32.71 71.07 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.975 -1.078 . . . . 1.45 110.636 -179.372 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.51 86.88 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.038 -1.039 . . . . 0.60999999999999999 110.598 179.329 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.0 mt -66.33 -47.66 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.118 -0.989 . . . . 0.65000000000000002 109.828 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -72.04 -36.54 69.65 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.219 -0.925 . . . . 0.66000000000000003 110.018 179.822 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.92 -39.11 84.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.493 -0.754 . . . . 1.1899999999999999 110.074 -179.966 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.01 -35.37 83.92 Favored Glycine 0 N--CA 1.484 1.867 0 C-N-CA 119.795 -1.193 . . . . 0.53000000000000003 110.491 179.579 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -60.22 -41.27 92.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -1.135 . . . . 1.27 110.542 179.117 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.4 mt -60.96 -41.94 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.025 -1.047 . . . . 0.54000000000000004 110.423 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.0 ttm -59.77 -40.57 88.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -0.866 . . . . 1.74 110.576 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -60.39 -46.32 90.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.914 -1.116 . . . . 0.55000000000000004 110.032 179.799 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.0 tp -59.0 -40.36 84.65 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.402 -0.811 . . . . 0.46999999999999997 110.487 179.81 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -87.08 8.01 25.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.506 -0.746 . . . . 1.4199999999999999 112.685 -179.887 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -60.26 118.94 7.01 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.185 -0.947 . . . . 1.27 109.61 179.609 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.57 -18.36 63.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.772 0.796 . . . . 1.3500000000000001 110.954 -179.532 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.82 -52.79 8.33 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.747 -0.781 . . . . 2.2200000000000002 110.401 -179.918 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.4 mt -61.24 -37.87 84.62 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.18 -1.008 . . . . 0.62 110.441 -179.529 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -58.88 -48.6 80.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 1.29 110.497 179.216 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.4 -38.81 91.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.285 -0.884 . . . . 1.52 110.476 179.814 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.78 -48.17 72.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.991 -1.068 . . . . 1.3 110.503 179.713 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 93.1 mt -58.29 -42.09 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.252 -0.905 . . . . 0.60999999999999999 109.973 179.419 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.2 mt -63.43 -41.39 92.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.466 -0.772 . . . . 0.78000000000000003 110.167 179.797 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.93 99.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.426 -0.796 . . . . 0.81999999999999995 110.664 -179.778 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.0 mt -59.66 -43.72 93.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.80000000000000004 110.492 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.56 -48.2 89.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.051 -1.031 . . . . 0.77000000000000002 109.911 179.72 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.94 -36.23 41.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.783 . . . . 2.1200000000000001 111.709 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -78.94 -48.29 14.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.709 -1.244 . . . . 1.51 111.315 -178.985 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -101.32 8.65 42.27 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.311 -0.868 . . . . 1.98 112.358 -177.685 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m80 50.67 51.31 17.18 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.972 -1.091 . . . . 1.3200000000000001 111.568 179.892 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.9 mtp -107.79 157.0 18.51 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.55 -0.719 . . . . 1.3799999999999999 109.239 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.2 p -73.95 158.76 33.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.606 -0.684 . . . . 0.67000000000000004 109.407 177.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.75 91.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.485 -0.76 . . . . 0.52000000000000002 110.613 179.347 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 28.8 p-10 -68.05 -42.84 79.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.953 -1.092 . . . . 2.25 110.014 179.314 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -68.28 -50.64 52.34 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.461 -0.896 . . . . 0.64000000000000001 110.734 -179.885 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.24 88.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 0.56000000000000005 110.592 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.69 -45.65 91.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 0.46000000000000002 111.39 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -60.45 -39.24 86.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.792 -1.192 . . . . 1.3200000000000001 111.539 -179.686 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.49 -47.89 78.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.693 -1.255 . . . . 1.3 111.031 179.597 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.18 -44.25 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.723 -1.235 . . . . 0.60999999999999999 109.742 179.854 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -62.74 -34.7 67.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.631 -0.668 . . . . 0.65000000000000002 110.755 179.998 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -56.6 -40.55 75.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.845 . . . . 2.1099999999999999 111.214 179.469 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.21 -34.07 13.26 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.201 -1.476 . . . . 0.82999999999999996 112.91 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -59.97 -38.26 82.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.398 -1.648 . . . . 1.28 110.04 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.04 -47.23 38.2 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.722 0.773 . . . . 0.89000000000000001 110.704 179.599 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.7 m -60.37 -40.17 89.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.092 -1.005 . . . . 1.8700000000000001 110.599 -178.585 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.6 -47.16 86.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.377 -0.827 . . . . 1.05 110.929 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.12 -29.76 69.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.881 -1.137 . . . . 1.02 110.837 -179.829 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -65.06 -22.35 66.96 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.342 -0.849 . . . . 2.04 110.571 179.437 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -71.1 -12.94 61.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.909 0.862 . . . . 1.73 110.815 179.87 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.5 mt -88.49 135.86 33.27 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.806 -1.183 . . . . 1.3700000000000001 107.806 178.712 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 45.6 t0 -97.99 40.99 1.14 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.388 -0.82 . . . . 2.8799999999999999 111.98 -179.381 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -114.53 140.38 48.81 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 121.007 -1.058 . . . . 1.5800000000000001 108.966 178.987 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.07 -40.35 73.46 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.871 -0.732 . . . . 3.04 110.816 178.557 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -71.23 -56.88 5.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.102 -0.999 . . . . 0.90000000000000002 110.59 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.62 -40.5 83.51 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.19 -0.944 . . . . 1.0600000000000001 110.41 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -63.31 -47.77 80.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.02 -1.05 . . . . 2.1800000000000002 109.794 179.866 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -60.17 -31.15 69.85 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.213 -0.929 . . . . 2.1499999999999999 110.092 179.715 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -61.66 -30.07 70.48 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.552 -1.259 . . . . 2.3300000000000001 109.262 179.269 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.78 -50.38 73.69 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.74 -0.784 . . . . 0.81999999999999995 109.423 178.682 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.55 -43.42 80.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.679 0.752 . . . . 0.84999999999999998 110.315 179.769 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -62.8 -32.7 73.94 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.671 0.748 . . . . 1.3899999999999999 110.283 -179.691 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 t -68.69 -39.63 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.419 -0.801 . . . . 0.56000000000000005 110.097 179.589 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -59.48 -37.45 78.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.057 -1.027 . . . . 3.1200000000000001 109.764 178.852 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -59.92 -40.16 87.93 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.484 0.659 . . . . 1.28 110.259 179.436 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.6 mt -59.57 -39.8 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.48999999999999999 110.456 179.598 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.33 -45.51 69.09 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 110.54 -1.024 . . . . 0.46000000000000002 110.54 179.388 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -59.15 -46.77 87.5 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.059 -1.259 . . . . 2.71 110.208 179.41 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 64.4 mtt-85 -62.22 -38.89 90.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.888 -1.132 . . . . 2.1400000000000001 110.273 179.751 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.0 tp -60.15 -41.02 91.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.682 -0.637 . . . . 1.05 109.852 178.911 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.3 mt -59.66 -40.05 86.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.606 -0.684 . . . . 0.52000000000000002 110.58 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -60.28 -39.21 86.08 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.206 -0.934 . . . . 2.3500000000000001 111.256 179.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -73.56 -41.62 62.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.108 . . . . 1.3899999999999999 110.985 -179.866 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.33 -40.08 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.849 . . . . 0.68000000000000005 110.548 -178.436 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.3 mt -89.32 -8.0 54.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.031 -1.043 . . . . 0.82999999999999996 111.891 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.57 23.22 70.79 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.761 -1.209 . . . . 0.91000000000000003 113.518 -179.511 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 18.6 tp -67.23 139.91 57.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.934 -0.745 . . . . 0.94999999999999996 109.115 179.578 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -70.03 146.97 50.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.421 -0.799 . . . . 2.4300000000000002 109.357 177.892 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 79.7 mt -108.68 138.67 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 121.128 -0.982 . . . . 1.1000000000000001 108.619 178.746 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.719 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -78.66 131.65 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.702 -1.249 . . . . 1.5800000000000001 108.808 178.888 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -94.51 97.37 10.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.396 -1.705 . . . . 1.6200000000000001 106.396 178.686 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 mt -77.58 -13.37 59.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.473 -0.767 . . . . 0.80000000000000004 111.916 -177.861 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.8 t -82.9 3.33 30.27 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.906 -1.121 . . . . 1.5600000000000001 112.584 -179.734 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.5 15.26 22.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.316 -0.865 . . . . 0.83999999999999997 112.31 179.451 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 24.6 mt -71.93 140.05 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.565 -0.71 . . . . 0.81999999999999995 109.591 178.801 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -127.91 -6.71 5.56 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.717 0.77 . . . . 2.3100000000000001 112.323 -179.436 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -110.2 140.21 44.57 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.571 -0.9 . . . . 1.54 108.571 179.459 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -71.61 120.84 17.77 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.589 -0.893 . . . . 1.3799999999999999 108.589 178.403 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.51 171.74 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.985 -0.746 . . . . 0.68999999999999995 108.985 -179.864 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.3 mt -93.18 141.12 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.295 -1.002 . . . . 0.53000000000000003 108.295 178.275 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 26.8 tp -96.79 120.98 38.13 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.0 -1.063 . . . . 0.64000000000000001 108.627 178.46 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.42 HG12 HG22 ' A' ' 209' ' ' THR . 44.6 t -121.21 131.15 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 107.816 -1.179 . . . . 0.67000000000000004 107.816 179.781 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.403 ' C ' HG21 ' A' ' 209' ' ' THR . . . -162.94 157.98 21.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.018 . . . . 0.78000000000000003 108.785 179.084 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.404 ' N ' HG21 ' A' ' 209' ' ' THR . . . -61.35 -34.45 75.31 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.303 -1.498 . . . . 1.0 109.474 178.079 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -173.04 154.91 2.91 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.827 -0.805 . . . . 2.4199999999999999 108.827 179.574 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 69.0 mt -121.64 137.81 54.59 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.375 -1.343 . . . . 0.75 107.375 177.519 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.8 p -93.45 148.24 35.17 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.843 -1.161 . . . . 0.78000000000000003 108.676 179.529 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -39.72 -40.99 2.52 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 122.066 1.844 . . . . 0.67000000000000004 113.485 178.811 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.4 m -60.98 -50.23 74.22 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.254 -0.903 . . . . 0.69999999999999996 110.238 -179.727 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -61.61 -38.55 88.0 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.952 -1.093 . . . . 1.21 109.704 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.4 p -68.61 -36.93 79.32 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.335 0.588 . . . . 0.59999999999999998 110.639 179.524 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.36 -35.02 79.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.402 -0.811 . . . . 0.62 110.64 179.869 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -97.26 -0.6 46.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.477 -0.764 . . . . 1.1599999999999999 112.503 -179.08 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.6 tp -64.21 153.72 37.12 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.735 -0.603 . . . . 0.72999999999999998 109.646 179.749 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.13 113.15 24.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 106.848 -1.538 . . . . 2.2400000000000002 106.848 177.615 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.36 -17.0 60.88 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.873 -0.517 . . . . 1.4299999999999999 112.356 -178.018 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -84.63 -15.43 45.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.105 -0.997 . . . . 2.1499999999999999 112.421 -178.574 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -103.69 -9.7 18.93 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.685 0.994 . . . . 2.04 113.685 -178.032 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 178' ' ' GLY . 59.3 t -109.51 129.98 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.768 -0.827 . . . . 0.55000000000000004 108.768 179.666 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.582 HD13 ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -88.07 -11.56 46.78 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.075 -1.016 . . . . 1.6299999999999999 111.827 -179.428 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.427 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -173.8 167.78 40.43 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.292 -1.523 . . . . 0.46999999999999997 109.292 179.807 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -124.15 131.99 53.59 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.218 -1.166 . . . . 0.54000000000000004 107.995 178.586 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.5 mt -131.49 132.14 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.019 -1.104 . . . . 0.68999999999999995 108.019 178.795 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 203' ' ' VAL . 55.5 p -135.5 163.37 30.23 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.192 -1.04 . . . . 0.81999999999999995 108.192 178.08 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.452 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 17.6 m-20 -106.51 12.35 29.65 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.248 -0.908 . . . . 2.3700000000000001 112.133 179.065 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 184' ' ' GLY . . . -134.66 -62.5 0.73 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.154 -0.966 . . . . 1.1100000000000001 113.184 -177.068 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 183' ' ' ALA . . . -38.27 151.22 0.04 OUTLIER Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.453 -0.659 . . . . 1.6699999999999999 111.453 -176.443 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 172.2 -70.3 0.11 Allowed Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.194 -1.479 . . . . 1.54 112.516 179.343 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.509 ' O ' HG23 ' A' ' 187' ' ' THR . 57.7 mtp180 -54.61 -42.2 70.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -1.223 . . . . 4.4800000000000004 110.755 -178.915 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 186' ' ' ARG . 31.2 p -159.08 45.73 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.825 . . . . 2.6299999999999999 111.114 -179.498 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.0 p -78.85 136.94 37.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.908 -1.12 . . . . 1.6899999999999999 109.355 -179.476 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -60.14 -30.86 69.57 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.627 -0.671 . . . . 1.0700000000000001 110.492 178.863 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.4 m -59.43 -39.6 84.05 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.152 -0.968 . . . . 1.5800000000000001 110.028 179.424 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 87.0 p -59.52 -37.56 78.68 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.271 -0.893 . . . . 1.6000000000000001 110.281 179.366 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.09 -39.75 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 1.45 110.493 179.48 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 45.0 mtp -61.74 -44.31 97.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.994 -1.067 . . . . 1.05 109.524 179.484 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.72 -50.58 72.91 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.373 -0.83 . . . . 0.71999999999999997 111.187 179.992 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -60.57 -42.75 97.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.025 -1.047 . . . . 3.0499999999999998 110.886 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.7 m -69.98 -38.44 76.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.932 -1.105 . . . . 0.89000000000000001 110.521 179.968 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.9 mt -91.66 -8.48 47.0 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.686 0.755 . . . . 0.78000000000000003 112.918 -179.222 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 194' ' ' ALA . 93.8 mt-10 56.75 9.88 0.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.244 1.201 . . . . 1.45 114.244 179.725 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.7 mt -71.41 149.49 93.8 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.945 -1.097 . . . . 0.67000000000000004 108.086 179.167 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.76 140.22 94.09 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.376 1.384 . . . . 0.64000000000000001 109.86 178.741 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.26 163.66 35.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.206 -1.559 . . . . 0.67000000000000004 110.132 179.881 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.462 ' CD1' HD11 ' A' ' 220' ' ' LEU . 11.8 mt -150.25 158.15 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.343 -1.354 . . . . 0.68999999999999995 107.343 178.17 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 181' ' ' THR . 7.0 m -146.78 -25.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 O-C-N 119.958 -1.714 . . . . 0.84999999999999998 113.672 -179.578 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -100.93 43.64 1.7 Allowed Glycine 0 N--CA 1.5 2.948 0 O-C-N 120.886 -1.134 . . . . 0.92000000000000004 110.564 -178.679 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.452 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 33.5 p -63.05 -21.02 65.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.08 -1.247 . . . . 0.94999999999999996 111.658 -179.651 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.84 -83.01 0.51 Allowed Glycine 0 N--CA 1.499 2.88 0 O-C-N 121.518 -0.739 . . . . 1.04 111.32 179.148 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 77.7 p -134.82 31.67 3.31 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.843 -1.386 . . . . 1.5700000000000001 113.256 -178.58 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.447 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 78.8 t -60.05 -37.92 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.173 -1.58 . . . . 0.83999999999999997 110.645 179.576 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.42 HG22 HG12 ' A' ' 159' ' ' VAL . 51.9 p -60.12 -18.97 51.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.174 -0.954 . . . . 0.98999999999999999 112.474 -179.623 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.7 m -94.31 -0.27 55.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 1.7 112.213 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -131.53 8.35 4.58 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.627 -0.671 . . . . 2.2000000000000002 112.545 -178.161 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.85 148.63 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.601 -0.687 . . . . 0.83999999999999997 109.625 -179.146 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -119.01 150.25 40.26 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.939 -1.134 . . . . 2.2000000000000002 107.939 177.857 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 49.6 p-10 -55.68 142.69 33.17 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.899 -1.125 . . . . 2.2799999999999998 110.374 178.414 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 m-20 80.34 -1.8 1.95 Allowed 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 114.276 1.213 . . . . 2.3500000000000001 114.276 179.289 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.14 147.63 50.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.921 -1.112 . . . . 1.97 108.816 177.718 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -88.64 118.35 28.25 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.362 -1.461 . . . . 2.6499999999999999 107.274 177.782 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.558 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.2 mt -128.22 150.34 50.07 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.837 -0.539 . . . . 0.63 109.788 -179.26 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.37 127.92 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 106.964 -1.495 . . . . 0.62 106.964 177.79 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.462 HD11 ' CD1' ' A' ' 202' ' ' ILE . 44.7 tp -100.35 119.92 39.16 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.005 -1.48 . . . . 0.64000000000000001 107.005 178.478 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.638 ' O ' ' N ' ' A' ' 223' ' ' VAL . 34.4 t0 -92.35 -25.37 18.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.771 -1.206 . . . . 2.0499999999999998 112.258 -177.873 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.883 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.34 11.11 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.025 0.75 . . . . 0.83999999999999997 113.025 -179.077 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.6 t -110.45 -62.27 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 120.836 -1.165 . . . . 1.02 109.108 179.776 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -88.52 5.9 40.44 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.213 1.006 . . . . 2.5099999999999998 110.23 -179.804 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.593 HD21 ' H ' ' A' ' 4' ' ' GLY . 1.0 OUTLIER 62.73 52.39 2.8 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.208 -0.905 . . . . 1.54 112.184 179.355 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -145.54 150.51 36.55 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.279 1.038 . . . . 1.95 109.973 178.111 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.11 138.23 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.29 -1.374 . . . . 0.70999999999999996 107.29 178.261 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -103.51 130.92 50.99 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.174 -1.047 . . . . 1.01 108.174 178.463 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 30.2 t -109.2 129.8 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 107.789 -1.189 . . . . 0.81999999999999995 107.789 178.815 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.442 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 19.4 t-20 54.26 49.98 6.27 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 1.54 113.47 178.764 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.4 Cg_endo -68.4 150.27 75.68 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.847 2.365 . . . . 0.93999999999999995 110.608 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.8 p -73.74 160.59 31.3 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.805 -1.184 . . . . 1.8 110.137 178.238 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.37 -41.62 89.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.537 -0.727 . . . . 2.73 110.702 179.046 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -61.94 -34.93 77.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.257 -0.902 . . . . 3.1699999999999999 110.586 -179.804 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.21 -37.4 76.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.965 -1.084 . . . . 1.3400000000000001 109.865 179.386 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.4 mt -58.29 -45.19 89.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.127 -0.983 . . . . 1.2 110.386 179.066 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -58.48 -39.98 81.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 2.7000000000000002 110.489 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -61.63 -45.52 93.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.4 -0.813 . . . . 2.5899999999999999 110.664 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 75.5 mtp -72.3 -35.52 68.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.036 -1.04 . . . . 1.3799999999999999 110.596 -179.697 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -57.46 -37.62 73.15 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.125 -0.985 . . . . 2.8399999999999999 110.664 -179.904 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -69.27 -46.08 68.13 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.44 -0.904 . . . . 1.8799999999999999 110.669 179.748 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 95.9 t -59.88 -47.72 90.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.111 -0.993 . . . . 2.3999999999999999 111.817 -179.445 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.64 -49.32 78.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.765 -1.209 . . . . 3.52 111.191 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.51 -36.63 84.39 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.21 -0.931 . . . . 1.8799999999999999 111.692 -179.455 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -61.22 -28.76 69.38 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.076 -1.449 . . . . 3.0099999999999998 110.041 179.426 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.04 -41.83 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.762 -0.775 . . . . 2.4500000000000002 110.368 178.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.09 -38.64 83.54 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.749 0.785 . . . . 2.75 110.233 179.566 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.8 t -68.69 -31.01 69.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.381 -0.824 . . . . 3.1600000000000001 110.863 179.761 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -62.24 -41.39 98.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.094 -1.004 . . . . 3.5699999999999998 110.507 179.631 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -68.52 -38.58 81.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 4.2999999999999998 110.491 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.49 -3.28 33.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.432 -0.793 . . . . 4.4500000000000002 112.368 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -70.85 -14.4 62.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.26 -0.9 . . . . 5.9699999999999998 112.034 -178.527 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.06 -39.62 86.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.673 -1.267 . . . . 6.1799999999999997 109.939 -179.9 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -71.5 -24.7 62.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 6.6600000000000001 110.832 179.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -88.45 32.95 0.76 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.135 0.969 . . . . 8.1999999999999993 112.153 -179.865 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.33 6.79 7.56 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.748 0.785 . . . . 8.0700000000000003 112.529 -179.675 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -81.24 -3.27 51.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 9.4499999999999993 112.399 179.809 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -96.83 -54.73 3.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.206 -0.934 . . . . 10.119999999999999 111.05 -179.438 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 117.928 -1.034 . . . . 11.49 108.806 -178.996 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.2 mtp . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.891 -0.411 . . . . 3.0699999999999998 109.891 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.8 mt -93.08 107.86 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 105.869 -1.9 . . . . 1.0700000000000001 105.869 177.315 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.8 m -106.93 120.28 41.62 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.929 -1.137 . . . . 1.24 107.929 -179.358 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.698 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -100.94 -156.21 27.25 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.602 -1.799 . . . . 1.01 108.602 179.496 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 5' ' ' ILE . 67.4 mt -96.88 1.41 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -1.209 . . . . 1.1100000000000001 112.713 -179.507 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 tp 48.82 98.11 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.044 -1.035 . . . . 0.98999999999999999 112.674 178.565 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -87.28 -39.16 15.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 0.84999999999999998 110.842 179.364 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -146.55 144.66 21.19 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.049 -1.093 . . . . 1.3799999999999999 108.049 -179.454 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.87 145.32 25.17 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.396 2.064 . . . . 0.93999999999999995 111.917 178.307 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.931 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.96 174.36 23.28 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.803 -1.719 . . . . 0.81000000000000005 108.803 178.116 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.9 mt -131.28 139.59 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.846 -1.168 . . . . 0.82999999999999996 107.846 179.759 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.52 148.54 42.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.662 -1.274 . . . . 0.53000000000000003 108.963 178.402 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -119.23 135.7 54.57 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 107.575 -1.269 . . . . 0.77000000000000002 107.575 177.348 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.1 168.41 40.23 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 118.304 -1.903 . . . . 0.51000000000000001 110.112 178.239 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -77.39 159.32 29.55 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.836 -0.802 . . . . 1.8999999999999999 108.836 178.12 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -83.85 120.26 25.85 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.766 -1.209 . . . . 0.66000000000000003 108.011 178.557 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.0 tp -102.46 102.66 12.98 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 105.266 -2.124 . . . . 0.82999999999999996 105.266 178.138 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.8 tp -88.96 130.03 35.52 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.735 -1.209 . . . . 0.85999999999999999 107.735 179.427 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.43 119.54 35.1 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.994 -1.484 . . . . 0.92000000000000004 106.994 178.389 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -110.19 137.57 47.75 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.465 -1.309 . . . . 2.0299999999999998 107.465 -179.787 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -116.22 139.31 50.48 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.111 -0.993 . . . . 2.6600000000000001 108.843 179.004 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -81.66 130.2 34.97 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.599 -1.26 . . . . 2.3199999999999998 107.599 177.758 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.35 141.17 58.87 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.575 -0.898 . . . . 2.1099999999999999 108.575 178.847 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.4 mt -95.73 132.55 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.275 -1.009 . . . . 0.72999999999999998 108.275 178.289 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.95 129.56 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.686 -1.227 . . . . 0.87 107.686 178.87 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.99 137.55 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.541 -0.911 . . . . 0.81000000000000005 108.541 179.302 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -92.34 125.18 36.89 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.944 -1.097 . . . . 1.3400000000000001 108.25 178.751 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -96.98 18.09 15.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -0.853 . . . . 2.8900000000000001 112.1 -179.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -66.9 152.63 45.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.17 -0.956 . . . . 2.0899999999999999 110.377 179.307 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -93.71 134.6 35.86 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.87 -0.789 . . . . 2.1899999999999999 108.87 177.975 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -95.92 169.26 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.526 -0.733 . . . . 0.75 109.784 179.336 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.0 p -94.25 161.93 14.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 0.91000000000000003 109.932 178.494 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.65 -23.08 15.69 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.799 -1.188 . . . . 0.93000000000000005 111.891 179.137 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -69.29 -37.41 77.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.424 -0.798 . . . . 2.2799999999999998 111.016 -179.47 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -88.47 -7.92 55.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.898 -1.126 . . . . 1.45 112.854 -179.852 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.75 -41.18 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.329 -0.857 . . . . 0.81000000000000005 110.219 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.4 -39.3 82.94 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.104 -0.998 . . . . 1.54 110.157 179.243 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -62.29 -40.28 95.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.622 -0.674 . . . . 2.3599999999999999 110.922 -179.993 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.63 -39.58 88.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 1.3100000000000001 110.771 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.12 -41.53 86.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.246 -0.982 . . . . 0.81999999999999995 110.111 179.275 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -61.54 -48.36 81.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.847 -1.158 . . . . 1.5 109.938 179.594 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.527 ' HG2' HH11 ' A' ' 42' ' ' ARG . 14.9 mtt-85 -60.52 -39.5 88.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.123 -0.986 . . . . 2.23 109.628 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -73.39 -52.85 12.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.979 -1.076 . . . . 0.84999999999999998 110.029 179.23 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.97 -45.12 95.06 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.121 -1.032 . . . . 0.91000000000000003 109.643 -179.868 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 9.3 t -67.99 -35.23 77.98 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.957 0.884 . . . . 0.90000000000000002 109.812 -179.761 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.84 -44.49 94.28 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.758 -1.337 . . . . 0.68999999999999995 109.758 178.733 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.416 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 38.1 ttm-85 -57.25 -32.29 66.41 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.065 0.936 . . . . 2.8799999999999999 109.495 178.869 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.76 -44.39 86.12 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.884 0.849 . . . . 0.84999999999999998 109.947 179.251 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -83.47 -43.92 15.29 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.59 -0.694 . . . . 2.3500000000000001 110.964 179.347 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.68 -42.96 89.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 0.65000000000000002 110.244 -179.898 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.415 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 22.9 t -62.89 -40.72 98.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.331 -0.856 . . . . 1.45 109.362 179.772 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.46 -48.79 54.18 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.411 0.624 . . . . 0.63 110.915 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -61.82 -47.75 83.67 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.581 -1.324 . . . . 1.3400000000000001 110.727 -178.592 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.69 -39.2 91.02 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.202 -0.936 . . . . 1.5600000000000001 110.34 -179.611 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 51' ' ' SER . 32.8 mm-40 -60.01 -40.55 89.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.807 -0.558 . . . . 1.1899999999999999 110.724 179.3 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.8 m -64.49 -41.56 96.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.71999999999999997 110.964 -179.887 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.78 -38.83 77.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.379 -0.826 . . . . 0.62 110.97 -179.873 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -52.92 -43.53 66.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 1.05 110.945 179.305 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -70.2 -38.32 75.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.912 -1.117 . . . . 0.64000000000000001 110.279 -179.638 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -62.26 -39.13 91.87 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 118.637 -1.225 . . . . 1.73 109.427 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.24 -28.88 65.6 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.438 -0.789 . . . . 0.56000000000000005 110.768 179.52 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.4 -35.69 13.87 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.423 -1.37 . . . . 0.68999999999999995 110.815 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -81.34 -23.62 37.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.127 -1.219 . . . . 1.48 111.261 -179.91 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -88.66 -48.87 7.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.902 -0.499 . . . . 0.97999999999999998 111.182 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -108.34 -8.05 15.75 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.996 1.11 . . . . 1.1599999999999999 113.996 -177.759 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.06 156.89 19.27 Favored Glycine 0 N--CA 1.501 2.987 0 O-C-N 121.369 -0.832 . . . . 0.84999999999999998 113.577 178.452 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -50.7 -21.73 1.75 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.573 -0.957 . . . . 3.8599999999999999 112.536 179.072 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -54.3 -38.15 65.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.785 -1.197 . . . . 2.3500000000000001 111.814 -179.972 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -80.18 -19.24 47.55 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.747 -1.221 . . . . 1.6699999999999999 112.443 -178.989 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -61.08 -35.5 77.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.984 -1.072 . . . . 1.45 110.811 -179.47 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.79 88.01 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.107 -0.996 . . . . 0.60999999999999999 111.364 179.773 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt -67.91 -46.86 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.465 -1.397 . . . . 0.65000000000000002 110.178 179.771 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -72.25 -28.57 63.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.87 . . . . 0.66000000000000003 111.129 -179.885 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -60.92 -40.56 93.64 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.679 -0.808 . . . . 1.1899999999999999 109.888 179.565 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.22 -42.17 91.25 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.192 -1.163 . . . . 0.53000000000000003 110.192 179.857 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -59.58 -45.99 90.25 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.472 -1.017 . . . . 1.27 110.79 179.39 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.6 mt -61.21 -40.48 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.663 -1.273 . . . . 0.54000000000000004 110.504 -179.945 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.4 ttm -60.29 -38.35 83.31 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.295 -0.878 . . . . 1.74 110.214 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.5 tp -59.3 -45.77 90.37 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.055 -1.028 . . . . 0.55000000000000004 110.358 179.208 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.416 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 60.0 tp -60.56 -42.38 96.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.526 -0.734 . . . . 0.46999999999999997 110.225 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -84.81 4.87 31.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.304 -0.872 . . . . 1.4199999999999999 112.849 -179.55 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -59.84 125.96 25.71 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.829 -1.169 . . . . 1.27 110.087 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.2 -19.14 65.13 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.542 -0.724 . . . . 1.3500000000000001 111.351 -179.332 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.61 -53.36 9.52 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.144 -1.023 . . . . 2.2200000000000002 110.687 179.946 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.3 mt -62.48 -39.28 92.93 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.32 -0.862 . . . . 0.62 110.753 -179.524 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -58.56 -47.0 85.69 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.152 -0.967 . . . . 1.29 110.822 179.338 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -63.12 -40.48 97.73 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.282 -0.886 . . . . 1.52 110.683 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -66.3 -48.3 70.8 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.939 -1.105 . . . . 1.3 110.646 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.38 -44.79 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.636 -1.29 . . . . 0.60999999999999999 110.028 179.632 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.1 -43.85 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.457 -0.777 . . . . 0.78000000000000003 110.486 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.4 -44.52 94.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 0.81999999999999995 111.027 -179.673 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -60.04 -40.25 88.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.075 -1.016 . . . . 0.80000000000000004 110.735 -179.716 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.55 -47.31 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.056 -1.027 . . . . 0.77000000000000002 110.57 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -83.31 -31.73 26.69 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.327 -0.858 . . . . 2.1200000000000001 112.035 -179.786 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -78.05 -47.85 17.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.511 -1.368 . . . . 1.51 110.9 -178.365 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -104.55 11.45 34.28 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 119.672 -0.811 . . . . 1.98 111.796 -178.05 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.3 m80 52.0 47.56 24.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.043 -1.036 . . . . 1.3200000000000001 111.913 179.809 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 64.5 mtt -98.39 159.85 14.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.141 -0.975 . . . . 1.3799999999999999 109.796 178.656 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.5 p -76.24 160.81 29.32 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.591 -0.693 . . . . 0.67000000000000004 109.894 178.173 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.23 -42.75 86.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.368 -0.832 . . . . 0.52000000000000002 110.989 178.786 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.535 ' OD2' HD21 ' A' ' 142' ' ' LEU . 92.6 m-20 -70.04 -38.97 75.99 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.658 -1.276 . . . . 2.25 110.19 -179.997 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.85 -51.56 39.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.859 -1.151 . . . . 0.64000000000000001 111.589 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.96 92.26 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.792 -1.163 . . . . 0.56000000000000005 110.811 -179.813 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.35 95.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.798 -0.564 . . . . 0.46000000000000002 110.988 179.832 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -60.78 -40.25 91.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.629 -1.294 . . . . 1.3200000000000001 111.236 -179.514 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.27 -49.87 76.19 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.843 -1.16 . . . . 1.3 111.4 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -59.43 -45.75 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.924 -1.11 . . . . 0.60999999999999999 109.99 179.929 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.6 mm -62.72 -30.45 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-O 121.388 0.613 . . . . 0.65000000000000002 110.329 179.768 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -57.36 -40.22 77.64 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.793 -0.763 . . . . 2.1099999999999999 110.509 179.16 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.16 -30.67 22.05 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 119.249 -1.453 . . . . 0.82999999999999996 112.877 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -61.34 -41.54 97.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.383 -1.657 . . . . 1.28 110.293 -179.914 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.7 -46.91 51.32 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 119.805 -0.758 . . . . 0.89000000000000001 110.524 -179.975 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 50.4 p -62.99 -35.67 80.98 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.33 -0.856 . . . . 1.8700000000000001 110.782 -178.447 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.97 87.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.604 -0.685 . . . . 1.05 110.898 179.951 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 mt -65.33 -28.74 69.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.868 -1.145 . . . . 1.02 111.271 -179.509 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -66.43 -19.69 65.86 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.355 -0.938 . . . . 2.04 110.671 179.179 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -72.42 -11.22 60.59 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.471 -0.891 . . . . 1.73 110.654 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.499 HD13 HD13 ' A' ' 123' ' ' LEU . 69.4 mt -86.44 141.61 29.0 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.522 0.677 . . . . 1.3700000000000001 109.213 179.535 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -98.13 38.14 1.35 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.193 -0.942 . . . . 2.8799999999999999 112.206 179.48 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -113.79 137.7 51.28 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.26 -1.015 . . . . 1.5800000000000001 108.26 178.873 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.63 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 28.2 mp0 -59.12 -39.86 83.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.972 -1.08 . . . . 3.04 111.076 179.182 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -71.24 -52.92 16.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.743 -1.223 . . . . 0.90000000000000002 110.531 179.774 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.499 HD13 HD13 ' A' ' 118' ' ' LEU . 36.2 mt -59.98 -40.39 88.97 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.865 -1.147 . . . . 1.0600000000000001 110.384 -179.595 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -59.1 -45.72 90.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.893 -1.129 . . . . 2.1800000000000002 110.2 179.483 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.48 -31.98 70.98 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.369 -0.933 . . . . 2.1499999999999999 109.906 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 130' ' ' VAL . 34.8 ttm180 -60.6 -31.2 70.37 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.829 -1.148 . . . . 2.3300000000000001 109.106 178.896 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.61 76.44 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.556 0.693 . . . . 0.81999999999999995 110.249 179.026 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.98 78.03 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.126 -0.63 . . . . 0.84999999999999998 110.138 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.34 -34.84 78.58 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.629 0.728 . . . . 1.3899999999999999 110.673 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 126' ' ' ARG . 29.6 t -68.23 -41.02 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.128 -0.982 . . . . 0.56000000000000005 110.3 179.723 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -57.9 -38.73 76.34 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.445 -1.302 . . . . 3.1200000000000001 109.429 179.121 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -59.79 -37.58 79.51 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 120.124 -0.631 . . . . 1.28 110.181 179.199 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.99 -39.81 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 0.48999999999999999 109.591 179.355 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.93 -46.03 77.56 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.885 -1.15 . . . . 0.46000000000000002 110.408 179.082 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -57.38 -41.85 81.01 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.356 -1.085 . . . . 2.71 110.163 179.299 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.442 ' HG2' HH11 ' A' ' 136' ' ' ARG . 50.7 mtt-85 -61.52 -42.98 99.62 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.251 -0.979 . . . . 2.1400000000000001 110.006 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.77 -42.33 97.25 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.782 -0.767 . . . . 1.05 109.536 179.78 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.5 mt -60.05 -43.78 95.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.526 -0.734 . . . . 0.52000000000000002 110.404 179.698 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.468 ' NH1' HD23 ' A' ' 144' ' ' LEU . 49.8 mtt-85 -60.54 -36.41 78.36 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.622 -0.674 . . . . 2.3500000000000001 110.703 -179.974 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -73.94 -40.36 63.12 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.32 -0.863 . . . . 1.3899999999999999 111.011 179.719 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.463 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.8 mt -60.55 -40.38 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.889 -1.132 . . . . 0.68000000000000005 110.614 -178.815 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.535 HD21 ' OD2' ' A' ' 101' ' ' ASP . 81.4 mt -87.51 -11.17 49.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.669 -1.27 . . . . 0.82999999999999996 111.855 -178.951 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.79 18.61 74.9 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.763 -1.208 . . . . 0.91000000000000003 112.402 -179.71 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.468 HD23 ' NH1' ' A' ' 139' ' ' ARG . 47.8 tp -63.74 145.32 55.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.921 -0.752 . . . . 0.94999999999999996 109.194 179.218 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -69.02 147.27 51.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.51 -0.744 . . . . 2.4300000000000002 109.534 178.508 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.0 mt -106.84 141.21 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.383 -0.969 . . . . 1.1000000000000001 108.383 178.143 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.555 HD12 ' H ' ' A' ' 147' ' ' ILE . 5.3 mp -76.01 123.72 32.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.357 -0.979 . . . . 1.5800000000000001 108.357 178.238 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -99.62 100.52 11.53 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 106.064 -1.828 . . . . 1.6200000000000001 106.064 178.98 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.4 mt -75.2 -14.26 60.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.313 -0.867 . . . . 0.80000000000000004 111.759 -177.885 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.6 p -78.42 3.07 16.78 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.317 1.055 . . . . 1.5600000000000001 112.153 -179.331 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.28 19.83 14.7 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.125 -0.984 . . . . 0.83999999999999997 112.744 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 22.6 mt -74.1 137.42 23.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.907 -1.121 . . . . 0.81999999999999995 109.241 179.172 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -115.52 -14.27 11.53 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.856 0.836 . . . . 2.3100000000000001 112.558 -178.717 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -113.47 136.35 52.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.502 -1.295 . . . . 1.54 107.502 179.932 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -73.67 124.55 26.19 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.588 -0.893 . . . . 1.3799999999999999 108.588 178.689 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -146.45 175.58 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.46 -0.775 . . . . 0.68999999999999995 109.404 -179.69 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.1 mt -87.53 148.49 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.53000000000000003 108.975 178.135 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -99.75 120.54 39.89 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.055 -1.091 . . . . 0.64000000000000001 108.055 178.114 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -121.58 129.59 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 N-CA-C 107.718 -1.215 . . . . 0.67000000000000004 107.718 179.391 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.1 155.97 21.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.968 -1.083 . . . . 0.78000000000000003 108.863 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.454 ' O ' ' CG ' ' A' ' 162' ' ' ASP . . . -60.59 -37.58 81.81 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.395 -1.441 . . . . 1.0 109.674 178.131 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 161' ' ' ALA . 58.0 m-20 -167.81 153.86 7.51 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.733 -0.839 . . . . 2.4199999999999999 108.733 179.179 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.8 mt -116.46 139.91 49.94 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 108.374 -0.972 . . . . 0.75 108.374 177.76 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.5 p -96.85 148.97 35.2 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.22 -0.925 . . . . 0.78000000000000003 108.892 179.402 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.68 -40.01 7.53 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.747 1.632 . . . . 0.67000000000000004 113.599 179.092 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.6 m -61.75 -49.69 75.39 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.024 -1.047 . . . . 0.69999999999999996 109.922 -179.336 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -61.87 -39.96 93.71 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.085 -1.01 . . . . 1.21 110.077 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.8 p -67.67 -37.62 82.63 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.417 -0.802 . . . . 0.59999999999999998 110.267 179.506 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.22 -36.05 82.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.402 -0.811 . . . . 0.62 111.322 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -98.44 -0.47 43.47 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.351 -0.843 . . . . 1.1599999999999999 112.795 -179.276 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.7 tp -64.14 154.88 33.31 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.951 -0.7 . . . . 0.72999999999999998 109.906 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.631 HD22 ' N ' ' A' ' 173' ' ' LEU . 0.3 OUTLIER -97.41 118.76 34.62 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.984 -1.487 . . . . 2.2400000000000002 106.984 177.427 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.631 ' N ' HD22 ' A' ' 172' ' ' ASN . 44.9 mt -76.52 -19.6 57.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.512 -0.742 . . . . 1.4299999999999999 111.953 -178.126 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.609 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 66.3 mttm -82.39 -19.86 38.27 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.06 -1.025 . . . . 2.1499999999999999 112.455 -178.904 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -102.44 -0.76 31.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.46 -0.775 . . . . 2.04 113.065 -178.012 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 178' ' ' GLY . 46.9 t -109.23 121.22 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.591 -1.262 . . . . 0.55000000000000004 107.591 179.049 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.1 tp -84.74 -4.04 58.86 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.144 -0.972 . . . . 1.6299999999999999 111.821 -179.434 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.491 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.96 171.29 36.82 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.872 -1.691 . . . . 0.46999999999999997 108.872 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 3.6 m-85 -125.0 129.69 50.82 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.941 -1.133 . . . . 0.54000000000000004 107.941 178.463 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.444 ' CG2' HG21 ' A' ' 205' ' ' THR . 30.1 mt -129.92 121.43 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 106.173 -1.788 . . . . 0.68999999999999995 106.173 177.908 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 203' ' ' VAL . 39.4 p -139.88 172.31 12.96 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.631 -1.293 . . . . 0.81999999999999995 110.355 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.487 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 4.8 m-20 -105.29 51.96 0.75 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.529 -0.732 . . . . 2.3700000000000001 109.676 179.382 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -103.93 153.94 20.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.366 -0.834 . . . . 1.1100000000000001 109.709 179.617 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -58.88 -36.2 86.38 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 120.212 -0.994 . . . . 1.6699999999999999 110.712 178.517 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 96.52 -17.86 58.52 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 121.164 -1.198 . . . . 1.54 114.157 179.458 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.405 ' HG2' ' NH1' ' A' ' 186' ' ' ARG . 59.4 mtt-85 -58.67 -41.13 85.45 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.835 -1.391 . . . . 4.4800000000000004 110.212 179.289 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 75.5 p -140.83 36.29 1.78 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.539 -0.726 . . . . 2.6299999999999999 111.212 -179.391 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 69.9 m -81.9 123.06 28.51 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.553 -1.277 . . . . 1.6899999999999999 107.553 179.489 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -60.5 -37.58 81.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.669 -0.645 . . . . 1.0700000000000001 110.741 -179.828 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 23.0 m -52.96 -42.51 65.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 1.5800000000000001 110.439 179.253 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.8 m -59.65 -40.43 87.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.03 -1.044 . . . . 1.6000000000000001 110.107 179.463 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.34 -35.69 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.593 -0.692 . . . . 1.45 110.848 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 57.1 mtp -62.6 -40.81 98.1 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.093 0.949 . . . . 1.05 109.453 179.481 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.0 -41.73 92.71 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.589 -0.732 . . . . 0.71999999999999997 110.515 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -59.8 -44.93 93.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 3.0499999999999998 110.712 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.1 m -71.19 -39.35 71.88 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.002 -1.061 . . . . 0.89000000000000001 110.164 -179.843 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.1 mt -90.98 -7.94 50.6 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 112.712 0.634 . . . . 0.78000000000000003 112.712 -178.124 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 54.29 9.03 0.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.207 1.188 . . . . 1.45 114.207 179.836 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 39.5 mt -71.37 148.92 93.77 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 108.326 -0.99 . . . . 0.67000000000000004 108.326 179.133 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.45 144.25 92.29 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.456 1.438 . . . . 0.64000000000000001 109.368 178.608 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -157.9 160.67 37.88 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.086 -1.446 . . . . 0.67000000000000004 109.65 179.647 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.587 HD12 HD11 ' A' ' 220' ' ' LEU . 14.8 mt -150.78 149.07 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.862 -1.162 . . . . 0.68999999999999995 107.862 178.386 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.5 m -134.21 -32.18 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.245 -0.909 . . . . 0.84999999999999998 112.811 -179.755 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.51 33.56 0.83 Allowed Glycine 0 N--CA 1.483 1.792 0 O-C-N 121.183 -0.948 . . . . 0.92000000000000004 113.037 -178.135 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.487 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 35.0 p -59.67 -26.95 65.97 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 121.465 -1.021 . . . . 0.94999999999999996 111.085 -179.199 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 79.53 -93.38 1.35 Allowed Glycine 0 N--CA 1.488 2.102 0 C-N-CA 120.181 -1.009 . . . . 1.04 110.952 179.386 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.5 m -123.54 29.74 6.49 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.246 0.832 . . . . 1.5700000000000001 113.246 -178.798 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 70.3 t -59.84 -33.59 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.824 -1.172 . . . . 0.83999999999999997 110.237 179.027 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 58.8 p -59.33 -23.23 62.32 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.087 -1.008 . . . . 0.98999999999999999 111.459 179.947 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.1 t -92.27 -0.38 57.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.914 -1.116 . . . . 1.7 111.428 -179.288 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -124.47 -7.22 7.51 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.617 -0.72 . . . . 2.2000000000000002 112.681 -177.938 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.43 141.82 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.164 -0.68 . . . . 0.83999999999999997 109.164 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -116.72 151.44 36.38 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.1 -1.074 . . . . 2.2000000000000002 108.1 178.296 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 48.2 t30 -53.25 143.29 18.79 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.279 -0.968 . . . . 2.2799999999999998 110.44 178.318 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.1 t0 82.2 -6.99 1.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.099 1.148 . . . . 2.3500000000000001 114.099 179.524 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 16' ' ' ALA . 87.6 m-20 -63.18 143.23 57.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.636 -1.29 . . . . 1.97 108.288 177.466 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -88.23 119.1 28.31 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.388 -1.338 . . . . 2.6499999999999999 107.388 178.124 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.438 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 42.4 mt -127.83 144.51 51.09 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.137 -0.69 . . . . 0.63 109.137 -179.04 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.9 mt -111.94 128.61 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 106.918 -1.512 . . . . 0.62 106.918 177.72 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.587 HD11 HD12 ' A' ' 202' ' ' ILE . 44.1 tp -99.97 118.67 36.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.975 -1.861 . . . . 0.64000000000000001 105.975 178.35 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 223' ' ' VAL . 35.0 p-10 -92.65 -22.19 19.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 2.0499999999999998 112.736 -177.558 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.931 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.75 16.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 112.756 0.65 . . . . 0.83999999999999997 112.756 -179.206 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.632 ' N ' ' O ' ' A' ' 221' ' ' ASP . 15.7 t -111.21 -63.81 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.056 -1.027 . . . . 1.02 108.78 179.694 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -90.22 9.15 29.65 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.245 1.021 . . . . 2.5099999999999998 110.463 -179.779 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.698 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.8 OUTLIER 61.62 52.8 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.067 -0.97 . . . . 1.54 112.157 179.61 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -148.29 153.46 38.7 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.409 1.1 . . . . 1.95 110.25 179.131 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.4 135.48 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.542 -1.281 . . . . 0.70999999999999996 107.542 177.465 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -101.15 136.93 40.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.987 -1.071 . . . . 1.01 108.719 178.744 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.7 t -109.84 130.04 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.171 -1.048 . . . . 0.81999999999999995 108.171 179.104 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.451 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 60.7 t30 48.44 50.32 8.86 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.914 . . . . 1.54 113.292 178.913 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.7 Cg_endo -63.41 151.66 83.82 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.32 2.013 . . . . 0.93999999999999995 110.712 -179.904 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.9 m -73.97 156.79 37.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.795 -1.191 . . . . 1.8 109.226 177.65 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.407 ' HA ' HD12 ' A' ' 236' ' ' ILE . 29.8 m120 -56.79 -40.05 75.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.033 -1.042 . . . . 2.73 111.133 179.054 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.448 ' H ' ' CD ' ' A' ' 234' ' ' GLU . 45.2 mp0 -59.12 -39.52 82.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.044 -1.035 . . . . 3.1699999999999999 110.288 179.687 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.8 -37.94 78.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.759 0.79 . . . . 1.3400000000000001 110.097 179.732 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 233' ' ' ASN . 84.5 mt -58.09 -43.77 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.133 -0.979 . . . . 1.2 110.398 179.292 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.73 -39.7 85.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 2.7000000000000002 110.768 179.822 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -61.72 -41.45 97.63 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.909 -1.119 . . . . 2.5899999999999999 110.78 179.873 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.5 mtp -73.36 -36.5 66.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.325 -0.859 . . . . 1.3799999999999999 111.013 -179.419 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -59.73 -38.54 81.98 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.249 -0.907 . . . . 2.8399999999999999 110.765 -179.729 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.52 -44.53 67.37 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.834 -1.166 . . . . 1.8799999999999999 111.157 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 97.6 t -58.87 -51.02 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.551 -1.343 . . . . 2.3999999999999999 111.557 -178.258 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -62.1 -49.88 74.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.054 -1.029 . . . . 3.52 110.555 -179.921 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.43 -35.64 78.12 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.433 -0.792 . . . . 1.8799999999999999 110.87 -179.489 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.81 -29.32 69.39 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.569 -1.253 . . . . 3.0099999999999998 109.995 179.325 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.36 -47.63 88.76 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 C-N-CA 118.894 -1.122 . . . . 2.4500000000000002 109.529 178.81 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.03 -36.46 81.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 2.75 110.456 -179.943 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.7 t -66.94 -36.26 81.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.47 -0.769 . . . . 3.1600000000000001 110.582 179.657 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -62.18 -45.62 92.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 3.5699999999999998 110.244 179.65 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -68.8 -39.3 80.17 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.797 0.808 . . . . 4.2999999999999998 110.33 -179.868 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.16 23.98 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.389 -0.819 . . . . 4.4500000000000002 112.815 -179.808 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.68 -38.03 83.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.964 -1.085 . . . . 5.9699999999999998 111.113 -179.226 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.08 -32.84 74.55 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.837 -1.164 . . . . 6.1799999999999997 110.432 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -75.15 -8.88 57.82 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.474 -0.766 . . . . 6.6600000000000001 112.872 -179.765 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -80.14 0.59 31.54 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.058 -1.026 . . . . 8.1999999999999993 112.927 -178.969 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.552 ' N ' HD22 ' A' ' 256' ' ' LEU . 3.0 mm? -82.34 -5.47 58.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.778 -1.202 . . . . 8.0700000000000003 112.319 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -87.43 0.54 55.35 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.221 -0.924 . . . . 9.4499999999999993 112.925 -178.473 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -92.97 -40.91 10.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.355 -0.841 . . . . 10.119999999999999 112.046 -178.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 . . . . . 0 N--CA 1.498 1.929 0 O-C-N 120.966 -1.084 . . . . 11.49 110.15 -177.324 . . . . . . . . 0 0 . 1 stop_ save_